PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aichelburg, MC; Weseslindtner, L; Mandorfer, M; Strassl, R; Rieger, A; Reiberger, T; Puchhammer-Stockl, E; Grabmeier-Pfistershammer, K				Aichelburg, Maximilian C.; Weseslindtner, Lukas; Mandorfer, Mattias; Strassl, Robert; Rieger, Armin; Reiberger, Thomas; Puchhammer-Stoeckl, Elisabeth; Grabmeier-Pfistershammer, Katharina			Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; GAMMA RELEASE ASSAY; HUMAN CYTOMEGALOVIRUS; TRANSPLANT RECIPIENTS; NATURAL-HISTORY; ANTIVIRAL PROPHYLAXIS; ERA; RESPONSES; RISK	Background Among HIV-1-infected individuals, cytomegalovirus (CMV) reactivation and disease occur in the setting of advanced immunosuppression. The value of a standardized assessment of CMV-specific T-cell mediated immunity by the CMV QuantiFERON assay (CMV-QFT) has not yet been thoroughly investigated in HIV-1-infected subjects. Methods Prospective, longitudinal study in 153 HIV-1-infected subjects with a CD4(+) T cell count < 350/mu L who simultaneously underwent CMV-QFT, CMV serology testing and CMV-DNA quantification. Factors associated with CMV-QFT were evaluated. Clinical screening for CMV manifestations was then performed every 3 months. Results Among the 141 CMV IgG-seropositive individuals the CMV-QFT assay yielded reactive results in 84% (118/141), negative results in 15% (21/141) and indeterminate (negative mitogen IFN-gamma response) results in 1% (2/141) of subjects. The mean actual CD4(+) T cell count was significantly higher in CMV-QFT reactive subjects, when compared to CMV-QFT non-reactive individuals (183 +/- 102 vs. 126 +/- 104 cells/mu L, P = 0.015). A significantly lower proportion of CMV-QFT reactive vs. non-reactive patients displayed CMV DNAemia > 100 copies/mL (23% (27/118) vs. 48% (11/23), P = 0.02). Furthermore, a statistically significant inverse association between mitogen IFN-gamma response and CMV-DNAemia > 1000 copies/mL was observed (P < 0.001). During the observational period, 5 CMV end-organ manifestations were observed. In three of the CMV cases the CMV-QFT yielded indeterminate results. Conclusions While CMV-QFT reactivity indicates CMV-specific immunity, indeterminate results due to negative mitogen IFN-gamma response might reflect HIV-1-induced immunodeficiency. Thus, dependency upon CD4(+) T cell count should be considered when interpreting CMV-QFT results.	[Aichelburg, Maximilian C.; Rieger, Armin; Grabmeier-Pfistershammer, Katharina] Med Univ Vienna, Div Immunol Allergy & Infect Dis DIAID, Dept Dermatol, Vienna, Austria; [Weseslindtner, Lukas; Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Dept Virol, Vienna, Austria; [Mandorfer, Mattias; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, HIV & Liver Study Grp, Vienna, Austria; [Strassl, Robert] Med Univ Vienna, Div Clin Virol, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Aichelburg, MC (corresponding author), Med Univ Vienna, Div Immunol Allergy & Infect Dis DIAID, Dept Dermatol, Vienna, Austria.	maximilian.aichelburg@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019; Mandorfer, Mattias/H-7603-2019	Reiberger, Thomas/0000-0002-4590-3583; Mandorfer, Mattias/0000-0003-2330-0017; Weseslindtner, Lukas/0000-0001-8950-937X; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414				Abate D, 2013, J CLIN MICROBIOL, V51, P2501, DOI 10.1128/JCM.00563-13; Aichelburg MC, 2012, J CLIN MICROBIOL, V50, P2767, DOI 10.1128/JCM.01054-12; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Clari MA, 2012, CLIN VACCINE IMMUNOL, V19, P791, DOI 10.1128/CVI.05633-11; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Bowen EF, 1996, AIDS, V10, pS37; Deayton J, 1999, AIDS, V13, P1203, DOI 10.1097/00002030-199907090-00008; Fleming T, 2010, J MED VIROL, V82, P433, DOI 10.1002/jmv.21727; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; Hsu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077479; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jacobson MA, 2004, J INFECT DIS, V189, P1362, DOI 10.1086/382964; Jacobson MA, 2000, CLIN INFECT DIS, V30, P231, DOI 10.1086/313612; Jacobson MA, 2001, J INFECT DIS, V183, P1399, DOI 10.1086/319854; Johnson SC, 2001, CLIN INFECT DIS, V32, P815, DOI 10.1086/319219; Kumar D, 2009, AM J TRANSPLANT, V9, P1214, DOI 10.1111/j.1600-6143.2009.02618.x; Lisboa LF, 2011, TRANSPLANTATION, V92, P1063, DOI 10.1097/TP.0b013e31822fa4b7; Lochmanova A, 2010, TRANSPL P, V42, P3574, DOI 10.1016/j.transproceed.2010.07.101; Manuel O, 2013, CLIN INFECT DIS, V56, P817, DOI 10.1093/cid/cis993; O'Sullivan CE, 1999, J INFECT DIS, V180, P847, DOI 10.1086/314943; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Shepp DH, 1996, J ACQ IMMUN DEF SYND, V11, P460, DOI 10.1097/00042560-199604150-00006; Singh KP, 2007, CLIN IMMUNOL, V124, P200, DOI 10.1016/j.clim.2007.04.018; Solano C, 2011, TRANSPLANTATION, V92, pE17, DOI 10.1097/TP.0b013e318224f263; Steininger C, 2006, J CLIN VIROL, V37, P1, DOI 10.1016/j.jcv.2006.03.005; Tey SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074744; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x; Weinberg A, 2006, J INFECT DIS, V193, P488, DOI 10.1086/499826; Weinberg A, 2003, AIDS, V17, P2445, DOI 10.1097/00002030-200311210-00006; Weseslindtner L, 2012, AM J TRANSPLANT, V12, P2172, DOI 10.1111/j.1600-6143.2012.04076.x; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732	34	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137096	10.1371/journal.pone.0137096	http://dx.doi.org/10.1371/journal.pone.0137096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322514	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500065
J	Doret, M; Spilka, J; Chudacek, V; Goncalves, P; Abry, P				Doret, Muriel; Spilka, Jiri; Chudacek, Vaclav; Goncalves, Paulo; Abry, Patrice			Fractal Analysis and Hurst Parameter for Intrapartum Fetal Heart Rate Variability Analysis: A Versatile Alternative to Frequency Bands and LF/HF Ratio	PLOS ONE			English	Article							POWER SPECTRUM ANALYSIS; DYNAMICS; VALUES; LABOR; TIME; CTG; CARDIOTOCOGRAPHY; INTEROBSERVER; FLUCTUATION; AGREEMENT	Background The fetal heart rate (FHR) is commonly monitored during labor to detect early fetal acidosis. FHR variability is traditionally investigated using Fourier transform, often with adult predefined frequency band powers and the corresponding LF/HF ratio. However, fetal conditions differ from adults and modify spectrum repartition along frequencies. Aims This study questions the arbitrariness definition and relevance of the frequency band splitting procedure, and thus of the calculation of the underlying LF/HF ratio, as efficient tools for characterizing intrapartum FHR variability. Study Design The last 30 minutes before delivery of the intrapartum FHR were analyzed. Subjects Case-control study. A total of 45 singletons divided into two groups based on umbilical cord arterial pH: the Index group with pH <= 7.05 (n = 15) and Control group with pH > 7.05 (n = 30). Outcome Measures Frequency band-based LF/HF ratio and Hurst parameter. Results This study shows that the intrapartum FHR is characterized by fractal temporal dynamics and promotes the Hurst parameter as a potential marker of fetal acidosis. This parameter preserves the intuition of a power frequency balance, while avoiding the frequency band splitting procedure and thus the arbitrary choice of a frequency separating bands. The study also shows that extending the frequency range covered by the adult-based bands to higher and lower frequencies permits the Hurst parameter to achieve better performance for identifying fetal acidosis. Conclusions The Hurst parameter provides a robust and versatile tool for quantifying FHR variability, yields better acidosis detection performance compared to the LF/HF ratio, and avoids arbitrariness in spectral band splitting and definitions.	[Doret, Muriel] Hop Femme Mere Enfant, Hosp Civils Lyon, Dept Obstet & Gynaecol, Bron, France; [Spilka, Jiri; Abry, Patrice] ENS Lyon, Dept Phys, CNRS, Lyon, France; [Spilka, Jiri; Chudacek, Vaclav] Czech Tech Univ, Czech Inst Informat Robot & Cybernet, CR-16635 Prague, Czech Republic; [Goncalves, Paulo] ENS Lyon, Dept Comp Sci, INRIA, Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Czech Technical University Prague; Ecole Normale Superieure de Lyon (ENS de LYON); Inria	Doret, M (corresponding author), Hop Femme Mere Enfant, Hosp Civils Lyon, Dept Obstet & Gynaecol, Bron, France.	muriel.doret@chu-lyon.fr	Spilka, Jiri/F-6184-2011; Gonçalves, Paulo B/G-9818-2012	Spilka, Jiri/0000-0002-4136-0083; Gonçalves, Paulo B/0000-0002-0671-1466; Abry, Patrice/0000-0002-7096-8290	Agence Nationale de la Recherche, Programme blanc [18535]; Hopital Femme Mere Enfant, Projet Hospitalier de Recherche Clinique; Czech Science Foundation Agency project [14-28462P]	Agence Nationale de la Recherche, Programme blanc(French National Research Agency (ANR)); Hopital Femme Mere Enfant, Projet Hospitalier de Recherche Clinique; Czech Science Foundation Agency project	This work was supported by Agence Nationale de la Recherche, Programme blanc 2010, Project 18535 FETUSES: Fetal Evaluation at Term Using Statistical ECG Signal processing and Hospices Civil de Lyon, Hopital Femme Mere Enfant, Projet Hospitalier de Recherche Clinique, and by Czech Science Foundation Agency project 14-28462P Statistical methods of intrapartum CTG signal processing in the context of clinical information.	Abry P., 1995, LECT NOTES STAT, V103; Abry P, 2013, COMP MED SY, P131, DOI 10.1109/CBMS.2013.6627777; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Amer-Wahlin I, 2001, LANCET, V358, P534, DOI 10.1016/S0140-6736(01)05703-8; Anwar A, 2014, HEART, V100, pA1, DOI 10.1136/heartjnl-2014-306118.2; Camm AJ, 1996, EUR HEART J, V17, P354; Chandraharan E, 2007, BEST PRACT RES CL OB, V21, P609, DOI 10.1016/j.bpobgyn.2007.02.008; Chauhan SP, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.027; Chudacek V, 2011, PHYSIOL MEAS, V32, P1347, DOI 10.1088/0967-3334/32/8/022; Chudacek V, 2014, IEEE T BIO-MED ENG, V61, P1100, DOI 10.1109/TBME.2013.2294324; Chung DY, 2001, INT J GYNECOL OBSTET, V73, P109, DOI 10.1016/S0020-7292(01)00348-4; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Costa MD, 2014, EARLY HUM DEV, V90, P67, DOI 10.1016/j.earlhumdev.2013.10.002; David M, 2007, J APPL PHYSIOL, V102, P1057, DOI 10.1152/japplphysiol.00114.2006; DAWES GS, 1992, OBSTET GYNECOL, V80, P673; Doret M, 2011, EUR J OBSTET GYN R B, V156, P35, DOI 10.1016/j.ejogrb.2010.12.042; Doret M, 2011, AM J PERINAT, V28, P259, DOI 10.1055/s-0030-1268713; Figueras F, 2005, J PERINAT MED, V33, P241, DOI 10.1515/JPM.2005.044; Fortrat JO, 2002, AM J CARDIOL, V90, P346, DOI 10.1016/S0002-9149(02)02399-8; Francis DP, 2002, J PHYSIOL-LONDON, V542, P619, DOI 10.1113/jphysiol.2001.013389; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goncalves H, 2007, EARLY HUM DEV, V83, P585, DOI 10.1016/j.earlhumdev.2006.12.006; Gustafson KM, 2011, EARLY HUM DEV, V87, P467, DOI 10.1016/j.earlhumdev.2011.03.012; Huikuri HV, 2013, PROG CARDIOVASC DIS, V56, P153, DOI 10.1016/j.pcad.2013.07.003; Ivanov PC, 2007, IEEE ENG MED BIOL, V26, P33, DOI 10.1109/MEMB.2007.907093; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Koome ME, 2014, EXP PHYSIOL, V99, P80, DOI 10.1113/expphysiol.2013.074567; Kwon JY, 2014, EARLY HUM DEV, V90, P9, DOI 10.1016/j.earlhumdev.2013.11.005; Kwon JY, 2012, EARLY HUM DEV, V88, P203, DOI 10.1016/j.earlhumdev.2011.08.007; Larma JD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.053; Leonarduzzi RF, 2014, SIGNAL PROCESS, V105, P243, DOI 10.1016/j.sigpro.2014.06.002; Low JA, 1999, OBSTET GYNECOL, V93, P285, DOI 10.1016/S0029-7844(98)00441-4; Macones GA, 2008, OBSTET GYNECOL, V112, P661, DOI 10.1097/AOG.0b013e3181841395; Nakamura T, 2006, IEEE T BIO-MED ENG, V53, P83, DOI 10.1109/TBME.2005.859796; Ohta T, 1999, FETAL DIAGN THER, V14, P92, DOI 10.1159/000020896; OPPENHEIMER LW, 1994, BAILLIERE CLIN OB GY, V8, P643, DOI 10.1016/S0950-3552(05)80203-2; Pardey J, 2002, AM J OBSTET GYNECOL, V186, P1095, DOI 10.1067/mob.2002.122447; Prabhakar NR, 2013, J PHYSIOL-LONDON, V591, P2245, DOI 10.1113/jphysiol.2012.247759; Rantonen T, 2001, EARLY HUM DEV, V60, P233, DOI 10.1016/S0378-3782(00)00124-9; RIBBERT LSM, 1993, EARLY HUM DEV, V31, P195, DOI 10.1016/0378-3782(93)90195-Z; Salamalekis E, 2006, J MATERN-FETAL NEO M, V19, P165, DOI 10.1080/14767050500233290; Schneider U, 2009, PHYSIOL MEAS, V30, P215, DOI 10.1088/0967-3334/30/2/008; Signorini MG, 2003, IEEE T BIO-MED ENG, V50, P365, DOI 10.1109/TBME.2003.808824; Siira SM, 2013, EARLY HUM DEV, V89, P739, DOI 10.1016/j.earlhumdev.2013.05.007; Siira SM, 2005, BJOG-INT J OBSTET GY, V112, P418, DOI 10.1111/j.1471-0528.2004.00454.x; Tan CO, 2009, J PHYSIOL-LONDON, V587, P3929, DOI 10.1113/jphysiol.2009.169219; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x; Van Leeuwen P, 2003, PRENATAL DIAG, V23, P909, DOI 10.1002/pd.723; Vayssiere C, 2009, BJOG-INT J OBSTET GY, V116, P1081, DOI 10.1111/j.1471-0528.2009.02204.x; Veitch D, 1999, IEEE T INFORM THEORY, V45, P878, DOI 10.1109/18.761330; Victory R, 2004, AM J OBSTET GYNECOL, V191, P2021, DOI 10.1016/j.ajog.2004.04.026	53	40	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136661	10.1371/journal.pone.0136661	http://dx.doi.org/10.1371/journal.pone.0136661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322889	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500026
J	Hwang, SH; Kim, DE; Sung, H; Park, BM; Cho, MJ; Yoon, OJ; Lee, DH				Hwang, Sang-Hyun; Kim, Dong-Eun; Sung, Heungsup; Park, Byeong-Min; Cho, Mi-Jeong; Yoon, Ok-Jin; Lee, Do-Hoon			Simple Detection of the IS6110 Sequence of Mycobacterium tuberculosis Complex in Sputum, Based on PCR with Graphene Oxide	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PEPTIDE NUCLEIC-ACID; RESISTANCE; PLATFORM	Graphene oxide (GO) has proven to be a satisfactory DNA-sensor platform for applications in enzyme-free signal amplification, fluorescence-based amplification, and nanoparticle-based platforms because of its excellent electrical, thermal, and optical properties. In this study, we designed a novel platform for the fluorescence detection of biomolecules, using a fluorescent dye-labeled primer and GO. We applied this system for the detection of the IS6110 insertion sequence of the Mycobacterium tuberculosis complex (MTB) and evaluated its feasibility for use inmolecular diagnostics. Fifty-four sputum specimens were collected at our institution from October 2010 to March 2012. To detect MTB in the samples, we performed PCR amplification of the IS6110 DNA sequence using FAM-labeled primers, after which the PCR amplicon was incubated with GO and the fluorescence was measured. The results were compared with those obtained by conventional real-time quantitative PCR (RQ-PCR). The fluorescence intensity observed increased in a concentration-dependent manner with the FAM-labeled IS6110 amplicon. The results of the PCR-GO system for detecting IS6110 DNA were in good agreement with those obtained with conventional RQ-PCR (kappa statistic = 0.925). The PCR-GO system detected MTB DNA in 23 of 25 RQ-PCR-positive sputum samples (92.0%; 95% CI, 75.0-98.0%), but not in 29 of 29 RQ-PCR-negative sputum samples (100%; 95% CI, 88.1-100.0%). These results indicate the utility of the PCR-GO system in molecular diagnostics.	[Hwang, Sang-Hyun; Park, Byeong-Min; Cho, Mi-Jeong; Yoon, Ok-Jin; Lee, Do-Hoon] Natl Canc Ctr, Res Inst & Hosp, Ctr Diagnost Oncol, Dept Lab Med, Goyang Si 410769, Gyeinggi Do, South Korea; [Hwang, Sang-Hyun] Natl Canc Ctr, Res Inst & Hosp, Hematol Malignancy Branch, Goyang Si 410769, Gyeinggi Do, South Korea; [Kim, Dong-Eun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Sung, Heungsup] Univ Ulsan, Coll Med, Dept Lab Med, Seoul 138736, South Korea; [Sung, Heungsup] Asan Med Ctr, Seoul 138736, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Konkuk University; University of Ulsan	Hwang, SH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Ctr Diagnost Oncol, Dept Lab Med, Goyang Si 410769, Gyeinggi Do, South Korea.	mindcatch@ncc.re.kr	Hwang, Sanghyun/L-5314-2019; Kim, Dong-Eun/D-8304-2011	Hwang, Sanghyun/0000-0003-3201-5728; Kim, Dong-Eun/0000-0001-6545-8387	National Cancer Center [NCC-1510100]	National Cancer Center	This research was supported by the National Cancer Center, Grant NCC-1510100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Cristobal P, 2015, ACS APPL MAT INTERFA; Antonenka U, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-280; Artiles MS, 2011, ADV DRUG DELIVER REV, V63, P1352, DOI 10.1016/j.addr.2011.07.005; Chang HX, 2010, ANAL CHEM, V82, P2341, DOI 10.1021/ac9025384; Dong HF, 2010, ANAL CHEM, V82, P5511, DOI 10.1021/ac100852z; Huang PJJ, 2012, ANAL CHEM, V84, P4192, DOI 10.1021/ac300778s; Hwang SH, 2014, BIOSENS BIOELECTRON, V53, P112, DOI 10.1016/j.bios.2013.09.011; Kang T, 2014, J PHYS CHEM B, V118, P6297, DOI 10.1021/jp501820j; Kim YJ, 2008, KOREAN J LAB MED, V28, P34, DOI 10.3343/kjlm.2008.28.1.34; Lee J, 2014, BIOSENS BIOELECTRON, V62, P140, DOI 10.1016/j.bios.2014.06.028; Lim J, 2014, J MICROBIOL BIOTECHN, V24, P1004, DOI 10.4014/jmb.1403.03071; Liu F, 2010, BIOSENS BIOELECTRON, V25, P2361, DOI 10.1016/j.bios.2010.02.022; Liu YH, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-8; Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907; Lok KH, 2002, EMERG INFECT DIS, V8, P1310, DOI 10.3201/eid0811.020291; Park JS, 2014, LANGMUIR, V30, P12587, DOI 10.1021/la503401d; Rozen S, 2000, Methods Mol Biol, V132, P365; Veigas B, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-38; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; WHO, 2014, GLOB TUB REP 2014; Wu M, 2011, LANGMUIR, V27, P2731, DOI 10.1021/la1037926; Zhang CL, 2011, ANGEW CHEM INT EDIT, V50, P6851, DOI 10.1002/anie.201100769; Zhang M, 2013, ACS APPL MATER INTER, V5, P8278, DOI 10.1021/am402429n; Zhu DB, 2015, BIOSENS BIOELECTRON, V65, P152, DOI 10.1016/j.bios.2014.10.019; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	25	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136954	10.1371/journal.pone.0136954	http://dx.doi.org/10.1371/journal.pone.0136954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322510	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500053
J	Li, SM; Shen, T; Liang, YS; Zhang, Y; Bai, B				Li, Shuming; Shen, Tong; Liang, Yongshan; Zhang, Ying; Bai, Bo			Effects of Miniscalpel-Needle Release on Chronic Neck Pain: A Retrospective Analysis with 12-Month Follow-Up	PLOS ONE			English	Article							TRIGGER-POINT; THERAPEUTIC MASSAGE; GENERAL-POPULATION; RAT MODEL; ACUPUNCTURE; ELECTROACUPUNCTURE; TRIAL; HYPERALGESIA; DISABILITY; INJECTION	Objective Chronic neck pain is a highly prevalent condition, and is often treated with non-steroidal anti-inflammatory drugs. Limited clinical studies with short-term follow-up have shown promising efficacy of acupuncture as well as miniscalpel-needle (MSN) release. In this retrospective study, we examined whether MSN release could produce long-lasting relief in patients with chronic neck pain. Methods We retrieved the medical records of all patients receiving weekly MSN release treatment for chronic neck pain at this institution during a period from May 2012 to December 2013. Only cases with the following information at prior to, and 1, 6, and 12 months after the treatment, were included in the analysis: neck disability index (NDI), numerical pain rating scale (NPRS), and active cervical range of motion (CROM). The primary analysis of interest is comparison of the 12-month measures with the baseline. Patients who took analgesic drugs or massage within 2 weeks prior to assessment were excluded from the analysis. For MSN release, tender points were identified manually by an experienced physician, and did not necessarily follow the traditional acupuncture system. MSN was inserted vertically (parallel to the spine) until breaking through resistance and patient reporting of distention, soreness or heaviness. The depth of the needling ranged from 10 to 50 mm. The release was carried out by moving the MSN up and down 3-5 times without rotation. Results A total of 559 cases (patients receiving weekly MSN release treatment for chronic neck pain) were screened. The number of cases with complete information (NDI, NPRS, and CROM at baseline, 1, 6 and 12 months after last treatment) was 180. After excluding the cases with analgesic treatment or massage within 2 weeks of assessment (n = 53), a total of 127 cases were included in data analysis. The number of MSN release session was 7 (range: 4-11). At 12 months after the treatment, both NPRS and NDI were significantly lower [3 (0, 9) vs. 7 (5, 10) at the baseline for NPRS; [7 (0, 21) vs. 17 (9, 36) for NDI; p< 0.001 for both]. All 6 measures of CROM were significantly higher at 12 months vs. the baseline. No severe complications (such as nerve damage and hematoma) were noted. Discussion MSN release is effective, even 12 months after the treatment, in patients with chronic neck pain. Caution must be exercised in data interpretation due to the respective nature of the study and lack of a comparator group.	[Li, Shuming; Shen, Tong; Liang, Yongshan; Zhang, Ying] Guangzhou Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China; [Li, Shuming; Bai, Bo] Guangzhou Med Univ, Affiliated Hosp 1, Dept Orthopaed Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Zhang, Y (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China.	lzyzhn@163.com; drbobai@126.com						Audette I, 2010, J ORTHOP SPORT PHYS, V40, P318, DOI 10.2519/jospt.2010.3180; Borg-Stein J, 2002, ARCH PHYS MED REHAB, V83, pS40, DOI 10.1053/apmr.2002.32155; Chao M, 2009, J HAND SURG-EUR VOL, V34E, P522, DOI 10.1177/1753193409100961; Cheng KJ, 2014, J ACUPUNCT MERIDIAN, V7, P105, DOI 10.1016/j.jams.2013.07.008; Childs JD, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0303; Cleland J., 2004, J MAN MANIP THER, V12, P82, DOI [10.1179/106698104790825284, DOI 10.1179/106698104790825284]; Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004; Dong FH, 2003, CHINA J ORTHOP TRAUM, V16, P308; Dunning JR, 2012, J ORTHOP SPORT PHYS, V42, P5, DOI 10.2519/jospt.2012.3894; Grayson JE, 2012, MANUAL THER, V17, P292, DOI 10.1016/j.math.2012.02.004; Gross A, 2010, MANUAL THER, V15, P315, DOI 10.1016/j.math.2010.04.002; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Han SC, 1997, REGION ANESTH, V22, P89, DOI 10.1016/S1098-7339(06)80062-3; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; Hu Wu-Bin, 2012, Zhen Ci Yan Jiu, V37, P247; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kong LJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/613279; Lewis M, 2006, PHYSIOTHERAPY, V92, P146, DOI 10.1016/j.physio.2006.02.008; Li SM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/164714; Liang ZH, 2011, COMPLEMENT THER MED, V19, pS26, DOI 10.1016/j.ctim.2010.11.005; Lin WC, 2012, ACUPUNCT MED, V30, P142, DOI 10.1136/acupmed-2012-010149; Ma C, 2010, CLIN J PAIN, V26, P251, DOI 10.1097/AJP.0b013e3181b8cdc8; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Mcphee SJ, 2007, CURRENT MED DIAGNOSI; Monticone Marco, 2013, G Ital Med Lav Ergon, V35, P36; Park JY, 2014, J PAIN, V15, P535, DOI 10.1016/j.jpain.2014.01.498; Plastaras CT, 2011, PHYS MED REH CLIN N, V22, P521, DOI 10.1016/j.pmr.2011.02.011; Sefton JM, 2011, MANUAL THER, V16, P487, DOI 10.1016/j.math.2011.04.002; Simon DG, 1999, TRAVELL SIMONS MYOFA; Vas J, 2006, PAIN, V126, P245, DOI 10.1016/j.pain.2006.07.002; Wang CX, 2007, J ALTERN COMPLEM MED, V13, P14, DOI 10.1089/acm.2006.6128; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; [伍少玲 WU Shaoling], 2008, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V23, P625; YONEHARA N, 1992, NEUROSCI LETT, V142, P53, DOI 10.1016/0304-3940(92)90618-H; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zhang RX, 2007, ANESTH ANALG, V105, P1482, DOI 10.1213/01.ane.0000284705.34629.c5; Zhang RX, 2005, PHARMACOL BIOCHEM BE, V81, P146, DOI 10.1016/j.pbb.2005.03.002; Zhang Y, 2012, BRIT J ANAESTH, V109, P245, DOI 10.1093/bja/aes136; Zheng YJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/235817; Zhu HZ, 2002, ACUPOTOMOLOGY THEORY	41	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137033	10.1371/journal.pone.0137033	http://dx.doi.org/10.1371/journal.pone.0137033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322786	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500061
J	Riverin, BD; Maguire, JL; Li, P				Riverin, Bruno D.; Maguire, Jonathon L.; Li, Patricia			Vitamin D Supplementation for Childhood Asthma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; LUNG-FUNCTION; RANDOMIZED-TRIAL; D DEFICIENCY; CHILDREN; QUALITY; HEALTH; EXACERBATIONS; ASSOCIATION; RISK	Importance There is growing evidence that vitamin D plays a role in the pathogenesis of asthma but it is unclear whether supplementation during childhood may improve asthma outcomes. Objectives The objective of this systematic review and meta-analysis was to evaluate the efficacy and safety of vitamin D supplementation as a treatment or adjunct treatment for asthma. Data Sources We searched MEDLINE, Embase, CENTRAL, and CINAHL through July 2014. Study Selection We included RCTs that evaluated vitamin D supplementation in children versus active control or placebo for asthma. Data Extraction and Synthesis One reviewer extracted data and one reviewer verified data accuracy. We qualitatively summarized the main results of efficacy and safety and meta-analyzed data on comparable outcomes across studies. We used GRADE for strength of evidence. Main Outcome Measures Main planned outcomes measures were ED visits and hospitalizations. As secondary outcomes, we examined measures of asthma control, including frequency of asthma exacerbations, asthma symptom scores, measures of lung function, beta(2)-agonist use and daily steroid use, adverse events and 25-hydroxyvitamin D levels. Results Eight RCTs (one parallel, one crossover design) comprising 573 children aged 3 to 18 years were included. One study (moderate-quality, n = 100) reported significantly less ED visits for children treated with vitamin D. No other studies examined the primary outcome (ED visits and hospitalizations). There was a reduced risk of asthma exacerbations in children receiving vitamin D (low-quality; RR 0.41, 95% CI 0.27 to 0.63, 3 studies, n = 378). There was no significant effect for asthma symptom scores and lung function. The serum 25(OH) D level was higher in the vitamin D group at the end of the intervention (low-quality; MD 19.66 nmol/L, 95% CI 5.96 nmol/L to 33.37 nmol/L, 5 studies, n = 167). Limitations We identified a high degree of clinical diversity (interventions and outcomes) and methodological heterogeneity (sample size and risk of bias) in included trials. Conclusions and Relevance Randomized controlled trials provide some low-quality evidence to support vitamin D supplementation for the reduction of asthma exacerbations. Evidence on the benefits of vitamin D supplementation for other asthma-related outcomes in children is either limited or inconclusive. We recommend that future trials focus on patient-relevant outcomes that are comparable across studies, including standardized definitions of asthma exacerbations.	[Riverin, Bruno D.; Li, Patricia] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Riverin, Bruno D.; Li, Patricia] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Maguire, Jonathon L.] Univ Toronto, St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Dept Pediat, Toronto, ON M5B 1W8, Canada; [Maguire, Jonathon L.] Univ Toronto, Hosp Sick Children, Dept Pediat, PORT,Div Pediat Med, Toronto, ON M5G 1X8, Canada	McGill University; McGill University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Li, P (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pediat, Montreal, PQ H3H 1P3, Canada.	patricia.li@mcgill.ca						Agrawal T, 2013, CLIN EXP ALLERGY, V43, P672, DOI 10.1111/cea.12102; [Anonymous], 2012, AUST J PHARM, V93, P78; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Baris S, 2014, ALLERGY, V69, P246, DOI 10.1111/all.12278; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Brehm JM, 2012, AM J RESP CRIT CARE, V186, P140, DOI 10.1164/rccm.201203-0431OC; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Chinellato I, 2011, EUR RESPIR J, V37, P1366, DOI 10.1183/09031936.00044710; Darabi B, 2013, IRAN J ASTHMA IMMUNO, V12, pS87; Fares Munes M, 2015, BMC Res Notes, V8, P23, DOI 10.1186/s13104-014-0961-3; Gerber AN, 2011, AM J RESP CRIT CARE, V184, P1324, DOI 10.1164/rccm.201109-1737ED; Gergen PJ, 2013, AM J CLIN NUTR, V97, P1228, DOI 10.3945/ajcn.112.046961; Global Initiative for Asthma (GINA), 2011, GLOB STRAT ASTHM MAN; group TGw, 2005, GRAD REC ASS DEV EV; Gupta A, 2012, PAEDIATR RESPIR REV, V13, P236, DOI 10.1016/j.prrv.2011.07.003; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Institute of Medicine, 2011, DIETARY REFERENCE IN; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Khanh VQL, 2012, PULM PHARMACOL THER, V25, P137, DOI 10.1016/j.pupt.2012.02.003; Lewis E, 2011, J ALLERGY CLIN IMMUN, V127, pAB262, DOI 10.1016/j.jaci.2010.12.1044; Lewis E, 2012, ANN ALLERG ASTHMA IM, V108, P281, DOI 10.1016/j.anai.2012.01.003; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, pS144, DOI 10.1016/j.jaci.2007.12.1110; Litonjua AA, 2012, CURR OPIN ALLERGY CL, V12, P179, DOI 10.1097/ACI.0b013e3283507927; Machura E, 1996, Pediatr Pol, V71, P97; Majak P, 2009, CLIN EXP ALLERGY, V39, P1830, DOI 10.1111/j.1365-2222.2009.03357.x; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Mazahery H, 2015, NUTRIENTS, V7, P5111, DOI 10.3390/nu7075111; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Neagu F, 2012, J ALLERGY CLIN IMMUN, V129, pAB153, DOI 10.1016/j.jaci.2011.12.332; Niruban SJ, 2012, AM J EPIDEMIOL, V176, P82; Paul G, 2012, AM J RESP CRIT CARE, V185, P124, DOI 10.1164/rccm.201108-1502CI; Pludowski P, 2013, AUTOIMMUN REV; Pojsupap S., 2014, J ASTHMA, V21, P1; Salas NM, 2014, J ASTHMA, V51, P950, DOI 10.3109/02770903.2014.930883; Schou AJ, 2003, PEDIATR PULM, V36, P399, DOI 10.1002/ppul.10379; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Sharma S, 2014, THORAX, V69, P481, DOI 10.1136/thoraxjnl-2014-205166; Song YF, 2007, RESPIROLOGY, V12, P486, DOI 10.1111/j.1440-1843.2007.01099.x; Szczawinska-Poplonyk A, 2012, POSTEP DERM ALERGOL, V29, P176; Theodoratou E, 2014, VITAMIN D MULTIPLE H; Tolppanen AM, 2013, EPIDEMIOLOGY, V24, P310, DOI [10.1097/EDE.obo13e318280dd5e, 10.1097/EDE.0b013e318280dd5e]; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; van Oeffelen AAM, 2011, PEDIAT ALLERG IMM-UK, V22, P784, DOI 10.1111/j.1399-3038.2011.01190.x; Wolthers OD, 1999, DOUBLE BLIND TRIAL V, pP355; Wu AC, 2012, AM J RESP CRIT CARE, V186, P508, DOI 10.1164/rccm.201202-0351OC; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yadav M, 2013, INDIAN J PEDIATR	58	59	66	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136841	10.1371/journal.pone.0136841	http://dx.doi.org/10.1371/journal.pone.0136841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322509	gold, Green Submitted, Green Published			2022-12-27	WOS:000360435500041
J	Ding, L; Gao, R; Xiong, XQ; Gao, XY; Chen, Q; Li, YH; Kang, YM; Zhu, GQ				Ding, Lei; Gao, Run; Xiong, Xiao-Qing; Gao, Xing-Ya; Chen, Qi; Li, Yue-Hua; Kang, Yu-Ming; Zhu, Guo-Qing			GABA in Paraventricular Nucleus Regulates Adipose Afferent Reflex in Rats	PLOS ONE			English	Article							SYMPATHETIC VASOMOTOR TONE; HYPERTENSIVE-RATS; OBESITY HYPERTENSION; SUPEROXIDE ANIONS; ACTIVATION; TISSUE; RECEPTORS; HYPOTHALAMUS; INNERVATION; GLUTAMATE	Background Chemical stimulation of white adipose tissue (WAT) induces adipose afferent reflex (AAR), and thereby causes a general sympathetic activation. Paraventricular nucleus (PVN) is important in control of sympathetic outflow. This study was designed to investigate the role of gamma-aminobutyric acid (GABA) in PVN in regulating the AAR. Methodology/Principal Findings Experiments were carried out in anesthetized rats. Renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were continuously recorded. AAR was evaluated by the RSNA and MAP responses to electrical stimulation of the right epididymal WAT (eWAT) afferent nerve. Electrical stimulation of eWAT afferent nerve increase RSNA. Bilateral microinjection of the GABA(A) receptor agonist isoguvacine or the GABA(B) receptor agonist baclofen attenuated the AAR. The effect of isoguvacine on the AAR was greater than that of baclofen. The GABA(A) receptor antagonist gabazine enhanced the AAR, while the GABA(B) receptor antagonist CGP-35348 had no significant effect on the AAR. Bilateral PVN microinjection of vigabatrin, a selective GABA-transaminase inhibitor, to increase endogenous GABA levels in the PVN abolished the AAR. The inhibitory effect of vigabatrin on the AAR was attenuated by the pretreatment with gabazine or CGP-35348. Pretreatment with combined gabazine and CGP-35348 abolished the effects of vigabatrin. Conclusions Activation of GABAA or GABAB receptors in the PVN inhibits the AAR. Blockade of GABAA receptors in the PVN enhances the AAR. Endogenous GABA in the PVN plays an important role in regulating the AAR.	[Ding, Lei; Gao, Run; Xiong, Xiao-Qing; Gao, Xing-Ya; Zhu, Guo-Qing] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Qi; Li, Yue-Hua] Nanjing Med Univ, Dept Pathophysiol, Nanjing 210029, Jiangsu, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol & Pathophysiol, Xian 710061, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xi'an Jiaotong University	Zhu, GQ (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing 210029, Jiangsu, Peoples R China.	gqzhucn@njmu.edu.cn	LI, Yue/GRS-8071-2022	Zhu, Guo-Qing/0000-0002-3132-9592	Chinese National Natural Science Fund [31171095, 31271213, 91439120]	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science Fund (31171095, 31271213 & 91439120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Benturquia N, 2004, J CHROMATOGR B, V806, P237, DOI 10.1016/j.jchromb.2004.03.061; Brown JT, 2007, EUR J NEUROSCI, V25, P2982, DOI 10.1111/j.1460-9568.2007.05544.x; Chen WW, 2015, ACTA PHYSIOL, V213, P778, DOI 10.1111/apha.12447; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Cui BP, 2013, ACTA PHYSIOL, V209, P45, DOI 10.1111/apha.12125; Ding L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083771; Gan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094234; Jia LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085481; Li DP, 2007, HYPERTENSION, V49, P916, DOI 10.1161/01.HYP.0000259666.99449.74; Li DP, 2007, J PHARMACOL EXP THER, V320, P615, DOI 10.1124/jpet.106.109538; Li DP, 2006, AM J PHYSIOL-HEART C, V290, pH1110, DOI 10.1152/ajpheart.00788.2005; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080295; Li YF, 2006, AM J PHYSIOL-HEART C, V291, pH2847, DOI 10.1152/ajpheart.00625.2005; Mussalo H, 2002, CLIN AUTON RES, V12, P465, DOI 10.1007/s10286-002-0069-z; Serafini R, 1998, EUR J NEUROSCI, V10, P1771, DOI 10.1046/j.1460-9568.1998.00187.x; Shi Z, 2012, J APPL PHYSIOL, V112, P1008, DOI 10.1152/japplphysiol.01164.2011; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Stratford TR, 1997, J NEUROSCI, V17, P4434; Sun HJ, 2014, ACTA PHYSIOL, V212, P267, DOI 10.1111/apha.12405; Sun HJ, 2014, ACTA PHYSIOL, V210, P534, DOI 10.1111/apha.12188; Xi ZX, 2000, J PHARMACOL EXP THER, V294, P613; Xiong XQ, 2014, ACTA PHYSIOL, V210, P468, DOI 10.1111/apha.12182; Xiong XQ, 2012, HYPERTENSION, V60, P1280, DOI 10.1161/HYPERTENSIONAHA.112.198002; Yin M, 1996, HYPERTENSION, V27, P1291, DOI 10.1161/01.HYP.27.6.1291; Zhang F, 2014, ACTA PHYSIOL, V212, P17, DOI 10.1111/apha.12342	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136983	10.1371/journal.pone.0136983	http://dx.doi.org/10.1371/journal.pone.0136983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317425	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100188
J	Grant, MP; Cavanaugh, A; Breitwieser, GE				Grant, Michael P.; Cavanaugh, Alice; Breitwieser, Gerda E.			14-3-3 Proteins Buffer Intracellular Calcium Sensing Receptors to Constrain Signaling	PLOS ONE			English	Article							HUMAN CA2+ RECEPTOR; CELL-SURFACE; COUPLED RECEPTORS; BETA-ARRESTINS; EXPRESSION; MUTATIONS; DESENSITIZATION; DEGRADATION; MATURATION; HYPOCALCEMIA	Calcium sensing receptors (CaSR) interact with 14-3-3 binding proteins at a carboxyl terminal arginine-rich motif. Mutations identified in patients with familial hypocalciuric hypercalcemia, autosomal dominant hypocalcemia, pancreatitis or idiopathic epilepsy support the functional importance of this motif. We combined total internal reflection fluorescence microscopy and biochemical approaches to determine the mechanism of 14-3-3 protein regulation of CaSR signaling. Loss of 14-3-3 binding caused increased basal CaSR signaling and plasma membrane levels, and a significantly larger signaling-evoked increase in plasma membrane receptors. Block of core glycosylation with tunicamycin demonstrated that changes in plasma membrane CaSR levels were due to differences in exocytic rate. Western blotting to quantify time-dependent changes in maturation of expressed wt CaSR and a 14-3-3 protein binding-defective mutant demonstrated that signaling increases synthesis to maintain constant levels of the immaturely and maturely glycosylated forms. CaSR thus operates by a feed-forward mechanism, whereby signaling not only induces anterograde trafficking of nascent receptors but also increases biosynthesis to maintain steady state levels of net cellular CaSR. Overall, these studies suggest that 14-3-3 binding at the carboxyl terminus provides an important buffering mechanism to increase the intracellular pool of CaSR available for signaling-evoked trafficking, but attenuates trafficking to control the dynamic range of responses to extracellular calcium.	[Grant, Michael P.; Cavanaugh, Alice; Breitwieser, Gerda E.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Breitwieser, GE (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	gebreitwieser@geisinger.edu		Grant, Michael/0000-0003-3758-5009; Breitwieser, Gerda/0000-0001-9081-0362	Geisinger Clinic; American Heart Association, Great Rivers Affiliate	Geisinger Clinic; American Heart Association, Great Rivers Affiliate(American Heart Association)	This work was funded by Geisinger Clinic to GEB and the American Heart Association, Great Rivers Affiliate, to MPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ruiz MA, 2011, EUR J PHARMACOL, V670, P365, DOI 10.1016/j.ejphar.2011.09.027; Arulpragasam A, 2012, BIOCHEM J, V441, P885; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Breitwieser GE, 2013, BEST PRACT RES CL EN, V27, P303, DOI 10.1016/j.beem.2013.03.003; Breitwieser GE, 2012, MOL ENDOCRINOL, V26, P1955, DOI 10.1210/me.2012-1306; Brennan SC, 2015, ENDOCRINOLOGY, V156, P1330, DOI 10.1210/en.2014-1771; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; Carvajal K, 2014, CELL CALCIUM, V56, P408, DOI 10.1016/j.ceca.2014.08.003; Cavanaugh A, 2010, J BIOL CHEM, V285, P19854, DOI 10.1074/jbc.M110.124792; Chakravarti B, 2012, ADV EXP MED BIOL, V740, P103, DOI 10.1007/978-94-007-2888-2_5; Conigrave AD, 2013, BEST PRACT RES CL EN, V27, P315, DOI 10.1016/j.beem.2013.05.010; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Cross BM, 2014, AM J PHYSIOL-CELL PH, V306, pC515, DOI 10.1152/ajpcell.00330.2013; Deshpande LS, 2011, EXP NEUROL, V229, P264, DOI 10.1016/j.expneurol.2011.02.007; Dong G, 2015, AM J PHYSIOL-RENAL, V308, pF267, DOI 10.1152/ajprenal.00629.2014; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Felderbauer P, 2006, SCAND J GASTROENTERO, V41, P343, DOI 10.1080/00365520510024214; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Goldsmith PK, 1997, J BONE MINER RES, V12, P1780, DOI 10.1359/jbmr.1997.12.11.1780; Grant MP, 2012, MOL ENDOCRINOL, V26, P2081, DOI 10.1210/me.2012-1232; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Kapoor A, 2008, ANN NEUROL, V64, P158, DOI 10.1002/ana.21428; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; Lienhardt A, 2001, J CLIN ENDOCR METAB, V86, P5313, DOI 10.1210/jc.86.11.5313; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Luttrell LM, 2002, J CELL SCI, V115, P455; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; May LT, 2005, J PHARMACOL EXP THER, V312, P382, DOI 10.1124/jpet.104.073767; Miedlich S, 2002, J BIOL CHEM, V277, P49691, DOI 10.1074/jbc.M205578200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pi M, 2005, MOL ENDOCRINOL, V19, P1078, DOI 10.1210/me.2004-0450; Rivero-Rios P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00053; Saidak Z, 2009, MOL PHARMACOL, V76, P1131, DOI 10.1124/mol.109.058784; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; von Zastrow M, 2001, BIOCHEM SOC T, V29, P500, DOI 10.1042/BST0290500; Wang HP, 2015, TOXICOL APPL PHARM, V283, P157, DOI 10.1016/j.taap.2014.12.019; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhuang XL, 2012, J BIOL CHEM, V287, P4165, DOI 10.1074/jbc.M111.271528	48	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136702	10.1371/journal.pone.0136702	http://dx.doi.org/10.1371/journal.pone.0136702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317416	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100124
J	Hadjipanayi, E; Kuhn, PH; Moog, P; Bauer, AT; Kuekrek, H; Mirzoyan, L; Hummel, A; Kirchhoff, K; Salgin, B; Isenburg, S; Dornseifer, U; Ninkovic, M; Machens, HG; Schilling, AF				Hadjipanayi, Ektoras; Kuhn, Peer-Hendrik; Moog, Philipp; Bauer, Anna-Theresa; Kuekrek, Haydar; Mirzoyan, Lilit; Hummel, Anja; Kirchhoff, Katharina; Salgin, Burak; Isenburg, Sarah; Dornseifer, Ulf; Ninkovic, Milomir; Machens, Hans-Guenther; Schilling, Arndt F.			The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLATELET FACTOR-IV; CARDIOVASCULAR-DISEASE; ENERGY-METABOLISM; VENOUS THROMBUS; CELLS; EXPRESSION; HYPOXIA; BINDING; SYSTEM	Conceptually, premature initiation of post-wound angiogenesis could interfere with hemostasis, as it relies on fibrinolysis. The mechanisms facilitating orchestration of these events remain poorly understood, however, likely due to limitations in discerning the individual contribution of cells and extracellular matrix. Here, we designed an in vitro Hemostatic-Components- Model (HCM) to investigate the role of the fibrin matrix as protein factor-carrier, independent of its cell-scaffold function. After characterizing the proteomic profile of HCM-harvested matrix releasates, we demonstrate that the key pro-/anti-angiogenic factors, VEGF and PF4, are differentially bound by the matrix. Changing matrix fibrin mass consequently alters the balance of releasate factor concentrations, with differential effects on basic endothelial cell (EC) behaviors. While increasing mass, and releasate VEGF levels, promoted EC chemotactic migration, it progressively inhibited tube formation, a response that was dependent on PF4. These results indicate that the clot's matrix component initially serves as biochemical anti-angiogenic barrier, suggesting that post-hemostatic angiogenesis follows fibrinolysis-mediated angiogenic disinhibition. Beyond their significance towards understanding the spatiotemporal regulation of wound healing, our findings could inform the study of other pathophysiological processes in which coagulation and angiogenesis are prominent features, such as cardiovascular and malignant disease.	[Hadjipanayi, Ektoras; Moog, Philipp; Bauer, Anna-Theresa; Kuekrek, Haydar; Mirzoyan, Lilit; Hummel, Anja; Kirchhoff, Katharina; Dornseifer, Ulf; Machens, Hans-Guenther; Schilling, Arndt F.] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Plast Surg, Clin Plast & Hand Surg, D-81675 Munich, Germany; [Hadjipanayi, Ektoras; Isenburg, Sarah; Dornseifer, Ulf; Ninkovic, Milomir] Bogenhausen Hosp, Dept Plast Reconstruct Hand & Burn Surg, D-81925 Munich, Germany; [Kuhn, Peer-Hendrik] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Kuhn, Peer-Hendrik] Tech Univ Munich, Klinikum Rechts Isar, Neuroprote, D-81675 Munich, Germany; [Salgin, Burak] Univ Childrens Hosp Dusseldorf, Dept Gen Paediat Neonatol & Paediat Cardiol, D-40225 Dusseldorf, Germany; [Salgin, Burak] Univ Cambridge, Dept Paediat, Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Schilling, Arndt F.] Ctr Appl New Technol Engn Regenerat Med Canter, Munich, Germany	Technical University of Munich; Munchen Klinik; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Cambridge	Schilling, AF (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Plast Surg, Clin Plast & Hand Surg, D-81675 Munich, Germany.	a.schilling@tum.de		Kuhn, Peer-Hendrik/0000-0001-7891-5102; Kirchhoff, Katharina/0000-0001-5547-5140				Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; AKAHORI M, 1995, HAEMATOLOGIA, V26, P191; Amelot AA, 2007, J BIOL CHEM, V282, P710, DOI 10.1074/jbc.M606650200; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808; Daly ME, 2003, JNCI-J NATL CANCER I, V95, P1660, DOI 10.1093/jnci/djg101; Dziurla R, 2010, IMMUNOL LETT, V131, P97, DOI 10.1016/j.imlet.2010.02.008; Evans CE, 2010, ARTERIOSCL THROM VAS, V30, P2443, DOI 10.1161/ATVBAHA.110.215038; Feng Xiaodong, 2013, Int J Cell Biol, V2013, P231279, DOI 10.1155/2013/231279; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Hadjipanayi E, 2013, J CONTROL RELEASE, V169, P91, DOI 10.1016/j.jconrel.2013.04.008; Hang TC, 2013, MOL CELL PROTEOMICS, V12, P3704, DOI 10.1074/mcp.M113.030528; Harrison S, 2011, AM J SPORT MED, V39, P729, DOI 10.1177/0363546511401576; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hu CJ, 2006, J CEREBR BLOOD F MET, V26, P1519, DOI 10.1038/sj.jcbfm.9600304; Jamison J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093968; Klein-Soyer C, 1997, CR ACAD SCI III-VIE, V320, P857, DOI 10.1016/S0764-4469(97)80870-0; Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601; Laderoute KR, 2000, CLIN CANCER RES, V6, P2941; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; LEITZEL K, 1991, CANCER RES, V51, P4149; Levy AP, 1999, CORONARY ARTERY DIS, V10, P427, DOI 10.1097/00019501-199909000-00013; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Modarai B, 2005, THROMB HAEMOSTASIS, V93, P801, DOI 10.1160/TH04-09-0596; Mollet NR, 2002, CIRCULATION, V106, P2873, DOI 10.1161/01.CIR.0000044389.51236.91; Monroe DM, 2012, HAEMOPHILIA, V18, P11, DOI 10.1111/j.1365-2516.2012.02889.x; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; PAULY RR, 1992, CIRCULATION, V86, P68; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rhee JS, 2004, THROMB HAEMOSTASIS, V92, P394, DOI 10.1160/TH03-04-0213; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; SATO Y, 1990, BIOCHEM BIOPH RES CO, V172, P595, DOI 10.1016/0006-291X(90)90715-Y; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Tang JY, 2011, ACTA NEUROCHIR SUPPL, V111, P25, DOI 10.1007/978-3-7091-0693-8_5; Tayebjee MH, 2004, QJM-INT J MED, V97, P259, DOI 10.1093/qjmed/hch053; Tenan M, 2000, J EXP MED, V191, P1789, DOI 10.1084/jem.191.10.1789; THOMPSON WD, 1991, J PATHOL, V165, P311, DOI 10.1002/path.1711650406; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Weijers EM, 2010, J THROMB HAEMOST, V8, P2800, DOI 10.1111/j.1538-7836.2010.04096.x; Wojtukiewicz MZ, 2001, NEOPLASIA, V3, P371, DOI 10.1038/sj.neo.7900184; Yunoki K, 2013, J ATHEROSCLER THROMB, V20, P524, DOI 10.5551/jat.17608; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668; Zhang W, 2013, J BLOOD MED, V4, P141, DOI 10.2147/JBM.S45071	53	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135618	10.1371/journal.pone.0135618	http://dx.doi.org/10.1371/journal.pone.0135618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317771	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100039
J	Hamamoto, Y; Ito, H; Furu, M; Hashimoto, M; Fujii, T; Ishikawa, M; Yamakawa, N; Terao, C; Azukizawa, M; Iwata, T; Mimori, T; Matsuda, S				Hamamoto, Yosuke; Ito, Hiromu; Furu, Moritoshi; Hashimoto, Motomu; Fujii, Takao; Ishikawa, Masahiro; Yamakawa, Noriyuki; Terao, Chikashi; Azukizawa, Masayuki; Iwata, Takahiro; Mimori, Tsuneyo; Matsuda, Shuichi			Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study	PLOS ONE			English	Article							RHEUMATOLOGY/EUROPEAN LEAGUE; RADIOGRAPHIC PROGRESSION; AMERICAN-COLLEGE; PREDICTOR; REMISSION; DAMAGE; DISABILITY; BIOMARKERS; FOOT; LIFE	Objective To investigate clinical and radiological differences between joint destruction in the wrist and the feet in patients with RA. Methods A cross-sectional clinical study was conducted in an RA cohort at a single institution. Clinical data included age, sex and duration of disease. Laboratory data included sero-positivity for anti-cyclic citrullinated peptide (CCP) antibody and RF. Radiological measurements included Larsen grades and the modified Sharp/van der Heijde method (SHS) for the hands/wrists and the feet. Statistical analyses were performed using the Kruskal-Wallis H-test, a dummy variable linear regression model and multivariate logistic regression analysis with 95% confidence interval and odds ratios. Results A total of 405 patients were enrolled, and 314 patients were analysed in this study. The duration of disease in the foot-dominant group was significantly less than that in the wrist-dominant group. When patients were subdivided by duration of disease, the Larsen grade of the feet was significantly higher than that of the wrist in the first quadrant subgroup, but this was reversed with increasing duration of disease. Anti-CCP status was a significant predictive factor for joint destruction in the wrist but not in the feet, while RF status was not predictive in either the wrist or the feet. Conclusions Joint destruction in the feet started earlier than in the wrist, but the latter progresses faster with increasing duration of disease. Anti-CCP status predicts joint destruction in the wrist better than in the feet.	[Hamamoto, Yosuke; Ito, Hiromu; Furu, Moritoshi; Ishikawa, Masahiro; Azukizawa, Masayuki; Iwata, Takahiro; Matsuda, Shuichi] Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan; [Furu, Moritoshi; Hashimoto, Motomu; Fujii, Takao; Ishikawa, Masahiro] Kyoto Univ, Dept Control Rheumat Dis, Grad Sch Med, Kyoto, Japan; [Yamakawa, Noriyuki; Mimori, Tsuneyo] Kyoto Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ito, H (corresponding author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp		Matsuda, Shuichi/0000-0003-0802-1255	Mitsubishi-Tanabe; Chugai; Bristol-Myers; Eisai; Daiichi-Sankyo; Abbvie; Astellas; Pfizer Japan	Mitsubishi-Tanabe(Mitsubishi Tanabe Pharma Corporation); Chugai; Bristol-Myers(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Abbvie(AbbVie); Astellas(Astellas Pharmaceuticals); Pfizer Japan(Pfizer)	M.F., M.H., M.I., and T.F. belong to the department that is financially supported by 4 pharmaceutical companies (Mitsubishi-Tanabe, Chugai, Bristol-Myers, and Eisai). H. I. has received research grants and/or speaker fees from Chugai, Mitsubishi-Tanabe, Daiichi-Sankyo, Eisai, Bristol-Myers, Abbvie, and Astellas. M.F. and M.I. have received grant and research support from Astellas and Pfizer Japan. T.F. has received grant and research support from Bristol-Myers and Pfizer Japan. Y.H., N.Y., C.T., M.A., T.I, T.M., and S.M. declared no conflict of interest exists. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Bosello S, 2011, ANN RHEUM DIS, V70, P1292, DOI 10.1136/ard.2010.142729; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; Forslind K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4058; Furst DE, 2011, ARTHRIT CARE RES, V63, P856, DOI 10.1002/acr.20452; Furu M, 2014, SCAND J RHEUMATOL, V43, P291, DOI 10.3109/03009742.2013.869831; Gremese E, 2013, ANN RHEUM DIS, V72, P858, DOI 10.1136/annrheumdis-2012-201456; Grondal L, 2008, ACTA ORTHOP, V79, P257, DOI 10.1080/17453670710015067; Hashimoto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098202; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; Krabben A, 2013, J RHEUMATOL, V40, P1303, DOI 10.3899/jrheum.121392; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Matsumoto T, 2014, ARTHRIT CARE RES, V66, P499, DOI 10.1002/acr.22174; Momohara S, 2014, J RHEUMATOL, V41, P862, DOI 10.3899/jrheum.131018; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Renner N, 2014, ARTHRITIS RHEUMATOL, V66, P3283, DOI 10.1002/art.38862; Rojas-Villarraga A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-67; Shidara K, 2012, J RHEUMATOL, V39, P476, DOI 10.3899/jrheum.110770; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Syversen SW, 2010, ANN RHEUM DIS, V69, P845, DOI 10.1136/ard.2009.122325; Terao C, 2015, ARTHRITIS RHEUMATOL, V67; Terao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085376; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Tobon G, 2013, ARTHRIT CARE RES, V65, P1907, DOI 10.1002/acr.22078; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van der Leeden M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1596, DOI 10.1002/art.24188; van Nies JAB, 2014, ANN RHEUM DIS, V73, P861, DOI 10.1136/annrheumdis-2012-203130; Vander Cruyssen B, 2007, ANN RHEUM DIS, V66, P364, DOI 10.1136/ard.2006.053470; VanderHeijde DMFM, 1996, BAILLIERE CLIN RHEUM, V10, P435, DOI 10.1016/S1521-6942(96)80007-6; Verstappen SMM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1882; Vittecoq O, 2003, RHEUMATOLOGY, V42, P939, DOI 10.1093/rheumatology/keg257; Wevers-de Boer KVC, 2015, ANN RHEUM DIS, V74, P341, DOI 10.1136/annrheumdis-2013-203749; Yamanaka H, 2000, ARTHRITIS RHEUM, V43, P852, DOI 10.1002/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136611	10.1371/journal.pone.0136611	http://dx.doi.org/10.1371/journal.pone.0136611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317770	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100111
J	Liu, MY; Zhang, LL; Li, J; Li, Y; Li, N; Chen, MQ				Liu, Ming-Yang; Zhang, Ling-Lei; Li, Jia; Li, Yong; Li, Nan; Chen, Ming-Qian			Characteristics of the Cross-Sectional Vorticity of the Natural Spawning Grounds of Schizothorax prenanti and a Vague-Set Similarity Model for Ecological Restoration	PLOS ONE			English	Article							INCOMPRESSIBLE 2-PHASE FLOWS; COUPLED LEVEL SET; YANGTZE-RIVER; CHINESE STURGEON; ATLANTIC SALMON; REGULATED RIVER; CHINOOK SALMON; FLUID METHOD; BROWN TROUT; CHUM SALMON	Schizothorax prenanti is an endemic fish in the mountain rivers of southwestern China with unique protection value. To further explore the vortex motion of hydraulic habitats, which is closely related to the fish breeding process, the cross-sectional vorticity was used to evaluate the hydraulic conditions of the natural spawning habitat of S. prenanti. A coupled levelset and volume-of-fluid (CLSVOF) three-dimensional (3D) model was applied to simulate the hydraulic habitat of the Weimen reach, a typical natural spawning ground for S. prenanti in the upper Yangtze River. The model was used in conjunction with the Wilcoxon rank sum test to distinguish the distributions of vertical vorticity in spawning and non-spawning reaches. Statistical analysis revealed that the cross-sectional vorticity in spawning reaches was significantly greater than in non-spawning reaches, with likely biological significance in the spawning process. The range of cross-sectional mean values of vorticity was 0.17 s(-1) - 0.35 s(-1) in areas with concentrated fish sperm and eggs; the minimum value was 0.17 s(-1), and the majority of values were greater than 0.26 s(-1). Based on this study, a vague-set similarity model was used to assess the effectiveness of ecological restoration by evaluating the similarity of the cross-sectional vorticity of the natural spawning reach and rehabilitated spawning reach after implementing ecological restoration measures. The outcome might provide a theoretical basis for the recovery of damaged S. prenanti spawning grounds and act as an important complement for the assessment of recovery effectiveness and as a useful reference for the coordination of ecological water use with the demands of hydraulic and hydropower engineering.	[Liu, Ming-Yang; Zhang, Ling-Lei; Li, Jia; Li, Yong; Li, Nan; Chen, Ming-Qian] Sichuan Univ, Inst Ecol & Environm, Coll Water Resource Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Sichuan, Peoples R China; [Liu, Ming-Yang] Sichuan Univ, Sch Econ, Chengdu 610065, Sichuan, Peoples R China; [Liu, Ming-Yang] Water Bur Dazhou City, Dazhou 635000, Sichuan, Peoples R China; [Chen, Ming-Qian] Sichuan Environm & Engn Appraisal Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhang, LL (corresponding author), Sichuan Univ, Inst Ecol & Environm, Coll Water Resource Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Sichuan, Peoples R China.	zhanglinglei@hotmail.com			National Natural Science Foundation of China [51309170, 51379136, 51479127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 51309170, 51379136 and 51479127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JD, 2003, FISH RES, V62, P143, DOI 10.1016/S0165-7836(02)00160-1; Bandyopadhyay PR, 2000, J FLUID ENG-T ASME, V122, P219, DOI 10.1115/1.483274; Capitani LD, 2011, STAT PROBABIL LETT, V81, P937; [陈明千 Chen Mingqian], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P1303; Chen MQ, 2012, THESIS SICHUAN U; Chen Y., 2000, FAUNA SINICA OSTEICH, P273; Clark MJ, 2002, AQUAT CONSERV, V12, P471, DOI 10.1002/aqc.530; Crimaldi JP, 2012, J EXP BIOL, V215, P1031, DOI 10.1242/jeb.060145; Crimaldi JP, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2963139; Crimaldi JP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016307; Crimaldi JP, 2004, J MARINE SYST, V49, P3, DOI 10.1016/j.jmarsys.2003.06.005; Crowder DW, 2000, CAN J FISH AQUAT SCI, V57, P1497, DOI 10.1139/cjfas-57-7-1497; Crowder DW, 2006, RIVER RES APPL, V22, P79, DOI 10.1002/rra.893; Crowder DW, 2002, CAN J FISH AQUAT SCI, V59, P633, DOI 10.1139/F02-037; de Rooij F, 1999, J FLUID MECH, V383, P249, DOI 10.1017/S0022112098003966; Downs PW, 2011, ENVIRON MANAGE, V48, P847, DOI 10.1007/s00267-011-9736-y; Falke JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079232; Feng GC, 2014, QUAL QUANT, V48, P2355, DOI 10.1007/s11135-014-0034-7; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Fu Jing jing, 2013, Journal of Sichuan University (Engineering Science Edition), V45, P12; Fu XL, 2007, J HYDRODYN, V19, P78, DOI 10.1016/S1001-6058(07)60031-6; [付小莉 FU Xiaoli], 2006, [水科学进展, Advances in Water Science], V17, P700; Gao X, 2009, ENVIRON BIOL FISH, V86, P325, DOI 10.1007/s10641-009-9521-4; Geist DR, 2002, N AM J FISH MANAGE, V22, P1077, DOI 10.1577/1548-8675(2002)022<1077:PCOTHZ>2.0.CO;2; Gostner W, 2013, HYDROBIOLOGIA, V712, P43, DOI 10.1007/s10750-012-1288-5; Habersack H, 2014, HYDROBIOLOGIA, V729, P33, DOI 10.1007/s10750-012-1429-x; Hanke W, 2000, J EXP BIOL, V203, P1193; Hou BD, 2010, YANGTZE RIVER, V41, P32; Jafarzadegan K, 2014, STOCH ENV RES RISK A, V28, P1343, DOI 10.1007/s00477-013-0841-8; Jemison M, 2013, J SCI COMPUT, V54, P454, DOI 10.1007/s10915-012-9614-7; JOWETT IG, 1993, NEW ZEAL J MAR FRESH, V27, P241, DOI 10.1080/00288330.1993.9516563; Lamouroux N, 1999, FRESHWATER BIOL, V42, P275, DOI 10.1046/j.1365-2427.1999.444498.x; Li DF, 2002, PATTERN RECOGN LETT, V23, P221, DOI 10.1016/S0167-8655(01)00110-6; Liu Jun, 2004, China Environmental Science, V24, P395; Liu Mingyang, 2014, Journal of Sichuan University (Engineering Science Edition), V46, P37; Liu MY, 2014, THESIS SICHUAN U; Louhi P, 2008, RIVER RES APPL, V24, P330, DOI 10.1002/rra.1072; Luo X, 1993, FISH SCI TECHNOL INF, V20, P173; Mao Xi, 2012, Journal of Sichuan University, V44, P13; Menard T, 2007, INT J MULTIPHAS FLOW, V33, P510, DOI 10.1016/j.ijmultiphaseflow.2006.11.001; Merz J.E., 2004, INT J RIVER BASIN MA, V2, P21, DOI [10.1080/15715124.2004.9635219, DOI 10.1080/15715124.2004.9635219]; Merz JE, 2006, GEOMORPHOLOGY, V76, P207, DOI 10.1016/j.geomorph.2005.11.004; Moir H. J., 1998, Fisheries Management and Ecology, V5, P241, DOI 10.1046/j.1365-2400.1998.00105.x; Moir HJ, 2008, GEOMORPHOLOGY, V100, P527, DOI 10.1016/j.geomorph.2008.02.001; Moore GI, 2014, MAR BIOL, V161, P1543, DOI 10.1007/s00227-014-2439-1; Noakes DL, 2009, CHINESE FISHES, V28; Olsson E, 2007, J COMPUT PHYS, V225, P785, DOI 10.1016/j.jcp.2006.12.027; Qiang JH, 2006, P INT C HYDR, P2412; Rosenfeld JS, 2011, GEOMORPHOLOGY, V130, P127, DOI 10.1016/j.geomorph.2011.03.007; SEMPESKI P, 1995, J FISH BIOL, V47, P256, DOI 10.1006/jfbi.1995.0131; Shen Y, 2008, J HYDROL, V348, P195, DOI 10.1016/j.jhydrol.2007.09.060; Sussman M, 2000, J COMPUT PHYS, V162, P301, DOI 10.1006/jcph.2000.6537; Taheri SM, 2013, STAT PAP, V54, P457, DOI 10.1007/s00362-012-0443-4; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Vehanen T, 2005, HYDROBIOLOGIA, V545, P257, DOI 10.1007/s10750-005-3318-z; Versteeg HK, INTRO COMPUTATIONAL; Wang YK, 2012, HYDROL PROCESS, V26, P3489, DOI 10.1002/hyp.8407; Wang YK, 2011, AQUAT ECOL, V45, P255, DOI 10.1007/s10452-011-9351-2; [王远坤 WANG YuanKun], 2009, [生态学报, Acta Ecologica Sinica], V29, P538; Wang YK, 2009, ECOL MODEL, V220, P1443, DOI 10.1016/j.ecolmodel.2009.03.003; Xie JY, 2010, J ANHUI AGR SCI, V38, P13726; Xie JY, 2010, J ANHUI AGR SCI, V38, P13721; Yang Y, 2008, J HYDRODYN, V20, P225, DOI 10.1016/S1001-6058(08)60050-5; Yang Y, 2009, ADVANCES IN WATER RESOURCES AND HYDRAULIC ENGINEERING, VOLS 1-6, P635, DOI 10.1007/978-3-540-89465-0_110; [杨宇 YANG Yu], 2007, [水科学进展, Advances in Water Science], V18, P701; Zhao QH, 2012, STOCH ENV RES RISK A, V26, P993, DOI 10.1007/s00477-012-0583-z; [周波 Zhou Bo], 2013, [西南农业学报, Southwest China Journal of Agricultural Sciences], V26, P811; Zhu ZW, 2013, J APPL ICHTHYOL, V29, P1463, DOI 10.1111/jai.12372	68	2	3	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136724	10.1371/journal.pone.0136724	http://dx.doi.org/10.1371/journal.pone.0136724			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317847	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100128
J	Liu, Y; Gracewski, SM; Nam, JH				Liu, Yanju; Gracewski, Sheryl M.; Nam, Jong-Hoon			Consequences of Location-Dependent Organ of Corti Micro-Mechanics	PLOS ONE			English	Article							OUTER HAIR-CELLS; BASILAR-MEMBRANE VIBRATION; AUDITORY-NERVE FIBERS; GUINEA-PIG COCHLEA; TECTORIAL MEMBRANE; TRAVELING-WAVES; MAMMALIAN COCHLEA; FORCE GENERATION; MECHANOELECTRICAL TRANSDUCTION; SUBTECTORIAL SPACE	The cochlea performs frequency analysis and amplification of sounds. The graded stiffness of the basilar membrane along the cochlear length underlies the frequency-location relationship of the mammalian cochlea. The somatic motility of outer hair cell is central for cochlear amplification. Despite two to three orders of magnitude change in the basilar membrane stiffness, the force capacity of the outer hair cell's somatic motility, is nearly invariant over the cochlear length. It is puzzling how actuators with a constant force capacity can operate under such a wide stiffness range. We hypothesize that the organ of Corti sets the mechanical conditions so that the outer hair cell's somatic motility effectively interacts with the media of traveling waves-the basilar membrane and the tectorial membrane. To test this hypothesis, a computational model of the gerbil cochlea was developed that incorporates organ of Corti structural mechanics, cochlear fluid dynamics, and hair cell electro-physiology. The model simulations showed that the micro-mechanical responses of the organ of Corti are different along the cochlear length. For example, the top surface of the organ of Corti vibrated more than the bottom surface at the basal (high frequency) location, but the amplitude ratio was reversed at the apical (low frequency) location. Unlike the basilar membrane stiffness varying by a factor of 1700 along the cochlear length, the stiffness of the organ of Corti complex felt by the outer hair cell remained between 1.5 and 0.4 times the outer hair cell stiffness. The Y-shaped structure in the organ of Corti formed by outer hair cell, Deiters cell and its phalange was the primary determinant of the elastic reactance imposed on the outer hair cells. The stiffness and geometry of the Deiters cell and its phalange affected cochlear amplification differently depending on the location.	[Liu, Yanju; Gracewski, Sheryl M.; Nam, Jong-Hoon] Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA; [Gracewski, Sheryl M.; Nam, Jong-Hoon] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Nam, JH (corresponding author), Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA.	jong-hoon.nam@rochester.edu		Nam, Jong-Hoon/0000-0002-7477-5453	NSF CMMI [1233595]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014685] Funding Source: NIH RePORTER; Directorate For Engineering [1233595] Funding Source: National Science Foundation	NSF CMMI(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by NSF CMMI 1233595 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1233595&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; COOPER NP, 1995, HEARING RES, V82, P225, DOI 10.1016/0378-5955(94)00180-X; Cooper NP, 2000, RADIAL VARIATION VIB; Cormack J, 2015, J ACOUSTICAL SOC AM; DIEPENDAAL RJ, 1987, J ACOUST SOC AM, V82, P1655, DOI 10.1121/1.395157; Dong W, 2013, BIOPHYS J, V105, P1067, DOI 10.1016/j.bpj.2013.06.049; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Edge RM, 1998, HEARING RES, V124, P1, DOI 10.1016/S0378-5955(98)00090-2; Emadi G, 2004, J NEUROPHYSIOL, V91, P474, DOI 10.1152/jn.00446.2003; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GEISLER CD, 1993, HEARING RES, V68, P253, DOI 10.1016/0378-5955(93)90129-O; Ghaffari R, 2007, P NATL ACAD SCI USA, V104, P16510, DOI 10.1073/pnas.0703665104; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Gu JWW, 2008, BIOPHYS J, V95, P2529, DOI 10.1529/biophysj.107.124727; Gueta R, 2006, P NATL ACAD SCI USA, V103, P14790, DOI 10.1073/pnas.0603429103; Guinan JJ, 2012, HEARING RES, V292, P35, DOI 10.1016/j.heares.2012.08.005; Hallworth R, 1995, J NEUROPHYSIOL, V74, P2319, DOI 10.1152/jn.1995.74.6.2319; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Iwasa K, 1997, BIOPHYSICAL J; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; Johnson SL, 2011, NEURON IN PRESS; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kolston PJ, 1996, J ACOUST SOC AM, V99, P455, DOI 10.1121/1.414557; Lamb JS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.088101; Lee HY, 2015, P NATL ACAD SCI USA, V112, P3128, DOI 10.1073/pnas.1500038112; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIGHTHILL J, 1981, J FLUID MECH, V106, P149, DOI 10.1017/S0022112081001560; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lim KM, 2002, HEARING RES, V170, P190, DOI 10.1016/S0378-5955(02)00491-4; Liu YW, 2010, J ACOUST SOC AM, V127, P2420, DOI 10.1121/1.3337233; Lu TK, 2006, HEARING RES, V214, P45, DOI 10.1016/j.heares.2006.01.018; Mahendrasingam S, 2010, EUR J NEUROSCI, V31, P1595, DOI 10.1111/j.1460-9568.2010.07182.x; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1993, J ACOUST SOC AM, V93, P3320, DOI 10.1121/1.405716; Maoileidigh DO, 2013, P NATL ACAD SCI USA, V110, P5474, DOI 10.1073/pnas.1302911110; Meaud J, 2012, BIOPHYS J, V102, P1237, DOI 10.1016/j.bpj.2012.02.026; Meaud J, 2011, BIOPHYS J, V100, P2576, DOI 10.1016/j.bpj.2011.04.049; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; Naidu RC, 2001, JARO, V2, P257; Nakajima HH, 2009, JARO-J ASSOC RES OTO, V10, P23, DOI 10.1007/s10162-008-0150-y; Nam JH, 2008, BIOPHYS J, V95, P4948, DOI 10.1529/biophysj.108.138560; Nam JH, 2014, BIOPHYS J, V106, P2426, DOI 10.1016/j.bpj.2014.04.018; Nam JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050572; Nam JH, 2010, BIOPHYS J, V98, P2813, DOI 10.1016/j.bpj.2010.03.052; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Nowotny M, 2006, P NATL ACAD SCI USA, V103, P2120, DOI 10.1073/pnas.0511125103; Nowotny M, 2011, J ACOUST SOC AM, V130, P3852, DOI 10.1121/1.3651822; Olson ES, 2012, HEARING RES, V293, P31, DOI 10.1016/j.heares.2012.04.017; Ospeck M, 2012, BIOPHYS J, V102, P1767, DOI 10.1016/j.bpj.2012.02.049; Plassmann W, 1987, COCHLEA GERBILLINE R; Prodanovic S, 2015, BIOPHYS J, V108, P479, DOI 10.1016/j.bpj.2014.12.027; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; Ramamoorthy S, 2007, J ACOUST SOC AM, V121, P2758, DOI 10.1121/1.2713725; Ramamoorthy S, 2012, BIOPHYS J, V102, P388, DOI 10.1016/j.bpj.2011.12.040; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Ren TY, 2001, HEARING RES, V151, P48, DOI 10.1016/S0378-5955(00)00211-2; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; Schweitzer L, 1996, HEARING RES, V97, P84, DOI 10.1016/0378-5955(96)00063-9; Soons JA, 2014, J ASS RES OTOLARYNGO; Steele CR, 2009, J MECH MATER STRUCT, V4, P755, DOI 10.2140/jomms.2009.4.755; STRELIOFF D, 1984, HEARING RES, V15, P19, DOI 10.1016/0378-5955(84)90221-1; Temchin AN, 2010, JARO-J ASSOC RES OTO, V11, P297, DOI 10.1007/s10162-009-0197-4; Teudt IU, 2014, J ASS RES OTOLARYNGO; van der Heijden M, 2014, P NATL ACAD SCI US; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Yoon YJ, 2007, J ACOUST SOC AM, V122, P952, DOI 10.1121/1.2747162; Yoon YJ, 2011, BIOPHYS J, V100, P1, DOI 10.1016/j.bpj.2010.11.039; Zetes DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049338; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	82	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133284	10.1371/journal.pone.0133284	http://dx.doi.org/10.1371/journal.pone.0133284			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317521	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100005
J	Merten, S; Hilber, AM; Biaggi, C; Secula, F; Bosch-Capblanch, X; Namgyal, P; Hombach, J				Merten, Sonja; Hilber, Adriane Martin; Biaggi, Christina; Secula, Florence; Bosch-Capblanch, Xavier; Namgyal, Pem; Hombach, Joachim			Gender Determinants of Vaccination Status in Children: Evidence from a Meta-Ethnographic Systematic Review	PLOS ONE			English	Review							CHILDHOOD IMMUNIZATIONS; QUALITATIVE RESEARCH; SOCIAL DETERMINANTS; COVERAGE; HEALTH; POLIO; CARE; EPI; EXPERIENCE; RESISTANCE	Using meta-ethnographic methods, we conducted a systematic review of qualitative research to understand gender-related reasons at individual, family, community and health facility levels why millions of children in low and middle income countries are still not reached by routine vaccination programmes. A systematic search of Medline, Embase, CINAHL, Cochrane Library, ERIC, Anthropological Lit, CSA databases, IBSS, ISI Web of Knowledge, JSTOR, Soc Index and Sociological Abstracts was conducted. Key words were built around the themes of immunization, vaccines, health services, health behaviour, and developing countries. Only papers, which reported on in-depth qualitative data, were retained. Twenty-five qualitative studies, which investigated barriers to routine immunisation, were included in the review. These studies were conducted between 1982 and 2012; eighteen were published after 2000. The studies represent a wide range of low-to middle income countries including some that have well known coverage challenges. We found that women's low social status manifests on every level as a barrier to accessing vaccinations: access to education, income, as well as autonomous decision-making about time and resource allocation were evident barriers. Indirectly, women's lower status made them vulnerable to blame and shame in case of childhood illness, partly reinforcing access problems, but partly increasing women's motivation to use every means to keep their children healthy. Yet in settings where gender discrimination exists most strongly, increasing availability and information may not be enough to reach the under immunised. Programmes must actively be designed to include mitigation measures to facilitate women's access to immunisation services if we hope to improve immunisation coverage. Gender inequality needs to be addressed on structural, community and household levels if the number of unvaccinated children is to substantially decrease.	[Merten, Sonja; Hilber, Adriane Martin; Biaggi, Christina; Secula, Florence; Bosch-Capblanch, Xavier] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Merten, Sonja; Hilber, Adriane Martin; Biaggi, Christina; Secula, Florence; Bosch-Capblanch, Xavier] Univ Basel, Basel, Switzerland; [Namgyal, Pem; Hombach, Joachim] World Hlth Org, Initiat Vaccines Res, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; World Health Organization	Hilber, AM (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	adriane.martinhiber@unibas.ch	Bosch-Capblanch, Xavier/ABD-7059-2020	Bosch-Capblanch, Xavier/0000-0002-4469-0395; Merten, Sonja/0000-0003-4115-106X	WHO-Initiative; GAVI	WHO-Initiative; GAVI	The study was funded by WHO-Initiative for Vaccine Research. WHO staff that participated in the study were not responsible for the actual funding. This was decided by a supervisory panel related to GAVI where the original funding was provided from for WHO. The actual donor funders-GAVI-had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. WHO Reference 2009/53693-1, Purchase Order 200151849, Reg. File I8-TSA-035, Unit Reference IVR/IMR.	AZEVEDO MJ, 1991, SOC SCI MED, V32, P1341, DOI 10.1016/0277-9536(91)90194-H; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; BASTIEN JW, 1995, SOC SCI MED, V41, P77, DOI 10.1016/0277-9536(94)00297-7; Berhanel Y, 2000, ETHIOPIAN MED J, V38, P1; Bisht S, 2000, ECON POLIT WEEKLY, V35, P697; Bosch-Capblanch X, 2012, TROP MED INT HEALTH, V17, P697, DOI 10.1111/j.1365-3156.2012.02989.x; Braka F, 2012, MATERN CHILD HLTH J, V16, P1045, DOI 10.1007/s10995-011-0826-5; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Brugha RF, 1996, INT J EPIDEMIOL, V25, P840, DOI 10.1093/ije/25.4.840; CASTLE SE, 1994, MED ANTHROPOL Q, V8, P314, DOI 10.1525/maq.1994.8.3.02a00040; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; COREIL J, 1994, SOC SCI MED, V38, P231, DOI 10.1016/0277-9536(94)90393-X; Dasgupta R, 2008, INDIAN PEDIATR, V45, P357; Mavimbe JCD, 2006, HEALTH POLICY, V79, P92, DOI 10.1016/j.healthpol.2005.12.002; Emirbayer M, 1998, AM J SOCIOL, V103, P962, DOI 10.1086/231294; ENG E, 1991, HEALTH EDUC QUART, V18, P97, DOI 10.1177/109019819101800110; FASSIN D, 1986, SOC SCI MED, V23, P1121, DOI 10.1016/0277-9536(86)90329-1; Goldstein Susan, 2011, Morbidity and Mortality Weekly Report, V60, P1520; Harvey Desley J, 2007, Rural Remote Health, V7, P823; Helman CG, 2004, SAMJ S AFR MED J, V94, P835; Hilber AM., 2010, GENDER IMMUNISATION; HILL K, 1995, POPUL DEV REV, V21, P127, DOI 10.2307/2137416; Jatrana S, 2004, ASIAN METACENTRE RES, V16; Johnson S., 2005, EUR J DEV RES, V17, P224, DOI DOI 10.1080/09578810500130831; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kamat VR, 2006, SOC SCI MED, V62, P2945, DOI 10.1016/j.socscimed.2005.11.042; Lachenmann G., 2001, GESCHLECHTSSPEZIFISC; Lewin S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-125; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; Mabilia M., 2000, ANTHROPOL MED, V7, P191, DOI DOI 10.1080/713650590; Malpass A, 2009, SOC SCI MED, V68, P154, DOI 10.1016/j.socscimed.2008.09.068; Meillassoux C, 1975, FEMMES GRENIERS CAPI; Nair MKC, 2007, VULNERABLE CHILD YOU, V2, P71, DOI 10.1080/17450120601122646; NICHTER M, 1995, SOC SCI MED, V41, P617, DOI 10.1016/0277-9536(95)00034-5; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; ODEBIYI AI, 1993, E AFR MED J, V70, P25; ODEBIYI AI, 1982, J EPIDEMIOL COMMUN H, V36, P209, DOI 10.1136/jech.36.3.209; Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381; Oluwadare C, 2009, STUD ETHNO-MED, V3, P49, DOI 10.1080/09735070.2009.11886337; Ozcirpici B, 2006, PUBLIC HEALTH, V120, P145, DOI 10.1016/j.puhe.2005.04.008; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Pool R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-213; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Schwarz NG, 2009, VACCINE, V27, P5371, DOI 10.1016/j.vaccine.2009.06.100; Sen G, 2008, Glob Public Health, V3 Suppl 1, P1, DOI 10.1080/17441690801900795; Sen G., 2007, UNEQUAL UNFAIR INEFF; Streefland PH, 1999, B WORLD HEALTH ORGAN, V77, P722; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Suresh K, 2000, Indian J Public Health, V44, P15; Tadesse H, 2009, ARCH MED SCI, V5, P233; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; Topuzoglu A, 2007, EUR J PUBLIC HEALTH, V17, P348, DOI 10.1093/eurpub/ckl250; Uddin MJ, 2010, HEALTH POLICY PLANN, V25, P50, DOI 10.1093/heapol/czp041; UNICEF, 2006, STAT WORLDS CHILDR 2; Unisa S, 2006, J FAM WELFARE, V52, P62; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Walsh D, 2006, MIDWIFERY, V22, P108, DOI 10.1016/j.midw.2005.05.004; WHO, 2008, WORLD HLTH REPORT 20; WHO/UNICEF, 2012, WHO UNICEF COV EST 2	62	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135222	10.1371/journal.pone.0135222	http://dx.doi.org/10.1371/journal.pone.0135222			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317975	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100025
J	Mertens, L; Van Cauwenberg, J; Ghekiere, A; Van Holle, V; De Bourdeaudhuij, I; Deforche, B; Nasar, J; Van de Weghe, N; Van Dyck, D				Mertens, Lieze; Van Cauwenberg, Jelle; Ghekiere, Ariane; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Deforche, Benedicte; Nasar, Jack; Van de Weghe, Nico; Van Dyck, Delfien			Does the Effect of Micro-Environmental Factors on a Street's Appeal for Adults' Bicycle Transport Vary across Different Macro-Environments? An Experimental Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; ACTIVE-TRANSPORT; HEALTH-BENEFITS; ATTRIBUTES; INVITINGNESS; RECREATION; WALKING; WEIGHT; PEOPLE	Background Characteristics of the physical environment can be classified into two broad categories: macro-("raw" urban planning features influenced on a regional level) and micro-(features specifically within a streetscape influenced on a neighborhood level) environmental factors. In urban planning applications, it is more feasible to modify conditions at the neighborhood level than at the regional level. Yet for the promotion of bicycle transport we need to know whether relationships between micro-environmental factors and bicycle transport depend on different types of macro-environments. This study aimed to identify whether the effect of three micro-environmental factors (i.e., evenness of the cycle path surface, speed limits and type of separation between cycle path and motorized traffic) on the street's appeal for adults' bicycle transport varied across three different macro-environments (i.e., low, medium and high residential density street). Methods In total, 389 middle-aged adults completed a web-based questionnaire consisting of socio-demographic characteristics and a series of choice tasks with manipulated photographs, depicting two possible routes to cycle along. Conjoint analysis was used to analyze the data. Results Although themagnitude of the overall effects differed, in each macro-environment (i.e., low, medium and high residential density), middle-aged adults preferred a speed limit of 30 km/h, an even cycle path surface and a hedge as separation between motorized traffic and the cycle path compared to a speed limit of 50 or 70 km/h, a slightly uneven or uneven cycle path surface and a curb as separation or no separation between motorized traffic and the cycle path. Conclusions Our results suggest that irrespective of the macro-environment, the same micro-environmental factors are preferred in middle-aged adults concerning the street's appeal for bicycle transport. The controlled environment simulations in the experimental choice task have the potential to inform real life environmental interventions and suggest that micro-environmental changes can have similar results in different macro-environments.	[Mertens, Lieze; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Van Dyck, Delfien] Univ Ghent, Dept Movement & Sport Sci, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Ghekiere, Ariane; Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Ghekiere, Ariane; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, B-1050 Brussels, Belgium; [Van Cauwenberg, Jelle; Ghekiere, Ariane; Van Holle, Veerle; Van Dyck, Delfien] Res Fdn Flanders FWO, B-1000 Brussels, Belgium; [Nasar, Jack] Ohio State Univ, City & Reg Planning, Columbus, OH 43210 USA; [Van de Weghe, Nico] Univ Ghent, Dept Geog, Fac Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; University System of Ohio; Ohio State University; Ghent University	De Bourdeaudhuij, I (corresponding author), Univ Ghent, Dept Movement & Sport Sci, Fac Med & Hlth Sci, Watersportlaan 2, B-9000 Ghent, Belgium.	Ilse.Debourdeaudhuij@Ugent.be	Van Dyck, Delfien/AAO-8981-2020; Van de Weghe, Nico/B-7680-2011; Van de Weghe, Nico/N-4214-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Mertens, Lieze/AAG-3340-2020	Van de Weghe, Nico/0000-0002-5327-4000; Van de Weghe, Nico/0000-0002-5327-4000; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241; Van Dyck, Delfien/0000-0003-1783-9075; Mertens, Lieze/0000-0001-7144-2656	Fund for Scientific Research Flanders (FWO) [11N0313N, GA11111N, 11O3115N, FWO12/PDO/158]	Fund for Scientific Research Flanders (FWO)(FWO)	AG, JVC, VVH and DVD are supported by a grant from the Fund for Scientific Research Flanders (FWO) (grant numbers: JVC: 11N0313N AG: GA11111N VVH: 11O3115N DVD: FWO12/PDO/158; www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2013, ADOBE PHOTOSHOP CC; Allenby GM, 2014, ON THE OF DEMAND HET, V35, P384; Alves S, 2008, FACILITIES, V26, P433, DOI 10.1108/02632770810895705; Badland H, 2013, PREV MED, V57, P396, DOI 10.1016/j.ypmed.2013.06.015; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Belgian Federal Government, 2013, STATISTICS BELGIUM; Bidordinova A, 2010, MOTIVATORS BARRIERS, P1; Buehler R, 2012, TR NEWS 280, P280; Cain KL, 2014, SOC SCI MED, V116, P82, DOI 10.1016/j.socscimed.2014.06.042; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Commission of the European Communities, 2007, GREEN PAPER TOWARDS; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cubukcu E, 2005, ENVIRON PLANN B, V32, P777, DOI 10.1068/b31191; Danner UN, 2008, BRIT J SOC PSYCHOL, V47, P245, DOI 10.1348/014466607X230876; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-19; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Departement of Health-Physical activity-Health improvement and prevention, 2004, AT LEAST FIVE A WEEK; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Foster CE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-61; Fraser SDS, 2011, EUR J PUBLIC HEALTH, V21, P738, DOI 10.1093/eurpub/ckq145; Gaffron P, 2003, TRANSPORT POLICY, V10, P235, DOI DOI 10.1016/S0967-070X(03)00024-6; Ghekiere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106696; Grasser G, 2013, INT J PUBLIC HEALTH, V58, P615, DOI 10.1007/s00038-012-0435-0; Janssens D, 2014, ONDERZOEK VERPLAATSI, P116; Jongeneel-Grimen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062525; Krenn PJ, 2013, AM J PREV MED, V41, P1; Lenders S, 2006, AFBAKENING VAN HET V; Massiani J, 2008, EUR TRANSP, P59; McCormack G, 2004, J Sci Med Sport, V7, P81, DOI 10.1016/S1440-2440(04)80282-2; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Mertens L, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0088-x; Moudon AV, 2005, TRANSPORT RES D-TR E, V10, P245, DOI 10.1016/j.trd.2005.04.001; Multon K.D., 2010, ENCY RES DESIGN, P627; Nasar JL, 2008, AM J PREV MED, V34, P357, DOI 10.1016/j.amepre.2008.01.013; Nordh H, 2011, URBAN FOR URBAN GREE, V10, P95, DOI 10.1016/j.ufug.2010.12.003; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Orme BK, 2009, GETTING STARTED WITH; Owen N, 2010, J URBAN HEALTH, V87, P189, DOI 10.1007/s11524-009-9424-x; Portney L., 2009, FDN CLIN RES APPL PR; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rissel Chris E, 2009, N S W Public Health Bull, V20, P10, DOI 10.1071/NB08043; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Rudinger G, 2006, SOCIETAL TRENDS MOBI; Sallis JF, 2013, PREV MED, V57, P456, DOI 10.1016/j.ypmed.2013.06.014; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sawtooth Software Inc, 2013, THE CBC SYSTEM FOR C, P1; Scheepers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073105; Spittaels H, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-39; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Titze S, 2010, J PHYS ACT HEALTH, V7, P423, DOI 10.1123/jpah.7.4.423; Van Cauwenberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112107; Van Dyck D, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-70; Van Holle V, 2014, TRANSPORT RES A-POL, V69, P432, DOI 10.1016/j.tra.2014.09.009; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Vandenbulcke G, 2009, TRANSPORT POLICY, V16, P77, DOI 10.1016/j.tranpol.2009.03.004; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Winters M, 2011, TRANSPORTATION, V38, P153, DOI 10.1007/s11116-010-9284-y; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2008, INSUFFICIENT PHYSICA; World Health Organization, 2010, GLOBAL RECOMMENDATIO; World Health Organization, 2009, INT DIET PHYS ACT WH	68	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136715	10.1371/journal.pone.0136715	http://dx.doi.org/10.1371/journal.pone.0136715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317754	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100127
J	Preis, MA; Kroner-Herwig, B; Schmidt-Samoa, C; Dechent, P; Barke, A				Preis, Mira A.; Kroener-Herwig, Birgit; Schmidt-Samoa, Carsten; Dechent, Peter; Barke, Antonia			Neural Correlates of Empathy with Pain Show Habituation Effects. An fMRI Study	PLOS ONE			English	Article							DISPOSITIONAL EMPATHY; PRIOR EXPERIENCE; NEUROSCIENCE; AMYGDALA; BRAIN; EMOTIONALITY; PERCEPTION; MECHANISMS; RESPONSES; NETWORK	Background Neuroimaging studies have demonstrated that the actual experience of pain and the perception of another person in pain share common neural substrates, including the bilateral anterior insular cortex and the anterior midcingulate cortex. As many fMRI studies include the exposure of participants to repeated, similar stimuli, we examined whether empathic neural responses were affected by habituation and whether the participants' prior pain experience influenced these habituation effects. Method In 128 trials (four runs), 62 participants (31 women, 23.0 +/- 4.2 years) were shown pictures of hands exposed to painful pressure (pain pictures) and unexposed (neutral pictures). After each trial, the participants rated the pain of the model. Prior to the experiment, participants were either exposed to the same pain stimulus (pain exposure group) or not (touch exposure group). In order to assess possible habituation effects, linear changes in the strength of the BOLD response to the pain pictures (relative to the neutral pictures) and in the ratings of the model's pain were evaluated across the four runs. Results Although the ratings of the model's pain remained constant over time, we found neural habituation in the bilateral anterior/midinsular cortex, the posterior midcingulate extending to dorsal posterior cingulate cortex, the supplementary motor area, the cerebellum, the right inferior parietal lobule, and the left superior frontal gyrus, stretching to the pregenual anterior cingulate cortex. The participant's prior pain experience did neither affect their ratings of the model's pain nor their maintenance of BOLD activity in areas associated with empathy. Interestingly, participants with high trait personal distress and fantasy tended to show less habituation in the anterior insula. Conclusion Neural structures showed a decrease of the BOLD signal, indicating habituation over the course of 45 minutes. This can be interpreted as a neuronal mechanism responding to the repeated exposure to pain depictions, which may be regarded as functional in a range of contexts.	[Preis, Mira A.; Kroener-Herwig, Birgit] Univ Gottingen, Georg Elias Mueller Inst Psychol, Dept Clin Psychol & Psychotherapy, D-37073 Gottingen, Germany; [Schmidt-Samoa, Carsten; Dechent, Peter] Univ Med Ctr Goettingen, Dept Cognit Neurol, MR Res Neurol & Psychiat, D-37075 Gottingen, Germany; [Barke, Antonia] Univ Marburg, Dept Clin Psychol & Psychotherapy, D-35032 Marburg, Germany	University of Gottingen; University of Gottingen; Philipps University Marburg	Preis, MA (corresponding author), Univ Gottingen, Georg Elias Mueller Inst Psychol, Dept Clin Psychol & Psychotherapy, Gosslerstr 14, D-37073 Gottingen, Germany.	mira.preis@psych.uni-goettingen.de	Barke, Antonia/D-9286-2011	Barke, Antonia/0000-0002-6863-3213				Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; Batson CD, 1996, PERS SOC PSYCHOL B, V22, P474, DOI 10.1177/0146167296225005; Batson CD., 1991, ALTRUISM QUESTION SO; Blackford JU, 2013, SOC COGN AFFECT NEUR, V8, P143, DOI 10.1093/scan/nsr078; Bufalari I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00393; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Eisenberg N, 1996, J PERS, V64, P157, DOI 10.1111/j.1467-6494.1996.tb00818.x; Eklund J, 2009, SCAND J PSYCHOL, V50, P65, DOI 10.1111/j.1467-9450.2008.00673.x; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; Enzi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008429; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gobel H, 1988, Schmerz, V2, P205, DOI 10.1007/BF02527918; Gobel H, 1987, Schmerz, V1, P114, DOI 10.1007/BF02527738; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Lamm C, 2008, CEREB CORTEX, V18, P2369, DOI 10.1093/cercor/bhn006; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lang S, 2011, COGN AFFECT BEHAV NE, V11, P386, DOI 10.3758/s13415-011-0035-0; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Mooradian TA, 2008, MARKET LETT, V19, P79, DOI 10.1007/s11002-008-9032-7; Mooradian TA, 2011, AM J PSYCHOL, V124, P99, DOI 10.5406/amerjpsyc.124.1.0099; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; O'Connor LE, 2002, J AFFECT DISORDERS, V71, P19, DOI 10.1016/S0165-0327(01)00408-6; Okun MA, 2000, PERS INDIV DIFFER, V28, P367, DOI 10.1016/S0191-8869(99)00107-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus C, 2009, SAARBRUCKER PERSONAL; Preis MA, 2012, EUR J PAIN, V16, P1311, DOI 10.1002/j.1532-2149.2012.00119.x; Preis MA, 2013, PAIN, V154, P411, DOI 10.1016/j.pain.2012.11.014; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2007, EMPATHY IN MENTAL ILLNESS, P428, DOI 10.1017/CBO9780511543753.024; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Riecansky I, 2015, SOC COGN AFFECT NEUR, V10, P893, DOI 10.1093/scan/nsu139; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Schreiter S, 2013, J AFFECT DISORDERS, V150, P1, DOI 10.1016/j.jad.2013.03.009; SIDDLE DAT, 1991, PSYCHOPHYSIOLOGY, V28, P245, DOI 10.1111/j.1469-8986.1991.tb02190.x; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sokolov E.N., 1963, PERCEPTION CONDITION; Swartz JR, 2013, J AM ACAD CHILD PSY, V52, P84, DOI 10.1016/j.jaac.2012.10.012; Thoma P, 2011, PSYCHIAT RES, V189, P373, DOI 10.1016/j.psychres.2011.07.030; Thomas J, 2013, J SOC SERV RES, V39, P365, DOI 10.1080/01488376.2013.771596; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2014, CORTEX, V59, P197, DOI 10.1016/j.cortex.2014.04.002	60	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137056	10.1371/journal.pone.0137056	http://dx.doi.org/10.1371/journal.pone.0137056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317858	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100200
J	Bertoia, ML; Bertrand, KA; Sawyer, SJ; Rimm, EB; Mukamal, KJ				Bertoia, Monica L.; Bertrand, Kimberly A.; Sawyer, Sherilyn J.; Rimm, Eric B.; Mukamal, Kenneth J.			Reproducibility of Circulating MicroRNAs in Stored Plasma Samples	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BREAST-CANCER; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-DISEASE; BIOMARKERS; RISK; EXPRESSION; BLOOD; DESIGN	Background Most studies of microRNA (miRNA) and disease have examined tissue-specific expression in limited numbers of samples. The presence of circulating miRNAs in plasma samples provides the opportunity to examine prospective associations between miRNA expression and disease in initially healthy individuals. However, little data exist on the reproducibility of miRNAs in stored plasma. Methods We used Real-Time PCR to measure 61 pre-selected microRNA candidates in stored plasma. Coefficients of variation (CVs) were used to assess inter-assay reliability (n = 15) and within-person stability over one year (n = 80). Intraclass correlation coefficients (ICCs) and polychoric correlation coefficients were used to assess within-person stability and delayed processing reproducibility (whole blood stored at 4 degrees C for 0, 24 and 48 hours; n = 12 samples). Results Of 61 selected miRNAs, 23 were detected in at least 50% of samples and had average CVs below 20% for inter-assay reproducibility and 31 for delayed processing reproducibility. Ten miRNAs were detected in at least 50% of samples, had average CVs below 20% and had ICCs above 0.4 for within-person stability over 1-2 years, six of which satisfied criteria for both interassay reproducibility and short-term within-person stability (miR-17-5p, -191-5p, -26a-5p, -27b-3p, -320a, and -375) and two all three types of reproducibility (miR-27b-3p and -26a-5p). However, many miRNAs with acceptable average CVs had high maximum CVs, most had low expression levels, and several had low ICCs with delayed processing. Conclusions About a tenth of miRNAs plausibly related to chronic disease were reliably detected in stored samples of healthy adults.	[Bertoia, Monica L.; Rimm, Eric B.; Mukamal, Kenneth J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Bertrand, Kimberly A.; Sawyer, Sherilyn J.; Rimm, Eric B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Bertrand, Kimberly A.; Sawyer, Sherilyn J.; Rimm, Eric B.] Harvard Univ, Sch Med, Boston, MA USA; [Bertrand, Kimberly A.; Rimm, Eric B.] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center	Bertoia, ML (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	mbertoia@hsph.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Bertrand, Kimberly/0000-0002-4565-7618	National Institutes of Health [UM1 CA167552, U01 CA152904]; Simeon J. Fortin Charitable Foundation; Bank of America, N.A.; NATIONAL CANCER INSTITUTE [UM1CA167552, U01CA152904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simeon J. Fortin Charitable Foundation; Bank of America, N.A.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health (UM1 CA167552, U01 CA152904). K.A.B. was supported in part by the Simeon J. Fortin Charitable Foundation, Bank of America, N.A., Co-Trustee. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Chu NF, 2001, INT J OBESITY, V25, P346, DOI 10.1038/sj.ijo.0801549; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rosner B., 2005, FUNDAMENTALS BIOSTAT; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Tworoger SS, 2006, CANCER CAUSE CONTROL, V17, P889, DOI 10.1007/s10552-006-0035-5; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Ward J.A., 2013, FAM MED MED SCI RES, V2, P108, DOI [10.4172/2327-4972.1000108, DOI 10.4172/2327-4972.1000108]; White Emily, 2011, IARC Sci Publ, P143; WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341	27	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136665	10.1371/journal.pone.0136665	http://dx.doi.org/10.1371/journal.pone.0136665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313271	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000082
J	Lehnen, N; Heuser, F; Saglam, M; Schulz, CM; Wagner, KJ; Taki, M; Kochs, EF; Jahn, K; Brandt, T; Glasauer, S; Schneider, E				Lehnen, Nadine; Heuser, Fabian; Saglam, Murat; Schulz, Christian M.; Wagner, Klaus J.; Taki, Masakatsu; Kochs, Eberhard F.; Jahn, Klaus; Brandt, Thomas; Glasauer, Stefan; Schneider, Erich			Opioid-Induced Nausea Involves a Vestibular Problem Preventable by Head-Rest	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; MOTION SICKNESS; POSTOPERATIVE NAUSEA; SUSCEPTIBILITY; PERCEPTION; MECHANISMS; MANAGEMENT; RECEPTORS; VELOCITY; ETIOLOGY	Background and Aims Opioids are indispensable for pain treatment but may cause serious nausea and vomiting. The mechanism leading to these complications is not clear. We investigated whether an opioid effect on the vestibular system resulting in corrupt head motion sensation is causative and, consequently, whether head-rest prevents nausea. Methods Thirty-six healthy men (26.6 +/- 4.3 years) received an opioid remifentanil infusion (45 min, 0.15 mu g/kg/min). Outcome measures were the vestibulo-ocular reflex (VOR) gain determined by video-head-impulse-testing, and nausea. The first experiment (n = 10) assessed outcome measures at rest and after a series of five 1-Hz forward and backward head-trunk movements during one-time remifentanil administration. The second experiment (n = 10) determined outcome measures on two days in a controlled crossover design: (1) without movement and (2) with a series of five 1-Hz forward and backward head-trunk bends 30 min after remifentanil start. Nausea was psychophysically quantified (scale from 0 to 10). The third controlled crossover experiment (n = 16) assessed nausea (1) without movement and (2) with head movement; isolated head movements consisting of the three axes of rotation (pitch, roll, yaw) were imposed 20 times at a frequency of 1 Hz in a random, unpredictable order of each of the three axes. All movements were applied manually, passively with amplitudes of about +/- 45 degrees. Results The VOR gain decreased during remifentanil administration (p<0.001), averaging 0.92 +/- 0.05 (mean +/- standard deviation) before, 0.60 +/- 0.12 with, and 0.91 +/- 0.05 after infusion. The average half-life of VOR recovery was 5.3 +/- 2.4 min. 32/36 subjects had no nausea at rest (nausea scale 0.00/0.00 median/interquartile range). Head-trunk and isolated head movement triggered nausea in 64% (p<0.01) with no difference between head-trunk and isolated head movements (nausea scale 4.00/7.25 and 1.00/4.5, respectively). Conclusions Remifentanil reversibly decreases VOR gain at a half-life reflecting the drug's pharmacokinetics. We suggest that the decrease in VOR gain leads to a perceptual mismatch of multisensory input with the applied head movement, which results in nausea, and that, consequently, vigorous head movements should be avoided to prevent opioid-induced nausea.	[Lehnen, Nadine; Glasauer, Stefan] Munich Univ Hosp, Ctr Sensorimotor Res, Munich, Germany; [Lehnen, Nadine; Jahn, Klaus; Brandt, Thomas; Glasauer, Stefan; Schneider, Erich] Munich Univ Hosp, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Lehnen, Nadine; Glasauer, Stefan] Munich Univ Hosp, Dept Neurol, Munich, Germany; [Heuser, Fabian; Schulz, Christian M.; Wagner, Klaus J.; Kochs, Eberhard F.] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80290 Munich, Germany; [Saglam, Murat] Gediz Univ, Fac Engn & Architecture, Dept Biomed Engn, Izmir, Turkey; [Taki, Masakatsu] Kyoto Prefectural Univ Med, Dept Otolaryngol HNS, Kyoto, Japan; [Jahn, Klaus] Schon Klin Bad Aibling, Bad Aibling, Germany; [Brandt, Thomas; Schneider, Erich] Munich Univ Hosp, Inst Clin Neurosci, Munich, Germany; [Schneider, Erich] Brandenburg Inst Technol, Inst Med Technol, Cottbus, Germany	University of Munich; University of Munich; University of Munich; Technical University of Munich; Gediz University; Kyoto Prefectural University of Medicine; University of Munich	Heuser, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80290 Munich, Germany.	F.Heuser@lrz.tu-muenchen.de	Glasauer, Stefan/A-5898-2008; Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010; Saglam, Murat/L-3123-2014	Glasauer, Stefan/0000-0002-4313-6210; Jahn, Klaus/0000-0002-1669-3652; Saglam, Murat/0000-0001-8766-3883	German Federal Ministry of Education [01 EO 0901]; Faculty of Medicine of the University of Munich	German Federal Ministry of Education(Federal Ministry of Education & Research (BMBF)); Faculty of Medicine of the University of Munich	The German Federal Ministry of Education (Grant 01 EO 0901) and the Faculty of Medicine of the University of Munich funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Apfel CC, 2004, NEW ENGL J MED, V350, P2441, DOI 10.1056/NEJMoa032196; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; Bles W, 2000, CURR OPIN NEUROL, V13, P19, DOI 10.1097/00019052-200002000-00005; Brandt T, 1976, Fortschr Med, V94, P1177; Brandt T, 1999, VERTIGO ITS MULTISEN, P485; CARPENTER DO, 1992, ANN NY ACAD SCI, V656, P668, DOI 10.1111/j.1749-6632.1992.tb25244.x; CHINN HI, 1953, J PHARMACOL EXP THER, V108, P69; Chou R, 2003, J PAIN SYMPTOM MANAG, V26, P1026, DOI 10.1016/j.jpainsymman.2003.03.003; COHEN MM, 1994, ANESTH ANALG, V78, P7; COHEN MM, 1990, ANESTH ANALG, V70, P160; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gan TJ, 2001, ANESTH ANALG, V92, P393, DOI 10.1213/00000539-200102000-00022; Gan TJ, 2002, JAMA-J AM MED ASSOC, V287, P1233, DOI 10.1001/jama.287.10.1233; GOLD BS, 1989, JAMA-J AM MED ASSOC, V262, P3008, DOI 10.1001/jama.262.21.3008; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Golding JF, 2005, CURR OPIN NEUROL, V18, P29, DOI 10.1097/00019052-200502000-00007; Golding JF, 2015, CURR OPIN NEUROL, V28, P83, DOI 10.1097/WCO.0000000000000163; Golding JF, 2011, AUTON NEUROSCI-BASIC, V160, P53, DOI 10.1016/j.autneu.2010.09.009; GUTNER LB, 1952, J CLIN INVEST, V31, P259, DOI 10.1172/JCI102601; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Institute for Healthcare Informatics, 2014, US MED UN STAT REV 2; Ishiyama A, 2001, ADDICTION, V96, P1363; Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022; National Center for Health Statistics, 2014, NUMB INP SURG PER YE; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; Oman CM, 2014, EXP BRAIN RES, V232, P2483, DOI 10.1007/s00221-014-3973-2; Paillard AC, 2013, J VESTIBUL RES-EQUIL, V23, P203, DOI 10.3233/VES-130501; Platzer S, 2000, NEUROSCI LETT, V283, P213, DOI 10.1016/S0304-3940(00)00943-5; Popper P, 2004, NEUROSCIENCE, V129, P225, DOI 10.1016/j.neuroscience.2004.08.008; Porreca F, 2009, PAIN MED, V10, P654, DOI 10.1111/j.1526-4637.2009.00583.x; Ramaioli C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110322; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Rottach KG, 2002, J NEUROL, V249, P1200, DOI 10.1007/s00415-002-0806-1; RUBIN A, 1950, J CLIN INVEST, V29, P1261, DOI 10.1172/JCI102363; Sharma Krishan, 1997, Acta Geneticae Medicae et Gemellologiae, V46, P105; Watcha MF, 2000, ANESTHESIOLOGY, V92, P931, DOI 10.1097/00000542-200004000-00007; WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023; WESTMORELAND CL, 1993, ANESTHESIOLOGY, V79, P893, DOI 10.1097/00000542-199311000-00005	41	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135263	10.1371/journal.pone.0135263	http://dx.doi.org/10.1371/journal.pone.0135263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313751	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000015
J	Straube, J; Gorse, AD; Huang, BE; Le Cao, KA				Straube, Jasmin; Gorse, Alain-Dominique; Huang, Bevan Emma; Le Cao, Kim-Anh		PROOF Ctr Excellence Team	A Linear Mixed Model Spline Framework for Analysing Time Course 'Omics' Data	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; MECHANISMS; DISCOVERY; POWER; TOOL	Time course 'omics' experiments are becoming increasingly important to study system-wide dynamic regulation. Despite their high information content, analysis remains challenging. 'Omics' technologies capture quantitative measurements on tens of thousands of molecules. Therefore, in a time course 'omics' experiment molecules are measured for multiple subjects over multiple time points. This results in a large, high-dimensional dataset, which requires computationally efficient approaches for statistical analysis. Moreover, methods need to be able to handle missing values and various levels of noise. We present a novel, robust and powerful framework to analyze time course 'omics' data that consists of three stages: quality assessment and filtering, profile modelling, and analysis. The first step consists of removing molecules for which expression or abundance is highly variable over time. The second step models each molecular expression profile in a linear mixed model framework which takes into account subject-specific variability. The best model is selected through a serial model selection approach and results in dimension reduction of the time course data. The final step includes two types of analysis of the modelled trajectories, namely, clustering analysis to identify groups of correlated profiles over time, and differential expression analysis to identify profiles which differ over time and/or between treatment groups. Through simulation studies we demonstrate the high sensitivity and specificity of our approach for differential expression analysis. We then illustrate how our framework can bring novel insights on two time course 'omics' studies in breast cancer and kidney rejection. The methods are publicly available, implemented in the R CRAN package lmms.	[Straube, Jasmin; Gorse, Alain-Dominique] Univ Queensland, Inst Mol Biosci, QFAB Bioinformat, Brisbane, Qld, Australia; Univ British Columbia, Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC V5Z 1M9, Canada; [PROOF Ctr Excellence Team] Providence Hlth Care, Vancouver, BC, Canada; [Huang, Bevan Emma] CSIRO Digital Prod Flagship, Brisbane, Qld, Australia; [Straube, Jasmin; Le Cao, Kim-Anh] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Le Cao, KA (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia.	k.lecao@uq.edu.au	Gorse, Dominique/GRJ-6993-2022; Gorse, Alain-Dominique JP/G-2444-2010; Straube, Jasmin/Y-1355-2018; Le Cao, Kim-Anh/B-6637-2013; Huang, Bevan/A-5949-2009	Straube, Jasmin/0000-0002-1748-0659; Le Cao, Kim-Anh/0000-0003-3923-1116; Huang, Bevan/0000-0002-1981-5838; Gorse, Alain-Dominique/0000-0003-1230-4194	Wound Management Innovation under the Australian Government's Cooperative Research Centres Program; Australian Cancer Research Foundation; Australian Research Council [DE120101127]	Wound Management Innovation under the Australian Government's Cooperative Research Centres Program; Australian Cancer Research Foundation; Australian Research Council(Australian Research Council)	This work was supported by the Wound Management Innovation established and supported under the Australian Government's Cooperative Research Centres Program to JS; the Australian Cancer Research Foundation for the Diamantina Individualised Oncology Care Centre at The University of Queensland Diamantina Institute to KALC; and the Australian Research Council Discovery Early Career Researcher Award (project number DE120101127) to EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk M, 2011, BIOINFORMATICS, V27, P1979, DOI 10.1093/bioinformatics/btr289; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brock G., 2011, CLVALID VALIDATION C; Brumback BA, 1998, J AM STAT ASSOC, V93, P961, DOI 10.2307/2669837; Carlson M, 2014, ORG HS ED DB GENOME; Chen Xin, 2009, Journal of Bioinformatics and Computational Biology, V7, P645, DOI 10.1142/S0219720009004291; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Coffey N, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1671; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Currie ID, 2002, STAT MODEL, V2, P333, DOI 10.1191/1471082x02st039ob; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S17; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; Dejean S, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/70561; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Durban M, 2005, STAT MED, V24, P1153, DOI 10.1002/sim.1991; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Freue GVC, 2010, MOL CELL PROTEOMICS, V9, P1954, DOI 10.1074/mcp.M110.000554; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Haghighi A, 2011, CLIN KIDNEY J, V4, P421, DOI 10.1093/ndtplus/sfr096; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Koestler DC, 2014, TRANSL CANCER RES, V3, P217, DOI 10.3978/j.issn.2218-676X.2014.06.04; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Maechler M., 2013, CLUSTER CLUSTER ANAL; Magni P, 2008, BIOINFORMATICS, V24, P430, DOI 10.1093/bioinformatics/btm605; Moschella F, 2011, CANCER RES, V71, P3528, DOI 10.1158/0008-5472.CAN-10-4523; Murphy JP, 2010, PROTEOMICS, V10, P1847, DOI 10.1002/pmic.200900711; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pinheiro J, 2020, R PACKAGE VERSION 31; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Rice JA, 2001, BIOMETRICS, V57, P253, DOI 10.1111/j.0006-341X.2001.00253.x; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Smyth GK., 2013, LIMMA LINEAR MODELS; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tai YC, 2009, BIOMETRICS, V65, P40, DOI 10.1111/j.1541-0420.2008.01057.x; Thompson DA, 2013, ELIFE, V2, DOI [10.7554/eLife.01114, 10.7554/eLife.00603]; Tikkanen I, 1996, AM J NEPHROL, V16, P273, DOI 10.1159/000169009; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Wehrens R., 2007, SELF SUPER ORG MAPS; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Zhang TY, 2014, SCI REP-UK, V4, DOI 10.1038/srep03867	50	26	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0134540	10.1371/journal.pone.0134540	http://dx.doi.org/10.1371/journal.pone.0134540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313144	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000009
J	Vaz, ER; Fujimura, PT; Araujo, GR; da Silva, CAT; Silva, RL; Cunha, TM; Lopes-Ferreira, M; Lima, C; Ferreira, MJ; Cunha-Junior, JP; Taketomi, EA; Goulart, LR; Ueira-Vieira, C				Vaz, Emilia R.; Fujimura, Patricia T.; Araujo, Galber R.; da Silva, Carlos A. T.; Silva, Rangel L.; Cunha, Thiago M.; Lopes-Ferreira, Monica; Lima, Carla; Ferreira, Marcio J.; Cunha-Junior, Jair P.; Taketomi, Ernesto A.; Goulart, Luiz R.; Ueira-Vieira, Carlos			A Short Peptide That Mimics the Binding Domain of TGF-beta 1 Presents Potent Anti-Inflammatory Activity	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; HUMAN ENDOTHELIAL-CELLS; TGF-BETA; E-SELECTIN; TNF-ALPHA; IN-VIVO; AUTOIMMUNE-DISEASE; NOD MICE	The transforming growth factor beta 1 (TGF-beta 1) is a pleiotropic cytokine with multiple roles in development, wound healing, and immune regulation. TGF-beta 1-mediated immune dysfunction may lead to pathological conditions, such as inflammation. Chronic inflammatory process is characterized by a continuous release of pro-inflammatory cytokines, and the inhibition or the blockage of these cytokines signaling pathways are considered a target treatment. In this context, despite the high numbers of TGF-beta-targeted pathways, the inducible regulatory T cells (iTreg) to control inflammation seems to be a promising approach. Our aim was to develop novel peptides through phage display (PhD) technology that could mimic TGF-beta 1 function with higher potency. Specific mimetic peptides were obtained through a PhD subtraction strategy from whole cell binding using TGF-beta 1 recombinant as a competitor during elution step. We have selected a peptide that seems to play an important role on cellular differentiation and modulation of TNF-alpha and IL-10 cytokines. The synthetic pm26TGF-beta 1 peptide tested in PBMC significantly down-modulated TNF-alpha and up-regulated IL-10 responses, leading to regulatory T cells (Treg) phenotype differentiation. Furthermore, the synthetic peptide was able to decrease leukocytes rolling in BALB/C mice and neutrophils migration during inflammatory process in C57BL/6 mice. These data suggest that this peptide may be useful for the treatment of inflammatory diseases, especially because it displays potent anti-inflammatory properties and do not exhibit neutrophils' chemoattraction.	[Vaz, Emilia R.; Fujimura, Patricia T.; Araujo, Galber R.; da Silva, Carlos A. T.; Goulart, Luiz R.; Ueira-Vieira, Carlos] Univ Fed Uberlandia, Inst Genet & Biochem, Lab Nanobiotechnol, BR-38400 Uberlandia, MG, Brazil; [Silva, Rangel L.; Cunha, Thiago M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Lopes-Ferreira, Monica; Lima, Carla; Ferreira, Marcio J.] Butantan Inst, Special Lab Appl Toxicol CEPID FAPESP, Immunoregulat Unit, Sao Paulo, Sao Paulo State, Brazil; [Cunha-Junior, Jair P.; Taketomi, Ernesto A.] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunotechnol & Immunochem, BR-38400 Uberlandia, MG, Brazil; [Goulart, Luiz R.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	Universidade Federal de Uberlandia; Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Instituto Butantan; Universidade Federal de Uberlandia; University of California System; University of California Davis	Vaz, ER (corresponding author), Univ Fed Uberlandia, Inst Genet & Biochem, Lab Nanobiotechnol, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	emiliarezendev@gmail.com	Lima, Carla/B-6750-2019; da Silva, Carlos Antonio/A-2880-2019; Silva, Rangel Leal/G-2009-2016; Araujo, Galber/P-5936-2019; da Silva, Carlos Antonio Trindade/AAN-6561-2020; da Silva, Carlos Antonio Trindade/I-4250-2013; Ueira-Vieira, Carlos/J-8998-2014; Goulart, Luiz R/G-7357-2012; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Cunha, Thiago M/B-7729-2012	Lima, Carla/0000-0002-8161-966X; da Silva, Carlos Antonio/0000-0002-7102-2077; Silva, Rangel Leal/0000-0002-1322-7808; Araujo, Galber/0000-0001-6038-8893; da Silva, Carlos Antonio Trindade/0000-0002-5669-4190; da Silva, Carlos Antonio Trindade/0000-0002-5669-4190; Ueira-Vieira, Carlos/0000-0002-8369-9069; Goulart, Luiz R/0000-0002-1803-4861; Cunha, Thiago M/0000-0003-1084-0065; Lopes-Ferreira, Monica/0000-0003-0244-7482	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [APQ 00981-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Brazilian research funding agencies: Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG-APQ 00981-11), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES).	Araujo GR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0685-3; Araujo TG, 2014, CANCER LETT, V343, P275, DOI 10.1016/j.canlet.2013.09.029; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Bignone PA, 2016, METHODS MOL BIOL, V1357, P269, DOI 10.1007/7651_2014_144; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bouma G, 2010, BRIT J HAEMATOL, V151, P312, DOI 10.1111/j.1365-2141.2010.08361.x; Chatzikyriakidou A, 2009, CLIN EXP RHEUMATOL, V27, P645; Chen ZJ, 2015, MOL PHARMACEUT, V12, P2180, DOI 10.1021/acs.molpharmaceut.5b00177; Cheng MH, 2013, CURR OPIN ENDOCRINOL, V20, P271, DOI 10.1097/MED.0b013e32836313eb; CONQUER JA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P1, DOI 10.1016/0167-4889(92)90021-3; Corrado A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/945945; Crane M, 2014, J INFECT DIS, V210, P745, DOI 10.1093/infdis/jiu119; Cunha FQ, 1999, BRIT J PHARMACOL, V127, P671, DOI 10.1038/sj.bjp.0702601; Cuzzocrea S, 2000, AM J RESP CRIT CARE, V162, P1859, DOI 10.1164/ajrccm.162.5.9912125; DiChiara MR, 2000, J EXP MED, V192, P695, DOI 10.1084/jem.192.5.695; Dinarello C A, 1992, Semin Immunol, V4, P133; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Evans HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4199; Figueiredo J, 2013, N-S ARCH PHARMACOL, V386, P311, DOI 10.1007/s00210-013-0834-7; Freier E, 2010, PSYCHONEUROENDOCRINO, V35, P663, DOI 10.1016/j.psyneuen.2009.10.005; GAMBLE JR, 1993, J IMMUNOL, V150, P4494; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Habibagahi M, 2011, RHEUMATOL INT, V31, P1219, DOI 10.1007/s00296-010-1427-0; Hall SW, 2011, MAMM GENOME, V22, P377, DOI 10.1007/s00335-011-9338-2; He QM, 2013, J IMMUNOL, V191, P5858, DOI 10.4049/jimmunol.1302273; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hinck AP, 2011, CURR PHARM BIOTECHNO, V12, P2081; Jenner W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089375; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Keijzer C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00245; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kim A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078061; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kondelkova Katerina, 2010, Acta Medica (Hradec Kralove), V53, P73; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu GQ, 2012, BLOOD, V120, P1942, DOI 10.1182/blood-2011-12-397430; Lopes-Ferreira M, 2014, TOXICON, V90, P237, DOI 10.1016/j.toxicon.2014.08.007; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; Mahmoud AMA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.11901; Moriconi A, 2014, P NATL ACAD SCI USA, V111, P16937, DOI 10.1073/pnas.1417365111; Mukherjee S, 2002, J LEUKOCYTE BIOL, V72, P921; Murakami M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00323; Naviglio S, 2014, J CROHNS COLITIS, V8, P770, DOI 10.1016/j.crohns.2014.01.013; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Phong HDD, 2011, BRIT J CLIN PHARMACO, V72, P912, DOI 10.1111/j.1365-2125.2011.04020.x; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011348; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Slobodin G, 2007, CLIN RHEUMATOL, V26, P764, DOI 10.1007/s10067-006-0371-6; Smith WB, 1996, J IMMUNOL, V157, P360; Sriramarao P, 1996, J IMMUNOL, V157, P4672; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Tse KH, 2014, NEUROSCIENCE, V267, P241, DOI 10.1016/j.neuroscience.2014.02.041; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Wang H, 2013, TRANSPL P, V45, P1822, DOI 10.1016/j.transproceed.2012.10.061; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040314; You S, 2008, ANN NY ACAD SCI, V1150, P300, DOI 10.1196/annals.1447.046; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhang L, 2013, CLIN IMMUNOL, V149, P365, DOI 10.1016/j.clim.2013.08.008; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112	76	7	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136116	10.1371/journal.pone.0136116	http://dx.doi.org/10.1371/journal.pone.0136116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312490	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000042
J	Chung, JM; Robins, RW				Chung, Joanne M.; Robins, Richard W.			Exploring Cultural Differences in the Recognition of the Self-Conscious Emotions	PLOS ONE			English	Article							FACIAL EXPRESSIONS; UNITED-STATES; NONVERBAL EXPRESSION; SHAME; PRIDE; JAPAN; PERCEPTION; ANGER; FACE; AFFORDANCES	Recent research suggests that the self-conscious emotions of embarrassment, shame, and pride have distinct, nonverbal expressions that can be recognized in the United States at above-chance levels. However, few studies have examined the recognition of these emotions in other cultures, and little research has been conducted in Asia. Consequently the cross-cultural generalizability of self-conscious emotions has not been firmly established. Additionally, there is no research that examines cultural variability in the recognition of the self-conscious emotions. Cultural values and exposure to Western culture have been identified as contributors to variability in recognition rates for the basic emotions; we sought to examine this for the self-conscious emotions using the University of California, Davis Set of Emotion Expressions (UCDSEE). The present research examined recognition of the self-conscious emotion expressions in South Korean college students and found that recognition rates were very high for pride, low but above chance for shame, and near zero for embarrassment. To examine what might be underlying the recognition rates we found in South Korea, recognition of self-conscious emotions and several cultural values were examined in a U.S. college student sample of European Americans, Asian Americans, and Asian-born individuals. Emotion recognition rates were generally similar between the European Americans and Asian Americans, and higher than emotion recognition rates for Asian-born individuals. These differences were not explained by cultural values in an interpretable manner, suggesting that exposure to Western culture is a more important mediator than values.	[Chung, Joanne M.; Robins, Richard W.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Chung, Joanne M.] Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands	University of California System; University of California Davis; Tilburg University	Chung, JM (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	j.m.h.chung@uvt.nl	Chung, Joanne M./N-4122-2015	Chung, Joanne M./0000-0002-2191-9644	National Institute of Mental Health Predoctoral Fellowship [T32-MH2006]; National Institute on Drug Abuse [R01-DA-017902]; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH002006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017902] Funding Source: NIH RePORTER	National Institute of Mental Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute of Mental Health Predoctoral Fellowship T32-MH2006 to J.M.C. and National Institute on Drug Abuse Grant R01-DA-017902 to R.W.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Beaupre M.G., 2000, MONTREAL SET FACIAL; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Boiger M, 2014, COGNITION EMOTION, V28, P1255, DOI 10.1080/02699931.2014.881324; Boiger M, 2013, PERS SOC PSYCHOL B, V39, P540, DOI 10.1177/0146167213478201; Butler EA, 2007, EMOTION, V7, P30, DOI 10.1037/1528-3542.7.1.30; Cole PM, 2006, CHILD DEV, V77, P1237, DOI 10.1111/j.1467-8624.2006.00931.x; Crystal DS, 2001, INT J BEHAV DEV, V25, P113, DOI 10.1080/01650250042000177; DUCCI L, 1982, J CROSS CULT PSYCHOL, V13, P340, DOI 10.1177/0022002182013003005; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; Ekman P., 1972, NEBRASKA S MOTIVATIO, P207, DOI DOI 10.1037/0022-3514.53.4.712; Ekman P., 2003, EMOTIONS REVEALED RE, Vsecond; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Fessler D., 2004, J COGNITION CULTURE, V4, P207, DOI DOI 10.1163/1568537041725097; Galvo MG, 2014, J NONVERBAL BEHAV, V38, p[549, 567]; Haidt J, 1999, COGNITION EMOTION, V13, P225, DOI 10.1080/026999399379267; Hofstede G., 2001, CULTURES CONSEQUENCE; Izard C.E., 1971, FACE EMOTION; Jack RE, 2012, J EXP PSYCHOL GEN, V141, P19, DOI 10.1037/a0023463; KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441; Kim Bryan K, 2005, Cultur Divers Ethnic Minor Psychol, V11, P187, DOI 10.1037/1099-9809.11.3.187; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P890, DOI 10.1037/0022-3514.91.5.890; Lagattuta K. H., 2007, SELF CONSCIOUS EMOTI, P91; Lam AG, 2004, J CROSS CULT PSYCHOL, V35, P446, DOI 10.1177/0022022104266108; LEWIS M, 1989, CHILD DEV, V60, P146, DOI 10.1111/j.1467-8624.1989.tb02704.x; LEWIS M, 1992, CHILD DEV, V63, P630, DOI 10.2307/1131351; Lewis M, 2010, INT J BEHAV DEV, V34, P53, DOI 10.1177/0165025409348559; Markus HR, 2010, PERSPECT PSYCHOL SCI, V5, P420, DOI 10.1177/1745691610375557; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; MATSUMOTO D, 1992, J CROSS CULT PSYCHOL, V23, P72, DOI 10.1177/0022022192231005; MATSUMOTO D, 1989, J CROSS CULT PSYCHOL, V20, P92, DOI 10.1177/0022022189201006; Matsumoto D, 2002, COGNITION EMOTION, V16, P721, DOI 10.1080/02699930143000608; Matsumoto D, 1988, JAPANESE CAUCASIAN F; Matsumoto D., 2008, HDB EMOTIONS, V3, P211, DOI DOI 10.1016/J.BRAT.2006.05.004; Matsumoto D, 2012, EVOL HUM BEHAV, V33, P520, DOI 10.1016/j.evolhumbehav.2012.01.005; Prado C, 2014, MOTIV EMOTION, V38, P420, DOI 10.1007/s11031-013-9383-0; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Stipek D, 1998, J CROSS CULT PSYCHOL, V29, P616, DOI 10.1177/0022022198295002; Tanaka A, 2010, PSYCHOL SCI, V21, P1259, DOI 10.1177/0956797610380698; Tangney J. P., 2012, HDB SELF IDENTITY, P446, DOI DOI 10.4135/9781446263402; Tangney JP, 2002, SHAME GUILT INTERPER; Tracy JL, 2008, J PERS SOC PSYCHOL, V94, P516, DOI 10.1037/0022-3514.94.3.516; Tracy JL, 2007, EMOTION, V7, P789, DOI 10.1037/1528-3542.7.4.789; Tracy JL, 2009, EMOTION, V9, P554, DOI 10.1037/a0015766; Tracy JL, 2007, SELF CONSCIOUS EMOTI, P3; Wan C, 2007, J PERS SOC PSYCHOL, V92, P337, DOI 10.1037/0022-3514.92.2.337; Wong Y, 2007, SELF CONSCIOUS EMOTI, P210; Wong Y, 2007, SELF CONSCIOUS EMOTI, P223; Zane N, 2002, INT CUL PSY, P123	49	8	8	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136411	10.1371/journal.pone.0136411	http://dx.doi.org/10.1371/journal.pone.0136411			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26309215	gold, Green Published			2022-12-27	WOS:000360069400122
J	Krehenwinkel, H; Pekar, S				Krehenwinkel, Henrik; Pekar, Stano			An Analysis of Factors Affecting Genotyping Success from Museum Specimens Reveals an Increase of Genetic and Morphological Variation during a Historical Range Expansion of a European Spider	PLOS ONE			English	Article							DNA; ADMIXTURE; PRESERVATIVES; COLLECTIONS; SEQUENCES	Natural history collections house an enormous amount of plant and animal specimens, which constitute a promising source for molecular analyses. Storage conditions differ among taxa and can have a dramatic effect on the success of DNA work. Here, we analyze the feasibility of DNA extraction from ethanol preserved spiders (Araneae). We tested genotyping success using several hundred specimens of the wasp spider, Argiope bruennichi, deposited in two large German natural history collections. We tested the influence of different factors on the utility of specimens for genotyping. Our results show that not the specimen's age, but the museum collection is a major predictor of genotyping success. These results indicate that long term storage conditions should be optimized in natural history museums to assure the utility of collections for DNA work. Using historical material, we also traced historical genetic and morphological variation in the course of a poleward range expansion of A. bruennichi by comparing contemporary and historical specimens from a native and an invasive population in Germany. We show that the invasion of A. bruennichi is tightly correlated with an historical increase of genetic and phenotypic variation in the invasive population.	[Krehenwinkel, Henrik] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, D-24306 Plon, Germany; [Pekar, Stano] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Krehenwinkel, Henrik] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Max Planck Society; Masaryk University Brno; University of California System; University of California Berkeley	Krehenwinkel, H (corresponding author), Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, August Thienemann Str 2, D-24306 Plon, Germany.	Krehenwinkel@berkeley.edu	Pekar, Stano/F-4148-2010	Pekar, Stano/0000-0002-0197-5040	Max Planck Society; Studienstiftung des Deutschen Volkes	Max Planck Society(Max Planck SocietyFoundation CELLEX); Studienstiftung des Deutschen Volkes	This work was supported by institutional funds of the Max Planck Society and a PhD scholarship of the Studienstiftung des Deutschen Volkes.	Casas-Marce M, 2010, MOL ECOL RESOUR, V10, P502, DOI 10.1111/j.1755-0998.2009.02784.x; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Espeland M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-2; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Guttmann R., 1979, Bonner Zoologische Beitraege, V30, P454; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HOUDE P, 1988, AUK, V105, P773; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Krehenwinkel H, 2015, GLOBAL CHAN IN PRESS; Krehenwinkel H, 2013, MOL ECOL, V22, P2232, DOI 10.1111/mec.12223; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Miller JA, 2013, ZOOKEYS, P245, DOI 10.3897/zookeys.365.5787; Moreau CS, 2013, INVERTEBR SYST, V27, P81, DOI 10.1071/IS12067; Paplinska JZ, 2011, BIOL CONSERV, V144, P290, DOI 10.1016/j.biocon.2010.09.005; Pekar S, 2012, MODERN ANAL BIOL DAT, V2; Puillandre N, 2012, MOL ECOL RESOUR, V12, P396, DOI 10.1111/j.1755-0998.2011.03105.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Vink CJ, 2005, INVERTEBR SYST, V19, P99, DOI 10.1071/IS04039; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Watts PC, 2007, J INSECT CONSERV, V11, P195, DOI 10.1007/s10841-006-9024-y; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	29	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136337	10.1371/journal.pone.0136337	http://dx.doi.org/10.1371/journal.pone.0136337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309219	gold, Green Published			2022-12-27	WOS:000360069400109
J	Rother, S; Hundrieser, J; Pokoyski, C; Kollrich, S; Borns, K; Blasczyk, R; Poehnert, D; Klempnauer, J; Schwinzer, R				Rother, Sascha; Hundrieser, Joachim; Pokoyski, Claudia; Kollrich, Sonja; Borns, Katja; Blasczyk, Rainer; Poehnert, Daniel; Klempnauer, Juergen; Schwinzer, Reinhard			The c.503T > C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules	PLOS ONE			English	Article							LECTIN-LIKE TRANSCRIPT-1; HUMAN NK CELLS; T-CELLS; MULTIPLE-SCLEROSIS; HUMAN NKR-P1A; PROINFLAMMATORY CYTOKINES; FUNCTIONAL-ANALYSIS; IMMUNE-RESPONSES; TARGET-CELLS; CUTTING EDGE	Studying genetic diversity of immunologically relevant molecules can improve our knowledge on their functional spectrum in normal immune responses and may also uncover a possible role of different variants in diseases. We characterized the c.503T>C polymorphism in the human KLRB1 gene (Killer cell lectin-like receptor, subfamily B, member 1) coding for the cell surface receptor CD161. CD161 is expressed by subsets of CD4(+) and CD8(+) T cells and the great majority of CD56(+) natural killer (NK) cells, acting as inhibitory receptor in the latter population. Genotyping a cohort of 118 healthy individuals revealed 40% TT homozygotes, 46% TC heterozygotes, and 14% carriers of CC. There was no difference in the frequency of CD161 expressing CD4(+) and CD8(+) T cells between the different genotypes. However, the frequency of CD161(+) NK cells was significantly decreased in CC carriers as compared to TT homozygotes. c.503T>C causes an amino acid exchange (p.Ile168Thr) in an extracellular loop of the CD161 receptor, which is regarded to be involved in binding of its ligand Lectin-like transcript 1 (LLT1). Binding studies using soluble LLT1-Fc on 293 transfectants over-expressing CD161 receptors from TT or CC carriers suggested diminished binding to the CC variant. Furthermore, triggering of CD161 either by LLT1 or anti-CD161 antibodies inhibited NK cell activation less effectively in cells from CC individuals than cells from TT carriers. These data suggest that the c.503T>C polymorphism is associated with structural alterations of the CD161 receptor. The regulation of NK cell homeostasis and activation apparently differs between carriers of the CC and TT variant of CD161.	[Rother, Sascha; Hundrieser, Joachim; Pokoyski, Claudia; Kollrich, Sonja; Borns, Katja; Poehnert, Daniel; Klempnauer, Juergen; Schwinzer, Reinhard] Hannover Med Sch, Transplant Lab, Dept Gen Visceral & Transplantat Surg, Hannover, Germany; [Blasczyk, Rainer] Hannover Med Sch, Dept Transfus Med, Hannover, Germany	Hannover Medical School; Hannover Medical School	Schwinzer, R (corresponding author), Hannover Med Sch, Transplant Lab, Dept Gen Visceral & Transplantat Surg, Hannover, Germany.	schwinzer.reinhard@mh-hannover.de		Blasczyk, Rainer/0000-0003-3875-3190	Deutsche Forschungsgemeinschaft [SFB 738]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft, SFB 738/Project B1 RS and JK received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2002, TRENDS IMMUNOL, V23, P1, DOI 10.1016/S1471-4906(01)02091-9; Afzali B, 2013, EUR J IMMUNOL, V43, P2043, DOI 10.1002/eji.201243296; Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bowles JA, 2005, J IMMUNOL METHODS, V304, P88, DOI 10.1016/j.jim.2005.06.018; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Do HT, 2006, J IMMUNOL, V176, P931, DOI 10.4049/jimmunol.176.2.931; Dulat HJ, 2001, TRANSPLANT P, V33, P262, DOI 10.1016/S0041-1345(00)02795-0; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Flornes LM, 2010, IMMUNOGENETICS, V62, P521, DOI 10.1007/s00251-010-0455-y; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Kamishikiryo J, 2011, J BIOL CHEM, V286, P23823, DOI 10.1074/jbc.M110.214254; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; LANIER LL, 1994, J IMMUNOL, V153, P2417; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Pesenacker AM, 2013, BLOOD, V121, P2647, DOI 10.1182/blood-2012-08-443473; Poggi A, 1997, EUR J IMMUNOL, V27, P2345, DOI 10.1002/eji.1830270932; Poggi A, 2002, J IMMUNOL, V168, P6071, DOI 10.4049/jimmunol.168.12.6071; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Roth P, 2007, CANCER RES, V67, P3540, DOI 10.1158/0008-5472.CAN-06-4783; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Sondergaard HB, 2011, EUR J HUM GENET, V19, P1100, DOI 10.1038/ejhg.2011.88; Sovova Z, 2011, J MOL MODEL, V17, P1353, DOI 10.1007/s00894-010-0837-y; Sullivan JA, 2014, TRANSPLANTATION, V97, P483, DOI 10.1097/TP.0000000000000000; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Warren HS, 2001, INT IMMUNOL, V13, P1043, DOI 10.1093/intimm/13.8.1043	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135682	10.1371/journal.pone.0135682	http://dx.doi.org/10.1371/journal.pone.0135682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309225	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400070
J	Levick, B; Laudisoit, A; Wilschut, L; Addink, E; Ageyev, V; Yeszhanov, A; Sapozhnikov, V; Belayev, A; Davydova, T; Eagle, S; Begon, M				Levick, Bethany; Laudisoit, Anne; Wilschut, Liesbeth; Addink, Elisabeth; Ageyev, Vladimir; Yeszhanov, Aidyn; Sapozhnikov, Valerij; Belayev, Alexander; Davydova, Tania; Eagle, Sally; Begon, Mike			The Perfect Burrow, but for What? Identifying Local Habitat Conditions Promoting the Presence of the Host and Vector Species in the Kazakh Plague System	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; POCKET GOPHERS; SOIL TEXTURE; TEMPERATURE; FLEA; THRESHOLDS; RODENTIA; WILDLIFE; ECOLOGY; DESERT	Introduction The wildlife plague system in the Pre-Balkhash desert of Kazakhstan has been a subject of study for many years. Much progress has been made in generating a method of predicting outbreaks of the disease (infection by the gram negative bacterium Yersinia pestis) but existing methods are not yet accurate enough to inform public health planning. The present study aimed to identify characteristics of individual mammalian host (Rhombomys opimus) burrows related to and potentially predictive of the presence of R. opimus and the dominant flea vectors (Xenopsylla spp.). Methods Over four seasons, burrow characteristics, their current occupancy status, and flea and tick burden of the occupants were recorded in the field. A second data set was generated of long term occupancy trends by recording the occupancy status of specific burrows over multiple occasions. Generalised linear mixed models were constructed to identify potential burrow properties predictive of either occupancy or flea burden. Results At the burrow level, it was identified that a burrow being occupied by Rhombomys, and remaining occupied, were both related to the characteristics of the sediment in which the burrow was constructed. The flea burden of Rhombomys in a burrow was found to be related to the tick burden. Further larger scale properties were also identified as being related to both Rhombomys and flea presence, including latitudinal position and the season. Conclusions Therefore, in advancing our current predictions of plague in Kazakhstan, we must consider the landscape at this local level to increase our accuracy in predicting the dynamics of gerbil and flea populations. Furthermore this demonstrates that in other zoonotic systems, it may be useful to consider the distribution and location of suitable habitat for both host and vector species at this fine scale to accurately predict future epizootics.	[Levick, Bethany; Laudisoit, Anne; Begon, Mike] Univ Liverpool, Inst Integrat Biol, Ecol Evolut & Genom Infect Dis Res Grp, Liverpool L69 3BX, Merseyside, England; [Wilschut, Liesbeth; Addink, Elisabeth] Univ Utrecht, Dept Phys Geog, Utrecht, Netherlands; [Ageyev, Vladimir; Yeszhanov, Aidyn; Sapozhnikov, Valerij; Belayev, Alexander] M Akimbayevs Kazakh Sci Ctr Quarantine & Zoonot D, Alma Ata, Kazakhstan; [Belayev, Alexander; Davydova, Tania] Taldykorgan Antiplague Stn, Taldykorgan, Kazakhstan; [Eagle, Sally] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Utrecht University; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; University of Liverpool	Levick, B (corresponding author), Univ Liverpool, Inst Integrat Biol, Ecol Evolut & Genom Infect Dis Res Grp, Liverpool L69 3BX, Merseyside, England.	b.a.levick@liverpool.ac.uk	LAUDISOIT, Anne/O-5773-2019; Levick, Bethany/AAN-5877-2020; Yeszhanov, Aidyn/E-7440-2015; Laudisoit, Anne M/F-2646-2017; Addink, Elisabeth/E-3340-2012	LAUDISOIT, Anne/0000-0001-7626-9426; Levick, Bethany/0000-0002-6371-8744; Yeszhanov, Aidyn/0000-0001-6572-5668; Laudisoit, Anne M/0000-0001-7626-9426; Addink, Elisabeth/0000-0002-0919-6498; Begon, Mike/0000-0003-1715-5327	Wellcome Trust [090213/z/09/z]; Natural Ecological Research Council grant [NE/L501670/1]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security); Fogarty International Center (National Institutes of Health); NERC [NE/E007899/1] Funding Source: UKRI; Natural Environment Research Council [1370745, NE/E007899/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Natural Ecological Research Council grant; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security); Fogarty International Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding by Wellcome Trust grant 090213/z/09/z http://www.wellcome.ac.uk/ and Natural Ecological Research Council grant NE/L501670/1 http://www.nerc.ac.uk/ MB is supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security) and the Fogarty International Center (National Institutes of Health).	Addink EA, 2010, REMOTE SENS ENVIRON, V114, P674, DOI 10.1016/j.rse.2009.11.015; [Anonymous], 2014, R LANG ENV STAT COMP; BEST TL, 1973, ECOLOGY, V54, P1311, DOI 10.2307/1934193; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brewer SW, 1999, J VEG SCI, V10, P165, DOI 10.2307/3237138; Buhnerkempe MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022498; Burdelov LA, 1998, GUIDE EMERGENCY FIEL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bykov LT, 1966, P TEZ DOLK AK SOV, V3, P47; CAVANAUGH DC, 1971, AM J TROP MED HYG, V20, P264, DOI 10.4269/ajtmh.1971.20.264; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Deom J, 2012, INT WORKSH ALM, P49; FEDOROV V N, 1960, Bull World Health Organ, V23, P275; GA Korneyev, 2005, CAPTURE COUNT FORECA; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gvozdetskii NA, 1963, PHYS GEOGRAPHY USSR, P566; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hoffman JD, 2007, SOUTHWEST NAT, V52, P296, DOI 10.1894/0038-4909(2007)52[296:EOLUAS]2.0.CO;2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Krasnov BR, 2001, MED VET ENTOMOL, V15, P249, DOI 10.1046/j.0269-283x.2001.00295.x; Laundre JW, 1987, GREAT BASIN NAT, V53, P358; Levick B, 2015, DATA PERFECT BURROW; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Naumov NP., 1975, RODENTS DESERT ENV, P465; Onishchenko GG, 2004, NATURAL PLAGUE FOCI; Pogrebinsky MA., 1963, SOILS OF KAZAKHSTAN, V4, P306; Randall Ja, 2005, BEHAV ECOLOGY, V16, P961; Rapoport LP., 2010, ENTOMOL REV, V90, P1003; Reichman O. J., 1990, CURRENT MAMMALOGY, P369; Reijniers J, 2012, ECOL LETT, V15, P554, DOI 10.1111/j.1461-0248.2012.01767.x; RHODES DH, 1985, AM MIDL NAT, V113, P102, DOI 10.2307/2425352; Rivkus JZ, 1992, EPIDEMIOLOGY PROPHYL; Roberts HR, 2014, SW NATURALIST, V42, P323; Ryan Easterday W, 2015, P NATL ACAD SCI USA, P1, DOI [10.1073/pnas.1412887112/-/dcsupplemental:1-10, DOI 10.1073/PNAS.1412887112/-/DCSUPPLEMENTAL:110]; Semachko LL, 1981, ZOD ZH, V40, P1070; Shenbrot G, 2002, J ARID ENVIRON, V51, P265, DOI 10.1006/jare.2001.0945; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Venables WN., 2002, MODERN APPL STAT S 4; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Whitford WG, 1999, J ARID ENVIRON, V41, P203, DOI 10.1006/jare.1998.0482; Wikel SK, 1999, BIOSCIENCE, V49, P311, DOI 10.2307/1313614; Wilkins KT, 2007, SOUTHWEST NAT, V52, P83, DOI 10.1894/0038-4909(2007)52[83:CAOBSO]2.0.CO;2; Wilschut LI, 2013, INT J APPL EARTH OBS, V23, P81, DOI 10.1016/j.jag.2012.11.007; Wilschut LI, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-49; Xu WX, 2012, ECOL RES, V27, P775, DOI 10.1007/s11284-012-0952-6	51	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136962	10.1371/journal.pone.0136962	http://dx.doi.org/10.1371/journal.pone.0136962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325073	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700077
J	Peng, J; Lu, YJ; Liu, WY; Zhu, YW; Yan, XL; Xu, JX; Wang, X; Wang, Y; Liu, W; Sun, ZY				Peng, Jing; Lu, Yanjun; Liu, Weiyong; Zhu, Yaowu; Yan, Xiaoling; Xu, Jingxin; Wang, Xiong; Wang, Yue; Liu, Wei; Sun, Ziyong			Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central China	PLOS ONE			English	Article							INJECTION-DRUG USERS; GENETIC HISTORY; SOUTHERN CHINA; BLOOD-DONORS; 6 VARIANTS; INFECTION; COINFECTION; SUBTYPES; DIVERSITY; DISEASE	Background Little is known about the molecular epidemiology of hepatitis C virus (HCV) infection in Central China. Methodology/Principal Findings A total of 570 patients from Hubei Province in central China were enrolled. These patients were tested positive for HCV antibody prior to blood transfusion. Among them, 177 were characterized by partial NS5B and/or Core-E1 sequences and classified into five subtypes: 1b, 83.0%(147/177); 2a, 13.0% (23/177); 3b, 2.3% (4/177); 6a, 1.1% (2/177); 3a, 0.6% (1/177). Analysis of genotype-associated risk factors revealed that paid blood donation and transfusion before 1997 were strongly associated with subtypes 1b and 2a, while some subtype 2a cases were also found in individuals with high risk sexual behaviors; subtypes 3b, 6a, and 3a were detected only in intravenous drug users. Phylogeographic analyses based on the coalescent datasets demonstrated that 1b, 2a, 3b, and 6a were locally epidemic in Hubei Province. Among them, subtype 1b Hubei strains may have served as the origins of this subtype in China, and 2a and 3b Hubei strains may have descended from the northwest and southwest of China, respectively, while 6a Hubei strains may have been imported from the central south and southwest. Conclusion/Significance The results suggest that the migration patterns of HCV in Hubei are complex and variable among different subtypes. Implementation of mandatory HCV screening before donation has significantly decreased the incidence of transfusion-associated HCV infection since 1997. More attention should be paid to intravenous drug use and unsafe sexual contact, which may have become new risk factors for HCV infection in Hubei Province.	[Peng, Jing; Lu, Yanjun; Liu, Weiyong; Zhu, Yaowu; Yan, Xiaoling; Xu, Jingxin; Wang, Xiong; Wang, Yue; Sun, Ziyong] Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Liu, Wei] Huazhong Univ Sci & Technol, Dept Publ Hlth, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Sun, ZY (corresponding author), Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	zysun@tjh.tjmu.edu.cn	Wang, Xiong/ABF-2904-2021		Infectious Diseases Control Project from Ministry of Health of China [2012zx10004-207]	Infectious Diseases Control Project from Ministry of Health of China	This work was supported by the Infectious Diseases Control Project from Ministry of Health of China (2012zx10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2014, WORLD J GASTROENTERO, V20, P9633, DOI 10.3748/wjg.v20.i29.9633; Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Brown M S, 1984, Nurse Pract, V9, P42; Brown MS, 1984, NURSE PRACT, V9, P42; Brown MS, 1984, NURSE PRACT, V9, P6; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gu L, 2013, J CLIN VIROL, V57, P311, DOI 10.1016/j.jcv.2013.04.013; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Hsu E, 1996, SOC SCI MED, V42, P421, DOI 10.1016/0277-9536(95)00106-9; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Lu L, 2014, J VIROL, V88, P7120, DOI 10.1128/JVI.00414-14; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Wu SJ, 2011, J MED VIROL, V83, P1930, DOI 10.1002/jmv.22168; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Xu R, 2013, INFECT GENET EVOL, V20, P225, DOI 10.1016/j.meegid.2013.08.014; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698; ZHANG YY, 1995, J CLIN MICROBIOL, V33, P2931, DOI 10.1128/JCM.33.11.2931-2934.1995; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082598; Zhao R, 2013, J MED VIROL, V85, P1712, DOI 10.1002/jmv.23650	38	17	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137059	10.1371/journal.pone.0137059	http://dx.doi.org/10.1371/journal.pone.0137059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325070	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700088
J	Noor, AM; Kibuchi, E; Mitto, B; Coulibaly, D; Doumbo, OK; Snow, RW				Noor, Abdisalan Mohamed; Kibuchi, Eliud; Mitto, Bernard; Coulibaly, Drissa; Doumbo, Ogobara K.; Snow, Robert W.			Sub-National Targeting of Seasonal Malaria Chemoprevention in the Sahelian Countries of the Nouakchott Initiative	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; VIVAX MALARIA; TRANSMISSION; INFECTION	Background Seasonal malaria chemoprevention (SMC) has been shown to be highly efficacious against clinical malaria in areas where transmission is acutely seasonal. SMC targeting depends on a complex interplay of climate, malaria transmission and population distribution. In this study a spatial decision support framework was developed to identify health districts suitable for the targeting of SMC across seven Sahelian countries and northern states of Nigeria that are members of the Nouakchott Initiative. Methods A spatially explicit decision support framework that links information on seasonality, age-structured population, urbanization, malaria endemicity and the length of transmission season was developed to inform SMC targeting in health districts. Thresholds of seasonality, population and receptive risks were defined to delineate SMC suitable health districts and define the age range of children for targeting. Numbers of children were then computed for the period 2015-2020 in SMC districts. For 2015, this was combined with maps of length of malaria transmission seasons and WHO recommended treatment regimen to quantify the number of tablets required across the SMC health districts. Results A total of 597 Sahelian health districts were mapped, out of which 478 (80.1%) were considered suitable for SMC based on seasonality and endemicity thresholds. These districts had an estimated 119.8 million (85%) of the total population in 2015. In the six years from 20152020, it is estimated that a total of 158 million children 3m to <5 years, 121 million of whom were in rural areas, will need SMC to achieve universal coverage in the Sahel. If the upper age limit of SMC targeted children was increased to <10 years in low transmission districts, a total 177 million overall, of whom 135 million were rural children, will require chemoprevention in 2015-2020. In 2015 alone, an estimated 49-72 million SP tablets and 148-217 million AQ tablets will be needed to cover all or rural children respectively under the different scenarios of upper age limits. Conclusions Our proposed framework provides a standardised approach to support targeting and scale up of SMC by the countries of the Nouakchott Initiative. Our analysis suggests that the vast majority of the population in this region are likely to benefit from SMC and substantial resources will be required to reach universal coverage each year.	[Noor, Abdisalan Mohamed; Kibuchi, Eliud; Mitto, Bernard; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Spatial Hlth Metr Grp, INFORM Informat Malaria, Nairobi, Kenya; [Noor, Abdisalan Mohamed; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Coulibaly, Drissa; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali	Kenya Medical Research Institute; University of Oxford; University of Science & Technology of Bamako	Noor, AM (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Spatial Hlth Metr Grp, INFORM Informat Malaria, Nairobi, Kenya.	anoor@kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [095127, 079080, 103602]; UK's Department for International Development; Clinton Health Access Initiative	Wellcome Trust(Wellcome TrustEuropean Commission); UK's Department for International Development; Clinton Health Access Initiative	AMN is supported by the Wellcome Trust as an Intermediate Fellow (#095127), RWS is supported by the Wellcome Trust as Principal Research Fellow (# 079080 and # 103602) that also supported BM and EK. This work received support from the UK's Department for International Development through a grant to the Roll Back Malaria Partnership and the Clinton Health Access Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabeu M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-405; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; FOLLAND C, 1991, J FORECASTING, V10, P21, DOI 10.1002/for.3980100104; Global Administrative Unit Layers, BORD COUNTR ADM COUN; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-67; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Grover-Kopec EK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-38; Hadley Centre, 2010, SAH CLIM CURR PRED; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Koita OA, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/367160; Lekweiry KM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-92; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lodoun T, 2013, THEOR APPL CLIMATOL; Meremikwu MM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub4; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Pindolia DK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-397; RAMSDALE CD, 1983, J TROP MED HYG, V86, P51; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Snow RW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0254-7; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; The NOAA Climate Prediction Center, 2002, AFR RAINF EST ALG VE; United Nations Population Division, WORLD URB PROSP 2012; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, SEAS MAL CHEM SULPH; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; World Health Organization, GLOB TECHN STRART MA; Wurtz N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-336	32	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136919	10.1371/journal.pone.0136919	http://dx.doi.org/10.1371/journal.pone.0136919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322634	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000360435500048
J	da Cruz, VAR; Schenkel, FS; Savegnago, RP; Grupioni, NV; Stafuzza, NB; Sargolzaei, M; Ibelli, AMG; Peixoto, JD; Ledur, MC; Munari, DP				Rocha da Cruz, Valdecy Aparecida; Schenkel, Flavio Schramm; Savegnago, Rodrigo Pelicioni; Grupioni, Natalia Vinhal; Stafuzza, Nedenia Bonvino; Sargolzaei, Mehdi; Guaratini Ibelli, Adriana Mercia; Peixoto, Jane de Oliveira; Ledur, Monica Correa; Munari, Danisio Prado			Association of Apolipoprotein B and Adiponectin Receptor 1 Genes with Carcass, Bone Integrity and Performance Traits in a Paternal Broiler Line	PLOS ONE			English	Article							ADIPOSE-TISSUE; CHICKEN; GROWTH; POLYMORPHISM; WEIGHT; RESTRICTION; LIPOPROTEIN; EXPRESSION; DENSITY; PROFILE	Apolipoprotein B (APOB) and Adiponectin Receptor 1 (ADIPOR1) are related to the regulation of feed intake, fat metabolism and protein deposition and are candidate genes for genomic studies in birds. In this study, associations of two single nucleotide polymorphisms (SNPs) g.102A>T (APOB) and g.729C>T (ADIPOR1) with carcass, bone integrity and performance traits in broilers were investigated. Genotyping was performed on a paternal line of 1,454 broilers. The SNP detection was carried out by PCR-RFLP technique using the restriction enzymes HhaI for the SNP g.729C>T and Msll for the SNP g.102A>T. The association analyses of the two SNPs with 85 traits were performed using the restricted maximum likelihood (REML) and Generalized Quasi-Likelihood Score (GQLS) methods. For REML the model included the random additive genetic effect of animal and fixed effects of sex, hatch and SNP genotypes. In the GQLS method, a logistic regression was used to associate the genotypes with phenotypes adjusted for fixed effects of sex and hatch. The SNP g.729C>T in the ADIPOR1 gene was associated with thickness of the femur and breast skin yield. Thus, the ADIPOR1 gene seems implicated in the metabolism and/or fat deposition and bone integrity in broilers.	[Rocha da Cruz, Valdecy Aparecida; Savegnago, Rodrigo Pelicioni; Grupioni, Natalia Vinhal; Stafuzza, Nedenia Bonvino; Munari, Danisio Prado] Univ Estadual Paulista UNESP, Dept Ciencias Exatas, Fac Ciencias Agr & Vet FCAV, Sao Paulo, Brazil; [Schenkel, Flavio Schramm] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Sargolzaei, Mehdi] Semex Alliance, Guelph, ON, Canada; [Guaratini Ibelli, Adriana Mercia; Peixoto, Jane de Oliveira; Ledur, Monica Correa] Embrapa Suinos & Aves, Concordia, SC, Brazil	Universidade Estadual Paulista; University of Guelph; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Munari, DP (corresponding author), Univ Estadual Paulista UNESP, Dept Ciencias Exatas, Fac Ciencias Agr & Vet FCAV, Sao Paulo, Brazil.	danisio@fcav.unesp.br	Stafuzza, Nedenia Bonvino/M-9224-2019; Ibelli, Adriana/B-4510-2010; Cruz, Valdecy A R/F-3067-2014; Stafuzza, Nedenia B./C-4419-2013; Savegnago, Rodrigo Pelicioni/H-7396-2012; Ibelli, Adriana/AAC-5017-2020; Ledur, Monica/A-5667-2013; Schenkel, Flavio/ABG-1842-2021; Munari, Danisio P/C-6384-2012	Stafuzza, Nedenia Bonvino/0000-0001-6432-2330; Ibelli, Adriana/0000-0003-0626-8879; Cruz, Valdecy A R/0000-0003-2853-3514; Stafuzza, Nedenia B./0000-0001-6432-2330; Savegnago, Rodrigo Pelicioni/0000-0002-6551-2168; Ibelli, Adriana/0000-0003-0626-8879; Ledur, Monica/0000-0002-2645-4735; Munari, Danisio P/0000-0001-6915-038X; Schenkel, Flavio/0000-0001-8700-0633	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES) [12280-12-7]; "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP); CAPES; "Brazilian Agricultural Research Corporation Swine and Poultry' (EMBRAPA); National Counsel of Technological and Scientific Development (CNPq); CNPq	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); "Brazilian Agricultural Research Corporation Swine and Poultry' (EMBRAPA)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	VARC would like to thank the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES) (grantee n. 12280-12-7). RPS was supported by a fellowship from "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP). NVG was supported by fellowship from CAPES and "Brazilian Agricultural Research Corporation Swine and Poultry' (EMBRAPA). NBS was supported by postdoctoral fellowship from National Counsel of Technological and Scientific Development (CNPq). DPM was supported by productivity research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBATO GF, 1994, J NUTR, V124, pS1341, DOI 10.1093/jn/124.suppl_8.1341S; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Chung ER, 2005, ASIAN AUSTRAL J ANIM, V18, P1061, DOI 10.5713/ajas.2005.1061; Crespo N, 2001, POULTRY SCI, V80, P71, DOI 10.1093/ps/80.1.71; Crooijmans RPMA, 2000, MAMM GENOME, V11, P360, DOI 10.1007/s003350010068; Dalanezi JA, 2005, ARQ BRAS MED VET ZOO, V57, P250, DOI 10.1590/S0102-09352005000200018; Dransfield E, 1999, POULTRY SCI, V78, P743, DOI 10.1093/ps/78.5.743; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feng Z, 2011, ANN APPL STAT, V5, P2109, DOI 10.1214/11-AOAS465; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gilmour AR, 2009, ASREML USER GUIDE RE; Gonnelli S, 2008, CALCIFIED TISSUE INT, V83, P55, DOI 10.1007/s00223-008-9149-y; Gonzales E, 1998, POULTRY SCI, V77, P1646, DOI 10.1093/ps/77.11.1646; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; HOOD RL, 1982, POULTRY SCI, V61, P117, DOI 10.3382/ps.0610117; Jiang YL, 2002, ASIAN AUSTRAL J ANIM, V15, P1543, DOI 10.5713/ajas.2002.1543; Jin ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100339; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Li H, 2003, POULTRY SCI, V82, P347, DOI 10.1093/ps/82.3.347; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Luo NL, 2012, DIABETES, V61, pA415; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; Meng H, 2005, ASIAN AUSTRAL J ANIM, V18, P1221, DOI 10.5713/ajas.2005.1221; Mignon-Grasteau S, 2000, J ANIM SCI, V78, P2515; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ninov K, 2008, SCI AGR, V65, P214, DOI 10.1590/S0103-90162008000200016; Pisto P, 2012, SCAND J CLIN LAB INV, V72, P395, DOI 10.3109/00365513.2012.687759; SAS, 2001, SAS US GUID STAT; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; SINSIGALLI NA, 1987, J NUTR, V117, P941, DOI 10.1093/jn/117.5.941; Tahmoorespur M, 2010, POULTRY SCI, V89, P2092, DOI 10.3382/ps.2010-00772; Vieira SL, 1998, J APPL POULTRY RES, V7, P339, DOI 10.1093/japr/7.4.339; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Xu DQ, 2005, ASIAN AUSTRAL J ANIM, V18, P1519, DOI 10.5713/ajas.2005.1519; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang BZ, 2005, ASIAN AUSTRAL J ANIM, V18, P458, DOI 10.5713/ajas.2005.458; Zhang S, 2006, POULTRY SCI, V85, P178, DOI 10.1093/ps/85.2.178	45	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136824	10.1371/journal.pone.0136824	http://dx.doi.org/10.1371/journal.pone.0136824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322976	Green Published, gold			2022-12-27	WOS:000360435500039
J	Binyaruka, P; Patouillard, E; Powell-Jackson, T; Greco, G; Maestad, O; Borghi, J				Binyaruka, Peter; Patouillard, Edith; Powell-Jackson, Timothy; Greco, Giulia; Maestad, Ottar; Borghi, Josephine			Effect of Paying for Performance on Utilisation, Quality, and User Costs of Health Services in Tanzania: A Controlled Before and After Study	PLOS ONE			English	Article							PRIMARY-CARE; INCENTIVES; PAYMENT; IMPACT; IMPROVEMENTS; PROGRAM; REFORM	Background Despite widespread implementation across Africa, there is limited evidence of the effect of payment for performance (P4P) schemes in low income countries on the coverage of quality services and affordability, consistent with universal health coverage objectives. We examined the effect of a government P4P scheme on utilisation, quality, and user costs of health services in Tanzania. Methods We evaluated the effects of a P4P scheme on utilisation of all maternal and child immunization services targeted by the scheme, and non-targeted general outpatient service use. We also evaluated effects on patient satisfaction with care and clinical content of antenatal care, and user costs. The evaluation was done in 150 facilities across all 7 intervention districts and 4 comparison districts with two rounds of data collection over 13-months in January 2012 and February 2013. We sampled 3000 households of women who had delivered in the 12 months prior to interview; 1500 patients attending health facilities for targeted and non-targeted services at each round of data collection. Difference-in-difference regression analysis was employed. Findings We estimated a significant positive effect on two out of eight targeted indicators. There was an 8.2% (95% CI: 3.6% to 12.8%) increase in coverage of institutional deliveries among women in the intervention area, and a 10.3%(95% CI: 4.4% to 16.1%) increase in the provision of anti-malarials during pregnancy. Use of non-targeted services reduced at dispensaries by 57.5 visits per month among children under five (95% CI: -110.2 to -4.9) and by 90.8 visits per month for those aged over five (95% CI: -156.5 to -25.2). There was no evidence of an effect of P4P on patient experience of care for targeted services. There was a 0.05 (95% CI: 0.01 to 0.10) increase in the patient satisfaction score for non-targeted services. P4P was associated with a 5.0% reduction in those paying out of pocket for deliveries (95% CI: -9.3% to -0.7%) but there was no evidence of an effect on the average amount paid. Conclusion This study adds to the very limited evidence on the effects of P4P at scale and highlights the potential risks of such schemes in relation to non-targeted service use. Further consideration of the design of P4P schemes is required to enhance progress towards universal health coverage, and close monitoring of effects on non-targeted services and user costs should be encouraged.	[Binyaruka, Peter] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Patouillard, Edith; Powell-Jackson, Timothy; Greco, Giulia; Borghi, Josephine] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Maestad, Ottar] CHR Michelsen Inst, Bergen, Norway	Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine	Borghi, J (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	jo.borghi@lshtm.ac.uk		Greco, Giulia/0000-0002-5448-9521; Borghi, Josephine/0000-0002-0482-5451; Patouillard, Edith/0000-0001-7347-2824	Government of Norway [TAN-3108, TAN 13/0005]	Government of Norway	This study was funded by the Government of Norway, grant numbers: TAN-3108 and TAN 13/0005. http://www.norad.no/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bonfrer I, 2014, SOC SCI MED, V123, P96, DOI 10.1016/j.socscimed.2014.11.004; Bonfrer I, 2014, HEALTH AFFAIR, V33, P2179, DOI 10.1377/hlthaff.2014.0081; Borghi J, 2015, HEALTH AFFAIR, V34, P406, DOI 10.1377/hlthaff.2014.0608; Borghi J, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-80; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Eichler R, 2013, J HEALTH POPUL NUTR, V31, P36; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Ettner SL, 2006, HEALTH SERV RES, V41, P1221, DOI 10.1111/j.1475-6773.2006.00533.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Hasnain Z., 2012, POLICY RES WORKING P; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Huntington D, 2010, J HEALTH POPUL NUTR, V28, P273; Ireland M, 2011, B WORLD HEALTH ORGAN, V89, P695, DOI [10.2471/BLT.11.87379, 10.2471/BLT.11.087379]; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Kruk ME, 2008, TROP MED INT HEALTH, V13, P1442, DOI 10.1111/j.1365-3156.2008.02173.x; Martinez P, 2012, EVALUATION HLTH RESU; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Morad S, 2013, EVIDENCE BASED MIDWI; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Morgan L, 2013, J HEALTH POPUL NUTR, V31, P8; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; Nabukera SK, 2006, J COMMUN HEALTH, V31, P84, DOI 10.1007/s10900-005-9003-3; Njuki R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-426; Pearson M., 2011, RESULTS BASED AID RE; Quick J, 2014, PLOS MED, V11; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Skiles MP, 2013, HEALTH POLICY PLANN, V28, P825, DOI 10.1093/heapol/czs122; Soeters R, 2011, HEALTH AFFAIR, V30, P1518, DOI 10.1377/hlthaff.2009.0019; Steel Nicholas, 2010, Qual Prim Care, V18, P117; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Tanzania URo, 2013, 2012 POP HOUS CENS; UN, 2013, HIGH LEVEL DIALOGUE; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wang H, 2011, HEALTH AFFAIR, V30, P2427, DOI 10.1377/hlthaff.2009.0022; WHO, 2010, WOR HEALT REP, P1; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; World Bank, IMP EV TOOLK; World Health Organization, 2014, MON PROGR UN HLTH CO; Zeng W, 2013, HEALTH POLICY PLANN, V28, P596, DOI 10.1093/heapol/czs099	43	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135013	10.1371/journal.pone.0135013	http://dx.doi.org/10.1371/journal.pone.0135013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317510	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000360299100021
J	Bordas-Le Floch, V; Le Mignon, M; Bouley, J; Groeme, R; Jain, K; Baron-Bodo, V; Nony, E; Mascarell, L; Moingeon, P				Bordas-Le Floch, Veronique; Le Mignon, Maxime; Bouley, Julien; Groeme, Rachel; Jain, Karine; Baron-Bodo, Veronique; Nony, Emmanuel; Mascarell, Laurent; Moingeon, Philippe			Identification of Novel Short Ragweed Pollen Allergens Using Combined Transcriptomic and Immunoproteomic Approaches	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; AMBROSIA-ARTEMISIIFOLIA; MUGWORT POLLEN; GRASS-POLLEN; AMB; SENSITIZATION; EXPRESSION; REACTIVITY; PROTEOME; SPECTRUM	Background Allergy to short ragweed (Ambrosia artemisiifolia) pollen is a serious and expanding health problem in North America and Europe. Whereas only 10 short ragweed pollen allergens are officially recorded, patterns of IgE reactivity observed in ragweed allergic patients suggest that other allergens contribute to allergenicity. The objective of the present study was to identify novel allergens following extensive characterization of the transcriptome and proteome of short ragweed pollen. Methods Following a Proteomics-Informed-by-Transcriptomics approach, a comprehensive transcriptomic data set was built up from RNA-seq analysis of short ragweed pollen. Mass spectrometry-based proteomic analyses and IgE reactivity profiling after high resolution 2D-gel electrophoresis were then combined to identify novel allergens. Results Short ragweed pollen transcripts were assembled after deep RNA sequencing and used to inform proteomic analyses, thus leading to the identification of 573 proteins in the short ragweed pollen. Patterns of IgE reactivity of individual sera from 22 allergic patients were assessed using an aqueous short ragweed pollen extract resolved over 2D-gels. Combined with information derived from the annotated pollen proteome, those analyses revealed the presence of multiple unreported IgE reactive proteins, including new Amb a 1 and Amb a 3 isoallergens as well as 7 novel candidate allergens reacting with IgEs from 20-70% of patients. The latter encompass members of the carbonic anhydrase, enolase, galactose oxidase, GDP dissociation inhibitor, pathogenesis related-17, polygalacturonase and UDPglucose pyrophosphorylase families. Conclusions We extended the list of allergens identified in short ragweed pollen. These findings have implications for both diagnosis and allergen immunotherapy purposes.	[Bordas-Le Floch, Veronique; Le Mignon, Maxime; Bouley, Julien; Groeme, Rachel; Jain, Karine; Baron-Bodo, Veronique; Nony, Emmanuel; Mascarell, Laurent; Moingeon, Philippe] Stallergenes, F-92183 Antony, France	Stallergenes Greer	Moingeon, P (corresponding author), Stallergenes, 6 Rue Alexis de Tocqueville, F-92183 Antony, France.	pmoingeon@stallergenes.com		Nony, Emmanuel/0000-0003-1820-8881	Stallergenes SA	Stallergenes SA	This study was supported by Stallergenes SA which provided support in the form of salaries for authors V.B.L.F., M.L.M., J.B., R.G., K.J., V.B.B., E.N., L.M. and P.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are listed in the 'author contributions' section. No other specific funding was received for this work.	ADOLPHSON C, 1978, J ALLERGY CLIN IMMUN, V62, P197, DOI 10.1016/0091-6749(78)90208-7; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Asero R, 2014, ANN ALLERG ASTHMA IM, V113, P307, DOI 10.1016/j.anai.2014.06.009; Augustin S, 2013, ALLERGY, V68, P118; Bouley J, 2015, J ALLERGY CLIN IMMUN, V136, P1055, DOI 10.1016/j.jaci.2015.03.001; Burbach GJ, 2009, ALLERGY, V64, P664, DOI 10.1111/j.1398-9995.2009.01975.x; Campbell BC, 2015, J ALLERGY CLIN IMMUN, V135, P133, DOI 10.1016/j.jaci.2014.06.034; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Conti A, 2007, Eur Ann Allergy Clin Immunol, V39, P116; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; El Kelish A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-176; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; Fonseca C, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-17; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2004, CURR ALLERGY ASTHM R, V4, P391, DOI 10.1007/s11882-004-0090-5; GHOSH B, 1993, J IMMUNOL, V150, P5391; Hiller KM, 1998, SCAND J IMMUNOL, V48, P26; Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P155, DOI 10.1159/000024392; Hur GY, 2008, J KOREAN MED SCI, V23, P72, DOI 10.3346/jkms.2008.23.1.72; Jahn-Schmid B, 2012, J IMMUNOL, V188, P1559, DOI 10.4049/jimmunol.1102445; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; Leonard R, 2010, J BIOL CHEM, V285, P27192, DOI 10.1074/jbc.M110.127118; Lopez-Casado G, 2012, PROTEOMICS, V12, P761, DOI 10.1002/pmic.201100164; Midoro-Horiuti T, 2001, ANN ALLERG ASTHMA IM, V87, P261, DOI 10.1016/S1081-1206(10)62238-7; Nandy A, 2011, J ALLERGY CLIN IMMUN, V127, pAB168, DOI 10.1016/j.jaci.2010.12.668; Nandy A, 2013, J ALLERGY CLIN IMMUN, V131, pAB16, DOI 10.1016/j.jaci.2012.12.736; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Schulten V, 2013, P NATL ACAD SCI USA, V110, P3459, DOI 10.1073/pnas.1300512110; Sinha M, 2014, SCI WORLD J, DOI 10.1155/2014/543195; Wopfner N, 2008, ALLERGY, V63, P872, DOI 10.1111/j.1398-9995.2008.01635.x; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; Zhang PF, 2010, PLANT PHYSIOL, V153, P1479, DOI 10.1104/pp.110.157396; Zhao F, 2016, PLANT CELL ENVIRON, V39, P147, DOI 10.1111/pce.12601	35	20	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136258	10.1371/journal.pone.0136258	http://dx.doi.org/10.1371/journal.pone.0136258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317427	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100068
J	Chen, SR; Gendelman, HK; Roche, JP; Alsharif, P; Graf, ER				Chen, Shirui; Gendelman, Hannah K.; Roche, John P.; Alsharif, Peter; Graf, Ethan R.			Mutational Analysis of Rab3 Function for Controlling Active Zone Protein Composition at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; PUTATIVE TARGET PROTEIN; ACTIVATING PROTEIN; STRUCTURAL BASIS; BINDING PROTEIN; NEUROTRANSMITTER RELEASE; GLUTAMATE RECEPTORS; PANCREATIC ACINI; VESICLE RELEASE; EFFECTOR DOMAIN	At synapses, the release of neurotransmitter is regulated by molecular machinery that aggregates at specialized presynaptic release sites termed active zones. The complement of active zone proteins at each site is a determinant of release efficacy and can be remodeled to alter synapse function. The small GTPase Rab3 was previously identified as playing a novel role that controls the distribution of active zone proteins to individual release sites at the Drosophila neuromuscular junction. Rab3 has been extensively studied for its role in the synaptic vesicle cycle; however, the mechanism by which Rab3 controls active zone development remains unknown. To explore this mechanism, we conducted a mutational analysis to determine the molecular and structural requirements of Rab3 function at Drosophila synapses. We find that GTP-binding is required for Rab3 to traffick to synapses and distribute active zone components across release sites. Conversely, the hydrolytic activity of Rab3 is unnecessary for this function. Through a structure-function analysis we identify specific residues within the effector-binding switch regions that are required for Rab3 function and determine that membrane attachment is essential. Our findings suggest that Rab3 controls the distribution of active zone components via a vesicle docking mechanism that is consistent with standard Rab protein function.	[Chen, Shirui; Gendelman, Hannah K.; Roche, John P.; Alsharif, Peter; Graf, Ethan R.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Amherst College	Graf, ER (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	egraf@amherst.edu			National Institute of Neurological Disorders and Stroke [R15 NS087601]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS087601] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke R15 NS087601 to ERG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; Bruckner JJ, 2012, J NEUROSCI, V32, P17048, DOI 10.1523/JNEUROSCI.3267-12.2012; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Graf ER, 2012, J NEUROSCI, V32, P16586, DOI 10.1523/JNEUROSCI.0965-12.2012; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Hurd DD, 1996, GENETICS, V144, P1075; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lardong JA, 2015, ACTA CRYSTALLOGR F, V71, P34, DOI 10.1107/S2053230X1402617X; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; MCKIERNAN CJ, 1993, J BIOL CHEM, V268, P24449; Michel K, 2015, EXP CELL RES; Muller M, 2011, NEURON, V69, P749, DOI 10.1016/j.neuron.2011.01.025; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paul MM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00029; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136938	10.1371/journal.pone.0136938	http://dx.doi.org/10.1371/journal.pone.0136938			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317909	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100176
J	Crinelli, R; Bianchi, M; Radici, L; Carloni, E; Giacomini, E; Magnani, M				Crinelli, Rita; Bianchi, Marzia; Radici, Lucia; Carloni, Elisa; Giacomini, Elisa; Magnani, Mauro			Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions	PLOS ONE			English	Article							POLYUBIQUITIN GENE UBC; TRANSCRIPTION FACTOR; PROTEIN-DEGRADATION; KEY FEATURES; REAL-TIME; EXPRESSION; STRESS; QUANTIFICATION; RECOGNITION; BINDING	The promoter of the polyubiquitin C gene (UBC) contains putative heat shock elements (HSEs) which are thought to mediate UBC induction upon stress. However, the mapping and the functional characterization of the cis-acting determinants for its up-regulation have not yet been addressed. In this study, the sequence encompassing 916 nucleotides upstream of the transcription start site of the human UBC gene has been dissected by in silico, in vitro and in vivo approaches. The information derived from this analysis was used to study the functional role and the interplay of the identified HSEs in mediating the transcriptional activation of the UBC gene under conditions of proteotoxic stress, induced by the proteasome inhibitor MG132. Here we demonstrate that at least three HSEs, with different configurations, exist in the UBC promoter: two distal, residing within nucleotides -841/-817 and -715/-691, and one proximal to the transcription start site (nt -100/-65). All of them are bound by transcription factors belonging to the heat shock factor (HSF) family, as determined by bandshift, supershift and ChIP analyses. Site-directed mutagenesis of reporter constructs demonstrated that while the distal elements are involved in the up-regulation of UBC in response to proteasome inhibition, the proximal one appears rather to function as negative regulator of the stress-induced transcriptional activity. This is the first evidence that an HSE may exert a negative role on the transcription driven by other HSE motifs on the same gene promoter, highlighting a new level of complexity in the regulation of HSFs and in the control of ubiquitin levels.	[Crinelli, Rita; Bianchi, Marzia; Radici, Lucia; Carloni, Elisa; Giacomini, Elisa; Magnani, Mauro] Univ Urbino Carlo Bo, Sect Biochem & Mol Biol, Dept Biomol Sci, Urbino, Italy	University of Urbino	Crinelli, R (corresponding author), Univ Urbino Carlo Bo, Sect Biochem & Mol Biol, Dept Biomol Sci, Urbino, Italy.	rita.crinelli@uniurb.it	Magnani, Mauro/A-1919-2008; Giacomini, Elisa/K-3208-2016	Giacomini, Elisa/0000-0003-3289-3221; Carloni, Elisa/0000-0003-1178-9353; Crinelli, Rita/0000-0002-1235-8910; Magnani, Mauro/0000-0001-6456-6626; Bianchi, Marzia/0000-0001-9352-7319	Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN [2008BP25KN_001]	Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca http://hubmiur.pubblica.istruzione.it/web/ricerca/home. PRIN 2008 n. 2008BP25KN_001, granted to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Bianchi M, 2015, GENE, V573, P100, DOI 10.1016/j.gene.2015.07.030; Bianchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065932; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Cooper AR, 2015, NUCLEIC ACIDS RES, V43, P682, DOI 10.1093/nar/gku1312; Crinelli R, 2008, MOL CELL BIOCHEM, V318, P129, DOI 10.1007/s11010-008-9864-8; Crinelli R, 2010, ACS NANO, V4, P2791, DOI 10.1021/nn100057c; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Flick K, 2012, SEMIN CELL DEV BIOL, V23, P515, DOI 10.1016/j.semcdb.2012.01.019; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Frejtag W, 2001, J BIOL CHEM, V276, P14685, DOI 10.1074/jbc.M009224200; Fujimuro M, 2005, BIOL PHARM BULL, V28, P2315, DOI 10.1248/bpb.28.2315; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Lecomte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Nenoi M, 1996, GENE, V175, P179, DOI 10.1016/0378-1119(96)00145-X; Oh C, 2013, ANAL BIOCHEM, V443, P153, DOI 10.1016/j.ab.2013.09.011; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Park CW, 2014, BMB REP, V47, P475, DOI 10.5483/BMBRep.2014.47.9.128; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Pitulescu ME, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-16; Radici L., 2013, ADV BIOSCI BIOTECHNO, V04, P1057, DOI [DOI 10.4236/ABB.2013.412141, 10.4236/abb.2013.412141]; Ryu HW, 2011, BIOCHEM BIOPH RES CO, V404, P470, DOI 10.1016/j.bbrc.2010.12.004; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Tachibana T, 2002, J BIOL CHEM, V277, P22140, DOI 10.1074/jbc.M201267200; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Vihervaara A, 2013, P NATL ACAD SCI USA, V110, pE3388, DOI 10.1073/pnas.1305275110; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x	46	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136882	10.1371/journal.pone.0136882	http://dx.doi.org/10.1371/journal.pone.0136882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317694	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100159
J	Dansithong, W; Paul, S; Scoles, DR; Pulst, SM; Huynh, DP				Dansithong, Warunee; Paul, Sharan; Scoles, Daniel R.; Pulst, Stefan M.; Huynh, Duong P.			Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening	PLOS ONE			English	Article							ALPHA-SYNUCLEIN GENE; FAMILIAL PARKINSONS-DISEASE; MESSENGER-RNA; RAT MODEL; IN-VIVO; DEGRADATION PATHWAYS; LOCUS TRIPLICATION; LYSOSOMAL PATHWAY; ALLELIC VARIATION; SUBSTANTIA-NIGRA	Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by loss of dopaminergic neurons of the substantia nigra. The hallmark of PD is the appearance of neuronal protein aggregations known as Lewy bodies and Lewy neurites, of which alpha-synuclein forms a major component. Familial PD is rare and is associated with missense mutations of the SNCA gene or increases in gene copy number resulting in SNCA overexpression. This suggests that lowering SNCA expression could be therapeutic for PD. Supporting this hypothesis, SNCA reduction was neuroprotective in cell line and rodent PD models. We developed novel cell lines expressing SNCA fused to the reporter genes luciferase (luc) or GFP with the objective to enable high-throughput compound screening (HTS) for small molecules that can lower SNCA expression. Because SNCA expression is likely regulated by far-upstream elements (including the NACP-REP1 located at 8852 bp upstream of the transcription site), we employed zinc finger nuclease (ZFN) genome editing to insert reporter genes in-frame downstream of the SNCA gene in order to retain native SNCA expression control. This ensured full retention of known and unknown up- and downstream genetic elements controlling SNCA expression. Treatment of cells with the histone deacetylase inhibitor valproic acid (VPA) resulted in significantly increased SNCA-luc and SNCA-GFP expression supporting the use of our cell lines for identifying small molecules altering complex modes of expression control. Cells expressing SNCA-luc treated with a luciferase inhibitor or SNCA siRNA resulted in Z'-scores >= 0.75, suggesting the suitability of these cell lines for use in HTS. This study presents a novel use of genome editing for the creation of cell lines expressing alpha-synuclein fusion constructs entirely under native expression control. These cell lines are well suited for HTS for compounds that lower SNCA expression directly or by acting at long-range sites to the SNCA promoter and 5'-UTR.	[Dansithong, Warunee; Paul, Sharan; Scoles, Daniel R.; Pulst, Stefan M.; Huynh, Duong P.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Huynh, DP (corresponding author), Univ Utah, Dept Neurol, 175 North Med Ctr Dr East,5th Floor, Salt Lake City, UT 84112 USA.	dhuynh@genetics.utah.edu		Lewis, Patrick/0000-0003-4537-0489	Rapid Response Innovation Awards Program from the Michael J. Fox Foundation; National Institutes of Health [R37NS033123, RC4NS073009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073009, R37NS033123] Funding Source: NIH RePORTER	Rapid Response Innovation Awards Program from the Michael J. Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Rapid Response Innovation Awards Program (2011-2013) from the Michael J. Fox Foundation to DPH, by grants R37NS033123 to SMP, and RC4NS073009 to DRS and SMP from National Institutes of Health.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Alvarez-Castelao B, 2014, BBA-MOL CELL RES, V1843, P352, DOI 10.1016/j.bbamcr.2013.11.018; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Choi JY, 2014, BIOCHEM BIOPH RES CO, V450, P372, DOI 10.1016/j.bbrc.2014.05.132; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Ebrahimi-Fakhari D, 2012, AUTOPHAGY, V8, P281, DOI 10.4161/auto.8.2.18938; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Grundemann J, 2011, METHODS MOL BIOL, V755, P363, DOI 10.1007/978-1-61779-163-5_30; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hofer A, 2005, J NEURAL TRANSM, V112, P1249, DOI 10.1007/s00702-004-0263-3; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Khodr CE, 2011, BRAIN RES, V1395, P94, DOI 10.1016/j.brainres.2011.04.036; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Koprich JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017698; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McCormack AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012122; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Park JS, 2011, HUM MUTAT, V32, P956, DOI 10.1002/humu.21527; Paul S, 2011, J BIOL CHEM, V286, P38427, DOI 10.1074/jbc.M111.255224; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Raichur A, 2006, NEUROSCIENCE, V142, P859, DOI 10.1016/j.neuroscience.2006.06.052; Ross NT, IDENTIFICATION OF A; Rott R, 2014, CNS NEUROL DISORD-DR, V13, P630, DOI 10.2174/18715273113126660195; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sato A, 2006, J CELL PHYSIOL, V209, P172, DOI 10.1002/jcp.20719; Sato K, 2014, J STROKE CEREBROVASC, V23, P1554, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.051; Scoles DR, 2012, HUM MOL GENET, V21, P5048, DOI 10.1093/hmg/dds349; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Takahashi M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.14; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	71	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136930	10.1371/journal.pone.0136930	http://dx.doi.org/10.1371/journal.pone.0136930			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317803	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100175
J	Haverinen-Shaughnessy, U; Shaughnessy, RJ				Haverinen-Shaughnessy, Ulla; Shaughnessy, Richard J.			Effects of Classroom Ventilation Rate and Temperature on Students' Test Scores	PLOS ONE			English	Article							PERFORMANCE; SCHOOLS; HEALTH	Using a multilevel approach, we estimated the effects of classroom ventilation rate and temperature on academic achievement. The analysis is based on measurement data from a 70 elementary school district (140 fifth grade classrooms) from Southwestern United States, and student level data (N = 3109) on socioeconomic variables and standardized test scores. There was a statistically significant association between ventilation rates and mathematics scores, and it was stronger when the six classrooms with high ventilation rates that were indicated as outliers were filtered (>7.1 l/s per person). The association remained significant when prior year test scores were included in the model, resulting in less unexplained variability. Students' mean mathematics scores (average 2286 points) were increased by up to eleven points (0.5%) per each liter per second per person increase in ventilation rate within the range of 0.9-7.1 l/s per person (estimated effect size 74 points). There was an additional increase of 12-13 points per each 1 degrees C decrease in temperature within the observed range of 20-25 degrees C (estimated effect size 67 points). Effects of similar magnitude but higher variability were observed for reading and science scores. In conclusion, maintaining adequate ventilation and thermal comfort in classrooms could significantly improve academic achievement of students.	[Haverinen-Shaughnessy, Ulla; Shaughnessy, Richard J.] Univ Tulsa, Indoor Air Program, Tulsa, OK 74104 USA; [Haverinen-Shaughnessy, Ulla] Natl Inst Hlth & Welf, Dept Hlth Protect, Kuopio 70701, Finland	University of Tulsa; Finland National Institute for Health & Welfare	Shaughnessy, RJ (corresponding author), Univ Tulsa, Indoor Air Program, 600 S Coll Ave, Tulsa, OK 74104 USA.	rjstulsau@aol.com	Haverinen-Shaughnessy, Ulla/O-5688-2015	Haverinen-Shaughnessy, Ulla/0000-0002-9456-7256	Cleaning Industry Research Institute International (Albany NY, USA); ISSA-The Worldwide Cleaning Industry Association (Lincolnwood IL, USA) as a part of project "Clean standards research for schools K-12"	Cleaning Industry Research Institute International (Albany NY, USA); ISSA-The Worldwide Cleaning Industry Association (Lincolnwood IL, USA) as a part of project "Clean standards research for schools K-12"	The data collection was supported by a collaborative grant from the Cleaning Industry Research Institute International (Albany NY, USA) and ISSA-The Worldwide Cleaning Industry Association (Lincolnwood IL, USA) as a part of project "Clean standards research for schools K-12". The authors had no funding for data analyses and publication of the results.	[Anonymous], 1997, EXP FACT HDB; [Anonymous], 2007, D6245 ASTM; ASHRAE, 2004, 6212004 ASHRAE; ASHRAE, 1992, 551992 ASHRAE; Bako-Biro Z, 2012, BUILD ENVIRON, V48, P215, DOI 10.1016/j.buildenv.2011.08.018; Balfanz R., 2012, CHRONIC ABSENTEEISM; Bearg D. W., 1993, INDOOR AIR QUALITY H; DUNN R., 1990, J MULTICULT COUNS D, V18, P68; Ewing N J, 1992, ROEPER REV, V14; Haverinen-Shaughnessy U, 2011, INDOOR AIR, V21, P121, DOI 10.1111/j.1600-0668.2010.00686.x; Haverinen-Shaughnessy U., 2012, BR J ED RES, V2, P42; Haverinen-Shaughnessy U, 2015, BUILDING ENV; Maddalena R, 2015, INDOOR AIR, V25, P362, DOI 10.1111/ina.12149; Mendell MJ, 2013, INDOOR AIR, V23, P515, DOI 10.1111/ina.12042; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Persily A.K., 1997, ASHRAE T, V103, P193; Rivkin SG, 2005, ECONOMETRICA, V73, P417, DOI 10.1111/j.1468-0262.2005.00584.x; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; Turunen M, 2014, INT J HYG ENVIR HEAL, V217, P733, DOI 10.1016/j.ijheh.2014.03.002; US EPA, 2013, HEAT VENT AIR COND H; Wargocki P, 2007, HVAC&R RES, V13, P193, DOI 10.1080/10789669.2007.10390951	25	65	66	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136165	10.1371/journal.pone.0136165	http://dx.doi.org/10.1371/journal.pone.0136165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317643	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100062
J	Liang, C; Li, YQ; Liu, ZM; Wu, WJ; Hu, BR				Liang, Chao; Li, Yunqiu; Liu, Zhiming; Wu, Wenjian; Hu, Biru			Protein Aggregation Formed by Recombinant cp19k Homologue of Balanus albicostatus Combined with an 18 kDa N-Terminus Encoded by pET-32a(+) Plasmid Having Adhesion Strength Comparable to Several Commercial Glues	PLOS ONE			English	Article							BARNACLE UNDERWATER ADHESIVE; MUSSEL ADHESIVE; PHRAGMATOPOMA-CALIFORNICA; ANTIFOULING COATINGS; ESCHERICHIA-COLI; CEMENT PROTEINS; AMPHITRITE; SURFACES; DOPA; CONFORMATION	The barnacle is well known for its tenacious and permanent attachment to a wide variety of underwater substrates, which is accomplished by synthesizing, secreting and curing a mixture of adhesive proteins termed "barnacle cement". In order to evaluate interfacial adhesion abilities of barnacle cement proteins, the cp19k homologous gene in Balanus albicostatus (Balcp19k) was cloned and expressed in Escherichia coli. Here, we report an intriguing discovery of a gel-like super adhesive aggregation produced by Trx-Balcp19k, a recombinant Balcp19k fusion protein. The Trx-Balcp19k consists of an 18 kDa fragment at the N-terminus, which is encoded by pET-32a(+) plasmid and mainly comprised of a thioredoxin (Trx) tag, and Balcp19k at the C-terminus. The sticky aggregation was designated as "Trx-Balcp19k gel", and the bulk adhesion strength, biochemical composition, as well as formation conditions were all carefully investigated. The Trx-Balcp19k gel exhibited strong adhesion strength of 2.10 +/- 0.67 MPa, which was approximately fifty folds higher than that of the disaggregated Trx-Balcp19k (40 +/- 8 kPa) and rivaled those of commercial polyvinyl acetate (PVA) craft glue (Mont Marte, Australia) and UHU glue (UHU GmbH & Co. KG, Germany). Lipids were absent from the Trx-Balcp19k gel and only a trace amount of carbohydrates was detected. We postulate that the electrostatic interactions play a key role in the formation of Trx-Balcp19k gel, by mediating self-aggregation of Trx-Balcp19k based on its asymmetric distribution pattern of charged amino acids. Taken together, we believe that our discovery not only presents a promising biological adhesive with potential applications in both biomedical and technical fields, but also provides valuable paradigms for molecular design of bio-inspired peptide- or protein-based materials.	[Liang, Chao; Li, Yunqiu; Liu, Zhiming; Wu, Wenjian; Hu, Biru] Natl Univ Def Technol, Dept Biol & Chem, Coll Sci, Changsha, Hunan, Peoples R China; [Wu, Wenjian] State Key Lab NBC Protect Civilian, Beijing, Peoples R China	National University of Defense Technology - China	Hu, BR (corresponding author), Natl Univ Def Technol, Dept Biol & Chem, Coll Sci, Changsha, Hunan, Peoples R China.	hubiru08@nudt.edu.cn		Liang, Chao/0000-0003-3101-5021	Specialized Research Fund for the Doctoral Program of Higher Education of China [20134307120010]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20134307120010).	Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932; Barlow DE, 2009, BIOFOULING, V25, P359, DOI 10.1080/08927010902812009; Barlow DE, 2010, LANGMUIR, V26, P6549, DOI 10.1021/la9041309; Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v; Burden DK, 2012, LANGMUIR, V28, P13364, DOI 10.1021/la301695m; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; Cha HJ, 2009, BIOFOULING, V25, P99, DOI 10.1080/08927010802563108; Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129; Choi BH, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-52; Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027; Choi YS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-139; Choi YS, 2011, BIOFOULING, V27, P729, DOI 10.1080/08927014.2011.600830; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Flammang P, 1998, J EXP BIOL, V201, P2383; FRINGS CS, 1972, CLIN CHEM, V18, P673; Gohad NV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5414; Graham LD, 2005, BIOMACROMOLECULES, V6, P3300, DOI 10.1021/bm050335e; Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004; Jonker JL, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0062; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 2001, BIOCHEM J, V356, P503, DOI 10.1042/0264-6021:3560503; Kamino K., 2013, BIOFOULING, V29, P735, DOI [10.1080/08927014.2013.800863, DOI 10.1080/08927014.2013.800863]; Kamino K., 2013, STRUCTURAL INTERFACE, P175, DOI [DOI 10.1007/978-1-4614-3317-0_9, 10.1007/978-1-4614-3317-0_9]; Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3; Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8; Kamino K, 2012, FEBS J, V279, P1750, DOI 10.1111/j.1742-4658.2012.08552.x; Kamino K, 2010, J ADHESION, V86, P96, DOI 10.1080/00218460903418139; Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lim S, 2010, BIOMATERIALS, V31, P3715, DOI 10.1016/j.biomaterials.2010.01.063; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759; Mori Y, 2007, FEBS J, V274, P6436, DOI 10.1111/j.1742-4658.2007.06161.x; Nakano M, 2007, BIOMACROMOLECULES, V8, P1830, DOI 10.1021/bm0612236; Nakano M, 2015, BIOCHEMISTRY-US, V54, P826, DOI 10.1021/bi500965f; Raman S, 2011, BIOFOULING, V27, P569, DOI 10.1080/08927014.2011.589027; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330; Stewart RJ, 2011, APPL MICROBIOL BIOT, V89, P27, DOI 10.1007/s00253-010-2913-8; Sullan RMA, 2009, BIOFOULING, V25, P263, DOI 10.1080/08927010802688095; Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; Wang J, 2007, BIOMATERIALS, V28, P3456, DOI 10.1016/j.biomaterials.2007.04.009; Wei W, 2014, ACTA BIOMATER, V10, P1663, DOI 10.1016/j.actbio.2013.09.007; Wiegemann M, 2003, J ADHES SCI TECHNOL, V17, P1957, DOI 10.1163/156856103770572070; Yang B, 2014, ANGEW CHEM INT EDIT, V53, P13360, DOI 10.1002/anie.201406099; Yang B, 2013, BIOFOULING, V29, P483, DOI 10.1080/08927014.2013.782541; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zheden V, 2014, BIOFOULING, V30, P949, DOI 10.1080/08927014.2014.954557; Zhong C, 2014, NAT NANOTECHNOL, V9, P858, DOI 10.1038/nnano.2014.199	56	18	18	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136493	10.1371/journal.pone.0136493	http://dx.doi.org/10.1371/journal.pone.0136493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317205	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100090
J	Zhao, YD; Chu, L; Lin, K; Granton, E; Yin, L; Peng, J; Hsin, M; Wu, LC; Yu, A; Waddell, T; Keshavjee, S; Granton, J; de Perrot, M				Zhao, Yidan D.; Chu, Lei; Lin, Kathleen; Granton, Elise; Yin, Li; Peng, Jenny; Hsin, Michael; Wu, Licun; Yu, Amy; Waddell, Thomas; Keshavjee, Shaf; Granton, John; de Perrot, Marc			A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung	PLOS ONE			English	Article							PHARMACOLOGICAL TARGETS; SPHINGOLIPID METABOLISM; NITRIC-OXIDE; COLLAGEN; RESISTANCE; STRATEGY; PROLINE; CELLS	Pulmonary arterial hypertension (PAH) is a vascular disease characterized by persistent precapillary pulmonary hypertension (PH), leading to progressive right heart failure and premature death. The pathological mechanisms underlying this condition remain elusive. Analysis of global metabolomics from lung tissue of patients with PAH (n = 8) and control lung tissue (n = 8) leads to a better understanding of disease progression. Using a combination of high-throughput liquid-and-gas-chromatography-based mass spectrometry, we showed unbiased metabolomic profiles of disrupted arginine pathways with increased Nitric oxide (NO) and decreased arginine. Our results also showed specific metabolic pathways and genetic profiles with increased Sphingosine-1-phosphate (S1P) metabolites as well as increased Heme metabolites with altered oxidative pathways in the advanced stage of the human PAH lung. The results suggest that PAH has specific metabolic pathways contributing to the vascular remodeling in severe pulmonary hypertension. Profiling metabolomic alterations of the PAH lung has provided a new understanding of the pathogenic mechanisms of PAH, which benefits therapeutic targeting to specific metabolic pathways involved in the progression of PAH.	[Zhao, Yidan D.; Chu, Lei; Lin, Kathleen; Granton, Elise; Yin, Li; Peng, Jenny; Hsin, Michael; Wu, Licun; Yu, Amy; Waddell, Thomas; Keshavjee, Shaf; de Perrot, Marc] Univ Toronto, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Zhao, Yidan D.; Chu, Lei; Lin, Kathleen; Granton, Elise; Yin, Li; Peng, Jenny; Hsin, Michael; Wu, Licun; Yu, Amy; Waddell, Thomas; Keshavjee, Shaf; de Perrot, Marc] Univ Toronto, Div Thorac Surg, Univ Hlth Network, Toronto, ON, Canada; [Granton, John] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Clin Studies Resource Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhao, YD (corresponding author), Univ Toronto, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	Yidanzhao@gmail.com; marc.deperrot@uhn.on.ca	Wu, Licun/AAL-9596-2021	Wu, Licun/0000-0003-4803-9361; de Perrot, Marc/0000-0003-2000-9427; Keshavjee, Shaf/0000-0003-4547-8094; Zhao, Yidan/0000-0002-7304-1802	TGH Hospital Foundation	TGH Hospital Foundation	This work received funding from the TGH Hospital Foundation made possible through donations from Bayer Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi Taimur, 2013, Handb Exp Pharmacol, P201, DOI 10.1007/978-3-7091-1511-4_10; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Balint B, 2001, EUR RESPIR J, V17, P1201, DOI 10.1183/09031936.01.00072501; Brittain EL, 2014, CHEST, V146, P1478, DOI 10.1378/chest.14-0809; Chen Jinhu, 2014, Int J Endocrinol, V2014, P203930, DOI 10.1155/2014/203930; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Couttas TA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-9; Delgado A, 2012, ANTI-CANCER AGENT ME, V12, P285, DOI 10.2174/187152012800228643; Fessel Joshua P, 2012, Pulm Circ, V2, P201, DOI 10.4103/2045-8932.97606; Fox Charles J, 2011, Perspect Vasc Surg Endovasc Ther, V23, P112, DOI 10.1177/1531003511400627; Galie N, 2014, TURK KARDIYOL DERN A, V42, P1; Gillespie MN, 2010, ADV EXP MED BIOL, V661, P375, DOI 10.1007/978-1-60761-500-2_24; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hassoun PM, 2013, 5 WORLD S PULM HYP N; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kajiwara K, 2012, MOL MICROBIOL, V86, P1246, DOI 10.1111/mmi.12056; Kepka-Lenhart D, 2000, AM J PHYSIOL-REG I, V279, pR2237; KERR JS, 1987, AM REV RESPIR DIS, V135, P300; Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; POIANI GJ, 1990, J APPL PHYSIOL, V68, P1542, DOI 10.1152/jappl.1990.68.4.1542; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Russo S B, 2013, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-7091-1511-4_19; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Simon PM, 2006, PULM PHARMACOL THER, V19, P242, DOI 10.1016/j.pupt.2005.07.001; Sutendra G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001327; Takeda Y, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-22; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Thomas M, 2010, ADV EXP MED BIOL, V661, P475, DOI 10.1007/978-1-60761-500-2_31; Tuder RM, 2012, AM J RESP CRIT CARE, V185, P260, DOI 10.1164/rccm.201108-1536PP; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Xu RH, 2005, CANCER RES, V65, P613; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850; Zhao YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088727; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zuckerbraun BS, 2011, CARDIOVASC RES, V89, P542, DOI 10.1093/cvr/cvq370	42	26	29	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134958	10.1371/journal.pone.0134958	http://dx.doi.org/10.1371/journal.pone.0134958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317340	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100019
J	Alshamsi, A; Pianesi, F; Lepri, B; Pentland, A; Rahwan, I				Alshamsi, Aamena; Pianesi, Fabio; Lepri, Bruno; Pentland, Alex; Rahwan, Iyad			Beyond Contagion: Reality Mining Reveals Complex Patterns of Social Influence	PLOS ONE			English	Article							PERSON-SITUATION DEBATE; EMOTIONAL CONTAGION; NETWORK; PERFORMANCE; SPREAD; POWER; MOOD	Contagion, a concept from epidemiology, has long been used to characterize social influence on people's behavior and affective (emotional) states. While it has revealed many useful insights, it is not clear whether the contagion metaphor is sufficient to fully characterize the complex dynamics of psychological states in a social context. Using wearable sensors that capture daily face-to-face interaction, combined with three daily experience sampling surveys, we collected the most comprehensive data set of personality and emotion dynamics of an entire community of work. From this high-resolution data about actual (rather than self-reported) face-to-face interaction, a complex picture emerges where contagion (that can be seen as adaptation of behavioral responses to the behavior of other people) cannot fully capture the dynamics of transitory states. We found that social influence has two opposing effects on states: adaptation effects that go beyond mere contagion, and complementarity effects whereby individuals' behaviors tend to complement the behaviors of others. Surprisingly, these effects can exhibit completely different directions depending on the stable personality or emotional dispositions (stable traits) of target individuals. Our findings provide a foundation for richer models of social dynamics, and have implications on organizational engineering and workplace well-being.	[Alshamsi, Aamena; Rahwan, Iyad] Masdar Inst Sci & Technol, Dept Elect Engn & Comp Sci, Abu Dhabi, U Arab Emirates; [Pianesi, Fabio; Lepri, Bruno] Fdn Bruno Kessler, Trento, Italy; [Lepri, Bruno; Pentland, Alex; Rahwan, Iyad] MIT, Media Lab, Cambridge, MA 02139 USA	Khalifa University of Science & Technology; Fondazione Bruno Kessler; Massachusetts Institute of Technology (MIT)	Rahwan, I (corresponding author), Masdar Inst Sci & Technol, Dept Elect Engn & Comp Sci, Abu Dhabi, U Arab Emirates.	irahwan@acm.org	Rahwan, Iyad/ABB-2422-2020	Rahwan, Iyad/0000-0002-1796-4303; Alshamsi, Aamena/0000-0001-6846-4627	European Union [PCOFUND-GA-2008 226070]	European Union(European Commission)	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under the agreement no PCOFUND-GA-2008 226070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Barrick MR, 2001, INT J SELECT ASSESS, V9, P9, DOI 10.1111/1468-2389.00160; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Barsoukova SY, 2003, SOTSIOL ISSLED+, P3; Bell ST, 2007, J APPL PSYCHOL, V92, P595, DOI 10.1037/0021-9010.92.3.595; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Csikszentmihalyi M., 2014, THE J, P89, DOI [10.1007/978-94-017-9088-8_6, DOI 10.1023/A:1024409732742]; Dodds PS, 2005, J THEOR BIOL, V232, P587, DOI 10.1016/j.jtbi.2004.09.006; Fleeson W, 2004, CURR DIR PSYCHOL SCI, V13, P83, DOI 10.1111/j.0963-7214.2004.00280.x; Fleeson W, 2001, J PERS SOC PSYCHOL, V80, P1011, DOI 10.1037/0022-3514.80.6.1011; Fleeson W, 2007, J PERS, V75, P825, DOI 10.1111/j.1467-6494.2007.00458.x; Fleeson W, 2008, SOC PERSONAL PSYCHOL, V2, P1667, DOI 10.1111/j.1751-9004.2008.00122.x; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Friedkin N.E., 2011, SOCIAL INFLUENCE NET, V33; Friedkin NE, 2010, SOC PSYCHOL QUART, V73, P196, DOI 10.1177/0190272510369661; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hatfield E., 1994, REV PERSONALITY SOCI; Hill AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000968; Hill AL, 2010, P ROY SOC B-BIOL SCI, V277, P3827, DOI 10.1098/rspb.2010.1217; HOWES MJ, 1985, J PERS SOC PSYCHOL, V49, P1110, DOI 10.1037/0022-3514.49.4.1110; Ilies R, 2002, ORGAN BEHAV HUM DEC, V89, P1119, DOI 10.1016/S0749-5978(02)00018-3; Jordan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066199; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Lepri B, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P623, DOI 10.1109/SocialCom-PASSAT.2012.71; Madan A, 2010, WIREL HLTH, V2010, P104, DOI DOI 10.1145/1921081.1921094; Madan A, 2010, UBICOMP 2010: PROCEEDINGS OF THE 2010 ACM CONFERENCE ON UBIQUITOUS COMPUTING, P291; Mani A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01735; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Olguin DO, 2009, IEEE T SYST MAN CY B, V39, P43, DOI 10.1109/TSMCB.2008.2006638; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pentland A., 2014, SOCIAL PHYS; Pentland A. S., 2010, HONEST SIGNALS; Pentland A, 2012, HARVARD BUS REV, V90, P61; Perugini M, 2012, BIG 5 MARKER SCALES; Pugh SD, 2001, ACAD MANAGE J, V44, P1018, DOI 10.2307/3069445; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Smilkov D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04795; Steeg GV, 2013, PAPER PRESENTED AT I; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tellegen A, 1985, STRUCTURES MOOD PERS; Tellegen A., 2008, SAGE HDB PERSONALITY, P261, DOI [10.4135/9781849200479.n13, DOI 10.4135/9781849200479.N13]; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Todd PM, 2007, P NATL ACAD SCI USA, V104, P15011, DOI 10.1073/pnas.0705290104; Tsvetkova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087275; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Wood W, 2000, ANNU REV PSYCHOL, V51, P539, DOI 10.1146/annurev.psych.51.1.539; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	68	15	15	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135740	10.1371/journal.pone.0135740	http://dx.doi.org/10.1371/journal.pone.0135740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313449	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000024
J	Li, WD; Huang, M; Lu, WG; Chen, X; Shen, MH; Li, XM; Wang, RX; Ke, CH				Li, Wei-Dong; Huang, Min; Lu, Wen-Gang; Chen, Xiao; Shen, Ming-Hui; Li, Xiang-Min; Wang, Rong-Xia; Ke, Cai-Huan			Involvement of Antizyme Characterized from the Small Abalone Haliotis diversicolor in Gonadal Development	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; POLYAMINE TRANSPORT; CELLULAR POLYAMINES; INHIBITORY PROTEIN; MAMMALIAN ANTIZYME; MESSENGER-RNAS; EXPRESSION; DEGRADATION; CELLS; TARGET	The small abalone Haliotis diversicolor is an economically important mollusk that is widely cultivated in Southern China. Gonad precocity may affect the aquaculture of small abalone. Polyamines, which are small cationic molecules essential for cellular proliferation, may affect gonadal development. Ornithine decarboxylase (ODC) and antizyme (AZ) are essential elements of a feedback circuit that regulates cellular polyamines. This paper presents the molecular cloning and characterization of AZ from small abalone. Sequence analysis showed that the cDNA sequence of H. diversicolor AZ (HdiODCAZ) consisted of two overlapping open reading frames (ORFs) and conformed to the +1 frameshift property of the frame. Thin Layer chromatography (TLC) analysis suggested that the expressed protein encoded by +1 ORF2 was the functional AZ that targets ODC to 26S proteasome degradation. The result demonstrated that the expression level of AZ was higher than that of ODC in the ovary of small abalone. In addition, the expression profiles of ODC and AZ at the different development stages of the ovary indicated that these two genes might be involved in the gonadal development of small abalone.	[Li, Wei-Dong; Huang, Min; Shen, Ming-Hui; Li, Xiang-Min; Wang, Rong-Xia] Hainan Acad Ocean & Fisheries Sci, Haikou, Hainan Province, Peoples R China; [Lu, Wen-Gang; Ke, Cai-Huan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Fujian Province, Peoples R China; [Chen, Xiao] Guangxi Mangrove Res Ctr, Guangxi Key Lab Mangrove Conservat & Utilizat, Beihai, Guangxi Provinc, Peoples R China	Xiamen University	Ke, CH (corresponding author), Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Fujian Province, Peoples R China.	chke@xmu.edu.cn			National Natural Science Foundation of China [31160528, U1205121]; National High Technology Research and Development Program of China [2012AA10A412]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; South China Sea Bio-Resource Exploitation and Utilization Collaborative Innovation Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Earmarked Fund for Modern Agro-industry Technology Research System; South China Sea Bio-Resource Exploitation and Utilization Collaborative Innovation Center	This work was financially supported by National Natural Science Foundation of China (31160528 and U1205121), National High Technology Research and Development Program of China (2012AA10A412), Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), and South China Sea Bio-Resource Exploitation and Utilization Collaborative Innovation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDOCZ S, 1999, POLYAMINES HLTH NUTR, P1; Bekaert M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-178; Bercovich Z, 2011, J BIOL CHEM, V286, P33778, DOI 10.1074/jbc.M111.270637; Chen J, 2012, INT J DEV BIOL, V56, P369, DOI 10.1387/ijdb.113487zc; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; COHEN SS, 1998, GUIDE POLYAMINES, P231; Cook PA, 2010, J SHELLFISH RES, V29, P569, DOI 10.2983/035.029.0303; Rivas BD, 2008, J FOOD PROTECT, V71, P657, DOI 10.4315/0362-028X-71.3.657; Fong LYY, 2003, CANCER RES, V63, P3945; FONG WF, 1976, BIOCHIM BIOPHYS ACTA, V428, P456, DOI 10.1016/0304-4165(76)90054-4; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Garcia-Moruno E, 2005, J FOOD PROTECT, V68, P625, DOI 10.4315/0362-028X-68.3.625; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; He H, 2014, GENE, V545, P247, DOI 10.1016/j.gene.2014.05.022; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HOLTTA E, 1993, J CELL BIOL, V122, P903, DOI 10.1083/jcb.122.4.903; Hoshino K, 2005, J BIOL CHEM, V280, P42801, DOI 10.1074/jbc.M505445200; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2004, J MOL BIOL, V339, P495, DOI 10.1016/j.jmb.2004.03.082; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kasbek C, 2010, MOL BIOL CELL, V21, P3878, DOI 10.1091/mbc.E10-04-0281; KAY JE, 1973, BIOCHEM J, V132, P791, DOI 10.1042/bj1320791; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li WD, 2010, J WORLD AQUACULT SOC, V41, P721, DOI 10.1111/j.1749-7345.2010.00414.x; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Liu L, 2009, AM J PHYSIOL-CELL PH, V296, pC801, DOI 10.1152/ajpcell.00620.2008; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Metallinou C, 2007, REPROD SCI, V14, P737, DOI 10.1177/1933719107310707; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nuurai P, 2010, ACTA HISTOCHEM, V112, P557, DOI 10.1016/j.acthis.2009.06.002; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pietila M, 2014, TRANSGENIC RES, V23, P153, DOI 10.1007/s11248-013-9763-y; Ray RM, 2014, AMINO ACIDS, V46, P2231, DOI 10.1007/s00726-014-1777-0; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; RUSSELL DH, 1969, MOL PHARMACOL, V5, P253; RUSSELL DH, 1980, PHARMACOLOGY, V20, P117; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schipper RG, 2003, BIOCHEM SOC T, V31, P375, DOI 10.1042/BST0310375; Shantz LM, 1999, INT J BIOCHEM CELL B, V31, P107, DOI 10.1016/S1357-2725(98)00135-6; Shantz LM, 1998, CANCER RES, V58, P2748; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Ueda A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-2; Valenzuela-Munoz V, 2013, MAR GENOM, V10, P11, DOI 10.1016/j.margen.2012.12.003; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425	59	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135251	10.1371/journal.pone.0135251	http://dx.doi.org/10.1371/journal.pone.0135251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313647	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000014
J	Schmidt, LH; Kummel, A; Gorlich, D; Mohr, M; Brockling, S; Mikesch, JH; Grunewald, I; Marra, A; Schultheis, AM; Wardelmann, E; Muller-Tidow, C; Spieker, T; Schliemann, C; Berdel, WE; Wiewrodt, R; Hartmann, W				Schmidt, Lars Henning; Kuemmel, Andreas; Goerlich, Dennis; Mohr, Michael; Broeckling, Sebastian; Mikesch, Jan Henrik; Gruenewald, Inga; Marra, Alessandro; Schultheis, Anne M.; Wardelmann, Eva; Mueller-Tidow, Carsten; Spieker, Tilmann; Schliemann, Christoph; Berdel, Wolfgang E.; Wiewrodt, Rainer; Hartmann, Wolfgang			PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups	PLOS ONE			English	Article							CELL LUNG-CANCER; TUMOR-INFILTRATING LYMPHOCYTES; LIGAND 1 EXPRESSION; T-CELLS; B7-H1; INTERLEUKIN-2; CHEMOTHERAPY; GEFITINIB; ANTIBODY; IMPACT	Background Immunotherapy can become a crucial therapeutic option to improve prognosis for lung cancer patients. First clinical trials with therapies targeting the programmed cell death receptor PD-1 and its ligand PD-L1 have shown promising results in several solid tumors. However, in lung cancer the diagnostic, prognostic and predictive value of these immunologic factors remains unclear. Method The impact of both factors was evaluated in a study collective of 321 clinically well-annotated patients with non-small lung cancer (NSCLC) using immunohistochemistry. Results PD-1 expression by tumor infiltrating lymphocytes (TILs) was found in 22%, whereas tumor cell associated PD-L1 expression was observed in 24% of the NSCLC tumors. In Fisher's exact test a positive correlation was found for PD-L1 and Bcl-xl protein expression (p = 0.013). Interestingly, PD-L1 expression on tumor cells was associated with improved overall survival in pulmonary squamous cell carcinomas (SCC, p = 0.042, log rank test), with adjuvant therapy (p = 0.017), with increased tumor size (pT2-4, p = 0.039) and with positive lymph node status (pN1-3, p = 0.010). These observations were confirmed by multivariate cox regression models. Conclusion One major finding of our study is the identification of a prognostic implication of PD-L1 in subsets of NSCLC patients with pulmonary SCC, with increased tumor size, with a positive lymph node status and NSCLC patients who received adjuvant therapies. This study provides first data for immune-context related risk stratification of NSCLC patients. Further studies are necessary both to confirm this observation and to evaluate the predictive value of PD-1 and PD-L1 in NSCLC in the context of PD-1 inhibition.	[Schmidt, Lars Henning; Mohr, Michael; Broeckling, Sebastian; Mikesch, Jan Henrik; Schliemann, Christoph; Berdel, Wolfgang E.; Wiewrodt, Rainer] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, D-48149 Munster, Germany; [Kuemmel, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med 3, Div Pulm, D-55101 Mainz, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Gruenewald, Inga; Wardelmann, Eva; Hartmann, Wolfgang] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Marra, Alessandro] Klinikum Bremen Ost, Chest Surg, D-28325 Bremen, Germany; [Schultheis, Anne M.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Mueller-Tidow, Carsten] Univ Halle, Dept Med Hematol & Oncol 4, D-06120 Halle, Germany; [Spieker, Tilmann] St Franziskus Hosp, Inst Pathol, D-48145 Munster, Germany	University of Munster; Johannes Gutenberg University of Mainz; University of Munster; University of Munster; Klinikum Bremen-Ost; Memorial Sloan Kettering Cancer Center; Martin Luther University Halle Wittenberg; St. Franziskus-Hospital	Schmidt, LH (corresponding author), Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, D-48149 Munster, Germany.	larshenning.schmidt@ukmuenster.de	Görlich, Dennis/C-8950-2012; Müller-Tidow, Carsten/O-7207-2018; Hartmann, Wolfgang/G-1893-2017	Görlich, Dennis/0000-0002-2574-9419; Müller-Tidow, Carsten/0000-0002-7166-5232; Hartmann, Wolfgang/0000-0002-7609-5021	Innovative Medizinische Forschung Munster University [IMF: I-SC110818]; Deutsche Krebshilfe e. V. [107888, 109666]; Open Access Publication Fund of University of Muenster; Wilhelm Sander-Stiftung [2009.041.1]; Deutsche Forschungsgemeinschaft [DFG EXC 1003]	Innovative Medizinische Forschung Munster University; Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); Open Access Publication Fund of University of Muenster; Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	NSCLC research in the authors' laboratory is funded by the Innovative Medizinische Forschung Munster University (IMF: I-SC110818), Deutsche Krebshilfe e. V. (107888; 109666), Open Access Publication Fund of University of Muenster and Wilhelm Sander-Stiftung (2009.041.1). W.E.B. is supported by Deutsche Forschungsgemeinschaft DFG EXC 1003 Cells in Motion-Cluster of Excellence.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Boland JM, 2013, CLIN LUNG CANCER, V14, P157, DOI 10.1016/j.cllc.2012.05.006; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Chen YW, 2013, J GASTROEN HEPATOL, V28, P1; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; JANSEN RLH, 1992, J IMMUNOTHER, V12, P70, DOI 10.1097/00002371-199207000-00009; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; REMMELE W, 1987, PATHOLOGE, V8, P138; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; SCHILLER JH, 1995, AM J CLIN ONCOL-CANC, V18, P47, DOI 10.1097/00000421-199502000-00010; Schmidt LH, 2014, J THORAC ONCOL, V9, P1294, DOI 10.1097/JTO.0000000000000243; Schmidt LH, 2009, ANTICANCER RES, V29, P201; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soria JC, 2013, EUR J CANC, V49; Sundar R, 2014, LUNG CANCER, V85, P101, DOI 10.1016/j.lungcan.2014.05.005; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wimberly H, 2015, CANCER IMMUNOL RES, V3, P326, DOI 10.1158/2326-6066.CIR-14-0133; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018	33	177	184	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136023	10.1371/journal.pone.0136023	http://dx.doi.org/10.1371/journal.pone.0136023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313362	Green Published, gold			2022-12-27	WOS:000360144000035
J	Stepien, CA; Pierce, LR; Leaman, DW; Niner, MD; Shepherd, BS				Stepien, Carol A.; Pierce, Lindsey R.; Leaman, Douglas W.; Niner, Megan D.; Shepherd, Brian S.			Gene Diversification of an Emerging Pathogen: A Decade of Mutation in a Novel Fish Viral Hemorrhagic Septicemia (VHS) Substrain since Its First Appearance in the Laurentian Great Lakes	PLOS ONE			English	Article							INFECTIOUS HEMATOPOIETIC NECROSIS; VIRUS VHSV; GENOTYPE IVB; MOLECULAR EPIDEMIOLOGY; SNAKEHEAD RHABDOVIRUS; GLYCOPROTEIN GENE; MATRIX PROTEIN; ROUND GOBIES; RABIES VIRUS; EBOLA-VIRUS	Viral Hemorrhagic Septicemia virus (VHSv) is an RNA rhabdovirus, which causes one of the world's most serious fish diseases, infecting >80 freshwater and marine species across the Northern Hemisphere. A new, novel, and especially virulent substrain-VHSv-IVb-first appeared in the Laurentian Great Lakes about a decade ago, resulting in massive fish kills. It rapidly spread and has genetically diversified. This study analyzes temporal and spatial mutational patterns of VHSv-IVb across the Great Lakes for the novel non-virion (Nv) gene that is unique to this group of novirhabdoviruses, in relation to its glycoprotein (G), phosphoprotein (P), and matrix (M) genes. Results show that the Nv-gene has been evolving the fastest (k = 2.0x10(-3) substitutions/site/year), with the G-gene at similar to 1/7 that rate (k = 2.8x10(-4)). Most (all but one) of the 12 unique Nv-haplotypes identified encode different amino acids, totaling 26 changes. Among the 12 corresponding G-gene haplotypes, seven vary in amino acids with eight total changes. The P-and M-genes are more evolutionarily conserved, evolving at just similar to 1/15 (k = 1.2x10(-4)) of the Nv-gene's rate. The 12 isolates contained four P-gene haplotypes with two amino acid changes, and six M-gene haplotypes with three amino acid differences. Patterns of evolutionary changes coincided among the genes for some of the isolates, but appeared independent in others. New viral variants were discovered following the large 2006 outbreak; such differentiation may have been in response to fish populations developing resistance, meriting further investigation. Two 2012 variants were isolated by us from central Lake Erie fish that lacked classic VHSv symptoms, having genetically distinctive Nv-, G-, and M-gene sequences (with one of them also differing in its P-gene); they differ from each other by a G-gene amino acid change and also differ from all other isolates by a shared Nv-gene amino acid change. Such rapid evolutionary differentiation may allow new viral variants to evade fish host recognition and immune responses, facilitating longtime persistence along with expansion to new geographic areas.	[Stepien, Carol A.; Pierce, Lindsey R.; Niner, Megan D.] Univ Toledo, Lake Erie Ctr, Great Lakes Genet Genom Lab, Toledo, OH 43616 USA; [Stepien, Carol A.; Pierce, Lindsey R.; Niner, Megan D.] Univ Toledo, Dept Environm Sci, Toledo, OH 43616 USA; [Leaman, Douglas W.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Shepherd, Brian S.] Univ Wisconsin, ARS, USDA, Sch Freshwater Sci, Milwaukee, WI 53204 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Milwaukee	Stepien, CA (corresponding author), Univ Toledo, Lake Erie Ctr, Great Lakes Genet Genom Lab, Toledo, OH 43616 USA.	carol.stepien@utoledo.edu	A.Stepien, Carol/AAW-5270-2020; Stepien, Carol A./A-7898-2011; Stepien, Carol Ann/GWU-8631-2022	Stepien, Carol A./0000-0002-5544-4333; 	National Science Foundation [DBI-1354806, GK-12 DGE-0742395]; United States Department of Agriculture - Agriculture Research Service Specific Cooperative Agreement [58-3655-9-748 A01]; National Oceanic Atmospheric Administration Ohio Sea Grant [R/LR-015]; United States Department of Agriculture - National Institute of Food and Agriculture [2008-38927-19156, 2009-38927-20043, 2010-38927-21048]; National Science Foundation Doctoral Dissertation Improvement Grant [1110495]; National Institutes of Health [R01AK068133]; Division Of Integrative Organismal Systems [1354806] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture - Agriculture Research Service Specific Cooperative Agreement; National Oceanic Atmospheric Administration Ohio Sea Grant; United States Department of Agriculture - National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the following awards: National Science Foundation DBI-1354806 (DWL, CAS); United States Department of Agriculture - Agriculture Research Service Specific Cooperative Agreement Number 58-3655-9-748 A01 (CAS, DWL, LRP, MDN); National Oceanic Atmospheric Administration Ohio Sea Grant R/LR-015 (CAS, DWL, LRP, MDN); United States Department of Agriculture - National Institute of Food and Agriculture 2008-38927-19156, 2009-38927-20043, 2010-38927-21048 (CAS, DWL, LRP, MDN); National Science Foundation Doctoral Dissertation Improvement Grant 1110495 (LRP, CAS); National Science Foundation GK-12 DGE-0742395 (CAS, LRP); National Institutes of Health R01AK068133 (DWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J VIROL, V78, P5875, DOI 10.1128/JVI.78.11.5875-5882.2004; Ammayappan A, 2011, J VIROL, V85, P8393, DOI 10.1128/JVI.00597-11; Ammayappan A, 2011, MAR BIOTECHNOL, V13, P672, DOI 10.1007/s10126-010-9329-4; Ammayappan A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-171; Avise John C., 2004, P1; Baker CS, 2013, J HERED, V104, P1, DOI 10.1093/jhered/ess137; Bearzotti M, 1999, J VIROL, V73, P7703, DOI 10.1128/JVI.73.9.7703-7709.1999; Benmansour A, 1997, J GEN VIROL, V78, P2837, DOI 10.1099/0022-1317-78-11-2837; Biacchesi S, 2002, J VIROL, V76, P2881, DOI 10.1128/JVI.76.6.2881-2889.2002; Biacchesi S, 2000, J VIROL, V74, P11247, DOI 10.1128/JVI.74.23.11247-11253.2000; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; Brown JE, 2009, MOL ECOL, V18, P64, DOI 10.1111/j.1365-294X.2008.04014.x; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornwell ER, 2015, J GREAT LAKES RES, V41, P520, DOI 10.1016/j.jglr.2015.01.002; Cornwell ER, 2014, J GREAT LAKES RES, V40, P1002, DOI 10.1016/j.jglr.2014.09.006; Cornwell ER, 2012, J GREAT LAKES RES, V38, P278, DOI 10.1016/j.jglr.2012.01.006; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dietzgen RG, 2012, RHABDOVIRUSES MOL TA, P5; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Einer-jensen K, 2004, J GEN VIROL, V85, P1167, DOI 10.1099/vir.0.79820-0; Elsayed E, 2006, J FISH DIS, V29, P611, DOI 10.1111/j.1365-2761.2006.00755.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faisal M, 2012, VIRUSES-BASEL, V4, P734, DOI 10.3390/v4050734; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Frattini SA, 2011, J GREAT LAKES RES, V37, P194, DOI 10.1016/j.jglr.2010.11.004; Galinier R, 2012, VIRUS RES, V166, P1, DOI 10.1016/j.virusres.2012.02.020; Garver KA, 2013, DIS AQUAT ORGAN, V104, P93, DOI 10.3354/dao02588; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goodall-Copestake WP, 2012, HEREDITY, V109, P50, DOI 10.1038/hdy.2012.12; Great Lakes Fish Health Committee, 2011, ANN REP GLFHC YEAR 2; Groocockl GH, 2007, DIS AQUAT ORGAN, V76, P187, DOI 10.3354/dao076187; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafson LL, 2014, PREV VET MED, V114, P174, DOI 10.1016/j.prevetmed.2014.02.011; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamblin J., 2014, ATLANTIC MONTHL 1026; Hawley LM, 2008, DIS AQUAT ORGAN, V82, P171, DOI 10.3354/dao01998; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P211, DOI 10.3354/dao055211; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Holmes E. C., 2009, EVOLUTION EMERGENCE; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; Imanse SM, 2014, J GREAT LAKES RES, V40, P879, DOI 10.1016/j.jglr.2014.08.004; International Committee on Taxonomy of Viruses, 2013, VIRUS TAXONOMY; Jaag HM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001156; Johnson MC, 2000, J VIROL, V74, P2343, DOI 10.1128/JVI.74.5.2343-2350.2000; Kane-Sutton M, 2010, J GREAT LAKES RES, V36, P37, DOI 10.1016/j.jglr.2009.11.004; Kim SH, 2015, VIRUS RES, V195, P203, DOI 10.1016/j.virusres.2014.10.013; Kopecky SA, 2003, J VIROL, V77, P4658, DOI 10.1128/JVI.77.8.4658-4669.2003; Kurath G, 2012, RHABDOVIRUSES MOL TA, P89, DOI DOI 10.1128/JVI.01960-08; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAKAREWICZ JC, 1991, BIOSCIENCE, V41, P216, DOI 10.2307/1311411; Meyers Theodore R., 1995, Annual Review of Fish Diseases, V5, P3, DOI 10.1016/0959-8030(95)00002-X; Molecular Epidemiology of Aquatic Pathogens, 2013, MOL EPIDEMIOLOGY AQU; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Olesen NJ, 2013, MANUAL DIAGNOSTIC TE, P347; Padhi A, 2008, VIRUS RES, V132, P229, DOI 10.1016/j.virusres.2007.11.011; Pierce LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071851; Pierce LR, 2013, J VIROL METHODS, V189, P129, DOI 10.1016/j.jviromet.2013.01.006; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; Pore AJ, 2015, THESIS U TOLEDO; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; R Core Team, 2021, R LANGUAGE ENV STAT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Smail DA, 1999, FISH DISEASES AND DISORDERS, VOL 3, P123; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stepien Carol A., 1997, P1, DOI 10.1016/B978-012417540-2/50002-6; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson TM, 2011, DIS AQUAT ORGAN, V96, P29, DOI 10.3354/dao02362; Thoulouze MI, 2004, J VIROL, V78, P4098, DOI 10.1128/JVI.78.8.4098-4107.2004; Troyer RM, 2003, DIS AQUAT ORGAN, V55, P175, DOI 10.3354/dao055175; United States Department of Agriculture (USDA) and Animal Health Plant Inspection Service (APHIS), 2006, VIR HEM SEPT GREAT L; Whelan GE, 2009, VIRAL HEMORRHAGIC SE; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Winton Jr, 2002, REV M T FIS, V3, P49; Wisconsin Department of Natural Resources, 2008, VHS FISH DIS FOUND Y; Wolf K., 1988, FISH VIRUSES FISH VI, P217, DOI [10.7591/9781501746383, DOI 10.7591/9781501746383]; Wu XC, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-46	85	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135146	10.1371/journal.pone.0135146	http://dx.doi.org/10.1371/journal.pone.0135146			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313549	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000013
J	Dajka, J; Kloda, D; Lobejko, M; Sladkowski, J				Dajka, Jerzy; Kloda, Dawid; Lobejko, Marcin; Sladkowski, Jan			Quantum Two Player Game in Thermal Environment	PLOS ONE			English	Article							DILEMMA; QUBITS	A two-player quantum game is considered in the presence of thermal decoherence. It is shown how the thermal environment modeled in terms of rigorous Davies approach affects payoffs of the players. The conditions for either beneficial or pernicious effect of decoherence are identified. The general considerations are exemplified by the quantum version of Prisoner Dilemma.	[Dajka, Jerzy; Kloda, Dawid; Lobejko, Marcin; Sladkowski, Jan] Univ Silesia, Inst Phys, Katowice, Poland; [Dajka, Jerzy] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Sladkowski, J (corresponding author), Univ Silesia, Inst Phys, Katowice, Poland.	jan.sladkowski@us.edu.pl	Sladkowski, Jan/AAF-3401-2019; Sładkowski, Jan Antoni/I-2782-2019	Sładkowski, Jan Antoni/0000-0002-1898-4824; Dajka, Jerzy/0000-0003-4912-4859	Polish National Science Centre; EU from the European Social Fund;  [DEC-2013/09/B/ST3/01659];  [DEC-2011/01/B/ST6/07197]	Polish National Science Centre; EU from the European Social Fund; ; 	This work was supported by the Polish National Science Centre by the contract DEC-2013/09/B/ST3/01659 (JD), DEC-2011/01/B/ST6/07197 (JS) and the Forszt project co-financed by EU from the European Social Fund (DK).	Alicki R, 2007, LECT NOTES PHYS; Bruza PD, 2010, QUANTUM INFORM COGNI; Chen LK, 2003, PHYS LETT A, V316, P317, DOI 10.1016/S0375-9601(03)01175-7; Dajka J, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.022301; Dajka J, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/48/485306; Dajka J, 2011, QUANTUM INF PROCESS, V10, P85, DOI 10.1007/s11128-010-0178-x; Davies E. B., 1976, QUANTUM THEORY OPEN; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, FLUCT NOISE LETT, V2, pR175, DOI 10.1142/S0219477502000981; Flitney AP, 2007, QUANTUM INF COMPUT, V7, P111; Flitney AP, 2005, PROC SPIE, V5846, P175, DOI 10.1117/12.609363; Flitney AP, 2005, J PHYS A-MATH GEN, V38, P449, DOI 10.1088/0305-4470/38/2/011; Flitney AP, 2003, P ROY SOC A-MATH PHY, V459, P2463, DOI 10.1098/rspa.2003.1136; Gawron P, 2014, QUANTUM INF PROCESS, V13, P665, DOI 10.1007/s11128-013-0681-y; Haven E, 2013, QUANTUM SOCIAL SCI, DOI [10.1017/CBO9781139003261, DOI 10.1017/CB09781139003261]; Iqbal A, 2014, ARXIV14094878V3QUANT; Kloda D, 2015, QUANTUM INF PROCESS, V14, P135, DOI 10.1007/s11128-014-0831-x; Kuhn S, 2014, THE STANFORD ENCYCLO; Lendi K, 2007, J PHYS A-MATH THEOR, V40, P279, DOI 10.1088/1751-8113/40/2/007; Levitt MH, 2008, SPIN DYNAMICS BASICS, VSecond; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Miszczak JA, 2014, FLUCT NOISE LETT, V13, DOI 10.1142/S0219477514500126; Neumann JV, 1953, THEORY GAMES EC BEHA; Pawela L, 2013, PHYSICA D, V256, P51, DOI 10.1016/j.physd.2013.04.010; Pawela L, 2013, PHYSICA A, V392, P910, DOI 10.1016/j.physa.2012.10.034; Piotrowski EW, 2008, PHYSICA A, V387, P3949, DOI 10.1016/j.physa.2008.02.071; Piotrowski EW, 2004, QUANT FINANC, V4, pC61, DOI 10.1080/14697680400014344; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Roga W, 2010, REP MATH PHYS, V66, P311, DOI 10.1016/S0034-4877(11)00003-6; Sladkowski J, 2003, PHYSICA A, V324, P234, DOI 10.1016/S0378-4371(02)01859-9; Szelag M, 2008, ACTA PHYS POL B, V39, P1177; Vladimir G, 2010, QUANTUM NEURAL COMPU; Wu HY, 2011, INT J QUANTUM INF, V9, P615, DOI 10.1142/S021974991100706X	34	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134916	10.1371/journal.pone.0134916	http://dx.doi.org/10.1371/journal.pone.0134916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322833	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500003
J	Hung, YC; Tseng, YJ; Hu, WL; Chen, HJ; Li, TC; Tsai, PY; Chen, HP; Huang, MH; Su, FY				Hung, Yu-Chiang; Tseng, Ying-Jung; Hu, Wen-Long; Chen, Hsuan-Ju; Li, Tsai-Chung; Tsai, Pei-Yuan; Chen, Hsin-Ping; Huang, Meng-Hsuan; Su, Fang-Yen			Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study	PLOS ONE			English	Article							GEGEN DECOCTION PROTECTS; SMOOTH-MUSCLE-CELLS; SALVIA-MILTIORRHIZA; CARDIOVASCULAR-DISEASE; PUERARIA-LOBATA; DANSHEN; MEDICINE; FORMULA; RADIX; PHARMACOLOGY	Objective Combinations of Chinese herbal products (CHPs) are widely used for ischemic heart disease (IHD) in Taiwan. We analyzed the usage and frequency of CHPs prescribed for patients with IHD. Methods A nationwide population-based cross-sectional study was conducted, 53531 patients from a random sample of one million in the National Health Insurance Research Database (NHIRD) from 2000 to 2010 were enrolled. Descriptive statistics, the multiple logistic regression method and Poisson regression analysis were employed to estimate the adjusted odds ratios (aORs) and adjusted risk ratios (aRRs) for utilization of CHPs. Results The mean age of traditional Chinese medicine (TCM) nonusers was significantly higher than that of TCM users. Zhi-Gan-Cao-Tang (24.85%) was the most commonly prescribed formula CHPs, followed by Xue-Fu-Zhu-Yu-Tang (16.53%) and Sheng-Mai-San (16.00%). The most commonly prescribed single CHPs were Dan Shen (29.30%), Yu Jin (7.44%), and Ge Gen (6.03%). After multivariate adjustment, patients with IHD younger than 29 years had 2.62 times higher odds to use TCM than those 60 years or older. Residents living in Central Taiwan, having hyperlipidemia or cardiac dysrhythmias also have higher odds to use TCM. On the contrary, those who were males, who had diabetes mellitus (DM), hypertension, stroke, myocardial infarction (MI) were less likely to use TCM. Conclusions Zhi-Gan-Cao-Tang and Dan Shen are the most commonly prescribed CHPs for IHD in Taiwan. Our results should be taken into account by physicians when devising individualized therapy for IHD. Further large-scale, randomized clinical trials are warranted in order to determine the effectiveness and safety of these herbal medicines.	[Hung, Yu-Chiang; Tseng, Ying-Jung; Hu, Wen-Long; Tsai, Pei-Yuan; Chen, Hsin-Ping; Huang, Meng-Hsuan; Su, Fang-Yen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung 833, Taiwan; [Hung, Yu-Chiang; Tseng, Ying-Jung; Hu, Wen-Long; Tsai, Pei-Yuan; Chen, Hsin-Ping; Huang, Meng-Hsuan; Su, Fang-Yen] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Kaohsiung 833, Taiwan; [Hung, Yu-Chiang] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung 84001, Taiwan; [Hu, Wen-Long] Fooyin Univ, Coll Nursing, Kaohsiung 831, Taiwan; [Hu, Wen-Long] Kaohsiung Med Univ, Coll Med, Kaohsiung 807, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung 40447, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung 40402, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung 40402, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung 41354, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; I Shou University; Fooyin University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Hung, YC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, 123 Dapi Rd, Kaohsiung 833, Taiwan.	e120845@cgmh.org.tw; tcli@mail.cmu.edu.tw	Li, Tsai-Chung/P-2052-2015; Hung, yu-chiang/ABE-7636-2020; Hu, Wen-Long/N-1660-2014	Li, Tsai-Chung/0000-0002-3346-7462; Hu, Wen-Long/0000-0001-9549-6202	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Ministry of Science and Technology of Taiwan (National Science Council) [NSC101-2632-B-039-001-MY3]; China Medical University Hospital	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Ministry of Science and Technology of Taiwan (National Science Council); China Medical University Hospital	The use of National Health Insurance Research Database (NHIRD) was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, Katsuzo and Kiyo Aoshima Memorial Funds, Japan, and the Ministry of Science and Technology of Taiwan (National Science Council) (NSC101-2632-B-039-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TAIWAN J CLIN CHINES, V14, P308; Cai RL, 2011, J ETHNOPHARMACOL, V133, P177, DOI 10.1016/j.jep.2010.09.013; Chang LC, 2008, J CLIN PHARM THER, V33, P243, DOI 10.1111/j.1365-2710.2008.00911.x; Chen HY, 2011, J ETHNOPHARMACOL, V137, P1261, DOI 10.1016/j.jep.2011.07.053; Chiu PY, 2012, PHYTOMEDICINE, V19, P99, DOI 10.1016/j.phymed.2011.07.002; Chiu PY, 2011, PHYTOMEDICINE, V18, P916, DOI 10.1016/j.phymed.2011.03.006; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hu F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-249; Hu F, 2012, PHYTOMEDICINE, V19, P1051, DOI 10.1016/j.phymed.2012.07.007; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Hung YC, 2009, J ETHNOPHARMACOL, V124, P463, DOI 10.1016/j.jep.2009.05.020; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Koon CM, 2011, J ETHNOPHARMACOL, V138, P175, DOI 10.1016/j.jep.2011.08.073; Kuukasjarvi P, 2006, INT J TECHNOL ASSESS, V22, P219, DOI 10.1017/S026646230605104X; Liao Yueh-Hsiang, 2013, Evid Based Complement Alternat Med, V2013, P984876, DOI 10.1155/2013/984876; Liao YH, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-146; Liu HX, 2011, J TRADIT CHIN MED, V31, P269, DOI 10.1016/S0254-6272(12)60002-8; Liu L, 2004, CHEM PHARM BULL, V52, P1295, DOI 10.1248/cpb.52.1295; Ministry of Health and Welfare (MOHW), 2014, 2013 STAT CAUS DEATH; MOHW, 2014, 2012 STAT CAUS DEATH; Ng CF, 2011, J ETHNOPHARMACOL, V137, P1366, DOI 10.1016/j.jep.2011.08.006; Pratt C, 2010, PRIMARY CARE, V37, P325, DOI 10.1016/j.pop.2010.02.009; Tam WY, 2009, J ALTERN COMPLEM MED, V15, P415, DOI 10.1089/acm.2008.0400; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; Wan AKS, 2008, J NAT PROD, V71, P1825, DOI 10.1021/np800119k; Wang NY, 2001, AM J CHINESE MED, V29, P367, DOI 10.1142/S0192415X01000381; Wang XY, 2011, J ETHNOPHARMACOL, V135, P662, DOI 10.1016/j.jep.2011.03.070; Wang YQ, 2013, PHARM BIOL, V51, P1219, DOI 10.3109/13880209.2013.784920; World Health Organization (WHO), 2014, CARD DIS CVDS; Wu L, 2010, J PHARMACEUT BIOMED, V52, P438, DOI 10.1016/j.jpba.2010.01.021; Yao K, 2012, WORLD J INTEGRATED T, V2012, P1029; Zhang YA, 2010, FOOD CHEM TOXICOL, V48, P2656, DOI 10.1016/j.fct.2010.06.036; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	34	30	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137058	10.1371/journal.pone.0137058	http://dx.doi.org/10.1371/journal.pone.0137058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322893	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500062
J	Juan, CJ; Cheng, CC; Chiu, SC; Jen, YM; Liu, YJ; Chiu, HC; Kao, HW; Wang, CW; Chung, HW; Huang, GS; Hsu, HH				Juan, Chun-Jung; Cheng, Cheng-Chieh; Chiu, Su-Chin; Jen, Yee-Min; Liu, Yi-Jui; Chiu, Hui-Chu; Kao, Hung-Wen; Wang, Chih-Wei; Chung, Hsiao-Wen; Huang, Guo-Shu; Hsu, Hsian-He			Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study	PLOS ONE			English	Article							SALIVARY-GLAND FUNCTION; RADIATION-INDUCED CHANGES; INTRAVOXEL INCOHERENT MOTION; NECK-CANCER; WEIGHTED MRI; ORAL-CANCER; HEAD; INJURY; IRRADIATION; THERAPY	Purpose To concurrently quantify the radiation-induced changes and temporal evolutions of parotid volume and parotid apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma (NPC) patients treated by intensity-modulated radiotherapy by usingmagnetic resonance imaging (MRI). Materials and Methods A total of 11 NPC patients (9 men and 2 women; 48.7 +/- 11.7 years, 22 parotid glands) were enrolled. Radiation dose, parotid sparing volume, severity of xerostomia, and radiation-to-MR interval (RMI) was recorded. MRI studies were acquired four times, including one before and three after radiotherapy. The parotid volume and the parotid ADC weremeasured. Statistical analysis was performed using SPSS and MedCalc. Bonferroni correction was applied formultiple comparisons. A P value less than 0.05 was considered as statistically significant. Results The parotid volume was 26.2 +/- 8.0 cm(3) before radiotherapy. The parotid ADC was 0.8 +/- 0.15 x 10(-3) mm(2)/sec before radiotherapy. The parotid glands received a radiation dose of 28.7 +/- 4.1 Gy and a PSV of 44.1 +/- 12.6%. The parotid volume was significantly smaller at MR stage 1 and stage 2 as compared to pre-RT stage (P < .005). The volume reduction ratio was 31.2 +/- 13.0%, 26.1 +/- 13.5%, and 17.1 +/- 16.6% at stage 1, 2, and 3, respectively. The parotid ADC was significantly higher at all post-RT stages as compared to pre-RT stage reciprocally (P < .005 at stage 1 and 2, P < .05 at stage 3). The ADC increase ratio was 35.7 +/- 17.4%, 27.0 +/- 12.8%, and 20.2 +/- 16.6% at stage 1, 2, and 3, respectively. The parotid ADC was negatively correlated to the parotid volume (R = -0.509; P < .001). The parotid ADC was positively associated with the radiation dose significantly (R-2 = 0.212; P = .0001) and was negatively associated with RMI significantly (R-2 = 0.203; P = .00096) significantly. Multiple regression analysis further showed that the post-RT parotid ADC was related to the radiation dose and RMI significantly (R-2 = 0.3580; P < .0001). At MR stage 3, the parotid volume was negatively associated with the dry mouth grade significantly (R-2 = 0.473; P < .0001), while the parotid ADC was positively associated with the dry mouth grade significantly (R-2 = 0.288; P = .015). Conclusion Our pilot study successfully demonstrates the concurrent changes and temporal evolution of parotid volume and parotid ADC quantitatively in NPC patients treated by IMRT. Our results suggest that the reduction of parotid volume and increase of parotid ADC are dominated by the effect of acinar loss rather than edema at early to intermediate phases and the following recovery of parotid volume and ADC toward the baseline values might reflect the acinar regeneration of parotid glands.	[Juan, Chun-Jung; Kao, Hung-Wen; Wang, Chih-Wei; Chung, Hsiao-Wen; Huang, Guo-Shu; Hsu, Hsian-He] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Juan, Chun-Jung; Cheng, Cheng-Chieh; Chiu, Su-Chin; Kao, Hung-Wen; Wang, Chih-Wei; Chung, Hsiao-Wen; Huang, Guo-Shu; Hsu, Hsian-He] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Cheng, Cheng-Chieh; Chiu, Su-Chin; Chung, Hsiao-Wen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Jen, Yee-Min] Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Jen, Yee-Min] Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Liu, Yi-Jui] Feng Chia Univ, Dept Automat Control Engn, Taichung 40724, Taiwan; [Chiu, Hui-Chu] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; Feng Chia University; Chung Hua University	Juan, CJ (corresponding author), Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	peterjuancj@yahoo.com.tw	Juan, Chun-Jung/AAE-8438-2020; Liu, Yi-Jui/AAH-8540-2020	Liu, Yi-Jui/0000-0001-5865-6836; Chung, Hsiao-Wen/0000-0001-7127-1244	National Science Council [NSC-100-2314-B-016-009]; Tri-Service General Hospital [TSGH-C104-049]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	CJJ received the funding partly from National Science Council (NSC-100-2314-B-016-009) and Tri-Service General Hospital (TSGH-C104-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 1997, RADIOGRAPHICS, V17, P5, DOI 10.1148/radiographics.17.1.9017796; Brown PJ, 1997, J SMALL ANIM PRACT, V38, P234, DOI 10.1111/j.1748-5827.1997.tb03353.x; Buus S, 2004, RADIOTHER ONCOL, V73, P289, DOI 10.1016/j.radonc.2004.09.009; CAIRNCROSS JG, 1980, ANN NEUROL, V7, P385, DOI 10.1002/ana.410070419; Chang HC, 2014, EUR RADIOL, V24, P2069, DOI 10.1007/s00330-014-3265-z; Chen HC, 2004, OTOLARYNG HEAD NECK, V130, P388, DOI 10.1016/j.otohns.2003.08.010; Cheng CC, 2013, MAGN RESON IMAGING, V31, P1278, DOI 10.1016/j.mri.2013.03.018; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; CRUMP M, 1990, BONE MARROW TRANSPL, V6, P259; Dirix P, 2008, INT J RADIAT ONCOL, V71, P1365, DOI 10.1016/j.ijrobp.2007.12.011; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; GUSTAFSSON H, 1995, ACTA ONCOL, V34, P193, DOI 10.3109/02841869509093955; Houweling AC, 2011, RADIOTHER ONCOL, V100, P386, DOI 10.1016/j.radonc.2011.08.020; Jen YM, 2006, ORAL SURG ORAL MED O, V101, P322, DOI 10.1016/j.tripleo.2005.01.011; Juan C, 2009, RADIOLOGY, V253; Juan CJ, 2009, EUR RADIOL, V19, P94, DOI 10.1007/s00330-008-1104-9; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1090, DOI 10.1016/j.ijrobp.2004.12.035; Lee FKH, 2011, RADIAT RES, V175, P291, DOI 10.1667/RR2370.1; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Li C, 2015, ZHONGHUA ER BI YAN H, V50, P5; Li J, 2005, INT J RADIAT ONCOL, V62, P1510, DOI 10.1016/j.ijrobp.2005.04.029; Lin ZX, 2011, THYROID, V21, P19, DOI 10.1089/thy.2010.0229; Liu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124118; Luo CB, 2006, EUR ARCH OTO-RHINO-L, V263, P644, DOI 10.1007/s00405-006-0028-8; Marzi S, 2015, J MAGN RESON IMAGING, V41, P974, DOI 10.1002/jmri.24626; Mukherjee P, 2001, RADIOLOGY, V219, P756, DOI 10.1148/radiology.219.3.r01jn48756; Munter MW, 2004, INT J RADIAT ONCOL, V58, P175, DOI 10.1016/S0360-3016(03)01437-8; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; Nishimura Y, 2005, JPN J CLIN ONCOL, V35, P375, DOI 10.1093/jjco/hyi108; Nomayr A, 2001, EUR RADIOL, V11, P1807; PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373; Radfar L, 2003, ORAL SURG ORAL MED O, V96, P267, DOI 10.1016/S1079-2104(03)00369-X; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; Siala W, 2009, CANCER RADIOTHER, V13, P709, DOI 10.1016/j.canrad.2009.05.006; SIMOVIC S, 1977, J FR OTORHINOLARYNG, V26, P541; STEPHENS LC, 1986, AM J PATHOL, V124, P469; Studer G, 2005, INT J RADIAT ONCOL, V63, pS361, DOI 10.1016/j.ijrobp.2005.07.617; Sumi M, 2002, AM J ROENTGENOL, V178, P959, DOI 10.2214/ajr.178.4.1780959; Takahashi S, 1998, INT J EXP PATHOL, V79, P293, DOI 10.1046/j.1365-2613.1998.710405.x; Teshima K, 2010, JPN J CLIN ONCOL, V40, P42, DOI 10.1093/jjco/hyp113; Thoeny HC, 2004, J MAGN RESON IMAGING, V20, P786, DOI 10.1002/jmri.20196; Tomitaka E, 2011, JPN J CLIN ONCOL, V41, P503, DOI 10.1093/jjco/hyq236; VANANDEL JG, 1982, CLIN RADIOL, V33, P95, DOI 10.1016/S0009-9260(82)80368-1; Wada A, 2009, AM J NEURORADIOL, V30, P53, DOI 10.3174/ajnr.A1322; Wang YXJ, 2010, RADIOLOGY, V254, P210, DOI 10.1148/radiol.09090428; Wang ZH, 2009, LARYNGOSCOPE, V119, P1966, DOI 10.1002/lary.20601; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Zhang L, 2001, J MAGN RESON IMAGING, V14, P223, DOI 10.1002/jmri.1177; Zhang YY, 2013, ACTA RADIOL, V54, P928, DOI 10.1177/0284185113491089	51	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137073	10.1371/journal.pone.0137073	http://dx.doi.org/10.1371/journal.pone.0137073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323091	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500064
J	Ramos, M; Calvao, AM; Anteneodo, C				Ramos, Marlon; Calvao, Angelo M.; Anteneodo, Celia			Statistical Patterns in Movie Rating Behavior	PLOS ONE			English	Article							DYNAMICS; NETWORKS; SANDPILE; MAJORITY; MODEL	Currently, users and consumers can review and rate products through online services, which provide huge databases that can be used to explore people's preferences and unveil behavioral patterns. In this work, we investigate patterns in movie ratings, considering IMDb (the Internet Movie Database), a highly visited site worldwide, as a source. We find that the distribution of votes presents scale-free behavior over several orders of magnitude, with an exponent very close to 3/2, with exponential cutoff. It is remarkable that this pattern emerges independently of movie attributes such as average rating, age and genre, with the exception of a few genres and of high-budget films. These results point to a very general underlying mechanism for the propagation of adoption across potential audiences that is independent of the intrinsic features of a movie and that can be understood through a simple spreading model with mean-field avalanche dynamics.	[Ramos, Marlon; Calvao, Angelo M.; Anteneodo, Celia] Pontificia Univ Catolica Rio de Janeiro, Dept Phys, Rio de Janeiro, Brazil; [Anteneodo, Celia] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	Pontificia Universidade Catolica do Rio de Janeiro	Anteneodo, C (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Phys, Rio de Janeiro, Brazil.	celia.fis@puc-rio.br	Anteneodo, Celia/C-7179-2013; Anteneodo, Celia/B-2021-2009	Anteneodo, Celia/0000-0001-9130-2933; Anteneodo, Celia/0000-0001-9130-2933	Brazilian Agency CNPq; Brazilian Agency CAPES; Brazilian Agency Faperj	Brazilian Agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Agency Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors acknowledge financial support from Brazilian Agencies CNPq, CAPES and Faperj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTROM P, 1988, PHYS REV A, V38, P4905, DOI 10.1103/PhysRevA.38.4905; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baxter GJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051134; Baxter GJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011103; BONABEAU E, 1995, J PHYS SOC JPN, V64, P327, DOI 10.1143/JPSJ.64.327; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Chen P, 2005, J PHYS A-MATH GEN, V38, P7239, DOI 10.1088/0305-4470/38/33/003; Christensen K., 1992, SELF ORG MODELS SAND; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; DEOLIVEIRA MJ, 1993, J PHYS A-MATH GEN, V26, P2317, DOI 10.1088/0305-4470/26/10/006; Dover Y, 2012, MARKET SCI, V31, P689, DOI 10.1287/mksc.1120.0711; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; GALAM S, 1986, J MATH PSYCHOL, V30, P426, DOI 10.1016/0022-2496(86)90019-2; Goh KI, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148701; Goltsev AV, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056101; Harris T.E., 1963, THEORY BRANCHING PRO, VVol. 6, DOI [DOI 10.1007/978-3-642-51866-9, 10.1007/978-3-642-51866-9]; Koenigstein N., 2011, P 5 ACM C REC SYST, P165, DOI DOI 10.1145/2043932.2043964; Lee DS, 2004, J KOREAN PHYS SOC, V44, P633, DOI 10.3938/jkps.44.633; Lorenz J, 2009, EUR PHYS J B, V71, P251, DOI 10.1140/epjb/e2009-00283-3; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lyra ML, 2003, EUROPHYS LETT, V62, P131, DOI 10.1209/epl/i2003-00371-6; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016132, 10.1103/PhysRevE.64.026118]; OLAMI Z, 1992, PHYS REV A, V46, pR1720, DOI 10.1103/PhysRevA.46.R1720; Przybylski AK, 2013, COMPUT HUM BEHAV, V29, P1841, DOI 10.1016/j.chb.2013.02.014; Ramos M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10032; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701; Vany A. de, 1999, Journal of Cultural Economics, V23, P285, DOI 10.1023/A:1007608125988; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	36	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136083	10.1371/journal.pone.0136083	http://dx.doi.org/10.1371/journal.pone.0136083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322899	Green Published, gold			2022-12-27	WOS:000360435500014
J	Stecklov, G; Weinreb, AA; Sana, M				Stecklov, Guy; Weinreb, Alexander A.; Sana, Mariano			Family Planning for Strangers: An Experiment on the Validity of Reported Contraceptive Use	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; SENSITIVE BEHAVIOR; EXPENDITURE DATA; ADOLESCENTS; QUALITY; INTERVIEWERS; FERTILITY; SOCIOLOGY; KNOWLEDGE; COUNTRIES	Sterilization levels reported in the Dominican Republic appear well above what we would normally expect given prevailing patterns in the region. We suspect that the use of strangers as interviewers-the normative approach in data collection in both developed and developing country settings-may be partly responsible for this result, and may underlie a long history of bias in family planning data. We present findings from a field experiment conducted in a Dominican town in 2010, where interviewer assignment was randomized by level of preexisting level of familiarity between interviewer and respondent. In our data, sterilization use is higher when the interviewer is an outsider, as opposed to someone known to the respondent or from the same community. In addition, high sterilization use is correlated with a propensity of respondents to present themselves in a positive light to interviewers. These results call into question the routine use of strangers and outsiders as interviewers in demographic and health surveys.	[Stecklov, Guy] Hebrew Univ Jerusalem, Dept Sociol & Anthropol, Jerusalem, Israel; [Weinreb, Alexander A.] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA; [Weinreb, Alexander A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Sana, Mariano] Vanderbilt Univ, Dept Sociol, Nashville, TN 37235 USA	Hebrew University of Jerusalem; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Vanderbilt University	Stecklov, G (corresponding author), Hebrew Univ Jerusalem, Dept Sociol & Anthropol, Jerusalem, Israel.	Stecklov@huji.ac.il	Weinreb, Alex/L-3187-2018		NIH [1R21HD054731-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042849] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD054731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH Grant 1R21HD054731-01A1.	Agar M.H, 1980, PROFESSIONAL STRANGE; Ali MM, 2005, SOC SCI MED, V60, P1175, DOI 10.1016/j.socscimed.2004.07.002; AXINN WG, 1991, SOCIOL METHOD RES, V20, P187, DOI 10.1177/0049124191020002001; Becker S, 2001, STUD FAMILY PLANN, V32, P111, DOI 10.1111/j.1728-4465.2001.00111.x; BECKER S, 1995, STUD FAMILY PLANN, V26, P233, DOI 10.2307/2137848; Biemer PP, 1991, MEASUREMENT ERROR SU; Blanc AK, 1998, STUD FAMILY PLANN, V29, P106, DOI 10.2307/172153; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brea JA, 2003, POPULATION DYNAMICS; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Chen K-H, 1976, CULTURE NATALITY FAM, P241; CLELAND J, 1973, STUD FAMILY PLANN, V4, P42, DOI 10.2307/1964829; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2013, LANCET, V381, P1604, DOI 10.1016/S0140-6736(13)60588-7; CRESSEY PG, 1983, URBAN LIFE, V12, P102, DOI 10.1177/0098303983012001007; EVERHART RB, 1977, AM EDUC RES J, V14, P1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frye M, 2012, AM J SOCIOL, V117, P1565, DOI 10.1086/664542; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Gill GJ.O.K, 1993, MED ANTHR Q; GREEN EC, 1988, STUD FAMILY PLANN, V19, P109, DOI 10.2307/1966495; Greene William H, 2003, ECONOMETRIC ANAL, V5th; Hox JJ, 1991, MEASUREMENT ERROR SU; Jansen SC, 1980, QUALITATIVE SOCIOLOG, V2, P22; Johnson-Hanks J, 2005, CURR ANTHROPOL, V46, P363, DOI 10.1086/428799; Launiala A, 2009, ANTHR MATTERS; Levy MJ, 1972, MODERNIZATION LATECO; Lind Amy, 2010, DEV SEXUAL RIGHTS GL; LOAIZA E, 1995, STUD FAMILY PLANN, V26, P39, DOI 10.2307/2138050; Luke N, 2011, DEMOGRAPHY, P1; Marcus G, 1992, REREADING CULTURAL A; MASSEY DS, 1987, INT MIGR REV, V21, P1498, DOI 10.2307/2546522; Mayoni JR, 1983, ANTHROPOLOGICA, V25, P221; Meijer E, 2000, ECON LETT, V69, P277, DOI 10.1016/S0165-1765(00)00328-1; Mensch BS, 2008, INT FAM PLAN PERSPEC, V34, P169, DOI 10.1363/ifpp.34.169.08; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; NASH D, 1963, SOUTHWEST J ANTHROP, V19, P149, DOI 10.1086/soutjanth.19.2.3629165; O'Barr WM, 1973, SURVEY RES AFRICA; O'Muircheartaigh C, 1998, J ROY STAT SOC A STA, V161, P63, DOI 10.1111/1467-985X.00090; Paulhus DL, 2003, J PERS SOC PSYCHOL, V84, P890, DOI 10.1037/0022-3514.84.4.890; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Plummer ML, 2004, TROP MED INT HEALTH, V9, P737, DOI 10.1111/j.1365-3156.2004.01254.x; Potter JE, 8675020 AG INT DEV; Poulin M, 2010, DEMOGR RES, V22, P237, DOI 10.4054/DemRes.2010.22.11; Powdermaker Hortense, 1966, STRANGER FRIEND WAY; Rodriguez LA, 2015, FIELD METHOD, V27, P163, DOI 10.1177/1525822X14549315; Rogers EM, 1999, COMMUN THEOR, V9, P58, DOI 10.1111/j.1468-2885.1999.tb00162.x; Sana M, POPULATION IN PRESS; Sana M, 2008, SOCIOL METHOD RES, V36, P515, DOI 10.1177/0049124107313857; Silverman, 2004, QUALITATIVE RES THEO, P141; Simmel G., 1950, SOCIOLOGY G SIMMEL; Simmel G, 1906, AM J SOCIOL, V11, P441, DOI 10.1086/211418; STONE L, 1984, HUM ORGAN, V43, P27, DOI 10.17730/humo.43.1.6wl5k01724878166; SUDMAN S, 1974, J MARKETING RES, V11, P128, DOI 10.2307/3150549; Sullivan TM, 2006, J BIOSOC SCI, V38, P501, DOI 10.1017/S0021932005026647; Tourangeau Roger, 2000, PSYCHOL SURVEY RESPO; Vaessen M, 2005, HOUSEHOLD SAMPLE SUR; Weinreb AA, 2011, RESULTS METHODOLOGIC; Weinreb AA, 2006, AM SOCIOL REV, V71, P1014, DOI 10.1177/000312240607100607; Westoff C. F., 1988, International Family Planning Perspectives, V14, P45, DOI 10.2307/2947679; Yoder PS, 1997, MED ANTHROPOL Q, V11, P131, DOI 10.1525/maq.1997.11.2.131; Zimmerman L, 2015, AFRICAN POPULATION S, V29, P1699, DOI 10.11564/29-1-719	64	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136972	10.1371/journal.pone.0136972	http://dx.doi.org/10.1371/journal.pone.0136972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26322898	Green Submitted, gold, Green Published			2022-12-27	WOS:000360435500056
J	Chen, DQ; Wang, SW; Xiong, BL; Cao, BB; Deng, XP				Chen, Daoqian; Wang, Shiwen; Xiong, Binglin; Cao, Beibei; Deng, Xiping			Carbon/Nitrogen Imbalance Associated with Drought-Induced Leaf Senescence in Sorghum bicolor	PLOS ONE			English	Article							NITRATE REDUCTASE-ACTIVITY; ABSCISIC-ACID; NITROGEN AVAILABILITY; GLUTAMINE-SYNTHETASE; GENE-EXPRESSION; MESSENGER-RNA; WATER-STRESS; PLANTS; CARBON; ARABIDOPSIS	Drought stress triggers mature leaf senescence, which supports plant survival and remobilization of nutrients; yet leaf senescence also critically decreases post-drought crop yield. Drought generally results in carbon/nitrogen imbalance, which is reflected in the increased carbon: nitrogen (C:N) ratio in mature leaves, and which has been shown to be involved in inducing leaf senescence under normal growth conditions. Yet the involvement of the carbon/nitrogen balance in regulation of drought-induced leaf senescence is unclear. To investigate the role of carbon/nitrogen balance in drought-induced senescence, sorghum seedlings were subjected to a gradual soil drought treatment. Leaf senescence symptoms and the C: N ratio, which was indicated by the ratio of non-structural carbohydrate to total N content, were monitored during drought progression. In this study, leaf senescence developed about 12 days after the start of drought treatment, as indicated by various senescence symptoms including decreasing photosynthesis, photosystem II photochemistry efficiency (Fv/Fm) and chlorophyll content, and by the differential expression of senescence marker genes. The C: N ratio was significantly enhanced 10 to 12 days into drought treatment. Leaf senescence occurred in the older (lower) leaves, which had higher C: N ratios, but not in the younger (upper) leaves, which had lower C: N ratios. In addition, a detached leaf assay was conducted to investigate the effect of carbon/nitrogen availability on drought-induced senescence. Exogenous application of excess sugar combined with limited nitrogen promoted drought-induced leaf senescence. Thus our results suggest that the carbon/nitrogen balance may be involved in the regulation of drought-induced leaf senescence.	[Chen, Daoqian; Deng, Xiping] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Wang, Shiwen; Deng, Xiping] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Xiong, Binglin] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Xiong, Binglin] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Cao, Beibei] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Wang, SW (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	shiwenwang@ms.iswc.ac.cn	Wang, Shiwen/AAA-9751-2019	Wang, Shiwen/0000-0003-3195-5531; deng, xi ping/0000-0003-4577-9217; Chen, Daoqian/0000-0002-1339-6767	West Light Foundation of the Chinese Academy of Sciences; Chinese Universities Scientific Fund [Z109021202]; National Basic Research Program of China [2015CB150402]	West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Universities Scientific Fund; National Basic Research Program of China(National Basic Research Program of China)	This study was supported by West Light Foundation of the Chinese Academy of Sciences, http://english.cas.cn/, Wang; Chinese Universities Scientific Fund (Z109021202), http://www.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html, Wang; and National Basic Research Program of China (2015CB150402), http://www.most.gov.cn/eng/, Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera E, 2010, PHYSIOL PLANTARUM, V138, P256, DOI 10.1111/j.1399-3054.2009.01336.x; Aoyama S, 2014, PLANT CELL PHYSIOL, V55, P293, DOI 10.1093/pcp/pcu002; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLEGG K. M., 1956, Journal of the Science of Food and Agriculture, V7, P40, DOI 10.1002/jsfa.2740070108; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Abreu ME, 2008, ENVIRON EXP BOT, V64, P105, DOI 10.1016/j.envexpbot.2007.12.016; ENGELS C, 1994, ANN BOT-LONDON, V73, P211, DOI 10.1006/anbo.1994.1025; Ferrario-Mery S, 1998, PLANT PHYSIOL, V117, P293, DOI 10.1104/pp.117.1.293; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; Ishiyama K, 2004, J BIOL CHEM, V279, P16598, DOI 10.1074/jbc.M313710200; Juvany M, 2012, J INTEGR PLANT BIOL, V54, P584, DOI 10.1111/j.1744-7909.2012.01141.x; Khanna-Chopra R, 2012, PROTOPLASMA, V249, P469, DOI 10.1007/s00709-011-0308-z; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu P, 2014, J EXP BOT, V65, P4747, DOI 10.1093/jxb/eru220; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Nio SA, 2011, PLANT PHYSIOL BIOCH, V49, P1126, DOI 10.1016/j.plaphy.2011.05.011; Ogbaga CC, 2011, PHYSIOL PLANTARUM, V152, P389; Ono K, 1996, PLANT CELL PHYSIOL, V37, P1083, DOI 10.1093/oxfordjournals.pcp.a029057; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pinto-Marijuan M, 2014, J EXP BOT, V65, P3845, DOI 10.1093/jxb/eru086; Pourtau N, 2004, PLANTA, V219, P765, DOI 10.1007/s00425-004-1279-5; Reguera M, 2013, PLANT PHYSIOL, V163, P1609, DOI 10.1104/pp.113.227702; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Robredo A, 2011, ENVIRON EXP BOT, V71, P399, DOI 10.1016/j.envexpbot.2011.02.011; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Schildhauer J, 2008, PLANT BIOLOGY, V10, P76, DOI 10.1111/j.1438-8677.2008.00075.x; SHANER DL, 1976, PLANT PHYSIOL, V58, P505, DOI 10.1104/pp.58.4.505; Wingler A, 2008, PLANT BIOLOGY, V10, P50, DOI 10.1111/j.1438-8677.2008.00086.x; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wingler A, 2015, J EXP BOT, V66, P355, DOI 10.1093/jxb/eru426; Wingler A, 2012, PLANT PHYSIOL, V158, P1241, DOI 10.1104/pp.111.191908; Xu WZ, 2014, ACTA PHYSIOL PLANT, V36, P1033, DOI 10.1007/s11738-013-1481-9; Xu ZZ, 2006, J PLANT GROWTH REGUL, V25, P252, DOI 10.1007/s00344-006-0043-4; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; ZHANG HS, 2013, PLANT MOL BIOL, V82, P539, DOI DOI 10.1007/s11103-012-9980-4	44	40	48	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137026	10.1371/journal.pone.0137026	http://dx.doi.org/10.1371/journal.pone.0137026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317421	Green Published, gold			2022-12-27	WOS:000360299100196
J	Famulare, M				Famulare, Michael			Has Wild Poliovirus Been Eliminated from Nigeria?	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUSES; POLIOMYELITIS ERADICATION; SURVEILLANCE; PROGRESS; STRATEGY	Wild poliovirus type 3 (WPV3) has not been seen anywhere since the last case of WPV3-associated paralysis in Nigeria in November 2012. At the time of writing, the most recent case of wild poliovirus type 1 (WPV1) in Nigeria occurred in July 2014, and WPV1 has not been seen in Africa since a case in Somalia in August 2014. No cases associated with circulating vaccine-derived type 2 poliovirus (cVDPV2) have been detected in Nigeria since November 2014. Has WPV1 been eliminated from Africa? Has WPV3 been eradicated globally? Has Nigeria interrupted cVDPV2 transmission? These questions are difficult because polio surveillance is based on paralysis and paralysis only occurs in a small fraction of infections. This report provides estimates for the probabilities of poliovirus elimination in Nigeria given available data as of March 31, 2015. It is based on a model of disease transmission that is built from historical polio incidence rates and is designed to represent the uncertainties in transmission dynamics and poliovirus detection that are fundamental to interpreting long time periods without cases. The model estimates that, as of March 31, 2015, the probability of WPV1 elimination in Nigeria is 84%, and that if WPV1 has not been eliminated, a new case will be detected with 99% probability by the end of 2015. The probability of WPV3 elimination (and thus global eradication) is > 99%. However, it is unlikely that the ongoing transmission of cVDPV2 has been interrupted; the probability of cVDPV2 elimination rises to 83% if no new cases are detected by April 2016.	Inst Dis Modeling, Bellevue, WA 98005 USA		Famulare, M (corresponding author), Inst Dis Modeling, Bellevue, WA 98005 USA.	mfamulare@intven.com		Famulare, Michael/0000-0001-9275-7454	Global Good, Bellevue, WA, USA; Institute for Disease Modeling (Global Good)	Global Good, Bellevue, WA, USA; Institute for Disease Modeling (Global Good)	This work was supported by Global Good, Bellevue, WA, USA. The Institute for Disease Modeling (which is funded by Global Good) provided support in the form of a salary for author MF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P278; [Anonymous], 2013, MMWR-MORBID MORTAL W, V59, P802; [Anonymous], 2014, NIGERIA POLIO SITUAT; [Anonymous], 2005, DECISION THEORY BRIE; [Anonymous], 2015, POLIO IN SOMALIA; [Anonymous], 2015, GLOBAL POLIO ERADICA; [Anonymous], 2013, 2014 NIG POL ER EM P; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P942; Debanne SM, 1998, MATH BIOSCI, V150, P83, DOI 10.1016/S0025-5564(98)00007-8; DEGROOT MH, 1986, PROBABILITY STAT; Diop OM, 2014, MMWR-MORBID MORTAL W, V63, P242; Dunkle Stacie, 2012, Morbidity and Mortality Weekly Report, V61, P899; Eichner E, 1996, AM J EPIDEMIOL, V143, P816, DOI 10.1093/oxfordjournals.aje.a008820; Etsano A, 2014, MMWR-MORBID MORTAL W, V63, P1059; Etsano A, 2013, MMWR-MORBID MORTAL W, V62, P1009; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Hull BP, 1997, J INFECT DIS, V175, pS113, DOI 10.1093/infdis/175.Supplement_1.S113; Kalkowska DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0791-5; Kalkowska DA, 2012, AM J EPIDEMIOL, V175, P936, DOI 10.1093/aje/kwr399; Kew OM, 2014, MMWR-MORBID MORTAL W, V63, P1031; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Mangal TD, 2014, LANCET GLOB HEALTH, V2, pE90, DOI 10.1016/S2214-109X(13)70168-2; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; Shulman LM, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.7.20709; Smith SJ, 2004, B WHO, V82; Sutter RW, 2006, CURR TOP MICROBIOL, V304, P195; Tebbens RJD, 2013, RISK ANAL, V33, P680, DOI 10.1111/risa.12022; Upfill-Brown AM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-92; WHO SAGE Polio Working Group, 2014, OPV CESS PLAN TOPV C; World Health Organization, 2015, GLOB POL ER IN DAT M	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135765	10.1371/journal.pone.0135765	http://dx.doi.org/10.1371/journal.pone.0135765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317401	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100044
J	Ibanez, G; Bernard, JY; Rondet, C; Peyre, H; Forhan, A; Kaminski, M; Saurel-Cubizolles, MJ				Ibanez, Gladys; Bernard, Jonathan Y.; Rondet, Claire; Peyre, Hugo; Forhan, Anne; Kaminski, Monique; Saurel-Cubizolles, Marie-Josephe		EDEN Mother-Child Cohort Study Grp	Effects of Antenatal Maternal Depression and Anxiety on Children's Early Cognitive Development: A Prospective Cohort Study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MENTAL-HEALTH; PRETERM BIRTH; PREGNANCY; STRESS; RISK; PSYCHOPATHOLOGY; MODEL; AGE; DETERMINANTS	Introduction Studies have shown that depression or anxiety occur in 10-20% of pregnant women. These disorders are often undertreated and may affect mothers and children's health. This study investigates the relation between antenatal maternal depression, anxiety and children's early cognitive development among 1380 two-year-old children and 1227 three-yearold children. Methods In the French EDEN Mother-Child Cohort Study, language ability was assessed with the Communicative Development Inventory at 2 years of age and overall development with the Ages and Stages Questionnaire at 3 years of age. Multiple regressions and structural equation modeling were used to examine links between depression, anxiety during pregnancy and child cognitive development. Results We found strong significant associations between maternal antenatal anxiety and poorer children's cognitive development at 2 and 3 years. Antenatal maternal depression was not associated with child development, except when antenatal maternal anxiety was also present. Both postnatal maternal depression and parental stimulation appeared to play mediating roles in the relation between antenatal maternal anxiety and children's cognitive development. At 3 years, parental stimulation mediated 13.2% of the effect of antenatal maternal anxiety while postnatal maternal depression mediated 26.5%. Discussion The partial nature of these effects suggests that other mediators may play a role. Implications for theory and research on child development are discussed.	[Ibanez, Gladys; Kaminski, Monique; Saurel-Cubizolles, Marie-Josephe] Paris Descartes Univ, Obstetr Perinatal & Pediat Epidemiol Res Team, Ctr Epidemiol & Biostat, INSERM,U1153, Paris, France; [Ibanez, Gladys; Rondet, Claire] Univ Paris 06, Sch Med, Dept Gen Practice, Paris, France; [Bernard, Jonathan Y.; Forhan, Anne] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth CESP, Team Epidemiol Diabet Obes & Kidney Dis Lifelong, F-94807 Villejuif, France; [Bernard, Jonathan Y.; Forhan, Anne] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Peyre, Hugo] Ecole Normale Super, CNRS, Lab Sci Cognit & Psycholinguist, EHESS, Paris, France; [Peyre, Hugo] Hop Robert Debre, APHP, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Ibanez, G (corresponding author), Paris Descartes Univ, Obstetr Perinatal & Pediat Epidemiol Res Team, Ctr Epidemiol & Biostat, INSERM,U1153, Paris, France.	gladys.ibanez@upmc.fr	Annesi-Maesano, Isabella/D-9173-2016; Bernard, Jonathan/T-7064-2017; Lepeule, Johanna/N-2579-2013; Dargent-Molina, Patricia/N-3887-2017; Heude, Barbara/G-3095-2016; Charles, Marie Aline/S-1866-2019; de Lauzon-Guillain, Blandine/P-4659-2016; FRITEL, Xavier/K-8566-2012; Charles, Marie Aline/F-8567-2017; Peyre, Hugo/A-5656-2018; Saurel-Cubizolles, Marie-Josephe/D-1571-2014	Annesi-Maesano, Isabella/0000-0002-6340-9300; Bernard, Jonathan/0000-0002-6418-983X; Lepeule, Johanna/0000-0001-8907-197X; Dargent-Molina, Patricia/0000-0001-8596-6899; Heude, Barbara/0000-0002-1565-1629; Charles, Marie Aline/0000-0003-4025-4390; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; FRITEL, Xavier/0000-0002-4987-8127; Charles, Marie Aline/0000-0003-4025-4390; , Gladys/0000-0002-5592-699X; Peyre, Hugo/0000-0001-8757-0783; Germa, Alice/0000-0002-0505-4986; Saurel-Cubizolles, Marie-Josephe/0000-0002-2210-974X; HANKARD, Regis/0000-0001-8450-5839	Fondation pour la Recherche Medicale (FRM); French Ministry of Research: IFR program; INSERM Nutrition Research Program; French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; Nestle; Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR); Institute of Research in Public Health (IRESP: Cohort program); Nestle Nutrition and Guigoz; French Group of General Pediatrics; French Epidemiological Research Group for Pediatrics; French National Institute for Health Education (INPES)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministry of Research: IFR program(Ministry of Research, France); INSERM Nutrition Research Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET)(French National Research Agency (ANR)); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; Nestle(Nestle SA); Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR)(French National Research Agency (ANR)); Institute of Research in Public Health (IRESP: Cohort program); Nestle Nutrition and Guigoz(Nestle SA); French Group of General Pediatrics; French Epidemiological Research Group for Pediatrics; French National Institute for Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Fondation pour la Recherche Medicale (FRM), French Ministry of Research: IFR program, INSERM Nutrition Research Program, French Ministry of Health Perinatality Program, French Agency for Environment Security (AFFSET), French National Institute for Population Health Surveillance (INVS), Paris-Sud University, French National Institute for Health Education (INPES), Nestle, Mutuelle Generale de l'Education Nationale (MGEN), French Speaking Association for the Study of Diabetes and Metabolism (Alfediam), National Agency for Research (ANR), the Institute of Research in Public Health (IRESP: Cohort program) and Nestle Nutrition and Guigoz, the French Group of General Pediatrics, and the French Epidemiological Research Group for Pediatrics.	Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Ammerman RT, 2014, ARCH WOMENS MENT HLT; Austin MP, 2005, EARLY HUM DEV, V81, P917, DOI 10.1016/j.earlhumdev.2005.07.005; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bernard JY, 2013, J PEDIATR-US, V163, P36, DOI 10.1016/j.jpeds.2012.11.090; Bricker D, 1999, AGES STAGES QUESTION, V2; Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; Drouillet P, 2009, BRIT J NUTR, V101, P583, DOI 10.1017/S0007114508025038; Fenson L., 1993, MACARTHUR COMMUNICAT; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Fisher M, 2010, AUST NZ J PSYCHIAT, V44, P1057, DOI 10.3109/00048674.2010.509311; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Gray PH, 2013, EARLY HUM DEV, V89, P625, DOI 10.1016/j.earlhumdev.2013.04.005; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Gutierrez-Galve L, 2015, PEDIATRICS; Hanington L, 2012, CHILD CARE HLTH DEV, V38, P520, DOI 10.1111/j.1365-2214.2011.01270.x; Hinnant JB, 2003, CHILD DEV, V84, P3; Ibanez G, 2012, EARLY HUM DEV, V88, P643, DOI 10.1016/j.earlhumdev.2012.01.014; Jackson-Maldonado D., 2003, MACARTHUR INVENTARIO; Jensen SKG, 2014, DEPRESS ANXIETY, V31, P599, DOI 10.1002/da.22147; Kane P, 2004, CLIN PSYCHOL REV, V24, P339, DOI 10.1016/j.cpr.2004.03.004; Keim SA, 2011, EARLY HUM DEV, V87, P373, DOI 10.1016/j.earlhumdev.2011.02.004; Kern S., 2003, GLOSSA, V85, P48; Koutra K, 2013, SOC PSYCH PSYCH EPID, V48, P1335, DOI 10.1007/s00127-012-0636-0; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Loomans EM, 2012, DEV PSYCHOBIOL, V54, P441, DOI 10.1002/dev.20606; Lukasiewicz M, 2008, ALCOHOL ALCOHOLISM, V43, P287, DOI 10.1093/alcalc/agm183; Mennes M, 2006, NEUROSCI BIOBEHAV R, V30, P1078, DOI 10.1016/j.neubiorev.2006.04.003; Miszkurka M, 2012, SOC PSYCH PSYCH EPID, V47, P1639, DOI 10.1007/s00127-011-0469-2; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; Pawlby S, 2011, BRIT J PSYCHIAT, V199, P106, DOI 10.1192/bjp.bp.110.087734; Petzoldt J, 2014, ARCH DIS CHILD, V99, P800, DOI 10.1136/archdischild-2013-305562; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reising MM, 2013, J CHILD FAM STUD, P22; Smith T, 2012, MCN-AM J MATERN-CHIL, V37, P80, DOI 10.1097/NMC.0b013e3182446401; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spielberger CD, 1993, INVENTAIRE ANXIETE T; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Squires J, 2009, ASQ 3 AGES STAGES QU; Van den Bergh BRH, 2011, DEV MED CHILD NEUROL, V53, P19, DOI 10.1111/j.1469-8749.2011.04057.x; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Wu J, 2002, AM J OBSTET GYNECOL, V187, P864, DOI 10.1067/mob.2002.127126	51	47	47	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135849	10.1371/journal.pone.0135849	http://dx.doi.org/10.1371/journal.pone.0135849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317609	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100046
J	Kal, EC; van der Kamp, J; Houdijk, H; Groet, E; van Bennekom, CAM; Scherder, EJA				Kal, E. C.; van der Kamp, J.; Houdijk, H.; Groet, E.; van Bennekom, C. A. M.; Scherder, E. J. A.			Stay Focused! The Effects of Internal and External Focus of Attention on Movement Automaticity in Patients with Stroke	PLOS ONE			English	Article							COGNITIVE-MOTOR INTERFERENCE; WORKING-MEMORY; STOPS WALKING; EMG ACTIVITY; PERFORMANCE; PREDICTOR; FEEDBACK; TALKING; PEOPLE; REACH	Dual-task performance is often impaired after stroke. This may be resolved by enhancing patients' automaticity of movement. This study sets out to test the constrained action hypothesis, which holds that automaticity of movement is enhanced by triggering an external focus (on movement effects), rather than an internal focus (on movement execution). Thirty-nine individuals with chronic, unilateral stroke performed a one-leg-stepping task with both legs in single-and dual-task conditions. Attentional focus was manipulated with instructions. Motor performance (movement speed), movement automaticity (fluency of movement), and dual-task performance (dual-task costs) were assessed. The effects of focus on movement speed, single- and dual-task movement fluency, and dual-task costs were analysed with generalized estimating equations. Results showed that, overall, single-task performance was unaffected by focus (p = .341). Regarding movement fluency, no main effects of focus were found in single- or dual-task conditions (p's >= .13). However, focus by leg interactions suggested that an external focus reduced movement fluency of the paretic leg compared to an internal focus (single-task conditions: p = .068; dual-task conditions: p = .084). An external focus also tended to result in inferior dual-task performance (beta = -2.38, p = .065). Finally, a near-significant interaction (beta = 2.36, p = .055) suggested that dual-task performance was more constrained by patients' attentional capacity in external focus conditions. We conclude that, compared to an internal focus, an external focus did not result in more automated movements in chronic stroke patients. Contrary to expectations, trends were found for enhanced automaticity with an internal focus. These findings might be due to patients' strong preference to use an internal focus in daily life. Future work needs to establish the more permanent effects of learning with different attentional foci on re-automating motor control after stroke.	[Kal, E. C.; Houdijk, H.; Groet, E.; van Bennekom, C. A. M.] Heliomare Rehabil Ctr, Res & Dev, Wijk Aan Zee, Netherlands; [Kal, E. C.; van der Kamp, J.; Houdijk, H.; Scherder, E. J. A.] Vrije Univ Amsterdam, Fac Behav & Human Movement Sci, Amsterdam, Netherlands; [van der Kamp, J.] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [van Bennekom, C. A. M.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat & Environm Hlth, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Kal, EC (corresponding author), Heliomare Rehabil Ctr, Res & Dev, Wijk Aan Zee, Netherlands.	e.kal@heliomare.nl	Houdijk, Han/GXV-2986-2022	Houdijk, Han/0000-0002-7069-1973; van der Kamp, John/0000-0002-3826-1973; van Bennekom, coen/0000-0002-9754-261X; Kal, Elmar/0000-0002-1481-3016				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Abernethy B, 2012, HDB SPORT PSYCHOL, P245, DOI [10.1002/9781118270011, DOI 10.1002/9781118270011.CHL]; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brinckenkamp R, 2007, D2 AANDACHTS CONCENR; Cirstea AC, 2007, NEUROREHAB NEURAL RE, V21, P398, DOI 10.1177/1545968306298414; Culbertson W. C., 2005, TOL DX TOWER LONDON; D'Elia L.F., 1996, COLOR TRAILS TEST; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Durham KF, 2014, PHYSIOTHERAPY, V100, P108, DOI 10.1016/j.physio.2013.03.004; Durham K, 2009, PHYSIOTHER RES INT, V14, P77, DOI 10.1002/pri.431; Fasoli SE, 2002, AM J OCCUP THER, V56, P380, DOI 10.5014/ajot.56.4.380; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; HOLM S, 1979, SCAND J STAT, V6, P65; Hreljac A, 2000, GAIT POSTURE, V11, P199, DOI 10.1016/S0966-6362(00)00045-X; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Johnson L, 2013, PHYS THER, V93, P957, DOI 10.2522/ptj.20120300; Kal EC, 2013, HUM MOVEMENT SCI, V32, P527, DOI 10.1016/j.humov.2013.04.001; Kleynen M, 2013, CLIN REHABIL, V27, P160, DOI 10.1177/0269215512448381; Kok R. M., 2002, DUTCH TRANSLATION MI; Kramer J.H, 2007, DELIS KAPLAN EXECUTI; Lohse KR, 2010, HUM MOVEMENT SCI, V29, P542, DOI 10.1016/j.humov.2010.05.001; Malthotra N, 2015, PSYCHOL SPORT EXERC, V18, P1; Masters R. S. W., 2005, INT SOC SPORT PSYCHO; Maurer H, 2013, HUM MOVEMENT SCI, V32, P730, DOI 10.1016/j.humov.2013.02.001; Maxwell JP, 2003, CONSCIOUS COGN, V12, P376, DOI 10.1016/S1053-8100(03)00005-9; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McNevin NH, 2003, PSYCHOL RES-PSYCH FO, V67, P22, DOI 10.1007/s00426-002-0093-6; Orrell AJ, 2009, NEUROREHAB NEURAL RE, V23, P177, DOI 10.1177/1545968308317752; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Poolton JM, 2006, J SPORT SCI, V24, P89, DOI 10.1080/02640410500130854; Schmand B., 2008, TIJDSCHR GERONTOL GE, V39, P65; Thomas JR, 2000, J EXP CHILD PSYCHOL, V75, P228, DOI 10.1006/jecp.1999.2535; UNESCO, 2006, INT STAND CLASS ED I; Vance J, 2004, J MOTOR BEHAV, V36, P450, DOI 10.3200/JMBR.36.4.450-459; Wechsler D., 2012, WAIS 4 NEDERLANDSTAL; Wechsler D, 2005, WAIS 3 NEDERLANDSTAL; Weiss SM, 2008, J SPORT SCI, V26, P1049, DOI 10.1080/02640410802098874; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035	47	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136917	10.1371/journal.pone.0136917	http://dx.doi.org/10.1371/journal.pone.0136917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317437	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100172
J	Kim, Y; Kong, KA				Kim, Yuna; Kong, Kyoung Ae			Do Hypertensive Individuals Who Are Aware of Their Disease Follow Lifestyle Recommendations Better than Those Who Are Not Aware?	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; POTASSIUM INTAKE; SODIUM-INTAKE; 7TH REPORT; ASSOCIATION; CONSUMPTION; PATTERNS; HEALTH; PREVALENCE; TRENDS	Lifestyle modification is the first step in hypertension management. Our objective was to assess adherence to lifestyle recommendations by individuals who were aware of their hypertension and to identify characteristics associated with non-adherence. Using data from the Korea National Health and Nutrition Examination Survey conducted in 2010-2012, we compared the adherence to six lifestyle recommendations of hypertensive subjects aware of the status of their condition with that of those who were not aware, based on survey regression analysis. The characteristics associated with non-adherence were assessed by multiple logistic regression analysis. Of all hypertensive subjects, <20% adhered to a healthy diet and reduced salt intake and about 80% moderated alcohol consumption and did not smoke. Half of all subjects maintained normal body weight and engaged in physical activity. Most lifestyle features of aware hypertensive Koreans did not differ greatly from those of hypertensive individuals who were not aware. Reduction in salt intake was slightly more prevalent among those aware of their hypertensive status. Obesity was more prevalent among the aware hypertensive subjects, and the prevalence of obesity increased with the duration of hypertension. Male gender, younger age, residence in a rural area, low income, and the use of antihypertensive medication were associated with non-adherence to lifestyle recommendations by hypertensive individuals. Many hypertensive Koreans do not comply with lifestyle recommendations for the management of hypertension. The association between the use of antihypertensive medications and non-adherence suggested an over-reliance on medication rather than a commitment to a healthy lifestyle. Our study highlights that efforts encouraging healthy lifestyles, as the first step in hypertension management, need to be increased.	[Kim, Yuna] Korea Ctr Dis Control & Prevent, Div Hlth & Nutr Survey, Cheongju, Chungcheongbuk, South Korea; [Kim, Yuna] Seoul Natl Univ, Coll Nursing, Seoul, South Korea; [Kong, Kyoung Ae] Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Seoul National University (SNU); Ewha Womans University	Kong, KA (corresponding author), Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea.	kkong@ewha.ac.kr	Kim, Yuna/GXV-6765-2022					[Anonymous], 2012, KOR HLTH STAT 2012 K; Antman EM, 2014, CIRCULATION, V129, pE660, DOI 10.1161/CIR.0000000000000051; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Banegas JR, 2012, HYPERTENSION, V60, P898, DOI 10.1161/HYPERTENSIONAHA.112.193078; Baustista LE, 2010, CHRONIC DIS EPIDEMIO; Bihan H, 2010, J NUTR, V140, P823, DOI 10.3945/jn.109.118273; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Crispim SP, 2011, BRIT J NUTR, V105, P447, DOI 10.1017/S0007114510003648; Drewnowski A, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-3; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; FRA, 2012, EU LGBT SURV; Gee ME, 2012, AM J CARDIOL, V109, P570, DOI 10.1016/j.amjcard.2011.09.051; Heymann AD, 2011, ISR MED ASSOC J, V13, P553; Hu HH, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/526949; Institute for Health Metrics and Evaluation, 2019, GBD DAT, DOI DOI 10.6069/VFWJ-JF14; Kim HI, 2013, NUTR RES, V33, P789, DOI 10.1016/j.nutres.2013.07.014; Korean Ministry of Health & Welfare, 2011, NAT HLTH PEOPL 2020; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lallukka T, 2010, EUR J CLIN NUTR, V64, P324, DOI 10.1038/ejcn.2009.155; Lee HS, 2013, J HUM HYPERTENS, V27, P298, DOI 10.1038/jhh.2012.43; Lee HS, 2010, CLIN EXP HYPERTENS, V32, P166, DOI 10.3109/10641960903254497; Lee K, 2010, PUBLIC HEALTH, V124, P698, DOI 10.1016/j.puhe.2010.07.004; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Mercado CI, 2015, AM J CLIN NUTR, V101, P376, DOI 10.3945/ajcn.113.081604; Neutel CI, 2008, CAN J CARDIOL, V24, P199; Redmond N, 2011, HYPERTENSION, V57, P383, DOI 10.1161/HYPERTENSIONAHA.110.161950; Scheltens T, 2010, J HUM HYPERTENS, V24, P561, DOI 10.1038/jhh.2010.26; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Tsubyama-Kasaoka N, 2013, J NUTR SCI VITAMINOL, V59, P584, DOI 10.3177/jnsv.59.584; van Mierlo LAJ, 2010, ARCH INTERN MED, V170, P1501, DOI 10.1001/archinternmed.2010.284; Weir MR, 2000, ARCH INTERN MED, V160, P481, DOI 10.1001/archinte.160.4.481	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136858	10.1371/journal.pone.0136858	http://dx.doi.org/10.1371/journal.pone.0136858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317336	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100155
J	Liu, F; Yang, YN; Xie, X; Li, XM; Ma, X; Fu, ZY; Chen, BD; Huang, Y; Shan, CF; Ma, YT; Gao, XM				Liu, Fen; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Chen, Bang-Dang; Huang, Ying; Shan, Chun-Fang; Ma, Yi-Tong; Gao, Xiao-Ming			Prevalence of Congenital Heart Disease in Xinjiang Multi-Ethnic Region of China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; NATURAL-HISTORY; RISK-FACTORS; DEFECTS; POPULATION; ANOMALIES; COUNCIL; BIRTH	Background The prevalence and risk factors of congenital heart disease among Xinjiang, northwestern part of China is currently unknown. Methods This multiple-ethnic, community-based, cross-sectional study was conducted to estimate the prevalence and distribution of congenital heart disease (CHD) in Xinjiang, northwestern part of China. Four major ethnics, Uygur, Han, Kazak, and Hui children in this region were investigated during February 2010 and May 2012. Results A total of 14,530 children (0-18 yr) were examined. Of these children, 240 (boys, 43.8%, and girls, 56.3%) were identified with CHD, giving an overall prevalence of 16.5 parts per thousand(17.7 parts per thousand in Uygur, 6.9 parts per thousand in Han, 11.4 parts per thousand in Kazak, and 38.1 parts per thousand in Hui Chinese, respectively). Ventricular septal defect (VSD, 29.2%), atrial septal defect (ASD, 20.8%), patent ductus arteriosus (PDA, 13.7%), acleistocardia (13.7%), Bicuspid aortic valve (7.9%), pulmonary valve stenosis (5.4%), and tetralogy of fallot (TOF, 4.2%) were common cyanotic and cyanotic defects observed. Compared to non-CHD children, children with CHD had a higher percentage of history of abortion, CHD history of family, consanguinity and premature birth (all P<0.05). In CHD children, 24% of mothers caught a cold, 10% had a febrile illness and 6.7% received antibiotic treatment during the first trimester of pregnancy, that were higher than non-CHD group (all P<0.05). Conclusion The overall prevalence of CHD in four ethnic children at ages 0-18 yr in Xinjiang was 16.5 parts per thousand. VSD, ASD and TOF were the most common acyanotic and cyanotic congenital heart defects, respectively. This study also identified some modifiable risk factors that may contribute to the incidence of CHD among the 4 ethnic groups.	[Liu, Fen; Yang, Yi-Ning; Chen, Bang-Dang; Ma, Yi-Tong; Gao, Xiao-Ming] Xinjiang Med Univ, Clin Med Res Inst, Xinjiang Key Lab Cardiovasc Dis, Affiliated Hosp 1, Urumqi, Peoples R China; [Liu, Fen; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Chen, Bang-Dang; Huang, Ying; Shan, Chun-Fang; Ma, Yi-Tong] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China; [Gao, Xiao-Ming] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Xinjiang Medical University; Xinjiang Medical University; Baker Heart and Diabetes Institute	Ma, YT (corresponding author), Xinjiang Med Univ, Clin Med Res Inst, Xinjiang Key Lab Cardiovasc Dis, Affiliated Hosp 1, Urumqi, Peoples R China.	myt_xj@sina.com; xiaoming.gao@bakeridi.edu.au	xie, xiang/AAG-2128-2021		Science and Technology Program of Xinjiang Uygur Autonomous Region, China [201233138]	Science and Technology Program of Xinjiang Uygur Autonomous Region, China	This work was supported financially by a grant from the Science and Technology Program of Xinjiang Uygur Autonomous Region, China (Grant No. 201233138; website: http://www.xjkjt.gov.cn/www. xjkjt.gov.cn/zxgz/kjzj/xmrcxq/index.htm). YTM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaruddoza, 1994, CLIN GENET, V45, P288; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Botto LD, 2001, EPIDEMIOLOGY, V12, P485, DOI 10.1097/00001648-200109000-00004; Contran RS, 1999, PATHOLOGIC BASIS DIS, V6th, P543; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; GIBSON S, 1952, AMA AM J DIS CHILD, V83, P317, DOI 10.1001/archpedi.1952.02040070063007; Grech V, 1999, J PAEDIATR CHILD H, V35, P387, DOI 10.1046/j.1440-1754.1999.00388.x; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu Z, 2014, J THORAC CARDIOV SUR, V148, P596, DOI 10.1016/j.jtcvs.2013.08.067; Hussain S, 2014, J PAK MED ASSOC, V64, P175; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kapoor R, 2008, INDIAN PEDIATR, V45, P309; KIDD L, 1993, CIRCULATION, V87, P38; Koyak Z, 2012, CIRCULATION, V126, P1944, DOI 10.1161/CIRCULATIONAHA.112.104786; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; MIAO CY, 1988, J AM COLL CARDIOL, V12, P224, DOI 10.1016/0735-1097(88)90378-6; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; NADERI S, 1979, OBSTET GYNECOL, V53, P195; Nikyar B, 2011, IRAN J PEDIATR, V21, P307; Patel SS, 2013, PEDIATR CARDIOL, V34, P1535, DOI 10.1007/s00246-013-0775-4; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Robida A, 1997, INT J CARDIOL, V60, P19, DOI 10.1016/S0167-5273(97)00067-3; Shan J., 2010, CONGENITAL HEART DIS; Shieh JTC, 2012, AM J MED GENET A, V158A, P1236, DOI 10.1002/ajmg.a.35272; STUCKEY D, 1956, BRIT HEART J, V18, P519; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Zhang YL, 2011, J ULTRAS MED, V30, P989, DOI 10.7863/jum.2011.30.7.989; Zhao QM, 2013, ACTA PAEDIATR, V102, P397, DOI 10.1111/apa.12170	30	22	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133961	10.1371/journal.pone.0133961	http://dx.doi.org/10.1371/journal.pone.0133961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317413	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100012
J	Nagpure, NS; Rashid, I; Pathak, AK; Singh, M; Pati, R; Singh, SP; Sarkar, UK				Nagpure, Naresh Sahebrao; Rashid, Iliyas; Pathak, Ajey Kumar; Singh, Mahender; Pati, Rameshwar; Singh, Shri Prakash; Sarkar, Uttam Kumar			FMiR: A Curated Resource of Mitochondrial DNA Information for Fish	PLOS ONE			English	Article							GENOME DATABASE; CONTROL REGION; RIBOSOMAL-RNA; PATTERNS; MICROSATELLITES; FREQUENCY; SEQUENCES; REPEATS; RICE	Mitochondrial genome sequences have been widely used for evolutionary and phylogenetic studies. Among vertebrates, fish are an important, diverse group, and their mitogenome sequences are growing rapidly in public repositories. To facilitate mitochondrial genome analysis and to explore the valuable genetic information, we developed the Fish Mitogenome Resource (FMiR) database to provide a workbench for mitogenome annotation, species identification and microsatellite marker mining. The microsatellites are also known as simple sequence repeats (SSRs) and used as molecular markers in studies on population genetics, gene duplication and marker assisted selection. Here, easy-to-use tools have been implemented for mining SSRs and for designing primers to identify species/habitat specific markers. In addition, FMiR can analyze complete or partial mitochondrial genome sequence to identify species and to deduce relational distances among sequences across species. The database presently contains curated mitochondrial genomes from 1302 fish species belonging to 297 families and 47 orders reported from saltwater and freshwater ecosystems. In addition, the database covers information on fish species such as conservation status, ecosystem, family, distribution and occurrence downloaded from the FishBase and IUCN Red List databases. Those fish information have been used to browse mitogenome information for the species belonging to a particular category. The database is scalable in terms of content and inclusion of other analytical modules.	[Nagpure, Naresh Sahebrao; Rashid, Iliyas; Singh, Mahender; Pati, Rameshwar] Natl Bur Fish Genet Resources, Div Mol Biol & Biotechnol, Lucknow 226002, Uttar Pradesh, India; [Pathak, Ajey Kumar; Singh, Shri Prakash; Sarkar, Uttam Kumar] Natl Bur Fish Genet Resources, Div Fish Taxon & Resources, Lucknow 226002, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources	Singh, M (corresponding author), Natl Bur Fish Genet Resources, Div Mol Biol & Biotechnol, Lucknow 226002, Uttar Pradesh, India.	mahender@scientist.com	Rashid, Iliyas/AAW-9086-2020	Rashid, Iliyas/0000-0001-7186-8200; Scaria, Vinod/0000-0001-7644-7181; Singh, Mahender/0000-0001-5335-5460; PATI, RAMESHWAR/0000-0002-9487-2058	National Agricultural Innovation Project [30(68)/2009/Bio-informatics/NAIP/OM]	National Agricultural Innovation Project	All the funding was provided by National Agricultural Innovation Project (File No. 30(68)/2009/Bio-informatics/NAIP/O&M) for establishment of National Agricultural Bioinformatics Grid for National Agricultural Research and Education System in India. Dr. N.S. Nagpure was the Principal Investigator for the fisheries domain project. The project aimed at capacity building in fish bioinformatics and ended on 30th June, 2014. The role of the funders was only to create infrastructure and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernardi G, 2014, B MAR SCI, V90, P533, DOI 10.5343/bms.2013.1036; Bernatchez L, 1992, MOL ECOL, V1, P161, DOI 10.1111/j.1365-294X.1992.tb00172.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; de Vasconcelos ATR, 2005, BIOINFORMATICS, V21, P2566, DOI 10.1093/bioinformatics/bti326; Froese R., 2021, FISHBASE WORLD WIDE; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Irwin DM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0188-x; IUCN, 2014, FISH COS STAT IUCN R; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Khan HA, 2008, GENET MOL RES, V7, P1392, DOI 10.4238/vol7-4gmr514; Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177; Lee YS, 2008, NUCLEIC ACIDS RES, V36, pD938, DOI 10.1093/nar/gkm763; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Nagpure NS, 2015, MITOCHONDR DNA, V26, P195, DOI 10.3109/19401736.2014.892075; Nagpure NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-630; Nagpure NS, 2012, BIOINFORMATION, V8, P1005, DOI 10.6026/97320630081005; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajendrakumar P, 2007, BIOINFORMATICS, V23, P1, DOI 10.1093/bioinformatics/btl547; Ramsden SD, 2003, TRENDS ECOL EVOL, V18, P607, DOI 10.1016/j.tree.2003.09.020; Rostami S, 2013, VET PARASITOL, V197, P141, DOI 10.1016/j.vetpar.2013.07.001; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubino F, 2012, NUCLEIC ACIDS RES, V40, pD1150, DOI 10.1093/nar/gkr1086; Sablok G, 2013, DNA RES, V20, P127, DOI 10.1093/dnares/dss038; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schuler GD, 1996, METHOD ENZYMOL, V266, P141; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; von der Heyden S, 2011, J EVOLUTION BIOL, V24, P2505, DOI 10.1111/j.1420-9101.2011.02382.x; Wolfsberg TG, 2001, TRENDS BIOCHEM SCI, V26, P199, DOI 10.1016/S0968-0004(00)01773-4	43	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136711	10.1371/journal.pone.0136711	http://dx.doi.org/10.1371/journal.pone.0136711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317619	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100126
J	Shinjoh, M; Sugaya, N; Yamaguchi, Y; Tomidokoro, Y; Sekiguchi, S; Mitamura, K; Fujino, M; Shiro, H; Komiyama, O; Taguchi, N; Nakata, Y; Yoshida, N; Narabayashi, A; Myokai, M; Sato, M; Furuichi, M; Baba, H; Fujita, H; Sato, A; Ookawara, I; Tsunematsu, K; Yoshida, M; Kono, M; Tanaka, F; Kawakami, C; Kimiya, T; Takahashi, T; Iwata, S				Shinjoh, Masayoshi; Sugaya, Norio; Yamaguchi, Yoshio; Tomidokoro, Yuka; Sekiguchi, Shinichiro; Mitamura, Keiko; Fujino, Motoko; Shiro, Hiroyuki; Komiyama, Osamu; Taguchi, Nobuhiko; Nakata, Yuji; Yoshida, Naoko; Narabayashi, Atsushi; Myokai, Michiko; Sato, Masanori; Furuichi, Munehiro; Baba, Hiroaki; Fujita, Hisayo; Sato, Akihiro; Ookawara, Ichiro; Tsunematsu, Kenichiro; Yoshida, Makoto; Kono, Mio; Tanaka, Fumie; Kawakami, Chiharu; Kimiya, Takahisa; Takahashi, Takao; Iwata, Satoshi		Keio Pediat Influenza Res Grp	Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; A INFECTION; SCHOOLCHILDREN; PROTECTION; EFFICACY; SEASON; AGE	We assessed vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza in children 6 months to 15 years of age in 22 hospitals in Japan during the 201314 season. Our study was conducted according to a test-negative case-control design based on influenza rapid diagnostic test (IRDT) results. Outpatients who came to our clinics with a fever of 38 degrees C or over and had undergone an IRDT were enrolled in this study. Patients with positive IRDT results were recorded as cases, and patients with negative results were recorded as controls. Between November 2013 and March 2014, a total of 4727 pediatric patients (6 months to 15 years of age) were enrolled: 876 were positive for influenza A, 66 for A(H1N1)pdm09 and in the other 810 the subtype was unknown; 1405 were positive for influenza B; and 2445 were negative for influenza. Overall VE was 46% (95% confidence interval [CI], 39-52). Adjusted VE against influenza A, influenza A(H1N1) pdm09, and influenza B was 63% (95% CI, 56-69), 77% (95% CI, 59-87), and 26% (95% CI, 14-36), respectively. Influenza vaccine was not effective against either influenza A or influenza B in infants 6 to 11 months of age. Two doses of influenza vaccine provided better protection against influenza A infection than a single dose did. VE against hospitalization influenza A infection was 76%. Influenza vaccine was effective against influenza A, especially against influenza A(H1N1)pdm09, but was much less effective against influenza B.	[Shinjoh, Masayoshi; Sekiguchi, Shinichiro; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo, Japan; [Shinjoh, Masayoshi; Iwata, Satoshi] Keio Univ, Sch Med, Ctr Infect Dis & Infect Control, Shinjuku Ku, Tokyo, Japan; [Sugaya, Norio; Taguchi, Nobuhiko] Keiyu Hosp, Dept Paediat, Yokohama, Kanagawa, Japan; [Yamaguchi, Yoshio] Tochigi Med Ctr, Natl Hosp Org, Dept Clin Res, Utsunomiya, Tochigi, Japan; [Tomidokoro, Yuka; Kimiya, Takahisa] Tokyo Metropolitan Otsuka Hosp, Dept Pediat, Toshima Ku, Tokyo, Japan; [Mitamura, Keiko] Eiju Gen Hosp, Dept Pediat, Taito Ku, Tokyo, Japan; [Fujino, Motoko] Saiseikai Cent Hosp, Dept Pediat, Minato Ku, Tokyo, Japan; [Shiro, Hiroyuki] Yokohama Rosai Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Komiyama, Osamu] Tokyo Med Ctr, Natl Hosp Org, Dept Pediat, Meguro Ku, Tokyo, Japan; [Nakata, Yuji] Nippon Kokan Ltd Co Hosp, Dept Pediat, Kawasaki, Kanagawa, Japan; [Yoshida, Naoko] Kyosai Tachikawa Hosp, Dept Pediat, Tokyo, Japan; [Narabayashi, Atsushi] Kawasaki Municipal Hosp, Dept Paediat, Kawasaki, Kanagawa, Japan; [Myokai, Michiko] Shizuoka City Shimizu Hosp, Dept Pediat, Shizuoka, Japan; [Sato, Masanori] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Pediat, Ichikawa, Chiba, Japan; [Furuichi, Munehiro] Saitama City Hosp, Dept Pediat, Saitama, Japan; [Baba, Hiroaki] Ota Mem Hosp, Fuji Heavy Ind Hlth Insurance Soc, Dept Pediat, Ota, Gunma, Japan; [Fujita, Hisayo] Hiratsuka Kyosai Hosp, Dept Pediat, Hiratsuka, Kanagawa, Japan; [Sato, Akihiro] Yokohama Municipal Citizens Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Ookawara, Ichiro] Japanese Red Cross Shizuoka Hosp, Dept Pediat, Shizuoka, Japan; [Tsunematsu, Kenichiro] Hino Municipal Hosp, Dept Pediat, Tokyo, Japan; [Yoshida, Makoto] Sano Kousei Gen Hosp, Dept Pediat, Sano, Tochigi, Japan; [Kono, Mio] Saitama Natl Hosp, Natl Hosp Org, Dept Pediat, Wako, Saitama, Japan; [Tanaka, Fumie] Hiratsuka City Hosp, Dept Pediat, Hiratsuka, Kanagawa, Japan; [Kawakami, Chiharu] Yokohama City Inst Hlth, Yokohama, Kanagawa 2350012, Japan; [Iwata, Satoshi] Keio Univ, Sch Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; Tokyo Saiseikai Central Hospital; Yokohama Rosai Hospital; Tachikawa Hospital; Tokyo Dental College; Keio University	Sugaya, N (corresponding author), Keiyu Hosp, Dept Paediat, Yokohama, Kanagawa, Japan.	sugaya-n@za2.so-net.ne.jp	Furuichi, Munehiro/GLT-6225-2022; Shinjoh, Masayoshi/ABF-3935-2021	Shinjoh, Masayoshi/0000-0002-6291-7186	Japan Vaccine; Chugai; Shionogi; Daiichi Sankyo; GlaxoSmithKline; Takeda; Astellas	Japan Vaccine; Chugai; Shionogi; Daiichi Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Takeda(Takeda Pharmaceutical Company Ltd); Astellas(Astellas Pharmaceuticals)	Within 36 months, MS has received speakers' honoraria from Chugai, Shionogi, Daiichi Sankyo, Japan Vaccine, and Astellas; and grant support from Japan Vaccine outside of the submitted work. NS has received speakers' honoraria from Chugai, Shionogi, Daiichi Sankyo, GlaxoSmithKline, Astellas, Takeda, Mitsubishi Tanabe, and Denka Seiken. YY has received speaker's honorarium from Shionogi. KM has received speakers' honoraria from Shionogi, Daiichi Sankyo, Japan Vaccine, Takeda, Astellas, and Denka Seiken. TT has received speakers' honoraria from Japan Vaccine and Astellas; and grant support from Chugai and Shionogi outside of the submitted work. SI has received speakers' honoraria from Chugai, Shionogi, Daiichi Sankyo, GlaxoSmithKline, Japan Vaccine, Astellas, Takeda, and Denka Seiken; and grant support from Chugai, Shionogi, Daiichi Sankyo, GlaxoSmithKline, Japan Vaccine, Takeda, and Astellas outside of the submitted work. Other authors have no competing interests regarding this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Allison MA, 2006, J PEDIATR-US, V149, P755, DOI 10.1016/j.jpeds.2006.06.036; [Anonymous], EURO SURVEILL; Blyth CC, 2014, PEDIATRICS, V133, pE1218, DOI 10.1542/peds.2013-3707; Bragstad K, 2013, EURO SURVEILL, V18; Castilla J, 2013, EUROSURVEILLANCE, V18, P6; Centers for Disease C, 2013, MMWR-MORBID MORTAL W, V62, P119; Charu V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026282; Cowling BJ, 2014, VACCINE, V32, P5278, DOI 10.1016/j.vaccine.2014.07.084; Eisenberg KW, 2008, PEDIATRICS, V122, P911, DOI 10.1542/peds.2007-3304; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; Flannery B, 2014, MMWR-MORBID MORTAL W, V63, P137; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Hata Atsuko, 2004, Kansenshogaku Zasshi, V78, P846; Hoberman A, 2003, JAMA-J AM MED ASSOC, V290, P1608, DOI 10.1001/jama.290.12.1608; Jefferson Tom, 2012, Cochrane Database Syst Rev, pCD004879, DOI 10.1002/14651858.CD004879.pub4; Katayose M, 2011, VACCINE, V29, P1844, DOI 10.1016/j.vaccine.2010.12.049; Kawai N, 2003, VACCINE, V21, P4507, DOI 10.1016/S0264-410X(03)00508-5; Maeda T, 2004, PEDIATR INT, V46, P122, DOI 10.1046/j.1442-200x.2004.01852.x; McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647; National Institute of Infectious Diseases, 2014, 2013 14 INFL SEAS; National Institute of Infectious Diseases, 2013, PREEP ANT TIT; Neuzil KM, 2001, PEDIATR INFECT DIS J, V20, P733, DOI 10.1097/00006454-200108000-00004; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Pebody RG, 2013, EUROSURVEILLANCE, V18, P25; Pharmaceuticals and Medical Devices Agency, 2014, INS MED DIAGN DEV; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; SUGAYA N, 1994, JAMA-J AM MED ASSOC, V272, P1122, DOI 10.1001/jama.272.14.1122; Sugaya N, 2005, CLIN INFECT DIS, V41, P939, DOI 10.1086/432938; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Sugaya N, 2014, EXPERT REV VACCINES, V13, P1563, DOI 10.1586/14760584.2014.951036; Sugaya N, 2011, J INFECT CHEMOTHER, V17, P595, DOI 10.1007/s10156-011-0288-0; Sugaya N, 2011, J INFECTION, V63, P288, DOI 10.1016/j.jinf.2011.06.008; Sullivan SG, 2014, EXPERT REV VACCINES, V13, P1571, DOI 10.1586/14760584.2014.966695; Turner N, 2014, EUROSURVEILLANCE, V19, P19, DOI 10.2807/1560-7917.ES2014.19.42.20934; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331	42	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136539	10.1371/journal.pone.0136539	http://dx.doi.org/10.1371/journal.pone.0136539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317334	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100099
J	van Agthoven, T; Dorssers, LCJ; Lehmann, U; Kreipe, H; Looijenga, LHJ; Christgen, M				van Agthoven, Ton; Dorssers, Lambert C. J.; Lehmann, Ulrich; Kreipe, Hans; Looijenga, Leendert H. J.; Christgen, Matthias			Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; ENDOCRINE RESISTANCE; PROGNOSTIC VALUE; DOWNSTREAM; ACTIVATION; MUTATIONS; PHENOTYPE; PATHWAYS; PROTEIN; GENES	Background Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenings in in vitro cell models have identified genes, which override growth suppression induced by anti-estrogenic drugs like tamoxifen. Using that approach, we have previously identified Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) as a mediator of cell proliferation and tamoxifen-resistance. Here, we show high level of expression and function of BCAR4 in human breast cancer. Methods BCAR4 mRNA expression was evaluated by (q) RT-PCR in a panel of human normal tissues, primary breast cancers and cell lines. A new antibody raised against C78-I97 of the putative BCAR4 protein and used for western blot and immunoprecipitation assays. Furthermore, siRNA-mediated gene silencing was implemented to study the function of BCAR4 and its downstream targets ERBB2/3. Results Except for placenta, all human normal tissues tested were BCAR4-negative. In primary breast cancers, BCAR4 expression was comparatively rare (10%), but associated with enhanced proliferation. Relative high BCAR4 mRNA expression was identified in IPH-926, a cell line derived from an endocrine-resistant lobular breast cancer. Moderate BCAR4 expression was evident in MDA-MB-134 and MDA-MB-453 breast cancer cells. BCAR4 protein was detected in breast cancer cells with ectopic (ZR-75-1-BCAR4) and endogenous (IPH-926, MDA-MB-453) BCAR4 mRNA expression. Knockdown of BCAR4 inhibited cell proliferation. A similar effect was observed upon knockdown of ERBB2/3 and exposure to lapatinib, implying that BCAR4 acts in an ERBB2/3-dependent manner. Conclusion BCAR4 encodes a functional protein, which drives proliferation of endocrine-resistant breast cancer cells. Lapatinib, a clinically approved EGFR/ERBB2 inhibitor, counteracts BCAR4-driven tumor cell growth, a clinical relevant observation.	[van Agthoven, Ton; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Lehmann, Ulrich; Kreipe, Hans; Christgen, Matthias] Hannover Med Sch, Inst Pathol, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Hannover Medical School	van Agthoven, T (corresponding author), Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands.	a.vanagthoven@erasmusmc.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911	Hannelore-Munke-Fellowship	Hannelore-Munke-Fellowship	MC was supported by a Hannelore-Munke-Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa FO, 2011, BREAST CANCER RES TR, V126, P797, DOI 10.1007/s10549-010-1329-6; Angulo L, 2013, HUM REPROD, V28, P430, DOI 10.1093/humrep/des412; Bai YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079901; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Cheung KL, 2007, BREAST, V16, P327, DOI 10.1016/j.breast.2007.03.004; Christgen M, 2008, INT J CANCER, V123, P2239, DOI 10.1002/ijc.23806; Christgen M, 2013, CANCER SCI, V104, P1726, DOI 10.1111/cas.12276; Christgen M, 2013, GENE CHROMOSOME CANC, V52, P69, DOI 10.1002/gcc.22007; Christgen M, 2012, LAB INVEST, V92, P1635, DOI 10.1038/labinvest.2012.126; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Droog M, 2013, EUR J PHARMACOL, V717, P47, DOI 10.1016/j.ejphar.2012.11.071; Droufakou S, 2001, INT J CANCER, V92, P404, DOI 10.1002/ijc.1208; ENGEL LW, 1978, CANCER RES, V38, P3352; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Godinho MFE, 2012, BRIT J CANCER, V107, P947, DOI 10.1038/bjc.2012.351; Godinho MFE, 2010, BRIT J CANCER, V103, P1284, DOI 10.1038/sj.bjc.6605884; Godinho M, 2011, J CELL PHYSIOL, V226, P1741, DOI 10.1002/jcp.22503; Hayes EL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0542-y; Hoefnagel LDC, 2012, CANCER-AM CANCER SOC, V118, P4929, DOI 10.1002/cncr.27518; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Krech T, 2012, CANCER LETT, V315, P153, DOI 10.1016/j.canlet.2011.09.038; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Ross JS, 2013, CLIN CANCER RES, V19, P2668, DOI 10.1158/1078-0432.CCR-13-0295; van Agthoven T, 2012, INT J CANCER, V131, P1998, DOI 10.1002/ijc.27489; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013	33	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136845	10.1371/journal.pone.0136845	http://dx.doi.org/10.1371/journal.pone.0136845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317614	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100150
J	Van Sinderen, ML; Steinberg, GR; Jorgensen, SB; Honeyman, J; Chow, JD; Herridge, KA; Winship, AL; Dimitriadis, E; Jones, MEE; Simpson, ER; Boon, WC				Van Sinderen, Michelle L.; Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane; Chow, Jenny D.; Herridge, Kerrie A.; Winship, Amy L.; Dimitriadis, Evdokia; Jones, Margaret E. E.; Simpson, Evan R.; Boon, Wah Chin			Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; DEFICIENT ARKO MICE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; HEPATIC GLUCONEOGENESIS; STEROID-HORMONES; IN-VIVO; METABOLISM; LEPTIN; INFLAMMATION	The maintenance of glucose homeostasis within the body is crucial for constant and precise performance of energy balance and is sustained by a number of peripheral organs. Estrogens are known to play a role in the maintenance of glucose homeostasis. Aromatase knockout (ArKO) mice are estrogen-deficient and display symptoms of dysregulated glucose metabolism. We aim to investigate the effects of estrogen ablation and exogenous estrogen administration on glucose homeostasis regulation. Six month-old female wildtype, ArKO, and 17 beta-estradiol (E2) treated ArKO mice were subjected to whole body tolerance tests, serum examination of estrogen, glucose and insulin, ex-vivo muscle glucose uptake, and insulin signaling pathway analyses. Female ArKO mice display increased body weight, gonadal (omental) adiposity, hyperinsulinemia, and liver triglycerides, which were ameliorated upon estrogen treatment. Tolerance tests revealed that estrogen-deficient ArKO mice were pyruvate intolerant hence reflecting dysregulated hepatic gluconeogenesis. Analyses of skeletal muscle, liver, and adipose tissues supported a hepatic-based glucose dysregulation, with a down-regulation of Akt phosphorylation (a key insulin signaling pathway molecule) in the ArKO liver, which was improved with E2 treatment. Concurrently, estrogen treatment lowered ArKO serum leptin and adiponectin levels and increased inflammatory adipokines such as tumour necrosis factor alpha (TNF alpha) and interleukin 6 (IL6). Furthermore, estrogen deficiency resulted in the infiltration of CD45 macrophages into gonadal adipose tissues, which cannot be reversed by E2 treatment. This study describes the effects of estrogens on glucose homeostasis in female ArKO mice and highlights a primary phenotype of hepatic glucose dysregulation and a parallel estrogen modified adipokine profile.	[Van Sinderen, Michelle L.; Chow, Jenny D.; Herridge, Kerrie A.; Winship, Amy L.; Dimitriadis, Evdokia; Jones, Margaret E. E.; Simpson, Evan R.; Boon, Wah Chin] MIMR PHI Inst Med Res, Clayton, Vic 3180, Australia; [Boon, Wah Chin] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3000, Australia; [Van Sinderen, Michelle L.; Chow, Jenny D.; Jones, Margaret E. E.; Boon, Wah Chin] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia	Prince Henry's Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne	Boon, WC (corresponding author), MIMR PHI Inst Med Res, Clayton, Vic 3180, Australia.	wah.chin.boon@florey.edu.au	dimitriadis, e/AAD-7601-2021	Winship, Amy/0000-0001-7848-1447; Dimitriadis, Eva/0000-0001-8698-1927; Steinberg, Gregory/0000-0001-5425-8275; dimitriadis, eva/0000-0003-1425-950X; Jones, Margaret/0000-0002-0678-3187	Australian National Health and Medical Research Council [338510, 628553, 441100]; Monash Postgraduate Scholarship; Fred P. Archer Fellowship; Victorian Government through the Operational Infrastructure Scheme	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Postgraduate Scholarship; Fred P. Archer Fellowship; Victorian Government through the Operational Infrastructure Scheme	This research was supported by Australian National Health and Medical Research Council project grants ID 338510, and 628553 and program grant 441100. MLS was supported by Monash Postgraduate Scholarship; WCB was supported by a Fred P. Archer Fellowship. The authors acknowledge the support of the Victorian Government through the Operational Infrastructure Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardawi MSM, 2005, FERTIL STERIL, V83, P1708, DOI 10.1016/j.fertnstert.2004.11.077; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Chow JD, 2001, J ENDOCRINOL, V210, P323; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Cutolo M, 1996, J CLIN ENDOCR METAB, V81, P820, DOI 10.1210/jc.81.2.820; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gao XL, 2008, CHINESE MED J-PEKING, V121, P701, DOI 10.1097/00029330-200804020-00008; Jelenik T, 2013, ENDOCRINOLOGY, V154, P989, DOI 10.1210/en.2013-1112; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Jorgensen SB, 2009, AM J PHYSIOL-ENDOC M, V297, pE57, DOI 10.1152/ajpendo.90744.2008; Kim JH, 2014, ENDOCR J, V61, P1055, DOI 10.1507/endocrj.EJ14-0262; Kristensen K, 1999, BIOCHEM BIOPH RES CO, V259, P624, DOI 10.1006/bbrc.1999.0842; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lindmark S, 2006, CLIN ENDOCRINOL, V65, P301, DOI 10.1111/j.1365-2265.2006.02593.x; Machinal F, 1999, ENDOCRINOLOGY, V140, P1567, DOI 10.1210/en.140.4.1567; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Misso ML, 2003, ENDOCRINOLOGY, V144, P1474, DOI 10.1210/en.2002-221123; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Robertson KM, 1999, P NATL ACAD SCI USA, V96, P7986, DOI 10.1073/pnas.96.14.7986; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Tanaka M, 2001, HORM RES, V56, P98, DOI 10.1159/000048099; Tanko LB, 2006, CLIMACTERIC, V9, P169, DOI 10.1080/13697130600738765; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Van Sinderen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087230; Van Sinderen ML, 2009, MENOPAUSE, V16, P582, DOI 10.1097/gme.0b013e31818fb20b; Wang Q, 2014, CLIN SCI, V127, P91, DOI 10.1042/CS20130670; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Winkler G, 2002, DIABETES RES CLIN PR, V56, P93, DOI 10.1016/S0168-8227(01)00355-2; Wood GW, 1997, MOL REPROD DEV, V46, P62, DOI 10.1002/(SICI)1098-2795(199701)46:1<62::AID-MRD10>3.0.CO;2-5	45	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136143	10.1371/journal.pone.0136143	http://dx.doi.org/10.1371/journal.pone.0136143			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317527	Green Published, gold			2022-12-27	WOS:000360299100061
J	Pietrzyk-Nivau, A; Poirault-Chassac, S; Gandrille, S; Derkaoui, SM; Kauskot, A; Letourneur, D; Le Visage, C; Baruch, D				Pietrzyk-Nivau, Audrey; Poirault-Chassac, Sonia; Gandrille, Sophie; Derkaoui, Sidi-Mohammed; Kauskot, Alexandre; Letourneur, Didier; Le Visage, Catherine; Baruch, Dominique			Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes	PLOS ONE			English	Article							POLYSACCHARIDE-BASED SCAFFOLDS; IN-VITRO; BONE-MARROW; PROPLATELET FORMATION; PROGENITOR CELLS; POLYPLOIDIZATION; ACTIVATION; BIOREACTOR; BLOOD; MEGAKARYOPOIESIS	Hematopoietic stem cells (HSC) differentiate into megakaryocytes (MK), whose function is to release platelets. Attempts to improve in vitro platelet production have been hampered by the low amplification of MK. Providing HSC with an optimal three-dimensional (3D) architecture may favor MK differentiation by mimicking some crucial functions of the bone marrow structure. To this aim, porous hydrogel scaffolds were used to study MK differentiation from HSC as well as platelet production. Flow cytometry, qPCR and perfusion studies showed that 3D was suitable for longer kinetics of CD34(+) cell proliferation and for delayed megakaryocytic differentiation far beyond the limited shelf-life observed in liquid culture but also increased production of functional platelets. We provide evidence that these 3D effects were related to 1) persistence of MK progenitors and precursors and 2) prolongation of expression of EKLF and c-myb transcription factors involved in early MK differentiation. In addition, presence of abundant mature MK with increased ploidy and impressive cytoskeleton elongations was in line with expression of NF-E2 transcription factor involved in late MK differentiation. Platelets produced in flow conditions were functional as shown by integrin alpha IIb beta 3 activation following addition of exogenous agonists. This study demonstrates that spatial organization and biological cues synergize to improve MK differentiation and platelet production. Thus, 3D environment constitutes a powerful tool for unraveling the physiological mechanisms of megakaryopoiesis and thrombopoiesis in the bone marrow environment, potentially leading to an improved amplification of MK and platelet production.	[Pietrzyk-Nivau, Audrey; Poirault-Chassac, Sonia; Gandrille, Sophie; Kauskot, Alexandre; Baruch, Dominique] Univ Paris 05, INSERM, UMR S 1140, Sorbonne Paris Cite, Paris, France; [Gandrille, Sophie] Georges Pompidou European Hosp, AP HP, Dept Hematol, Paris, France; [Derkaoui, Sidi-Mohammed; Letourneur, Didier; Le Visage, Catherine] Univ Paris Diderot, INSERM, UMR S 1148, Paris, France; [Derkaoui, Sidi-Mohammed; Letourneur, Didier; Le Visage, Catherine] Univ Paris 13, Sorbonne Paris Cite, F-93430 Villetaneuse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13	Baruch, D (corresponding author), Univ Paris 05, INSERM, UMR S 1140, Sorbonne Paris Cite, Paris, France.	dominique.baruch@parisdescartes.fr	Didier, letourneur/H-5268-2012; baruch, dominique/F-8189-2013; Baruch, Dominique/ABA-1791-2020; Kauskot, Alexandre/J-6794-2015; Le Visage, Catherine/E-5460-2011	Didier, letourneur/0000-0003-2197-9468; Baruch, Dominique/0000-0003-2835-5500; Kauskot, Alexandre/0000-0002-4064-8114; Le Visage, Catherine/0000-0003-1816-1649; GANDRILLE, Sophie/0000-0003-1367-6352	DIM Stem Pole; INSERM; Universities Paris Descartes; Paris Diderot; Paris Nord; ANR [ANR-09-EBIO-001-01, ANR-09-EBIO-001-09, ANR-10-EMMA-009-01, ANR-11-BSV-010-01]	DIM Stem Pole; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universities Paris Descartes; Paris Diderot; Paris Nord; ANR(French National Research Agency (ANR))	These studies were made available through the funding from DIM Stem Pole, INSERM, Universities Paris Descartes, Paris Diderot, Paris Nord and grants from ANR (ANR-09-EBIO-001-01; ANR-09-EBIO-001-09; ANR-10-EMMA-009-01; ANR-11-BSV-010-01).	Abed A, 2011, J BIOMED MATER RES A, V96A, P535, DOI 10.1002/jbm.a.33007; Appleby LJ, 2013, IMMUNOL LETT, V152, P32, DOI 10.1016/j.imlet.2013.03.004; Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004; Avanzi MP, 2014, BRIT J HAEMATOL, V164, P867, DOI 10.1111/bjh.12709; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Cabrita GJM, 2003, TRENDS BIOTECHNOL, V21, P233, DOI 10.1016/S0167-7799(03)00076-3; Chang Y, 2007, J THROMB HAEMOST, V5, P318, DOI 10.1111/j.1538-7836.2007.02472.x; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Cortegano I, 2014, CELL DEATH DIFFER, V21, P1081, DOI 10.1038/cdd.2014.27; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Eckly A, 2014, BLOOD, V123, P921, DOI 10.1182/blood-2013-03-492330; Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029; Hamidi S, 2014, TISSUE ENG PT A, V20, P1285, DOI [10.1089/ten.tea.2013.0149, 10.1089/ten.TEA.2013.0149]; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaushansky K, 2005, ANN NY ACAD SCI, V1044, P139, DOI 10.1196/annals.1349.018; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Lavergne M, 2012, MACROMOL BIOSCI, V12, P901, DOI 10.1002/mabi.201100431; Le Visage C, 2012, TISSUE ENG PT A, V18, P35, DOI [10.1089/ten.TEA.2011.0053, 10.1089/ten.tea.2011.0053]; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lordier L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1704; Lu QJ, 2011, ARTIF ORGANS, V35, P137, DOI 10.1111/j.1525-1594.2010.01051.x; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14, DOI 10.1002/jlb.58.1.14; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Nakagawa Y, 2013, EXP HEMATOL, V41, P742, DOI 10.1016/j.exphem.2013.04.007; Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011; Pallotta I, 2011, TISSUE ENG PART C-ME, V17, P1223, DOI 10.1089/ten.tec.2011.0134; Pallotta I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008359; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Purnama A, 2013, DRUG DELIV TRANSL RE, P1; Raic A, 2014, BIOMATERIALS, V35, P929, DOI 10.1016/j.biomaterials.2013.10.038; Raslova H, 2007, BLOOD, V109, P3225, DOI 10.1182/blood-2006-07-037838; Reems JA, 2010, TRANSFUS MED REV, V24, P33, DOI 10.1016/j.tmrv.2009.09.003; Robert A, 2012, METHODS MOL BIOL, V788, P219, DOI 10.1007/978-1-61779-307-3_16; Robert D, 2010, BIOMATERIALS, V31, P1586, DOI 10.1016/j.biomaterials.2009.11.014; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Sullenbarger B, 2009, EXP HEMATOL, V37, P101, DOI 10.1016/j.exphem.2008.09.009; Takayama N, 2012, CELL MOL LIFE SCI, V69, P3419, DOI 10.1007/s00018-012-0995-4; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Thacker E, 2001, VET IMMUNOL IMMUNOP, V80, P93, DOI 10.1016/S0165-2427(01)00278-1; Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1; Thon JN, 2014, BLOOD, V124, P1857, DOI 10.1182/blood-2014-05-574913; Tijssen MR, 2013, J THROMB HAEMOST, V11, P593, DOI 10.1111/jth.12131; Tiwari A, 2014, CURR PROTOC STEM CEL, V28; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	53	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136652	10.1371/journal.pone.0136652	http://dx.doi.org/10.1371/journal.pone.0136652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313154	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000081
J	Poteet, E; Lewis, P; Li, F; Zhang, S; Gu, JH; Chen, C; Ho, SO; Do, T; Chiang, SM; Fujii, G; Yao, QZ				Poteet, Ethan; Lewis, Phoebe; Li, Feng; Zhang, Sheng; Gu, Jianhua; Chen, Changyi; Ho, Sam On; Do, Thai; Chiang, SuMing; Fujii, Gary; Yao, Qizhi			A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; NASAL IMMUNIZATION; DENDRITIC CELLS; MUCOSAL IGA; VACCINE; INDUCTION; ANTIGEN; ESCAPE	HIV virus-like particles (VLPs) present the HIV envelope protein in its native conformation, providing an ideal vaccine antigen. To enhance the immunogenicity of the VLP vaccine, we sought to improve upon two components; the route of administration and the additional adjuvant. Using HIV VLPs, we evaluated sub-cheek as a novel route of vaccine administration when combined with other conventional routes of immunization. Of five combinations of distinct prime and boost sequences, which included sub-cheek, intranasal, and intradermal routes of administration, intranasal prime and sub-cheek boost (IN+SC) resulted in the highest HIV-specific IgG titers among the groups tested. Using the IN+SC regimen we tested the adjuvant VesiVax Conjugatable Adjuvant Lipid Vesicles (CALV) + monophosphoryl lipid A (MPLA) at MPLA concentrations of 0, 7.5, 12.5, and 25 mu g/dose in combination with our VLPs. Mice that received 12.5 or 25 mu g/dose MPLA had the highest concentrations of Env-specific IgG2c (20.7 and 18.4 mu g/ml respectively), which represents a Th1 type of immune response in C57BL/6 mice. This was in sharp contrast to mice which received 0 or 7.5 mu g MPLA adjuvant (6.05 and 5.68 mu g/ml of IgG2c respectively). In contrast to IgG2c, MPLA had minor effects on Env-specific IgG1; therefore, 12.5 and 25 mu g/dose of MPLA induced the optimal IgG1/ IgG2c ratio of 1.3. Additionally, the percentage of germinal center B cells increased significantly from 15.4% in the control group to 31.9% in the CALV + 25 mu g MPLA group. These mice also had significantly more IL-2 and less IL-4 Env-specific CD8(+) T cells than controls, correlating with an increased percentage of Env-specific central memory CD4(+) and CD8(+) T cells. Our study shows the strong potential of IN+SC as an efficacious route of administration and the effectiveness of VLPs combined with MPLA adjuvant to induce Env specific Th1-oriented HIV-specific immune responses.	[Poteet, Ethan; Lewis, Phoebe; Li, Feng; Zhang, Sheng; Chen, Changyi; Yao, Qizhi] Baylor Coll Med, Michael DeBakey Dept Surg, Div Surg Res, Houston, TX 77030 USA; [Gu, Jianhua] Houston Methodist Res Inst, Houston, TX 77030 USA; [Ho, Sam On; Do, Thai; Chiang, SuMing; Fujii, Gary] Mol Express Inc, Rancho Dominguez, CA 90220 USA; [Yao, Qizhi] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine	Yao, QZ (corresponding author), Baylor Coll Med, Michael DeBakey Dept Surg, Div Surg Res, Houston, TX 77030 USA.	qizhiyao@bcm.edu			VA merit grants [1I01BX001474-01A1]; NIH SBIR [R43AI104073]; IMSD [R25GM56929]; Baylor-UT Houston Center for AIDS Research (CFAR), an NIH [AI036211]; NIH [P30 AI036211, P30 CA125123, S10 RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R43AI104073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	VA merit grants; NIH SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMSD; Baylor-UT Houston Center for AIDS Research (CFAR), an NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by VA merit grants 1I01BX001474-01A1 (PI: Yao), NIH SBIR R43AI104073 (PI: Fujii). The conjugatable liposome patent by Molecular Express, Inc. - US Patent #8,765,171. Phoebe Lewis received IMSD support R25GM56929. This publication was made possible with help from the Baylor-UT Houston Center for AIDS Research (CFAR), an NIH funded program (AI036211); the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123, and S10 RR024574) and the expert assistance of Joel M. Sederstrom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Moore J, 2011, VACCINE, V29, P4460, DOI 10.1016/j.vaccine.2011.04.040; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Baldridge JR, 2000, VACCINE, V18, P2416, DOI 10.1016/S0264-410X(99)00572-1; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Buglione-Corbett R, 2014, HUM VACC IMMUNOTHER, V10, P1078, DOI 10.4161/hv.27907; Buglione-Corbett R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074820; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; CLERICI M, 1994, IMMUNOL TODAY, V15, P575, DOI 10.1016/0167-5699(94)90220-8; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4; De Becker G, 2000, INT IMMUNOL, V12, P807, DOI 10.1093/intimm/12.6.807; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Gibbons DL, 2011, MUCOSAL IMMUNOL, V4, P148, DOI 10.1038/mi.2010.85; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; Guo LZ, 2003, VIROLOGY, V313, P502, DOI 10.1016/S0042-6822(03)00372-6; HAGGERTY S, 1991, AIDS RES HUM RETROV, V7, P501, DOI 10.1089/aid.1991.7.501; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hayashi M, 2001, TOXICOL APPL PHARM, V177, P38, DOI 10.1006/taap.2001.9286; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heckman CA, 2006, ONCOGENE, V25, P888, DOI 10.1038/sj.onc.1209127; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hu K, 2013, J IMMUNOL, V191, P1935, DOI 10.4049/jimmunol.1300120; Johansson EL, 2001, INFECT IMMUN, V69, P7481, DOI 10.1128/IAI.69.12.7481-7486.2001; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kang SM, 2003, J VIROL, V77, P9823, DOI 10.1128/JVI.77.18.9823-9830.2003; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li HB, 2012, VACCINE, V31, P120, DOI 10.1016/j.vaccine.2012.10.091; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Mascarell L, 2005, J VIROL, V79, P9872, DOI 10.1128/JVI.79.15.9872-9884.2005; Mata M, 1999, J IMMUNOL, V163, P1449; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matthews VB, 2001, IMMUNOL CELL BIOL, V79, P576, DOI 10.1046/j.1440-1711.2001.01039.x; Olson K, 2009, VACCINE, V28, P548, DOI 10.1016/j.vaccine.2009.09.120; Pouliot K, 2014, VACCINE, V32, P5049, DOI 10.1016/j.vaccine.2014.07.010; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Sailaja G, 2007, VIROLOGY, V362, P331, DOI 10.1016/j.virol.2006.12.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SEIBERT SA, 1995, MOL BIOL EVOL, V12, P803; Snoeck V, 2006, VET RES, V37, P455, DOI 10.1051/vetres:2006010; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Ugolini S, 1997, J IMMUNOL, V159, P3000; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yao QZ, 2004, J IMMUNOL, V173, P1951, DOI 10.4049/jimmunol.173.3.1951; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zhang JS, 2014, J IMMUNOL, V192, P1693, DOI 10.4049/jimmunol.1302511; Zhang RX, 2010, VACCINE, V28, P5114, DOI 10.1016/j.vaccine.2010.03.079; Zhang S, 2009, MOL IMMUNOL, V46, P1988, DOI 10.1016/j.molimm.2009.03.008; Zhang ZP, 2012, MOL IMMUNOL, V50, P169, DOI 10.1016/j.molimm.2011.11.006	78	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136862	10.1371/journal.pone.0136862	http://dx.doi.org/10.1371/journal.pone.0136862			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312747	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000103
J	Shuto, Y; Asai, A; Nagao, M; Sugihara, H; Oikawa, S				Shuto, Yuki; Asai, Akira; Nagao, Mototsugu; Sugihara, Hitoshi; Oikawa, Shinichi			Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; POSTPRANDIAL HYPERGLYCEMIA; DIFFERENT SUSCEPTIBILITIES; ADHESION MOLECULES; ENDOTHELIAL-CELL; VASCULAR-DISEASE; TOLERANCE; MORTALITY	Background A number of epidemiological studies demonstrated that postprandial hyperglycemia is a risk factor for cardiovascular disease in individuals with impaired glucose tolerance. Although several laboratory studies have addressed the plausible causal role of postprandial acute hyperglycemia (glucose spikes) in the development of atherosclerosis, there is little convincing evidence in vivo whether the atherosclerotic lesion formation can be accelerated solely by glucose spikes. Here, we assessed the effect of repetitive glucose spikes on atherosclerotic lesion formation in mice. Methods Female C57BL/6 mice were fed an atherogenic diet from 8 to 28 weeks of age. During the atherogenic diet feeding period, the mice orally received a glucose solution (50 mg glucose/mouse; G group) or water (Wgroup) twice daily, 6 days a week. Atherosclerotic lesion formation in the aortic sinus was quantitatively analyzed in serial cross-sections by oil red O staining. Results G group mice showed transient increases in blood glucose level (similar to 5 mmol/L above W group), and the levels returned to levels similar to those in W group mice within 60 min. No significant differences in glucose tolerance, insulin sensitivity, and plasma lipid profiles were observed after the 20-week repetitive administration between the 2 groups. G group mice showed an approximately 4-fold greater atherosclerotic lesion size in the aortic sinus than W group mice. Gene expression levels of Cd68 and Icam1 in the thoracic aorta were higher in G group mice than in W group mice. Conclusions These results indicate that glucose spikes can accelerate atherosclerotic lesion formation, with little influence on other metabolic disorders. Repetitive glucose administration in wild-type mice may serve as a simple and useful approach to better understanding the causal role of glycemic spikes in the development of atherosclerosis.	[Shuto, Yuki; Asai, Akira; Nagao, Mototsugu; Sugihara, Hitoshi; Oikawa, Shinichi] Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, Tokyo 113, Japan; [Asai, Akira] Tohoku Univ, Food & Hlth Sci Res Unit, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Nippon Medical School; Tohoku University	Oikawa, S (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, 1-1-5 Sendagi, Tokyo 113, Japan.	shinich@nms.ac.jp	Nagao, Mototsugu/D-3473-2018	Nagao, Mototsugu/0000-0001-6880-5161; Asai, Akira/0000-0003-2557-9111	Merck Co.; Sanofi; Japan Society for the Promotion of Science [C26460497]	Merck Co.(Merck & Company); Sanofi(Sanofi-Aventis); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by research grants from Merck & Co. (to YS) and Sanofi (to YS), and a Grant-in-Aid for Scientific Research (C26460497) from the Japan Society for the Promotion of Science (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2013, ATHEROSCLEROSIS, V231, P421, DOI 10.1016/j.atherosclerosis.2013.10.009; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; Beckman JA, 2013, EUR HEART J, V34, P2444, DOI 10.1093/eurheartj/eht142; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Goldberg IJ, 2006, ARTERIOSCL THROM VAS, V26, P1693, DOI 10.1161/01.ATV.0000231521.76545.f6; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Mita T, 2007, BIOCHEM BIOPH RES CO, V358, P679, DOI 10.1016/j.bbrc.2007.04.118; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nagao M, 2015, ENDOCR J, V62, P371, DOI 10.1507/endocrj.EJ14-0241; Nagao M, 2012, J DIABETES INVEST, V3, P245, DOI 10.1111/j.2040-1124.2011.00175.x; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Saydah SH, 2001, DIABETES CARE, V24, P1397, DOI 10.2337/diacare.24.8.1397; Standl E, 2011, DIABETES CARE, V34, pS120, DOI 10.2337/dc11-s206; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Wu KK, 2007, ATHEROSCLEROSIS, V191, P241, DOI 10.1016/j.atherosclerosis.2006.08.030	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136840	10.1371/journal.pone.0136840	http://dx.doi.org/10.1371/journal.pone.0136840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313920	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000100
J	Urbanek, AN; Allwood, EG; Smith, AP; Booth, WI; Ayscough, KR				Urbanek, Agnieszka N.; Allwood, Ellen G.; Smith, Adam P.; Booth, Wesley I.; Ayscough, Kathryn R.			Distinct Actin and Lipid Binding Sites in Ysc84 Are Required during Early Stages of Yeast Endocytosis	PLOS ONE			English	Article							CAPPING PROTEIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEDIATED ENDOCYTOSIS; ARP2/3 COMPLEX; DOMAIN; WASP; POLYPHOSPHOINOSITIDES; INTERNALIZATION; MACHINERY; FILAMENT	During endocytosis in S. cerevisiae, actin polymerization is proposed to provide the driving force for invagination against the effects of turgor pressure. In previous studies, Ysc84 was demonstrated to bind actin through a conserved N-terminal domain. However, full length Ysc84 could only bind actin when its C-terminal SH3 domain also bound to the yeast WASP homologue Las17. Live cell-imaging has revealed that Ysc84 localizes to endocytic sites after Las17/WASP but before other known actin binding proteins, suggesting it is likely to function at an early stage of membrane invagination. While there are homologues of Ysc84 in other organisms, including its human homologue SH3yl-1, little is known of its mode of interaction with actin or how this interaction affects actin filament dynamics. Here we identify key residues involved both in Ysc84 actin and lipid binding, and demonstrate that its actin binding activity is negatively regulated by PI(4,5) P2. Ysc84 mutants defective in their lipid or actin-binding interaction were characterized in vivo. The abilities of Ysc84 to bind Las17 through its C-terminal SH3 domain, or to actin and lipid through the N-terminal domain were all shown to be essential in order to rescue temperature sensitive growth in a strain requiring YSC84 expression. Live cell imaging in strains with fluorescently tagged endocytic reporter proteins revealed distinct phenotypes for the mutants indicating the importance of these interactions for regulating key stages of endocytosis.	[Urbanek, Agnieszka N.; Allwood, Ellen G.; Smith, Adam P.; Booth, Wesley I.; Ayscough, Kathryn R.] Univ Sheffield, Dept Biomed Sci, Firth Court, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Ayscough, KR (corresponding author), Univ Sheffield, Dept Biomed Sci, Firth Court, Sheffield S10 2TN, S Yorkshire, England.	k.ayscough@sheffield.ac.uk	Smith, Adam/GPS-8322-2022	Allwood, Ellen/0000-0003-3825-4789	Biotechnology and Biological Sciences Research Council [BB/K002511/1]; Medical Research Council [G060160]; BBSRC [BB/K002511/1, BB/J017094/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017094/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding from Biotechnology and Biological Sciences Research Council (BB/K002511/1). Award to KRA supporting ANU, EGA and WIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from Medical Research Council, a senior non-clinical Fellowship to KRA (G060160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Coburn RF, 2006, J CELL PHYSIOL, V209, P405, DOI 10.1002/jcp.20729; Dewar H, 2002, MOL BIOL CELL, V13, P3646, DOI 10.1091/mbc.E02-05-0262; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Gheorghe DM, 2008, J BIOL CHEM, V283, P15037, DOI 10.1074/jbc.M710332200; Hasegawa J, 2011, J CELL BIOL, V193, P901, DOI 10.1083/jcb.201012161; HAUS U, 1991, BIOCHEM BIOPH RES CO, V181, P833, DOI 10.1016/0006-291X(91)91265-E; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; Huang SJ, 2006, MOL BIOL CELL, V17, P1946, DOI 10.1091/mbc.E05-09-0840; Kaiser C., 1994, METHODS YEAST GENETI, P234; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Robertson AS, 2009, MOL BIOL CELL, V20, P1618, DOI 10.1091/mbc.E08-09-0982; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Urbanek AN, 2013, CURR BIOL, V23, P196, DOI 10.1016/j.cub.2012.12.024; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Winder SJ, 2003, BIOCHEM J, V375, P287, DOI 10.1042/BJ20030796; WINDER SJ, 1995, J CELL SCI, V108, P63; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136732	10.1371/journal.pone.0136732	http://dx.doi.org/10.1371/journal.pone.0136732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312755	Green Published, Green Accepted, gold			2022-12-27	WOS:000360144000091
J	Winkler, DE; Kaiser, TM				Winkler, Daniela E.; Kaiser, Thomas M.			Structural Morphology of Molars in Large Mammalian Herbivores: Enamel Content Varies between Tooth Positions	PLOS ONE			English	Article							TEETH; RUMINANTS; EXTINCT	The distribution of dental tissues in mammalian herbivores can be very different from taxon to taxon. While grazers tend to have more elaborated and complexly folded enamel ridges, browsers have less complex enamel ridges which can even be so far reduced that they are completely lost. The gradient in relative enamel content and complexity of structures has so far not been addressed within a single species. However, several studies have noted tooth position specific wear rates in small mammals (rabbits, guinea pigs) which may be related to individual tooth morphology. We investigate whether differentiated enamel content by tooth position is also to be found in large herbivores. We use CT-scanning techniques to quantify relative enamel content in upper and lower molar teeth of 21 large herbivorous mammal species. By using a broad approach and including both perissodactyls and artiodactyls, we address phylogenetic intraspecific differences in relative enamel content. We find that enamel is highly unevenly distributed among molars (upper M1, M2, M3 and lower m1, m2, m3) in most taxa and that relative enamel content is independent of phylogeny. Overall, relative enamel content increases along the molar tooth row and is significantly higher in lower molars compared to upper molars. We relate this differential enamel content to prolonged mineralisation in the posterior tooth positions and suggest a compensatory function of m3 and M3 for functional losses of anterior teeth.	[Winkler, Daniela E.; Kaiser, Thomas M.] Univ Hamburg, Ctr Nat Hist, Hamburg, Germany	University of Hamburg	Winkler, DE (corresponding author), Univ Hamburg, Ctr Nat Hist, Hamburg, Germany.	daniela.winkler@uni-hamburg.de	Winkler, Daniela Eileen/AFS-9644-2022; Kaiser, Thomas/G-8883-2015	Winkler, Daniela Eileen/0000-0001-7501-2506; Kaiser, Thomas/0000-0002-8154-1751	Deutsche Forschungsgemeinschaft (DFG) [KA 1525/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by Deutsche Forschungsgemeinschaft (DFG, KA 1525/8-1) and is part of DEW's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer D, 2002, J ZOOL, V257, P13, DOI 10.1017/S0952836902000614; Armour-Chelu Miranda, 2003, P25; Azorit C, 2002, ANALES BIOL, V24, P193; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; CALDWELL ROBERT C., 1957, JOUR DENTAL RES, V36, P732, DOI 10.1177/00220345570360051401; Casella G., 2008, STAT DESIGN; Chambers JM., 1992, STAT MODELS S; CRAIG R. G., 1958, JOUR DENTAL RES, V37, P661; DOW SUMNER A., 1962, JOUR WILDLIFE MANAGEMENT, V26, P1, DOI 10.2307/3798162; DRIESSENS FCM, 1985, CARIES RES, V19, P390, DOI 10.1159/000260872; Famoso NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090184; Famoso NA, 2013, PALAEOGEOGR PALAEOCL, V387, P211, DOI 10.1016/j.palaeo.2013.07.006; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fox J., 2019, R COMPANION APPL REG, V.; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gailer JP, 2014, J MORPHOL, V275, P328, DOI 10.1002/jmor.20217; Greenfield HJ, 2008, J ARCHAEOL SCI, V35, P836, DOI 10.1016/j.jas.2007.06.003; Harmon L, 2015, R PACKAGE VERSION 2; Harvey PHaM RM, 1991, OXFORD MONOGRAPHS EC; Heywood JJN, 2010, J ZOOL, V281, P1, DOI 10.1111/j.1469-7998.2009.00668.x; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V206, P355, DOI 10.1016/j.palaeo.2004.01.012; Kaiser TM, 2010, J ZOOL, V281, P12, DOI 10.1111/j.1469-7998.2009.00674.x; Kaiser Thomas M., 2002, Senckenbergiana Lethaea, V82, P167; Kaiser TM, 2003, J MORPHOL, V258, P67, DOI 10.1002/jmor.10125; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Muller J, 2015, J ANIM PHYSIOL AN N, V99, P591, DOI 10.1111/jpn.12226; Muller J, 2014, J EXP ZOOL PART A, V321, P283, DOI 10.1002/jez.1864; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; R.D.C. Team, 2009, R LANG ENV STAT COMP; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Smith B. Holly, 2000, P212, DOI 10.1017/CBO9780511542626.015; Talbot LM, 1963, E AFRICAN WILDLIFE M, V12; Thenius E, 1989, HDB ZOOLOGY 56; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Winkler DE, 2015, PEERJ, V3, DOI 10.7717/peerj.1002; Winkler DE, 2013, GEOBIOS-LYON, V46, P143, DOI 10.1016/j.geobios.2012.10.010; Yandell BS, 1997, PRACTICAL DATA ANAL	41	8	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135716	10.1371/journal.pone.0135716	http://dx.doi.org/10.1371/journal.pone.0135716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313359	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000023
J	Hu, JY; Li, TF; Xiu, ZD; Zhang, H				Hu, Jiyuan; Li, Tengfei; Xiu, Zidi; Zhang, Hong			MAFsnp: A Multi-Sample Accurate and Flexible SNP Caller Using Next-Generation Sequencing Data	PLOS ONE			English	Article							GENOME VARIATION; COMMON; DNA; DISCOVERY; VARIANTS; PROJECT; RARE; MAP	Most existing statistical methods developed for calling single nucleotide polymorphisms (SNPs) using next-generation sequencing (NGS) data are based on Bayesian frameworks, and there does not exist any SNP caller that produces p-values for calling SNPs in a frequentist framework. To fill in this gap, we develop a new method MAFsnp, a Multiple-sample based Accurate and Flexible algorithm for calling SNPs with NGS data. MAFsnp is based on an estimated likelihood ratio test (eLRT) statistic. In practical situation, the involved parameter is very close to the boundary of the parametric space, so the standard large sample property is not suitable to evaluate the finite-sample distribution of the eLRT statistic. Observing that the distribution of the test statistic is a mixture of zero and a continuous part, we propose to model the test statistic with a novel two-parameter mixture distribution. Once the parameters in the mixture distribution are estimated, p-values can be easily calculated for detecting SNPs, and the multiple-testing corrected p-values can be used to control false discovery rate (FDR) at any pre-specified level. With simulated data, MAFsnp is shown to have much better control of FDR than the existing SNP callers. Through the application to two real datasets, MAFsnp is also shown to outperform the existing SNP callers in terms of calling accuracy. An R package "MAFsnp" implementing the new SNP caller is freely available at http://homepage.fudan.edu.cn/zhangh/softwares/.	[Hu, Jiyuan; Xiu, Zidi; Zhang, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Hu, Jiyuan; Xiu, Zidi; Zhang, Hong] Fudan Univ, Inst Biostat, Shanghai 200433, Peoples R China; [Li, Tengfei] Hong Kong Univ Sci & Technol, HKUST Jockey Club Inst Adv Study, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Hong Kong University of Science & Technology	Zhang, H (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	zhangh@fudan.edu.cn	Hu, Jiyuan/AAC-1370-2019	Hu, Jiyuan/0000-0003-1332-5587; Li, Tengfei/0000-0001-6142-3865	State Key Development Program for Basic Research of China [2012CB316505]; National Natural Science Foundation of China [11371101]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Development Program for Basic Research of China (http://program.most.gov.cn/, grant number 2012CB316505) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/nsfc/cen/2015sqsl/index.html, grant number 11371101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Kitts A., 2014, DATABASE SHORT GENET; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wetterstrand K. A., 2019, DNA SEQUENCING COSTS	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135332	10.1371/journal.pone.0135332	http://dx.doi.org/10.1371/journal.pone.0135332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309201	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400057
J	Bozic, M; Alvarez, A; de Pablo, C; Sanchez-Nino, MD; Ortiz, A; Dolcet, X; Encinas, M; Fernandez, E; Valdivielso, JM				Bozic, Milica; Alvarez, Angeles; de Pablo, Carmen; Sanchez-Nino, Maria-Dolores; Ortiz, Alberto; Dolcet, Xavier; Encinas, Mario; Fernandez, Elvira; Manuel Valdivielso, Jose			Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; D-RECEPTOR ACTIVATION; 3RD NATIONAL-HEALTH; KAPPA-B ACTIVITY; 1,25-DIHYDROXYVITAMIN D-3; DOWN-REGULATION; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ADHESION MOLECULES; NITRIC-OXIDE; INTERLEUKIN-6	Endothelial cell activation leading to leukocyte recruitment and adhesion plays an essential role in the initiation and progression of atherosclerosis. Vitamin D has cardioprotective actions, while its deficiency is a risk factor for the progression of cardiovascular damage. Our aim was to assess the role of basal levels of vitamin D receptor (VDR) on the early leukocyte recruitment and related endothelial cell-adhesion-molecule expression, as essential prerequisites for the onset of atherosclerosis. Knockdown of VDR in endothelial cells (shVDR) led to endothelial cell activation, characterized by upregulation of VCAM-1, ICAM-1 and IL-6, decreased peripheral blood mononuclear cell (PBMC) rolling velocity and increased PBMC rolling flux and adhesion to the endothelium. shVDR cells showed decreased I kappa B alpha levels and accumulation of p65 in the nucleus compared to shRNA controls. Inhibition of NF-kappa B activation with super-repressor I kappa B alpha blunted all signs of endothelial cell activation caused by downregulation of VDR in endothelial cells. In vivo, deletion of VDR led to significantly larger aortic arch and aortic root lesions in apoE(-/-) mice, with higher macrophage content. apoE(-/-) VDR-/- mice showed higher aortic expression of VCAM-1, ICAM-1 and IL-6 when compared to apoE(-/-) VDR+/+ mice. Our data demonstrate that lack of VDR signaling in endothelial cells leads to a state of endothelial activation with increased leukocyte-endothelial cell interactions that may contribute to the more severe plaque accumulation observed in apoE(-/-) VDR-/- mice. The results reveal an important role for basal levels of endothelial VDR in limiting endothelial cell inflammation and atherosclerosis.	[Bozic, Milica; Fernandez, Elvira; Manuel Valdivielso, Jose] IRB Lleida, Nephrol Res Dept, Lleida, Spain; [Alvarez, Angeles; de Pablo, Carmen] Univ Valencia, Dept Pharmacol, Valencia, Spain; [Alvarez, Angeles; de Pablo, Carmen] Univ Valencia, CIBERehd, Valencia, Spain; [Sanchez-Nino, Maria-Dolores; Ortiz, Alberto] UAM, Sch Med, IIS Fdn Jimenez Diaz, Madrid, Spain; [Sanchez-Nino, Maria-Dolores; Ortiz, Alberto] IRSIN, Madrid, Spain; [Dolcet, Xavier] Univ Lleida, Hosp Univ Arnau Vilanova, Pathol & Mol Genet Dept, Pathol Grp, Lleida, Spain; [Dolcet, Xavier; Encinas, Mario] IRB Lleida, Lleida, Spain; [Encinas, Mario] Univ Lleida, Dept Expt Med, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia; Autonomous University of Madrid; Fundacion Jimenez Diaz; Universitat de Lleida; University Hospital Arnau de Vilanova; Universitat de Lleida	Valdivielso, JM (corresponding author), IRB Lleida, Nephrol Res Dept, Lleida, Spain.	valdivielso@medicina.udl.cat	Giráldez, Elvira Dolores Fernández/D-3358-2009; Sanchez-Niño, Maria Dolores/B-7350-2019; Valdivielso, Jose M/B-5673-2009; Dolcet, Xavi/B-5665-2009; ortiz, alberto/Y-7582-2018; Alvarez, Angeles/ABF-4589-2020; Encinas, Mario/B-5600-2009; Bozic, Milica/B-7425-2009	Giráldez, Elvira Dolores Fernández/0000-0001-5236-1762; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Valdivielso, Jose M/0000-0003-1343-0184; Dolcet, Xavi/0000-0003-1921-0449; ortiz, alberto/0000-0002-9805-9523; Encinas, Mario/0000-0003-3509-7431; Bozic, Milica/0000-0002-6064-1446; Alvarez, Angeles/0000-0002-2301-9746	Fondo de Investigaciones Sanitarias [PS12/01770, FIS PI13/00047]; ISCIII-RETIC [REDinREN RD12/0021]; Comunidad de Madrid [S2010/BMD-2378]; CYTED IBERERC; Programa Intensificacion Actividad Investigadora (ISCIII); MSDN by Sara Borrell; REDinREN [RD12/0021/0026]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); CYTED IBERERC; Programa Intensificacion Actividad Investigadora (ISCIII); MSDN by Sara Borrell; REDinREN	This work was supported by Fondo de Investigaciones Sanitarias (http://www.isciii.es/) grants PS12/01770, FIS PI13/00047, ISCIII-RETIC REDinREN RD12/0021, Comunidad de Madrid S2010/BMD-2378, and CYTED IBERERC. AO was supported by Programa Intensificacion Actividad Investigadora (ISCIII) and MSDN by Sara Borrell. MB was supported by the REDinREN (RD12/0021/0026).	Beer TM, 2004, MOL CANCER THER, V3, P373; Bergada L, 2014, LAB INVEST, V94, P608, DOI 10.1038/labinvest.2014.57; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Bozic M, 2011, J AM SOC NEPHROL, V22, P1099, DOI 10.1681/ASN.2010070701; Brewer LC, 2011, CURR DRUG TARGETS, V12, P54; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Cardus A, 2007, J BONE MINER RES, V22, P860, DOI 10.1359/JBMR.070305; Cardus A, 2009, ATHEROSCLEROSIS, V204, P85, DOI 10.1016/j.atherosclerosis.2008.08.020; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Pablo C, 2013, J INFECT DIS, V208, P1448, DOI 10.1093/infdis/jit340; De Pablo C, 2012, ANTIVIR THER, V17, P1615, DOI 10.3851/IMP2357; De Pablo C, 2010, AIDS, V24, P1259, DOI 10.1097/QAD.0b013e32833a2b02; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074/jbc.M308448200; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; EMEIS JJ, 1988, BLOOD, V71, P1669; ETTINGER WH, 1995, J GERONTOL A-BIOL, V50, pM137, DOI 10.1093/gerona/50A.3.M137; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Gurlek A, 2002, ENDOCR REV, V23, P763, DOI 10.1210/er.2001-0044; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Martinez-Miguel P, 2014, AM J PHYSIOL-ENDOC M, V307, pE1085, DOI 10.1152/ajpendo.00156.2014; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McIntyre TM, 2003, CURR OPIN HEMATOL, V10, P150, DOI 10.1097/00062752-200303000-00009; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; MERKE J, 1987, CALCIFIED TISSUE INT, V41, P112, DOI 10.1007/BF02555253; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Molinari C, 2011, CELL PHYSIOL BIOCHEM, V27, P661, DOI 10.1159/000330075; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971; Pallares J, 2009, ANAL QUANT CYTOL, V31, P217; Panizo S, 2013, NEPHROL DIAL TRANSPL, V28, P2735, DOI 10.1093/ndt/gft268; Porsti IH, 2008, KIDNEY INT, V74, P1371, DOI 10.1038/ki.2008.424; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schmidt N, 2014, J NUTR, V144, P638, DOI 10.3945/jn.113.189118; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Valcheva P, 2014, ATHEROSCLEROSIS, V235, P247, DOI 10.1016/j.atherosclerosis.2014.05.911; Valdivielso JM, 2009, EXPERT OPIN THER TAR, V13, P29, DOI [10.1517/14728220802564390, 10.1517/14728220802564390 ]; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; VELDHUIS GJ, 1995, J CLIN ONCOL, V13, P2585, DOI 10.1200/JCO.1995.13.10.2585; Verhave G, 2010, NETH J MED, V68, P113; Watson C, 1996, CLIN EXP IMMUNOL, V105, P112, DOI 10.1046/j.1365-2249.1996.d01-717.x; Weber K, 2013, J ANIM PHYSIOL AN N, V97, P675, DOI 10.1111/j.1439-0396.2012.01308.x; Weng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054625; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4	78	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136863	10.1371/journal.pone.0136863	http://dx.doi.org/10.1371/journal.pone.0136863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322890	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500044
J	Chen, CM; Yang, JM; Lai, JY; Li, H; Yuan, JJ; Abbasi, NU				Chen, Changming; Yang, Jiemin; Lai, Jiayu; Li, Hong; Yuan, Jiajin; Abbasi, Najam ul Hasan			Correlating Gray Matter Volume with Individual Difference in the Flanker Interference Effect	PLOS ONE			English	Article							EVENT-RELATED FMRI; GO/NO-GO TASKS; RESPONSE-INHIBITION; ATTENTIONAL CONTROL; ANTERIOR CINGULATE; UNIQUE COMPONENTS; COGNITIVE CONTROL; BRAIN; CONFLICT; ACTIVATION	The Eriksen Flanker task has been widely used as a measurement of cognitive control, however till now information is still scarce about how the neuroanatomical properties are related to performance in this task. Using voxel-based morphometry technique (VBM), the current study identified a set of distributed areas where the gray matter volume (GM) correlated positively with participants' efficiency in interference inhibition. These areas included the bilateral prefrontal gyri, left insula and inferior temporal gyrus, the left inferior parietal lobule. Further analysis using a novel machine learning algorithm with balanced cross-validation procedure confirmed that in these areas the GM-behavioral association was unlikely a byproduct of outlier values, instead, the gray matter volume could predict reliably participants' interference inhibition efficiency. These results underscore the importance of the fronto-parietal and insula systems to the brain functioning of interference inhibition from the neuroanatomical perspective.	[Chen, Changming; Yang, Jiemin; Li, Hong; Yuan, Jiajin] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Chen, Changming; Yang, Jiemin; Yuan, Jiajin] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Lai, Jiayu] Hope Primary Sch, Chongqing, Peoples R China; [Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Guangdong, Peoples R China; [Abbasi, Najam ul Hasan] Nanchang Normal Univ, Dept Educ, Nanchang, Jiangxi, Peoples R China; [Abbasi, Najam ul Hasan] Univ Sindh, Dept Psychol, Jamshoro, Sindh, Pakistan	Southwest University - China; Shenzhen University; Nanchang Normal University; University of Sindh	Li, H (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	lihongwrm@vip.sina.com; yuanjiaj@swu.edu.cn	Abbasi, Najam ul Hasan/D-3165-2018	Abbasi, Najam ul Hasan/0000-0002-3795-230X; Yuan, Jiajin/0000-0002-5630-2230	National Natural Science Foundation of China [NSFC31170989, 31371042, 31271088, 81171289]; Natural Science Foundation of Chongqing [cstc2012jjA40063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This research was funded by the National Natural Science Foundation of China (NSFC31170989,31371042,31271088,81171289), and the Natural Science Foundation of Chongqing (cstc2012jjA40063).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Blasi G, 2006, EUR J NEUROSCI, V23, P1658, DOI 10.1111/j.1460-9568.2006.04680.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Cieslik EC, 2015, NEUROSCI BIOBEHAV R, V48, P22, DOI 10.1016/j.neubiorev.2014.11.003; Cohen JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00047; Colcombe SJ, 2005, PSYCHOL AGING, V20, P363, DOI 10.1037/0882-7974.20.3.363; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Grajewska BZV, 2011, BRAIN RES, V1421, P52, DOI 10.1016/j.brainres.2011.09.022; Hazeltine E, 2003, NEUROPSYCHOLOGIA, V41, P1208, DOI 10.1016/S0028-3932(03)00040-X; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Hester R, 2004, NEUROIMAGE, V23, P202, DOI 10.1016/j.neuroimage.2004.05.024; Hirose S, 2012, J NEUROSCI, V32, P9059, DOI 10.1523/JNEUROSCI.0540-12.2012; Huyser C, 2011, J CHILD PSYCHOL PSYC, V52, P1251, DOI 10.1111/j.1469-7610.2011.02439.x; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kim SH, 2012, NEUROSCI RES, V74, P256, DOI 10.1016/j.neures.2012.08.008; King JA, 2012, J NEUROSCI, V32, P8192, DOI 10.1523/JNEUROSCI.0934-12.2012; Klein TA, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00014, 10.3389/fnins.2013.00113]; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Luks TL, 2010, NEUROPSYCHOLOGIA, V48, P165, DOI 10.1016/j.neuropsychologia.2009.09.001; Madsen K, 2011, PSYCHOPHARMACOLOGY, V213, P573, DOI 10.1007/s00213-010-1926-4; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Nagamatsu LS, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-37; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; Qin SZ, 2014, BIOL PSYCHIAT, V75, P892, DOI 10.1016/j.biopsych.2013.10.006; Shen S, 2013, J MAGN RESON IMAGING, V37, P1468, DOI 10.1002/jmri.23927; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Supekar K, 2013, P NATL ACAD SCI USA, V110, P8230, DOI 10.1073/pnas.1222154110; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087	60	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136877	10.1371/journal.pone.0136877	http://dx.doi.org/10.1371/journal.pone.0136877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322974	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500045
J	Ebner, S; Mangge, H; Langhof, H; Halle, M; Siegrist, M; Aigner, E; Paulmichl, K; Paulweber, B; Datz, C; Sperl, W; Kofler, B; Weghuber, D				Ebner, Sabine; Mangge, Harald; Langhof, Helmut; Halle, Martin; Siegrist, Monika; Aigner, Elmar; Paulmichl, Katharina; Paulweber, Bernhard; Datz, Christian; Sperl, Wolfgang; Kofler, Barbara; Weghuber, Daniel			Mitochondrial Haplogroup T Is Associated with Obesity in Austrian Juveniles and Adults	PLOS ONE			English	Article							DNA VARIANT; METABOLIC SYNDROME; MTDNA HAPLOGROUPS; DISEASE; RISK; AGE; POLYMORPHISMS; DISCORDANT; PARAMETERS	Background Recent publications have reported contradictory data regarding mitochondrial DNA (mtDNA) variation and its association with body mass index. The aim of the present study was to compare the frequencies of mtDNA haplogroups as well as control region (CR) polymorphisms of obese juveniles (n = 248) and obese adults (n = 1003) versus normal weight controls (njuvenile = 266, nadults = 595) in a well-defined, ethnically homogenous, age-matched comparative cohort of Austrian Caucasians. Methodology and Principal Findings Using SNP analysis and DNA sequencing, we identified the nine major European mitochondrial haplogroups and CR polymorphisms. Of these, only the T haplogroup frequency was increased in the juvenile obese cohort versus the control subjects [11.7% in obese vs. 6.4% in controls], although statistical significance was lost after adjustment for sex and age. Similar data were observed in a local adult cohort, in which haplogroup T was found at a significantly higher frequency in the overweight and obese subjects than in the normal weight group [9.7% vs. 6.2%, p = 0.012, adjusted for sex and age]. When all obese subjects were considered together, the difference in the frequency of haplogroup T was even more clearly seen [10.1% vs. 6.3%, p = 0.002, OR (95% CI) 1.71 (1.2-2.4), adjusted for sex and age]. The frequencies of the T haplogroup-linked CR polymorphisms C16294T and the C16296T were found to be elevated in both the juvenile and the adult obese cohort compared to the controls. Nevertheless, no mtDNA haplogroup or CR polymorphism was robustly associated with any of several investigated metabolic and cardiovascular parameters (e.g., blood pressure, blood glucose concentration, triglycerides, cholesterol) in all obese subjects. Conclusions and Significance By investigation of this large ethnically and geographically homogenous cohort of Middle European Caucasians, only mtDNA haplogroup T was identified as an obesity risk factor.	[Ebner, Sabine; Paulmichl, Katharina; Sperl, Wolfgang; Kofler, Barbara; Weghuber, Daniel] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Mangge, Harald] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Mangge, Harald] BioTechMed Graz, Graz, Austria; [Langhof, Helmut] Klin Schonsicht, Berchtesgaden, Germany; [Halle, Martin; Siegrist, Monika] Tech Univ Munich, Klinikum Rechts Isar, Dept Prevent Rehabil & Sports Med, D-80290 Munich, Germany; [Aigner, Elmar; Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med, Salzburg, Austria; [Aigner, Elmar; Paulmichl, Katharina; Weghuber, Daniel] Paracelsus Med Univ, Obes Res Unit, Salzburg, Austria; [Aigner, Elmar; Paulmichl, Katharina; Weghuber, Daniel] Salzburger Landeskliniken, Salzburg, Austria; [Datz, Christian] Gen Hosp Oberndorf, Dept Internal Med, Oberndorf, Austria; [Halle, Martin] DZHK German Ctr Cardiovasc Res, Munich, Germany; [Halle, Martin] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Zentrum, D-80290 Munich, Germany	Paracelsus Private Medical University; Medical University of Graz; Technical University of Munich; Paracelsus Private Medical University; Paracelsus Private Medical University; German Centre for Cardiovascular Research; Technical University of Munich	Weghuber, D (corresponding author), Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.	d.weghuber@salk.at	Weghuber, Daniel/AAN-1422-2020	Halle, Martin/0000-0003-3065-530X; Kofler, Barbara/0000-0002-1198-4776; Mangge, Harald/0000-0003-4067-247X	German Society of Paediatric Gastroenterology, Hepatology and Nutrition (GPGE); European Commission [279153]; "Gesellschaft zur Forderung Padiatrischer Forschung und Fortbildung" at the Department of Pediatrics, Paracelsus Medical University; PMU-Forschungsforderungsfonds [E13/17/086-AIG]	German Society of Paediatric Gastroenterology, Hepatology and Nutrition (GPGE); European Commission(European CommissionEuropean Commission Joint Research Centre); "Gesellschaft zur Forderung Padiatrischer Forschung und Fortbildung" at the Department of Pediatrics, Paracelsus Medical University; PMU-Forschungsforderungsfonds	This study was supported by a start-up research grant by the German Society of Paediatric Gastroenterology, Hepatology and Nutrition (GPGE) to Daniel Weghuber (www.gpge.de). Daniel Weghuber and Katharina Paulmichl would like to acknowledge support by a grant from the European Commission (FP7 contract 279153, Beta-JUDO; http://www.cordis.europa.eu/fp7), and a grant by the "Gesellschaft zur Forderung Padiatrischer Forschung und Fortbildung" at the Department of Pediatrics, Paracelsus Medical University (www.salk.at). ElmarAigner is supported by PMU-Forschungsforderungsfonds (E13/17/086-AIG; www.pmu.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2010, EUR J CLIN INVEST, V40, P155, DOI 10.1111/j.1365-2362.2009.02238.x; Castro MG, 2007, MITOCHONDRION, V7, P354, DOI 10.1016/j.mito.2007.06.002; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; Ebner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027192; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gill-Randall R, 2001, DIABETIC MED, V18, P413, DOI 10.1046/j.1464-5491.2001.00477.x; Grant SFA, 2012, INT J OBESITY, V36, P80, DOI 10.1038/ijo.2011.206; Hatzfeld JJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110136; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Knoll N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094882; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kurian AK, 2007, ETHNIC DIS, V17, P143; Mangge H, 2014, OBESITY, V22, P195, DOI 10.1002/oby.20491; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Mustelin L, 2008, AM J PHYSIOL-ENDOC M, V295, pE148, DOI 10.1152/ajpendo.00580.2007; Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082; Naukkarinen J, 2014, DIABETOLOGIA, V57, P167, DOI 10.1007/s00125-013-3066-y; Palmieri VO, 2011, NUTRITION, V27, P773, DOI 10.1016/j.nut.2010.08.016; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Parker E, 2005, AM J PHYSIOL-ENDOC M, V289, pE1110, DOI 10.1152/ajpendo.00600.2004; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Soto-Hermida A, 2014, MITOCHONDRION, V15, P18, DOI 10.1016/j.mito.2014.03.001; Torroni A, 1996, GENETICS, V144, P1835; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086; Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595; Zelzer S, 2011, CLIN CHIM ACTA, V412, P1345, DOI 10.1016/j.cca.2011.03.031	43	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135622	10.1371/journal.pone.0135622	http://dx.doi.org/10.1371/journal.pone.0135622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322975	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500009
J	Horje, CSHT; Bruijnen, R; Roovers, L; Groenen, MJM; Joosten, FBM; Wahab, PJ				Horje, C. S. Horjus Talabur; Bruijnen, R.; Roovers, L.; Groenen, M. J. M.; Joosten, F. B. M.; Wahab, P. J.			Contrast Enhanced Abdominal Ultrasound in the Assessment of Ileal Inflammation in Crohn's Disease: A Comparison with MR Enterography	PLOS ONE			English	Article							BOWEL WALL VASCULARITY; MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; INTESTINAL INFLAMMATION; ENDOSCOPIC ACTIVITY; ULCERATIVE-COLITIS; ULTRASONOGRAPHY; CLASSIFICATION; ENTEROCLYSIS; VALIDATION	Background and Aims To prospectively examine the feasibility and accuracy of Contrast Enhanced Ultrasound (CEUS) in the assessment of Crohn's disease (CD) activity in the terminal ileum in comparison to Magnetic Resonance Enterography (MRE), using endoscopy as a reference standard. Methods 105 consecutive patients with alleged clinically active CD were assessed by MRE and CEUS. CEUS of the terminal ileum was performed using an intravenous microbubble contrast enhancer. Accuracy values of CEUS and MRE for the presence of active terminal ileitis were evaluated using the Receiver Operating Characteristic method, using endoscopic findings as a reference standard. Sensitivity and specificity values of MRE and CEUS were compared by the McNemar test. Results CEUS was feasible in 98% of patients, MRE in all. Optimal diagnostic accuracy in CEUS was obtained at a peak intensity value of 10%, showing 100% sensitivity, 92% specificity and an accuracy of 99% in demonstrating ileal mucosal inflammation. For MRE, overall sensitivity, specificity and accuracy were, 87%, 100%, and 88%, respectively. CEUS and MRE were highly correlated in assessing length and wall thickness of the terminal ileum. CEUS identified 11 of 16 MRE-detected strictures, but no fistulae. Conclusion The accuracy of CEUS is comparable to that of MRE in the assessment of active, uncomplicated terminal ileal CD and therefore a valuable bedside alternative to MRE in the follow-up of these patients.	[Horje, C. S. Horjus Talabur; Groenen, M. J. M.; Wahab, P. J.] Rijnstate Hosp, Dept Gastroenterol, Arnhem, Netherlands; [Bruijnen, R.; Joosten, F. B. M.] Rijnstate Hosp, Dept Radiol, Arnhem, Netherlands; [Roovers, L.] Rijnstate Hosp, Dept Epidemiol & Stat, Arnhem, Netherlands	Rijnstate Hospital; Rijnstate Hospital; Rijnstate Hospital	Horje, CSHT (corresponding author), Rijnstate Hosp, Dept Gastroenterol, Arnhem, Netherlands.	chthorje@rijnstate.nl						Ansari A, 2003, SCAND J GASTROENTERO, V38, P1184, DOI 10.1080/00365520310006018; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRAHME F, 1970, GUT, V11, P928, DOI 10.1136/gut.11.11.928; Cipriano LE, 2012, INFLAMM BOWEL DIS, V18, P1240, DOI 10.1002/ibd.21862; CRAMABOHBOUTH G, 1989, GUT, V30, P1236, DOI 10.1136/gut.30.9.1236; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; De Franco A, 2012, ABDOM IMAGING, V37, P359, DOI 10.1007/s00261-011-9831-9; Drews BH, 2009, EUR RADIOL, V19, P1379, DOI 10.1007/s00330-008-1290-5; Fraquelli M, 2005, RADIOLOGY, V236, P95, DOI 10.1148/radiol.2361040799; Girlich C, 2009, CLIN HEMORHEOL MICRO, V43, P141, DOI 10.3233/CH-2009-1228; HARVEY RF, 1980, LANCET, V1, P514; Hassan C, 2003, INT J COLORECTAL DIS, V18, P121, DOI 10.1007/s00384-002-0455-y; Israeli E, 2013, ALIMENT PHARM THER, V38, P513, DOI 10.1111/apt.12410; Karoui S, 2010, J CROHNS COLITIS, V4, P334, DOI 10.1016/j.crohns.2009.12.011; Lee SS, 2009, RADIOLOGY, V251, P751, DOI 10.1148/radiol.2513081184; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leyendecker JR, 2009, RADIOGRAPHICS, V29, P1827, DOI 10.1148/rg.296095510; Maconi G, 1998, GUT, V43, P645, DOI 10.1136/gut.43.5.645; Malago R, 2012, RADIOL MED, V117, P268, DOI 10.1007/s11547-011-0783-5; Paredes JM, 2013, J CROHNS COLITIS, V7, P192, DOI 10.1016/j.crohns.2012.03.017; Martinez MJ, 2009, ABDOM IMAGING, V34, P141, DOI 10.1007/s00261-008-9365-y; Miao YM, 2002, CLIN RADIOL, V57, P913, DOI 10.1053/crad.2002.1059; Migaleddu V, 2011, ABDOM IMAGING, V36, P142, DOI 10.1007/s00261-010-9622-8; Migaleddu V, 2009, GASTROENTEROLOGY, V137, P43, DOI 10.1053/j.gastro.2009.03.062; Moreno N, 2014, J CROHNS COLITIS, V8, P1079, DOI 10.1016/j.crohns.2014.02.008; Negaard A, 2007, EUR RADIOL, V17, P2294, DOI 10.1007/s00330-007-0648-4; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Pauls S, 2006, EUR RADIOL, V16, P2410, DOI 10.1007/s00330-006-0330-2; Peloquin JM, 2008, AM J GASTROENTEROL, V103, P2015, DOI 10.1111/j.1572-0241.2008.01920.x; Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0; Quaia E, 2013, EUR RADIOL, V23, P1650, DOI 10.1007/s00330-012-2754-1; Reimund JM, 1999, GASTROEN CLIN BIOL, V23, P740; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Ripolles T, 2013, EUR J RADIOL, V82, pE525, DOI 10.1016/j.ejrad.2013.05.043; Ripolles T, 2011, INSIGHTS IMAGING, V2, P639, DOI 10.1007/s13244-011-0124-1; Ripolles T, 2013, J CROHNS COLITIS, V7, P120, DOI 10.1016/j.crohns.2012.03.002; Ripolles T, 2009, RADIOLOGY, V253, P241, DOI 10.1148/radiol.2531082269; Saevik F, 2014, INFLAMMATORY BOWEL D; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Sinha R, 2009, CLIN RADIOL, V64, P341, DOI 10.1016/j.crad.2008.08.006; Sostegni R, 2003, ALIMENT PHARM THER, V17, P11, DOI 10.1046/j.1365-2036.17.s2.17.x; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Takenaka K, 2014, GASTROENTEROLOGY, V147, P334, DOI 10.1053/j.gastro.2014.04.008; van Bodegraven Ad A, 2010, Ned Tijdschr Geneeskd, V154, pA1899; WAKEFIELD AJ, 1989, LANCET, V2, P1057	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136105	10.1371/journal.pone.0136105	http://dx.doi.org/10.1371/journal.pone.0136105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322970	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500015
J	Pscheidt, C; Nagel, G; Zitt, E; Kramar, R; Concin, H; Lhotta, K				Pscheidt, Constanze; Nagel, Gabriele; Zitt, Emanuel; Kramar, Reinhard; Concin, Hans; Lhotta, Karl			Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GAMMA-GLUTAMYL-TRANSFERASE; BODY-MASS INDEX; METABOLIC SYNDROME; BLOOD-PRESSURE; MEN; WOMEN; ALBUMINURIA; LIPIDS	Objective We investigated the association between metabolic factors and End-Stage Renal Disease (ESRD) and quantified the magnitude of their influence dependent on sex and time of exposure up to 20 years. Material and Methods A prospective cohort study was conducted to determine risk factors for the development of ESRD. From 1988 to 2005 185,341 persons (53.9% women) participated in the "Vorarlberg Health Monitoring and Promotion Programme" (VHM&PP). Data on body mass index (BMI), fasting blood glucose (FBG), systolic (BPsys) and diastolic (BPdia) blood pressure, total cholesterol (TC), triglycerides (TG), gamma-glutamyltransferase (GGT) and smoking status were collected. Data of the population-based VHM&PP were merged with the Austrian Dialysis and Transplant Registry. Cox proportional hazards models were applied to calculate hazard ratios (HRs) for ESRD, stratified by sex and 5-year time intervals. Results During a mean follow-up of 17.5 years 403 patients (39.1% women) developed ESRD. Significant risk factors were: BMI (per 1 kg/m2) HR 1.04 (95% CI 1.01-1.06), FBG (per 1 mmol/L) HR 1.09 (1.05-1.12), BPsys (per 5 mmHg) HR 1.10 (1.07-1.14), BPdia (per 5 mmHg) HR 1.09 (1.03-1.15), TG (per 1 mmol/L) HR 1.07 (1.02-1.13), TC (per 1 mmol/L) HR 1.22 (1.13-1.32). We observed a sex-specific risk pattern with an increased ESRD risk for men for increasing TG and smoking, and for women for increasing BMI and GGT. In time interval analyses BPsys and TC were associated with early ESRD onset, whereas BMI, FBG, BPdia and GGT were associated with later onset. Conclusions Anthropometric and metabolic factors are differentially associated with the long-term risk for ESRD in a sex- and time-dependent manner. Consideration of these patterns in preventive and therapeutic strategies could have an impact on ESRD incidence.	[Pscheidt, Constanze; Nagel, Gabriele; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Austria; [Pscheidt, Constanze; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria; [Kramar, Reinhard] Austrian Dialysis & Transplant Registry, Rohr, Austria	Ulm University	Lhotta, K (corresponding author), Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria.	karl.lhotta@lkhf.at	vhmpp, aks/F-9756-2012; Nagel, Gabriele/C-3635-2012; Zitt, Emanuel/ABE-1926-2020	Nagel, Gabriele/0000-0001-6185-8535; Zitt, Emanuel/0000-0001-6944-6041	state government of Vorarlberg; Austrian Society of Nephrology; Hans Drexel	state government of Vorarlberg; Austrian Society of Nephrology; Hans Drexel	This study was supported by a grant from Hans Drexel to the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT). The Vorarlberg Health Monitoring & Promotion Programme (VHM&PP) is funded by the state government of Vorarlberg. The Austrian Dialysis- and Transplantregistry (OEDTR) is funded by the Austrian Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogun W O, 2008, Afr J Med Med Sci, V37, P177; Boucquemont J, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-45; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Kastarinen M, 2010, J INTERN MED, V267, P612, DOI 10.1111/j.1365-2796.2009.02197.x; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; McMahon GM, 2014, J AM SOC NEPHROLOGY; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nagel G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-177; Panwar B, 2014, KIDNEY INT; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; Society AD, 2014, FAST PLASM GLUC AM D; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Targher G, 2010, NUTR METAB CARDIOVAS, V20, P583, DOI 10.1016/j.numecd.2009.05.012; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Turin TC, 2012, J AM SOC NEPHROL, V23, P1569, DOI 10.1681/ASN.2012020164; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; WHO, 2014, BMI CLASS; Wimmer F, 2003, NEPHROL DIAL TRANSPL, V18, P1562, DOI 10.1093/ndt/gfg184	33	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135052	10.1371/journal.pone.0135052	http://dx.doi.org/10.1371/journal.pone.0135052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322515	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500005
J	Yoo, DH; Song, SW; Yun, TJ; Kim, TM; Lee, SH; Kim, JH; Sohn, CH; Park, SH; Park, CK; Kim, IH; Choi, SH				Yoo, Dong Hyun; Song, Sang Woo; Yun, Tae Jin; Kim, Tae Min; Lee, Se-Hoon; Kim, Ji-Hoon; Sohn, Chul-Ho; Park, Sung-Hye; Park, Chul-Kee; Kim, Il Han; Choi, Seung Hong			MR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain Tumors	PLOS ONE			English	Article							LOW-GRADE GLIOMA; CENTRAL-NERVOUS-SYSTEM; INDUCED TELANGIECTASIA; RANDOMIZED-TRIAL; FOLLOW-UP; RADIOTHERAPY; CHILDREN; MALFORMATIONS; CHEMOTHERAPY; VASCULOPATHY	The purpose of our study was to determine the frequency and severity of intracerebral hemorrhages and T2 hyperintense white matter lesions (WMLs) following radiation therapy for brain tumors in adult patients. Of 648 adult brain tumor patients who received radiation therapy at our institute, magnetic resonance (MR) image data consisting of a gradient echo (GRE) and FLAIR T2-weighted image were available three and five years after radiation therapy in 81 patients. Intracerebral hemorrhage was defined as a hypointense dot lesion appearing on GRE images after radiation therapy. The number and size of the lesions were evaluated. The T2 hyperintense WMLs observed on the FLAIR sequences were graded according to the extent of the lesion. Intracerebral hemorrhage was detected in 21 (25.9%) and 35 (43.2) patients in the three-and five-year follow-up images, respectively. The number of intracerebral hemorrhages per patient tended to increase as the follow-up period increased, whereas the size of the intracerebral hemorrhages exhibited little variation over the course of follow-up. T2 hyperintense WMLs were observed in 27 (33.3%) and 32 (39.5) patients in the three and five year follow-up images, respectively. The age at the time of radiation therapy was significantly higher (p < 0.001) in the patients with T2 hyperintense WMLs than in those without lesions. Intracerebral hemorrhages are not uncommon in adult brain tumor patients undergoing radiation therapy. The incidence and number of intracerebral hemorrhages increased over the course of follow-up. T2 hyperintense WMLs were observed in more than one-third of the study population.	[Yoo, Dong Hyun; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho; Choi, Seung Hong] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Song, Sang Woo; Park, Chul-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Kim, Tae Min; Lee, Se-Hoon] Seoul Natl Univ Hosp, Dept Internal Med, Canc Res Inst, Seoul 110744, South Korea; [Park, Sung-Hye] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Kim, Il Han] Seoul Natl Univ Hosp, Dept Radiat Oncol, Canc Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Park, CK (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea.	nsckpark@snu.ac.kr; ihkim@snu.ac.kr; verocay@snuh.org	Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021; Kim, Ji-hoon/D-5754-2012	Park, Chul-Kee/0000-0002-2350-9876; Kim, Ji-hoon/0000-0002-6349-6950	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare Family Affairs [HI13C0015]; Research Center Program of IBS (Institute for Basic Science) in Korea	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea	This study was supported by a grant from Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare & Family Affairs, grant number HI13C0015 (http://www.mw.go.kr/), recipient SHC, and the Research Center Program of IBS (Institute for Basic Science) in Korea (no grant number, http://www.ibs.re.kr/), recipient SHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL WS, 1992, AM J NEURORADIOL, V13, P761; BRANTZAWADZKI M, 1985, AM J NEURORADIOL, V6, P675; BRANTZAWADZKI M, 1980, AM J ROENTGENOL, V134, P51, DOI 10.2214/ajr.134.1.51; Chan MSM, 2006, AM J NEURORADIOL, V27, P548; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; GAENSLER EHL, 1994, RADIOLOGY, V193, P629, DOI 10.1148/radiology.193.3.7972799; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Johannesen TB, 2003, RADIOTHER ONCOL, V69, P169, DOI 10.1016/S0167-8140(03)00192-0; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Koike S, 2004, RADIOLOGY, V230, P93, DOI 10.1148/radiol.2301021143; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lee BCP, 1999, AM J NEURORADIOL, V20, P1239; MEYER JS, 1992, J NEUROL SCI, V110, P1; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; OI S, 1990, Neurologia Medico-Chirurgica, V30, P36, DOI 10.2176/nmc.30.36; POUSSAINT TY, 1995, AM J NEURORADIOL, V16, P693; Pozzati E, 1996, NEUROSURGERY, V39, P677, DOI 10.1097/00006123-199610000-00004; Rabin BM, 1996, RADIOGRAPHICS, V16, P1055, DOI 10.1148/radiographics.16.5.8888390; Reddick WE, 2009, AM J NEURORADIOL, V30, P1947, DOI 10.3174/ajnr.A1733; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; TSURUDA JS, 1987, AM J ROENTGENOL, V149, P165, DOI 10.2214/ajr.149.1.165; Tsushima Y, 2003, AM J NEURORADIOL, V24, P88; VALK PE, 1991, AM J NEURORADIOL, V12, P45; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Wang YXJ, 2010, RADIOLOGY, V254, P210, DOI 10.1148/radiol.09090428; WILSON DA, 1991, RADIOLOGY, V180, P205, DOI 10.1148/radiology.180.1.2052695	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136795	10.1371/journal.pone.0136795	http://dx.doi.org/10.1371/journal.pone.0136795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322780	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500037
J	Dalmia, N; Klimstra, WB; Mason, C; Ramsay, AJ				Dalmia, Neha; Klimstra, William B.; Mason, Carol; Ramsay, Alistair J.			DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection	PLOS ONE			English	Article							VENEZUELAN EQUINE ENCEPHALITIS; TUBERCULOSIS VACCINE; IMMUNE-RESPONSES; ENHANCED IMMUNOGENICITY; INTERFERON-GAMMA; RHESUS MACAQUES; CELL RESPONSES; BOOST STRATEGY; VIRUS; EXPRESSION	There is an urgent need for effective prophylactic measures against Mycobacterium tuberculosis (Mtb) infection, particularly given the highly variable efficacy of Bacille Calmette-Guerin (BCG), the only licensed vaccine against tuberculosis (TB). Most studies indicate that cell-mediated immune responses involving both CD4+ and CD8+ T cells are necessary for effective immunity against Mtb. Genetic vaccination induces humoral and cellular immune responses, including CD4+ and CD8+ T-cell responses, against a variety of bacterial, viral, parasitic and tumor antigens, and this strategy may therefore hold promise for the development of more effective TB vaccines. Novel formulations and delivery strategies to improve the immunogenicity of DNA-based vaccines have recently been evaluated, and have shown varying degrees of success. In the present study, we evaluated DNA-launched Venezuelan equine encephalitis replicons (Vrep) encoding a novel fusion of the mycobacterial antigens a-crystallin (Acr) and antigen 85B (Ag85B), termed Vrep-Acr/Ag85B, for their immunogenicity and protective efficacy in a murine model of pulmonary TB. Vrep-Acr/Ag85B generated antigen-specific CD4+ and CD8+ T cell responses that persisted for at least 10 wk post-immunization. Interestingly, parenterally administered Vrep-Acr/Ag85B also induced T cell responses in the lung tissues, the primary site of infection, and inhibited bacterial growth in both the lungs and spleens following aerosol challenge with Mtb. DNA-launched Vrep may, therefore, represent an effective approach to the development of gene-based vaccines against TB, particularly as components of heterologous prime-boost strategies or as BCG boosters.	[Dalmia, Neha; Mason, Carol; Ramsay, Alistair J.] LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Klimstra, William B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramsay, AJ (corresponding author), LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.	aramsa@lsuhsc.edu			National Institutes of Health [R01 AI058810, PO1 HL076100, R01 AI083383, R01 AA 011760]; Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083383, R01AI058810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health grants R01 AI058810 (AJR), PO1 HL076100 (AJR and CM), R01 AI083383 (WBK), R01 AA 011760 (CM) and the Louisiana Vaccine Center funded by the Louisiana Board of Regents. National Institutes of Health (www.nih.gov), Louisiana Board of Regents (regents.louisiana.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Atkins Gregory J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000859; Auten MW, 2012, VACCINE, V30, P2768, DOI 10.1016/j.vaccine.2012.02.020; Balasuriya UBR, 2000, J VIROL, V74, P10623, DOI 10.1128/JVI.74.22.10623-10630.2000; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; Britton WJ, 2003, IMMUNOL CELL BIOL, V81, P34, DOI 10.1046/j.0818-9641.2002.01143.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Dalmia N, 2012, EXPERT REV VACCINES, V11, P1221, DOI [10.1586/erv.12.94, 10.1586/ERV.12.94]; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; Derrick SC, 2005, INFECT IMMUN, V73, P7727, DOI 10.1128/IAI.73.11.7727-7735.2005; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Garcia I, 1997, EUR J IMMUNOL, V27, P3182, DOI 10.1002/eji.1830271215; Gardner JP, 2000, J VIROL, V74, P11849, DOI 10.1128/JVI.74.24.11849-11857.2000; Genesca M, 2007, J IMMUNOL, V179, P4732, DOI 10.4049/jimmunol.179.7.4732; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Giri M, 2004, CLIN MICROBIOL REV, V17, P370, DOI 10.1128/CMR.17.2.370-389.2004; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Jeyanathan M, 2013, MUCOSAL IMMUNOL, V6, P612, DOI 10.1038/mi.2012.103; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kirman JR, 2003, INFECT IMMUN, V71, P575, DOI 10.1128/IAI.71.1.575-579.2003; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; Leitner WW, 2003, J CLIN INVEST, V112, P22, DOI 10.1172/JCI200319069; Li ML, 2004, INT REV IMMUNOL, V23, P7, DOI 10.1080/08830180490265529; Li ZM, 2006, VACCINE, V24, P4565, DOI 10.1016/j.vaccine.2005.08.021; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Lu S, 2008, EXPERT REV VACCINES, V7, P175, DOI 10.1586/14760584.7.2.175; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; McShane H, 2009, SWISS MED WKLY, V139, P156, DOI smw-12374; Powell K, 2004, NAT BIOTECHNOL, V22, P799, DOI 10.1038/nbt0704-799; Purkayastha A, 2002, INFECT IMMUN, V70, P1518, DOI 10.1128/IAI.70.3.1518-1529.2002; Pushko P, 1997, VIROLOGY, V239, P389, DOI 10.1006/viro.1997.8878; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Thompson JM, 2008, VACCINE, V26, P4267, DOI 10.1016/j.vaccine.2008.05.046; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; VORDERMEIER HM, 1993, IMMUNOLOGY, V80, P6; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; World Health Organization, WHO GLOB TUB REP 201; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856; Yin J, 2009, J VIROL, V83, P10036, DOI 10.1128/JVI.01209-09; Ying YA, 1996, J BACTERIOL, V178, P4484, DOI 10.1128/jb.178.15.4484-4492.1996; Young SL, 2010, IMMUNOL CELL BIOL, V88, P651, DOI 10.1038/icb.2010.25; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	70	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136635	10.1371/journal.pone.0136635	http://dx.doi.org/10.1371/journal.pone.0136635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317509	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000360299100117
J	De Paepe, AL; Crombez, G; Legrain, V				De Paepe, Annick L.; Crombez, Geert; Legrain, Valery			From a Somatotopic to a Spatiotopic Frame of Reference for the Localization of Nociceptive Stimuli	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; PRIMARY SOMATOSENSORY CORTEX; EXOGENOUS SPATIAL ATTENTION; TEMPORAL-ORDER JUDGMENT; NEGLECT-LIKE SYMPTOMS; PRIOR ENTRY; BODY REPRESENTATION; TACTILE STIMULI; SYNDROME CRPS; SPACE	To react efficiently to potentially threatening stimuli, we have to be able to localize these stimuli in space. In daily life we are constantly moving so that our limbs can be positioned at the opposite side of space. Therefore, a somatotopic frame of reference is insufficient to localize nociceptive stimuli. Here we investigated whether nociceptive stimuli are mapped into a spatiotopic frame of reference, and more specifically a peripersonal frame of reference, which takes into account the position of the body limbs in external space, as well as the occurrence of external objects presented near the body. Two temporal order judgment (TOJ) experiments were conducted, during which participants had to decide which of two nociceptive stimuli, one applied to either hand, had been presented first while their hands were either uncrossed or crossed over the body midline. The occurrence of the nociceptive stimuli was cued by uninformative visual cues. We found that the visual cues prioritized the perception of nociceptive stimuli applied to the hand laying in the cued side of space, irrespective of posture. Moreover, the influence of the cues was smaller when they were presented far in front of participants' hands as compared to when they were presented in close proximity. Finally, participants' temporal sensitivity was reduced by changing posture. These findings are compatible with the existence of a peripersonal frame of reference for the localization of nociceptive stimuli. This allows for the construction of a stable representation of our body and the space closely surrounding our body, enabling a quick and efficient reaction to potential physical threats.	[De Paepe, Annick L.; Crombez, Geert] Univ Ghent, Dept Experimental Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Legrain, Valery] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium	Ghent University; Universite Catholique Louvain	De Paepe, AL (corresponding author), Univ Ghent, Dept Experimental Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Annick.DePaepe@Ugent.be	Crombez, Geert/O-2268-2013	Crombez, Geert/0000-0002-4744-8561; De Paepe, Annick/0000-0002-9366-3692	Research Foundation Flanders (FWO, Belgium); Fund for Scientific Research of the French speaking Community of Belgium (F.R.S.-FNRS)	Research Foundation Flanders (FWO, Belgium)(FWO); Fund for Scientific Research of the French speaking Community of Belgium (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	A.L. De Paepe is supported by the Research Foundation Flanders (FWO, Belgium, http://www.fwo.be). V. Legrain is supported by the Fund for Scientific Research of the French speaking Community of Belgium (F.R.S.-FNRS, http://www.fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1999, J COGNITIVE NEUROSCI, V11, P67, DOI 10.1162/089892999563256; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Bultitude JH, 2010, EXP BRAIN RES, V204, P409, DOI 10.1007/s00221-009-2107-8; CAIRNEY PT, 1975, ACTA PSYCHOL, V39, P329, DOI 10.1016/0001-6918(75)90025-6; Churyukanov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035817; De Paepe AL, 2014, NEUROPSYCHOLOGIA, V56, P219, DOI 10.1016/j.neuropsychologia.2014.01.016; De Ruddere L, 2013, PAIN, V154, P669, DOI 10.1016/j.pain.2012.12.018; De Ruddere L, 2011, PAIN, V152, P2342, DOI 10.1016/j.pain.2011.06.028; DREW F, 1896, AM J PSYCHOL, V7, P533, DOI DOI 10.2307/1411848; Durnez W, 2015, J PAIN, V16, P135, DOI 10.1016/j.jpain.2014.10.012; Frettloh J, 2006, PAIN, V124, P184, DOI 10.1016/j.pain.2006.04.010; Galer BS, 1999, J PAIN SYMPTOM MANAG, V18, P213, DOI 10.1016/S0885-3924(99)00076-7; GALER BS, 1995, J PAIN SYMPTOM MANAG, V10, P385, DOI 10.1016/0885-3924(95)00061-3; Gallace A, 2011, PAIN, V152, P1418, DOI 10.1016/j.pain.2011.02.029; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; GRAZIANO MSA, 1994, COGNITIVE NEUROSCIEN, P1021; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes NP, 2006, BRAIN RES, V1077, P108, DOI 10.1016/j.brainres.2005.11.010; Inui K, 2006, CEREB CORTEX, V16, P355, DOI 10.1093/cercor.bhi114; Kennett S, 2002, PERCEPT PSYCHOPHYS, V64, P1083, DOI 10.3758/BF03194758; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Legrain V, 2012, PAIN, V153, P948, DOI 10.1016/j.pain.2011.12.010; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Mancini F, 2013, CURR BIOL, V23, P496, DOI 10.1016/j.cub.2013.02.008; Mancini F, 2012, J NEUROSCI, V32, P17155, DOI 10.1523/JNEUROSCI.3059-12.2012; Moseley GL, 2012, BRAIN, V135, P3676, DOI 10.1093/brain/aws297; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Mouraux A, 2014, NEUROSCI LETT, V561, P69, DOI 10.1016/j.neulet.2013.12.017; Pagel B, 2009, DEVELOPMENTAL SCI, V12, P929, DOI 10.1111/j.1467-7687.2009.00845.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Sambo CF, 2013, PAIN, V154, P242, DOI 10.1016/j.pain.2012.10.010; Shore DI, 2005, PERCEPTION, V34, P1251, DOI 10.1068/p3313; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; SMANIA N, 1995, NEUROLOGY, V45, P1725, DOI 10.1212/WNL.45.9.1725; Spence C, 2001, CAN J EXP PSYCHOL, V55, P133, DOI 10.1037/h0087360; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C., 2004, CROSSMODAL SPACE CRO; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Stein BE., 1993, MERGING SENSES; Sumitani M, 2007, NEUROLOGY, V68, P128, DOI 10.1212/01.wnl.0000250242.99683.57; Van Damme S, 2009, BRAIN RES, V1253, P100, DOI 10.1016/j.brainres.2008.11.072; van Elk M, 2013, CONSCIOUS COGN, V22, P545, DOI 10.1016/j.concog.2013.02.006; VANDERIET K, 1987, PAIN, V30, P395, DOI 10.1016/0304-3959(87)90027-3; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; West B. T., 2007, LINEAR MIXED MODELS; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	53	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137120	10.1371/journal.pone.0137120	http://dx.doi.org/10.1371/journal.pone.0137120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317671	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100206
J	Friborg, O; Emaus, N; Rosenvinge, JH; Bilden, U; Olsen, JA; Pettersen, G				Friborg, Oddgeir; Emaus, Nina; Rosenvinge, Jan H.; Bilden, Unni; Olsen, Jan Abel; Pettersen, Gunn			Violence Affects Physical and Mental Health Differently: The General Population Based Tromso Study	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; STRESSFUL LIFE EVENTS; INTERPERSONAL VIOLENCE; COMMUNITY VIOLENCE; DOMESTIC VIOLENCE; RESILIENCE; EXPOSURE; IMPACT; ABUSE; RISK	This general population-based study examined associations between violence and mental health, musculoskeletal pain, and early disability pension. The prevalence and consequences of good vs. poor adjustment (resilience vs. vulnerability) following encounters with violence were also examined. Data were based on the sixth wave of the "Tromso Study" (N = 12,981; 65.7% response rate, 53.4% women, M-age = 57.5 years, SD-age = 12.7 years). Self-reported data on psychological (threats) and physical violence (beaten/kicked), mental health (anxiety/depression), musculoskeletal pain (MSP), and granting of disability pension (DP) were collected. Men suffered more violent events during childhood than women did, and vice versa during adulthood. Psychological violence implied poorer mental health and slightly more MSP than physical violence. The risk of MSP was highest for violence occurring during childhood in women and during the last year for men. A dose-response relationship between an increasing number of violent encounters and poorer health was observed. About 58% of individuals reported no negative impact of violence (hence, resilience group), whereas 42% considered themselves as more vulnerable following encounters with violence. Regression analyses indicated comparable mental health but slightly more MSP in the resilience group compared to the unexposed group, whereas the vulnerable group had significantly worse health overall and a higher risk of early granting of DP. Resilience is not an all-or-nothing matter, as physical ailments may characterize individuals adapting well following encounters with violence.	[Friborg, Oddgeir; Rosenvinge, Jan H.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Psychol, Tromso, Norway; [Emaus, Nina; Bilden, Unni; Pettersen, Gunn] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Olsen, Jan Abel] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Friborg, O (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Psychol, Tromso, Norway.	oddgeir.friborg@uit.no		Friborg, Oddgeir/0000-0001-6629-0782	UiT the Arctic University of Tromso	UiT the Arctic University of Tromso	The survey data comes from a large population-based study conducted in the city of Tromso. The Project is funded by the UiT the Arctic University of Tromso.	Akyuz A, 2012, AGGRESS VIOLENT BEH, V17, P514, DOI 10.1016/j.avb.2012.07.005; Anandacoomarasamy A, 2008, INT J OBESITY, V32, P211, DOI 10.1038/sj.ijo.0803715; Arnow BA, 2004, J CLIN PSYCHIAT, V65, P10; Beasley M, 2003, PERS INDIV DIFFER, V34, P77, DOI 10.1016/S0191-8869(02)00027-2; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Castine MR, 1998, J PSYCHIAT RES, V32, P283, DOI 10.1016/S0022-3956(98)00017-X; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Cooley-Quille M, 2001, J CLIN CHILD PSYCHOL, V30, P199, DOI 10.1207/S15374424JCCP3002_7; COURTNEY JG, 1993, EPIDEMIOLOGY, V4, P407, DOI 10.1097/00001648-199309000-00005; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eliassen BM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-522; Evans SE, 2008, AGGRESS VIOLENT BEH, V13, P131, DOI 10.1016/j.avb.2008.02.005; Felitti Vincent J, 2002, Perm J, V6, P44; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Fridh M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-29; Goodwin RD, 2004, PSYCHOL MED, V34, P509, DOI 10.1017/S003329170300134X; Hardt J, 2015, J AFFECT DISORDERS, V175, P168, DOI 10.1016/j.jad.2014.12.044; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P10, DOI 10.1177/1403494810380774; Hinkka K, 2013, J OCCUP ENVIRON MED, V55, P191, DOI 10.1097/JOM.0b013e31827943fe; Iverson KM, 2013, PSYCHOL VIOLENCE, V3, P273, DOI 10.1037/a0030956; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jerlock M, 2008, J INTERN MED, V264, P265, DOI 10.1111/j.1365-2796.2008.01961.x; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Kataoka Y, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-84; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kringlen E, 2001, AM J PSYCHIAT, V158, P1091, DOI 10.1176/appi.ajp.158.7.1091; Leander K, 2012, SCAND J PUBLIC HEALT, V40, P229, DOI 10.1177/1403494812459609; Lien L, 2007, ACTA PAEDIATR, V96, P301, DOI 10.1111/j.1651-2227.2007.00084.x; Lien L, 2012, J PSYCHOSOM RES, V72, P226, DOI 10.1016/j.jpsychores.2011.12.001; Lin CWC, 2011, PAIN, V152, P607, DOI 10.1016/j.pain.2010.11.034; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Luthar SS, 2006, DEV PSYCHOL, V3, P739, DOI DOI 10.1002/9780470939406.CH20; Margolin G, 2000, ANNU REV PSYCHOL, V51, P445, DOI 10.1146/annurev.psych.51.1.445; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Nickerson A, 2011, J TRAUMA, V71, P1821, DOI 10.1097/TA.0b013e318226ec53; Reigstad B, 2006, NORD J PSYCHIAT, V60, P58, DOI 10.1080/08039480500504933; Resnick HS, 1997, BEHAV MED, V23, P65, DOI 10.1080/08964289709596730; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Schlack R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-628; Sprague S SM, 2013, BMC MUSCULOSKEL DIS, V14, P1; Springer KW, 2003, J GEN INTERN MED, V18, P864, DOI 10.1046/j.1525-1497.2003.20918.x; Stickley A, 2010, SCAND J PUBLIC HEALT, V38, P404, DOI 10.1177/1403494810364560; Stormark KM, 2008, J ABNORM CHILD PSYCH, V36, P411, DOI 10.1007/s10802-007-9187-3; Suglia SF, 2015, AM J PREV MED, V48, P205, DOI 10.1016/j.amepre.2014.09.013; THEORELL T, 1971, J PSYCHOSOM RES, V15, P25, DOI 10.1016/0022-3999(71)90070-5; Walby S, 2001, BRIT J CRIMINOL, V41, P502, DOI 10.1093/bjc/41.3.502; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P341, DOI 10.1093/jpepsy/16.3.341; WEAVER TL, 1995, CLIN PSYCHOL REV, V15, P115, DOI 10.1016/0272-7358(95)00004-9; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Werner E.E., 2001, JOURNEYS CHILDHOOD M; WERNER EE, 1989, AM J ORTHOPSYCHIAT, V59, P72, DOI 10.1111/j.1939-0025.1989.tb01636.x; Werner Vach, 2012, REGRESSION MODELS TO; World Health Organization, 2002, WORLD REPORT VIOLENC	64	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136588	10.1371/journal.pone.0136588	http://dx.doi.org/10.1371/journal.pone.0136588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317970	Green Published, gold			2022-12-27	WOS:000360299100105
J	Sailani, MR; Santoni, FA; Letourneau, A; Borel, C; Makrythanasis, P; Hibaoui, Y; Popadin, K; Bonilla, X; Guipponi, M; Gehrig, C; Vannier, A; Carre-Pigeon, F; Feki, A; Nizetic, D; Antonarakis, SE				Sailani, M. Reza; Santoni, Federico A.; Letourneau, Audrey; Borel, Christelle; Makrythanasis, Periklis; Hibaoui, Youssef; Popadin, Konstantin; Bonilla, Ximena; Guipponi, Michel; Gehrig, Corinne; Vannier, Anne; Carre-Pigeon, Frederique; Feki, Anis; Nizetic, Dean; Antonarakis, Stylianos E.			DNA-Methylation Patterns in Trisomy 21 Using Cells from Monozygotic Twins	PLOS ONE			English	Article							PATHOLOGICAL CARDIAC-HYPERTROPHY; CONGENITAL HEART-DISEASE; DOWN-SYNDROME; GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSOR; MAMMALIAN DEVELOPMENT; TARGETED DISRUPTION; HOXB5 EXPRESSION; GENOME; MALFORMATIONS	DNA methylation is essential in mammalian development. We have hypothesized that methylation differences induced by trisomy 21 (T21) contribute to the phenotypic characteristics and heterogeneity in Down syndrome (DS). In order to determine the methylation differences in T21 without interference of the interindividual genomic variation, we have used fetal skin fibroblasts from monozygotic (MZ) twins discordant for T21. We also used skin fibroblasts from MZ twins concordant for T21, normal MZ twins without T21, and unrelated normal and T21 individuals. Reduced Representation Bisulfite Sequencing (RRBS) revealed 35 differentially methylated promoter regions (DMRs) (Absolute methylation differences = 25%, FDR < 0.001) in MZ twins discordant for T21 that have also been observed in comparison between unrelated normal and T21 individuals. The identified DMRs are enriched for genes involved in embryonic organ morphogenesis (FDR = 1.60 e -03) and include genes of the HOXB and HOXD clusters. These DMRs are maintained in iPS cells generated from this twin pair and are correlated with the gene expression changes. We have also observed an increase in DNA methylation level in the T21 methylome compared to the normal euploid methylome. This observation is concordant with the up regulation of DNA methyltransferase enzymes (DNMT3B and DNMT3L) and down regulation of DNA demethylation enzymes (TET2 and TET3) observed in the iPSC of the T21 versus normal twin. Altogether, the results of this study highlight the epigenetic effects of the extra chromosome 21 in T21 on loci outside of this chromosome that are relevant to DS associated phenotypes.	[Sailani, M. Reza; Santoni, Federico A.; Letourneau, Audrey; Borel, Christelle; Makrythanasis, Periklis; Popadin, Konstantin; Bonilla, Ximena; Guipponi, Michel; Gehrig, Corinne; Vannier, Anne; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Sailani, M. Reza; Letourneau, Audrey; Antonarakis, Stylianos E.] Univ Geneva, Natl Ctr Competence Res Frontiers Genet Program, Geneva, Switzerland; [Hibaoui, Youssef; Feki, Anis] Univ Hosp Geneva, Dept Obstet & Gynecol, Stem Cell Res Lab, Geneva, Switzerland; [Hibaoui, Youssef; Feki, Anis] Hop Cantonal Fribourgeois, Dept Obstet & Gynecol, Fribourg, Switzerland; [Carre-Pigeon, Frederique] Hop Maison Blanche, Ctr Hosp Univ Reims, Serv Genet & Biol Reprod, CECOS, F-51092 Reims, France; [Nizetic, Dean] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med, London E1 2AT, England; [Nizetic, Dean] Nanyang Technol Univ, Lee Kong Chian Sch Med, Unit 04 11, Singapore 138673, Singapore; [Antonarakis, Stylianos E.] Univ Geneva, iGE3 Inst Genet & Genom Geneva, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; CHU de Reims; Universite de Reims Champagne-Ardenne; University of London; Queen Mary University London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Geneva	Antonarakis, SE (corresponding author), Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland.	Stylianos.Antonarakis@unige.ch	Bonilla, Ximena/AAI-7910-2021; Makrythanasis, Periklis/AAD-7180-2019; Antonarakis, Stylianos E/N-8866-2014; borel, christelle/AAC-9645-2019; Nizetic, Dean/F-9509-2015; Popadin, Konstantin/L-7459-2017	Antonarakis, Stylianos E/0000-0001-8907-5823; Feki, Anis/0000-0002-9817-9445; Nizetic, Dean/0000-0001-5486-5761; Bonilla, Ximena/0000-0002-4950-6825; Santoni, Federico/0000-0002-3258-4747	NCCR-Frontiers in Genetics; European AnEuploidy project; Fondation Child Care; Wellcome Trust [WT 098330/Z/12/Z]; Ernest Boninchi Fondation; Genico; SNF [144082]; ERC [249968]	NCCR-Frontiers in Genetics(Swiss National Science Foundation (SNSF)); European AnEuploidy project; Fondation Child Care; Wellcome Trust(Wellcome TrustEuropean Commission); Ernest Boninchi Fondation; Genico; SNF; ERC(European Research Council (ERC)European Commission)	This study was supported by grants from the NCCR-Frontiers in Genetics, the European AnEuploidy project, Fondation Child Care, SNF 144082, and ERC 249968 to S.E.A., the Wellcome Trust Strategic Award WT 098330/Z/12/Z (The LonDownS Consortium) to D.N., and grants from the Ernest Boninchi Fondation and Genico to A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhattacharya R, 2012, BLOOD, V119, P4798, DOI 10.1182/blood-2011-11-392563; Billingsley CN, 2013, AM J MED GENET A, V161, P1866, DOI 10.1002/ajmg.a.36006; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Dahoun S, 2008, AM J MED GENET A, V146A, P2086, DOI 10.1002/ajmg.a.32431; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; FERENCZ C, 1989, J PEDIATR-US, V114, P79, DOI 10.1016/S0022-3476(89)80605-5; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Grynberg M, 2007, PRENATAL DIAG, V27, P552, DOI 10.1002/pd.1711; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hu YG, 2008, HUM MOL GENET, V17, P2654, DOI 10.1093/hmg/ddn165; Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; KAUR S, 1992, J EXP ZOOL, V264, P323, DOI 10.1002/jez.1402640311; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Kirov S, 2014, METHODS MOL BIOL, V1101, P31, DOI 10.1007/978-1-62703-721-1_3; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lange AW, 2006, DEV BIOL, V292, P407, DOI 10.1016/j.ydbio.2006.01.017; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Low FM, 2011, EPIGENOMICS-UK, V3, P279, DOI [10.2217/EPI.11.17, 10.2217/epi.11.17]; Malinge S, 2013, BLOOD, V122, pE33, DOI 10.1182/blood-2013-05-503011; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mill J, 2013, NAT REV GENET, V14, P585, DOI 10.1038/nrg3405; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Sailani MR, 2013, GENOME RES, V23, P1410, DOI 10.1101/gr.147991.112; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Serra-Juhe C, 2015, EPIGENETICS, V0; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; Tucci R, 2011, J APPL ORAL SCI, V19, P125, DOI 10.1590/S1678-77572011000200008; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Ye X, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004070; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang LT, 2009, EUR J HUM GENET, V17, P1010, DOI 10.1038/ejhg.2008.269; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	68	38	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135555	10.1371/journal.pone.0135555	http://dx.doi.org/10.1371/journal.pone.0135555			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317209	gold, Green Published			2022-12-27	WOS:000360299100034
J	Wasielica-Poslednik, J; Butsch, C; Lampe, C; Elflein, H; Lamparter, J; Weyer, V; Pitz, S				Wasielica-Poslednik, Joanna; Butsch, Christina; Lampe, Christina; Elflein, Heike; Lamparter, Julia; Weyer, Veronika; Pitz, Susanne			Comparison of Rebound Tonometry, Perkins Applanation Tonometry and Ocular Response Analyser in Mucopolysaccharidosis Patients	PLOS ONE			English	Article							DYNAMIC CONTOUR; GLAUCOMA	Aims To investigate the feasibility and to compare three devices measuring intraocular pressure (IOP) in mucopolysaccharidosis patients (MPS): iCare rebound tonometer (RT), Perkins applanation tonometer (PAT) and ocular response analyzer (ORA) Methods MPS patients who underwent at least two examinations out of: RT, PAT and ORA at the same visit were identified and retrospectively analyzed in this study. Results 17 patients fulfilled the inclusion criterion. In all 17 patients IOP measurements were performed with RT (34 eyes) and ORA (33 eyes), while PAT measurement was possible in only 12 (24 eyes) patients. The RT, corneal-compensated intraocular pressure (IOPcc) and Goldmann-correlated intraocular pressure (IOPg) differed relevantly from IOP assessed with PAT. Corneal clouding in MPS patients correlated positively with PAT, RT and IOPg (r = 0.3, 0.5, and 0.5 respectively), but not with IOPcc (r = 0.07). The MPS-related corneal clouding correlated positively with biomechanical corneal parameters assessed with ORA: corneal hysteresis (r = 0.77) and corneal resistance factor (r = 0.77) either. Conclusions RT and ORA measurements were tolerated better than applanation tonometry in MPS patients. IOP measurements assessed with RT and ORA differed relevantly from PAT. Corneal-compensated IOP assessed with ORA seems to be less affected by the MPS-related corneal clouding than applanation or rebound tonometry. RT and ORA measurements should be preferred for IOP assessment in patients with MPS.	[Wasielica-Poslednik, Joanna; Butsch, Christina; Elflein, Heike; Lamparter, Julia; Pitz, Susanne] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany; [Lampe, Christina] Dr Horst Schmidt Clin GmbH, Dept Pediat, Wiesbaden, Germany; [Weyer, Veronika] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat IMBEI, Univ Med Ctr, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Wasielica-Poslednik, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	joanna.wasielica-poslednik@unimedizin-mainz.de	Weyer-Elberich, Veronika/AAB-8993-2020					Abitbol O, 2010, ACTA OPHTHALMOL, V88, P116, DOI 10.1111/j.1755-3768.2009.01554.x; Ashworth J, 2015, ACTA OPHTHALMOL, V93, pE111, DOI 10.1111/aos.12607; Ashworth JL, 2006, EYE, V20, P553, DOI 10.1038/sj.eye.6701921; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; BECK M, 1984, BRIT J OPHTHALMOL, V68, P590, DOI 10.1136/bjo.68.8.590; Boehm AG, 2008, INVEST OPHTH VIS SCI, V49, P2472, DOI 10.1167/iovs.07-1366; CANTOR LB, 1989, AM J OPHTHALMOL, V108, P426, DOI 10.1016/S0002-9394(14)73311-2; Chui WS, 2008, OPHTHALMOLOGY, V115, P80, DOI 10.1016/j.ophtha.2007.03.061; Couprie J, 2010, J FR OPHTALMOL, V33, P617, DOI 10.1016/j.jfo.2010.09.008; Coutinho MF, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/471325; Fahnehjelm KT, 2012, ACTA OPHTHALMOL, V90, P445, DOI 10.1111/j.1755-3768.2010.02085.x; Ganesh A, 2013, CURR OPIN OPHTHALMOL, V24, P379, DOI 10.1097/ICU.0b013e3283644ea1; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Martinez-de-la-Casa JM, 2006, OPHTHALMOLOGY, V113, P2156, DOI 10.1016/j.ophtha.2006.06.016; Nessim M, 2013, CONTACT LENS ANTERIO, V36, P57, DOI 10.1016/j.clae.2012.11.001; NOWACZYK MJ, 1988, ARCH DIS CHILD, V63, P1091, DOI 10.1136/adc.63.9.1091; Schumacher RG, 2008, PEDIATR RADIOL, V38, P543, DOI 10.1007/s00247-008-0788-y; Suman S, 2014, J GLAUCOMA, V23, P633, DOI 10.1097/IJG.0b013e318285fefd; Summers CG, 2011, RHEUMATOLOGY, V50, pV34, DOI 10.1093/rheumatology/ker392; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Yu AY, 2012, BRIT J OPHTHALMOL, V96, P640, DOI 10.1136/bjophthalmol-2011-300124	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133586	10.1371/journal.pone.0133586	http://dx.doi.org/10.1371/journal.pone.0133586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317991	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100009
J	Weikard, R; Demasius, W; Hadlich, F; Kuhn, C				Weikard, Rosemarie; Demasius, Wiebke; Hadlich, Frieder; Kuehn, Christa			Different Blood Cell-Derived Transcriptome Signatures in Cows Exposed to Vaccination Pre- or Postpartum	PLOS ONE			English	Article							PERIPARTURIENT DAIRY-COWS; MITOCHONDRIAL COMPLEX I; BODY CONDITION SCORE; RNA-SEQ EXPERIMENTS; MILK-PRODUCTION; NEUTROPHIL FUNCTION; MAMMARY-GLAND; ALTERNATIVE ACTIVATION; MYCOBACTERIUM-BOVIS; ARGININE METABOLISM	Periparturient cows have been found to reveal immunosuppression, frequently associated with increased susceptibility to uterine and mammary infections. To improve understanding of the causes and molecular regulatory mechanisms accounting for this phenomenon around calving, we examined the effect of an antigen challenge on gene expression modulation on cows prior to (BC) or after calving (AC) using whole transcriptome sequencing (RNAseq). The transcriptome analysis of the cows' blood identified a substantially higher number of loci affected in BC cows (2,235) in response to vaccination compared to AC cows (208) and revealed a divergent transcriptional profile specific for each group. In BC cows, a variety of loci involved in immune defense and cellular signaling processes were transcriptionally activated, whereas protein biosynthesis and posttranslational processes were tremendously impaired in response to vaccination. Furthermore, energy metabolism in the blood cells of BC cows was shifted from oxidative phosphorylation to the glycolytic system. In AC cows, the number and variety of regulated pathways involved in immunomodulation and maintenance of immnunocompetence are considerably lower after vaccination, and upregulation of arginine degradation was suggested as an immunosuppressive mechanism. Elevated transcript levels of erythrocyte-specific genes involved in gas exchange processes were a specific transcriptional signature in AC cows pointing to hematopoiesis activation. The divergent and substantially lower magnitude of transcriptional modulation in response to vaccination in AC cows provides evidence for a suppressed immune capacity of early lactating cows on the molecular level and demonstrates that an efficient immune response of cows is related to their physiological and metabolic status.	[Weikard, Rosemarie; Demasius, Wiebke; Hadlich, Frieder; Kuehn, Christa] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Weikard, R (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany.	weikard@fbn-dummerstorf.de		Kuehn, Christa/0000-0002-0216-424X	German Ministry of Food, Agriculture, and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food (BLE) [2810HS27]	German Ministry of Food, Agriculture, and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food (BLE)	This study was funded by the German Ministry of Food, Agriculture, and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food (BLE), grant number 2810HS27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlaud GJ, 2001, IMMUNOL REV, V180, P136, DOI 10.1034/j.1600-065X.2001.1800112.x; Auffray I, 2001, BLOOD, V97, P2872, DOI 10.1182/blood.V97.9.2872; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Burvenich C, 2007, J DAIRY SCI, V90, pE39, DOI 10.3168/jds.2006-696; Buttchereit N, 2012, J ANIM BREED GENET, V129, P280, DOI 10.1111/j.1439-0388.2011.00976.x; CAI TQ, 1994, AM J VET RES, V55, P934; Cammann C, 2012, CLIN CELL IMMUNOL S, V012; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carbonneau E, 2012, J DAIRY SCI, V95, P6503, DOI 10.3168/jds.2012-5643; Demasius W, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-93; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323, DOI 10.4081/ijas.2005.323; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graugnard DE, 2012, J DAIRY SCI, V95, P1749, DOI 10.3168/jds.2011-4579; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Hammon HM, 2007, J DAIRY SCI, V90, P3247, DOI 10.3168/jds.2006-748; Hammon HM, 2010, J DAIRY SCI, V93, P3007, DOI 10.3168/jds.2009-2931; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jonsson NN, 2013, J DAIRY SCI, V96, P2283, DOI 10.3168/jds.2012-6173; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; KEHRLI ME, 1989, AM J VET RES, V50, P207; Kehrli ME, 2001, VET CLIN N AM-FOOD A, V17, P495, DOI 10.1016/S0749-0720(15)30003-7; Kimura K, 1999, J DAIRY SCI, V82, P2385, DOI 10.3168/jds.S0022-0302(99)75489-5; Kimura K, 1999, J DAIRY SCI, V82, P315, DOI 10.3168/jds.S0022-0302(99)75238-0; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Mallard BA, 1998, J DAIRY SCI, V81, P585, DOI 10.3168/jds.S0022-0302(98)75612-7; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Marelli-Berg FM, 2012, IMMUNOLOGY, V136, P363, DOI 10.1111/j.1365-2567.2012.03583.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McLoughlin KE, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00396; MCNAMARA JP, 1986, J DAIRY SCI, V69, P3032, DOI 10.3168/jds.S0022-0302(86)80766-4; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Nalpas NC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-230; Nonnecke BJ, 2003, J DAIRY SCI, V86, P2359, DOI 10.3168/jds.S0022-0302(03)73829-6; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Pryce JE, 2001, J DAIRY SCI, V84, P1508, DOI 10.3168/jds.S0022-0302(01)70184-1; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Ripoll VM, 2012, FASEB J, V26, P3550, DOI 10.1096/fj.11-199935; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Sheldon IM, 2004, ANIM REPROD SCI, V82-3, P295, DOI 10.1016/j.anireprosci.2004.04.006; Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378; SIEBERT PD, 1987, P NATL ACAD SCI USA, V84, P6735, DOI 10.1073/pnas.84.19.6735; Ster C, 2012, J DAIRY SCI, V95, P708, DOI 10.3168/jds.2011-4695; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urosevic N, 2003, IMMUNOL CELL BIOL, V81, P224, DOI 10.1046/j.1440-1711.2003.01156.x; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wallner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094102; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wathes DC, 2009, PHYSIOL GENOMICS, V39, P1, DOI 10.1152/physiolgenomics.00064.2009; Weikard R, 2012, PHYSIOL GENOMICS, V44, P728, DOI 10.1152/physiolgenomics.00007.2012; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zerbe H, 2000, THERIOGENOLOGY, V54, P771, DOI 10.1016/S0093-691X(00)00389-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	89	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136927	10.1371/journal.pone.0136927	http://dx.doi.org/10.1371/journal.pone.0136927			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317664	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100174
J	Diaz, LA; Goni, SE; Iserte, JA; Quaglia, AI; Singh, A; Logue, CH; Powers, AM; Contigiani, MS				Diaz, Luis A.; Goni, Sandra E.; Iserte, Javier A.; Quaglia, Agustn I.; Singh, Amber; Logue, Christopher H.; Powers, Ann M.; Contigiani, Marta S.			Exploring Genomic, Geographic and Virulence Interactions among Epidemic and Non-Epidemic St. Louis Encephalitis Virus (Flavivirus) Strains	PLOS ONE			English	Article							WEST-NILE-VIRUS; PHYLOGENETIC ANALYSIS; BUENOS-AIRES; ARGENTINA; EVOLUTION; OUTBREAK; TRANSLATION; SEQUENCE; REGION	St. Louis encephalitis virus (SLEV) is a re-emerging arbovirus in South America. In 2005, an encephalitis outbreak caused by SLEV was reported in Argentina. The reason for the outbreak remains unknown, but may have been related to virological factors, changes in vectors populations, avian amplifying hosts, and/or environmental conditions. The main goal of this study was to characterize the complete genome of epidemic and non-epidemic SLEV strains from Argentina. Seventeen amino acid changes were detected; ten were non-conservative and located in proteins E, NS1, NS3 and NS5. Phylogenetic analysis showed two major clades based on geography: the North America and northern Central America (NAnCA) clade and the South America and southern Central America (SAsCA) clade. Interestingly, the presence of SAsCA genotype V SLEV strains in the NAnCA clade was reported in California, Florida and Texas, overlapping with known bird migration flyways. This work represents the first step in understanding the molecular mechanisms underlying virulence and biological variation among SLEV strains.	[Diaz, Luis A.; Quaglia, Agustn I.; Contigiani, Marta S.] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Lab Arbovirus, RA-5000 Cordoba, Argentina; [Diaz, Luis A.] Univ Nacl Cordoba, CONICET, Inst Invest Biol & Tecnol, RA-5000 Cordoba, Argentina; [Goni, Sandra E.] Univ Nacl Quilmes, Inst Microbiol Basica & Aplicada, Lab Ingn Genet & Biol Celular & Mol, Dept Ciencia Tecnol,Area Virosis Emergentes & Zoo, Buenos Aires, DF, Argentina; [Iserte, Javier A.] CABA, Fdn Inst Leloir, Lab Bioinformat Estruct, Buenos Aires, DF, Argentina; [Singh, Amber; Powers, Ann M.] Ctr Dis Control & Prevent, Ft Collins, CO USA; [Logue, Christopher H.] Publ Hlth England, Novel & Dangerous Pathogens Training, Porton Down, England	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Leloir Institute; Centers for Disease Control & Prevention - USA; Public Health England	Diaz, LA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Lab Arbovirus, RA-5000 Cordoba, Argentina.	adrian.diaz@conicet.gov.ar	Logue, Christopher H/ABH-3469-2020	Iserte, Javier Alonso/0000-0003-0056-1177; Diaz, Adrian/0000-0001-5953-2907	Agencia Nacional de Promocion Cientifica y Tecnologica, Fondo Nacional de Ciencia y Tecnologia (ANPCYT-FONCYT) [2010/38060, 2013/1779]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); Secretaria de Ciencia y Tecnica -Universidad Nacional de Cordoba (SECYT-UNC); International Society for Infectious Diseases; UNESCO-IUMS-SGM (United Nations Educational, Scientific and Cultural Organization, International Union Microbiology Societies-Society of General Microbiology); Bunge y Born Foundation [FBBEI8/10]; US Centers for Disease Control and Prevention	Agencia Nacional de Promocion Cientifica y Tecnologica, Fondo Nacional de Ciencia y Tecnologia (ANPCYT-FONCYT)(ANPCyTFONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica -Universidad Nacional de Cordoba (SECYT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); International Society for Infectious Diseases; UNESCO-IUMS-SGM (United Nations Educational, Scientific and Cultural Organization, International Union Microbiology Societies-Society of General Microbiology); Bunge y Born Foundation; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Fondo Nacional de Ciencia y Tecnologia (ANPCYT-FONCYT) Grant number 2010/38060 and 2013/1779 (www.agencia.mincyt.gob.ar), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (www.conicet.gov.ar), Secretaria de Ciencia y Tecnica -Universidad Nacional de Cordoba (SECYT-UNC) (http://www.unc.edu.ar/investigacion/cienciaytecnologia/novedades-informacion-cyt), International Society for Infectious Diseases (http:// www.isid.org/), UNESCO-IUMS-SGM (United Nations Educational, Scientific and Cultural Organization, International Union Microbiology Societies-Society of General Microbiology) (http://www.iums.org/), Bunge y Born Foundation (FBBEI8/10) (http://www.fundacionbyb.org), and the US Centers for Disease Control and Prevention (www.cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz LA, 2008, EMERG INFECT DIS, V14, P689, DOI 10.3201/eid1404.071257; Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486; Diaz LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001489; Diaz LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001177; Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001; Auguste AJ, 2009, INFECT GENET EVOL, V9, P709, DOI 10.1016/j.meegid.2008.07.006; Beasley DWC, 2004, ARCH VIROL, P35; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BOWEN GS, 1980, AM J TROP MED HYG, V29, P1411, DOI 10.4269/ajtmh.1980.29.1411; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Ciota AT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-71; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CT, 2007, J VIROL, V81, P6111, DOI 10.1128/JVI.02387-06; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DESOUZALOPES O, 1978, AM J EPIDEMIOL, V108, P394, DOI 10.1093/oxfordjournals.aje.a112637; Rivarola ME, 2014, MEM I OSWALDO CRUZ, V109, P197, DOI 10.1590/0074-0276130475; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007; Legendre P., 1998, NUMERICAL ECOLOGY; Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0; MONATH TP, 1980, AM J TROP MED HYG, V29, P948, DOI 10.4269/ajtmh.1980.29.948; Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905; Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2; Parks CL, 2001, J VIROL, V75, P910, DOI 10.1128/JVI.75.2.910-920.2001; R Core Team, 2021, R LANGUAGE ENV STAT; Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3; Rice CMS, 1990, VIROL S, P10; Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008; Rodrigues SG, 2010, J GEN VIROL, V91, P2420, DOI 10.1099/vir.0.019117-0; Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537; Seijo A, 2011, MEDICINA-BUENOS AIRE, V71, P211; Shiryaev SA, 2010, FUTURE VIROL, V5, P593, DOI 10.2217/FVL.10.39; Spinsanti L, 2003, EMERG INFECT DIS, V9, P271; Spinsanti LI, 2008, J CLIN VIROL, V42, P27, DOI 10.1016/j.jcv.2007.11.022; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valinotto LE, 2012, J CLIN VIROL, V54, P349, DOI 10.1016/j.jcv.2012.04.005	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136316	10.1371/journal.pone.0136316	http://dx.doi.org/10.1371/journal.pone.0136316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312485	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000054
J	Rahgozar, S; Amirian, T; Qi, M; Shahshahan, Z; Entezar-E-Ghaem, M; Tehrani, HG; Miroliaei, M; Krilis, SA; Giannakopoulos, B				Rahgozar, Soheila; Amirian, Tayebeh; Qi, Miao; Shahshahan, Zahra; Entezar-E-Ghaem, Mansureh; Tehrani, Hatav Ghasemi; Miroliaei, Mehran; Krilis, Steven A.; Giannakopoulos, Bill			Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ADVANCED MATERNAL AGE; VITAMIN-C; BETA(2)-GLYCOPROTEIN I; RANDOMIZED-TRIAL; PREGNANT-WOMEN; HIGH-RISK; RENIN; SUPPLEMENTATION; OXIDOREDUCTASES	Objective Angiotensinogen exists in two distinct redox forms in plasma, the oxidized sulfhydryl-bridge form and the reduced, unbridged, free thiol form. The oxidized form of angiotensinogen compared to the free thiol form preferentially interacts with renin resulting in increased generation of angiotensin. The predictive potential of the ratio of free-thiol to oxidized angiotensinogen in the plasma for pre-eclampsia was first suggested by the Read group in ref 10. We propose an improved method for determining the ratio and validate the method in a larger cohort of pregnant women. Methods Plasma samples from 115 individuals with pre-eclampsia and from 55 healthy pregnant control subjects were collected sequentially over a 2 year period. Using two distinct enzyme-linked immunosorbent assays (ELISAs) the plasma levels of total and free thiol angiotensinogen were quantified. The oxidized angiotensinogen plasma level is derived by subtracting the level of free thiol, reduced angiotensinogen from the total angiotensinogen levels in the plasma. Results The relative proportion of free thiol angiotensinogen, expressed as a percentage of that observed with an in-house standard, is significantly decreased in pre-eclamptic patients (70.85% +/- 29.49%) (mean +/- SD) as compared to healthy pregnant controls (92.98 +/- 24.93%) (mean +/- SD) p <= 0.0001. The levels of total angiotensinogen did not differ between the two groups. Conclusion Patients with pre-eclampsia had substantially lower levels of free thiol angiotensinogen compared to healthy pregnant controls, whilst maintaining similar total angiotensinogen levels in the plasma. Hence, elevated levels of plasma oxidized angiotensinogen may be a contributing factor to hypertension in the setting of pre-eclampsia.	[Rahgozar, Soheila; Amirian, Tayebeh; Entezar-E-Ghaem, Mansureh; Miroliaei, Mehran] Univ Isfahan, Fac Sci, Dept Biol, Esfahan, Iran; [Qi, Miao; Krilis, Steven A.; Giannakopoulos, Bill] Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia; [Qi, Miao; Krilis, Steven A.; Giannakopoulos, Bill] Univ New S Wales, St George Hosp, Dept Med, Sydney, NSW, Australia; [Shahshahan, Zahra; Tehrani, Hatav Ghasemi] Isfahan Univ Med Sci, Shahid Beheshti Hosp, Dept Obstet & Gynaecol, Esfahan, Iran	University of Isfahan; St George Hospital; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; Isfahan University Medical Science	Giannakopoulos, B (corresponding author), Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia.	bill.giannakopoulos@unsw.edu.au	ghasemi-tehrani, hatav/G-9683-2019; Ataollah, Ghahiri/E-1402-2018; Naghshineh, Elham/D-7645-2018; Shahshahan, Zahra/E-1410-2018; Rahgozar, Soheila/T-7240-2017	Shahshahan, Zahra/0000-0002-1764-9821; ghasemi tehrani, hatav/0000-0003-3112-8085	University of Isfahan/committee of Biotechnology [90/67178]	University of Isfahan/committee of Biotechnology	This work was supported by The University of Isfahan/committee of Biotechnology (90/67178) to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2013, AM COLL OBSTET GYNEC, V122, P1122; Beazley D, 2005, AM J OBSTET GYNECOL, V192, P520, DOI 10.1016/j.ajog.2004.09.005; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Curtin W M, 1999, J Perinatol, V19, P138, DOI 10.1038/sj.jp.7200165; Giannakopoulos B, 2012, J AUTOIMMUN, V39, P121, DOI 10.1016/j.jaut.2012.05.005; Guang C, 2012, ARCH CARDIOVASC DIS, V105, P373, DOI 10.1016/j.acvd.2012.02.010; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Ioannou Y, 2011, ARTHRITIS RHEUM-US, V63, P2774, DOI 10.1002/art.30383; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Ozalp Sinan, 2003, Archives of Gynecology and Obstetrics, V268, P172, DOI 10.1007/s00404-002-0359-7; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Passam FH, 2010, BLOOD, V116, P1995, DOI 10.1182/blood-2010-02-271494; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Raijmakers MTM, 2001, OBSTET GYNECOL, V97, P272, DOI 10.1016/S0029-7844(00)01127-3; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2011, AM J OBSTET GYNECOL, V205, P191, DOI 10.1016/j.ajog.2011.07.017; Sigmund CD, 2010, NATURE, V468, P46, DOI 10.1038/468046a; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; XU H, 2010, AM J OBSTET GYNECOL, V202, pE231; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	30	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135905	10.1371/journal.pone.0135905	http://dx.doi.org/10.1371/journal.pone.0135905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312482	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000030
J	Santos, SD; Galatro, TFD; Watanabe, RA; Oba-Shinjo, SM; Marie, SKN; Fujita, A				Santos, Suzana de Siqueira; de Almeida Galatro, Thais Fernanda; Watanabe, Rodrigo Akira; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue; Fujita, Andre			CoGA: An R Package to Identify Differentially Co-Expressed Gene Sets by Analyzing the Graph Spectra	PLOS ONE			English	Article							EXPRESSION; LINKS	Gene set analysis aims to identify predefined sets of functionally related genes that are differentially expressed between two conditions. Although gene set analysis has been very successful, by incorporating biological knowledge about the gene sets and enhancing statistical power over gene-by-gene analyses, it does not take into account the correlation (association) structure among the genes. In this work, we present CoGA (Co-expression Graph Analyzer), an R package for the identification of groups of differentially associated genes between two phenotypes. The analysis is based on concepts of Information Theory applied to the spectral distributions of the gene co-expression graphs, such as the spectral entropy to measure the randomness of a graph structure and the Jensen-Shannon divergence to discriminate classes of graphs. The package also includes common measures to compare gene co-expression networks in terms of their structural properties, such as centrality, degree distribution, shortest path length, and clustering coefficient. Besides the structural analyses, CoGA also includes graphical interfaces for visual inspection of the networks, ranking of genes according to their "importance" in the network, and the standard differential expression analysis. We show by both simulation experiments and analyses of real data that the statistical tests performed by CoGA indeed control the rate of false positives and is able to identify differentially co-expressed genes that other methods failed.	[Santos, Suzana de Siqueira; Fujita, Andre] Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil; [de Almeida Galatro, Thais Fernanda; Watanabe, Rodrigo Akira; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Fujita, A (corresponding author), Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil.	fujita@ime.usp.br	Galatro, Thais/J-7564-2016; Marie, Suely Kazue Nagahashi/D-1870-2012; Galatro, Thais/C-9934-2013; Oba-Shinjo, Sueli M./C-4017-2012; de Siqueira Santos, Suzana/AAY-4362-2020; Fujita, Andre/Q-1271-2019	Galatro, Thais/0000-0002-3811-7680; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; de Siqueira Santos, Suzana/0000-0002-0535-0734; Fujita, Andre/0000-0002-7756-7051; Akira Watanabe, Rodrigo/0000-0003-2240-6506	Sao Paulo Research Foundation [2014/09576-5, 2013/03447-6, 2011/50761-2, 2012/25417-9]; National Council for Scientific and Technological Development [304020/2013-3, 473063/2013-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Nucleo de Apoio a Pesquisa-Pro-Reitoria de Pesquisa da Universidade de Sao Paulo	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Nucleo de Apoio a Pesquisa-Pro-Reitoria de Pesquisa da Universidade de Sao Paulo	This work was supported by Sao Paulo Research Foundation 2014/09576-5 (http://www.fapesp.br/, AF), Sao Paulo Research Foundation 2013/03447-6 (http://www.fapesp.br/, AF), Sao Paulo Research Foundation 2011/50761-2 (http://www.fapesp.br/, AF), Sao Paulo Research Foundation 2012/25417-9 (http://www.fapesp.br/, SSS), National Council for Scientific and Technological Development 304020/2013-3 (http://www.cnpq.br/, AF), National Council for Scientific and Technological Development 473063/2013-1 (http://www.cnpq.br/, AF), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (AF), and Nucleo de Apoio a Pesquisa-Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002955; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan WY, 2000, AM J PATHOL, V156, P409, DOI 10.1016/S0002-9440(10)64744-X; Choi Y, 2009, BIOINFORMATICS, V25, P2780, DOI 10.1093/bioinformatics/btp502; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Huber RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057793; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kato K, 2003, INT J GYNECOL PATHOL, V22, P334, DOI 10.1097/01.pgp.0000092129.10100.5e; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silverman B.W., 1986, DENSITY ESTIMATION S; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049949; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Van Mieghem P., 2010, GRAPH SPECTRA COMPLE; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Yu H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-315; Zhang XH, 2012, CANCER SCI, V103, P181, DOI 10.1111/j.1349-7006.2011.02154.x	31	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135831	10.1371/journal.pone.0135831	http://dx.doi.org/10.1371/journal.pone.0135831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313749	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000027
J	Matsubayashi, T; Ueda, M				Matsubayashi, Tetsuya; Ueda, Michiko			Relative Age in School and Suicide among Young Individuals in Japan: A Regression Discontinuity Approach	PLOS ONE			English	Article							RISK-FACTORS; PERFORMANCE; ADOLESCENTS; DEPRESSION	Objective Evidence collected in many parts of the world suggests that, compared to older students, students who are relatively younger at school entry tend to have worse academic performance and lower levels of income. This study examined how relative age in a grade affects suicide rates of adolescents and young adults between 15 and 25 years of age using data from Japan. Method We examined individual death records in the Vital Statistics of Japan from 1989 to 2010. In contrast to other countries, late entry to primary school is not allowed in Japan. We took advantage of the school entry cutoff date to implement a regression discontinuity (RD) design, assuming that the timing of births around the school entry cutoff date was randomly determined and therefore that individuals who were born just before and after the cutoff date have similar baseline characteristics. Results We found that those who were born right before the school cutoff day and thus youngest in their cohort have higher mortality rates by suicide, compared to their peers who were born right after the cutoff date and thus older. We also found that those with relative age disadvantage tend to follow a different career path than those with relative age advantage, which may explain their higher suicide mortality rates. Conclusion Relative age effects have broader consequences than was previously supposed. This study suggests that policy intervention that alleviates the relative age effect can be important.	[Matsubayashi, Tetsuya] Osaka Univ, Osaka Sch Int Publ Policy, Toyonaka, Osaka 560, Japan; [Ueda, Michiko] Syracuse Univ, Dept Polit Sci, Syracuse, NY USA	Osaka University; Syracuse University	Matsubayashi, T (corresponding author), Osaka Univ, Osaka Sch Int Publ Policy, Toyonaka, Osaka 560, Japan.	matsubayashi@osipp.osaka-u.ac.jp		Ueda, Michiko/0000-0001-6552-8090	JSPS [26870326]; Itochube Foundation; Sumitomo Life Insurance Research Grant	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Itochube Foundation; Sumitomo Life Insurance Research Grant	TM was supported by JSPS Grants-in-Aid for Scientific Research Grant Number 26870326 (https://www.jsps.go.jp/) and the Itochube Foundation (http://www.koueki.jp/disclosure/sa/ito_chube/). MU was supported by the Sumitomo Life Insurance Research Grant (http://www.sumitomolife.co.jp/about/csr/community/mirai_child/women/bosyu.html). These grants were used to collect and analyze the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beautrais AL, 1996, J AM ACAD CHILD PSY, V35, P1174, DOI 10.1097/00004583-199609000-00015; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Black SE, 2011, REV ECON STAT, V93, P455, DOI 10.1162/REST_a_00081; Dobkin C, 2010, ECON EDUC REV, V29, P40, DOI 10.1016/j.econedurev.2009.04.003; Elder TE, 2009, J HUM RESOUR, V44, P641; Fredriksson P., 2013, ECON J, V124, P977, DOI DOI 10.1111/ECOJ.12047; Frojd SA, 2008, J ADOLESCENCE, V31, P485, DOI 10.1016/j.adolescence.2007.08.006; Goodman E, 1999, AM J PUBLIC HEALTH, V89, P1522, DOI 10.2105/AJPH.89.10.1522; Kawaguchi D, 2011, J JPN INT ECON, V25, P64, DOI 10.1016/j.jjie.2009.02.002; Madge N, 2011, EUR CHILD ADOLES PSY, V20, P499, DOI 10.1007/s00787-011-0210-4; Martin G, 2005, J ADOLESCENCE, V28, P75, DOI 10.1016/j.adolescence.2004.04.005; Qin P, 2000, BRIT J PSYCHIAT, V177, P546, DOI 10.1192/bjp.177.6.546; Quiroga CV, 2013, J EDUC PSYCHOL, V105, P552, DOI 10.1037/a0031524; Taliaferro LA, 2014, SUICIDE LIFE-THREAT, V44, P6, DOI 10.1111/sltb.12046; Thompson AH, 1999, CAN J PSYCHIAT, V44, P82, DOI 10.1177/070674379904400111	15	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135349	10.1371/journal.pone.0135349	http://dx.doi.org/10.1371/journal.pone.0135349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26309241	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400058
J	Liu, YJ; Li, K; Yang, L; Tang, ST; Wang, XX; Cao, GQ; Li, S; Lei, HY; Zhang, X				Liu, Yong-jun; Li, Kang; Yang, Li; Tang, Shao-tao; Wang, Xin-xing; Cao, Guo-qing; Li, Shuai; Lei, Hai-yan; Zhang, Xi			Dendritic Cells Regulate Treg-Th17 Axis in Obstructive Phase of Bile Duct Injury in Murine Biliary Atresia	PLOS ONE			English	Article							DELTA-T CELLS; TH17 CELLS; CD4(+); EXPRESSION; INFECTION; INFANTS; TYPE-1; MODEL; IL-17; TIME	Several cell types are considered to be effector cells in bile duct injury in rhesus rotavirus (RRV)-induced experimental biliary atresia (BA). Here, we identified an increased T helper 17 (Th17) cell population in a BA mode. By depleting the Th17 cells, the BA symptoms (onset of jaundice, acholic stools and retarded growth) were attenuated and the survival rate was improved. Furthermore, we found that in mice with BA, the percentage of CD4(+)CD25(high)Foxp3(+) T regulatory (Treg) cells decreased along with the increased percentage of Th17 cells. However, the absolute numbers of Treg and Th17 cells were both increased in liver of RRV-injected mice compared to saline-injected mice. The proportion of Th17 cells at 7 days post-infection was decreased if Treg cells isolated from normal adult mice, but not Treg cells from the livers of mice with BA, were intraperitoneally transferred on day 5 of life. In vitro experiments also showed that Treg cells from mice with BA had a diminished suppressive effect on Th17 cell generation. To determine the mechanisms, we investigated the production of cytokines in the liver. The level of IL-6, which has been shown to be abundantly secreted by activated dendritic cells (DCs), was remarkably elevated. Importantly, in a Treg/Th17 cell suppression assay, IL-6 was demonstrated to paralyze the Treg cells' suppressive effect on Th17 cells and eventually the unrestrained increase of Th17 cells contributed to bile duct injury. In conclusion, the DC-regulated Treg-Th17 axis, probably in conjunction with other effector T cells, aggravates progressive inflammatory injury at the time of ductal obstruction.	[Liu, Yong-jun; Li, Kang; Yang, Li; Tang, Shao-tao; Wang, Xin-xing; Cao, Guo-qing; Li, Shuai; Lei, Hai-yan; Zhang, Xi] Huazhong Univ Sci & Technol, Dept Pediat Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Tang, ST (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	tshaotao83@126.com	Yang, Li/Y-4002-2018; Yang, Li/L-7334-2019		National Natural Science Foundation of China [30973137, 81270481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30973137 and 81270481, http://www.nsfc.gov.cn/Portal0/). Dr. YJL, KL, LY, STT, XXW, GQC, SL, HYL, and XZ have no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Bleier JI, 2006, J IMMUNOL, V176, P7189, DOI 10.4049/jimmunol.176.12.7189; Brindley SM, 2012, HEPATOLOGY, V55, P1130, DOI 10.1002/hep.24807; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Ghoneim EM, 2011, HEPATOL RES, V41, P763, DOI 10.1111/j.1872-034X.2011.00832.x; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang YH, 2007, LAB INVEST, V87, P66, DOI 10.1038/labinvest.3700490; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lages CS, 2012, HEPATOLOGY, V56, P219, DOI 10.1002/hep.25662; Li J, 2011, J CLIN INVEST, V121, P4244, DOI 10.1172/JCI57728; Licata LA, 2013, J LEUKOCYTE BIOL, V94, P813, DOI 10.1189/jlb.0313137; Loong CC, 2002, EVIDENCE EARLY INVOL; Lu BR, 2010, GASTROENTEROLOGY, V139, P1753, DOI 10.1053/j.gastro.2010.07.042; Mack CL, 2007, GASTROENTEROLOGY, V133, P278, DOI 10.1053/j.gastro.2007.04.032; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; Mack CL, 2004, PEDIATR RES, V56, P79, DOI 10.1203/01.PDR.0000130480.51066.FB; Maher BM, 2013, INFECT IMMUN, V81, P4478, DOI 10.1128/IAI.01026-13; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Qiu Y, 2014, PLOS PATHOG, V3; Rong G, 2009, CLIN EXP IMMUNOL, V156, P217, DOI 10.1111/j.1365-2249.2009.03898.x; Saxena V, 2011, SCI TRANSL MED, V102, p102r; Schmidl C, 2011, EUR J IMMUNOL, V41, P1491, DOI 10.1002/eji.201041067; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Tucker RM, 2013, J HEPATOL, V59, P790, DOI 10.1016/j.jhep.2013.05.010; Wu J, 2013, TRANSPLANTATION, V95, P434, DOI 10.1097/TP.0b013e31827a48f5; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Yang Y, 2013, PEDIATR SURG INT, V29, P1249, DOI 10.1007/s00383-013-3421-6; Zhao L, 2010, J DIGEST DIS, V11, P126, DOI 10.1111/j.1751-2980.2010.00428.x	33	12	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136214	10.1371/journal.pone.0136214	http://dx.doi.org/10.1371/journal.pone.0136214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325187	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700034
J	Srivastava, A; Tiwari, R; Srivastava, V; Singh, TB; Asthana, RK				Srivastava, Akanksha; Tiwari, Ratnakar; Srivastava, Vikas; Singh, Tej Bali; Asthana, Ravi Kumar			Fresh Water Cyanobacteria Geitlerinema sp CCC728 and Arthrospira sp CCC729 as an Anticancer Drug Resource	PLOS ONE			English	Article							MARINE NATURAL-PRODUCTS; DISCOVERY; APOPTOSIS; CELLS; SPIRULINA; LYNGBYA	An increasing number of cancer patients worldwide, especially in third world countries, have raised concern to explore natural drug resources, such as the less explored fresh water filamentous cyanobacteria. Six strains of cyanobacteria (Phormidium sp. CCC727, Geitlerinema sp. CCC728, Arthrospira sp. CCC729, Phormidium sp. CCC731, Phormidium sp. CCC730, and Leptolyngbya sp. CCC732) were isolated (paddy fields and ponds in the Banaras Hindu University, campus) and five strains screened for anticancer potential using human colon adenocarcinoma (HT29) and human kidney adenocarcinoma (A498) cancer cell lines. Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 were the most potent as determined by examination of morphological features and by inhibition of growth by graded concentrations of crude extracts and thin-layer chromatography (TLC) eluates. Cell cycle analysis and multiplex assays using cancer biomarkers also confirmed Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 as cancer drug resources. Apoptotic studies in the cells of A498 (cancer) and MCF-10A (normal human epithelial) exposed to crude extracts and TLC fractions revealed no significant impact on MCF-10A cells emphasizing its importance in the development of anticancer drug. Identification of biomolecules from these extracts are in progress.	[Srivastava, Akanksha; Asthana, Ravi Kumar] Banaras Hindu Univ, Ctr Adv Study Bot, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Tiwari, Ratnakar; Singh, Tej Bali] Banaras Hindu Univ, Inst Med Sci, Div Stat, Varanasi 221005, Uttar Pradesh, India; [Srivastava, Vikas] Indian Inst Toxicol Res, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Asthana, RK (corresponding author), Banaras Hindu Univ, Ctr Adv Study Bot, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	asthana.ravi@gmail.com		Tiwari, Ratnakar/0000-0001-8130-8960	Council of Scientific and Industrial Research, New Delhi [38(1364)/13/EMR II]; Akanksha Srivastava, from the Center of Advanced Study in Botany Banaras, Hindu University [Bot./2012-2013/CAS-SRF/80970]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Akanksha Srivastava, from the Center of Advanced Study in Botany Banaras, Hindu University	This work was supported by the Council of Scientific and Industrial Research, New Delhi, (Ref. no. 38(1364)/13/EMR II dated 1/10/2013) and Akanksha Srivastava, from the Center of Advanced Study in Botany Banaras, Hindu University, in the form of SRF (Bot./2012-2013/CAS-SRF/80970).	Andrianasolo EH, 2005, ORG LETT, V7, P1375, DOI 10.1021/ol050188x; Bernard C, 2009, ENVIRON TOXICOL, V26, P260; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Catassi A, 2006, CELL MOL LIFE SCI, V63, P2377, DOI 10.1007/s00018-006-6264-7; Chu WL, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-53; Costa M, 2012, MAR DRUGS, V10, P2181, DOI 10.3390/md10102181; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; Desikachary T. V., 1959, CYANOPHYTA DESIKACHA; Doan NT, 2000, J APPL PHYCOL, V12, P409; Engene N, 2010, J PHYCOL, V46, P591, DOI 10.1111/j.1529-8817.2010.00840.x; Gerwick WH, 2012, CHEM BIOL, V19, P85, DOI 10.1016/j.chembiol.2011.12.014; Harrigan GG, 1998, J NAT PROD, V61, P1221, DOI 10.1021/np9801211; HOSHAW RW, 1973, HDB PHYCOLOGICAL MET, P54; Lee HU, 2014, SCI REP-UK, V4, DOI 10.1038/srep04665; Martins RF, 2008, MAR DRUGS, V6, P1, DOI 10.3390/md6010001; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Nunnery JK, 2010, CURR OPIN BIOTECH, V21, P787, DOI 10.1016/j.copbio.2010.09.019; Oftedal L, 2010, MAR DRUGS, V8, P2659, DOI 10.3390/md8102659; Plaza A, 2006, J ORG CHEM, V71, P6898, DOI 10.1021/jo061044e; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Salvador LA, 2010, J NAT PROD, V73, P1606, DOI 10.1021/np100467d; Sambrook J., 2001, MOL CLONING LAB MANU; Schwartzman D, 2008, ASTROBIOLOGY, V8, P187, DOI 10.1089/ast.2006.0074; Stewart B, 2014, WORLD CANC REPORT 20; Tan LT, 2007, PHYTOCHEMISTRY, V68, P954, DOI 10.1016/j.phytochem.2007.01.012; Tan LT, 2013, DRUG DISCOV TODAY, V18, P863, DOI 10.1016/j.drudis.2013.05.010; Tan LT, 2010, J APPL PHYCOL, V22, P659, DOI 10.1007/s10811-010-9506-x; Wu LC, 2005, J AGR FOOD CHEM, V53, P4207, DOI 10.1021/jf0479517	31	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136838	10.1371/journal.pone.0136838	http://dx.doi.org/10.1371/journal.pone.0136838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325186	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700067
J	Catanzaro, A; Rodwell, TC; Catanzaro, DG; Garfein, RS; Jackson, RL; Seifert, M; Georghiou, SB; Trollip, A; Groessl, E; Hillery, N; Crudu, V; Victor, TC; Rodrigues, C; Lin, GSY; Valafar, F; Desmond, E; Eisenach, K				Catanzaro, Antonino; Rodwell, Timothy C.; Catanzaro, Donald G.; Garfein, Richard S.; Jackson, Roberta L.; Seifert, Marva; Georghiou, Sophia B.; Trollip, Andre; Groessl, Erik; Hillery, Naomi; Crudu, Valeriu; Victor, Thomas C.; Rodrigues, Camilla; Lin, Grace Shou-Yean; Valafar, Faramarz; Desmond, Edward; Eisenach, Kathleen			Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MICROSCOPIC-OBSERVATION; SUSCEPTIBILITY ASSAY; RIFAMPIN RESISTANCE; 2ND-LINE DRUGS; MODS ASSAY; TRANSMISSION; 1ST	Background The aim of this study was to compare the performance of several recently developed assays for the detection of multi-and extensively drug-resistant tuberculosis (M/XDR-TB) in a large, multinational field trial. Methods Samples from 1,128 M/XDR-TB suspects were examined by Line Probe Assay (LPA), Pyrosequencing (PSQ), and Microscopic Observation of Drug Susceptibility (MODS) and compared to the BACTEC MGIT960 reference standard to detect M/XDR-TB directly from patient sputum samples collected at TB clinics in India, Moldova, and South Africa. Results Specificity for all three assays was excellent: 97-100% for isoniazid (INH), rifampin (RIF), moxifloxacin (MOX) and ofloxacin (OFX) and 99-100% for amikacin (AMK), capreomycin (CAP) and kanamycin (KAN) resistance. Sensitivities were lower, but still very good: 94100% for INH, RIF, MOX and OFX, and 84-90% for AMK and CAP, but only 48-62% for KAN. In terms of agreement, statistically significant differences were only found for detection of RIF (MODS outperformed PSQ) and KAN (MODS outperformed LPA and PSQ) resistance. Mean time-to-result was 1.1 days for LPA and PSQ, 14.3 days forMODS, and 24.7 days forMGIT. Conclusions All three rapid assays evaluated provide clinicians with timely detection of resistance to the drugs tested; with molecular results available one day following laboratory receipt of samples. In particular, the very high specificity seen for detection of drug resistance means that clinicians can use the results of these rapid tests to avoid the use of toxic drugs to which the infecting organism is resistant and develop treatment regiments that have a higher likelihood of yielding a successful outcome.	[Catanzaro, Antonino; Rodwell, Timothy C.; Garfein, Richard S.; Jackson, Roberta L.; Seifert, Marva; Georghiou, Sophia B.; Groessl, Erik; Hillery, Naomi] Univ Calif San Diego, La Jolla, CA 92093 USA; [Catanzaro, Donald G.] Univ Arkansas, Fayetteville, AR 72701 USA; [Trollip, Andre; Victor, Thomas C.] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Crudu, Valeriu] Inst Phthisiopneumol, Kishinev, Moldova; [Rodrigues, Camilla] PD Hinduja Hosp & Med Res Ctr, Bombay, Maharashtra, India; [Lin, Grace Shou-Yean; Desmond, Edward] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA; [Valafar, Faramarz] San Diego State Univ, San Diego, CA 92182 USA; [Eisenach, Kathleen] Univ Arkansas, Little Rock, AR 72204 USA	University of California System; University of California San Diego; University of Arkansas System; University of Arkansas Fayetteville; Stellenbosch University; California Department of Public Health; California State University System; San Diego State University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Catanzaro, A (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	acatanzaro@mail.ucsd.edu	Catanzaro, Donald/AAA-4932-2019	Catanzaro, Donald/0000-0003-1760-0574; Valafar, Faramarz/0000-0002-3648-9384; Seifert, Marva/0000-0002-7554-6396; Georghiou, Sophia/0000-0003-0099-903X	Global Consortium for Drug-resistant TB Diagnostics (GCDD) - National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI082229]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105185, U01AI082229] Funding Source: NIH RePORTER	Global Consortium for Drug-resistant TB Diagnostics (GCDD) - National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The specimens, data, and funding for this project were provided by the Global Consortium for Drug-resistant TB Diagnostics (GCDD [see http://gcdd.ucsd.edu]), funded by National Institute of Allergy and Infectious Diseases (NIAID) grant U01-AI082229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajbani K, 2015, ANTIMICROB AGENTS CH; Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bravo LTC, 2009, J CLIN MICROBIOL, V47, P3985, DOI 10.1128/JCM.01229-09; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dixit P, 2012, J MICROBIOL METH, V88, P122, DOI 10.1016/j.mimet.2011.11.006; Engstrom A, 2012, J CLIN MICROBIOL, V50, P2026, DOI 10.1128/JCM.06664-11; Geiter L, 2000, END NEGL EL TUB US; GGenotype MTBDRplus V. 2.0 instruction for use, 2012, TEST INSTR; Hillery N, 2014, TRIALS UNPUB; Huang ZK, 2014, INT J TUBERC LUNG D, V18, P461, DOI 10.5588/ijtld.13.0736; Huang ZK, 2014, TUBERCULOSIS, V94, P506, DOI 10.1016/j.tube.2014.06.005; ILSTRUP DM, 1990, CLIN MICROBIOL REV, V3, P219, DOI 10.1128/CMR.3.3.219-226.1990; Jureen P, 2006, J CLIN MICROBIOL, V44, P1925, DOI 10.1128/JCM.02210-05; Kent PT, 1985, PUBLIC HLTH MYCOBACT, Vviii; Lifescience H., 2009, GENOTYPE MTBDRSL VER; Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Makamure B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055872; Martin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107258; Marttila H, 2009, EUR J CLIN MICROBIOL, V28, P33, DOI 10.1007/s10096-008-0584-5; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Tagliani E, 2015, J CLIN MICROBIOL, V53, P2961, DOI 10.1128/JCM.01257-15; Trollip AP, 2014, INT J TUBERC LUNG D, V18, P227, DOI 10.5588/ijtld.13.0229; WHO, 2014, GLOB TUB REP 2014; WHO, 2013, WHO POL STAT US MOL; World Health Organization, 2008, WHO POL STAT MOL LIN; World Health Organization, 2008, EXP GROUP REP MOL LI; World Health organization, 2008, POL GUID DRUG SUSC T	37	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136861	10.1371/journal.pone.0136861	http://dx.doi.org/10.1371/journal.pone.0136861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322781	gold, Green Submitted, Green Published			2022-12-27	WOS:000360435500043
J	Fortini, LB; Cropper, WP; Zarin, DJ				Fortini, Lucas B.; Cropper, Wendell P., Jr.; Zarin, Daniel J.			Modeling the Complex Impacts of Timber Harvests to Find Optimal Management Regimes for Amazon Tidal Floodplain Forests	PLOS ONE			English	Article							RAIN-FOREST; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; YIELD REGULATION; LOGGING DAMAGE; GROWTH; RECOVERY; SUSTAINABILITY; REGENERATION; FIELD	At the Amazon estuary, the oldest logging frontier in the Amazon, no studies have comprehensively explored the potential long-term population and yield consequences of multiple timber harvests over time. Matrix population modeling is one way to simulate long-term impacts of tree harvests, but this approach has often ignored common impacts of tree harvests including incidental damage, changes in post-harvest demography, shifts in the distribution of merchantable trees, and shifts in stand composition. We designed a matrix-based forest management model that incorporates these harvest-related impacts so resulting simulations reflect forest stand dynamics under repeated timber harvests as well as the realities of local smallholder timber management systems. Using a wide range of values for management criteria (e.g., length of cutting cycle, minimum cut diameter), we projected the long-term population dynamics and yields of hundreds of timber management regimes in the Amazon estuary, where small-scale, unmechanized logging is an important economic activity. These results were then compared to find optimal stand-level and species-specific sustainable timber management (STM) regimes using a set of timber yield and population growth indicators. Prospects for STM in Amazonian tidal floodplain forests are better than for many other tropical forests. However, generally high stock recovery rates between harvests are due to the comparatively high projected mean annualized yields from fast-growing species that effectively counterbalance the projected yield declines from other species. For Amazonian tidal floodplain forests, national management guidelines provide neither the highest yields nor the highest sustained population growth for species under management. Our research shows that management guidelines specific to a region's ecological settings can be further refined to consider differences in species demographic responses to repeated harvests. In principle, such fine-tuned management guidelines could make management more attractive, thus bridging the currently prevalent gap between tropical timber management practice and regulation.	[Fortini, Lucas B.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI 96818 USA; [Cropper, Wendell P., Jr.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL USA; [Zarin, Daniel J.] Climate & Land Use Alliance, San Francisco, CA USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Fortini, LB (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI 96818 USA.	lfortini@usgs.gov	Cropper, Wendell P/E-5952-2010	Cropper, Wendell P/0000-0001-7851-7382; Fortini, Lucas/0000-0002-5781-7295	Tropical Conservation and Development Program at the University of Florida; NSF Working Forest in the Tropics IGERT; NSF DDI program; South East AGEP; EPA STAR program [FP-91688001]; USGS Pacific Island Ecosystems Research Center	Tropical Conservation and Development Program at the University of Florida; NSF Working Forest in the Tropics IGERT(National Science Foundation (NSF)); NSF DDI program; South East AGEP; EPA STAR program(United States Environmental Protection Agency); USGS Pacific Island Ecosystems Research Center	This research was supported by the Tropical Conservation and Development Program at the University of Florida, the NSF Working Forest in the Tropics IGERT, the NSF DDI program, the South East AGEP, the EPA STAR program (FP-91688001), and the USGS Pacific Island Ecosystems Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AB, 1990, EXTRACTION FOREST MA, P65; Asner GP, 2004, ECOL APPL, V14, pS280; BARROS AC, 1995, FOREST ECOL MANAG, V77, P87, DOI 10.1016/0378-1127(95)03574-T; Blundell AG, 2004, ECOLOGY, V85, P704, DOI 10.1890/01-4101; Broadbent EN, 2006, ECOL APPL, V16, P1148, DOI 10.1890/1051-0761(2006)016[1148:ROFSAS]2.0.CO;2; Caswell, 2000, MATRIX POPULATION MO; Chapman CA, 1997, BIOTROPICA, V29, P396, DOI 10.1111/j.1744-7429.1997.tb00035.x; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Cropper WP, 2006, ECOL MODEL, V198, P487, DOI 10.1016/j.ecolmodel.2006.05.034; Dauber E, 2005, FOREST ECOL MANAG, V214, P294, DOI 10.1016/j.foreco.2005.04.019; Figueira A, 2008, J GEOPHYS RES-BIOGEO, P113; Finegan B, 1999, FOREST ECOL MANAG, V121, P177, DOI 10.1016/S0378-1127(98)00550-7; Fortini LB, 2006, FOREST ECOL MANAG, V231, P78, DOI 10.1016/j.foreco.2006.04.038; Fortini LB, 2011, FOREST ECOL MANAG, V261, P551, DOI 10.1016/j.foreco.2010.11.007; Fortini LB, 2014, J FOREST ECON, V20, P223, DOI 10.1016/j.jfe.2014.06.001; Fortini LB, 2010, OECOLOGIA, V162, P923, DOI 10.1007/s00442-009-1524-5; Freckleton RP, 2003, J APPL ECOL, V40, P846, DOI 10.1046/j.1365-2664.2003.00842.x; Fredericksen TS, 2000, FOREST ECOL MANAG, V131, P47, DOI 10.1016/S0378-1127(99)00199-1; Fredericksen TS, 2003, BIODIVERS CONSERV, V12, P1445, DOI 10.1023/A:1023673625940; Gardiner BA, 1997, FORESTRY, V70, P233, DOI 10.1093/forestry/70.3.233; Glauner R, 2003, CAN J FOREST RES, V33, P521, DOI [10.1139/x03-013, 10.1139/X03-013]; Gourlet-Fleury S, 2005, FOREST ECOL MANAG, V209, P69, DOI 10.1016/j.foreco.2005.01.010; Haefner J. W., 1996, MODELING BIOL SYSTEM; Holm JA, 2008, BIOTROPICA, V40, P550, DOI 10.1111/j.1744-7429.2008.00412.x; Jackson SM, 2002, FOREST ECOL MANAG, V166, P271, DOI 10.1016/S0378-1127(01)00681-8; Johns JS, 1996, FOREST ECOL MANAG, V89, P59, DOI 10.1016/S0378-1127(96)03869-8; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; Keefe K, 2009, FOREST ECOL MANAG, V258, P1950, DOI 10.1016/j.foreco.2009.07.037; Lentini M., 2005, FATOS FLORESTAIS AMA; Lima E, 2006, ENVIRONMENT, V48, P26, DOI 10.3200/ENVT.48.1.26-38; Luckert MK, 2005, CAN J FOREST RES, V35, P356, DOI [10.1139/x04-172, 10.1139/X04-172]; MACEDO DS, 1993, BIOTROPICA, V25, P151, DOI 10.2307/2389179; Morris W. F., 2002, QUANTITATIVE CONSERV; Pena-Claros M, 2008, FOREST ECOL MANAG, V256, P1458, DOI 10.1016/j.foreco.2007.11.013; Phillips PD, 2004, ECOL MODEL, V173, P335, DOI 10.1016/j.ecolmodel.2003.09.023; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Pinedo-Vasquez M, 2001, HUM ECOL, V29, P219, DOI 10.1023/A:1011064031078; Rice R., 2001, SUSTAINABLE FOREST M; Rockwell CA, 2007, FOREST ECOL MANAG, V242, P108, DOI 10.1016/j.foreco.2006.12.028; Rondon XJ, 2009, FOREST ECOL MANAG, V257, P588, DOI 10.1016/j.foreco.2008.09.051; Schmidt IB, 2011, J APPL ECOLOGY; Schongart J, 2008, FOREST ECOL MANAG, V256, P46, DOI 10.1016/j.foreco.2008.03.037; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; Schulze M, 2006, FOREST ECOL MANAG, V236, P56, DOI 10.1016/j.foreco.2006.08.333; Sears RR, 2007, HUM ECOL, V35, P697, DOI 10.1007/s10745-006-9109-y; Sears RR, 2004, BIOL RESOURCE MANAGE, P258; Sears RR, 2003, NEW FORESTRY FLOODPL; SEYDACK AHW, 1995, FOREST ECOL MANAG, V77, P139, DOI 10.1016/0378-1127(95)03577-W; SILVA JNM, 1995, FOREST ECOL MANAG, V71, P267, DOI 10.1016/0378-1127(94)06106-S; Sist P, 2002, FOREST ECOL MANAG, V165, P85, DOI 10.1016/S0378-1127(01)00649-1; Sist P, 2007, FOREST ECOL MANAG, V243, P199, DOI 10.1016/j.foreco.2007.02.014; Valle D, 2006, FOREST ECOL MANAG, V236, P127, DOI 10.1016/j.foreco.2006.08.340; van Gardingen PR, 2006, FOREST ECOL MANAG, V231, P184, DOI 10.1016/j.foreco.2006.05.047; Wang S, 2004, FOREST POLICY ECON, V6, P205, DOI 10.1016/j.forpol.2004.03.004; Wittmann F, 2003, J BIOGEOGR, V30, P1533, DOI 10.1046/j.1365-2699.2003.00966.x; Zarin DJ, 2007, CONSERV BIOL, V21, P916, DOI 10.1111/j.1523-1739.2007.00670.x; Zarin DJ, 1998, AGROFOREST SYST, V41, P307, DOI 10.1023/A:1006072421536	57	6	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136740	10.1371/journal.pone.0136740	http://dx.doi.org/10.1371/journal.pone.0136740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322896	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500032
J	Johansson, MM; Van Geystelen, A; Larmuseau, MHD; Djurovic, S; Andreassen, OA; Agartz, I; Jazin, E				Johansson, Martin M.; Van Geystelen, Anneleen; Larmuseau, Maarten H. D.; Djurovic, Srdjan; Andreassen, Ole A.; Agartz, Ingrid; Jazin, Elena			Microarray Analysis of Copy Number Variants on the Human Y Chromosome Reveals Novel and Frequent Duplications Overrepresented in Specific Haplogroups	PLOS ONE			English	Article							MALE-SPECIFIC REGION; MALE-INFERTILITY; SPERMATOGENIC IMPAIRMENT; MOSAIC LOSS; DELETION; GENOME; POPULATION; ASSOCIATION; SELECTION; CANCER	Background The human Y chromosome is almost always excluded from genome-wide investigations of copy number variants (CNVs) due to its highly repetitive structure. This chromosome should not be forgotten, not only for its well-known relevance in male fertility, but also for its involvement in clinical phenotypes such as cancers, heart failure and sex specific effects on brain and behaviour. Results We analysed Y chromosome data from Affymetrix 6.0 SNP arrays and found that the signal intensities for most of 8179 SNP/CN probes in the male specific region (MSY) discriminated between a male, background signals in a female and an isodicentric male containing a large deletion of the q-arm and a duplication of the p-arm of the Y chromosome. Therefore, this SNP/CN platform is suitable for identification of gain and loss of Y chromosome sequences. In a set of 1718 males, we found 25 different CNV patterns, many of which are novel. We confirmed some of these variants by PCR or qPCR. The total frequency of individuals with CNVs was 14.7%, including 9.5% with duplications, 4.5% with deletions and 0.7% exhibiting both. Hence, a novel observation is that the frequency of duplications was more than twice the frequency of deletions. Another striking result was that 10 of the 25 detected variants were significantly overrepresented in one or more haplogroups, demonstrating the importance to control for haplogroups in genome-wide investigations to avoid stratification. NO-M214( xM175) individuals presented the highest percentage (95%) of CNVs. If they were not counted, 12.4% of the rest included CNVs, and the difference between duplications (8.9%) and deletions (2.8%) was even larger. Conclusions Our results demonstrate that currently available genome-wide SNP platforms can be used to identify duplications and deletions in the human Y chromosome. Future association studies of the full spectrum of Y chromosome variants will demonstrate the potential involvement of gain or loss of Y chromosome sequence in different human phenotypes.	[Johansson, Martin M.; Jazin, Elena] Uppsala Univ, Dept Organismal Biol, EBC, Uppsala, Sweden; [Van Geystelen, Anneleen; Larmuseau, Maarten H. D.] Katholieke Univ Leuven, Dept Biol, Lab Socioecol & Social Evolut, Leuven, Belgium; [Larmuseau, Maarten H. D.] Katholieke Univ Leuven, Dept Imaging & Pathol, Forens Biomed Sci, Leuven, Belgium; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, Dept Clin Sci, NORMENT, KG Jebsen Ctr Psychosis Res, Bergen, Norway; [Andreassen, Ole A.; Agartz, Ingrid] Univ Oslo, Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT,KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Andreassen, Ole A.; Agartz, Ingrid] Univ Oslo, Inst Clin Med, Oslo, Norway; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway	Uppsala University; KU Leuven; KU Leuven; University of Oslo; University of Bergen; University of Oslo; University of Oslo; Diakonhjemmet Hospital	Johansson, MM (corresponding author), Uppsala Univ, Dept Organismal Biol, EBC, Uppsala, Sweden.	martin.johansson@ebc.uu.se; elena.jazin@ebc.uu.se	Andreassen, Ole A./AAY-7531-2020; Larmuseau, Maarten/GSJ-0393-2022	Djurovic, Srdjan/0000-0002-8140-8061; Larmuseau, Maarten H.D./0000-0002-5974-7235; Agartz, Ingrid/0000-0002-9839-5391	Swedish Research Foundation [K2012-61X-22089-01-3]; KG Jebsen Foundation; Research Council of Norway [213837, 223273]; KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics' [PF/2010/07]; KU Leuven BOF-GOA 'New approaches to the social dynamics of long-term fertility change' [3H130264]	Swedish Research Foundation; KG Jebsen Foundation; Research Council of Norway(Research Council of Norway); KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics'; KU Leuven BOF-GOA 'New approaches to the social dynamics of long-term fertility change'	This study was funded by the Swedish Research Foundation, grant name: Sex determination factors in the brain encoded in the Y chromosome (Project number K2012-61X-22089-01-3) (EJ), the KG Jebsen Foundation and the Research Council of Norway (Project numbers 213837 and 223273) (IA), the KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics' (Project number PF/2010/07) and the KU Leuven BOF-GOA 'New approaches to the social dynamics of long-term fertility change' (Project number 3H130264) (MHDL). MHDL is a postdoctoral fellow of the FWO Vlaanderen (Research Foundation Flanders).	Aston KI, 2014, ANDROLOGY-US, V2, P315, DOI 10.1111/j.2047-2927.2014.00188.x; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Betran Esther, 2012, Int J Evol Biol, V2012, P207958, DOI 10.1155/2012/207958; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elhaik E, 2013, GENOME BIOL EVOL, V5, P1021, DOI 10.1093/gbe/evt066; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Ferlin A, 2007, J CLIN ENDOCR METAB, V92, P762, DOI 10.1210/jc.2006-1981; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hallast P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003666; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Jamain S, 2002, MOL PSYCHIATR, V7, P217, DOI 10.1038/sj.mp.4000968; Jangravi Z, 2013, J PROTEOME RES, V12, P6, DOI 10.1021/pr300864k; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kido T, 2010, GENES-BASEL, V1, P283, DOI 10.3390/genes1020283; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Kozina V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023174; Krausz C, 2010, GENES-BASEL, V1, P308, DOI 10.3390/genes1020308; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Larmuseau MHD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2400; Larmuseau MHD, 2012, EUR J HUM GENET, V20, P434, DOI 10.1038/ejhg.2011.218; Lin YW, 2005, GENOMICS, V86, P431, DOI 10.1016/j.ygeno.2005.07.003; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; Lou HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027341; Lu CC, 2011, HUM MOL GENET, V20, P4411, DOI 10.1093/hmg/ddr369; Mancini TI, 2012, MOL SYNDROMOL, V3, P39, DOI 10.1159/000338468; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Mensah MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004578; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Qureshi SJ, 1996, MOL HUM REPROD, V2, P775, DOI 10.1093/molehr/2.10.775; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repnikova EA, 2013, FORENSIC SCI INT-GEN, V7, P475, DOI 10.1016/j.fsigen.2013.05.008; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; Riggs Erin Rooney, 2014, Curr Genet Med Rep, V2, P146; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rozen SG, 2012, AM J HUM GENET, V91, P890, DOI 10.1016/j.ajhg.2012.09.003; Siggberg L, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-84; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sin HS, 2010, HUM REPROD, V25, P2396, DOI 10.1093/humrep/deq191; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Talseth-Palmer BA, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-10; Tozzo P, 2013, J FORENSIC LEG MED, V20, P387, DOI 10.1016/j.jflm.2013.03.012; Van Geystelen A, 2013, FORENSIC SCI INT-GEN, V7, P573, DOI 10.1016/j.fsigen.2013.03.010; Van Geystelen A, 2014, ELECTROPHORESIS, V35, P3102, DOI 10.1002/elps.201300459; Van Geystelen A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-101; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; Venkatachalam R, 2011, INT J CANCER, V129, P1635, DOI 10.1002/ijc.25821; Watkins WS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-39; Yuen RKC, 2014, FERTIL STERIL, V101, P1079, DOI 10.1016/j.fertnstert.2013.12.027	64	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137223	10.1371/journal.pone.0137223	http://dx.doi.org/10.1371/journal.pone.0137223			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322892	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500068
J	Wolf, J; Tang, L; Rubnitz, JE; Brennan, RC; Shook, DR; Stokes, DC; Monagle, P; Curtis, N; Worth, LJ; Allison, K; Sun, YL; Flynn, PM				Wolf, Joshua; Tang, Li; Rubnitz, Jeffrey E.; Brennan, Rachel C.; Shook, David R.; Stokes, Dennis C.; Monagle, Paul; Curtis, Nigel; Worth, Leon J.; Allison, Kim; Sun, Yilun; Flynn, Patricia M.			Monitoring Central Venous Catheter Resistance to Predict Imminent Occlusion: A Prospective Pilot Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CHILDREN; MANAGEMENT; THROMBOSIS; CANCER; FLOW	Background Long-term central venous catheters are essential for the management of chronic medical conditions, including childhood cancer. Catheter occlusion is associated with an increased risk of subsequent complications, including bloodstream infection, venous thrombosis, and catheter fracture. Therefore, predicting and pre-emptively treating occlusions should prevent complications, but no method for predicting such occlusions has been developed. Methods We conducted a prospective trial to determine the feasibility, acceptability, and efficacy of catheter-resistance monitoring, a novel approach to predicting central venous catheter occlusion in pediatric patients. Participants who had tunneled catheters and were receiving treatment for cancer or undergoing hematopoietic stem cell transplantation underwent weekly catheter-resistance monitoring for up to 12 weeks. Resistance was assessed by measuring the inline pressure at multiple flow-rates via a syringe pump system fitted with a pressure-sensing transducer. When turbulent flow through the device was evident, resistance was not estimated, and the result was noted as "non-laminar." Results Ten patients attended 113 catheter-resistance monitoring visits. Elevated catheter resistance (>8.8% increase) was strongly associated with the subsequent development of acute catheter occlusion within 10 days (odds ratio = 6.2; 95% confidence interval, 1.8-21.5; p < 0.01; sensitivity, 75%; specificity, 67%). A combined prediction model comprising either change in resistance greater than 8.8% or a non-laminar result predicted subsequent occlusion (odds ratio = 6.8; 95% confidence interval, 2.0-22.8; p = 0.002; sensitivity, 80%; specificity, 63%). Participants rated catheter-resistance monitoring as highly acceptable. Conclusions In this pediatric hematology and oncology population, catheter-resistance monitoring is feasible, acceptable, and predicts imminent catheter occlusion. Larger studies are required to validate these findings, assess the predictive value for other clinical outcomes, and determine the impact of pre-emptive therapy.	[Wolf, Joshua; Allison, Kim; Flynn, Patricia M.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Tang, Li; Sun, Yilun] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Rubnitz, Jeffrey E.; Brennan, Rachel C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Shook, David R.] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, Memphis, TN 38105 USA; [Wolf, Joshua; Rubnitz, Jeffrey E.; Stokes, Dennis C.; Flynn, Patricia M.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN USA; [Monagle, Paul] Royal Childrens Hosp, Dept Haematol, Parkville, Vic 3052, Australia; [Monagle, Paul; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia; [Worth, Leon J.] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Wolf, Joshua; Monagle, Paul; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Worth, Leon J.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Wolf, J (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	Joshua.Wolf@stjude.org	Flynn, Patricia M/N-8146-2018; Wolf, Joshua/G-8766-2018; Curtis, Nigel/B-3491-2012; Rubnitz, Jeffrey E/N-2619-2018; Tang, Li/N-8123-2018; Brennan, Rachel/N-8149-2018; Wolf, Joshua/ADO-0221-2022	Wolf, Joshua/0000-0002-9912-3646; Curtis, Nigel/0000-0003-3446-4594; Rubnitz, Jeffrey E/0000-0001-9885-3527; Sun, Yilun/0000-0003-1905-9216; Monagle, Paul/0000-0002-3970-8984; Worth, Leon/0000-0003-4304-6845	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA021765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler A, 2006, J PEDIAT HEMATOL ONC, V28, P23; Arai J, 2002, PAEDIATR ANAESTH, V12, P621, DOI 10.1046/j.1460-9592.2002.00928.x; Athale UH, 2012, J PEDIAT HEMATOL ONC, V34, P188, DOI 10.1097/MPH.0b013e31823dd284; Baskin JL, 2009, LANCET, V374, P159, DOI 10.1016/S0140-6736(09)60220-8; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Deitcher SR, 2004, J PEDIATR-US, V145, P848, DOI 10.1016/j.jpeds.2004.05.055; Dillon PW, 2004, J CLIN ONCOL, V22, P2718, DOI 10.1200/JCO.2004.07.019; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; Perez-Granda MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091838; Journeycake JM, 2006, J CLIN ONCOL, V24, P4575, DOI 10.1200/JCO.2005.05.5343; Kayton ML, 2010, J PEDIATR SURG, V45, P1961, DOI 10.1016/j.jpedsurg.2010.05.014; LAQUAGLIA MP, 1992, J PEDIATR SURG, V27, P840, DOI 10.1016/0022-3468(92)90379-L; Lucas TC, 2014, ARTIF ORGANS, V38, P556, DOI 10.1111/aor.12243; Macha DB, 2009, RADIOLOGY, V253, P870, DOI 10.1148/radiol.2533081086; Peng C, 2011, ARCH DIS CHILD, V96, P885, DOI 10.1136/adc.2010.194969; Rowan CM, 2013, PEDIATR CRIT CARE ME, V14, P306, DOI 10.1097/PCC.0b013e318271f48a; STOKES DC, 1989, J PEDIATR SURG, V24, P257, DOI 10.1016/S0022-3468(89)80007-7; The Centers for Disease Control and Prevention, 2010, NAT HEALTHC SAF NETW NAT HEALTHC SAF NETW; Wolf J, 2013, PEDIATR INFECT DIS J, V32, P905, DOI 10.1097/INF.0b013e3182996b6e	19	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135904	10.1371/journal.pone.0135904	http://dx.doi.org/10.1371/journal.pone.0135904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322512	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500011
J	Budd, KE; Mccoy, F; Monecke, S; Cormican, P; Mitchell, J; Keane, OM				Budd, Kathleen E.; Mccoy, Finola; Monecke, Stefan; Cormican, Paul; Mitchell, Jennifer; Keane, Orla M.			Extensive Genomic Diversity among Bovine-Adapted Staphylococcus aureus: Evidence for a Genomic Rearrangement within CC97	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; CLINICAL MASTITIS; GENES; PATHOGEN; MILK; POPULATION; ADAPTATION; EVOLUTION; INSIGHTS	Staphylococcus aureus is an important pathogen associated with both human and veterinary disease and is a common cause of bovine mastitis. Genomic heterogeneity exists between S. aureus strains and has been implicated in the adaptation of specific strains to colonise particular mammalian hosts. Knowledge of the factors required for host specificity and virulence is important for understanding the pathogenesis and management of S. aureus mastitis. In this study, a panel of mastitis-associated S. aureus isolates (n = 126) was tested for resistance to antibiotics commonly used to treat mastitis. Over half of the isolates (52%) demonstrated resistance to penicillin and ampicillin but all were susceptible to the other antibiotics tested. S. aureus isolates were further examined for their clonal diversity by Multi-Locus Sequence Typing (MLST). In total, 18 different sequence types (STs) were identified and eBURST analysis demonstrated that the majority of isolates grouped into clonal complexes CC97, CC151 or sequence type (ST) 136. Analysis of the role of recombination events in determining S. aureus population structure determined that ST diversification through nucleotide substitutions were more likely to be due to recombination compared to point mutation, with regions of the genome possibly acting as recombination hotspots. DNA microarray analysis revealed a large number of differences amongst S. aureus STs in their variable genome content, including genes associated with capsule and biofilm formation and adhesion factors. Finally, evidence for a genomic arrangement was observed within isolates from CC97 with the ST71-like subgroup showing evidence of an IS431 insertion element having replaced approximately 30 kb of DNA including the ica operon and histidine biosynthesis genes, resulting in histidine auxotrophy. This genomic rearrangement may be responsible for the diversification of ST71 into an emerging bovine adapted subgroup.	[Budd, Kathleen E.; Cormican, Paul; Keane, Orla M.] TEAGASC, AGRIC, Anim & Biosci Dept, Dunsany, Meath, Ireland; [Budd, Kathleen E.; Mitchell, Jennifer] Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [Mccoy, Finola] Anim Hlth Ireland, Carrick On Shannon, Leitrim, Ireland; [Monecke, Stefan] Alere Technol GmbH, D-07749 Jena, Germany	Teagasc; University College Dublin; Alere	Keane, OM (corresponding author), TEAGASC, AGRIC, Anim & Biosci Dept, Dunsany, Meath, Ireland.	orla.keane@teagasc.ie	KEANE, ORLA/AAQ-1148-2021; Mitchell, Jennifer/H-6612-2019	Mitchell, Jennifer/0000-0003-4956-1530; Keane, Orla/0000-0002-9507-2191	Teagasc Walsh Fellowship Scheme [6082]; Alere Technologies GmbH	Teagasc Walsh Fellowship Scheme; Alere Technologies GmbH	Funding from the Teagasc Walsh Fellowship Scheme (grant number 6082) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alere Technologies GmbH provided support in the form of salaries for authors (SM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "authors contributions" section.	Andrews JM, 2008, J ANTIMICROB CHEMOTH, V62, P256, DOI 10.1093/jac/dkn194; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Biggs A, 2009, MASTITIS DAIRY CATTL; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brody T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003074; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CLSI, 2008, PERFORMANCE STANDARD; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fernandez G, 2013, VET RES COMMUN, V37, P259, DOI 10.1007/s11259-013-9570-1; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamrozy DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040458; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P541, DOI 10.1271/bbb.61.541; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Keane OM, 2013, VET REC, V173, P17, DOI 10.1136/vr.101308; Kumar Shukla S, 2012, J ANTIBIOT; Lam TJGM, 1996, AM J VET RES, V57, P39; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Monecke S, 2005, CLIN MICROBIOL INFEC, V11, P825, DOI 10.1111/j.1469-0691.2005.01243.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pyorala S, 1997, J DAIRY SCI, V80, P2820, DOI 10.3168/jds.S0022-0302(97)76246-5; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Schlotter K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-42; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Zadoks RN, 2002, J CLIN MICROBIOL, V40, P3894, DOI 10.1128/JCM.40.11.3894-3902.2002; Zhang LF, 2012, J MOL EVOL, V75, P43, DOI 10.1007/s00239-012-9520-5; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631; Zschock M, 2000, J DAIRY RES, V67, P429, DOI 10.1017/S0022029900004325	58	30	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134592	10.1371/journal.pone.0134592	http://dx.doi.org/10.1371/journal.pone.0134592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317849	gold, Green Published			2022-12-27	WOS:000360299100016
J	Cuadrado, E; Tabernero, C				Cuadrado, Esther; Tabernero, Carmen			Affective Balance, Team Prosocial Efficacy and Team Trust: A Multilevel Analysis of Prosocial Behavior in Small Groups	PLOS ONE			English	Article							ORGANIZATIONAL CITIZENSHIP BEHAVIOR; POSITIVE AFFECT; SELF-EFFICACY; COOPERATION; PERSONALITY; PERFORMANCE; INTERDEPENDENCE; CONSEQUENCES; NEIGHBORHOOD; ANTECEDENTS	Little research has focused on how individual- and team-level characteristics jointly influence, via interaction, how prosocially individuals behave in teams and few studies have considered the potential influence of team context on prosocial behavior. Using a multilevel perspective, we examined the relationships between individual (affective balance) and group (team prosocial efficacy and team trust) level variables and prosocial behavior towards team members. The participants were 123 students nested in 45 small teams. A series of multilevel random models was estimated using hierarchical linear and nonlinear modeling. Individuals were more likely to behave prosocially towards in-group members when they were feeling good. Furthermore, the relationship between positive affective balance and prosocial behavior was stronger in teams with higher team prosocial efficacy levels as well as in teams with higher team trust levels. Finally, the relevance of team trust had a stronger influence on behavior than team prosocial efficacy.	[Cuadrado, Esther; Tabernero, Carmen] Univ Cordoba, Fac Educ Sci, Dept Psychol, Cordoba, Spain	Universidad de Cordoba	Cuadrado, E (corresponding author), Univ Cordoba, Fac Educ Sci, Dept Psychol, Cordoba, Spain.	esther.cuadrado@uco.es; carmen.tabernero@uco.es	Cuadrado, Esther/B-8729-2017; Cuadrado, Esther/AAM-2209-2021; Carmen, Tabernero/D-5173-2009	Cuadrado, Esther/0000-0002-9903-0052; Cuadrado, Esther/0000-0002-9903-0052; Carmen, Tabernero/0000-0003-4338-7367	Spanish Ministry of Economy and Competitiveness [PSI 2009-07423, PSI2014-58609-R]; Spanish Ministry of Education [AP2009-2164]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education(Spanish Government)	This article was based on two research projects financially supported by the Spanish Ministry of Economy and Competitiveness under Grant PSI 2009-07423 and Grant PSI2014-58609-R in which Carmen Tabernero is the main researcher. The manuscript was written while Esther Cuadrado was a fellow doctoral researcher financially supported by the Spanish Ministry of Education within the framework of the National Program of university teacher training (2010-2014) under grant AP2009-2164.	Anderson D., 2012, HIERARCHICAL LINEAR; Arthaud-Day ML, 2012, J APPL PSYCHOL, V97, P792, DOI 10.1037/a0027352; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; Bandura A, 2000, CURR DIR PSYCHOL SCI, V9, P75, DOI 10.1111/1467-8721.00064; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Berigan N, 2011, SOC PSYCHOL QUART, V74, P341, DOI 10.1177/0190272511422451; Bliese P.D., 2000, MULTILEVEL THEORY RE, P349; Caprara GV, 2012, J PERS SOC PSYCHOL, V102, P1289, DOI 10.1037/a0025626; Caprara GV, 2005, J SOC CLIN PSYCHOL, V24, P191, DOI 10.1521/jscp.24.2.191.62271; Carlo G, 2003, J EARLY ADOLESCENCE, V23, P107, DOI 10.1177/0272431602239132; Carlo G, 2012, J SOC PERS RELAT, V29, P337, DOI 10.1177/0265407511431181; Chen CHV, 2009, J PSYCHOL, V143, P625, DOI 10.1080/00223980903218273; Chen G, 2007, J APPL PSYCHOL, V92, P331, DOI 10.1037/0021-9010.92.2.331; Chen ZS, 2012, J EXP SOC PSYCHOL, V48, P1029, DOI 10.1016/j.jesp.2012.04.002; Costa AC, 2003, PERS REV, V32, P605, DOI 10.1108/00483480310488360; Costa PL, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013498244; Cuadrado E, 2015, MOTIV EMOTION, V39, P344, DOI 10.1007/s11031-014-9460-z; de Jong BA, 2010, ACAD MANAGE J, V53, P535, DOI 10.5465/AMJ.2010.51468649; Derfler-Rozin R, 2010, ORGAN BEHAV HUM DEC, V112, P140, DOI 10.1016/j.obhdp.2010.02.005; Dickert S, 2011, J BEHAV DECIS MAKING, V24, P361, DOI 10.1002/bdm.697; Fernandez-Berrocal P, 2006, PSICOTHEMA, V18, P72; Ferrin DL, 2008, ORGAN BEHAV HUM DEC, V107, P161, DOI 10.1016/j.obhdp.2008.02.012; Fredrickson BL., 2008, SCI SUBJECTIVE WELL, P449; Greenhalgh L, 1998, GROUP DECIS NEGOT, V7, P465, DOI 10.1023/A:1008694307035; Hsu MH, 2007, INT J HUM-COMPUT ST, V65, P153, DOI 10.1016/j.ijhcs.2006.09.003; Isen AM, 2001, J CONSUM PSYCHOL, V11, P75, DOI 10.1207/S15327663JCP1102_01; Leach CW, 2006, PERS SOC PSYCHOL B, V32, P1232, DOI 10.1177/0146167206289729; Leon FJ, 2012, SOC SCI INFORM, V51, P389, DOI 10.1177/0539018412441756; Lester SW, 2002, ACAD MANAGE J, V45, P352, DOI 10.2307/3069351; Mathieu J, 2008, J MANAGE, V34, P410, DOI 10.1177/0149206308316061; Nezlek JB, 2001, PERS SOC PSYCHOL B, V27, P771, DOI 10.1177/0146167201277001; Ng KY, 2005, GROUP ORGAN MANAGE, V30, P514, DOI 10.1177/1059601104269107; Okun MA, 2000, PERS INDIV DIFFER, V28, P367, DOI 10.1016/S0191-8869(99)00107-5; Pearce CL, 2004, J SOC PSYCHOL, V144, P293, DOI 10.3200/SOCP.144.3.293-310; Raudenbush S., 2005, HLM 6 HIERARCHICAL L; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rotenberg KJ, 2005, BRIT J DEV PSYCHOL, V23, P271, DOI 10.1348/026151005X26192; Rusbult C. E., 2010, PROSOCIAL MOTIVES EM, P327, DOI DOI 10.1037/12061-017; Salanova M, 2011, APPL PSYCHOL-INT REV, V60, P255, DOI 10.1111/j.1464-0597.2010.00435.x; Sato Y, 1998, DISS ABSTR INT A, V59-09, P3263; Stewart M, 2001, PUBLIC HEALTH NURS, V18, P54, DOI 10.1046/j.1525-1446.2001.00054.x; Tabernero Carmen, 2007, Psicologia, V21, P83; Tasa K, 2011, J ORGAN BEHAV, V32, P65, DOI 10.1002/job.680; Tett RP, 2003, J APPL PSYCHOL, V88, P500, DOI 10.1037/0021-9010.88.3.500; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Valentino NA, 2009, POLIT BEHAV, V31, P307, DOI 10.1007/s11109-008-9076-7; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang L, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/05/055001; Wang L, 2012, ORGAN BEHAV HUM DEC, V119, P54, DOI 10.1016/j.obhdp.2012.05.002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Yamagishi T, 2011, SCI MIND, P1, DOI 10.1007/978-4-431-53936-0; Yanagisawa K, 2011, SOC NEUROSCI-UK, V6, P190, DOI 10.1080/17470919.2010.506139; Zhang DG, 2014, IEEE T IND INFORM, V10, P766, DOI 10.1109/TII.2013.2250910; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	57	5	5	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136874	10.1371/journal.pone.0136874	http://dx.doi.org/10.1371/journal.pone.0136874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317608	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100158
J	Dalgard, O; Martinot-Peignoux, M; Verbaan, H; Bjoro, K; Ring-Larsen, H; Marcellin, P				Dalgard, Olav; Martinot-Peignoux, Michelle; Verbaan, Hans; Bjoro, Kristian; Ring-Larsen, Helmer; Marcellin, Patrick			The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; PEGYLATED INTERFERON; RIBAVIRIN; PEGINTERFERON-ALPHA-2A; AMPLIFICATION; THERAPY; RNA	The aim of this study was to determine in patients with HCV genotype 2 or 3 the performance at week 4 of two assays with different sensitivities for HCV RNA detection, for the prediction of SVR and stratification for treatment duration (14 and 24 weeks). Recruitment was from two trials comparing 14 and 24 weeks treatment to patients with rapid virological response (RVR) (n = 550). RVR was originally defined as HCV RNA <50 IU/ml at week 4. Patients with an available frozen plasma sample drawn at week 4 and with follow-up data week 24 post-treatment were included (n = 429). HCV-RNA was prospectively measured with COBAS Amplicor V2, Roche (CA) (lower detection limit 50 IU/ml) and retrospectively assessed with VERSANT HCV-RNA Qualitative Assay, Siemens (TMA) (lower limit detection 10 IU/ml). Genotype 3 was present in 80% and genotype 2 in 20%. A SVR was achieved in 82%. At week 4 HCV-RNA was undetectable in 74.8% and 63% of serum samples tested with CA and TMA, respectively. CA undetectable/TMA positive was observed in 61/341 (18%) of the samples. In genotype 3 patients a relapse was seen in 9% of the patients with both CA and TMA undetectable and in 25% of the patients who were CA undetectable/TMA positive (p = 0.006). In patients allocated to 14 weeks treatment a relapse was observed in 11% of TMA undetectable patients and 26% of TMA positive (p = 0.031). In genotype 2 patients treated for 14 weeks relapse was observed in 6% of the patients with both CA and TMA undetectable week 4. Assays with high sensitivity for HCV RNA identifies patients at week 4 with high risk of virological relapse. We recommend that patients with genotype 3 and detectable HCV RNA at levels below 50 IU/ml do not receive truncated therapy with pegIFN and ribavirin.	[Dalgard, Olav] Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway; [Dalgard, Olav; Bjoro, Kristian] Univ Oslo, Fac Med, Oslo, Norway; [Martinot-Peignoux, Michelle] Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, U773, Paris, France; [Verbaan, Hans] Malmo Univ Hopsital, Dept Med, Malmo, Sweden; [Bjoro, Kristian] Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Ring-Larsen, Helmer] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Copenhagen, Denmark; [Marcellin, Patrick] Hop Beaujon, Serv Hepatol, Clichy, France	University of Oslo; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oslo; National Hospital Norway; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Dalgard, O (corresponding author), Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway.	odalgard@medisin.uio.no			Helse Ost Norway	Helse Ost Norway	The study was financed though a grant from Helse Ost Norway.	Chevaliez S, 2012, GASTROENTEROLOGY, V142, P1303, DOI 10.1053/j.gastro.2012.02.027; Comanor L, 2001, AM J GASTROENTEROL, V96, P2968, DOI 10.1111/j.1572-0241.2001.04669.x; Dalgard O, 2004, HEPATOLOGY; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; Dalgard O, 2010, EUR J GASTROEN HEPAT, V22, P552, DOI 10.1097/MEG.0b013e328335b29e; Diago M, 2010, HEPATOLOGY, V51, P1897, DOI [DOI 10.1002/HEP.23531, 10.1002/hep.23531]; European Association for the Study of the Liver, 2011, Journal of Hepatology, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Lange CM, J HEPATOL; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Martinot-Peignoux M, 2006, J VIRAL HEPATITIS, V13, P701, DOI 10.1111/j.1365-2893.2006.00750.x; Martinot-Peignoux M, 2009, J CLIN VIROL, V46, P216, DOI 10.1016/j.jcv.2009.08.011; Martinot-Peignoux M, 2009, ANTIVIR THER, V14, P501; Ross RS, 2001, J CLIN LAB ANAL, V15, P308, DOI 10.1002/jcla.1042; Sarrazin C, 2010, J HEPATOL, V52, P832, DOI 10.1016/j.jhep.2010.01.030; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0120866	10.1371/journal.pone.0120866	http://dx.doi.org/10.1371/journal.pone.0120866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317978	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100001
J	Deng, YT; Kang, WB; Zhao, JN; Liu, G; Zhao, MG				Deng, Ya-ting; Kang, Wen-bo; Zhao, Jian-ning; Liu, Gang; Zhao, Ming-gao			Osteoprotective Effect of Echinocystic Acid, a Triterpone Component from Eclipta prostrata, in Ovariectomy-Induced Osteoporotic Rats	PLOS ONE			English	Article							SAUDI POSTMENOPAUSAL WOMEN; BONE TURNOVER MARKERS; VITAMIN-D STATUS; NF-KAPPA-B; IN-VITRO; OSTEOCLAST DIFFERENTIATION; MINERAL DENSITY; MICE; CELLS; INFLAMMATION	Echinocystic acid (EA) is a natural triterpone enriched in various herbs and has been used for medicinal purposes in China. In the present study, we systematically examined the effects of EA on ovariectomy-induced osteoporosis in rats for the first time. Three-month-old female ovariectomy (OVX) Sprague-Dawley rats were used to evaluate the osteoprotective effect of EA. Results showed that administration of EA (5 or 15 mg/kg/day) for 12 weeks prevented lower levels of maximum stress and Young's modulus of femur induced by OVX. EA also recovered bone metabolic biomarkers levels in OVX rats, including osteocalcin, alkaline phosphatese, deoxypyridinoline, and urinary calcium and phosphorus. EA (5 and 15 mg/kg/day) could prevent the alteration of total bone mineral density in the femur caused by OVX. However, only high dose (15 mg/kg/day) of EA significantly improved trabecular architecture, as evidenced by higher levels of bone volume/tissue volume, trabecula number, and trabecula thickness, and lower levels of trabecula separation and structure model index compared with OVX rats. In addition, EA treatment decresed the serum levels of IL-1 beta and TNF-alpha in OVX rats. In conclusion, EA could prevent reduction of bone mass and strength and improve the cancellous bone structure and biochemical properties in OVX rats. Hence, EA may serve as a new candidate or a leading compound for antiosteoporosis.	[Deng, Ya-ting; Zhao, Ming-gao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Kang, Wen-bo; Zhao, Jian-ning; Liu, Gang] Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Naval Medical University	Zhao, JN (corresponding author), Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Orthoped, Nanjing, Jiangsu, Peoples R China.	jnzhao2002@163.com; liugene@hotmail.com; minggao@fmmu.edu.cn		Zhao, Ming-gao/0000-0002-7539-3887	National Natural Science Foundation of China [81403064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China No. 81403064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuohashish HM, 2015, ACTA PHARMACOL SIN, V36, P209, DOI 10.1038/aps.2014.111; Al-Daghri NM, 2014, INT J CLIN EXP MED, V7, P3528; Al-Daghri NM, 2014, INT J CLIN EXP MED, V7, P2812; Bhattacharya A, 2007, J NUTR BIOCHEM, V18, P372, DOI 10.1016/j.jnutbio.2006.07.002; Bian Q, 2012, MENOPAUSE, V19, P225, DOI 10.1097/gme.0b013e3182272ef1; Bouxsein Mary L, 2003, Clin Cornerstone, VSuppl 2, pS13; Chan BY, 2008, BONE, V43, P567, DOI 10.1016/j.bone.2008.04.018; Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892; DAVICCO MJ, 1992, REPROD NUTR DEV, V32, P313, DOI 10.1051/rnd:19920401; Devareddy L, 2006, BONE, V38, P686, DOI 10.1016/j.bone.2005.10.024; Fu HJ, 2014, J MED CHEM, V57, P4692, DOI 10.1021/jm5002293; Joh EH, 2014, ARCH PHARM RES, V37, P225, DOI 10.1007/s12272-013-0092-8; Joh EH, 2012, BIOCHEM PHARMACOL, V84, P331, DOI 10.1016/j.bcp.2012.04.020; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Lee SU, 2008, PHARMACOL RES, V58, P290, DOI 10.1016/j.phrs.2008.08.008; Leung F, 2009, BMJ CASE REP, V2009; Li NH, 2013, J ORTHOP SCI, V18, P478, DOI 10.1007/s00776-013-0362-9; Lim DW, 2013, NUTRIENTS, V5, P2734, DOI 10.3390/nu5072734; Liu SB, 2014, NEUROMOL MED, V16, P350, DOI 10.1007/s12017-013-8280-8; Liu ZG, 2009, J ETHNOPHARMACOL, V123, P74, DOI 10.1016/j.jep.2009.02.025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McNamara LM, 2010, J R SOC INTERFACE, V7, P353, DOI 10.1098/rsif.2009.0282; Min C, 2010, STUDY ANTIOSTEOPOROT; Moriwaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097177; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Polat B, 2013, EUR J PHARMACOL, V718, P469, DOI 10.1016/j.ejphar.2013.07.033; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; Ryu S, 2013, PLANTA MED, V79, P1031, DOI 10.1055/s-0032-1328767; Shen Y, 2010, J NAT MED-TOKYO, V64, P336, DOI 10.1007/s11418-010-0416-7; Tan H, 2014, J AGR FOOD CHEM, V62, P836, DOI 10.1021/jf402735u; Tong XH, 2004, CANCER LETT, V212, P21, DOI 10.1016/j.canlet.2004.03.035; Tsuji M, 2009, J BONE MINER METAB, V27, P673, DOI 10.1007/s00774-009-0088-0; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; TURNER CH, 1995, J DENT RES, V74, P1475, DOI 10.1177/00220345950740080701; Wang H, 2013, EUR J MED CHEM, V64, P160, DOI 10.1016/j.ejmech.2013.03.041; Wang QW, 2011, EUR J DRUG METAB PH, V35, P131, DOI 10.1007/s13318-010-0015-8; Wang ZQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/356260; Wu JM, 2010, FITOTERAPIA, V81, P8, DOI 10.1016/j.fitote.2009.06.015; Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127; Zhang R, 2014, J ETHNOPHARMACOL, V155, P104, DOI 10.1016/j.jep.2014.04.031; Zhao Y, 2011, MENOPAUSE, V18, P690, DOI 10.1097/gme.0b013e3181fd7f4b	41	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136572	10.1371/journal.pone.0136572	http://dx.doi.org/10.1371/journal.pone.0136572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317835	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100104
J	Kim, A; Servetas, SL; Kang, J; Kim, J; Jang, S; Cha, HJ; Lee, WJ; Kim, J; Romero-Gallo, J; Peek, RM; Merrell, DS; Cha, JH				Kim, Aeryun; Servetas, Stephanie L.; Kang, Jieun; Kim, Jinmoon; Jang, Sungil; Cha, Ho Jin; Lee, Wan Jin; Kim, June; Romero-Gallo, Judith; Peek, Richard M., Jr.; Merrell, D. Scott; Cha, Jeong-Heon			Helicobacter pylori bab Paralog Distribution and Association with cagA, vacA, and homA/B Genotypes in American and South Korean Clinical Isolates	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; GEOGRAPHIC ORIGIN; INFECTION; ADHESIN; GENE; POLYMORPHISMS; DISEASE; COLONIZATION; EXPRESSION; EVOLUTION	Helicobacter pylori genetic variation is a crucial component of colonization and persistence within the inhospitable niche of the gastric mucosa. As such, numerous H. pylori genes have been shown to vary in terms of presence and genomic location within this pathogen. Among the variable factors, the Bab family of outer membrane proteins (OMPs) has been shown to differ within subsets of strains. To better understand genetic variation among the bab genes and to determine whether this variation differed among isolates obtained from different geographic locations, we characterized the distribution of the Bab family members in 80 American H. pylori clinical isolates (AH) and 80 South Korean H. pylori clinical isolates (KH). Overall, we identified 23 different bab genotypes (19 in AH and 11 in KH), but only 5 occurred in greater than 5 isolates. Regardless of strain origin, a strain in which locus A and locus B were both occupied by a bab gene was the most common (85%); locus C was only occupied in those isolates that carried bab paralog at locus A and B. While the babA/babB/genotype predominated in the KH (78.8%), no single genotype could account for greater than 40% in the AH collection. In addition to basic genotyping, we also identified associations between bab genotype and well known virulence factors cagA and vacA. Specifically, significant associations between babA at locus A and the cagA EPIYA-ABD motif (P<0.0001) and the vacA s1/i1/m1 allele (P< 0.0001) were identified. Log-linear modeling further revealed a three-way association between bab carried at locus A, vacA, and number of OMPs from the HOM family (P<0.002). En masse this study provides a detailed characterization of the bab genotypes from two distinct populations. Our analysis suggests greater variability in the AH, perhaps due to adaptation to a more diverse host population. Furthermore, when considering the presence or absence of both the bab and homA/B paralogs at their given loci and the vacA genotype, an association was observed. Our results highlight the multifactorial nature of H. pylori mediated disease and the importance of considering how the specific combinations of H. pylori virulence genes and their multiple interactions with the host will collectively impact disease progression.	[Kim, Aeryun; Kang, Jieun; Kim, Jinmoon; Jang, Sungil; Cha, Ho Jin; Lee, Wan Jin; Kim, June; Cha, Jeong-Heon] Yonsei Univ, Coll Dent, Oral Sci Res Ctr, Dept Oral Biol, Seoul 120749, South Korea; [Kim, Aeryun; Kang, Jieun; Kim, Jinmoon; Cha, Jeong-Heon] Yonsei Univ, Coll Dent, Dept Appl Life Sci, Plus Project BK21, Seoul 120749, South Korea; [Servetas, Stephanie L.; Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Romero-Gallo, Judith; Peek, Richard M., Jr.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA; [Romero-Gallo, Judith; Peek, Richard M., Jr.] Vanderbilt Univ, Dept Med, Nashville, TN 37240 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Uniformed Services University of the Health Sciences - USA; Vanderbilt University; Vanderbilt University	Merrell, DS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	douglas.merrell@usuhs.edu; jcha@yuhs.ac	Servetas, Stephanie/AAN-7263-2020	Servetas, Stephanie/0000-0002-4924-4511; Cha, Jeong-Heon/0000-0002-9385-2653; Jang, Sungil/0000-0001-6144-6899	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A2A1A11051054]; NATIONAL CANCER INSTITUTE [R01CA077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A2A1A11051054).	Abadi ATB, 2013, INTERN EMERG MED, V8, P497, DOI 10.1007/s11739-011-0631-6; Abdullah Shahla M, 2012, Arab J Gastroenterol, V13, P166, DOI 10.1016/j.ajg.2012.12.001; Ahuja V, 2002, GASTROENTEROLOGY, V123, P653, DOI 10.1053/gast.2002.35224; Alfizah H, 2012, HELICOBACTER, V17, P340, DOI 10.1111/j.1523-5378.2012.00956.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Ando T, 2002, J CLIN MICROBIOL, V40, P239, DOI 10.1128/JCM.40.1.239-246.2002; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backstrom A, 2004, P NATL ACAD SCI USA, V101, P16923, DOI 10.1073/pnas.0404817101; Beswick EJ, 2006, WORLD J GASTROENTERO, V12, P5599, DOI 10.3748/wjg.v12.i35.5599; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bridge DR, 2013, GUT MICROBES, V4, P101, DOI 10.4161/gmic.23797; Colbeck JC, 2006, INFECT IMMUN, V74, P4375, DOI 10.1128/IAI.00485-06; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Felsenstein J., 2009, PHYLIP PHYLOGENY INF; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Hennig EE, 2006, INFECT IMMUN, V74, P3046, DOI 10.1128/IAI.74.5.3046-3051.2006; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Armitano RI, 2013, INFECT GENET EVOL, V16, P377, DOI 10.1016/j.meegid.2013.02.024; Jang S, 2010, J CLIN MICROBIOL, V48, P559, DOI 10.1128/JCM.01501-09; Jones KR, 2011, J CLIN MICROBIOL, V49, P101, DOI 10.1128/JCM.01782-10; Jones KR, 2009, J CLIN MICROBIOL, V47, P959, DOI 10.1128/JCM.02330-08; Jung SW, 2009, J CLIN MICROBIOL, V47, P3241, DOI 10.1128/JCM.00293-09; Kalaf EA, 2013, SAUDI J GASTROENTERO, V19, P69, DOI 10.4103/1319-3767.108474; Kang J, 2012, J CLIN MICROBIOL, V50, P1082, DOI 10.1128/JCM.06293-11; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Liu H, 2015, INT J MED MICROBIOL, V305, P392, DOI 10.1016/j.ijmm.2015.03.002; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Matteo MJ, 2011, INT J MOL EPIDEMIOL, V2, P286; Nagasawa S, 2013, FORENSIC SCI INT, V229, P7, DOI 10.1016/j.forsciint.2013.02.028; Nell S, 2014, MBIO, V5, DOI 10.1128/mBio.02281-14; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Oleastro M, 2008, J INFECT DIS, V198, P1379, DOI 10.1086/592166; Oleastro Monica, 2013, Biology (Basel), V2, P1110, DOI 10.3390/biology2031110; Oleastro M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-248; Pride DT, 2002, J MOL BIOL, V316, P629, DOI 10.1006/jmbi.2001.5311; Pride DT, 2001, INFECT IMMUN, V69, P1160, DOI 10.1128/IAI.69.2.1160-1171.2001; Sheu SM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-89; Shin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tokudome S, 2007, ASIAN PAC J CANCER P, V8, P462; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Torres LE, 2009, WORLD J GASTROENTERO, V15, P204, DOI 10.3748/wjg.15.204; Wada A, 2004, J BIOCHEM, V136, P741, DOI 10.1093/jb/mvh181; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074; Zhang XS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004621	50	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137078	10.1371/journal.pone.0137078	http://dx.doi.org/10.1371/journal.pone.0137078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317221	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100202
J	Mortaz, E; Adcock, IM; Ricciardolo, FLM; Varahram, M; Jamaati, H; Velayati, AA; Folkerts, G; Garssen, J				Mortaz, Esmaeil; Adcock, Ian M.; Ricciardolo, Fabio L. M.; Varahram, Mohammad; Jamaati, Hamidreza; Velayati, Ali Akbar; Folkerts, Gert; Garssen, Johan			Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MURINE MODEL; ALVEOLAR MACROPHAGES; PROBIOTICS; NEUTROPHILS; RELEASE; HMGB1; INFLAMMASOME; RECOGNITION; RESPONSES	Background Chronic obstructive pulmonary disease (COPD) is a major global health problem with cigarette smoke (CS) as the main risk factor for its development. Airway inflammation in COPD involves the increased expression of inflammatory mediators such as CXCL-8 and IL-1 beta which are important mediators for neutrophil recruitment. Macrophages are an important source of these mediators in COPD. Lactobacillus rhamnosus (L. rhamnosus) and Befidobacterium breve (B. breve) attenuate the development of 'allergic asthma' in animals but their effects in COPD are unknown. Objective To determine the anti-inflammatory effects of L. rhamnosus and B. breve on CS and Toll-like receptor (TLR) activation. Design We stimulated the human macrophage cell line THP-1 with CS extract in the presence and absence of L. rhamnosus and B. breve and measured the expression and release of inflammatory mediators by RT-qPCR and ELISA respectively. An activity assay and Western blotting were used to examine NF-kappa B activation. Results Both L. rhamnosus and B. breve were efficiently phagocytized by human macrophages. L. rhamnosus and B. breve significantly suppressed the ability of CS to induce the expression of IL-1 beta, IL-6, IL-10, IL-23, TNF alpha, CXCL-8 and HMGB1 release (all p<0.05) in human THP-1 macrophages. Similar suppression of TLR4- and TLR9-induced CXCL8 expression was also observed (p<0.05). The effect of L. rhamnosus and B. breve on inflammatory mediator release was associated with the suppression of CS-induced NF-kappa B activation (p<0.05). Conclusions This data indicate that these probiotics may be useful anti-inflammatory agents in CS-associated disease such as COPD.	[Mortaz, Esmaeil; Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cell & Mol Biol Grp, Airways Dis Sect,Fac Med, London, England; [Mortaz, Esmaeil; Jamaati, Hamidreza] Shahid Beheshti Univ Med Sci, Chron Resp Res Ctr, Natl Res & Inst TB & Lung Dis NRITLD, Tehran, Iran; [Mortaz, Esmaeil] Shahid Beheshti Univ Med Sci, Fac Med, Dept Immunol, Tehran, Iran; [Ricciardolo, Fabio L. M.] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Varahram, Mohammad; Velayati, Ali Akbar] Shahid Beheshti Univ Med Sci, Mycobacteriol Res Ctr MRC, Natl Res Inst TB & Lung Dis NRITLD, Tehran, Iran; [Folkerts, Gert; Garssen, Johan] Univ Utrecht, Fac Sci, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Garssen, Johan] Nutricia Res Ctr Specialized Nutr, Utrecht, Netherlands	Imperial College London; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; University of Turin; Shahid Beheshti University Medical Sciences; Utrecht University	Adcock, IM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cell & Mol Biol Grp, Airways Dis Sect,Fac Med, Dovehouse St, London, England.	ian.adcock@imperial.ac.uk	Varahram, Mohammad/A-1395-2018; Adcock, Ian/L-3217-2019; jamaati, hamidreza/G-4098-2017; Ricciardolo, F. L. M./K-5330-2018; Velayati, Ali Akbar/H-1448-2017; garssen, johan/I-7159-2016; mortaz, esmael/G-7647-2017	Varahram, Mohammad/0000-0002-8033-1867; jamaati, hamidreza/0000-0002-9372-3253; Ricciardolo, F. L. M./0000-0003-1826-5018; mortaz, esmael/0000-0002-6689-3556; Adcock, Ian/0000-0003-2101-8843; Mortaz, Esmaeil/0000-0003-0250-087X; Velayati, Ali Akbar/0000-0001-9398-5838	MRC [G1001367/1]; Wellcome Trust [093080/Z/10/Z]; Interuniversity Attraction Poles (IAP) Project [P7/30]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London; ERS Long Term Fellowship [LTRF 2013-2052]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Interuniversity Attraction Poles (IAP) Project(Belgian Federal Science Policy Office); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London; ERS Long Term Fellowship	IMA is supported by the MRC (G1001367/1), the Wellcome Trust (093080/Z/10/Z) and by Interuniversity Attraction Poles (IAP) Project P7/30. Research by IMA is also supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London. EM is supported by an ERS Long Term Fellowship (LTRF 2013-2052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Barnes PJ, 2010, SCIENCE, V330, P40, DOI 10.1126/science.1196017; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Bezerra FS, 2011, RESP PHYSIOL NEUROBI, V177, P120, DOI 10.1016/j.resp.2011.03.023; Black H, 2007, CHEST, V131, P524, DOI 10.1378/chest.06-1074; Blidberg K, 2012, INNATE IMMUN-LONDON, V18, P503, DOI 10.1177/1753425911423270; Caglar E, 2005, ORAL DIS, V11, P131, DOI 10.1111/j.1601-0825.2005.01109.x; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Chaichalotornkul S, 2015, BIOCHEM BIOPH RES CO, V456, P92, DOI 10.1016/j.bbrc.2014.11.040; Cosio MG, 2009, NEW ENGL J MED, V360, P2396; D'Souza AL, 2012, BMJ-BRIT MED J; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; DREVETS DA, 1995, J IMMUNOL METHODS, V187, P69, DOI 10.1016/0022-1759(95)00168-A; FAO/WHO Codex Alimentarius Commission, 2001, EXPERT CONSULTATION, P1; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Heijink IH, 2015, AM J RESP CELL MOL, V52, P554, DOI 10.1165/rcmb.2013-0505OC; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hosoya T, 2014, PLOS ONE, V30; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006; Jan RL, 2011, BR J NUTR, V14, P1; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Keely S, 2014, CHEST, V145, P199, DOI 10.1378/chest.13-2077; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Marteau PR, 2001, AM J CLIN NUTR, V73, p430S, DOI 10.1093/ajcn/73.2.430s; Miettinen M, 2012, GUT MICROBES, V3, P510, DOI 10.4161/gmic.21736; Morelli L, 2002, DIGEST LIVER DIS, V34, pS8, DOI 10.1016/S1590-8658(02)80156-6; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Mortaz E, 2010, EUR RESPIR J, V36, P1143, DOI 10.1183/09031936.00062209; Mortaz E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/751068; Mortaz E, 2012, BBA-MOL BASIS DIS, V1822, P1154, DOI 10.1016/j.bbadis.2012.03.006; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Pan SJ, 2010, PEDIAT ALLERG IMM-UK, V21, pE659, DOI 10.1111/j.1399-3038.2010.01061.x; Pons AR, 2005, EUR RESPIR J, V25, P647, DOI 10.1183/09031936.05.00062304; Pouwels SD, 2014, MUCOSAL IMMUNOL, V7, P215, DOI 10.1038/mi.2013.77; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Ruane D, 2013, J EXP MED, V210, P1871, DOI 10.1084/jem.20122762; Sagar S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-46; Sagar S, 2014, BBA-MOL BASIS DIS, V1842, P573, DOI 10.1016/j.bbadis.2014.01.005; Saiwichai T, 2010, SE ASIAN J TROP MED, V41, P250; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Tanaka A, 2011, LETT APPL MICROBIOL, V53, P35, DOI 10.1111/j.1472-765X.2011.03079.x; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Tzanakis NE, 2010, WORLD J GASTROENTERO, V16, P299, DOI 10.3748/wjg.v16.i3.299; van Bergenhenegouwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089121; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Youn HN, 2012, ANTIVIR RES, V93, P138, DOI 10.1016/j.antiviral.2011.11.004; Zhang YH, 2014, J THORAC DIS, V6, P734, DOI 10.3978/j.issn.2072-1439.2014.04.31	58	52	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136455	10.1371/journal.pone.0136455	http://dx.doi.org/10.1371/journal.pone.0136455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317628	Green Published, gold			2022-12-27	WOS:000360299100086
J	Piao, Y; Li, Y; Xu, Q; Liu, JW; Xing, CZ; Xie, XD; Yuan, Y				Piao, Ying; Li, Ying; Xu, Qian; Liu, Jing-wei; Xing, Cheng-zhong; Xie, Xiao-dong; Yuan, Yuan			Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PI3K/AKT/MTOR PATHWAY; RISK; ALCOHOL; TRANSLATION; ACTIVATION; CARCINOMA; 3-KINASE	Background The phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB, AKT)/mammalian target of rapamycin (mTOR) signaling pathway plays a critical role in angiogenesis and cell growth, proliferation, metabolism, migration, differentiation, and apoptosis. Genetic diversity in key factors of this pathway may influence protein function and signal transduction, contributing to disease initiation and progression. Studies suggest that MTOR rs1064261 and AKT rs1130233 polymorphisms are associated with risk and/or prognosis of multiple cancer types. However, this relationship with gastric cancer (GC) remains unclear. The aim of this study was to investigate the role of MTOR and AKT polymorphisms in the risk and prognosis of GC. Methods The Sequenom MassARRAY platform was used to genotype 1842 individuals for MTOR rs1064261 T -> C and AKT rs1130233 G -> A polymorphisms. ELISA was used to detect Helicobacter pylori antibodies in serum. Immunohistochemical analysis was used to detect total and phosphorylated MTOR and AKT proteins. Results The MTOR rs1064261 (TC+CC) genotype and the AKT rs1130233 (GA+AA) genotype were associated with increased risk of GC in men (P = 0.049, P = 0.030). In H. pylori-negative individuals, the AKT rs1130233 GA and (GA+AA) genotypes were related to increased risk of atrophic gastritis (AG; P = 0.012, P = 0.024). Notably, the AKT rs1130233 (GA+AA) genotype demonstrated significant interactions with H. pylori in disease progression from healthy controls (CON) to AG (P = 0.013) and from AG to GC (P = 0.049). Additionally, for individuals with the AKT rs1130233 variant, those in the H. pylori-positive group had higher levels of phosphorylated AKT (p-AKT) expression. The AKT rs1130233 genotype was found to be associated with clinicopathological parameters including lymph node metastasis and alcohol drinking (P<0.05). Conclusion MTOR rs1064261 and AKT rs1130233 polymorphisms were associated with increased GC risk in males and increased AG risk in H. pylori-negative individuals. A significant interaction existed between the AKT rs1130233 genotype and H. pylori infection in CON -> AG -> GC disease progression. The AKT rs1130233 genotype influenced p-AKT protein expression in H. pylori-infected individuals.	[Piao, Ying; Li, Ying; Xu, Qian; Liu, Jing-wei; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang, Peoples R China; [Piao, Ying; Li, Ying; Xu, Qian; Liu, Jing-wei; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang, Peoples R China; [Piao, Ying; Xie, Xiao-dong] Gen Hosp Shenyang Mil Reg, Dept Oncol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang, Peoples R China.	yyuan3@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304), the National Natural Science Foundation of China (Ref No. 31200968).	Ali Z, 2012, J NANOSCI NANOTECHNO, V12, P8241, DOI 10.1166/jnn.2012.6692; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Avan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108057; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302; De Marco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055362; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Duell EJ, 2011, AM J CLIN NUTR, V94, P1266, DOI 10.3945/ajcn.111.012351; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Giovannetti E, 2010, MOL CANCER THER, V9, P581, DOI 10.1158/1535-7163.MCT-09-0665; Gong YH, 2010, EUR J CLIN MICROBIOL, V29, P907, DOI 10.1007/s10096-010-0944-9; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Isomoto H, 2010, TOHOKU J EXP MED, V220, P3, DOI 10.1620/tjem.220.3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kim MJ, 2012, J SURG ONCOL, V105, P167, DOI 10.1002/jso.22071; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Li QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071968; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Sanghera KP, 2011, MOL CELL NEUROSCI, V47, P145, DOI 10.1016/j.mcn.2011.03.010; Shao JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097085; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Tapia O, 2014, VIRCHOWS ARCH, V465, P25, DOI 10.1007/s00428-014-1588-4; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Wang XT, 2014, J CANCER RES CLIN, V140, P1399, DOI 10.1007/s00432-014-1663-x; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YQ, 2014, INFORM SYST, V44, P1, DOI 10.1016/j.is.2014.02.003; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060080; Xu Q, 2013, GENE, V529, P104, DOI 10.1016/j.gene.2013.07.070; Xu Q, 2009, INT J ONCOL, V35, P1313, DOI 10.3892/ijo_00000449; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang XA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092135; Zhu ML, 2013, J THORAC ONCOL, V8, P788, DOI 10.1097/JTO.0b013e31828916c6	46	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136447	10.1371/journal.pone.0136447	http://dx.doi.org/10.1371/journal.pone.0136447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317520	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100085
J	Silva, APC; Macedo, AA; Costa, LF; Rocha, CE; Garcia, LNN; Farias, JRD; Gomes, PPR; Teixeira, GC; Fonseca, KWJ; Maia, ARF; Neves, GG; Romao, EL; Silva, TMA; Mol, JPS; Oliveira, RM; Araujo, MSS; Nascimento, EF; Martins, OA; Brandao, HM; Paixao, TA; Santos, RL				Silva, Ana Patrcia C.; Macedo, Auricelio A.; Costa, Luciana F.; Rocha, Claudia E.; Garcia, Luize N. N.; Farias, Jade R. D.; Gomes, Priscilla P. R.; Teixeira, Gustavo C.; Fonseca, Kessler W. J.; Maia, Andrea R. F.; Neves, Gabriela G.; Romao, Everton L.; Silva, Teane M. A.; Mol, Juliana P. S.; Oliveira, Renata M.; Araujo, Marcio S. S.; Nascimento, Ernane F.; Martins-Filho, Olindo A.; Brandao, Humberto M.; Paixao, Tatiane A.; Santos, Renato L.			Encapsulated Brucella ovis Lacking a Putative ATP-Binding Cassette Transporter (Delta abcBA) Protects against Wild Type Brucella ovis in Rams	PLOS ONE			English	Article							LIVE VACCINE; INFECTION; MICE; PCR; DIAGNOSIS; INSULIN	This study aimed to evaluate protection induced by the vaccine candidate B. ovis Delta abcBA against experimental challenge with wild type B. ovis in rams. Rams were subcutaneously immunized with B. ovis Delta abcBA encapsulated with sterile alginate or with the non encapsulated vaccine strain. Serum, urine, and semen samples were collected during two months after immunization. The rams were then challenged with wild type B. ovis (ATCC25840), and the results were compared to non immunized and experimentally challenged rams. Immunization, particularly with encapsulated B. ovis Delta abcBA, prevented infection, secretion of wild type B. ovis in the semen and urine, shedding of neutrophils in the semen, and the development of clinical changes, gross and microscopic lesions induced by the wild type B. ovis reference strain. Collectively, our data indicates that the B. ovis Delta abcBA strain is an exceptionally good vaccine strain for preventing brucellosis caused by B. ovis infection in rams.	[Silva, Ana Patrcia C.; Macedo, Auricelio A.; Garcia, Luize N. N.; Farias, Jade R. D.; Gomes, Priscilla P. R.; Teixeira, Gustavo C.; Fonseca, Kessler W. J.; Maia, Andrea R. F.; Neves, Gabriela G.; Romao, Everton L.; Silva, Teane M. A.; Mol, Juliana P. S.; Nascimento, Ernane F.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, BR-31270901 Belo Horizonte, MG, Brazil; [Costa, Luciana F.; Rocha, Claudia E.; Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, BR-31270901 Belo Horizonte, MG, Brazil; [Oliveira, Renata M.] Univ Estadual Maranhao, Dept Patol, BR-65057630 Sao Luis, MA, Brazil; [Araujo, Marcio S. S.; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Brandao, Humberto M.] Embrapa Gado Leite, BR-36038330 Juiz De Fora, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual do Maranhao; Fundacao Oswaldo Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, BR-31270901 Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	Gomes, Teane Milagres Augusto/AAP-2686-2021; Martins-Filho, Olindo Assis/ABE-6278-2021; de Lima Santos, Renato/A-1134-2008; Farias Filho, J.R./AAI-4847-2020; Brandão, Humberto m/C-2831-2017	Gomes, Teane Milagres Augusto/0000-0002-3752-8613; Martins-Filho, Olindo Assis/0000-0002-5494-4889; de Lima Santos, Renato/0000-0002-4830-0470; Farias Filho, J.R./0000-0003-1843-8695; Brandão, Humberto m/0000-0002-7405-3928; Mol, Juliana/0000-0002-6946-8213	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil); CNPq; CAPES	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work in RLS lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil). RLS and OAMF have fellowships from CNPq. APCS has a scholarship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas-Gamboa AM, 2009, INFECT IMMUN, V77, P877, DOI 10.1128/IAI.01017-08; Arenas-Gamboa AM, 2008, INFECT IMMUN, V76, P2448, DOI 10.1128/IAI.00767-07; Arenas-Gamboa AM, 2009, J WILDLIFE DIS, V45, P165, DOI 10.7589/0090-3558-45.1.165; Banai M, 2002, VET MICROBIOL, V90, P497, DOI 10.1016/S0378-1135(02)00231-6; Blandino A, 1999, J BIOSCI BIOENG, V88, P686, DOI 10.1016/S1389-1723(00)87103-0; Blasco J. M., 1990, Animal brucellosis., P351; Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; Carvalho CA, 2012, SMALL RUMINANT RES, V102, P213, DOI 10.1016/j.smallrumres.2011.08.004; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Costa EA, 2012, ARQ BRAS MED VET ZOO, V64, P751, DOI 10.1590/S0102-09352012000300029; Avila-Calderon ED, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743509; Davis DS, 2002, VET MICROBIOL, V90, P533, DOI 10.1016/S0378-1135(02)00233-X; Estein SM, 2009, VACCINE, V27, P6704, DOI 10.1016/j.vaccine.2009.08.097; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, V2; Grillo MJ, 2000, BIOLOGICALS, V28, P119, DOI 10.1006/biol.2000.0249; Hanes J, 1997, ADV DRUG DELIVER REV, V28, P97, DOI 10.1016/S0169-409X(97)00053-7; JANSEN BC, 1980, ONDERSTEPOORT J VET, V47, P263; Lantier F, 1985, BRUCELLA MELITENSIS, P247; MARIN CM, 1990, RES VET SCI, V48, P209, DOI 10.1016/S0034-5288(18)30992-5; Marschutz MK, 2000, BIOMATERIALS, V21, P1499, DOI 10.1016/S0142-9612(00)00039-9; Matrone M, 2009, BRAZ J MICROBIOL, V40, P480, DOI 10.1590/S1517-838220090003000010; Moustacas VS, 2014, SCI WORLD J, DOI 10.1155/2014/241452; Murillo M, 2001, VACCINE, V19, P4099, DOI 10.1016/S0264-410X(01)00177-3; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; Olsen SC, 2013, REV SCI TECH OIE, V32, P207; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Qiu B, 2003, BIOMATERIALS, V24, P11, DOI 10.1016/S0142-9612(02)00227-2; Robinson A., 2003, GUIDELINES COORDINAT; Sa JC, 2012, VET MICROBIOL, V159, P130, DOI 10.1016/j.vetmic.2012.03.029; Sancho P, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-61; Santos RL, 2013, PESQUI VET BRASIL, V33, P759, DOI 10.1590/S0100-736X2013000600012; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva APC, 2015, CLIN VACCIN IN PRESS; Silva TMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114532; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Soler-Llorens P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0072-0; Takenaga M, 2002, J CONTROL RELEASE, V79, P81, DOI 10.1016/S0168-3659(01)00518-1; Thoen C. O., 1993, P236; VERSHILOVA P, 1961, B WORLD HEALTH ORGAN, V24, P85; Visscher G E, 1987, J Biomater Appl, V2, P118; Xavier MN, 2010, VET MICROBIOL, V145, P158, DOI 10.1016/j.vetmic.2010.02.037	44	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136865	10.1371/journal.pone.0136865	http://dx.doi.org/10.1371/journal.pone.0136865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317399	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100156
J	Subramanian, M; Ozcan, L; Ghorpade, DS; Ferrante, AW; Tabas, I				Subramanian, Manikandan; Ozcan, Lale; Ghorpade, Devram Sampat; Ferrante, Anthony W., Jr.; Tabas, Ira			Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity	PLOS ONE			English	Article							REGULATORY T-CELLS; DIET-INDUCED OBESITY; DENDRITIC CELLS; TISSUE MACROPHAGES; MICE; SENSITIVITY; MECHANISMS; MYD88; IL-33; PROLIFERATION	Obesity-induced inflammation in visceral adipose tissue (VAT) is a major contributor to insulin resistance and type 2 diabetes. Whereas innate immune cells, notably macrophages, contribute to visceral adipose tissue (VAT) inflammation and insulin resistance, the role of adaptive immunity is less well defined. To address this critical gap, we used a model in which endogenous activation of T cells was suppressed in obese mice by blocking MyD88-mediated maturation of CD11c(+) antigen-presenting cells. VAT CD11c(+) cells from Cd11cCre(+)Myd88(fl/fl) vs. control Myd88(fl/fl) mice were defective in activating T cells in vitro, and VAT T and B cell activation was markedly reduced in Cd11cCre(+)Myd88(fl/fl) obese mice. However, neither macrophage-mediated VAT inflammation nor systemic inflammation were altered in Cd11cCre(+)Myd88(fl/fl) mice, thereby enabling a focused analysis on adaptive immunity. Unexpectedly, fasting blood glucose, plasma insulin, and the glucose response to glucose and insulin were completely unaltered in Cd11cCre(+)Myd88(fl/fl) vs. control obese mice. Thus, CD11c(+) cells activate VAT T and B cells in obese mice, but suppression of this process does not have a discernible effect on macrophage-mediated VAT inflammation or systemic glucose homeostasis.	[Subramanian, Manikandan; Ozcan, Lale; Ghorpade, Devram Sampat; Ferrante, Anthony W., Jr.; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Subramanian, M (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	ms4144@cumc.columbia.edu	Ferrante, Anthony/AAC-7763-2019	Ferrante, Anthony/0000-0001-9272-2593; Ozcan, Lale/0000-0002-2710-7057; Subramanian, Manikandan/0000-0002-2608-3890	American Heart Association Scientist Development Grant [11SDG5300022]; New York Obesity and Nutrition Research Center Pilot and Feasibility Grant [DK26687]; National Institutes of Health [HL075662, HL106019]; NIH/NIDDK Center [5P30DK063608]; Office of the Director, National Institutes of Health [S10OD020056]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106019, R01HL075662, P01HL087123, R01HL132412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK101942, P30DK063608, R01DK066525] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); New York Obesity and Nutrition Research Center Pilot and Feasibility Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by an American Heart Association Scientist Development Grant (11SDG5300022) and a New York Obesity and Nutrition Research Center Pilot and Feasibility Grant (DK26687) to LO, and National Institutes of Health grants HL075662 and HL106019 to IT. Studies reported in this publication used the resources of the CCTI/DERC Flow Core facility funded in part by NIH/NIDDK Center grant 5P30DK063608, and by the Office of the Director, National Institutes of Health, under Shared Instrumentation grant S10OD020056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoras ALB, 2003, J INVEST ALLERG CLIN, V13, P181; Ballak DB, 2013, CYTOKINE, V62, P96, DOI 10.1016/j.cyto.2013.02.009; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hosoi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012537; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khare A, 2011, APOPTOSIS, V16, P334, DOI 10.1007/s10495-010-0569-6; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Mantegazza AR, 2014, P NATL ACAD SCI USA, V111, P15508, DOI 10.1073/pnas.1412998111; Melcher M, 2008, J IMMUNOL, V180, P8048, DOI 10.4049/jimmunol.180.12.8048; Montes VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067709; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stefanovic-Racic M, 2012, DIABETES, V61, P2330, DOI 10.2337/db11-1523; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu LDH, 2012, METABOLISM, V61, P1633, DOI 10.1016/j.metabol.2012.04.015; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314	49	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135842	10.1371/journal.pone.0135842	http://dx.doi.org/10.1371/journal.pone.0135842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317499	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100045
J	Sanchez-Gonzalez, LA; Hosner, PA; Moyle, RG				Antonio Sanchez-Gonzalez, Luis; Hosner, Peter A.; Moyle, Robert G.			Genetic Differentiation in Insular Lowland Rainforests: Insights from Historical Demographic Patterns in Philippine Birds	PLOS ONE			English	Article							AVES TURDIDAE COPSYCHUS; BENT-TOED GECKOS; ADAPTIVE RADIATION; MITOCHONDRIAL-DNA; MOLECULAR SYSTEMATICS; EVOLUTIONARY HISTORY; SOUTHEAST-ASIA; COMPARATIVE PHYLOGEOGRAPHY; HUXLEYS MODIFICATION; SPECIATION DYNAMICS	Phylogeographic studies of Philippine birds support that deep genetic structure occurs across continuous lowland forests within islands, despite the lack of obvious contemporary isolation mechanisms. To examine the pattern and tempo of diversification within Philippine island forests, and test if common mechanisms are responsible for observed differentiation, we focused on three co-distributed lowland bird taxa endemic to Greater Luzon and Greater Negros-Panay: Blue-headed Fantail (Rhipidura cyaniceps), White-browed Shama (Copsychus luzoniensis), and Lemon-throated Leaf-Warbler (Phylloscopus cebuensis). Each species has two described subspecies within Greater Luzon, and a single described subspecies on Greater Negros/Panay. Each of the three focal species showed a common geographic pattern of two monophyletic groups in Greater Luzon sister to a third monophyletic group found in Greater Negros-Panay, suggesting that common or similar biogeographic processes may have produced similar distributions. However, studied species displayed variable levels of mitochondrial DNA differentiation between clades, and genetic differentiation within Luzon was not necessarily concordant with described subspecies boundaries. Population genetic parameters for the three species suggested both rapid population growth from small numbers and geographic expansion across Luzon Island. Estimates of the timing of population expansion further supported that these events occurred asynchronously throughout the Pleistocene in the focal species, demanding particular explanations for differentiation, and support that co-distribution may be secondarily congruent.	Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Sanchez-Gonzalez, LA (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Evolut, Museo Zool Alfonso L Herrera, Apdo Postal 70-399, Mexico City 04510, DF, Mexico.	lasg@ciencias.unam.mx		Hosner, Peter/0000-0001-7499-6224; Sanchez-Gonzalez, Luis A./0000-0002-8932-1657	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [Expediente 93730]; National Science Foundation [DEB 0743491, DEB-0743576]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF))	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Expediente 93730) to LASG, National Science Foundation (DEB 0743491 and DEB-0743576 to RGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bairlein F, 2006, HDB BIRDS WORLD, V11, P492; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Bermingham E, 1998, MOL ECOL, V7, P367, DOI 10.1046/j.1365-294x.1998.00424.x; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Sanguila MB, 2011, MOL PHYLOGENET EVOL, V61, P333, DOI 10.1016/j.ympev.2011.06.019; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; Brown RM, 2002, BIOL J LINN SOC, V76, P393, DOI 10.1111/j.1095-8312.2002.tb01704.x; BROWN RM, 2002, SILLIMAN J, V42, P133; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; BUSH MB, 1990, J VEG SCI, V1, P105, DOI 10.2307/3236060; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Coates B.J., 1997, GUIDE BIRDS WALLACEA; Collar NJ, 2011, FORKTAIL, P29; Correa-Metrio A, 2012, QUATERNARY SCI REV, V38, P63, DOI 10.1016/j.quascirev.2012.01.025; Coyne JA, 2000, EVOLUTION, V54, P2166; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delacour J, 1946, BIRDS PHILIPPINES; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; DICKINSON EC, 1991, BIRDS PHILIPPINES CH; Esselstyn JA, 2010, J BIOGEOGR, V37, P2054, DOI 10.1111/j.1365-2699.2010.02378.x; Esselstyn JA, 2009, MOL PHYLOGENET EVOL, V53, P171, DOI 10.1016/j.ympev.2009.05.034; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fjeldsa J, 2007, J ORNITHOL, V148, pS359, DOI 10.1007/s10336-007-0179-4; Fjeldsa J, 2012, ANNU REV ECOL EVOL S, V43, P249, DOI 10.1146/annurev-ecolsys-102710-145113; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Fu YX, 1997, GENETICS, V147, P915; Gamauf A, 2005, BIRD CONSERV INT, V15, P99, DOI 10.1017/S0959270905000080; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GILLIARD ET, 1950, B AM MUS NAT HIST, V94, P459; Grant PR, 2002, AM SCI, V90, P130, DOI 10.1511/2002.2.130; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hamilton M.B., 2009, POPULATION GENETICS; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Heaney L.R., 1985, Modern Quaternary Research in Southeast Asia, V9, P127; Heaney Lawrence R., 2011, Fieldiana-Life and Earth Sciences, V2, P1; Heaney LR, 2005, J BIOGEOGR, V32, P229, DOI 10.1111/j.1365-2699.2004.01120.x; Heslewood MM, 1998, ELECTROPHORESIS, V19, P142, DOI 10.1002/elps.1150190203; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hosner PA, 2014, EVOLUTION, V68, P2658, DOI 10.1111/evo.12459; Hosner PA, 2013, CONDOR, V115, P630, DOI 10.1525/cond.2013.120124; Hosner PA, 2013, J BIOGEOGR, V40, P1094, DOI 10.1111/jbi.12074; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Jones AW, 2008, BIOL J LINN SOC, V95, P620, DOI 10.1111/j.1095-8312.2008.01073.x; Jones AW, 2008, CONDOR, V110, P35, DOI 10.1525/cond.2008.110.1.35; Justiniano R, 2015, J BIOGEOGR, V42, P51, DOI 10.1111/jbi.12401; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kennedy R.S., 2000, GUIDE BIRDS PHILIPPI; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim HC, 2014, AUK, V131, P629, DOI 10.1642/AUK-14-80.1; Lim HC, 2011, EVOLUTION, V65, P321, DOI 10.1111/j.1558-5646.2010.01105.x; Lim HC, 2010, J BIOGEOGR, V37, P1894, DOI 10.1111/j.1365-2699.2010.02343.x; Linkem CW, 2010, MOL PHYLOGENET EVOL, V56, P572, DOI 10.1016/j.ympev.2010.03.043; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Marini MA, 2002, AUK, V119, P1114, DOI 10.1642/0004-8038(2002)119[1114:AMATTC]2.0.CO;2; Marks BD, 2002, MOL PHYLOGENET EVOL, V24, P153, DOI 10.1016/S1055-7903(02)00233-6; Marks BD, 2010, MOL PHYLOGENET EVOL, V55, P178, DOI 10.1016/j.ympev.2009.10.027; MAYR E, 1986, EVOLUTION, V40, P55, DOI 10.1111/j.1558-5646.1986.tb05717.x; Mayr E., 2001, BIRDS NO MELANESIA S; McGregor R.C., 1909, MANUAL PHILIPPINE BI; Mila B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-158; Miura GI, 2001, J AVIAN BIOL, V32, P102, DOI 10.1034/j.1600-048X.2001.320202.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nguembock B, 2009, J AVIAN BIOL, V40, P113, DOI 10.1111/j.1600-048X.2009.04410.x; Nyari A, 2009, ZOOL SCR, V2009, P1; Nylander JAA., 2004, BIOINFORMATICS; Oliveros CH, 2010, MOL PHYLOGENET EVOL, V54, P822, DOI 10.1016/j.ympev.2009.12.001; Olsson U, 2005, MOL PHYLOGENET EVOL, V36, P261, DOI 10.1016/j.ympev.2005.01.012; Parkes KC, 1958, AM MUS NOVIT, P1891; Peterson AT, 2006, BIRD CONSERV INT, V16, P155, DOI 10.1017/S0959270906000256; Peterson AT, 2013, GLOBAL ECOL BIOGEOGR, V22, P596, DOI 10.1111/geb.12010; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Rambaut A., 2007, TRACER 1 5 0; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ricklefs RE, 2007, AM NAT, V169, P285, DOI 10.1086/510730; Roberts TE, 2006, MOL ECOL, V15, P2183, DOI 10.1111/j.1365-294X.2006.02928.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy MS, 2001, MOL PHYLOGENET EVOL, V18, P74, DOI 10.1006/mpev.2000.0862; Sanchez-Gonzalez LA, 2011, MOL PHYLOGENET EVOL, V61, P290, DOI 10.1016/j.ympev.2011.06.013; Schlick-Steiner BC, 2007, TRENDS ECOL EVOL, V22, P391, DOI 10.1016/j.tree.2007.05.004; Schmidt BK, 2008, ZOOTAXA, P27; Schneider S, 1999, GENETICS, V152, P1079; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; SHELDON F. H., 2015, J ORNITHOL, V156, P91; Sheldon FH, 2005, MOL PHYLOGENET EVOL, V35, P254, DOI 10.1016/j.ympev.2004.11.008; Sheldon FH, 2012, MOL PHYLOGENET EVOL, V65, P54, DOI 10.1016/j.ympev.2012.05.023; Sheldon FH, 2009, J BIOGEOGR, V36, P1070, DOI 10.1111/j.1365-2699.2009.02087.x; Siler CD, 2010, MOL PHYLOGENET EVOL, V55, P699, DOI 10.1016/j.ympev.2010.01.027; SLADE RW, 1993, MOL ECOL, V2, P359, DOI 10.1111/j.1365-294X.1993.tb00029.x; SLATKIN M, 1991, GENETICS, V129, P555; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steppan SJ, 2003, BIOL J LINN SOC, V80, P699, DOI 10.1111/j.1095-8312.2003.00274.x; TAJIMA F, 1989, GENETICS, V123, P597; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Welton LJ, 2014, ZOOTAXA, V3881, P201, DOI 10.11646/zootaxa.3881.3.1; Welton LJ, 2010, HERPETOL MONOGR, V24, P55, DOI 10.1655/HERPMONOGRAPHS-D-10-00005.1; Whittingham LA, 2002, MOL PHYLOGENET EVOL, V22, P430, DOI 10.1006/mpev.2001.1073; Wilgenbush J.C., 2004, AWTY SYSTEM GRAPHICA; Winker K, 2009, BIOSCIENCE, V59, P657, DOI 10.1525/bio.2009.59.8.7; Zink RM, 1995, AUK, V112, P701; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	124	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0134284	10.1371/journal.pone.0134284	http://dx.doi.org/10.1371/journal.pone.0134284			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312748	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000007
J	Grehl, S; Tutic, A				Grehl, Sascha; Tutic, Andreas			Experimental Evidence on Iterated Reasoning in Games	PLOS ONE			English	Article							DECISION-MAKING; PLAYERS MODELS; EQUILIBRIUM; INDUCTION; BELIEFS	We present experimental evidence on two forms of iterated reasoning in games, i.e. backward induction and interactive knowledge. Besides reliable estimates of the cognitive skills of the subjects, our design allows us to disentangle two possible explanations for the observed limits in performed iterated reasoning: Restrictions in subjects' cognitive abilities and their beliefs concerning the rationality of co-players. In comparison to previous literature, our estimates regarding subjects' skills in iterated reasoning are quite pessimistic. Also, we find that beliefs concerning the rationality of co-players are completely irrelevant in explaining the observed limited amount of iterated reasoning in the dirty faces game. In addition, it is demonstrated that skills in backward induction are a solid predictor for skills in iterated knowledge, which points to some generalized ability of the subjects in iterated reasoning.	[Grehl, Sascha; Tutic, Andreas] Univ Leipzig, Inst Sociol, D-04109 Leipzig, Germany	Leipzig University	Grehl, S (corresponding author), Univ Leipzig, Inst Sociol, D-04109 Leipzig, Germany.	sascha.grehl@uni-leipzig.de		Grehl, Sascha/0000-0002-4289-7122	Deutsche Forschungsgemeinschaft [TU 409/1-1]; German Research Foundation (DFG); Universitat Leipzig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	This work was supported by Deutsche Forschungsgemeinschaft, grant number: TU 409/1-1, receiver of the funding: Andreas Tutic, website: http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.	Agranov M, 2012, NAIVE PLAY PROCESS C; Agranov M, 2012, GAME ECON BEHAV, V75, P449, DOI 10.1016/j.geb.2012.02.002; Arad A, 2012, J ECON BEHAV ORGAN, V84, P571, DOI 10.1016/j.jebo.2012.09.004; Arad A, 2012, AM ECON REV, V102, P3561, DOI 10.1257/aer.102.7.3561; AUMANN R, 1995, ECONOMETRICA, V63, P1161, DOI 10.2307/2171725; Bayer R.-C., 2009, LOGICAL OMNISCIENCE; Bayer R.-C., 2007, DIRTY FACES GAME REV; Bayer RC, 2013, WORKING PAPER; Blume A, 2010, GAME ECON BEHAV, V68, P488, DOI 10.1016/j.geb.2009.07.011; Bock O, 2012, HROOT HAMBURG RECRUI; Bosch-Domenech A, 2010, EXP ECON, V13, P461, DOI 10.1007/s10683-010-9251-7; Burnham TC, 2009, J ECON BEHAV ORGAN, V72, P171, DOI 10.1016/j.jebo.2009.05.015; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Carpenter J, 2013, GAME ECON BEHAV, V80, P115, DOI 10.1016/j.geb.2013.02.012; Devetag G, 2003, J ECON PSYCHOL, V24, P189, DOI 10.1016/S0167-4870(02)00202-7; Dufwenberg M, 2010, J ECON BEHAV ORGAN, V75, P132, DOI 10.1016/j.jebo.2010.03.025; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gneezy U, 2010, J ECON BEHAV ORGAN, V75, P144, DOI 10.1016/j.jebo.2010.04.005; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Grosskopf B, 2008, GAME ECON BEHAV, V62, P93, DOI 10.1016/j.geb.2007.03.004; Huck S, 2002, J ECON BEHAV ORGAN, V47, P71, DOI 10.1016/S0167-2681(01)00170-6; Kahneman D., 2012, PENSAR RAPIDO PENSAR; Levitt SD, 2011, AM ECON REV, V101, P975, DOI 10.1257/aer.101.2.975; Nagel R, 1995, AM ECON REV, V85, P1313; Osborne MJ, 1998, AM ECON REV, V88, P834; Palacios-Huerta I, 2009, AM ECON REV, V99, P1619, DOI 10.1257/aer.99.4.1619; Penczynski SP, 2014, STRATEGIC THINKING T; Rubinstein A., 1998, MODELING BOUNDED RAT; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Rubinstein A, 2013, JUDGM DECIS MAK, V8, P540; Spiegler R, 2002, REV ECON STUD, V69, P691, DOI 10.1111/1467-937X.00222; STAHL DO, 1994, J ECON BEHAV ORGAN, V25, P309, DOI 10.1016/0167-2681(94)90103-1; STAHL DO, 1995, GAME ECON BEHAV, V10, P218, DOI 10.1006/game.1995.1031; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Weber R. A., 2001, Experimental Economics, V4, P229, DOI 10.1007/BF01673535	37	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136524	10.1371/journal.pone.0136524	http://dx.doi.org/10.1371/journal.pone.0136524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312486	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000066
J	Song, JW; Guan, M; Zhao, ZW; Zhang, JJ				Song, Jianwen; Guan, Ming; Zhao, Zhenwen; Zhang, Junjie			Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; GENE-EXPRESSION; RECEPTOR; CELLS; MOTILITY; IDENTIFICATION; CHEMOTAXIS; ALPHA/BETA; REGULATOR	Lysophosphatidic acid (LPA) is an important phospholipid mediator in inflammation and immunity. However, the mechanism of LPA regulation during inflammatory response is largely unknown. Autotaxin (ATX) is the key enzyme to produce extracellular LPA from lysophosphatidylcholine (LPC). In this study, we found that ATX was induced in monocytic THP-1 cells by TLR4 ligand lipopolysaccharide (LPS), TLR9 ligand CpG oligonucleotide, and TLR3 ligand poly(I:C), respectively. The ATX induction by TLR ligand was abolished by the neutralizing antibody against IFN-beta or the knockdown of IFNAR1, indicating that type I IFN autocrine loop is responsible for the ATX induction upon TLR activation. Both IFN-beta and IFN-alpha were able to induce ATX expression via the JAK-STAT and PI3K-AKT pathways but with different time-dependent manners. The ATX induction by IFN-beta was dramatically enhanced by IFN-gamma, which had no significant effect on ATX expression alone, suggesting a synergy effect between type I and type II IFNs in ATX induction. Extracellular LPA levels were significantly increased when THP-1 cells were treated with IFN-alpha/beta or TLR ligands. In addition, the type I IFN-mediated ATX induction was identified in human monocyte-derived dendritic cells (moDCs) stimulated with LPS or poly(I: C), and IFN-alpha/beta could induce ATX expression in human peripheral blood mononuclear cells (PBMCs) and monocytes isolated form blood samples. These results suggest that, in response to TLR activation, ATX is induced through a type I INF autocrine-paracrine loop to enhance LPA generation.	[Song, Jianwen; Zhang, Junjie] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China; [Guan, Ming; Zhao, Zhenwen] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing 100080, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Zhang, JJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China.	jjzhang@bnu.edu.cn		Zhang, Junjie/0000-0001-8809-1485	National Nature Science Foundation of China [31470765]; Science and Technology Program of Beijing Municipality [Z131100005213009]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Beijing Municipality	This work was supported in part by the National Nature Science Foundation of China (No. 31470765) and the Science and Technology Program of Beijing Municipality (No. Z131100005213009).	ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MG, 2014, FEBS LETT; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Idzko M, 2004, J IMMUNOL, V172, P4480, DOI 10.4049/jimmunol.172.7.4480; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin YX, 2003, EUR J IMMUNOL, V33, P2083, DOI 10.1002/eji.200323711; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li S, 2012, FEBS LETT, V586, P792, DOI 10.1016/j.febslet.2012.01.044; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Martino A, 2006, HAEMATOLOGICA, V91, P1273; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Panther E, 2002, J IMMUNOL, V169, P4129, DOI 10.4049/jimmunol.169.8.4129; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosskopf D, 1998, AM J PHYSIOL-CELL PH, V274, pC1573, DOI 10.1152/ajpcell.1998.274.6.C1573; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Silvennoinen O, 1993, INTERFERON INDUCED N; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takeda K., 2004, SEMINARS IMMUNOLOGY; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Teo K, 2014, BIOCHEM J, V463, P157, DOI 10.1042/BJ20140680; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tou JS, 2005, CELL SIGNAL, V17, P77, DOI 10.1016/j.cellsig.2004.06.003; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao ZW, 2009, J CHROMATOGR B, V877, P3739, DOI 10.1016/j.jchromb.2009.08.032; Zheng YH, 2001, J IMMUNOL, V166, P2317, DOI 10.4049/jimmunol.166.4.2317; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	64	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136629	10.1371/journal.pone.0136629	http://dx.doi.org/10.1371/journal.pone.0136629			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313906	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000076
J	Soebiyanto, RP; Gross, D; Jorgensen, P; Buda, S; Bromberg, M; Kaufman, Z; Prosenc, K; Socan, M; Alonso, TV; Widdowson, MA; Kiang, RK				Soebiyanto, Radina P.; Gross, Diane; Jorgensen, Pernille; Buda, Silke; Bromberg, Michal; Kaufman, Zalman; Prosenc, Katarina; Socan, Maja; Alonso, Tomas Vega; Widdowson, Marc-Alain; Kiang, Richard K.			Associations between Meteorological Parameters and Influenza Activity in Berlin (Germany), Ljubljana (Slovenia), Castile and Leon (Spain) and Israeli Districts	PLOS ONE			English	Article								Background Studies in the literature have indicated that the timing of seasonal influenza epidemic varies across latitude, suggesting the involvement of meteorological and environmental conditions in the transmission of influenza. In this study, we investigated the link between meteorological parameters and influenza activity in 9 sub-national areas with temperate and subtropical climates: Berlin (Germany), Ljubljana (Slovenia), Castile and Leon (Spain) and all 6 districts in Israel. Methods We estimated weekly influenza-associated influenza-like-illness (ILI) or Acute Respiratory Infection (ARI) incidence to represent influenza activity using data from each country's sentinel surveillance during 2000-2011 (Spain) and 2006-2011 (all others). Meteorological data was obtained from ground stations, satellite and assimilated data. Two generalized additive models (GAM) were developed, with one using specific humidity as a covariate and another using minimum temperature. Precipitation and solar radiation were included as additional covariates in both models. The models were adjusted for previous weeks' influenza activity, and were trained separately for each study location. Results Influenza activity was inversely associated (p<0.05) with specific humidity in all locations. Minimum temperature was inversely associated with influenza in all 3 temperate locations, but not in all subtropical locations. Inverse associations between influenza and solar radiation were found in most locations. Associations with precipitation were location-dependent and inconclusive. We used the models to estimate influenza activity a week ahead for the 2010/2011 period which was not used in training the models. With exception of Ljubljana and Israel's Haifa District, the models could closely follow the observed data especially during the start and the end of epidemic period. In these locations, correlation coefficients between the observed and estimated ranged between 0.55 to 0.91and the model-estimated influenza peaks were within 3 weeks from the observations. Conclusion Our study demonstrated the significant link between specific humidity and influenza activity across temperate and subtropical climates, and that inclusion of meteorological parameters in the surveillance system may further our understanding of influenza transmission patterns.	[Soebiyanto, Radina P.] Univ Space Res Associat, Goddard Earth Sci Technol & Res, Columbia, MD USA; [Soebiyanto, Radina P.; Kiang, Richard K.] NASA Goddard Space Flight Ctr, Global Change Data Ctr, Greenbelt, MD 20771 USA; [Gross, Diane; Jorgensen, Pernille] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Gross, Diane; Widdowson, Marc-Alain] US Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA USA; [Buda, Silke] Robert Koch Inst, Berlin, Germany; [Bromberg, Michal; Kaufman, Zalman] Minist Hlth, Israel Ctr Dis Control, Tel Hashomer, Israel; [Prosenc, Katarina] Natl Inst Publ Hlth Slovenia, Virol Lab, Ljubljana, Slovenia; [Socan, Maja] Natl Inst Publ Hlth, Communicable Dis & Environm Hlth Care, Ljubljana, Slovenia; [Alonso, Tomas Vega] Publ Hlth Directorate, Dept Hlth, Valladolid, Spain	Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; World Health Organization; Centers for Disease Control & Prevention - USA; Robert Koch Institute	Kiang, RK (corresponding author), NASA Goddard Space Flight Ctr, Global Change Data Ctr, Greenbelt, MD 20771 USA.	richard.k.kiang@nasa.gov			NASA Applied Sciences Public Health program; CDC Influenza Division	NASA Applied Sciences Public Health program; CDC Influenza Division(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by NASA Applied Sciences Public Health program and CDC Influenza Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	34	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134701	10.1371/journal.pone.0134701	http://dx.doi.org/10.1371/journal.pone.0134701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309214	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400031
J	Lopez-Gongora, M; Escartin, A; Martinez-Horta, S; Fernandez-Bobadilla, R; Querol, L; Romero, S; Mananas, MA; Riba, J				Lopez-Gongora, Mariana; Escartin, Antonio; Martinez-Horta, Saul; Fernandez-Bobadilla, Ramon; Querol, Luis; Romero, Sergio; Mananas, Miquel Angel; Riba, Jordi			Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; COGNITIVE DYSFUNCTION; ERROR-DETECTION; ATTENTION SYSTEM; IMPAIRMENT; PERFORMANCE; ACTIVATION; DISABILITY; SEVERITY; SUBTYPES	Multiple sclerosis (MS) is a chronic central nervous system disorder characterized by white matter inflammation, demyelination and neurodegeneration. Although cognitive dysfunction is a common manifestation, it may go unnoticed in recently-diagnosed patients. Prior studies suggest MS patients develop compensatory mechanisms potentially involving enhanced performance monitoring. Here we assessed the performance monitoring system in early-stage MS patients using the error-related negativity (ERN), an event-related brain potential (ERP) observed following behavioral errors. Twenty-seven early-stage MS patients and 31 controls were neuropsychologically assessed. Electroencephalography recordings were obtained while participants performed: a) a stop task and b) an auditory oddball task. Behavior and ERP measures were assessed. No differences in performance were found between groups in most neuropsychological tests or in behavior or ERP components in the auditory oddball task. However, the amplitude of the ERN associated with stop errors in the stop task was significantly higher in patients. ERN amplitude correlated positively with scores on the Expanded Disability Status Scale and the Multiple Sclerosis Severity Score, and negatively with the time since last relapse. Patients showed higher neuronal recruitment in tasks involving performance monitoring. Results suggest the development of compensatory brain mechanisms in early-stage MS and reflect the sensitivity of the ERN to detect these changes.	[Lopez-Gongora, Mariana; Escartin, Antonio; Querol, Luis] Univ Autonoma Barcelona, Dept Neurol, Multiple Sclerosis Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Lopez-Gongora, Mariana; Escartin, Antonio] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Lopez-Gongora, Mariana; Escartin, Antonio; Querol, Luis] Biomed Res Inst IIB St Pau, Multiple Sclerosis Res Grp, Barcelona, Spain; [Martinez-Horta, Saul; Fernandez-Bobadilla, Ramon] Univ Autonoma Barcelona, Dept Neurol, Movement Disorders Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Martinez-Horta, Saul; Fernandez-Bobadilla, Ramon] Biomed Res Inst IIB St Pau, Parkinsons Dis & Movement Disorders Res Grp, Barcelona, Spain; [Romero, Sergio; Mananas, Miquel Angel] Univ Politecn Cataluna, BarcelonaTech UPC, Dept Automat Control ESAII, Biomed Engn Res Ctr CREB, Barcelona, Spain; [Romero, Sergio; Mananas, Miquel Angel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Barcelona, Spain; [Riba, Jordi] Biomed Res Inst IIB St Pau, Human Neuropsychopharmacol Grp, Barcelona, Spain; [Riba, Jordi] Univ Autonoma Barcelona, Ctr Invest Medicaments, Serv Farmacol Clin, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Riba, Jordi] Univ Autonoma Barcelona, Dept Farmacol & Terapeut, E-08193 Barcelona, Spain; [Riba, Jordi] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona	Escartin, A (corresponding author), Univ Autonoma Barcelona, Dept Neurol, Multiple Sclerosis Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain.	aescartin@santpau.cat	Romero, Sergio/K-9236-2016; martinez-horta, saul/ABA-4265-2020; Querol, Luis/H-2119-2015; Mañanas, Miguel Angel/AAI-2961-2021	Querol, Luis/0000-0002-4289-8264; Fernandez-Bobadilla, Ramon/0000-0002-5045-732X; Riba, Jordi/0000-0002-9375-8421; Mananas, Miguel Angel/0000-0001-9836-6083; Martinez-Horta, Saul/0000-0003-0125-7249	Bayer Hispania SL; Instituto de Salud Carlos III, Ministry of Economy and Competitiveness [FIS JR13/00014]	Bayer Hispania SL; Instituto de Salud Carlos III, Ministry of Economy and Competitiveness	This work was supported by Bayer Hispania SL who was not involved in the conception of the study, data collection or preparation of the article. LQ is supported by a Juan Rodes research contract (FIS JR13/00014) from the Instituto de Salud Carlos III, Ministry of Economy and Competitiveness.	Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Aminoff JC, 2001, J CLIN NEUROPHYSIOL, V18, P372, DOI 10.1097/00004691-200107000-00009; Beck A., 1993, BECK ANXIETY INVENTO; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Deloire MSA, 2006, MULT SCLER J, V12, P445, DOI 10.1191/1352458506ms1289oa; Ellger T, 2002, J NEUROL SCI, V205, P35, DOI 10.1016/S0022-510X(02)00278-2; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Glanz BI, 2007, MULT SCLER J, V13, P1004, DOI 10.1177/1352458507077943; Hankomaki E, 2014, ACTA NEUROL SCAND, V129, P184, DOI 10.1111/ane.12161; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Marco-Pallares J, 2010, NEUROIMAGE, V53, P962, DOI 10.1016/j.neuroimage.2010.02.012; Penner IK, 2003, J NEUROL, V250, P461, DOI 10.1007/s00415-003-1025-0; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reuter F, 2011, J NEUROL NEUROSUR PS, V82, P1157, DOI 10.1136/jnnp.2010.213744; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Romero S, 2008, COMPUT BIOL MED, V38, P348, DOI 10.1016/j.compbiomed.2007.12.001; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sadiq S., 2005, MERRITTS NEUROLOGY, P94; Simoes-Franklin C, 2010, HUM BRAIN MAPP, V31, P458, DOI 10.1002/hbm.20879; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; Sundgren M, 2015, CLIN NEUROPHYSIOL, V126, P689, DOI 10.1016/j.clinph.2014.07.024; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	37	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136786	10.1371/journal.pone.0136786	http://dx.doi.org/10.1371/journal.pone.0136786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322632	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500036
J	Maier, T; Haraszti, T				Maier, Timo; Haraszti, Tamas			Reversibility and Viscoelastic Properties of Micropillar Supported and Oriented Magnesium Bundled F-Actin	PLOS ONE			English	Article							SEMIFLEXIBLE POLYMERS; ENTANGLED NETWORKS; BIOMIMETIC MODELS; CORTEX MODELS; MUSCLE ACTIN; FILAMENTS; ELASTICITY; PROTEINS; BINDING; PROBE	Filamentous actin is one of the most important cytoskeletal elements. Not only is it responsible for the elastic properties of many cell types, but it also plays a vital role in cellular adhesion and motility. Understanding the bundling kinetics of actin filaments is important in the formation of various cytoskeletal structures, such as filopodia and stress fibers. Utilizing a unique pillar-structured microfluidic device, we investigated the time dependence of bundling kinetics of pillar supported free-standing actin filaments. Microparticles attached to the filaments allowed the measurement of thermal motion, and we found that bundling takes place at lower concentrations than previously found in 3-dimensional actin gels, i.e. actin filaments formed bundles in the presence of 5-12 mM of magnesium chloride in a time-dependent manner. The filaments also displayed long term stability for up to hours after removing the magnesium ions from the buffer, which suggests that there is an extensive hysteresis between cation induced crosslinking and decrosslinking.	[Maier, Timo; Haraszti, Tamas] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Maier, Timo; Haraszti, Tamas] Heidelberg Univ, Inst Phys Chem, Dept Biophys Chem, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Haraszti, T (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenberg Str 3, D-70569 Stuttgart, Germany.	tamas.haraszti@uni-heidelberg.de		Haraszti, Tamas/0000-0002-7095-4358	Max Planck Society; ERC Advanced grant "SynAd" [294852]	Max Planck Society(Max Planck Society); ERC Advanced grant "SynAd"	This work was financially supported by the Max Planck Society. Part of the research leading to these results has received funding from the ERC Advanced grant "SynAd" (No 294852). This work is also part of the excellence cluster CellNetwork at the University of Heidelberg (http://www.cellnetworks.uni-hd.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini TE, 2003, P NATL ACAD SCI USA, V100, P8634, DOI 10.1073/pnas.1533355100; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; Colby R.H., 2003, POLYM PHYS; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Deme B, 2000, EUR PHYS J E, V2, P125, DOI 10.1007/s101890050046; Dichtl MA, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/318; Dichtl MA, 2002, P NATL ACAD SCI USA, V99, P6533, DOI 10.1073/pnas.052432499; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Haraszti T, 2009, CHEMPHYSCHEM, V10, P2777, DOI 10.1002/cphc.200900581; Haraszti Tamas, 2009, Biophysical Reviews and Letters, V4, P17, DOI 10.1142/S1793048009001009; He J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011908; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Hu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031385; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jahne B., 2002, DIGITAL IMAGE PROCES; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Jones E, 2001, SCIPY OPEN SOURCE SC, DOI [10.1126/science.1063852, DOI 10.1126/SCIENCE.1063852]; Kasza KE, 2010, BIOPHYS J, V99, P1091, DOI 10.1016/j.bpj.2010.06.025; Keller M, 2003, PHILOS T R SOC A, V361, P699, DOI 10.1098/rsta.2002.1158; Kierfeld J, 2006, J COMPUT THEOR NANOS, V3, P898, DOI 10.1166/jctn.2006.006; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Lodish H., 1999, MOL CELL BIOL; Luan Y, 2008, BIOPHYS J, V94, P688, DOI 10.1529/biophysj.107.112417; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Maier T, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-144; Maier T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011501; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MEEUSEN RL, 1979, J CELL BIOL, V82, P57, DOI 10.1083/jcb.82.1.57; Mohrdieck C, 2007, SMALL, V3, P1015, DOI 10.1002/smll.200600565; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; MULLER O, 1991, MACROMOLECULES, V24, P3111; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Roos WH, 2003, CHEMPHYSCHEM, V4, P872, DOI 10.1002/cphc.200300712; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Streichfuss M, 2011, NANO LETT, V11, P3676, DOI 10.1021/nl201630y; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; Thoresen T, 2011, BIOPHYS J, V100, P2698, DOI 10.1016/j.bpj.2011.04.031; Uhde J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268101; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Weisse S, 2011, PHYS CHEM CHEM PHYS, V13, P13395, DOI 10.1039/c1cp20153k; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	47	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136432	10.1371/journal.pone.0136432	http://dx.doi.org/10.1371/journal.pone.0136432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322783	gold, Green Submitted, Green Published			2022-12-27	WOS:000360435500019
J	Nabilou, B; Feizi, A; Seyedin, H				Nabilou, Bahram; Feizi, Aram; Seyedin, Hesam			Patient Safety in Medical Education: Students' Perceptions, Knowledge and Attitudes	PLOS ONE			English	Article							QUALITY	Patient safety is a new and challenging discipline in the Iranian health care industry. Among the challenges for patient safety improvement, education of medical and paramedical students is intimidating. The present study was designed to assess students' perceptions of patient safety, and their knowledge and attitudes to patient safety education. This cross-sectional analytical study was conducted in 2012 at Urmia University of Medical Sciences, West Azerbaijan province, Iran. 134 students studying medicine, nursing, and midwifery were recruited through census for the study. A questionnaire was used for collecting data, which were then analyzed through SPSS statistical software (version 16.0), using Chisquare test, Spearman correlation coefficient, F and LSD tests. A total of 121 questionnaires were completed, and 50% of the students demonstrated good knowledge about patient safety. The relationships between students' attitudes to patient safety and years of study, sex and course were significant (0.003, 0.001 and 0.017, respectively). F and LSD tests indicated that regarding the difference between the mean scores of perceptions of patient safety and attitudes to patient safety education, there was a significant difference among medical and nursing/midwifery students. Little knowledge of students regarding patient safety indicates the inefficiency of informal education to fill the gap; therefore, it is recommended to consider patient safety in the curriculums of all medical and paramedical sciences and formulate better policies for patient safety.	[Nabilou, Bahram] Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Orumiyeh, Iran; [Feizi, Aram] Urmia Univ Med Sci, Patient Safety Res Ctr, Orumiyeh, Iran; [Seyedin, Hesam] Iran Univ Med Sciecnes, Sch Hlth Management & Informat Sci, Tehran, Iran	Urmia University of Medical Sciences; Urmia University of Medical Sciences	Seyedin, H (corresponding author), Iran Univ Med Sciecnes, Sch Hlth Management & Informat Sci, Tehran, Iran.	h.seyedin@iums.ac.ir	Feizi, Aram/O-1587-2017; nabilou, bahram/ABI-4723-2020; nabilou, bahram/G-7659-2017	Feizi, Aram/0000-0002-2260-1451; nabilou, bahram/0000-0001-7188-9992; nabilou, bahram/0000-0001-7188-9992	Urmia University of Medical Sciences	Urmia University of Medical Sciences	This work was funded by Urmia University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi Z, 2013, J NURSING MANAGEMENT; Andermann A, 2011, BMJ QUAL SAF, V20, P96, DOI 10.1136/bmjqs.2010.041814; Bowman C, 2013, ACAD MED, V88, P802, DOI 10.1097/ACM.0b013e31828fd4f4; Carruthers S, 2009, MED TEACH, V31, pE370, DOI 10.1080/01421590802650142; Cheragi Mohammad Ali, 2013, Iran J Nurs Midwifery Res, V18, P228; Hanafi Somayeh, 2012, Iran J Nurs Midwifery Res, V17, P21; Hindle D, 2005, CTR CLIN GOVERNANCE; Jafari G, 2010, HOSP ACCREDITATION S; Kerfoot BP, 2007, J GEN INTERN MED, V22, P1150, DOI 10.1007/s11606-007-0247-8; Khalili H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000367; Khani-Jazani R, 2015, IRAN J PHARM RES, V14, P495; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Kouhestani H, 2008, IRANIAN J MED ED, V8, P285; Leung Gilberto K. K., 2010, Hong Kong Medical Journal, V16, P101; Madigosky WS, 2006, ACAD MED, V81, P94, DOI 10.1097/00001888-200601000-00022; Moghri J, 2013, J CLIN RES GOVERNANC, V2, P47; Mwachofi A, 2011, INT J HEALTH CARE Q, V24, P274, DOI 10.1108/09526861111125589; Nie YL, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-33; Patey R, 2007, QUAL SAF HEALTH CARE, V16, P256, DOI 10.1136/qshc.2006.021014; Rall M, 2011, BEST PRACT RES-CLIN, V25, P251, DOI 10.1016/j.bpa.2011.02.013; Sorensen R, 2008, J HEALTH SERV RES PO, V13, P227, DOI 10.1258/jhsrp.2008.008062; Stelfox HT, 2006, QUAL SAF HEALTH CARE, V15, P174, DOI 10.1136/qshc.2006.017947; Swick HM, 1999, JAMA-J AM MED ASSOC, V282, P830, DOI 10.1001/jama.282.9.830; Vazin Afsaneh, 2012, Acta Med Iran, V50, P425; Walton M, 2010, QUAL SAF HEALTH CARE, V19, P542, DOI 10.1136/qshc.2009.036970; Walton MM, 2006, MED J AUSTRALIA, V184, pS60; Wong BM, 2010, ACAD MED, V85, P1425, DOI 10.1097/ACM.0b013e3181e2d0c6; Yoshikawa JM, 2013, ACTA PAUL ENFERM, V26, P21, DOI 10.1590/S0103-21002013000100005	28	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135610	10.1371/journal.pone.0135610	http://dx.doi.org/10.1371/journal.pone.0135610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322897	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500008
J	Bowen, AC; Mahe, A; Hay, RJ; Andrews, RM; Steer, AC; Tong, SYC; Carapetis, JR				Bowen, Asha C.; Mahe, Antoine; Hay, Roderick J.; Andrews, Ross M.; Steer, Andrew C.; Tong, Steven Y. C.; Carapetis, Jonathan R.			The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma	PLOS ONE			English	Review							PRIMARY-SCHOOL CHILDREN; ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; UPPER RESPIRATORY-TRACT; SKIN DISEASES; STREPTOCOCCAL PYODERMA; NORTHERN-TERRITORY; STAPHYLOCOCCUS-AUREUS; RHEUMATIC-FEVER; RURAL-COMMUNITY; INFECTIONS	Objective We conducted a comprehensive, systematic review of the global childhood population prevalence of impetigo and the broader condition pyoderma. Methods PubMed was systematically searched for impetigo or pyoderma studies published between January 1 1970 and September 30 2014. Two independent reviewers extracted data from each relevant article on the prevalence of impetigo. Findings Sixty-six articles relating to 89 studies met our inclusion criteria. Based on population surveillance, 82 studies included data on 145,028 children assessed for pyoderma or impetigo. Median childhood prevalence was 12.3% (IQR 4.2-19.4%). Fifty-eight (65%) studies were from low or low-middle income countries, where median childhood prevalences were 8.4% (IQR 4.2-16.1%) and 14.5% (IQR 8.3-20.9%), respectively. However, the highest burden was seen in underprivileged children from marginalised communities of high-income countries; median prevalence 19.4%, (IQR 3.9-43.3%). Conclusion Based on data from studies published since 2000 from low and low-middle income countries, we estimate the global population of children suffering from impetigo at any one time to be in excess of 162 million, predominantly in tropical, resource-poor contexts. Impetigo is an under-recognised disease and in conjunction with scabies, comprises a major childhood dermatological condition with potential lifelong consequences if untreated.	[Bowen, Asha C.; Andrews, Ross M.; Tong, Steven Y. C.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Bowen, Asha C.; Carapetis, Jonathan R.] Princess Margaret Hosp Children, Dept Infect Dis, Perth, WA, Australia; [Bowen, Asha C.; Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Mahe, Antoine] Hop Louis Pasteur, Dept Dermatol, Colmar, France; [Hay, Roderick J.] Int Fdn Dermatol, London, England; [Hay, Roderick J.] Kings Coll Hosp NHS Trust, Skin Infect Clin, London, England; [Steer, Andrew C.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Steer, Andrew C.] Univ Melbourne, Inst Child Hlth Res, Melbourne, Vic 3010, Australia; [Tong, Steven Y. C.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Telethon Kids Institute; University of Western Australia; King's College Hospital NHS Foundation Trust; King's College Hospital; Royal Children's Hospital Melbourne; University of Melbourne	Bowen, AC (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Asha.bowen@menzies.edu.au	Bowen, Asha Clare/X-5221-2018; Tong, Steven/N-2353-2013; Carapetis, Jonathan R/H-8933-2014	Bowen, Asha Clare/0000-0002-3242-1155; Tong, Steven/0000-0002-1368-8356; Carapetis, Jonathan R/0000-0002-1182-9792	National Health and Medical Research Council [605845, 1065736]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	AB was supported by a National Health and Medical Research Council (www.nhmrc.gov.au) scholarship 605845. ST was supported by a National Health and Medical Research Council (www.nhmrc.gov.au) fellowship 1065736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AM, 1974, AM J TROP MED HYG, V23, P950, DOI 10.4269/ajtmh.1974.23.950; Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; BECHELLI LM, 1981, DERMATOLOGICA, V163, P78, DOI 10.1159/000250144; BELCHER DW, 1977, T ROY SOC TROP MED H, V71, P204, DOI 10.1016/0035-9203(77)90007-4; Bhalla KK, 1984, INDIAN J DERMATOL, V50, P213; Bhatia V, 1997, Indian J Dermatol Venereol Leprol, V63, P22; Bhavsar B S, 1985, Indian J Public Health, V29, P233; Bissek ACZK, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-7; BRAHMADATHAN KN, 1988, J TROP MED HYG, V91, P306; Brook I, 1997, PEDIATR DERMATOL, V14, P192, DOI 10.1111/j.1525-1470.1997.tb00235.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1995, J PAEDIATR CHILD H, V31, P563, DOI 10.1111/j.1440-1754.1995.tb00886.x; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; CHUTTANI CS, 1971, INDIAN J MED RES, V59, P1822; DAGNEW MB, 1991, TROP GEOGR MED, V43, P152; DAJANI AS, 1973, ARCH DERMATOL, V108, P517, DOI 10.1001/archderm.108.4.517; Dogra S, 2003, PEDIATR DERMATOL, V20, P470, DOI 10.1111/j.1525-1470.2003.20602.x; dos Santos MML, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-61; EASON RJ, 1985, PAPUA NEW GUINEA MED, V28, P247; Fathy H, 2004, East Mediterr Health J, V10, P416; Ferie J, 2006, TROP DOCT, V36, P219, DOI 10.1258/004947506778604823; Figueroa JI, 1996, PEDIATR DERMATOL, V13, P378, DOI 10.1111/j.1525-1470.1996.tb00704.x; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gibbs S, 1996, INT J DERMATOL, V35, P633, DOI 10.1111/j.1365-4362.1996.tb03687.x; HARRIS M, 1992, PAPUA NEW GUINEA MED, V35, P137; HAY RJ, 1994, BRIT MED J, V309, P848, DOI 10.1136/bmj.309.6958.848; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Henderson CA, 1996, INT J DERMATOL, V35, P640, DOI 10.1111/j.1365-4362.1996.tb03688.x; Hogewoning A, 2013, INT J DERMATOL, V52, P589, DOI 10.1111/j.1365-4632.2012.05822.x; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002300, 10.1371/journal.pntd.0002570]; Hoy WE, 2012, KIDNEY INT, V81, P1026, DOI 10.1038/ki.2011.478; Inanir I, 2002, PEDIATR DERMATOL, V19, P307, DOI 10.1046/j.1525-1470.2002.00087.x; Jackson SJ, 2011, TROP MED INT HEALTH, V16, P2, DOI 10.1111/j.1365-3156.2010.02670.x; JINADU MK, 1985, J ROY SOC HEALTH, V105, P25, DOI 10.1177/146642408510500106; Komba EV, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-765; Koning S, 2006, BRIT J DERMATOL, V154, P239, DOI 10.1111/j.1365-2133.2005.06766.x; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; KOSHI G, 1977, INDIAN J MED RES, V66, P379; Kotloff K, 2008, STANDARDIZATION EPID; KOTTENHAHN RK, 1994, TROP DOCT, V24, P87, DOI 10.1177/004947559402400224; Kumar R, 2009, INDIAN J MED RES, V130, P765; LAWRENCE DN, 1979, AM J TROP MED HYG, V28, P547, DOI 10.4269/ajtmh.1979.28.548; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; Lehmann D, 2003, BRIT MED J, V327, P415, DOI 10.1136/bmj.327.7412.415; LINES DR, 1977, AUST NZ J MED, V7, P143, DOI 10.1111/j.1445-5994.1977.tb04681.x; MAHE A, 1995, T ROY SOC TROP MED H, V89, P467, DOI 10.1016/0035-9203(95)90068-3; Mahe A, 2005, T ROY SOC TROP MED H, V99, P39, DOI 10.1016/j.trstmh.2004.03.008; Mahe AH, 2005, EPIDEMIOLOGY MANAGEM; MARGOLIS HS, 1980, AM J DIS CHILD, V134, P681, DOI 10.1001/archpedi.1980.02130190049013; Marshall CS, 2011, AM J TROP MED HYG, V85, P703, DOI 10.4269/ajtmh.2011.11-0185; MASAWE AEJ, 1975, TROP GEOGR MED, V27, P288; MASAWE AEJ, 1975, ARCH DERMATOL, V111, P1312, DOI 10.1001/archderm.111.10.1312; Mohammedamin RS, 2006, BMC DERMATOL, V6, DOI 10.1186/1471-5945-6-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murgia V, 2010, INT J DERMATOL, V49, P666, DOI 10.1111/j.1365-4632.2009.04284.x; NELSON KE, 1976, AM J EPIDEMIOL, V103, P270, DOI 10.1093/oxfordjournals.aje.a112225; NICOLLE LE, 1990, CLIN INVEST MED, V13, P99; NIMMO GR, 1992, MED J AUSTRALIA, V157, P521, DOI 10.5694/j.1326-5377.1992.tb137346.x; Norazah A., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P803; Norhayati M., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P58; Ogunbiyi Adebola O, 2009, Int J Adolesc Med Health, V21, P235, DOI 10.1515/IJAMH.2009.21.2.235; Patel R B, 1982, Indian J Pediatr, V49, P135; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PNMKCBS Behl, 1979, INDIAN J DERMATOL, V50, P213; PORTER MJ, 1980, T ROY SOC TROP MED H, V74, P162, DOI 10.1016/0035-9203(80)90237-0; PORTER MJ, 1984, INT J DERMATOL, V23, P613, DOI 10.1111/j.1365-4362.1984.tb05701.x; Razmjou RG, 2009, ENVIRON RES, V109, P590, DOI 10.1016/j.envres.2009.03.003; San Sebastian M, 1999, J TROP PEDIATRICS, V45, P379, DOI 10.1093/tropej/45.6.379; Saw SM, 2001, T ROY SOC TROP MED H, V95, P384, DOI 10.1016/S0035-9203(01)90189-0; Schmeller W, 1998, INT J DERMATOL, V37, P370, DOI 10.1046/j.1365-4362.1998.00243.x; Schmeller W, 2001, BRIT J DERMATOL, V144, P118, DOI 10.1046/j.1365-2133.2001.03962.x; Shallcross LJ, 2013, EMERG INFECT DIS, V19, P1646, DOI 10.3201/eid1910.130433; Sharma N K, 1986, Indian J Dermatol Venereol Leprol, V52, P330; SHARMA RS, 1984, ANN TROP MED PARASIT, V78, P157, DOI 10.1080/00034983.1984.11811789; Shelby-James TM, 2002, PEDIATR INFECT DIS J, V21, P375, DOI 10.1097/00006454-200205000-00005; Skull SA, 1999, AUST NZ J MED, V29, P66, DOI 10.1111/j.1445-5994.1999.tb01590.x; Steer AC, 1999, ARCH DIS CHILD, V81, P373, DOI 10.1136/adc.81.4.372d; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Stenderup A SE, 1983, FIJI MED J       JAN, P18; STREETON CL, 1995, J PAEDIATR CHILD H, V31, P245, DOI 10.1111/j.1440-1754.1995.tb00795.x; TAPLIN D, 1973, LANCET, V1, P501; Thomas Mark, 2005, N Z Med J, V118, pU1492; Tibazarwa KB, 2008, HEART, V94, P1534, DOI 10.1136/hrt.2007.141309; Tong SYC, 2015, EPIDEMIOL INFECT, V143, P1519, DOI 10.1017/S0950268814002611; VANBUYNDER PG, 1992, MED J AUSTRALIA, V156, P537, DOI 10.5694/j.1326-5377.1992.tb121414.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker SL, 2008, BRIT J DERMATOL, V158, P334, DOI 10.1111/j.1365-2133.2007.08107.x; Wong LCF, 2001, MED J AUSTRALIA, V175, P367, DOI 10.5694/j.1326-5377.2001.tb143620.x; Wu YH, 2000, J FORMOS MED ASSOC, V99, P128; Yamamah GA, 2012, INT J DERMATOL, V51, P1180, DOI 10.1111/j.1365-4632.2012.05475.x	90	123	125	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136789	10.1371/journal.pone.0136789	http://dx.doi.org/10.1371/journal.pone.0136789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317533	gold, Green Published			2022-12-27	WOS:000360299100141
J	Gui, X; Zhang, ZY; Liu, ST; Ma, YH; Zhang, P; He, X; Li, YY; Zhang, J; Li, HF; Rui, YK; Liu, LM; Cao, WD				Gui, Xin; Zhang, Zhiyong; Liu, Shutong; Ma, Yuhui; Zhang, Peng; He, Xiao; Li, Yuanyuan; Zhang, Jing; Li, Huafen; Rui, Yukui; Liu, Liming; Cao, Weidong			Fate and Phytotoxicity of CeO2 Nanoparticles on Lettuce Cultured in the Potting Soil Environment	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; RARE-EARTH-ELEMENTS; NANOMATERIALS; TOXICITY; PLANTS; BIOTRANSFORMATION; ZNO; L.	Cerium oxide nanoparticles (CeO2 NPs) have been shown to have significant interactions in plants. Previous study reported the specific-species phytotoxicity of CeO2 NPs by lettuce (Lactuca sativa), but their physiological impacts and vivo biotransformation are not yet well understood, especially in relative realistic environment. Butterhead lettuce were germinated and grown in potting soil for 30 days cultivation with treatments of 0, 50, 100, 1000 mg CeO2 NPs per kg soil. Results showed that lettuce in 100 mg.kg(-1) treated groups grew significantly faster than others, but significantly increased nitrate content. The lower concentrations treatment had no impact on plant growth, compared with the control. However, the higher concentration treatment significantly deterred plant growth and biomass production. The stress response of lettuce plants, such as Superoxide dismutase (SOD), Peroxidase (POD), Malondialdehyde(MDA) activity was disrupted by 1000 mg.kg(-1) CeO2 NPs treatment. In addition, the presence of Ce (III) in the roots of butterhead lettuce explained the reason of CeO2 NPs phytotoxicity. These findings demonstrate CeO2 NPs modification of nutritional quality, antioxidant defense system, the possible transfer into the food chain and biotransformation in vivo.	[Gui, Xin; Liu, Shutong; Li, Huafen; Rui, Yukui; Liu, Liming] China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China; [Zhang, Zhiyong; Ma, Yuhui; Zhang, Peng; He, Xiao; Li, Yuanyuan] Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100049, Peoples R China; [Zhang, Zhiyong; Ma, Yuhui; Zhang, Peng; He, Xiao; Li, Yuanyuan] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Analyt Tech, Beijing 100049, Peoples R China; [Zhang, Jing] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Rui, Yukui] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Cao, Weidong] Chinese Acad Agr Sci, Inst Agr Resource & Reg Planning, Beijing 100081, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Rui, YK (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China.	ruiyukui@163.com	Zhang, Peng/H-9461-2018; He, Xiao/D-6584-2014; He, Xiao/K-8033-2019	Zhang, Peng/0000-0002-2774-5534; He, Xiao/0000-0002-5188-4382; Li, Yuanyuan/0000-0002-9286-9664; Zhang, Zhiyong/0000-0001-9753-0873; Ma, Yuhui/0000-0002-7031-4596	Key National Natural Science Foundation of China [41130526]; National Natural Science Foundation of China [41371471]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Key National Natural Science Foundation of China (No.41130526) and the National Natural Science Foundation of China (No.41371471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCONI A, 1987, PHYS REV B, V35, P806, DOI 10.1103/PhysRevB.35.806; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chai MW, 2013, PLANT GROWTH REGUL, V71, P171, DOI 10.1007/s10725-013-9817-4; Cui D, 2014, ENVIRON SCI-NANO, V1, P459, DOI [10.1039/c4en00025k, 10.1039/C4EN00025K]; Dimkpa CO, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1125-9; Gantt B, 2014, ENVIRON SCI TECHNOL, V48, P10607, DOI 10.1021/es502169p; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Krystofova O, 2013, INT J ENV RES PUB HE, V10, P47, DOI 10.3390/ijerph10010047; Kunhikrishnan A, 2015, CRIT REV ENV SCI TEC, V45, P277, DOI 10.1080/10643389.2013.852407; Lawrence NJ, 2011, NANO LETT, V11, P2666, DOI 10.1021/nl200722z; Lee J, 2010, ACS NANO, V4, P3580, DOI 10.1021/nn100866w; Lee WM, 2012, CHEMOSPHERE, V86, P491, DOI 10.1016/j.chemosphere.2011.10.013; Lopez-Moreno ML, 2010, ENVIRON SCI TECHNOL, V44, P7315, DOI 10.1021/es903891g; Ma CX, 2013, ACS SUSTAIN CHEM ENG, V1, P768, DOI 10.1021/sc400098h; Ma YH, 2010, CHEMOSPHERE, V78, P273, DOI 10.1016/j.chemosphere.2009.10.050; Miralles P, 2012, ENVIRON SCI TECHNOL, V46, P9224, DOI 10.1021/es202995d; Morales MI, 2013, J AGR FOOD CHEM, V61, P6224, DOI 10.1021/jf401628v; Olson B.J.S.C., 2007, ASSAYS DETERMINATION, DOI [10.1002/0471140864.ps0304s48, DOI 10.1002/0471140864.PS0304S48]; Ouzounidou G, 2013, HORTIC SCI, V40, P119, DOI 10.17221/15/2013-HORTSCI; Priester JH, 2012, P NATL ACAD SCI USA, V109, pE2451, DOI 10.1073/pnas.1205431109; Rico CM, 2013, ENVIRON SCI TECHNOL, V47, P14110, DOI 10.1021/es4033887; Saadat-Monfared A, 2014, COLLOID SURFACE A, V441, P752, DOI 10.1016/j.colsurfa.2012.10.064; Schwabe F, 2013, CHEMOSPHERE, V91, P512, DOI 10.1016/j.chemosphere.2012.12.025; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Wang Q, 2012, METALLOMICS, V4, P1105, DOI 10.1039/c2mt20149f; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yuan DG, 2001, CHEMOSPHERE, V43, P327, DOI 10.1016/S0045-6535(00)00142-9; Zhang P, 2015, NANOTOXICOLOGY, V9, P1, DOI 10.3109/17435390.2013.855829; Zhang P, 2012, ACS NANO, V6, P9943, DOI 10.1021/nn303543n; Zhang ZY, 2011, METALLOMICS, V3, P816, DOI 10.1039/c1mt00049g; Zhao LJ, 2013, J AGR FOOD CHEM, V61, P11945, DOI 10.1021/jf404328e; Zhao LJ, 2012, ACS NANO, V6, P9615, DOI 10.1021/nn302975u	33	65	67	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134261	10.1371/journal.pone.0134261	http://dx.doi.org/10.1371/journal.pone.0134261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317617	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100014
J	Kim, YJ; Lee, DH; Ahn, J; Chung, WJ; Jang, YJ; Seong, KS; Moon, JH; Ha, TY; Jung, CH				Kim, Yang-Ji; Lee, Da-Hye; Ahn, Jiyun; Chung, Woo-Jae; Jang, Young Jin; Seong, Ki-Seung; Moon, Jae-Hak; Ha, Tae Youl; Jung, Chang Hwa			Pharmacokinetics, Tissue Distribution, and Anti-Lipogenic/Adipogenic Effects of Allyl-Isothiocyanate Metabolites	PLOS ONE			English	Article							CHEMOPREVENTIVE AGENTS; CRUCIFEROUS VEGETABLES; BENZYL ISOTHIOCYANATE; SIGNALING PATHWAY; NITRIC-OXIDE; CANCER; SULFORAPHANE; GLUTATHIONE; ACTIVATION; ARREST	Allyl-isothiocyanate (AITC) is an organosulfur phytochemical found in abundance in common cruciferous vegetables such as mustard, wasabi, and cabbage. Although AITC is metabolized primarily through the mercapturic acid pathway, its exact pharmacokinetics remains undefined and the biological function of AITC metabolites is still largely unknown. In this study, we evaluated the inhibitory effects of AITC metabolites on lipid accumulation in vitro and elucidated the pharmacokinetics and tissue distribution of AITC metabolites in rats. We found that AITC metabolites generally conjugate with glutathione (GSH) or N-acetylcysteine (NAC) and are distributed in most organs and tissues. Pharmacokinetic analysis showed a rapid uptake and complete metabolism of AITC following oral administration to rats. Although AITC has been reported to exhibit anti-tumor activity in bladder cancer, the potential bioactivity of its metabolites has not been explored. We found that GSH-AITC and NAC-AITC effectively inhibit adipogenic differentiation of 3T3-L1 preadipocytes and suppress expression of PPAR-gamma, C/EBP alpha, and FAS, which are up-regulated during adipogenesis. GSH-AITC and NAC-AITC also suppressed oleic acid-induced lipid accumulation and lipogenesis in hepatocytes. Our findings suggest that AITC is almost completely metabolized in the liver and rapidly excreted in urine through the mercapturic acid pathway following administration in rats. AITC metabolites may exert anti-obesity effects through suppression of adipogenesis or lipogenesis.	[Kim, Yang-Ji; Lee, Da-Hye; Ahn, Jiyun; Ha, Tae Youl; Jung, Chang Hwa] Korea Univ Sci & Technol, Dept Food Biotechnol, Songnam 463746, South Korea; [Ahn, Jiyun; Jang, Young Jin; Seong, Ki-Seung; Ha, Tae Youl; Jung, Chang Hwa] Korea Food Res Inst, Metab Mech Res Grp, Songnam 463746, South Korea; [Chung, Woo-Jae] Sungkyunkwan Univ, Dept Genet Engn, Suwon 440746, South Korea; [Moon, Jae-Hak] Chonnam Natl Univ, Dept Food Sci & Technol, Gwangju 500757, South Korea	Korea Food Research Institute (KFRI); Sungkyunkwan University (SKKU); Chonnam National University	Ha, TY (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Songnam 463746, South Korea.	tyhap@kfri.re.kr; chjung@kfri.re.kr	Jang, Young Jin/AAT-1192-2020		Korea Food Research Institute of South Korea [E0143033653]	Korea Food Research Institute of South Korea	This study was supported by a grant (E0143033653) from the Korea Food Research Institute of South Korea (www.kfri.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2014, J NUTR BIOCHEM, V25, P1026, DOI 10.1016/j.jnutbio.2014.05.006; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bhattacharya A, 2012, CARCINOGENESIS, V33, P394, DOI 10.1093/carcin/bgr283; Bollard M, 1997, FOOD CHEM TOXICOL, V35, P933, DOI 10.1016/S0278-6915(97)00103-8; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; BRUGGEMAN IM, 1986, TOXICOL APPL PHARM, V83, P349, DOI 10.1016/0041-008X(86)90312-1; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388; Chung FL, 1998, CANCER EPIDEM BIOMAR, V7, P103; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Gao Y, 2015, CURR MED CHEM; Ippoushi K, 2002, LIFE SCI, V71, P411, DOI 10.1016/S0024-3205(02)01685-5; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; JIAO D, 1994, CANCER EPIDEM BIOMAR, V3, P487; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; Kumar GN, 2001, MED RES REV, V21, P397, DOI 10.1002/med.1016; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee JH, 2012, BIOCHEM BIOPH RES CO, V426, P492, DOI 10.1016/j.bbrc.2012.08.107; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Luang-In V, 2014, MOL NUTR FOOD RES, V58, P875, DOI 10.1002/mnfr.201300377; Mori N, 2013, J NUTR SCI VITAMINOL, V59, P56, DOI 10.3177/jnsv.59.56; MOSS EJ, 1985, CHEM-BIOL INTERACT, V55, P139, DOI 10.1016/S0009-2797(85)80124-1; Myzak MC, 2006, CURR DRUG TARGETS, V7, P443, DOI 10.2174/138945006776359467; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Okulicz M, 2010, PLANT FOOD HUM NUTR, V65, P217, DOI 10.1007/s11130-010-0183-3; Rose P, 2005, NITRIC OXIDE-BIOL CH, V12, P237, DOI 10.1016/j.niox.2005.03.001; Sticha KRK, 2002, CARCINOGENESIS, V23, P1433, DOI 10.1093/carcin/23.9.1433; Sultana T, 2003, J FOOD AGRIC ENVIRON, V1, P117; Tsai SC, 2012, INT J ONCOL, V41, P2065, DOI 10.3892/ijo.2012.1640; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Yamasaki M, 2013, NUTR RES PRACT, V7, P267, DOI 10.4162/nrp.2013.7.4.267; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	40	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0132151	10.1371/journal.pone.0132151	http://dx.doi.org/10.1371/journal.pone.0132151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317351	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100003
J	Nakagawa, S; Nishihara, K; Miyata, H; Shinke, H; Tomita, E; Kajiwara, M; Matsubara, T; Iehara, N; Igarashi, Y; Yamada, H; Fukatsu, A; Yanagita, M; Matsubara, K; Masuda, S				Nakagawa, Shunsaku; Nishihara, Kumiko; Miyata, Hitomi; Shinke, Haruka; Tomita, Eri; Kajiwara, Moto; Matsubara, Takeshi; Iehara, Noriyuki; Igarashi, Yoshinobu; Yamada, Hiroshi; Fukatsu, Atsushi; Yanagita, Motoko; Matsubara, Kazuo; Masuda, Satohiro			Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							INJURY MOLECULE-1; TRANSPLANT BIOPSIES; MICROARRAY ANALYSIS; RENAL FIBROSIS; EXPRESSION; BIOMARKER; IDENTIFICATION; REJECTION; PATHWAY; KIM-1	In chronic kidney disease (CKD), progressive nephron loss causes glomerular sclerosis, as well as tubulointerstitial fibrosis and progressive tubular injury. In this study, we aimed to identify molecular changes that reflected the histopathological progression of renal tubulointerstitial fibrosis and tubular cell damage. A discovery set of renal biopsies were obtained from 48 patients with histopathologically confirmed CKD, and gene expression profiles were determined by microarray analysis. The results indicated that hepatitis A virus cellular receptor 1 (also known as Kidney Injury Molecule-1, KIM-1), lipocalin 2 (also known as neutrophil gelatinase-associated lipocalin, NGAL), SRY-box 9, WAP four-disulfide core domain 2, and NK6 homeobox 2 were differentially expressed in CKD. Their expression levels correlated with the extent of tubulointerstitial fibrosis and tubular cell injury, determined by histopathological examination. The expression of these 5 genes was also increased as kidney damage progressed in a rodent unilateral ureteral obstruction model of CKD. We calculated a molecular score using the microarray gene expression profiles of the biopsy specimens. The composite area under the receiver operating characteristics curve plotted using this molecular score showed a high accuracy for diagnosing tubulointerstitial fibrosis and tubular cell damage. The robust sensitivity of this score was confirmed in a validation set of 5 individuals with CKD. These findings identified novel molecular markers with the potential to contribute to the detection of tubular cell damage and tubulointerstitial fibrosis in the kidney.	[Nakagawa, Shunsaku; Nishihara, Kumiko; Shinke, Haruka; Tomita, Eri; Kajiwara, Moto; Matsubara, Kazuo; Masuda, Satohiro] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan; [Miyata, Hitomi; Matsubara, Takeshi; Iehara, Noriyuki; Fukatsu, Atsushi; Yanagita, Motoko] Kyoto Univ Hosp, Grad Sch Med, Dept Nephrol, Sakyo Ku, Kyoto 6068507, Japan; [Igarashi, Yoshinobu; Yamada, Hiroshi] Natl Inst Biomed Innovat Hlth & Nutr, Toxicogen Informat Project, Ibaraki, Osaka 5670085, Japan	Kyoto University; Kyoto University	Masuda, S (corresponding author), Kyushu Univ Hosp, Dept Pharm, Higashi Ku, Fukuoka 8128582, Japan.	satomsdb@pharm.med.kyushu-u.ac.jp	FUKATSU, ATSUSHI/R-7941-2019; Masuda, Satohiro/E-6691-2010; Yanagita, Motoko/AAJ-7731-2021	Masuda, Satohiro/0000-0002-3589-5989; Yanagita, Motoko/0000-0002-0339-9008; Nakagawa, Shunsaku/0000-0002-1285-122X	Ministry of Health, Labour and Welfare of Japan [08062855]; Funding Program for Next Generation World-Leading Researchers (NEXT Program) [LS073]; Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT) of Japan; Grants-in-Aid for Scientific Research [14J07845, 26860101] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT) of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Research on Biological Markers for New Drug Development and Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (08062855 to S. Masuda); by a Funding Program for Next Generation World-Leading Researchers (NEXT Program: LS073 to S. Masuda) initiated by the Council for Science and Technology Policy of the Japan Society for the Promotion of Science; and by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT) of Japan.	Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Bunnag S, 2009, J AM SOC NEPHROL, V20, P1149, DOI 10.1681/ASN.2008080863; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Hellstrom I, 2010, CANCER LETT, V296, P43, DOI 10.1016/j.canlet.2010.03.013; Hosohata K, 2011, TOXICOLOGY, V290, P82, DOI 10.1016/j.tox.2011.08.019; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mueller TF, 2007, AM J TRANSPLANT, V7, P2712, DOI 10.1111/j.1600-6143.2007.02005.x; Naesens M, 2011, KIDNEY INT, V80, P1364, DOI 10.1038/ki.2011.245; Nakagawa S, 2010, BIOCHEM PHARMACOL, V79, P67, DOI 10.1016/j.bcp.2009.07.015; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nickolas TL, 2012, KIDNEY INT, V82, P718, DOI 10.1038/ki.2012.195; Nishihara K, 2010, AM J PHYSIOL-RENAL, V298, pF923, DOI 10.1152/ajprenal.00567.2009; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Rodriguez-Segui S, 2012, J CLIN INVEST, V122, P3469, DOI 10.1172/JCI65751; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schwab K, 2004, AM J NEPHROL, V24, P438, DOI 10.1159/000080188; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Xu PC, 2011, NEPHROL DIAL TRANSPL, V26, P3229, DOI 10.1093/ndt/gfr023; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	32	73	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136994	10.1371/journal.pone.0136994	http://dx.doi.org/10.1371/journal.pone.0136994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317775	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100191
J	Singh, VK; Bozkaya, B; Pentland, A				Singh, Vivek Kumar; Bozkaya, Burcin; Pentland, Alex			Money Walks: Implicit Mobility Behavior and Financial Well-Being	PLOS ONE			English	Article							CREDIT; RISK	Traditional financial decision systems (e.g. credit) had to rely on explicit individual traits like age, gender, job type, and marital status, while being oblivious to spatio-temporal mobility or the habits of the individual involved. Emerging trends in geo-aware and mobile payment systems, and the resulting "big data," present an opportunity to study human consumption patterns across space and time. Taking inspiration from animal behavior studies that have reported significant interconnections between animal spatio-temporal "foraging" behavior and their life outcomes, we analyzed a corpus of hundreds of thousands of human economic transactions and found that financial outcomes for individuals are intricately linked with their spatio-temporal traits like exploration, engagement, and elasticity. Such features yield models that are 30% to 49% better at predicting future financial difficulties than the comparable demographic models.	[Singh, Vivek Kumar; Pentland, Alex] MIT, Media Lab, Cambridge, MA 02139 USA; [Bozkaya, Burcin] Sabanci Univ, Sch Management, Istanbul, Turkey; [Singh, Vivek Kumar] Rutgers State Univ, Sch Commun & Informat, New Brunswick, NJ 08903 USA	Massachusetts Institute of Technology (MIT); Sabanci University; Rutgers State University New Brunswick	Singh, VK (corresponding author), MIT, Media Lab, 20 Amherst St, Cambridge, MA 02139 USA.	singhv@mit.edu	Singh, Vivek/AAD-2381-2019; Bozkaya, Burcin/AAY-8995-2020	Bozkaya, Burcin/0000-0002-3685-4791				[Anonymous], NY TIMES; [Anonymous], FORBES; [Anonymous], 2013, THE NILSON REPORT; [Anonymous], 2014, FEDERAL RESERVE B; Bolton RJ, 2002, STAT SCI, V17, P235; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; Christiansen J, 2001, United States patent US, Patent No. [6,202,053, 6202053]; Clark A.B., 1987, Perspectives in Ethology, V7, P1; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; de Montjoye YA, 2013, NATURE SREP, V3; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; Drakakis K., 2008, INT MATH FORUM, V3, P1853; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Federal Reserve Board Consumers and Mobile Financial Services, 2014, CONS MOB FIN SERV; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hall M. A., 1998, CORRELATION BASED FE; Harrison PM, 2014, BEHAV ECOLOGY; Krumme C, 2013, NATURE SREP, V3; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lenormand M, 2014, ARXIV14117895; Rampini AA, 2010, J FINANC, V65, P2293, DOI 10.1111/j.1540-6261.2010.01616.x; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Saavedra S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2901; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; SMITH JNM, 1974, ECOLOGY, V55, P1216, DOI 10.2307/1935451; Sobolevsky S, 2014, IEEE INT CONGR BIG, P136, DOI 10.1109/BigData.Congress.2014.28; Storbacka K., 1997, J MARKET MANAG, V13, P479, DOI [DOI 10.1080/0267257X.1997.9964487, 10.1080/0267257X.1997.9964487]; Thomas LC, 2005, J OPER RES SOC, V56, P1006, DOI 10.1057/palgrave.jors.2602018; Thomas LC, 2000, INT J FORECASTING, V16, P149, DOI 10.1016/S0169-2070(00)00034-0; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wired.com-Business, 2014, HIDDEN PRIV THREAT F	35	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136628	10.1371/journal.pone.0136628	http://dx.doi.org/10.1371/journal.pone.0136628			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317339	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100115
J	Brown, AD; Beemer, BT; Greene, NT; Argo, T; Meegan, GD; Tollin, DJ				Brown, Andrew D.; Beemer, Brianne T.; Greene, Nathaniel T.; Argo, Theodore; Meegan, G. Douglas; Tollin, Daniel J.			Effects of Active and Passive Hearing Protection Devices on Sound Source Localization, Speech Recognition, and Tone Detection	PLOS ONE			English	Article							NOISE; CUES; EAR; SENSITIVITY; IMPACT	Hearing protection devices (HPDs) such as earplugs offer to mitigate noise exposure and reduce the incidence of hearing loss among persons frequently exposed to intense sound. However, distortions of spatial acoustic information and reduced audibility of low-intensity sounds caused by many existing HPDs can make their use untenable in high-risk (e.g., military or law enforcement) environments where auditory situational awareness is imperative. Here we assessed (1) sound source localization accuracy using a head-turning paradigm, (2) speech-in-noise recognition using a modified version of the QuickSIN test, and (3) tone detection thresholds using a two-alternative forced-choice task. Subjects were 10 young normal-hearing males. Four different HPDs were tested (two active, two passive), including two new and previously untested devices. Relative to unoccluded (control) performance, all tested HPDs significantly degraded performance across tasks, although one active HPD slightly improved high-frequency tone detection thresholds and did not degrade speech recognition. Behavioral data were examined with respect to head-related transfer functions measured using a binaural manikin with and without tested HPDs in place. Data reinforce previous reports that HPDs significantly compromise a variety of auditory perceptual facilities, particularly sound localization due to distortions of high-frequency spectral cues that are important for the avoidance of front-back confusions.	[Brown, Andrew D.; Greene, Nathaniel T.; Tollin, Daniel J.] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA; [Beemer, Brianne T.] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA; [Argo, Theodore; Meegan, G. Douglas] Appl Res Associates Inc, Littleton, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Applied Research Associates, Inc.	Brown, AD (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA.	Andrew.D.Brown@ucdenver.edu		, Daniel/0000-0001-6790-1290; Greene, Nathaniel/0000-0001-5872-9169	US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-12-C-0121]; National Institute on Deafness and Other Communication Disorders [F32-DC013927, T32-DC012280]; Applied Research Associates, Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC013927, T32DC012280] Funding Source: NIH RePORTER	US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Applied Research Associates, Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the US Army Medical Research and Materiel Command (USAMRMC) under Contract No. W81XWH-12-C-0121 and the National Institute on Deafness and Other Communication Disorders (F32-DC013927 [ADB] and T32-DC012280 [NTG]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Applied Research Associates, Inc. provided support in the form of salaries for authors TA and GDM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abel SM, 2008, AVIAT SPACE ENVIR MD, V79, P591, DOI 10.3357/ASEM.2262.2008; Abel SM, 1996, SCAND AUDIOL, V25, P3, DOI 10.3109/01050399609047549; Abel SM, 1999, ACUSTICA, V85, P378; ABEL SM, 1985, SCAND AUDIOL, V14, P161, DOI 10.3109/01050398509045937; Abel SM, 2005, AVIAT SPACE ENVIR MD, V76, P1128; Blauert J., 1997, SPATIAL HEARING PSYC; Casali JG, 1996, AM IND HYG ASSOC J, V57, P175, DOI 10.1080/15428119691015115; Casali JG, 2015, INT J AUDIOL, V54, pS37, DOI 10.3109/14992027.2014.973538; Casali JG, 2012, NAV ENG J, V124, P149; Clasing JE, 2014, INT J AUDIOL, V53, pS43, DOI 10.3109/14992027.2013.860489; Fernandes JC, 2003, APPL ACOUST, V64, P581, DOI 10.1016/S0003-682X(02)00141-X; GARDNER MB, 1973, J ACOUST SOC AM, V53, P400, DOI 10.1121/1.1913336; Giguere C, 2015, INT J AUDIOL, V54, pS9, DOI 10.3109/14992027.2014.973540; Greene NT, 2014, HEARING RES, V316, P1, DOI 10.1016/j.heares.2014.07.004; HARTMANN WM, 1983, J ACOUST SOC AM, V74, P1380, DOI 10.1121/1.390163; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kumpik DP, 2010, J NEUROSCI, V30, P4883, DOI 10.1523/JNEUROSCI.5488-09.2010; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; MIDDLEBROOKS JC, 1990, J ACOUST SOC AM, V87, P2149, DOI 10.1121/1.399183; MIDDLEBROOKS JC, 1989, J ACOUST SOC AM, V86, P89, DOI 10.1121/1.398224; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; OHLIN D, 1996, MED SURVEILLANCE MON, V2, P8; Rife D., 1989, INT J CONTROL, V37, P419; ROBINSON DW, 1956, BRIT J APPL PHYS, V7, P166, DOI 10.1088/0508-3443/7/5/302; Simpson BD, 2005, HUM FACTORS, V47, P188, DOI 10.1518/0018720053653866; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; Tufts JB, 2011, NOISE HEALTH, V13, P26, DOI 10.4103/1463-1741.73998; Tufts JB, 2009, J AM ACAD AUDIOL, V20, P539, DOI 10.3766/jaaa.20.9.3; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Zeng F-G, 2010, OXFORD HDB AUDITORY; Zimpfer V, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00135	33	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136568	10.1371/journal.pone.0136568	http://dx.doi.org/10.1371/journal.pone.0136568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313145	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000069
J	de Haan, S; Rietveld, E; Stokhof, M; Denys, D				de Haan, Sanneke; Rietveld, Erik; Stokhof, Martin; Denys, Damiaan			Effects of Deep Brain Stimulation on the Lived Experience of Obsessive-Compulsive Disorder Patients: In-Depth Interviews with 18 Patients	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; NEUROSURGERY; IMPULSIVITY; MECHANISMS; CESSATION; CRITERIA; OUTCOMES; DISEASE; MIND	Deep Brain Stimulation (DBS) is a relatively new, experimental treatment for patients suffering from treatment-refractory Obsessive Compulsive Disorder (OCD). The effects of treatment are typically assessed with psychopathological scales that measure the amount of symptoms. However, clinical experience indicates that the effects of DBS are not limited to symptoms only: patients for instance report changes in perception, feeling stronger and more confident, and doing things unreflectively. Our aim is to get a better overview of the whole variety of changes that OCD patients experience during DBS treatment. For that purpose we conducted in-depth, semi-structured interviews with 18 OCD patients. In this paper, we present the results from this qualitative study. We list the changes grouped in four domains: with regard to (a) person, (b) (social) world, (c) characteristics of person-world interactions, and (d) existential stance. We subsequently provide an interpretation of these results. In particular, we suggest that many of these changes can be seen as different expressions of the same process; namely that the experience of anxiety and tension gives way to an increased basic trust and increased reliance on one's abilities. We then discuss the clinical implications of our findings, especially with regard to properly informing patients of what they can expect from treatment, the usefulness of including CBT in treatment, and the limitations of current measures of treatment success. We end by making several concrete suggestions for further research.	[de Haan, Sanneke; Rietveld, Erik; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Rietveld, Erik] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Rietveld, Erik; Stokhof, Martin] Univ Amsterdam, Dept Philosophy, Inst Log Language & Computat, Amsterdam, Netherlands; [Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Denys, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	ddenys@gmail.com	Stokhof, Martin/AAI-3468-2020	Stokhof, Martin/0000-0002-8966-8095; Rietveld, Erik/0000-0001-5197-142X	Netherlands Organisation for Scientific Research; Medtronic Inc.	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medtronic Inc.(Medtronic)	This work has been supported by a VENI Grant from The Netherlands Organisation for Scientific Research (http://www.nwo.nl/en) to Dr. Erik Rietveld. The Deep Brain Stimulation devices used in this study were provided by Medtronic Inc. Dr. Denys was supported by an unrestricted investigator-initiated research grant by Medtronic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Agid Y, 2006, J NEURAL TRANSM-SUPP, P409; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Bruineberg J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00599; Chang CH, 2010, J NEUROSURG, V112, P1299, DOI 10.3171/2009.10.JNS09918; Chemero A, 2003, ECOL PSYCHOL, V15, P181, DOI 10.1207/S15326969ECO1502_5; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; de Haan S, 2013, ANXIETY DISORDERS; de Haan S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00653; de Koning PP, 2011, CURR PSYCHIAT REP, V13, P274, DOI 10.1007/s11920-011-0200-8; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Dougherty DD, 2014, BIOLOGICAL PSYCHIATR; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Gibson J. J., 1979, THE ECOLOGICAL APPRO; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Greenberg BD, 2010, NEUROPSYCHOPHARMACOL, V35, P317, DOI 10.1038/npp.2009.128; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Haq IU, 2010, STEREOT FUNCT NEUROS, V88, P322, DOI 10.1159/000319960; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Heyman I, 2006, BMJ-BRIT MED J, V333, P424, DOI 10.1136/bmj.333.7565.424; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Kuhn J, 2009, EUR ADDICT RES, V15, P196, DOI 10.1159/000228930; Kuhn J, 2007, J NEUROL NEUROSUR PS, V78, P1152, DOI 10.1136/jnnp.2006.113092; Lipsman N, 2013, BIOETHICS, V27, P465, DOI 10.1111/j.1467-8519.2012.01978.x; Luigjes J, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.03.009; Luigjes J, 2011, INT CLIN PSYCHOPHARM, V26, P338, DOI 10.1097/YIC.0b013e32834af505; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; Mantione M, 2014, PSYCHOL MED, P1; Mantione M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00152; Mantione M, 2010, NEUROSURGERY, V66, P218, DOI 10.1227/01.NEU.0000360570.40339.64; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Montgomery EB, 2008, NEUROSCI BIOBEHAV R, V32, P388, DOI 10.1016/j.neubiorev.2007.06.003; Okun MS, 2007, J NEUROL NEUROSUR PS, V78, P310, DOI 10.1136/jnnp.2006.095315; Ooms P, 2014, BRAIN STIMUL, V7, P727, DOI 10.1016/j.brs.2014.06.009; Ooms P, 2014, J NEUROL NEUROSUR PS, V85, P153, DOI 10.1136/jnnp-2012-302550; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P226; Reed E. S., 1996, ENCOUNTERING THE WOR; Rietveld E, 2014, ECOL PSYCHOL, V26, P325, DOI 10.1080/10407413.2014.958035; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Schermer M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00017; Schupbach M, 2006, NEUROLOGY, V66, P1811, DOI 10.1212/01.wnl.0000234880.51322.16; Servello D, 2008, J NEUROL NEUROSUR PS, V79, P136, DOI 10.1136/jnnp.2006.104067; Shapira NA, 2006, J NEUROL NEUROSUR PS, V77, P410, DOI 10.1136/jnnp.2005.069906; Spitzer U, 2009, NERVENHEILKUNDE, V28, P634; Stoffregen TA, 2003, ECOL PSYCHOL, V15, P115, DOI 10.1207/S15326969ECO1502_2; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Summerfeldt LJ, 2004, J CLIN PSYCHOL, V60, P1155, DOI 10.1002/jclp.20080; Synofzik Matthis, 2008, Biotechnology Journal, V3, P1511, DOI 10.1002/biot.200800187; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsai Hsin-Chi, 2010, Biol Psychiatry, V68, pe7, DOI 10.1016/j.biopsych.2010.04.001; van Westen Maarten, 2015, Curr Behav Neurosci Rep, V2, P41; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022	62	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135524	10.1371/journal.pone.0135524	http://dx.doi.org/10.1371/journal.pone.0135524			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26312488	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000018
J	Shafiee, MJ; Azimifar, Z; Wong, A				Shafiee, Mohammad Javad; Azimifar, Zohreh; Wong, Alexander			A Deep-Structured Conditional Random Field Model for Object Silhouette Tracking	PLOS ONE			English	Article								In this work, we introduce a deep-structured conditional random field (DS-CRF) model for the purpose of state-based object silhouette tracking. The proposed DS-CRF model consists of a series of state layers, where each state layer spatially characterizes the object silhouette at a particular point in time. The interactions between adjacent state layers are established by inter-layer connectivity dynamically determined based on inter-frame optical flow. By incorporate both spatial and temporal context in a dynamic fashion within such a deep-structured probabilistic graphical model, the proposed DS-CRF model allows us to develop a framework that can accurately and efficiently track object silhouettes that can change greatly over time, as well as under different situations such as occlusion and multiple targets within the scene. Experiment results using video surveillance datasets containing different scenarios such as occlusion and multiple targets showed that the proposed DS-CRF approach provides strong object silhouette tracking performance when compared to baseline methods such as mean-shift tracking, as well as state-of-the-art methods such as context tracking and boosted particle filtering.	[Shafiee, Mohammad Javad; Wong, Alexander] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Azimifar, Zohreh] Shiraz Univ, Dept Comp Sci & Engn, Shiraz, Fars, Iran	University of Waterloo; Shiraz University	Shafiee, MJ (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.	mjshafiee@uwaterloo.ca	Wong, Alexander/GZM-2929-2022; MohammadShafiee, MohammadReza/J-2988-2013	Wong, Alexander/0000-0002-5295-2797; 	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Ontario Ministry of Economic Development and Innovation; Shiraz University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Economic Development and Innovation; Shiraz University	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Canada Research Chairs Program, and the Ontario Ministry of Economic Development and Innovation. The financial support provided by Shiraz University for this work is also appreciated.	Ablavsky V, 2011, IEEE T PATTERN ANAL, V33, P1758, DOI 10.1109/TPAMI.2011.43; Barrena J. A., 2005, 2005 EUR C POW EL AP, P1; Boudoukh G, 2009, IEEE IMAGE PROC, P3625, DOI 10.1109/ICIP.2009.5414280; Comaniciu D, 2000, PROC CVPR IEEE, P142, DOI 10.1109/CVPR.2000.854761; Dinh TB, 2011, PROC CVPR IEEE, P1177, DOI 10.1109/CVPR.2011.5995733; Frankovich M, 2011, IEEE SIGNAL PROC LET, V18, P375, DOI 10.1109/LSP.2011.2140396; Jain A, 2012, IEEE IMAGE PROC, P1073, DOI 10.1109/ICIP.2012.6467049; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jazwinski Andrew H., 2007, STOCHASTIC PROCESSES; Julier S. J., 1997, INT S AER DEF SENS S, V3, P3; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Klinge R, 2007, CLASSICAL PROBABILIS, P1; Kumar S, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1150, DOI 10.1109/ICCV.2003.1238478; Kumar S, 2003, NEURAL INFORM PROCES, P1; Lafferty J, 2001, P WORKSH LANG MOD IN, P1; Okuma K, 2004, LECT NOTES COMPUT SC, V3021, P28, DOI 10.1007/978-3-540-24670-1_3; Ratajczak M, 2014, P WORKSHOP LEARNING, V1, P1; Ren X., 2007, P CVPR, P1, DOI DOI 10.1109/CVPR.2007.383177; Scharfenberger C, 2014, INT C IM PROC ICIP, P1; Scharfenberger C, 2013, PROC CVPR IEEE, P979, DOI 10.1109/CVPR.2013.131; Shafiee MJ, 2010, IEEE IMAGE PROC, P4645, DOI 10.1109/ICIP.2010.5653823; Shafiee M J, 2015, ARXIV150100752; Shafique Muhammad, 2014, P 51 ACM EDAC IEEE D, P1; Sigal L, 2007, LECT NOTES COMPUT SC, V3417, P223; Sorenson HW, 1958, KALMAN FILTERING THE; Taycher L., 2006, P IEEE CVPR, V1, P222; Verbeek J., 2007, P NIPS, P1; Vermaak J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1110; Wallach H, 2002, P 6 ANN CLUK RES C, P1; Wang Y, 2005, PROC CVPR IEEE, P264; Yu D., 2009, 2009 P NIPS WORKSH D, P1, DOI [10.1145/2069216.2069246, DOI 10.1145/2069216.2069246]; Yu D, 2010, IEEE J-STSP, V4, P965, DOI 10.1109/JSTSP.2010.2075990; Zhang L, 2008, MULTIRESOLUTION ANOM, P1	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0133036	10.1371/journal.pone.0133036	http://dx.doi.org/10.1371/journal.pone.0133036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313943	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000005
J	Sneideris, T; Darguzis, D; Botyriute, A; Grigaliunas, M; Winter, R; Smirnovas, V				Sneideris, Tomas; Darguzis, Domantas; Botyriute, Akvile; Grigaliunas, Martynas; Winter, Roland; Smirnovas, Vytautas			pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils	PLOS ONE			English	Article							PRION-LIKE MECHANISMS; NEURODEGENERATIVE DISEASES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; STRUCTURAL BASIS; A-BETA; STRAINS; PROTEIN; CONFORMATIONS; LEVEL	Prions are infective proteins, which can self-assemble into different strain conformations, leading to different disease phenotypes. An increasing number of studies suggest that prion-like self-propagation may be a common feature of amyloid-like structures. Thus it is important to unravel every possible factor leading to the formation of different amyloid strains. Here we report on the formation of two types of insulin amyloid-like fibrils with distinct infrared spectroscopic features grown under slightly different pH conditions. Similar to prion strains, both insulin fibril types are able to self-propagate their conformational template under conditions, favoring spontaneous formation of different type fibrils. The low-pH-induced insulin amyloid strain is structurally very similar to previously reported strains formed either in the presence of 20% ethanol, or by modification of the amino acid sequence of insulin. A deeper analysis of literature data in the context of our current findings suggests a shift of the monomer-dimer equilibrium of insulin as a possible factor controlling the formation of different strains.	[Sneideris, Tomas; Darguzis, Domantas; Botyriute, Akvile; Grigaliunas, Martynas; Smirnovas, Vytautas] Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania; [Winter, Roland] TU Dortmund Univ, Fac Chem & Chem Biol, Phys Chem Biophys Chem 1, Dortmund, Germany	Vilnius University; Dortmund University of Technology	Smirnovas, V (corresponding author), Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania.	vytautas.smirnovas@bti.vu.lt	Šneideris, Tomas/AAQ-9054-2020; Smirnovas, Vytautas/O-6270-2018	Šneideris, Tomas/0000-0001-5285-871X; Smirnovas, Vytautas/0000-0002-1829-5455; Winter, Roland/0000-0002-3512-6928	European Social Fund under the Global Grant Measure [VP1-3.1-SMM-07-K-02-020]	European Social Fund under the Global Grant Measure	This research was funded by the European Social Fund under the Global Grant Measure, project number VP1-3.1-SMM-07-K-02-020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Abramovich L, 2012, NAT CHEM BIOL, V8, P701, DOI [10.1038/NCHEMBIO.1002, 10.1038/nchembio.1002]; Aguzzi A, 2014, NATURE, V512, P32, DOI 10.1038/512032a; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BRYANT C, 1993, BIOCHEMISTRY-US, V32, P8075, DOI 10.1021/bi00083a004; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chatani E, 2012, J BIOL CHEM, V287, P22827, DOI 10.1074/jbc.M111.333310; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t; Dzwolak W, 2005, PHYS CHEM CHEM PHYS, V7, P1349, DOI 10.1039/b502255j; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Eisele YS, 2013, BRAIN PATHOL, V23, P333, DOI 10.1111/bpa.12049; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Grudzielanek S, 2005, J MOL BIOL, V351, P879, DOI 10.1016/j.jmb.2005.06.046; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kim SK, 2010, PHYS CHEM CHEM PHYS, V12, P3334, DOI 10.1039/c004156b; Kurouski D, 2012, BIOPHYS J, V103, P522, DOI 10.1016/j.bpj.2012.04.042; Kurouski D, 2012, CHEM COMMUN, V48, P2837, DOI 10.1039/c2cc16895b; Kurouski D, 2010, CHEM COMMUN, V46, P7154, DOI 10.1039/c0cc02423f; Malisauskas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121231; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Milto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068684; Nettleton EJ, 2000, BIOPHYS J, V79, P1053, DOI 10.1016/S0006-3495(00)76359-4; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Surmacz-Chwedoruk W, 2014, J PHYS CHEM B, V118, P13582, DOI 10.1021/jp510980b; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; Tamamis P, 2009, BIOPHYS J, V96, P5020, DOI 10.1016/j.bpj.2009.03.026; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004	54	44	45	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136602	10.1371/journal.pone.0136602	http://dx.doi.org/10.1371/journal.pone.0136602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313643	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000074
J	Barciszewska, AM; Gurda, D; Glodowicz, P; Nowak, S; Naskret-Barciszewska, MZ				Barciszewska, Anna-Maria; Gurda, Dorota; Glodowicz, Pawel; Nowak, Stanislaw; Naskret-Barciszewska, Miroslawa Z.			A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells	PLOS ONE			English	Article							DNA DEMETHYLATION; GLIOBLASTOMA; CLASSIFICATION; METHYLATION	Temozolomide (TMZ) is an oral alkylating chemotherapeutic agent that prolongs the survival of patients with glioblastoma (GBM). Despite that high TMZ potential, progression of disease and recurrence are still observed. Therefore a better understanding of the mechanism of action of this drug is necessary and may allow more durable benefit from its antiglioma properties. Using nucleotide post-labelling method and separation on thin-layer chromatography we measured of global changes of 5-methylcytosine (m(5)C) in DNA of glioma cells treated with TMZ. Although m5C is not a product of TMZ methylation reaction of DNA, we analysed the effects of the drug action on different glioma cell lines through global changes at the level of the DNA main epigenetic mark. The first effect of TMZ action we observed is DNA hypermethylation followed by global demethylation. Therefore an increase of DNA methylation and down regulation of some genes expression can be ascribed to activation of DNA methyltransferases (DNMTs). On the other hand hypomethylation is induced by oxidative stress and causes uncontrolled expression of pathologic protein genes. The results of brain tumours treatment with TMZ suggest the new mechanism of modulation epigenetic marker in cancer cells. A high TMZ concentration induced a significant increase of m5C content in DNA in the short time, but a low TMZ concentration at longer time hypomethylation is observed for whole range of TMZ concentrations. Therefore TMZ administration with low doses of the drug and short time should be considered as optimal therapy.	[Barciszewska, Anna-Maria; Nowak, Stanislaw] Poznan Univ Med Sci, Dept Neurosurg & Neurotraumatol, PL-60355 Poznan, Poland; [Gurda, Dorota; Glodowicz, Pawel; Naskret-Barciszewska, Miroslawa Z.] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Barciszewska, AM (corresponding author), Poznan Univ Med Sci, Dept Neurosurg & Neurotraumatol, Przybyszewskiego 49, PL-60355 Poznan, Poland.	abarcisz@man.poznan.pl	Barciszewska, Anna-Maria/J-5978-2018	Barciszewska, Anna-Maria/0000-0002-7179-1474; Gurda, Dorota/0000-0002-6562-6739	University of Medical Sciences [502-14-01122178-09753]; Polish Ministry of Science and Higher Education	University of Medical Sciences; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by University of Medical Sciences through the grant for young scientists No. 502-14-01122178-09753 (AMB) and Polish Ministry of Science and Higher Education under KNOW programme (MZB).	Augustine CK, 2009, CLIN CANCER RES, V15, P502, DOI 10.1158/1078-0432.CCR-08-1916; Avgeropoulos N G, 1999, Oncologist, V4, P209; Barciszewska AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092599; Barciszewska AM, 2009, THERAPEUTIC RIBONUCLEIC ACIDS IN BRAIN TUMORS, P141, DOI 10.1007/978-3-642-00475-9_7; Barciszewska MZ, 2007, BIOGERONTOLOGY, V8, P673, DOI 10.1007/s10522-007-9109-3; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Citisli V, 2015, TUMOUR BIOL; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Fan CH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.388; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fisher T, 2007, CANCER J, V13, P335, DOI 10.1097/PPO.0b013e318157053f; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; Happold C, 2012, J NEUROCHEM, V122, P444, DOI 10.1111/j.1471-4159.2012.07781.x; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Lewandowska-Gnatowska E, 2014, PLANT PHYSIOL BIOCH, V82, P202, DOI 10.1016/j.plaphy.2014.06.003; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mhaidat NM, 2007, BRIT J CANCER, V97, P1225, DOI 10.1038/sj.bjc.6604017; Michalak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070693; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Neidle S, 2005, NAT REV CANCER, V5, P285, DOI 10.1038/nrc1587; Shen W, 2014, J INT MED RES, V42, P164, DOI 10.1177/0300060513501753; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tentori L, 2009, CURR MED CHEM, V16, P245, DOI 10.2174/092986709787002718; Ulahannan N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-5; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zukiel R, 2004, MOL CANCER RES, V2, P196	30	51	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136669	10.1371/journal.pone.0136669	http://dx.doi.org/10.1371/journal.pone.0136669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309255	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400149
J	Ciapala, S; Adamski, P				Ciapala, Szymon; Adamski, Pawel			Methodological Aspects of the Potential Use of Dendrochronological Techniques When Analyzing the Long-Term Impact of Tourism on Protected Areas	PLOS ONE			English	Article							SLOPE	Intensification of pedestrian tourism causes damage to trees near tourist tracks, and likewise changes the soil structure. As a result, one may expect that annual amount of trees growing near tracks is significantly lower than deeper in the forest. However, during the study of the long-term impact of tourism on the environment (determined from tree increment dynamics), some methodological problems may occur. It is particularly important in protected areas where law and administrative regulations related to nature conservation force research to be conducted using small samples. In this paper we have analyzed the data collected in the Polish part of the Tatra National Park in the two study plots divided into two zones each: the area directly under the influence of the tourist's trampling and the control group. The aim of such analyses was to present the potential effects of the factors which may affect the results of dendrochronological analysis: (i) small size of samples that affects their representativeness, (ii) spatial differences in the rates of the process, as a result of spatial variability of environmental factors and (iii) temporal differences in the rates of the process. This study confirms that the factors mentioned above could significantly influence the results and should be taken into consideration during the analysis.	[Ciapala, Szymon] Univ Sch Phys Educ, Fac Ecol, Dept Nat Environm Sci, Krakow, Poland; [Adamski, Pawel] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Polish Academy of Sciences	Ciapala, S (corresponding author), Univ Sch Phys Educ, Fac Ecol, Dept Nat Environm Sci, Krakow, Poland.	szymon.ciapala@gmail.com	Adamski, Paweł/GQA-4210-2022	Adamski, Pawel/0000-0002-2276-5739				Armitage P., 2001, STAT METHODS MED RES; Becken S., 2006, Journal of Sustainable Tourism, V14, P323, DOI 10.2167/jost547.0; Buckley R, 1996, ANN TOURISM RES, V23, P925, DOI 10.1016/0160-7383(96)00005-9; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Ciapala S, 2013, FOLIA TURISTICA, V28, P227; Ciapala S, 2014, GEOCHRONOMETRIA, V41, P392, DOI 10.2478/s13386-013-0170-1; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Crowley MJ., 2007, R BOOK; Czochanski J.T., 2002, UZYTKOWANIE TURYSTYC, P385; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Fantucci R, 1999, GEOMORPHOLOGY, V30, P165, DOI 10.1016/S0169-555X(99)00052-5; Font X, 1999, FOREST TOURISM RECRE, P87; Freitag R, 2008, TRENDS ISSUES GLOBAL, P3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gambio J., 2005, FUNCTIONS PPS SAMPLI; Helama S, 2004, THEOR APPL CLIMATOL, V79, P239, DOI 10.1007/s00704-004-0077-0; Huet S., 2004, STAT TOOLS NONLINEAR; Israel GD, 1992, SAMPLING EVIDENCE EX; Kaczka RJ, 2012, STUD MAT CEPL ROGOW, V1, P111; Kim MK, 2012, ENVIRON MANAGE, V50, P956, DOI 10.1007/s00267-012-9905-7; Kraemer HC, 1987, MANY SUBJECTS STAT P; Lajczak A, 1996, STUDIA NATURAE, V41, P131; LIDDLE M, 1997, RECREATION ECOLOGY E; LIDDLE MJ, 1991, TRENDS ECOL EVOL, V6, P13, DOI 10.1016/0169-5347(91)90141-J; Lomnicki A., 2010, WPROWADZENIE STATYST; Makomaska-Juchiewicz M, 2003, EKOLOGICZNA SIEC NAT; Malik I, 2012, STUDIA MAT CEPL ROGO, V14, P157; MANLEY BFJ, 1994, MULTIVARIATE STAT ME; Plucinska A, 2006, PROBABILISTYKA RACHU; QUINN NW, 1980, J ENVIRON MANAGE, V10, P155; R Core Team, 2013, R LANG DEF; Reiter A, 2011, TR ISS GLOB TOUR, P93, DOI 10.1007/978-3-642-17767-5_10; Martin-Cejas RR, 2010, TOURISM MANAGE, V31, P98, DOI 10.1016/j.tourman.2009.01.007; Sall J, 2005, SAS PRESS SERIES; Schweingruber F. H., 1996, Tree rings and environment: dendroecology.; Skov-Petersen H, 2009, EUROPEAN FOREST RECR; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Speer JH, 2010, FUNDAMENTALS TREE RI; Sporek K, 2008, DOSWIADCZALNICTWO EK; Stoffel M, 2005, Z GEOMORPHOL, V49, P89; Stoffel M, 2013, GEOMORPHOLOGY, V200, P106, DOI 10.1016/j.geomorph.2012.12.017; Viljoen J. H., 2000, Development Southern Africa, V17, P135, DOI 10.1080/03768350050003460; Wimmer Rupert, 2002, Dendrochronologia, V20, P21, DOI 10.1078/1125-7865-00005; Zaremba D, 2007, EKOTURYSTYKA	45	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136830	10.1371/journal.pone.0136830	http://dx.doi.org/10.1371/journal.pone.0136830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325062	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700066
J	Esteve-Gassent, MD; Smith, TC; Small, CM; Thomas, DP; Seshu, J				Esteve-Gassent, Maria D.; Smith, Trever C., II; Small, Christina M.; Thomas, Derek P.; Seshu, J.			Absence of sodA Increases the Levels of Oxidation of Key Metabolic Determinants of Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; METHYL VIOLOGEN PARAQUAT; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; IXODES-SCAPULARIS; ESCHERICHIA-COLI; PROTEOME ANALYSIS; MAMMALIAN HOST; NITRIC-OXIDE; STRUCTURAL PROTEOMICS	Borrelia burgdorferi, the causative agent of Lyme disease, alters its gene expression in response to environmental signals unique to its tick vector or vertebrate hosts. B. burgdorferi carries one superoxide dismutase gene (sodA) capable of controlling intracellular superoxide levels. Previously, sodA was shown to be essential for infection of B. burgdorferi in the C3H/HeN model of Lyme disease. We employed two-dimensional electrophoresis (2DE) and immunoblot analysis with antibodies specific to carbonylated proteins to identify targets that were differentially oxidized in the soluble fractions of the sodA mutant compared to its isogenic parental control strain following treatment with an endogenous superoxide generator, methyl viologen (MV, paraquat). HPLC-ESI-MS/MS analysis of oxidized proteins revealed that several proteins of the glycolytic pathway (BB0057, BB0020, BB0348) exhibited increased carbonylation in the sodA mutant treated with MV. Levels of ATP and NAD/NADH were reduced in the sodA mutant compared with the parental strain following treatment with MV and could be attributed to increased levels of oxidation of proteins of the glycolytic pathway. In addition, a chaperone, HtpG (BB0560), and outer surface protein A (OspA, BBA15) were also observed to be oxidized in the sodA mutant. Immunoblot analysis revealed reduced levels of Outer surface protein C (OspC), Decorin binding protein A (DbpA), fibronectin binding protein (BBK32), RpoS and BosR in the sodA mutant compared to the control strains. Viable sodA mutant spirochetes could not be recovered from both gp91/phox(-/-) and iNOS deficient mice while borrelial DNA was detected in multiple tissues samples from infected mice at significantly lower levels compared to the parental strain. Taken together, these observations indicate that the increased oxidation of select borrelial determinants and reduced levels of critical pathogenesis-associated lipoproteins contribute to the in vivo deficit of the sodA mutant in the mouse model of Lyme disease. This study, utilizing the sodA mutant, has provided insights into adaptive capabilities critical for survival of B. burgdorferi in its hosts.	[Esteve-Gassent, Maria D.; Smith, Trever C., II; Thomas, Derek P.; Seshu, J.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Smith, Trever C., II; Seshu, J.] Univ Texas San Antonio, Ctr Excellence Infect Genom, San Antonio, TX 78249 USA; [Esteve-Gassent, Maria D.; Small, Christina M.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Thomas, Derek P.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Texas A&M University System; Texas A&M University College Station	Seshu, J (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	j.seshu@utsa.edu	Esteve-Gassent, Maria/AAF-2597-2020	Esteve-Gassent, Maria/0000-0001-5921-2794; Brock, Christina/0000-0001-9204-8252; Smith II, Trever/0000-0002-1651-313X	Public Health Service Grant from the National Institute Of Allergy and Infectious Diseases [SC1AI078559]; Army Research Office of DoD [W911NF-11-1-0136]; Faculty Research Award from UTSA; American Heart Association Institutional Mass Spectrometry Laboratory at the University of Texas Health Science Center-San Antonio - NIH [AHA-0825175F, P30 CA54174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI078559] Funding Source: NIH RePORTER	Public Health Service Grant from the National Institute Of Allergy and Infectious Diseases; Army Research Office of DoD; Faculty Research Award from UTSA; American Heart Association Institutional Mass Spectrometry Laboratory at the University of Texas Health Science Center-San Antonio - NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Public Health Service Grant Number SC1AI078559 from the National Institute Of Allergy and Infectious Diseases, Army Research Office of DoD, Grant Number: W911NF-11-1-0136 and Faculty Research Award from UTSA (JS) and a post-doctoral fellowship (AHA-0825175F) from American Heart Association Institutional Mass Spectrometry Laboratory at the University of Texas Health Science Center-San Antonio supported by NIH grant P30 CA54174 (MDEG).	Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Anderton JM, 2004, INFECT IMMUN, V72, P2035, DOI 10.1128/IAI.72.4.2035-2044.2004; Batinic-Haberle I, 2008, FREE RADICAL RES, V42, P618, DOI 10.1080/10715760802209639; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2003, P NATL ACAD SCI USA, V100, P11684, DOI 10.1073/pnas.2032956100; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Boylan Julie A., 2008, V431, P213; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Caimano MJ, 2007, MOL MICROBIOL; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Coleman JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000676; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dulebohn DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093141; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fikrig E, 2006, MICROBES INFECT, V8, P1390, DOI 10.1016/j.micinf.2005.12.022; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Guan JQ, 2005, TRENDS BIOCHEM SCI, V30, P583, DOI 10.1016/j.tibs.2005.08.007; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hayes BM, 2014, MBIO, V5, DOI 10.1128/mBio.01017-14; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Hyde JA, 2006, MICROBIOL-SGM, V152, P2599, DOI 10.1099/mic.0.28996-0; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; JONES RW, 1976, BIOCHEM SOC T, V4, P671, DOI 10.1042/bst0040671; Karna SLR, 2013, INFECT IMMUN, V81, P2972, DOI 10.1128/IAI.00494-13; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Ma JF, 1998, J BACTERIOL, V180, P1741, DOI 10.1128/JB.180.7.1741-1749.1998; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Maruskova M, 2008, INFECT IMMUN; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Norris SJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-209; Norris Steven J, 2012, Open Neurol J, V6, P119, DOI 10.2174/1874205X01206010119; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Peterson CN, 2012, GENE DEV, V26, P548, DOI 10.1101/gad.183517.111; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Raju BVS, 2011, INFECT IMMUN, V79, P3407, DOI 10.1128/IAI.05234-11; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V376, P59, DOI 10.1006/abbi.1999.1680; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Roggenkamp A, 1997, INFECT IMMUN, V65, P4705, DOI 10.1128/IAI.65.11.4705-4710.1997; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sanjuan E, 2009, INFECT IMMUN; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Thomas Derek P., 2006, Infectious Disorders - Drug Targets, V6, P335, DOI 10.2174/187152606779025815; Thomas DP, 2009, J PROTEOMICS, V73, P342, DOI 10.1016/j.jprot.2009.10.003; Troxell B, 2012, J BIOL CHEM, V287, P19284, DOI 10.1074/jbc.M112.344903; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Young M, 2009, PROTEOMICS, V9, P2578, DOI 10.1002/pmic.200800713; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993	88	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136707	10.1371/journal.pone.0136707	http://dx.doi.org/10.1371/journal.pone.0136707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322513	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500029
J	Cox, R; Phillips, O; Fukumoto, J; Fukumoto, I; Parthasarathy, PT; Mandry, M; Cho, Y; Lockey, R; Kolliputi, N				Cox, Ruan, Jr.; Phillips, Oluwakemi; Fukumoto, Jutaro; Fukumoto, Itsuko; Parthasarathy, Prasanna Tamarapu; Mandry, Maria; Cho, Young; Lockey, Richard; Kolliputi, Narasaiah			Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PRORESOLVING LIPID MEDIATORS; ANIMAL-MODELS; PULMONARY INFLAMMATION; EDEMA FLUID; TNF-ALPHA; EXPRESSION; NEUTROPHILS; ADHESION	Background Inflammation is a key hallmark of ALI and is mediated through ungoverned cytokine signaling. One such cytokine, interleukin-1beta (IL-1 beta) has been demonstrated to be the most bioactive cytokine in ALI patients. Macrophages are the key players responsible for IL-1 beta secretion into the alveolar space. Following the binding of IL-1 beta to its receptor, "activated" alveolar epithelial cells show enhanced barrier dysfunction, adhesion molecule expression, cytokine secretion, and leukocyte attachment. More importantly, it is an important communication molecule between the macrophage and alveolar epithelium. While the molecular determinants of this inflammatory event have been well documented, endogenous resolution processes that decrease IL-1 beta secretion and resolve alveolar epithelial cell activation and tissue inflammation have not been well characterized. Lipid mediator Aspirin-Triggered Resolvin D1 (AT-RvD1) has demonstrated potent pro-resolutionary effects in vivo models of lung injury; however, the contribution of the alveoli to the protective benefits of this molecule has not been well documented. In this study, we demonstrate that AT-RvD1 treatment lead to a significant decrease in oxidant induced macrophage IL-1 beta secretion and production, IL-1 beta-mediated cytokine secretion, adhesion molecule expression, leukocyte adhesion and inflammatory signaling. Methods THP-1 macrophages were treated with hydrogen peroxide and extracellular ATP in the presence or absence of AT-RvD1 (1000-0.1 nM). A549 alveolar-like epithelial cells were treated with IL-1 beta (10 ng/mL) in the presence or absence of AT-RvD1 (0.1 mu M). Following treatment, cell lysate and cell culture supernatants were collected for Western blot, qPCR and ELISA analysis of pro-inflammatory molecules. Functional consequences of IL-1 beta induced alveolar epithelial cell and macrophage activation were also measured following treatment with IL-1 beta +/- AT-RvD1. Results Results demonstrate that macrophages exposed to H2O2 and ATP in the presence of resolvins show decreased IL-1 beta production and activity. A549 cells treated with IL-1 beta in the presence of AT-RvD1 show a reduced level of proinflammatory cytokines IL-6 and IL-8. Further, IL-1 beta-mediated adhesion molecule expression was also reduced with AT-RvD1 treatment, which was correlated with decreased leukocyte adhesion. AT-RvD1 treatment demonstrated reduced MAP-Kinase signaling. Taken together, our results demonstrate AT-RvD1 treatment reduced IL-1 beta-mediated alveolar epithelial cell activation. This is a key step in unraveling the protective effects of resolvins, especially AT-RvD1, during injury.	[Cox, Ruan, Jr.; Phillips, Oluwakemi; Fukumoto, Jutaro; Fukumoto, Itsuko; Parthasarathy, Prasanna Tamarapu; Mandry, Maria; Cho, Young; Lockey, Richard; Kolliputi, Narasaiah] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33612 USA; [Cox, Ruan, Jr.; Kolliputi, Narasaiah] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Kolliputi, N (corresponding author), Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33612 USA.	nkollipu@health.usf.edu			American Heart Association National Scientist Development Grant [09SDG2260957]; National Institutes of Health [R01 HL105932]; American Heart Association predoctoral fellowship award [13PRE17070137]; American Heart Association postdoctoral fellowship award [14POST18200004]; Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship award(American Heart Association); American Heart Association postdoctoral fellowship award(American Heart Association); Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NK was funded by the American Heart Association National Scientist Development Grant 09SDG2260957 and National Institutes of Health R01 HL105932 and the Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology. RC was funded by the American Heart Association predoctoral fellowship award 13PRE17070137. JF was funded by the American Heart Association postdoctoral fellowship award 14POST18200004.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Casilli F, 2005, BIOCHEM PHARMACOL, V69, P385, DOI 10.1016/j.bcp.2004.10.007; Chen Ya-feng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P1039; Cox Jr R, 2015, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2014-0339OC, DOI 10.1165/RCMB.2014-03390C]; Davis BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033304; Deng JC, 2011, COMPR PHYSIOL, V1, P81, DOI 10.1002/cphy.c090011; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; FLICK M R, 1986, Critical Care Clinics, V2, P455; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kim H, 2008, EXP MOL MED, V40, P167, DOI 10.3858/emm.2008.40.2.167; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Kolliputi N, 2012, J CELL PHYSIOL, V227, P3310, DOI 10.1002/jcp.24026; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Lagishetty V, 2014, DYSREGULATION CLOCK, pC999; Lee JW, 2007, J BIOL CHEM, V282, P24109, DOI 10.1074/jbc.M700821200; Levitt Joseph E, 2009, J Intensive Care Med, V24, P151, DOI 10.1177/0885066609332603; Levy BD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00390; Lichtenstein A, 2000, CRIT CARE MED, V28, P1497, DOI 10.1097/00003246-200005000-00040; Looney MR, 2006, CRIT CARE MED, V34, pS132, DOI 10.1097/01.CCM.0000214287.58444.2D; Matthay MA, 1999, CRIT CARE MED, V27, P2028, DOI 10.1097/00003246-199909000-00055; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Meager A, 1999, CYTOKINE GROWTH F R, V10, P27, DOI 10.1016/S1359-6101(98)00024-0; Miller EJ, 1996, CRIT CARE MED, V24, P1448, DOI 10.1097/00003246-199609000-00004; Mulligan MS, 1996, P ASSOC AM PHYSICIAN, V108, P198; Nagato A, 2009, EXP LUNG RES, V35, P713, DOI 10.3109/01902140902853184; Okutani D, 2007, AM J PHYSIOL-LUNG C, V292, pL144, DOI 10.1152/ajplung.00002.2006; Pritchard KA, 2004, AM J PHYSIOL-LUNG C, V286, pL705, DOI 10.1152/ajplung.00288.2002; Rocker GM, 2000, CRIT CARE MED, V28, P3354, DOI 10.1097/00003246-200009000-00043; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Schmausser B, 2004, INFECT IMMUN, V72, P6773, DOI 10.1128/IAI.72.12.6773-6779.2004; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Silva E, 2007, INTENS CARE MED, V33, P1829, DOI 10.1007/s00134-007-0748-2; SIMPSON JF, 1991, AM REV RESPIR DIS, V143, P585, DOI 10.1164/ajrccm/143.3.585; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Su X, 2011, INFLAMM RES, V60, P619, DOI 10.1007/s00011-011-0313-x; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Ware LB, 2013, SEMIN RESP CRIT CARE, V34, P439, DOI 10.1055/s-0033-1351163; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Yacoubian S, 2007, NAT CLIN PRACT RHEUM, V3, P570, DOI 10.1038/ncprheum0616; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019	56	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136755	10.1371/journal.pone.0136755	http://dx.doi.org/10.1371/journal.pone.0136755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317859	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100136
J	Dietz, J; Susser, S; Berkowski, C; Perner, D; Zeuzem, S; Sarrazin, C				Dietz, Julia; Susser, Simone; Berkowski, Caterina; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph			Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients	PLOS ONE			English	Article							DACLATASVIR PLUS SOFOSBUVIR; NS5A INHIBITOR BMS-790052; TREATMENT-NAIVE PATIENTS; IN-VITRO; CHRONIC HCV; OPEN-LABEL; POLYMERASE INHIBITORS; PEGYLATED INTERFERON; EXPERIENCED PATIENTS; VARIANTS RESISTANT	Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3-53% in hepatitis C virus (HCV) genotype 1 infected patients depending on different predictors and the DAA regimen used. Frequencies of single and combined resistance to NS3, NS5A and NS5B inhibitors and consequences for the applicability of different treatment regimens are unknown. Parallel population based sequencing of HCV NS3, NS5A and NS5B genes in 312 treatment-naive Caucasian HCV genotype 1 infected patients showed the presence of major resistant variants in 20.5% (NS3), 11.9% (NS5A), and 22.1% (NS5B) with important differences for HCV subtypes. In NS3, Q80K was observed in 34.7% and 2.1% of subtype 1a and 1b patients, respectively while other RAVs to second generation protease inhibitors were detected rarely (1.4%). Within NS5A RAVs were observed in 7.1% of subtype 1a and 17.6% in subtype 1b infected patients. RAVs to non-nucleoside NS5B inhibitors were observed in 3.5% and 44.4% of subtype 1a and 1b patients, respectively. Considering all three DAA targets all subtype 1a and 98.6% of subtype 1b infected patients were wildtype for at least one interferon free DAA regimen currently available. In conclusion, baseline resistance testing allows the selection of at least one RAVs-free treatment option for nearly all patients enabling a potentially cost- and efficacy-optimized treatment of chronic hepatitis C.	[Dietz, Julia; Susser, Simone; Berkowski, Caterina; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph] Goethe Univ Hosp, Med Dept 1, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sarrazin, C (corresponding author), Goethe Univ Hosp, Med Dept 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019		DZIF (Deutsches Zentrum fur Infektionsforschung) [TTU 05.902]; Janssen-Cilag GmbH	DZIF (Deutsches Zentrum fur Infektionsforschung); Janssen-Cilag GmbH	This study was supported by a DZIF (Deutsches Zentrum fur Infektionsforschung) (http://www.dzif.de/forschung/hepatitis/) grant entitled "Geno- & phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" to Christoph Sarrazin and Stefan Zeuzem (TTU 05.902). Further support was obtained in part from Janssen-Cilag GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; De Luca A, 2014, CURR OPIN PHARMACOL, V18, P9, DOI 10.1016/j.coph.2014.07.016; DeGoey DA, 2014, J MED CHEM, V57, P2047, DOI 10.1021/jm401398x; Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Krishnan P, 2014, J HEPATOL, V60, pS498, DOI 10.1016/S0168-8278(14)61390-8; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Krishnan P, 2014, HEPATOLOGY, V60, p1134A; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwo P, 2015, J HEPATOL, V62, pS270, DOI 10.1016/S0168-8278(15)30168-9; Lawitz E, 2015, J HEPATOL, V62, pS264, DOI 10.1016/S0168-8278(15)30158-6; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; McPhee F, 2013, HEPATOLOGY, V58, P902, DOI 10.1002/hep.26388; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P3670, DOI 10.1128/AAC.00308-12; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Poordad F, 2015, J HEPATOL, V62, pS261, DOI 10.1016/S0168-8278(15)30154-9; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Sarrazin C, 2015, J HEPATOL, V62, pS620, DOI 10.1016/S0168-8278(15)30976-4; Sarrazin C, 2015, ANTIVIR RES, V116, P10, DOI 10.1016/j.antiviral.2015.01.003; Sarrazin C, 2014, HEPATOLOGY, V60, p1128A; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Svarovskaia ES, 2014, HEPATOLOGY, V60, p218A; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Wyles DL, 2015, J HEPATOL, V62, pS263, DOI 10.1016/S0168-8278(15)30155-0; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	56	62	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134395	10.1371/journal.pone.0134395	http://dx.doi.org/10.1371/journal.pone.0134395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317755	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100015
J	Filtz, EA; Emery, A; Lu, HR; Forster, CL; Karasch, C; Hallstrom, TC				Filtz, Emma A.; Emery, Ann; Lu, Huarui; Forster, Colleen L.; Karasch, Chris; Hallstrom, Timothy C.			Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; TRANSCRIPTION FACTOR; RETINOBLASTOMA GENE; PROGENITOR CELLS; BONE-DEVELOPMENT; ADIPOSE-TISSUE; LACKING PTEN; OSTEOSARCOMA; DIFFERENTIATION; INACTIVATION	The Rb and Pten tumor suppressor genes are important regulators of bone development and both are frequently mutated in the bone cancer osteosarcoma (OS). To determine if Rb1 and Pten synergize as tumor suppressor genes for osteosarcoma, we co-deleted them in osteoprogenitor cells. Surprisingly, we observed rapid development of adipogenic but not osteosarcoma tumors in the Delta Rb1/Pten mice solo deleted mice also developed lipoma tumors but at a much reduced frequency and later onset than those co-deleted for Rb1. Pten deletion also led to a marked increase in adipocytes in the bone marrow. To better understand the function of Pten in bone development in vivo, we conditionally deleted Pten in OSX+ osteoprogenitor cells using OSX-Cre mice. mu CT analysis revealed a significant thickening of the calvaria and an increase in trabeculae volume and number in the femur, consistent with increased bone formation in thesemice. To determine if Pten and Rb1 deletion actively promotes adipogenic differentiation, we isolated calvarial cells from Pten(fl/fl) and Pten(fl/fl); Rb1(fl/fl) mice, infected them with CRE or GFP expressing adenovirus, treated with differentiation media. We observed slightly increased adipogenic, and osteogenic differentiation in the Delta Pten cells. Both phenotypes were greatly increased upon Rb1/Pten co-deletion. This was accompanied by an increase in expression of genes required for adipogenesis. These data indicate that Pten deletion in osteoblast precursors is sufficient to promote frequent adipogenic, but only rare osteogenic tumors. Rb1 hetero- or homo-zygous co-deletion greatly increases the incidence and the rapidity of onset of adipogenic tumors, again, with only rare osteosarcoma tumors.	[Filtz, Emma A.; Lu, Huarui; Karasch, Chris; Hallstrom, Timothy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Emery, Ann] Univ Minnesota, Sch Dent, Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Forster, Colleen L.] Univ Minnesota, Acad Hlth Ctr, BioNet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hallstrom, TC (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	halls026@umn.edu			National Institutes of Health [R01CA168622]; Children's Cancer Research Fund, Minneapolis, MN; NATIONAL CANCER INSTITUTE [R01CA168622] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Research Fund, Minneapolis, MN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by grants to T.H. from National Institutes of Health (R01CA168622) and the Children's Cancer Research Fund, Minneapolis, MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Broege A, 2013, J BIOL CHEM, V288, P37230, DOI 10.1074/jbc.M113.496950; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Daikoku T, 2011, GYNECOL ONCOL, V122, P424, DOI 10.1016/j.ygyno.2011.04.022; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Hsieh SC, 2009, MOL CARCINOGEN, V48, P545, DOI 10.1002/mc.20491; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Levine RA, 2002, VET PATHOL, V39, P372, DOI 10.1354/vp.39-3-372; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HR, 2013, J BIOL CHEM, V288, P23833, DOI 10.1074/jbc.M112.447276; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Tiozzo C, 2012, J CLIN INVEST, V122, P3862, DOI 10.1172/JCI61334; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; WADAYAMA B, 1994, CANCER RES, V54, P3042; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; Xie CC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0360-y; Yang G, 2008, DEVELOPMENT, V135, P3587, DOI 10.1242/dev.028118	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136729	10.1371/journal.pone.0136729	http://dx.doi.org/10.1371/journal.pone.0136729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317218	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100130
J	Huang, YH; Rose, PW; Hsu, CN				Huang, Yi-Hung; Rose, Peter W.; Hsu, Chun-Nan			Citing a Data Repository: A Case Study of the Protein Data Bank	PLOS ONE			English	Article								The Protein Data Bank (PDB) is the worldwide repository of 3D structures of proteins, nucleic acids and complex assemblies. The PDB's large corpus of data (> 100,000 structures) and related citations provide a well-organized and extensive test set for developing and understanding data citation and access metrics. In this paper, we present a systematic investigation of how authors cite PDB as a data repository. We describe a novel metric based on information cascade constructed by exploring the citation network to measure influence between competing works and apply that to analyze different data citation practices to PDB. Based on this new metric, we found that the original publication of RCSB PDB in the year 2000 continues to attract most citations though many follow-up updates were published. None of these follow-up publications by members of the wwPDB organization can compete with the original publication in terms of citations and influence. Meanwhile, authors increasingly choose to use URLs of PDB in the text instead of citing PDB papers, leading to disruption of the growth of the literature citations. A comparison of data usage statistics and paper citations shows that PDB Web access is highly correlated with URL mentions in the text. The results reveal the trend of how authors cite a biomedical data repository and may provide useful insight of how to measure the impact of a data repository.	[Huang, Yi-Hung] Natl Taiwan Univ, Dept Comp Sci, Taipei 106, Taiwan; [Huang, Yi-Hung] Natl Taiwan Univ, Intel NTU Connected Context Comp Ctr, Taipei 106, Taiwan; [Rose, Peter W.] Univ Calif San Diego, San Diego Supercomp Ctr, RCSB Prot Data Bank, La Jolla, CA 92093 USA; [Hsu, Chun-Nan] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA	National Taiwan University; Intel Corporation; National Taiwan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Hsu, CN (corresponding author), Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA.	chunnan@ucsd.edu		Rose, Peter/0000-0001-9981-9750	National Institutes of Health Big Data to Knowledge (BD2K) Initiative [U24AI117966]; Ministry of Science and Technology, Taiwan [MOST 103-2911-I-002-001]; National Taiwan University-Intel Corporation [NTU-ICRP-104R7501, NTU-ICRP-104R7501-1]; RCSB PDB grant from the National Science Foundation [NSF DBI-1338415]; National Institute of General Medical Sciences (NIGMS); Office of Science, Department of Energy (DOE); National Library of Medicine (NLM); National Cancer Institute (NCI); National Institute of Neurological Disorders and Stroke (NINDS); National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Intel-NTU Connected Context Computing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI117966] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1338415] Funding Source: National Science Foundation	National Institutes of Health Big Data to Knowledge (BD2K) Initiative; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University-Intel Corporation; RCSB PDB grant from the National Science Foundation; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Department of Energy (DOE)(United States Department of Energy (DOE)); National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intel-NTU Connected Context Computing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The project is supported in part by Grant U24AI117966 National Institutes of Health Big Data to Knowledge (BD2K) Initiative to PWR and CNH and by Ministry of Science and Technology, Taiwan under Grant MOST 103-2911-I-002-001, and National Taiwan University-Intel Corporation NTU-ICRP-104R7501 and NTU-ICRP-104R7501-1 to YHH. PWR was in part supported by the RCSB PDB grant from the National Science Foundation NSF DBI-1338415; National Institute of General Medical Sciences (NIGMS); Office of Science, Department of Energy (DOE); National Library of Medicine (NLM); National Cancer Institute (NCI); National Institute of Neurological Disorders and Stroke (NINDS); and National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). Intel-NTU Connected Context Computing Center provided support in the form of a salary for author YHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the "author contributions" section.	Arbesman S, 2012, HALF LIFE FACTS WHY; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bourne PE, 2004, NUCLEIC ACIDS RES, V32, pD223, DOI 10.1093/nar/gkh096; Boutselakis H, 2003, NUCLEIC ACIDS RES, V31, P458, DOI 10.1093/nar/gkg065; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Davidson L.A., 1998, J ELECT PUBL, V4, DOI [10.3998/3336451.0004.203, DOI 10.3998/3336451.0004.203]; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FORCE11 Data Citation Synthesis Group, 2014, JOINT DECL DAT CIT P; Ghosh R., 2011, 2011 IEEE International Conference on Data Mining Workshops, P373, DOI 10.1109/ICDMW.2011.183; Ghosh R, 2011, P 4 ACM INT C WEB SE; Golovin A, 2004, NUCLEIC ACIDS RES, V32, pD211, DOI 10.1093/nar/gkh078; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Huang YH, 2013, IEEE DATA MINING, P291, DOI 10.1109/ICDM.2013.120; Kafkas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063184, DOI 10.1371/J0URNAL.P0NE.0063184]; KAHN AB, 1962, COMMUN ACM, V5, P558, DOI 10.1145/368996.369025; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Neveol A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas026; Priem J., 2010, ALTMETRICS MANIFESTO; Prlic A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-220; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sayyadi H., 2009, SIAM INT C DAT MIN 2, P533; Standley DM, 2008, BRIEF BIOINFORM, V9, P276, DOI 10.1093/bib/bbn015; Subelj L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06496; Task Group on Data Citation Standards and Practices CODATA-ICSTI, 2013, DATA SCI J, V12, P1, DOI [10.2481/dsj.OSOM13-043, DOI 10.2481/DSJ.OSOM13-043]; Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a; Westbrook J, 2005, BIOINFORMATICS, V21, P988, DOI 10.1093/bioinformatics/bti082; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245	42	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136631	10.1371/journal.pone.0136631	http://dx.doi.org/10.1371/journal.pone.0136631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317409	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100116
J	Kishi, T; Matsunaga, S; Iwata, N				Kishi, Taro; Matsunaga, Shinji; Iwata, Nakao			Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials	PLOS ONE			English	Review							RECEPTOR ANTAGONIST; EFFICACY; SAFETY; TREAT; SLEEP	Objective We performed a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials evaluating suvorexant for primary insomnia. Methods Relevant studies were identified through searches of PubMed, databases of the Cochrane Library, and PsycINFO citations through June 27, 2015. We performed a systematic review and meta-analysis of suvorexant trial efficacy and safety outcomes. The primary efficacy outcomes were either subjective total sleep time (sTST) or subjective time-to-sleep onset (sTSO) at 1 month. The secondary outcomes were other efficacy outcomes, discontinuation rate, and individual adverse events. The risk ratio, number-needed-to-treat/harm, and weighted mean difference (WMD) and 95% confidence intervals (CI) based on a random effects model were calculated. Results The computerized literature database search initially yielded 48 results, from which 37 articles were excluded following a review of titles and abstracts and another eight review articles after full-text review. Thus, we identified 4 trials that included a total of 3,076 patients. Suvorexant was superior to placebo with regard to the two primary efficacy outcomes (sTST: WMD = -20.16, 95% CI = -25.01 to -15.30, 1889 patients, 3 trials, sTSO: WMD = -7.62, 95% CI = -11.03 to -4.21, 1889 patients, 3 trials) and was not different from placebo in trial discontinuations. Suvorexant caused a higher incidence than placebo of at least one side effects, abnormal dreams, somnolence, excessive daytime sleepiness/sedation, fatigue, dry mouth, and rebound insomnia. Conclusions Our analysis of published trial results suggests that suvorexant is effective in treating primary insomnia and is well-tolerated.	[Kishi, Taro; Matsunaga, Shinji; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan	Fujita Health University	Kishi, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.	tarok@fujita-hu.ac.jp		IWATA, Nakao/0000-0003-3189-6076	GlaxoSmithKline; Otsuka	GlaxoSmithKline(GlaxoSmithKline); Otsuka(Otsuka Pharmaceutical)	Dr. Kishi has received speaker's honoraria from Abbott, Astellas, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, GlaxoSmithKline, Janssen, Yoshitomi, Otsuka, Meiji, Shionogi, Tanabe-Mitsubishi, Tsumura, Novartis, and Pfizer. Dr. Matsunaga has received speaker's honoraria from Eisai, Janssen, Novartis, Daiichi Sankyo, Ono, Eli Lilly, Takeda, and Otsuka. Dr. Iwata has received speaker's honoraria from Astellas, Dainippon Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Yoshitomi, Otsuka, Meiji, Shionogi, Novartis, and Pfizer and has research grant from GlaxoSmithKline and Otsuka. All authors declare that they have no direct conflicts of interest relevant to this study. No grants or other funding sources were used for this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Citrome L, 2014, INT J CLIN PRACT, V68, P1429, DOI 10.1111/ijcp.12568; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dubey AK, 2015, J PHARMACOL PHARMACO, V6, P118, DOI 10.4103/0976-500X.155496; Etori K, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00008; Fitch TE, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00005; Guy W, 1970, MANUAL ECDEU ASSESSM; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Herring WJ, 2012, NEUROLOGY, V79, P2265, DOI 10.1212/WNL.0b013e31827688ee; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Krystal AD, 2013, J CLIN PSYCHIAT, V74, P3, DOI 10.4088/JCP.13011su1c; Kuriyama A, 2014, SLEEP MED, V15, P385, DOI 10.1016/j.sleep.2013.11.788; Lader M, 2011, ADDICTION, V106, P2086, DOI 10.1111/j.1360-0443.2011.03563.x; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Ohayon MM, 2002, J SLEEP RES, V11, P339, DOI 10.1046/j.1365-2869.2002.00317.x; Rapoport MJ, 2009, J CLIN PSYCHIAT, V70, P663, DOI 10.4088/JCP.08m04325; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Soehner AM, 2013, SLEEP MED CLIN, V8, P361, DOI 10.1016/j.jsmc.2013.04.007; Thompson MD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00057; TYRER P, 1990, J AFFECT DISORDERS, V19, P53, DOI 10.1016/0165-0327(90)90009-W; Winkler A, 2014, CNS DRUGS, V28, P799, DOI 10.1007/s40263-014-0198-7; Yeoh JW, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00036	23	44	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136910	10.1371/journal.pone.0136910	http://dx.doi.org/10.1371/journal.pone.0136910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317363	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100171
J	Lieblein-Boff, JC; Johnson, EJ; Kennedy, AD; Lai, CS; Kuchan, MJ				Lieblein-Boff, Jacqueline C.; Johnson, Elizabeth J.; Kennedy, Adam D.; Lai, Chron-Si; Kuchan, Matthew J.			Exploratory Metabolomic Analyses Reveal Compounds Correlated with Lutein Concentration in Frontal Cortex, Hippocampus, and Occipital Cortex of Human Infant Brain	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; NERVOUS-SYSTEM MYELINATION; MACULAR PIGMENT; VISUAL-CORTEX; LYSOPHOSPHATIDIC ACID; TAURINE DEPRIVATION; COGNITIVE FUNCTION; OLDER-ADULTS; HOMOCARNOSINE; CAROTENOIDS	Lutein is a dietary carotenoid well known for its role as an antioxidant in the macula, and recent reports implicate a role for lutein in cognitive function. Lutein is the dominant carotenoid in both pediatric and geriatric brain tissue. In addition, cognitive function in older adults correlated with macular and postmortem brain lutein concentrations. Furthermore, lutein was found to preferentially accumulate in the infant brain in comparison to other carotenoids that are predominant in diet. While lutein is consistently related to cognitive function, the mechanisms by which lutein may influence cognition are not clear. In an effort to identify potential mechanisms through which lutein might influence neurodevelopment, an exploratory study relating metabolite signatures and lutein was completed. Post-mortem metabolomic analyses were performed on human infant brain tissues in three regions important for learning and memory: the frontal cortex, hippocampus, and occipital cortex. Metabolomic profiles were compared to lutein concentration, and correlations were identified and reported here. A total of 1276 correlations were carried out across all brain regions. Of 427 metabolites analyzed, 257 were metabolites of known identity. Unidentified metabolite correlations (510) were excluded. In addition, moderate correlations with xenobiotic relationships (2) or those driven by single outliers (3) were excluded from further study. Lutein concentrations correlated with lipid pathway metabolites, energy pathway metabolites, brain osmolytes, amino acid neurotransmitters, and the antioxidant homocarnosine. These correlations were often brain region-specific. Revealing relationships between lutein and metabolic pathways may help identify potential candidates on which to complete further analyses and may shed light on important roles of lutein in the human brain during development.	[Lieblein-Boff, Jacqueline C.; Lai, Chron-Si; Kuchan, Matthew J.] Abbott Nutr, Res & Dev, Columbus, OH 43215 USA; [Johnson, Elizabeth J.] Tufts Univ, Jean Mayer United States Dept Agr, Human Nutr Res Ctr Aging, Antioxidants Res Lab, Boston, MA 02111 USA; [Kennedy, Adam D.] Metabolon Inc, Durham, NC USA	Tufts University; United States Department of Agriculture (USDA); Metabolon	Lieblein-Boff, JC (corresponding author), Abbott Nutr, Res & Dev, Columbus, OH 43215 USA.	jacqueline.boff@abbott.com			Abbott Nutrition; Metabolon, Inc.	Abbott Nutrition(Abbott Laboratories); Metabolon, Inc.	This work was funded by Abbott Nutrition. Co-authors Jacqueline C. Lieblein-Boff, Chron-Si Lai, and Matthew J. Kuchan are employed by Abbott Nutrition, therefore Abbott Nutrition provided support in the form of salaries for authors JCL-B, C-SL, and MJK, and approved the study design and decision to publish initiated by these authors. Co-author Adam D. Kennedy is employed by Metabolon, Inc., which provided salary support to ADK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	ABRAHAM D, 1962, ARCH BIOCHEM BIOPHYS, V99, P210, DOI 10.1016/0003-9861(62)90002-4; Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; Birdsall T C, 1998, Altern Med Rev, V3, P128; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3; BOURRE JM, 1978, NEUROSCI LETT, V7, P225, DOI 10.1016/0304-3940(78)90172-6; Bovier ER, 2015, ARCH BIOCHEM BIOPHYS, V572, P54, DOI 10.1016/j.abb.2014.11.012; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Cheng JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044106; Dingledine R., 1999, BASIC NEUROCHEMISTRY, V6th; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Feeney J, 2013, NEUROBIOL AGING, V34, P2449, DOI 10.1016/j.neurobiolaging.2013.05.007; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gonzalez S, 2003, J INVEST DERMATOL, V121, P399, DOI 10.1046/j.1523-1747.2003.12355.x; Gossage CP, 2002, AM J CLIN NUTR, V76, P193, DOI 10.1093/ajcn/76.1.193; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Johnson Elizabeth J, 2013, J Aging Res, V2013, P951786, DOI 10.1155/2013/951786; Johnson EJ, 2012, AM J CLIN NUTR, V96, p1161S, DOI 10.3945/ajcn.112.034611; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; KIRSCHFELD K, 1982, PROC R SOC SER B-BIO, V216, P71, DOI 10.1098/rspb.1982.0061; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Li SY, 2012, NEUROBIOL DIS, V45, P624, DOI 10.1016/j.nbd.2011.10.008; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; McNulty H, 2008, AM J CARDIOL, V101, p20D, DOI 10.1016/j.amjcard.2008.02.004; McNulty HP, 2007, BBA-BIOMEMBRANES, V1768, P167, DOI 10.1016/j.bbamem.2006.09.010; NEURINGER M, 1994, ADV EXP MED BIOL, V359, P385; Nogaroli L, 2009, NEUROCHEM RES, V34, P182, DOI 10.1007/s11064-008-9772-z; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Palombo P, 2007, SKIN PHARMACOL PHYS, V20, P199, DOI 10.1159/000101807; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Perrone S, 2013, BRAIN SUSCEPTIBILITY, DOI [10.3109/14767058.2013.796170, DOI 10.3109/14767058.2013.796170]; Perry A, 2009, J FOOD COMPOS ANAL, V22, P9, DOI 10.1016/j.jfca.2008.07.006; PISANO JJ, 1961, J BIOL CHEM, V236, P499; Renzi LM, 2014, NEUROBIOL AGING, V35, P1695, DOI 10.1016/j.neurobiolaging.2013.12.024; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rubin LP, 2012, J PERINATOL, V32, P418, DOI 10.1038/jp.2011.87; Schweigert FJ, 2004, EUR J NUTR, V43, P39, DOI 10.1007/s00394-004-0439-5; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Shivaraj MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042935; Socaciu C, 2000, CHEM PHYS LIPIDS, V106, P79, DOI 10.1016/S0009-3084(00)00135-3; STURMAN JA, 1994, ADV EXP MED BIOL, V359, P369; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tanaka T, 2012, MOLECULES, V17, P3202, DOI 10.3390/molecules17033202; Torkhovskaya TI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P125, DOI 10.1134/S0006297907020010; Vishwanathan R, 2014, J PEDIATR GASTR NUTR, V59, P659, DOI 10.1097/MPG.0000000000000389; Vishwanathan R, 2014, AGE AGEING, V43, P271, DOI 10.1093/ageing/aft210; Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Wisniewska A, 2003, CELL MOL BIOL LETT, V8, P147; Wisniewska A, 2006, FREE RADICAL BIO MED, V40, P1820, DOI 10.1016/j.freeradbiomed.2006.01.016; Yeum KJ, 1996, AM J CLIN NUTR, V64, P594, DOI 10.1093/ajcn/64.4.594	62	43	46	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136904	10.1371/journal.pone.0136904	http://dx.doi.org/10.1371/journal.pone.0136904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317757	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100167
J	Liu, HL; White, J; Crawford, F; Jin, NY; Ju, XW; Liu, KT; Jiang, CY; Marrack, P; Zhang, GY; Kappler, JW				Liu, Haolin; White, Janice; Crawford, Frances; Jin, Niyun; Ju, Xiangwu; Liu, Kangtai; Jiang, Chengyu; Marrack, Philippa; Zhang, Gongyi; Kappler, John W.			A Rapid Method to Characterize Mouse IgG Antibodies and Isolate Native Antigen Binding IgG B Cell Hybridomas	PLOS ONE			English	Article							IMMUNOGLOBULIN; SWITCH; VARIANTS; RECEPTOR	B cell hybridomas are an important source of monoclonal antibodies. In this paper, we developed a high-throughput method to characterize mouse IgG antibodies using surface plasmon resonance technology. This assay rapidly determines their sub-isotypes, whether they bind native antigen and their approximate affinities for the antigen using only 50 mu l of hybridoma cell culture supernatant. Moreover, we found that mouse hybridomas secreting IgG antibodies also have membrane form IgG expression without Ig alpha. Based on this surface IgG, we used flow cytometry to isolate rare gamma 2a isotype switched variants from a gamma 2b antibody secreting hybridoma cell line. Also, we used fluorescent antigen to single cell sort antigen binding hybridoma cells from bulk mixture of fused hybridoma cells instead of the traditional multi-microwell plate screening and limiting dilution sub-cloning thus saving time and labor. The IgG monoclonal antibodies specific for the native antigen identified with these methods are suitable for in vivo therapeutic uses, but also for sandwich ELISA assays, histology, flow cytometry, immune precipitation and x-ray crystallography.	[Liu, Haolin; Crawford, Frances; Jin, Niyun; Marrack, Philippa; Kappler, John W.] Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Denver, CO 80206 USA; [Liu, Haolin; White, Janice; Crawford, Frances; Jin, Niyun; Marrack, Philippa; Zhang, Gongyi; Kappler, John W.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Liu, Haolin; White, Janice; Crawford, Frances; Jin, Niyun; Marrack, Philippa; Zhang, Gongyi; Kappler, John W.] Univ Colorado Denver, Dept Immunol & Microbiol, Denver, CO USA; [Ju, Xiangwu; Liu, Kangtai; Jiang, Chengyu] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Kappler, JW (corresponding author), Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Denver, CO 80206 USA.	kapplerj@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, R01AI018785] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Howard Hughes Medical Institute (to John W. Kappler).	BAUMHACKEL H, 1982, J IMMUNOL, V128, P1217; BERZOFSKY JA, 1976, J IMMUNOL, V116, P270; Bruce SR, 2003, RNA, V9, P1264, DOI 10.1261/rna.5820103; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; FAGUET GB, 1993, J IMMUNOL METHODS, V165, P217, DOI 10.1016/0022-1759(93)90347-A; FLASPOHLER JA, 1990, J IMMUNOL, V144, P2802; Hammers CM, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2013.521; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kovari LC, 1995, STRUCTURE, V3, P1291, DOI 10.1016/S0969-2126(01)00266-0; LIESEGANG B, 1978, P NATL ACAD SCI USA, V75, P3901, DOI 10.1073/pnas.75.8.3901; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Price PW, 2009, J IMMUNOL METHODS, V343, P28, DOI 10.1016/j.jim.2009.01.005; SCHWAB C, 1992, J IMMUNOL METHODS, V147, P125, DOI 10.1016/S0022-1759(12)80037-8; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	20	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136613	10.1371/journal.pone.0136613	http://dx.doi.org/10.1371/journal.pone.0136613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317987	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100113
J	Mikosik, A; Henc, I; Ruckemann-Dziurdzinska, K; Ckowiak, JEF; Ploszynska, A; Balcerska, A; Bryl, E; Witkowski, JM				Mikosik, Anna; Henc, Izabella; Ruckemann-Dziurdzinska, Katarzyna; Ckowiak, Joanna E. Fr; Ploszynska, Anna; Balcerska, Anna; Bryl, Ewa; Witkowski, Jacek M.			Increased mu-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL-DEATH; CONVENTIONAL CALPAINS; LYMPHOMA-CELLS; BONE-MARROW; C-MYC; CALPASTATIN; EXPRESSION; ACTIVATION; INDUCTION	Childhood acute lymphoblastic leukemia (ALL) blasts are characterized by inhibited apoptosis promoting fast disease progress. It is known that in chronic lymphocytic and acute myeloid leukemias the reduced apoptosis is strongly related with the activity of calpain-calpastatin system (CCS) composed of cytoplasmic proteases-calpains-performing the modulatory proteolysis of key proteins involved in cell proliferation and apoptosis, and of their endogenous inhibitor-calpastatin. Here, the CCS protein abundance and activity was for the first time studied in childhood ALL blasts and in control bone marrow CD19(+) B cells by semi-quantitative flow cytometry and western blotting of calpastatin fragments resulting from endogenous calpain activity. Significantly higher mu-calpain (CAPN1) gene transcription, protein amounts and activity (but not those of m-calpain), with calpastatin amount and transcription of its gene (CAST) greatly varying were observed in CD19(+) ALL blasts compared to control cells. Significant inverse relation between the amount/activity of calpain and spontaneous apoptosis was noted. Patients older than 10 years (considered at higher risk) displayed increased amounts and activities of blast calpain. Finally, treatment of blasts with the tripeptide calpain inhibitors II and IV significantly and in dose-dependent fashion increased the percentage of blasts entering apoptosis. Together, these findings make the CCS a potential new predictive tool and therapeutic target in childhood ALL.	[Mikosik, Anna; Ckowiak, Joanna E. Fr; Witkowski, Jacek M.] Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland; [Henc, Izabella; Ruckemann-Dziurdzinska, Katarzyna; Bryl, Ewa] Med Univ Gdansk, Dept Pathol & Expt Rheumatol, Gdansk, Poland; [Ploszynska, Anna; Balcerska, Anna] Med Univ Gdansk, Clin Pediat Hematol & Oncol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Witkowski, JM (corresponding author), Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland.	jawit@gumed.edu.pl	Bzoma, Izabella/AAE-3704-2020; Witkowski, Jacek M./B-8488-2013	Bzoma, Izabella/0000-0001-7417-4810; Witkowski, Jacek M./0000-0003-2906-1109; Mikosik-Roczynska, Anna/0000-0002-7211-1514; Bryl, Ewa/0000-0002-1410-4287; Ruckemann-Dziurdzinska, Katarzyna/0000-0002-5018-0818	Polish Ministry of Science and Higher Education [2 P05E 103 30, 02-0058/07/262]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education grant No 2 P05E 103 30 (to AP) and by a statutory (ST-58) grant from Polish Ministry of Science and Higher Education 02-0058/07/262 (to JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Bedner E, 1999, CYTOMETRY, V35, P181, DOI 10.1002/(SICI)1097-0320(19990301)35:3<181::AID-CYTO1>3.0.CO;2-5; BERGER R, 1992, CANCER GENET CYTOGEN, V61, P201, DOI 10.1016/0165-4608(92)90087-O; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; Catusse J, 2010, J CELL PHYSIOL, V225, P792, DOI 10.1002/jcp.22284; Cheng G, 2003, PHARMACOL RES, V48, P571, DOI 10.1016/S1043-6618(03)00245-7; Choi J, 2007, BLOOD, V109, P471, DOI 10.1182/blood-2006-07-032557; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fulda S, 2009, BRIT J HAEMATOL, V145, P441, DOI 10.1111/j.1365-2141.2009.07603.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GUROFF G, 1964, J BIOL CHEM, V239, P149; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hochberg J, 2013, BRIT J HAEMATOL, V161, P27, DOI 10.1111/bjh.12239; Hunger SP, 2011, PEDIATR BLOOD CANCER, V56, P984, DOI 10.1002/pbc.22996; JOHANSSON B, 1994, LEUKEMIA, V8, P953; Kaminskyy V, 2008, TOXICOL LETT, V177, P168, DOI 10.1016/j.toxlet.2008.01.009; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leloup L, 2011, EXPERT OPIN THER TAR, V15, P309, DOI 10.1517/14728222.2011.553611; Li HB, 2012, EXP HEMATOL, V40, P548, DOI 10.1016/j.exphem.2012.02.002; Lin CW, 2002, LEUKEMIA RES, V26, P551, DOI 10.1016/S0145-2126(01)00170-9; Lo Nigro L, 2013, J PEDIAT HEMATOL ONC, V35, P245, DOI 10.1097/MPH.0b013e31828f8746; Loncarevic IF, 1999, GENE CHROMOSOME CANC, V24, P272, DOI 10.1002/(SICI)1098-2264(199903)24:3<272::AID-GCC13>3.3.CO;2-L; Lopatniuk P, 2011, ACTA BIOCHIM POL, V58, P287; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Lucio P, 1999, LEUKEMIA, V13, P419, DOI 10.1038/sj.leu.2401279; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Mikosik A, 2007, FOLIA HISTOCHEM CYTO, V45, P343; Mikosik A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-27; Mittal MK, 2007, PEDIATR EMERG CARE, V23, P397, DOI 10.1097/01.pec.0000278391.94634.95; Momeni HR, 2011, CELL J, V13, P65; MORRISJONES PH, 1990, ARCH DIS CHILD, V65, P638, DOI 10.1136/adc.65.6.638; Mowafi F, 2008, PEDIATR BLOOD CANCER, V50, P812, DOI 10.1002/pbc.21370; Nakagawa Y, 2004, LEUKEMIA RES, V28, P487, DOI 10.1016/j.leukres.2003.10.013; Niapour M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.50; Niapour M, 2008, J BIOL CHEM, V283, P21371, DOI 10.1074/jbc.M801462200; Panzer-Grumayer ER, 2000, BLOOD, V95, P790, DOI 10.1182/blood.V95.3.790.003k48_790_794; Pegahi R, 2005, EUR CYTOKINE NETW, V16, P223; Ploszynska A, 2012, FOLIA HISTOCHEM CYTO, V50, P304, DOI 10.5603/FHC.2012.0040; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Pui CH, 2010, J FORMOS MED ASSOC, V109, P777, DOI 10.1016/S0929-6646(10)60123-4; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reverter D, 2001, TRENDS CARDIOVAS MED, V11, P222, DOI 10.1016/S1050-1738(01)00112-8; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; SCHWARZBENMEIR N, 1994, BIOCHEM J, V304, P365, DOI 10.1042/bj3040365; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smith TPL, 2001, J ANIM SCI, V79, P552; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; South ST, 2006, CANCER GENET CYTOGEN, V168, P177, DOI 10.1016/j.cancergencyto.2005.12.005; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tompa P, 2002, J BIOL CHEM, V277, P9022, DOI 10.1074/jbc.C100700200; Trehan A, 2009, J PEDIAT HEMATOL ONC, V31, P424, DOI 10.1097/MPH.0b013e3181a1c12b; Volm H, 1999, ANTICANCER RES, V19, P4327; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhu DM, 2000, CLIN CANCER RES, V6, P2456	63	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136615	10.1371/journal.pone.0136615	http://dx.doi.org/10.1371/journal.pone.0136615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317226	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100114
J	Simpson-Abelson, MR; Childs, EE; Ferreira, MC; Bishu, S; Conti, HR; Gaffen, SL				Simpson-Abelson, Michelle R.; Childs, Erin E.; Ferreira, M. Carolina; Bishu, Shrinivas; Conti, Heather R.; Gaffen, Sarah L.			C/EBP beta Promotes Immunity to Oral Candidiasis through Regulation of beta-Defensins	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC MUCOCUTANEOUS CANDIDIASIS; IL-17 RECEPTOR; TH17 CELLS; SEQUENTIAL PHOSPHORYLATION; BETA-DEFENSIN-2 EXPRESSION; OROPHARYNGEAL CANDIDIASIS; SIGNAL-TRANSDUCTION; AIRWAY EPITHELIUM; ALBICANS	Humans or mice subjected to immunosuppression, such as corticosteroids or anti-cytokine biologic therapies, are susceptible to mucosal infections by the commensal fungus Candida albicans. Recently it has become evident that the Th17/IL-17 axis is essential for immunity to candidiasis, but the downstream events that control immunity to this fungus are poorly understood. The CCAAT/Enhancer Binding Protein-beta (C/EBP beta) transcription factor is important for signaling by multiple inflammatory stimuli, including IL-17. C/EBP beta is regulated in a variety of ways by IL-17, and controls several downstream IL-17 target genes. However, the role of C/EBP beta in vivo is poorly understood, in part because C/EBP beta-deficient mice are challenging to breed and work with. In this study, we sought to understand the role of C/EBP beta in the context of an IL-17-dependent immune response, using C. albicans infection as a model system. Confirming prior findings, we found that C/EBP beta is required for immunity to systemic candidiasis. In contrast, C/EBP beta(-/-) mice were resistant to oropharyngeal candidiasis (OPC), in a manner indistinguishable from immunocompetent WT mice. However, C/EBP beta(-/-) mice experienced more severe OPC than WT mice in the context of cortisone-induced immunosuppression. Expression of the antimicrobial peptide beta-defensin (BD)-3 correlated strongly with susceptibility in C/EBP beta(-/-) mice, but no other IL-17-dependent genes were associated with susceptibility. Therefore, C/EBP beta contributes to immunity to mucosal candidiasis during cortisone immunosuppression in a manner linked to beta-defensin 3 expression, but is apparently dispensable for the IL-17-dependent response.	[Simpson-Abelson, Michelle R.; Childs, Erin E.; Ferreira, M. Carolina; Bishu, Shrinivas; Conti, Heather R.; Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	sarah.gaffen@pitt.edu	Bishu, Shrinivas/S-6084-2019	Bishu, Shrinivas/0000-0003-4823-5805; Ferreira dos Santos, Maria/0000-0003-0231-6538	NIH [DE022550, DE023815, AI107825, F32-AI098423]; Arthritis Foundation;  [F32-DE023293]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI098423, R01AI107825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022550, R01DE023815, F32DE023293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	SLG was supported by NIH grants DE022550, DE023815 and AI107825. MSA was supported by the Arthritis Foundation and NIH grant F32-AI098423. HRC was supported by F32-DE023293. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Browne SK, 2010, CURR OPIN ALLERGY CL, V10, P534, DOI 10.1097/ACI.0b013e3283402b41; Conti HR, 2011, MUCOSAL IMMUNOL, V4, P448, DOI 10.1038/mi.2011.5; Conti Heather R, 2014, Curr Protoc Immunol, V105, DOI 10.1002/0471142735.im1906s105; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Ferreira MC, 2014, INFECT IMMUN, V82, P1030, DOI 10.1128/IAI.01389-13; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Lee AYS, 2015, CYTOKINE, V72, P97, DOI 10.1016/j.cyto.2014.11.029; Liu Y, 2015, GENOME RES; Lu Q, 2006, J INVEST DERMATOL, V126, P2049, DOI 10.1038/sj.jid.5700346; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Pandiyan P, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-4; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schofield DA, 2004, J INFECT DIS, V190, P1327, DOI 10.1086/423856; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Suarez-Carmona M, 2014, CYTOKINE GROWTH FACT; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tomalka J, 2015, J IMMUNOL, V194, P1788, DOI 10.4049/jimmunol.1203239; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Whibley N, 2014, EUR J IMMUNOL, V44, P1069, DOI 10.1002/eji.201343604; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	51	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136538	10.1371/journal.pone.0136538	http://dx.doi.org/10.1371/journal.pone.0136538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317211	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000360299100098
J	Sugiyama, T; Pramanik, MK; Yumura, S				Sugiyama, Tatsuroh; Pramanik, Md. Kamruzzaman; Yumura, Shigehiko			Microtubule-Mediated Inositol Lipid Signaling Plays Critical Roles in Regulation of Blebbing	PLOS ONE			English	Article							DICTYOSTELIUM CELLS; PLASMA-MEMBRANE; MYOSIN-II; ZEBRAFISH GASTRULATION; EUKARYOTIC CHEMOTAXIS; AMEBOID MOVEMENT; DISTINCT MODES; MIGRATION; ACTIN; MOTILITY	Cells migrate by extending pseudopods such as lamellipodia and blebs. Although the signals leading to lamellipodia extension have been extensively investigated, those for bleb extension remain unclear. Here, we investigated signals for blebbing in Dictyostelium cells using a newly developed assay to induce blebbing. When cells were cut into two pieces with a microneedle, the anucleate fragments vigorously extended blebs. This assay enabled us to induce blebbing reproducibly, and analyses of knockout mutants and specific inhibitors identified candidate molecules that regulate blebbing. Blebs were also induced in anucleate fragments of leukocytes, indicating that this assay is generally applicable to animal cells. After cutting, microtubules in the anucleate fragments promptly depolymerized, followed by the extension of blebs. Furthermore, when intact cells were treated with a microtubule inhibitor, they frequently extended blebs. The depolymerization of microtubules induced the delocalization of inositol lipid phosphatidylinositol 3,4,5-trisphosphate from the cell membrane. PI3 kinase-null cells frequently extended blebs, whereas PTEN-null cells extended fewer blebs. From these observations, we propose a model in which microtubules play a critical role in bleb regulation via inositol lipid metabolism.	[Sugiyama, Tatsuroh; Pramanik, Md. Kamruzzaman; Yumura, Shigehiko] Yamaguchi Univ, Grad Sch Med, Dept Funct Mol Biol, Yamaguchi, Japan; [Pramanik, Md. Kamruzzaman] Bangladesh Atom Energy Commiss, Microbiol & Ind Irradiat Div, IFRB, AERE, Dhaka, Bangladesh	Yamaguchi University	Yumura, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Funct Mol Biol, Yamaguchi, Japan.	yumura@yamaguchi-u.ac.jp	yumura, shigehiko/E-8672-2013	yumura, shigehiko/0000-0001-8249-0100; Pramanik, Md Kamruzzaman/0000-0002-7332-3316				Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FINK RD, 1988, DEV BIOL, V129, P179, DOI 10.1016/0012-1606(88)90172-8; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Insall R, 2013, CURR OPIN CELL BIOL, V25, P526, DOI 10.1016/j.ceb.2013.04.009; Itoh G, 2007, J CELL SCI, V120, P4302, DOI 10.1242/jcs.015875; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; King JS, 2010, J CELL SCI, V123, P2246, DOI 10.1242/jcs.063735; KITANISHI T, 1984, PROTOPLASMA, V120, P185, DOI 10.1007/BF01282599; KURIYAMA R, 1982, CELL MOTIL CYTOSKEL, V2, P257, DOI 10.1002/cm.970020306; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Loomis WF, 2014, DEV BIOL, V391, P1, DOI 10.1016/j.ydbio.2014.04.001; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Pierini LM, 2003, CURR PROTOC CELL BIO; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rehberg M, 2005, MOL BIOL CELL, V16, P2759, DOI 10.1091/mbc.E05-01-0069; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shiratsuchi A, 2002, J BIOCHEM, V132, P381, DOI 10.1093/oxfordjournals.jbchem.a003233; Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Tang L, 2008, GENE DEV, V22, P2278, DOI 10.1101/gad.1694508; Tarbashevich K, 2011, DEV BIOL, V349, P169, DOI 10.1016/j.ydbio.2010.10.016; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Tvorogova A V, 2012, Tsitologiia, V54, P742; Van Haastert PJM, 2010, J CELL SCI, V123, P3031, DOI 10.1242/jcs.071118; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Wang Y, 2011, DEV GROWTH DIFFER, V53, P495, DOI 10.1111/j.1440-169X.2011.01265.x; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894; Yumura S, 1998, J CELL SCI, V111, P2097; YUMURA S, 1992, J CELL BIOL, V117, P1231, DOI 10.1083/jcb.117.6.1231; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; YUMURA S, 1995, CELL STRUCT FUNCT, V20, P185, DOI 10.1247/csf.20.185; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147; Zhao SY, 2014, FEBS OPEN BIO, V4, P190, DOI 10.1016/j.fob.2014.02.003; Zhou QQ, 2010, CURR BIOL, V20, P1881, DOI 10.1016/j.cub.2010.09.048	58	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137032	10.1371/journal.pone.0137032	http://dx.doi.org/10.1371/journal.pone.0137032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317626	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100198
J	Amancio, DR				Amancio, Diego Raphael			A Complex Network Approach to Stylometry	PLOS ONE			English	Article							HUMAN LANGUAGE; ZIPFS; CLASSIFICATION; METRICS	Statistical methods have been widely employed to study the fundamental properties of language. In recent years, methods from complex and dynamical systems proved useful to create several language models. Despite the large amount of studies devoted to represent texts with physical models, only a limited number of studies have shown how the properties of the underlying physical systems can be employed to improve the performance of natural language processing tasks. In this paper, I address this problem by devising complex networks methods that are able to improve the performance of current statistical methods. Using a fuzzy classification strategy, I show that the topological properties extracted from texts complement the traditional textual description. In several cases, the performance obtained with hybrid approaches outperformed the results obtained when only traditional or networked methods were used. Because the proposed model is generic, the framework devised here could be straightforwardly used to study similar textual applications where the topology plays a pivotal role in the description of the interacting agents.	Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Amancio, DR (corresponding author), Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil.	diego@icmc.usp.br	Amancio, Diego Raphael/I-1071-2012		Sao Paulo Research Foundation (FAPESP) [14/20830-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The author acknowledges support from Sao Paulo Research Foundation (FAPESP) (grant number 14/20830-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrini P, 2004, CHAOS SOLITON FRACT, V20, P95, DOI 10.1016/S0960-0779(03)00432-6; Amancio DR, 2011, PHYSICA A, V390, P131, DOI 10.1016/j.physa.2010.08.052; Amancio DR, 2008, INT J MOD PHYS C, V19, P583, DOI 10.1142/S0129183108012285; Amancio DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118394; Amancio DR, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03005; Amancio DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067310; Amancio DR, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58002; Amancio DR, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/18002; Amancio DR, 2012, PHYSICA A, V391, P1855, DOI 10.1016/j.physa.2011.10.015; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amancio DR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043029; Amancio DR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123024; Antiqueira L, 2007, PHYSICA A, V373, P811, DOI 10.1016/j.physa.2006.06.002; Antiqueira L. L., 2007, INTELIGENCIA ARTIFIC, V11, P51, DOI DOI 10.4114/IA.V11I36.891; Antiqueira L, 2009, INFORM SCIENCES, V179, P584, DOI 10.1016/j.ins.2008.10.032; Baixeries J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053227; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Berger AL, 1996, COMPUT LINGUIST, V22, P39; Bergstra J. S., 2011, P 24 INT C NEUR INF, P2546, DOI DOI 10.1145/3065386; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Bochkarev VV, 2014, J PHYS CONF SER, V490, DOI 10.1088/1742-6596/490/1/012009; Bonissone P, 2010, INT J APPROX REASON, V51, P729, DOI 10.1016/j.ijar.2010.02.003; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Capitan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043694; Carpena P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.035102; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; Corominas-Murtra B, 2009, ADV COMPLEX SYST, V12, P371, DOI 10.1142/S0219525909002192; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa LD, 2008, PHYSICA A, V387, P6201, DOI 10.1016/j.physa.2008.06.034; Font-Clos F, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093033; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Gravino P, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500543; HAVLIN S, 1995, PHYSICA A, V216, P148, DOI 10.1016/0378-4371(95)00069-J; Herrera JP, 2008, EUR PHYS J B, V63, P135, DOI 10.1140/epjb/e2008-00206-x; Jankowska M, 2012, IEEE C VIS AN SCI TE; Kali R, 2003, APPL ECON LETT, V10, P717, DOI 10.1080/1350485032000139006; Katz S., 1996, Natural Language Engineering, V2, P15, DOI 10.1017/S1351324996001246; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Kulig A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032810; Lin CF, 2002, IEEE T NEURAL NETWOR, V13, P464, DOI 10.1109/72.991432; Lu LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01082; Manning C.D., 1999, FDN STAT NATURAL LAN; Martinez-Romo J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046108; Masucci AP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026102; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mihalcea R, 2012, GRAPH BASED NATURAL; Mitchell T.M, 2003, MACH LEARN; Mosteller F, 1964, INFERENCE DISPUTED A; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Oakes M., 2004, P 5 INT C REC ADV SO; Olaru C, 2003, FUZZY SET SYST, V138, P221, DOI 10.1016/S0165-0114(03)00089-7; PAL SK, 1992, IEEE T NEURAL NETWOR, V3, P683, DOI 10.1109/72.159058; Patton JM, 2004, COMPUT HUMANITIES, V38, P457, DOI 10.1007/s10579-004-1906-6; Roxas RM, 2010, INT J MOD PHYS C, V21, P503, DOI 10.1142/S0129183110015257; Silva TC, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/58001; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Travencolo BAN, 2008, PHYS LETT A, V373, P89, DOI 10.1016/j.physleta.2008.10.069; Veronis J, 2004, COMPUT SPEECH LANG, V18, P223, DOI 10.1016/j.csl.2004.05.002; Vilensky B, 1996, PHYSICA A, V231, P705, DOI 10.1016/0378-4371(96)00109-4; Widdows D., 2002, P 19 INT C COMPUTATI, P1, DOI DOI 10.3115/1072228.1072342; Witten I. H., 2005, DATA MINING PRACTICA; Yang ACC, 2003, PHYSICA A, V329, P473, DOI 10.1016/S0378-4371(03)00622-8; Yu B., 2006, THESIS U ILLINOIS UR; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	67	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136076	10.1371/journal.pone.0136076	http://dx.doi.org/10.1371/journal.pone.0136076			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313921	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000040
J	Barra, M; Petitgas, P; Bonanno, A; Somarakis, S; Woillez, M; Machias, A; Mazzola, S; Basilone, G; Giannoulaki, M				Barra, Marco; Petitgas, Pierre; Bonanno, Angelo; Somarakis, Stylianos; Woillez, Mathieu; Machias, Athanasios; Mazzola, Salvatore; Basilone, Gualtiero; Giannoulaki, Marianna			Interannual Changes in Biomass Affect the Spatial Aggregations of Anchovy and Sardine as Evidenced by Geostatistical and Spatial Indicators	PLOS ONE			English	Article							AEGEAN SEA; ENGRAULIS-ENCRASICOLUS; PILCHARDUS; HABITAT; DYNAMICS; PATTERNS; CLUSTERS; FISHERY; AREA	Geostatistical techniques were applied and a series of spatial indicators were calculated (occupation, aggregation, location, dispersion, spatial autocorrelation and overlap) to characterize the spatial distributions of European anchovy and sardine during summer. Two ecosystems were compared for this purpose, both located in the Mediterranean Sea: the Strait of Sicily (upwelling area) and the North Aegean Sea (continental shelf area, influenced by freshwater). Although the biomass of anchovy and sardine presented high inter-annual variability in both areas, the location of the centres of gravity and the main spatial patches of their populations were very similar between years. The size of the patches representing the dominant part of the abundance (80%) was mostly ecosystem-and species-specific. Occupation (area of presence) appears to be shaped by the extent of suitable habitats in each ecosystem whereas aggregation patterns (how the populations are distributed within the area of presence) were species-specific and related to levels of population biomass. In the upwelling area, both species showed consistently higher occupation values compared to the continental shelf area. Certain characteristics of the spatial distribution of sardine (e.g. spreading area, overlapping with anchovy) differed substantially between the two ecosystems. Principal component analysis of geostatistical and spatial indicators revealed that biomass was significantly related to a suite of, rather than single, spatial indicators. At the spatial scale of our study, strong correlations emerged between biomass and the first principal component axis with highly positive loadings for occupation, aggregation and patchiness, independently of species and ecosystem. Overlapping between anchovy and sardine increased with the increase of sardine biomass but decreased with the increase of anchovy. This contrasting pattern was attributed to the location of the respective major patches combined with the specific occupation patterns of the two species. The potential use of spatial indices as auxiliary stock monitoring indicators is discussed.	[Barra, Marco; Bonanno, Angelo; Mazzola, Salvatore; Basilone, Gualtiero] Inst Coastal & Marine Environm, Detached Units Capo Granitola, Mazara Del Vallo, Italy; [Barra, Marco; Bonanno, Angelo; Mazzola, Salvatore; Basilone, Gualtiero] Inst Coastal & Marine Environm, Detached Units Capo Granitola, Naples, Italy; [Petitgas, Pierre; Woillez, Mathieu] IFREMER, Lab Ecol Halieut, Nantes, France; [Somarakis, Stylianos; Machias, Athanasios; Giannoulaki, Marianna] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Iraklion, Greece	Ifremer; Hellenic Centre for Marine Research	Giannoulaki, M (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Iraklion, Greece.	marianna@hcmr.gr	Barra, Marco/AAY-1562-2020; Basilone, Gualtiero/D-2896-2017; Bonanno, Angelo/H-9025-2013	Barra, Marco/0000-0002-8621-504X; Basilone, Gualtiero/0000-0002-5732-5055; Bonanno, Angelo/0000-0002-3868-751X; Woillez, Mathieu/0000-0002-1032-2105; Mazzola, Salvatore/0000-0002-4622-8129	European Union [MARE/2009/09]	European Union(European Commission)	Surveys were part of the European Union through the Data Collection Framework (DCF) in Greece and Sicily. This study is also part of the Negotiated Procedure No MARE/2009/09 (AcousMed) funded by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Antonakakis K, 2011, MEDITERR MAR SCI, V12, P333, DOI 10.12681/mms.36; Ayon P, 2011, MAR ECOL PROG SER, V422, P211, DOI 10.3354/meps08918; Barange M, 2005, ICES J MAR SCI, V62, P645, DOI 10.1016/j.icesjms.2004.12.019; Barange M, 2009, PROG OCEANOGR, V83, P251, DOI 10.1016/j.pocean.2009.07.027; Bez N, 2001, FISH RES, V50, P41, DOI 10.1016/S0165-7836(00)00241-1; Bez N, 2014, CAN J FISH AQUAT SCI, V71, P709, DOI 10.1139/cjfas-2013-0437; Bonanno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101498; Castillo-Jordan C, 2007, AQUAT LIVING RESOUR, V20, P77, DOI 10.1051/alr:2007018; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P12; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Giannoulaki M, 2006, ICES J MAR SCI, V63, P650, DOI 10.1016/j.icesjms.2005.10.017; Giannoulaki M, 2011, FISH OCEANOGR, V20, P367, DOI 10.1111/j.1365-2419.2011.00590.x; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Husson F, 2007, FACTOMINER FACTOR AN; Isari S, 2006, J PLANKTON RES, V28, P241, DOI 10.1093/plankt/fbi058; Isari S, 2011, J MAR BIOL ASSOC UK, V91, P51, DOI 10.1017/S0025315410000123; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Maravelias CD, 1995, NETH J SEA RES, V34, P319, DOI 10.1016/0077-7579(95)90041-1; Hieu NT, 2014, ACTA BIOTHEOR, V62, P339, DOI 10.1007/s10441-014-9220-1; Nikolioudakis N, 2012, MAR ECOL PROG SER, V453, P173, DOI 10.3354/meps09656; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; Petitgas P, 2003, ICES J MAR SCI, V60, P872, DOI 10.1016/S1054-3139(03)00025-0; Petitgas P, 1998, ICES J MAR SCI, V55, P443, DOI 10.1006/jmsc.1997.0345; Petitgas P., 2010, 306 ICES; PETITGAS P, 1997, 1997Y22 ICES CM; Petitgas P, 1993, AQUAT LIVING RESOUR, V6, P201, DOI 10.1051/alr:1993021; Petitgas Pierre, 2009, P191, DOI 10.1007/978-1-4020-8636-6_7; Tugores MP, 2011, MAR ECOL PROG SER, V443, P181, DOI 10.3354/meps09366; Planque B, 2011, FISH OCEANOGR, V20, P1, DOI 10.1111/j.1365-2419.2010.00546.x; R Core Team, 2016, R FDN STAT COMP; Saraux C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111211; Scott J. M., 2002, PREDICTING SPECIES O; Simmonds EJ, 2009, ICES J MAR SCI, V66, P1341, DOI 10.1093/icesjms/fsp118; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Somarakis S, 2004, ICES J MAR SCI, V61, P944, DOI 10.1016/j.icesjms.2004.07.018; STECF, 2013, 26614 STECF EUR EN; Tsagarakis K, 2008, HYDROBIOLOGIA, V612, P215, DOI 10.1007/s10750-008-9500-3; Tugores MP, 2010, ICES J MAR SCI, V67, P1574, DOI 10.1093/icesjms/fsq057; Warren WG, 1997, CAN J FISH AQUAT SCI, V54, P139, DOI 10.1139/cjfas-54-S1-139; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P155, DOI 10.1051/alr/2009017	46	32	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135808	10.1371/journal.pone.0135808	http://dx.doi.org/10.1371/journal.pone.0135808			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313648	Green Published, gold			2022-12-27	WOS:000360144000026
J	Guo, SS; Tang, LQ; Chen, QY; Zhang, L; Liu, LT; Huang, PY; Cao, KJ; Guo, L; Mo, HY; Guo, X; Hong, MH; Zeng, MS; Qian, CN; Mai, HQ				Guo, Shan-Shan; Tang, Lin-Quan; Chen, Qiu-Yan; Zhang, Lu; Liu, Li-Ting; Huang, Pei-Yu; Cao, Ka-Jia; Guo, Ling; Mo, Hao-Yuan; Guo, Xiang; Hong, Ming-Huang; Zeng, Mu-Sheng; Qian, Chao-Nan; Mai, Hai-Qiang			Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SEQUENTIAL CHEMORADIOTHERAPY; TREATMENT RESISTANCE; ESOPHAGEAL CANCER; ANEMIA; HYPOXIA; SURVIVAL; IMPACT; TUMORS; DNA	Background Hemoglobin (Hb) levels are regarded as an important determinant of outcome in a number of cancers treated with radiotherapy. However, for patients treated with intensity modulated radiotherapy (IMRT), information regarding the prognostic value of hemoglobin level is scarce. Patients and Methods A total of 650 patients with nasopharyngeal carcinoma (NPC), enrolled between May, 2005, and November, 2012, were included in this study. The prognostic significance of hemoglobin level (anemia or no-anemia) at three different time points was investigated, including before treatment, during treatment and at the last week of treatment. Univariate and multivariate analyses were conducted using the log-rank test and the Cox proportional hazards model, respectively. Results The 5-year OS (overall survival) rate of patients who were anemia and no-anemia before treatment were 89.1%, and 80.7%(P = 0.01), respectively. The 5-year DMFS (distant metastasis-free survival) rate of patients who were anemia and no-anemia before treatment were 88.9%, and 78.2% (P = 0.01), respectively. The 5-year OS rate of patients who were anemia and no-anemia during treatment were 91.7% and 83.3% (P = 0.004). According to multivariate analysis, the pre-treatment Hb level predicted a decreased DMFS (P = 0.007, HR = 2.555, 95% CI1.294-5.046). Besides, the mid-treatment Hb level predicted a decreased OS (P = 0.013, HR = 2.333, 95% CI1.199-4.541). Conclusions Hemoglobin level is a useful prognostic factor in NPC patients receiving IMRT. It is important to control the level of hemoglobin both before and during chemoradiotherapy.	[Guo, Shan-Shan; Tang, Lin-Quan; Chen, Qiu-Yan; Zhang, Lu; Liu, Li-Ting; Huang, Pei-Yu; Cao, Ka-Jia; Guo, Ling; Mo, Hao-Yuan; Guo, Xiang; Hong, Ming-Huang; Zeng, Mu-Sheng; Qian, Chao-Nan; Mai, Hai-Qiang] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Shan-Shan; Tang, Lin-Quan; Chen, Qiu-Yan; Zhang, Lu; Liu, Li-Ting; Huang, Pei-Yu; Cao, Ka-Jia; Guo, Ling; Mo, Hao-Yuan; Guo, Xiang; Qian, Chao-Nan; Mai, Hai-Qiang] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Hong, Ming-Huang] Sun Yat Sen Univ, Canc Ctr, GCP Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Mai, HQ (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	maihq@sysucc.org.cn			National Science Foundation for Distinguished Young Scholars of China [81425018]; National Natural Science Foundation of China [81072226]; 863 Project [2012AA02A501]; National Key Basic Research Program of China [2013CB910304]; Sci-Tech Project Foundation of Guangdong Province [2011B080701034, 2012B031800364]; Sci-Tech Project Foundation of Guangzhou City [2011J4300100]; Sun Yat-sen University Clinical Research 5010 Program; Fundamental Research Funds for the Central Universities	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Sci-Tech Project Foundation of Guangdong Province; Sci-Tech Project Foundation of Guangzhou City; Sun Yat-sen University Clinical Research 5010 Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the National Science Foundation for Distinguished Young Scholars of China (No. 81425018), the National Natural Science Foundation of China (No. 81072226), the 863 Project (No. 2012AA02A501), the National Key Basic Research Program of China (No. 2013CB910304), the Sci-Tech Project Foundation of Guangdong Province (No. 2011B080701034 and No. 2012B031800364), the Sci-Tech Project Foundation of Guangzhou City (No. 2011J4300100), the Sun Yat-sen University Clinical Research 5010 Program and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2000, INT J RADIAT ONCOL, V46, P459, DOI 10.1016/S0360-3016(99)00384-3; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chua DTT, 2004, CANCER, V101, P307, DOI 10.1002/cncr.20366; Cordella C, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-35; Gao J, 2012, INT J RADIAT ONCOL, V82, P1471, DOI 10.1016/j.ijrobp.2011.05.009; Gao Jin, 2010, Chin J Cancer, V29, P561; Grogan M, 1999, CANCER, V86, P1528, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E; Gu MF, 2013, INT J CANCER, V132, P215, DOI 10.1002/ijc.27638; Henke M, 2000, INT J RADIAT ONCOL, V48, P339, DOI 10.1016/S0360-3016(00)00595-2; Hong B, 2013, HEAD NECK-J SCI SPEC, V35, P133, DOI 10.1002/hed.21877; Kadokura Genmu, 2014, Gan To Kagaku Ryoho, V41, P416; Kong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091362; Kong FF, 2014, EUR ARCH OTO-RHINO-L, V271, P3283, DOI 10.1007/s00405-014-2900-2; Leung SF, 2014, ANN ONCOL, V25, P1204, DOI 10.1093/annonc/mdu117; Moretto F, 2014, RADIOL MED, V119, P634, DOI 10.1007/s11547-013-0359-7; Mujcic H, 2014, CURR MOL MED, V14, P565, DOI 10.2174/1566524014666140603115831; Munstedt K, 2004, ONCOL REP, V11, P711; Pattle SB, 2006, EXPERT OPIN BIOL TH, V6, P1193, DOI 10.1517/14712598.6.11.1193; Rades D, 2006, CLIN ONCOL-UK, V18, P139, DOI 10.1016/j.clon.2005.10.007; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Walter CJ, 2013, COLORECTAL DIS, V15, P52, DOI 10.1111/j.1463-1318.2012.03112.x; Xu ZJ, 2013, CHIN J CANCER, V32, P453, DOI 10.5732/cjc.013.10118; Yoshino Ichiro, 2014, Gan To Kagaku Ryoho, V41, P426; YOUNG LS, 1988, J GEN VIROL, V69, P1051, DOI 10.1099/0022-1317-69-5-1051; Zenda S, 2008, DIS ESOPHAGUS, V21, P195, DOI 10.1111/j.1442-2050.2007.00750.x; Zhao Chong, 2004, Ai Zheng, V23, P1532; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	28	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136033	10.1371/journal.pone.0136033	http://dx.doi.org/10.1371/journal.pone.0136033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313452	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000036
J	Leuzzi, A; Di Martino, ML; Campilongo, R; Falconi, M; Barbagallo, M; Marcocci, L; Pietrangeli, P; Casalino, M; Grossi, M; Micheli, G; Colonna, B; Prosseda, G				Leuzzi, Adriano; Di Martino, Maria Letizia; Campilongo, Rosaria; Falconi, Maurizio; Barbagallo, Marialuisa; Marcocci, Lucia; Pietrangeli, Paola; Casalino, Mariassunta; Grossi, Milena; Micheli, Gioacchino; Colonna, Bianca; Prosseda, Gianni			Multifactor Regulation of the MdtJI Polyamine Transporter in Shigella	PLOS ONE			English	Article							VIRULENCE GENE ICSA; PROTEIN H-NS; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; CHROMOSOMAL GENES; VIRF PROMOTER; EVOLUTION; INVASION; PATHOGENICITY; TRANSCRIPTION	The polyamine profile of Shigella, the etiological agent of bacillary dysentery in humans, differs markedly from that of E. coli, its innocuous commensal ancestor. Pathoadaptive mutations such as the loss of cadaverine and the increase of spermidine favour the full expression of the virulent phenotype of Shigella. Spermidine levels affect the expression of the MdtJI complex, a recently identified efflux pump belonging to the small multi-drug resistance family of transporters. In the present study, we have addressed the regulation of the mdtJI operon in Shigella by asking which factors influence its expression as compared to E. coli. In particular, after identifying the mdtJI promoter by primer extension analysis, in vivo transcription assays and gel-retardation experiments were carried out to get insight on the silencing of mdtJI in E. coli. The results indicate that H-NS, a major nucleoid protein, plays a key role in repressing the mdtJI operon by direct binding to the regulatory region. In the Shigella background mdtJI expression is increased by the high levels of spermidine typically found in this microorganism and by VirF, the plasmid-encoded regulator of the Shigella virulence regulatory cascade. We also show that the expression of mdtJI is stimulated by bile components. Functional analyses reveal that MdtJI is able to promote the excretion of putrescine, the spermidine precursor. This leads us to consider the MdtJI complex as a possible safety valve allowing Shigella to maintain spermidine to a level optimally suited to survival within infected macrophages and, at the same time, prevent toxicity due to spermidine over-accumulation.	[Leuzzi, Adriano; Di Martino, Maria Letizia; Campilongo, Rosaria; Barbagallo, Marialuisa; Grossi, Milena; Colonna, Bianca; Prosseda, Gianni] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Falconi, Maurizio] Univ Camerino, Scuola Biosci & Med Vet, Lab Genet Mol & Microrganismi, I-62032 Camerino, Italy; [Marcocci, Lucia; Pietrangeli, Paola] Univ Roma La Sapienza, Dipartimento Biochim, I-00185 Rome, Italy; [Casalino, Mariassunta] Univ Roma Tre, Dipartimento Sci, I-00146 Rome, Italy; [Micheli, Gioacchino] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Camerino; Sapienza University Rome; Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Prosseda, G (corresponding author), Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol C Darwin, Via Sardi 70, I-00185 Rome, Italy.	gianni.prosseda@uniroma1.it	Di Martino, Maria Letizia/L-7066-2019; Falconi, Maurizio/AAW-2929-2020; Micheli, Gioacchino/G-5797-2013; Barbagallo, Marialuisa/ABG-1234-2020	Di Martino, Maria Letizia/0000-0002-9491-4000; Falconi, Maurizio/0000-0002-4646-6741; Micheli, Gioacchino/0000-0002-4133-8492; Barbagallo, Marialuisa/0000-0003-0294-2299; Marcocci, Lucia/0000-0003-2301-7166; PROSSEDA, Gianni/0000-0001-5235-0086; Campilongo, Rosaria/0000-0003-4319-5453	Ministero della Ricerca e dell'Istruzione [PRIN 2012/WWJSX8K]; "Ministero della Ricerca e dell'Istruzione" (FIRB); Sapienza Universita di Roma; Istituto Pasteur - Fondazione Cenci Bolognetti; PRIN; Sapienza University	Ministero della Ricerca e dell'Istruzione; "Ministero della Ricerca e dell'Istruzione" (FIRB); Sapienza Universita di Roma; Istituto Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Sapienza University	This work was supported by grants from "Ministero della Ricerca e dell'Istruzione" (PRIN 2012/WWJSX8K and FIRB) and from "Sapienza Universita di Roma". RC was supported by fellowships of the "Istituto Pasteur - Fondazione Cenci Bolognetti". MLDM was supported by a post-doc grant from PRIN and Sapienza University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; BERTIN P, 1994, J BACTERIOL, V176, P5537, DOI 10.1128/JB.176.17.5537-5540.1994; Campilongo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106589; Tran CN, 2011, NUCLEIC ACIDS RES, V39, P8122, DOI 10.1093/nar/gkr521; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Carolis E, 2011, INT J MED MICROBIOL, V301, P273, DOI 10.1016/j.ijmm.2010.10.001; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P651, DOI 10.1016/j.ijmm.2013.09.007; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; FALCONI M, 1993, MOL MICROBIOL, V10, P273, DOI 10.1111/j.1365-2958.1993.tb01953.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Feng Y, 2011, PLOS ONE, V6; FUKUCHI JI, 1995, J BIOL CHEM, V270, P18831, DOI 10.1074/jbc.270.32.18831; Giangrossi M, 2010, NUCLEIC ACIDS RES, V38, P3362, DOI 10.1093/nar/gkq025; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Kurihara S, 2011, J BIOL CHEM, V286, P10185, DOI 10.1074/jbc.M110.176032; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2004, J BACTERIOL, V186, P1423, DOI 10.1128/JB.186.5.1423-1429.2004; Nishino K, 2003, J BACTERIOL, V185, P2667, DOI 10.1128/JB.185.8.2667-2672.2003; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Prosseda G, 2004, MOL MICROBIOL, V51, P523, DOI 10.1046/j.1365-2958.2003.03848.x; Prosseda G, 1998, RES MICROBIOL, V149, P15, DOI 10.1016/S0923-2508(97)83619-4; Prosseda G, 2002, RES MICROBIOL, V153, P461, DOI 10.1016/S0923-2508(02)01346-3; Prosseda G, 2006, J BACTERIOL, V188, P4681, DOI 10.1128/JB.00332-06; Prosseda G, 2012, RES MICROBIOL, V163, P399, DOI 10.1016/j.resmic.2012.07.004; Prosseda G, 2010, BIOCHEMISTRY-US, V49, P2778, DOI 10.1021/bi902003g; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; SAKAI T, 1986, INFECT IMMUN, V54, P395, DOI 10.1128/IAI.54.2.395-402.1986; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; SANSONETTI PJ, 1982, ANN INST PASTEUR MIC, VA133, P351; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; SHPIGELMAN ES, 1993, COMPUT APPL BIOSCI, V9, P435; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Tomitori H, 2012, AMINO ACIDS, V42, P733, DOI 10.1007/s00726-011-0989-9; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; ZHOU MY, 1995, BIOTECHNIQUES, V19, P34	53	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136744	10.1371/journal.pone.0136744	http://dx.doi.org/10.1371/journal.pone.0136744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313003	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000092
J	Lekva, T; Bollerslev, J; Norwitz, ER; Aukrust, P; Henriksen, T; Ueland, T				Lekva, Tove; Bollerslev, Jens; Norwitz, Errol R.; Aukrust, Pal; Henriksen, Tore; Ueland, Thor			Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; ARTERIAL STIFFNESS; DISEASE; INSULIN; GLUCOSE; TRIGLYCERIDES; HYPERGLYCEMIA; SENSITIVITY; DYSFUNCTION; POPULATION	Gestational diabetes mellitus (GDM) is a significant risk factor for cardiovascular disease (CVD) in later life, but the mechanism remains unclear. The aim of the study was to investigate indices of glucose metabolism, dyslipidemia, and arterial stiffness (as measured by pulse wave velocity (PWV)), in women with and without a history of GDM, using both the old WHO and new IADPSG diagnostic criteria, at 5 years after the index pregnancy. Dyslipidemia and PWV were used as surrogate markers for CVD risk. The population-based prospective cohort included 300 women from the original STORK study. All participants had an oral glucose tolerance test (OGTT) during pregnancy. Five years later, the OGTT was repeated along with dual-energy x-ray absorptiometry, lipid analysis, and PWV analysis. Measurements were compared between those women who did and did not have GDM based on both the WHO and IADPSG criteria. We found that women with GDM based on the old WHO criteria had higher CVD risk at 5 years than those without GDM, with markedly elevated PWV and more severe dyslipidemia (higher triglycerides (TG)/HDL cholesterol ratio). After adjusting for known risk factors, the most important predictors for elevated PWV and TG/HDL-C ratio at 5-year follow-up were maternal age, BMI, GDM, systolic blood pressure, and indices of glucose metabolism in the index pregnancy. In conclusion, we found a higher risk for CVD, based on the surrogate markers PWV and TG/HDL-C ratio, at 5-year follow-up in women diagnosed with GDM in the index pregnancy when using the old WHO diagnostic criteria.	[Lekva, Tove; Aukrust, Pal; Ueland, Thor] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Lekva, Tove; Norwitz, Errol R.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA; [Bollerslev, Jens] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Specialized Endocrinol,Dept Endocrinol, N-0027 Oslo, Norway; [Bollerslev, Jens; Aukrust, Pal; Henriksen, Tore; Ueland, Thor] Univ Oslo, Fac Med, Oslo, Norway; [Norwitz, Errol R.] Tufts Med Ctr, Dept Obstet & Gynecol, Boston, MA USA; [Norwitz, Errol R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Henriksen, Tore] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Obstet, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; Tufts Medical Center; University of Oslo; National Hospital Norway; University of Oslo; Tufts Medical Center; Tufts University; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Lekva, T (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	tove.lekva@rr-research.no	Stefanadis, Christodoulos/ABH-2232-2020; Sánchez-Margalet, Victor/AAB-9986-2021	Stefanadis, Christodoulos/0000-0001-5974-6454; Sánchez-Margalet, Victor/0000-0001-8638-8680; Lekva, Tove/0000-0002-7962-4726	South-Eastern Norway Regional Health Authority	South-Eastern Norway Regional Health Authority	The project has been financially supported by a grant to TU (personal postdoctoral research grant for TL) from South-Eastern Norway Regional Health Authority.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Anastasiou E, 1998, DIABETES CARE, V21, P2111, DOI 10.2337/diacare.21.12.2111; Arca M, 2012, CURR VASC PHARMACOL, V10, P684, DOI 10.2174/157016112803520864; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Bo S, 2007, ATHEROSCLEROSIS, V194, pE72, DOI 10.1016/j.atherosclerosis.2006.09.017; Bouguerra S A, 2001, Int J Exp Diabetes Res, V2, P37, DOI 10.1155/EDR.2001.37; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Bulzico DA, 2012, DIABETIC MED, V29, P227, DOI 10.1111/j.1464-5491.2011.03471.x; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Davenport MH, 2012, AM J PHYSIOL-REG I, V302, pR768, DOI 10.1152/ajpregu.00115.2011; Ergun DL, 2012, GE HEALTHCARE ADV DX; Fadl H, 2014, BJOG-INT J OBSTET GY, V121, P1530, DOI 10.1111/1471-0528.12754; Heitritter SM, 2005, J CLIN ENDOCR METAB, V90, P3983, DOI 10.1210/jc.2004-2494; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Lauenborg J, 2005, J CLIN ENDOCR METAB, V90, P4004, DOI 10.1210/jc.2004-1713; Lekva T, 2015, EUR J ENDOCRINOL; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McIntyre HD, 2015, BEST PRACT RES CL OB, V29, P194, DOI 10.1016/j.bpobgyn.2014.04.022; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Olarescu NC, 2014, J CLIN ENDOCR METAB, V99, pE1727, DOI 10.1210/jc.2014-2059; Petersen KS, 2015, ARTERIOSCL THROM VAS, V35, P243, DOI 10.1161/ATVBAHA.114.304798; Prenner SB, 2015, ATHEROSCLEROSIS, V238, P370, DOI 10.1016/j.atherosclerosis.2014.12.023; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Retnakaran R, 2009, CAN MED ASSOC J, V181, P371, DOI 10.1503/cmaj.090569; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Safar ME, 2006, J AM SOC NEPHROL, V17, pS109, DOI 10.1681/ASN.2005121321; Salazar MR, 2014, J AM SOC HYPERTENS, V8, P724, DOI 10.1016/j.jash.2014.08.002; Salmi AA, 2012, VASA, V41, P96, DOI 10.1024/0301-1526/a000171; Savvidou MD, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.021; Schram MT, 2004, HYPERTENSION, V43, P176, DOI 10.1161/01.HYP.0000111829.46090.92; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Sokup A, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/278050; Sokup A, 2012, ACTA OBSTET GYN SCAN, V91, P182, DOI 10.1111/j.1600-0412.2011.01289.x; SOMOZA E, 1989, INT J BIOMED COMPUT, V24, P153, DOI 10.1016/0020-7101(89)90029-9; Stanley JL, 2010, AM J PHYSIOL-REG I, V299, pR862, DOI 10.1152/ajpregu.00200.2010; STOUT RW, 1992, EUR J EPIDEMIOL, V8, P134, DOI 10.1007/BF00145365; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Wu LY, 2014, METABOLISM, V63, P1469, DOI 10.1016/j.metabol.2014.08.010	42	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136892	10.1371/journal.pone.0136892	http://dx.doi.org/10.1371/journal.pone.0136892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309121	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400160
J	Fernandez-Palomeque, C; Grau, A; Perello, J; Sanchis, P; Isern, B; Prieto, RM; Costa-Bauza, A; Caldes, OJ; Bonnin, O; Garcia-Raja, A; Bethencourt, A; Grases, F				Fernandez-Palomeque, Carlos; Grau, Andres; Perello, Joan; Sanchis, Pilar; Isern, Bernat; Prieto, Rafel M.; Costa-Bauza, Antonia; Caldes, Onofre J.; Bonnin, Oriol; Garcia-Raja, Ana; Bethencourt, Armando; Grases, Felix			Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; MITRAL ANNULAR CALCIFICATION; CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; INOSITOL HEXAKISPHOSPHATE; CARDIOVASCULAR RISK; DIALYSIS PATIENTS; DIETARY PHYTATE; BREAST-CANCER; CALCIUM	Pathological calcification generally consists of the formation of solid deposits of hydroxyapatite (calcium phosphate) in soft tissues. Supersaturation is the thermodynamic driving force for crystallization, so it is believed that higher blood levels of calcium and phosphate increase the risk of cardiovascular calcification. However several factors can promote or inhibit the natural process of pathological calcification. This cross-sectional study evaluated the relationship between physiological levels of urinary phytate and heart valve calcification in a population of elderly out subjects. A population of 188 elderly subjects (mean age: 68 years) was studied. Valve calcification was measured by echocardiography. Phytate determination was performed from a urine sample and data on blood chemistry, end-systolic volume, concomitant diseases, cardiovascular risk factors, medication usage and food were obtained. The study population was classified in three tertiles according to level of urinary phytate: low (<0.610 mu M), intermediate (0.61-1.21 mu M), and high (>1.21 mu M). Subjects with higher levels of urinary phytate had less mitral annulus calcification and were less likely to have diabetes and hypercholesterolemia. In the multivariate analysis, age, serum phosphorous, leukocytes total count and urinary phytate excretion appeared as independent factors predictive of presence of mitral annulus calcification. There was an inverse correlation between urinary phytate content and mitral annulus calcification in our population of elderly out subjects. These results suggest that consumption of phytate-rich foods may help to prevent cardiovascular calcification evolution.	[Fernandez-Palomeque, Carlos; Grau, Andres; Caldes, Onofre J.; Bonnin, Oriol; Garcia-Raja, Ana; Bethencourt, Armando] Hosp Univ Son Espases, IdISPa, Palma Of Mallorca 07120, Spain; [Perello, Joan; Sanchis, Pilar; Isern, Bernat; Prieto, Rafel M.; Costa-Bauza, Antonia; Grases, Felix] Univ Balearic Isl, Lab Renal Lithiasis Res, Inst Hlth Sci Res IUNICS IdISPa, Palma Of Mallorca 07122, Spain; [Prieto, Rafel M.; Costa-Bauza, Antonia; Grases, Felix] Inst Salud Carlos III, CIBERobn CB06 03, Madrid 28029, Spain	Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Grases, F (corresponding author), Univ Balearic Isl, Lab Renal Lithiasis Res, Inst Hlth Sci Res IUNICS IdISPa, Palma Of Mallorca 07122, Spain.	fgrases@uib.es	Isern, Bernat/ABF-3751-2021; Fernandez-Palomeque, Carlos/A-4019-2011; Perello, Joan/A-7387-2019; Sanchis, Pilar/AAH-4684-2020; Prieto, Rafel M./J-3995-2017	Fernandez-Palomeque, Carlos/0000-0002-6881-4487; Perello, Joan/0000-0003-2671-3386; Prieto, Rafel M./0000-0001-8814-900X; Costa-Bauza, Antonia/0000-0003-0647-4154; Sanchis, Pilar/0000-0003-0618-0594; Grases, Felix/0000-0001-5636-9139; Sanchis, Pilar/0000-0001-8565-1811	Ministerio de Economia y Competitividad (Gobierno de Espana) [PI14/00853]; FEDER funds (European Union); Ministerio de Educacion y Cultura (Gobierno de Espana); Conselleria d'Innovacio i Energia del (Govern de les Illes Balears); Conselleria de Educacio, Cultura i Universitats (Govern de les Illes Balears) [PD/009/2013]	Ministerio de Economia y Competitividad (Gobierno de Espana); FEDER funds (European Union)(European Commission); Ministerio de Educacion y Cultura (Gobierno de Espana); Conselleria d'Innovacio i Energia del (Govern de les Illes Balears); Conselleria de Educacio, Cultura i Universitats (Govern de les Illes Balears)	This work was supported by grant PI14/00853 from the Ministerio de Economia y Competitividad (Gobierno de Espana), and by FEDER funds (European Union). JP expresses his appreciation to Ministerio de Educacion y Cultura (Gobierno de Espana) for the fellowship of the FPU program. BI expresses his appreciation to the Conselleria d'Innovacio i Energia del (Govern de les Illes Balears) for the doctoral fellowship. PS express her appreciation for the postdoctoral fellowship PD/009/2013 to the Conselleria de Educacio, Cultura i Universitats (Govern de les Illes Balears) and the European Social Fund through the ESF Operational Programme of the Balearic Islands 2013-2017.	Agarwal S, 2013, DIABETES CARE, V36, P972, DOI 10.2337/dc12-1548; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; DALEYYATES PT, 1991, CALCIFIED TISSUE INT, V49, P433, DOI 10.1007/BF02555856; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Eiseman J, 2011, METABOLISM, V60, P1465, DOI 10.1016/j.metabol.2011.02.015; ELLIOTT RJ, 1994, CALCIFIED TISSUE INT, V54, P268, DOI 10.1007/BF00295949; Elmariah S, 2013, AM HEART J, V166, P904, DOI 10.1016/j.ahj.2013.08.015; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Grases F, 2003, CLIN CHIM ACTA, V334, P131, DOI 10.1016/S0009-8981(03)00227-4; Grases F, 2006, FRONT BIOSCI-LANDMRK, V11, P136, DOI 10.2741/1786; Grases F, 2004, ANAL CHIM ACTA, V510, P41, DOI 10.1016/j.aca.2003.12.061; Grases F, 2009, J PERIODONTAL RES, V44, P616, DOI 10.1111/j.1600-0765.2008.01168.x; Grases F, 2001, BIOFACTORS, V15, P53, DOI 10.1002/biof.5520150105; Grases F, 2001, J NUTR BIOCHEM, V12, P595, DOI 10.1016/S0955-2863(01)00178-4; Grases F, 2001, BRIT J NUTR, V86, P225, DOI 10.1079/BJN2001389; Grases F, 2000, BJU INT, V85, P138, DOI 10.1046/j.1464-410x.2000.00324.x; Grases F, 2008, FRONT BIOSCI-LANDMRK, V13, P7115, DOI 10.2741/3214; Hanke H, 2001, ACTA CHIR BELG, V101, P162; Hou LF, 2013, EUR J EPIDEMIOL, V28, P735, DOI 10.1007/s10654-013-9842-7; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kizer JR, 2005, STROKE, V36, P2533, DOI 10.1161/01.STR.0000190005.09442.ad; Korkmaz L, 2012, TURK KARDIYOL DERN A, V40, P223, DOI 10.5543/tkda.2012.37801; Kwak SM, 2014, ARTERIOSCL THROM VAS, V34, P1763, DOI 10.1161/ATVBAHA.114.303440; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Potter SM., 1995, J NUTR S, V125, P606; Prieto RM, 2010, EUR J NUTR, V49, P321, DOI 10.1007/s00394-009-0087-x; Reslerova M, 2003, AM J KIDNEY DIS, V41, pS96, DOI 10.1053/ajkd.2003.50094; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Rossi A, 2014, HEART VESSELS, V29, P776, DOI 10.1007/s00380-013-0433-z; Schlemmer U, 2009, MOL NUTR FOOD RES, V53, pS330, DOI 10.1002/mnfr.200900099; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Varol E, 2014, BLOOD COAGUL FIBRIN, V25, P557, DOI 10.1097/MBC.0000000000000094; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; ZHOU JR, 1995, CRIT REV FOOD SCI, V35, P495, DOI 10.1080/10408399509527712	40	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136560	10.1371/journal.pone.0136560	http://dx.doi.org/10.1371/journal.pone.0136560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322979	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500021
J	Min, B; Liljeros, F; Makse, HA				Min, Byungjoon; Liljeros, Fredrik; Makse, Hernan A.			Finding Influential Spreaders from Human Activity beyond Network Location	PLOS ONE			English	Article							COMPUTER-NETWORKS; INTERNET; STRATEGIES; SEARCH; NODES; MODEL	Most centralities proposed for identifying influential spreaders on social networks to either spread a message or to stop an epidemic require the full topological information of the network on which spreading occurs. In practice, however, collecting all connections between agents in social networks can be hardly achieved. As a result, such metrics could be difficult to apply to real social networks. Consequently, a new approach for identifying influential people without the explicit network information is demanded in order to provide an efficient immunization or spreading strategy, in a practical sense. In this study, we seek a possible way for finding influential spreaders by using the social mechanisms of how social connections are formed in real networks. We find that a reliable immunization scheme can be achieved by asking people how they interact with each other. From these surveys we find that the probabilistic tendency to connect to a hub has the strongest predictive power for influential spreaders among tested social mechanisms. Our observation also suggests that people who connect different communities is more likely to be an influential spreader when a network has a strong modular structure. Our finding implies that not only the effect of network location but also the behavior of individuals is important to design optimal immunization or spreading schemes.	[Min, Byungjoon; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Min, Byungjoon; Makse, Hernan A.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Liljeros, Fredrik] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Liljeros, Fredrik] Inst Futures Study, Stockholm, Sweden	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Stockholm University	Min, B (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.	min.byungjoon@gmail.com	Liljeros, Fredrik G I/I-2667-2018	Liljeros, Fredrik G I/0000-0001-8642-6624	NIH-NIGMS [1R21GM107641]; 358 Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation) [BR. 359 P12-0705:1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM107641] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 358 Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH-NIGMS 1R21GM107641. FL was supported by 358 Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation) Grant BR. 359 P12-0705:1.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ANDERSON R M, 1991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brin S, 2012, COMPUT NETW, V56, P3825, DOI 10.1016/j.comnet.2012.10.007; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Castellano C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00371; Chen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077455; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Contractor NS, 2006, ACAD MANAGE REV, V31, P681, DOI [10.2307/20159236, 10.5465/AMR.2006.21318925]; Domingos P., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P57, DOI 10.1145/502512.502525; Dorogovtsev SN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.040601; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fridlund V, 2014, SCAND J PUBLIC HEALT, V42, P759, DOI 10.1177/1403494814550518; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gujarati D.N., 2012, BASIC ECONOMETRICS; Holme P, 2004, EUROPHYS LETT, V68, P908, DOI 10.1209/epl/i2004-10286-2; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056109; Kempe D, 2005, LECT NOTES COMPUT SC, V3580, P1127, DOI 10.1007/11523468_91; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123018; Min B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036102; Monge P. R., 2003, THEORIES COMMUNICATI, DOI 10.1093/oso/9780195160369.001.0001; MONTGOMERY JD, 1992, AM SOCIOL REV, V57, P586, DOI 10.2307/2095914; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pei S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126894; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Serrano MA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056115; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702	46	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136831	10.1371/journal.pone.0136831	http://dx.doi.org/10.1371/journal.pone.0136831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26323015	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500040
J	Staron, R; Van Swelm, RPL; Lipinski, P; Gajowiak, A; Lenartowicz, M; Bednarz, A; Gajewska, M; Pieszka, M; Laarakkers, CMM; Swinkels, DW; Starzynski, RR				Staron, Robert; Van Swelm, Rachel P. L.; Lipinski, Pawel; Gajowiak, Anna; Lenartowicz, Malgorzata; Bednarz, Aleksandra; Gajewska, Malgorzata; Pieszka, Marek; Laarakkers, Coby M. M.; Swinkels, Dorine W.; Starzynski, Rafal R.			Urinary Hepcidin Levels in Iron-Deficient and Iron-Supplemented Piglets Correlate with Hepcidin Hepatic mRNA and Serum Levels and with Body Iron Status	PLOS ONE			English	Article							EXPRESSION; QUANTIFICATION; UTILITY; ANEMIA; KIDNEY; ASSAYS; GENE; 1ST	Among livestock, domestic pig (Sus scrofa) is a species, in which iron metabolism has been most intensively examined during last decade. The obvious reason for studying the regulation of iron homeostasis especially in young pigs is neonatal iron deficiency anemia commonly occurring in these animals. Moreover, supplementation of essentially all commercially reared piglets with iron entails a need for monitoring the efficacy of this routine practice followed in the swine industry for several decades. Since the discovery of hepcidin many studies confirmed its role as key regulator of iron metabolism and pointed out the assessment of its concentrations in biological fluids as diagnostic tool for iron-related disorder. Here we demonstrate that urine hepcidin-25 levels measured by a combination of weak cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF MS) are highly correlated with mRNA hepcidin expression in the liver and plasma hepcidin-25 concentrations in anemic and iron-supplemented 28-day old piglets. We also found a high correlation between urine hepcidin level and hepatic non-heme iron content. Our results show that similarly to previously described transgenic mouse models of iron disorders, young pigs constitute a convenient animal model to explore accuracy and relationship between indicators for assessing systemic iron status.	[Staron, Robert; Lipinski, Pawel; Gajowiak, Anna; Starzynski, Rafal R.] Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland; [Lenartowicz, Malgorzata; Bednarz, Aleksandra] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland; [Gajewska, Malgorzata] Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland; [Pieszka, Marek] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Krakow, Poland; [Van Swelm, Rachel P. L.; Laarakkers, Coby M. M.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med LGEM 830, NL-6525 ED Nijmegen, Netherlands	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University; Warsaw University of Life Sciences; National Research Institute of Animal Production; Radboud University Nijmegen	Lipinski, P (corresponding author), Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland.	p.lipinski@ighz.pl; r.starzynski@ighz.pl	van Swelm, Rachel PL/P-6063-2015; Swinkels, Dorine W./H-8098-2014	Swinkels, Dorine W./0000-0002-1040-9446; Bednarz, Aleksandra/0000-0003-2256-2998; Gajewska, Malgorzata/0000-0001-7249-8627; , Rafal/0000-0002-7470-0507	National Science Centre [2012/05/E/NZ5/02126]	National Science Centre(National Science Centre, Poland)	This work was supported by The National Science Centre, grant no. 2012/05/E/NZ5/02126 (https://www.ncn.gov.pl/?language = en).	Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Egeli AK, 1999, RES VET SCI, V66, P179, DOI 10.1053/rvsc.1998.0223; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Ho J, 2011, CLIN J AM SOC NEPHRO, V6, P2340, DOI 10.2215/CJN.01000211; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Konz T, 2014, METALLOMICS, V6, P1583, DOI 10.1039/c4mt00063c; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Laarakkers CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075518; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Lipinski P, 2010, AM J PATHOL, V177, P1233, DOI 10.2353/ajpath.2010.091020; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peters HPE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-70; Peters JC, 2008, J ANIM SCI, V86, P2261, DOI 10.2527/jas.2007-0577; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rincker MJ, 2005, J ANIM SCI, V83, P2137; Starzynski RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064022; Svoboda M., 2005, Folia Veterinaria, V49, P104; Szabo P, 2002, J VET MED A, V49, P390, DOI 10.1046/j.1439-0442.2002.00448.x; Tjalsma H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016762; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; World Health Organization, 2004, GLOB BURD DIS 2004 U	34	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136695	10.1371/journal.pone.0136695	http://dx.doi.org/10.1371/journal.pone.0136695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323096	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500028
J	Davis, A; Taylor, J; Cohen, E				Davis, Arran; Taylor, Jacob; Cohen, Emma			Social Bonds and Exercise: Evidence for a Reciprocal Relationship	PLOS ONE			English	Article							SYNCHRONY; PAIN; PERFORMANCE; PLACEBO; SCALE	In two experimental studies, we investigated mechanisms hypothesized to underpin two pervasive and interrelated phenomena: that certain forms of group movement and exercise lead to social bonding and that social bonding can lead to enhanced exercise performance. In Study 1, we manipulated synchrony and exercise intensity among rowers and found that, compared with low intensity exercise, moderate intensity exercise led to significantly higher levels of cooperation in an economic game; no effect of synchrony vs. non-synchrony was found. In Study 2, we investigated the effects of bonding on performance, using synchrony as a cue of existing supportive social bonds among participants. An elite, highly bonded team of rugby players participated in solo, synchronized, and non-synchronized warm-up sessions; participants' anaerobic performance significantly improved after the brief synchronous warm-up relative to the non-synchronous warm-up. The findings substantiate claims concerning the reciprocal links between group exercise and social bonding, and may help to explain the ubiquity of collective physical activity across cultural domains as varied as play, ritual, sport, and dance.	[Davis, Arran; Taylor, Jacob; Cohen, Emma] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford OX2 6PN, England; [Cohen, Emma] Univ Oxford Wadham Coll, Oxford OX1 3PN, England	University of Oxford; University of Oxford	Davis, A (corresponding author), Univ Oxford, Inst Cognit & Evolutionary Anthropol, 64 Banbury Rd, Oxford OX2 6PN, England.	arran.davis@anthro.ox.ac.uk		Davis, Arran/0000-0002-8561-7768; Taylor, Jacob/0000-0001-9367-0369	British Academy [MD130076]; University of Oxford [132/117]	British Academy; University of Oxford	This work was supported by British Academy (http://www.britac.ac.uk/) Fellowship number MD130076 to EC; and the John Fell Fund (https://www.admin.ox.ac.uk/pras/jff/) award, University of Oxford [number 132/117] to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Bastian B, 2014, PSYCHOL SCI, V25, P2079, DOI 10.1177/0956797614545886; Beedie CJ, 2009, SPORTS MED, V39, P313, DOI 10.2165/00007256-200939040-00004; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Buehler A, 2012, FIELDWORK RELIG, V7, P70, DOI 10.1558/fiel.v7i1.70; Carron AV, 2002, J SPORT EXERCISE PSY, V24, P168, DOI 10.1123/jsep.24.2.168; Cohen E, GROUP EXERCISE SOCIA; Cohen E, 2014, RELIG BRAIN BEHAV, V4, P20, DOI 10.1080/2153599X.2012.741075; Cohen EEA, 2010, BIOL LETTERS, V6, P106, DOI 10.1098/rsbl.2009.0670; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Dunbar RIM, 2012, PHILOS T R SOC B, V367, P1837, DOI 10.1098/rstb.2011.0217; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Durkheim E., 1995, ELEMENTARY FORMS REL; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Fattore L, 2010, EXP NEUROL, V224, P23, DOI 10.1016/j.expneurol.2010.03.020; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Humphrey N, 2012, CURR BIOL, V22, pR695, DOI 10.1016/j.cub.2012.06.018; Julien D, 2000, CAN J BEHAV SCI, V32, P84, DOI 10.1037/h0087103; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Machin AJ, 2011, BEHAVIOUR, V148, P985, DOI 10.1163/000579511X596624; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; MCAULEY E, 1994, J SPORT EXERCISE PSY, V16, P163, DOI 10.1123/jsep.16.2.163; McNeil W. H., 1995, KEEPING TOGETHER TIM; Naugle KM, 2014, MED SCI SPORT EXER, V46, P817, DOI 10.1249/MSS.0000000000000143; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; PLINER P, 1974, J EXP SOC PSYCHOL, V10, P17, DOI 10.1016/0022-1031(74)90053-5; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Raichlen DA, 2013, EUR J APPL PHYSIOL, V113, P869, DOI 10.1007/s00421-012-2495-5; Raichlen DA, 2012, J EXP BIOL, V215, P1331, DOI 10.1242/jeb.063677; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; Sullivan P, 2013, INT J SPORT EXERC PS, V11, P286, DOI 10.1080/1612197X.2013.750139; Sullivan PJ, 2014, GROUP DYN-THEOR RES, V18, P122, DOI 10.1037/gdn0000001; Tarr B, SYNCHRONY EXER UNPUB; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Velicer W.F., 2000, PROBLEMS SOLUTIONS H, P41, DOI [10.1007/978-1-4615-4397-8_3, DOI 10.1007/978-1-4615-4397-8_3]; Wheatley T, 2012, SOC PERSONAL PSYCHOL, V6, P589, DOI 10.1111/j.1751-9004.2012.00450.x; WHITE GL, 1981, J PERS SOC PSYCHOL, V41, P56, DOI 10.1037/0022-3514.41.1.56; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910; Yee TW, 2010, J STAT SOFTW, V32, P1	53	29	29	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136705	10.1371/journal.pone.0136705	http://dx.doi.org/10.1371/journal.pone.0136705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317514	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100125
J	Derzelle, S; Girault, G; Kokotovic, B; Angen, O				Derzelle, Sylviane; Girault, Guillaume; Kokotovic, Branko; Angen, Oystein			Whole Genome-Sequencing and Phylogenetic Analysis of a Historical Collection of Bacillus anthracis Strains from Danish Cattle	PLOS ONE			English	Article							POPULATION-STRUCTURE; INJECTIONAL ANTHRAX; GENETIC DIVERSITY; HEROIN USERS; FRANCE; EUROPE; ASSAYS	Bacillus anthracis, the causative agent of anthrax, is known as one of the most genetically monomorphic species. Canonical single-nucleotide polymorphism (SNP) typing and whole-genome sequencing were used to investigate the molecular diversity of eleven B. anthracis strains isolated from cattle in Denmark between 1935 and 1988. Danish strains were assigned into five canSNP groups or lineages, i.e. A.Br.001/002 (n = 4), A.Br.Ames (n = 2), A.Br.008/011 (n = 2), A.Br.005/006 (n = 2) and A.Br.Aust94 (n = 1). The match with the A. Br.Ames lineage is of particular interest as the occurrence of such lineage in Europe is demonstrated for the first time, filling an historical gap within the phylogeography of the lineage. Comparative genome analyses of these strains with 41 isolates from other parts of the world revealed that the two Danish A.Br.008/011 strains were related to the heroin-associated strains responsible for outbreaks of injection anthrax in drug users in Europe. Eight novel diagnostic SNPs that specifically discriminate the different sub-groups of Danish strains were identified and developed into PCR-based genotyping assays.	[Derzelle, Sylviane; Girault, Guillaume] Univ Paris Est, Anses, Hlth Anim Lab, Maisons Alfort, France; [Kokotovic, Branko; Angen, Oystein] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Technical University of Denmark	Angen, O (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark.	oystein.angen@vetinst.no		Derzelle, Sylviane/0000-0002-2302-2291	French National Research Agency (ANR); Direction Generale de l'Armement (DGA) [ANR11ASTR0007]; Anses; DGA grants [A537]	French National Research Agency (ANR)(French National Research Agency (ANR)); Direction Generale de l'Armement (DGA)(General Electric); Anses; DGA grants	This work was supported by the French National Research Agency (ANR) and Direction Generale de l'Armement (DGA) (project number ANR11ASTR0007) (URL: http://www.agence-nationale- recherche.fr/suivibilan/ingenierie-procedessecuriteaccompagnement-specifique-des-travauxderecherches-et-dinnovation-defense/). GG is a PhD student co-supported by Anses and DGA grants (convention number A537) (URL: http://www.ixarm.com/Theses-DGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger T, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.32.20877; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Derzelle S, 2013, BIOSECUR BIOTERROR, V11, pS166, DOI 10.1089/bsp.2013.0003; Girault G., 2014, Advances in Bioscience and Biotechnology, V5, P669, DOI 10.4236/abb.2014.57079; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Grunow R, 2013, EUROSURVEILLANCE, V18, P2; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hughes-Jones M, 1999, J APPL MICROBIOL, V87, P189, DOI 10.1046/j.1365-2672.1999.00867.x; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Khmaladze E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102651; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Liu XK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029875; Marston CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028274; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; Okinaka RT, 2008, EMERG INFECT DIS, V14, P653, DOI 10.3201/eid1404.070984; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Ringertz SH, 2000, LANCET, V356, P1574, DOI 10.1016/S0140-6736(00)03133-0; Ruckert C, 2012, J BACTERIOL, V194, P5997, DOI 10.1128/JB.01410-12; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06	27	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134699	10.1371/journal.pone.0134699	http://dx.doi.org/10.1371/journal.pone.0134699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317972	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100017
J	Ellison, MA; Thurman, G; Gearheart, CM; Seewald, RH; Porter, CC; Ambruso, DR				Ellison, Michael A.; Thurman, Gail; Gearheart, Christy M.; Seewald, Ryan H.; Porter, Christopher C.; Ambruso, Daniel R.			INF-gamma Enhances Nox2 Activity by Upregulating phox Proteins When Applied to Differentiating PLB-985 Cells but Does Not Induce Nox2 Activity by Itself	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; COLONY-STIMULATING FACTOR; NEUTROPHIL CYTOCHROME-B; INTERFERON-GAMMA; NADPH OXIDASE; CYTOSOLIC COMPONENT; GENE-EXPRESSION; LEUKEMIA; METABOLISM	Background The cytokine and drug interferon-gamma enhances superoxide anion production by the antimicrobicidal Nox2 enzyme of neutrophils. Because mature neutrophils have a short lifespan, we hypothesized that the effects of interferon-gamma on these cells might be mediated by its prolonged exposure to differentiating neutrophil precursors in the bone marrow rather than its brief exposure to mature circulating neutrophils. Effects of INF-gamma on Nox2 Activity To address this possibility we exposed the myeloid PLB-985 cell line to interferon-gamma for 3 days in the presence of dimethyl sulfoxide which induces terminal differentiation of these cells. Interferon-gamma was found to enhance superoxide production by Nox2 in a concentration dependent manner. In contrast, application of interferon-gamma alone for 3 days failed to induce detectible Nox2 activity. Additionally, application of interferon-gamma for 3 hours to pre-differentiated PLB-985 cells, which models studies using isolated neutrophils, was much less effective at enhancing superoxide anion production. Effects of INF-gamma on phox Protein Levels Addition of interferon-gamma during differentiation was found to upregulate the Nox2 proteins gp91phox and p47phox in concert with elevated transcription of their genes. The p22phox protein was upregulated in the absence of increased transcription presumably reflecting stabilization resulting from binding to the elevated gp91phox. Thus, increased levels of gp91phox, p47phox and p22phox likely account for the interferon-gamma mediated enhancement of dimethyl sulfoxide-induced Nox2 activity. In contrast, although interferon-gamma alone also increased various phox proteins and their mRNAs, the pattern was very different to that seen with interferon-gamma plus dimethyl sulfoxide. In particular, p47phox was not induced thus explaining the inability of interferon-gamma alone to enhance Nox2 activity. Short application of interferon-gamma to already differentiated cells failed to increase any phox proteins. Conclusions Our findings indicate that interferon-gamma has complex effects on phox protein expression and that these are different in cells undergoing terminal differentiation. Understanding these changes may indicate additional therapeutic uses for this cytokine in human disorders.	[Ellison, Michael A.; Thurman, Gail; Gearheart, Christy M.; Seewald, Ryan H.; Porter, Christopher C.; Ambruso, Daniel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Ambruso, Daniel R.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Ambruso, Daniel R.] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Ambruso, Daniel R.] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Transfus Serv, Aurora, CO USA; [Ambruso, Daniel R.] Hematol Oncol & Bone Marrow Transplantat Labs, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Ambruso, DR (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	Daniel.ambruso@ucdenver.edu	Porter, Christopher/AAE-8918-2020	Porter, Christopher/0000-0001-8774-0180	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study received support from Horizon Pharma Ireland Ltd and the Stacey True Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin A, 1997, BLOOD, V89, P3396, DOI 10.1182/blood.V89.9.3396; Ambruso DR, 2012, BIOCHIM BIOPHYS ACTA, V1823, P306, DOI [10.1016/j.bbamcr.2011.11.014, DOI 10.1016/J.BBAMCR.2011.11.014]; Ambruso DR, 2012, KENDIG CHERNICKS DIS, V8; BERTON G, 1986, BIOCHEM BIOPH RES CO, V138, P1276, DOI 10.1016/S0006-291X(86)80421-1; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; CASSATELLA MA, 1991, J BIOL CHEM, V266, P22079; CASSATELLA MA, 1988, IMMUNOLOGY, V63, P499; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; GALLAGHER R, 1979, BLOOD, V54, P713; GUPTA JW, 1992, CANCER RES, V52, P2530; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Leavey PJ, 1998, BLOOD, V92, P4366, DOI 10.1182/blood.V92.11.4366.423k23_4366_4374; LETO TL, 1991, J BIOL CHEM, V266, P19812; LEVY R, 1990, J IMMUNOL, V145, P2595; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Peterson VM, 1994, PHAGOCYTE FUNCTION P; PORTER CD, 1994, BLOOD, V84, P2767; Rosenthal J, 1996, BLOOD, V88, P4321; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; TENNENBERG SD, 1993, J LEUKOCYTE BIOL, V53, P301, DOI 10.1002/jlb.53.3.301; TSUNAWAKI S, 1994, BIOCHEM BIOPH RES CO, V199, P1378, DOI 10.1006/bbrc.1994.1383; TUCKER KA, 1987, BLOOD, V70, P372; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136766	10.1371/journal.pone.0136766	http://dx.doi.org/10.1371/journal.pone.0136766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317224	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100138
J	Huston, RK; Christensen, JM; Alshahrani, SM; Mohamed, SM; Clark, SM; Nason, JA; Wu, YX				Huston, Robert K.; Christensen, J. Mark; Alshahrani, Sultan M.; Mohamed, Sumeia M.; Clark, Sara M.; Nason, Jeffrey A.; Wu, Ying Xing			Calcium Chloride in Neonatal Parenteral Nutrition Solutions with and without Added Cysteine: Compatibility Studies Using Laser and Micro-Flow Imaging Methodology	PLOS ONE			English	Article							INTRAVENOUS-FEEDING SOLUTIONS; INORGANIC-PHOSPHATE SALTS; ORGANIC CALCIUM; ALUMINUM CONTAMINATION; PHYSICAL COMPATIBILITY; SODIUM-PHOSPHATE; ADMIXTURES; INFANTS; PRECIPITATION; SOLUBILITY	Background Previous studies of compatibility of calcium chloride (CaCl2) and phosphates have not included particle counts in the range specified by the United States Pharmacopeia. Microflow imaging techniques have been shown to be comparable to light obscuration when determining particle count and size in pharmaceutical solutions. Objective The purpose of this study was to do compatibility testing for parenteral nutrition (PN) solutions containing CaCl2 using dynamic light scattering and micro-flow imaging techniques. Methods Solutions containing TrophAmine (Braun Medical Inc, Irvine, CA), CaCl2, and sodium phosphate (NaPhos) were compounded with and without cysteine. All solutions contained standard additives to neonatal PN solutions including dextrose, trace metals, and electrolytes. Control solutions contained no calcium or phosphate. Solutions were analyzed for particle size and particle count. Means of Z-average particle size and particle counts of controls were determined. Study solutions were compared to controls and United States Pharmacopeia (USP) Chapter 788 guidelines. The maximum amount of Phos that was compatible in solutions that contained at least 10 mmol/L of Ca in 2.5% amino acids (AA) was determined. Compatibility of these solutions was verified by performing analyses of 5 repeats of these solutions. Microscopic analyses of the repeats were also performed. Results Amounts of CaCl2 and NaPhos that were compatible in solutions containing 1.5%, 2%, 2.5%, and 3% AA were determined. The maximum amount of NaPhos that could be added to TrophAmine solutions of > = 2.5% AA containing at least 10 mmol/L of CaCl2 was 7.5 mmol/L. Adding 50 mg/dL of cysteine increased the amount of NaPhos that could be added to solutions containing 10 mmol/L of CaCl2 to 10 mmol/L. Conclusion Calcium chloride can be added to neonatal PN solutions containing NaPhos in concentrations that can potentially provide an intravenous intake of adequate amounts of calcium and phosphorus.	[Huston, Robert K.] Northwest Newborn Specialists PC, Portland, OR 97227 USA; [Huston, Robert K.] Pediatrix Med Grp, Portland, OR USA; [Christensen, J. Mark; Alshahrani, Sultan M.; Mohamed, Sumeia M.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Clark, Sara M.] Providence St Vincent Med Ctr, Neonatal Pharm, Portland, OR USA; [Nason, Jeffrey A.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA; [Wu, Ying Xing] Providence Hlth & Serv, Med Data Res Ctr, Portland, OR USA	Oregon State University; Oregon State University	Huston, RK (corresponding author), Northwest Newborn Specialists PC, Portland, OR 97227 USA.	Robert_Huston@pediatrix.com	Alshahrani, Sultan/CAF-7886-2022; Alshahrani, Sultan M./AAB-3081-2019	Alshahrani, Sultan/0000-0002-6194-7092; Alshahrani, Sultan M./0000-0002-6194-7092	Northwest Newborn Specialists, PC	Northwest Newborn Specialists, PC	The funder (Northwest Newborn Specialists, PC) provided support in the form of salary for RKH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of RKH is articulated in the 'author contributions' section.	Bishop NJ, 1997, NEW ENGL J MED, V336, P1557, DOI 10.1056/NEJM199705293362203; Bohrer D, 2002, JPEN-PARENTER ENTER, V26, P382, DOI 10.1177/0148607102026006382; Bouchoud L, 2010, JPEN-PARENTER ENTER, V34, P542, DOI 10.1177/0148607110374615; BOULET M, 1962, ARCH BIOCHEM BIOPHYS, V96, P629, DOI 10.1016/0003-9861(62)90348-X; Braake FWJT, 2009, PEDIATRICS, V124, pE978, DOI 10.1542/peds.2008-2477; Driscoll DF, 2012, JPEN-PARENTER ENTER, V36, P497, DOI 10.1177/0148607112455064; Fewtrell MS, 2009, PEDIATRICS, V124, P1372, DOI 10.1542/peds.2009-0783; FITZGERALD KA, 1986, AM J HOSP PHARM, V43, P88, DOI 10.1093/ajhp/43.1.88; Food and Drug Administration, 2002, FED REGISTER, V67, P70691; Frey OR, 2000, ANN PHARMACOTHER, V34, P811, DOI 10.1345/aph.19306; Gonyon T, 2014, JPEN-PARENTER ENTER, V38, P717, DOI 10.1177/0148607113495415; HENRY RS, 1980, AM J HOSP PHARM, V37, P673, DOI 10.1093/ajhp/37.5.673; Huang CT, 2009, J PHARM SCI-US, V98, P3058, DOI 10.1002/jps.21575; Huston RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106825; Huston RK, 2012, JPEN-PARENTER ENTER, V36, P498, DOI 10.1177/0148607112456297; Kerner, 1983, MANUAL PEDIAT PARENT, P177; Kruger PC, 2014, JPEN-PARENTER ENTER, V38, P728, DOI 10.1177/0148607113491981; MacKay M, 2015, JPEN-PARENTER ENTER, V39, P725, DOI 10.1177/0148607114528982; MACMAHON P, 1990, ARCH DIS CHILD-FETAL, V65, P352, DOI 10.1136/adc.65.4_Spec_No.352; Mathaes R, 2013, INT J PHARMACEUT, V453, P620, DOI 10.1016/j.ijpharm.2013.05.046; Migaki EA, 2012, JPEN-PARENTER ENTER, V36, P470, DOI 10.1177/0148607111420154; Nehra D, 2013, JPEN-PARENTER ENTER, V37, P570, DOI 10.1177/0148607113487216; NICOLI DF, 1995, AM LAB, V27, P41; Oma P, 2010, PHARMACOPEIAL FORUM, V36, P311; Parikh MJ, 2005, AM J HEALTH-SYST PH, V62, P1177, DOI 10.1093/ajhp/62.11.1177; Poole RL, 2008, JPEN-PARENTER ENTER, V32, P242, DOI 10.1177/0148607108316187; RAUPP P, 1991, JPEN-PARENTER ENTER, V15, P469, DOI 10.1177/0148607191015004469; Singh H, 2009, PEDIATR CRIT CARE ME, V10, P213, DOI 10.1097/PCC.0b013e31819a3bf4; Soghier LM, 2009, COCHRANE DB SYST REV; United States Pharmacopeia, 2011, US PHARM, P326; Zolls S, 2013, AAPS J, V15, P1200, DOI 10.1208/s12248-013-9522-2	31	5	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136894	10.1371/journal.pone.0136894	http://dx.doi.org/10.1371/journal.pone.0136894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317344	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100163
J	Kigawa, K; Izumizaki, M; Tsukada, S; Hakuta, N				Kigawa, Kazuyoshi; Izumizaki, Masahiko; Tsukada, Setsuro; Hakuta, Naoyuki			Proprioceptive Interaction between the Two Arms in a Single-Arm Pointing Task	PLOS ONE			English	Article							LIMB POSITION-SENSE; HUMAN ELBOW JOINT; BODY-IMAGE; MUSCLE THIXOTROPY; TENDON VIBRATION; HUMAN FOREARM; ILLUSIONS; MOVEMENT; REPRESENTATION; CONTRACTION	Proprioceptive signals coming from both arms are used to determine the perceived position of one arm in a two-arm matching task. Here, we examined whether the perceived position of one arm is affected by proprioceptive signals from the other arm in a one-arm pointing task in which participants specified the perceived position of an unseen reference arm with an indicator paddle. Both arms were hidden from the participant's view throughout the study. In Experiment 1, with both arms placed in front of the body, the participants received 70-80 Hz vibration to the elbow flexors of the reference arm (=right arm) to induce the illusion of elbow extension. This extension illusion was compared with that when the left arm elbow flexors were vibrated or not. The degree of the vibration-induced extension illusion of the right arm was reduced in the presence of left arm vibration. In Experiment 2, we found that this kinesthetic interaction between the two arms did not occur when the left arm was vibrated in an abducted position. In Experiment 3, the vibration-induced extension illusion of one arm was fully developed when this arm was placed at an abducted position, indicating that the brain receives increased proprioceptive input from a vibrated arm even if the arm was abducted. Our results suggest that proprioceptive interaction between the two arms occurs in a one-arm pointing task when the two arms are aligned with one another. The position sense of one arm measured using a pointer appears to include the influences of incoming information from the other arm when both arms were placed in front of the body and parallel to one another.	[Kigawa, Kazuyoshi; Izumizaki, Masahiko; Tsukada, Setsuro; Hakuta, Naoyuki] Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan; [Kigawa, Kazuyoshi; Hakuta, Naoyuki] Showa Univ, Fujigaoka Hosp, Dept Orthopaed Surg, Yokohama, Kanagawa 227, Japan; [Tsukada, Setsuro] Showa Univ, Sch Med, Dept Neurol, Tokyo 142, Japan	Showa University; Showa University; Showa University	Izumizaki, M (corresponding author), Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan.	masahiko@med.showa-u.ac.jp						ALLEBECK P, 1976, J PSYCHOSOM RES, V20, P583, DOI 10.1016/0022-3999(76)90060-X; Allen TJ, 2007, J PHYSIOL-LONDON, V580, P423, DOI 10.1113/jphysiol.2006.125161; Allen TJ, 2010, J PHYSIOL-LONDON, V588, P1369, DOI 10.1113/jphysiol.2010.187732; Benson PJ, 1999, BEHAV RES METH INS C, V31, P446, DOI 10.3758/BF03200725; Cafri G., 2004, PSYCHOL MEN MASCULIN, V5, P18, DOI [DOI 10.1037/1524-9220.5.1.18, 10.1037/1524-9220.5.1.18]; CRASKE B, 1977, SCIENCE, V196, P71, DOI 10.1126/science.841342; Duclos C, 2007, GAIT POSTURE, V26, P595, DOI 10.1016/j.gaitpost.2006.12.005; Ferrer-Garcia M, 2008, BEHAV RES METHODS, V40, P394, DOI 10.3758/BRM.40.2.394; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; Gooey K, 2000, EXP BRAIN RES, V133, P340, DOI 10.1007/s002210000380; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; GREGORY JE, 1988, J NEUROPHYSIOL, V59, P1220, DOI 10.1152/jn.1988.59.4.1220; Hakuta N, 2014, EXP BRAIN RES, V232, P2197, DOI 10.1007/s00221-014-3911-3; Inui N, 2011, J PHYSIOL-LONDON, V589, P5775, DOI 10.1113/jphysiol.2011.219949; Ishihara Y, 2004, MUSCLE NERVE, V30, P486, DOI 10.1002/mus.20133; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; LACKNER JR, 1983, J NEUROSCI, V3, P2280; LACKNER JR, 1984, EXP NEUROL, V85, P107, DOI 10.1016/0014-4886(84)90165-1; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Proske U, 2014, J PHYS FITNESS SPORT, V3, P509, DOI [10.7600/jpfsm.3.509, DOI 10.7600/JPFSM.3.509]; Proske U, 2014, EXP BRAIN RES, V232, P3397, DOI 10.1007/s00221-014-4088-5; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Sekihara C, 2007, MUSCLE NERVE, V35, P781, DOI 10.1002/mus.20779; Tsay A, 2015, EXP BRAIN RES, V233, P2635, DOI 10.1007/s00221-015-4334-5; Tsay A, 2014, J PHYSIOL-LONDON, V592, P2679, DOI 10.1113/jphysiol.2013.269365; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7; Walsh LD, 2013, J PHYSIOL-LONDON, V591, P6103, DOI 10.1113/jphysiol.2013.259127; WANN JP, 1992, EXP BRAIN RES, V91, P162; White O, 2009, EXP BRAIN RES, V192, P113, DOI 10.1007/s00221-008-1561-z; Yasuda T, 2006, EUR J APPL PHYSIOL, V96, P511, DOI 10.1007/s00421-005-0102-8	35	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137031	10.1371/journal.pone.0137031	http://dx.doi.org/10.1371/journal.pone.0137031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317518	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100197
J	Noritake, K; Aki, T; Funakoshi, T; Unuma, K; Uemura, K				Noritake, Kanako; Aki, Toshihiko; Funakoshi, Takeshi; Unuma, Kana; Uemura, Koichi			Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes	PLOS ONE			English	Article							GAP-JUNCTIONS; CONNEXIN EXPRESSION; DEPENDENT MANNER; HEART-FAILURE; LIVING CELLS; PATHWAY; PROTEIN; APOPTOSIS; ALCOHOL; COMMUNICATION	Direct exposure of cardiomyocytes to ethanol causes cardiac damage such as cardiac arrythmias and apoptotic cell death. Cardiomyocytes are connected to each other through intercalated disks (ID), which are composed of a gap junction (GJ), adherens junction, and desmosome. Changes in the content as well as the subcellular localization of connexin43 (Cx43), the main component of the cardiac GJ, are reportedly involved in cardiac arrythmias and subsequent damage. Recently, the hippo-YAP signaling pathway, which links cellular physical status to cell proliferation, differentiation, and apoptosis, has been implicated in cardiac homeostasis under physiological as well as pathological conditions. This study was conducted to explore the possible involvement of junctional intercellular communication, mechanotransduction through cytoskeletal organization, and the hippo-YAP pathway in cardiac damage caused by direct exposure to ethanol. HL-1 murine atrial cardiac cells were used since these cells retain cardiac phenotypes through ID formation and subsequent synchronous contraction. Cells were exposed to 0.5-2% ethanol; significant apoptotic cell death was observed after exposure to 2% ethanol for 48 hours. A decrease in Cx43 levels was already observed after 3 hours exposure to 2% ethanol, suggesting a rapid degradation of this protein. Upon exposure to ethanol, Cx43 translocated into lysosomes. Cellular cytoskeletal organization was also dysregulated by ethanol, as demonstrated by the disruption of myofibrils and intermediate filaments. Coinciding with the loss of cell-cell adherence, decreased phosphorylation of YAP, a hippo pathway effector, was also observed in ethanol-treated cells. Taken together, the results provide evidence that cells exposed directly to ethanol show 1) impaired cell-cell adherence/communication, 2) decreased cellular mechanotransduction by the cytoskeleton, and 3) a suppressed hippo-YAP pathway. Suppression of hippo-YAP pathway signaling should be effective in maintaining cellular homeostasis in cardiomyocytes exposed to ethanol.	[Noritake, Kanako; Aki, Toshihiko; Funakoshi, Takeshi; Unuma, Kana; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo, Japan.	aki.legm@tmd.ac.jp			MEXT KAKENHI [25460862, 25460863];  [13J08099]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by a Grant-in-Aid for JSPS Fellows (grant number 13J08099 to KN) and MEXT KAKENHI (grant number 25460862 to TA and grant number 25460863 to K. Uemura).	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Chen DB, 2000, LIFE SCI, V67, P1683, DOI 10.1016/S0024-3205(00)00759-1; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090266; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Guan ZJ, 2004, J CARDIOVASC PHARM, V44, P696, DOI 10.1097/00005344-200412000-00012; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hata Y, 2013, MAR DRUGS, V11, P896, DOI 10.3390/md11030896; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Hills CE, 2009, CELL PHYSIOL BIOCHEM, V24, P177, DOI 10.1159/000233244; Ilanges A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078880; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Lai YJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-72; Laonigro I, 2009, EUR J HEART FAIL, V11, P453, DOI 10.1093/eurjhf/hfp037; Ma H, 2010, J MOL CELL CARDIOL, V49, P322, DOI 10.1016/j.yjmcc.2010.03.017; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Noritake K, 2012, TOXICOL IN VITRO, V26, P849, DOI 10.1016/j.tiv.2012.04.027; Oyamada M, 2013, BBA-BIOMEMBRANES, V1828, P118, DOI 10.1016/j.bbamem.2011.12.031; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Severs NJ, 2004, BBA-BIOMEMBRANES, V1662, P138, DOI 10.1016/j.bbamem.2003.10.019; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Valiunas V, 2002, CIRC RES, V91, P104, DOI 10.1161/01.RES.0000025638.24255.AA; Vinken M, 2012, TOXICOL SCI, V125, P175, DOI 10.1093/toxsci/kfr277; Walker RK, 2013, ALCOHOL CLIN EXP RES, V37, P1253, DOI 10.1111/acer.12109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhuo L, 2013, TOXICOLOGY, V310, P61, DOI 10.1016/j.tox.2013.05.013	47	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136952	10.1371/journal.pone.0136952	http://dx.doi.org/10.1371/journal.pone.0136952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317911	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100184
J	Peters, JPM; Hooft, L; Grolman, W; Stegeman, I				Peters, Jeroen P. M.; Hooft, Lotty; Grolman, Wilko; Stegeman, Inge			Reporting Quality of Systematic Reviews and Meta-Analyses of Otorhinolaryngologic Articles Based on the PRISMA Statement	PLOS ONE			English	Article							COMPLETENESS; IMPLEMENTATION; GUIDELINES; ABSTRACTS; PROTOCOLS	Background Systematic reviews (SRs) and meta-analyses (MAs) provide the highest possible level of evidence. However, poor conduct or reporting of SRs and MAs may reduce their utility. The PRISMA Statement (Preferred Reporting Items for Systematic reviews and Meta-Analyses) was developed to help authors report their SRs and MAs adequately. Objectives Our objectives were to (1) evaluate the quality of reporting of SRs and MAs and their abstracts in otorhinolaryngologic literature using the PRISMA and PRISMA for Abstracts checklists, respectively, (2) compare the quality of reporting of SRs and MAs published in Ear Nose Throat (ENT) journals to the quality of SRs and MAs published in the 'gold standard' Cochrane Database of Systematic Reviews (CDSR), and (3) formulate recommendations to improve reporting of SRs and MAs in ENT journals. Methods On September 3, 2014, we searched the Pubmed database using a combination of filters to retrieve SRs and MAs on otorhinolaryngologic topics published in 2012 and 2013 in the top 5 ENT journals (ISI Web of Knowledge 2013) or CDSR and relevant articles were selected. We assessed how many, and which, PRISMA (for Abstracts) items were reported adequately per journal type. Results We identified large differences in the reporting of individual items between the two journal types with room for improvement. In general, SRs and MAs published in ENT journals (n = 31) reported a median of 54.4% of the PRISMA items adequately, whereas the 49 articles published in the CDSR reported a median of 100.0 adequately (difference statistically significant, p < 0.001). For abstracts, medians of 41.7% for ENT journals and 75.0% for the CDSR were found ( p < 0.001). Conclusion The reporting of SRs and MAs in ENT journals leaves room for improvement and would benefit if the PRISMA Statement were endorsed by these journals.	[Peters, Jeroen P. M.; Grolman, Wilko; Stegeman, Inge] Univ Med Ctr Utrecht, Dept Otorhinolaryngol & Head & Neck Surg, Utrecht, Netherlands; [Peters, Jeroen P. M.; Grolman, Wilko; Stegeman, Inge] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hooft, Lotty] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dutch Cochrane Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Peters, JPM (corresponding author), Univ Med Ctr Utrecht, Dept Otorhinolaryngol & Head & Neck Surg, Utrecht, Netherlands.	ENT-research@umcutrecht.nl	Stegeman, Inge/AAP-3949-2021	Grolman, Wilko/0000-0002-3524-3526; Stegeman, Inge/0000-0001-5154-7178				[Anonymous], 2009, OXFORD CTR EVIDENCE; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Fleming PS, 2013, ANGLE ORTHOD, V83, P158, DOI 10.2319/032612-251.1; Hopewell S, 2015, J CLIN EPIDEMIOL, V68, P1488, DOI 10.1016/j.jclinepi.2015.03.006; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; National Institutes of Health US National Library of Medicine, SEARCH STRAT US CREA; Pandis N, 2014, J CLIN EPIDEMIOL, V67, P1044, DOI 10.1016/j.jclinepi.2014.04.001; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Seehra J, 2013, EUR J ORAL SCI, V121, P57, DOI 10.1111/eos.12027; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Stevens A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3804; Sun GH, 2013, HEAD NECK-J SCI SPEC, V35, P1515, DOI 10.1002/hed.23151; Tao KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027611; Tunis AS, 2013, RADIOLOGY, V269, P413, DOI 10.1148/radiol.13130273	21	53	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136540	10.1371/journal.pone.0136540	http://dx.doi.org/10.1371/journal.pone.0136540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317406	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100100
J	Popping, R; Wittek, R				Popping, Roel; Wittek, Rafael			Success and Failure of Parliamentary Motions: A Social Dilemma Approach	PLOS ONE			English	Article							NO-CONFIDENCE MOTIONS; POLICY	Parliamentary motions are a vital and frequently used element of political control in democratic regimes. Despite their high incidence and potential impact on the political fate of a government and its policies, we know relatively little about the conditions under which parliamentary motions are likely to be accepted or rejected. Current collective decision-making models use a voting power framework in which power and influence of the involved parties are the main predictors. We propose an alternative, social dilemma approach, according to which a motion's likelihood to be accepted depends on the severity of the social dilemma underlying the decision issue. Actor-and dilemma-centered hypotheses are developed and tested with data from a stratified random sample of 822 motions that have been voted upon in the Dutch Parliament between September 2009 and February 2011. The social dilemma structure of each motion is extracted through content coding, applying a cognitive mapping technique developed by Anthony, Heckathorn and Maser. Logistic regression analyses are in line with both, actor-centered and social-dilemma centered approaches, though the latter show stronger effect sizes. Motions have a lower chance to be accepted if voting potential is low, the proposer is not from the voting party, and if the problem underlying the motion reflects a prisoner's dilemma or a pure competition game as compared to a coordination game. The number of proposing parties or a battle of the sexes structure does not significantly affect the outcome.	[Popping, Roel; Wittek, Rafael] Univ Groningen, Dept Sociol, Groningen, Netherlands	University of Groningen	Popping, R (corresponding author), Univ Groningen, Dept Sociol, Groningen, Netherlands.	r.popping@rug.nl	Wittek, Rafael/E-5560-2012	Wittek, Rafael/0000-0002-8473-6984				ANDEWEG RB, 1992, LEGIS STUD QUART, V17, P161, DOI 10.2307/440056; Andeweg RB, 2007, BINNENHOF BINNENUIT; Andeweg RB, 2011, PARTY POLIT, V17, P655, DOI 10.1177/1354068810377188; ANTHONY DL, 1994, RATION SOC, V6, P489, DOI 10.1177/1043463194006004004; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Axelrod RM, 1976, COGNITIVE MAPS POLIT, P55; Coleman JS, 1972, J MATH SOCIOL, V2, P145; DAVIS MD, 1970, GAME THEORY NONTECHN; Goeree M, 2014, QUAL QUANT, V48, P3253, DOI 10.1007/s11135-013-9954-x; Heckathorn DD, 1996, AM SOCIOL REV, V61, P250, DOI 10.2307/2096334; HECKATHORN DD, 1990, J POLIT, V52, P1101, DOI 10.2307/2131684; Holzhacker R., 2002, EUR UNION POLIT, V3, P459, DOI DOI 10.1177/1465116502003004004; Hopmann Terence, 2002, INT NEGOTIATION, V7, P67; Laver M, 2003, AM POLIT SCI REV, V97, P311; Luce R. D., 1989, GAMES DECISIONS INTR; Otjes S, 2011, ACTA POLIT, V46, P400, DOI 10.1057/ap.2011.12; Popping R., 2013, OPEN J POLITICAL RES, V3, P16; Popping R, 2010, SOC SCI COMPUT REV, V28, P391, DOI 10.1177/0894439309351394; Poundstone William, 1992, PRISONERS DILEMMA; Scott WA, 1955, PUBLIC OPIN QUART, V19, P321, DOI 10.1086/266577; Somer-Topcu Z, 2014, EUR J POLIT RES, V53, P600, DOI 10.1111/1475-6765.12038; Steur J, 2005, COGNITIVE MAPP UNPUB; Stokman FN, 2013, HDB RATIONAL CHOICE, P151; Stokman FN, 2014, ENCY SOCIAL NETWORK, P1; Sturgis A, 1966, STURGIS STANDARD COD; Williams LK, 2011, COMP POLIT STUD, V44, P1474, DOI 10.1177/0010414011407470	26	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133510	10.1371/journal.pone.0133510	http://dx.doi.org/10.1371/journal.pone.0133510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317869	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100008
J	Sanfelix-Gimeno, G; Hurtado, I; Sanfelix-Genoves, J; Baixauli-Perez, C; Rodriguez-Bernal, CL; Peiro, S				Sanfelix-Gimeno, Gabriel; Hurtado, Isabel; Sanfelix-Genoves, Jose; Baixauli-Perez, Cristobal; Rodriguez-Bernal, Clara L.; Peiro, Salvador			Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain	PLOS ONE			English	Article							HEALTH-CARE SERVICES; FRACTURE RISK-FACTORS; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE; ESOSVAL COHORT; UNITED-STATES; VALENCIA; QUALITY; PROBABILITY; PREVALENCE	Inappropriate prescribing of antiosteoporotic medications has been observed; however, the joint study of both overuse and underuse has barely been attempted. Spain, with its high utilization rates, constitutes a good example to assess differences in over and under use according to diverse highly-influential osteoporosis guidelines (HIOG) worldwide. We used data of a population-based cross-sectional study including 824 post-menopausal women >= 50 years old living in the city of Valencia, Spain and aimed to estimate the percentage of women eligible for treatment, and the proportion of overuse and underuse of antiosteoporotic treatment according to HIOG. The prevalence of antiosteoporotic treatment in postmenopausal women >= 50 in Valencia was 20.9% (95% CI: 17.6-24.4). The type of antiosteoporotic drugs prescribed varied greatly depending on the medical specialty responsible of the initial prescription. When applying the HIOG, the percentage of women 50 and over who should be treated varied from less than 9% to over 44%. In real terms, from the approximately eight million women of 50 years old and over in Spain, the number eligible for treatment would range from 0.7 to 3.8 million, depending on the guideline used. A huge proportion of inappropriate treatments was found when applying these guidelines to the Spanish population, combining a high overuse (42-78% depending on the guideline used) and underuse (7-41%). In conclusion, we found that the pharmacological management of osteoporosis in women of 50 and over in this population combines an important overuse and, to a lesser extent, underuse, although the level of inappropriateness varied strikingly depending on the CPG used. It seems urgent to reduce treatment overuse without neglecting underuse, as is urgent an attempt to reach wider agreement worldwide regarding osteoporosis management, in order to facilitate appropriate treatment and development of policies to reduce effectively treatment inappropriateness.	[Sanfelix-Gimeno, Gabriel; Hurtado, Isabel; Sanfelix-Genoves, Jose; Baixauli-Perez, Cristobal; Rodriguez-Bernal, Clara L.; Peiro, Salvador] Ctr Publ Hlth Res FISABIO, Hlth Serv Res Unit, Valencia, Spain; [Sanfelix-Gimeno, Gabriel; Hurtado, Isabel; Sanfelix-Genoves, Jose; Baixauli-Perez, Cristobal; Rodriguez-Bernal, Clara L.; Peiro, Salvador] Red Invest Serv Salud Enfermedades Cronicas REDIS, Valencia, Spain; [Sanfelix-Genoves, Jose] Fdn Invest Hosp Clin Univ, Inst Invest Sanitaria INCLIVA, Valencia, Spain		Sanfelix-Gimeno, G (corresponding author), Ctr Publ Hlth Res FISABIO, Hlth Serv Res Unit, Valencia, Spain.	sanfelix_gab@gva.es	Hurtado, Isabel/I-3395-2017; Sanfélix-Gimeno, Gabriel/E-9140-2012; Rodriguez-Bernal, Clara/ABF-9659-2021; Peiro, Salvador/H-5778-2017	Hurtado, Isabel/0000-0002-8475-8112; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; Rodriguez-Bernal, Clara/0000-0003-2617-8635; Peiro, Salvador/0000-0002-3902-569X; Baixauli Perez, Cristobal/0000-0002-7567-0995	Ministry of Health of the Autonomous Government of Valencia [0018/2005]; Sanofi-Aventis	Ministry of Health of the Autonomous Government of Valencia; Sanofi-Aventis(Sanofi-Aventis)	The FRAVO study was funded by the Ministry of Health of the Autonomous Government of Valencia (Project 0018/2005) and a non-conditioned research grant from Sanofi-Aventis. None of the sponsors were involved in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the Center for Public Health Research (CSISP-FISABIO), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), Valencia, Spain; or Fundacion de Investigacion del Hospital Clinico Universitario - Instituto de Investigacion Sanitaria INCLIVA. Valencia, Spain. No additional funding and support declared in our competing interest statement are specific to this study.	Andrade SE, 2003, ARCH INTERN MED, V163, P2052, DOI 10.1001/archinte.163.17.2052; [Anonymous], 2008, OST MAN AT PRIM; [Anonymous], 2010, GUIA PRACT CLIN OST; [Anonymous], 2006, DOC CLIN SEMERGEN OS; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1856, DOI 10.1210/jc.2009-2157; Chan KS, 2013, MED CARE RES REV, V70, P473, DOI 10.1177/1077558713492202; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; de Felipe R, 2010, ATEN PRIM, V42, P559, DOI 10.1016/j.aprim.2009.10.022; Diez-Perez A, 2011, BONE, V49, P493, DOI 10.1016/j.bone.2011.05.007; Eisenberg JM, 2002, MED CARE, V40, P1016, DOI 10.1097/00005650-200211000-00004; Emery DJ, 2013, JAMA INTERN MED, V173, P823, DOI 10.1001/jamainternmed.2013.3804; Salgueiro ME, 2013, MATURITAS, V74, P74, DOI 10.1016/j.maturitas.2012.10.002; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Grupo de trabajo de la Guia de Practica Clinica sobre Osteoporosis y Prevencion de Fracturas por Fragilidad-Guia Salud. Guia de Practica Clinica sobre Osteoporosis yPrevencion de Fracturas por Fragilidad, 2010, GUIA PRACT CLIN OST; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hurtado I, 2014, J CLIN ENDOCR METAB, V99, P142, DOI 10.1210/jc.2013-3448; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Keyhani S, 2008, HEALTH SERV RES, V43, P1923, DOI 10.1111/j.1475-6773.2008.00920.x; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; Lipitz-Snyderman A, 2013, JAMA INTERN MED, V173, P1277, DOI 10.1001/jamainternmed.2013.6181; Liu SK, 2013, J AM GERIATR SOC, V61, P1855, DOI 10.1111/jgs.12507; Martinez JMO, 2008, REV CLIN ESP, V208, P247, DOI 10.1157/13119919; National Institute for Clinical Excellence (NICE), 2011, NICE TECHN APPR GUID, V217; National Osteoporosis Foundation (NOF), 2010, CLIN GUID PREV TREAT; National Osteoporosis Guideline Group (NOGG) on behalf of the Bone Research Society British Geriatrics Society British Orthopaedic Association British Society of Rheumatology National Osteoporosis Society Osteoporosis 2000 Osteoporosis Dorset Primary Care Rheumatology Society Royal College of Physicians and Society for Endocrinology, 2010, OST 2000 OST DORS PR; Naves M, 2003, OSTEOPOROSIS INT, V14, P520, DOI 10.1007/s00198-003-1405-4; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; PARK RE, 1986, AM J PUBLIC HEALTH, V76, P766, DOI 10.2105/AJPH.76.7.766; Edo LP, 2011, REUMATOL CLIN, V7, P357, DOI 10.1016/j.reuma.2011.05.013; Richards M, 2010, EXTENT CAUSES INT VA; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sanfelix-Genoves J, 2013, OSTEOPOROSIS INT, V24, P1045, DOI 10.1007/s00198-012-2018-6; Sanfelix-Genoves J, 2012, OSTEOPOROSIS INT, V23, P2129, DOI 10.1007/s00198-011-1819-3; Sanfelix-Genoves J, 2014, MED CLIN-BARCELONA, V142, P15, DOI 10.1016/j.medcli.2012.10.025; Sanfelix-Genoves J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-20; Sanfelix-Genoves J, 2010, BONE, V47, P610, DOI 10.1016/j.bone.2010.06.015; Sanfelix-Gimeno G, 2013, BONE, V52, P393, DOI 10.1016/j.bone.2012.10.022; Smetana GW, 2007, ARCH INTERN MED, V167, P10, DOI 10.1001/archinte.167.1.10; Wang L, 2013, PRIM HEALTH CARE RES, V14, P1, DOI 10.1017/S1463423612000114	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135475	10.1371/journal.pone.0135475	http://dx.doi.org/10.1371/journal.pone.0135475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317872	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100032
J	Wang, XY; Huang, ZX; Chen, YG; Lu, X; Zhu, P; Wen, K; Fu, N; Liu, BY				Wang, Xiang-Yu; Huang, Zhao-Xia; Chen, Yi-Guo; Lu, Xiao; Zhu, Ping; Wen, Kun; Fu, Ning; Liu, Bei-Yi			A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus	PLOS ONE			English	Article							IMMUNE-RESPONSES; VACCINE; INTERLEUKIN-17A; HOST; EPITOPES; SURVIVAL; ANTIBODY; GAMMA; IMMUNIZATION; NEUTROPHIL	Due to the enormous capacity of Staphylococcus aureus to acquire antibiotic resistance, it becomes imperative to develop vaccines for decreasing the risk of its life-threatening infections. Peptidoglycan (PGN) is a conserved and major component of S. aureus cell wall. However, it has not been used as a vaccine candidate since it is a thymus-independent antigen. In this study, we synthesized a multiple antigenic peptide, named MAP27, which comprised four copies of a peptide that mimics the epitope of PGN. After immunization with MAP27 five times and boosting with heat-inactivated bacterium one time, anti-MAP27 serum bound directly to S. aureus or PGN. Immunization with MAP27 decreased the bacterial burden in organs of BALB/c mice and significantly prolonged their survival time after S. aureus lethal-challenge. The percentage of IFN-gamma(+)CD3(+) T cells and IL-17(+)CD4(+) T cells in spleen, as well as the levels of IFN-gamma, IL-17A/F and CCL3 in spleen and lung, significantly increased in the MAP27-immunized mice after infection. Moreover, in vitro incubation of heat-inactivated S. aureus with splenocytes isolated from MAP27-immunized mice stimulated the production of IFN-gamma and IL-17A/F. Our findings demonstrated that MAP27, as a thymus-dependent antigen, is efficient at eliciting T cell-mediated responses to protect mice from S. aureus infection. This study sheds light on a possible strategy to design vaccines against S. aureus.	[Wang, Xiang-Yu; Huang, Zhao-Xia; Chen, Yi-Guo; Lu, Xiao; Zhu, Ping; Fu, Ning; Liu, Bei-Yi] Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou, Guangdong, Peoples R China; [Wen, Kun; Fu, Ning] Southern Med Univ, Zhujiang Hosp, Lab Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China; [Wen, Kun; Fu, Ning] Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Liu, BY (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou, Guangdong, Peoples R China.	lbydodo@163.com	WEN, Kun/AAD-7962-2019	WEN, Kun/0000-0002-4331-0661	National Natural Science Foundation of China [31270980]; Guangdong Natural Science Foundation [S2012010009562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This research was supported by National Natural Science Foundation of China (Grant No: 31270980) to BYL and Guangdong Natural Science Foundation (Grant No: S2012010009562) to BYL. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amexis G, 2007, VIRAL IMMUNOL, V20, P657, DOI 10.1089/vim.2007.0029; Archer NK, 2013, INFECT IMMUN, V81, P2070, DOI 10.1128/IAI.00084-13; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bolesta E, 2005, CANCER RES, V65, P3410, DOI 10.1158/0008-5472.CAN-04-2164; Broker BM, 2014, INT J MED MICROBIOL, V304, P204, DOI 10.1016/j.ijmm.2013.11.008; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; Chen YG, 2011, J MED MICROBIOL, V60, P995, DOI 10.1099/jmm.0.028647-0; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Elshabrawy HA, 2014, J VIROL, V88, P4353, DOI 10.1128/JVI.03050-13; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Fujita Y, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-48; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Ishida W, 2013, BRIT J OPHTHALMOL, V97, P492, DOI 10.1136/bjophthalmol-2012-302639; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2011, NEW ENGL J MED, V364, P1987, DOI 10.1056/NEJMp1100251; Ma JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-227; Mahajan B, 2010, INFECT IMMUN, V78, P4613, DOI 10.1128/IAI.00533-10; Miron N, 2014, IMMUNOL INVEST, V43, P267, DOI 10.3109/08820139.2013.868474; Montgomery CP, 2014, INFECT IMMUN, V82, P2125, DOI 10.1128/IAI.01491-14; Monzavi-Karbassi B, 2001, INT IMMUNOL, V13, P1361, DOI 10.1093/intimm/13.11.1361; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Oscherwitz J, 2010, J IMMUNOL, V185, P3661, DOI 10.4049/jimmunol.1001749; Ota S, 2002, CANCER RES, V62, P1471; Sato E, 2000, J LAB CLIN MED, V135, P161, DOI 10.1067/mlc.2000.104307; Schmaler M, 2011, J IMMUNOL, V186, P443, DOI 10.4049/jimmunol.1001407; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Uppada SB, 2011, VACCINE, V29, P9352, DOI 10.1016/j.vaccine.2011.09.129; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wang YH, 2011, VACCINE, V29, P8619, DOI 10.1016/j.vaccine.2011.09.016; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; Zhao YX, 1998, IMMUNOLOGY, V93, P80; Zuo QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081212	50	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136888	10.1371/journal.pone.0136888	http://dx.doi.org/10.1371/journal.pone.0136888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317210	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100162
J	Zou, J; Shankar, N				Zou, Jun; Shankar, Nathan			Roles of TLR/MyD88/MAPK/NF-kappa B Signaling Pathways in the Regulation of Phagocytosis and Proinflammatory Cytokine Expression in Response to E. faecalis Infection	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; LIPOTEICHOIC ACID; BACTERIA; MACROPHAGES; SEPSIS; EPIDEMIOLOGY; CONTRIBUTES; ACTIVATION; MECHANISMS; PATHOGENS	Enterococcus faecalis is a commensal bacterium residing in the gastrointestinal tract of mammals, but in certain situations it is also an opportunistic pathogen which can cause serious disease. Macrophages have been shown to play a critical role in controlling infections by commensal enterococci and also have an important role in mediating chromosomal instability and promoting colon cancer during high-level enterococcal colonization in genetically susceptible mice. However, the molecular mechanisms involved in the interaction of macrophages with enterococci during infection are not fully understood. In this study, using BMDM and RAW264.7 macrophages we show that enterococcal infection activates ERK, JNK and p38 MAPK as well as NF-kappa B, and drives polarization of macrophages towards the M1 phenotype. Inhibition of NF-kappa B activation significantly reduced the expression of TNF-alpha and IL-1 beta, as did the inhibition of ERK, JNK and p38 MAPK, although to differing extent. Enterococci-induced activation of these pathways and subsequent cytokine expression was contact dependent, modest compared to activation by E. coli and, required the adaptor protein MyD88. Phagocytosis of enterococci by macrophages was enhanced by preopsonization with E. faecalis antiserum and involved the ERK and JNK signaling pathways, with the adaptor protein MyD88 as an important mediator. This study of the interaction of macrophages with enterococci could provide a foundation for studying the pathogenesis of infection by this opportunistic pathogen and to developing new therapeutic approaches to combat enterococcal infection.	[Zou, Jun; Shankar, Nathan] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Shankar, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA.	nathan-shankar@ouhsc.edu	ZOU, JUN/AAD-3904-2019		University of Oklahoma	University of Oklahoma	The authors received no specific funding for this work. Part of this work was supported through a President's Associates Presidential Professorship awarded to NS by the University of Oklahoma.	Baik JE, 2008, J ENDODONT, V34, P975, DOI 10.1016/j.joen.2008.05.005; Bar K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-145; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DZIWISCH L, 1988, MED MICROBIOL IMMUN, V177, P101; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; Fazal N, 2012, FEMS IMMUNOL MED MIC, V64, P191, DOI 10.1111/j.1574-695X.2011.00881.x; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Fitzgerald ML, 2000, J IMMUNOL, V164, P2692, DOI 10.4049/jimmunol.164.5.2692; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Leendertse M, 2008, J IMMUNOL, V180, P4865, DOI 10.4049/jimmunol.180.7.4865; Leendertse Masja, 2009, Innate Immun, V15, P3, DOI 10.1177/1753425908100238; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Papasian CJ, 2002, INFECT IMMUN, V70, P6628, DOI 10.1128/IAI.70.12.6628-6637.2002; Park OJ, 2013, J LEUKOCYTE BIOL, V94, P1275, DOI 10.1189/jlb.1012522; Saito S, 2006, CLIN VACCINE IMMUNOL, V13, P876, DOI 10.1128/CVI.00075-06; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Wang SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097523; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; Yang YH, 2013, TRANSL ONCOL, V6, P596, DOI 10.1593/tlo.13412; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112010; Zou J, 2014, INFECT IMMUN, V82, P5132, DOI 10.1128/IAI.02426-14	37	22	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136947	10.1371/journal.pone.0136947	http://dx.doi.org/10.1371/journal.pone.0136947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317438	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100180
J	Geary, MB; Orner, CA; Bawany, F; Awad, HA; Hammert, WC; O'Keefe, RJ; Loiselle, AE				Geary, Michael B.; Orner, Caitlin A.; Bawany, Fatima; Awad, Hani A.; Hammert, Warren C.; O'Keefe, Regis J.; Loiselle, Alayna E.			Systemic EP4 Inhibition Increases Adhesion Formation in a Murine Model of Flexor Tendon Repair	PLOS ONE			English	Article							PATELLAR TENDON; GENE-EXPRESSION; FIBROBLAST PROLIFERATION; ANTIINFLAMMATORY DRUGS; COLLAGEN-SYNTHESIS; LUNG FIBROBLASTS; PULLEY SYSTEM; PROSTAGLANDIN-E-2; RECEPTOR; CAMP	Flexor tendon injuries are a common clinical problem, and repairs are frequently complicated by post-operative adhesions forming between the tendon and surrounding soft tissue. Prostaglandin E2 and the EP4 receptor have been implicated in this process following tendon injury; thus, we hypothesized that inhibiting EP4 after tendon injury would attenuate adhesion formation. A model of flexor tendon laceration and repair was utilized in C57BL/6J female mice to evaluate the effects of EP4 inhibition on adhesion formation and matrix deposition during flexor tendon repair. Systemic EP4 antagonist or vehicle control was given by intraperitoneal injection during the late proliferative phase of healing, and outcomes were analyzed for range of motion, biomechanics, histology, and genetic changes. Repairs treated with an EP4 antagonist demonstrated significant decreases in range of motion with increased resistance to gliding within the first three weeks after injury, suggesting greater adhesion formation. Histologic analysis of the repair site revealed a more robust granulation zone in the EP4 antagonist treated repairs, with early polarization for type III collagen by picrosirius red staining, findings consistent with functional outcomes. RT-PCR analysis demonstrated accelerated peaks in F4/80 and type III collagen (Col3a1) expression in the antagonist group, along with decreases in type I collagen (Col1a1). Mmp9 expression was significantly increased after discontinuing the antagonist, consistent with its role in mediating adhesion formation. Mmp2, which contributes to repair site remodeling, increases steadily between 10 and 28 days post-repair in the EP4 antagonist group, consistent with the increased matrix and granulation zones requiring remodeling in these repairs. These findings suggest that systemic EP4 antagonism leads to increased adhesion formation and matrix deposition during flexor tendon healing. Counter to our hypothesis that EP4 antagonism would improve the healing phenotype, these results highlight the complex role of EP4 signaling during tendon repair.	[Geary, Michael B.; Orner, Caitlin A.; Bawany, Fatima; Awad, Hani A.; Hammert, Warren C.; O'Keefe, Regis J.; Loiselle, Alayna E.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14627 USA; [Geary, Michael B.; Orner, Caitlin A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Hammert, Warren C.; Loiselle, Alayna E.] Univ Rochester, Dept Orthopaed & Rehabil, Rochester, NY USA; [Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14627 USA.	Alayna_Loiselle@urmc.rochester.edu	Mostafa, Taymour/H-6834-2019; Awad, Hani/G-6976-2014	Mostafa, Taymour/0000-0003-3627-0662; Awad, Hani/0000-0003-2197-2610	American Society for Surgery of the Hand Pilot Award; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health [TL1 TR000096]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056696, P50AR054041] Funding Source: NIH RePORTER	American Society for Surgery of the Hand Pilot Award; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the American Society for Surgery of the Hand Pilot Award (www. assh. org) (to AEL); MBG was supported by the University of Rochester CTSA award number TL1 TR000096 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin Atakan, 2004, Acta Orthop Traumatol Turc, V38, P54; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Beredjiklian PK, 2003, J BONE JOINT SURG AM, V85A, P539, DOI 10.2106/00004623-200303000-00025; Boor P, 2012, KIDNEY INT, V82, P132, DOI 10.1038/ki.2012.125; Chechik O, 2014, ARCH ORTHOP TRAUM SU, V134, P515, DOI 10.1007/s00402-014-1928-5; Chesney A, 2011, PLAST RECONSTR SURG, V127, P1583, DOI 10.1097/PRS.0b013e318208d28e; Cilli F, 2004, CLIN J SPORT MED, V14, P232, DOI 10.1097/00042752-200407000-00006; CLARK JG, 1982, J BIOL CHEM, V257, P8098; DOYLE JR, 1989, J HAND SURG-AM, V14, P349, DOI 10.1016/0363-5023(89)90110-X; DOYLE JR, 1988, J HAND SURG-AM, V13A, P473, DOI 10.1016/S0363-5023(88)80082-0; FALL PM, 1994, J BONE MINER RES, V9, P1935; Ferry ST, 2007, AM J SPORT MED, V35, P1326, DOI 10.1177/0363546507301584; FINE A, 1989, J BIOL CHEM, V264, P16988; Harirforoosh S, 2013, J PHARM PHARM SCI, V16, P821, DOI 10.18433/J3VW2F; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Kawahara K, 2014, BIOCH BIOPHYS ACTA; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kim CH, 2005, INT J BIOCHEM CELL B, V37, P375, DOI 10.1016/j.biocel.2004.07.013; Kollitz K M, 2014, Hand (N Y), V9, P217, DOI 10.1007/s11552-013-9583-9; Koshima H, 2007, J ORTHOP RES, V25, P92, DOI 10.1002/jor.20241; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; KULICK MI, 1986, J HAND SURG-AM, V11A, P110, DOI 10.1016/S0363-5023(86)80116-2; Lama V, 2002, AM J RESP CELL MOL, V27, P752, DOI 10.1165/rcmb.4857; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Lister G, 1985, Hand Clin, V1, P133; Loiselle AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040602; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Momeni A, 2010, HAND CLIN, V26, P179, DOI 10.1016/j.hcl.2009.11.004; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Starr HM, 2013, J HAND SURG-AM, V38A, P1712, DOI 10.1016/j.jhsa.2013.06.025; Strickland, 1995, J Am Acad Orthop Surg, V3, P44; Sugg KB, 2014, J ORTHOP RES, V32, P944, DOI 10.1002/jor.22624; Tanaka T, 2003, J ORTHOPAED RES, V21, P813, DOI 10.1016/S0736-0266(03)00004-4; Thampatty BP, 2007, GENE, V386, P154, DOI 10.1016/j.gene.2006.08.027; Thampatty BP, 2006, GENE, V372, P103, DOI 10.1016/j.gene.2005.12.013; VARGA J, 1987, BIOCHEM BIOPH RES CO, V147, P1282, DOI 10.1016/S0006-291X(87)80209-7; Virchenko O, 2004, AM J SPORT MED, V32, P1743, DOI 10.1177/0363546504263403; Vukicevic S, 2006, KIDNEY INT, V70, P1099, DOI 10.1038/sj.ki.5001715; Wang JHC, 2004, CLIN ORTHOP RELAT R, P243, DOI 10.1097/01.blo.0000126337.65685.e4; Wong JKF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112672; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136351	10.1371/journal.pone.0136351	http://dx.doi.org/10.1371/journal.pone.0136351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312751	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000055
J	Gupta, S; Rao, AR; Varadwaj, PK; De, S; Mohapatra, T				Gupta, Saurabh; Rao, Atmakuri Ramakrishna; Varadwaj, Pritish Kumar; De, Sachinandan; Mohapatra, Trilochan			Extrapolation of Inter Domain Communications and Substrate Binding Cavity of Camel HSP70 1A: A Molecular Modeling and Dynamics Simulation Study	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHAPERONE ACTIVITY; INTERDOMAIN COMMUNICATION; SERINE PROTEINASE; STRUCTURAL BASIS; MECHANISM; SYSTEM; SERVER; HSC70	Heat shock protein 70 (HSP70) is an important chaperone, involved in protein folding, refolding, translocation and complex remodeling reactions under normal as well as stress conditions. However, expression of HSPA1A gene in heat and cold stress conditions associates with other chaperons and perform its function. Experimental structure for Camel HSP70 protein (cHSP70) has not been reported so far. Hence, we constructed 3D models of cHSP70 through multi-template comparative modeling with HSP110 protein of S. cerevisiae (open state) and with HSP70 protein of E. coli 70kDa DnaK (close state) and relaxed them for 100 nanoseconds (ns) using all-atom Molecular Dynamics (MD) Simulation. Two stable conformations of cHSP70 with Substrate Binding Domain (SBD) in open and close states were obtained. The collective mode analysis of different transitions of open state to close state and vice versa was examined via Principal Component Analysis (PCA) and Minimum Distance Matrix (MDM). The results provide mechanistic representation of the communication between Nucleotide Binding Domain (NBD) and SBD to identify the role of sub domains in conformational change mechanism, which leads the chaperone cycle of cHSP70. Further, residues present in the chaperon functioning site were also identified through protein-peptide docking. This study provides an overall insight into the inter domain communication mechanism and identification of the chaperon binding cavity, which explains the underlying mechanism involved during heat and cold stress conditions in camel.	[Gupta, Saurabh; Rao, Atmakuri Ramakrishna] ICAR Indian Agr Stat Res Inst, Ctr Agr Bioinformat, New Delhi 110012, India; [Gupta, Saurabh; Varadwaj, Pritish Kumar] Indian Inst Informat Technol, Dept Bioinformat, Allahabad 210012, Uttar Pradesh, India; [De, Sachinandan] ICAR Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, India; [Mohapatra, Trilochan] ICAR Cent Rice Res Inst, Cuttack 753006, Odisha, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Indian Institute of Information Technology Allahabad; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Rao, AR (corresponding author), ICAR Indian Agr Stat Res Inst, Ctr Agr Bioinformat, Lib Ave, New Delhi 110012, India.	rao.cshl.work@gmail.com	Varadwaj, Pritish Kumar/AAS-2394-2020; Gupta, Saurabh/F-9004-2017	Varadwaj, Pritish Kumar/0000-0001-5706-2411; Gupta, Saurabh/0000-0002-1327-7389; Rao, Atmakuri Ramakrishna/0000-0002-3914-6248; De, Sachinandan/0000-0002-3182-0904	World Bank-funded National Agricultural Innovation Project (NAIP) [NAIP/Comp-4/C4/C-30033/2008-09]; CABin scheme of ICAR-IASRI [Agril.Edn.4-1/2013-AP]	World Bank-funded National Agricultural Innovation Project (NAIP); CABin scheme of ICAR-IASRI	The study received financial support from World Bank-funded National Agricultural Innovation Project (NAIP) grant NAIP/Comp-4/C4/C-30033/2008-09 and CABin scheme of ICAR-IASRI grant Agril.Edn.4-1/2013-A&P.	Abdallah H. R., 2012, Emirates Journal of Food and Agriculture, V24, P272; Aggarwal A, 2012, SPRINGER SCI BUSINES, DOI [10.1007/978-81-322-0879-2, DOI 10.1007/978-81-322-0879-2]; Ahmad S, 2010, PAK VET J, V30, P191; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Banerjee D, 2014, CELL STRESS CHAPERON, V19, P401, DOI 10.1007/s12192-013-0469-0; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Garbuz DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027205; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kakkar V, 2014, DIS MODEL MECH, V7, P421, DOI 10.1242/dmm.014563; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kishore A, 2014, CELL STRESS CHAPERON, V19, P613, DOI 10.1007/s12192-013-0486-z; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Lou HF, 2006, J PHYS CHEM B, V110, P12796, DOI 10.1021/jp061976m; Maisuradze GG, 2009, J MOL BIOL, V385, P312, DOI 10.1016/j.jmb.2008.10.018; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Prasad CVSS, 2013, APPL BIOCHEM BIOTECH, V170, P1996, DOI 10.1007/s12010-013-0342-8; Prasad CVSS, 2013, BIOINFORMATION, V9, P1, DOI 10.6026/97320630009001; Prasad CVSS, 2012, BIOINFORMATION, V8, P673, DOI 10.6026/97320630008673; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X; Sanchez R, 2000, METH MOL B, V143, P97; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057	53	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136630	10.1371/journal.pone.0136630	http://dx.doi.org/10.1371/journal.pone.0136630			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313938	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000077
J	Liao, RR; Wang, Z; Chen, Q; Tu, YY; Chen, ZL; Wang, QS; Yang, CS; Zhang, XZ; Pan, YC				Liao, Rongrong; Wang, Zhen; Chen, Qiang; Tu, Yingying; Chen, Zhenliang; Wang, Qishan; Yang, Changsuo; Zhang, Xiangzhe; Pan, Yuchun			An Efficient Genotyping Method in Chicken Based on Genome Reducing and Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; SNP DISCOVERY; POPULATION; MICROARRAYS; EXTENT; LOCI	Single nucleotide polymorphisms (SNPs) are essential for identifying the genetic mechanisms of complex traits. In the present study, we applied genotyping by genome reducing and sequencing (GGRS) method to construct a 252-plex sequencing library for SNP discovery and genotyping in chicken. The library was successfully sequenced on an Illumina HiSeq 2500 sequencer with a paired-end pattern; approximately 400 million raw reads were generated, and an average of approximately 1.4 million good reads per sample were generated. A total of 91,767 SNPs were identified after strict filtering, and all of the 252 samples and all of the chromosomes were well represented. Compared with the Illumina 60K chicken SNP chip data, approximately 34,131 more SNPs were identified using GGRS, and a higher SNP density was found using GGRS, which could be beneficial for downstream analysis. Using the GGRS method, more than 3528 samples can be sequenced simultaneously, and the cost is reduced to $ 18 per sample. To the best of our knowledge, this study describes the first report of such highly multiplexed sequencing in chicken, indicating potential applications for genome-wide association and genomic selection in chicken.	[Liao, Rongrong; Wang, Zhen; Chen, Zhenliang; Wang, Qishan; Zhang, Xiangzhe; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Chen, Qiang] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Tu, Yingying; Yang, Changsuo] Shanghai Acad Agr Sci, Natl Poultry Engn Res Ctr, Anim Husb & Vet Res Inst, Shanghai, Peoples R China; [Wang, Qishan; Zhang, Xiangzhe; Pan, Yuchun] Shanghai Jiao Tong Univ, Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Kunming University of Science & Technology; Shanghai Academy of Agricultural Sciences; Shanghai Jiao Tong University	Zhang, XZ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	xiangzhezhang@sjtu.edu.cn; panyuchun1963@aliyun.com			National Natural Science Foundation of China [31101706]; China Agriculture Research Systems [CARS-41-K05]; National 948 Project of China [2012-Z26, 2014-Z29]; Agriculture Development through Science and Technology Key Project of Shanghai [2012 (2-3)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research Systems; National 948 Project of China; Agriculture Development through Science and Technology Key Project of Shanghai	The National Natural Science Foundation of China (31101706) http://www.nsfc.gov.cn/publish/portal1/ XZ, China Agriculture Research Systems (CARS-41-K05) http://119.253.58.231/ XZ, the National 948 Project of China (2012-Z26, 2014-Z29) http://www.stee.agri.gov.cn/ YP and Agriculture Development through Science and Technology Key Project of Shanghai (grant No. 2012 (2-3)) http://en.shac.gov.cn/ YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Aerts J, 2007, CYTOGENET GENOME RES, V117, P338, DOI 10.1159/000103196; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Guillot G, 2009, BIOINFORMATICS, V25, P552, DOI 10.1093/bioinformatics/btn665; Kerstens HHD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-94; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Li GQ, 2014, POULTRY SCI, V93, P2983, DOI 10.3382/ps.2014-04164; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mao XY, 2007, CURR GENOMICS, V8, P219; Megens HJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-86; Miller MM, 1996, P NATL ACAD SCI USA, V93, P3958, DOI 10.1073/pnas.93.9.3958; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rao YS, 2008, HEREDITAS, V145, P251, DOI 10.1111/j.1601-5223.2008.02043.x; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Seo DW, 2015, MOL BIOL REP, V42, P471, DOI 10.1007/s11033-014-3790-5; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Sundstrom H, 2004, GENETICS, V167, P377, DOI 10.1534/genetics.167.1.377; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101025	37	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0137010	10.1371/journal.pone.0137010	http://dx.doi.org/10.1371/journal.pone.0137010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313744	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000111
J	Torrungruang, K; Jitpakdeebordin, S; Charatkulangkun, O; Gleebbua, Y				Torrungruang, Kitti; Jitpakdeebordin, Supawadee; Charatkulangkun, Orawan; Gleebbua, Yingampa			Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Treponema denticola / Prevotella intermedia Co-Infection Are Associated with Severe Periodontitis in a Thai Population	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUBGINGIVAL MICROBIOTA; QUANTITATIVE-ANALYSIS; BACTERIAL PATHOGENS; DISEASE; QUANTIFICATION; ABUNDANCE; CULTURE; PLAQUE	Periodontitis is a polymicrobial infection of tooth-supporting tissues. This cross-sectional study aimed to examine the associations between five target species and severe periodontitis in a Thai population. Using the CDC/AAP case definition, individuals diagnosed with no/mild and severe periodontitis were included. Quantitative analyses of Aggregatibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf), Treponema denticola (Td), and Prevotella intermedia (Pi) in subgingival plaque were performed using real-time polymerase chain reaction. The association between target species and severe periodontitis was examined using logistic regression analysis. The study subjects comprised 479 individuals with no/mild periodontitis and 883 with severe periodontitis. Bacterial prevalence and quantity were higher in subjects with severe periodontitis than in those with no/mild disease. In the fully adjusted model, all species except Tf showed a dose-dependent relationship with periodontitis. The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aa, Td, and Pi had to reach the critical thresholds to be significantly associated with disease. Compared to individuals with low levels of both Td and Pi, high colonization by either Td or Pi alone significantly increased the odds of having severe periodontitis by 2.5 (95% CI 1.7-3.5) folds. The odds ratio was further increased to 14.8 (95% CI 9.2-23.8) in individuals who were highly colonized by both species. Moreover, the presence of Pg and high colonization by Aa were independently associated with severe periodontitis with odds ratios of 5.6 (95% CI 3.4-9.1) and 2.2 (95% CI 1.5-3.3), respectively. Our findings suggest that the presence of Pg and high colonization by Aa, Td, and Pi play an important role in severe periodontitis in this study population. We also demonstrate for the first time that individuals co-infected with Td and Pi were more likely to have periodontitis than were those infected with a single pathogen.	[Torrungruang, Kitti] Chulalongkorn Univ, Fac Dent, Dept Microbiol, Bangkok, Thailand; [Jitpakdeebordin, Supawadee] Mahidol Univ, Fac Sci, Lab Anim Facil, Bangkok 10400, Thailand; [Charatkulangkun, Orawan] Chulalongkorn Univ, Fac Dent, Dept Periodontol, Bangkok, Thailand; [Gleebbua, Yingampa] Elect Generating Author Thailand, Hlth Div, Med & Hlth Dept, Nonthaburi, Thailand	Chulalongkorn University; Mahidol University; Chulalongkorn University	Torrungruang, K (corresponding author), Chulalongkorn Univ, Fac Dent, Dept Microbiol, Bangkok, Thailand.	Kitti.T@chula.ac.th	torrungruang, kitti/ABH-5125-2020		National Research Council of Thailand; Asia Research Center at Chulalongkorn University	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Asia Research Center at Chulalongkorn University	This study was supported by the National Research Council of Thailand, and the Asia Research Center at Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lourenco TGB, 2014, J CLIN PERIODONTOL, V41, P1027, DOI 10.1111/jcpe.12302; Boutaga K, 2005, FEMS IMMUNOL MED MIC, V45, P191, DOI 10.1016/j.femsim.2005.03.011; Boutaga K, 2003, J CLIN MICROBIOL, V41, P4950, DOI 10.1128/JCM.41.11.4950-4954.2003; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; CHRISTERSSON LA, 1992, J PERIODONTOL, V63, P418, DOI 10.1902/jop.1992.63.5.418; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; He JY, 2012, CLIN ORAL INVEST, V16, P1579, DOI 10.1007/s00784-011-0654-4; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; JANSEN HJ, 1995, ORAL MICROBIOL IMMUN, V10, P138, DOI 10.1111/j.1399-302X.1995.tb00134.x; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Laine ML, 2013, J DENT RES, V92, P45, DOI 10.1177/0022034512465435; Loozen G, 2014, J CLIN PERIODONTOL, V41, P1, DOI 10.1111/jcpe.12167; Miller DP, 2014, MOL ORAL MICROBIOL, V29, P194, DOI 10.1111/omi.12054; Mineoka T, 2008, J PERIODONTOL, V79, P670, DOI [10.1902/jop.2008.070398, 10.1902/jop.2008.070398 ]; Nonnenmacher C, 2005, J PERIODONTOL, V76, P1542, DOI 10.1902/jop.2005.76.9.1542; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Papapanou PN, 1997, J PERIODONTOL, V68, P651, DOI 10.1902/jop.1997.68.7.651; Papapanou PN, 2002, EUR J ORAL SCI, V110, P345, DOI 10.1034/j.1600-0722.2002.21361.x; Potempa M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000316; Pradhan-Palikhe P, 2013, J PERIODONTOL, V84, P1809, DOI 10.1902/jop.2013.120537; Sanz M, 2000, EUR J ORAL SCI, V108, P383, DOI 10.1034/j.1600-0722.2000.108005383.x; Sarkar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088361; Saygun I, 2008, J PERIODONTAL RES, V43, P352, DOI 10.1111/j.1600-0765.2007.01043.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Torrungruang K, 2005, J PERIODONTOL, V76, P558, DOI 10.1902/jop.2005.76.4.558; Torrungruang K, 2009, J PERIODONTOL, V80, P122, DOI [10.1902/jop.2009.080248, 10.1902/jop.2009.080248 ]; Vathesatogkit P, 2012, INT J EPIDEMIOL, V41, P359, DOI 10.1093/ije/dyq218; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; Yamazaki T, 2006, MICROBES INFECT, V8, P1758, DOI 10.1016/j.micinf.2006.02.013; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	34	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136646	10.1371/journal.pone.0136646	http://dx.doi.org/10.1371/journal.pone.0136646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313005	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000080
J	Abeles, SR; Ly, M; Santiago-Rodriguez, TM; Pride, DT				Abeles, Shira R.; Ly, Melissa; Santiago-Rodriguez, Tasha M.; Pride, David T.			Effects of Long Term Antibiotic Therapy on Human Oral and Fecal Viromes	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; VIRAL COMMUNITIES; ONLINE TOOL; BACTERIOPHAGE; COEVOLUTION; DIVERSITY; VIRUSES; PHAGE; SEQUENCES; EVOLUTION	Viruses are integral members of the human microbiome. Many of the viruses comprising the human virome have been identified as bacteriophage, and little is known about how they respond to perturbations within the human ecosystem. The intimate association of phage with their cellular hosts suggests their communities may change in response to shifts in bacterial community membership. Alterations to human bacterial biota can result in human disease including a reduction in the host's resilience to pathogens. Here we report the ecology of oral and fecal viral communities and their responses to long-term antibiotic therapy in a cohort of human subjects. We found significant differences between the viral communities of each body site with a more heterogeneous fecal virus community compared with viruses in saliva. We measured the relative diversity of viruses, and found that the oral viromes were significantly more diverse than fecal viromes. There were characteristic changes in the membership of oral and fecal bacterial communities in response to antibiotics, but changes in fecal viral communities were less distinguishing. In the oral cavity, an abundance of papillomaviruses found in subjects on antibiotics suggests an association between antibiotics and papillomavirus production. Despite the abundance of papillomaviruses identified, in neither the oral nor the fecal viromes did antibiotic therapy have any significant impact upon overall viral diversity. There was, however, an apparent expansion of the reservoir of genes putatively involved in resistance to numerous classes of antibiotics in fecal viromes that was not paralleled in oral viromes. The emergence of antibiotic resistance in fecal viromes in response to long-term antibiotic therapy in humans suggests that viruses play an important role in the resilience of human microbial communities to antibiotic disturbances.	[Abeles, Shira R.; Pride, David T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ly, Melissa; Santiago-Rodriguez, Tasha M.; Pride, David T.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pride, DT (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dpride@ucsd.edu			Burroughs Wellcome Fund [1007681.01]	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This study was supported by the Burroughs Wellcome Fund 1007681.01 to DTP.	Abeles SR, 2014, ISME J, V8, P1753, DOI 10.1038/ismej.2014.31; Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Duerkop BA, 2012, P NATL ACAD SCI USA, V109, P17621, DOI 10.1073/pnas.1206136109; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Haerter JO, 2014, ISME J, V8, P2317, DOI 10.1038/ismej.2014.80; Haynes Ma, 2011, METAGENOMICS OF THE; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; HUANG A, 1987, J BACTERIOL, V169, P4308, DOI 10.1128/jb.169.9.4308-4312.1987; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ly M, 2014, MBIO, V5, DOI 10.1128/mBio.01133-14; Matsushiro A, 1999, J BACTERIOL, V181, P2257, DOI 10.1128/JB.181.7.2257-2260.1999; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McDonald JAK, 2015, J MICROBIOL METH, V108, P36, DOI 10.1016/j.mimet.2014.11.007; McDonald JAK, 2013, J MICROBIOL METH, V95, P167, DOI 10.1016/j.mimet.2013.08.008; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Murphy F. A., 1995, VIRUS TAXONOMY SIZTH; Naidu M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-175; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; OBRIEN AD, 1983, LANCET, V1, P702; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robles-Sikisaka R, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-146; Robles-Sikisaka R, 2013, ISME J, V7, P1710, DOI 10.1038/ismej.2013.63; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Santiago-Rodriguez TM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00014; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stanton TB, 2008, APPL ENVIRON MICROB, V74, P2950, DOI 10.1128/AEM.00189-08; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	61	65	66	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134941	10.1371/journal.pone.0134941	http://dx.doi.org/10.1371/journal.pone.0134941			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309137	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400043
J	Winter, BJ; O'Connell, HE; Bowden, S; Carey, M; Eisen, DP				Winter, Benjamin J.; O'Connell, Helen E.; Bowden, Scott; Carey, Marcus; Eisen, Damon P.			A Case Control Study Reveals that Polyomaviruria Is Significantly Associated with Interstitial Cystitis and Vesical Ulceration	PLOS ONE			English	Article							HEMORRHAGIC CYSTITIS; INFECTIOUS AGENTS; BK-VIRUS; REPLICATION; CIDOFOVIR; TRANSPLANTATION; SODIUM	Objectives To investigate whether polyomaviruses contribute to interstitial cystitis pathogenesis. Subjects and Methods A prospective study was performed with 50 interstitial cystitis cases compared with 50 age-matched, disease-free controls for the frequency of polyomaviruria. Associations between polyomaviruria and disease characteristics were analysed in cases. Polyomavirus in urine and bladder tissue was detected with species (JC virus vs. BK virus) specific, real-time PCR. Results Case patients were reflective of interstitial cystitis epidemiology with age range from 26-88 years (median 58) and female predominance (41/50 F). There was a significant increase in the frequency of polyomavirus shedding between cases and controls (p<0.02). Polyomavirus shedding, in particular BK viruria, was associated with vesical ulceration, a marker of disease severity, among interstitial cystitis cases after adjustment for age and sex (OR 6.8, 95% CI 1.89-24.4). There was a significant association among cases between the presence of BK viruria and response to intravesical Clorpactin therapy (OR 4.50, 95% CI 1.17-17.4). Conclusion The presence of polyomaviruria was found to be associated with the ulcerative form of interstitial cystitis. Clorpactin, which has anti-DNA virus activity, was more likely to improve symptoms in the presence of BK viruria. These data from this pilot study suggest associations between polyomaviruria and interstitial cystitis warranting further investigation.	[Winter, Benjamin J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic 3052, Australia; [O'Connell, Helen E.] Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia; [Bowden, Scott] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia; [Carey, Marcus] Royal Womens Hosp, Dept Urogynaecol, Parkville, Vic, Australia; [Eisen, Damon P.] Royal Melbourne Hosp, Doherty Inst, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Eisen, Damon P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; Victorian Infectious Diseases Reference Laboratory; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne	Eisen, DP (corresponding author), Royal Melbourne Hosp, Doherty Inst, Victorian Infect Dis Serv, Melbourne, Vic, Australia.	damon.eisen@mh.org.au	eisen, damon/AAC-7433-2019	Eisen, Damon/0000-0002-8987-4358				Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Al-Hadithi HN, 2005, J UROLOGY, V174, P151, DOI 10.1097/01.ju.0000161605.14804.a9; Bernhoff E, 2008, AM J TRANSPLANT, V8, P1413, DOI 10.1111/j.1600-6143.2008.02269.x; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Duncan JL, 1997, UROLOGY, V49, P48, DOI 10.1016/S0090-4295(99)80331-8; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Eisen DP, 2009, CLIN INFECT DIS, V48, pE86, DOI 10.1086/597827; Farasati NA, 2005, TRANSPLANTATION, V79, P116, DOI 10.1097/01.TP.0000149338.97084.5F; Fioriti D, 2005, INT J IMMUNOPATH PH, V18, P799, DOI 10.1177/039463200501800424; Gilis L, 2014, BONE MARROW TRANSPL, V49, P664, DOI 10.1038/bmt.2013.235; HIRAOKA A, 1991, BONE MARROW TRANSPL, V7, P107; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; KLEIN RJ, 1987, LANCET, V1, P281; Lubeck DP, 2001, UROLOGY, V57, P62, DOI 10.1016/S0090-4295(01)01126-8; Nickeleit V, 2003, CURR OPIN NEPHROL HY, V12, P599, DOI 10.1097/00041552-200311000-00005; Ottem DP, 2005, UROLOGY, V66, P494, DOI 10.1016/j.urology.2005.04.011; SANT GR, 1994, UROL CLIN N AM, V21, P73; Sharma BN, 2011, ANTIVIR RES, V92, P115, DOI 10.1016/j.antiviral.2011.07.012; Simon LJ, 1997, UROLOGY, V49, P64, DOI 10.1016/S0090-4295(99)80334-3; van der Aa F, 2014, MED HYPOTHESES, V83, P317, DOI 10.1016/j.mehy.2014.06.004; Zabihi N, 2007, J UROLOGY, V177, P149, DOI 10.1016/j.juro.2006.08.095; Zhong S, 2007, J CLIN MICROBIOL, V45, P193, DOI 10.1128/JCM.01645-06	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137310	10.1371/journal.pone.0137310	http://dx.doi.org/10.1371/journal.pone.0137310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325074	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700110
J	Arefin, B; Kucerova, L; Krautz, R; Kranenburg, H; Parvin, F; Theopold, U				Arefin, Badrul; Kucerova, Lucie; Krautz, Robert; Kranenburg, Holger; Parvin, Farjana; Theopold, Ulrich			Apoptosis in Hemocytes Induces a Shift in Effector Mechanisms in the Drosophila Immune System and Leads to a Pro-Inflammatory State	PLOS ONE			English	Article							GENE; EXPRESSION; INCREASES; INFECTION; REVEALS; SIGNALS; PROTEIN; GROWTH; CELLS	Apart from their role in cellular immunity via phagocytosis and encapsulation, Drosophila hemocytes release soluble factors such as antimicrobial peptides, and cytokines to induce humoral responses. In addition, they participate in coagulation and wounding, and in development. To assess their role during infection with entomopathogenic nematodes, we depleted plasmatocytes and crystal cells, the two classes of hemocytes present in naive larvae by expressing proapoptotic proteins in order to produce hemocyte-free (Hml-apo, originally called Hemo(less)) larvae. Surprisingly, we found that Hml-apo larvae are still resistant to nematode infections. When further elucidating the immune status of Hml-apo larvae, we observe a shift in immune effector pathways including massive lamellocyte differentiation and induction of Toll-as well as repression of imd signaling. This leads to a pro-inflammatory state, characterized by the appearance of melanotic nodules in the hemolymph and to strong developmental defects including pupal lethality and leg defects in escapers. Further analysis suggests that most of the phenotypes we observe in Hml-apo larvae are alleviated by administration of antibiotics and by changing the food source indicating that they are mediated through the microbiota. Biochemical evidence identifies nitric oxide as a key phylogenetically conserved regulator in this process. Finally we show that the nitric oxide donor L-arginine similarly modifies the response against an early stage of tumor development in fly larvae.	[Arefin, Badrul; Kucerova, Lucie; Krautz, Robert; Parvin, Farjana; Theopold, Ulrich] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Kranenburg, Holger] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Stockholm University; University of Munster	Theopold, U (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	uli.theopold@su.se	Arefin, Badrul/P-9532-2018; Theopold, Ulrich/P-7205-2015; Kucerova, Lucie/N-1176-2016; Arefin, Badrul/AAZ-9621-2021	Arefin, Badrul/0000-0003-1117-9125; Theopold, Ulrich/0000-0002-1009-8254; Kucerova, Lucie/0000-0002-6382-4467; Krautz, Robert/0000-0003-0457-1348	Cancerfonden [CAN 2013/546]; Vetenskapsradet [VR-2010-5988]; KAW [KAW2012.0058]; STINT [IG2011-2042]	Cancerfonden(Swedish Cancer Society); Vetenskapsradet(Swedish Research Council); KAW; STINT	Funding was provided by Cancerfonden CAN 2013/546, https://www.cancerfonden.se/, Vetenskapsradet VR-2010-5988, www.vr.se, KAW KAW2012.0058, www.wallenberg.com/kaw/, STINT IG2011-2042, http://www.stint.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin B, 2014, J INNATE IMMUN, V6, P192, DOI 10.1159/000353734; Battinelli E, 2000, BLOOD, V95, P3451, DOI 10.1182/blood.V95.11.3451.011k34_3451_3459; Battinelli E, 2001, P NATL ACAD SCI USA, V98, P14458, DOI 10.1073/pnas.241427398; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Dantoft W, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-99; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dobes P, 2012, FLY, V6, P75, DOI 10.4161/fly.19553; Dragojlovic-Munther M, 2012, DEVELOPMENT, V139, P3752, DOI 10.1242/dev.074203; Dzik JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00544; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; Fors L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108795; Glittenberg MT, 2011, DIS MODEL MECH, V4, P515, DOI 10.1242/dmm.006627; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Hauling T, 2014, BIOL OPEN, V3, P250, DOI 10.1242/bio.20146494; Hyrsl P, 2011, J INNATE IMMUN, V3, P65, DOI 10.1159/000320634; Kraaijeveld AR, 2011, DEV COMP IMMUNOL, V35, P857, DOI 10.1016/j.dci.2011.03.019; Krautz R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00342; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Scherfer C, 2006, DEV BIOL, V295, P156, DOI 10.1016/j.ydbio.2006.03.019; Schmid MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102568; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wing JP, 2001, MECH DEVELOP, V102, P193, DOI 10.1016/S0925-4773(01)00316-1	39	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136593	10.1371/journal.pone.0136593	http://dx.doi.org/10.1371/journal.pone.0136593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322507	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500023
J	Kraemer, N; Issa-Jahns, L; Neubert, G; Ravindran, E; Mani, S; Ninnemann, O; Kaindl, AM				Kraemer, Nadine; Issa-Jahns, Lina; Neubert, Gerda; Ravindran, Ethiraj; Mani, Shyamala; Ninnemann, Olaf; Kaindl, Angela M.			Novel Alternative Splice Variants of Mouse Cdk5rap2	PLOS ONE			English	Article								Autosomal recessive primary microcephaly (MCPH) is a rare neurodevelopmental disorder characterized by a pronounced reduction of brain volume and intellectual disability. A current model for the microcephaly phenotype invokes a stem cell proliferation and differentiation defect, which has moved the disease into the spotlight of stem cell biology and neurodevelopmental science. Homozygous mutations of the Cyclin-dependent kinase-5 regulatory subunit-associated protein 2 gene CDK5RAP2 are one genetic cause of MCPH. To further characterize the pathomechanism underlying MCPH, we generated a conditional Cdk5rap2 LoxP/hCMV Cre mutant mouse. Further analysis, initiated on account of a lack of a microcephaly phenotype in these mutant mice, revealed the presence of previously unknown splice variants of the Cdk5rap2 gene that are at least in part accountable for the lack of microcephaly in the mice.	[Kraemer, Nadine; Issa-Jahns, Lina; Neubert, Gerda; Ravindran, Ethiraj; Ninnemann, Olaf; Kaindl, Angela M.] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Kraemer, Nadine; Issa-Jahns, Lina; Neubert, Gerda; Ravindran, Ethiraj; Kaindl, Angela M.] Charite, Dept Pediat Neurol, D-13353 Berlin, Germany; [Mani, Shyamala] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India; [Kaindl, Angela M.] Charite, Sozialpadiatr Zentrum SPZ, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Indian Institute of Science (IISC) - Bangalore; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kraemer, N (corresponding author), Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.	nadine.kraemer@charite.de; angela.kaindl@charite.de		Kraemer, Nadine/0000-0002-7002-5161; Kaindl, Angela/0000-0001-9454-206X	German Research Foundation [SFB665]; Sonnenfeld Stiftung; Federal Ministry of Education and research (BMBF); Berlin Institute of Health (BIH); Academic Exchange Service (DAAD)	German Research Foundation(German Research Foundation (DFG)); Sonnenfeld Stiftung; Federal Ministry of Education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); Berlin Institute of Health (BIH); Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by German Research Foundation (SFB665), http://www.sfb665.de/; Sonnenfeld Stiftung, http://www.sonnenfeld-stiftung.de/; Federal Ministry of Education and research (BMBF); Berlin Institute of Health (BIH), http://www.bmbf.de/en/; Academic Exchange Service (DAAD), https://www.daad.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Issa L, 2013, CEREB CORTEX, V23, P2245, DOI 10.1093/cercor/bhs212; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kraemer N, 2015, CELL CYCLE, V14, P2044, DOI 10.1080/15384101.2015.1044169; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Nagy ZP, 2003, REPROD BIOMED ONLINE; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136684	10.1371/journal.pone.0136684	http://dx.doi.org/10.1371/journal.pone.0136684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322982	Green Published, Green Accepted, gold			2022-12-27	WOS:000360435500027
J	Ray, A; Yuan, CY; Miller, NM; Mei, H; Dittel, BN				Ray, Avijit; Yuan, Cheng-Yin; Miller, Nichole M.; Mei, Hong; Dittel, Bonnie N.			2B4 Is Dispensable for T-Dependent B Cell Immune Responses, but Its Deficiency Leads to Enhanced T-Independent Responses Due to an Increase in Peritoneal Cavity B1b Cells	PLOS ONE			English	Article							SLAM; CD48; SAP; NK; RECEPTORS; CD244; LYMPHOCYTES; DIFFERENTIATION; ACTIVATION; EXPRESSION	The signaling lymphocyte activation molecule (SLAM) family plays important roles in adaptive immune responses. Herein, we evaluated whether the SLAM family member 2B4 (CD244) plays a role in immune cell development, homeostasis and antibody responses. We found that the splenic cellularity in Cd244(-/-) mice was significantly reduced due to a reduction in both CD4 T cells and follicular (Fo) B cells; whereas, the number of peritoneal cavity B cells was increased. These findings led us to examine whether 2B4 modulates B cell immune responses. When we examined T-dependent B cell responses, while there was no difference in the kinetics or magnitude of the antigen-specific IgM and IgG(1) antibody response there was a reduction in bone marrow (BM) memory, but not plasma cells in Cd244(-/-) mice. When we evaluated T-independent immune responses, we found that antigen-specific IgM and IgG(3) were elevated in the serum following immunization. These data indicate that 2B4 dampens T-independent B cell responses due to a reduction in peritoneal cavity B cells, but has minimal impact on T-dependent B cell responses.	[Ray, Avijit; Miller, Nichole M.; Mei, Hong; Dittel, Bonnie N.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; [Yuan, Cheng-Yin; Dittel, Bonnie N.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Dittel, BN (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA.	bonnie.dittel@bcw.edu	Yuan, Cheng Yin/AAT-3750-2021; Ray, Avijit/K-5611-2015	Ray, Avijit/0000-0002-1732-9836	National Institutes of Health [R01 AI069358, R56 AI106672-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069358, R56AI106672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grants R01 AI069358 and R56 AI106672-01.	Alugupalli KR, 2008, CURR TOP MICROBIOL, V319, P105; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067587; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Dellabona P, 2014, EUR J IMMUNOL, V44, P2230, DOI 10.1002/eji.201344399; Elishmereni M, 2011, INT J BIOCHEM CELL B, V43, P25, DOI 10.1016/j.biocel.2010.09.001; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Gao N, 2005, J IMMUNOL, V174, P4113, DOI 10.4049/jimmunol.174.7.4113; Gao N, 2001, J IMMUNOL, V167, P2011, DOI 10.4049/jimmunol.167.4.2011; Hoffmann JC, 1998, CELL BIOL INT, V22, P21, DOI 10.1006/cbir.1997.0208; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; Klyushnenkova EN, 1996, CELL IMMUNOL, V174, P90, DOI 10.1006/cimm.1996.0297; Latchman Y, 1998, EUR J IMMUNOL, V28, P4325, DOI 10.1002/(SICI)1521-4141(199812)28:12<4325::AID-IMMU4325>3.0.CO;2-T; Liu DY, 2014, J EXP MED, V211, P297, DOI 10.1084/jem.20130902; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Perez-Quintero LA, 2014, J EXP MED, V211, P727, DOI 10.1084/jem.20132038; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Romero X, 2004, TISSUE ANTIGENS, V64, P132, DOI 10.1111/j.1399-0039.2004.00247.x; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; THORLEYLAWSON DA, 1982, CELL, V30, P415, DOI 10.1016/0092-8674(82)90239-2; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Vargas-Inchaustegui DA, 2012, J IMMUNOL, V189, P1878, DOI 10.4049/jimmunol.1201026; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137314	10.1371/journal.pone.0137314	http://dx.doi.org/10.1371/journal.pone.0137314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323020	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500070
J	Peron, JPS; de Brito, AA; Pelatti, M; Brandao, WN; Vitoretti, LB; Greiffo, FR; da Silveira, EC; Oliveira, MC; Maluf, M; Evangelista, L; Halpern, S; Nisenbaum, MG; Perin, P; Czeresnia, CE; Camara, NOS; Aimbire, F; Vieira, RD; Zatz, M; de Oliveira, APL				Schatzmann Peron, Jean Pierre; de Brito, Aurileia Aparecida; Pelatti, Mayra; Brandao, Wesley Nogueira; Vitoretti, Luana Beatriz; Greiffo, Flavia Regina; da Silveira, Elaine Cristina; Oliveira-Junior, Manuel Carneiro; Maluf, Mariangela; Evangelista, Lucila; Halpern, Silvio; Nisenbaum, Marcelo Gil; Perin, Paulo; Czeresnia, Carlos Eduardo; Saraiva Camara, Niels Olsen; Aimbire, Flavio; Vieira, Rodolfo de Paula; Zatz, Mayana; Ligeiro de Oliveira, Ana Paula			Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STEM-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; AIRWAY INFLAMMATION; LUNG; FIBROSIS; RECOVERY; ASTHMA	Cigarette smoke-induced chronic obstructive pulmonary disease is a very debilitating disease, with a very high prevalence worldwide, which results in a expressive economic and social burden. Therefore, new therapeutic approaches to treat these patients are of unquestionable relevance. The use of mesenchymal stromal cells (MSCs) is an innovative and yet accessible approach for pulmonary acute and chronic diseases, mainly due to its important immunoregulatory, anti-fibrogenic, anti-apoptotic and pro-angiogenic. Besides, the use of adjuvant therapies, whose aim is to boost or synergize with their function should be tested. Low level laser (LLL) therapy is a relatively new and promising approach, with very low cost, no invasiveness and no side effects. Here, we aimed to study the effectiveness of human tube derived MSCs (htMSCs) cell therapy associated with a 30mW/3J-660 nm LLL irradiation in experimental cigarette smoke-induced chronic obstructive pulmonary disease. Thus, C57BL/6 mice were exposed to cigarette smoke for 75 days (twice a day) and all experiments were performed on day 76. Experimental groups receive htMSCS either intraperitoneally or intranasally and/or LLL irradiation either alone or in association. We show that co-therapy greatly reduces lung inflammation, lowering the cellular infiltrate and pro-inflammatory cytokine secretion (IL-1 beta, IL-6, TNF-alpha and KC), which were followed by decreased mucus production, collagen accumulation and tissue damage. These findings seemed to be secondary to the reduction of both NF-kappa B and NF-AT activation in lung tissues with a concomitant increase in IL-10. In summary, our data suggests that the concomitant use of MSCs + LLLT may be a promising therapeutic approach for lung inflammatory diseases as COPD.	[Schatzmann Peron, Jean Pierre; Brandao, Wesley Nogueira] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Neuroimmune Interact Lab, Sao Paulo, SP, Brazil; [de Brito, Aurileia Aparecida; Vitoretti, Luana Beatriz; Greiffo, Flavia Regina; da Silveira, Elaine Cristina; Zatz, Mayana] Nove Julho Univ UNINOVE, Lab Pulm & Exercise Immunol LABPEI, Sao Paulo, SP, Brazil; [Pelatti, Mayra; Oliveira-Junior, Manuel Carneiro; Vieira, Rodolfo de Paula; Ligeiro de Oliveira, Ana Paula] Univ Sao Paulo, Div Human Genome, Res Ctr, Biosci Inst, Sao Paulo, SP, Brazil; [Maluf, Mariangela; Perin, Paulo] CEERH Specialized Ctr Human Reprod, Div Reprod Med, Sao Paulo, SP, Brazil; [Evangelista, Lucila; Halpern, Silvio; Nisenbaum, Marcelo Gil; Czeresnia, Carlos Eduardo] Div Reprod Med Celula Mater, Sao Paulo, SP, Brazil; [Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Transplantat Immunobiol, Sao Paulo, SP, Brazil; [Aimbire, Flavio] Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, SP, Brazil	Universidade de Sao Paulo; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	de Oliveira, APL (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Neuroimmune Interact Lab, Sao Paulo, SP, Brazil.	apligeiro@gmail.com	de Oliveira Junior, Manoel Carneiro/P-5597-2019; de Paula Vieira, Rodolfo/E-9315-2011; Aimbire, Flavio/E-6193-2012; Zatz, Mayana/M-5338-2015; Brandão, Wesley N/K-5919-2017; Peron, Jean Pierre S/F-9248-2012; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011	de Oliveira Junior, Manoel Carneiro/0000-0002-1698-9920; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Aimbire, Flavio/0000-0002-4290-541X; Zatz, Mayana/0000-0003-3970-8025; Brandão, Wesley N/0000-0001-9306-3251; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Peron, Jean Pierre/0000-0003-1638-8866; Brito, Aurileia/0000-0001-9683-4410; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo) [2011/18703-2, 2012/16498-5]	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support from FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo) grants # 2011/18703-2 for Peron JPS and 2012/16498-5 for Ligeiro de Oliveira AP.	Al Jumah MA, 2012, INT J MOL SCI, V13, P9298, DOI 10.3390/ijms13079298; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Atsuta I, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt322; Barnes PJ, 2008, REV SERIES CYTOKINE, V118; Biselli PJC, 2011, BRAZ J MED BIOL RES, V44, P460, DOI 10.1590/S0100-879X2011007500040; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; de Lima FM, 2014, J LASERS MED SCI, V5, P63; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; Eduardo CP, 2008, LASERS SURG MED, V40; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Figeac F, 2014, STEM CELLS, V32, P216, DOI 10.1002/stem.1560; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Hizume DC, 2012, RESP PHYSIOL NEUROBI, V181, P167, DOI 10.1016/j.resp.2012.03.005; Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803; Jazedje T, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-46; John G, 2014, CLIN SCI, V126, P207, DOI 10.1042/CS20130117; Jones BJ, 2007, PLACENTA, V28, P1174, DOI 10.1016/j.placenta.2007.07.001; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Kubo H, 2012, STEM CELL TRANSL MED, V1, P627, DOI 10.5966/sctm.2012-0065; Lin F, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-16; Lino-dos-Santos-Franco A, 2010, TOXICOL LETT, V197, P211, DOI 10.1016/j.toxlet.2010.05.022; Longhini-dos-Santos N, 2013, STEM CELL REV REP, V9, P210, DOI 10.1007/s12015-012-9419-y; Morse D, 2014, ANNU REV PHYSIOL, V76, P493, DOI 10.1146/annurev-physiol-021113-170411; Oton-Leite AF, 2013, SPEC CARE DENT, V33, P294, DOI 10.1111/j.1754-4505.2012.00303.x; Park M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08616; Peron JPS, 2012, STEM CELL REV REP, V8, P940, DOI 10.1007/s12015-011-9338-3; Leal ECP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089453; Plass CA, 2012, LASER SURG MED, V44, P705, DOI 10.1002/lsm.22075; Postma DS, 2014, CLIN CHEST MED, V35, P143, DOI 10.1016/j.ccm.2013.09.010; Rastrick JMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054128; Rennard SI, 2004, NEW ENGL J MED, V350, P965, DOI 10.1056/NEJMp048022; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Secco M, 2013, STEM CELL REV REP, V9, P93, DOI 10.1007/s12015-012-9380-9; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Silva RA, 2010, EUR RESPIR J, V35, P994, DOI 10.1183/09031936.00049509; Silva VR, 2014, RESP PHYSIOL NEUROBI, V194, P37, DOI 10.1016/j.resp.2014.01.008; Stessuk Talita, 2013, Rev. Bras. Hematol. Hemoter., V35, P352, DOI 10.5581/1516-8484.20130113; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Weiss DJ, 2014, PLACEBO CONTROLLED R; Wu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-5; Zhang XM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-138; Zucconi E, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/715251	50	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136942	10.1371/journal.pone.0136942	http://dx.doi.org/10.1371/journal.pone.0136942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322981	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500051
J	Barennes, H; Phimmasane, M; Rajaonarivo, C				Barennes, Hubert; Phimmasane, Maniphet; Rajaonarivo, Christian			Insect Consumption to Address Undernutrition, a National Survey on the Prevalence of Insect Consumption among Adults and Vendors in Laos	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; THIAMIN DEFICIENCY; YOUNG-CHILDREN; EDIBLE INSECTS; ENTOMOPHAGY; WOMEN; NUTRITION; VIENTIANE; THAILAND; BERIBERI	Background Insect consumption (entomophagy) is a potentially high nutritious and healthy source of food with high fat, protein, vitamin, fiber and micronutrient content. At least 2 billion people globally eat insects (over 1900 edible species) though this habit is regarded negatively by others. There is a limited amount of data on the perception and consumption of insects. We conducted a national cross-sectional survey in the Lao People's Democratic Republic (Laos) to assess the prevalence and characteristics of insect consumption among adult lay people and insect vendors. Methods We conducted a multi stage randomized national survey in 1303 households in 96 villages in 16 Lao provinces. Three insect vendors or collectors per village were also included. A standardized pretested questionnaire addressed the following issues: socioeconomic characteristics, type of insects consumed and frequency of consumption, reasons and trends in consumption as well as reports on side effects, over the last 10 years. Results A total of 1059 adults (Sex ratio F/M: 1.2, 30 ethnic groups), and 256 vendors were enrolled. A total of 1025 (96.8%) lay people were currently insect consumers, 135 (13.0%) daily or weekly consumers, and 322 (31.1%) consumed several times per month. For the majority (575, 55.6%) the consumption was infrequent (less than a few times per year) and only 22 (2%) had never eaten insects. Consumption started in childhood. Insect availability was seasonal (670, 63.2%) and respondents would have eaten more insects, if they had been more available (919, 86.7%). Hmong and Leu ethnic groups had significantly lower consumption levels than the general population. Eggs of weaver ants, short-tailed crickets, crickets, grasshoppers, and cicadas were the top 5 insects consumed. Consumption had decreased in the last decade, mostly due to less availability (869; 84.0%) and change of life (29; 5.5%). Of 1059, 80 (7.5%) reported allergy problems and 106 (10.0%) reported some use in traditional medicine. A total of 874 (82.6%) were regular collectors. Insect vendors (Sex ratio F/M: 5.3) were also collectors (185; 72.2%). They dedicated a mean time of 4.7 hours during the last harvesting period. The majority sold insects at markets (141, 55.0%). They had earned, on average, USD 6.0 the day before. Five insects (weaver ant eggs; bamboo worms; short-tailed crickets; crickets; wasps) represented 85% of the market. Conclusion Entomophagy is general in Laos, and well accepted despite a decreasing trend in consumption over the last decade. Its contribution to the Lao diet is limited to a minority of frequent consumers. Income through insect sales benefits mostly women. Consumption varies according to ethnicity, residence and season. Development of insect farming is still at an early stage. It could however increase availability of insects and contribute to the generation of income.	[Barennes, Hubert; Phimmasane, Maniphet; Rajaonarivo, Christian] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert] Agence Natl Rech VIH & Hepatites Phnom Penh, Phnom Penh, Cambodia; [Barennes, Hubert] Univ Bordeaux, Ctr INSERM Epidemiol Biostat U897, ISPED, F-33000 Bordeaux, France; [Barennes, Hubert] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr			Institut pour la Francophonie de Medecine Tropicale (Vientiane); Food and Agriculture Organization of the United Nations	Institut pour la Francophonie de Medecine Tropicale (Vientiane); Food and Agriculture Organization of the United Nations	The survey was supported by Institut pour la Francophonie de Medecine Tropicale (Vientiane) and funds from Food and Agriculture Organization of the United Nations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold H., 2013, EDIBLE INSECTS FUTUR, V171, P1; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; Barennes H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003581; Barennes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030634; Barennes H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1379; Berger J, 2013, FOOD NUTR BULL, V34, pS133, DOI 10.1177/15648265130342S115; Christensen DL, 2006, INT J FOOD SCI NUTR, V57, P198, DOI 10.1080/09637480600738252; Coghlan B, 2014, ASIA PAC J CLIN NUTR, V23, P105, DOI 10.6133/apjcn.2014.23.1.16; de Sa J, 2013, MATERN CHILD NUTR, V9, P452, DOI 10.1111/j.1740-8709.2012.00406.x; Department of Statistics-Ministry of Planning and Investment, 2007, LAND COV CHANG QUEEN, P1; Doung-ngern P., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P130; Fontaneto D, 2011, ECOL FOOD NUTR, V50, P351, DOI 10.1080/03670244.2011.586316; Holmes W, 2007, ASIA PAC J CLIN NUTR, V16, P537; Khounnorath S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000969; Knowles J, 2013, BRIT J NUTR, V110, P2285, DOI 10.1017/S000711451300158X; Kounnavong Sengchanh, 2011, Trop Med Health, V39, P95, DOI 10.2149/tmh.2011-13; Kounnavong S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-129; Lensvelt EJS, 2014, ECOL FOOD NUTR, V53, P543, DOI 10.1080/03670244.2013.879865; Mayxay M, 2007, TROP MED INT HEALTH, V12, P363, DOI 10.1111/j.1365-3156.2006.01804.x; Mayxay M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-275; Megido RC, 2016, J SCI FOOD AGR, V96, P627, DOI 10.1002/jsfa.7133; Nadeau L, 2015, ECOL FOOD NUTR, V54, P200, DOI 10.1080/03670244.2014.930032; Perks C, 2006, B WORLD HEALTH ORGAN, V84, P132, DOI 10.2471/BLT.05.025403; Phengxay M, 2007, PEDIATR INT, V49, P260, DOI 10.1111/j.1442-200X.2007.02354.x; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Schweigert FJ, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-17; Shantibala T, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.14; Soukaloun D, 2003, ANN TROP PAEDIATR, V23, P181, DOI 10.1179/027249303322296493; Tracy JM, 2011, MT SINAI J MED, V78, P773, DOI 10.1002/msj.20286; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF, 2015, LAOS SIT CHILDR; United Nations Development Program, 2014, HUM DEV REP 2014; Yhoung-Aree J, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P415; YhoungAree J, 1997, ECOL FOOD NUTR, V36, P133, DOI 10.1080/03670244.1997.9991511	34	31	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136458	10.1371/journal.pone.0136458	http://dx.doi.org/10.1371/journal.pone.0136458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317772	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100087
J	Damos, P; Soulopoulou, P				Damos, Petros; Soulopoulou, Polyxeni			Do Insect Populations Die at Constant Rates as They Become Older? Contrasting Demographic Failure Kinetics with Respect to Temperature According to the Weibull Model	PLOS ONE			English	Article							ANARSIA-LINEATELLA LEPIDOPTERA; DROSOPHILA-MELANOGASTER; LIFE-SPAN; MORTALITY-RATES; AGE; EVOLUTION; RELIABILITY; SURVIVAL; GELECHIIDAE; SENESCENCE	Temperature implies contrasting biological causes of demographic aging in poikilotherms. In this work, we used the reliability theory to describe the consistency of mortality with age in moth populations and to show that differentiation in hazard rates is related to extrinsic environmental causes such as temperature. Moreover, experiments that manipulate extrinsic mortality were used to distinguish temperature-related death rates and the pertinence of the Weibull aging model. The Newton-Raphson optimization method was applied to calculate parameters for small samples of ages at death by estimating the maximum likelihoods surfaces using scored gradient vectors and the Hessian matrix. The study reveals for the first time that the Weibull function is able to describe contrasting biological causes of demographic aging for moth populations maintained at different temperature regimes. We demonstrate that at favourable conditions the insect death rate accelerates as age advances, in contrast to the extreme temperatures in which each individual drifts toward death in a linear fashion and has a constant chance of passing away. Moreover, slope of hazard rates shifts towards a constant initial rate which is a pattern demonstrated by systems which are not wearing out (e.g. non-aging) since the failure, or death, is a random event independent of time. This finding may appear surprising, because, traditionally, it was mostly thought as rule that in aging population force of mortality increases exponentially until all individuals have died. Moreover, in relation to other studies, we have not observed any typical decelerating aging patterns at late life (mortality leveling-off), but rather, accelerated hazard rates at optimum temperatures and a stabilized increase at the extremes. In most cases, the increase in aging-related mortality was simulated reasonably well according to the Weibull survivorship model that is applied. Moreover, semi log- probability hazard rate model illustrations and maximum likelihoods may be usefully in defining periods of mortality leveling off and provide clear evidence that environmental variability may affect parameter estimates and insect population failure rate. From a reliability theory standpoint, failure rates vary according to a linear function of age at the extremes indicating that the life system (i.e., population) is able to eliminate earlier failure and/or to keep later failure rates constant. The applied model was able to identify the major correlates of extended longevity and to suggest new ideas for using demographic concepts in both basic and applied population biology and aging.	[Damos, Petros] Aristotle Univ Thessaloniki, Dept Crop Prod, Fac Agr Forestry & Nat Environm, GR-54006 Thessaloniki, Greece; [Soulopoulou, Polyxeni] Univ Aegean, Dept Environm, Mitilini, Lesvos, Greece	Aristotle University of Thessaloniki; University of Aegean	Damos, P (corresponding author), Aristotle Univ Thessaloniki, Dept Crop Prod, Fac Agr Forestry & Nat Environm, GR-54006 Thessaloniki, Greece.	petrosdamos@gmail.com	Damos, Petros/AAJ-3397-2020	Damos, Petros/0000-0002-4055-0977				Abernethy R.B., 2000, NEW WEIBULL HDB, VFourth; ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Aghdam HR, 2009, ENVIRON ENTOMOL, V38, P885, DOI 10.1603/022.038.0343; Barlow R. E., 1975, STAT THEORY RELIABIL; Bogdanoff JL, 1985, PROBABILISTIC MODELS; BROOKS A, 1994, SCIENCE, V263, P668, DOI 10.1126/science.8303273; BROWN KS, 1974, J GERONTOL, V29, P46, DOI 10.1093/geronj/29.1.46; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Carey JR., 1993, APPL DEMOGRAPHY BIOL; CAREY JR, 2005, LONGEVITY FRAILTY, P1, DOI DOI 10.1007/3-540-27388-3_1; Chi H., 2005, TWOSEX MSCHART COMPU; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; Damos P., 2009, PHYSIOL ENTOMOL, V35, P67; Damos PT, 2008, J ECON ENTOMOL, V101, P1557, DOI 10.1603/0022-0493(2008)101[1557:TBAMOA]2.0.CO;2; Damos P, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.59; Damos P, 2013, J ECON ENTOMOL, V106, P675, DOI 10.1603/EC11327; Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405; Devroye L., 1986, NONUNIFORM RANDOM VA; Duyck PF, 2010, BIOL J LINN SOC, V101, P345, DOI 10.1111/j.1095-8312.2010.01497.x; ECONOMOS AC, 1980, J SOC BIOL STRUCT, V3, P317, DOI 10.1016/0140-1750(80)90039-1; ECONOMOS AC, 1979, AGE, V2, P74, DOI 10.1007/BF02432250; Finch CE, 1990, LONGEVITY SENESCENCE; FUKUI HH, 1993, EXP GERONTOL, V28, P585, DOI 10.1016/0531-5565(93)90048-I; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; Gavrilov LA, 2004, ANN NY ACAD SCI, V1019, P509, DOI 10.1196/annals.1297.094; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Gavrilov LA, 2003, BIOGERONTOLOGY, V34-35, P19; GAVRILOV LA, 2003, SCIENCE, V2003, P1; Gavrilov LA, 2011, N AM ACTUAR J, V15, P432, DOI 10.1080/10920277.2011.10597629; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Haghani Mostafa, 2006, Insect Science, V13, P477, DOI 10.1111/j.1744-7917.2006.00118.x; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Jin KL, 2010, AGING DIS, V1, P72; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lawless J.F, 1982, STAT MODELS METHODS; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; MANN NR, 1970, TECHNOMETRICS, V12, P345, DOI 10.2307/1267239; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; MATLAB, 2012, MATLAB STAT TOOLB RE; Morgan B. J. T., 2008, APPL STOCHASTIC MODE; Mueller L. D., 2011, DOES AGING STOP; Muller HG, 2004, AGING CELL, V3, P125, DOI 10.1111/j.1474-9728.2004.00096.x; Novoseltsev VN, 2011, ADV GERONTOL, V1, P95; Patel JK., 1976, HDB STAT DISTRIBUTIO; Pletcher SD, 1998, EVOLUTION, V52, P454, DOI [10.2307/2411081, 10.1111/j.1558-5646.1998.tb01645.x]; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; R Core Team, 2012, R LANG ENV STAT COMP; Rausand M., 2004, SYSTEM RELIABILITY T; Rauser CL, 2006, AGEING RES REV, V5, P14, DOI 10.1016/j.arr.2005.06.003; Ricklefs RE, 2002, J GERONTOL A-BIOL, V57, pB69, DOI 10.1093/gerona/57.2.B69; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Scholz F., 2008, INFERENCE WEIBULL DI; Shahrestani P, 2012, REJUV RES, V12, P1; Strehler BL, 1978, TIME CELLS AND AGING; THOMAN DR, 1970, TECHNOMETRICS, V12, P363, DOI 10.2307/1267240; Tuljapurkar S., 2008, ASIA PACIFIC J RISK, V3, P37; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Vanfleteren JR, 1998, J GERONTOL A-BIOL, V53, pB393, DOI 10.1093/gerona/53A.6.B393; Vargas RI, 2000, ANN ENTOMOL SOC AM, V93, P75, DOI 10.1603/0013-8746(2000)093[0075:CDOTHF]2.0.CO;2; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Venables WN., 2002, MODERN APPL STAT S 4; Vieira C, 2000, GENETICS, V154, P213; Wang MH, 2004, AGING CELL, V3, P133, DOI 10.1111/j.1474-9728.2004.00098.x; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; [No title captured], DOI DOI 10.1016/B978-012369391-4/50006-0	66	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0127328	10.1371/journal.pone.0127328	http://dx.doi.org/10.1371/journal.pone.0127328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317217	gold, Green Published			2022-12-27	WOS:000360299100002
J	Janik, P; Berdynski, M; Safranow, K; Zekanowski, C				Janik, Piotr; Berdynski, Mariusz; Safranow, Krzysztof; Zekanowski, Cezary			Association of ADORA1 rs2228079 and ADORA2A rs5751876 Polymorphisms with Gilles de la Tourette Syndrome in the Polish Population	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ADENOSINE A(2A); RECEPTOR HETEROMERIZATION; DOPAMINE-D-2; CAFFEINE; RAT; LOCALIZATION; NEUROBIOLOGY; MUTATIONS; TICS	Background Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by motor and vocal tics. Hyperactivity of dopaminergic transmission is considered a prime abnormality in the pathophysiology of tics. There are reciprocal antagonistic interactions between adenosine and dopamine transmission. The aim of the study was to analyze the association of two polymorphisms, rs2228079 in ADORA1 and rs5751876 in ADORA2A, with the risk of GTS and co-morbid disorders. Material and Methods A total of 162 Polish GTS patients and 270 healthy persons were enrolled in the study. Two polymorphisms were selected on the basis of knowledge of SNPs frequencies in ADORA1 and ADORA2A. Chi-square test was used for allelic and genotypic association studies. Association of genotypes with age of tic onset was analyzed with Mann-Whitney test. Multivariate logistic regression was used to find independent predictors of GTS risk. Results We found that the risk of GTS was associated with rs2228079 and rs5751876 polymorphisms. The GG+GT genotypes of rs2228079 in ADORA1 were underrepresented in GTS patients (p = 0.011), whereas T allele of rs5751876 in ADORA2A was overrepresented (p = 0.017). The GG genotype of rs2228079 was associated with earlier age of tic onset (p = 0.046). We found also that the minor allele G of rs2228079 was more frequent in GTS patients with depression as compared to the patients without depression (p = 0.015). Also the genotype GG was significantly more frequent in patients with obsessive compulsive disorder/behavior (OCD/OCB, p = 0.021) and depression (p = 0.032), as compared to the patients without these co-morbidities. The minor allele T frequency of rs5751876 was lower in GTS patients with co-morbid attention deficit hyperactivity disorder (p = 0.022), and TT+TC genotypes were less frequent in the non-OCD anxiety disorder group (p = 0.045). Conclusion ADORA1 and ADORA2A variants are associated with the risk of GTS, co-morbid disorders, and may affect the age of tic onset.	[Janik, Piotr] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Berdynski, Mariusz; Zekanowski, Cezary] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Safranow, Krzysztof] Pomeranian Med Univ, Dept Biochem & Med Chem, Szczecin, Poland	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Pomeranian Medical University	Janik, P (corresponding author), Med Univ Warsaw, Dept Neurol, Warsaw, Poland.	piotr.janik@wum.edu.pl	Janik, Piotr/M-5836-2018; Berdyński, Mariusz/W-2382-2018; Safranow, Krzysztof/B-5127-2015	Janik, Piotr/0000-0002-2701-191X; Berdyński, Mariusz/0000-0003-2076-4318; Safranow, Krzysztof/0000-0001-9415-2758; Zekanowski, Cezary/0000-0001-7332-8494				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alexander GM, 2004, DEV PSYCHOPATHOL, V16, P407, DOI 10.1017/S095457940404458X; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Antoniou K, 2005, PSYCHOPHARMACOLOGY, V183, P154, DOI 10.1007/s00213-005-0173-6; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Berardelli A, 2003, J NEUROL, V250, P781, DOI 10.1007/s00415-003-1102-4; Burd L, 1999, J PERINAT MED, V27, P295, DOI 10.1515/JPM.1999.042; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Cavanna AE, 2013, NEUROSCI BIOBEHAV R, V37, P1008, DOI 10.1016/j.neubiorev.2012.10.011; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Ciruela F, 2011, BBA-BIOMEMBRANES, V1808, P1245, DOI 10.1016/j.bbamem.2011.02.007; Cohen SC, 2013, NEUROSCI BIOBEHAV R, V37, P997, DOI 10.1016/j.neubiorev.2012.11.013; Daly JW, 1998, DRUG ALCOHOL DEPEN, V51, P199, DOI 10.1016/S0376-8716(98)00077-5; de Alvarenga PG, 2012, CNS SPECTRUMS, V17, P87, DOI 10.1017/S1092852912000491; Deng H, 2012, NAT REV NEUROL, V8, P203, DOI 10.1038/nrneurol.2012.26; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; El Yacoubi M, 2003, NEUROPHARMACOLOGY, V45, P977, DOI 10.1016/S0028-3908(03)00254-5; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Ferraro L, 2012, BRAIN RES, V1476, P96, DOI 10.1016/j.brainres.2012.01.032; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Ferre Sergi, 2007, ScientificWorldJournal, V7, P74; Ferre S, 2007, BRAIN RES REV, V55, P55, DOI 10.1016/j.brainresrev.2007.01.007; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P228, DOI 10.1111/j.1600-0773.1995.tb00135.x; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fuxe K, 1998, BRAIN RES REV, V26, P258, DOI 10.1016/S0165-0173(97)00049-0; Hauser RA, 2011, LANCET NEUROL, V10, P221, DOI 10.1016/S1474-4422(11)70012-6; Hettinger BD, 2001, J COMP NEUROL, V431, P331, DOI 10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W; Hoekstra PJ, 2004, CELL MOL LIFE SCI, V61, P886, DOI 10.1007/s00018-003-3320-4; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Kudlacek O, 2003, NEUROPSYCHOPHARMACOL, V28, P1317, DOI 10.1038/sj.npp.1300181; Kull B, 1999, BIOCHEM PHARMACOL, V58, P1035, DOI 10.1016/S0006-2952(99)00184-7; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lebowitz ER, 2012, EUR CHILD ADOLES PSY, V21, P451, DOI 10.1007/s00787-012-0278-5; LECKMAN JF, 1987, ARCH GEN PSYCHIAT, V44, P100; LeWitt PA, 2008, ANN NEUROL, V63, P295, DOI 10.1002/ana.21315; Martino D, 2009, MOVEMENT DISORD, V24, P1267, DOI 10.1002/mds.22504; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Muller-Vahl KR, 2008, ACTA PAEDIATR, V97, P442, DOI 10.1111/j.1651-2227.2008.00675.x; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; O'Rourke JA, 2011, AM J MED GENET B, V156B, P553, DOI 10.1002/ajmg.b.31195; Ochiishi T, 1999, J COMP NEUROL, V411, P301; PALMER TM, 1995, NEUROPHARMACOLOGY, V34, P683, DOI 10.1016/0028-3908(95)00044-7; Paschou P, 2013, INT REV NEUROBIOL, V112, P155, DOI 10.1016/B978-0-12-411546-0.00006-8; Paschou P, 2013, NEUROSCI BIOBEHAV R, V37, P1026, DOI 10.1016/j.neubiorev.2013.01.016; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Robertson Mary M., 2003, P443; Robertson MM, 2006, J PSYCHOSOM RES, V61, P349, DOI 10.1016/j.jpsychores.2006.07.019; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Sebastiao AM, 2000, TRENDS PHARMACOL SCI, V21, P341, DOI 10.1016/S0165-6147(00)01517-0; Shinohara M, 2013, NEUROLOGY, V80, P1571, DOI 10.1212/WNL.0b013e31828f18d8; Singer HS, 2010, MED HYPOTHESES, V74, P862, DOI 10.1016/j.mehy.2009.11.028; State MW, 2011, CURR OPIN GENET DEV, V21, P302, DOI 10.1016/j.gde.2011.01.007; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83	60	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136754	10.1371/journal.pone.0136754	http://dx.doi.org/10.1371/journal.pone.0136754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317759	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100135
J	Kari, JT; Pehkonen, J; Hirvensalo, M; Yang, XL; Hutri-Kahonen, N; Raitakari, OT; Tammelin, TH				Kari, Jaana T.; Pehkonen, Jaakko; Hirvensalo, Mirja; Yang, Xiaolin; Hutri-Kahonen, Nina; Raitakari, Olli T.; Tammelin, Tuija H.			Income and Physical Activity among Adults: Evidence from Self-Reported and Pedometer-Based Physical Activity Measurements	PLOS ONE			English	Article							ECONOMIC COSTS; PARTICIPATION; INACTIVITY; HEALTH; OBESITY; BURDEN; DETERMINANTS; MORTALITY; SPORTS; RISK	This study examined the relationship between income and physical activity by using three measures to illustrate daily physical activity: the self-reported physical activity index for leisure-time physical activity, pedometer-based total steps for overall daily physical activity, and pedometer-based aerobic steps that reflect continuous steps for more than 10 min at a time. The study population consisted of 753 adults from Finland (mean age 41.7 years; 64% women) who participated in 2011 in the follow-up of the ongoing Young Finns study. Ordinary least squares models were used to evaluate the associations between income and physical activity. The consistency of the results was explored by using register-based income information from Statistics Finland, employing the instrumental variable approach, and dividing the pedometer-based physical activity according to weekdays and weekend days. The results indicated that higher income was associated with higher self-reported physical activity for both genders. The results were robust to the inclusion of the control variables and the use of register-based income information. However, the pedometer-based results were gender-specific and depended on the measurement day (weekday vs. weekend day). In more detail, the association was positive for women and negative or non-existing for men. According to the measurement day, among women, income was positively associated with aerobic steps despite the measurement day and with totals steps measured on the weekend. Among men, income was negatively associated with aerobic steps measured on weekdays. The results indicate that there is an association between income and physical activity, but the association is gender-specific and depends on the measurement type of physical activity.	[Kari, Jaana T.; Yang, Xiaolin; Tammelin, Tuija H.] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Kari, Jaana T.; Pehkonen, Jaakko] Univ Jyvaskyla, Sch Business & Econ, Jyvaskyla, Finland; [Hirvensalo, Mirja] Univ Jyvaskyla, Dept Sport Sci, Jyvaskyla, Finland; [Hutri-Kahonen, Nina] Univ Tampere, Dept Pediat, FIN-33101 Tampere, Finland; [Hutri-Kahonen, Nina] Tampere Univ Hosp, Tampere, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland	University of Jyvaskyla; University of Jyvaskyla; Tampere University; Tampere University; Tampere University Hospital; University of Turku; University of Turku	Kari, JT (corresponding author), LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland.	jaana.kari@likes.fi	Raitakari, Olli/AAQ-7389-2021	Kari, Jaana/0000-0001-5205-7031; Pehkonen, Jaakko/0000-0002-9684-7139	Finnish Ministry of Education and Culture; Juho Vainio Foundation; Academy of Finland [134309, 126925, 121584, 124282, 129378, 117797, 41071]; Social Insurance Institution of Finland; Turku University Hospital Medical Fund; Sigrid Juselius Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Kuopio University Hospital Medical Fund; Tampere University Hospital Medical Fund	Finnish Ministry of Education and Culture; Juho Vainio Foundation; Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Turku University Hospital Medical Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Kuopio University Hospital Medical Fund; Tampere University Hospital Medical Fund	This study was funded by the Finnish Ministry of Education and Culture and the Juho Vainio Foundation, The Young Finns Study has been financially supported by the Academy of Finland: grants 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117797 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds, Juho Vainio Foundation, Sigrid Juselius Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrave D, 2015, J EPIDEMIOL COMMUN H, V69, P738, DOI 10.1136/jech-2014-205230; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 1996, JAMA, V276, P241; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Brown H, 2011, SOC SCI MED, V73, P383, DOI 10.1016/j.socscimed.2011.06.001; CAULEY JA, 1991, MED SCI SPORT EXER, V23, P343; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Eberth B, 2010, ECON MODEL, V27, P822, DOI 10.1016/j.econmod.2009.10.003; EU. Special Eurobarometer 412, 2014, SPEC EUR, V412, P1, DOI [10.2766/73002, DOI 10.2766/73002]; Ewing BT, 1998, ECON LETT, V59, P113, DOI 10.1016/S0165-1765(98)00006-8; Farrell L, 2002, J ROY STAT SOC A STA, V165, P335, DOI 10.1111/1467-985X.00626; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Helldan A, 2013, HLTH BEHAV HLTH FINN; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hirvensalo M, 2011, SCAND J PUBLIC HEALT, V39, P669, DOI 10.1177/1403494811420324; Humphreys BR, 2006, 0613 INT ASS SPORT E; Humphreys BR, 2007, CONTEMP ECON POLICY, V25, P538, DOI 10.1111/j.1465-7287.2007.00079.x; Humphreys BR, 2011, BE J ECON ANAL POLI, V11, DOI 10.2202/1935-1682.2522; Hyytinen A, 2013, SOC SCI MED, V96, P129, DOI 10.1016/j.socscimed.2013.07.019; Katzmarzyk PT, 2000, CAN MED ASSOC J, V163, P1435; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kosteas VD, 2012, J LABOR RES, V33, P225, DOI 10.1007/s12122-011-9129-2; Kuehnle D, 2014, J HEALTH ECON, V36, P137, DOI 10.1016/j.jhealeco.2014.03.011; Laaksonen M, 2003, J EPIDEMIOL COMMUN H, V57, P711, DOI 10.1136/jech.57.9.711; Lechner M, 2009, J HEALTH ECON, V28, P839, DOI 10.1016/j.jhealeco.2009.05.003; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leisure Gronau R., 1977, J POLITICAL EC, V85, P1099, DOI [10.3386/w0137, DOI 10.3386/W0137]; LONG JE, 1991, REV ECON STAT, V73, P525, DOI 10.2307/2109580; MCCONNELL KE, 1992, AM J AGR ECON, V74, P918, DOI 10.2307/1243189; Meltzer DO, 2010, J HEALTH ECON, V29, P347, DOI 10.1016/j.jhealeco.2010.03.005; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Ridder G, 2007, HBK ECON, V2, P5469, DOI 10.1016/S1573-4412(07)06075-8; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Sebastiao E, 2012, PUBLIC HEALTH, V126, P967, DOI 10.1016/j.puhe.2012.07.004; Stevenson B, 2010, REV ECON STAT, V92, P284, DOI 10.1162/rest.2010.11623; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Sluijs EMF, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-53; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	48	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135651	10.1371/journal.pone.0135651	http://dx.doi.org/10.1371/journal.pone.0135651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317865	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100040
J	Kim, S; Jung, J; Jung, JH; Kim, SK; Kim, RB; Hahm, JR				Kim, Sungsu; Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Kim, Rock-Bum; Hahm, Jong Ryeal			Risk Factors of Bone Mass Loss at the Lumbar Spine: A Longitudinal Study in Healthy Korean Pre- and Perimenopausal Women Older than 40 Years	PLOS ONE			English	Article							MINERAL DENSITY; POSTMENOPAUSAL WOMEN; OSTEOPOROTIC FRACTURES; URIC-ACID; FAT MASS; BODY-COMPOSITION; LIPID PROFILE; SERUM-LIPIDS; MEN; ASSOCIATION	Longitudinal studies on bone mass decline for healthy women are sparse. We performed a retrospective longitudinal study to evaluate the factor associated with bone mass changes at the lumbar spine in healthy Korean pre- and perimenopausal women over the age of 40. We examined the relation of blood tests including thyroid function tests at baseline and follow-up to the annual percentage changes in average BMD of L2-L4 (A%Delta LSBMD). Four hundred and forty-three subjects without diseases or medications pertaining to bone metabolism were analyzed. The mean A%Delta LSBMD in these subjects was -0.45%/ year. Though a significant correlation was observed between the A%Delta LSBMD and age, serum thyroid-stimulating hormone (TSH) level, total cholesterol (TC) level, low-density lipoprotein cholesterol (LDL-C) level, and estimated glomerular filtration rate (eGFR) at baseline and follow-up, there was a weak correlation between A%Delta LSBMD and these variables. From multiple linear regression analyses, the percent body fat, age, serum TSH level, serum uric acid level, and the menopause at follow-up were showed to have a significant association with the A%Delta LSBMD. Unlike age, percent body fat, and menopause at follow-up, which had a negative association with the A%Delta LSBMD, serum TSH level and serum uric acid level, had a positive association with the A%Delta LSBMD. The results from our study showed that the notable risk factors of BMD loss at the lumbar spine in population of our study were advancing age, menopause, higher percent body fat, lower normal TSH, and lower serum uric acid levels.	[Kim, Sungsu; Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol, Jinju, South Korea; [Kim, Sungsu; Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeonsang Natl Univ Hosp, Jinju, South Korea; [Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea; [Kim, Rock-Bum] Dong A Univ, Ctr Environm Hlth, Busan, South Korea	Gyeongsang National University; Gyeongsang National University; Dong A University	Kim, SK (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol, Jinju, South Korea.	9854008@naver.com; jrhahm@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology [NRF-2012-0000305, 2012R1A1A4A01015109]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education Science and Technology (NRF-2012-0000305) (2012R1A1A4A01015109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Bauer DC, 1997, J CLIN ENDOCR METAB, V82, P2931, DOI 10.1210/jc.82.9.2931; Brownbill RA, 2006, J WOMENS HEALTH, V15, P261, DOI 10.1089/jwh.2006.15.261; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; COMPSTON JE, 1992, CLIN ENDOCRINOL, V37, P426, DOI 10.1111/j.1365-2265.1992.tb02354.x; Cui LH, 2005, OSTEOPOROSIS INT, V16, P1975, DOI 10.1007/s00198-005-1977-2; Dennison EM, 2007, QJM-INT J MED, V100, P297, DOI 10.1093/qjmed/hcm023; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Grimnes G, 2008, THYROID, V18, P1147, DOI 10.1089/thy.2008.0158; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jeong IK, 2010, CALCIFIED TISSUE INT, V87, P507, DOI 10.1007/s00223-010-9427-3; JONES G, 1994, BRIT MED J, V309, P691, DOI 10.1136/bmj.309.6956.691; Kim DJ, 2006, CLIN ENDOCRINOL, V64, P86, DOI 10.1111/j.1365-2265.2005.02422.x; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Lee EY, 2012, J CLIN ENDOCR METAB, V97, P3310, DOI 10.1210/jc.2012-1488; Lin JD, 2011, ENDOCR RES, V36, P1, DOI 10.3109/07435800.2010.514877; Makovey J, 2013, BONE, V52, P400, DOI 10.1016/j.bone.2012.10.025; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Morin S, 2009, OSTEOPOROSIS INT, V20, P363, DOI 10.1007/s00198-008-0688-x; Morris MS, 2007, BONE, V40, P1128, DOI 10.1016/j.bone.2006.12.001; Nabipour I, 2011, J BONE MINER RES, V26, P955, DOI 10.1002/jbmr.286; Namwongprom S, 2013, INT J WOMENS HEALTH, V5, P87, DOI 10.2147/IJWH.S41884; POUILLES JM, 1993, CALCIFIED TISSUE INT, V52, P340, DOI 10.1007/BF00310195; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; Sheu Yahtyng, 2011, Curr Osteoporos Rep, V9, P67, DOI 10.1007/s11914-011-0051-6; Sugiura M, 2008, OSTEOPOROSIS INT, V19, P211, DOI 10.1007/s00198-007-0457-2; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211	37	13	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136283	10.1371/journal.pone.0136283	http://dx.doi.org/10.1371/journal.pone.0136283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317525	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100069
J	Yamada, Y; Eto, M; Ito, Y; Mochizuki, S; Son, BK; Ogawa, S; Iijima, K; Kaneki, M; Kozaki, K; Toba, K; Akishita, M; Ouchi, Y				Yamada, Yoko; Eto, Masato; Ito, Yuki; Mochizuki, Satoru; Son, Bo-Kyung; Ogawa, Sumito; Iijima, Katsuya; Kaneki, Masao; Kozaki, Koichi; Toba, Kenji; Akishita, Masahiro; Ouchi, Yasuyoshi			Suppressive Role of PPAR gamma-Regulated Endothelial Nitric Oxide Synthase in Adipocyte Lipolysis	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; S-NITROSYLATION; DISEASE; EXPRESSION; OBESITY; GENE; MICE; DIET; STEATOHEPATITIS	Introduction Metabolic syndrome causes insulin resistance and is associated with risk factor clustering, thereby increasing the risk of atherosclerosis. Recently, endothelial nitric oxide synthase deficient (eNOS-/-) mice have been reported to show metabolic disorders. Interestingly, eNOS has also been reported to be expressed in non-endothelial cells including adipocytes, but the functions of eNOS in adipocytes remain unclear. Methods and Results The eNOS expression was induced with adipocyte differentiation and inhibition of eNOS/NO enhanced lipolysis in vitro and in vivo. Furthermore, the administration of a high fat diet (HFD) was able to induce non-alcoholic steatohepatitis (NASH) in eNOS-/- mice but not in wild type mice. A PPAR. antagonist increased eNOS expression in adipocytes and suppressed HFD-induced fatty liver changes. Conclusions eNOS-/- mice induce NASH development, and these findings provide new insights into the therapeutic approach for fatty liver disease and related disorders.	[Yamada, Yoko; Eto, Masato; Ito, Yuki; Mochizuki, Satoru; Son, Bo-Kyung; Ogawa, Sumito; Iijima, Katsuya; Akishita, Masahiro; Ouchi, Yasuyoshi] Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Tokyo, Japan; [Kaneki, Masao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med,Shriners Hos, Boston, MA USA; [Kozaki, Koichi; Toba, Kenji] Kyorin Univ, Sch Med, Dept Geriatr Med, Tokyo, Japan	University of Tokyo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Kyorin University	Eto, M (corresponding author), Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Tokyo, Japan.	meto-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (to M.E.) and by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (to Y.Y.).	Arendt BM, 2009, J NUTR, V139, P691, DOI 10.3945/jn.108.101782; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; DAY CP, 1994, BBA-LIPID LIPID MET, V1215, P33, DOI 10.1016/0005-2760(94)90089-2; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lowenstein CJ, 2006, J CLIN INVEST, V116, P2075, DOI 10.1172/JCI29406; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Malinowski JM, 2000, CLIN THER, V22, P1151, DOI 10.1016/S0149-2918(00)83060-X; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Peter A, 2011, AM J PHYSIOL-ENDOC M, V300, pE321, DOI 10.1152/ajpendo.00306.2010; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; TERAMOTO K, 1993, TRANSPLANTATION, V55, P737, DOI 10.1097/00007890-199304000-00010; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	36	6	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136597	10.1371/journal.pone.0136597	http://dx.doi.org/10.1371/journal.pone.0136597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317347	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100107
J	Yoshida, H; Imamura, T; Saito, AM; Takahashi, Y; Suenobu, S; Hasegawa, D; Deguchi, T; Hashii, Y; Kawasaki, H; Endo, M; Hori, H; Suzuki, N; Kosaka, Y; Kato, K; Yumura-Yagi, K; Hara, J; Oda, M; Sato, A; Horibe, K				Yoshida, Hideki; Imamura, Toshihiko; Saito, Akiko M.; Takahashi, Yoshihiro; Suenobu, So-ichi; Hasegawa, Daiichiro; Deguchi, Takao; Hashii, Yoshiko; Kawasaki, Hirohide; Endo, Mikiya; Hori, Hiroki; Suzuki, Nobuhiro; Kosaka, Yoshiyuki; Kato, Koji; Yumura-Yagi, Keiko; Hara, Junichi; Oda, Megumi; Sato, Atsushi; Horibe, Keizo		Japan Assoc Childhood Leukemia	Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							DIABETIC-KETOACIDOSIS; INSULIN-RESISTANCE; CHILDREN; ADOLESCENTS; THERAPY; REMISSION; CONSENSUS	Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether the profile of this adverse event is affected by intensification of L-asparaginase administration. Here, we analyzed the profile of L-asparaginase related hyperglycemia in a 1,176 patients with pediatric acute lymphoblastic leukemia treated according to the Japan Association of Childhood Leukemia Study ALL-02 protocol using protracted L-asparaginase administration in maintenance phase. We determined that a total of 75 L-asparaginase related hyperglycemia events occurred in 69 patients. Although 17 events (17/1176, 1.4%) developed in induction phase, which was lower incidence than those (10-15%) in previous reports, 45 events developed during the maintenance phase with protracted L-asparaginase administration. Multivariate analysis showed that older age at onset (>= 10 years) was a sole independent risk factor for L-asparaginase-related hyperglycemia (P<0.01), especially in maintenance phase. Contrary to the previous reports, obesity was not associated with L-asparaginase-related hyperglycemia. These findings suggest that protracted administration of L-asparaginase is the risk factor for hyperglycemia when treating adolescent and young adult acute lymphoblastic leukemia patients.	[Yoshida, Hideki; Imamura, Toshihiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Saito, Akiko M.; Horibe, Keizo] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Takahashi, Yoshihiro] Aomori Prefectural Cent Hosp, Dept Pediat, Aomori, Japan; [Suenobu, So-ichi] Oita Univ, Dept Pediat, Div Gen Pediat & Emergency Med, Oita 87011, Japan; [Hasegawa, Daiichiro; Kosaka, Yoshiyuki] Hyogo Prefectural Childrens Hosp, Dept Hematol Oncol, Kobe, Hyogo, Japan; [Deguchi, Takao; Hori, Hiroki] Mie Univ, Dept Pediat, Tsu, Mie 514, Japan; [Hashii, Yoshiko] Osaka Univ, Dept Pediat, Suita, Osaka, Japan; [Kawasaki, Hirohide] Kansai Med Univ, Dept Pediat, Hirakata, Osaka, Japan; [Endo, Mikiya] Iwate Med Univ, Dept Pediat, Morioka, Iwate 020, Japan; [Suzuki, Nobuhiro] Hokkaido Med Ctr Child Hlth & Rehabil Sapporo, Dept Pediat, Sapporo, Hokkaido, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol Oncol, Nagoya, Aichi, Japan; [Yumura-Yagi, Keiko] Yumura Clin, Osaka, Japan; [Hara, Junichi] Osaka City Gen Hosp, Dept Pediat Hematol Oncol, Osaka, Japan; [Oda, Megumi] Okayama Univ, Dept Pediat, Okayama, Japan; [Sato, Atsushi] Miyagi Childrens Hosp, Dept Pediat Hematol Oncol, Sendai, Miyagi, Japan	Kyoto Prefectural University of Medicine; Nagoya Medical Center; Oita University; Mie University; Osaka University; Kansai Medical University; Iwate Medical University; Red Cross Nagoya Daiichi Hospital; Osaka City General Hospital; Okayama University	Imamura, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan.	imamura@koto.kpu-m.ac.jp		Hasegawa, Daiichiro/0000-0003-2245-6554; Deguchi, Takao/0000-0001-9932-4299				Barry E, 2007, J CLIN ONCOL, V25, P813, DOI 10.1200/JCO.2006.08.6397; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; Bhojwani D, 2014, EUR J CANCER, V50, P2685, DOI 10.1016/j.ejca.2014.06.023; Boissel N, 2003, J CLIN ONCOL, V21, P774, DOI 10.1200/JCO.2003.02.053; Caruso V, 2006, BLOOD, V108, P2216, DOI 10.1182/blood-2006-04-015511; Dunger DB, 2004, ARCH DIS CHILD, V89, P188, DOI 10.1136/adc.2003.044875; Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444; Hasegawa D, 2011, ASH ANN M, V118, P1506; HILL JM, 1967, J AMER MED ASSOC, V202, P882, DOI 10.1001/jama.202.9.882; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Kearney SL, 2009, PEDIATR BLOOD CANCER, V53, P162, DOI 10.1002/pbc.22076; LAND VJ, 1972, CANCER, V30, P339, DOI 10.1002/1097-0142(197208)30:2<339::AID-CNCR2820300206>3.0.CO;2-P; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Loeb E, 1970, Recent Results Cancer Res, V33, P204; Lowas SR, 2009, PEDIATR BLOOD CANCER, V52, P814, DOI 10.1002/pbc.21980; Nachman JB, 2009, J CLIN ONCOL, V27, P5189, DOI 10.1200/JCO.2008.20.8959; PUI CH, 1981, J PEDIATR-US, V99, P46, DOI 10.1016/S0022-3476(81)80955-9; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Ramanujachar R, 2006, PEDIATR BLOOD CANCER, V47, P748, DOI 10.1002/pbc.20776; RAO SP, 1986, AM J PEDIAT HEMATOL, V8, P83; Ratei R, 2009, LEUKEMIA, V23, P528, DOI 10.1038/leu.2008.324; Roberson JR, 2008, PEDIATR BLOOD CANCER, V50, P1207, DOI 10.1002/pbc.21505; Sonabend RY, 2009, J PEDIATR-US, V155, P73, DOI 10.1016/j.jpeds.2009.01.072; Suzuki N, 2010, PEDIATR BLOOD CANCER, V54, P71, DOI 10.1002/pbc.22217; TURNER GR, 1983, CLIN PEDIATR, V22, P363, DOI 10.1177/000992288302200507; Vrooman LM, 2010, PEDIATR BLOOD CANCER, V54, P199, DOI 10.1002/pbc.22225; Wood WA, 2011, BLOOD, V117, P5803, DOI 10.1182/blood-2010-12-283093; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136428	10.1371/journal.pone.0136428	http://dx.doi.org/10.1371/journal.pone.0136428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317422	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100084
J	Zhao, JX; Wang, B; You, GX; Wang, Y; Chen, G; Wang, Q; Zhang, XG; Zhao, L; Zhou, H; He, YZ				Zhao, Jing-xiang; Wang, Bo; You, Guo-xing; Wang, Ying; Chen, Gan; Wang, Quan; Zhang, Xi-gang; Zhao, Lian; Zhou, Hong; He, Yue-zhong			Hypertonic Saline Dextran Ameliorates Organ Damage in Beagle Hemorrhagic Shock	PLOS ONE			English	Article							ADHESION MOLECULE-1 EXPRESSION; CARBON-DIOXIDE DIFFERENCE; FLUID RESUSCITATION; 6-PERCENT DEXTRAN-70; 7.5-PERCENT NACL; TRAUMA PATIENTS; EFFICACY; NEUTROPHIL; SALINE/DEXTRAN; HYPOTENSION	Objective The goal of this study was to investigate the effect of hypertonic saline with 6% Dextran-70 (HSD) resuscitation on organ damage and the resuscitation efficiency of the combination of HSD and lactated ringers (LR) in a model of hemorrhage shock in dogs. Methods Beagles were bled to hold their mean arterial pressure (MAP) at 50 +/- 5 mmHg for 1 h. After hemorrhage, beagles were divided into three groups (n = 7) to receive pre-hospital resuscitation for 1 h (R1): HSD (4 ml/kg), LR (40 ml/kg), and HSD+LR (a combination of 4 ml/kg HSD and 40 ml/kg LR). Next, LR was transfused into all groups as in-hospital resuscitation (R2). After two hours of observation (R3), autologous blood was transfused. Hemodynamic responses and systemic oxygenation were measured at predetermined phases. Three days after resuscitation, the animals were sacrificed and tissues including kidney, lung, liver and intestinal were obtained for pathological analysis. Results Although the initial resuscitation with HSD was shown to be faster than LR with regard to an ascending MAP, the HSD group showed a similar hemodynamic performance compared to the LR group throughout the experiment. Compared with the LR group, the systemic oxygenation performance in the HSD group was similar but showed a lower venous-to-arterial CO2 gradient (Pv-aCO(2)) at R3 (p < 0.05). Additionally, the histology score of the kidneys, lungs and liver were significantly lower in the HSD group than in the LR group (p < 0.05). The HSD+LR group showed a superior hemodynamic response but higher extravascular lung water (EVLW) and lower arterial oxygen tension (PaO2) than the other groups (p < 0.05). The HSD+LR group showed a marginally improved systemic oxygenation performance and lower histology score than other groups. Conclusions Resuscitation after hemorrhagic shock with a bolus of HSD showed a similar hemodynamic response compared with LR at ten times the volume of HSD, but HSD showed superior efficacy in organ protection. Our findings suggest that resuscitation with the combination of HSD and LR in the pre-hospital setting is an effective treatment.	[Zhao, Jing-xiang; Wang, Bo; You, Guo-xing; Wang, Ying; Chen, Gan; Wang, Quan; Zhao, Lian; Zhou, Hong] Acad Mil Med Sci, Inst Transfus Med, Beijing, Peoples R China; [Zhang, Xi-gang] Chinese Peoples Liberat Army 307 Hosp, Emergency Dept, Beijing, Peoples R China; [He, Yue-zhong] Acad Mil Med Sci, Sci & Technol Dept, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Zhao, L (corresponding author), Acad Mil Med Sci, Inst Transfus Med, 27th Taiping Rd, Beijing, Peoples R China.	zhaolian@bmi.ac.cn; zhouhtt1966@163.com; yzhe751@163.com	Chen, Gan/O-8508-2019; zhao, jing/B-3868-2019	Chen, Gan/0000-0003-4586-4526; 	Capital Health Project of Beijing Science and Technology Commission [Z121100005312014]; National High Technology Research and Development Program of China [2012AA021902]	Capital Health Project of Beijing Science and Technology Commission; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from Capital Health Project of Beijing Science and Technology Commission (Z121100005312014) and the National High Technology Research and Development Program of China (No. 2012AA021902).	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alam HB, 2000, J SURG RES, V94, P145, DOI 10.1006/jsre.2000.6011; Alam HB, 2001, J AM COLL SURGEONS, V193, P255, DOI 10.1016/S1072-7515(01)01004-3; [Anonymous], 2013, UK AMB SERV CLIN PRA; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Banerjee A, 2013, SHOCK, V39, P366, DOI 10.1097/SHK.0b013e3182894016; BEHRMAN SW, 1991, J TRAUMA, V31, P589, DOI 10.1097/00005373-199105000-00001; BICKELL WH, 1992, ANN EMERG MED, V21, P1077, DOI 10.1016/S0196-0644(05)80648-1; Boldt J, 2006, SHOCK, V25, P103, DOI 10.1097/01.shk.0000189595.35661.40; Boldt J, 2010, INTENS CARE MED, V36, P1299, DOI 10.1007/s00134-010-1912-7; Bruscagin V, 2002, J TRAUMA, V52, P1147, DOI 10.1097/00005373-200206000-00021; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cabrales P, 2007, SHOCK, V27, P380, DOI 10.1097/01.shk.0000239782.71516.ba; Cuschieri J, 2005, INTENS CARE MED, V31, P818, DOI 10.1007/s00134-005-2602-8; De Backer D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-27; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Dubick MA, 2006, SHOCK, V25, P321, DOI 10.1097/01.shk.0000209525.50990.28; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Elgjo GI, 2000, CRIT CARE MED, V28, P163, DOI 10.1097/00003246-200001000-00027; HANNON JP, 1989, CIRC SHOCK, V29, P205; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Kerger H, 1999, AM J PHYSIOL-HEART C, V276, pH2035, DOI 10.1152/ajpheart.1999.276.6.H2035; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MAZZONI MC, 1990, CIRC SHOCK, V31, P407; Monnet X, 2007, INTENS CARE MED, V33, P448, DOI 10.1007/s00134-006-0498-6; Monnet X, 2013, CRIT CARE MED, V41, P1412, DOI 10.1097/CCM.0b013e318275cece; Orso CO, 1999, J TRAUMA, V46, P417; Parlakpinar H, 2007, INT J UROL, V14, P743, DOI 10.1111/j.1442-2042.2007.01806.x; PRIST R, 1992, CIRC SHOCK, V36, P13; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Riddez L, 2001, MIL MED, V166, P695, DOI 10.1093/milmed/166.8.695; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; SONDEEN JL, 1990, RESUSCITATION, V20, P231, DOI 10.1016/0300-9572(90)90006-Z; Stapley SA, 2002, SHOCK, V17, P146, DOI 10.1097/00024382-200202000-00011; Sun LL, 1999, SHOCK, V11, P416; Tollofsrud S, 1998, ACTA ANAESTH SCAND, V42, P145, DOI 10.1111/j.1399-6576.1998.tb05100.x; Vallee F, 2008, INTENS CARE MED, V34, P2218, DOI 10.1007/s00134-008-1199-0; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Wade CE, 1996, CLIN CHEM, V42, P779; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; Wade CE, 2003, J TRAUMA, V55, P413, DOI 10.1097/01.TA.0000057247.02378.5E; WADE CE, 1989, CIRC SHOCK, V29, P193; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yang DJ, 2014, EUR REV MED PHARMACO, V18, P3069; ZHANG HB, 1993, AM REV RESPIR DIS, V148, P867, DOI 10.1164/ajrccm/148.4_Pt_1.867; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao L, 2009, RESUSCITATION, V80, P253, DOI 10.1016/j.resuscitation.2008.10.014	53	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136012	10.1371/journal.pone.0136012	http://dx.doi.org/10.1371/journal.pone.0136012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317867	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100056
J	Baron-Cohen, S; Bowen, DC; Holt, RJ; Allison, C; Auyeung, B; Lombardo, MV; Smith, P; Lai, MC				Baron-Cohen, Simon; Bowen, Daniel C.; Holt, Rosemary J.; Allison, Carrie; Auyeung, Bonnie; Lombardo, Michael V.; Smith, Paula; Lai, Meng-Chuan			The "Reading the Mind in the Eyes" Test: Complete Absence of Typical Sex Difference in similar to 400 Men and Women with Autism	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; FETAL TESTOSTERONE; NORMAL ADULTS; EMOTION RECOGNITION; SOCIAL COGNITION; EMPATHY QUOTIENT; BRAIN; IMPAIRMENTS; CHILDREN	The "Reading the Mind in the Eyes" test (Eyes test) is an advanced test of theory of mind. Typical sex difference has been reported (i.e., female advantage). Individuals with autism show more difficulty than do typically developing individuals, yet it remains unclear how this is modulated by sex, as females with autism have been under-represented. Here in a large, non-male-biased sample we test for the effects of sex, diagnosis, and their interaction. The Eyes test (revised version) was administered online to 395 adults with autism (178 males, 217 females) and 320 control adults (152 males, 168 females). Two-way ANOVA showed a significant sex-by-diagnosis interaction in total correct score (F(1,711) = 5.090, p = 0.024, eta(2)(p) = 0.007) arising from a significant sex difference between control males and females (p < 0.001, Cohen's d = 0.47), and an absence of a sex difference between males and females with autism (p = 0.907, d = 0.01); significant case-control differences were observed across sexes, with effect sizes of d = 0.35 in males and d = 0.69 in females. Group-difference patterns fit with the extreme-male-brain (EMB) theory predictions. Eyes test-Empathy Quotient and Eyes test-Autism Spectrum Quotient correlations were significant only in females with autism (r = 0.35, r = -0.32, respectively), but not in the other 3 groups. Support vector machine (SVM) classification based on response pattern across all 36 items classified autism diagnosis with a relatively higher accuracy for females (72.2%) than males (65.8%). Nevertheless, an SVM model trained within one sex generalized equally well when applied to the other sex. Performance on the Eyes test is a sex-independent phenotypic characteristic of adults with autism, reflecting sex-common social difficulties, and provides support for the EMB theory predictions for both males and females. Performance of females with autism differed from same-sex controls more than did that of males with autism. Females with autism also showed stronger coherence between self-reported dispositional traits and Eyes test performance than all other groups.	[Baron-Cohen, Simon; Bowen, Daniel C.; Holt, Rosemary J.; Allison, Carrie; Auyeung, Bonnie; Lombardo, Michael V.; Smith, Paula; Lai, Meng-Chuan] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Baron-Cohen, Simon; Lai, Meng-Chuan] Cambridgeshire & Peterborough NHS Fdn Trust, CLASS Clin, Cambridge, England; [Auyeung, Bonnie] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Lombardo, Michael V.] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Lombardo, Michael V.] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus; [Lai, Meng-Chuan] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lai, Meng-Chuan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Lai, Meng-Chuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Lai, Meng-Chuan] Coll Med, Taipei, Taiwan	University of Cambridge; University of Edinburgh; University of Cyprus; University of Cyprus; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; National Taiwan University; National Taiwan University Hospital	Baron-Cohen, S (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	sb205@cam.ac.uk; mcl45@cam.ac.uk	Lombardo, Michael V/J-1773-2012; Lai, Meng-Chuan/K-7407-2016	Lombardo, Michael V/0000-0001-6780-8619; Lai, Meng-Chuan/0000-0002-9593-5508; Baron-Cohen, Simon/0000-0001-9217-2544	UK Medical Research Council [G0600977]; Wellcome Trust [091774/Z/10/Z]; Autism Research Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England (CLAHRC-EoE); William Binks Autism Neuroscience Fellowship; Medical Research Council [G0600977] Funding Source: researchfish; MRC [G0600977] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Autism Research Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England (CLAHRC-EoE); William Binks Autism Neuroscience Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by grants from the UK Medical Research Council (G0600977, http://www.mrc.ac.uk/), the Wellcome Trust (091774/Z/10/Z, http://www.wellcome.ac.uk/), and the Autism Research Trust (http://autismresearchtrust.org/) to SB-C. The research was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England (CLAHRC-EoE). M-CL was supported by the William Binks Autism Neuroscience Fellowship during the period of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baker CA, 2014, INTELLIGENCE, V44, P78, DOI 10.1016/j.intell.2014.03.001; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 1992, MIND LANG, V7, P172, DOI DOI 10.1111/J.1468-0017.1992.TB00203.X; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S., 2013, UNDERSTANDING OTHER; Baron-Cohen S., 2011, ZERO DEGREES EMPATHY; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; BaronCohen S, 1997, CHILD DEV, V68, P48; BARONCOHEN S, 1987, BRIT J DEV PSYCHOL, V5, P139, DOI 10.1111/j.2044-835X.1987.tb01049.x; BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; BaronCohen S, 1997, J COGNITIVE NEUROSCI, V9, P548, DOI 10.1162/jocn.1997.9.4.548; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1989, BRIT J DEV PSYCHOL, V7, P113, DOI 10.1111/j.2044-835X.1989.tb00793.x; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; BARONCOHEN S, 2006, ARCH DIS CHILD, V91, P2, DOI DOI 10.1136/ADC.2005.075846; BARONCOHEN S, 1996, BRIT J PSYCHIAT, V168, P158, DOI DOI 10.1192/BJP.168.2.158; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Beacher FDCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038355; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Blair RJR, 1997, PSYCHOPHYSIOLOGY, V34, P192; Boucher J, 2012, AUTISM, V16, P226, DOI 10.1177/1362361311430403; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cacciotti-Saija C, 2015, SCHIZOPHRENIA BULL, V41, P483, DOI 10.1093/schbul/sbu094; Carlin JD, 2013, CURR OPIN NEUROBIOL, V23, P450, DOI 10.1016/j.conb.2012.11.014; Cassidy S, 2014, LANCET PSYCHIAT, V1, P142, DOI 10.1016/S2215-0366(14)70248-2; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Chawarska K, 2014, J AM ACAD CHILD PSY, V53, P1317, DOI 10.1016/j.jaac.2014.09.015; Dal Monte O, 2014, CORTEX, V58, P9, DOI 10.1016/j.cortex.2014.05.002; Daniels AM, 2012, J AUTISM DEV DISORD, V42, P257, DOI 10.1007/s10803-011-1236-7; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; Decety J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00489; Decety J, 2013, JAMA PSYCHIAT, V70, P638, DOI 10.1001/jamapsychiatry.2013.27; Dehning S, 2014, PATIENT EDUC COUNS, V95, P259, DOI 10.1016/j.pec.2014.01.013; Dorris L, 2004, J CHILD PSYCHOL PSYC, V45, P412, DOI 10.1111/j.1469-7610.2004.00232.x; EISENBERG L, 1956, AM J ORTHOPSYCHIAT, V26, P556, DOI 10.1111/j.1939-0025.1956.tb06202.x; Elsabbagh M, 2013, BEHAV BRAIN RES, V251, P147, DOI 10.1016/j.bbr.2012.07.030; Fernandez-Abascal EG, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-33; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Frick C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041650; FRITH U, 1991, TRENDS NEUROSCI, V14, P433, DOI 10.1016/0166-2236(91)90041-R; Frith U, 2012, Q J EXP PSYCHOL, V65, P2073, DOI 10.1080/17470218.2012.697178; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Gomez J., 1991, NATURAL THEORIES MIN, P195; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Hezel DM, 2014, BEHAV THER, V45, P530, DOI 10.1016/j.beth.2014.02.010; Holt RJ, 2014, PSYCHOL MED, V44, P3215, DOI 10.1017/S0033291714000233; Hysek CM, 2012, PSYCHOPHARMACOLOGY, V222, P293, DOI 10.1007/s00213-012-2645-9; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Knickmeyer RC, 2008, J AUTISM DEV DISORD, V38, P1028, DOI 10.1007/s10803-007-0475-0; Koizumi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086093; Kreiser NL, 2014, CLIN CHILD FAM PSYCH, V17, P67, DOI 10.1007/s10567-013-0148-9; Lai MC, 2015, J AM ACAD CHILD PSY, V54, P11, DOI 10.1016/j.jaac.2014.10.003; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lai MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047198; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Lombardo MV, 2011, CONSCIOUS COGN, V20, P130, DOI 10.1016/j.concog.2010.09.006; Losh M, 2009, ARCH GEN PSYCHIAT, V66, P518, DOI 10.1001/archgenpsychiatry.2009.34; Lugnegard T, 2013, SCHIZOPHR RES, V143, P277, DOI 10.1016/j.schres.2012.12.001; Mazza M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00791; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Oldershaw A, 2011, EUR EAT DISORD REV, V19, P462, DOI 10.1002/erv.1069; Overgaauw S, 2015, SOC COGN AFFECT NEUR, V10, P619, DOI 10.1093/scan/nsu095; Peterson E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00220; Piven J, 1997, AM J PSYCHIAT, V154, P185; Prevost M, 2014, COGN NEUROPSYCHIATRY, V19, P189, DOI 10.1080/13546805.2013.823859; Riem MME, 2014, PROG NEURO-PSYCHOPH, V51, P105, DOI 10.1016/j.pnpbp.2014.01.014; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Russell TA, 2009, PSYCHIAT RES, V168, P181, DOI 10.1016/j.psychres.2008.10.028; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Rutherford HJV, 2012, PERSONAL DISORD, V3, P393, DOI 10.1037/a0028938; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Sandvik AM, 2014, SCAND J PSYCHOL, V55, P585, DOI 10.1111/sjop.12138; Schiffer B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060278; Schoelkopf B., 2002, LEARNING KERNELS; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Senju A, 2012, NEUROSCIENTIST, V18, P108, DOI 10.1177/1073858410397208; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Sinclair S, 2006, J PERS SOC PSYCHOL, V90, P529, DOI 10.1037/0022-3514.90.4.529; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Uzefovsky F, 2012, PSYCHONEUROENDOCRINO, V37, P576, DOI 10.1016/j.psyneuen.2011.07.018; Valla JM, 2010, AUTISM RES, V3, P174, DOI 10.1002/aur.143; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Voracek M, 2006, PERS INDIV DIFFER, V41, P1481, DOI 10.1016/j.paid.2006.06.009; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Wilson CE, 2014, AUTISM RES, V7, P568, DOI 10.1002/aur.1394; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	112	133	133	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136521	10.1371/journal.pone.0136521	http://dx.doi.org/10.1371/journal.pone.0136521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313946	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000360144000065
J	De Sordi, L; Butt, MA; Pye, H; Kohoutova, D; Mosse, CA; Yahioglu, G; Stamati, I; Deonarain, M; Battah, S; Ready, D; Allan, E; Mullany, P; Lovat, LB				De Sordi, Luisa; Butt, M. Adil; Pye, Hayley; Kohoutova, Darina; Mosse, Charles A.; Yahioglu, Gokhan; Stamati, Ioanna; Deonarain, Mahendra; Battah, Sinan; Ready, Derren; Allan, Elaine; Mullany, Peter; Lovat, Laurence B.			Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile	PLOS ONE			English	Article							METHYLENE-BLUE; VISIBLE-LIGHT; BILE-ACIDS; INACTIVATION; THERAPY; RESISTANCE; INFECTION; BACTERIAL; OXYGEN; EPIDEMIOLOGY	Background Clostridium difficile is the leading cause of antibiotic-associated diarrhoea and pseudo membranous colitis in the developed world. The aim of this study was to explore whether Photodynamic Antimicrobial Chemotherapy (PACT) could be used as a novel approach to treating C. difficile infections. Methods PACT utilises the ability of light-activated photosensitisers (PS) to produce reactive oxygen species (ROS) such as free radical species and singlet oxygen, which are lethal to cells. We screened thirteen PS against C. difficile planktonic cells, biofilm and germinating spores in vitro, and cytotoxicity of effective compounds was tested on the colorectal adenocarcinoma cell-line HT-29. Results Three PS were able to kill 99.9% of bacteria in both aerobic and anaerobic conditions, both in the planktonic state and in a biofilm, after exposure to red laser light (0.2 J/cm(2)) without harming model colon cells. The applicability of PACT to eradicate C. difficile germinative spores indirectly was also shown, by first inducing germination with the bile salt taurocholate, followed by PACT. Conclusion This innovative and simple approach offers the prospect of a new antimicrobial therapy using light to treat C. difficile infection of the colon.	[De Sordi, Luisa; Butt, M. Adil; Pye, Hayley; Kohoutova, Darina; Mosse, Charles A.; Lovat, Laurence B.] UCL, Res Dept Tissue & Energy, London, England; [Butt, M. Adil; Kohoutova, Darina; Lovat, Laurence B.] Univ Coll London Hosp, Div Gastrointestinal Serv, London, England; [Yahioglu, Gokhan; Stamati, Ioanna] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Yahioglu, Gokhan; Deonarain, Mahendra] PhotoBiotics Ltd, Imperial Coll London, London, England; [Deonarain, Mahendra] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Battah, Sinan] Organix Ltd, Colchester, Essex, England; [Battah, Sinan] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Ready, Derren] Publ Hlth Lab London, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; Imperial College London; Imperial College London; University of Essex; Public Health England	Butt, MA (corresponding author), UCL, Res Dept Tissue & Energy, London, England.	adil.butt@ucl.ac.uk	De Sordi, Luisa/ABC-2581-2021; Lovat, Laurence/C-1986-2009	Lovat, Laurence/0000-0003-4542-3915; De Sordi, Luisa/0000-0002-3785-550X; Ready, Derren/0000-0003-4894-3641	Charles Wolfson Charitable Trust [238043]; National Institute for Health Research Biomedical Research Centres; University College London Experimental Cancer Medicine Centre; PhotoBiotics Ltd.; Organix Ltd.	Charles Wolfson Charitable Trust; National Institute for Health Research Biomedical Research Centres; University College London Experimental Cancer Medicine Centre; PhotoBiotics Ltd.; Organix Ltd.	This work was primarily funded by the Charles Wolfson Charitable Trust (Charity number: 238043). This research was undertaken at University College London in laboratories part funded by the National Institute for Health Research Biomedical Research Centres funding scheme (https://www.uclh.nhs.uk/Research/BRC/Pages/Home.aspx) and the University College London Experimental Cancer Medicine Centre (http://www.ecmcnetwork.org.uk/network-centres/london-ucl/). PhotoBiotics Ltd., provided support in the form of salaries for authors GY & MD, and Organix Ltd., provided support in the form of salaries for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Ashkenazi H, 2003, FEMS IMMUNOL MED MIC, V35, P17, DOI 10.1111/j.1574-695X.2003.tb00644.x; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Beirao S, 2014, PHOTOCHEM PHOTOBIOL, V90, P1387, DOI 10.1111/php.12331; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Calin MA, 2009, LASER MED SCI, V24, P453, DOI 10.1007/s10103-008-0588-5; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Cornaglia G., 2011, Lancet Infectious Diseases, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Costa L, 2011, ANTIVIR RES, V91, P278, DOI 10.1016/j.antiviral.2011.06.007; da Silva RN, 2012, MICROBIOL IMMUNOL, V56, P692, DOI 10.1111/j.1348-0421.2012.00493.x; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Decraene V, 2006, APPL ENVIRON MICROB, V72, P4436, DOI 10.1128/AEM.02945-05; Demidova TN, 2005, APPL ENVIRON MICROB, V71, P6918, DOI 10.1128/AEM.71.11.6918-6925.2005; Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005; Denis TGS, 2011, VIRULENCE, V2, P509, DOI 10.4161/viru.2.6.17889; Donald RG, 2013, MICROBIOLOGY; Gad F, 2004, ANTIMICROB AGENTS CH, V48, P2173, DOI 10.1128/AAC.48.6.2173-2178.2004; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; Gardiner DF, 2009, VACCINE, V27, P3598, DOI 10.1016/j.vaccine.2009.03.058; Giuliani F, 2010, ANTIMICROB AGENTS CH, V54, P637, DOI 10.1128/AAC.00603-09; Hamblin MR, 2005, ANTIMICROB AGENTS CH, V49, P2822, DOI 10.1128/AAC.49.7.2822-2827.2005; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Huang LY, 2012, FREE RADICAL BIO MED, V53, P2062, DOI 10.1016/j.freeradbiomed.2012.09.006; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; KOOPMAN BJ, 1985, CLIN CHIM ACTA, V152, P115, DOI 10.1016/0009-8981(85)90182-2; Kraus CN, 2008, CURR OPIN MICROBIOL, V11, P434, DOI 10.1016/j.mib.2008.09.009; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Liu BC, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.088001; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Maclean M, 2008, J PHOTOCH PHOTOBIO B, V92, P180, DOI 10.1016/j.jphotobiol.2008.06.006; Maclean M, 2013, PHOTOCHEM PHOTOBIOL, V89, P120, DOI 10.1111/j.1751-1097.2012.01202.x; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Merrigan MM, 2009, INT J ANTIMICROB AG, V33, pS46, DOI 10.1016/S0924-8579(09)70017-2; Min D B, 2002, Compr Rev Food Sci Food Saf, V1, P58, DOI 10.1111/j.1541-4337.2002.tb00007.x; O'Donoghue C, 2011, CURR OPIN GASTROEN, V27, P38, DOI 10.1097/MOG.0b013e3283411634; OKUDA H, 1984, HEPATO-GASTROENTEROL, V31, P168; Oliveira A, 2009, J APPL MICROBIOL, V106, P1986, DOI 10.1111/j.1365-2672.2009.04168.x; OSEROFF AR, 1986, P NATL ACAD SCI USA, V83, P9729, DOI 10.1073/pnas.83.24.9729; PASS HI, 1993, JNCI-J NATL CANCER I, V85, P443, DOI 10.1093/jnci/85.6.443; Plusa S M, 1991, J R Coll Surg Edinb, V36, P303; Preuss A, 2013, J APPL MICROBIOL, V114, P36, DOI 10.1111/jam.12018; Sayedy L, 2010, WORLD J GASTRO ENDOS, V2, P293, DOI 10.4253/wjge.v2.i8.293; Soukos NS, 2005, ANTIMICROB AGENTS CH, V49, P1391, DOI 10.1128/AAC.49.4.1391-1396.2005; Stamati I, 2010, PHOTOCH PHOTOBIO SCI, V9, P1033, DOI 10.1039/c0pp00038h; Tardivo JP, 2006, PHOTOMED LASER SURG, V24, P528, DOI 10.1089/pho.2006.24.528; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Turner M, 2011, NATURE, V474, P137, DOI 10.1038/474137a; Usuda J, 2006, J THORAC ONCOL, V1, P489, DOI 10.1097/01243894-200606000-00018; VALDUGA G, 1993, J PHOTOCH PHOTOBIO B, V21, P81, DOI 10.1016/1011-1344(93)80168-9; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Via LD, 2001, CURR MED CHEM, V8, P1405, DOI 10.2174/0929867013372076; Vicente M, 2006, FEMS MICROBIOL REV, V30, P841, DOI 10.1111/j.1574-6976.2006.00038.x; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Wang S, 2010, EXPERT OPIN PHARMACO, V11, P133, DOI 10.1517/14656560903463893; WANG WY, 1991, JPEN-PARENTER ENTER, V15, P294, DOI 10.1177/0148607191015003294	59	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135039	10.1371/journal.pone.0135039	http://dx.doi.org/10.1371/journal.pone.0135039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313448	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000012
J	Dorfman, D; Aranda, ML; Rosenstein, RE				Dorfman, Damian; Aranda, Marcos L.; Rosenstein, Ruth E.			Enriched Environment Protects the Optic Nerve from Early Diabetes-Induced Damage in Adult Rats	PLOS ONE			English	Article							VISUAL-SYSTEM; CONTRAST SENSITIVITY; AXONAL-TRANSPORT; RETINAL ISCHEMIA; BRAIN PLASTICITY; SPINAL-CORD; RETINOPATHY; CORTEX; INJURY; PHOSPHORYLATION	Diabetic retinopathy is a leading cause of reduced visual acuity and acquired blindness. Axoglial alterations of the distal (close to the chiasm) optic nerve (ON) could be the first structural change of the visual pathway in streptozotocin (STZ)-induced diabetes in rats. We analyzed the effect of environmental enrichment on axoglial alterations of the ON provoked by experimental diabetes. For this purpose, three days after vehicle or STZ injection, animals were housed in enriched environment (EE) or remained in a standard environment (SE) for 6 weeks. Anterograde transport, retinal morphology, optic nerve axons (toluidine blue staining and phosphorylated neurofilament heavy immunoreactivity), microglia/macrophages (ionized calcium binding adaptor molecule 1 (Iba-1) immunoreactivity), astrocyte reactivity (glial fibrillary acid protein-immunostaining), myelin (myelin basic protein immunoreactivity), ultrastructure, and brain derived neurotrophic factor (BDNF) levels were assessed in non-diabetic and diabetic animals housed in SE or EE. No differences in retinal morphology or retinal ganglion cell number were observed among groups. EE housing which did not affect the STZ-induced weight loss and hyperglycemia, prevented a decrease in the anterograde transport from the retina to the superior colliculus, ON axon number, and phosphorylated neurofilament heavy immunoreactivity. Moreover, EE housing prevented an increase in Iba-1 immunoreactivity, and astrocyte reactivity, as well as ultrastructural myelin alterations in the ON distal portion at early stages of diabetes. In addition, EE housing avoided a decrease in BDNF levels induced by experimental diabetes. These results suggest that EE induced neuroprotection in the diabetic visual pathway.	[Dorfman, Damian; Aranda, Marcos L.; Rosenstein, Ruth E.] Univ Buenos Aires, CONICET, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem,Sch Med CEFyBO, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rosenstein, RE (corresponding author), Univ Buenos Aires, CONICET, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem,Sch Med CEFyBO, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Aranda, Marcos/0000-0003-1891-3476	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1623]; University of Buenos Aires [20020100100678]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 1911]; Fundacion Florencio Fiorini, Buenos Aires, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini, Buenos Aires, Argentina	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1623]; The University of Buenos Aires [20020100100678]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 1911], and Fundacion Florencio Fiorini, Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barone I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050726; Baydas G, 2003, EUR J PHARMACOL, V462, P67, DOI 10.1016/S0014-2999(03)01294-9; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2004, BRAIN RES, V1018, P130, DOI 10.1016/j.brainres.2004.06.001; Caleo M, 2009, EXP NEUROL, V216, P515, DOI 10.1016/j.expneurol.2008.12.016; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; DILEO MAS, 1992, DIABETES CARE, V15, P620, DOI 10.2337/diacare.15.5.620; Dorfman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101829; Dorfman D, 2013, EXP NEUROL, V240, P146, DOI 10.1016/j.expneurol.2012.11.017; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Fawcett JW, 2009, NAT MED, V15, P735, DOI 10.1038/nm0709-735; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; GHAFOUR IM, 1982, BRIT J OPHTHALMOL, V66, P492, DOI 10.1136/bjo.66.8.492; Ghita A M, 2013, J Med Life, V6, P340; Fleitas MFG, 2015, CHRONOBIOL INT, V32, P152, DOI 10.3109/07420528.2014.959526; Grigsby JG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/705783; Heravian Javad, 2012, J Ophthalmic Vis Res, V7, P225; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Islam MS, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/149452; Jackson GR, 2010, CURR DIABETES REP, V10, P380, DOI 10.1007/s11892-010-0132-4; Karlica D, 2010, COLLEGIUM ANTROPOL, V34, P525; Kashiwagi K, 2003, INVEST OPHTH VIS SCI, V44, P154, DOI 10.1167/iovs.02-0398; Kern TS, 2014, DIABETES METAB J, V38, P163, DOI 10.4093/dmj.2014.38.3.163; Keyvani K, 2004, J NEUROPATH EXP NEUR, V63, P598, DOI 10.1093/jnen/63.6.598; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; MOSS SE, 1988, OPHTHALMOLOGY, V95, P1340; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; NIXON RA, 1994, NEUROCHEM RES, V19, P1445, DOI 10.1007/BF00972474; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Quattromani MJ, 2014, NEUROBIOL DIS, V66, P66, DOI 10.1016/j.nbd.2014.02.010; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Shi YK, 2014, LANCET, V383, P1947, DOI 10.1016/S0140-6736(14)60886-2; Shimazawa M, 2012, J NEUROSCI RES, V90, P1960, DOI 10.1002/jnr.23078; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Soffie M, 1999, BEHAV BRAIN RES, V101, P37, DOI 10.1016/S0166-4328(98)00139-9; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Tognini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034815; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Yang S, 2013, NEUROSCIENCE, V234, P13, DOI 10.1016/j.neuroscience.2013.01.003; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang XY, 2013, INT J BIOCHEM CELL B, V45, P1525, DOI 10.1016/j.biocel.2013.03.002; Zhao JP, 2010, INT J OPHTHALMOL-CHI, V3, P291, DOI 10.3980/j.issn.2222-3959.2010.04.03	63	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136637	10.1371/journal.pone.0136637	http://dx.doi.org/10.1371/journal.pone.0136637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312758	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000079
J	Elbl, P; Navarro, BV; de Oliveira, LF; Almeida, J; Mosini, C; dos Santos, ALW; Rossi, M; Floh, EIS				Elbl, Paula; Navarro, Bruno V.; de Oliveira, Leandro F.; Almeida, Juliana; Mosini, C.; dos Santos, Andre L. W.; Rossi, Magdalena; Floh, Eny I. S.			Identification and Evaluation of Reference Genes for Quantitative Analysis of Brazilian Pine (Araucaria angustifolia Bertol. Kuntze) Gene Expression	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; ACCURATE NORMALIZATION; TRANSCRIPTOME ANALYSIS; SOMATIC EMBRYOGENESIS; VALIDATION; QUANTIFICATION; TISSUES	Quantitative analysis of gene expression is a fundamental experimental approach in many fields of plant biology, but it requires the use of internal controls representing constitutively expressed genes for reliable transcript quantification. In this study, we identified fifteen putative reference genes from an A. angustifolia transcriptome database. Variation in transcript levels was first evaluated in silico by comparing read counts and then by quantitative real-time PCR (qRT-PCR), resulting in the identification of six candidate genes. The consistency of transcript abundance was also calculated applying geNorm and NormFinder software packages followed by a validation approach using four target genes. The results presented here indicate that a diverse set of samples should ideally be used in order to identify constitutively expressed genes, and that the use of any two reference genes in combination, of the six tested genes, is sufficient for effective expression normalization. Finally, in agreement with the in silico prediction, a comprehensive analysis of the qRT-PCR data combined with validation analysis revealed that AaEIF4B-L and AaPP2A are the most suitable reference genes for comparative studies of A. angustifolia gene expression.	[Elbl, Paula; Navarro, Bruno V.; de Oliveira, Leandro F.; Almeida, Juliana; Mosini, C.; dos Santos, Andre L. W.; Rossi, Magdalena; Floh, Eny I. S.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil	Universidade de Sao Paulo	Floh, EIS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil.	enyfloh@usp.br	de Oliveira, Leandro Francisco/ACG-6315-2022; ALMEIDA, JULIANA/G-4796-2013; Rossi, Magdalena/B-7847-2012; de Oliveira, Leandro Francisco/I-4521-2012; Iochevet Segal Floh, Eny/D-9526-2012	de Oliveira, Leandro Francisco/0000-0002-5318-2771; ALMEIDA, JULIANA/0000-0002-2085-9993; Rossi, Magdalena/0000-0003-3650-772X; de Oliveira, Leandro Francisco/0000-0002-5318-2771; Iochevet Segal Floh, Eny/0000-0001-6529-2065; Navarro, Bruno/0000-0001-9289-4328	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [02437/09-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51659-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307238/2013-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (02437/09-0), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/51659-7) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(307238/2013-0).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; BECWAR MR, 1989, IN VITRO CELL DEV B, V25, P575, DOI 10.1007/BF02623571; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Elbl P, 2015, PLANT CELL TISS ORG, V120, P903, DOI 10.1007/s11240-014-0523-3; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang LK, 2014, BIOENERG RES, V7, P1201, DOI 10.1007/s12155-014-9457-1; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jo L, 2014, TREE PHYSIOL, V34, P94, DOI 10.1093/treephys/tpt102; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Majumdar R, 2013, PLANT CELL PHYSL; Mhamdi A, 2012, ARCH BIOCHEM BIOPHYS, V525, P181, DOI 10.1016/j.abb.2012.04.015; Milone DH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-438; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Perini P, 2014, MOL BREEDING, V34, P829, DOI 10.1007/s11032-014-0078-3; Quadrana L, 2013, PLANT MOL BIOL, V81, P309, DOI 10.1007/s11103-012-0001-4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Schlogl PS, 2012, GENET MOL BIOL, V35, P172, DOI 10.1590/S1415-47572012005000005; Schlogl PS, 2012, PLANT CELL TISS ORG, V108, P173, DOI 10.1007/s11240-011-0023-7; Steiner N, 2008, FUNCT PLANT SCI BIOT, V2, P20; Steiner N, 2012, PLANT CELL TISS ORG, V109, P41, DOI 10.1007/s11240-011-0071-z; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu Tao, 2012, African Journal of Agricultural Research, V7, P3701; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438	51	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136714	10.1371/journal.pone.0136714	http://dx.doi.org/10.1371/journal.pone.0136714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313945	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000089
J	Kitatani, K; Wada, M; Perry, D; Usui, T; Sun, Y; Obeid, LM; Yaegashi, N; Grabowski, GA; Hannun, YA				Kitatani, Kazuyuki; Wada, Masayuki; Perry, David; Usui, Toshinori; Sun, Ying; Obeid, Lina M.; Yaegashi, Nobuo; Grabowski, Gregory A.; Hannun, Yusuf A.			Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; TUMOR-NECROSIS-FACTOR; CYTOKINE PRODUCTION; TRANSGENIC MICE; NERVOUS-SYSTEM; MOUSE MODELS; MAP-KINASES; INTERLEUKIN-6; PATHWAY; INFLAMMATION	Gaucher's disease is caused by defects in acid beta-glucosidase 1 (GBA1) and has been also proposed as an inflammatory disease. GBA1 cleaves glucosylceramide to form ceramide, an established bioactive lipid, and defects in GBA1 lead to aberrant accumulation in glucosylceramide and insufficient formation of ceramide. We investigated if the pro-inflammatory kinase p38 is activated in Gaucher's disease, since ceramide has been proposed to suppress p38 activation. Three Gaucher's disease mouse models were employed, and p38 was found to be activated in lung and liver tissues of all Gaucher's disease mice. Most interestingly, neuronopathic Gaucher's disease type mice, but not non-neuronopathic ones, displayed significant activation of p38 and up-regulation of p38-inducible proinflammatory cytokines in brain tissues. In addition, all type of Gaucher's disease mice also showed increases in serum IL-6. As cellular signalling is believed to represent an in vivo inflammatory phenotype in Gaucher's disease, activation of p38 and possibly its-associated formation of proinflammatory cytokines were assessed in fibroblasts established from neuronopathic Gaucher's disease mice. In mouse Gaucher's disease cells, p38 activation and IL-6 formation by TNF-alpha treatment were enhanced as compared to those of wild type. Furthermore, human fibroblasts from Gaucher's disease patients also displayed increases in p38 activation and IL-6 formation as comparison to healthy counterpart. These results raise the potential that proinflammatory responses such as p38 activation and IL-6 formation are augmented in Gaucher's disease.	[Kitatani, Kazuyuki; Usui, Toshinori; Yaegashi, Nobuo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kitatani, Kazuyuki; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Wada, Masayuki; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Perry, David] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Obeid, Lina M.] Northport Vet Affairs Hosp, Northport, NY USA; [Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	Tohoku University; Tohoku University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kitatani, K (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan.	kitatani@med.tohoku.ac.jp; yusuf.hannun@sbumed.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135	Gaucher Generation Program Award; NIH [CA087584, DK 36729]; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Gaucher Generation Program Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by the Gaucher Generation Program Award (KK), by NIH grant CA087584 (YAH) and DK 36729 (GAG).	Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Bachstetter AD, 2010, AGING DIS, V1, P199; Barak V, 1999, EUR CYTOKINE NETW, V10, P205; BRADY RO, 1978, ANNU REV BIOCHEM, V47, P687, DOI 10.1146/annurev.bi.47.070178.003351; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; GRABOWSKI GA, 1993, ADV HUM GENET, V21, P377; Hollak CEM, 1997, BLOOD CELL MOL DIS, V23, P201, DOI 10.1006/bcmd.1997.0137; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; MISTRY PK, 1993, J MED GENET, V30, P889, DOI 10.1136/jmg.30.11.889; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Pandey MK, 2012, MOL GENET METAB, V106, P310, DOI 10.1016/j.ymgme.2012.04.020; Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019037; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3	33	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136633	10.1371/journal.pone.0136633	http://dx.doi.org/10.1371/journal.pone.0136633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312487	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000078
J	Mercurio, P; Mueller, JF; Eaglesham, G; Flores, F; Negri, AP				Mercurio, Philip; Mueller, Jochen F.; Eaglesham, Geoff; Flores, Florita; Negri, Andrew P.			Herbicide Persistence in Seawater Simulation Experiments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; LOWER BURDEKIN REGION; ENVIRONMENTAL-CONDITIONS; TRIAZINE HERBICIDES; ANTIFOULING PAINT; WATER; AUSTRALIA; DEGRADATION; PESTICIDES; LAGOON	Herbicides are detected year-round in marine waters, including those of the World Heritage listed Great Barrier Reef (GBR). The few previous studies that have investigated herbicide persistence in seawater generally reported half-lives in the order of months, and several studies were too short to detect significant degradation. Here we investigated the persistence of eight herbicides commonly detected in the GBR or its catchments in standard OECD simulation flask experiments, but with the aim to mimic natural conditions similar to those found on the GBR (i.e., relatively low herbicide concentrations, typical temperatures, light and microbial communities). Very little degradation was recorded over the standard 60 d period (Experiment 1) so a second experiment was extended to 365 d. Half-lives of PSII herbicides ametryn, atrazine, diuron, hexazinone and tebuthiuron were consistently greater than a year, indicating high persistence. The detection of atrazine and diuron metabolites and longer persistence in mercuric chloride-treated seawater confirmed that biodegradation contributed to the breakdown of herbicides. The shortest half-life recorded was 88 d for growth-regulating herbicide 2,4-D at 31 degrees C in the dark, while the fatty acid-inhibitor metolachlor exhibited a minimum half-life of 281 d. The presence of moderate light and elevated temperatures affected the persistence of most of the herbicides; however, the scale and direction of the differences were not predictable and were likely due to changes in microbial community composition. The persistence estimates here represent some of the first appropriate data for application in risk assessments for herbicide exposure in tropical marine systems. The long persistence of herbicides identified in the present study helps explain detection of herbicides in nearshore waters of the GBR year round. Little degradation of these herbicides would be expected during the wet season with runoff and associated flood plumes transporting a high proportion of the original herbicide from rivers into the GBR lagoon.	[Mercurio, Philip; Flores, Florita; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Mercurio, Philip; Mueller, Jochen F.; Eaglesham, Geoff] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia	Australian Institute of Marine Science; University of Queensland	Mercurio, P (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	pmercurio@gmail.com	Mueller, Jochen F/C-6241-2008; Negri, Andrew P/G-9909-2017; Flores, Florita/I-3033-2017	Negri, Andrew P/0000-0003-1388-7395; Flores, Florita/0000-0003-4637-1379; Mueller, Jochen/0000-0002-0000-1973	Australian Government's National Environmental Research Program; ARC future fellowship [FF120100546]	Australian Government's National Environmental Research Program(Australian Government); ARC future fellowship(Australian Research Council)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2. Jochen F. Mueller acknowledges funding by an ARC future fellowship (FF120100546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen J, 2003, CHEMOSPHERE, V51, P529, DOI 10.1016/S0045-6535(02)00861-5; AIMS, 2013, SEA TEMP MON PROGR; Amaral-Zettler L., 2010, GLOBAL CENSUS MARINE, P223; Bainbridge ZT, 2012, MAR POLLUT BULL, V65, P236, DOI 10.1016/j.marpolbul.2012.01.043; Bainbridge ZT, 2009, MAR FRESHWATER RES, V60, P1081, DOI 10.1071/MF08333; Bentley C, 2012, PESTICIDE MONITORING; Beulke S, 2001, BIOL FERT SOILS, V33, P558, DOI 10.1007/s003740100364; Bourne D.G., 2013, CORAL REEF BACTERIAL, P163; Bourne DG, 2013, ISME J, V7, P1452, DOI 10.1038/ismej.2012.172; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Brodie J, 2012, MAR POLLUT BULL, V65, P267, DOI 10.1016/j.marpolbul.2011.12.011; Dabrowska D, 2006, B ENVIRON CONTAM TOX, V77, P245, DOI 10.1007/s00128-006-1056-1; Davies-Colley RJ, 2001, J AM WATER RESOUR AS, V37, P1085, DOI 10.1111/j.1752-1688.2001.tb03624.x; Davis A.M., 2011, AGR ECOSYST ENV; Davis Aaron, 2008, Australasian Journal of Ecotoxicology, V14, P89; Davis AM, 2012, MAR POLLUT BULL, V65, P182, DOI 10.1016/j.marpolbul.2011.08.025; Ganapathy C, 1996, ENV FATE HEXAZINONE, P1; GBRMPA, 2010, WAT QUAL GUID GREAT; Giacomazzi S, 2004, CHEMOSPHERE, V56, P1021, DOI 10.1016/j.chemosphere.2004.04.061; Glockner FO, 2012, MARINE MICROBIAL DIV, P17; Hargreaves PA, 1999, P AUSTR SOC SUG CAN; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Konstantinou IK, 2001, J ENVIRON QUAL, V30, P121, DOI 10.2134/jeq2001.301121x; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lazartigues A, 2013, CHEMOSPHERE, V91, P530, DOI 10.1016/j.chemosphere.2012.12.032; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Mandelbaum RT, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P301, DOI 10.1016/B978-044451167-6.50025-8; Meakins NC, 1995, MAR POLLUT BULL, V30, P812, DOI 10.1016/0025-326X(95)00074-W; Mercurio P, 2014, MAR POLLUT BULL, V85, P385, DOI 10.1016/j.marpolbul.2014.01.021; Miller C.B., 2009, BIOL OCEANOGRAPHY; Moncada A., 2004, ENV FATE DIURON; Navarro S, 2004, SCI TOTAL ENVIRON, V329, P87, DOI 10.1016/j.scitotenv.2004.03.013; Navarro S, 2004, CHEMOSPHERE, V57, P51, DOI 10.1016/j.chemosphere.2004.05.016; Negri AP, 2015, AQUAT TOXICOL; OECD, 1992, ORGAN EC COOP DEV, P1; OECD, 2004, SECT 2 EFF BIOT SYST; OECD, 2005, OECD GUID TEST CHE 1; Okamura H, 2002, CHEMOSPHERE, V48, P43, DOI 10.1016/S0045-6535(02)00025-5; PPDB, 2011, PEST PROP DAT U HERT; Radosevich M, 2004, ACS SYM SER, V863, P129; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Stasinakis AS, 2009, WATER RES, V43, P1471, DOI 10.1016/j.watres.2008.12.040; Thomas KV, 2002, SCI TOTAL ENVIRON, V293, P117, DOI 10.1016/S0048-9697(01)01153-6; Trebst A, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P101, DOI 10.1016/B978-044451167-6.50011-8; Uthicke S, 2010, LIMNOL OCEANOGR, V55, P1681, DOI 10.4319/lo.2010.55.4.1681; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	51	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136391	10.1371/journal.pone.0136391	http://dx.doi.org/10.1371/journal.pone.0136391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313296	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000058
J	Mushtaq, M; Darekar, S; Klein, G; Kashuba, E				Mushtaq, Muhammad; Darekar, Suhas; Klein, George; Kashuba, Elena			Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; GLUCOSE-METABOLISM; MYC ONCOGENE; GROWTH; EXPRESSION; HYPOXIA; ACRIFLAVINE; INHIBITOR; APOPTOSIS; BIOLOGY	Background The Warburg effect is one of the hallmarks of cancer and rapidly proliferating cells. It is known that the hypoxia-inducible factor 1-alpha (HIF1A) and MYC proteins cooperatively regulate expression of the HK2 and PDK1 genes, respectively, in the Burkitt lymphoma (BL) cell line P493-6, carrying an inducible MYC gene repression system. However, the mechanism of aerobic glycolysis in BL cells has not yet been fully understood. Methods and Findings Western blot analysis showed that the HIF1A protein was highly expressed in Epstein-Barr virus (EBV)-positive BL cell lines. Using biochemical assays and quantitative PCR (Q-PCR), we found that-unlike in lymphoblastoid cell lines (LCLs)-the MYC protein was the master regulator of the Warburg effect in these BL cell lines. Inhibition of the transactivation ability of MYC had no influence on aerobic glycolysis in LCLs, but it led to decreased expression of MYC-dependent genes and lactate dehydrogenase A (LDHA) activity in BL cells. Conclusions Our data suggest that aerobic glycolysis, or the Warburg effect, in BL cells is regulated by MYC expressed at high levels, whereas in LCLs, HIF1A is responsible for this phenomenon.	[Mushtaq, Muhammad; Darekar, Suhas; Klein, George; Kashuba, Elena] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Kashuba, Elena] NASU, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine	Karolinska Institutet; National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU	Kashuba, E (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	Elena.Kashuba@ki.se	Kashuba, Elena/O-5389-2015; Kashuba, Elena/Q-4739-2019	Kashuba, Elena/0000-0001-7001-4035; Kashuba, Elena/0000-0001-7001-4035; Darekar, Suhas/0000-0003-4895-3313; Mushtaq Yasinzai, Muhammad/0000-0002-0896-3720	Swedish Cancer Society; Concern Foundation (Los Angeles); Cancer Research Institute (New York); Swedish Institute; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Concern Foundation (Los Angeles); Cancer Research Institute (New York); Swedish Institute; Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Society, by matching grants from the Concern Foundation (Los Angeles) and the Cancer Research Institute (New York), by the Swedish Institute and by Karolinska Institutet. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altman BJ, 2012, FEBS J, V279, P2598, DOI 10.1111/j.1742-4658.2012.08651.x; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; Dang C, 2013, COLD SPRING HARB PER, V3; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Darekar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042072; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; GURTSEVITCH VE, 1988, INT J CANCER, V41, P87, DOI 10.1002/ijc.2910410117; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Jayachandra S, 1999, P NATL ACAD SCI USA, V96, P11566, DOI 10.1073/pnas.96.20.11566; Keyhani E, 2009, ANN NY ACAD SCI, V1171, P284, DOI 10.1111/j.1749-6632.2009.04682.x; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim SG, 1998, DRUG METAB DISPOS, V26, P66; Klein G, 2010, BIOCHEM BIOPH RES CO, V396, P67, DOI 10.1016/j.bbrc.2010.02.146; Klein G, 2009, SEMIN CANCER BIOL, V19, P347, DOI 10.1016/j.semcancer.2009.07.001; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lewis BC, 2000, CANCER RES, V60, P6178; Ma L, 2014, CANCER LETT, V355, P96, DOI 10.1016/j.canlet.2014.09.011; Muller I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097285; Pokrovskaja K, 1996, CELL GROWTH DIFFER, V7, P1723; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Spaka I., 2012, WASET, V6, P1138; WALTER J, 1992, INT J CANCER, V50, P265, DOI 10.1002/ijc.2910500217; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	28	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136142	10.1371/journal.pone.0136142	http://dx.doi.org/10.1371/journal.pone.0136142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312753	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000043
J	Oong, XY; Ng, KT; Lam, TTY; Pang, YK; Chan, KG; Hanafi, NS; Kamarulzaman, A; Tee, KK				Oong, Xiang Yong; Ng, Kim Tien; Lam, Tommy Tsan-Yuk; Pang, Yong Kek; Chan, Kok Gan; Hanafi, Nik Sherina; Kamarulzaman, Adeeba; Tee, Kok Keng			Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; GENETIC-CHARACTERIZATION; STRUCTURAL BASIS; HEMAGGLUTININ; LINEAGES; TRANSMISSION; COCIRCULATION; REASSORTMENT; RESISTANCE; EMERGENCE	Epidemiological and evolutionary dynamics of influenza B Victoria and Yamagata lineages remained poorly understood in the tropical Southeast Asia region, despite causing seasonal outbreaks worldwide. From 2012-2014, nasopharyngeal swab samples collected from outpatients experiencing acute upper respiratory tract infection symptoms in Kuala Lumpur, Malaysia, were screened for influenza viruses using a multiplex RT-PCR assay. Among 2,010/3,935 (51.1%) patients infected with at least one respiratory virus, 287 (14.3%) and 183 (9.1%) samples were tested positive for influenza A and B viruses, respectively. Influenza-positive cases correlate significantly with meteorological factors-total amount of rainfall, relative humidity, number of rain days, ground temperature and particulate matter (PM10). Phylogenetic reconstruction of haemagglutinin (HA) gene from 168 influenza B viruses grouped them into Yamagata Clade 3 (65, 38.7%), Yamagata Clade 2 (48, 28.6%) and Victoria Clade 1 (55, 32.7%). With neuraminidase (NA) phylogeny, 30 intra-clade (29 within Yamagata Clade 3, 1 within Victoria Clade 1) and 1 inter-clade (Yamagata Clade 2-HA/Yamagata Clade 3-NA) reassortants were identified. Study of virus temporal dynamics revealed a lineage shift from Victoria to Yamagata (2012-2013), and a clade shift from Yamagata Clade 2 to Clade 3 (2013-2014). Yamagata Clade 3 predominating in 2014 consisted of intra-clade reassortants that were closely related to a recent WHO vaccine candidate strain (B/Phuket/3073/2013), with the reassortment event occurred approximately 2 years ago based on Bayesian molecular clock estimation. Malaysian Victoria Clade 1 viruses carried H274Y substitution in the active site of neuraminidase, which confers resistance to oseltamivir. Statistical analyses on clinical and demographic data showed Yamagata-infected patients were older and more likely to experience headache while Victoria-infected patients were more likely to experience nasal congestion and sore throat. This study describes the evolution of influenza B viruses in Malaysia and highlights the importance of continuous surveillance for better vaccination policy in this region.	[Oong, Xiang Yong; Ng, Kim Tien; Pang, Yong Kek; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Lam, Tommy Tsan-Yuk] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia; [Hanafi, Nik Sherina] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia	Universiti Malaya; University of Hong Kong; Universiti Malaya; Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010; Chan, Kok Gan/B-8347-2010; Hanafi, Nik Sherina/B-9250-2010; Tee, Kok Keng/A-8148-2008; Ng, Kim Tien/K-7667-2013; Pang, Yong-Kek/Q-7347-2019; Lam, Tsan Yuk/D-4837-2012	Chan, Kok Gan/0000-0002-1883-1115; Hanafi, Nik Sherina/0000-0001-9140-0955; Tee, Kok Keng/0000-0002-7923-5448; Ng, Kim Tien/0000-0002-4097-9984; Lam, Tsan Yuk/0000-0002-9769-1527; Oong, Xiang Yong/0000-0002-1426-1987	Ministry of Education, Malaysia: High Impact Research [H-500001-00-A000012-000001]	Ministry of Education, Malaysia: High Impact Research	This work was supported by grants from the Ministry of Education, Malaysia: High Impact Research H-500001-00-A000012-000001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2014, J MED VIROL, V86, P1003, DOI 10.1002/jmv.23819; Barr IG, 2003, VIRUS RES, V98, P35, DOI 10.1016/j.virusres.2003.08.011; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Burnham AJ, 2015, J VIROL, V89, P4575, DOI 10.1128/JVI.02473-14; Burnham AJ, 2014, ANTIMICROB AGENTS CH, V58, P2718, DOI 10.1128/AAC.02628-13; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Chi XS, 2003, J CLIN MICROBIOL, V41, P5770, DOI 10.1128/JCM.41.12.5770-5773.2003; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dudas G, 2015, MOL BIOL EVOL, V32, P162, DOI 10.1093/molbev/msu287; Fang QX, 2015, ARCH VIROL, V160, P1083, DOI 10.1007/s00705-015-2362-x; Farrukee R, 2015, J ANTIMICROB CHEMOTH; Francesca P, 2009, DIAGN MICR INFEC DIS, V64, P158, DOI 10.1016/j.diagmicrobio.2009.02.013; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Glezen W Paul, 2004, Pediatr Infect Dis J, V23, pS202, DOI 10.1097/01.inf.0000144662.86396.07; Hall T., 2011, GERF B BIOSCI, V2, P60; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hwang SM, 2015, J CLIN LAB ANAL, V29, P116, DOI 10.1002/jcla.21738; Jackson D, 2005, J ANTIMICROB CHEMOTH, V55, P162, DOI 10.1093/jac/dkh528; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Jumat Muhammad Raihan, 2014, BMC Res Notes, V7, P863, DOI 10.1186/1756-0500-7-863; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Lugovtsev VY, 2007, VIROLOGY, V365, P315, DOI 10.1016/j.virol.2007.04.006; Malaysian Meteorological Department, 2014, GEN CLIM MAL; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; Pabbaraju K, 2011, J CLIN MICROBIOL, V49, P1738, DOI 10.1128/JCM.02090-10; Paynter S, 2014, EPIDEMIOLOGY INFECT, V13, P1; Qin J., 2012, OPEN J AIR POLLUT, V1, P59, DOI DOI 10.4236/OJAP.2012.13008; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; ROTA PA, 1992, J GEN VIROL, V73, P2737, DOI 10.1099/0022-1317-73-10-2737; Roy T, 2011, INFECT GENET EVOL, V11, P1595, DOI 10.1016/j.meegid.2011.05.022; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sam IC, 2015, J VIROL, V89, P9689, DOI 10.1128/JVI.00708-15; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shen J, 2009, J MED VIROL, V81, P114, DOI 10.1002/jmv.21335; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang QH, 2007, P NATL ACAD SCI USA, V104, P16874, DOI 10.1073/pnas.0708363104; WHO, 2014, SEPT 2014 INT REP RE; WHO, 2015, FEBR 2015 INT REP RE; WHO. World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5N1 Evolution Working Group, 2013, INFLUENZA OTHER RESP, V8, P384; Wong CM, 2009, ENVIRON HEALTH PERSP, V117, P248, DOI 10.1289/ehp.11605; World Health Organization (WHO), 2014, REC COMP INFL VIR VA; World Health Organization (WHO), 2014, WHO INF MOL DIAGN IN; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396; Zhu N, 2013, VIRUS GENES, V46, P28, DOI 10.1007/s11262-012-0826-6	64	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136254	10.1371/journal.pone.0136254	http://dx.doi.org/10.1371/journal.pone.0136254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313754	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000051
J	Valkovic, P; Minar, M; Singliarova, H; Harsany, J; Hanakova, M; Martinkova, J; Benetin, J				Valkovic, Peter; Minar, Michal; Singliarova, Helena; Harsany, Jan; Hanakova, Marta; Martinkova, Jana; Benetin, Jan			Pain in Parkinson's Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life	PLOS ONE			English	Article							MOTOR COMPLICATIONS; SEX-DIFFERENCES; SYMPTOMS; LEVODOPA; THRESHOLD; DOPAMINE; SIGNS	Pain is an important and distressing symptom in Parkinson's disease (PD). Our aim was to determine the prevalence of pain, its various types and characteristics, as well as its impact on depression and quality of life (QoL) in patients with PD. How pain differs in early-and advanced-stage PD and male and female PD patients was of special interest. One hundred PD patients on dopaminergic medications had a neurological examination and participated in a structured interview on pain characteristics and completed standardized questionnaires. A total of 76% of the patients had pain. The following types of pain were present: musculoskeletal pain accounted for 41% of the total pain, dystonic pain for 17%, central neuropathic pain for 22%, radicular pain for 27%, and other pains (non-radicular low back pain, arthritic, and visceral pain) made up 24%. One type of pain affected 29% of all the subjects, two types 35%, three types 10%, and four types of pain were reported by 2%. All types of pain were more prevalent in advanced-stage PD subjects than in early-stage PD subjects, except for arthritic pain (subclassified under"other pain"). The frequency and intensity of actual, average, and worst experienced pain were significantly more severe in advanced-stage subjects. PD subjects with general pain and in advanced stages were more depressed and had poorer QoL. Depression correlated with worst pain in the last 24 hours and with pain periodicity (the worst depression score in patients with constant pain). QoL correlated with average pain in the last 7 days. Pain is a frequent problem in PD patients, and it worsens during the course of the disease.	[Valkovic, Peter; Minar, Michal; Singliarova, Helena; Harsany, Jan; Hanakova, Marta; Martinkova, Jana] Comenius Univ, Fac Med, Dept Neurol 2, Bratislava, Slovakia; [Valkovic, Peter] Slovak Acad Sci, Inst Normal & Pathol Physiol, Lab Motor Control, Bratislava, Slovakia; [Singliarova, Helena] Ruzinov Univ Hosp, Dept Physiatry & Rehabil, Bratislava, Slovakia; [Benetin, Jan] Slovak Med Univ, Fac Med, Dept Neurol, Bratislava, Slovakia	Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; Slovak Medical University Bratislava	Valkovic, P (corresponding author), Comenius Univ, Fac Med, Dept Neurol 2, Bratislava, Slovakia.	peter.valkovic@gmail.com; mmminar@gmail.com	Minár, Michal/AAE-9061-2022	Minár, Michal/0000-0002-0812-2366	Slovak Research and Development Agency [SK-CZ-2013-0131]	Slovak Research and Development Agency(Slovak Research and Development Agency)	PV was supported by the Slovak Research and Development Agency under the contract No. SK-CZ-2013-0131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone P, 2010, EUR J NEUROL, V17, P364, DOI 10.1111/j.1468-1331.2009.02900.x; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beiske AG, 2009, PAIN, V141, P173, DOI 10.1016/j.pain.2008.12.004; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bernfort L, 2015, PAIN; Broetz D, 2007, MOVEMENT DISORD, V22, P853, DOI 10.1002/mds.21439; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Cleeland CS, 1991, EFFECT CANC QUALITY, P294; da Silva EG, 2008, ARQ NEURO-PSIQUIAT, V66, P26, DOI 10.1590/S0004-282X2008000100007; Defazio G, 2008, ARCH NEUROL-CHICAGO, V65, P1191, DOI 10.1001/archneurol.2008.2; Dellapina E, 2011, MOVEMENT DISORD, V26, P153, DOI 10.1002/mds.23406; Drobny M, 2000, BRAIN RES BULL, V53, P425, DOI 10.1016/S0361-9230(00)00367-1; Ehrt U, 2009, AM J GERIAT PSYCHIAT, V17, P269, DOI 10.1097/JGP.0b013e31818af7ef; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Ford B, 2010, MOVEMENT DISORD, V25, pS98, DOI 10.1002/mds.22716; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; Gierthmuhlen J, 2010, MOVEMENT DISORD, V25, P1195, DOI 10.1002/mds.23128; Goetz C G, 1986, Mov Disord, V1, P45, DOI 10.1002/mds.870010106; Hanagasi HA, 2011, CLIN NEUROL NEUROSUR, V113, P11, DOI 10.1016/j.clineuro.2010.07.024; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jenkinson C, 1997, PSYCHOL HEALTH, V12, P805, DOI 10.1080/08870449708406741; Keogh E, 2009, EUR J PAIN, V13, P629, DOI 10.1016/j.ejpain.2008.07.002; Lee MA, 2006, J PAIN SYMPTOM MANAG, V32, P462, DOI 10.1016/j.jpainsymman.2006.05.020; Muller T, 2011, NEUROEPIDEMIOLOGY, V37, P183, DOI 10.1159/000331911; Negre-Pages L, 2008, MOVEMENT DISORD, V23, P1361, DOI 10.1002/mds.22142; QUINN NP, 1986, LANCET, V1, P1366; Quittenbam BH, 2004, PARKINSONISM RELAT D, V10, P129, DOI 10.1016/j.parkreldis.2003.12.001; Rana AQ, 2013, CLIN NEUROL NEUROSUR, V115, P2313, DOI 10.1016/j.clineuro.2013.08.022; Roh JH, 2009, ACTA NEUROL SCAND, V119, P397, DOI 10.1111/j.1600-0404.2008.01114.x; Santos-Garcia D, 2011, REV NEUROLOGIA, V52, P385, DOI 10.33588/rn.5207.2010558; Storch A, 2013, NEUROLOGY, V80, P800, DOI 10.1212/WNL.0b013e318285c0ed; Tarsy D, 2008, NEUROLOGY, V71, P1651, DOI 10.1212/01.wnl.0000339368.54460.68; Tinazzi M, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.079053; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Traub RJ, 2013, FRONT NEUROENDOCRIN, V34, P350, DOI 10.1016/j.yfrne.2013.07.002; Wasner G, 2012, NAT REV NEUROL, V8, P284, DOI 10.1038/nrneurol.2012.54; Wen Hong-Bo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS222, DOI 10.1016/S1353-8020(11)70068-2	38	63	69	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136541	10.1371/journal.pone.0136541	http://dx.doi.org/10.1371/journal.pone.0136541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309254	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400136
J	Wensink, GE; Schoffelen, AF; Tempelman, HA; Rookmaaker, MB; Hoepelman, AIM; Barth, RE				Wensink, G. Emerens; Schoffelen, Annelot F.; Tempelman, Hugo A.; Rookmaaker, Maarten B.; Hoepelman, Andy I. M.; Barth, Roos E.			Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa	PLOS ONE			English	Article							KIDNEY-FUNCTION; RENAL-FUNCTION; PROTEINURIA; DISEASE; MICROALBUMINURIA; INDIVIDUALS; COHORT	Context As life expectancy improves among Human Immunodeficiency Virus (HIV) patients, renal and cardiovascular diseases are increasingly prevalent in this population. Renal and cardiovascular disease are mutual risk factors and are characterized by albuminuria. Understanding the interactions between HIV, cardiovascular risk factors and renal disease is the first step in tackling this new therapeutic frontier in HIV. Methods In a rural primary health care centre, 903 HIV-infected adult patients were randomly selected and data on HIV-infection and cardiovascular risk factors were collected. Glomerular filtration rate (eGFR) was estimated. Albuminuria was defined as an Albumin-Creatinine-Ratio above 30 mg/g. Multivariate logistic regression analysis was used to analyse albuminuria and demographic, clinical and HIV-associated variables. Results The study population consisted of 903 HIV-infected patients, with a median age of 40 years (Inter-Quartile Range (IQR) 34-48 years), and included 625 (69%) women. The median duration since HIV diagnosis was 26 months (IQR 12-58 months) and 787 (87%) received antiretroviral therapy. Thirty-six (4%) of the subjects were shown to have diabetes and 205 (23%) hypertension. In the cohort, 21% had albuminuria and 2% an eGFR <60 mL/min/1.73m(2). Albuminuria was associated with hypertension (adjusted odds ratio (aOR) 1.59; 95% confidence interval (CI) 1.05-2.41; p<0.05), total cholesterol (aOR 1.31; 95% CI 1.11-1.54; p<0.05), eGFR (aOR 0.98; 95% CI 0.97-0.99; p<0.001) and detectable viral load (aOR 2.74; 95% CI 1.56-4.79; p<0.001). Hypertension was undertreated: 78% were not receiving treatment, while another 11% were inadequately treated. No patients were receiving lipid-lowering medication. Conclusion Glomerular filtration rate was well conserved, while albuminuria was common amongst HIV-infected patients in rural South Africa. Both cardiovascular and HIV-specific variables were associated with albuminuria. Improved cardiovascular risk prevention as well as adequate virus suppression might be the key to escape the vicious circle of renal failure and cardiovascular disease and improve the long-term prognosis of HIV-infected patients.	[Wensink, G. Emerens; Schoffelen, Annelot F.; Hoepelman, Andy I. M.; Barth, Roos E.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Tempelman, Hugo A.] Ndlovu Care Grp Elandsdoorn, Limpopo, South Africa; [Rookmaaker, Maarten B.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Wensink, GE (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	emerensw@gmail.com		Wensink, Emerens/0000-0002-4103-5811	Van Wijck-Stam-Caspers Foundation; Boehringer Ingelheim The Netherlands [S12218/26808]	Van Wijck-Stam-Caspers Foundation; Boehringer Ingelheim The Netherlands(Boehringer Ingelheim)	GEW received funds from the Van Wijck-Stam-Caspers Foundation (cardiovascular research abroad grant, no grant # available, 2000 euros, http://www.umcutrecht.nl/nl/Opleidingen/Onderwijs-Servicepunt/Prijzen-beurzen#Van_Wijck-Stam-Caspers_(WSC)_Fund). AFS received a grant from Boehringer Ingelheim The Netherlands (S12218/26808, https://www.boehringer-ingelheim.com/global_activities/europe/the_netherlands.html). For the remaining authors none were declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendse CG, 2010, KIDNEY INT, V78, P239, DOI 10.1038/ki.2010.155; Baekken M, 2008, NEPHROL DIAL TRANSPL, V23, P3130, DOI 10.1093/ndt/gfn236; Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; BERNARD AM, 1982, CLIN CHIM ACTA, V126, P1, DOI 10.1016/0009-8981(82)90356-4; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Cohen SD, 2007, NEPHROL DIAL TRANSPL, V22, P2116, DOI 10.1093/ndt/gfm263; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dieleman JP, 2003, JAIDS-J ACQ IMM DEF, V32, P135, DOI 10.1097/00126334-200302010-00004; Fabian J, 2009, ETHNIC DIS, V19, P80; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gravemann S, 2014, AIDS, V28, P1783, DOI 10.1097/QAD.0000000000000324; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Han TM, 2006, KIDNEY INT, V69, P2243, DOI 10.1038/sj.ki.5000339; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOB REP UNAIDS REP, P1; Jotwani V, 2013, ANTIVIR THER; Kim PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024610; Kopp JB, 2002, CLIN INFECT DIS, V34, P1122, DOI 10.1086/339486; Krzesinski JM, 2007, NEPHROL DIAL TRANSPL, V22, P332, DOI 10.1093/ndt/gfl494; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Lucas GM, 2010, JAIDS-J ACQ IMM DEF, V55, P491, DOI 10.1097/QAI.0b013e3181e8d5a8; Naicker S, 2003, KIDNEY INT, V63, P119, DOI 10.1046/j.1523-1755.63.s83.25.x; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Serrano-Villar S, 2012, JAIDS-J ACQ IMM DEF, V59, P141, DOI 10.1097/QAI.0b013e3182414366; Sise ME, 2015, AIDS, V29, P941, DOI 10.1097/QAD.0000000000000628; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Stein JH, 2008, J CLIN LIPIDOL, V2, P464, DOI 10.1016/j.jacl.2008.08.442; Szczech LA, 2002, KIDNEY INT, V61, P195, DOI 10.1046/j.1523-1755.2002.00094.x; Szczech LA, 2007, AIDS, V21, P1003, DOI 10.1097/QAD.0b013e3280d3587f; Tongma Chawat, 2013, Hawaii J Med Public Health, V72, P34; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO Consultation on Obesity, 2000, WHO TECH REP SER, V1; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Yanagisawa N, 2011, NEPHRON CLIN PRACT, V118, pC285, DOI 10.1159/000322278	37	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136529	10.1371/journal.pone.0136529	http://dx.doi.org/10.1371/journal.pone.0136529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309226	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400135
J	Banziger, T; Hosoya, G; Scherer, KR				Banziger, Tanja; Hosoya, Georg; Scherer, Klaus R.			Path Models of Vocal Emotion Communication	PLOS ONE			English	Article							LENS MODEL; MUSIC PERFORMANCE; PERSONALITY JUDGMENTS; CUE UTILIZATION; EXPRESSION; VOICE; SPEECH; PERCEPTION; ACCURACY; PERSPECTIVE	We propose to use a comprehensive path model of vocal emotion communication, encompassing encoding, transmission, and decoding processes, to empirically model data sets on emotion expression and recognition. The utility of the approach is demonstrated for two data sets from two different cultures and languages, based on corpora of vocal emotion enactment by professional actors and emotion inference by naive listeners. Lens model equations, hierarchical regression, and multivariate path analysis are used to compare the relative contributions of objectively measured acoustic cues in the enacted expressions and subjective voice cues as perceived by listeners to the variance in emotion inference from vocal expressions for four emotion families (fear, anger, happiness, and sadness). While the results confirm the central role of arousal in vocal emotion communication, the utility of applying an extended path modeling framework is demonstrated by the identification of unique combinations of distal cues and proximal percepts carrying information about specific emotion families, independent of arousal. The statistical models generated show that more sophisticated acoustic parameters need to be developed to explain the distal underpinnings of subjective voice quality percepts that account for much of the variance in emotion inference, in particular voice instability and roughness. The general approach advocated here, as well as the specific results, open up new research strategies for work in psychology (specifically emotion and social perception research) and engineering and computer science (specifically research and development in the domain of affective computing, particularly on automatic emotion detection and synthetic emotion expression in avatars).	[Banziger, Tanja] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden; [Hosoya, Georg] Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany; [Scherer, Klaus R.] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	Mid-Sweden University; Free University of Berlin; University of Geneva	Scherer, KR (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	Klaus.Scherer@unige.ch	Hosoya, Georg/AAY-2498-2020	Hosoya, Georg/0000-0002-8130-2259	Swiss National Science Foundation [100014-122491]; European Research Council Advanced grant [230331]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council Advanced grant(European Research Council (ERC))	The research program as a whole was supported by funds from Swiss National Science Foundation grant (100014-122491) and European Research Council Advanced grant (no. 230331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2012, J PERS SOC PSYCHOL, V103, P718, DOI 10.1037/a0029395; Anolli L, 2008, J CROSS CULT PSYCHOL, V39, P565, DOI 10.1177/0022022108321178; B?nziger T., 2010, BLUEPRINT AFFECTIVE, P271, DOI DOI 10.1037/A0025827; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Banziger T, 2014, J NONVERBAL BEHAV, V38, P31, DOI 10.1007/s10919-013-0165-x; Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bernieri FJ, 2001, LEA SER PER CLIN PSY, P67; Boersma P., 2010, PRAAT DOING PHONETIC; Brunswik E., 1956, PERCEPTION REPRESENT; Cartei V, 2014, HORM BEHAV, V66, P569, DOI 10.1016/j.yhbeh.2014.08.006; Chuenwattanapranithi S, 2008, PHONETICA, V65, P210, DOI 10.1159/000192793; DUNCAN OD, 1966, AM J SOCIOL, V72, P1, DOI 10.1086/224256; Eyben F, IEEE TRANSACTIONS ON; GIFFORD R, 1994, J PERS SOC PSYCHOL, V66, P398, DOI 10.1037/0022-3514.66.2.398; Goudbeek M, 2010, J ACOUST SOC AM, V128, P1322, DOI 10.1121/1.3466853; HAMMOND KR, 1964, PSYCHOL REV, V71, P438, DOI 10.1037/h0040736; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hirschmuller S, 2013, J PERS SOC PSYCHOL, V104, P335, DOI 10.1037/a0030383; HURSCH CJ, 1964, PSYCHOL REV, V71, P42, DOI 10.1037/h0041729; Juslin P., 1998, FUNCTIONALIST PERSPE; Juslin PN, 2006, J EXP PSYCHOL-APPL, V12, P79, DOI 10.1037/1076-898X.12.2.79; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; Kappas A, 1991, FUNDAMENTALS NONVERB, P200; Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404; Ko SJ, 2015, PSYCHOL SCI, V26, P3, DOI 10.1177/0956797614553009; Min CS, 2011, COGNITION EMOTION, V25, P1376, DOI 10.1080/02699931.2010.544865; Muthen B., 2010, MPLUS USERS GUIDE; Nestler S, 2012, J PERS SOC PSYCHOL, V103, P689, DOI 10.1037/a0029461; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Patel S., 2013, HDB NONVERBAL COMMUN, P167; Patel S, 2011, BIOL PSYCHOL, V87, P93, DOI 10.1016/j.biopsycho.2011.02.010; Reynolds DJ, 2001, PERS SOC PSYCHOL B, V27, P187, DOI 10.1177/0146167201272005; Rule NO, 2013, J PERS SOC PSYCHOL, V104, P409, DOI 10.1037/a0031050; Sauter DA, 2010, Q J EXP PSYCHOL, V63, P2251, DOI 10.1080/17470211003721642; Scherer KR, 2013, STRUNGMANN FORUM REP, P107; Scherer KR, 2011, INT J PSYCHOL, V46, P401, DOI 10.1080/00207594.2011.626049; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Scherer KR, 2003, SER AFFECTIVE SCI, P433; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; SCHERER KR, 1978, EUR J SOC PSYCHOL, V8, P467, DOI 10.1002/ejsp.2420080405; Shuman V, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00261, 10.3389/fpsyg.2013.00922]; Spackman MP, 2009, COGNITION EMOTION, V23, P1565, DOI 10.1080/02699930802536268; Stanislavski K., 1988, ACTOR PREPARES; TARTTER VC, 1980, PERCEPT PSYCHOPHYS, V27, P24, DOI 10.3758/BF03199901; Thayer R. E., 1978, MOTIV EMOTION, V2, DOI [10.1007/BF00992729, DOI 10.1007/BF00992729]; TUCKER LR, 1964, PSYCHOL REV, V71, P528, DOI 10.1037/h0047061; Van Bezooijen RA., 1984, THESIS; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	54	34	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136675	10.1371/journal.pone.0136675	http://dx.doi.org/10.1371/journal.pone.0136675			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325076	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700055
J	O'Nions, E; Tick, B; Rijsdijk, F; Happe, F; Plomin, R; Ronald, A; Viding, E				O'Nions, Elizabeth; Tick, Beata; Rijsdijk, Fruhling; Happe, Francesca; Plomin, Robert; Ronald, Angelica; Viding, Essi			Examining the Genetic and Environmental Associations between Autistic Social and Communication Deficits and Psychopathic Callous-Unemotional Traits	PLOS ONE			English	Article							CONDUCT PROBLEMS; ANTISOCIAL-BEHAVIOR; GENERAL-POPULATION; SPECTRUM DISORDER; CHILDREN; CHILDHOOD; TWIN; EMPATHY; QUESTIONNAIRE; MULTIVARIATE	Background Difficulties in appropriate social interaction are characteristic of both children with autism spectrum disorders and children with callous-unemotional traits (who are at risk of developing psychopathy). Extant experimental studies suggest that the nature of atypical social cognition that characterises these two profiles is not identical. However, 'empathizing' difficulties have been hypothesised for both groups, raising questions about the degree of aetiological separation between social impairments that characterize each disorder. This study explored the relative contribution of independent vs. shared aetiological influences to social and communication impairments associated with autistic traits and callous-unemotional traits, indexed by parent-report in a population-based cohort of twins. Methods Participants were over 5,000 twin pairs from a UK cohort (the Twins Early Development Study; TEDS), assessed for callous-unemotional traits at 7 years and autistic social and communication impairments at 8 years. Multivariate model-fitting was used to explore the relative contribution of independent vs. overlapping genetic/environmental influences on these traits. Results Both social and communication impairments and callous-unemotional traits were highly heritable, although the genetic and environmental influences accounting for individual differences on each domain were predominantly independent. Conclusions Extant evidence from experimental and neuro-imaging studies has suggested that, despite some superficially overlapping behaviours, the social difficulties seen in children with autism spectrum disorders and callous-unemotional traits are largely distinct. The current study is the first to demonstrate considerable aetiological independence of the social interaction difficulties seen in children with autism spectrum disorders and those with callous-unemotional traits.	[O'Nions, Elizabeth; Tick, Beata; Rijsdijk, Fruhling; Happe, Francesca; Plomin, Robert; Viding, Essi] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [O'Nions, Elizabeth; Viding, Essi] UCL, Dev Risk & Resilience Unit, Clin Educ & Hlth Psychol Res Dept, Div Psychol & Language Sci, London, England; [Ronald, Angelica] Univ London, Dept Psychol Sci, London, England	University of London; King's College London; University of London; University College London; University of London	Viding, E (corresponding author), Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	e.viding@ucl.ac.uk	Ronald, Angelica/C-7812-2009	Ronald, Angelica/0000-0002-9576-2176; Rijsdijk, Fruhling/0000-0003-4762-2803; O'Nions, Elizabeth/0000-0003-4427-0910; Viding, Essi/0000-0001-8468-8874; Plomin, Robert/0000-0002-0756-3629; Happe, Francesca/0000-0001-9226-4000	UK Medical Research Council (MRC) [G0901245, G0500079]; Economic and Social Research Council 1+3 PhD studentship [ES/H031367/1]; MRC 1+3 PhD studentship [MR/J500380/1]; MRC [G0500079, G0901245, G9817803, G19/2] Funding Source: UKRI; Medical Research Council [G0500079, G9817803, G19/2, 1092728, G9817803B, G0901245] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council 1+3 PhD studentship; MRC 1+3 PhD studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Twins Early Development Study (TEDS) is supported by a program grant [G0901245; and previously G0500079] from the UK Medical Research Council (MRC). E. O'Nions was supported by an Economic and Social Research Council 1+3 PhD studentship [ES/H031367/1]. B. Tick was supported by an MRC 1+3 PhD studentship [MR/J500380/1]. We gratefully acknowledge the ongoing contribution of the participants in the Twins Early Development Study (TEDS) and their families.	Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Baron-Cohen S., 2011, ZERO DEGREES EMPATHY; BARONCOHEN S, 1989, J AUTISM DEV DISORD, V19, P579, DOI 10.1007/BF02212859; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Blair RJR, 1999, PERS INDIV DIFFER, V26, P477, DOI 10.1016/S0191-8869(98)00154-8; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Dadds MR, 2009, J CHILD PSYCHOL PSYC, V50, P599, DOI 10.1111/j.1469-7610.2008.02058.x; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; FRICK PJ, 1994, J ABNORM PSYCHOL, V103, P700, DOI 10.1037/0021-843X.103.4.700; Frick PJ., 2001, ANTISOCIAL PROCESS S; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Haworth CMA, 2012, TWIN RES HUM GENET, V16, P1; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Jones AP, 2010, J CHILD PSYCHOL PSYC, V51, P1188, DOI 10.1111/j.1469-7610.2010.02280.x; Jones AP, 2009, CRIM JUSTICE BEHAV, V36, P1198, DOI 10.1177/0093854809342949; Larsson H, 2007, PSYCHOL MED, V37, P15, DOI 10.1017/S003329170600907X; Lockwood PL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00760; Loehlin JC, 1996, BEHAV GENET, V26, P65, DOI 10.1007/BF02361160; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Murrie DC, 2007, J CHILD PSYCHOL PSYC, V48, P714, DOI 10.1111/j.1469-7610.2007.01734.x; Neale MC, 1992, METHODOLOGY GENETIC; O'Nions E, 2014, DEVELOPMENTAL SCI, V17, P786, DOI 10.1111/desc.12167; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Poythress NG, 2006, ASSESSMENT, V13, P107, DOI 10.1177/1073191105284279; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rijsdijk F, 2005, ENCY STAT BEHAV SCI; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Robinson EB, 2012, BEHAV GENET, V42, P245, DOI 10.1007/s10519-011-9500-3; Rogers J, 2006, PSYCHOL MED, V36, P1789, DOI 10.1017/S0033291706008853; Ronald A, 2011, MOL PSYCHIATR, V16, P1039, DOI 10.1038/mp.2010.82; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P1206, DOI 10.1097/01.chi.0000230165.54117.41; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Schwenck C, 2012, J CHILD PSYCHOL PSYC, V53, P651, DOI 10.1111/j.1469-7610.2011.02499.x; Scott FJ, 2002, AUTISM, V6, P9, DOI 10.1177/1362361302006001003; Scourfield J, 2004, ARCH GEN PSYCHIAT, V61, P489, DOI 10.1001/archpsyc.61.5.489; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2007, BRIT J PSYCHIAT, P190; Viding E, 2007, BRIT J PSYCHIAT, V190, pS33, DOI 10.1192/bjp.190.5.s33; Viding E, 2012, J ROY SOC MED, V105, P195, DOI 10.1258/jrsm.2011.110223; Wallace GL, 2012, J NEUROSCI, V32, P4856, DOI 10.1523/JNEUROSCI.6214-11.2012; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	45	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134331	10.1371/journal.pone.0134331	http://dx.doi.org/10.1371/journal.pone.0134331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325039	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360437700011
J	Gu, N; Ru, T; Wang, ZQ; Dai, YM; Zheng, MM; Xu, BY; Hu, YL				Gu, Ning; Ru, Tong; Wang, Zhiqun; Dai, Yimin; Zheng, Mingming; Xu, Biyun; Hu, Yali			Foley Catheter for Induction of Labor at Term: An Open-Label, Randomized Controlled Trial	PLOS ONE			English	Article							VAGINAL PROSTAGLANDIN-E2 GEL; BALLOON	Objective This study aimed to determine the optimal Foley catheter balloon volume (30-mL vs. 80-mL) and the maximum time for cervical ripening (12 hours vs. 24 hours) to improve vaginal delivery rate within 24 hours of induction. Methods We conducted an open-label, randomized controlled trial in a teaching hospital in China. Women with a term singleton pregnancy, cephalic presentation, intact membrane and an unfavorable cervix (Bishop score < 6) were randomly allocated, in 1: 1: 1: 1 ratio, to receive either one of the four treatments: (1) 30-mL balloon for a maximum of 12 hours, (2) 30-mL balloon for a maximum of 24 hours, (3) 80-mL balloon for a maximum of 12 hours, and (4) 80-mL balloon for a maximum of 24 hours. The primary outcome was vaginal delivery within 24 hours. Secondary outcomes included cesarean section rate and maternal/neonatal morbidity. Data were analyzed on a per-protocol basis. Results Five hundred and four women were recruited and randomized (126 women in each group); nine women did not receive the assigned intervention. More women achieved vaginal delivery within 24 hours in 12-hour Foley catheter groups than in the 24-hour Foley catheter groups (30-mL/12 hours: 54.5%, 30-mL/24 hours: 33.1%, 80-mL/12 hours: 46.4%, 80-mL/24 hours: 24.0%, p < 0.001). Cesarean section rates and the incidence of chorioaminonitis were comparable among four groups. After adjustment for confounding factors, both ripening time and balloon size did not affect the proportion of women delivered vaginally within 24 hours of induction. Conclusion For women with an unfavorable cervix at term, induction of labor with a Foley catheter is safe and effective. Higher balloon volume (80-mL vs. 30-mL) and longer ripening time (24 hours vs. 12 hours) would not shorten induction to delivery interval or reduce cesarean section rate.	[Gu, Ning; Ru, Tong; Wang, Zhiqun; Dai, Yimin; Zheng, Mingming; Hu, Yali] Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Xu, Biyun] Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing Medical University; Nanjing University	Hu, YL (corresponding author), Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China.	glyyhuyali@163.com		Gu, Ning/0000-0002-1854-5311	National Key Clinical Department of Ministry of Health of China [2011271]; Research Grant for Maternal and Infant Health, from the Department of Health of Jiangsu Province [F201328]	National Key Clinical Department of Ministry of Health of China; Research Grant for Maternal and Infant Health, from the Department of Health of Jiangsu Province	This study was supported by the National Key Clinical Department of Ministry of Health of China (2011271) and Research Grant for Maternal and Infant Health, from the Department of Health of Jiangsu Province (F201328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; Cromi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.020; Delaney S, 2010, OBSTET GYNECOL, V115, P1239, DOI 10.1097/AOG.0b013e3181dec6d0; HAUTH JC, 1985, OBSTET GYNECOL, V66, P59; Heinemann J, 2008, AM J OBSTET GYNECOL, V199, P177, DOI 10.1016/j.ajog.2008.05.005; Jozwiak M, 2012, COCHRANE DB SYST REV, V14, P3, DOI DOI 10.1002/14651858.CD001233.PUB2/PDF/STANDARD; Jozwiak M, 2011, LANCET, V378, P2095, DOI 10.1016/S0140-6736(11)61484-0; Levy R, 2004, AM J OBSTET GYNECOL, V191, P1632, DOI 10.1016/j.ajog.2004.03.033; Pennell CE, 2009, BJOG-INT J OBSTET GY, V116, P1443, DOI 10.1111/j.1471-0528.2009.02279.x; Prager M, 2008, BJOG-INT J OBSTET GY, V115, P1443, DOI 10.1111/j.1471-0528.2008.01843.x; Rouse DJ, 2011, OBSTET GYNECOL, V117, P267, DOI 10.1097/AOG.0b013e318207887a; Uccella S, 2011, AM J OBSTET GYNECOL, V205, pE6, DOI 10.1016/j.ajog.2011.08.013; van Baaren GJ, 2013, BJOG-INT J OBSTET GY, V120, P987, DOI 10.1111/1471-0528.12221; Zheng MM, 2011, J PERINATAL MED, V14, P648	15	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136856	10.1371/journal.pone.0136856	http://dx.doi.org/10.1371/journal.pone.0136856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322635	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500042
J	Boussaha, M; Esquerre, D; Barbieri, J; Djari, A; Pinton, A; Letaief, R; Salin, G; Escudie, F; Roulet, A; Fritz, S; Samson, F; Grohs, C; Bernard, M; Klopp, C; Boichard, D; Rocha, D				Boussaha, Mekki; Esquerre, Diane; Barbieri, Johanna; Djari, Anis; Pinton, Alain; Letaief, Rabia; Salin, Gerald; Escudie, Frederic; Roulet, Alain; Fritz, Sebastien; Samson, Franck; Grohs, Cecile; Bernard, Maria; Klopp, Christophe; Boichard, Didier; Rocha, Dominique			Genome-Wide Study of Structural Variants in Bovine Holstein, Montbeliarde and Normande Dairy Breeds	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; COMMON DELETION POLYMORPHISMS; SEGMENTAL DUPLICATIONS; SCALE VARIATION; BLACK ANGUS; SHORT-READ; CATTLE; POPULATION; SNP; SEQUENCE	High-throughput sequencing technologies have offered in recent years new opportunities to study genome variations. These studies have mostly focused on single nucleotide polymorphisms, small insertions or deletions and on copy number variants. Other structural variants, such as large insertions or deletions, tandem duplications, translocations, and inversions are less well-studied, despite that some have an important impact on phenotypes. In the present study, we performed a large-scale survey of structural variants in cattle. We report the identification of 6,426 putative structural variants in cattle extracted from whole-genome sequence data of 62 bulls representing the three major French dairy breeds. These genomic variants affect DNA segments greater than 50 base pairs and correspond to deletions, inversions and tandem duplications. Out of these, we identified a total of 547 deletions and 410 tandem duplications which could potentially code for CNVs. Experimental validation was carried out on 331 structural variants using a novel high-throughput genotyping method. Out of these, 255 structural variants (77%) generated good quality genotypes and 191 (75%) of them were validated. Gene content analyses in structural variant regions revealed 941 large deletions removing completely one or several genes, including 10 single-copy genes. In addition, some of the structural variants are located within quantitative trait loci for dairy traits. This study is a pan-genome assessment of genomic variations in cattle and may provide a new glimpse into the bovine genome architecture. Our results may also help to study the effects of structural variants on gene expression and consequently their effect on certain phenotypes of interest.	[Boussaha, Mekki; Letaief, Rabia; Fritz, Sebastien; Grohs, Cecile; Boichard, Didier; Rocha, Dominique] INRA, UMR1313, Genet Anim & Biol Integrat, Jouy En Josas, France; [Boussaha, Mekki; Letaief, Rabia; Fritz, Sebastien; Grohs, Cecile; Boichard, Didier; Rocha, Dominique] AgroParisTech, UMR1313, Genet Anim & Biol Integrat, Jouy En Josas, France; [Esquerre, Diane; Barbieri, Johanna; Pinton, Alain; Salin, Gerald; Escudie, Frederic; Roulet, Alain] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Esquerre, Diane; Barbieri, Johanna; Pinton, Alain; Salin, Gerald; Escudie, Frederic; Roulet, Alain] Univ Toulouse, INPT, ENSAT, Genet Physiol & Syst Elevage UMR1388, Castanet Tolosan, France; [Esquerre, Diane; Barbieri, Johanna; Pinton, Alain; Salin, Gerald; Escudie, Frederic; Roulet, Alain] Univ Toulouse, INPT, ENVT, Genet Physiol & Syst Elevage UMR1388, Toulouse, France; [Djari, Anis; Bernard, Maria; Klopp, Christophe] INRA, SIGENAE, UR 875, INRA Auzeville, F-31326 Castanet Tolosan, France; [Fritz, Sebastien] Union Natl Cooperat Agr Elevage & Inseminat Anim, Paris, France; INRA, UR1077, Math Informat & Genome, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Boussaha, M (corresponding author), INRA, UMR1313, Genet Anim & Biol Integrat, Jouy En Josas, France.	mekki.boussaha@jouy.inra.fr	Klopp, Christophe/J-3164-2019; Pinton, Alain/AAQ-1648-2020; Rocha, Dominique/R-5546-2019; Boichard, Didier/AAD-8675-2020	Klopp, Christophe/0000-0001-7126-5477; Pinton, Alain/0000-0002-0809-7180; Rocha, Dominique/0000-0003-4998-9641; Boichard, Didier/0000-0003-0361-2961; FRITZ, Sebastien/0000-0002-3378-1048; Bernard, Maria/0000-0001-9005-5563; boussaha, mekki/0000-0002-5432-4604; Roulet, Alain/0000-0002-2824-9954	INRA; Agence Nationale de la Recherche [ANR-10-GENM-018]; Apis-Gene	INRA; Agence Nationale de la Recherche(French National Research Agency (ANR)); Apis-Gene	This work was funded by INRA, the Agence Nationale de la Recherche (contract ANR-10-GENM-018) and Apis-Gene. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Barris W, 2012, ANIM PROD SCI, V52, P133, DOI 10.1071/AN11095; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Canavez FC, 2012, J HERED, V103, P342, DOI 10.1093/jhered/esr153; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Choi JW, 2013, MAMM GENOME, V24, P151, DOI 10.1007/s00335-013-9449-z; Cicconardi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-124; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Drogemuller C, 2001, GENOME RES, V11, P1699, DOI 10.1101/gr.182501; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Falush D, 2003, GENETICS, V164, P1567; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hirano T, 2000, GENOME RES, V10, P659, DOI 10.1101/gr.10.5.659; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jansen S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-446; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048732; Kadri NK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004049; Kijas JW, 2011, GENE, V482, P73, DOI 10.1016/j.gene.2011.04.011; Koch CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077841; Koks S, 2014, MAMM GENOME, V25, P363, DOI 10.1007/s00335-014-9511-5; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lee HJ, 2014, GENOME BIOL EVOL, V6, P1366, DOI 10.1093/gbe/evu102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XP, 2013, GENOME, V56, P592, DOI 10.1139/gen-2013-0082; Liu GE, 2008, DEV BIOLOGICALS, V132, P231, DOI 10.1159/000317165; Liu GE, 2011, MAMM GENOME, V22, P111, DOI 10.1007/s00335-010-9308-0; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McClure M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059251; McDaneld TG, 2014, J ANIM SCI, V92, P1378, DOI 10.2527/jas.2013-6821; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Meyers SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-337; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Ohba Y, 2000, GENOMICS, V68, P229, DOI 10.1006/geno.2000.6298; Pritchard JK, 2000, GENETICS, V155, P945; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shin DH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-240; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Sugimoto M, 2003, ANIM GENET, V34, P191, DOI 10.1046/j.1365-2052.2003.00990.x; Tsuda K, 2013, GENOMICS, V102, P372, DOI 10.1016/j.ygeno.2013.08.002; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venhoranta H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075659; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Xu LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-683; Xu LY, 2014, FUNCT INTEGR GENOMIC, V14, P333, DOI 10.1007/s10142-014-0371-6; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhan BJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-557; Zhang LZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-480; Zhang Q, 2014, MOL GENET GENOMICS; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	89	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135931	10.1371/journal.pone.0135931	http://dx.doi.org/10.1371/journal.pone.0135931			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317361	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100051
J	Koryachko, A; Matthiadis, A; Muhammad, D; Foret, J; Brady, SM; Ducoste, JJ; Tuck, J; Long, TA; Williams, C				Koryachko, Alexandr; Matthiadis, Anna; Muhammad, Durreshahwar; Foret, Jessica; Brady, Siobhan M.; Ducoste, Joel J.; Tuck, James; Long, Terri A.; Williams, Cranos			Clustering and Differential Alignment Algorithm: Identification of Early Stage Regulators in the Arabidopsis thaliana Iron Deficiency Response	PLOS ONE			English	Article							GENE-EXPRESSION DATA; TIME-SERIES DATA; TRANSCRIPTIONAL REGULATION; STRESS RESPONSES; NETWORKS; HOMEOSTASIS; ROOTS; ASSOCIATION; MATURATION; INFERENCE	Time course transcriptome datasets are commonly used to predict key gene regulators associated with stress responses and to explore gene functionality. Techniques developed to extract causal relationships between genes from high throughput time course expression data are limited by low signal levels coupled with noise and sparseness in time points. We deal with these limitations by proposing the Cluster and Differential Alignment Algorithm (CDAA). This algorithm was designed to process transcriptome data by first grouping genes based on stages of activity and then using similarities in gene expression to predict influential connections between individual genes. Regulatory relationships are assigned based on pairwise alignment scores generated using the expression patterns of two genes and some inferred delay between the regulator and the observed activity of the target. We applied the CDAA to an iron deficiency time course microarray dataset to identify regulators that influence 7 target transcription factors known to participate in the Arabidopsis thaliana iron deficiency response. The algorithm predicted that 7 regulators previously unlinked to iron homeostasis influence the expression of these known transcription factors. We validated over half of predicted influential relationships using qRT-PCR expression analysis in mutant backgrounds. One predicted regulator-target relationship was shown to be a direct binding interaction according to yeast one-hybrid (Y1H) analysis. These results serve as a proof of concept emphasizing the utility of the CDAA for identifying unknown or missing nodes in regulatory cascades, providing the fundamental knowledge needed for constructing predictive gene regulatory networks. We propose that this tool can be used successfully for similar time course datasets to extract additional information and infer reliable regulatory connections for individual genes.	[Koryachko, Alexandr; Tuck, James; Williams, Cranos] N Carolina State Univ, Elect & Comp Engn, Raleigh, NC 27695 USA; [Matthiadis, Anna; Muhammad, Durreshahwar; Long, Terri A.] N Carolina State Univ, Plant & Microbial Biol, Raleigh, NC 27695 USA; [Foret, Jessica; Brady, Siobhan M.] Univ Calif Davis, Plant Biol, Davis, CA 95616 USA; [Ducoste, Joel J.] N Carolina State Univ, Civil Construct & Environm Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of California System; University of California Davis; University of North Carolina; North Carolina State University	Long, TA (corresponding author), N Carolina State Univ, Plant & Microbial Biol, Raleigh, NC 27695 USA.	terri_long@ncsu.edu; cmwilli5@ncsu.edu	Tuck, James M/I-3418-2018; Brady, Siobhan/AAY-1729-2021; Ducoste, Joel/A-1964-2016; Long, Terri/AAA-1984-2020	Tuck, James M/0000-0001-8975-0294; Ducoste, Joel/0000-0002-3021-3942; Long, Terri/0000-0001-7846-0195; Matthiadis, Anna/0000-0002-2465-8451; Brady, Siobhan/0000-0001-9424-8055	National Science Foundation [1247427]; National Science Foundation Graduate Research Fellowship [1252376]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by National Science Foundation (www.nsf.gov) grant no. 1247427: CW JJD TAL JT and National Science Foundation Graduate Research Fellowship (www.nsf.gov) grant no. 1252376: AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BARKER NA, 2011, COMPUTATIONAL BIOL B, V8, P152, DOI DOI 10.1109/TCBB.2009.48; Barr MS, 2012, PLANT SIGNAL BEHAV, V7, P205, DOI 10.4161/psb.18893; Bickel DR, 2005, BIOINFORMATICS, V21, P1121, DOI 10.1093/bioinformatics/bti140; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gao MJ, 2009, PLANT CELL, V21, P54, DOI 10.1105/tpc.108.061309; Gaudinier A, 2011, NAT METHODS, V8, P1053, DOI [10.1038/NMETH.1750, 10.1038/nmeth.1750]; Grillet L, 2013, FRONT PLANT SCI, V4; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Iyer-Pascuzzi AS, 2011, DEV CELL, V21, P770, DOI 10.1016/j.devcel.2011.09.009; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Kabir M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S56; Karas B, 2009, PLANT PHYSIOL, V151, P1175, DOI 10.1104/pp.109.143867; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Kwon AT, 2003, BIOINFORMATICS, V19, P905, DOI 10.1093/bioinformatics/btg106; Lin W.-D., 2011, PLANT PHYSIOL, P110; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Ma PCH, 2008, IEEE T FUZZY SYST, V16, P455, DOI 10.1109/TFUZZ.2007.894969; Ma Patrick C H, 2007, J Bioinform Comput Biol, V5, P651, DOI 10.1142/S0219720007002692; Misra A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-126; Nie J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-53; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Palmer CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003953; Ram R., 2006, COMP INT BIOINF COMP, P1, DOI [10.1109/CIBCB.2006.330982, DOI 10.1109/CIBCB.2006.330982]; Redestig H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-454; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosa BA, 2012, BIOINFORMATICS, V28, P2773, DOI 10.1093/bioinformatics/bts511; Roschzttardtz H, 2011, PLANT CELL, V23, P2725, DOI 10.1105/tpc.111.088088; Rueda L, 2008, LECT NOTES COMPUT SC, V5410, P100, DOI 10.1007/978-3-540-92273-5_6; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804; Selote D, 2014, PLANT PHYSIOL, P114; Shi YX, 2007, BIOINFORMATICS, V23, P755, DOI 10.1093/bioinformatics/btl676; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Sivitz AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044843; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zhang J, 2015, PLANT CELL, V27, P787, DOI 10.1105/tpc.114.132704; Zhao WT, 2006, BIOINFORMATICS, V22, P2129, DOI 10.1093/bioinformatics/btl364; Zheng Y, 2006, INT J DATA MIN BIOIN, V1, P111, DOI 10.1504/IJDMB.2006.010851	52	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136591	10.1371/journal.pone.0136591	http://dx.doi.org/10.1371/journal.pone.0136591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317202	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100106
J	Mouzaki, A; Rodi, M; Dimisianos, N; Emmanuil, A; Kalavrizioti, D; Lagoudaki, R; Grigoriadis, NC; Papathanasopoulos, P				Mouzaki, Athanasia; Rodi, Maria; Dimisianos, Nikolaos; Emmanuil, Andreas; Kalavrizioti, Dimitra; Lagoudaki, Rosa; Grigoriadis, Nikolaos C.; Papathanasopoulos, Panagiotis			Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; BLOOD MONONUCLEAR-CELLS; T-CELLS; CEREBROSPINAL-FLUID; AUTOIMMUNE INFLAMMATION; B-CELLS; NEUROMYELITIS-OPTICA; CYTOKINE PROFILE; DISEASE; INTERLEUKIN-17	Background/Aim Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Effector T helper cells, mainly Th1 and Th17, cytotoxic T-cells, B-cells, macrophages, microglia, and the cytokines they secrete, are implicated in the initiation and maintenance of a deregulated immune response to myelin antigens and the ensuing immune-mediated demyelination. In this study, we investigated whether signature cytokines exist in MS patients at presentation to gain an insight into the underlying immunopathogenic processes at the early stage of the disease. Methods We collected serum and cerebrospinal fluid (CSF) samples from 123 patients at presentation, eventually diagnosed with MS or non-inflammatory (NIND) or inflammatory neurological diseases (IND) or symptomatic controls (SC). The levels of cytokines IFN-gamma, TNF-alpha, TGF-beta 1, IL-2, IL-4, IL-6, IL-10 and IL-17 were measured, and cytokine ratios, such as Th1/Th2, Th1/Th17, and Type-1/Type-2, were calculated. All parameters were tested for their correlations with the intrathecal IgG synthesis. Results Cytokine levels in CSF were lower than in serum in all the patients, with the exception of IL6. Serum or CSF cytokine levels of MS patients did not differ significantly from NIND or SC, with the exception of serum IFN-gamma and TNF-alpha that were significantly higher in NIND. IND patients presented with the highest levels of all cytokines in serum and CSF, with the exception of serum IL-10 and CSF IL-17. MS patients had a significantly lower serum Th1/Th2 ratio compared to the NIND and IND groups, and significantly lower serum Type-1/Type-2, IFN-gamma/IL-10 and CSF Th1/Th17 ratios compared to IND patients. MS patients had a significantly higher CSF IL-17/IL-10 ratio compared to IND patients. The IgG index was higher in MS patients compared to the control groups; the differences reached statistical significance between the MS and the NIND and SC groups. Reiber-Felgenhauer analysis of the QIgG and QAlb indices revealed higher intrathecal IgG synthesis in MS patients, and higher blood-CSF barrier dysfunction in IND patients. The IgG index correlated with CSF IL-4 in MS patients only. Conclusions We found no signature cytokines or profiles thereof in MS patients at presentation. Only IND patients presented with a clear Th1 cytokine polarization in serum and CSF. The parameters that distinguished MS patients from patients with other neurological disorders were IgG intrathecal synthesis, the IgG index and its correlation with CSF IL-4 levels.	[Mouzaki, Athanasia; Rodi, Maria; Kalavrizioti, Dimitra] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece; [Dimisianos, Nikolaos; Papathanasopoulos, Panagiotis] Patras Univ Hosp, Dept Neurol, Patras, Greece; [Emmanuil, Andreas] Patras Univ Hosp, Hematol Lab, Patras, Greece; [Lagoudaki, Rosa; Grigoriadis, Nikolaos C.] AHEPA Univ Hosp, Dept Neurol, Thessaloniki, Greece	University of Patras; University of Patras; University of Patras; Aristotle University of Thessaloniki; Ahepa University Hospital	Mouzaki, A (corresponding author), Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece.	mouzaki@upatras.gr		Rodi, Maria/0000-0001-6578-0851	Greek General Secretariat of Research and Technology "Cooperation" grant [09SYN-21-69]; Genesis Pharma S.A.	Greek General Secretariat of Research and Technology "Cooperation" grant; Genesis Pharma S.A.	This work was supported by the Greek General Secretariat of Research and Technology "Cooperation" grant 09SYN-21-69 (O.P. Competitiveness & Entrepreneurship, EPAN II) to AM, and by an unconditional grant by Genesis Pharma S.A. to ND. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatab S, 2011, MINERVA MED, V102, P461; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Awad A, 2010, J NEUROIMMUNOL, V219, P1, DOI 10.1016/j.jneuroim.2009.09.002; Barun B, 2012, CLIN IMMUNOL, V142, P31, DOI 10.1016/j.clim.2011.04.005; Chatzantoni K, 2004, J AUTOIMMUN, V23, P169, DOI 10.1016/j.jaut.2004.05.007; Chatzantoni K., 2009, NEUROVASCULAR MED PU, P345; Chen Z, 2008, CYTOKINE, V41, P71, DOI 10.1016/j.cyto.2007.09.009; Codarri L, 2010, CURR OPIN NEUROL, V23, P205, DOI 10.1097/WCO.0b013e3283391feb; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Deraos G, 2008, J MED CHEM, V51, P7834, DOI 10.1021/jm800891n; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Edwards LJ, 2010, CYTOKINE, V50, P19, DOI 10.1016/j.cyto.2009.12.003; Frisullo G, 2008, CYTOKINE, V44, P22, DOI 10.1016/j.cyto.2008.08.007; Graber JJ, 2008, J NEUROIMMUNOL, V196, P124, DOI 10.1016/j.jneuroim.2008.02.008; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Johansson-Lindbom B, 2002, J IMMUNOL, V168, P3165, DOI 10.4049/jimmunol.168.7.3165; Kallaur AP, 2013, MOL MED REP, V7, P1010, DOI 10.3892/mmr.2013.1256; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lassmann H., 2010, CLIN EXP NEUROIMMUNO, V1, P2, DOI [10.1111/j.1759-1961.2009.00003.x, DOI 10.1111/J.1759-1961.2009.00003.X]; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lublin FD, 2008, NEUROLOGY CLIN PRACT, P1583; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Panitsas FP, 2004, BLOOD, V103, P2645, DOI 10.1182/blood-2003-07-2268; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Saruhan-Direskeneli G, 2003, J NEUROIMMUNOL, V145, P127, DOI 10.1016/j.jneuroim.2003.08.040; Sriram S, 2005, ANN NEUROL, V58, P939, DOI 10.1002/ana.20743; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wang KC, 2013, J INTERF CYTOK RES, V33, P58, DOI 10.1089/jir.2012.0040; Weissert R, 2013, J NEUROIMMUNE PHARM, V8, P857, DOI 10.1007/s11481-013-9467-3; Wekerle H, 2006, MCALPINES MULTIPLE S, P491; Wu AM, 2012, CAN J NEUROL SCI, V39, P813, DOI 10.1017/S0317167100015663; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	43	17	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135434	10.1371/journal.pone.0135434	http://dx.doi.org/10.1371/journal.pone.0135434			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317430	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100028
J	Sanchez-Antolin, G; Almohalla-Alvarez, C; Bueno, P; Almansa, R; Iglesias, V; Rico, L; Ortega, A; Munoz-Conejero, E; Garcia-Pajares, F; Bermejo-Martin, JF				Sanchez-Antolin, Gloria; Almohalla-Alvarez, Carolina; Bueno, Pilar; Almansa, Raquel; Iglesias, Veronica; Rico, Lucia; Ortega, Alicia; Munoz-Conejero, Eva; Garcia-Pajares, Felix; Bermejo-Martin, Jesus F.			Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; LARGE GENE LISTS; HEPATOCELLULAR-CARCINOMA; HEPATIC-FIBROSIS; EXPRESSION; MECHANISMS; SIGNATURE; MARKERS; SYSTEM	The role of systemic immunity in the pathogenesis of cirrhosis is not fully understood. Analysis of transcriptomic profiles in blood is an easy approach to obtain a wide picture of immune response at the systemic level. We studied gene expression profiles in blood from thirty cirrhotic patients and compared them against those of eight healthy volunteers. Most of our patients were male [n = 21, 70%] in their middle ages [57.4 +/- 6.8 yr]. Alcohol abuse was the most frequent cause of cirrhosis (n = 22, 73%). Eleven patients had hepatocellular carcinoma (36.7%). Eight patients suffered from hepatitis C virus infection (26.7%). We found a signature constituted by 3402 genes which were differentially expressed in patients compared to controls (2802 over-expressed and 600 under-expressed). Evaluation of this signature evidenced the existence of an active pro-fibrotic transcriptomic program in the cirrhotic patients, involving the [extra-cellular matrix (ECM)-receptor interaction] & [TGF-beta signaling] pathways along with the [Cell adhesion molecules] pathway. This program coexists with alterations in pathways participating in [Glycine, serine and threonine metabolism], [Phenylalanine metabolism], [Tyrosine metabolism], [ABC transporters], [Purine metabolism], [Arachidonic acid metabolism]. In consequence, our results evidence the coexistence in blood of a genomic program mediating pro-fibrotic mechanisms and metabolic alterations in advanced cirrhosis. Monitoring expression levels of the genes involved in these programs could be of interest for predicting/monitoring cirrhosis evolution. These genes could constitute therapeutic targets in this disease.	[Sanchez-Antolin, Gloria; Almohalla-Alvarez, Carolina; Garcia-Pajares, Felix] Hosp Univ Rio Hortega, Unidad Trasplante Hepaico, Unidad Hepatol, Valladolid, Spain; [Bueno, Pilar] Hosp Clin Univ Valladolid, Serv Analisis Clin, Valladolid, Spain; [Almansa, Raquel; Iglesias, Veronica; Rico, Lucia; Ortega, Alicia; Bermejo-Martin, Jesus F.] Hosp Clin Univ Valladolid IECSCYL, Invest Med Infecc & Inmunidad IMI, Valladolid, Spain; [Munoz-Conejero, Eva] Escuela Enfermeria Univ Valladolid, Valladolid, Spain	Hospital del Rio Hortega	Sanchez-Antolin, G (corresponding author), Hosp Univ Rio Hortega, Unidad Trasplante Hepaico, Unidad Hepatol, Valladolid, Spain.	gloriasanchez_antolin@hotmail.com	Almansa, Raquel/T-3414-2019; Bermejo-Martin, Jesus F/J-4574-2019	Bermejo-Martin, Jesus F/0000-0002-7998-6268; Almansa, Raquel/0000-0002-4144-7808; Sanchez Antolin, Gloria/0000-0003-2108-4971; Almohalla, Carolina/0000-0002-7295-0027	Consejeria de Sanidad de Castilla y Leon, Proyectos de la Gerencia REgional de Salud; Instituto de SAlud Carloss III, Spain, EMER 07/050	Consejeria de Sanidad de Castilla y Leon, Proyectos de la Gerencia REgional de Salud; Instituto de SAlud Carloss III, Spain, EMER 07/050	This work was supported by the Consejeria de Sanidad de Castilla y Leon, Proyectos de la Gerencia REgional de Salud, (https://www.saludcastillayleon.es/es) and the Instituto de SAlud Carloss III, Spain, EMER 07/050, (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-41; Almansa R, 2015, J INFECTION, V70, P445, DOI 10.1016/j.jinf.2014.12.010; Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Estep JM, 2010, DIGEST DIS SCI, V55, P496, DOI 10.1007/s10620-009-0919-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kasprzycka M, 2015, CELL ADHES MIGR, V9, P83, DOI 10.4161/19336918.2014.994901; Kovalszky I, 1998, SCAND J GASTROENTERO, V33, P51, DOI 10.1080/003655298750026561; Lebensztejn DM, 2006, WORLD J GASTROENTERO, V12, P3338, DOI 10.3748/wjg.v12.i21.3338; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Pivonello C, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-27; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Sacerdoti D, 2015, PROSTAG OTH LIPID M, V120, P80, DOI 10.1016/j.prostaglandins.2015.05.008; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Sands CJ, 2015, AM J GASTROENTEROL, V110, P159, DOI 10.1038/ajg.2014.370; Scarpellini A, 2014, J AM SOC NEPHROL, V25, P1013, DOI 10.1681/ASN.2013050563; Shi M, 2014, EUR J CANCER, V50, P928, DOI 10.1016/j.ejca.2013.11.026; Tamayo E, 2014, CRIT CARE, V18, DOI 10.1186/cc13910; Tatrai P, 2006, LAB INVEST, V86, P1149, DOI 10.1038/labinvest.3700475; Tessari P, 2010, CURR OPIN CLIN NUTR, V13, P81, DOI 10.1097/MCO.0b013e32833383af; Utsunomiya T, 2007, WORLD J GASTROENTERO, V13, P383, DOI 10.3748/wjg.v13.i3.383; Yokomori H, 2015, MICRON, V76, P52, DOI 10.1016/j.micron.2015.03.009; Yue Beatrice, 2014, J Glaucoma, V23, pS20, DOI 10.1097/IJG.0000000000000108; Zhang B, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-30; Zhou WC, 2014, WORLD J GASTROENTERO, V20, P7312, DOI 10.3748/wjg.v20.i23.7312; Zhu CH, 2015, INT J CLIN EXP MED, V8, P5989	29	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137128	10.1371/journal.pone.0137128	http://dx.doi.org/10.1371/journal.pone.0137128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317806	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100207
J	Tapia, G; Boas, H; de Muinck, EJ; Cinek, O; Stene, LC; Torjesen, PA; Rasmussen, T; Ronningen, KS				Tapia, German; Boas, Hakon; de Muinck, Eric J.; Cinek, Ondrej; Stene, Lars C.; Torjesen, Peter A.; Rasmussen, Trond; Ronningen, Kjersti S.			Saffold Virus, a Human Cardiovirus, and Risk of Persistent Islet Autoantibodies in the Longitudinal Birth Cohort Study MIDIA	PLOS ONE			English	Article							GENETIC RISK; CHILDREN; INFECTIONS; ENTEROVIRUS; CIRCULATION; PARECHOVIRUS; PATHOGENESIS; AUTOIMMUNITY; POPULATION; DIARRHEA	The aim of this study was to describe the frequency and distribution of Saffold virus in longitudinal stool samples from children, and test for association with development of persistent autoantibodies predictive of type 1 diabetes. A cohort of Norwegian children carrying the HLA genotype associated with highest risk of type 1 diabetes ("DR4-DQ8/DR3-DQ2") was followed with monthly stool samples from 3 to 35 months of age. Blood samples were tested for autoantibodies to insulin, glutamic acid decarboxylase(65) and Islet Antigen-2. 2077 stool samples from 27 children with >= 2 repeatedly positive islet autoantibodies (cases), and 53 matched controls were analysed for Saffold virus genomic RNA by semi-quantitative realtime reverse transcriptase PCR. Saffold virus was found in 53 of 2077 (2.6%) samples, with similar proportions between cases (2.5%) and controls (2.6%). The probability of being infected by 3 years of age was 28% (95% CI 0.18-0.40). Viral quantities ranged from <1 to almost 10(5) copies/mu l. Estimated odds ratio between islet autoimmunity and infection episodes prior to seroconversion was 1.98 (95% CI: 0.57-6.91, p = 0.29). Saffold virus had no statistically significant association with islet autoimmunity.	[Tapia, German; Boas, Hakon] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway; [de Muinck, Eric J.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Cinek, Ondrej] Charles Univ Prague, Fac Med 2, Dept Paediat, Prague, Czech Republic; [Cinek, Ondrej] Univ Hosp Motol, Prague, Czech Republic; [Stene, Lars C.] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway; [Torjesen, Peter A.] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Rasmussen, Trond] Norwegian Inst Publ Hlth, Div Inst Resources, Dept IT & EHlth, Oslo, Norway; [Ronningen, Kjersti S.] Oslo Univ Hosp, Dept Pediat Res, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; Charles University Prague; Motol University Hospital; Norwegian Institute of Public Health (NIPH); University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Boas, H (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway.	hakon.boas@fhi.no	Tapia, German/AAS-8467-2020; Cinek, Ondrej/AAF-6664-2020	Tapia, German/0000-0002-1770-1183; Cinek, Ondrej/0000-0002-0526-8714; de Muinck, Eric/0000-0001-5606-3172; Boas, Hakon/0000-0002-5917-1563	Research Council of Norway [205086/F20, 185610/V40, 166515/V50]; Ministry of Health of the Czech Republic [IGA MZ 11465-5]; Project for the Conceptual Development of Research Organization [00064203]	Research Council of Norway(Research Council of Norway); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Project for the Conceptual Development of Research Organization	This work was supported by The Research Council of Norway (grant numbers 205086/F20 to GT, 185610/V40 to HB, 166515/V50 to KSR)m the Ministry of Health of the Czech Republic (IGA MZ 11465-5 to OC) and the Project for the Conceptual Development of Research Organization 00064203 (University Hospital Motol, Prague, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Bjornvold M, 2008, DIABETOLOGIA, V51, P589, DOI 10.1007/s00125-008-0932-0; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; CRAIGHEAD JE, 1968, SCIENCE, V162, P913, DOI 10.1126/science.162.3856.913; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Galama J, 2011, EMERG INFECT DIS, V17, P1572, DOI 10.3201/eid1708.101953; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Khamrin P, 2013, INFECT GENET EVOL, V13, P339, DOI 10.1016/j.meegid.2012.11.004; Khamrin P, 2011, EMERG INFECT DIS, V17, P1150, DOI [10.3201/eid1706.101983, 10.3201/eid/1706.101983]; Knip M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007690; Kolehmainen P, 2013, J MED VIROL, V85, P1619, DOI 10.1002/jmv.23659; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Naeem A, 2014, J GEN VIROL, V95, P1945, DOI 10.1099/vir.0.066498-0; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P1694, DOI 10.3201/eid1810.120793; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; PETROV PA, 1970, AM J TROP MED HYG, V19, P146, DOI 10.4269/ajtmh.1970.19.146; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Ren LL, 2009, EMERG INFECT DIS, V15, P1509, DOI 10.3201/eid1509.081531; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Simonen-Tikka ML, 2011, DIABETOLOGIA, V54, P2995, DOI 10.1007/s00125-011-2305-3; Simonen-Tikka ML, 2013, J MED VIROL, V85, P1678, DOI 10.1002/jmv.23625; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; Stene LC, 2007, J AUTOIMMUN, V29, P44, DOI 10.1016/j.jaut.2007.04.003; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Tapia G, 2011, PEDIATR DIABETES, V12, P58, DOI 10.1111/j.1399-5448.2010.00658.x; Tapia G, 2011, DIABETES CARE, V34, P151, DOI 10.2337/dc10-1413; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136849	10.1371/journal.pone.0136849	http://dx.doi.org/10.1371/journal.pone.0136849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317929	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100153
J	Tarczewska, A; Kozlowska, M; Dobryszycki, P; Kaus-Drobek, M; Dadlez, M; Ozyhar, A				Tarczewska, Aneta; Kozlowska, Malgorzata; Dobryszycki, Piotr; Kaus-Drobek, Magdalena; Dadlez, Michal; Ozyhar, Andrzej			Insight into the Unfolding Properties of Chd64, a Small, Single Domain Protein with a Globular Core and Disordered Tails	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; MOLTEN-GLOBULE; ACTIN-BINDING; CH DOMAINS; STATES; CALPONIN	Two major lipophilic hormones, 20-hydroxyecdysone (20E) and juvenile hormone (JH), govern insect development and growth. While the mode of action of 20E is well understood, some understanding of JH-dependent signalling has been attained only in the past few years, and the crosstalk of the two hormonal pathways remains unknown. Two proteins, the calponin-like Chd64 and immunophilin FKBP39 proteins, have recently been found to play pivotal roles in the formation of dynamic, multiprotein complex that cross-links these two signalling pathways. However, the molecular mechanism of the interaction remains unexplored. The aim of this work was to determine structural elements of Chd64 to provide an understanding of molecular basis of multiple interactions. We analysed Chd64 in two unrelated insect species, Drosophila melanogaster (DmChd64) and Tribolium castaneum (TcChd64). Using hydrogen-deuterium exchange mass spectrometry (HDX-MS), we showed that both Chd64 proteins have disordered tails that outflank the globular core. The folds of the globular cores of both Chd64 resemble the calponin homology (CH) domain previously resolved by crystallography. Monitoring the unfolding of DmChd64 and TcChd64 by far-ultraviolet (UV) circular dichroism (CD) spectroscopy, fluorescence spectroscopy and size-exclusion chromatography (SEC) revealed a highly complex process. Chd64 unfolds and forms of a molten globule (MG)-like intermediate state. Furthermore, our data indicate that in some conditions, Chd64 may exists in discrete structural forms, indicating that the protein is pliable and capable of easily acquiring different conformations. The plasticity of Chd64 and the existence of terminal intrinsically disordered regions (IDRs) may be crucial for multiple interactions with many partners.	[Tarczewska, Aneta; Kozlowska, Malgorzata; Dobryszycki, Piotr; Ozyhar, Andrzej] Wroclaw Univ Technol, Dept Biochem, Fac Chem, PL-50370 Wroclaw, Poland; [Kaus-Drobek, Magdalena; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Wroclaw University of Science & Technology; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Ozyhar, A (corresponding author), Wroclaw Univ Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	andrzej.ozyhar@pwr.edu.pl		OZYHAR, Andrzej/0000-0002-5874-784X; Dadlez, Michal/0000-0001-8811-5176; Kaus-Drobek, Magdalena/0000-0001-6202-4567	National Science Centre grant [2012/05/B/NZ1/00659]	National Science Centre grant(National Science Centre, Poland)	The work was supported by the National Science Centre grant (2012/05/B/NZ1/00659). The publication fee was covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Begg GE, 2001, CURR PROTOC PROTEIN; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; Chouard T, 2011, NATURE, V471, P151, DOI 10.1038/471151a; DEHAEN C, 1987, ANAL BIOCHEM, V166, P235, DOI 10.1016/0003-2697(87)90570-7; DeLano WL, 2002, PYMOL USERS MANUAL; Dobryszycki P, 1999, BBA-PROTEIN STRUCT M, V1431, P338, DOI 10.1016/S0167-4838(99)00055-2; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kozlowska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096809; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 1996, FOLD DES, V1, P117, DOI 10.1016/S1359-0278(96)00020-X; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	31	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137074	10.1371/journal.pone.0137074	http://dx.doi.org/10.1371/journal.pone.0137074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325194	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700089
J	Alba, P; Feltrin, F; Cordaro, G; Porrero, MC; Kraushaar, B; Argudin, MA; Nykasenoja, S; Monaco, M; Stegger, M; Aarestrup, FM; Butaye, P; Franco, A; Battisti, A				Alba, Patricia; Feltrin, Fabiola; Cordaro, Gessica; Concepcion Porrero, Maria; Kraushaar, Britta; Argudin, Maria Angeles; Nykasenoja, Suvi; Monaco, Monica; Stegger, Marc; Aarestrup, Frank M.; Butaye, Patrick; Franco, Alessia; Battisti, Antonio			Livestock-Associated Methicillin Resistant and Methicillin Susceptible Staphylococcus aureus Sequence Type (CC)1 in European Farmed Animals: High Genetic Relatedness of Isolates from Italian Cattle Herds and Humans	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR ASSAY; LONG-TERM; MRSA; IDENTIFICATION; PREVALENCE; DATABASE; STRAINS; REGION; MECA	Methicillin-resistant Staphylococcus aureus (MRSA) Sequence Type (ST)1, Clonal Complex( CC) 1, SCCmec V is one of the major Livestock-Associated (LA-) lineages in pig farming industry in Italy and is associated with pigs in other European countries. Recently, it has been increasingly detected in Italian dairy cattle herds. The aim of this study was to analyse the differences between ST1 MRSA and methicillin-susceptible S. aureus (MSSA) from cattle and pig herds in Italy and Europe and human isolates. Sixty-tree animal isolates from different holdings and 20 human isolates were characterized by pulsed-field gel electrophoresis (PFGE), spa-typing, SCCmec typing, and by micro-array analysis for several virulence, antimicrobial resistance, and strain/host-specific marker genes. Three major PFGE clusters were detected. The bovine isolates shared a high (>= 90% to 100%) similarity with human isolates and carried the same SCCmec type IVa. They often showed genetic features typical of human adaptation or present in human-associated CC1: Immune evasion cluster (IEC) genes sak and scn, or sea; sat and aphA3-mediated aminoglycoside resistance. Contrary, typical markers of porcine origin in Italy and Spain, like erm(A) mediated macrolide-lincosamide-streptograminB, and of vga(A)-mediated pleuromutilin resistance were always absent in human and bovine isolates. Most of ST(CC) 1 MRSA from dairy cattle were multidrug-resistant and contained virulence and immunomodulatory genes associated with full capability of colonizing humans. As such, these strains may represent a greater human hazard than the porcine strains. The zoonotic capacity of CC1 LA-MRSA from livestock must be taken seriously and measures should be implemented at farm-level to prevent spill-over.	[Alba, Patricia; Feltrin, Fabiola; Cordaro, Gessica; Franco, Alessia; Battisti, Antonio] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Diagnost Dept, Rome, Italy; [Concepcion Porrero, Maria] Univ Complutense Madrid, VISAVET Hlth Surveillance Ctr, Madrid, Spain; [Kraushaar, Britta] BfR Fed Inst Risk Assessment, Berlin, Germany; [Argudin, Maria Angeles; Butaye, Patrick] Vet & Agrochem Res Ctr VAR CODA CERVA, Groeselenberg, Belgium; [Nykasenoja, Suvi] Finnish Food Safety Author Evira, Helsinki, Finland; [Monaco, Monica] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Stegger, Marc] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Butaye, Patrick] Ross Univ, Sch Vet Med, Dept Biosci, Basseterre, St Kitts & Nevi; [Franco, Alessia] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Argudin, Maria Angeles] Univ Libre Bruxelles, Dept Microbiol, Hop Erasme Labo Reference MRSA Staphylocoques, Brussels, Belgium	IZS Lazio e Toscana; Complutense University of Madrid; Federal Institute for Risk Assessment; Finnish Food Authority; Istituto Superiore di Sanita (ISS); Statens Serum Institut; Technical University of Denmark; Ghent University; Universite Libre de Bruxelles	Battisti, A (corresponding author), Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Diagnost Dept, Rome, Italy.	antonio.battisti@izslt.it	Monaco, Monica/AAC-9666-2021; Butaye, Patrick/AAJ-8240-2020; MONACO, MONICA/C-8819-2016; studies, IT VISAVET Account for bibliometric/C-3115-2014; Alba, Patricia/T-3593-2018; Battisti, Antonio/AAQ-9243-2021; Argudin Regueiro, Maria Angeles/A-9684-2012	Monaco, Monica/0000-0002-6628-1621; MONACO, MONICA/0000-0002-6628-1621; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Alba, Patricia/0000-0002-9621-0955; Battisti, Antonio/0000-0003-1308-199X; Franco, Alessia/0000-0001-6968-973X; Aarestrup, Frank/0000-0002-7116-2723; Argudin Regueiro, Maria Angeles/0000-0003-4026-6447; Stegger, Marc/0000-0003-0321-1180; Butaye, Patrick/0000-0003-0780-6384	EMIDA ERA-NET (FP7-KBBE) European Union first transnational research call, Project "LA-MRSA" [68]	EMIDA ERA-NET (FP7-KBBE) European Union first transnational research call, Project "LA-MRSA"	Funded by EMIDA ERA-NET (FP7-KBBE) European Union first transnational research call, Project "LA-MRSA" (acronym title), ID 68.	Argudin MA, 2011, J MED MICROBIOL, V60, P172, DOI 10.1099/jmm.0.021758-0; Baron F, 2004, J FOOD PROTECT, V67, P2302, DOI 10.4315/0362-028X-67.10.2302; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Cortimiglia C, 2015, J DAIRY SCI, V98, P2307, DOI 10.3168/jds.2014-8923; Derbise A, 1996, PLASMID, V35, P174, DOI 10.1006/plas.1996.0020; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; European Medicines Agency, 2014, EMA3339212014; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Gentry DR, 2008, ANTIMICROB AGENTS CH, V52, P4507, DOI 10.1128/AAC.00915-08; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Luini M, 2015, VET MICROBIOL, V178, P270, DOI 10.1016/j.vetmic.2015.05.010; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Merialdi G, 2013, RES VET SCI, V94, P425, DOI 10.1016/j.rvsc.2012.10.020; Monaco M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-258; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Pilla R, 2012, VET REC, V170, DOI 10.1136/vr.100510; Shin CK, 1996, J MICROBIOL BIOTECHN, V6, P219; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; SU YC, 1995, APPL ENVIRON MICROB, V61, P1438, DOI 10.1128/AEM.61.4.1438-1443.1995; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vignaroli C, 2009, EMERG INFECT DIS, V15, P995, DOI 10.3201/eid1506.081632; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	32	76	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137143	10.1371/journal.pone.0137143	http://dx.doi.org/10.1371/journal.pone.0137143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322785	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000360435500067
J	Karstens, S; Joos, S; Hill, JC; Krug, K; Szecsenyi, J; Steinhauser, J				Karstens, Sven; Joos, Stefanie; Hill, Jonathan C.; Krug, Katja; Szecsenyi, Joachim; Steinhaeuser, Jost			General Practitioners Views of Implementing a Stratified Treatment Approach for Low Back Pain in Germany: A Qualitative Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE-SYSTEM; IMPACT BACK; START BACK; INTERVENTION; MANAGEMENT; THERAPY	Background and Objective The STarT Back stratified primary care approach has demonstrated clinical and cost effectiveness in the UK, and is commonly used by General Practitioners (GPs). However, it remains unknown how this approach could be implemented into the German healthcare system. The aim of this study was therefore to explore the views and perceptions of German GPs in respect to using a stratified primary care for low back pain (LBP). Methods A 90-minute think-tank workshop was conducted with 14 male and five female GPs, during which the STarT-Back-Screening-Tool (SBST) and related research evidence was presented. This was followed by two focus groups, based on a semi-structured interview guideline to identify potential implementation barriers and opportunities. Discussions were audiotaped, transcribed and coded using a content analysis approach. Results For the three deductively developed main themes, 15 subthemes emerged: (1) application of the SBST, with the following subthemes: which health profession should administer it, patients known to the GP practice, the reason for the GP consultation, scoring the tool, the tool format, and the anticipated impact on GP practice; (2) psychologically informed physiotherapy, with subthemes including: provision by a physiotherapist, anticipated impact, the skills of physiotherapists, management of patients with severe psychosocial problems, referral and remuneration; (3) the management of low-risk patients, with subthemes including: concern about the appropriate advising health professional, information and media, length of consultation, and local exercise venues. Conclusions The attitudes of GPs towards stratified primary care for LBP indicated positive support for pilot-testing in Germany. However, there were mixed reactions to the ability of German physiotherapists to manage high-risk patients and handle their complex clinical needs. GPs also mentioned practical difficulties in providing extended advice to low-risk patients, which nevertheless could be addressed by involvement of specifically trained medical assistants.	[Karstens, Sven; Joos, Stefanie; Krug, Katja; Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Hill, Jonathan C.] Keele Univ, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Steinhaeuser, Jost] Univ Hosp Schleswig Holstein, Inst Family Med, Lubeck, Germany	Ruprecht Karls University Heidelberg; Keele University; University of Kiel; Schleswig Holstein University Hospital	Karstens, S (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sven.karstens@med.uni-heidelberg.de	Hill, Jonathan/AAT-2744-2020; Karstens, Sven/AAF-7211-2020; Krug, Katja/AAV-5840-2020	Karstens, Sven/0000-0001-7403-3452; Krug, Katja/0000-0002-9795-7954	young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG); Ruprecht-Karls-Universitat Heidelberg	young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The study was funded by the young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' (http://www. versorgungsforschung-bw.de) of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg. Study design and preliminary results were discussed at the young scientists academy. We acknowledge financial support by Deutsche Forschungsgemeinschaft (DFG) and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing (http://www.ub.uni-heidelberg. de/service/openaccess/publikationsfonds.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Beaton DE, 2007, RECOMMENDATIONS CROS; Brunner E, 2013, DISABIL REHABIL, V35, P1, DOI 10.3109/09638288.2012.683848; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Chento J-F, 2014, VERSORGUNGS REPORT 2, P155; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Foster NE, 2013, BEST PRACT RES CL RH, V27, P649, DOI 10.1016/j.berh.2013.10.005; Freund T, 2015, INT J NURSING STUDIE; Hauser W, 2007, SCHMERZ, V21, P539, DOI 10.1007/s00482-007-0553-4; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hsu C, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-276; Institute of Primary Care and Health Sciences KU, START BACK TRANSL; Institute of Primary Care and Health Sciences KU, START BACJ SB TOOL O; Jager C, 2014, Z EVIDENZ FORTBILD Q, V108, P270, DOI 10.1016/j.zefq.2013.08.014; Jensen IB, 2009, PAIN, V142, P202, DOI 10.1016/j.pain.2008.12.015; Karstens S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061587; Keele IT Services, KEEL START BACK SCRE; Koch K, 2011, DTSCH ARZTEBL INT, V108, P255, DOI 10.3238/arztebl.2011.0255; Koch K, 2010, DTSCH ARZTEBL INT, V107, P427, DOI 10.3238/arztebl.2010.0427; Korzilius H., 2011, DTSCH ARZTEBL INT, V108, P984; Krueger RA, 1998, FOCUS GROUP KIT, V1-6; Laux G., 2010, ERGEBNISSE CONTENT P, P2006; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Main CJ, 2012, PHYSIOTHERAPY, V98, P110, DOI 10.1016/j.physio.2011.03.003; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; NHMRC, 2003, NAT HLTH MED RES COU; Nielsen M, 2014, PHYS THER, V94, P197, DOI 10.2522/ptj.20130047; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Sanders T, 2014, J HEALTH ORGAN MANAG, V28, P96, DOI 10.1108/JHOM-10-2011-0102; Sanders T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-65; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Schiltenwolf M, 2006, EUR SPINE J, V15, P1083, DOI 10.1007/s00586-005-0008-5; Schmidt CO, 2007, KLINIKARZT, V36, P680; Smeets RJEM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-5; Sowden G, 2012, FAM PRACT, V29, P50, DOI 10.1093/fampra/cmr037; van Bokhoven MA, 2003, QUAL SAF HEALTH CARE, V12, P215, DOI 10.1136/qhc.12.3.215; van der Zee J, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-94; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; Wensing M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101981	41	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136119	10.1371/journal.pone.0136119	http://dx.doi.org/10.1371/journal.pone.0136119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322985	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500016
J	Bufalino, A; Cervigne, NK; de Oliveira, CE; Fonseca, FP; Rodrigues, PC; Macedo, CCS; Sobral, LM; Miguel, MC; Lopes, MA; Leme, AFP; Lambert, DW; Salo, TA; Kowalski, LP; Graner, E; Coletta, RD				Bufalino, Andreia; Cervigne, Nilva K.; de Oliveira, Carine Ervolino; Fonseca, Felipe Paiva; Rodrigues, Priscila Campioni; Soares Macedo, Carolina Carneiro; Sobral, Lays Martin; Miguel, Marcia Costa; Lopes, Marcio Ajudarte; Paes Leme, Adriana Franco; Lambert, Daniel W.; Salo, Tuula A.; Kowalski, Luiz Paulo; Graner, Edgard; Coletta, Ricardo D.			Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; HUMAN BREAST; TGF-BETA; MESENCHYMAL TRANSITION; PROLIFERATION; EXPRESSION; GROWTH; METASTASIS; APOPTOSIS; INVASION	Deregulated expression of activin A is reported in several tumors, but its biological functions in oral squamous cell carcinoma (OSCC) are unknown. Here, we investigate whether activin A can play a causal role in OSCCs. Activin A expression was assessed by qPCR and immunohistochemistry in OSCC tissues. Low activin A-expressing cells were treated with recombinant activin A and assessed for apoptosis, proliferation, adhesion, migration, invasion and epithelial-mesenchymal transition (EMT). Those phenotypes were also evaluated in high activin A-expressing cells treated with follistatin (an activin A antagonist) or stably expressing shRNA targeting activin A. Transfections of microRNA mimics were performed to determine whether the overexpression of activin A is regulated by miR-143/miR-145 cluster. Activin A was overexpressed in OSCCs in comparison with normal oral mucosa, and high activin A levels were significantly associated with lymph node metastasis, tumor differentiation and poor survival. High activin A levels promoted multiple properties associated with malignant transformation, including decreased apoptosis and increased proliferation, migration, invasion and EMT. Both miR-143 and miR-145 were markedly downregulated in OSCC cell lines and in clinical specimens, and inversely correlated to activin A levels. Forced expression of miR-143 and miR-145 in OSCC cells significantly decreased the expression of activin A. Overexpression of activin A in OSCCs, which is controlled by downregulation of miR-143/miR-145 cluster, regulates apoptosis, proliferation and invasiveness, and it is clinically correlated with lymph node metastasis and poor survival.	[Bufalino, Andreia; Cervigne, Nilva K.; de Oliveira, Carine Ervolino; Fonseca, Felipe Paiva; Rodrigues, Priscila Campioni; Soares Macedo, Carolina Carneiro; Sobral, Lays Martin; Miguel, Marcia Costa; Lopes, Marcio Ajudarte; Salo, Tuula A.; Graner, Edgard; Coletta, Ricardo D.] Univ Estadual Campinas, Sch Dent, Dept Oral Diag, Piracicaba, SP, Brazil; [Miguel, Marcia Costa] Univ Fed Rio Grande do Norte, Dept Dent, BR-59072970 Natal, RN, Brazil; [Paes Leme, Adriana Franco] CNPEM, Brazilian Biociences Natl Lab, Campinas, SP, Brazil; [Lambert, Daniel W.] Univ Sheffield, Sch Clin Dent, Integrated Biosci, Sheffield, S Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, Sheffield Canc Ctr, Sheffield, S Yorkshire, England; [Salo, Tuula A.] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Salo, Tuula A.] Univ Oulu, Oulu Univ Hosp, Oulu, Finland; [Salo, Tuula A.] Univ Oulu, Med Res Ctr, Oulu, Finland; [Salo, Tuula A.] Univ Helsinki, Inst Dent, Helsinki, Finland; [Kowalski, Luiz Paulo] AC Camargo Canc Ctr, Dept Head & Neck Surg & Otorhinolaryngol, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal do Rio Grande do Norte; University of Sheffield; University of Sheffield; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; A.C.Camargo Cancer Center	Coletta, RD (corresponding author), Univ Estadual Campinas, Sch Dent, Dept Oral Diag, Piracicaba, SP, Brazil.	coletta@fop.unicamp.br	, tuula/ABG-2051-2021; MIGUEL, MÁRCIA COSTA/C-4059-2014; Fonseca, Felipe P/C-4158-2012; Bufalino, Andreia/H-7047-2014; Lopes, Marcio Ajudarte/AAV-1018-2020; Cervigne, Nilva K/L-1341-2016; Leme, Adriana F Paes/C-9679-2012; Coletta, Ricardo D./B-4909-2015; Kowalski, Luiz P/D-1701-2012; de Oliveira, Carine Ervolino/I-3087-2013; Graner, Edgard/K-4411-2012; Sobral, Lays M/G-4831-2012; Graner, Edgard/P-4651-2019	Fonseca, Felipe P/0000-0002-6657-4547; Bufalino, Andreia/0000-0002-6714-6253; Cervigne, Nilva K/0000-0002-6129-9136; Leme, Adriana F Paes/0000-0001-7959-147X; Coletta, Ricardo D./0000-0001-5285-3046; Kowalski, Luiz P/0000-0002-0481-156X; Graner, Edgard/0000-0002-4737-7935; Sobral, Lays M/0000-0002-8731-850X; Salo, Tuula/0000-0001-6039-0088; Carneiro Soares Macedo, Carolina/0000-0002-9858-8206; Campioni Rodrigues, Priscila/0000-0003-2770-1248; Ajudarte Lopes, Marcio/0000-0001-6677-0065; Miguel, Marcia/0000-0002-6661-2566	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Sao Paulo, Brazil [2010/52547-1, 2011/00691-7, 2013/01607-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Brasilia, Brazil [302464/2011-5, 473825/2013-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brasilia, Brazil [AUXPE-PVES-570/2013]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Sao Paulo, Brazil (2010/52547-1, 2011/00691-7 and 2013/01607-6); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Brasilia, Brazil (302464/2011-5 and 473825/2013-9); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brasilia, Brazil (AUXPE-PVES-570/2013).	Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chang KP, 2010, ANN SURG ONCOL, V17, P1945, DOI 10.1245/s10434-010-0926-2; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Chen YG, 2006, EXP BIOL MED, V231, P534; Cheng JC, 2014, BIOCHEM BIOPH RES CO, V443, P537, DOI 10.1016/j.bbrc.2013.12.010; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Deli A, 2008, WORLD J GASTROENTERO, V14, P1699, DOI 10.3748/wjg.14.1699; Drebber U, 2011, INT J ONCOL, V39, P409, DOI 10.3892/ijo.2011.1036; Ferreira MC, 2008, MOL HUM REPROD, V14, P301, DOI 10.1093/molehr/gan016; Gold E, 2012, MOL CELL ENDOCRINOL, V359, P107, DOI 10.1016/j.mce.2011.07.005; Hofland J, 2012, ENDOCRINOLOGY, V153, P5726, DOI 10.1210/en.2011-2065; Kang HY, 2009, J BONE MINER RES, V24, P1180, DOI [10.1359/JBMR.090219, 10.1359/jbmr.090219]; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kelner N, 2015, HEAD NECK-J SCI SPEC, V37, P479, DOI 10.1002/hed.23627; Kim YI, 2009, ONCOL REP, V21, P491, DOI 10.3892/or_00000249; Le Bras GF, 2014, LAB INVEST, V94, P1134, DOI 10.1038/labinvest.2014.97; Le Bras GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027063; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Murakami M, 2010, MOL BIOL REP, V37, P1279, DOI 10.1007/s11033-009-9502-x; Ottley E, 2012, CYTOKINE GROWTH F R, V23, P119, DOI 10.1016/j.cytogfr.2012.04.004; Reis FM, 2004, MOL CELL ENDOCRINOL, V225, P77, DOI 10.1016/j.mce.2004.02.016; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Shao Y, 2013, ONCOL LETT, V6, P1636, DOI 10.3892/ol.2013.1621; Sobral LM, 2011, ORAL ONCOL, V47, P840, DOI 10.1016/j.oraloncology.2011.06.011; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Valdimarsdottir G, 2005, APMIS, V113, P773, DOI 10.1111/j.1600-0463.2005.apm_3181.x; Wang BD, 2009, TOXICOLOGY, V258, P176, DOI 10.1016/j.tox.2009.01.023; Warnakulasuriya S, 2010, ORAL ONCOL, V46, P407, DOI 10.1016/j.oraloncology.2010.02.015; Wei JL, 2015, MOL MED REP, V11, P571, DOI 10.3892/mmr.2014.2675; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Wu DY, 2013, MOL MED REP, V8, P626, DOI 10.3892/mmr.2013.1501; Xu GH, 2013, NEURAL REGEN RES, V8, P1016, DOI 10.3969/j.issn.1673-5374.2013.11.007; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1	41	45	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136599	10.1371/journal.pone.0136599	http://dx.doi.org/10.1371/journal.pone.0136599			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317418	Green Published, gold, Green Accepted			2022-12-27	WOS:000360299100108
J	Filograna, R; Civiero, L; Ferrari, V; Codolo, G; Greggio, E; Bubacco, L; Beltramini, M; Bisaglia, M				Filograna, Roberta; Civiero, Laura; Ferrari, Vanni; Codolo, Gaia; Greggio, Elisa; Bubacco, Luigi; Beltramini, Mariano; Bisaglia, Marco			Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation	PLOS ONE			English	Article							NEURO-BLASTOMA CELLS; ACID-INDUCED DIFFERENTIATION; TRANS-RETINOIC ACID; IN-VITRO; DOPAMINERGIC-NEURONS; PROTEIN; EXPRESSION; OUTGROWTH; NEUROTOXICITY; STAUROSPORINE	Human cell lines are often used to investigate cellular pathways relevant for physiological or pathological processes or to evaluate cell toxicity or protection induced by different compounds, including potential drugs. In this study, we analyzed and compared the differentiating activities of three agents (retinoic acid, staurosporine and 12-O-tetradecanoylphorbol-13-acetate) on the human neuroblastoma SH-SY5Y and BE(2)-M17 cell lines; the first cell line is largely used in the field of neuroscience, while the second is still poorly characterized. After evaluating their effects in terms of cell proliferation and morphology, we investigated their catecholaminergic properties by assessing the expression profiles of the major genes involved in catecholamine synthesis and storage and the cellular concentrations of the neurotransmitters dopamine and noradrenaline. Our results demonstrate that the two cell lines possess similar abilities to differentiate and acquire a neuron-like morphology. The most evident effects in SH-SY5Y cells were observed in the presence of staurosporine, while in BE(2)-M17 cells, retinoic acid induced the strongest effects. Undifferentiated SH-SY5Y and BE(2)-M17 cells are characterized by the production of both NA and DA, but their levels are considerably higher in BE(2)-M17 cells. Moreover, the NAergic phenotype appears to be more pronounced in SH-SY5Y cells, while BE(2)-M17 cells have a more prominent DAergic phenotype. Finally, the catecholamine concentration strongly increases upon differentiation induced by staurosporine in both cell lines. In conclusion, in this work the catecholaminergic phenotype of the human BE(2)-M17 cell line upon differentiation was characterized for the first time. Our data suggest that SH-SY5Y and BE(2)-M17 represent two alternative cell models for the neuroscience field.	[Filograna, Roberta; Civiero, Laura; Ferrari, Vanni; Greggio, Elisa; Bubacco, Luigi; Beltramini, Mariano; Bisaglia, Marco] Univ Padua, Mol Physiol & Biophys Unit, Dept Biol, Padua, Italy; [Codolo, Gaia] Univ Padua, Gen Pathol Unit, Dept Biol, Padua, Italy	University of Padua; University of Padua	Beltramini, M (corresponding author), Univ Padua, Mol Physiol & Biophys Unit, Dept Biol, Padua, Italy.	mariano.beltramini@unipd.it; marco.bisaglia@unipd.it	Civiero, Laura/K-7665-2016; Civiero, Laura/GXG-2968-2022; Bubacco, Luigi/B-5602-2012	Civiero, Laura/0000-0002-5334-155X; Bubacco, Luigi/0000-0001-7927-9208; CODOLO, GAIA/0000-0002-7793-2549	University of Padova [PRAT2010-103503, PRAT2012-124045]; Italian Ministry of Education, University and Research [PRIN2010-M2JARJ]	University of Padova; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants obtained from the University of Padova (PRAT2010-103503, PRAT2012-124045) and the Italian Ministry of Education, University and Research (PRIN2010-M2JARJ).	Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; CICCARONE V, 1989, CANCER RES, V49, P219; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Daniele F, 2015, JOVE-J VIS EXP, DOI 10.3791/52267; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101; JALAVA A, 1993, J CELL PHYSIOL, V155, P301, DOI 10.1002/jcp.1041550211; JALAVA A, 1992, FEBS LETT, V300, P114, DOI 10.1016/0014-5793(92)80176-H; Kim SN, 2000, J CELL PHYSIOL, V182, P421, DOI 10.1002/(SICI)1097-4652(200003)182:3<421::AID-JCP13>3.0.CO;2-2; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kume T, 2008, NEUROSCI LETT, V443, P199, DOI 10.1016/j.neulet.2008.07.079; LELI U, 1992, J NEUROCHEM, V58, P1191, DOI 10.1111/j.1471-4159.1992.tb11328.x; LELI U, 1993, J NEUROCHEM, V60, P289, DOI 10.1111/j.1471-4159.1993.tb05850.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; PAHLMAN S, 1981, INT J CANCER, V28, P583, DOI 10.1002/ijc.2910280509; PAHLMAN S, 1983, CELL DIFFER DEV, V12, P165, DOI 10.1016/0045-6039(83)90006-4; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; RETTIG WJ, 1987, CANCER RES, V47, P1383; ROSS RA, 1983, J NATL CANCER I, V71, P741; Shi BX, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3491470; SPINELLI W, 1982, CANCER RES, V42, P5067; Uemura K, 2003, J NEUROSCI RES, V73, P166, DOI 10.1002/jnr.10641; Webster NJ, 2001, MOL BRAIN RES, V89, P50, DOI 10.1016/S0169-328X(01)00061-4; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zhao H, 2012, MOL CELL BIOCHEM, V363, P309, DOI 10.1007/s11010-011-1183-9	34	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136769	10.1371/journal.pone.0136769	http://dx.doi.org/10.1371/journal.pone.0136769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317353	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100139
J	Kerbrat, S; Vingert, B; Junier, MP; Castellano, F; Renault-Mihara, F; Tavares, SD; Surenaud, M; Noizat-Pirenne, F; Boczkowski, J; Guellaen, G; Chneiweiss, H; Le Gouvello, S				Kerbrat, Stephane; Vingert, Benoit; Junier, Marie-Pierre; Castellano, Flavia; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Surenaud, Mathieu; Noizat-Pirenne, France; Boczkowski, Jorge; Guellaen, Georges; Chneiweiss, Herve; Le Gouvello, Sabine			Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo	PLOS ONE			English	Article							MATURE DENDRITIC CELLS; ERK MAP KINASE; CYCLE PROGRESSION; EFFECTOR FUNCTION; CUTTING EDGE; SIGNAL; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-2; GROWTH	TCR-dependent and costimulation signaling, cell division, and cytokine environment are major factors driving cytokines expression induced by CD4+ T cell activation. PEA-15 15 (Protein Enriched in Astrocyte / 15kDa) is an adaptor protein that regulates death receptor-induced apoptosis and proliferation signaling by binding to FADD and relocating ERK1/2 to the cytosol, respectively. By using PEA-15-deficient mice, we examined the role of PEA-15 in TCR-dependent cytokine production in CD4+ T cells. TCR-stimulated PEA-15-deficient CD4+ T cells exhibited defective progression through the cell cycle associated with impaired expression of cyclin E and phosphoRb, two ERK1/2-dependent proteins of the cell cycle. Accordingly, expression of the division cycle-dependent cytokines IL-2 and IFN gamma, a Th1 cytokine, was reduced in stimulated PEA-15-deficient CD4+ T cells. This was associated with abnormal subcellular compartmentalization of activated ERK1/2 in PEA-15-deficient T cells. Furthermore, in vitro TCR-dependent differentiation of naive CD4(+) CD62L+ PEA-15-deficient T cells was associated with a lower production of the Th2 cytokine, IL-4, whereas expression of the Th17-associated molecule IL4I1 was enhanced. Finally, a defective humoral response was shown in PEA-15-deficient mice in a model of red blood cell alloimmunization performed with Poly IC, a classical adjuvant of Th1 response in vivo. Collectively, our data suggest that PEA-15 contributes to the specification of the cytokine pattern of activated Th cells, thus highlighting a potential new target to interfere with T cell functional polarization and subsequent immune response.	[Kerbrat, Stephane; Castellano, Flavia; Noizat-Pirenne, France; Boczkowski, Jorge; Guellaen, Georges; Le Gouvello, Sabine] Univ Paris Est, Creteil, France; [Kerbrat, Stephane; Vingert, Benoit; Castellano, Flavia; Surenaud, Mathieu; Noizat-Pirenne, France; Boczkowski, Jorge; Guellaen, Georges; Le Gouvello, Sabine] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Vingert, Benoit; Noizat-Pirenne, France] Etab Francais Sang, Creteil, France; [Junier, Marie-Pierre; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Chneiweiss, Herve] INSERM, U1130, Neurosci Paris Seine, IBPS, Paris, France; [Junier, Marie-Pierre; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Chneiweiss, Herve] Univ Paris 06, UM119, Neurosci Paris Seine, IBPS, Paris, France; [Junier, Marie-Pierre; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Chneiweiss, Herve] CNRS, UMR8246, Neurosci Paris Seine, IBPS, Paris, France; [Castellano, Flavia; Le Gouvello, Sabine] Hop H Mondor A Chenevier, AP HP, Pole Biol Pathol, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Chneiweiss, H (corresponding author), INSERM, U1130, Neurosci Paris Seine, IBPS, Paris, France.	herve.chneiweiss@inserm.fr; sabine.le-gouvello@hmn.aphp.fr	Boczkowski, Jorge/S-7474-2018; Castellano, Flavia/Q-2847-2018; , Renault-Mihara/L-3320-2013; herve, chneiweiss/Q-6818-2019	Boczkowski, Jorge/0000-0001-6619-5785; herve, chneiweiss/0000-0001-7675-5061; SURENAUD, Mathieu/0000-0002-3312-7871; Castellano, Flavia/0000-0001-9389-6704; VINGERT, Benoit/0000-0003-4156-2504; le gouvello, sabine/0000-0001-8147-2322	Association pour la recherche contre le cancer [3500]; Assistance-publique hopitaux de paris; Inserm; Legs Poix	Association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer); Assistance-publique hopitaux de paris; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Legs Poix	This work was supported by Association pour la recherche contre le cancer (grant no 3500) (HC); Assistance-publique hopitaux de paris (SLG); Inserm (HC and SLG); and Legs Poix (SLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fang LW, 2004, J BIOL CHEM, V279, P13, DOI 10.1074/jbc.M303860200; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Goplen N, 2012, FASEB J, V26, P1934, DOI 10.1096/fj.11-196477; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; Hendrickson JE, 2006, TRANSFUSION, V46, P1526, DOI 10.1111/j.1537-2995.2006.00946.x; Janardhan SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024931; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kitsberg D, 1999, J NEUROSCI, V19, P8244; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Lohoff M, 2010, J BIOL CHEM, V285, P1643, DOI 10.1074/jbc.M109.011585; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mor A, 2008, EUR J IMMUNOL, V38, P1493, DOI 10.1002/eji.200838292; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pastorino S, 2010, FASEB J, V24, P2818, DOI 10.1096/fj.09-144295; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Scarlata CM, 2015, EUR J IMMUNOL, V45, P474, DOI 10.1002/eji.201444897; Schade AE, 2004, J IMMUNOL, V172, P5828, DOI 10.4049/jimmunol.172.10.5828; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yu J, 2007, AM J HEMATOL, V82, P691, DOI 10.1002/ajh.20959; Zimring JC, 2005, BLOOD, V106, P1105, DOI 10.1182/blood-2005-03-1040	60	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136885	10.1371/journal.pone.0136885	http://dx.doi.org/10.1371/journal.pone.0136885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317969	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100161
J	Leonardo, DP; Albuquerque, DM; Lanaro, C; Baptista, LC; Cecatti, JG; Surita, FG; Parpinelli, MA; Costa, FF; Franco-Penteado, CF; Fertrin, KY; Costa, ML				Leonardo, Daniela P.; Albuquerque, Dulcinela M.; Lanaro, Carolina; Baptista, Leticia C.; Cecatti, Jose G.; Surita, Fernanda G.; Parpinelli, Mary A.; Costa, Fernando F.; Franco-Penteado, Carla F.; Fertrin, Kleber Y.; Costa, Maria Laura			Association of Nitric Oxide Synthase and Matrix Metalloprotease Single Nucleotide Polymorphisms with Preeclampsia and Its Complications	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HYPERTENSIVE DISORDERS; CARDIOVASCULAR-DISEASE; (MMP)-2 POLYMORPHISMS; MATERNAL MORTALITY; MMP-2 LEVELS; GENE; PREGNANCY; RISK; VARIANT	Background Preeclampsia is one of the leading causes of maternal and neonatal morbidity and mortality in the world, but its appearance is still unpredictable and its pathophysiology has not been entirely elucidated. Genetic studies have associated single nucleotide polymorphisms in genes encoding nitric oxide synthase and matrix metalloproteases with preeclampsia, but the results are largely inconclusive across different populations. Objectives To investigate the association of single nucleotide polymorphisms (SNPs) in NOS3 (G894T, T-786C, and a variable number of tandem repetitions VNTR in intron 4), MMP2 (C-1306T), and MMP9 (C-1562T) genes with preeclampsia in patients from Southeastern Brazil. Methods This prospective case-control study enrolled 77 women with preeclampsia and 266 control pregnant women. Clinical data were collected to assess risk factors and the presence of severe complications, such as eclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Results We found a significant association between the single nucleotide polymorphism NOS3 T-786C and preeclampsia, independently from age, height, weight, or the other SNPs studied, and no association was found with the other polymorphisms. Age and history of preeclampsia were also identified as risk factors. The presence of at least one polymorphic allele for NOS3 T-786C was also associated with the occurrence of eclampsia or HELLP syndrome among preeclamptic women. Conclusions Our data support that the NOS3 T-786C SNP is associated with preeclampsia and the severity of its complications.	[Leonardo, Daniela P.; Albuquerque, Dulcinela M.; Lanaro, Carolina; Baptista, Leticia C.; Costa, Fernando F.; Franco-Penteado, Carla F.; Fertrin, Kleber Y.] Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Sao Paulo, Brazil; [Cecatti, Jose G.; Surita, Fernanda G.; Parpinelli, Mary A.; Costa, Maria Laura] Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynaecol, Sao Paulo, Brazil; [Fertrin, Kleber Y.] Univ Campinas UNICAMP, Sch Med, Dept Clin Pathol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Fertrin, KY (corresponding author), Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Sao Paulo, Brazil.	fertrin@unicamp.br	Surita, Fernanda Garanhani/H-9575-2012; Fertrin, Kleber/M-4175-2013; Costa, Fernando F/D-1566-2012; Cecatti, Jose Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019	Surita, Fernanda Garanhani/0000-0003-4335-0337; Fertrin, Kleber/0000-0003-2637-3297; Costa, Fernando F/0000-0002-4632-572X; Cecatti, Jose Guilherme/0000-0003-1285-8445; Costa, Maria Laura/0000-0001-8280-3234; Leonardo, Daniela/0000-0002-7413-8606	FAEPEX - PRP/UNICAMP (Fundo de Apoio ao Ensino, Pesquisa e Extensao) [MLC 699/13]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [FFC 2014/00984-3, 2008/57441-0]	FAEPEX - PRP/UNICAMP (Fundo de Apoio ao Ensino, Pesquisa e Extensao); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financially supported by FAEPEX - PRP/UNICAMP (Fundo de Apoio ao Ensino, Pesquisa e Extensao, grant to MLC 699/13), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants to FFC 2014/00984-3 and 2008/57441-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2014, J AM COLL CARDIOL, V63, P1815, DOI 10.1016/j.jacc.2014.02.529; Alpoim PN, 2014, NITRIC OXIDE-BIOL CH, V42, P19, DOI 10.1016/j.niox.2014.07.006; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617; Dai BQ, 2013, GENE, V519, P187, DOI 10.1016/j.gene.2013.01.004; Davis LG, 1986, BASIC METHOD MOL BIO; De Moura RR, 2015, AM J HUM BIOL, V27, P674, DOI 10.1002/ajhb.22714; El Hassan MA, 2015, CLIN CHEM, V61, P694, DOI 10.1373/clinchem.2014.230565; Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670; Fernandez-Patron C, 1999, CIRC RES, V85, P906; Fong FM, 2014, AM J EPIDEMIOL, V180, P335, DOI 10.1093/aje/kwu151; Fraser R, 2008, BJOG-INT J OBSTET GY, V115, P1052, DOI 10.1111/j.1471-0528.2008.01771.x; Hakli T, 2003, J SOC GYNECOL INVEST, V10, P154, DOI 10.1016/S1071-5576(03)00003-0; Haram K, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/910751; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Hsu P, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00125; Kobashi G, 2001, AM J MED GENET, V103, P241, DOI 10.1002/ajmg.1535.abs; Landau R, 2004, AM J HYPERTENS, V17, P391, DOI 10.1016/j.amjhyper.2004.01.006; Luizon MR, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/914704; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Miyamoto Y, 2000, HUM MOL GENET, V9, P2629, DOI 10.1093/hmg/9.18.2629; Morgan AR, 2003, J MOL MED-JMM, V81, P321, DOI 10.1007/s00109-003-0441-z; Myers JE, 2005, HYPERTENS PREGNANCY, V24, P103, DOI 10.1081/PRG-200059836; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Palei ACT, 2012, PHARMACOGENOMICS J, V12, P489, DOI 10.1038/tpj.2011.31; Palei ACT, 2012, BASIC CLIN PHARMACOL, V111, P262, DOI 10.1111/j.1742-7843.2012.00905.x; Palei ACT, 2012, EXP MOL PATHOL, V92, P217, DOI 10.1016/j.yexmp.2012.01.008; Pollanen PJ, 2001, ARTERIOSCL THROM VAS, V21, P1446, DOI 10.1161/hq0901.095545; Rahimi Z, 2014, GENE, V538, P176, DOI 10.1016/j.gene.2013.12.013; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sandrim VC, 2010, MOL HUM REPROD, V16, P506, DOI 10.1093/molehr/gaq030; Sandrini VC, 2008, PHARMACOGENOMICS, V9, P1467, DOI 10.2217/14622416.9.10.1467; Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305; Seremak-Mrozikiewicz A, 2011, J MATERN-FETAL NEO M, V24, P432, DOI 10.3109/14767058.2010.511329; Serrano NC, 2004, HYPERTENSION, V44, P702, DOI 10.1161/01.HYP.0000143483.66701.ec; Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; von Dadelszen P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0454-8; Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Yoshimura T, 2000, J SOC GYNECOL INVEST, V7, P238, DOI 10.1016/S1071-5576(00)00060-5; Yu Christina K H, 2006, BMC Pregnancy Childbirth, V6, P7, DOI 10.1186/1471-2393-6-7; Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4; Zhang JH, 1999, J CELL PHYSIOL, V181, P312, DOI 10.1002/(SICI)1097-4652(199911)181:2<312::AID-JCP13>3.0.CO;2-1	50	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136693	10.1371/journal.pone.0136693	http://dx.doi.org/10.1371/journal.pone.0136693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317342	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100123
J	Ferreira, WAS; Araujo, MD; Anselmo, NP; de Oliveira, EHC; Brito, JRN; Burbano, RR; Harada, ML; Borges, BD				Silva Ferreira, Wallax Augusto; Araujo, Mariana Diniz; Anselmo, Nilson Praia; Correa de Oliveira, Edivaldo Herculano; Nascimento Brito, Jose Reginaldo; Burbano, Rommel Rodriguez; Harada, Maria Lucia; Borges, Barbara do Nascimento			Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors	PLOS ONE			English	Article							CPG-ISLAND METHYLATION; SQUAMOUS-CELL CARCINOMA; CYCLE REGULATORY GENES; DNA-REPLICATION; PROMOTER HYPERMETHYLATION; GLIOBLASTOMA-MULTIFORME; RETINOBLASTOMA PROTEIN; BMI-1 ONCOPROTEIN; PROGNOSTIC VALUE; EMERGING ROLES	Astrocytic gliomas, which are derived from glial cells, are considered the most common primary neoplasias of the central nervous system (CNS) and are histologically classified as low grade (I and II) or high grade (III and IV). Recent studies have shown that astrocytoma formation is the result of the deregulation of several pathways, including the RB/E2F pathway, which is commonly deregulated in various human cancers via genetic or epigenetic mechanisms. On the basis of the assumption that the study of the mechanisms controlling the INK4/ARF locus can help elucidate the molecular pathogenesis of astrocytic tumors, identify diagnostic and prognostic markers, and help select appropriate clinical treatments, the present study aimed to evaluate and compare methylation patterns using bisulfite sequencing PCR and evaluate the gene expression profile using real-time PCR in the genes CDKN2A, CDKN2B, CDC6, Bmi-1, CCND1, and RB1 in astrocytic tumors. Our results indicate that all the evaluated genes are not methylated independent of the tumor grade. However, the real-time PCR results indicate that these genes undergo progressive deregulation as a function of the tumor grade. In addition, the genes CDKN2A, CDKN2B, and RB1 were underexpressed, whereas CDC6, Bmi-1, and CCND1 were overexpressed; the increase in gene expression was significantly associated with decreased patient survival. Therefore, we propose that the evaluation of the expression levels of the genes involved in the RB/E2F pathway can be used in the monitoring of patients with astrocytomas in clinical practice and for the prognostic indication of disease progression.	[Silva Ferreira, Wallax Augusto; Araujo, Mariana Diniz; Anselmo, Nilson Praia; Harada, Maria Lucia; Borges, Barbara do Nascimento] Univ Fed Par UFPA, Fed Univ Para, Inst Biol Sci, Francisco Mauro Salzano Mol Biol Lab, Belem, Para, Brazil; [Correa de Oliveira, Edivaldo Herculano] Evandro Chagas Inst, Tissue Culture & Cytogenet Lab, Belem, Para, Brazil; [Nascimento Brito, Jose Reginaldo] Ophir Loyola Hosp, Belem, Para, Brazil; [Burbano, Rommel Rodriguez] UFPA, Human Cytogenet Lab, Inst Biol Sci, Belem, Para, Brazil; [Borges, Barbara do Nascimento] Fed Rural Univ Amazonia, Socioenvironm & Water Management Inst, Agr Technol Ctr, Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA)	Borges, BD (corresponding author), Univ Fed Par UFPA, Fed Univ Para, Inst Biol Sci, Francisco Mauro Salzano Mol Biol Lab, Belem, Para, Brazil.	barbara.borges@ufra.edu.br	de Oliveira, Edivaldo H. C./C-3368-2013; Burbano, Rommel R/C-4149-2012; Borges, Barbara N/G-1355-2012; Ferreira, Wallax A S/O-8395-2018	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Burbano, Rommel R/0000-0002-4872-234X; Borges, Barbara N/0000-0002-5989-8287; Ferreira, Wallax/0000-0002-9645-2292; Brito, Jose Reginaldo Nascimento/0000-0001-8130-250X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [483032/2010-7]; Universidade Federal do Para (UFPA); Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para [132/2010]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Para (UFPA); Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), and by research funds from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (483032/2010-7), Universidade Federal do Para (UFPA) and from Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para (132/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Amato A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-79; Bastian PJ, 2007, EUR UROL, V51, P665, DOI 10.1016/j.eururo.2006.08.008; Bello MJ, 2004, CANC THER, V2, P187; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Borges BD, 2013, TUMOR BIOL, V34, P2127, DOI 10.1007/s13277-013-0742-y; Borges BD, 2010, IN VIVO, V24, P579; Borges BN, 2010, THESIS FEDERAL U PAR; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Costello JF, 1996, CANCER RES, V56, P2405; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Esteller M, 2000, CANCER RES, V60, P4366; Feng CJ, 2013, TECHNOL CANCER RES T, V12, P173, DOI 10.7785/tcrt.2012.500302; Ferreira WAS, 2015, J GENET GENOME RES, V2, P012; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Gonzalez-Gomez P, 2003, BRIT J CANCER, V88, P109, DOI 10.1038/sj.bjc.6600737; Gonzalez-Gomez P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/549742; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; GREGER V, 1994, HUM GENET, V94, P491; Halaban R, 2005, CANCER METAST REV, V24, P339, DOI 10.1007/s10555-005-1582-z; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hayry V, 2010, BRIT J CANCER, V102, P892, DOI 10.1038/sj.bjc.6605544; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang LL, 2009, ACTA BIOCH BIOPH SIN, V41, P527, DOI 10.1093/abbs/gmp040; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Kanellou P, 2009, BRIT J DERMATOL, V160, P1215, DOI 10.1111/j.1365-2133.2009.09079.x; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kawamata N, 2005, EUR J HAEMATOL, V74, P424, DOI 10.1111/j.1600-0609.2005.00417.x; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kim YH, 2011, BRAIN PATHOL, V21, P645, DOI 10.1111/j.1750-3639.2011.00492.x; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li AFY, 2008, AM J CLIN PATHOL, V130, P535, DOI 10.1309/TLLVXK9HVA89CHPE; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Mizuarai S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-31; Munoz Jorge, 2012, ISRN Neurol, V2012, P576578, DOI 10.5402/2012/576578; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohta S, 2001, ONCOL REP, V8, P1063; Ohta T, 2006, ONCOL REP, V16, P957; OhtaniFujita N, 1997, CANCER GENET CYTOGEN, V98, P43, DOI 10.1016/S0165-4608(96)00395-0; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pinheiro DD, 2015, TRANSL GASTROIN CANC, V4, P265, DOI 10.3978/j.issn.2224-4778.2015.05.04; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Poi M. J., 2013, MOL CARCINOG; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Riemenschneider MJ, 2009, INT J MOL SCI, V10, P184, DOI 10.3390/ijms10010184; Rohde C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn083; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sakellariou S, 2008, ANTICANCER RES, V28, P1079; SAMBROOK J, 2000, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schuringa JJ, 2010, CURR OPIN HEMATOL, V17, P294, DOI 10.1097/MOH.0b013e328338c439; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Simpson DJ, 2000, CANCER RES, V60, P1211; Skiriute D, 2014, J CANCER, V5, P446, DOI 10.7150/jca.9140; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stirzaker C, 1997, CANCER RES, V57, P2229; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Ushio Y, 2003, FRONT BIOSCI, V8, pE281, DOI 10.2741/865; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Vrzalikova K, 2008, J CANCER RES CLIN, V134, P1037, DOI 10.1007/s00432-008-0361-y; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Wemmert S, 2009, INT J ONCOL, V34, P1743, DOI 10.3892/ijo_00000305; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wolter M, 2001, J NEUROPATH EXP NEUR, V60, P1170, DOI 10.1093/jnen/60.12.1170; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Yu J, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-65; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zolota V, 2008, NEUROPATHOLOGY, V28, P35, DOI 10.1111/j.1440-1789.2007.00844.x	111	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137259	10.1371/journal.pone.0137259	http://dx.doi.org/10.1371/journal.pone.0137259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317630	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100214
J	Yang, WF; Chen, M; Zheng, MF; He, ZG; Zhang, XX; Qiu, YS; Xu, WB; Ma, LL; Lin, ZY; Hu, WJ; Zeng, J				Yang, Weifeng; Chen, Min; Zheng, Minfang; He, Zhigang; Zhang, Xinxing; Qiu, Yusheng; Xu, Wangbin; Ma, Lili; Lin, Zhiyu; Hu, Wangjiang; Zeng, Jian			Influence of a Decaying Cyclonic Eddy on Biogenic Silica and Particulate Organic Carbon in the Tropical South China Sea Based on Th-234-U-238 Disequilibrium	PLOS ONE			English	Article							SMALL-VOLUME TECHNIQUE; MESOSCALE EDDIES; PARTICLE EXPORT; PHYTOPLANKTON DYNAMICS; WATER COLUMN; OCEAN; FLUX; VARIABILITY; LEE; ENHANCEMENT	Eddies play a critical role in regulating the biological pump by pumping new nutrients to the euphotic zone. However, the effects of cyclonic eddies on particle export are not well understood. Here, biogenic silica (BSi) and particulate organic carbon (POC) exports were examined inside and outside a decaying cyclonic eddy using Th-234-U-238 disequilibria in the tropical South China Sea. For the eddy and outside stations, the average concentrations of BSi in the euphotic zone were 0.17 +/- 0.09 mu mol L-1 (mean +/- sd, n = 20) and 0.21 +/- 0.06 mu mol L-1 (n = 34). The POC concentrations were 1.42 +/- 0.56 mu mol L-1 (n = 34) and 1.30 +/- 0.46 mu mol L-1 (n = 51). Both BSi and POC abundances did not show change at the 95% confidence level. Based on the 234Th-238U model, BSi export fluxes in the eddy averaged 0.18 +/- 0.15 mmol Si m(-2) d(-1), which was comparable with the 0.40 +/- 0.20 mmol Si m(-2) d(-1) outside the eddy. Similarly, the average POC export fluxes were 1.5 +/- 1.4 mmol C m(-2) d(-1) and 1.9 +/- 1.3 mmol C m(-2) d(-1) for the eddy and outside stations. From these results we concluded that cyclonic eddies in their decaying phase have little effect on the abundance and export of biogenic particles.	[Yang, Weifeng; Chen, Min; Qiu, Yusheng] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Yang, Weifeng; Chen, Min; Zheng, Minfang; He, Zhigang; Zhang, Xinxing; Qiu, Yusheng; Xu, Wangbin; Ma, Lili; Lin, Zhiyu; Hu, Wangjiang; Zeng, Jian] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University	Yang, WF (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	wyang@xmu.edu.cn	Chen, Min/B-7763-2012; Yang, Weifeng/G-3996-2010	Chen, Min/0000-0003-0369-694X; Yang, Weifeng/0000-0002-9339-1746	National Natural Science Foundation of China [41125020, 41476061]; State Oceanic Administration grant [GASI-03-01-02-02]; China Ocean Mineral Resources R & D Association grant [DY125-13-E-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Oceanic Administration grant; China Ocean Mineral Resources R & D Association grant	This study was supported by National Natural Science Foundation of China (41125020) to MC and (41476061) to WY, State Oceanic Administration grant (GASI-03-01-02-02) and China Ocean Mineral Resources R & D Association grant (DY125-13-E-01) to WY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon MP, 1996, DEEP-SEA RES PT II, V43, P1133, DOI 10.1016/0967-0645(96)00016-1; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Benitez-Nelson CR, 2001, J RADIOANAL NUCL CH, V248, P795, DOI 10.1023/A:1010621618652; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Buesseler K, 1998, DEEP-SEA RES PT II, V45, P2461, DOI 10.1016/S0967-0645(98)80022-2; Buesseler KO, 2008, DEEP-SEA RES PT II, V55, P1426, DOI 10.1016/j.dsr2.2008.02.007; Buesseler KO, 2006, MAR CHEM, V100, P213, DOI 10.1016/j.marchem.2005.10.013; BUESSELER KO, 1992, DEEP-SEA RES, V39, P1115, DOI 10.1016/0198-0149(92)90060-7; BUESSELER KO, 1995, DEEP-SEA RES PT II, V42, P777, DOI 10.1016/0967-0645(95)00043-P; Cai PH, 2002, SCI CHINA SER D, V45, P103, DOI 10.1007/BF02879787; Cai PH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027792; Cai PH, 2006, MAR CHEM, V100, P282, DOI 10.1016/j.marchem.2005.10.016; Cai PH, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004268; Cardona Y, 2012, OCEAN MODEL, V42, P1, DOI 10.1016/j.ocemod.2011.11.004; Charette MA, 1999, DEEP-SEA RES PT II, V46, P885, DOI 10.1016/S0967-0645(99)00006-5; Chen J, 1998, CHIN SCI B CHIN VER, V43, P639; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; Chen M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025186; Chen YFL, 2005, DEEP-SEA RES PT I, V52, P319, DOI 10.1016/j.dsr.2004.11.001; Chen YLL, 2007, J OCEANOGR, V63, P671, DOI 10.1007/s10872-007-0059-9; COCHRAN JK, 1995, J GEOPHYS RES-OCEANS, V100, P4399, DOI 10.1029/94JC01954; Conley DJ, 1998, MAR CHEM, V63, P39, DOI 10.1016/S0304-4203(98)00049-8; Du C, 2013, BIOGEOSCI DISCUSS, V10, P6939, DOI DOI 10.5194/BGD-10-6939-2013; Dunne JP, 1997, DEEP-SEA RES PT II, V44, P2049, DOI 10.1016/S0967-0645(97)00063-5; Ewart CS, 2008, DEEP-SEA RES PT II, V55, P1334, DOI 10.1016/j.dsr2.2008.02.013; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Guo LD, 2002, MAR CHEM, V78, P103, DOI 10.1016/S0304-4203(02)00012-9; Jeong HJ, 2004, AQUAT MICROB ECOL, V36, P171, DOI 10.3354/ame036171; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Krause JW, 2010, LIMNOL OCEANOGR, V55, P569, DOI 10.4319/lo.2009.55.2.0569; Landry MR, 2008, DEEP-SEA RES PT II, V55, P1348, DOI 10.1016/j.dsr2.2008.02.001; Letelier RM, 2000, J GEOPHYS RES-OCEANS, V105, P28723, DOI 10.1029/1999JC000306; Lin II, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043872; Lin Z, 2011, THESIS XIAMEN U; Liu KK, 2002, DEEP-SEA RES PT I, V49, P1387, DOI 10.1016/S0967-0637(02)00035-3; Ma Q, 2005, ACTA OCEANOL SIN, V24, P97; Maiti K, 2008, DEEP-SEA RES PT II, V55, P1445, DOI 10.1016/j.dsr2.2008.02.008; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; Moran SB, 2003, LIMNOL OCEANOGR, V48, P1018, DOI 10.4319/lo.2003.48.3.1018; Moran SB, 1999, MAR CHEM, V67, P33, DOI 10.1016/S0304-4203(99)00047-X; Mourino-Carballido B, 2006, LIMNOL OCEANOGR, V51, P2675, DOI 10.4319/lo.2006.51.6.2675; Mourino-Carballido B, 2009, DEEP-SEA RES PT I, V56, P1242, DOI 10.1016/j.dsr.2009.03.001; Murray JW, 1996, DEEP-SEA RES PT II, V43, P1095, DOI 10.1016/0967-0645(96)00036-7; Oschlies A, 1998, NATURE, V394, P266, DOI 10.1038/28373; Ragueneau O, 2005, CONT SHELF RES, V25, P697, DOI 10.1016/j.csr.2004.09.017; Resplandy L, 2012, DEEP-SEA RES PT I, V68, P24, DOI 10.1016/j.dsr.2012.05.015; Rii YM, 2008, DEEP-SEA RES PT II, V55, P1275, DOI 10.1016/j.dsr2.2008.01.013; Savoye N, 2006, MAR CHEM, V100, P234, DOI 10.1016/j.marchem.2005.10.014; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Van der Loeff MR, 2006, MAR CHEM, V100, P190, DOI 10.1016/j.marchem.2005.10.012; Verdeny E, 2008, DEEP-SEA RES PT II, V55, P1461, DOI 10.1016/j.dsr2.2008.02.009; Wan S, 2010, CHINESE SCI BULL, V40, P881; Xiu P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006800; Xiu P, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005657; Yang WF, 2009, CHINESE SCI BULL, V54, P2118, DOI 10.1007/s11434-009-0043-4; Zhang R, 2014, DEEP-SEA RES PT I, V83, P24, DOI 10.1016/j.dsr.2013.08.006; Zhou KB, 2013, EARTH PLANET SC LETT, V381, P198, DOI 10.1016/j.epsl.2013.07.039	59	15	15	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136948	10.1371/journal.pone.0136948	http://dx.doi.org/10.1371/journal.pone.0136948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317555	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100181
J	Byeon, H				Byeon, Haewon			Association between Weight Misperception Patterns and Depressive Symptoms in Korean Young Adolescents: National Cross-Sectional Study	PLOS ONE			English	Article							PSYCHOLOGICAL-FACTORS; PERCEIVED WEIGHT; OBESITY; PERCEPTION; OVERWEIGHT; RISK; DISORDER; HEALTH; BODY	Purpose Although distortion of weight perceptions has been known as a risk factor for adolescent depression, little has been known about the relationship between weight misperception patterns and depressive symptoms. This study explored the relationship between distortion of weight misperception patterns and depressive symptoms in Korean adolescents. Methods The subjects of this study were 109,373 middle school students who participated in the Korea Youth Risk Behavior Web-based Survey (KYRBWS) from 2011 to 2013. By comparing the difference between Body Mass Index (BMI) and subjective perceptions of body weight, misperceptions of weight were classified into two categories: misperception of underweight and misperception of overweight. Results When confounding variables were adjusted, the results of the logistic regression analysis revealed that male students who perceived themselves as underweight despite their normal weight were 110% more likely to have depressive symptoms (OR = 1.10, 95% CI: 1.03-1.18) than male students with accurate weight perceptions. On the contrary, for female students, misperceptions of underweight had no significant relationship with depression symptoms. Regarding misperceptions of overweight, female students who perceived themselves as overweight despite their normal weight were 107% (OR = 1.07, 95% CI: 1.02-1.11) more likely to have depressive symptoms than female students with accurate weight perceptions. Moreover, female students who perceived themselves as overweight when they were underweight were 137% (OR = 1.37, 95% CI: 1.18-1.58) more likely to have depressive symptoms. Conclusion Male students who underestimate their body weight and female students who overestimate their body weight were at a greater risk of depression emotions than students with accurate weight perceptions.	Nambu Univ, Sch Publ Hlth, Dept Speech Language Pathol & Audiol, Gwangju, South Korea	Nambu University	Byeon, H (corresponding author), Nambu Univ, Sch Publ Hlth, Dept Speech Language Pathol & Audiol, Cheomdanro 23, Gwangju, South Korea.	byeon@nambu.ac.kr	Byeon, Haewon/R-2113-2019	Byeon, Haewon/0000-0002-3363-390X				Al Mamun A, 2007, OBESITY, V15, P3097, DOI 10.1038/oby.2007.369; Anderson SE, 2007, PSYCHOSOM MED, V69, P740, DOI 10.1097/PSY.0b013e31815580b4; Atlantis E, 2008, INT J OBESITY, V32, P715, DOI 10.1038/sj.ijo.0803762; Baek SeolHyang, 2008, Korean Journal of Community Nutrition, V13, P386; Byeon H, 2014, INFORM AN INT INTERD, V17, P3493; Cash Thomas F, 2004, Body Image, V1, P1, DOI 10.1016/S1740-1445(03)00011-1; Centers for Disease Control and Prevention, CHILD DEV YOUNG TEEN; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; FRIEDMAN MA, 1995, PSYCHOL BULL, V117, P3, DOI 10.1037/0033-2909.117.1.3; Gaskin JL, 2013, J AFFECT DISORDERS, V150, P350, DOI 10.1016/j.jad.2013.04.017; HAYES D, 1986, J HEALTH SOC BEHAV, V27, P387, DOI 10.2307/2136952; Hyun MH, 2002, KOREAN J CLIN PSYCHO, V21, P565; Jung Y, 2006, DETERMINANTS HLTH KO; Korean Ministry of Education Science & Technology, 2014, SCH BAS STUD HLTH SU; Ladwig KH, 2003, BRAIN BEHAV IMMUN, V17, P268, DOI 10.1016/S0889-1591(03)00056-4; Lee SH, 1997, J KOREAN SOC ENDOCRI, V12, P295; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Ministry of Health and Welfare, 2014, KOR YOUTH RISK BEH W; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Park E, 2011, J SCHOOL HEALTH, V81, P57, DOI 10.1111/j.1746-1561.2010.00561.x; Phillips JH, 2003, CHILDREN SCH, V25, P147; Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Roberts RE, 2013, J PSYCHIATR RES, V47, P1110, DOI 10.1016/j.jpsychires.2013.03.019; Smolak Linda, 2004, Body Image, V1, P15, DOI 10.1016/S1740-1445(03)00008-1; Wagner B, 2013, DEPRESS ANXIETY, V30, P975, DOI 10.1002/da.22105; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280; Xie B, 2006, AM J HEALTH BEHAV, V30, P115, DOI 10.5993/AJHB.30.2.1; Xie B, 2003, J ADOLESCENT HEALTH, V33, P202, DOI 10.1016/S1054-139X(03)00099-5	30	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0131322	10.1371/journal.pone.0131322	http://dx.doi.org/10.1371/journal.pone.0131322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313680	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000002
J	Chaturvedi, SK; Zaidi, N; Alam, P; Khan, JM; Qadeer, A; Siddique, IA; Asmat, S; Zaidi, Y; Khan, RH				Chaturvedi, Sumit Kumar; Zaidi, Nida; Alam, Parvez; Khan, Javed Masood; Qadeer, Atiyatul; Siddique, Ibrar Ahmad; Asmat, Shamoon; Zaidi, Yusra; Khan, Rizwan Hasan			Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; HUMAN SERUM-ALBUMIN; FIBRIL FORMATION; PROTEIN AGGREGATION; ACRIDINE-DERIVATIVES; INHIBITION; BINDING; ALZHEIMERS; NEURODEGENERATION; FIBRILLOGENESIS	Amyloid fibril formation by proteins leads to variety of degenerative disorders called amyloidosis. While these disorders are topic of extensive research, effective treatments are still unavailable. Thus in present study, two anti-tuberculosis drugs, i.e., pyrazinamide (PYZ) and D-cycloserine (DCS), also known for treatment for Alzheimer's dementia, were checked for the anti-aggregation and anti-amyloidogenic ability on A beta-42 peptide and hen egg white lysozyme. Results demonstrated that both drugs inhibit the heat induced aggregation; however, PYZ was more potent and decelerated the nucleation phase as observed from various spectroscopic and microscopic techniques. Furthermore, pre-formed amyloid fibrils incubated with these drugs also increased the PC12/SH-SY5Y cell viability as compare to the amyloid fibrils alone; however, the increase was more pronounced for PYZ as confirmed by MTT assay. Additionally, molecular docking study suggested that the greater inhibitory potential of PYZ as compare to DCS may be due to strong binding affinity and more occupancy of hydrophobic patches of HEWL, which is known to form the core of the protein fibrils.	[Chaturvedi, Sumit Kumar; Zaidi, Nida; Alam, Parvez; Khan, Javed Masood; Qadeer, Atiyatul; Siddique, Ibrar Ahmad; Asmat, Shamoon; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Zaidi, Yusra] Aligarh Muslim Univ, Dept Zool, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Khan, Rizwan Hasan/F-8276-2014; khan, Javed Masood/AAZ-8079-2021; Chaturvedi, Sumit K/P-5052-2014; chaturvedi, sumit k/O-6083-2019; chaturvedi, sumit/G-2945-2016; Khan, Rizwan/GXZ-5789-2022; Khan, Javed Masood/AAZ-8034-2021; Alam, Dr Parvez/E-9136-2013	Khan, Rizwan Hasan/0000-0002-9965-8982; khan, Javed Masood/0000-0003-0567-5712; Chaturvedi, Sumit K/0000-0003-3600-8883; chaturvedi, sumit k/0000-0003-3600-8883; chaturvedi, sumit/0000-0003-3600-8883; Siddiqi, Ph.D., Mohammad Khursheed/0000-0002-6522-1643; Alam, Dr Parvez/0000-0002-4484-8340; Zaidi, Dr Nida/0000-0003-2579-2190	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	SK Chaturvedi, N Zaidi, P Alam, and JM Khan acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi, India, for providing financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09862; Alam P, 2015, J LUMIN, V164, P123, DOI 10.1016/j.jlumin.2015.03.011; Alam P, 2015, CELL BIOCHEM BIOPHYS, V71, P1199, DOI 10.1007/s12013-014-0329-2; Ali YO, 2012, HUM MOL GENET, V21, P237, DOI 10.1093/hmg/ddr449; Andersen JM, 2002, BEHAV BRAIN RES, V129, P211, DOI 10.1016/S0166-4328(01)00318-7; ARTYMIUK PJ, 1981, J MOL BIOL, V152, P737, DOI 10.1016/0022-2836(81)90125-X; Bayrakdar ET, 2014, CELL BIOCHEM FUNCT, V32, P557, DOI 10.1002/cbf.3049; Bernard AB, 2014, BIOTECHNOL BIOENG, V111, P1028, DOI 10.1002/bit.25153; Bhattacharya S, 2014, INT J BIOL MACROMOL, V70, P312, DOI 10.1016/j.ijbiomac.2014.07.003; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Chaturvedi SK, 2015, INT J BIOL MACROMOL, V80, P375, DOI 10.1016/j.ijbiomac.2015.06.035; Chaturvedi SK, 2015, MOL BIOSYST, V11, P307, DOI 10.1039/c4mb00548a; Churches QI, 2014, BIOORG MED CHEM LETT, V24, P3108, DOI 10.1016/j.bmcl.2014.05.008; DIAMOND R, 1974, J MOL BIOL, V82, P371, DOI 10.1016/0022-2836(74)90598-1; Du WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07992; Gazova Z, 2008, EUR BIOPHYS J BIOPHY, V37, P1261, DOI 10.1007/s00249-008-0313-0; Ghosh S., 2014, J BIOMOL STRUCT DYN, P1; Ghosh S, 2014, J PHOTOCH PHOTOBIO B, V138, P8, DOI 10.1016/j.jphotobiol.2014.04.021; Guerrero-Munoz MJ, 2014, BIOCHEM PHARMACOL, V88, P468, DOI 10.1016/j.bcp.2013.12.023; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; He JW, 2014, J AGR FOOD CHEM, V62, P9442, DOI 10.1021/jf5025449; Hofmann SG, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-11; Hopping G, 2014, ELIFE, V3, DOI 10.7554/eLife.01681; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Khan JM, 2014, SOFT MATTER, V10, P2591, DOI 10.1039/c3sm52435c; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Knubovets T, 1999, P NATL ACAD SCI USA, V96, P1262, DOI 10.1073/pnas.96.4.1262; Liang M, 2013, FOOD CHEM, V138, P1596, DOI 10.1016/j.foodchem.2012.11.027; Mahler HC, 2005, EUR J PHARM BIOPHARM, V59, P407, DOI 10.1016/j.ejpb.2004.12.004; McKoy AF, 2014, CHEM BIOL DRUG DES, V84, P505, DOI 10.1111/cbdd.12341; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Noda M, 2004, J BIOL CHEM, V279, P46143, DOI 10.1074/jbc.M404603200; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Qadeer A, 2013, ARCH BIOCHEM BIOPHYS, V540, P101, DOI 10.1016/j.abb.2013.10.015; Qin PF, 2012, MOL BIOSYST, V8, P1222, DOI 10.1039/c2mb05423j; Vuong QV, 2013, BIOMACROMOLECULES, V14, P1035, DOI 10.1021/bm301891q; Ross C.A., 2004, PROTEIN AGGREGATION; Shropshire TD, 2014, BIOL CHEM, V395, P109, DOI 10.1515/hsz-2013-0230; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Tokunaga Y, 2013, INT J BIOL SCI, V9, P219, DOI 10.7150/ijbs.5380; Varshney A, 2014, CELL BIOCHEM BIOPHYS, V70, P93, DOI 10.1007/s12013-014-9863-1; Vernaglia BA, 2004, BIOMACROMOLECULES, V5, P1362, DOI 10.1021/bm0498979; Wang SSS, 2009, BBA-PROTEINS PROTEOM, V1794, P1663, DOI 10.1016/j.bbapap.2009.07.017; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Wu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081982; Zaidi N, 2013, COMPREHENSIVE INSIGH, V8, DOI [10.1371/journal.pone.0071422, DOI 10.1371/JOURNAL.PONE.0071422]; Zaidi N, 2014, J PHYS CHEM B, V118, P13025, DOI 10.1021/jp501515g; Zaidi N, 2013, J PHYS CHEM B, V117, P2595, DOI 10.1021/jp3069877; Zhang D, 2015, INT J BIOL MACROMOL, V72, P243, DOI 10.1016/j.ijbiomac.2014.08.034	54	64	64	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136528	10.1371/journal.pone.0136528	http://dx.doi.org/10.1371/journal.pone.0136528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312749	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000067
J	Kearney, AY; Fan, YH; Giri, U; Saigal, B; Gandhi, V; Heymach, JV; Zurita, AJ				Kearney, Alper Y.; Fan, You-Hong; Giri, Uma; Saigal, Babita; Gandhi, Varsha; Heymach, John V.; Zurita, Amado J.			8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; CANCER H1299 CELLS; LUNG-CANCER; PROTEIN-KINASE; 8-CHLORO-ADENOSINE; APOPTOSIS; PHOSPHORYLATION; INDUCTION; AUTOPHAGY; DEPLETION	The adenosine analog 8-chloroadenosine has been shown to deplete ATP and inhibit tumor growth in hematological malignancies as well as in lung and breast cancer cell lines. We investigated effects of 8-chloroadenosine on clear cell (cc) renal cell carcinoma (RCC) cell lines. 8-chloroadenosine was effective against ccRCC cell viability in vitro, with IC50 ranging from 2 mu M in the most sensitive CAKI-1 to 36 mu M in the most resistant RXF-393. Proteomic analysis by reverse-phase protein array revealed that 8-chloroadenosine treatment leads to inhibition of the mTOR pathway. In time-course experiments, 8-chloroadenosine treatment rapidly activated AMPK, measured by AMPK and ACC phosphorylation, and subsequently caused dephosphorylation of p70S6K and ribosomal protein RPS6 in the sensitive cell lines. However, in the resistant cell lines, AMPK activity and the mTOR pathway were unaffected by the treatment. We also noted that the resistant cell lines had elevated basal levels of phospho RPS6 and AKT. Inhibition of PI3K pathway enhanced the efficacy of 8-chloroadenosine across all cell lines. Our observations indicate that 8-chloroadenosine activity is associated with inhibition of the mTOR pathway, and that phospho RPS6 and PI3K pathway activation status may determine resistance. Among solid tumors, RCC is one of the few susceptible to mTOR inhibition. We thus infer that 8-chloroadenosine may be effective in RCC by activating AMPK and inhibiting the mTOR pathway.	[Kearney, Alper Y.; Zurita, Amado J.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Fan, You-Hong; Giri, Uma; Saigal, Babita; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Thorac & Head & Neck Med Oncol, Houston, TX 77030 USA; [Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zurita, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	azurita@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	University of Texas MD Anderson Cancer Center Institutional Research Grant; V Foundation; NCI [P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA205150, P30CA016672, R01CA190628, R01CA168484] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center Institutional Research Grant; V Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AJZ received funding from The University of Texas MD Anderson Cancer Center Institutional Research Grant. JVH and VG received funding from V Foundation (http://www.jimmyv.org/), NCI award number P30CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 8 CHL AD CHRON LYMP; [Anonymous], 2013, NATURE, V499, P43, DOI DOI 10.1038/NATURE12222; Balakrishnan K, 2005, BLOOD, V105, P4455, DOI 10.1182/blood-2004-05-1699; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Bonini MG, 2013, IUBMB LIFE, V65, P889, DOI 10.1002/iub.1213; Chen LS, 2009, BIOCHEM PHARMACOL, V78, P583, DOI 10.1016/j.bcp.2009.05.019; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dennison JB, 2009, BRIT J HAEMATOL, V147, P297, DOI 10.1111/j.1365-2141.2009.07850.x; Fang Jiachun, 1995, Zhonghua Zhongliu Zazhi, V17, P5; Gandhi V, 2002, CANCER CHEMOTH PHARM, V50, P85, DOI 10.1007/S00280-002-0456-0; Gandhi V, 2001, CANCER RES, V61, P5474; Gu YY, 2006, BIOCHEM PHARMACOL, V72, P541, DOI 10.1016/j.bcp.2006.05.026; Han YY, 2013, MOL CELL BIOCHEM, V384, P187, DOI 10.1007/s11010-013-1797-1; Harshman LC, 2014, CLIN GENITOURIN CANC, V12, P335, DOI 10.1016/j.clgc.2014.03.003; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jiao YY, 2013, EUR J PHARM SCI, V48, P249, DOI 10.1016/j.ejps.2012.10.026; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Li WJ, 2009, CHEMOTHERAPY, V55, P335, DOI 10.1159/000230697; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu J, 2013, UROL ONCOL-SEMIN ORI, V31, P264, DOI 10.1016/j.urolonc.2011.01.003; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Robinson-White AJ, 2008, J CLIN ENDOCR METAB, V93, P1020, DOI 10.1210/jc.2007-2331; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; Schneider A, 2010, CANCER BIOL THER, V10, P1179, DOI 10.4161/cbt.10.11.13921; Stellrecht CM, 2007, CANCER RES, V67, P9913, DOI 10.1158/0008-5472.CAN-07-0770; Stellrecht CM, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-23; Stellrecht CM, 2010, BREAST CANCER RES TR, V121, P355, DOI 10.1007/s10549-009-0481-3; Stellrecht CM, 2003, CANCER RES, V63, P7968; Wang MJ, 2004, ONCOL REP, V12, P193; Woodard J, 2010, CANCER BIOL THER, V10, P1169, DOI 10.4161/cbt.10.11.13629	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135962	10.1371/journal.pone.0135962	http://dx.doi.org/10.1371/journal.pone.0135962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313261	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000034
J	Nitzschke, R; Wilgusch, J; Kersten, JF; Goepfert, MS				Nitzschke, Rainer; Wilgusch, Joana; Kersten, Jan Felix; Goepfert, Matthias Sebastian			Relationship between Sevoflurane Plasma Concentration, Clinical Variables and Bispectral Index Values during Cardiopulmonary Bypass	PLOS ONE			English	Article							HYPOTHERMIC CIRCULATORY ARREST; MINIMUM ALVEOLAR CONCENTRATION; CARDIAC-SURGERY; INTRAOPERATIVE AWARENESS; SPECTRAL ENTROPY; ELECTROENCEPHALOGRAM; ANESTHESIA; ISOFLURANE; MORTALITY; PROPOFOL	Background Anesthetic administration is increasingly guided by electroencephalography (EEG)-based monitoring, such as the bispectral index (BIS). However, during cardiopulmonary bypass (CPB), factors other than the administered hypnotic agents may influence EEG signals, and their effects on BIS values are unknown. Methods This report is a secondary analysis of data from a prospective, controlled interventional study comparing the effect of sevoflurane administration guided by BIS monitoring (group SevoBIS) and constant administration of sevoflurane (group Sevo(1.8Vol%)) during CPB. Sevoflurane plasma concentration (SPC) was measured using gas chromatography. The relationships of BIS to SPC, CPB pump flow, arterial pressure, hematocrit, temperature, time on CPB, and patient characteristics were analysed. Results No association was observed between BIS values and SPC in group SevoBIS. In group Sevo1.8Vol%, a 40 mu gml(-1) increase in SPC, which encompassed the entire range of observed values of the SPC in this analysis, was associated with a decrease of 3.6 (95% confidence interval (CI): 1.1-6.1) in BIS values (p = 0.005). Each increase in CPB time of 10 minutes was associated with an increase in BIS values of 0.25 (95% CI: 0.11-0.39, p<0.001). Path analysis revealed that the BIS values of SevoBIS patients were 5.3 (95% CI: 3.2-7.5) units higher than those of Sevo1.8Vol% patients (p<0.001), which was the strongest effect on BIS values. Path analysis revealed a slope of 0.5 (95% CI: 0.3-0.7) BIS units per 1 degrees C body temperature (p<0.001). Conclusion BIS monitoring is insensitive to clinically relevant changes in SPC in individual patients during CPB.	[Nitzschke, Rainer; Wilgusch, Joana; Goepfert, Matthias Sebastian] Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Ctr Anesthesiol & Intens Care Med, Hamburg, Germany; [Kersten, Jan Felix] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nitzschke, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Ctr Anesthesiol & Intens Care Med, Hamburg, Germany.	r.nitzschke@uke.de			Inomed, Emmendingen Germany; Covidien, Neustadt/Donau Germany; AbbVie, Wiesbaden, Germany; Pulsion Medical Systems, Munich Germany	Inomed, Emmendingen Germany; Covidien, Neustadt/Donau Germany; AbbVie, Wiesbaden, Germany(AbbVie); Pulsion Medical Systems, Munich Germany	RN has received funding for lectures from Inomed, Emmendingen Germany, Covidien, Neustadt/Donau Germany and AbbVie, Wiesbaden, Germany. MSG has received funding for lectures from Pulsion Medical Systems, Munich Germany and Covidien, Neustadt/Donau Germany. MSG is a member of the medical advisory board of AbbVie, Wiesbaden, Germany. The remaining authors have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aranake A, 2013, ANESTHESIOLOGY, V119, P1275, DOI 10.1097/ALN.0000000000000023; Bein B, 2008, ANAESTHESIA, V63, P1046, DOI 10.1111/j.1365-2044.2008.05563.x; Bruhn J, 2000, J Clin Monit Comput, V16, P593, DOI 10.1023/A:1012216600170; Ellerkmann RK, 2006, ANESTH ANALG, V102, P1456, DOI 10.1213/01.ane.0000204289.47792.56; Ellerkmann RK, 2004, ANESTHESIOLOGY, V101, P1275; Escallier KE, 2014, ANAESTHESIA, V69, P899, DOI 10.1111/anae.12711; Hayashi K, 2010, CLIN NEUROPHYSIOL, V121, P1198, DOI 10.1016/j.clinph.2010.03.018; Hayashida M, 2007, J CARDIOTHOR VASC AN, V21, P61, DOI 10.1053/j.jvca.2006.02.029; Honan D, 2006, EUR J ANAESTH, V23, P385, DOI 10.1017/S0265021505002309; Johansen JW, 2000, ANESTHESIOLOGY, V93, P1336, DOI 10.1097/00000542-200011000-00029; Kakinohana M, 2006, ANESTHESIOLOGY, V104, P939, DOI 10.1097/00000542-200605000-00008; Kertai MD, 2012, ANESTH ANALG, V114, P533, DOI 10.1213/ANE.0b013e31823ee030; Kertai MD, 2010, ANESTHESIOLOGY, V112, P1116, DOI 10.1097/ALN.0b013e3181d5e0a3; Kreuer S, 2008, ANESTH ANALG, V106, P1171, DOI 10.1213/ane.0b013e3181684227; Kreuer S, 2009, J CLIN MONIT COMPUT, V23, P299, DOI 10.1007/s10877-009-9196-6; Kunisawa T, 2010, J CARDIOTHOR VASC AN, V24, P740, DOI 10.1053/j.jvca.2009.07.011; Leslie K, 2011, ANESTH ANALG, V113, P660, DOI 10.1213/ANE.0b013e31822401cc; Lleras C., 2005, ENCY SOCIAL MEASUREM, V3, P25, DOI DOI 10.1016/B0-12-369398-5/00483-7; Lundell JC, 2001, J CARDIOTHOR VASC AN, V15, P551, DOI 10.1053/jcan.2001.26526; Mahaldar DAC, 2013, J CARDIOTHOR VASC AN, V27, P59, DOI 10.1053/j.jvca.2012.05.017; Mashour GA, 2012, ANESTHESIOLOGY, V117, P717, DOI 10.1097/ALN.0b013e31826904a6; Mathew JP, 2001, J CLIN ANESTH, V13, P301, DOI 10.1016/S0952-8180(01)00275-6; Morimoto Y, 2004, ANESTH ANALG, V98, P1336, DOI 10.1213/01.ANE.0000105867.17108.B6; Nitzschke R, 2013, BRIT J ANAESTH, V110, P957, DOI 10.1093/bja/aet018; Nitzschke R, 2014, EUR J ANAESTH, V31, P482, DOI 10.1097/EJA.0000000000000106; Puri GD, 2003, EUR J ANAESTH, V20, P451, DOI 10.1097/00003643-200306000-00004; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Schmidlin D, 2001, BRIT J ANAESTH, V86, P769, DOI 10.1093/bja/86.6.769; Sessler DI, 2012, ANESTHESIOLOGY, V116, P1195, DOI 10.1097/ALN.0b013e31825683dc; Takizawa E, 2006, BRIT J ANAESTH, V96, P179, DOI 10.1093/bja/aei293; Whitlock EL, 2011, ANESTHESIOLOGY, V115, P1209, DOI 10.1097/ALN.0b013e3182395dcb; Yang H, 2004, J CARDIOTHOR VASC AN, V18, P620, DOI 10.1053/j.jvca.2004.07.001; Yu RG, 2001, BRIT J ANAESTH, V86, P338, DOI 10.1093/bja/86.3.338; Ziegeler S, 2010, J CLIN ANESTH, V22, P340, DOI 10.1016/j.jclinane.2009.09.007	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0134097	10.1371/journal.pone.0134097	http://dx.doi.org/10.1371/journal.pone.0134097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312484	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000006
J	Webster, AF; Chepelev, N; Gagne, R; Kuo, B; Recio, L; Williams, A; Yauk, CL				Webster, A. Francina; Chepelev, Nikolai; Gagne, Remi; Kuo, Byron; Recio, Leslie; Williams, Andrew; Yauk, Carole L.			Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD)	PLOS ONE			English	Article							GENE-EXPRESSION; RISK-ASSESSMENT; RNA-SEQ; CANCER; TOXICOGENOMICS; CONCORDANCE; VARIANCE; FURAN	Many regulatory agencies are exploring ways to integrate toxicogenomic data into their chemical risk assessments. The major challenge lies in determining how to distill the complex data produced by high-content, multi-dose gene expression studies into quantitative information. It has been proposed that benchmark dose (BMD) values derived from toxico-genomics data be used as point of departure (PoD) values in chemical risk assessments. However, there is limited information regarding which genomics platforms are most suitable and how to select appropriate PoD values. In this study, we compared BMD values modeled from RNA sequencing-, microarray-, and qPCR-derived gene expression data from a single study, and explored multiple approaches for selecting a single PoD from these data. The strategies evaluated include several that do not require prior mechanistic knowledge of the compound for selection of the PoD, thus providing approaches for assessing data-poor chemicals. We used RNA extracted from the livers of female mice exposed to non-carcinogenic (0, 2 mg/kg/day, mkd) and carcinogenic (4, 8 mkd) doses of furan for 21 days. We show that transcriptional BMD values were consistent across technologies and highly predictive of the two-year cancer bioassay-based PoD. We also demonstrate that filtering data based on statistically significant changes in gene expression prior to BMD modeling creates more conservative BMD values. Taken together, this case study on mice exposed to furan demonstrates that high-content toxicogenomics studies produce robust data for BMD modelling that are minimally affected by inter-technology variability and highly predictive of cancer-based PoD doses.	[Webster, A. Francina; Chepelev, Nikolai; Gagne, Remi; Kuo, Byron; Williams, Andrew; Yauk, Carole L.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Webster, A. Francina] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Recio, Leslie] Integrated Lab Syst Inc, Res Triangle Pk, NC USA	Health Canada; Carleton University	Yauk, CL (corresponding author), Hlth Canada, Tunneys Pasture, Environm Hlth Sci & Res Bur, 50 Columbine Driveway, Ottawa, ON K1A 0L2, Canada.	Carole.Yauk@hc-sc.gc.ca		Yauk, Carole/0000-0002-6725-3454; Williams, Andrew/0000-0002-7637-7686	Health Canada Genomics RD Initiative; Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship; ILS; ILS Research and Development budgets	Health Canada Genomics RD Initiative; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); ILS; ILS Research and Development budgets	CLY's research is funded by the Health Canada Genomics R&D Initiative. AFW was supported by the Natural Science and Engineering Research Council of Canada and the Ontario Graduate Scholarship. LR is an employee of ILS. ILS funded only the in-life portion: the exposure of mice to furan, collection of tissues, and RNA extractions for downstream molecular analysis. ILS laboratories are accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AALAC) and the animal use protocol for this study was reviewed and approved by the ILS Institutional Animal Care & Use Committee (IACUC). Funding for the conduct of the in-life portion of this study was derived from the ILS Research and Development budgets. ILS has no competing interest with respect to furan manufacture, sales or research. All molecular analysis of the RNA derived from animal tissues from this study were analyzed at Health Canada (Ottawa). ILS provided support in the form of salaries for LR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat VS, 2013, TOXICOL SCI, V136, P205, DOI 10.1093/toxsci/kft182; Black MB, 2014, TOXICOL SCI, V137, P385, DOI 10.1093/toxsci/kft249; Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourdon JA, 2013, TOXICOLOGY, V303, P83, DOI 10.1016/j.tox.2012.10.014; Clewell HJ, 2014, TOXICOL APPL PHARM, V280, P78, DOI 10.1016/j.taap.2014.06.015; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Jackson AF, 2014, TOXICOL APPL PHARM, V274, P63, DOI 10.1016/j.taap.2013.10.019; Labib S, 2012, TOXICOL SCI, V129, P213, DOI 10.1093/toxsci/kfs177; Moffat I, 2015, CRIT REV TOXICOL, V45, P1, DOI 10.3109/10408444.2014.973934; Moser GJ, 2009, EXP TOXICOL PATHOL, V61, P101, DOI 10.1016/j.etp.2008.06.006; Powell CL, 2006, TOXICOL SCI, V93, P213, DOI 10.1093/toxsci/kfl030; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Romer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097640; Roy NC, 2011, BRIEF FUNCT GENOMICS, V10, P135, DOI 10.1093/bfgp/elr005; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thomas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063308; Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171; Thomas RS, 2013, TOXICOL SCI, V134, P180, DOI 10.1093/toxsci/kft094; Thomas RS, 2012, MUTAT RES-GEN TOX EN, V746, P135, DOI 10.1016/j.mrgentox.2012.01.007; Thomas RS, 2011, TOXICOL SCI, V120, P194, DOI 10.1093/toxsci/kfq355; Thybaud V, 2007, ENVIRON MOL MUTAGEN, V48, P369, DOI 10.1002/em.20304; United States Environmental Protection Agency (US EPA), 2012, EPA100R 12001; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; Webster AF, 2014, GENOM DATA, V2, P117, DOI 10.1016/j.gdata.2014.05.013; Wu H., 2003, MAANOVA SOFTWARE PAC; Yang LL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-387; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	37	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136764	10.1371/journal.pone.0136764	http://dx.doi.org/10.1371/journal.pone.0136764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313361	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000095
J	Ma, YD; Zhao, G; Tu, S; Zheng, Y				Ma, Yidan; Zhao, Guang; Tu, Shen; Zheng, Yong			Attentional Biases toward Attractive Alternatives and Rivals: Mechanisms Involved in Relationship Maintenance among Chinese Women	PLOS ONE			English	Article							SELECTIVE ATTENTION; ROMANTIC RELATIONSHIPS; IMPLICIT COGNITION; INVESTMENT MODEL; UNITED-STATES; LOVE; COMMITMENT; THREAT; MOTIVATION; VIGILANCE	A long-term romantic relationship can offer many benefits to committed individuals. Thus, humans possess relationship maintenance mechanisms to protect against threats from those who serve as attractive alternatives or intrasexual rivals. Many studies have indicated that romantic love can act as a commitment device to activate these mechanisms. To examine the attentional bias associated with relationship maintenance among 108 college students (49 single and 59 committed females) in China, we used a semantic priming procedure to activate mental representations associated with romantic love and then asked participants to complete a dot-probe task for the purpose of making a distinction between the engage and disengage components of attention. No significant engaging effects toward attractive faces were observed among committed females, but the following significant disengaging effects were found: when primed with romantic love, single females showed increased attention toward and difficulty in disengaging from attractive male faces, whereas females already in a committed relationship did not alter their attention, remaining as inattentive to attractive alternatives as they were in the baseline condition. In addition, committed females responded to love priming by exhibiting difficulty in disengaging from attractive rivals. The present findings provide evidence in the Chinese cultural context for the existence of early-stage attentional processes in the domain of relationship maintenance that committed Chinese females protected an ongoing relationship by not only being inattentive to attractive males who could serve as attractive alternatives, but also being more attentive to attractive females who could be potential rivals when mental representations associated with romantic love were primed.	[Ma, Yidan; Zheng, Yong] Southwest Univ, Key Lab Cognit & Personal MOE, Chongqing, Peoples R China; [Zhao, Guang] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Peoples R China; [Tu, Shen] China West Normal Univ, Dept Psychol, Nanchong, Peoples R China	Southwest University - China; Liaoning Normal University; China West Normal University	Zheng, Y (corresponding author), Southwest Univ, Key Lab Cognit & Personal MOE, Chongqing, Peoples R China.	zhengy@swu.edu.cn		Tu, Shen/0000-0001-9111-2398				Anderson US, 2010, J EXP SOC PSYCHOL, V46, P804, DOI 10.1016/j.jesp.2010.04.015; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Buss DM, 1997, J PERS SOC PSYCHOL, V72, P346, DOI 10.1037/0022-3514.72.2.346; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Cisler JM, 2010, BEHAV RES THER, V48, P74, DOI 10.1016/j.brat.2009.09.003; DeWall CN, 2011, J PERS SOC PSYCHOL, V101, P1302, DOI 10.1037/a0025497; DeWall CN, 2008, EVOL PSYCHOL, V6, P328, DOI 10.1177/147470490800600209; Ellenbogen MA, 2009, BEHAV RES THER, V47, P128, DOI 10.1016/j.brat.2008.10.021; Fisher HE, 1998, HUM NATURE-INT BIOS, V9, P23, DOI 10.1007/s12110-998-1010-5; Fisher M, 2011, PERS RELATIONSHIP, V18, P20, DOI 10.1111/j.1475-6811.2010.01307.x; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; [高笑 Gao Xiao], 2012, [心理学报, Acta Psychologica Sinica], V44, P498; Gonzaga GC, 2001, J PERS SOC PSYCHOL, V81, P247, DOI 10.1037//0022-3514.81.2.247; Gonzaga GC, 2008, EVOL HUM BEHAV, V29, P119, DOI 10.1016/j.evolhumbehav.2007.11.003; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Hatfield E., 1996, LOVE SEX CROSS CULTU; Higgins LT, 2002, SEX ROLES, V46, P75, DOI 10.1023/A:1016565426011; Jackson T, 2006, J CROSS CULT PSYCHOL, V37, P446, DOI 10.1177/0022022106288480; JOHNSON DJ, 1989, J PERS SOC PSYCHOL, V57, P967, DOI 10.1037/0022-3514.57.6.967; Karremans JC, 2011, COGNITION, V121, P422, DOI 10.1016/j.cognition.2011.07.008; Koster EHW, 2004, EMOTION, V4, P312, DOI 10.1037/1528-3542.4.3.312; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Leo JL, 2010, THESIS FLORIDA STATE; Li CG., 2010, J JIANGXI NORMAL U P, V43, P184; Li YM, 2012, SEX ROLES, V67, P544, DOI 10.1007/s11199-012-0196-5; Linardatos L, 2011, J PERS SOC PSYCHOL, V101, P737, DOI 10.1037/a0023647; Lu HJ, 2012, EVOL PSYCHOL-US, V10, P120, DOI 10.1177/147470491201000113; Lydon JE, 2008, J PERS SOC PSYCHOL, V95, P50, DOI 10.1037/0022-3514.95.1.50; Lydon JE, 2010, SOC PERSONAL PSYCHOL, V4, P635, DOI 10.1111/j.1751-9004.2010.00283.x; Maner JK, 2008, EVOL HUM BEHAV, V29, P343, DOI 10.1016/j.evolhumbehav.2008.04.003; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; Maner JK, 2007, EVOL HUM BEHAV, V28, P28, DOI 10.1016/j.evolhumbehav.2006.05.006; Maner JK, 2009, J PERS SOC PSYCHOL, V97, P74, DOI 10.1037/a0014055; Maner JK, 2009, J EXP SOC PSYCHOL, V45, P174, DOI 10.1016/j.jesp.2008.08.002; Miller RS, 1997, J PERS SOC PSYCHOL, V73, P758, DOI 10.1037/0022-3514.73.4.758; Miller SL, 2012, J EXP SOC PSYCHOL, V48, P566, DOI 10.1016/j.jesp.2011.10.012; Pillsworth E. G., 2006, ANN REV SEX RES, V17, P59, DOI DOI 10.1080/10532528.2006.10559837; Plant EA, 2010, J EXP SOC PSYCHOL, V46, P474, DOI 10.1016/j.jesp.2009.12.012; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ritter SM, 2010, J EXP SOC PSYCHOL, V46, P631, DOI 10.1016/j.jesp.2010.02.010; Rothbaum F, 1998, J CROSS CULT PSYCHOL, V29, P306, DOI 10.1177/0022022198292003; RUSBULT CE, 1983, J PERS SOC PSYCHOL, V45, P101, DOI 10.1037/0022-3514.45.1.101; RUSBULT CE, 1980, J EXP SOC PSYCHOL, V16, P172, DOI 10.1016/0022-1031(80)90007-4; Salemink E, 2007, BEHAV RES THER, V45, P607, DOI 10.1016/j.brat.2006.04.004; SIMPSON JA, 1987, J PERS SOC PSYCHOL, V53, P683, DOI 10.1037/0022-3514.53.4.683; SIMPSON JA, 1990, J PERS SOC PSYCHOL, V59, P1192, DOI 10.1037/0022-3514.59.6.1192; Visserman ML, 2014, PERS RELATIONSHIP, V21, P324, DOI 10.1111/pere.12035; [王一牛 WANG Yi-Niu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P608; Wilbur CJ, 2010, PERS INDIV DIFFER, V49, P749, DOI 10.1016/j.paid.2010.06.020; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Xu YS, 2013, FAM COURT REV, V51, P591, DOI 10.1111/fcre.12055; Zang Q, 2013, THESIS E CHINA NORMA; Zheng WJ, 2011, CULT HEALTH SEX, V13, P497, DOI 10.1080/13691058.2011.563866	57	4	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136662	10.1371/journal.pone.0136662	http://dx.doi.org/10.1371/journal.pone.0136662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26309232	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400148
J	Musolf, K; Meindl, S; Larsen, AL; Kalcounis-Rueppell, MC; Penn, DJ				Musolf, Kerstin; Meindl, Stefanie; Larsen, Angela L.; Kalcounis-Rueppell, Matina C.; Penn, Dustin J.			Ultrasonic Vocalizations of Male Mice Differ among Species and Females Show Assortative Preferences for Male Calls	PLOS ONE			English	Article							MUS-MUSCULUS; HOUSE MOUSE; SOCIAL-STATUS; WILD MICE; BEHAVIOR; SIGNALS; ECHOLOCATION; RECOGNITION; SONG; CLASSIFICATION	Male house mice (Mus musculus) emit ultrasonic vocalizations (USVs) during courtship, which attract females, and we aimed to test whether females use these vocalizations for species or subspecies recognition of potential mates. We recorded courtship USVs of males from different Mus species, Mus musculus subspecies, and populations (F1 offspring of wild-caught Mus musculus musculus, Mus musculus domesticus (and F1 hybrid crosses), and Mus spicilegus), and we conducted playback experiments to measure female preferences for male USVs. Male vocalizations contained at least seven distinct syllable types, whose frequency of occurrence varied among species, subspecies, and populations. Detailed analyses of multiple common syllable types indicated that Mus musculus and Mus spicilegus could be discriminated based on spectral and temporal characteristics of their vocalizations, and populations of Mus musculus were also distinctive regardless of the classification model used. Females were able to discriminate USVs from different species, and showed assortative preferences for conspecific males. We found no evidence that females discriminate USVs of males from a different subspecies or separate populations of the same species, even though our spectral analyses identified acoustic features that differ between species, subspecies, and populations of the same species. Our results provide the first comparison of USVs between Mus species or between Mus musculus subspecies, and the first evidence that male USVs potentially facilitate species recognition.	[Musolf, Kerstin; Meindl, Stefanie; Penn, Dustin J.] Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria; [Musolf, Kerstin] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Larsen, Angela L.; Kalcounis-Rueppell, Matina C.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	University of Veterinary Medicine Vienna; City University of New York (CUNY) System; Brooklyn College (CUNY); University of North Carolina; University of North Carolina Greensboro	Musolf, K (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria.	kerstinmusolf@msn.com		Larsen-Gray, Angela/0000-0002-7222-4201	Austrian Science Fund [FWF P 28141-B25]; U.S. Environmental Protection Agency (EPA) [FP-91763501-0]	Austrian Science Fund(Austrian Science Fund (FWF)); U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	The research was supported by a grant to Dustin J. Penn from the Austrian Science Fund (FWF P 28141-B25). Angela L. Larsen developed this publication under STAR Fellowship Assistance Agreement no. FP-91763501-0 awarded by the U.S. Environmental Protection Agency (EPA). The study has not been formally reviewed by EPA, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are solely those of the authors, and EPA does not endorse any products or commercial services mentioned in this publication.	[Anonymous], 1877, NATURE; [Anonymous], 2014, R LANG ENV STAT COMP; Armitage DW, 2010, ECOL INFORM, V5, P465, DOI 10.1016/j.ecoinf.2010.08.001; Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Asaba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087186; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bonhomme F, 2012, EVOLUTION HOUSE MOUS, P278; Bradbury Jack W., 1998, pi; Britton-Davidian J, 2005, BIOL J LINN SOC, V84, P379, DOI 10.1111/j.1095-8312.2005.00441.x; Brunelli SA, 1997, DEV PSYCHOBIOL, V31, P255, DOI 10.1002/(SICI)1098-2302(199712)31:4<255::AID-DEV3>3.0.CO;2-Q; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Christophe N, 1998, ANIM BEHAV, V56, P365, DOI 10.1006/anbe.1998.0798; DAMATO FR, 1991, ANIM BEHAV, V41, P875, DOI 10.1016/S0003-3472(05)80354-9; Davidson SM, 2002, J MAMMAL, V83, P526, DOI 10.1644/1545-1542(2002)083<0526:GAIVIV>2.0.CO;2; Ferkin Michael H., 2005, Acta Zoologica Sinica, V51, P772; FLOOD JF, 1995, PHYSIOL BEHAV, V57, P669, DOI 10.1016/0031-9384(94)00318-1; Flowerdew J.R., 1987, MAMMALS THEIR REPROD; Forejt J, 2012, EVOLUTION HOUSE MOUS, P482; Ganem G, 2008, HEREDITY, V100, P594, DOI 10.1038/hdy.2008.20; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Heth G, 2001, BIOL J LINN SOC, V73, P213, DOI 10.1006/bijl.2001.0531; Hoffmann F, 2008, ULTRASONIC COURTSHIP; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Hoffmann F, 2009, PHYSIOL BEHAV, V96, P602, DOI 10.1016/j.physbeh.2008.12.014; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Irwin DE, 1999, HEREDITY, V82, P347, DOI 10.1038/sj.hdy.6885270; Kalcounis-Rueppell MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009705; KALER LW, 1981, ENDOCRINOLOGY, V108, P712, DOI 10.1210/endo-108-2-712; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; KOTENKOVA EV, 1989, ACTA THERIOL, V34, P315, DOI 10.4098/AT.arch.89-31; Krebs C.J., 1993, INTRO BEHAV ECOLOGY; Krebs CJ, 1993, INTRO BEHAV ECOLOGY; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; Lumley LA, 1999, PHYSIOL BEHAV, V67, P769, DOI 10.1016/S0031-9384(99)00131-6; MAGGIO JC, 1986, BEHAV GENET, V16, P493, DOI 10.1007/BF01074267; MARKL H, 1973, Zeitschrift fuer Tierpsychologie, V33, P274; Miller JR, 2007, J MAMMAL, V88, P1447, DOI 10.1644/06-MAMM-A-386R.1; Musolf K., 2012, EVOLUTION HOUSE MOUS, P253, DOI [10.1017/CBO9781139044547.012, DOI 10.1017/CBO9781139044547.012]; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; NYBY J, 1977, J COMP PHYSIOL PSYCH, V91, P1424, DOI 10.1037/h0077411; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Nyby JG, 2010, HBK BEHAV NEUROSCI, V19, P303, DOI 10.1016/B978-0-12-374593-4.00029-2; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Pasch B, 2013, AM NAT, V182, pE161, DOI 10.1086/673263; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Redgwell RD, 2009, ALGORITHMS, V2, P907, DOI 10.3390/a2030907; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Roubertoux PL, 1996, BEHAV GENET, V26, P427, DOI 10.1007/BF02359487; Sales GD, 2010, HBK BEHAV NEUROSCI, V19, P77, DOI 10.1016/B978-0-12-374593-4.00009-7; Smadja C, 2005, J EVOLUTION BIOL, V18, P1485, DOI 10.1111/j.1420-9101.2005.00944.x; Smadja C, 2002, BEHAV ECOL, V13, P312, DOI 10.1093/beheco/13.3.312; Smadja C, 2008, BEHAV ECOL, V19, P223, DOI 10.1093/beheco/arm127; Snell GD, 1941, REPROD BIOL LAB MOUS; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Suzuki H., 2012, EVOLUTION HOUSE MOUS, P35, DOI DOI 10.1017/CBO9781139044547.004; Tabachnick B. G., 2001, USING MULTIVARIATE S; Teeter KC, 2010, EVOLUTION, V64, P472, DOI 10.1111/j.1558-5646.2009.00846.x; Teschke M, 2008, GENETICS, V180, P1537, DOI 10.1534/genetics.108.090811; Thonhauser KE, 2013, ANIM BEHAV, V86, P1013, DOI 10.1016/j.anbehav.2013.09.004; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; Thoss M, 2011, MOL ECOL, V20, P1546, DOI 10.1111/j.1365-294X.2011.05009.x; Tong WF, 2012, CURR BIOL, V22, pR858, DOI 10.1016/j.cub.2012.08.054; Tucker P. K., 2007, MOUSE BIOMEDICAL RES, P13; Tucker PK, 2005, BIOL J LINN SOC, V84, P653, DOI 10.1111/j.1095-8312.2005.00462.x; Zala SM, 2004, BEHAV ECOL, V15, P338, DOI 10.1093/beheco/arh022; Zippelius H. M., 1956, Naturwissenschaften, V43, P502	84	33	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134123	10.1371/journal.pone.0134123	http://dx.doi.org/10.1371/journal.pone.0134123			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309246	Green Published, gold			2022-12-27	WOS:000360069400019
J	Mosnier, A; Caini, S; Daviaud, I; Nauleau, E; Bui, TT; Debost, E; Bedouret, B; Agius, G; van der Werf, S; Lina, B; Cohen, JM				Mosnier, Anne; Caini, Saverio; Daviaud, Isabelle; Nauleau, Elodie; Bui, Tan Tai; Debost, Emmanuel; Bedouret, Bernard; Agius, Gerard; van der Werf, Sylvie; Lina, Bruno; Cohen, Jean Marie		GROG Network	Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections	PLOS ONE			English	Article							SEASONAL INFLUENZA; SURVEILLANCE; POPULATION; GUANGZHOU; LINEAGES; VICTORIA; FEATURES; ILLNESS; STRAINS; BURDEN	Background Studies that aimed at comparing the clinical presentation of influenza patients across virus types and subtypes/lineages found divergent results, but this was never investigated using data collected over several years in a countrywide, primary care practitioners-based influenza surveillance system. Methods The IBVD (Influenza B in Vircases Database) study collected information on signs and symptoms at disease onset from laboratory-confirmed influenza patients of any age who consulted a sentinel practitioner in France. We compared the clinical presentation of influenza patients across age groups (0-4, 5-14, 15-64 and 65+ years), virus types (A, B) and subtypes/lineages (A(H3N2), pandemic A(H1N1), B Victoria, B Yamagata). Results Overall, 14,423 influenza cases (23.9% of which were influenza B) were included between 2003-2004 and 2012-2013. Influenza A and B accounted for over 50% of total influenza cases during eight and two seasons, respectively. There were minor differences in the distribution of signs and symptoms across influenza virus types and subtypes/lineages. Compared to patients aged 0-4 years, those aged 5-14 years were more likely to have been infected with type B viruses (OR 2.15, 95% CI 1.87-2.47) while those aged 15-64 years were less likely (OR 0.83, 95% CI 0.73-0.96). Males and influenza patients diagnosed during the epidemic period were less likely to be infected with type B viruses. Conclusions Despite differences in age distribution, the clinical illness produced by the different influenza virus types and subtypes is indistinguishable among patients that consult a general practitioner for acute respiratory infections.	[Mosnier, Anne; Caini, Saverio; Daviaud, Isabelle; Nauleau, Elodie; Bui, Tan Tai; Cohen, Jean Marie] Open Rome Organize & Promote Epidemiol Network, Paris, France; [Debost, Emmanuel; Bedouret, Bernard] GROG Network, Paris, France; [Agius, Gerard] Ctr Hosp Univ Poitiers, Lab Virol, Poitiers, France; [van der Werf, Sylvie] Univ Paris Diderot, Ctr Natl Reference Virus Influenza, Genet Mol Virus Resp, Inst Pasteur,CNRS UMR 3569,Sorbonne Paris Cite, Paris, France; [Lina, Bruno] Univ Lyon 1, Hosp Civils Lyon & Virpath, Ctr Natl Reference Virus Influenza, CBPE, F-69365 Lyon, France	CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Mosnier, A (corresponding author), Open Rome Organize & Promote Epidemiol Network, Paris, France.	amos@openrome.org; enauleau@openrome.org	Caini, Saverio/AAI-3788-2020; lina, bruno/N-3663-2019	Caini, Saverio/0000-0002-2262-1102; lina, bruno/0000-0002-8959-2123; van der WERF, Sylvie/0000-0002-1148-4456	GSK Biologicals SA	GSK Biologicals SA(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	IBVD study was funded by GSK Biologicals SA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biere B, 2010, J CLIN MICROBIOL, V48, P1425, DOI 10.1128/JCM.02116-09; Chi CY, 2008, PEDIATR INFECT DIS J, V27, P640, DOI 10.1097/INF.0b013e31816be008; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; Heymann DL, 2008, CONTROL COMMUNICABLE; Hite LK, 2007, INT J INFECT DIS, V11, P40, DOI 10.1016/j.ijid.2005.10.008; Hu Jen-Jan, 2004, Journal of Microbiology Immunology and Infection, V37, P95; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Kiertiburanakul S, 2014, JPN J INFECT DIS, V67, P33, DOI 10.7883/yoken.67.33; Kilbourne ED, 1975, INFLUENZA VIRUS INFL; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Meerhoff T J, 2004, Euro Surveill, V9, P34; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Peltola V, 2003, CLIN INFECT DIS, V36, P299, DOI 10.1086/345909; Purakayastha DR, 2013, INDIAN J MED RES, V138, P962; Richard SA, 2010, VACCINE, V28, P2693, DOI 10.1016/j.vaccine.2010.01.053; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Shen CF, 2008, J MICROBIOL IMMUNOL, V41, P294; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Van Cauteren D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-947; VanWormer JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-231; Webster RG, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P1, DOI 10.1002/9781118636817; WHO, 2011, INF MOL DIAGN INFL V; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685; Yang ZF, 2012, JPN J INFECT DIS, V65, P208, DOI 10.7883/yoken.65.208; Yap J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-12	30	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136186	10.1371/journal.pone.0136186	http://dx.doi.org/10.1371/journal.pone.0136186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325069	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700033
J	Carmel, MS; Kahane, N; Oberman, F; Miloslavski, R; Sela-Donenfeld, D; Kalcheim, C; Yisraeli, JK				Carmel, Michal Shoshkes; Kahane, Nitza; Oberman, Froma; Miloslavski, Rachel; Sela-Donenfeld, Dalit; Kalcheim, Chaya; Yisraeli, Joel K.			A Novel Role for VICKZ Proteins in Maintaining Epithelial Integrity during Embryogenesis	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; NEURAL CREST MIGRATION; CELL-MIGRATION; BINDING PROTEIN-3; VG1 RBP; EXPRESSION; BETA; CANCER; GROWTH; CARCINOMA	Background VICKZ (IGF2BP1,2,3/ZBP1/Vg1RBP/IMP1,2,3) proteins bind RNA and help regulate many RNA-mediated processes. In the midbrain region of early chick embryos, VICKZ is expressed in the neural folds and along the basal surface of the neural epithelium, but, upon neural tube closure, is down-regulated in prospective cranial neural crest (CNC) cells, concomitant with their emigration and epithelial-to-mesenchymal transition (EMT). Electroporation of constructs that modulate cVICKZ expression demonstrates that this down-regulation is both necessary and sufficient for CNC EMT. These results suggest that VICKZ down-regulation in CNC cell-autonomously promotes EMT and migration. Reduction of VICKZ throughout the embryo, however, inhibits CNC migration non-cell-autonomously, as judged by transplantation experiments in Xenopus embryos. Results and Conclusions Given the positive role reported for VICKZ proteins in promoting cell migration of chick embryo fibroblasts and many types of cancer cells, we have begun to look for specific mRNAs that could mediate context-specific differences. We report here that the laminin receptor, integrin alpha 6, is down-regulated in the dorsal neural tube when CNC cells emigrate, this process is mediated by cVICKZ, and integrin alpha 6 mRNA is found in VICKZ ribonucleoprotein complexes. Significantly, prolonged inhibition of cVICKZ in either the neural tube or the nascent dermomyotome sheet, which also dynamically expresses cVICKZ, induces disruption of these epithelia. These data point to a previously unreported role for VICKZ in maintaining epithelial integrity.	[Carmel, Michal Shoshkes; Oberman, Froma; Miloslavski, Rachel; Yisraeli, Joel K.] Hebrew Univ Jerusalem, Fac Med, Dept Dev Biol & Canc Res, Jerusalem, Israel; [Kahane, Nitza; Kalcheim, Chaya] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Med Neurobiol, Jerusalem, Israel; [Sela-Donenfeld, Dalit] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Yisraeli, JK (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Dev Biol & Canc Res, Jerusalem, Israel.	yisraeli@cc.huji.ac.il	Shoshkes Carmel, Michal/AAY-5113-2021; Yisraeli, Joel/S-2031-2019	Shoshkes Carmel, Michal/0000-0002-8406-2158; Yisraeli, Joel/0000-0001-6538-6686; Sela-Donenfeld, Dalit/0000-0001-7498-061X	Israel Science Foundation; Company of Biologists Travel Fellowship	Israel Science Foundation(Israel Science Foundation); Company of Biologists Travel Fellowship	Funded by Israel Science Foundation (JKY) and Company of Biologists Travel Fellowship (MSC).	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Alfandari D, 2010, CELL ADHES MIGR, V4, P553, DOI 10.4161/cam.4.4.12202; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Borchers A, 2001, DEVELOPMENT, V128, P3049; BRONNERFRASER M, 1992, DEVELOPMENT, V115, P197; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; DALE L, 1987, DEVELOPMENT, V99, P527; Davidson B, 2014, HUM PATHOL, V45, P1520, DOI 10.1016/j.humpath.2014.03.005; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; DUBAND JL, 1987, DEVELOPMENT, V101, P461; Epstein M, 1997, DEVELOPMENT, V124, P3805; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Findeis-Hosey JJ, 2012, BIOTECH HISTOCHEM, V87, P24, DOI 10.3109/10520295.2011.591831; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jayaseelan S, 2014, METHODS, V67, P13, DOI 10.1016/j.ymeth.2013.11.001; Kahane N, 2013, DEVELOPMENT, V140, P1740, DOI 10.1242/dev.092726; Kalcheim C, 2005, CURR OPIN GENET DEV, V15, P371, DOI 10.1016/j.gde.2005.05.004; KLEIN G, 1988, CELL, V55, P331, DOI 10.1016/0092-8674(88)90056-6; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McLennan R, 2015, DEVELOPMENT, V142, P2014, DOI 10.1242/dev.117507; McLennan R, 2012, DEVELOPMENT, V139, P2935, DOI 10.1242/dev.081471; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; Natkunam Y, 2007, HAEMATOLOGICA, V92, P176, DOI 10.3324/haematol.10724; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Vainer G, 2008, J PATHOL, V215, P445, DOI 10.1002/path.2376; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weston JA, 2015, DEV BIOL, V401, P37, DOI 10.1016/j.ydbio.2014.12.035; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8	50	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136408	10.1371/journal.pone.0136408	http://dx.doi.org/10.1371/journal.pone.0136408			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317350	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100083
J	Hovick, TJ; Dahlgren, DK; Papes, M; Elmore, RD; Pitman, JC				Hovick, Torre J.; Dahlgren, David K.; Papes, Monica; Elmore, R. Dwayne; Pitman, James C.			Predicting Greater Prairie-Chicken Lek Site Suitability to Inform Conservation Actions	PLOS ONE			English	Article							SPECIES DISTRIBUTION; ENERGY DEVELOPMENT; WIND ENERGY; IMPACTS; BIODIVERSITY; POPULATIONS; VEGETATION; LOCATION; HABITAT; NESTS	The demands of a growing human population dictates that expansion of energy infrastructure, roads, and other development frequently takes place in native rangelands. Particularly, transmission lines and roads commonly divide rural landscapes and increase fragmentation. This has direct and indirect consequences on native wildlife that can be mitigated through thoughtful planning and proactive approaches to identifying areas of high conservation priority. We used nine years (2003-2011) of Greater Prairie-Chicken (Tympanuchus cupido) lek locations totaling 870 unique leks sites in Kansas and seven geographic information system (GIS) layers describing land cover, topography, and anthropogenic structures to model habitat suitability across the state. The models obtained had low omission rates (<0.18) and high area under the curve scores (AUC>0.81), indicating high model performance and reliability of predicted habitat suitability for Greater Prairie-Chickens. We found that elevation was the most influential in predicting lek locations, contributing three times more predictive power than any other variable. However, models were improved by the addition of land cover and anthropogenic features (transmission lines, roads, and oil and gas structures). Overall, our analysis provides a hierarchal understanding of Greater Prairie-Chicken habitat suitability that is broadly based on geomorphological features followed by land cover suitability. We found that when land features and vegetation cover are suitable for Greater Prairie-Chickens, fragmentation by anthropogenic sources such as roadways and transmission lines are a concern. Therefore, it is our recommendation that future human development in Kansas avoid areas that our models identified as highly suitable for Greater Prairie-Chickens and focus development on land cover types that are of lower conservation concern.	[Hovick, Torre J.] N Dakota State Univ, Sch Nat Resource Sci, Range Program, Fargo, ND 58105 USA; [Dahlgren, David K.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Papes, Monica] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Elmore, R. Dwayne] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Pitman, James C.] Western Assoc Fish & Wildlife Agencies, Emporia, KS USA	North Dakota State University Fargo; Utah System of Higher Education; Utah State University; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Hovick, TJ (corresponding author), N Dakota State Univ, Sch Nat Resource Sci, Range Program, Fargo, ND 58105 USA.	torre.hovick@gmail.com			USDA-AFRI (United States Department of Agriculture - Agriculture and Food Research Initiative) [2010-85101-20457]; Oklahoma Agricultural Experiment Station	USDA-AFRI (United States Department of Agriculture - Agriculture and Food Research Initiative); Oklahoma Agricultural Experiment Station	This work was supported by funding from USDA-AFRI (United States Department of Agriculture - Agriculture and Food Research Initiative) Managed Ecosystems grant #2010-85101-20457 and by the Oklahoma Agricultural Experiment Station.	Dzialak MR, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00325.1; ESRI, 2011, ARCGIS DESKT REL 10; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hamerstrom Jr F. N., 1973, WISCONSIN DEP NATURA, V64; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hovick TJ, 2015, RANGELAND ECOL MANAG, V68, P186, DOI 10.1016/j.rama.2015.01.009; Hovick TJ, 2014, J APPL ECOL, V51, P1680, DOI 10.1111/1365-2664.12331; International Energy Agency, WORLD EN OUTL 2009; Jarnevich CS, 2011, ENVIRON MANAGE, V47, P926, DOI 10.1007/s00267-011-9651-2; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnsgard PA, 2002, GRASSLAND GROUSE THE, P1; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; Mcnew LB, 2014, CONSERV BIOL, V28, P1089, DOI 10.1111/cobi.12258; Mcnew LB, 2012, J WILDLIFE MANAGE, V76, P38, DOI 10.1002/jwmg.237; Niemuth ND, 2000, J WILDLIFE MANAGE, V64, P278, DOI 10.2307/3803000; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Patten MA, 2007, TALL TIMB FIRE ECOL, P149; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearce-Higgins JW, 2012, J APPL ECOL, V49, P386, DOI 10.1111/j.1365-2664.2012.02110.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Polak T, 2014, J APPL ECOL, V51, P726, DOI 10.1111/1365-2664.12243; Pruett CL, 2009, CONSERV BIOL, V23, P1253, DOI 10.1111/j.1523-1739.2009.01254.x; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Robbins MB, 2002, N AM BIRDS, P2; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; SCHROEDER MA, 1993, BEHAV ECOL, V4, P266, DOI 10.1093/beheco/4.3.266; Schroeder MA, 1993, BIRDS N AM ACCOUNT; Schroeder MA, 2011, WILDLIFE SOC B, V29, P24; Svedarsky WD, 2000, WILDLIFE BIOL, V6, P277, DOI 10.2981/wlb.2000.027; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Winder VL, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00206.1; Winder VL, 2015, CONDOR, V117, P284, DOI 10.1650/CONDOR-14-98.1; With KA, 2008, BIOL CONSERV, V141, P3152, DOI 10.1016/j.biocon.2008.09.025	43	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137021	10.1371/journal.pone.0137021	http://dx.doi.org/10.1371/journal.pone.0137021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317349	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100195
J	Hu, YQ; Su, ZY; Li, WB; Li, JP; Ke, XD				Hu, Yanqiu; Su, Zhiyao; Li, Wenbin; Li, Jingpeng; Ke, Xiandong			Influence of Tree Species Composition and Community Structure on Carbon Density in a Subtropical Forest	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; ECOSYSTEM SERVICES; BIOMASS; STOCK; VEGETATION; CLIMATE	We assessed the impact of species composition and stand structure on the spatial variation of forest carbon density using data collected from a 4-ha plot in a subtropical forest in southern China. We found that 1) forest biomass carbon density significantly differed among communities, reflecting a significant effect of community structure and species composition on carbon accumulation; 2) soil organic carbon density increased whereas stand biomass carbon density decreased across communities, indicating that different mechanisms might account for the accumulation of stand biomass carbon and soil organic carbon in the subtropical forest; and 3) a small number of tree individuals of the medium- and large-diameter class contributed predominantly to biomass carbon accumulation in the community, whereas a large number of seedlings and saplings were responsible for a small proportion of the total forest carbon stock. These findings demonstrate that both biomass carbon and soil carbon density in the subtropical forest are sensitive to species composition and community structure, and that heterogeneity in species composition and stand structure should be taken into account to ensure accurate forest carbon accounting.	[Hu, Yanqiu; Su, Zhiyao; Li, Wenbin; Li, Jingpeng; Ke, Xiandong] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Su, ZY (corresponding author), South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China.	zysu@scau.edu.cn	Li, Wenbin/ABD-9849-2021	Li, Wenbin/0000-0003-2474-5595; Su, Zhiyao/0000-0003-4534-7502	Forestry Science and Technology Innovation Program of Guangdong Province [2011KJCX031-02]	Forestry Science and Technology Innovation Program of Guangdong Province	This research is funded by the Forestry Science and Technology Innovation Program of Guangdong Province (2011KJCX031-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, COMM FOR TREE VOL TA; Augusto L, 2002, ANN FOREST SCI, V59, P233, DOI 10.1051/forest:2002020; Beets PN, 2011, FOREST ECOL MANAG, V262, P1119, DOI 10.1016/j.foreco.2011.06.012; Ellison D, 2011, ENVIRON SCI POLICY, V14, P1062, DOI 10.1016/j.envsci.2011.07.001; Fang J. Y., 2007, SCI CHINA, V37, P804; Gibbs HK, 2007, ENVIRON RES LETT, V2; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; LIU GH, 2000, ACTA ECOLOGICA SINIC, V20, P733; Maslin M, 2011, NATURE, V475, P445, DOI 10.1038/475445a; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Oueslati I, 2013, PEDOSPHERE, V23, P48, DOI 10.1016/S1002-0160(12)60079-4; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Perdan S, 2011, ENERG POLICY, V39, P6040, DOI 10.1016/j.enpol.2011.07.003; Reich PB, 2011, NAT CLIM CHANGE, V1, P346; Rolecek J, 2009, J VEG SCI, V20, P596, DOI 10.1111/j.1654-1103.2009.01062.x; [方运霆 Fang Yunting], 2004, [生态学报, Acta Ecologica Sinica], V24, P135; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schwenk WS, 2012, ECOL APPL, V22, P1612, DOI 10.1890/11-0864.1; Somogyi Z, 2007, EUR J FOREST RES, V126, P197, DOI 10.1007/s10342-006-0125-7; Stockmann Keith D, 2012, Carbon Balance Manag, V7, P1, DOI 10.1186/1750-0680-7-1; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; Watanabe MDB, 2011, ENVIRON SCI POLICY, V14, P594, DOI 10.1016/j.envsci.2011.05.013; Watson C., 2009, FOREST CARBON ACCOUN; [徐新良 XU Xinliang], 2007, [地理科学进展, Progress in Geography], V26, P1	27	24	28	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136984	10.1371/journal.pone.0136984	http://dx.doi.org/10.1371/journal.pone.0136984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317523	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100189
J	Jung, Y; Park, HYL; Lee, NY; Yoo, YS; Park, CK				Jung, Younhea; Park, Hae-Young L.; Lee, Na Young; Yoo, Young-Sik; Park, Chan Kee			Difference in Outcomes between First-Operated vs. Fellow-Operated Eyes in Patients Undergoing Bilateral Trabeculectomies	PLOS ONE			English	Article							FILTRATION SURGERY; CORNEAL ABRASION; RISK-FACTORS; FOLLOW-UP; GLAUCOMA	Main Objective To compare the course and outcome of first- and fellow-operated eyes in patients who underwent bilateral trabeculectomies and to investigate the factors associated with the difference. Methods Preoperative characteristics, including the interval between surgeries, were compared between the first-and fellow-operated eyes in 42 patients who underwent bilateral trabeculectomies. Postoperative intraocular pressure and bleb vascularity, using postoperative anterior segment photos, were compared at various time points between the first- and fellow-operated eyes. Surgical success was evaluated at 1 year after surgery and at the final follow-up. Factors affecting the difference between the first and fellow eyes were analyzed. Results There was no significant difference in success or failure rates at 1 year postoperatively and at the final follow-up between the first- and fellow-operated eyes. Early postoperative IOP and the degree of bleb vascularity were higher in the fellow-operated eyes (P = 0.001 and 0.003, respectively at week 1 postoperative). The difference in IOP between the first- and fellow-operated eyes was greater in patients whose interval between surgeries was shorter than 3 weeks (P = 0.026). Conclusions In patients undergoing bilateral trabeculectomies, early postoperative IOP was higher in the fellow-operated eyes than the first-operated eyes; the difference was greater when the interval between surgeries was shorter. The first-operated eye may influence the early postoperative inflammatory response in the fellow-operated eye. Our findings have clinical implications for planning treatment of patients who may need bilateral surgery.	[Jung, Younhea; Park, Hae-Young L.; Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Lee, Na Young] Catholic Univ Korea, Incheon St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Inchon, South Korea; [Yoo, Young-Sik] Catholic Univ Korea, Coll Med, Dept Convergence Med Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.	ckpark@catholic.ac.kr						Alward WLM, 1996, AM J OPHTHALMOL, V121, P349; BROADWAY D, 1994, BRIT J OPHTHALMOL, V78, P466, DOI 10.1136/bjo.78.6.466; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Dally LG, 2002, AM J OPHTHALMOL, V134, P481; Estil S, 2001, ACTA OPHTHALMOL SCAN, V79, P389, DOI 10.1034/j.1600-0420.2001.079004389.x; Healthwise Staff, GLAUC SURG WHICH EYE; Hitchings R, 1998, ARCH OPHTHALMOL-CHIC, V116, P241; Jacobi PC, 1999, OPHTHALMIC SURG LAS, V30, P637; Kanski JJ, 2007, CLIN OPHTHALMOLOGY, P371; Landers J, 2012, OPHTHALMOLOGY, V119, P694, DOI 10.1016/j.ophtha.2011.09.043; Mietz H, 2002, OPHTHALMOLOGY, V109, P992, DOI 10.1016/S0161-6420(02)01014-X; Okimoto S, 2014, J GLAUCOMA, V23, P410, DOI 10.1097/IJG.0b013e318285fd7d; Quigley HA, 1996, NUMBER, V80, P389; Rask R, 1996, ACTA OPHTHALMOL SCAN, V74, P232; Towler H M, 1995, Ocul Immunol Inflamm, V3, P163, DOI 10.3109/09273949509069109; Tuli S, 2009, GLAUCOMA, P557; Van Bergen T, 2014, CLIN OPHTHALMOL, V8, P857, DOI 10.2147/OPTH.S48745; Wells AP, 2004, J GLAUCOMA, V13, P454, DOI 10.1097/00061198-200412000-00005; Won HJ, 2015, J GLAUCOMA IN PRESS; Wu FPK, 2003, DIS COLON RECTUM, V46, P147, DOI 10.1007/s10350-004-6516-2	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136869	10.1371/journal.pone.0136869	http://dx.doi.org/10.1371/journal.pone.0136869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317497	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100157
J	Shrestha, M; Xiao, Y; Robinson, H; Schubot, FD				Shrestha, Manisha; Xiao, Yi; Robinson, Howard; Schubot, Florian D.			Structural Analysis of the Regulatory Domain of ExsA, a Key Transcriptional Regulator of the Type Three Secretion System in Pseudomonas aeruginosa	PLOS ONE			English	Article							VIBRIO-CHOLERAE TOXT; BLEB-NICHE FORMATION; SELF-ASSOCIATION; DNA-BINDING; SALMONELLA-TYPHIMURIUM; ADAPTIVE IMMUNITY; EFFECTOR PROTEINS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; DENDRITIC CELLS	Pseudomonas aeruginosa employs a type three secretion system to facilitate infections in mammalian hosts. The operons encoding genes of structural components of the secretion machinery and associated virulence factors are all under the control of the AraC-type transcriptional activator protein, ExsA. ExsA belongs to a unique subfamily of AraC-proteins that is regulated through protein-protein contacts rather than small molecule ligands. Prior to infection, ExsA is inhibited through a direct interaction with the anti-activator ExsD. To activate ExsA upon host cell contact this interaction is disrupted by the anti-antiactivator protein ExsC. Here we report the crystal structure of the regulatory domain of ExsA, which is known to mediate ExsA dimerization as well as ExsD binding. The crystal structure suggests two models for the ExsA dimer. Both models confirmed the previously shown involvement of helix alpha-3 in ExsA dimerization but one also suggest a role for helix alpha-2. These structural data are supported by the observation that a mutation in alpha-2 greatly diminished the ability of ExsA to activate transcription in vitro. Additional in vitro transcription studies revealed that a conserved pocket, used by AraC and the related ToxT protein for the binding of small molecule regulators, although present in ExsA is not involved in binding of ExsD.	[Shrestha, Manisha; Xiao, Yi; Schubot, Florian D.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24060 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Schubot, FD (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Washington St, Blacksburg, VA 24060 USA.	fschubot@vt.edu		Schubot, Florian/0000-0002-7403-4735	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [1R21AI101774]; Department of Energy Office of Biological and Environmental Research; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by Public Health Service grant 1R21AI101774 to FDS from the National Institute of Allergy and Infectious Diseases. Funding for data collected at beamline 29 NSLS is provided by Department of Energy Office of Biological and Environmental Research and NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aepfelbacher M, 2005, REV PHYSIOL BIOCH P, V152, P65, DOI 10.1007/s10254-004-0035-3; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Angus AA, 2010, INFECT IMMUN, V78, P4500, DOI 10.1128/IAI.00417-10; Barison N, 2013, CELL MICROBIOL, V15, P1809, DOI 10.1111/cmi.12178; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; Brutinel ED, 2008, MOL MICROBIOL, V68, P657, DOI 10.1111/j.1365-2958.2008.06179.x; Brutinel ED, 2012, J BACTERIOL, V194, P2564, DOI 10.1128/JB.00106-12; Brutinel ED, 2010, J BACTERIOL, V192, P1479, DOI 10.1128/JB.01457-09; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Bueno SM, 2005, CRIT REV IMMUNOL, V25, P389, DOI 10.1615/CritRevImmunol.v25.i5.40; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dewoody RS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00004; Diaz MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00089; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DJ, 1998, INFECT IMMUN, V66, P1453, DOI 10.1128/IAI.66.4.1453-1459.1998; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Griffith KL, 2002, J MOL BIOL, V322, P237, DOI 10.1016/S0022-2836(02)00782-9; Hauser AR, 1999, INFECT IMMUN, V67, P5530, DOI 10.1128/IAI.67.10.5530-5537.1999; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hritonenko V, 2011, MICROB PATHOGENESIS, V51, P305, DOI 10.1016/j.micpath.2011.08.001; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Johnson LE, 2009, TRANSPL INFECT DIS, V11, P227, DOI 10.1111/j.1399-3062.2009.00380.x; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; King JM, 2012, J BACTERIOL, V194, P2573, DOI 10.1128/JB.00107-12; Laskowski MA, 2006, INFECT IMMUN, V74, P4462, DOI 10.1128/IAI.00575-06; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lin PC, 2013, BIOMETALS, V26, P1067, DOI 10.1007/s10534-013-9676-5; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Lykken GL, 2006, J BACTERIOL, V188, P6832, DOI 10.1128/JB.00884-06; Maresso AW, 2007, CELL MICROBIOL, V9, P97, DOI 10.1111/j.1462-5822.2006.00770.x; Marsden AE, 2014, J BACTERIOL, V196, P3546, DOI 10.1128/JB.01969-14; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pilonieta MC, 2008, J BACTERIOL, V190, P2249, DOI 10.1128/JB.01824-07; Plano GV, 2013, IMMUNOL RES, V57, P237, DOI 10.1007/s12026-013-8454-3; Plano GV, 2004, MOL MICROBIOL, V54, P287, DOI 10.1111/j.1365-2958.2004.04306.x; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Saliba AM, 2002, MICROB PATHOGENESIS, V33, P153, DOI 10.1006/mpat.2002.0522; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Soisson SM, 1997, J MOL BIOL, V273, P226, DOI 10.1006/jmbi.1997.1314; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Taliaferro LP, 2012, J MOL BIOL, V419, P139, DOI 10.1016/j.jmb.2012.03.019; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; Thomson JJ, 2014, J BACTERIOL, V196, P3872, DOI 10.1128/JB.01824-14; Tobar JA, 2006, INFECT IMMUN, V74, P6438, DOI 10.1128/IAI.00063-06; Tosi T, 2013, RES MICROBIOL, V164, P605, DOI 10.1016/j.resmic.2013.03.019; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Vakulskas CA, 2010, J BACTERIOL, V192, P3597, DOI 10.1128/JB.00129-10; Vakulskas CA, 2009, J BACTERIOL, V191, P6654, DOI 10.1128/JB.00902-09; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Weldon JE, 2006, PROTEIN SCI, V15, P2828, DOI 10.1110/ps.062327506; Wickstrum JR, 2004, J BACTERIOL, V186, P6277, DOI 10.1128/JB.186.18.6277-6285.2004; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yahr TL, 2004, MOL CELL, V16, P497, DOI 10.1016/j.molcel.2004.11.009; Zhang Y, 2011, INFECT IMMUN, V79, P4322, DOI 10.1128/IAI.05396-11; Zheng ZD, 2007, J BIOL CHEM, V282, P6136, DOI 10.1074/jbc.M611664200; Zolfaghar I, 2006, INFECT IMMUN, V74, P3880, DOI 10.1128/IAI.01891-05	87	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136533	10.1371/journal.pone.0136533	http://dx.doi.org/10.1371/journal.pone.0136533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317977	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100097
J	Wolsan, M; Suzuki, S; Asahara, M; Motokawa, M				Wolsan, Mieczyslaw; Suzuki, Satoshi; Asahara, Masakazu; Motokawa, Masaharu			Tooth Size Variation in Pinniped Dentitions	PLOS ONE			English	Article							DOG NYCTEREUTES-PROCYONOIDES; BADGER MELES-MELES; FOX VULPES-VULPES; SEXUAL-DIMORPHISM; RED FOX; BODY-SIZE; VARIABILITY; PATTERNS; TEETH; EVOLUTIONARY	It is contentious whether size variation among mammalian teeth is heterogeneous or homogeneous, whether the coefficient of variation is reliable, and whether the standard deviation of log-transformed data and the residual of standard deviation on mean variable size are useful replacements for the coefficient of variation. Most studies of tooth size variation have been on mammals with complex-crowned teeth, with relatively little attention paid to taxa with simple-crowned teeth, such as Pinnipedia. To fill this gap in knowledge and to resolve the existing controversies, we explored the variation of linear size variables (length and width) for all teeth from complete permanent dentitions of four pinniped species, two phocids (Histriophoca fasciata, Phoca largha) and two otariids (Callorhinus ursinus, Eumetopias jubatus). Size variation among these teeth was mostly heterogeneous both along the toothrow and among species. The incisors, canines, and mesial and distal postcanines were often relatively highly variable. The levels of overall dental size variation ranged from relatively low as in land carnivorans (Phoca largha and both otariids) to high (Histriophoca fasciata). Sexual size dimorphism varied among teeth and among species, with teeth being, on average, larger in males than in females. This dimorphism was more pronounced, and the canines were larger and more dimorphic relative to other teeth in the otariids than in the phocids. The coefficient of variation quantified variation reliably in most cases. The standard deviation of log-transformed data was redundant with the coefficient of variation. The residual of standard deviation on mean variable size was inaccurate when size variation was considerably heterogeneous among the compared variables, and was incomparable between species and between sexes. The existing hypotheses invoking developmental fields, occlusal complexity, and the relative timing of tooth formation and sexually dimorphic hormonal activity do not adequately explain the differential size variation along the pinniped toothrow.	[Wolsan, Mieczyslaw; Suzuki, Satoshi; Motokawa, Masaharu] Kyoto Univ, Kyoto Univ Museum, Kyoto, Japan; [Wolsan, Mieczyslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Asahara, Masakazu] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan	Kyoto University; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Kyoto University	Wolsan, M (corresponding author), Kyoto Univ, Kyoto Univ Museum, Kyoto, Japan.	wolsan@miiz.waw.pl	Wolsan, Mieczysław/C-2717-2012	Wolsan, Mieczysław/0000-0002-2083-7743; Suzuki, Satoshi/0000-0001-6490-5720; Asahara, Masakazu/0000-0002-2069-2134	National Science Centre [2012/05/B/NZ8/02687]; Japan Society for the Promotion of Science [11J01149]	National Science Centre(National Science Centre, Poland); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Partial support for this work came from the National Science Centre (www.ncn.gov.pl) through grant 2012/05/B/NZ8/02687 to MW. MA was supported during part of this study by a Japan Society for the Promotion of Science (www.jsps.go.jp) research fellowship for young scientists (11J01149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge Hermann, 1994, Zoologische Abhandlungen (Dresden), V48, P103; Asahara M, 2014, MAMM STUDY, V39, P181, DOI 10.3106/041.039.0308; Asahara M, 2013, ECOL EVOL, V3, P278, DOI 10.1002/ece3.436; Bateson W., 1894, MAT STUDY VARIATION; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Bonner J.T., 2006, WHY SIZE MATTERS; BRIGGS K, 1975, J MAMMAL, V56, P224, DOI 10.2307/1379622; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P1; COCHARD LR, 1981, AM J PHYS ANTHROPOL, V54, P139, DOI 10.1002/ajpa.1330540117; Cope Dana A., 1993, P211; CREIGHTON GK, 1980, J ZOOL, V191, P435; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Dayan T, 2002, PALEOBIOLOGY, V28, P508, DOI 10.1666/0094-8373(2002)028<0508:VACOSA>2.0.CO;2; Freedman L., 1963, Journal of Mammalogy, V44, P24, DOI 10.2307/1377165; GINGERICH P D, 1979, Primates, V20, P141, DOI 10.1007/BF02373833; Gingerich P.D., 1977, PATTERNS EVOLUTION I, V5, P591, DOI DOI 10.1016/S0920-5446(08)70335-2; GINGERICH PD, 1974, J PALEONTOL, V48, P895; GINGERICH PD, 1979, J MAMMAL, V60, P691, DOI 10.2307/1380186; GINGERICH PD, 1977, AM J PHYS ANTHROPOL, V47, P395, DOI 10.1002/ajpa.1330470308; GINGERICH PD, 1979, AM J PHYS ANTHROPOL, V51, P457, DOI 10.1002/ajpa.1330510318; GOULD SJ, 1975, AM ZOOL, V15, P351; Hillson S., 2005, TEETH, V2nd ed., DOI 10.1017/CBO9780511614477; Hlusko LJ, 2006, AM J PHYS ANTHROPOL, V131, P420, DOI 10.1002/ajpa.20435; Kerley G.I.H., 1987, NOAA Technical Report NMFS, V51, P121; KIESER JA, 1988, AM J PRIMATOL, V14, P141, DOI 10.1002/ajp.1350140205; Kim SI, 2012, J VET MED SCI, V74, P1609, DOI 10.1292/jvms.12-0281; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; KURTEN BJORN, 1966, ACTA ZOOL FENNICA, V115, P1; LAWS R. M., 1953, FALKLAND ISLANDS DEPENDENCIES SURVEY SCI REPT, V2, P1; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; LUPS P, 1988, ACTA THERIOL, V33, P21; LUPS P, 1990, Z SAUGETIERKD, V55, P16; Meiri S, 2005, FUNCT ECOL, V19, P337, DOI 10.1111/j.1365-2435.2005.00964.x; Miller EH, 2007, J MAMMAL, V88, P1325, DOI 10.1644/06-MAMM-A-243R.1; Miller EH, 2009, J MAMMAL, V90, P491, DOI 10.1644/08-MAMM-A-055.1; Pallas PS, 1811, ZOOGRAPHIA ROSSO ASI, V1; PENGILLY D, 1984, J MAMMAL, V65, P34, DOI 10.2307/1381197; Peters R. H., 1983, CAMBRIDGE STUDIES EC; Plavcan J. Michael, 1993, P239; Polly PD, 1998, BIOL J LINN SOC, V64, P83; Prevosti FJ, 2006, J ZOOL, V270, P636, DOI 10.1111/j.1469-7998.2006.00187.x; R Core Team, 2021, R LANGUAGE ENV STAT; Scheffe V. B., 1964, Fishery Bulletin Fish and Wildlife Service US, V63, P293; Schreber JCD, 1776, SAUGTHIERE ABBILDUNG, V3, P300; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Suzuki S, 2012, J ZOOL, V288, P57, DOI 10.1111/j.1469-7998.2012.00924.x; Szuma E, 2008, J ZOOL SYST EVOL RES, V46, P73, DOI 10.1111/j.1439-0469.2007.00418.x; SZUMA E, 1994, ACTA THERIOL, V39, P201, DOI 10.4098/AT.arch.94-23; Szuma E, 2000, ANN ZOOL FENN, V37, P113; Szuma E, 2008, ACTA THERIOL, V53, P289, DOI 10.1007/BF03195193; Szuma E, 2008, ANN ZOOL FENN, V45, P185, DOI 10.5735/086.045.0304; Turner W, 1888, REPORT SCI RESULTS V, V26, P1; VANVALEN L, 1970, DEV BIOL, V23, P456, DOI 10.1016/0012-1606(70)90110-7; VANVALEN L, 1962, EVOLUTION, V16, P272; Wolsan M., 1993, P770; WOLSAN M, 1985, ACTA THERIOL, V30, P79, DOI 10.4098/AT.arch.85-3; Wolsan M., 1993, P699; Yablokov A.V, 1974, VARIABILITY MAMMALS; ZHANG YY, 1982, AM J PHYS ANTHROPOL, V59, P21; Zimmermann EAW, 1783, GEOGRAPHISCHE GESCH, V3	60	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137100	10.1371/journal.pone.0137100	http://dx.doi.org/10.1371/journal.pone.0137100			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317362	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100203
J	Yin, J; Wang, Y; Yin, HL; Chen, WP; Jin, GF; Ma, HX; Dai, JC; Chen, JP; Jiang, Y; Wang, H; Liu, ZA; Hu, ZB; Shen, HB				Yin, Jian; Wang, Yi; Yin, Hanlu; Chen, Wenping; Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Chen, Jiaping; Jiang, Yue; Wang, Hui; Liu, Zhian; Hu, Zhibin; Shen, Hongbing			Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PERIPHERAL-BLOOD; STEM-CELLS; GROWTH; EXPRESSION	Background It has been considered that the detection methods for circulating tumor cells (CTCs) based on epithelial cell adhesion molecule (EpCAM) underestimate the number of CTCs and may miss a metastatic subpopulation with cancer stem cell (CSC) properties. Therefore, we investigated EpCAM-positive and - negative CTCs in non-small cell lung cancer (NSCLC) patients at different stages, assessed the clinical value of these CTCs and explored their capacity in the following CSC model. Methods CTCs were enriched by the depletion of leukocytes with bi-antibodies using a magnetic bead separation technique and then identified by the expression of EpCAM and cytokeratin 7 and 8 using multi-parameter flow cytometry. We determined the distribution of CTCs classified by the expression of EpCAM in 46 NSCLC patients with stages I to IV, assessed the diagnostic value of these CTCs by longitudinal monitoring in 4 index patients during adjuvant therapy and characterized the stemness of these CTCs by the expression of CXCR4 and CD133 in 10 patients. Results EpCAM- negative (E-) CTCs were detected to be significantly higher than EpCAM- positive (E+) CTCs in stage IV (p = 0.003). The patients with the percentage of E- CTCs more than 95% (r > 95%) were detected to be significantly increased from 13.3% in stage I-II to 61.1% in stage IV (p = 0.006). Kaplan-Meier analysis indicated that the patients with r > 95% had significantly shorter survival time than those with r <= 0.95 (p = 0.041). Longitudinal monitoring of CTCs indicated that the patients with a high percentage of E-CTCs in the blood were not responsive to either chemotherapy or targeted therapy. Further characterization of CTCs revealed that a stem-like subpopulation of CXCR4+CD133+CTCs were detected to be significantly more prevalent in E-CTCs than that in E+CTCs (p = 0.005). Conclusions The enrichment of CTCs by the depletion of leukocytes with bi-antibodies is a valuable method for estimating the number of CTCs, which can be potentially applied in predicting the prognosis, monitoring the therapeutic effect of NSCLC patients and further analyzing the biology of CTCs.	[Yin, Jian; Yin, Hanlu; Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Chen, Jiaping; Jiang, Yue; Wang, Hui; Liu, Zhian; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wang, Yi; Chen, Wenping] Nanjing Chest Hosp, Dept Resp Dis, Nanjing, Jiangsu, Peoples R China; [Yin, Jian; Yin, Hanlu; Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Chen, Jiaping; Jiang, Yue; Wang, Hui; Liu, Zhian; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, ZA (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	liuz@njmu.edu.cn; zhibin_hu@njmu.edu.cn; hbshen@njmu.edu.cn		Shen, Hongbing/0000-0002-2581-5906	Jiangsu Natural Science Foundation [BK20141435]; Introduction of Talent Foundation [2011RC11]; Medical Science and Technology Development Foundation, Nanjing Department of Health [YKK13088]; Key Program of the National Natural Science Foundation of China [81230067]; National Key Basic Research Program [2013CB911400]	Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Introduction of Talent Foundation; Medical Science and Technology Development Foundation, Nanjing Department of Health; Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China)	This work is supported by Jiangsu Natural Science Foundation (BK20141435); The Introduction of Talent Foundation (2011RC11); Medical Science and Technology Development Foundation, Nanjing Department of Health (YKK13088); The Key Program of the National Natural Science Foundation of China (81230067); National Key Basic Research Program Grant (2013CB911400).	Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bertran E, 2009, CELL SIGNAL, V21, P1595, DOI 10.1016/j.cellsig.2009.06.006; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P645, DOI 10.6004/jnccn.2013.0084; Fusi A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-52; Gallaher J, 2014, CANCER RES, V74, P426, DOI 10.1158/0008-5472.CAN-13-0759; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Jung MJ, 2013, ONCOGENE, V32, P209, DOI 10.1038/onc.2012.37; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Liu ZA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-70; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molloy TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032426; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Sher YP, 2005, CLIN CANCER RES, V11, P173; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weller P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113706; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	25	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137076	10.1371/journal.pone.0137076	http://dx.doi.org/10.1371/journal.pone.0137076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317979	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100201
J	Clark, R; Freedberg, M; Hazeltine, E; Voss, MW				Clark, Rachel; Freedberg, Michael; Hazeltine, Eliot; Voss, Michelle W.			Are There Age-Related Differences in the Ability to Learn Configural Responses?	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; OLDER-ADULTS; ASSOCIATIVE RECOGNITION; INDIVIDUAL-DIFFERENCES; SERIAL PATTERNS; HUMAN STRIATUM; IMPLICIT; SEQUENCE; MEMORY; YOUNG	Age is often associated with a decline in cognitive abilities that are important for maintaining functional independence, such as learning new skills. Many forms of motor learning appear to be relatively well preserved with age, while learning tasks that involve associative binding tend to be negatively affected. The current study aimed to determine whether age differences exist on a configural response learning task, which includes aspects of motor learning and associative binding. Young (M = 24 years) and older adults (M = 66.5 years) completed a modified version of a configural learning task. Given the requirement of associative binding in the configural relationships between responses, we predicted older adults would show significantly less learning than young adults. Older adults demonstrated lower performance (slower reaction time and lower accuracy). However, contrary to our prediction, older adults showed similar rates of learning as indexed by a configural learning score compared to young adults. These results suggest that the ability to acquire knowledge incidentally about configural response relationships is largely unaffected by cognitive aging. The configural response learning task provides insight into the task demands that constrain learning abilities in older adults.	[Clark, Rachel; Freedberg, Michael; Hazeltine, Eliot; Voss, Michelle W.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA; [Hazeltine, Eliot; Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Voss, Michelle W.] Univ Iowa, AMBI, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Voss, MW (corresponding author), Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA.	michelle-voss@uiowa.edu		Freedberg, Michael/0000-0003-3738-8259	University of Iowa	University of Iowa	This research was funded by MV's start-up funds provided by the University of Iowa.	Bates D, NLS NONLINEAR LEAST; Bates D, LME4 LINEAR MIXED EF; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; CHERRY KE, 1995, PSYCHOL AGING, V10, P379, DOI 10.1037/0882-7974.10.3.379; Dennis NA, 2006, EXP BRAIN RES, V175, P153, DOI 10.1007/s00221-006-0534-3; Ebner NC, 2008, BEHAV RES METHODS, V40, P130, DOI [10.3758/BRM.40.1.130, 10.3738/BRM.40.1.130]; EICHENBAUM H, 1995, CURR DIR PSYCHOL SCI, V4, P19, DOI 10.1111/1467-8721.ep10770954; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frensch PA., 1998, HDB IMPLICIT LEARNIN, P47; Gaillard V, 2014, CLIN EEG NEUROSCI, V45, P50, DOI 10.1177/1550059413516757; Gaillard V, 2009, EUR J COGN PSYCHOL, V21, P255, DOI 10.1080/09541440802257423; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Grafton ST, 1998, J COGNITIVE NEUROSCI, V7, P497; Gunning-Dixon FM, 1998, AM J NEURORADIOL, V19, P1501; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Hazeltine E, 2007, J EXP PSYCHOL HUMAN, V33, P1451, DOI 10.1037/0096-1523.33.6.1451; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Howard JH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00817; Howard JH, 2004, NEUROPSYCHOLOGY, V18, P124, DOI 10.1037/0894-4105.18.1.124; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Howard MW, 2006, PSYCHON B REV, V13, P439, DOI 10.3758/BF03193867; Kilb A, 2011, J EXP PSYCHOL LEARN, V37, P706, DOI 10.1037/a0022525; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Light LL, 2004, MEM COGNITION, V32, P1182, DOI 10.3758/BF03196891; Magezi DA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00002; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2009, MEMORY, V17, P220, DOI 10.1080/09658210802222183; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J., NLME LINEAR NONLINEA; Provyn JP, 2007, PSYCHOL AGING, V22, P846, DOI 10.1037/0882-7974.22.4.846; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Rhodes MG, 2008, PSYCHOL AGING, V23, P239, DOI 10.1037/0882-7974.23.2.239; Rieckmann A, 2010, NEUROIMAGE, V50, P1303, DOI 10.1016/j.neuroimage.2010.01.015; Salthouse TA, 1999, AGING NEUROPSYCHOL C, V6, P1, DOI 10.1076/anec.6.1.1.789; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sanchez DJ, 2010, PSYCHON B REV, V17, P790, DOI 10.3758/PBR.17.6.790; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seger CA, 2006, NEUROSCIENTIST, V12, P285, DOI 10.1177/1073858405285632; SEIBEL R, 1963, J EXP PSYCHOL, V66, P215, DOI 10.1037/h0048914; Seidler RD, 2007, BEHAV BRAIN RES, V183, P118, DOI 10.1016/j.bbr.2007.05.024; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Shea CH, 2006, PHYS THER, V86, P478, DOI 10.1093/ptj/86.4.478; Stillman CM, 2014, J GERONTOL B; Team R. D. C, 2011, R LANG ENV STAT COMP; Tombaugh TN, 2005, ARCH CLIN NEUROPSYCH, V20, P485, DOI 10.1016/j.acn.2004.11.004; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Wifall T, 2014, J EXP PSYCHOL GEN, V143, P312, DOI 10.1037/a0030865	58	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137260	10.1371/journal.pone.0137260	http://dx.doi.org/10.1371/journal.pone.0137260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317773	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100215
J	Geisler, T; Booth, J; Tavlaki, E; Karathanos, A; Mueller, K; Droppa, M; Gawaz, M; Yanez-Lopez, M; Davidson, SJ; Stables, RH; Banya, W; Zaman, A; Flather, M; Dalby, M				Geisler, Tobias; Booth, Jean; Tavlaki, Elli; Karathanos, Athanasios; Mueller, Karin; Droppa, Michal; Gawaz, Meinrad; Yanez-Lopez, Monica; Davidson, Simon J.; Stables, Rod H.; Banya, Winston; Zaman, Azfar; Flather, Marcus; Dalby, Miles			High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel	PLOS ONE			English	Article							HIGH-DOSE CLOPIDOGREL; INHIBITION; AGGREGATION; TICAGRELOR; THERAPY; UPDATE	Background Prasugrel is more effective than clopidogrel in reducing platelet aggregation in acute coronary syndromes. Data available on prasugrel reloading in clopidogrel treated patients with high residual platelet reactivity (HRPR) i.e. poor responders, is limited. Objectives To determine the effects of prasugrel loading on platelet function in patients on clopidogrel and high platelet reactivity undergoing percutaneous coronary intervention for acute coronary syndrome (ACS). Patients Patients with ACS on clopidogrel who were scheduled for PCI found to have a platelet reactivity >= 40 AUC with the Multiplate Analyzer, i.e. "poor responders" were randomised to prasugrel (60 mg loading and 10 mg maintenance dose) or clopidogrel (600 mg reloading and 150 mg maintenance dose). The primary outcome measure was proportion of patients with platelet reactivity <40 AUC 4 hours after loading with study medication, and also at one hour (secondary outcome). 44 patients were enrolled and the study was terminated early as clopidogrel use decreased sharply due to introduction of newer P2Y12 inhibitors. Results At 4 hours after study medication 100% of patients treated with prasugrel compared to 91% of those treated with clopidogrel had platelet reactivity <40 AUC (p = 0.49), while at 1 hour the proportions were 95% and 64% respectively (p = 0.02). Mean platelet reactivity at 4 and 1 hours after study medication in prasugrel and clopidogrel groups respectively were 12 versus 22 (p = 0.005) and 19 versus 34 (p = 0.01) respectively. Conclusions Routine platelet function testing identifies patients with high residual platelet reactivity ("poor responders") on clopidogrel. A strategy of prasugrel rather than clopidogrel reloading results in earlier and more sustained suppression of platelet reactivity. Future trials need to identify if this translates into clinical benefit.	[Geisler, Tobias; Tavlaki, Elli; Karathanos, Athanasios; Mueller, Karin; Droppa, Michal; Gawaz, Meinrad] Klinikum Eberhard Karls Univ Tubingen, Abt Kardiol & Kreislauferkrankungen, Tubingen, Germany; [Booth, Jean; Yanez-Lopez, Monica; Banya, Winston] Royal Brompton Hosp, Clin Trials & Evaluat Unit, London SW3 6LY, England; [Davidson, Simon J.] Royal Brompton & Harefield NHS Fdn Trust, Dept Haematol, London, England; [Stables, Rod H.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England; [Zaman, Azfar] Newcastle Univ, Freeman Hosp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Zaman, Azfar] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Flather, Marcus] Univ E Anglia, Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich NR4 7TJ, Norfolk, England; [Flather, Marcus] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Dalby, Miles] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, London, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Liverpool Heart & Chest Hospital; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; Norfolk & Norwich University Hospitals NHS Foundation Trust; University of East Anglia; University of East Anglia; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Geisler, T (corresponding author), Klinikum Eberhard Karls Univ Tubingen, Abt Kardiol & Kreislauferkrankungen, Tubingen, Germany.	togeisler@web.de	Geisler, Tobias/AAO-4472-2020; Davidson, Simon/AGX-8916-2022	Dalby, Matthew/0000-0002-0528-3359; Droppa, Michal/0000-0001-5807-7615; Dalby, Miles/0000-0003-0823-5093	Investigator Initiated Trial grant by Daiichi Sankyo/Eli Lilly; NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; National Health Service Foundation Trust and the German Ministry of Education and Research; Deutsche Forschungsgemeinschaft; Klinische Forschergruppe "Platelets-Basic Mechanisms and Translational Implications" [KFO274]; 'Atherothrombosis Research Grant' from the European Society of Cardiology; Eli Lilly/Daiichi Sankyo; Medicines Company; Bayer Health Care; Bristol Myer Squibb; Pfizer; Boehringer Ingelheim; Astra Zeneca; Boston Scientific; Medtronic; Abbot Vascular; GSK; Novartis; Organon; Mitsubishi Pharma; Bayer; Werfen China; Instrumentation Laboratory; Sanofi	Investigator Initiated Trial grant by Daiichi Sankyo/Eli Lilly; NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust; Imperial College London(General Electric); National Health Service Foundation Trust and the German Ministry of Education and Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe "Platelets-Basic Mechanisms and Translational Implications"; 'Atherothrombosis Research Grant' from the European Society of Cardiology; Eli Lilly/Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Medicines Company; Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Bristol Myer Squibb; Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Astra Zeneca(AstraZeneca); Boston Scientific(Boston Scientific); Medtronic(Medtronic); Abbot Vascular(Abbott Laboratories); GSK(GlaxoSmithKline); Novartis(Novartis); Organon; Mitsubishi Pharma; Bayer(Bayer AG); Werfen China; Instrumentation Laboratory; Sanofi	This work was supported by an Investigator Initiated Trial grant by Daiichi Sankyo/Eli Lilly, the NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, and in part by the National Health Service Foundation Trust and the German Ministry of Education and Research, the Deutsche Forschungsgemeinschaft, and the Klinische Forschergruppe KFO274 "Platelets-Basic Mechanisms and Translational Implications". TG was personally funded by the 'Atherothrombosis Research Grant' from the European Society of Cardiology. Eli Lilly/Daiichi Sankyo (TG, MD, MF, MG, AZ), The Medicines Company (TG, RS), Bayer Health Care(TG), Bristol Myer Squibb(TG), Pfizer (TG), Boehringer Ingelheim (TG), Astra Zeneca (TG, MD, MF, RS, MG, AZ), Boston Scientific (MD), Medtronic (MD), Abbot Vascular (MD), GSK (MF), Novartis (MF), Organon (SD), Mitsubishi Pharma (SD), Bayer (SD), Werfen China (SD), Instrumentation Laboratory (SD) and Sanofi (MG, AZ) provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexopoulos D, 2012, CARDIOVASC DRUG THER, V26, P393, DOI 10.1007/s10557-012-6407-z; Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Alfonso F, 2014, EUR HEART J, V35, P2541, DOI [DOI 10.1093/EURHEARTJ/EHU278, 10.1093/eurheartj/ ehu278, 10.1093/eurheartj/ehu278]; Angiolillo DJ, 2010, J AM COLL CARDIOL, V56, P1017, DOI 10.1016/j.jacc.2010.02.072; Bellemain-Appaix A, 2012, JAMA-J AM MED ASSOC, V308, P2507, DOI 10.1001/jama.2012.50788; Bonello L, 2013, INT J CARDIOL, V168, P4244, DOI 10.1016/j.ijcard.2013.07.147; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Ferrieres J, 2011, ARCH CARDIOVASC DIS, V104, P104, DOI 10.1016/j.acvd.2010.12.002; Geisler T, 2006, EUR HEART J, V27, P2420, DOI 10.1093/eurheartj/ehl275; Geisler T, 2013, THROMB HAEMOSTASIS, V110, P876, DOI 10.1160/TH13-02-0145; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Laine M, 2014, THROMB HAEMOSTASIS, V111, P273, DOI 10.1160/TH13-05-0384; Loh JP, 2013, AM J CARDIOL, V111, P841, DOI 10.1016/j.amjcard.2012.11.058; Mega JL, 2011, JAMA-J AM MED ASSOC, V306, P2221, DOI 10.1001/jama.2011.1703; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Montalescot G, 2010, THROMB HAEMOSTASIS, V103, P213, DOI 10.1160/TH09-07-0482; Pare G, 2011, CIRC-CARDIOVASC INTE, V4, P514, DOI 10.1161/CIRCINTERVENTIONS.111.962142; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Payne CD, 2008, PLATELETS, V19, P275, DOI 10.1080/09537100801891640; Piccolo R, 2014, ATHEROSCLEROSIS, V234, P176, DOI 10.1016/j.atherosclerosis.2014.02.024; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sardella G, 2012, CIRC-CARDIOVASC INTE, V5, P698, DOI 10.1161/CIRCINTERVENTIONS.112.972463; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stimpfle F, 2014, THROMB RES, V134, P105, DOI 10.1016/j.thromres.2014.05.006; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	30	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135037	10.1371/journal.pone.0135037	http://dx.doi.org/10.1371/journal.pone.0135037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317618	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000360299100022
J	Li, XH; Liang, Q; Zhuang, L; Zhang, XM; Chen, TW; Li, LJ; Liu, J; Calimente, H; Wei, YN; Hu, JN				Li, Xinghui; Liang, Qi; Zhuang, Ling; Zhang, Xiaoming; Chen, Tianwu; Li, Liangjun; Liu, Jun; Calimente, Horea; Wei, Yinan; Hu, Jiani			Preliminary Study of MR Diffusion Tensor Imaging of the Liver for the Diagnosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							B-VALUE; HEALTHY-VOLUNTEERS; HEPATIC-LESIONS; WEIGHTED MRI; WHITE-MATTER; TRACTOGRAPHY; BRAIN; MOTOR; STIMULATION; DIRECTIONS	Objectives To evaluate the feasibility of differentiating between hepatocellular carcinomas (HCC) and healthy liver using diffusion tensor imaging (DTI). Material and Methods All subjects underwent an abdominal examination on a 3.0T MRI scanner. Two radiologists independently scored the image quality (IQ). An optimal set of DTI parameters was obtained from a group of fifteen volunteers with multiple b-values (100, 300, 500, and 800 s/mm(2)) and various diffusion-encoding directions (NED = 6, 9, and 12) using two way ANOVA analysis. Eighteen Patients with HCC underwent DTI scans with the optimized parameters. Fractional anisotropy(FA) and average apparent diffusion coefficient (ADC) values were measured. The differences of FA and ADC values between liver healthy region and HCC lesion were compared through paired t tests. Results There were no significant changes in liver IQ and FA/ADC values with increased NED (P > 0.05), whereas the liver IQ and FA/ADC values decreased significantly with increased b-values(P < 0.05). Good IQ, acceptable scan time and reasonable FA/ADC values were acquired using NED = 9 with b-value of (0,300) s/mm(2). Using the optimized DTI sequence, ADC value of the tumor lesion was significantly lower than that of the healthy liver region (1.30 +/- 0.34x10(-3) vs 1.52 +/- 0.27x10(-3) mm(2)/s, P = 0.013), whereas the mean FA value of the tumor lesion (0.42 +/- 0.11) was significantly higher than the normal liver region (0.32 +/- 0.10) (P = 0.004). Conclusion Either FA or ADC value from DTI can be used to differentiate HCC from healthy liver. HCC lead to higher FA value and lower ADC value on DTI than healthy liver.	[Li, Xinghui; Zhang, Xiaoming; Chen, Tianwu; Li, Liangjun] North Sichuan Med Coll, Dept Radiol, Sichuan Key Lab Med Imaging, Affiliated Hosp, Nanchong 637000, Peoples R China; [Liang, Qi] North Sichuan Med Coll, Dept Lab, Affiliated Hosp, Nanchong 637000, Peoples R China; [Zhuang, Ling] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48201 USA; [Liu, Jun] Cent South Univ, Xiangya Hosp 2, Dept Radiol, Changsha 410011, Hunan, Peoples R China; [Calimente, Horea; Wei, Yinan; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA	North Sichuan Medical University; North Sichuan Medical University; Wayne State University; Central South University; Wayne State University	Zhang, XM (corresponding author), North Sichuan Med Coll, Dept Radiol, Sichuan Key Lab Med Imaging, Affiliated Hosp, Nanchong 637000, Peoples R China.	cjr.zhxm@vip.163.com; liujungreen@gmail.com	Zhang, Xiao Ming/H-7104-2019; liu, jun/AAW-9645-2020	Zhang, Xiao Ming/0000-0001-5327-8506; liu, jun/0000-0002-0344-4745				Bagadia A, 2011, J CLIN NEUROSCI, V18, P633, DOI 10.1016/j.jocn.2010.08.026; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bauer JS, 2006, RADIOLOGY, V241, P399, DOI 10.1148/radiol.2412051330; Beddy P, 2011, RADIOLOGY, V258, P583, DOI 10.1148/radiol.10100912; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Bonekamp S, 2011, J CLIN GASTROENTEROL, V45, P885, DOI 10.1097/MCG.0b013e318223bd2c; Boulanger Y, 2003, NMR BIOMED, V16, P132, DOI 10.1002/nbm.818; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Chuck NC, 2013, J CLIN IMAG SCI, V3, DOI 10.4103/2156-7514.122323; Cosottini M, 2010, J COMPUT ASSIST TOMO, V34, P746, DOI 10.1097/RCT.0b013e3181e35129; Erturk SM, 2014, ACTA RADIOL, V55, P654, DOI 10.1177/0284185113504916; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Guggenberger R, 2012, EUR J RADIOL, V81, pE775, DOI 10.1016/j.ejrad.2012.03.017; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kinoshita M, 2008, NEUROIMAGE, V43, P29, DOI 10.1016/j.neuroimage.2008.06.041; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kovanlikaya I, 2011, EUR J RADIOL, V77, P383, DOI 10.1016/j.ejrad.2009.08.012; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee Y, 2015, MAGN RESON MED, V73, P1602, DOI 10.1002/mrm.25253; Li XH, 2014, J MAGN RESON IMAGING, V40, P58, DOI 10.1002/jmri.24329; Maesawa S, 2010, WORLD NEUROSURG, V74, P153, DOI 10.1016/j.wneu.2010.03.022; Marusyk Andriy, 2010, Biochim Biophys Acta, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meng X, 2013, CLIN RADIOL, V68, P815, DOI 10.1016/j.crad.2013.03.009; Moteki T, 2002, J MAGN RESON IMAGING, V15, P564, DOI 10.1002/jmri.10101; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Okada T, 2006, RADIOLOGY, V240, P849, DOI 10.1148/radiol.2403050916; Saupe N, 2009, AM J ROENTGENOL, V192, pW282, DOI 10.2214/AJR.08.1340; Skorpil M, 2007, MAGN RESON IMAGING, V25, P406, DOI 10.1016/j.mri.2006.09.017; Sugita R, 2010, WORLD J GASTROENTERO, V16, P832, DOI 10.3748/wjg.v16.i7.832; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Taouli B, 2003, RADIOLOGY, V226, P71, DOI 10.1148/radiol.2261011904; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Testa ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101944; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; Tosun M, 2013, EUR J RADIOL, V82, P203, DOI 10.1016/j.ejrad.2012.09.009; Xia Y, 2010, J MAGN RESON IMAGING, V32, P733, DOI 10.1002/jmri.22278; Zheng ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113469; Zhu FP, 2012, NEUROSURGERY, V71, P1170, DOI 10.1227/NEU.0b013e318271bc61	40	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135568	10.1371/journal.pone.0135568	http://dx.doi.org/10.1371/journal.pone.0135568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317346	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100035
J	Arteni, AA; Fradot, M; Galzerano, D; Mendes-Pinto, MM; Sahel, JA; Picaud, S; Robert, B; Pascal, AA				Arteni, Ana-Andreea; Fradot, Mathias; Galzerano, Denise; Mendes-Pinto, Maria M.; Sahel, Jose-Alain; Picaud, Serge; Robert, Bruno; Pascal, Andrew A.			Structure and Conformation of the Carotenoids in Human Retinal Macular Pigment	PLOS ONE			English	Article							LIGHT-HARVESTING PROTEINS; IN-VIVO; BINDING-PROTEIN; PHOTOSYSTEM-II; HIGHER-PLANTS; ZEAXANTHIN; MECHANISM; LUTEIN; PHOTOPROTECTION; IDENTIFICATION	Human retinal macular pigment (MP) is formed by the carotenoids lutein and zeaxanthin (including the isomer meso-zeaxanthin). MP has several functions in improving visual performance and protecting against the damaging effects of light, and MP levels are used as a proxy for macular health-specifically, to predict the likelihood of developing age-related macular degeneration. While the roles of these carotenoids in retinal health have been the object of intense study in recent years, precise mechanistic details of their protective action remain elusive. We have measured the Raman signals originating from MP carotenoids in ex vivo human retinal tissue, in order to assess their structure and conformation. We show that it is possible to distinguish between lutein and zeaxanthin, by their excitation profile (related to their absorption spectra) and the position of their V-1 Raman mode. In addition, analysis of the V-4 Raman band indicates that these carotenoids are present in a specific, constrained conformation in situ, consistent with their binding to specific proteins as postulated in the literature. We discuss how these conclusions relate to the function of these pigments in macular protection. We also address the possibilities for a more accurate, consistent measurement of MP levels by Raman spectroscopy.	[Arteni, Ana-Andreea; Galzerano, Denise; Mendes-Pinto, Maria M.; Robert, Bruno; Pascal, Andrew A.] Univ Paris Saclay, CEA, UMR CNRS 8221, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Arteni, Ana-Andreea; Galzerano, Denise; Mendes-Pinto, Maria M.; Robert, Bruno; Pascal, Andrew A.] Univ Paris Saclay, CEA, UMR CNRS 8221, Inst Biol & Technol Saclay, Gif Sur Yvette, France; [Fradot, Mathias; Sahel, Jose-Alain; Picaud, Serge] INSERM, UMR S968, Inst Vis, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pascal, AA (corresponding author), Univ Paris Saclay, CEA, UMR CNRS 8221, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	andrew.pascal@cea.fr	Arteni, Ana Andreea/AAK-8561-2020; Robert, Bruno/D-1264-2012; Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017; Pinto, Maria Manuela Mendes/M-2804-2013; pascal, andrew/B-6186-2014	Robert, Bruno/0000-0001-5999-4538; Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; Mendes Pinto, Maria Manuela/0000-0001-7541-7335; ARTENI, Ana Andreea/0000-0001-6462-905X; pascal, andrew/0000-0002-1844-6065	European Research Council [267333]; French Infrastructure for Integrated Structural Biology [ANR-10-INSB-05-01]; CEA interdisciplinary program Technology for Health (MEDIASPEC project)	European Research Council(European Research Council (ERC)European Commission); French Infrastructure for Integrated Structural Biology; CEA interdisciplinary program Technology for Health (MEDIASPEC project)	This work was supported by the European Research Council (http://erc.europa.eu/) through the Advanced Grant PHOTPROT (contract number 267333, to BR); the French Infrastructure for Integrated Structural Biology https://www.structuralbiology.eu/networks/frisbi (grant number ANR-10-INSB-05-01, to BR); and the CEA interdisciplinary program Technology for Health (MEDIASPEC project, to BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2011, SPECTROCHIM ACTA A, V78, P1261, DOI 10.1016/j.saa.2010.12.071; Bernstein PS, 1997, INVEST OPHTH VIS SCI, V38, P167; Bhosale P, 2005, BBA-MOL BASIS DIS, V1740, P116, DOI 10.1016/j.bbadis.2005.02.002; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033; Britton G., 1999, PHOTOCHEMISTRY CAROT; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Ermakov I, 2004, J BIOMED OPT, V9, P139, DOI 10.1117/1.1627776; Gall A, 2011, BIOPHYS J, V101, P934, DOI 10.1016/j.bpj.2011.05.057; Gellermann W, 2002, J OPT SOC AM A, V19, P1172, DOI 10.1364/JOSAA.19.001172; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; Li BX, 2010, ARCH BIOCHEM BIOPHYS, V504, P56, DOI 10.1016/j.abb.2010.07.024; Loane E, 2008, SURV OPHTHALMOL, V53, P68, DOI 10.1016/j.survophthal.2007.10.008; Macernis M, 2014, J PHYS CHEM A, V118, P1817, DOI 10.1021/jp406449c; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Sharifzadeh M, 2008, J OPT SOC AM A, V25, P947, DOI 10.1364/JOSAA.25.000947; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; Soemmering P, 1798, PHILOS T R SOC LOND, V88, P332, DOI [10.1098/rstl.1798.0013, DOI 10.1098/RSTL.1798.0013]; Yemelyanov AY, 2001, EXP EYE RES, V72, P381, DOI 10.1006/exer.2000.0965	28	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135779	10.1371/journal.pone.0135779	http://dx.doi.org/10.1371/journal.pone.0135779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313550	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000025
J	Garneau, AP; Carpentier, GA; Marcoux, AA; Frenette-Cotton, R; Simard, CF; Remus-Borel, W; Caron, L; Jacob-Wagner, M; Noel, M; Powell, JJ; Belanger, R; Cote, F; Isenring, P				Garneau, Alexandre P.; Carpentier, Gabriel A.; Marcoux, Andree-Anne; Frenette-Cotton, Rachelle; Simard, Charles F.; Remus-Borel, Wilfried; Caron, Luc; Jacob-Wagner, Marieve; Noel, Micheline; Powell, Jonathan J.; Belanger, Richard; Cote, Francois; Isenring, Paul			Aquaporins Mediate Silicon Transport in Humans	PLOS ONE			English	Article							BONE-MINERAL DENSITY; WATER CHANNELS; RAT; LOCALIZATION; ESSENTIALITY; DIFFERENTIATION; ABSORPTION; PROTEIN; KIDNEY; GROWTH	In animals, silicon is an abundant and differentially distributed trace element that is believed to play important biological functions. One would thus expect silicon concentrations in body fluids to be regulated by silicon transporters at the surface of many cell types. Curiously, however, and even though they exist in plants and algae, no such transporters have been identified to date in vertebrates. Here, we show for the first time that the human aquaglyceroporins, i.e., AQP3, AQP7, AQP9 and AQP10 can act as silicon transporters in both Xenopus laevis oocytes and HEK-293 cells. In particular, heterologously expressed AQP7, AQP9 and AQP10 are all able to induce robust, saturable, phloretin-sensitive silicon transport activity in the range that was observed for low silicon rice 1 (lsi1), a silicon transporter in plant. Furthermore, we show that the aquaglyceroporins appear as relevant silicon permeation pathways in both mice and humans based on 1) the kinetics of substrate transport, 2) their presence in tissues where silicon is presumed to play key roles and 3) their transcriptional responses to changes in dietary silicon. Taken together, our data provide new evidence that silicon is a potentially important biological element in animals and that its body distribution is regulated. They should open up original areas of investigations aimed at deciphering the true physiological role of silicon in vertebrates.	[Garneau, Alexandre P.; Carpentier, Gabriel A.; Marcoux, Andree-Anne; Frenette-Cotton, Rachelle; Simard, Charles F.; Caron, Luc; Jacob-Wagner, Marieve; Noel, Micheline; Cote, Francois; Isenring, Paul] Univ Laval, Fac Med, Dept Med, Hotel Dieu,Quebec Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Remus-Borel, Wilfried; Belanger, Richard] Univ Laval, Fac Sci Agr & Alimentat, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; [Powell, Jonathan J.] Elsie Widdowson Lab, Med Res Council Human Nutr Res, Cambridge, England	Laval University; Laval University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Isenring, P (corresponding author), Univ Laval, Fac Med, Dept Med, Hotel Dieu,Quebec Res Ctr, Quebec City, PQ G1K 7P4, Canada.	paul.isenring@crhdq.ulaval.ca			Canadian Institutes of Health Research [FRN-84410]; MRC [MC_U105960399] Funding Source: UKRI; Medical Research Council [MC_U105960399] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by Canadian Institutes of Health Research, grant number FRN84410.	Aharon R, 2006, J BIOL CHEM, V281, P19305, DOI 10.1074/jbc.M601728200; BERCOWY GM, 1994, J ANAL TOXICOL, V18, P46, DOI 10.1093/jat/18.1.46; Bergeron MJ, 2009, J CELL PHYSIOL, V219, P787, DOI 10.1002/jcp.21725; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; BIRCHALL JD, 1995, CHEM SOC REV, V24, P351, DOI 10.1039/cs9952400351; Boassa D, 2006, J NEUROSCI, V26, P7811, DOI 10.1523/JNEUROSCI.0525-06.2006; Bu GY, 2012, BIOCHEM BIOPH RES CO, V419, P774, DOI 10.1016/j.bbrc.2012.02.100; CARLISLE EM, 1986, CIBA F SYMP, V121, P123; CARLISLE EM, 1982, NUTR REV, V40, P193, DOI 10.1111/j.1753-4887.1982.tb05307.x; CHAKKALAKAL DA, 1990, J BIOMECH, V23, P425, DOI 10.1016/0021-9290(90)90297-G; DOBBIE JW, 1982, SCOT MED J, V27, P17, DOI 10.1177/003693308202700105; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Freel RW, 1998, AM J PHYSIOL, V275, pC747; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; Hazama A, 2002, J BIOL CHEM, V277, P29224, DOI 10.1074/jbc.M204258200; HILDEBRAND M, 1993, GENE, V132, P213, DOI 10.1016/0378-1119(93)90198-C; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225; Jugdaohsingh R, 2008, BONE, V43, P596, DOI 10.1016/j.bone.2008.04.014; Kondo H, 2002, EUR J BIOCHEM, V269, P1814, DOI 10.1046/j.1432-1033.2002.02821.x; Laforenza U, 2005, BIOL CELL, V97, P605, DOI 10.1042/BC20040090; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; MEHARD CW, 1975, BIOINORG CHEM, V5, P107, DOI 10.1016/S0006-3061(00)80055-1; Mobasheri A, 2005, J MOL HISTOL, V36, P1, DOI 10.1007/s10735-004-2633-4; Mobasheri A, 2004, VET J, V168, P143, DOI 10.1016/j.tvjl.2003.08.001; Mobasheri A, 2004, HISTOCHEM CELL BIOL, V121, P463, DOI 10.1007/s00418-004-0657-1; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Nejsum LN, 2000, BIOCHEM BIOPH RES CO, V277, P164, DOI 10.1006/bbrc.2000.3638; Okada S, 2003, FEBS LETT, V540, P157, DOI 10.1016/S0014-5793(03)00256-4; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; ROBERTS NB, 1990, CLIN CHEM, V36, P1460; SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0; SIROTNAK FM, 1987, CANCER METAST REV, V6, P459, DOI 10.1007/BF00047462; Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x; Sripanyakorn S, 2009, BRIT J NUTR, V102, P825, DOI 10.1017/S0007114509311757; Van Dyck K, 2000, BIOL TRACE ELEM RES, V77, P25, DOI 10.1385/BTER:77:1:25; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Wu QT, 2007, CHEM RES CHINESE U, V23, P297, DOI 10.1016/S1005-9040(07)60063-4; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	40	36	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136149	10.1371/journal.pone.0136149	http://dx.doi.org/10.1371/journal.pone.0136149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313002	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000044
J	Bailon-Moscoso, N; Gonzalez-Arevalo, G; Velasquez-Rojas, G; Malagon, O; Vidari, G; Zentella-Dehesa, A; Ratovitski, EA; Ostrosky-Wegman, P				Bailon-Moscoso, Natalia; Gonzalez-Arevalo, Gabriela; Velasquez-Rojas, Gabriela; Malagon, Omar; Vidari, Giovanni; Zentella-Dehesa, Alejandro; Ratovitski, Edward A.; Ostrosky-Wegman, Patricia			Phytometabolite Dehydroleucodine Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Human Astrocytoma Cells through p73/p53 Regulation	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; MOLECULAR TARGETS; NATURAL-PRODUCTS; SESQUITERPENE LACTONES; TYROSINE KINASE; PHYTOCHEMICALS; P53; CHEMOPREVENTION; PREVENTION; P73	Accumulating evidence supports the idea that secondary metabolites obtained from medicinal plants (phytometabolites) may be important contributors in the development of new chemotherapeutic agents to reduce the occurrence or recurrence of cancer. Our study focused on Dehydroleucodine (DhL), a sesquiterpene found in the provinces of Loja and Zamora-Chinchipe. In this study, we showed that DhL displayed cytostatic and cytotoxic activities on the human cerebral astrocytoma D384 cell line. With lactone isolated from Gynoxys verrucosa Wedd, a medicinal plant from Ecuador, we found that DhL induced cell death in D384 cells by triggering cell cycle arrest and inducing apoptosis and DNA damage. We further found that the cell death resulted in the increased expression of CDKN1A and BAX proteins. A marked induction of the levels of total TP73 and phosphorylated TP53, TP73, and gamma-H2AX proteins was observed in D384 cells exposed to DhL, but no increase in total TP53 levels was detected. Overall these studies demonstrated the marked effect of DhL on the diminished survival of human astrocytoma cells through the induced expression of TP73 and phosphorylation of TP73 and TP53, suggesting their key roles in the tumor cell response to DhL treatment.	[Bailon-Moscoso, Natalia; Zentella-Dehesa, Alejandro; Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico; [Bailon-Moscoso, Natalia; Gonzalez-Arevalo, Gabriela; Velasquez-Rojas, Gabriela; Ratovitski, Edward A.] Univ Tecn Particular Loja, Dept Ciencias Salud, Loja, Ecuador; [Malagon, Omar] Univ Tecn Particular Loja, Dept Quim Aplicada, Loja, Ecuador; [Malagon, Omar; Vidari, Giovanni] Univ Pavia, Dipartimento Chim Organ, I-27100 Pavia, Italy; [Zentella-Dehesa, Alejandro] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Bioquim, Mexico City, DF, Mexico; [Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Head & Neck Canc Res Div, Baltimore, MD USA	Universidad Nacional Autonoma de Mexico; Universidad Tecnica Particular de Loja; Universidad Tecnica Particular de Loja; University of Pavia; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Johns Hopkins University	Ostrosky-Wegman, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	ostrosky@biomedicas.unam.mx	Bailon-Moscoso, Natalia/Z-1548-2019; Zentella-Dehesa, Alejandro/AAW-1647-2020	Zentella-Dehesa, Alejandro/0000-0002-5595-1466; Bailon Moscoso, Natalia/0000-0003-2754-1328; Malagon Aviles, Omar/0000-0001-7946-7858; Vidari, Giovanni/0000-0003-4606-2154	Prometeo Project of the Secretaria Nacional de Educacion Superior Ciencia, Tecnologia e Invocacion (SENESCYT) - Ecuador; Secretaria Nacional de Educacion Superior Ciencia, Tecnologia e Invocacion (SENESCYT) -Ecuador; Programa de Doctorado en Ciencias Biomedicas; Universidad Nacional Autonoma de Mexico; Universidad Tecnica Particular de Loja	Prometeo Project of the Secretaria Nacional de Educacion Superior Ciencia, Tecnologia e Invocacion (SENESCYT) - Ecuador; Secretaria Nacional de Educacion Superior Ciencia, Tecnologia e Invocacion (SENESCYT) -Ecuador; Programa de Doctorado en Ciencias Biomedicas; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Universidad Tecnica Particular de Loja	Funded by Prometeo Project of the Secretaria Nacional de Educacion Superior Ciencia, Tecnologia e Invocacion (SENESCYT) - Ecuador, Secretaria Nacional de Educacion Superior Ciencia, Tecnologia e Invocacion (SENESCYT) -Ecuador, Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and Universidad Tecnica Particular de Loja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon-Moscoso N, 2014, TUMOR BIOL, V35, P3981, DOI 10.1007/s13277-014-1649-y; Bhanot A., 2011, INT J PHYTOMED, V3, P9; Brengio SD, 2000, J PARASITOL, V86, P407, DOI 10.1645/0022-3395(2000)086[0407:TSLDDA]2.0.CO;2; Chen C, 2013, BRAZ J MED BIOL RES, V46, P643, DOI 10.1590/1414-431X20132979; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Costantino VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053168; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fan S, 2006, BRIT J CANCER, V94, P407, DOI 10.1038/sj.bjc.6602935; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fraga BM, 2007, NAT PROD REP, V24, P1350, DOI 10.1039/b706427f; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; Ortiz LMG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/924585; Guardia T, 2003, J ETHNOPHARMACOL, V88, P195, DOI 10.1016/S0378-8741(03)00211-3; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hiradeve SM, 2014, NAT PROD RES, V28, P819, DOI 10.1080/14786419.2014.883394; Jaganathan SK, 2012, MOLECULES, V17, P6290, DOI 10.3390/molecules17066290; Jones V, 2013, CANCER LETT, V335, P251, DOI 10.1016/j.canlet.2013.02.056; Kabeer FA, 2013, J INTEGR MED-JIM, V11, P269, DOI 10.3736/jintegrmed2013040; Kaur M, 2007, CURR CANCER DRUG TAR, V7, P355, DOI 10.2174/156800907780809732; LEE KH, 1971, CANCER RES, V31, P1649; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee KM, 2010, CANCER PREV RES, V3, P454, DOI 10.1158/1940-6207.CAPR-09-0137; Lee WC, 2013, J APPL MATH, DOI 10.1155/2013/547209; Lenzi M, 2014, CANCER TREAT RES, V159, P207, DOI 10.1007/978-3-642-38007-5_12; Lokshin M, 2005, COLD SH Q B, V70, P121, DOI 10.1101/sqb.2005.70.046; Lopez-Marure R, 2000, EUR J BIOCHEM, V267, P4325, DOI 10.1046/j.1432-1327.2000.01436.x; Madka V, 2013, CURR CANCER DRUG TAR, V13, P542; Mates JM, 2011, CURR MED CHEM, V18, P2315, DOI 0929-8673/11 $58.00+.00; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ordonez PE, 2011, J ETHNOPHARMACOL, V137, P1055, DOI 10.1016/j.jep.2011.07.012; Park EJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.202; Penissi A, 2006, MOL MED CHEM, V10, P1; Polo LM, 2007, EUR J PHARMACOL, V556, P19, DOI 10.1016/j.ejphar.2006.10.049; Pratheeshkumar P, 2012, ANTI-CANCER AGENT ME, V12, P1159, DOI 10.2174/187152012803833035; Priestap HA, 2012, PHYTOCHEM LETT, V5, P581, DOI 10.1016/j.phytol.2012.05.018; Rasul A, 2013, MOLECULES, V18, P1418, DOI 10.3390/molecules18021418; Rengarajan T, 2014, ASIAN PAC J CANCER P, V15, P1757, DOI 10.7314/APJCP.2014.15.4.1757; ROJAS E, 1993, ANTI-CANCER DRUG, V4, P637, DOI 10.1097/00001813-199312000-00005; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Shu LM, 2010, CANCER METAST REV, V29, P483, DOI 10.1007/s10555-010-9239-y; Shukla S, 2014, CANCER LETT, V355, P9, DOI 10.1016/j.canlet.2014.09.017; Singh RP, 2002, CELL CYCLE, V1, P156, DOI 10.4161/cc.1.3.117; Sinha R, 2004, CURR CANCER DRUG TAR, V4, P13, DOI 10.2174/1568009043481614; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sordo M, 2001, TERATOGEN CARCIN MUT, V21, P249, DOI 10.1002/tcm.1013; Tan HK, 2014, ASIAN PAC J CANCER P, V15, P6463, DOI 10.7314/APJCP.2014.15.16.6463; Tene V, 2007, J ETHNOPHARMACOL, V111, P63, DOI 10.1016/j.jep.2006.10.032; Valencia R., 2000, LIBRO ROJO PLANTAS E; Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281, DOI 10.2174/187152012803833026; Wang Jiao, 2012, World J Exp Med, V2, P45, DOI 10.5493/wjem.v2.i3.45; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Wang LG, 2004, INT J ONCOL, V24, P187; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443; Zhu JH, 1998, CANCER RES, V58, P5061	62	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136527	10.1371/journal.pone.0136527	http://dx.doi.org/10.1371/journal.pone.0136527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309132	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400134
J	Tanaka, T; Yamagami, H; Ihara, M; Motoyama, R; Fukuma, K; Miyagi, T; Nishimura, K; Toyoda, K; Nagatsuka, K				Tanaka, Tomotaka; Yamagami, Hiroshi; Ihara, Masafumi; Motoyama, Rie; Fukuma, Kazuki; Miyagi, Tetsuya; Nishimura, Kazutaka; Toyoda, Kazunori; Nagatsuka, Kazuyuki			Seizure Outcomes and Predictors of Recurrent Post-Stroke Seizure: A Retrospective Observational Cohort Study	PLOS ONE			English	Article							EPILEPTIC SEIZURES; ELDERLY-PEOPLE; ISCHEMIC-STROKE; DISABILITY; COMMUNITY; ETIOLOGY; ADULTS	Background Seizure is a common complication after stroke (termed "post-stroke seizure," PSS). Although many studies have assessed outcomes and risk factors of PSS, no reliable predictors are currently available to determine PSS recurrence. We compared baseline clinical characteristics and post-stroke treatment regimens between recurrent and non-recurrent PSS patients to identify factors predictive of recurrence. Methods Consecutive PSS patients admitted to our stroke center between January 2011 and July 2013 were monitored until February 2014 (median 357 days; IQR, 160-552) and retrospectively evaluated for baseline clinical characteristics and PSS recurrence. Cumulative recurrence rates at 90, 180, and 360 days post-stroke were estimated by Kaplan-Meier analysis. Independent predictors of recurrent PSS were identified by Cox proportional-hazards analysis. Results A total of 104 patients (71 men; mean age, 72.1 +/- 11.2 years) were analyzed. PSS recurred in 31 patients (30%) during the follow-up. Factors significantly associated with PSS recurrence by log-rank analysis included previous PSS, valproic acid (VPA) monotherapy, polytherapy with antiepileptic drugs (AEDs), frontal cortical lesion, and higher modified Rankin Scale score at discharge (all p < 0.05). Independent predictors of recurrent PSS were age < 74 years (HR 2.38, 95% CI 1.02-5.90), VPA monotherapy (HR 3.86, 95% CI 1.30-12.62), and convulsions on admission (HR 3.87, 95% CI 1.35-12.76). Conclusions Approximately one-third of PSS patients experienced seizure recurrence within one year. The predictors of recurrent PSS were younger age, presence of convulsions and VPA monotherapy. Our findings should be interpreted cautiously in countries where monotherapy with second-generation AEDs has been approved because this study was conducted while second-generation AEDs had not been officially approved for monotherapy in Japan.	[Tanaka, Tomotaka; Yamagami, Hiroshi; Ihara, Masafumi; Motoyama, Rie; Fukuma, Kazuki; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Div Neurol, Osaka, Japan; [Miyagi, Tetsuya; Nishimura, Kazutaka; Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Div Cerebrovasc Med, Res Inst, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Tanaka, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Div Neurol, Osaka, Japan.	tanakat@hsp.ncvc.go.jp	Ihara, Masafumi/O-5020-2019	Ihara, Masafumi/0000-0002-7102-4048; Fukuma, Kazuki/0000-0001-8117-8916				Alvarez-Sabin J, 2002, NEUROLOGY, V59, P1991, DOI 10.1212/01.WNL.0000038388.57824.B6; Arntz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055498; Beghi E, 2011, NEUROLOGY, V77, P1785, DOI 10.1212/WNL.0b013e3182364878; Berges S, 2000, EUR NEUROL, V43, P3, DOI 10.1159/000008120; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Brodie MJ, 2005, BMJ-BRIT MED J, V331, P1317, DOI 10.1136/bmj.331.7528.1317; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; Graham NSN, 2013, STROKE, V44, P605, DOI 10.1161/STROKEAHA.111.000220; GUPTA SR, 1988, STROKE, V19, P1477, DOI 10.1161/01.STR.19.12.1477; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Kraus JA, 1998, ACTA NEUROL SCAND, V97, P154; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; Misirli H, 2006, INT J CLIN PRACT, V60, P1536, DOI 10.1111/j.1742-1241.2005.00782.x; Nezu T, 2011, STROKE, V42, P2196, DOI 10.1161/STROKEAHA.111.614404; Olsen T S, 2001, Curr Atheroscler Rep, V3, P340, DOI 10.1007/s11883-001-0029-4; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; ROBERTS MA, 1982, AGE AGEING, V11, P24, DOI 10.1093/ageing/11.1.24; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Stefan H, 2011, ACTA NEUROL SCAND, V124, P223, DOI 10.1111/j.1600-0404.2010.01464.x; Stephen LJ, 2003, DRUG AGING, V20, P141, DOI 10.2165/00002512-200320020-00005; SUNG CY, 1990, AGE AGEING, V19, P25, DOI 10.1093/ageing/19.1.25; Sykes L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005398.pub3; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Werhahn KJ, 2011, SEIZURE-EUR J EPILEP, V20, P305, DOI 10.1016/j.seizure.2010.12.015	30	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136200	10.1371/journal.pone.0136200	http://dx.doi.org/10.1371/journal.pone.0136200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309124	Green Submitted, gold, Green Published			2022-12-27	WOS:000360069400095
J	Iyer, S; Casey, E; Bouzek, H; Kim, M; Deng, WJ; Larsen, BB; Zhao, H; Bumgarner, RE; Rolland, M; Mullins, JI				Iyer, Shyamala; Casey, Eleanor; Bouzek, Heather; Kim, Moon; Deng, Wenjie; Larsen, Brendan B.; Zhao, Hong; Bumgarner, Roger E.; Rolland, Morgane; Mullins, James I.			Comparison of Major and Minor Viral SNPs Identified through Single Template Sequencing and Pyrosequencing in Acute HIV-1 Infection	PLOS ONE			English	Article							QUASI-SPECIES RECONSTRUCTION; DRUG-RESISTANCE MUTATIONS; DIVERSITY; VACCINE; STEP; DNA; POPULATIONS; VARIANTS; IMMUNITY; ERROR	Massively parallel sequencing (MPS) technologies, such as 454-pyrosequencing, allow for the identification of variants in sequence populations at lower levels than consensus sequencing and most single-template Sanger sequencing experiments. We sought to determine if the greater depth of population sampling attainable using MPS technology would allow detection of minor variants in HIV founder virus populations very early in infection in instances where Sanger sequencing detects only a single variant. We compared single nucleotide polymorphisms (SNPs) during acute HIV-1 infection from 32 subjects using both single template Sanger and 454-pyrosequencing. Pyrosequences from a median of 2400 viral templates per subject and encompassing 40% of the HIV-1 genome, were compared to a median of five individually amplified near full-length viral genomes sequenced using Sanger technology. There was no difference in the consensus nucleotide sequences over the 3.6kb compared in 84% of the subjects infected with single founders and 33% of subjects infected with multiple founder variants: among the subjects with disagreements, mismatches were found in less than 1% of the sites evaluated (of a total of nearly 117,000 sites across all subjects). The majority of the SNPs observed only in pyrosequences were present at less than 2% of the subject's viral sequence population. These results demonstrate the utility of the Sanger approach for study of early HIV infection and provide guidance regarding the design, utility and limitations of population sequencing from variable template sources, and emphasize parameters for improving the interpretation of massively parallel sequencing data to address important questions regarding target sequence evolution.	[Iyer, Shyamala; Casey, Eleanor; Bouzek, Heather; Kim, Moon; Deng, Wenjie; Larsen, Brendan B.; Zhao, Hong; Bumgarner, Roger E.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Rolland, Morgane] US Mil HIV Res Program, WRAIR, Silver Spring, MD 20910 USA; [Rolland, Morgane] Henry Jackson Fdn Adv Mil Med Inc, Bethesda, MD 20817 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Walter Reed Army Institute of Research (WRAIR)	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu	Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger/K-3531-2015	Bumgarner, Roger/0000-0002-8168-6985	US Public Health Service [UM1 AI068618, P01 AI57005]; Molecular Profiling and Computational Biology Core of the Seattle Center for AIDS Research [P30AI027757]; NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068618, P30AI027757, P01AI057005] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Molecular Profiling and Computational Biology Core of the Seattle Center for AIDS Research; NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Public Health Service Grants UM1 AI068618, P01 AI57005 and the Molecular Profiling and Computational Biology Core of the Seattle Center for AIDS Research, P30AI027757, which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001022; Bakker MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044357; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; De Wolf H, 2011, J VIROL METHODS, V175, P129, DOI 10.1016/j.jviromet.2011.04.023; Deng WJ, 2013, BIOINFORMATICS, V29, P2402, DOI 10.1093/bioinformatics/btt434; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Iyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073015; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Larsen BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076502; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Li Y, 2013, STAT BIOSCI, V5, P3, DOI 10.1007/s12561-012-9067-4; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Love TMT, 2010, J VIROL, V84, P5802, DOI 10.1128/JVI.00117-10; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Mallona I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-404; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Prosperi MCF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-5; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Recordon-Pinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036549; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simen BB, 2014, J VIROL METHODS, V204, P31, DOI 10.1016/j.jviromet.2014.04.007; Stelzl E, 2011, J VIROL METHODS, V178, P94, DOI 10.1016/j.jviromet.2011.08.020; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135903	10.1371/journal.pone.0135903	http://dx.doi.org/10.1371/journal.pone.0135903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317928	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100049
J	Pappas, I; Pardalos, P				Pappas, Ioannis; Pardalos, Panos			Identifying Cognitive States Using Regularity Partitions	PLOS ONE			English	Article							CONNECTIVITY	Functional Magnetic Resonance (fMRI) data can be used to depict functional connectivity of the brain. Standard techniques have been developed to construct brain networks from this data; typically nodes are considered as voxels or sets of voxels with weighted edges between them representing measures of correlation. Identifying cognitive states based on fMRI data is connected with recording voxel activity over a certain time interval. Using this information, network and machine learning techniques can be applied to discriminate the cognitive states of the subjects by exploring different features of data. In this work we wish to describe and understand the organization of brain connectivity networks under cognitive tasks. In particular, we use a regularity partitioning algorithm that finds clusters of vertices such that they all behave with each other almost like random bipartite graphs. Based on the random approximation of the graph, we calculate a lower bound on the number of triangles as well as the expectation of the distribution of the edges in each subject and state. We investigate the results by comparing them to the state of the art algorithms for exploring connectivity and we argue that during epochs that the subject is exposed to stimulus, the inspected part of the brain is organized in an efficient way that enables enhanced functionality.	[Pappas, Ioannis; Pardalos, Panos] Univ Florida, Coll Engn, Dept Ind & Syst Engn, Gainesville, FL 32611 USA; [Pappas, Ioannis] Univ Florida, Coll Engn, Dept Biomed Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Pappas, I (corresponding author), Univ Florida, Coll Engn, Dept Ind & Syst Engn, Gainesville, FL 32611 USA.	Ioannis.p.pappas@ufl.edu	Pardalos, Panos/AAY-8591-2020					[Anonymous], HDB COMBINATORIAL OP, DOI [10.1007/978-1-4419-7997-1_70, DOI 10.1007/978-1-4419-7997-1_70]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chung F.R.K., 1990, RANDOM STRUCT ALGOR, V1, P105, DOI DOI 10.1002/RSA.3240010108; Conlon D, ONLINE NOTES EXTREMA; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Cuthill E., 1969, P 24 NAT C ACM, P157, DOI DOI 10.1145/800195.805928; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Diestel R., 2015, GRAPH THEORY; Gowers WT, 2006, COMB PROBAB COMPUT, V15, P143, DOI 10.1017/S0963548305007236; Hayes M.H., 1996, STAT DIGITAL SIGNAL; Komlos J, 2002, LECT NOTES COMPUT SC, V2292, P84; Kuhn HW, 1955, HUNGARIAN METHOD ASS, V2, P83; Mitchell Tom M, 2003, AMIA Annu Symp Proc, P465; Sales-Pardo M, P NATL ACAD SCI, V15224; Sarkozy GN, 2012, PRACTICAL REGULARITY; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Spadone S, P NATL ACAD SCI; Szemeredi E, 1969, ACTA MATH, V27, P299; Szemeredi E., 1978, PROBLEMES COMBINATOI, V260, P399; Szemeredi E, 1975, ACTA ARITH, V27, P155; Tao T, 2006, CONTRIB DISCRET MATH, V1, P8; Wang HE, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00405; Wang X, 2003, NEURAL INFORM PROCES; WANG Y, 2013, PLOS ONE, V2013; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137012	10.1371/journal.pone.0137012	http://dx.doi.org/10.1371/journal.pone.0137012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317983	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100193
J	Qi, Y; Dai, XF; Zhang, H; He, Y; Zhang, YY; Han, JJ; Zhu, P; Zhang, YX; Zheng, QX; Li, X; Zhao, C; Pang, JJ				Qi, Yan; Dai, Xufeng; Zhang, Hua; He, Ying; Zhang, Yangyang; Han, Juanjuan; Zhu, Ping; Zhang, Yuxin; Zheng, Qinxiang; Li, Xia; Zhao, Chen; Pang, Jijing			Trans-Corneal Subretinal Injection in Mice and Its Effect on the Function and Morphology of the Retina	PLOS ONE			English	Article							MEDIATED GENE-THERAPY; MOUSE MODEL; RD10 MOUSE; IN-VIVO; DEGENERATION; VECTOR; PHOTORECEPTOR; VISION; RESCUE; TRANSDUCTION	Purpose To introduce a practical method of subretinal injection in mice and evaluate injection-induced retinal detachment (RD) and damage using a dynamic imaging system, electrophysiology, and histology. Methods After full dilation of a 2-month-old C57BL/6J mouse pupil, the cornea near the limbus was punctured with a 30 1/2-gague disposable beveled needle. A 33 1/2-gauge blunt needle was inserted through the corneal perforation into the anterior chamber, avoiding the lens before going deeper into the vitreous cavity, and penetrating the inner retina to reach the subretinal space. The mice were divided into four groups: in group 1, about 80-100% of the retina was filled with subretinally injected solution; in group 2, approximately 50-70% of the retina was filled with injected solution; in group 3, the procedures were stopped before solution injection; and non-injected eyes were used as the negative control in group 4. An optical coherence tomography (OCT) imaging system was used to monitor retinal reattachment during the first three days following the injections. Histological and functional changes were examined by light microscopy and electroretinography (ERG) at five weeks post-injection. Results After a short-term training, a 70% success rate with 50% or more coverage (i.e., retinal blebs occupied 50% or more retinal area and filled with the injected solution) with minimal injection-related damages can be achieved. Bleb formation was associated with retinal detachment (RD) between the neuroretina and the retinal pigment epithelium (RPE) layer. Partial RD could be observed at post-injection day 1, and by day 2 most of the retina had reattached. At 5 weeks post-injection, compared to uninjected control group 4, the b-wave amplitudes of ERG decreased 22% in group 1, 16% in group 2, and 7% in group 3; the b-wave amplitudes were statistically different between the uninjected group and the groups with either 50-70% or 80-100% coverage. The subretinal injection-induced RD reattached and became stable at five weeks post-injection, although some photoreceptor damage could still be observed in and around the injection sites, especially in 80-100% coverage group. Conclusions Trans-corneal subretinal injection is effective and practical, although subretinal injection-related damages can cause some morphological and functional loss.	[Qi, Yan; Dai, Xufeng; Zhang, Hua; He, Ying; Zhang, Yangyang; Han, Juanjuan; Zheng, Qinxiang; Pang, Jijing] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Han, Juanjuan] Shanxi Med Univ, Fenyang Coll, Fenyang, Shanxi, Peoples R China; [Zhu, Ping; Zhang, Yuxin; Pang, Jijing] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Zhang, Yuxin; Zhao, Chen; Pang, Jijing] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Li, Xia] Guangxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanning, Guangxi, Peoples R China	Wenzhou Medical University; Shanxi Medical University; State University System of Florida; University of Florida; Nanjing Medical University; Guangxi Medical University	Pang, JJ (corresponding author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	jpangoph@hotmail.com	zhang, yangyang/GZG-7467-2022		National Natural Science Foundation of China [81371060, 81260155]; Wenzhou Medical University, Wenzhou, China [QTJ11018]; Wenzhou Science and Technology Bureau, China [Y20140352, Y20140355]; NIH [EY023543, EY021721]; UF FEO award; FFB; MVRF; RPB Inc.; Jiangsu Province Foundation for Research Innovative Team; NATIONAL EYE INSTITUTE [R21EY023543, R21EY018331, P30EY021721] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University, Wenzhou, China; Wenzhou Science and Technology Bureau, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UF FEO award; FFB; MVRF; RPB Inc.; Jiangsu Province Foundation for Research Innovative Team; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from the National Natural Science Foundation of China (81371060 and 81260155), a retinal gene therapy study grant from Wenzhou Medical University, Wenzhou, China (QTJ11018), scientific research funds from Wenzhou Science and Technology Bureau, China (Y20140352 and Y20140355), the Jiangsu Province Foundation for Research Innovative Team, NIH grants EY023543, EY021721, UF FEO award, FFB, MVRF, and RPB Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SA, 2013, CURR TOP MEMBR, V72, P231, DOI 10.1016/B978-0-12-417027-8.00007-6; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Gouras P, 2002, INVEST OPHTH VIS SCI, V43, P3307; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Li WS, 2009, MOL VIS, V15, P267; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Mao HY, 2012, HUM GENE THER, V23, P356, DOI 10.1089/hum.2011.213; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2006, MOL VIS, V12, P756; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Stieger K, 2010, CURR OPIN MOL THER, V12, P471; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Timmers A, 2001, MOL VIS, V7, P131; Wert KJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4286; Yao HL, 2014, NEURAL REGEN RES, V9, P1047, DOI 10.4103/1673-5374.133169; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241; Zheng QX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044855	27	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136523	10.1371/journal.pone.0136523	http://dx.doi.org/10.1371/journal.pone.0136523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317758	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100095
J	Shafiei, SS; Solati-Hashjin, M; Samadikuchaksaraei, A; Kalantarinejad, R; Asadi-Eydivand, M; Abu Osman, NA				Shafiei, Seyedeh Sara; Solati-Hashjin, Mehran; Samadikuchaksaraei, Ali; Kalantarinejad, Reza; Asadi-Eydivand, Mitra; Abu Osman, Noor Azuan			Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study	PLOS ONE			English	Article							LAYERED DOUBLE HYDROXIDES; CONTROLLED-RELEASE; INTERCALATION; CANCER; PREVENTION; PATHWAYS; DRUGS	In recent years, nanotechnology in merging with biotechnology has been employed in the area of cancer management to overcome the challenges of chemopreventive strategies in order to gain promising results. Since most biological processes occur in nano scale, nanoparticles can act as carriers of certain drugs or agents to deliver it to specific cells or targets. In this study, we intercalated Epigallocatechin-3-Gallate (EGCG), the most abundant polyphenol in green tea, into Ca/Al-NO3 Layered double hydroxide (LDH) nanoparticles, and evaluated its efficacy compared to EGCG alone on PC3 cell line. The EGCG loaded LDH nanohybrids were characterized by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscopy (TEM) and nanosizer analyses. The anticancer activity of the EGCG-loaded LDH was investigated in prostate cancer cell line (PC3) while the release behavior of EGCG from LDH was observed at pH 7.45 and 4.25. Besides enhancing of apoptotic activity of EGCG, the results showed that intercalation of EGCG into LDH can improve the anti-tumor activity of EGCG over 5-fold dose advantages in in-vitro system. Subsequently, the in-vitro release data showed that EGCG-loaded LDH had longer release duration compared to physical mixture, and the mechanism of diffusion through the particle was rate-limiting step. Acidic attack was responsible for faster release of EGCG molecules from LDH at pH of 4.25 compared to pH of 7.4. The results showed that Ca/Al-LDH nanoparticles could be considered as an effective inorganic host matrix for the delivery of EGCG to PC3 cells with controlled release properties.	[Shafiei, Seyedeh Sara] Natl Inst Genet Engn & Biotechnol, Inst Med Biotechnol, Dept Stem Cell & Regenerat Med, Tehran 14965161, Iran; [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran; [Shafiei, Seyedeh Sara; Solati-Hashjin, Mehran; Asadi-Eydivand, Mitra; Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Adv Technol Med, Dept Tissue Engn & Regenerat Med, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Tehran, Iran; [Kalantarinejad, Reza] Converging Technol Res Ctr, Tehran, Iran	Amirkabir University of Technology; Universiti Malaya; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Shafiei, SS (corresponding author), Natl Inst Genet Engn & Biotechnol, Inst Med Biotechnol, Dept Stem Cell & Regenerat Med, Tehran 14965161, Iran.	sarashafiei@aut.ac.ir; azaun@um.edu.my	Shafiei, Seyedeh Sara/R-7755-2017; Asadi-Eydivand, Mitra/H-4092-2019; Samadikuchaksaraei, Ali/H-6402-2019; ABU OSMAN, NOOR AZUAN/B-9265-2010; Solati-Hashjin, Mehran/X-8822-2019	Asadi-Eydivand, Mitra/0000-0002-7809-7880; Samadikuchaksaraei, Ali/0000-0002-2108-9927; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Solati-Hashjin, Mehran/0000-0002-1187-1237; Shafiei, Seyedeh Sara/0000-0002-4517-5969	High Impact Research Grant from the University of Malaya (UM) [UM.C/HIR/MOHE/ENG/10 D000010-16001]	High Impact Research Grant from the University of Malaya (UM)	This study was supported by High Impact Research Grant UM.C/HIR/MOHE/ENG/10 D000010-16001 from the University of Malaya (UM).	Ambrogi V, 2001, INT J PHARM, V220, P23, DOI 10.1016/S0378-5173(01)00629-9; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bugatti V, 2011, APPL CLAY SCI, V52, P34, DOI 10.1016/j.clay.2011.01.025; Choi SJ, 2008, J PHYS CHEM SOLIDS, V69, P1528, DOI 10.1016/j.jpcs.2007.10.140; Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083; Costantino U, 1997, SOLID STATE IONICS, V97, P203, DOI 10.1016/S0167-2738(97)00043-X; Dong H, 2014, APPL CLAY SCI, DOI [10.1016/j.clay.2014.04.28, DOI 10.1016/J.CLAY.2014.04.28]; Fang JY, 2006, J DERMATOL SCI, V42, P101, DOI 10.1016/j.jdermsci.2005.12.010; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Hsieh DS, 2011, BIOMATERIALS, V32, P7633, DOI 10.1016/j.biomaterials.2011.06.073; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kong XG, 2010, APPL CLAY SCI, V49, P324, DOI 10.1016/j.clay.2010.06.017; Li L, 2014, BIOMATERIALS, V35, P3331, DOI 10.1016/j.biomaterials.2013.12.095; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Pan DK, 2010, CHEM ENG SCI, V65, P3762, DOI 10.1016/j.ces.2010.03.013; Rives V, 2014, APPL CLAY SCI, V88-89, P239, DOI 10.1016/j.clay.2013.12.002; Shafiei SS, 2013, ADV APPL CERAM, V112, P59, DOI 10.1179/1743676112Y.0000000045; Siddiqui IA, 2008, CHEM-BIOL INTERACT, V171, P122, DOI 10.1016/j.cbi.2007.03.001; Siddiqui IA, 2009, CANCER RES, V69, P1712, DOI 10.1158/0008-5472.CAN-08-3978; Sparks D. L., 1989, KINETICS SOIL CHEM P; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Wang ZL, 2005, J SOLID STATE CHEM, V178, P736, DOI 10.1016/j.jssc.2004.11.005; Xia SJ, 2008, J SOLID STATE CHEM, V181, P2610, DOI 10.1016/j.jssc.2008.06.009; Xu ZP, 2001, CHEM MATER, V13, P4564, DOI 10.1021/cm010347g; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	25	23	24	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136530	10.1371/journal.pone.0136530	http://dx.doi.org/10.1371/journal.pone.0136530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317853	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100096
J	Song, WJ; Son, MY; Lee, HW; Seo, H; Kim, JH; Chung, SH				Song, Woo-Joo; Son, Mi-Young; Lee, Hye-Won; Seo, Hyemyung; Kim, Jeong Hee; Chung, Sul-Hee			Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CYCLIN-DEPENDENT KINASE-5; BETA-SECRETASE ACTIVITY; DOWN-SYNDROME; MULTIVESICULAR BODIES; HEPARAN-SULFATE; BASAL SECRETION; PRIMARY NEURONS; INCREASE BACE1; P25	The activity of beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is elevated during aging and in sporadic Alzheimer's disease (AD), but the underlying mechanisms of this change are not well understood. p25/Cyclin-dependent kinase 5 (Cdk5) has been implicated in the pathogenesis of several neurodegenerative diseases, including AD. Here, we describe a potential mechanism by which BACE activity is increased in AD brains. First, we show that BACE1 is phosphorylated by the p25/Cdk5 complex at Thr252 and that this phosphorylation increases BACE1 activity. Then, we demonstrate that the level of phospho-BACE1 is increased in the brains of AD patients and in mammalian cells and transgenic mice that overexpress p25. Furthermore, the fraction of p25 prepared from iodixanol gradient centrifugation was unexpectedly protected by protease digestion, suggesting that p25/Cdk5-mediated BACE1 phosphorylation may occur in the lumen. These results reveal a link between p25 and BACE1 in AD brains and suggest that upregulated Cdk5 activation by p25 accelerates AD pathogenesis by enhancing BACE1 activity via phosphorylation.	[Song, Woo-Joo; Chung, Sul-Hee] Kyung Hee Univ, Sch Med, Neurodegenerat Control Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea; [Song, Woo-Joo; Son, Mi-Young; Lee, Hye-Won; Chung, Sul-Hee] Inje Univ, Inst Brain Sci & Technol, Busan, South Korea; [Seo, Hyemyung] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan, Gyeonggi Do, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Seoul, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Inje University; Hanyang University; Kyung Hee University; Kyung Hee University	Kim, JH (corresponding author), Kyung Hee Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Seoul, South Korea.	jhkimh@khu.ac.kr; sulchung@khu.ac.kr		Kim, Jeong Hee/0000-0002-3884-4503	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea [A092004]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012R1A1A2040129]; BIO & Medical Technology Development Program of National Research Foundation of Korea grant (MEST) [2012M3A9C6049936]	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; BIO & Medical Technology Development Program of National Research Foundation of Korea grant (MEST)	This work was supported by grants from the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea (A092004 to WJS), from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012R1A1A2040129 to SHC) and from the BIO & Medical Technology Development Program of National Research Foundation of Korea grant (MEST, 2012M3A9C6049936 to JHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Giusti-Rodriguez P, 2011, J NEUROSCI, V31, P15751, DOI 10.1523/JNEUROSCI.3588-11.2011; Harada H, 2006, NEUROSCI RES, V54, P24, DOI 10.1016/j.neures.2005.10.001; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lee HW, 2007, NEUROSCI LETT, V421, P178, DOI 10.1016/j.neulet.2007.01.082; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Leuba G, 2005, DEMENT GERIATR COGN, V19, P171, DOI 10.1159/000083496; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Liu L, 2013, NEUROBIOL AGING, V34, P540, DOI 10.1016/j.neurobiolaging.2012.05.017; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Marlow L, 2003, J MOL NEUROSCI, V20, P233, DOI 10.1385/JMN:20:3:233; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Park JH, 2012, J NEUROCHEM, V122, P1081, DOI 10.1111/j.1471-4159.2012.07861.x; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PERRY G, 1991, J NEUROSCI, V11, P3679; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Sidera C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-25; SNOW AD, 1990, AM J PATHOL, V137, P1253; Son MY, 2010, MOL CELLS, V29, P51, DOI 10.1007/s10059-010-0016-0; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Stockley JH, 2006, FEBS LETT, V580, P6550, DOI 10.1016/j.febslet.2006.10.076; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Sun XL, 2012, J NEUROCHEM, V120, P62, DOI 10.1111/j.1471-4159.2011.07515.x; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	60	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136950	10.1371/journal.pone.0136950	http://dx.doi.org/10.1371/journal.pone.0136950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317805	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100183
J	Vagberg, M; Norgren, N; Dring, A; Lindqvist, T; Birgander, R; Zetterberg, H; Svenningsson, A				Vagberg, Mattias; Norgren, Niklas; Dring, Ann; Lindqvist, Thomas; Birgander, Richard; Zetterberg, Henrik; Svenningsson, Anders			Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction	PLOS ONE			English	Article							CSF NEUROFILAMENT; CEREBROSPINAL-FLUID; N-ACETYLASPARTATE; ATROPHY; DAMAGE	Background Neurofilament light (NFL) and Glial Fibrillary Acidic Protein (GFAP) are integral parts of the axonal and astrocytal cytoskeletons respectively and are released into the cerebrospinal fluid (CSF) in cases of cellular damage. In order to interpret the levels of these biomarkers in disease states, knowledge on normal levels in the healthy is required. Another biomarker for neurodegeneration is brain atrophy, commonly measured as brain parenchymal fraction (BPF) using magnetic resonance imaging (MRI). Potential correlations between levels of NFL, GFAP and BPF in healthy individuals have not been investigated. Objectives To present levels of NFL and GFAP in healthy individuals stratified for age, and investigate the correlation between them as well as their correlation with BPF. Methods The CSF was analysed in 53 healthy volunteers aged 21 to 70 (1 sample missing for GFAP analysis) and 48 of the volunteers underwent determination of BPF using MRI. Results Mean (+/- SD) NFL was 355 ng/L (+/- 214), mean GFAP was 421 ng/L (+/- 129) and mean BPF was 0.867 (+/- 0.035). All three biomarkers correlated with age. NFL also correlated with both GFAP and BPF. When controlled for age, only the correlation between NFL and GFAP retained statistical significance. Conclusions This study presents data on age-stratified levels of NFL and GFAP in the CSF of healthy individuals. There is a correlation between levels of NFL and GFAP and both increase with age. A correlation between NFL and BPF was also found, but did not retain statistical significance if controlled for age.	[Vagberg, Mattias; Dring, Ann; Svenningsson, Anders] Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosci, Umea, Sweden; [Norgren, Niklas] UmanDiagnost AB, Umea, Sweden; [Lindqvist, Thomas; Birgander, Richard] Umea Univ, Dept Radiat Sci, Sect Diagnost Radiol, Umea, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England	Umea University; Umea University; University of Gothenburg; University of London; University College London	Vagberg, M (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosci, Umea, Sweden.	mattias.vagberg@umu.se		Svenningsson, Anders/0000-0003-0663-2220	BiogenIdec AB; Neuro Sweden; Umea University; Vasterbotten County Council (ALF); UmanDiagnostics AB	BiogenIdec AB; Neuro Sweden; Umea University; Vasterbotten County Council (ALF); UmanDiagnostics AB	The study was partially funded by unrestricted research grants from BiogenIdec AB and Neuro Sweden. Financial support was further provided through a regional agreement between Umea University and Vasterbotten County Council (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UmanDiagnostics AB provided support in the form of salaries for author NN, supplied NFL-kits for the study and provided lab-space for NFL analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Appelman APA, 2010, CEREBROVASC DIS, V29, P28, DOI 10.1159/000255971; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Hjalmarsson C, 2014, J CENT NERV SYST DIS, V6, P51, DOI 10.4137/JCNSD.S13821; Khalil M, 2013, MULT SCLER J, V19, P436, DOI 10.1177/1352458512458010; Knoops AJG, 2009, HIPPOCAMPUS, V19, P1115, DOI 10.1002/hipo.20575; Kuhle J, 2011, NEUROLOGY, V76, P1206, DOI 10.1212/WNL.0b013e31821432ff; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Moscufo N, 2011, NEUROBIOL AGING, V32, P646, DOI 10.1016/j.neurobiolaging.2009.04.010; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Skillback T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt212; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262	18	74	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135886	10.1371/journal.pone.0135886	http://dx.doi.org/10.1371/journal.pone.0135886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317831	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100048
J	Wong, S; Mosabbir, AA; Truong, K				Wong, Stanley; Mosabbir, Abdullah A.; Truong, Kevin			An Engineered Split Intein for Photoactivated Protein Trans-Splicing	PLOS ONE			English	Article							FLUORESCENT PROTEIN; DNAE INTEIN; IN-VIVO; DOMAIN; LIGHT; CA2+; ACTIVATION; SEMISYNTHESIS; PHOTOTROPIN; MECHANISMS	Protein splicing is mediated by inteins that auto-catalytically join two separated protein fragments with a peptide bond. Here we engineered a genetically encoded synthetic photoactivatable intein (named LOVInC), by using the light-sensitive LOV2 domain from Avena sativa as a switch to modulate the splicing activity of the split DnaE intein from Nostoc punctiforme. Periodic blue light illumination of LOVInC induced protein splicing activity in mammalian cells. To demonstrate the broad applicability of LOVInC, synthetic protein systems were engineered for the light-induced reassembly of several target proteins such as fluorescent protein markers, a dominant positive mutant of RhoA, caspase-7, and the genetically encoded Ca2+ indicator GCaMP2. Spatial precision of LOVInC was demonstrated by targeting activity to specific mammalian cells. Thus, LOVInC can serve as a general platform for engineering light-based control for modulating the activity of many different proteins.	[Wong, Stanley; Mosabbir, Abdullah A.; Truong, Kevin] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Truong, Kevin] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	University of Toronto; University of Toronto	Truong, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.	kevin.truong@utoronto.ca		Truong, Kevin/0000-0002-9520-2144	Canadian Cancer Society Research Institute [701936]; NSERC [05322-14]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a grant from the Canadian Cancer Society Research Institute (#701936), received by KT, and NSERC (#05322-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (website: http://www.cancer.ca/en/?region = on).	Adam E, 2002, J MOL MICROB BIOTECH, V4, P479; Berrade L, 2010, CHEMBIOCHEM, V11, P1368, DOI 10.1002/cbic.201000157; Binschik J, 2011, ANGEW CHEM INT EDIT, V50, P3249, DOI 10.1002/anie.201007078; Bittl R, 2003, BIOCHEMISTRY-US, V42, P8506, DOI 10.1021/bi034123i; Bocker JK, 2015, ANGEW CHEM INT EDIT, V54, P2116, DOI 10.1002/anie.201409848; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jung D, 2015, CHEM COMMUN, V51, P9670, DOI 10.1039/c5cc01067e; Kottke T, 2003, BIOCHEMISTRY-US, V42, P9854, DOI 10.1021/bi034863r; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Mills E, 2012, ACS SYNTH BIOL, V1, P75, DOI 10.1021/sb200008j; Mills E, 2010, CELL CALCIUM, V48, P195, DOI 10.1016/j.ceca.2010.08.009; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nicastri MC, 2013, BIOCHEMISTRY-US, V52, P5920, DOI 10.1021/bi400736c; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Ren W, 2015, J AM CHEM SOC, V137, P2155, DOI 10.1021/ja508597d; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Skretas G, 2005, PROTEIN SCI, V14, P523, DOI 10.1110/ps.04996905; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Truong K, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-8; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Vila-Perello M, 2008, ANGEW CHEM INT EDIT, V47, P7764, DOI 10.1002/anie.200802502; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wong S, 2012, PROTEIN ENG DES SEL; Wong SSC, 2012, CELL CALCIUM, V51, P57, DOI 10.1016/j.ceca.2011.10.006; Wong SSC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014274; Wood DW, 2014, J BIOL CHEM, V289, P14512, DOI 10.1074/jbc.R114.552653; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zheng Changyu, 2008, V434, P205, DOI 10.1007/978-1-60327-248-3_13	55	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135965	10.1371/journal.pone.0135965	http://dx.doi.org/10.1371/journal.pone.0135965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317656	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100054
J	King, C; McCollum, ED; Mankhambo, L; Colbourn, T; Beard, J; Burgess, DCH; Costello, A; Izadnegahdar, R; Lufesi, N; Masache, G; Mwansambo, C; Nambiar, B; Johnson, E; Platt, R; Mukanga, D				King, Carina; McCollum, Eric D.; Mankhambo, Limangeni; Colbourn, Tim; Beard, James; Burgess, Debbie C. Hay; Costello, Anthony; Izadnegahdar, Raza; Lufesi, Norman; Masache, Gibson; Mwansambo, Charles; Nambiar, Bejoy; Johnson, Eric; Platt, Robert; Mukanga, David			Can We Predict Oral Antibiotic Treatment Failure in Children with Fast-Breathing Pneumonia Managed at the Community Level? A Prospective Cohort Study in Malawi	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; RESPIRATORY-INFECTIONS; AFRICAN CHILDREN; GLOBAL BURDEN; RISK-FACTORS; AMOXICILLIN; COTRIMOXAZOLE; THERAPY; MORTALITY; STANDARD	Background Pneumonia is the leading cause of infectious death amongst children globally, with the highest burden in Africa. Early identification of children at risk of treatment failure in the community and prompt referral could lower mortality. A number of clinical markers have been independently associated with oral antibiotic failure in childhood pneumonia. This study aimed to develop a prognostic model for fast-breathing pneumonia treatment failure in sub-Saharan Africa. Method We prospectively followed a cohort of children (2-59 months), diagnosed by community health workers with fast-breathing pneumonia using World Health Organisation (WHO) integrated community case management guidelines. Cases were followed at days 5 and 14 by study data collectors, who assessed a range of pre-determined clinical features for treatment outcome. We built the prognostic model using eight pre-defined parameters, using multivariable logistic regression, validated through bootstrapping. Results We assessed 1,542 cases of which 769 were included (32% ineligible; 19% defaulted). The treatment failure rate was 15% at day 5 and relapse was 4% at day 14. Concurrent malaria diagnosis (OR: 1.62; 95% CI: 1.06, 2.47) and moderate malnutrition (OR: 1.88; 95% CI: 1.09, 3.26) were associated with treatment failure. The model demonstrated poor calibration and discrimination (c-statistic: 0.56). Conclusion This study suggests that it may be difficult to create a pragmatic community-level prognostic child pneumonia tool based solely on clinical markers and pulse oximetry in an HIV and malaria endemic setting. Further work is needed to identify more accurate and reliable referral algorithms that remain feasible for use by community health workers.	[King, Carina; McCollum, Eric D.; Colbourn, Tim; Beard, James; Costello, Anthony; Nambiar, Bejoy] UCL, Inst Global Hlth, London, England; [McCollum, Eric D.] Johns Hopkins Sch Med, Div Pulmonol, Dept Pediat, Baltimore, MD USA; [Mankhambo, Limangeni; Masache, Gibson] Parent & Child Hlth Initiat, Lilongwe, Malawi; [Burgess, Debbie C. Hay; Izadnegahdar, Raza; Mukanga, David] Bill & Melinda Gates Fdn, Seattle, WA USA; [Lufesi, Norman] Minist Hlth, Acute Resp Infect Unit, Lilongwe, Malawi; [Mwansambo, Charles] Minist Hlth, Lilongwe, Malawi; [Johnson, Eric] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Platt, Robert] McGill Univ, Montreal, PQ, Canada	University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; Bill & Melinda Gates Foundation; Kaiser Permanente; McGill University	King, C (corresponding author), UCL, Inst Global Hlth, London, England.	c.king@ucl.ac.uk	Colbourn, Tim/AAE-6645-2019; McCollum, Eric D./AAE-7120-2020	Colbourn, Tim/0000-0002-6917-6552; Nambiar, Bejoy/0000-0002-1742-522X	Bill & Melinda Gates Foundation [23591]; National Institutes of Health National Heart Lung and Blood Institute [T32 HL072748-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Bill & Melinda Gates Foundation [#23591]. EDM received additional funding from the National Institutes of Health National Heart Lung and Blood Institute (T32 HL072748-11).	Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Ahmed S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19305; [Anonymous], 2013, CAR SICK CHILD COMM; Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Demers AM, 2000, PEDIATR INFECT DIS J, V19, P424, DOI 10.1097/00006454-200005000-00007; Eric DM, 2014, AM THOR SOC INT C; Fox MP, 2013, CLIN INFECT DIS, V56, P978, DOI 10.1093/cid/cis1201; Fu LY, 2006, PEDIATRICS, V118, pE1822, DOI 10.1542/peds.2005-2673; Garcia MS, 2009, INT J ANTIMICROB AG, V34; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Grant GB, 2009, LANCET INFECT DIS, V9, P185, DOI 10.1016/S1473-3099(09)70044-1; Hazir T, 2002, LANCET, V360, P835; Jeena P, 2006, B WORLD HEALTH ORGAN, V84, P269; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Khuluza F, 2014, MALAWI MED J, V26, P38; Liu L, 2014, LANCET; Malalwi Go, 2008, INTEGRATED MANAGEMEN; Mamtani M, 2009, PEDIATR PULM, V44, P379, DOI 10.1002/ppul.21014; McCollum ED, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0392-x; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Niessen L, 2009, B WORLD HEALTH ORGAN, V87, P472, DOI 10.2471/BLT.08.050872; Noorani QA, 2006, INT J TUBERC LUNG D, V10, P932; Rasmussen ZA, 2005, B WORLD HEALTH ORGAN, V83, P10; REDD SC, 1992, LANCET, V340, P1140, DOI 10.1016/0140-6736(92)93160-O; Roca A, 2006, TROP MED INT HEALTH, V11, P373, DOI 10.1111/j.1365-3156.2006.01566.x; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Team RDC, R LANG ENV STAT COMP; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zar HJ, 2003, PEDIATR PULM, V36, P457, DOI 10.1002/ppul.10345	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136839	10.1371/journal.pone.0136839	http://dx.doi.org/10.1371/journal.pone.0136839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313752	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000099
J	Sato, S; Yajima, H; Furuta, Y; Ikeda, K; Kawakami, K				Sato, Shigeru; Yajima, Hiroshi; Furuta, Yasuhide; Ikeda, Keiko; Kawakami, Kiyoshi			Activation of Six1 Expression in Vertebrate Sensory Neurons	PLOS ONE			English	Article							POU-DOMAIN FACTORS; EVOLUTIONARILY CONSERVED ENHANCERS; PROMOTER-TRANSCRIPTION FACTOR; EMBRYONAL CARCINOMA-CELLS; RETINOIC ACID RECEPTOR; CRANIAL PLACODES; XENOPUS-LAEVIS; BINDING-SITES; COUP-TF; BRANCHIOOTORENAL SYNDROME	SIX1 homeodomain protein is one of the essential key regulators of sensory organ development. Six1-deficient mice lack the olfactory epithelium, vomeronasal organs, cochlea, vestibule and vestibuloacoustic ganglion, and also show poor neural differentiation in the distal part of the cranial ganglia. Simultaneous loss of both Six1 and Six4 leads to additional abnormalities such as small trigeminal ganglion and abnormal dorsal root ganglia (DRG). The aim of this study was to understand the molecular mechanism that controls Six1 expression in sensory organs, particularly in the trigeminal ganglion and DRG. To this end, we focused on the sensory ganglia-specific Six1 enhancer (Six1-8) conserved between chick and mouse. In vivo reporter assays using both animals identified an important core region comprising binding consensus sequences for several transcription factors including nuclear hormone receptors, TCF/LEF, SMAD, POU homeodomain and basic-helix-loophelix proteins. The results provided information on upstream factors and signals potentially relevant to Six1 regulation in sensory neurons. We also report the establishment of a new transgenic mouse line (mSix1-8-NLSCre) that expresses Cre recombinase under the control of mouse Six1-8. Cre-mediated recombination was detected specifically in ISL1/2-positive sensory neurons of Six1-positive cranial sensory ganglia and DRG. The unique features of the mSix1-8-NLSCre line are the absence of Cre-mediated recombination in SOX10-positive glial cells and central nervous system and ability to induce recombination in a subset of neurons derived from the olfactory placode/epithelium. This mouse model can be potentially used to advance research on sensory development.	[Sato, Shigeru; Yajima, Hiroshi; Kawakami, Kiyoshi] Jichi Med Univ, Div Biol, Ctr Mol Med, Shimotsuke, Tochigi, Japan; [Furuta, Yasuhide] RIKEN Ctr Life Sci Technol CLST, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Furuta, Yasuhide] RIKEN Ctr Life Sci Technol CLST, Genet Engn Team, Div Biofunct Dynam Imaging, Kobe, Hyogo, Japan; [Ikeda, Keiko] Hyogo Coll Med, Div Biol, Nishinomiya, Hyogo 6638501, Japan	Jichi Medical University; RIKEN; RIKEN; Hyogo College of Medicine	Sato, S (corresponding author), Jichi Med Univ, Div Biol, Ctr Mol Med, Shimotsuke, Tochigi, Japan.	ssato@jichi.ac.jp	Sato, Shigeru/ABE-2090-2020		Japan Society for the Promotion of Science [19590179, 22590179, 25460252]; Narishige Zoological Science Award; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [25460251] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Narishige Zoological Science Award; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Numbers 19590179, 22590179 and 25460252) to SS, the Narishige Zoological Science Award 2011 to SS, and the Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan (2008-2012, 2013-2017).	Adam F, 2000, MOL ENDOCRINOL, V14, P1918, DOI 10.1210/me.14.12.1918; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; Ando Z, 2005, FEBS J, V272, P3026, DOI 10.1111/j.1742-4658.2005.04716.x; Artinger KB, 1998, J NEUROBIOL, V36, P572, DOI 10.1002/(SICI)1097-4695(19980915)36:4<572::AID-NEU10>3.0.CO;2-A; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; Bessarab DA, 2004, DEV DYNAM, V230, P781, DOI 10.1002/dvdy.20093; Bessarab DA, 2008, DEV BIOL, V323, P216, DOI 10.1016/j.ydbio.2008.08.015; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BUTLER AJ, 1995, NUCLEIC ACIDS RES, V23, P4143, DOI 10.1093/nar/23.20.4143; Chen B, 2009, DEV BIOL, V326, P75, DOI 10.1016/j.ydbio.2008.10.039; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Eckardt D, 2004, GENESIS, V38, P159, DOI 10.1002/gene.20011; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hans S, 2007, DEVELOPMENT, V134, P2449, DOI 10.1242/dev.000448; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Huang EJ, 1999, DEVELOPMENT, V126, P2869; HUGHES A, 1957, J ANAT, V91, P323; Ikeda K, 2007, DEV BIOL, V311, P53, DOI 10.1016/j.ydbio.2007.08.020; Ikeda K, 2010, INT J DEV BIOL, V54, P1453, DOI 10.1387/ijdb.093041ki; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Ishihara T, 2008, DEV DYNAM, V237, P3142, DOI 10.1002/dvdy.21716; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Knutson DC, 2015, TRANSGENIC RES, V24, P123, DOI 10.1007/s11248-014-9825-9; Kochhar A, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20714; Konishi Y, 2006, BRAIN RES, V1116, P93, DOI 10.1016/j.brainres.2006.07.103; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Kozmik Z, 2007, DEV BIOL, V306, P143, DOI 10.1016/j.ydbio.2007.03.009; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Lanier J, 2009, DEV DYNAM, V238, P3065, DOI 10.1002/dvdy.22145; Lassiter RNT, 2007, DEV BIOL, V308, P392, DOI 10.1016/j.ydbio.2007.05.032; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Maier EC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004858; Miller AM, 2010, J COMP NEUROL, V518, P4825, DOI 10.1002/cne.22497; Morgan MJ, 2004, J BIOL CHEM, V279, P46826, DOI 10.1074/jbc.M406140200; Nagy A., 2003, MANIPULATING MOUSE E; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; NEUMAN K, 1995, J NEUROSCI RES, V41, P39, DOI 10.1002/jnr.490410106; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Nord H, 2013, J CELL SCI, V126, P1868, DOI 10.1242/jcs.119917; O'Donovan KJ, 2014, J EXP MED, V211, P801, DOI 10.1084/jem.20131780; Ono K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004118; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Pandur PD, 2000, MECH DEVELOP, V96, P253, DOI 10.1016/S0925-4773(00)00396-8; Paschaki M, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-13; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Sato S, 2012, DEV BIOL, V368, P95, DOI 10.1016/j.ydbio.2012.05.023; Sato S, 2010, DEV BIOL, V344, P158, DOI 10.1016/j.ydbio.2010.04.029; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Schlosser G, 2008, DEV BIOL, V320, P199, DOI 10.1016/j.ydbio.2008.05.523; Shepherd TG, 2008, GENE, V414, P95, DOI 10.1016/j.gene.2008.02.015; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Trieu M, 2003, DEVELOPMENT, V130, P111, DOI 10.1242/dev.00194; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00497; Wong EYM, 2013, HEARING RES, V297, P13, DOI 10.1016/j.heares.2012.09.009; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yajima H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-40; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199; Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437; Zou M, 2012, DEV BIOL, V364, P114, DOI 10.1016/j.ydbio.2012.01.021	95	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136666	10.1371/journal.pone.0136666	http://dx.doi.org/10.1371/journal.pone.0136666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313368	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000083
J	Suauam, P; Yingyongnarongkul, BE; Palaga, T; Miyakawa, T; Yompakdee, C				Suauam, Pitipreya; Yingyongnarongkul, Boon-ek; Palaga, Tanapat; Miyakawa, Tokichi; Yompakdee, Chulee			Clausmarin A, Potential Immunosuppressant Revealed by Yeast-Based Assay and Interleukin-2 Production Assay in Jurkat T Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CYCLE REGULATION; BUDDING YEAST; CLAUSENA-PENTAPHYLLA; PHYSIOLOGICAL ROLES; CALCINEURIN; GROWTH; CA2+; INHIBITION; ACTIVATION	Small-molecule inhibitors of Ca2+-signaling pathways are of medicinal importance, as exemplified by the immunosuppressants FK506 and cyclosporin A. Using a yeast-based assay devised for the specific detection of Ca2+-signaling inhibitors, clausmarin A, a previously reported terpenoid coumarin, was identified as an active substance. Here, we investigated the likely mechanism of clausmarin A action in yeast and Jurkat T-cells. In the presence of 100 mM CaCl2 in the growth medium of Ca2+-sensitive Delta zds1 strain yeast, clausmarin A exhibited a dose-dependent alleviation of various defects due to hyperactivation of Ca2+ signaling, such as growth inhibition, polarized bud growth and G2 phase cell-cycle arrest. Furthermore, clausmarin A inhibited the growth of Delta mpk1 (lacking the Mpk1 MAP kinase pathway) but not Delta cnb1 (lacking the calcineurin pathway) strain, suggesting that clausmarin A inhibited the calcineurin pathway as presumed from the synthetic lethality of these pathways. Furthermore, clausmarin A alleviated the serious defects of a strain expressing a constitutively active form of calcineurin. In the human Jurkat T-cell line, clausmarin A exhibited a dose-dependent inhibition of IL-2 production and IL-2 gene transcription, as well as an inhibition of NFAT dephosphorylation. The effects of clausmarin A observed in both yeast and Jurkat cells are basically similar to those of FK506. Our study revealed that clausmarin A is an inhibitor of the calcineurin pathway, and that this is probably mediated via inhibition of calcineurin phosphatase activity. As such, clausmarin A is a potential immunosuppressant.	[Suauam, Pitipreya; Palaga, Tanapat; Yompakdee, Chulee] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok 10330, Thailand; [Yingyongnarongkul, Boon-ek] Ramkhamhang Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [Yingyongnarongkul, Boon-ek] Ramkhamhang Univ, Ctr Excellence Innovat Chem, Fac Sci, Bangkok, Thailand; [Miyakawa, Tokichi] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan	Chulalongkorn University; Ramkhamhaeng University; Ramkhamhaeng University; Hiroshima University	Yompakdee, C (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Sci, Phayathai Rd, Bangkok 10330, Thailand.	chulee.y@chula.ac.th		Yompakdee, Chulee/0000-0003-4690-4809	Thai Government; 90th Anniversary of Chulalongkorn University Fund; Chulalongkorn University; Chulalongkorn University through the Omics Sciences and Bioinformatics Center; Higher Education Research Promotion (HERP) Program, Office of the Higher Education Commission and Center of Excellence for Innovation in Chemistry (PERCH-CIC)	Thai Government; 90th Anniversary of Chulalongkorn University Fund(Chulalongkorn University); Chulalongkorn University(Chulalongkorn University); Chulalongkorn University through the Omics Sciences and Bioinformatics Center; Higher Education Research Promotion (HERP) Program, Office of the Higher Education Commission and Center of Excellence for Innovation in Chemistry (PERCH-CIC)	This work was supported by Thai Government Annual Budget Fund, CY; The 90th Anniversary of Chulalongkorn University Fund, CY; Chulalongkorn University Fund for Visiting Professor, TM; Chulalongkorn University through the Omics Sciences and Bioinformatics Center, CY; Higher Education Research Promotion (HERP) Program, Office of the Higher Education Commission and Center of Excellence for Innovation in Chemistry (PERCH-CIC), BY.	BALZI E, 1987, J BIOL CHEM, V262, P16871; Boonkerd S, 2014, ANN MICROBIOL, V64, P1049, DOI 10.1007/s13213-013-0742-6; Chanklan R, 2008, BIOSCI BIOTECH BIOCH, V72, P132, DOI 10.1271/bbb.70502; FUNG JJ, 1991, TRANSPLANT P, V23, P3105; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gummert JF, 1999, J AM SOC NEPHROL, V10, P1366; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; HEMMI K, 1995, BIOSCI BIOTECH BIOCH, V59, P482, DOI 10.1271/bbb.59.482; HUANG M, 1995, CANCER RES, V55, P3847; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU Y, 1991, MOL GEN GENET, V227, P52, DOI 10.1007/BF00260706; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; Mizunuma M, 2001, EMBO J, V20, P1074, DOI 10.1093/emboj/20.5.1074; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; Morris RE, 1995, TRANSPLANTATION LIVE; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura T, 1996, MOL GEN GENET, V251, P211; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; PATNAIK GK, 1982, J ETHNOPHARMACOL, V6, P127, DOI 10.1016/0378-8741(82)90001-0; Raj K, 2009, NAT PROD RES, V23, P1671, DOI 10.1080/14786410802176364; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Shitamukai A, 2000, BIOSCI BIOTECH BIOCH, V64, P1942, DOI 10.1271/bbb.64.1942; SHOEB A, 1978, J CHEM SOC CHEM COMM, P281, DOI 10.1039/c39780000281; Sohrab MH, 2000, BIOCHEM SYST ECOL, V28, P91, DOI 10.1016/S0305-1978(99)00035-6; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Wangkangwan W, 2009, BIOSCI BIOTECH BIOCH, V73, P1679, DOI 10.1271/bbb.90114	27	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136804	10.1371/journal.pone.0136804	http://dx.doi.org/10.1371/journal.pone.0136804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313553	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000097
J	Haack, RL; Horta, BL; Gigante, DP; Barros, FC; Oliveira, I; Silveira, VMF				Haack, Ricardo Lanzetta; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Barros, Fernando C.; Oliveira, Isabel; Silveira, Vera M. F.			Hypertriglyceridemic Waist Phenotype: Effect of Birthweight and Weight Gain in Childhood at 23 Years Old	PLOS ONE			English	Article							CATCH-UP GROWTH; ATHEROGENIC METABOLIC TRIAD; CORONARY-ARTERY-DISEASE; BLOOD-PRESSURE; NONFASTING TRIGLYCERIDES; BRAZILIAN MALES; HEART-DISEASE; YOUNG-ADULTS; IN-UTERO; RISK	Objective To evaluate the association of birthweight and weight gain during different periods in childhood with the prevalence of hypertriglyceridemic waist phenotype (HWP). Methods In 1982, all hospitals births in Pelotas, South Brazil, were identified, and the 5914 liveborn were examined and their mothers interviewed. This population has been followed for several times. In 2004-05, we tried to follow the whole cohort and the subjects were interviewed, examined, and a blood sample was collected. HWP was defined as a triglycerides >= 2 mmol/L and a waist circumference >= 90 cm for men, and triglycerides >= 1.5 mmol/L and waist circumference >= 85 cm for woman. Poisson regression with robust adjustment of the variance was used to obtain adjusted estimates of the prevalence ratio. Results Subjects whose weight-for-age z-score at mean age of 42 months was one or more standard deviation above the mean, according to gender and age, were 8.77 (95% confidence interval: 2.60; 29.64) times more likely of presenting the HWP than those subjects whose weight-for-age z-score at 42 months was more than one standard deviation below the mean. Among those subjects whose birthweight was adequate-for-gestational age (AGA), conditional weight at 20 months was positively associated to the risk of HWP [relative risk: 1.59 (95%: confidence interval: 1.32; 1.92)], whereas for small for gestational age (SGA) subjects conditional weight was not associated with HWP [relative risk: 1.05 (95% confidence interval: 0.77; 1.43)], p-value for interaction 0.08. Conclusion Early weight gain among SGA infants, did not increase the risk of HWP in early adulthood, whereas among those who were AGA, early weight gain increased the risk of the having the phenotype in early adulthood.	[Haack, Ricardo Lanzetta; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Barros, Fernando C.; Oliveira, Isabel; Silveira, Vera M. F.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil	Universidade Federal de Pelotas	Haack, RL (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	ricardohaack@yahoo.com.br	Horta, Bernardo/A-7604-2008	Horta, Bernardo/0000-0001-9843-412X; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust; Brazilian Research Council (CNPq); International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health	This article is based on data from the study "Pelotas Birth Cohort, 1982" conducted by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas with the collaboration of the Brazilian Public Health Association (ABRASCO). This study was supported by the Wellcome Trust and the Brazilian Research Council (CNPq). Previous phases of the study were supported by the International Development Research Center, the World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq) and Brazilian Ministry of Health. There are no conflicts of interest.	Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Blackburn P, 2008, DIABETES CARE, V31, P170, DOI 10.2337/dc07-0272; Crowther NJ, 2008, PEDIATRICS, V121, pE1715, DOI 10.1542/peds.2007-3147; de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; FREEDMAN DS, 1985, JAMA-J AM MED ASSOC, V254, P515, DOI 10.1001/jama.254.4.515; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Horta BL, 2009, EUR J CLIN NUTR, V63, P369, DOI 10.1038/sj.ejcn.1602934; Horta BL, 2009, INT J EPIDEMIOL, V38, P724, DOI 10.1093/ije/dyp168; Horta BL, 2009, ACTA PAEDIATR, V98, P1024, DOI 10.1111/j.1651-2227.2009.01247.x; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Law CM, 1996, J HYPERTENS, V14, P935; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; RYU JE, 1992, STROKE, V23, P823, DOI 10.1161/01.STR.23.6.823; Sinaiko AR, 1999, CIRCULATION, V99, P1471, DOI 10.1161/01.CIR.99.11.1471; Slining MM, 2011, AM J EPIDEMIOL, V173, P640, DOI 10.1093/aje/kwq435; St-Pierre J, 2002, AM J CARDIOL, V90, P15, DOI 10.1016/S0002-9149(02)02378-0; TANNER JM, 1981, BRIT MED BULL, V37, P233, DOI 10.1093/oxfordjournals.bmb.a071708; Victora CG, 2007, ACTA PAEDIATR, V96, P296, DOI 10.1111/j.1651-2227.2007.00110.x; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; Warrington NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079547; Warrington NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053897; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134121	10.1371/journal.pone.0134121	http://dx.doi.org/10.1371/journal.pone.0134121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309194	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400018
J	Sadoul, B; Martin, O; Prunet, P; Friggens, NC				Sadoul, Bastien; Martin, Olivier; Prunet, Patrick; Friggens, Nicolas C.			On the Use of a Simple Physical System Analogy to Study Robustness Features in Animal Sciences	PLOS ONE			English	Article							PLASMA-CORTISOL RESPONSE; RAINBOW-TROUT; CLIMATE-CHANGE; STRESS; REPRODUCTION; CONFINEMENT; ALLOSTASIS; BIOLOGY; COSTS; WATER	Environmental perturbations can affect the health, welfare, and fitness of animals. Being able to characterize and phenotype adaptive capacity is therefore of growing scientific concern in animal ecology and in animal production sciences. Terms borrowed from physics are commonly used to describe adaptive responses of animals facing an environmental perturbation, but no quantitative characterization of these responses has been made. Modeling the dynamic responses to an acute challenge was used in this study to facilitate the characterization of adaptive capacity and therefore robustness. A simple model based on a spring and damper was developed to simulate the dynamic responses of animals facing an acute challenge. The parameters characterizing the spring and the damper can be interpreted in terms of stiffness and resistance to the change of the system. The model was tested on physiological and behavioral responses of rainbow trout facing an acute confinement challenge. The model has proven to properly fit the different responses measured in this study and to quantitatively describe the different temporal patterns for each statistical individual in the study. It provides therefore a new way to explicitly describe, analyze and compare responses of individuals facing an acute perturbation. This study suggests that such physical models may be usefully applied to characterize robustness in many other biological systems.	[Sadoul, Bastien; Prunet, Patrick] INRA, LPGP Fish Physiol & Genom, UR1037, F-35042 Rennes, France; [Martin, Olivier; Friggens, Nicolas C.] INRA, Modelisat Syst Appl Ruminants, UMR0791, Paris, France; [Martin, Olivier; Friggens, Nicolas C.] AgroParisTech, Modelisat Syst Appl Ruminants, UMR0791, Paris, France	INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sadoul, B (corresponding author), INRA, LPGP Fish Physiol & Genom, UR1037, F-35042 Rennes, France.	bastiensadoul@hotmail.fr	Martin, Olivier/F-3775-2011	Martin, Olivier/0000-0001-7375-2850; Sadoul, Bastien/0000-0001-5968-3983	Institut National de la Recherche Agronomique; Region Bretagne [30000675]	Institut National de la Recherche Agronomique; Region Bretagne(Region Bretagne)	This work was supported by funds from the Institut National de la Recherche Agronomique. The first author received a fellowship from the Region Bretagne with grant number 30000675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auperin B, 1997, GEN COMP ENDOCR, V108, P35, DOI 10.1006/gcen.1997.6938; Codrea MC, 2011, J ANIM SCI, V89, P3089, DOI 10.2527/jas.2010-3753; de Goede DM, 2013, NJAS-WAGEN J LIFE SC, V64-65, P1, DOI 10.1016/j.njas.2012.03.001; Desnoyers M, 2009, J DAIRY SCI, V92, P3894, DOI 10.3168/jds.2008-1784; Ellis T, 2004, J FISH BIOL, V65, P1233, DOI 10.1111/j.0022-1112.2004.00499.x; Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003; Friggens NC, 2012, 2012 JOINT ANN M PHO, P671; Hojsgaard S, 2010, J DAIRY SCI, V93, P582, DOI 10.3168/jds.2009-2445; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Knap PW, 2005, AUST J EXP AGR, V45, P763, DOI 10.1071/EA05041; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lesne A, 2008, BIOL REV, V83, P509, DOI 10.1111/j.1469-185X.2008.00052.x; Marques S. P. C., 2012, COMPUTATIONAL VISCOE; Marshall JAR, 2015, CURR ZOOL, V61, P242, DOI 10.1093/czoolo/61.2.242; Mellor DJ, 2000, BIOLOGY OF ANIMAL STRESS, P171, DOI 10.1079/9780851993591.0171; Nikooyan AA, 2011, P I MECH ENG H, V225, P1121, DOI 10.1177/0954411911424210; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Quillet E, 2014, ANIM GENET, V45, P223, DOI 10.1111/age.12126; Sadoul B, 2014, MULTIVARIATE ANAL US; Sauvant D, 2010, PROD ANIM, V23, P5; Schuring E, 2012, APPETITE, V59, P601, DOI 10.1016/j.appet.2012.07.003; Strandberg E., 2009, Breeding for robustness in cattle, P17; Takase M, 2014, FISH PHYSIOL BIOCHEM, V40, P385, DOI 10.1007/s10695-013-9851-1; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; TENNAPEL J, 2006, UTILISING INTRINSIC; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Zeeman M L, 2003, Reprod Biomed Online, V7, P295	35	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137333	10.1371/journal.pone.0137333	http://dx.doi.org/10.1371/journal.pone.0137333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322508	Green Published, gold			2022-12-27	WOS:000360435500071
J	Struchiner, CJ; Rocklov, J; Wilder-Smith, A; Massad, E				Struchiner, Claudio Jose; Rockloev, Joacim; Wilder-Smith, Annelies; Massad, Eduardo			Increasing Dengue Incidence in Singapore over the Past 40 Years: Population Growth, Climate and Mobility	PLOS ONE			English	Article							AEDES-AEGYPTI; VIRUS; URBANIZATION; EPIDEMIOLOGY; SURVEILLANCE; TEMPERATURE; INFECTION; EMERGENCE; IMPACT	In Singapore, the frequency and magnitude of dengue epidemics have increased significantly over the past 40 years. It is important to understand the main drivers for the rapid increase in dengue incidence. We studied the relative contributions of putative drivers for the rise of dengue in Singapore: population growth, climate parameters and international air passenger arrivals from dengue endemic countries, for the time period of 1974 until 2011. We used multivariable Poisson regression models with the following predictors: Annual Population Size; Aedes Premises Index; Mean Annual Temperature; Minimum and Maximum Temperature Recorded in each year; Annual Precipitation and Annual Number of Air Passengers arriving from dengue-endemic South-East Asia to Singapore. The relative risk (RR) of the increase in dengue incidence due to population growth over the study period was 42.7, while the climate variables (mean and minimum temperature) together explained an RR of 7.1 (RR defined as risk at the end of the time period relative to the beginning and goodness of fit associated with the model leading to these estimates assessed by pseudo-R2 equal to 0.83). Estimating the extent of the contribution of these individual factors on the increasing dengue incidence, we found that population growth contributed to 86% while the residual 14% was explained by increase in temperature. We found no correlation with incoming air passenger arrivals into Singapore from dengue endemic countries. Our findings have significant implications for predicting future trends of the dengue epidemics given the rapid urbanization with population growth in many dengue endemic countries. It is time for policy-makers and the scientific community alike to pay more attention to the negative impact of urbanization and urban climate on diseases such as dengue.	[Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Struchiner, Claudio Jose] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Rockloev, Joacim; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden; [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Massad, Eduardo] LIM01 HCFMUSP, Sao Paulo, Brazil; [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Umea University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine	Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden.	anneliesws@gmail.com	Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015; Struchiner, Claudio J/M-9360-2013; Struchiner, Claudio Jose/HGB-9492-2022	Massad, Eduardo/0000-0002-7200-2916; Struchiner, Claudio J/0000-0003-2114-847X; Rocklov, Joacim/0000-0003-4030-0449	European Commission [282589]; Brazilian Research Council (CNPq); State of Rio de Janeiro Research Funding Agency (FAPERJ)	European Commission(European CommissionEuropean Commission Joint Research Centre); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro Research Funding Agency (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The research was funded by the European Commission under the 7th Framework, Grant Agreement Number: 282589. CJS was partially funded by The Brazilian Research Council (CNPq) and the State of Rio de Janeiro Research Funding Agency (FAPERJ).	Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; Fahrmeir L., 2013, REGRESSION, DOI DOI 10.1007/978-3-642-34333-9; Fokianos K, 2009, J AM STAT ASSOC, V104, P1430, DOI 10.1198/jasa.2009.tm08270; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Harrell FE, 2001, REGRESSION MODELING; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263; Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320; Jones P., 2008, CRU TIME SERIES TS H; Kedem KF, 2002, REGRESSION MODELS TI; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Liu-Helmersson J, 2014, PLOS ONE PRINT; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Messer William B., 2002, American Journal of Tropical Medicine and Hygiene, V66, P765; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Oki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048258; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; RCore Team, 2020, R LANG ENV STAT COMP; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Reiter P, 1996, B SOC PATHOL EXOT, V89, P120; Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701; Wilder-Smith A, 2012, GLOBAL HLTH ACTION, V5; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	42	81	83	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136286	10.1371/journal.pone.0136286	http://dx.doi.org/10.1371/journal.pone.0136286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322517	Green Published, Green Accepted, gold			2022-12-27	WOS:000360435500017
J	Asakura, A; Mihara, T; Goto, T				Asakura, Ayako; Mihara, Takahiro; Goto, Takahisa			The Effect of Preoperative Oral Carbohydrate or Oral Rehydration Solution on Postoperative Quality of Recovery: A Randomized, Controlled Clinical Trial	PLOS ONE			English	Article							ELECTIVE SURGERY; GENERAL-ANESTHESIA; METAANALYSIS; VOLUME	Background Numerous studies have demonstrated the beneficial effects of preoperative administration of oral carbohydrate (CHO) or oral rehydration solution (ORS). However, the effects of preoperative CHO or ORS on postoperative quality of recovery after anesthesia remain unclear. Consequently, the purpose of the current study was to evaluate the effect of preoperative CHO or ORS on patient recovery, using the Quality of Recovery 40 questionnaire (QoR-40). Methods This prospective, randomized, controlled clinical trial included American Society of Anesthesiologists (ASA) physical status 1 and 2 adult patients, who were scheduled to undergo a surgical procedure of body surface. Subjects were randomized to one of the three groups: 1) preoperative CHO group, 2) preoperative ORS group, and 3) control group. The primary outcome was the global QoR-40 administered 24 h after surgery. Intraoperative use of vasopressor, intraoperative body temperature changes, and postoperative nausea and vomiting (PONV) were also evaluated. Results We studied 134 subjects. The median [interquartile range (IQR)] global QoR-40 scores 24 h after the surgery were 187 [177-197], 186 [171-200], and 184 [171-198] for the CHO, ORS, and control groups, respectively (p = 0.916). No significant differences existed between the groups regarding intraoperative vasopressor use during the surgery (p = 0.475). Conclusions Results of the current study indicated that the preoperative administration of either CHO or ORS did not improve the quality of recovery in patients undergoing minimally invasive body surface surgery.	[Asakura, Ayako; Mihara, Takahiro; Goto, Takahisa] Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Mihara, Takahiro] Kanagawa Childrens Med Ctr, Dept Anesthesiol, Yokohama, Kanagawa, Japan	Yokohama City University	Asakura, A (corresponding author), Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	aauaaao@gmail.com	Mihara, Takahiro/AAH-8487-2020	Mihara, Takahiro/0000-0003-0613-511X				Awad S, 2013, CLIN NUTR, V32, P34, DOI 10.1016/j.clnu.2012.10.011; Bilku DK, 2014, ANN ROY COLL SURG, V96, P15, DOI 10.1308/003588414X13824511650614; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Buchanan FF, 2011, BRIT J ANAESTH, V106, P832, DOI 10.1093/bja/aer094; De Oliveira GS, 2011, BRIT J ANAESTH, V107, P362, DOI 10.1093/bja/aer156; Gornall BF, 2013, BRIT J ANAESTH, V25, P509; Hausel J, 2001, ANESTH ANALG, V93, P1344, DOI 10.1097/00000539-200111000-00063; Henriksen MG, 2003, ACTA ANAESTH SCAND, V47, P191, DOI 10.1034/j.1399-6576.2003.00047.x; Iwayama S, 2014, J ANESTH, V28, P132, DOI 10.1007/s00540-013-1670-0; Jacob M, 2008, ACTA ANAESTH SCAND, V52, P522, DOI 10.1111/j.1399-6576.2008.01587.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Khan S, 2010, COLORECTAL DIS, V12, P1175, DOI 10.1111/j.1463-1318.2009.01997.x; Li L, 2012, SURG TODAY, V42, P613, DOI 10.1007/s00595-012-0188-7; Melis GC, 2006, JPEN-PARENTER ENTER, V30, P21, DOI 10.1177/014860710603000121; Muller L, 2014, BRIT J ANAESTH, V112, P835, DOI 10.1093/bja/aet478; Myles PS, 2000, BRIT J ANAESTH, V84, P11, DOI 10.1093/oxfordjournals.bja.a013366; Noblett SE, 2006, COLORECTAL DIS, V8, P563, DOI 10.1111/j.1463-1318.2006.00965.x; Ozer AB, 2013, MED SCI MONITOR, V19, P625, DOI 10.12659/MSM.883991; Tanaka Y, 2011, J ANESTH, V25, P509, DOI 10.1007/s00540-011-1151-2; Taniguchi H, 2009, J ANESTH, V23, P222, DOI 10.1007/s00540-009-0743-6; Yatabe T, 2011, J ANESTH, V25, P558, DOI 10.1007/s00540-011-1170-z	21	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133309	10.1371/journal.pone.0133309	http://dx.doi.org/10.1371/journal.pone.0133309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317629	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100006
J	Cortes, LA; Castro, L; Pesce, B; Maya, JD; Ferreira, J; Castro-Castillo, V; Parra, E; Jara, JA; Lopez-Munoz, R				Cortes, Leonel A.; Castro, Lorena; Pesce, Barbara; Maya, Juan D.; Ferreira, Jorge; Castro-Castillo, Vicente; Parra, Eduardo; Jara, Jose A.; Lopez-Munoz, Rodrigo			Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; IN-VITRO; GALLIC ACID; MITOCHONDRIAL BIOENERGETICS; OXIDATIVE STRESS; CHAGAS-DISEASE; CELL-DEATH; VIVO; ANTIOXIDANTS; BENZNIDAZOLE	Chagas disease is one of the most neglected tropical diseases in the world, affecting nearly 15 million people, primarily in Latin America. Only two drugs are used for the treatment of this disease, nifurtimox and benznidazole. These drugs have limited efficacy and frequently induce adverse effects, limiting their usefulness. Consequently, new drugs must be found. In this study, we demonstrated the in vitro trypanocidal effects of a series of four gallic acid derivatives characterized by a gallate group linked to a triphenylphosphonium (TPP+) moiety (a delocalized cation) via a hydrocarbon chain of 8, 10, 11, or 12 atoms (TPP+-C-8, TPP+C10, TPP+-C-11, and TPP+-C-12, respectively). We analyzed parasite viability in isolated parasites (by MTT reduction and flow cytometry) and infected mammalian cells using T. cruzi Y strain trypomastigotes. Among the four derivatives, TPP+-C-10 and TPP+-C-12 were the most potent in both models, with EC50 values (in isolated parasites) of 1.0 +/- 0.6 and 1.0 +/- 0.7 mu M, respectively, and were significantly more potent than nifurtimox (EC50 = 4.1 +/- 0.6 mu M). At 1 mu M, TPP+-C-10 and TPP+-C-12 induced markers of cell death, such as phosphatidylserine exposure and propidium iodide permeabilization. In addition, at 1 mu M, TPP+-C-10 and TPP+-C-12 significantly decreased the number of intracellular amastigotes (TPP+-C-10: 24.3%, TPP+-C-12: 19.0% of control measurements, as measured by DAPI staining) and the parasite's DNA load (C-10: 10%, C-12: 13% of control measurements, as measured by qPCR). Based on the previous mode of action described for these compounds in cancer cells, we explored their mitochondrial effects in isolated trypomastigotes. TPP+-C-10 and TPP+-C-12 were the most potent compounds, significantly altering mitochondrial membrane potential at 1 mu M (measured by JC-1 fluorescence) and inducing mitochondrial transition pore opening at 5 mu M. Taken together, these results indicate that the TPP+-C-10 and TPP+-C-12 derivatives of gallic acid are promising trypanocidal agents with mitochondrial activity.	[Cortes, Leonel A.; Castro, Lorena; Pesce, Barbara; Maya, Juan D.; Ferreira, Jorge] Univ Chile, Fac Med, ICBM, Programa Farmacol Mol & Clin, Santiago 7, Chile; [Castro-Castillo, Vicente] Univ Metropolitana Ciencias Educ, Fac Ciencias Basicas, Dept Quim, Santiago, Chile; [Parra, Eduardo] Univ Tarapac, Lab Expt Biomed, Iquique, Chile; [Jara, Jose A.] Univ Chile, Fac Odontol, ICOD, Unidad Farmacol & Farmacogenet, Santiago, Chile; [Lopez-Munoz, Rodrigo] Univ Austral Chile, Inst Farmacol & Morfofisiol, Fac Ciencias Vet, Valdivia, Chile	Universidad de Chile; Universidad Metropolitana de Ciencias de la Educacion (UMCE); Universidad de Chile; Universidad Austral de Chile	Jara, JA (corresponding author), Univ Chile, Fac Odontol, ICOD, Unidad Farmacol & Farmacogenet, Santiago, Chile.	jsandovalj@u.uchile.cl; lopez@uach.cl	maya, Juan Diego/GNW-3307-2022; Lopez-Muñoz, Rodrigo/I-1097-2013; Castro, Vicente/I-8444-2017; Jara, Jose/GQB-5331-2022; Maya, Juan D/H-9561-2013; Jara, Jose/K-1936-2014	Lopez-Muñoz, Rodrigo/0000-0003-1825-8563; Castro, Vicente/0000-0002-7165-8569; Maya, Juan D/0000-0003-3934-6319; 	Consejo Nacional de Ciencia y Tecnologia (CONICYT-Chile) [FONDECYT 11110182, FONDECYT 1130772, FONDECYT 1130189]; Academy Insertion Grant [791220004]; Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile [U-INICIA 11/07, U-INICIA 2014]	Consejo Nacional de Ciencia y Tecnologia (CONICYT-Chile)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Academy Insertion Grant; Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile	This work was supported by the following grants from the Consejo Nacional de Ciencia y Tecnologia (CONICYT-Chile: http://www.conicyt.cl): FONDECYT 11110182 (RLM), FONDECYT 1130772 (JF), FONDECYT 1130189 (JDM), and the Academy Insertion Grant 791220004 (JAJ). The following grants were obtained from the Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile (http://www.uchile.cl/investigacion): U-INICIA 11/07 (RLM) and U-INICIA 2014 (JAJ). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1986, COMP BIOCHEM PHYS B, V85, P381, DOI 10.1016/0305-0491(86)90016-7; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Boiani M, 2010, BIOCHEM PHARMACOL, V79, P1736, DOI 10.1016/j.bcp.2010.02.009; Carranza JC, 2009, J BIOENERG BIOMEMBR, V41, P299, DOI 10.1007/s10863-009-9228-4; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; DENICOLASEOANE A, 1992, MOL BIOCHEM PARASIT, V54, P43, DOI 10.1016/0166-6851(92)90093-Y; Desoti VC, 2012, MAR DRUGS, V10, P1631, DOI 10.3390/md10081631; Diaz MV, 2014, ACTA TROP, V134, P1, DOI 10.1016/j.actatropica.2014.02.012; Fang J, 2003, ARCH BIOCHEM BIOPHYS, V414, P294, DOI 10.1016/S0003-9861(03)00196-6; Faundez M, 2005, ANTIMICROB AGENTS CH, V49, P126, DOI 10.1128/AAC.49.1.126-130.2005; Finichiu PG, 2013, J BIOENERG BIOMEMBR, V45, P165, DOI 10.1007/s10863-012-9493-5; GADELHA FR, 1989, MOL BIOCHEM PARASIT, V34, P117, DOI 10.1016/0166-6851(89)90003-0; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Gourley PL, 2005, TECHNOL CANCER RES T, V4, P585, DOI 10.1177/153303460500400602; Guida MC, 2007, EXP PARASITOL, V117, P188, DOI 10.1016/j.exppara.2007.04.015; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498; Huang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108286; Ibrahim HMS, 2011, J ANTIMICROB CHEMOTH, V66, P111, DOI 10.1093/jac/dkq401; Inacio JDF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003093; Jara JA, 2014, J MED CHEM, V57, P2440, DOI 10.1021/jm500174v; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jimenez V, 2014, PHYTOMEDICINE, V21, P1411, DOI 10.1016/j.phymed.2014.06.005; Jones SM, 2004, BIOORGAN MED CHEM, V12, P683, DOI 10.1016/j.bmc.2003.11.023; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Koide T, 1998, PLANTA MED, V64, P27, DOI 10.1055/s-2006-957360; LETELIER ME, 1990, EXP PARASITOL, V71, P357, DOI 10.1016/0014-4894(90)90061-G; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Barreiro SL, 2013, J AGR FOOD CHEM, V61, P6533, DOI 10.1021/jf400981x; Menna-Barreto RFS, 2007, PARASITOL RES, V101, P895, DOI 10.1007/s00436-007-0556-1; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Molina-Berrios A, 2013, ACTA TROP, V127, P6, DOI 10.1016/j.actatropica.2013.03.006; Fidalgo LM, 2011, PHARM RES-DORDR, V28, P2758, DOI 10.1007/s11095-011-0586-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nose M, 1998, BIOL PHARM BULL, V21, P583, DOI 10.1248/bpb.21.583; Olszewska A, 2013, IUBMB LIFE, V65, P273, DOI 10.1002/iub.1147; Paes LS, 2011, CURR PHARM DESIGN, V17, P2074, DOI 10.2174/138161211796904786; Luque-Ortega JR, 2010, J MED CHEM, V53, P1788, DOI 10.1021/jm901677h; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Menna-Barreto RFS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/614014; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SHAPIRO TA, 1989, J BIOL CHEM, V264, P4173; Silva TM, 2011, J BIOENERG BIOMEMBR, V43, P409, DOI 10.1007/s10863-011-9369-0; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; Taladriz A, 2012, J MED CHEM, V55, P2606, DOI 10.1021/jm2014259; Veiga-Santos P, 2010, PARASITOLOGY, V137, P1661, DOI 10.1017/S003118201000034X; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; WHO strategic and technical advisory group for tuberculosis (STAG-TB), 2010, WHO STRAT TECHN ADV, P9; WHO TDR, 2012, RES PRIOR CHAG DIS H, P975	54	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136852	10.1371/journal.pone.0136852	http://dx.doi.org/10.1371/journal.pone.0136852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317199	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100154
J	Dunn, TW; Sossin, WS				Dunn, Tyler William; Sossin, Wayne S.			Decline in the Recovery from Synaptic Depression in Heavier Aplysia Results from Decreased Serotonin-Induced Novel PKC Activation	PLOS ONE			English	Article							C APL-II; GILL-WITHDRAWAL REFLEX; PROTEIN-KINASE CS; ISOFORM SPECIFICITY; TRANSMITTER RELEASE; BEHAVIORAL-CHANGES; SENSORY NEURONS; FACILITATION; DISHABITUATION; TRANSLOCATION	The defensive withdrawal reflexes of Aplysia are important behaviors for protecting the animal from predation. Habituation and dishabituation allow for experience-dependent tuning of these reflexes and the mechanisms underlying these forms of behavioral plasticity involve changes in transmitter release from the sensory to motor neuron synapses through homosynaptic depression and the serotonin-mediated recovery from depression, respectively. Interestingly, dishabituation is reduced in older animals with no corresponding change in habituation. Here we show that the cultured sensory neurons of heavier animals (greater than 120g) that form synaptic connections with motor neurons have both reduced recovery from depression and reduced novel PKC Apl II activation with 5HT. The decrease in the recovery from depression correlated better with the size of the animal than the age of the animal. Much of this change in PKC activation and synaptic facilitation following depression can be rescued by direct activation of PKC Apl II with phorbol dibutyrate, suggesting a change in the signal transduction pathway upstream of PKC Apl II activation in the sensory neurons of larger animals.	[Dunn, Tyler William; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	wayne.sossin@mcgill.ca			Natural Science and Engineering Research Council of Canada [171404]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by Natural Science and Engineering Research Council of Canada grant 171404 to WSS, http://www.nserc-crsng.gc.ca/index_eng.asp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084793; Antonov I, 1999, J NEUROSCI, V19, P10438; Antonov I, 2010, J NEUROSCI, V30, P5781, DOI 10.1523/JNEUROSCI.4947-09.2010; Armitage BA, 1998, J NEUROSCI, V18, P8770; BAILEY CH, 1983, BEHAV NEURAL BIOL, V38, P70, DOI 10.1016/S0163-1047(83)90399-0; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Chitwood RA, 2001, J PHYSIOL-LONDON, V534, P501, DOI 10.1111/j.1469-7793.2001.00501.x; Dumitriu B, 2006, J NEUROPHYSIOL, V95, P2713, DOI 10.1152/jn.00642.2005; Dunn TW, 2013, J NEUROPHYSIOL, V110, P2071, DOI 10.1152/jn.00217.2013; Dunn TW, 2012, J NEUROPHYSIOL, V107, P292, DOI 10.1152/jn.00767.2011; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Farah CA, 2011, JOVE-J VIS EXP, DOI 10.3791/2516; Farah CA, 2009, J NEUROSCI, V29, P10281, DOI 10.1523/JNEUROSCI.1533-09.2009; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; Johnson PM, 1999, MAR FRESHW BEHAV PHY, V32, P147, DOI 10.1080/10236249909379045; Kadakkuzha BM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-880; Kempsell AT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00084; KRIEGSTEIN AR, 1977, J EXP ZOOL, V199, P275, DOI 10.1002/jez.1401990212; Lee YS, 2009, P NATL ACAD SCI USA, V106, P14634, DOI 10.1073/pnas.0907502106; Manseau F, 2001, J NEUROSCI, V21, P1247; Nagakura I, 2010, J NEUROCHEM, V115, P994, DOI 10.1111/j.1471-4159.2010.06986.x; PENNINGS SC, 1990, MAR ECOL PROG SER, V62, P95, DOI 10.3354/meps062095; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; PERETZ B, 1982, J NEUROBIOL, V13, P141, DOI 10.1002/neu.480130206; RANKIN CH, 1988, J NEUROSCI, V8, P197; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; RAYPORT SG, 1986, NEUROSCIENCE, V17, P283, DOI 10.1016/0306-4522(86)90247-2; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Stommes D, 2005, CONTEMP TOP LAB ANIM, V44, P31; WINKLER LINDSAY R., 1962, PACIFIC SCI, V16, P286; Zhao YL, 2006, J NEUROSCI, V26, P8847, DOI 10.1523/JNEUROSCI.1919-06.2006; Zhao YL, 2002, J NEUROSCI, V22, P10671	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136907	10.1371/journal.pone.0136907	http://dx.doi.org/10.1371/journal.pone.0136907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317974	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100169
J	Fatykhova, D; Rabes, A; Machnik, C; Guruprasad, K; Pache, F; Berg, J; Toennies, M; Bauer, TT; Schneider, P; Schimek, M; Eggeling, S; Mitchell, TJ; Mitchell, AM; Hilker, R; Hain, T; Suttorp, N; Hippenstiel, S; Hocke, AC; Opitz, B				Fatykhova, Diana; Rabes, Anne; Machnik, Christoph; Guruprasad, Kunchur; Pache, Florence; Berg, Johanna; Toennies, Mario; Bauer, Torsten T.; Schneider, Paul; Schimek, Maria; Eggeling, Stephan; Mitchell, Timothy J.; Mitchell, Andrea M.; Hilker, Rolf; Hain, Torsten; Suttorp, Norbert; Hippenstiel, Stefan; Hocke, Andreas C.; Opitz, Bastian			Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue	PLOS ONE			English	Article							PNEUMONIAE VIRULENCE FACTORS; STREPTOCOCCUS-PNEUMONIAE; NLRP3 INFLAMMASOME; PORE FORMATION; HOST-DEFENSE; PNEUMOLYSIN; MICE; COLONIZATION; PATHOGENESIS; CONTRIBUTES	Streptococcus pneumoniae is a major cause of pneumonia, sepsis and meningitis. The pore-forming toxin pneumolysin is a key virulence factor of S. pneumoniae, which can be sensed by the NLRP3 inflammasome. Among the over 90 serotypes, serotype 1 pneumococci (particularly MLST306) have emerged across the globe as a major cause of invasive disease. The cause for its particularity is, however, incompletely understood. We therefore examined pneumococcal infection in human cells and a human lung organ culture system mimicking infection of the lower respiratory tract. We demonstrate that different pneumococcal serotypes differentially activate inflammasome-dependent IL-1 beta production in human lung tissue and cells. Whereas serotype 2, 3, 6B, 9N pneumococci expressing fully haemolytic pneumolysins activate NLRP3 inflammasome-dependent responses, serotype 1 and 8 strains expressing non-haemolytic toxins are poor activators of IL-1 beta production. Accordingly, purified haemolytic pneumolysin but not serotype 1-associated non-haemolytic toxin activates strong IL-1 beta production in human lungs. Our data suggest that the evasion of inflammasome-dependent innate immune responses by serotype 1 pneumococci might contribute to their ability to cause invasive diseases in humans.	[Fatykhova, Diana; Rabes, Anne; Machnik, Christoph; Pache, Florence; Berg, Johanna; Suttorp, Norbert; Hippenstiel, Stefan; Hocke, Andreas C.; Opitz, Bastian] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Guruprasad, Kunchur] Ctr Cellular & Mol Biol, Bioinformat, Hyderabad 500007, Telangana, India; [Toennies, Mario; Bauer, Torsten T.] HELIOS Klinikum Emil von Behring, Lungenklin Heckeshorn, D-14165 Berlin, Germany; [Schneider, Paul] DRK Clin, Dept Gen & Thorac Surg, D-13359 Berlin, Germany; [Schimek, Maria; Eggeling, Stephan] Vivantes Klinikum Neukolln, Dept Thorac Surg, D-12351 Berlin, Germany; [Mitchell, Timothy J.; Mitchell, Andrea M.] Univ Birmingham, Sch Infect & Immun, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Hilker, Rolf; Hain, Torsten] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; [Hilker, Rolf] Univ Giessen, Dept Bioinformat & Syst Biol, D-35392 Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Helios Kliniken; VIivantes Klinikum Neukolln; University of Birmingham; Justus Liebig University Giessen; Justus Liebig University Giessen	Hocke, AC (corresponding author), Charite, Dept Internal Med Infect Dis & Pulm Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	andreas.hocke@charite.de; bastian.opitz@charite.de		Rabes, Anne/0000-0003-0495-5931; Fatykhova, Diana/0000-0003-4474-2025; Hippenstiel, Stefan/0000-0002-5146-1064; Mitchell, Andrea/0000-0002-2530-4460; Suttorp, Norbert/0000-0002-3958-1151; Opitz, Bastian/0000-0003-1276-836X; Mitchell, Timothy/0000-0002-8309-5556	Deutsche Forschungsgemeinschaft [GRK1673/B5, OP 86/7-2, SFB-TR84]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de)(GRK1673/B5 to A.R. and B.O., OP 86/7-2 to B.O., SFB-TR84 project B01 to T.H. and to N.S., project Z1a to A.C.H., project B06 to A.C.H and S.H., and project A01/A05 to B.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bewley MA, 2014, MBIO, V5, DOI 10.1128/mBio.01710-14; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Eitel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030379; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Harvey RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103625; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Husemann P, 2010, BIOINFORMATICS, V26, P570, DOI 10.1093/bioinformatics/btp690; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Karlstrom A, 2011, J INFECT DIS, V204, P1358, DOI 10.1093/infdis/jir522; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Knepper J, 2013, MBIO, V4, DOI 10.1128/mBio.00601-13; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Lamb KE, 2014, VACCINE, V32, P4356, DOI 10.1016/j.vaccine.2013.05.079; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Le Hello S, 2010, J CLIN MICROBIOL, V48, P2968, DOI 10.1128/JCM.01615-09; Lemon JK, 2015, MBIO, V6, DOI 10.1128/mBio.02110-14; Lock RA, 1996, MICROB PATHOGENESIS, V21, P71, DOI 10.1006/mpat.1996.0044; Lujan M, 2010, EUR RESPIR J, V36, P1073, DOI 10.1183/09031936.00176309; Marimon JM, 2009, CLIN MICROBIOL INFEC, V15, P875, DOI 10.1111/j.1469-0691.2009.02883.x; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Normark BH, 2001, J INFECT DIS, V184, P861, DOI 10.1086/323339; Noske N, 2009, J IMMUNOL, V183, P1952, DOI 10.4049/jimmunol.0804383; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rabes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117022; Rijneveld AW, 2001, J IMMUNOL, V167, P5240, DOI 10.4049/jimmunol.167.9.5240; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shak JR, 2013, MBIO, V4, DOI 10.1128/mBio.00655-13; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sonnen AFP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140044; Staples M, 2015, EPIDEMIOL INFECT, V143, P325, DOI 10.1017/S0950268814000648; Szymanski KV, 2012, EUR RESPIR J, V40, P1458, DOI 10.1183/09031936.00186911; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weinheimer VK, 2012, J INFECT DIS, V206, P1685, DOI 10.1093/infdis/jis455; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	53	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137108	10.1371/journal.pone.0137108	http://dx.doi.org/10.1371/journal.pone.0137108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317436	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100204
J	He, JT; Dong, L; Xu, W; Bai, KW; Lu, CH; Wu, YN; Huang, Q; Zhang, LL; Wang, T				He, Jintian; Dong, Li; Xu, Wen; Bai, Kaiwen; Lu, Changhui; Wu, Yanan; Huang, Qiang; Zhang, Lili; Wang, Tian			Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth Retardation	PLOS ONE			English	Article							LIVER-X-RECEPTOR; POLYUNSATURATED FATTY-ACIDS; HEPATIC STEATOSIS; SKELETAL-MUSCLE; GENE-EXPRESSION; RESTRICTION; LIPOPROTEIN; IMPROVES; BUTYRATE; MICE	Intrauterine growth retardation (IUGR) is associated with insulin resistance and lipid disorder. Tributyrin (TB), a pro-drug of butyrate, can attenuate dysfunctions in body metabolism. In this study, we investigated the effects of TB supplementation on insulin resistance and lipid metabolism in neonatal piglets with IUGR. Eight neonatal piglets with normal birth weight (NBW) and 16 neonatal piglets with IUGR were selected, weaned on the 7th day, and fed basic milk diets (NBW and IUGR groups) or basic milk diets supplemented with 0.1% tributyrin (IT group, IUGR piglets) until day 21 (n = 8). Relative parameters for lipid metabolism and mRNA expression were measured. Piglets with IUGR showed higher (P < 0.05) concentrations of insulin in the serum, higher (P < 0.05) HOMA-IR and total cholesterol, triglycerides (TG), non-esterified fatty acid (NEFA) in the liver, and lower (P < 0.05) enzyme activities (hepatic lipase [HL], lipoprotein lipase [LPL], total lipase [TL]) and concentration of glycogen in the liver than the NBW group. TB supplementation decreased (P < 0.05) the concentrations of insulin, HOMA-IR, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol in the serum, and the concentrations of TG and NEFA in the liver, and increased (P < 0.05) enzyme activities (HL, LPL, and TL) and concentration of glycogen in the liver of the IT group. The mRNA expression for insulin signal transduction pathway and hepatic lipogenic pathway (including transcription factors and nuclear factors) was significantly (P < 0.05) affected in the liver by IUGR, which was efficiently (P < 0.05) attenuated by diets supplemented with TB. TB supplementation has therapeutic potential for attenuating insulin resistance and abnormal lipid metabolism in IUGR piglets by increasing enzyme activities and upregulating mRNA expression, leading to an early improvement in the metabolic efficiency of IUGR piglets.	[He, Jintian; Dong, Li; Xu, Wen; Bai, Kaiwen; Lu, Changhui; Wu, Yanan; Huang, Qiang; Zhang, Lili; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com			National Natural Science Foundation of China [31201808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant number no. 31201808, http://www.nsfc.gov.cn/, full name "National Natural Science Foundation of China", received by Tian Wang. The funder supported and paid for the study design, animal experiment, lab experiment and publishing.	Ann S, 2013, OBESITY; Brenseke B, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/368461; Brown Laura D, 2011, Front Biosci (Schol Ed), V3, P428, DOI 10.2741/s162; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; BUCOLO G, 1973, CLIN CHEM, V19, P476; Cresci GA, 2014, ALCOHOL CLIN EXP RES, V38, P1489, DOI 10.1111/acer.12428; Dentin R, 2006, J NUTR, V136, P1145, DOI 10.1093/jn/136.5.1145; Djiane J, 2008, J PHYSIOL PHARMACOL, V59, P55; Dong L, 2015, CLIN NUTR; Edelman MJ, 2003, CANCER CHEMOTH PHARM, V51, P439, DOI 10.1007/s00280-003-0580-5; Evagelidou EN, 2007, EUR J ENDOCRINOL, V156, P271, DOI 10.1530/eje.1.02337; Friedman A., 2005, P 15 EUR S POULTR NU; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; GIRARD JR, 1973, J CLIN INVEST, V52, P3190, DOI 10.1172/JCI107519; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Hay W.W., 2001, NEOREVIEWS, V2, pe129, DOI [10.1542/neo.2-6-e129, DOI 10.1542/NEO.2-6-E129]; He QH, 2011, MOL BIOSYST, V7, P2147, DOI 10.1039/c1mb05024a; Hou YQ, 2014, BRIT J NUTR, V111, P1748, DOI 10.1017/S0007114514000038; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Jaquet D, 1998, J CLIN ENDOCR METAB, V83, P1243, DOI 10.1210/jc.83.4.1243; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kim HJ, 2002, ANN NY ACAD SCI, V967, P34; Kuroiwa-Trzmielina J, 2009, INT J CANCER, V124, P2520, DOI 10.1002/ijc.24212; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu C, 2013, J NUTR BIOCHEM, V24, P954, DOI 10.1016/j.jnutbio.2012.06.016; Liu J, 2014, J ANIM PLANT SCI, V24, P63; Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3; Lu H, 2012, J ANIM SCI, V90, P430, DOI 10.2527/jas.53817; Magee TR, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.022; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miyoshi M, 2011, CLIN NUTR, V30, P252, DOI 10.1016/j.clnu.2010.09.012; Mortensen OH, 2010, PEDIATR RES, V67, P47, DOI 10.1203/PDR.0b013e3181c4735c; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Vinolo MAR, 2012, AM J PHYSIOL-ENDOC M, V303, pE272, DOI 10.1152/ajpendo.00053.2012; Ramsay JE, 2004, J HYPERTENS, V22, P2177, DOI 10.1097/00004872-200411000-00021; Saleem T, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-41; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Su J, 2006, J PHARMACOL EXP THER, V316, P62, DOI 10.1124/jpet.105.090464; Suliburska J, 2014, EUR J NUTR, V53, P387, DOI 10.1007/s00394-013-0533-7; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang T, 2005, BIOL NEONATE, V88, P66, DOI 10.1159/000084645; Wang YX, 2012, BRIT J NUTR, V108, P1371, DOI 10.1017/S0007114511006763; World Health Organization, 1995, MAT ANTHR PREGN OUTC; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang H, 2014, BRIT J NUTR, V112, P876, DOI 10.1017/S000711451400155X	55	46	49	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136848	10.1371/journal.pone.0136848	http://dx.doi.org/10.1371/journal.pone.0136848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317832	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100152
J	Jonas, JB; Wang, YX; Zhang, Q; Liu, Y; Xu, L; Wei, WB				Jonas, Jost B.; Wang, Ya Xing; Zhang, Qi; Liu, Yi; Xu, Liang; Wei, Wen Bin			Macular Bruch's Membrane Length and Axial Length. The Beijing Eye Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; ZONE PARAPAPILLARY ATROPHY; OPEN-ANGLE GLAUCOMA; BETA-ZONE; HIGH MYOPIA; FUNDUS PHOTOGRAPHY; RETINAL FEATURES; FOVEA DISTANCE; DISC MARGIN	Purpose To assess whether macular Bruch's membrane gets lengthened in axial myopia. Methods Using the enhanced depth imaging mode of spectral-domain optical coherence tomography and examining a subgroup of participants of the population-based cross-sectional Beijing Eye Study, we measured the length of Bruch's membrane ("MacBMLength") from the fovea to the temporal edge of parapapillary gamma zone, and the distance between the fovea and the temporal optic disc border. Parapapillary gamma zone was defined as the parapapillary region without Bruch's membrane. We additionally measured ocular biometric parameters and assessed non-ophthalmologic variables. Results Measurements of MacBMLength were performed on 322 individuals. MacBMLength (mean: 3.99 +/- 0.33 mm; range: 3.17-4.93 mm) was not significantly associated with any systemic parameter or ocular biometric parameter. Gamma zone width (mean: 0.18 +/- 0.30mm; range: 0.00-2.61mm) was associated (multivariate analysis; correlation coefficient r: 0.80) with longer axial length (P<0.001; standardized correlation coefficient beta: 0.60; non-standardized correlation coefficient B:0.11; 95% CI:0.09,0.14) and with longer fovea-optic disc border distance (P<0.001; beta: 0.28; B: 0.19; 95% CI:0.14,0.25), but not with MacBMLength (P = 0.42). Fovea-temporal disc border distance (mean: 4.16 +/- 0.44mm; range: 3.17-5.86mm) was associated (overall correlation coefficient: 0.68) with longer axial length (P<0.001; beta: 0.36; B: 0.10; 95% CI: 0.06, 0.13), after adjusting for flatter anterior chamber depth (P = 0.003; beta:-0.14; B:-0.14; 95% CI: -0.23,-0.05) and wider parapapillary gamma zone (P<0.001; beta: 0.42; B: 0.62; 95% CI: 0.44,0.81). Conclusions In contrast to parapapillary gamma zone width and fovea-disc border distance, MacBM-Length was not significantly associated with axial length. Axial elongation associated increase in fovea-disc distance may predominantly occur through development or elongation of parapapillary gamma zone, while macular Bruch's membrane may mostly be independent of axial elongation.	[Jonas, Jost B.; Wang, Ya Xing; Zhang, Qi; Liu, Yi; Xu, Liang] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	tr_weiwenbin@163.com	wang, YA XING/K-9671-2016; wei, wei/HHR-8613-2022	wang, YA XING/0000-0003-2749-7793; 	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	Supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2013, AM J OPHTHALMOL, V155, P927, DOI 10.1016/j.ajo.2012.12.014; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Chui TYP, 2011, VISION RES, V51, P2132, DOI 10.1016/j.visres.2011.08.008; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; De Silva DJ, 2006, INVEST OPHTH VIS SCI, V47, P4683, DOI 10.1167/iovs.06-0152; Guist G, 1934, COINCIDENT OPHTHALMO; Hayashi K, 2012, INVEST OPHTH VIS SCI, V53, P1499, DOI 10.1167/iovs.11-8572; Heine, 1899, ARCH AUGENHEILKD, V38, P277; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P213, DOI 10.1007/BF02181183; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pe273, DOI 10.1111/aos.12324; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Kim YW, 2014, OPHTHALMOLOGY, V121, P1341, DOI 10.1016/j.ophtha.2014.01.008; Kitaguchi Y, 2007, JPN J OPHTHALMOL, V51, P456, DOI 10.1007/s10384-007-0477-7; Knaapi L, 2015, ACTA OPHTHALMOL, V93, P339, DOI 10.1111/aos.12554; Lee KYC, 2010, INVEST OPHTH VIS SCI, V51, P666, DOI 10.1167/iovs.09-3663; Lee M, 2014, GRAEF ARCH CLIN EXP, V252, P307, DOI 10.1007/s00417-013-2513-2; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; Na Jung Hwa, 2010, Korean J Ophthalmol, V24, P353, DOI 10.3341/kjo.2010.24.6.353; Nonaka A, 2011, INVEST OPHTH VIS SCI, V52, P6706, DOI 10.1167/iovs.11-7580; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; Panda-Jonas S, 2014, ACTA OPHTHALMOL, V92, P59, DOI 10.1111/j.1755-3768.2012.02570.x; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Park SC, 2010, INVEST OPHTH VIS SCI, V51, P6408, DOI 10.1167/iovs.09-5100; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Shao L, 2014, AM J OPHTHALMOL, V158, P702, DOI 10.1016/j.ajo.2014.05.023; Takahashi A, 2013, JPN J OPHTHALMOL, V57, P233, DOI 10.1007/s10384-012-0224-6; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; You QS, 2015, BEIJING E S IN PRESS	39	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136833	10.1371/journal.pone.0136833	http://dx.doi.org/10.1371/journal.pone.0136833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317992	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100145
J	Laborte, AG; Paguirigan, NC; Moya, PF; Nelson, A; Sparks, AH; Gregorio, GB				Laborte, Alice G.; Paguirigan, Neale C.; Moya, Piedad F.; Nelson, Andrew; Sparks, Adam H.; Gregorio, Glenn B.			Farmers' Preference for Rice Traits: Insights from Farm Surveys in Central Luzon, Philippines, 1966-2012	PLOS ONE			English	Article							GREEN-REVOLUTION; IMPROVEMENT; ADOPTION; DECADES	Many modern rice varieties (MVs) have been released but only a few have been widely adopted by farmers. To understand farmers' preferences, we characterized MVs released in the Philippines from 1966 to 2013 and identified important characteristics of the varieties that were widely adopted in Central Luzon using farm surveys conducted in 1966-2012. We found that farmers adopt MVs that are high yielding, mature faster, and have long and slender grains, high milling recovery, and intermediate amylose content. The amylose content of adopted varieties has been declining, suggesting value in developing softer rice. To have a high potential for adoption, new MVs should have characteristics within the ranges of values observed for the adopted MVs. In addition, new MVs should have higher head rice recovery, less chalky grains, and better resistance to pests and diseases. Most MVs released in 2005-2013 compared poorly in these three traits. To reduce the risk of severe outbreaks, broad spectrum resistance should be incorporated into new MVs. This analysis of five decades of farm surveys provides insights into the varietal characteristics preferred by farmers which could contribute to the establishment of a product profile for developing improved MVs that are more targeted and, hence, would have high potential for adoption by farmers in Central Luzon and similar areas. We recommend a similar analysis be done in other major rice growing regions to aid the development of MVs that are more responsive to farmers' needs and preferences.	[Laborte, Alice G.; Paguirigan, Neale C.; Moya, Piedad F.; Nelson, Andrew] IRRI, Social Sci Div, Los Banos, Laguna, Philippines; [Sparks, Adam H.] IRRI, Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Gregorio, Glenn B.] IRRI, Plant Breeding Genet & Biotechnol Div, Los Banos, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI)	Laborte, AG (corresponding author), IRRI, Social Sci Div, Los Banos, Laguna, Philippines.	a.g.laborte@irri.org	Nelson, Andy/G-3649-2012; Sparks, Adam H./D-3607-2011	Nelson, Andy/0000-0002-7249-3778; Sparks, Adam H./0000-0002-0061-8359	Consultative Group on International Agricultural Research (CGIAR) Global Rice Science Partnership (GRiSP) program; Japan Rice Breeding Project (JRBP)	Consultative Group on International Agricultural Research (CGIAR) Global Rice Science Partnership (GRiSP) program; Japan Rice Breeding Project (JRBP)	This work was supported by the Consultative Group on International Agricultural Research (CGIAR) Global Rice Science Partnership (GRiSP) program and the Japan Rice Breeding Project (JRBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina A.A., 1993, AGR EC, V9, P1993, DOI DOI 10.1016/0169-5150(93)90019-9; Barona-Edra ML, 2013, RICE TODAY, V12, P14; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Candole BL, 2000, CEREAL CHEM, V77, P535, DOI 10.1094/CCHEM.2000.77.5.535; Casiwan C. B., 2003, Economic and Political Weekly, V38, P2502; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; David C. C., 1994, MODERN RICE TECHNOLO; David CC, 2007, RES PAPER SERIES, V2006-03; Estudillo JP, 2006, DEV ECON, V44, P123, DOI 10.1111/j.1746-1049.2006.00010.x; Evenson RE, 2003, SCIENCE; Fajardo F. F., 2000, Philippine Journal of Crop Science, V25, P55; FEDER G, 1993, TECHNOL FORECAST SOC, V43, P215, DOI 10.1016/0040-1625(93)90053-A; Garrett KA, 2011, PLANT PATHOL, V60, P15, DOI 10.1111/j.1365-3059.2010.02409.x; Herdt R. W., 1983, ADOPTION SPREAD PROD; Hossain M, 2012, ADOPTION PRODUCTIVIT; IRRI (International Rice Research Institute), 2013, WORLD RIC STAT ONL Q; Juliano B.O., 1993, GRAIN QUALITY EVALUA; Juliano BO, 2010, GRAIN QUALITY PHILIP; Khush GS, 2005, IR VARIETIES THEIR I; Lanning SB, 2011, FIELD CROP RES, V124, P132, DOI 10.1016/j.fcr.2011.06.012; Launio CC, 2008, AGRON J, V100, P1380, DOI 10.2134/agronj2007.0297; Leung Hei, 2003, Plant Disease, V87, P1156, DOI 10.1094/PDIS.2003.87.10.1156; Mackill D.J., 1996, RAINFED LOWLAND RICE; Mataia AB, 2008, RICE TUNGRO VIRUS DI, P15; [NSIC] National Seed Industry Council, 2013, SEED CAT; Peng SB, 2003, PLANT PROD SCI, V6, P157, DOI 10.1626/pps.6.157; PhilRice (Philippine Rice Research Institute), 1994, RIC TECHN B, V1; PSA-BAS (Philippine Statistics Agency-Bureau of Agricultural Statistics Philippines), 2015, COUNTRYSTAT PHIL; Reyes L, 2014, RICE TODAY, V13, P14; SAVARY S, 1993, NETH J PLANT PATHOL, V99, P181, DOI 10.1007/BF03041408; Sombilla MA, 2014, 10 IFPRI RESAKSS AS; UNNEVEHR LJ, 1986, AM J AGR ECON, V68, P634, DOI 10.2307/1241547; Unnevehr LJ, 1992, CONSUMER DEMAND RICE, P159; Ut TT, 2006, DEV ECON, V44, P167, DOI 10.1111/j.1746-1049.2006.00012.x; Wang H., 2012, PATTERNS VARIETAL AD; Wedgwood H, 1992, CONSUMER DEMAND RICE, P159	36	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136562	10.1371/journal.pone.0136562	http://dx.doi.org/10.1371/journal.pone.0136562			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317505	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100101
J	Lewis, M; Chesterton, LS; Sim, J; Mallen, CD; Hay, EM; van der Windt, DA				Lewis, Martyn; Chesterton, Linda S.; Sim, Julius; Mallen, Christian D.; Hay, Elaine M.; van der Windt, Danielle A.			An Economic Evaluation of TENS in Addition to Usual Primary Care Management for the Treatment of Tennis Elbow: Results from the TATE Randomized Controlled Trial	PLOS ONE			English	Article							ELECTRICAL NERVE-STIMULATION; PREFERENCE-BASED MEASURE; COST-EFFECTIVENESS; CORTICOSTEROID INJECTIONS; LATERAL EPICONDYLITIS; PHYSIOTHERAPY; HEALTH; PREVALENCE; PAIN	Background The TATE trial was a multicentre pragmatic randomized controlled trial of supplementing primary care management (PCM)-consisting of a GP consultation followed by information and advice on exercises-with transcutaneous electrical nerve stimulation (TENS), to reduce pain intensity in patients with tennis elbow. This paper reports the health economic evaluation. Methods and Findings Adults with new diagnosis of tennis elbow were recruited from 38 general practices in the UK, and randomly allocated to PCM (n = 120) or PCM plus TENS (n = 121). Outcomes included reduction in pain intensity and quality-adjusted-life-years (QALYs) based on the EQ5D and SF6D. Two economic perspectives were evaluated: (i) healthcare-inclusive of NHS and private health costs for the tennis elbow; (ii) societal-healthcare costs plus productivity losses through work absenteeism. Mean outcome and cost differences between the groups were evaluated using a multiple imputed dataset as the base case evaluation, with uncertainty represented in cost-effectiveness planes and through probabilistic cost-effectiveness acceptability curves). Incremental healthcare cost was 33 pound (95% CI -40, 106) and societal cost 65 pound (95% CI -307, 176) for PCM plus TENS. Mean differences in outcome were: 0.11 (95% CI -0.13, 0.35) for change in pain (0-10 pain scale); -0.015 (95% CI -0.058, 0.029) for QALY(EQ5D); 0.007 (95% CI -0.022, 0.035) for QALY(SF6D) (higher score differences denote greater benefit for PCM plus TENS). The ICER (incremental cost effectiveness ratio) for the main evaluation of mean difference in societal cost () pound relative to mean difference in pain outcome was -582 (95% CI -8666, 8113). However, incremental ICERs show differences in cost-effectiveness of additional TENS, according to the outcome being evaluated. Conclusion Our findings do not provide evidence for or against the cost-effectiveness of TENS as an adjunct to primary care management of tennis elbow.	[Lewis, Martyn; Chesterton, Linda S.; Sim, Julius; Mallen, Christian D.; Hay, Elaine M.; van der Windt, Danielle A.] Keele Univ, Arthrit Res UK Primary Care Ctr, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England	Keele University	Lewis, M (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England.	a.m.lewis@keele.ac.uk			National Institute for Health Research (NIHR) under the Research for Patient Benefit Programme [PB-PG-0407-13189]; Arthritis Research UK clinician scientist award; Arthritis Research UK Primary Care Centre of Excellence [20202]; National Institute for Health Research [NF-SI-0611-10078, PB-PG-0407-13189] Funding Source: researchfish; Versus Arthritis [19634] Funding Source: researchfish	National Institute for Health Research (NIHR) under the Research for Patient Benefit Programme(National Institute for Health Research (NIHR)); Arthritis Research UK clinician scientist award(Versus Arthritis); Arthritis Research UK Primary Care Centre of Excellence(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	This paper presents independent research funded by the National Institute for Health Research (NIHR) under the Research for Patient Benefit Programme (grant reference No PB-PG-0407-13189). CDM is supported by an Arthritis Research UK clinician scientist award. EMH is an NIHR senior investigator. The Institute for Primary Care and Health Sciences at Keele has been awarded the Arthritis Research UK Primary Care Centre of Excellence (grant No 20202). The NIHR had no role in the conduct of the study, collection, management, analysis, and interpretation of the data, or preparation and review of the manuscript. The conclusions and views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health.	ALLANDER E, 1974, SCAND J RHEUMATOL, V3, P145, DOI 10.3109/03009747409097141; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Chesterton LS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5160; Chesterton LS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-156; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Curtis L, 2015, UNIT COSTS HLTH SOCI; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gabel Gerard T., 1999, Current Opinion in Rheumatology, V11, P138, DOI 10.1097/00002281-199903000-00010; HAMILTON PG, 1986, J ROY COLL GEN PRACT, V36, P464; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; Johnson MI, 2011, EXPERT REV NEUROTHER, V11, P735, DOI [10.1586/ern.11.48, 10.1586/ERN.11.48]; Joint Formulary Committee, 2011, 61 BNF BRIT MED ASS; Korthals-de Bos IBC, 2004, PHARMACOECONOMICS, V22, P185, DOI 10.2165/00019053-200422030-00004; Korthals-de Bos IBC, 2003, BRIT MED J, V326, P911; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; Obradovic M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-110; Office for National Statistics, 2011, ANN SURV HOURS EARN; Office of National Statistics, 2000, STAND OCC CLASS 2000, V2; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Smidt N, 2006, BMJ-BRIT MED J, V333, P927, DOI 10.1136/bmj.39017.396389.BE; Struijs PAA, 2006, BRIT J SPORT MED, V40, P637, DOI 10.1136/bjsm.2006.026187; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Watson T, 2000, MANUAL THER, V5, P132, DOI 10.1054/math.2000.0363; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whitehurst DGT, 2011, MED DECIS MAKING, V31, pE34, DOI 10.1177/0272989X11421529; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135460	10.1371/journal.pone.0135460	http://dx.doi.org/10.1371/journal.pone.0135460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317528	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000360299100029
J	Li, SZ; Zhou, XJ; Li, HB; Liu, YF; Zhu, LY; Guo, JJ; Liu, XQ; Fan, YL; Chen, JT; Chen, RM				Li, Suzhen; Zhou, Xiaojin; Li, Hongbo; Liu, Yuanfeng; Zhu, Liying; Guo, Jinjie; Liu, Xiaoqing; Fan, Yunliu; Chen, Jingtang; Chen, Rumei			Overexpression of ZmIRT1 and ZmZIP3 Enhances Iron and Zinc Accumulation in Transgenic Arabidopsis	PLOS ONE			English	Article							METAL TRANSPORTER; DEFICIENCY RESPONSES; RICE PLANTS; OVER-EXPRESSION; GENE-EXPRESSION; HOMEOSTASIS; THALIANA; NICOTIANAMINE; ROOTS; IRT1	Iron and zinc are important micronutrients for both the growth and nutrient availability of crop plants, and their absorption is tightly controlled by a metal uptake system. Zinc-regulated transporters, iron-regulated transporter-like proteins (ZIP), is considered an essential metal transporter for the acquisition of Fe and Zn in graminaceous plants. Several ZIPs have been identified in maize, although their physiological function remains unclear. In this report, ZmIRT1 was shown to be specifically expressed in silk and embryo, whereas ZmZIP3 was a leaf-specific gene. Both ZmIRT1 and ZmZIP3 were shown to be localized to the plasma membrane and endoplasmic reticulum. In addition, transgenic Arabidopsis plants overexpressing ZmIRT1 or ZmZIP3 were generated, and the metal contents in various tissues of transgenic and wild-type plants were examined based on ICP-OES and Zinpyr-1 staining. The Fe and Zn concentration increased in roots and seeds of ZmIRT1-overexpressing plants, while the Fe content in shoots decreased. Overexpressing ZmZIP3 enhanced Zn accumulation in the roots of transgenic plants, while that in shoots was repressed. In addition, the transgenic plants showed altered tolerance to various Fe and Zn conditions compared with wild-type plants. Furthermore, the genes associated with metal uptake were stimulated in ZmIRT1 transgenic plants, while those involved in intra-and intercellular translocation were suppressed. In conclusion, ZmIRT1 and ZmZIP3 are functional metal transporters with different ion selectivities. Ectopic overexpression of ZmIRT1 may stimulate endogenous Fe uptake mechanisms, which may facilitate metal uptake and homeostasis. Our results increase our understanding of the functions of ZIP family transporters in maize.	[Li, Suzhen; Li, Hongbo; Liu, Yuanfeng; Zhu, Liying; Guo, Jinjie; Chen, Jingtang] Agr Univ Hebei, Dept Agron, Hebei Subctr, Chinese Natl Maize Improvement Ctr, Baoding, Peoples R China; [Li, Suzhen; Zhou, Xiaojin; Liu, Xiaoqing; Fan, Yunliu; Chen, Rumei] Chinese Acad Agr Sci, Dept Crop Genom & Genet Improvement, Biotechnol Res Inst, Beijing 100193, Peoples R China	Hebei Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Chen, JT (corresponding author), Agr Univ Hebei, Dept Agron, Hebei Subctr, Chinese Natl Maize Improvement Ctr, Baoding, Peoples R China.	chenjingtang@126.com; chenrumei@caas.cn			National Special Program for GMO Development of China [2014ZX08003-002]; National Natural Science Foundation of China [31101095]	National Special Program for GMO Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Special Program for GMO Development of China (grant number 2014ZX08003-002) and by the National Natural Science Foundation of China (grant number 31101095).	An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Casterline JE, 1997, J NUTR, V127, P1966, DOI 10.1093/jn/127.10.1966; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Deinlein U, 2012, PLANT CELL, V24, P708, DOI 10.1105/tpc.111.095000; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Erikson KA, 2004, J NUTR BIOCHEM, V15, P335, DOI 10.1016/j.jnutbio.2003.12.006; Gainza-Cortes F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-111; Ghandilyan A, 2006, PHYSIOL PLANTARUM, V126, P407, DOI 10.1111/j.1399-3054.2006.00646.x; Grotz N, 2006, BBA-MOL CELL RES, V1763, P595, DOI 10.1016/j.bbamcr.2006.05.014; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hindt MN, 2012, BBA-MOL CELL RES, V1823, P1521, DOI 10.1016/j.bbamcr.2012.03.010; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, J EXP BOT, V58, P2909, DOI 10.1093/jxb/erm147; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Lee S, 2010, PLANT MOL BIOL, V73, P507, DOI 10.1007/s11103-010-9637-0; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Lee S, 2009, PLANT CELL ENVIRON, V32, P408, DOI 10.1111/j.1365-3040.2009.01935.x; Li SZ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-114; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishida S, 2011, PLANT CELL PHYSIOL, V52, P1433, DOI 10.1093/pcp/pcr089; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; PAHLSSON AMB, 1989, WATER AIR SOIL POLL, V47, P287, DOI 10.1007/BF00279329; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; PRICE AH, 1991, PLANT CELL ENVIRON, V14, P477, DOI 10.1111/j.1365-3040.1991.tb01517.x; Ramesh SA, 2004, PLANT MOL BIOL, V54, P373, DOI 10.1023/B:PLAN.0000036370.70912.34; Santi S, 2005, PLANT PHYSIOL BIOCH, V43, P287, DOI 10.1016/j.plaphy.2005.02.007; Santi S, 2008, J EXP BOT, V59, P697, DOI 10.1093/jxb/erm351; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stein AJ, 2010, PLANT SOIL, V335, P133, DOI 10.1007/s11104-009-0228-2; Tan S, 2015, TRANSGENIC RES, V24, P109, DOI 10.1007/s11248-014-9822-z; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Varotto C, 2002, PLANT J, V31, P589, DOI 10.1046/j.1365-313X.2002.01381.x; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Walker EL, 2008, CURR OPIN PLANT BIOL, V11, P530, DOI 10.1016/j.pbi.2008.06.013; Wang N, 2013, MOL PLANT, V6, P503, DOI 10.1093/mp/sss089; Wu HL, 2012, PLANT PHYSIOL, V158, P790, DOI 10.1104/pp.111.190983; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26	58	23	30	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136647	10.1371/journal.pone.0136647	http://dx.doi.org/10.1371/journal.pone.0136647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317616	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100118
J	Mandelli, S; Riva, E; Tettamanti, M; Detoma, P; Giacomin, A; Lucca, U				Mandelli, Sara; Riva, Emma; Tettamanti, Mauro; Detoma, Paolo; Giacomin, Adriano; Lucca, Ugo			Mortality Prediction in the Oldest Old with Five Different Equations to Estimate Glomerular Filtration Rate: The Health and Anemia Population-based Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COLLABORATION CKD-EPI; SERUM CREATININE; REFERENCE VALUES; ESTIMATING GFR; RENAL-DISEASE; ALL-CAUSE; ONE-SIZE; RISK; AGE	Background Kidney function declines considerably with age, but little is known about its clinical significance in the oldest-old. Objectives To study the association between reduced glomerular filtration rate (GFR) estimated according to five equations with mortality in the oldest-old. Design Prospective population-based study. Setting Municipality of Biella, Piedmont, Italy. Participants 700 subjects aged 85 and older participating in the "Health and Anemia" Study in 2007-2008. Measurements GFR was estimated using five creatinine-based equations: the Cockcroft-Gault (C-G), Modification of Diet in Renal Disease (MDRD), MAYO Clinic, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Berlin Initiative Study-1 (BIS-1). Survival analysis was used to study mortality in subjects with reduced eGFR (<60 mL/min/1.73m(2)) compared to subjects with eGFR >= 60 mL/min/1.73m(2). Results Prevalence of reduced GFR was 90.7% with the C-G, 48.1% with MDRD, 23.3% with MAYO, 53.6% with CKD-EPI and 84.4% with BIS-1. After adjustment for confounders, two-year mortality was significantly increased in subjects with reduced eGFR using BIS-1 and C-G equations (adjusted HRs: 2.88 and 3.30, respectively). Five-year mortality was significantly increased in subjects with eGFR <60 mL/min/1.73m(2) using MAYO, CKD-EPI and, in a graduated fashion in reduced eGFR categories, MDRD. After 5 years, oldest old with an eGFR <30 mL/min/1.73m(2) showed a significantly higher risk of death whichever equation was used (adjusted HRs between 2.04 and 2.70). Conclusion In the oldest old, prevalence of reduced eGFR varies noticeably depending on the equation used. In this population, risk of mortality was significantly higher for reduced GFR estimated with the BIS-1 and C-G equations over the short term. Though after five years the MDRD appeared on the whole a more consistent predictor, differences in mortality prediction among equations over the long term were less apparent. Noteworthy, subjects with a severely reduced GFR were consistently at higher risk of death regardless of the equation used to estimate GFR.	[Mandelli, Sara; Riva, Emma; Tettamanti, Mauro; Lucca, Ugo] IRCCS Ist Ric Farmacol Mario Negri, Lab Geriatr Neuropsychiat, Milan, Italy; [Detoma, Paolo] Osped Inferm Biella, Lab Anal, Biella, Italy; [Giacomin, Adriano] Local Hlth Author, Cty Canc Registry, Biella, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Riva, E (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Lab Geriatr Neuropsychiat, Milan, Italy.	riva@marionegri.it; ugo.lucca@marionegri.it	Mandelli, Sara/ABE-3983-2020; Tettamanti, Mauro/U-8925-2017; Lucca, Ugo/ABC-1460-2020	Mandelli, Sara/0000-0003-3553-7564; Tettamanti, Mauro/0000-0001-7345-0887; Lucca, Ugo/0000-0003-0452-3215	Amgen	Amgen(Amgen)	The "Health and Anemia Study" was supported by an unrestricted grant from Amgen. The sponsor had no role in the conception and design of the study; collection, management, analysis or interpretation of data; writing of the report; or the decision to submit the article for publication.	Bowling CB, 2013, JAMA-J AM MED ASSOC, V310, P1284, DOI 10.1001/jama.2013.252441; Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Campbell KH, 2008, CURR OPIN NEPHROL HY, V17, P298, DOI 10.1097/MNH.0b013e3282f5dd90; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Conte G, 2014, NEPHROL DIAL TRANSPL, V29, P770, DOI 10.1093/ndt/gft324; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cox HJ, 2008, NEPHRON CLIN PRACT, V110, pC67, DOI 10.1159/000151720; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P2664, DOI 10.1093/ndt/gfs265; Duru OK, 2009, J GEN INTERN MED, V24, P86, DOI 10.1007/s11606-008-0850-3; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Glassock RJ, 2014, NEPHROL DIAL TRANSPL, V29, P774, DOI 10.1093/ndt/gft306; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hallan SI, 2014, NEPHROL DIAL TRANSPL, V29, P780, DOI 10.1093/ndt/gft494; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kagiyama S, 2008, HYPERTENS RES, V31, P2053, DOI 10.1291/hypres.31.2053; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Maaravi Y, 2007, QJM-INT J MED, V100, P441, DOI 10.1093/qjmed/hcm043; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Montesanto A, 2014, AGE, V36, P1503, DOI 10.1007/s11357-014-9641-4; Muntner P, 2011, CLIN J AM SOC NEPHRO, V6, P2200, DOI 10.2215/CJN.02030311; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Rostoker G, 2007, J NEPHROL, V20, P576; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Shastri S, 2012, J AM GERIATR SOC, V60, P1201, DOI 10.1111/j.1532-5415.2012.04046.x; Shastri S, 2011, CLIN J AM SOC NEPHRO, V6, P1410, DOI 10.2215/CJN.08801010; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Stevens LA, 2008, AM J KIDNEY DIS, V51, P353, DOI 10.1053/j.ajkd.2008.01.009; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Tettamanti M, 2010, HAEMATOL-HEMATOL J, V95, P1849, DOI 10.3324/haematol.2010.023101; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Van Pottelbergh G, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-27; Van Pottelbergh G, 2011, AGE AGEING, V40, P401, DOI 10.1093/ageing/afr033; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	52	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136039	10.1371/journal.pone.0136039	http://dx.doi.org/10.1371/journal.pone.0136039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317988	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100057
J	Saina, MC; Bi, XQ; Lihana, R; Lwembe, R; Ishizaki, A; Panikulam, A; Palakudy, T; Musoke, R; Owens, M; Songok, EM; Ichimura, H				Saina, Matilda Chelimo; Bi, Xiuqiong; Lihana, Raphael; Lwembe, Raphael; Ishizaki, Azumi; Panikulam, Annie; Palakudy, Tresa; Musoke, Rachel; Owens, Mary; Songok, Elijah Maritim; Ichimura, Hiroshi			Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I; GENETIC-CHARACTERIZATION; ELITE CONTROLLERS; SUBTYPE; MUTATIONS; DEFECTS; NAIROBI; AFRICA; SUBSET	Objectives Disease progression varies among HIV-1-infected individuals. The present study aimed to explore possible viral and host factors affecting disease progression in HIV-1-infected children. Methods Since 2000, 102 HIV-1 vertically-infected children have been followed-up in Kenya. Here we studied 29 children (15 male/14 female) who started antiretroviral treatment at <5 years of age (rapid progressors; RP), and 32 (17 male/15 female) who started at >10 years of age (slow progressors; SP). Sequence variations in the HIV-1 gag and nef genes and the HLA class I-related epitopes were compared between the two groups. Results Based on nef sequences, HIV-1 subtypes A1/D were detected in 62.5%/12.5% of RP and 66.7%/20% of SP, with no significant difference in subtype distribution between groups (p = 0.8). In the ten Nef functional domains, only the PxxP(3) region showed significantly greater variation in RP (33.3%) than SP (7.7%, p = 0.048). Gag sequences did not significantly differ between groups. The reportedly protective HLA-A alleles, A*74:01, A*32:01 and A*26, were more commonly observed in SP (50.0%) than RP (11.1%, p = 0.010), whereas the reportedly disease-susceptible HLA-B*45:01 was more common in RP (33.3%) than SP (7.4%, p = 0.045). Compared to RP, SP showed a significantly higher median number of predicted HLA-B-related 12-mer epitopes in Nef (3 vs. 2, p = 0.037), HLA-B-related 11-mer epitopes in Gag (2 vs. 1, p = 0.029), and HLA-A-related 9-mer epitopes in Gag (4 vs. 1, p = 0.051). SP also had fewer HLA-C-related epitopes in Nef (median 4 vs. 5, p = 0.046) and HLA-C-related 11-mer epitopes in Gag (median 1 vs. 1.5, p = 0.044) than RP. Conclusions Compared to rapid progressors, slow progressors had more protective HLA-A alleles and more HLA-B-related epitopes in both the Nef and Gag proteins. These results suggest that the host factor HLA plays a stronger role in disease progression than the Nef and Gag sequence variations in HIV-1-infected Kenyan children.	[Saina, Matilda Chelimo; Bi, Xiuqiong; Ishizaki, Azumi; Ichimura, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa, Japan; [Lihana, Raphael; Lwembe, Raphael; Songok, Elijah Maritim] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Panikulam, Annie; Palakudy, Tresa; Owens, Mary] Nyumbani Childrens Home, Nairobi, Kenya; [Musoke, Rachel] Univ Nairobi, Dept Pediat, Nairobi, Kenya	Kanazawa University; Kenya Medical Research Institute; University of Nairobi	Bi, XQ (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Viral Infect & Int Hlth, Kanazawa, Ishikawa, Japan.	bixiuqio@staff.kanazawa-u.ac.jp; ichimura@med.kanazawa-u.ac.jp	ICHIMURA, Hiroshi/L-3605-2015	ICHIMURA, Hiroshi/0000-0003-4478-1964; Songok, Elijah/0000-0001-7790-7063	JSPS [23406013]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-Aid for Scientific Research (23406013) (https://www.jsps.go.jp/english/e-grants/).	Abidi SH, 2014, MED MICROBIOL IMMUN, V203, P57, DOI 10.1007/s00430-013-0314-1; Alexander L, 2006, PEDIATR INFECT DIS J, V25, P135, DOI 10.1097/01.inf.0000199299.00345.83; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Casartelli N, 2003, AIDS, V17, P1291, DOI 10.1097/00002030-200306130-00003; Chakraborty R, 2006, HIV MED, V7, P75, DOI 10.1111/j.1468-1293.2006.00341.x; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; Eller MA, 2014, J INFECT DIS; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Grifoni A, 2014, IMMUNOLOGY, V143, P631, DOI 10.1111/imm.12344; Gurdasani D, 2014, AIDS, V28, P149, DOI 10.1097/QAD.0000000000000049; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jia MM, 2012, CELL RES, V22, P903, DOI 10.1038/cr.2012.19; Jubier-Maurin V, 1999, AIDS RES HUM RETROV, V15, P23, DOI 10.1089/088922299311673; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; Kitawi RC, 2015, AIDS RES HUM RETROV, V31, P452, DOI [10.1089/aid.2014.0306, 10.1089/AID.2014.0306]; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Lihana RW, 2011, J CLIN VIROL, V52, P123, DOI 10.1016/j.jcv.2011.06.014; Luo M, 2002, TISSUE ANTIGENS, V59, P370, DOI 10.1034/j.1399-0039.2002.590503.x; Lwembe R, 2007, J MED VIROL, V79, P865, DOI 10.1002/jmv.20912; Lwembe R, 2009, AIDS RES HUM RETROV, V25, P141, DOI 10.1089/aid.2008.0144; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Muenchhoff M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00391; Naruto T, 2012, J VIROL, V86, P10870, DOI 10.1128/JVI.00689-12; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Peterson TA, 2013, TISSUE ANTIGENS, V81, P93, DOI 10.1111/tan.12051; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Pushker R, 2010, J VIROL, V84, P3644, DOI 10.1128/JVI.01959-09; Rimawi BH, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/752312; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Singh KK, 2009, PEDIATR RES, V65, p55R, DOI 10.1203/PDR.0b013e31819dca03; Trachtenberg EA, 2001, HIV MOL IMMUNOLOGY, pI; Wang B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00355	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137140	10.1371/journal.pone.0137140	http://dx.doi.org/10.1371/journal.pone.0137140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317223	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100210
J	Chiang, KH; Cheng, WL; Shih, CM; Lin, YW; Tsao, NW; Kao, YT; Lin, CT; Wu, SC; Huang, CY; Lin, FY				Chiang, Kuang-Hsing; Cheng, Wan-Li; Shih, Chun-Ming; Lin, Yi-Wen; Tsao, Nai-Wen; Kao, Yung-Ta; Lin, Chih-Ting; Wu, Shinn-Chih; Huang, Chun-Yao; Lin, Feng-Yen			Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells	PLOS ONE			English	Article							MOBILIZATION; ROSUVASTATIN; ANGIOGENESIS; SIMVASTATIN; KINASE	Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, are used to reduce cholesterol biosynthesis in the liver. Accordingly, statins regulate nitric oxide (NO) and glutamate metabolism, inflammation, angiogenesis, immunity and endothelial progenitor cells (EPCs) functions. The function of EPCs are regulated by stromal cell-derived factor 1 (SDF-1), vascular endothelial growth factor (VEGF), and transforming growth factor beta (TGF-beta), etc. Even though the pharmacologic mechanisms by which statins affect the neovasculogenesis of circulating EPCs, it is still unknown whether statins affect the EPCs function through the regulation of CXCR4, a SDF-1 receptor expression. Therefore, we desired to explore the effects of statins on CXCR4 expression in EPC-mediated neovascularization by in vitro and in vivo analyses. In animal studies, we analyzed the effects of atorvastatin or rosuvastatin treatments in recovery of capillary density and blood flow, the expression of vWF and CXCR4 at ischemia sites in hindlimb ischemia ICR mice. Additionally, we analyzed whether the atorvastatin or rosuvastatin treatments increased the mobilization, homing, and CXCR4 expression of EPCs in hindlimb ischemia ICR mice that underwent bone marrow transplantation. The results indicated that statins treatment led to significantly more CXCR4-positive endothelial progenitor cells incorporated into ischemic sites and in the blood compared with control mice. In vivo, we isolated human EPCs and analyzed the effect of statins treatment on the vasculogenic ability of EPCs and the expression of CXCR4. Compared with the control groups, the neovascularization ability of EPCs was significantly improved in the atorvastatin or rosuvastatin group; this improvement was dependent on CXCR4 up-regulation. The efficacy of statins on improving EPC neovascularization was related to the SDF-1 alpha/CXCR4 axis and might be regulated by the NO. In conclusion, atorvastatin and rosuvastatin improved neovascularization in hindlimb ischemia mice; this effect may have been mediated by increased CXCR4 expression in EPCs.	[Chiang, Kuang-Hsing; Shih, Chun-Ming; Lin, Yi-Wen; Kao, Yung-Ta; Huang, Chun-Yao; Lin, Feng-Yen] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chiang, Kuang-Hsing; Shih, Chun-Ming; Lin, Yi-Wen; Kao, Yung-Ta; Huang, Chun-Yao; Lin, Feng-Yen] Taipei Med Univ Hosp, Dept Internal Med, Cardiovasc Res Ctr, Taipei, Taiwan; [Chiang, Kuang-Hsing] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chiang, Kuang-Hsing; Lin, Chih-Ting] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Cheng, Wan-Li; Shih, Chun-Ming; Huang, Chun-Yao; Lin, Feng-Yen] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lin, Yi-Wen] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Tsao, Nai-Wen] Taipei Med Univ Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan; [Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University	Huang, CY (corresponding author), Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	cyhuang@tmu.edu.tw; g870905@tmu.edu.tw	Lin, Chih-Ting/J-2580-2014	Lin, Chih-Ting/0000-0002-4150-9693; Wu, Shinn-Chih/0000-0001-8881-1550; CHIANG, KUANG-HSING/0000-0003-0376-9862	Taipei Medical University [98TMU-TMUH-10]; National Science Council in Taiwan [NSC 101-2314-B-038 -041-MY3]	Taipei Medical University; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Taipei Medical University (98TMU-TMUH-10) and National Science Council (NSC 101-2314-B-038 -041-MY3) in Taiwan.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Balakumar P, 2012, J MOL CELL CARDIOL, V52, P83, DOI 10.1016/j.yjmcc.2011.09.014; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Fadini GP, 2013, ATHEROSCLEROSIS, V229, P23, DOI 10.1016/j.atherosclerosis.2013.04.007; Feig JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028534; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Hiroki J, 2004, J MOL CELL CARDIOL, V37, P537, DOI 10.1016/j.yjmcc.2004.05.008; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Huang PH, 2010, ATHEROSCLEROSIS, V212, P426, DOI 10.1016/j.atherosclerosis.2010.06.034; Kitahara M, 2010, BRIT J PHARMACOL, V159, P1418, DOI 10.1111/j.1476-5381.2009.00630.x; Koba S, NIHON RINSHO, V69, P138; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lenk K, 1985, J APPL PHYSIOL, V111, P321; Liu Y, 2012, AM J MED SCI, V344, P220, DOI 10.1097/MAJ.0b013e31824998f9; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Pelat M, 2003, CIRCULATION, V107, P2480, DOI 10.1161/01.CIR.0000065601.83526.3E; Sata M, 2001, FASEB J, V15, P2530, DOI 10.1096/fj.01-0415fje; Shepherd J, 2003, AM J CARDIOL, V91, p11C, DOI 10.1016/S0002-9149(03)00004-3; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Tousoulis D, 2011, ATHEROSCLEROSIS, V214, P151, DOI 10.1016/j.atherosclerosis.2010.11.002; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Urnemura T, 2008, J PHARMACOL SCI, V108, P1, DOI 10.1254/jphs.08R01CP; Wan J, 2010, EXP BIOL MED, V235, P989, DOI 10.1258/ebm.2010.010057; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f	29	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136405	10.1371/journal.pone.0136405	http://dx.doi.org/10.1371/journal.pone.0136405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309120	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400121
J	Ho, S; Foulsham, T; Kingstone, A				Ho, Simon; Foulsham, Tom; Kingstone, Alan			Speaking and Listening with the Eyes: Gaze Signaling during Dyadic Interactions	PLOS ONE			English	Article							MOVEMENTS; CONVERSATION	Cognitive scientists have long been interested in the role that eye gaze plays in social interactions. Previous research suggests that gaze acts as a signaling mechanism and can be used to control turn-taking behaviour. However, early research on this topic employed methods of analysis that aggregated gaze information across an entire trial (or trials), which masks any temporal dynamics that may exist in social interactions. More recently, attempts have been made to understand the temporal characteristics of social gaze but little research has been conducted in a natural setting with two interacting participants. The present study combines a temporally sensitive analysis technique with modern eye tracking technology to 1) validate the overall results from earlier aggregated analyses and 2) provide insight into the specific moment-to-moment temporal characteristics of turn-taking behaviour in a natural setting. Dyads played two social guessing games (20 Questions and Heads Up) while their eyes were tracked. Our general results are in line with past aggregated data, and using cross-correlational analysis on the specific gaze and speech signals of both participants we found that 1) speakers end their turn with direct gaze at the listener and 2) the listener in turn begins to speak with averted gaze. Convergent with theoretical models of social interaction, our data suggest that eye gaze can be used to signal both the end and the beginning of a speaking turn during a social interaction. The present study offers insight into the temporal dynamics of live dyadic interactions and also provides a new method of analysis for eye gaze data when temporal relationships are of interest.	[Ho, Simon; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Foulsham, Tom] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England	University of British Columbia; University of Essex	Ho, S (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	simonho213@gmail.com		Foulsham, Tom/0000-0002-8444-7269; Ho, Simon/0000-0003-3080-8900	Natural Sciences and Engineering Council of Canada [170077-11]; Social Sciences and Humanities Research Council [435-2013-2200]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	The present investigation was funded by grants awarded to AK by the Natural Sciences and Engineering Council of Canada (Grant #170077-11; http://www.nserc-crsng.gc.ca) and the Social Sciences and Humanities Research Council (Grant #435-2013-2200; http://www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, TUTORIALS CONT NONLI; Argyle M., 1976, GAZE MUTUAL GAZE; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; Coco MI, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00510; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; COOK M, 1977, AM SCI, V65, P328; Cummins F, 2012, LANG COGNITIVE PROC, V27, P1525, DOI 10.1080/01690965.2011.615220; Doherty-Sneddon G, 2005, MEM COGNITION, V33, P727, DOI 10.3758/BF03195338; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duncan Jr S, 1977, FACE TO FACE INTERAC; DUNCAN S, 1972, J PERS SOC PSYCHOL, V23, P283, DOI 10.1037/h0033031; DUNCAN S, 1969, PSYCHOL BULL, V72, P118, DOI 10.1037/h0027795; FODDY M, 1978, HUM RELAT, V31, P925, DOI 10.1177/001872677803101101; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Freeth M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053286; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gallup AC, 2012, BIOL LETTERS, V8, P520, DOI 10.1098/rsbl.2012.0160; Gonzalez-Montoro AM, 2015, J COMPUT NEUROSCI, V38, P577, DOI 10.1007/s10827-015-0557-5; HARRIGAN JA, 1985, COMMUN RES, V12, P233, DOI 10.1177/009365085012002004; Holler Judith, 2015, Front Psychol, V6, P98, DOI 10.3389/fpsyg.2015.00098; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Macdonald RG, 2013, EFFECT SOCIAL ROLES; Macdonald RG, 2013, J VISION, V13, DOI 10.1167/13.4.6; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson DC, 2005, COGNITIVE SCI, V29, P1045, DOI 10.1207/s15516709cog0000_29; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Sandgren O, 2012, INT J LANG COMM DIS, V47, P373, DOI 10.1111/j.1460-6984.2012.00151.x; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Tice M, 2011, TURN BOUNDARY PROJEC; Wu DWL, 2014, EVOL HUM BEHAV, V35, P211, DOI 10.1016/j.evolhumbehav.2014.01.005	36	68	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136905	10.1371/journal.pone.0136905	http://dx.doi.org/10.1371/journal.pone.0136905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26309216	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000360069400161
J	Jongman, RM; van Klarenbosch, J; Molema, G; Zijlstra, JG; de Vries, AJ; van Meurs, M				Jongman, Rianne M.; van Klarenbosch, Jan; Molema, Grietje; Zijlstra, Jan G.; de Vries, Adrianus J.; van Meurs, Matijs			Angiopoietin/Tie2 Dysbalance Is Associated with Acute Kidney Injury after Cardiac Surgery Assisted by Cardiopulmonary Bypass	PLOS ONE			English	Article							ORGAN DYSFUNCTION SYNDROME; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; LEVELS INCREASE; MORTALITY; INFLAMMATION; SURVIVAL; SEPSIS; ALPHA; SHOCK	Introduction The pathophysiology of acute kidney injury (AKI) after cardiac surgery is not completely understood. Recent evidence suggests a pivotal role for the endothelium in AKI. In experimental models of AKI, the endothelial specific receptor Tie2 with its ligands Angiopoietin (Ang) 1 and Ang2 are deranged. This study investigates their status after cardiac surgery, and a possible relation between angiopoietins and AKI. Methods From a cohort of 541 patients that underwent cardiac surgery, blood and urine was collected at 5 predefined time points. From this cohort we identified 21 patients who had at least 50% post-operative serum creatinine increase (AKI). We constructed a control group (n = 21) using propensity matching. Systemic levels of Ang1, Ang2, and sTie2 were measured in plasma and the AKI markers albumin, kidney injury molecule-1 (KIM-1) and N-acetyl-beta-D-glucosaminidase (NAG) were measured in the urine. Results Ang2 plasma levels increased over time in AKI (from 4.2 to 11.6 ng/ml) and control patients (from 3.0 to 6.7 ng/ml). Ang2 levels increased 1.7-fold more in patients who developed AKI after cardiac surgery compared to matched control patients. Plasma levels of sTie2 decreased 1.6-fold and Ang1 decreased 3-fold over time in both groups, but were not different between AKI and controls (Ang1 P = 0.583 and sTie2 P = 0.679). Moreover, we found a positive correlation between plasma levels of Ang2 and urinary levels of NAG. Conclusions The endothelial Ang/Tie2 system is in dysbalance in patients that develop AKI after cardiac surgery compared to matched control patients.	[Jongman, Rianne M.; de Vries, Adrianus J.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9713 AV Groningen, Netherlands; [Jongman, Rianne M.; Molema, Grietje; van Meurs, Matijs] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Jongman, Rianne M.; Zijlstra, Jan G.; van Meurs, Matijs] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, NL-9713 AV Groningen, Netherlands; [van Klarenbosch, Jan] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	van Meurs, M (corresponding author), Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands.	m.van.meurs@umcg.nl	; Zijlstra, Jan/E-6782-2011	Molema, Grietje/0000-0002-4147-6676; Zijlstra, Jan/0000-0001-9079-0795	Netherlands Organization for Health Research and Development (ZonMw); Dutch Society of Anesthesiology (NVA)	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Society of Anesthesiology (NVA)	This work was partly supported by The Netherlands Organization for Health Research and Development (ZonMw) to AJdV, and the Dutch Society of Anesthesiology (NVA) to MvM.	Aslan A, 2014, CRIT CARE, V18, DOI 10.1186/cc13806; Chang FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054668; Chen S, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/583076; Clajus C, 2012, CYTOKINE; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Giuliano JS, 2008, INTENS CARE MED, V34, P1851, DOI 10.1007/s00134-008-1174-9; GUSTAFSSON JEC, 1978, CLIN CHIM ACTA, V90, P241, DOI 10.1016/0009-8981(78)90263-2; Jongman RM, 2014, SHOCK; Kim DH, 2009, KIDNEY INT, V76, P1180, DOI 10.1038/ki.2009.387; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; Kumpers P, 2010, INTENS CARE MED, V36, P462, DOI 10.1007/s00134-009-1726-7; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Kurniati NF, 2012, NEPHROL DIAL TRANSPL; Li R, 2014, SHOCK; Linder A, 2014, AM J RESP CRIT CARE, V189, P1075, DOI 10.1164/rccm.201311-2097OC; Loef BG, 2009, BRIT J ANAESTH, V102, P749, DOI 10.1093/bja/aep088; Nauta FL, 2012, AM J KIDNEY DIS, V59, P586, DOI 10.1053/j.ajkd.2011.11.025; Nauta FL, 2011, AM J KIDNEY DIS, V57, P733, DOI 10.1053/j.ajkd.2010.12.022; Nonami Y, 1997, SURG TODAY, V27, P583, DOI 10.1007/BF02388212; Parikh SM, 2013, VIRULENCE, V4, P517, DOI 10.4161/viru.24906; POBER JS, 1987, CIBA F SYMP, V131, P170; Reents W, 2014, ANN THORAC SURG, V98, P9, DOI 10.1016/j.athoracsur.2014.01.088; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Stiehl T, 2014, CRIT CARE MED; Sutton TA, 2009, MICROVASC RES, V77, P4, DOI 10.1016/j.mvr.2008.09.004; van Meurs M, 2008, SHOCK, V29, P291, DOI 10.1097/shk.0b013e318145a7c1; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153; van Meurs M, 2009, AM J PHYSIOL-RENAL, V297, pF272, DOI 10.1152/ajprenal.00137.2009; Vermeijden WJ, 2014, ANN THORAC SURG; Wlodzimirow KA, 2012, CRIT CARE, V16, DOI 10.1186/cc11808; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567	36	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136205	10.1371/journal.pone.0136205	http://dx.doi.org/10.1371/journal.pone.0136205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309217	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400096
J	Ao, M; Miyauchi, M; Furusho, H; Inubushi, T; Kitagawa, M; Nagasaki, A; Sakamoto, S; Kozai, K; Takata, T				Ao, Min; Miyauchi, Mutsumi; Furusho, Hisako; Inubushi, Toshihiro; Kitagawa, Masae; Nagasaki, Atsuhiro; Sakamoto, Shinichi; Kozai, Katsuyuki; Takata, Takashi			Dental Infection of Porphyromonas gingivalis Induces Preterm Birth in Mice	PLOS ONE			English	Article							PREGNANT MICE; PREMATURE; WEIGHT; PROSTAGLANDINS; INFLAMMATION; MORTALITY; BACTERIA; INCREASE; OUTCOMES; LABOR	Background Epidemiological studies have revealed a link between dental infection and preterm birth or low birth weight (PTB/LBW), however, the underlying mechanisms remain unclear. Progress in understanding the associated mechanisms has been limited in part by lack of an animal model for chronic infection-induced PTB/LBW, mimicking pregnancy under conditions of periodontitis. We aimed to establish a mouse model of chronic periodontitis in order to investigate the link between periodontitis and PTB/LBW. Methods To establish chronic inflammation beginning with dental infection, we surgically opened mouse (female, 8 weeks old) 1st molar pulp chambers and directly infected with w83 strain Porphyromonas gingivalis (P.g.), a keystone periodontal pathogen. Mating was initiated at 6 wks post-infection, by which time dental granuloma tissue had developed and live P.g. was cultured from extracted tooth root, which serves as a persistent source of P.g. The gestational day (gd) and birth weight were recorded during for P.g.-infected and control mice, and serum and placental tissues were collected at gd 15 to evaluate the systemic and local conditions during pregnancy. Results Dental infection with P.g. significantly increased circulating TNF-alpha (2.5-fold), IL-17 (2-fold), IL-6 (2-fold) and IL-1 alpha (2-fold). The P.g.-infected group delivered at gd 18.25 vs. gd 20.45 in the non-infected control (NC) group (p < 0.01), and pups exhibited LBW compared to controls (p < 0.01). P.g. was localized to placental tissues by immunohistochemistry and PCR, and defects in placental tissues of P.g. infected mice included premature rupture of membrane, placental detachment, degenerative changes in trophoblasts and endothelial cells, including necrotic areas. P.g. infection caused significantly increased numbers of polymorphonuclear leukocytes (PMNLs) and macrophages in placental tissues, associated with increased local expression of pro-inflammatory mediators including TNF-alpha and COX-2. Further placental tissue damage was indicated in P.g. infectedmice by decreased CD-31 in endothelial cells, increased expression of 8OHdG, an indicator of oxidative DNA damage, and cleaved caspase-3, a marker of apoptosis. In vitro, P.g. lipopolysaccharide significantly increased expression of COX-2, IL-8 and TNF-alpha, in HTR-8 trophoblasts in an NF-kappa B-dependent fashion. Conclusions Our novel mouse model supports previous epidemiological studies signifying dental infection as predisposing factor for PTB/LBW. We demonstrate PTB and LBW in infected mice, translocation of P.g to placental tissues, increased circulating and local pro-inflammatory markers, and the capability of P.g. LPS to directly induce cytokine production in trophoblasts, in vitro. These findings further underscore the importance of local and systemic infections and inflammation during pregnancy and suggest that prevention and/or elimination of dental infections such as marginal or periapical periodontitis before pregnancy may have a beneficial effect on PTB/LBW.	[Ao, Min; Miyauchi, Mutsumi; Furusho, Hisako; Inubushi, Toshihiro; Nagasaki, Atsuhiro; Sakamoto, Shinichi; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Ao, Min; Kozai, Katsuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Pediat Dent, Hiroshima 7348553, Japan; [Kitagawa, Masae] Hiroshima Univ, Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Takata, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan.	ttakata@hiroshima-u.ac.jp	Furusho, Hisako/H-2351-2019; Miyauchi, Mutsumi/G-5268-2019		 [26670802]		This work was supported by Grants-in-Aid for Scientific Research (C). Research Project number: 26670802 https://www.jsps.go.jp/english/e-grants/grants01.html.	Ao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110519; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Boggess KA, 2005, AM J OBSTET GYNECOL, V192, P554, DOI 10.1016/j.ajog.2004.09.001; Carroll S, 1996, CURR OPIN OBSTET GYN, V8, P441; COLLINS JG, 1994, INFECT IMMUN, V62, P4356, DOI 10.1128/IAI.62.10.4356-4361.1994; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Furusho H, 2013, J GASTROENTEROL; HAMADA S, 1994, MOLECULAR PATHOGENESIS OF PERIODONTAL DISEASE, P105; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Inubushi T, 2012, J BIOL CHEM, V287, P23527, DOI 10.1074/jbc.M111.324673; Jayaprakash K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-193; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kaur M, 2014, J PERIODONTOL, V85, P1684, DOI 10.1902/jop.2014.140248; KOOPS BL, 1982, J PEDIATR-US, V101, P969; LeBlanc MM, 2012, EQUINE VET J, V44, P8, DOI 10.1111/j.2042-3306.2011.00502.x; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Li Y, 2011, PLACENTA, V32, P11, DOI 10.1016/j.placenta.2010.10.007; Lin DM, 2003, INFECT IMMUN, V71, P5163, DOI 10.1128/IAI.71.9.5163-5168.2003; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nath CA, 2010, AM J REPROD IMMUNOL, V63, P144, DOI 10.1111/j.1600-0897.2009.00773.x; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Olson DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1329, DOI 10.2741/2151; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Ouhara K, 2015, ORAL DIS, V21, P626, DOI 10.1111/odi.12326; Pereira CV, 2011, J PERIODONTOL, V82, P1767, DOI 10.1902/jop.2011.110063; Platt MJ, 2014, PUBLIC HEALTH, V128, P399, DOI 10.1016/j.puhe.2014.03.010; Puchner K, 2012, ARCH GYNECOL OBSTET, V285, P37, DOI 10.1007/s00404-011-1909-7; Horliana ACRT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098271; Saito D, 2009, J ENDODONT, V35, P1518, DOI 10.1016/j.joen.2009.08.005; Sakata M, 2008, OBSTET GYNECOL SURV, V63, P651, DOI 10.1097/OGX.0b013e318181a79f; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Wang WJ, 2014, HUM REPROD, V29, P946, DOI 10.1093/humrep/deu014; WILCOX AJ, 1992, AM J PUBLIC HEALTH, V82, P378, DOI 10.2105/AJPH.82.3.378; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000	37	56	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137249	10.1371/journal.pone.0137249	http://dx.doi.org/10.1371/journal.pone.0137249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322971	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500069
J	Moreno, J; Hidalgo, M; Duarte, C; Sanabria, O; Gabastou, JM; Ibarz-Pavon, AB				Moreno, Jaime; Hidalgo, Melissa; Duarte, Carolina; Sanabria, Olga; Gabastou, Jean Marc; Ibarz-Pavon, Ana Belen			Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia)	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; IDENTIFICATION; PREVALENCE; CHILDREN; CLONES; RISK; AGE	Background Meningococcal carriage studies are important to improve our understanding of the epidemiology of meningococcal disease. The aim of this study was to determine the prevalence of meningococcal carriage and the phenotypic and genotypic characteristics of isolates collected from a sample of students in the city of Bogota, Colombia. Materials and Methods A total of 1459 oropharyngeal samples were collected from students aged 15-21 years attending secondary schools and universities. Swabs were plated on a Thayer Martin agar and N. meningitidis was identified by standard microbiology methods and PCR. Results The overall carriage prevalence was 6.85%. Carriage was associated with cohabitation with smokers, and oral sex practices. Non-groupable and serogroup Y isolates were the most common capsule types found. Isolates presented a high genetic diversity, and circulation of the hypervirulent clonal complexes ST-23, ST-32 and ST-41/44 were detected. Conclusion The meningococcal carriage rate was lower than those reported in Europe and Africa, but higher than in other Latin American countries. Our data also revealed antigenic and genetic diversity of the isolates and the circulation of strains belonging to clonal complexes commonly associated with meningococcal disease.	[Moreno, Jaime; Hidalgo, Melissa; Duarte, Carolina; Sanabria, Olga] Inst Nacl Salud, Grp Microbiol, Bogota, Colombia; [Gabastou, Jean Marc; Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA	Instituto Nacional de Salud (Colombia); Pan American Health Organization	Moreno, J (corresponding author), Inst Nacl Salud, Grp Microbiol, Bogota, Colombia.	jmoreno@ins.gov.co		Trotter, Caroline/0000-0003-4000-2708	Sanofi-Pasteur, through the Pan-American Health and Education Foundation (PAHEF)	Sanofi-Pasteur, through the Pan-American Health and Education Foundation (PAHEF)	This study was supported by Sanofi-Pasteur, through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2014, EPIDEMIOL INFECT, V142, P2461, DOI 10.1017/S0950268814001149; Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; Agudelo CI, 2008, EMERG INFECT DIS, V14, P990, DOI 10.3201/eid1406.071357; Ala'Aldeen DAA, 2011, EMERG INFECT DIS, V17, P1761, DOI 10.3201/eid1709.101762; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P794; Araya P, 2015, EMERG INFECT DIS, V21, P339, DOI 10.3201/eid2102.140746; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Climent Y, 2010, J CLIN MICROBIOL, V48, P802, DOI 10.1128/JCM.01653-09; de los Monteros LEED, 2009, SALUD PUBLICA MEXICO, V51, P114, DOI 10.1590/S0036-36342009000200006; Esposito S, 2013, EUR J CLIN MICROBIOL, V32, P1129, DOI 10.1007/s10096-013-1856-2; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Instituto Nacional de Salud, AISL INV STREPT PNEU; Jounio U, 2012, J CLIN MICROBIOL, V50, P264, DOI 10.1128/JCM.05385-11; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lourenço Maria Cristina S., 2006, Braz J Infect Dis, V10, P154, DOI 10.1590/S1413-86702006000200015; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948; Pinzon-Redondo H, 2014, J HEALTH POPUL NUTR, V32, P539; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Rodriguez P, 2014, VACCINE, V32, P5677, DOI 10.1016/j.vaccine.2014.08.015; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Taha MK, 2007, FEMS MICROBIOL REV, V31, P37, DOI 10.1111/j.1574-6976.2006.00054.x; Tayal SC, 1997, J INFECTION, V34, P101, DOI 10.1016/S0163-4453(97)92357-4; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Urra E, 2005, EUR J CLIN MICROBIOL, V24, P51, DOI 10.1007/s10096-004-1257-7; von Gottberg A, 2008, CLIN INFECT DIS, V46, P377, DOI 10.1086/525260; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	41	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135497	10.1371/journal.pone.0135497	http://dx.doi.org/10.1371/journal.pone.0135497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322796	Green Published, gold			2022-12-27	WOS:000360435500007
J	Sasai-Sakuma, T; Kinoshita, A; Inoue, Y				Sasai-Sakuma, Taeko; Kinoshita, Akihiko; Inoue, Yuichi			Polysomnographic Assessment of Sleep Comorbidities in Drug-Naive Narcolepsy-Spectrum Disorders-A Japanese Cross-Sectional Study	PLOS ONE			English	Article							PERIODIC LEG MOVEMENTS; REM-SLEEP; BEHAVIOR DISORDER; IDIOPATHIC HYPERSOMNIA; LATENCY TEST; LIMB MOVEMENTS; CATAPLEXY; POPULATION; ATONIA; DIAGNOSIS	This is a large cross-sectional study which aimed to investigate comorbidity rate, degree of sleep-related breathing disorder, polysomnigraphically diagnosible rapid eye movement sleep behavior disorder/rapid eye movement sleep without atonia and periodic limb movements during sleep in Japanese drug-naive patients with narcolepsy-spectrum disorders. A total of 158 consecutive drug naive patients with narcolepsy with cataplexy, 295 patients with narcolepsy without cataplexy and 395 patients with idiopathic hypersomnia without long sleep time were enrolled. From retrospectively analyzed data of nocturnal polysomnography and multiple sleep latency test, higher rates of periodic limb movements during sleep (> = 15 h(-1)) (10.2%) and polysomnographically diagnosable rapid eye movement sleep behavior disorder (1.9%) were found in patients with narcolepsy with cataplexy. They had more severe periodic limb movements during sleep especially during rapid eye movement sleep and higher percentages of rapid eye movement sleep without atonia than the other two patient groups. In the present large sample study, Japanese drug naive patients with narcolepsy with cataplexy showed the highest comorbidity rates of periodic limb movements during sleep, polysomnographically diagnosable rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia among those with the other narcolepsy-spectrum disorders; the rates were lower than those for Western patients.	[Sasai-Sakuma, Taeko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Sasai-Sakuma, Taeko] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Div Biomed Lab Sci, Dept Life Sci & Bio informat, Tokyo, Japan; [Kinoshita, Akihiko; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan	Tokyo Medical University; Tokyo Medical & Dental University (TMDU)	Sasai-Sakuma, T (corresponding author), Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan.	taeko_ssi@yahoo.co.jp	Sasai-Sakuma, Taeko/V-7623-2019		MEXT/JSPS KAKENHI [24791435, 15K19499]; Charitable Trust Laboratory Medicine Research Foundation of Japan	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Charitable Trust Laboratory Medicine Research Foundation of Japan	This study was supported by a MEXT/JSPS KAKENHI Grant-in-Aid for Young Scientists (No. 24791435), MEXT/JSPS KAKENHI Grant-in-Aid for Young Scientists (No. 15K19499) and a grant from the Charitable Trust Laboratory Medicine Research Foundation of Japan to Dr. Taeko Sasai-Sakuma.	Aldrich MS, 1996, NEUROLOGY, V46, P393, DOI 10.1212/WNL.46.2.393; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Bahammam A, 2007, ACTA NEUROL SCAND, V115, P351, DOI 10.1111/j.1600-0404.2006.00754.x; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Cipolli C, 2011, SLEEP MED, V12, P635, DOI 10.1016/j.sleep.2010.12.016; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Dauvilliers Y, 2003, CLIN NEUROPHYSIOL, V114, P2000, DOI 10.1016/S1388-2457(03)00203-7; Dauvilliers Y, 2007, J SLEEP RES, V16, P333, DOI 10.1111/j.1365-2869.2007.00601.x; DelRosso LM, 2013, J CLIN SLEEP MED, V9, P675, DOI 10.5664/jcsm.2836; Ferri R, 2008, SLEEP, V31, P1409; Ferri R, 2006, SLEEP, V29, P1587, DOI 10.1093/sleep/29.12.1587; Franceschini C, 2011, SLEEP MED, V12, pS59, DOI 10.1016/j.sleep.2011.10.013; Frauscher B, 2013, J CLIN SLEEP MED, V9, P805, DOI 10.5664/jcsm.2926; Frauscher B, 2012, SLEEP, V35, P835, DOI 10.5665/sleep.1886; Hong SC, 2000, SLEEP MED, V1, P33, DOI 10.1016/S1389-9457(99)00007-6; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Khalil A, 2013, J CLIN SLEEP MED, V9, P1039, DOI 10.5664/jcsm.3078; Knudsen S, 2010, BRAIN, V133, P568, DOI 10.1093/brain/awp320; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Montplaisir J, 2000, SLEEP MED, V1, P163, DOI 10.1016/S1389-9457(00)00014-9; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Nevsimalova S, 2013, J NEUROL, V260, P767, DOI 10.1007/s00415-012-6702-4; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Oka Y, 2006, SLEEP, V29, P1439, DOI 10.1093/sleep/29.11.1439; Partinen M, 2005, PRINCIPLES PRACTICE, P626; Pataka AD, 2012, EUR J NEUROL, V19, P696, DOI 10.1111/j.1468-1331.2011.03610.x; Pizza F, 2013, EUR NEUROL, V70, P22, DOI 10.1159/000348719; Pizza F, 2013, J SLEEP RES, V22, P185, DOI 10.1111/j.1365-2869.2012.01061.x; Roth T, 2013, J CLIN SLEEP MED, V9, P955, DOI 10.5664/jcsm.3004; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sansa G, 2010, SLEEP MED, V11, P93, DOI 10.1016/j.sleep.2009.02.009; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sasai T, 2009, SLEEP MED, V10, P961, DOI 10.1016/j.sleep.2008.12.007; Sasai-Sakuma T, 2014, SLEEP MED, V15, P1009, DOI 10.1016/j.sleep.2014.02.010; SCHENCK CH, 1992, ANN NEUROL, V32, P3, DOI 10.1002/ana.410320103; Scofield H, 2008, SLEEP, V31, P1221; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Silber MH, 2001, NEUROLOGY, V56, P1616, DOI 10.1212/WNL.56.12.1616; Takei Y, 2012, CLIN NEUROPHYSIOL, V123, P137, DOI 10.1016/j.clinph.2011.05.024; Tan EK, 2001, MOVEMENT DISORD, V16, P577, DOI 10.1002/mds.1102; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136988	10.1371/journal.pone.0136988	http://dx.doi.org/10.1371/journal.pone.0136988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322978	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500057
J	Lin, TY; Huang, WL; Lee, WY; Luo, CW				Lin, Ting-Yu; Huang, Wei-Lin; Lee, Wei-Yu; Luo, Ching-Wei			Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CENTRAL-NERVOUS-SYSTEM; HORMONE-RECEPTOR; GROWTH-FACTOR; HETERODIMERIZATION; IDENTIFICATION; CANCER; OLIGOMERIZATION; DIMERIZATION; INHIBITION	Neuromedin U (NMU) activates two G protein-coupled receptors, NMUR1 and NMUR2; this signaling not only controls many physiological responses but also promotes tumorigenesis in diverse tissues. We recently identified a novel truncated NMUR2 derived by alternative splicing, namely NMUR2S, from human ovarian cancer cDNA. Sequence analysis, cell surface ELISA and immunocytochemical staining using 293T cells indicated that NMUR2S can be expressed well on the cell surface as a six-transmembrane protein. Receptor pull-down and fluorescent resonance energy transfer assays demonstrated that NMUR1, NMUR2 and this newly discovered NMUR2S can not only form homomeric complexes but also heteromeric complexes with each other. Although not activated by NMU itself, functional assay in combination with receptor quantification and radio-ligand binding in 293T cells indicated that NMUR2S does not alter the translocation and stability of NMUR1 or NMUR2, but rather effectively dampens their signaling by blocking their NMU binding capability through receptor heterodimerization. We further demonstrated that NMU signaling is significantly up-regulated in human ovarian cancers, whereas expression of NMUR2S can block endogenous NMU signaling and further lead to suppression of proliferation in SKOV-3 ovarian cancer cells. In contrast, in monocytic THP-1 cells that express comparable levels of NMUR1 and NMUR2S, depletion of NMUR2S restored both the signaling and effect of NMU. Thus, these results not only reveal the presence of previously uncharacterized heteromeric relationships among NMU receptors but also provide NMUR2S as a potential therapeutic target for the future treatment of NMU signaling-mediated cancers.	[Luo, Ching-Wei] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Luo, CW (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cwluo@ym.edu.tw		Lin, Ting-Yu/0000-0002-0300-0386	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-010-006-MY3, MOST 103-2627-M-400-001]; National Health Research Institutes, Taiwan [NHRI-EX102-10034BI]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by MOST 103-2314-B-010-006-MY3 and MOST 103-2627-M-400-001 - from Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx) and NHRI-EX102-10034BI from National Health Research Institutes, Taiwan (http://www.nhri.org.tw/) for CWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, JNCI-J NATL CANCER I, V103, P1287, DOI [10.1093/jnci/djr342, DOI 10.1093/JNCI/DJR342]; Bakker RA, 2006, MOL PHARMACOL, V69, P1194, DOI 10.1124/mol.105.019299; Bellucci F, 2004, EUR J PHARMACOL, V499, P229, DOI 10.1016/j.ejphar.2004.07.075; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hosoya M, 2000, J BIOL CHEM, V275, P29528, DOI 10.1074/jbc.M004261200; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Ivanov TR, 2002, ENDOCRINOLOGY, V143, P3813, DOI 10.1210/en.2002-220121; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Ketterer K, 2009, CANCER LETT, V277, P72, DOI 10.1016/j.canlet.2008.11.028; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lin TY, 2013, AM J PHYSIOL-ENDOC M, V304, pE800, DOI 10.1152/ajpendo.00548.2012; MAGGI CA, 1990, BRIT J PHARMACOL, V99, P186, DOI 10.1111/j.1476-5381.1990.tb14675.x; Markovic D, 2013, METHOD ENZYMOL, V520, P323, DOI 10.1016/B978-0-12-391861-1.00015-0; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Raddatz R, 2000, J BIOL CHEM, V275, P32452, DOI 10.1074/jbc.M004613200; Seck T, 2005, MOL ENDOCRINOL, V19, P2132, DOI 10.1210/me.2004-0472; Shan LX, 2000, J BIOL CHEM, V275, P39482, DOI 10.1074/jbc.C000522200; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; SHIKATA J, 1992, SPINE, V17, P1534, DOI 10.1097/00007632-199212000-00021; Takahashi K, 2006, CANCER RES, V66, P9408, DOI 10.1158/0008-5472.CAN-06-1349; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Wu Y, 2007, ONCOGENE, V26, P765, DOI 10.1038/sj.onc.1209835; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136836	10.1371/journal.pone.0136836	http://dx.doi.org/10.1371/journal.pone.0136836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317338	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100147
J	Mir, AR; Uddin, M; Khan, F; Alam, K; Ali, A				Mir, Abdul Rouf; Uddin, Moin; Khan, Farzana; Alam, Khursheed; Ali, Asif			Dicarbonyl Induced Structural Perturbations Make Histone H1 Highly Immunogenic and Generate an Auto-Immune Response in Cancer	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROTEIN CROSS-LINKING; IN-VITRO; MAILLARD REACTION; NONENZYMATIC GLYCATION; CONFORMATIONAL-CHANGES; SERUM-ALBUMIN; RAGE LIGANDS; METHYLGLYOXAL; BIOMARKERS	Increased oxidative stress under hyperglycemic conditions, through the interaction of AGEs with RAGE receptors and via activation of interleukin mediated transcription signalling, has been reported in cancer. Proteins modifications are being explored for their roles in the development and progression of cancer and autoantibody response against them is gaining interest as a probe for early detection of the disease. This study has analysed the changes in histone H1 upon modification by methylglyoxal (MG) and its implications in auto-immuno-pathogenesis of cancer. Modified histone showed modifications in the aromatic residues, changed tyrosine microenvironment, intermolecular cross linking and generation of AGEs. It showed masking of hydrophobic patches and a hypsochromic shift in the in ANS specific fluorescence. MG aggressively oxidized histone H1 leading to the accumulation of reactive carbonyls. Far UV CD measurements showed di-carbonyl induced enhancement of the alpha structure and the induction of beta sheet conformation; and thermal denaturation (Tm) studies confirmed the thermal stability of the modified histone. FTIR analysis showed amide I band shift, generation of a carboxyethyl group and N-C alpha vibrations in the modified histone. LCMS analysis confirmed the formation of N epsilon-(carboxyethyl) lysine and electron microscopic studies revealed the amorphous aggregate formation. The modified histone showed altered cooperative binding with DNA. Modified H1 induced high titre antibodies in rabbits and the IgG isolated form sera of rabbits immunized with modified H1 exhibited specific binding with its immunogen in Western Blot analysis. IgG isolated from the sera of patients with lung cancer, prostate cancer, breast cancer and cancer of head and neck region showed better recognition for neo-epitopes on the modified histone, reflecting the presence of circulating autoantibodies in cancer. Since reports suggest a link between AGE-RAGE axis and carcinogenesis, glycoxidation of histone H1 and its immunogenicity paves ways for understanding role of glycoxidatively damaged nuclear proteins in cancer.	[Mir, Abdul Rouf; Uddin, Moin; Khan, Farzana; Alam, Khursheed; Ali, Asif] Aligarh Muslim Univ, Fac Med, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Uddin, M (corresponding author), Aligarh Muslim Univ, Fac Med, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	MIR, ABDUL ROUF/ABD-7542-2020	MIR, ABDUL ROUF/0000-0002-2897-4419; Alam, Khursheed/0000-0001-9729-9966	DST under its FIST programme	DST under its FIST programme	Authors are thankful to the Department of science and Technology(DST) for instrument facilities created with the financial help from DST under its FIST programme.	Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Ali Rashid, 2002, Methods Mol Biol, V186, P171; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Ansari N.A., 2013, ISRN BIOCH; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chellan P, 1999, ARCH BIOCHEM BIOPHYS, V368, P98, DOI 10.1006/abbi.1999.1291; Chervona Y, 2012, AM J CANCER RES, V2, P589; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; DANNA JA, 1974, BIOCHEMISTRY-US, V13, P2093, DOI 10.1021/bi00707a015; Dixit K, 2011, HUM IMMUNOL, V72, P219, DOI 10.1016/j.humimm.2010.12.004; Ehrlich H, 2009, INT J BIOL MACROMOL, V44, P51, DOI 10.1016/j.ijbiomac.2008.10.001; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074336; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guedes S, 2011, ANAL BIOANAL CHEM, V399, P3529, DOI 10.1007/s00216-011-4679-y; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Iram A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072075; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kang JH, 2006, J BIOCHEM MOL BIOL, V39, P335; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Khan MA, 2012, SCAND J RHEUMATOL, V41, P426, DOI 10.3109/03009742.2012.698300; Khan TA, 2011, INT J PEPT RES THER, V17, P271, DOI 10.1007/s10989-011-9267-7; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050380; Ko SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110542; Krechler T, 2010, CLIN BIOCHEM, V43, P882, DOI 10.1016/j.clinbiochem.2010.04.004; Kuleva N V, 2006, Tsitologiia, V48, P515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LO TWC, 1994, J BIOL CHEM, V269, P32299; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Lu HL, 2008, J PROTEOME RES, V7, P1388, DOI 10.1021/pr700818f; Luo XG, 2011, BREAST CANC FOCUSING; Mir AR, 2014, INT J BIOL MACROMOL, V69, P260, DOI 10.1016/j.ijbiomac.2014.05.057; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Pashikanti S, 2011, FREE RADICAL BIO MED, V50, P1410, DOI 10.1016/j.freeradbiomed.2011.01.034; Pedersen JW, 2011, LABMEDICINE, V42, P623, DOI 10.1309/LM2T3OU3RZRTHKSN; Roberts MJ, 2003, MUTAT RES-FUND MOL M, V522, P45, DOI 10.1016/S0027-5107(02)00232-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sattarahmady N, 2008, CARBOHYD RES, V343, P2229, DOI 10.1016/j.carres.2008.04.036; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Soussi T, 2000, CANCER RES, V60, P1777; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stopper H, 2003, CANCER LETT, V190, P151, DOI 10.1016/S0304-3835(02)00626-2; Talasz H, 2002, J CELL BIOCHEM, V85, P24, DOI 10.1002/jcb.10103; TARKKA T, 1993, BIOCHIM BIOPHYS ACTA, V1180, P294, DOI 10.1016/0925-4439(93)90053-4; Van Heijst JWJ, 2005, ANN NY ACAD SCI, V1043, P725, DOI 10.1196/annals.1333.084; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; WELLSKNECHT KJ, 1995, J ORG CHEM, V60, P6246, DOI 10.1021/jo00125a001; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; Wondrak GT, 2000, BIOCHEM J, V351, P769, DOI 10.1042/0264-6021:3510769; Zhang G, 2011, J AGR FOOD CHEM, V59, P12037, DOI 10.1021/jf202515k	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136197	10.1371/journal.pone.0136197	http://dx.doi.org/10.1371/journal.pone.0136197			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317779	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100063
J	Rousseau, E; Joubert, M; Trzepla, G; Parienti, JJ; Freret, T; Vanthygem, MC; Desailloud, R; Lefebvre, H; Coquerel, A; Reznik, Y				Rousseau, Elise; Joubert, Michael; Trzepla, Geraldine; Parienti, Jean Jacques; Freret, Thomas; Vanthygem, Marie Christine; Desailloud, Rachel; Lefebvre, Herve; Coquerel, Antoine; Reznik, Yves		PHAD Study Grp	Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency	PLOS ONE			English	Article							MODIFIED-RELEASE HYDROCORTISONE; SUBJECTIVE HEALTH-STATUS; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; ADDISONS-DISEASE; PRODUCTION-RATES; PLASMA ACTH; THERAPY; SUBSTITUTION; MEN	Background Adjustment of daily hydrocortisone dose on clinical criteria lacks sensitivity for fine tuning. Long term hydrocortisone (HC) over-replacement may lead to increased morbidity and mortality in patients with adrenal insufficiency (AI). Biochemical criteria may help detecting over-or under-replacement but have been poorly evaluated. Methods Multicenter, institutional, pharmacokinetic study on ACTH and cortisol plasma profiles during HC replacement in 27 AI patients compared to 29 matched controls. All AI patients were administered HC thrice daily at doses of 6, 10 and 14 mg/m(2)/d. Blood samples were drawn hourly from 0800h to 1900h. The main outcome measures were: i) plasma peak cortisol and cortisol area under the curve (AUC) in AI patients compared to controls, ii) correlations between cortisol AUC vs single-point cortisol or ACTH decrease from baseline (Delta ACTH) and iii) the predictive value of the two latters for obtaining AI patients' cortisol AUC in the control range. Results Cortisol peaks were observed 1h after each HC intake and a dose response was demonstrated for cortisol peak and cortisol AUC. The comparison of AI patients' cortisol AUC to controls showed that 81.5% AI patients receiving 6mg/m(2)/d were adequately replaced, whereas most patients receiving higher doses were over-replaced. The correlation coefficient between 1000h/1400h cortisol concentrations and 0800-1900h cortisol AUC were 0.93/0.88 respectively, whereas the 0800-1200h Delta ACTH fairly correlated with 0800-1900h cortisol AUC (R = 0.57). ROC curve analysis indicated that the 1000h and 1400h cortisol concentrations best predicted over-replacement. Conclusions Patients receiving a 6mg/m(2) hydrocortisone daily dose exhibited the most physiological daytime cortisol profile. Single point plasma cortisol correlated with daytime cortisol AUC in AI patients. Although hydrocortisone dose should be currently determined on clinical grounds, our data suggest that single point plasma cortisol may be an adjunct for further hydrocortisone dose adjustment in AI patients.	[Rousseau, Elise; Joubert, Michael; Trzepla, Geraldine; Reznik, Yves] Caen Univ Hosp, Dept Endocrinol, F-14033 Caen, France; [Parienti, Jean Jacques] Caen Univ Hosp, Dept Clin Res, F-14033 Caen, France; [Freret, Thomas] Univ Caen Basse Normandie, UFR Sci Pharmaceut, EA4259, F-14032 Caen, France; [Vanthygem, Marie Christine] Lille Univ Hosp, Dept Endocrinol, F-59037 Lille, France; [Desailloud, Rachel] Hop SUD, Amiens Univ Hosp, Dept Endocrinol, F-80054 Amiens, France; [Lefebvre, Herve] Rouen Univ Hosp, Dept Endocrinol, F-76031 Rouen, France; [Lefebvre, Herve] Rouen Univ Hosp, INSERM, U413, IFRMP23, F-76031 Rouen, France; [Coquerel, Antoine] Caen Univ Hosp, Dept Pharmacol, F-14033 Caen, France; [Parienti, Jean Jacques; Freret, Thomas; Coquerel, Antoine; Reznik, Yves] Univ Caen Basse Normandie, Sch Med, F-14032 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Universite de Lille - ISITE; CHU Lille; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Universite de Franche-Comte	Reznik, Y (corresponding author), Caen Univ Hosp, Dept Endocrinol, F-14033 Caen, France.	reznik-y@chu-caen.fr	freret, thomas/AAA-2491-2019; Parienti, Jean-Jacques/AAD-1701-2021; Vantyghem, Marie-Christine/P-2939-2017; freret, thomas/B-2068-2012	freret, thomas/0000-0002-4446-4451; Parienti, Jean-Jacques/0000-0002-4774-5590; Vantyghem, Marie-Christine/0000-0002-9369-0463; freret, thomas/0000-0002-4446-4451; Lefebvre, Herve/0000-0002-6181-9648	Programme Hospitalier de Recherche Clinique, EudraCT [2007-005170-30]	Programme Hospitalier de Recherche Clinique, EudraCT	This study was supported by a grant from the Programme Hospitalier de Recherche Clinique 2007, EudraCT number 2007-005170-30.	AANDERUD S, 1982, ACTA ENDOCRINOL-COP, V100, P588, DOI 10.1530/acta.0.1000588; Arlt W, 2006, CLIN ENDOCRINOL, V64, P384, DOI 10.1111/j.1365-2265.2006.02473.x; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Behan LA, 2014, EUR J ENDOCRINOL, V170, P141, DOI 10.1530/EJE-13-0596; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bliesener N, 2003, EXP CLIN ENDOCR DIAB, V111, P443, DOI 10.1055/s-2003-44292; Crown A, 2005, CLIN ENDOCRINOL, V63, P483, DOI 10.1111/j.1365-2265.2005.02320.x; Debono M, 2009, J CLIN ENDOCR METAB, V94, P1548, DOI 10.1210/jc.2008-2380; DERENDORF H, 1991, J CLIN PHARMACOL, V31, P473, DOI 10.1002/j.1552-4604.1991.tb01906.x; ESTEBAN NV, 1990, STEROIDS, V55, P152, DOI 10.1016/0039-128X(90)90103-I; FEEK CM, 1981, CLIN ENDOCRINOL, V14, P451, DOI 10.1111/j.1365-2265.1981.tb00634.x; GROVES RW, 1988, J ROY SOC MED, V81, P514, DOI 10.1177/014107688808100906; Hahner S, 2007, J CLIN ENDOCR METAB, V92, P3912, DOI 10.1210/jc.2007-0685; Howlett TA, 1997, CLIN ENDOCRINOL, V46, P263, DOI 10.1046/j.1365-2265.1997.1340955.x; Husebye ES, 2014, J INTERN MED, V275, P104, DOI 10.1111/joim.12162; Jodar E, 2003, CLIN ENDOCRINOL, V58, P617, DOI 10.1046/j.1365-2265.2003.01761.x; Johannsson G, 2007, HORM RES, V68, P182, DOI 10.1159/000110621; Kraan GPB, 1998, J CLIN ENDOCR METAB, V83, P1247, DOI 10.1210/jc.83.4.1247; Lovas K, 2006, J ENDOCRINOL INVEST, V29, P727, DOI 10.1007/BF03344183; Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x; Mah PM, 2004, CLIN ENDOCRINOL, V61, P367, DOI 10.1111/j.1365-2265.2004.02106.x; Newell-Price J, 2008, CLIN ENDOCRINOL, V68, P130, DOI 10.1111/j.1365-2265.2007.03011.x; Peacey SR, 1997, CLIN ENDOCRINOL, V46, P255, DOI 10.1046/j.1365-2265.1997.780907.x; PEHUETFIGONI M, 1989, ANN ENDOCRINOL-PARIS, V50, P54; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Ragnarsson O, 2014, EUR J ENDOCRINOL, V171, P571, DOI 10.1530/EJE-14-0397; SCOTT RS, 1978, CLIN ENDOCRINOL, V9, P571, DOI 10.1111/j.1365-2265.1978.tb01516.x; Simon N, 2010, CLIN PHARMACOKINET, V49, P455, DOI 10.2165/11531290-000000000-00000; VALERO MA, 1994, BONE MINER, V26, P9, DOI 10.1016/S0169-6009(08)80158-4; Wichers M, 1999, CLIN ENDOCRINOL, V50, P759, DOI 10.1046/j.1365-2265.1999.00723.x; ZELISSEN PMJ, 1994, ANN INTERN MED, V120, P207, DOI 10.7326/0003-4819-120-3-199402010-00005; Zueger T, 2012, J CLIN ENDOCR METAB, V97, pE1938, DOI 10.1210/jc.2012-2432	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135975	10.1371/journal.pone.0135975	http://dx.doi.org/10.1371/journal.pone.0135975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317782	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100055
J	van Valkengoed, IGM; Vlaar, EMA; Nierkens, V; Middelkoop, BJC; Stronks, K				van Valkengoed, Irene G. M.; Vlaar, Everlina M. A.; Nierkens, Vera; Middelkoop, Barend J. C.; Stronks, Karien			The Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK; PREVENTION PROGRAM; GENERAL-PRACTICE; POPULATION; INTERVENTION; INDIVIDUALS; SURINAMESE; PREVALENCE; MELLITUS; DISEASE	Background Direct comparisons of the effect of a glycated haemoglobin measurement or an oral glucose tolerance test on the uptake and yield of screening in people of South Asian origin have not been made. We evaluated this in 18 to 60-year-old South Asian Surinamese. Materials and Methods We invited 3173 South Asian Surinamese for an oral glucose tolerance test between June 18th 2009-December 31st 2009 and 2012 for a glycated hemoglobin measurement between April 19th 2010-November 11th, 2010. Participants were selected from 48 general practices in The Hague, The Netherlands. We used mixed models regression to analyse differences in response and participation between the groups. We described differences in characteristics of participants and calculated the yield as the percentage of all cases identified, if all invitees had been offered screening with the specified method. Results The response and participation in the glycated hemoglobin group was higher than in the group offered an oral glucose tolerance test (participation 23.9 vs. 19.3; OR: 1.30, 95%-confidence interval1.01-1.69). After adjustment for age and sex, characteristics of participants were similar for both groups. Overall, glycated hemoglobin identified a similar percentage of type 2 diabetes cases but a higher percentage of prediabetes cases, in the population than the oral glucose tolerance test. Conclusion We found that glycated hemoglobin and the oral glucose tolerance test may be equally efficient for identification of type 2 diabetes in populations of South Asian origin. However, for programs aimed at identifying people at high risk of type 2 diabetes (i.e. with prediabetes), the oral glucose tolerance test may be a less efficient choice than glycated hemoglobin.	[van Valkengoed, Irene G. M.; Vlaar, Everlina M. A.; Nierkens, Vera; Stronks, Karien] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Middelkoop, Barend J. C.] Leiden Univ, Med Ctr, Dept Publ Hlth, Leiden, Netherlands; [Middelkoop, Barend J. C.] Publ Hlth Serv, The Hague, Netherlands	University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Valkengoed, IGM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.g.vanvalkengoed@amc.nl	van Valkengoed, Irene G.M./B-2974-2013; van Valkengoed, Irene/ABA-1551-2021	van Valkengoed, Irene G.M./0000-0002-9306-7831; van Valkengoed, Irene/0000-0002-9306-7831; Stronks, Karien/0000-0002-0921-2232; Catapano, Alberico Luigi/0000-0002-7593-2094	Netherlands Organization for Health Research and Development (ZonMW.nl) [120620023]	Netherlands Organization for Health Research and Development (ZonMW.nl)	This work was funded by the Netherlands Organization for Health Research and Development (ZonMW.nl; grant number 120620023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Banerjee AT, 2010, HEART LUNG, V39, P494, DOI 10.1016/j.hrtlng.2009.10.021; Bartlett C, 2005, Health Technol Assess, V9, piii; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; Choenni C., 2011, INTEGRATIE HINDOSTAN; Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Davies MJ, 1999, DIABETIC MED, V16, P131, DOI 10.1046/j.1464-5491.1999.00012.x; Dorman JS, 2012, DIABETES RES CLIN PR, V96, P156, DOI 10.1016/j.diabres.2011.12.017; Douglas A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-220; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; El Fakiri F, 2008, J IMMIGR MINOR HEALT, V10, P559, DOI 10.1007/s10903-008-9144-4; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gatewood JG, 2008, AM J HEALTH BEHAV, V32, P260; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; Gray LJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-56; Greaves CJ, 2004, FAM PRACT, V21, P57, DOI 10.1093/fampra/cmh113; Lawrence JM, 2001, BMJ-BRIT MED J, V323, P548, DOI 10.1136/bmj.323.7312.548; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Mangalmurti SS, 2010, ETHNIC DIS, V20, P474; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute of Health and Clinical Excellence, 2012, PREV TYP 2 DIAB RISK; Nicolaou M, 2014, HEALTH PROMOT INT, V29, P680, DOI 10.1093/heapro/dat018; O'Connor P J, 2001, Eff Clin Pract, V4, P271; Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Spijkerman AMW, 2002, DIABETES CARE, V25, P1784, DOI 10.2337/diacare.25.10.1784; Stronks K, 2011, DIABETOLOGIA, V54, P2214, DOI 10.1007/s00125-011-2258-6; The Working Group on Revised Hypertension Guidelines, 2000, REV HYP GUID; Toft UN, 2007, EUR J PUBLIC HEALTH, V17, P455, DOI 10.1093/eurpub/ckl262; van den Donk M, 2011, DIABETIC MED, V28, P1416, DOI 10.1111/j.1464-5491.2011.03365.x; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Vlaar EMA, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-8; Vlaar EMA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-371; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136734	10.1371/journal.pone.0136734	http://dx.doi.org/10.1371/journal.pone.0136734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317417	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100132
J	Vaz, S; Wilson, N; Falkmer, M; Sim, A; Scott, M; Cordier, R; Falkmer, T				Vaz, Sharmila; Wilson, Nathan; Falkmer, Marita; Sim, Angela; Scott, Melissa; Cordier, Reinie; Falkmer, Torbjorn			Factors Associated with Primary School Teachers' Attitudes Towards the Inclusion of Students with Disabilities	PLOS ONE			English	Article							SPECIAL EDUCATIONAL-NEEDS; SELF-EFFICACY; PRESERVICE; SENSE	Objective Teachers' attitudes toward inclusion are often based on the practical implementation of inclusive education rather than a specific ideology and understanding of inclusiveness. This study aimed to identify the factors associated with primary school teachers' attitudes towards inclusion of students with all disabilities in regular schools. Method Seventy four primary school teachers participated in a cross-sectional survey conducted in Western Australia. Teachers' attitudes and efficacy toward integration of students with disabilities were measured using the Opinions Relative to Integration of Students with Disabilities scale and Bandura's Teacher Efficacy scale respectively. Results Four teacher attributes-age, gender, teaching self-efficacy and training collectively explained 42% of the variability in teachers' attitude toward including students with disabilities. Conclusion The current study further contributes to the accumulation of knowledge that can unpack the complex pattern of factors that should be considered to promote positive attitudes towards inclusive schools.	[Vaz, Sharmila; Falkmer, Marita; Sim, Angela; Scott, Melissa; Cordier, Reinie; Falkmer, Torbjorn] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Wilson, Nathan] Univ Western Sydney, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, Sch Educ & Commun, CHILD Programme, Jonkoping, Sweden; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Rehabil Med, Linkoping, Sweden; [Falkmer, Torbjorn] Cty Council, Pain & Rehabil Ctr, UHL, Linkoping, Sweden	Curtin University; Western Sydney University; Jonkoping University; Linkoping University	Vaz, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	s.vaz@curtin.edu.au	Wilson, Nathan/ABF-9708-2020; Cordier, Reinie/AAH-6290-2019	Wilson, Nathan/0000-0002-6979-2099; Cordier, Reinie/0000-0002-9906-5300; Vaz, Sharmila/0000-0003-1003-9593; Chamberlain, Angela/0000-0002-9720-3095	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University; Healthway Australia	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University; Healthway Australia	This project was funded by the first author's doctoral scholarship provided by the Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University and Healthway Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghazo E.M., 2003, COLL STUD J, V37, P515; [Anonymous], 2003, AUST J LEARN DIFFIC, DOI [10.1080/19404150309546718, DOI 10.1080/19404150309546718]; [Anonymous], 2013, INCLUSION ED EQUALIT; [Anonymous], 1994, EUR J SPEC NEEDS EDU, DOI DOI 10.1080/0885625940090101; ANTONAK RF, 1995, EXCEPT CHILDREN, V62, P139, DOI 10.1177/001440299506200204; Avramidis E, 2000, TEACH TEACH EDUC, V16, P277, DOI 10.1016/S0742-051X(99)00062-1; Avramidis E., 2000, EDUC PSYCHOL-UK, V20, P191, DOI [10.1080/713663717, DOI 10.1080/713663717]; Avramidis E., 2002, EUR J SPEC NEEDS EDU, V17, P129, DOI [DOI 10.1080/08856250210129056, 10.1080/08856250210129056]; Bandura A, BANDURAS TEACHER EFF; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; BENDER WN, 1995, J LEARN DISABIL, V28, P87, DOI 10.1177/002221949502800203; Bizer GY, 2003, ATTITUDES ENCY COGNI, P247; Borko H., 1995, PROFESSIONAL DEV ED, P35; Brady K, 2008, BRIT J EDUC PSYCHOL, V78, P527, DOI 10.1348/000709907X268570; Burke K, 2004, EDUCATION, V125; Campbell J, 2003, J INTELLECT DEV DIS, V28, P369, DOI 10.1080/13668250310001616407; Molto MCC, 2010, EUR J TEACH EDUC, V33, P245, DOI 10.1080/02619768.2010.495771; Chester MD, 1996, AM EDUC RES J, V33, P233, DOI 10.2307/1163386; Cook BG, 2000, EXCEPTIONAL CHILDREN, V67; Costello S, 2013, AUST J TEACH EDUC, V38, P129; Cushman P, 2005, TEACH TEACH EDUC, V21, P227, DOI 10.1016/j.tate.2005.01.012; de Boer A, 2011, INT J INCLUSIVE EDUC, V15, P331, DOI 10.1080/13603110903030089; DEMBO MH, 1985, ELEM SCHOOL J, V86, P173, DOI 10.1086/461441; Department of Housing and Settlement Areas of Banyumas Regency, 2011, SPATIAL STRUCTURE MA; Ellins J, 2005, BRIT J SPEC EDUC, V32, P188, DOI 10.1111/j.1467-8578.2005.00396.x; Falkmer M, 2013, INT J DISABIL DEV ED, V62, P1; Field A., 2006, DISCOVERING STAT USI; Forlin C., 1995, BRIT J SPECIAL ED, V22, P179, DOI DOI 10.1111/J.1467-8578.1995.TB00932.X; Forlin C., 1996, INT J DISABIL DEV ED, V43, P19; Forlin C., 2003, INT J LEARNING, V10, P183; Forlin C, 2011, ASIA-PAC J TEACH EDU, V39, P17, DOI 10.1080/1359866X.2010.540850; Forlin C, 2009, INT J INCLUSIVE EDUC, V13, P195, DOI 10.1080/13603110701365356; Gething L, 1997, INT J REHABIL RES, V20, P149, DOI 10.1097/00004356-199706000-00004; GUSKEY TR, 1994, AM EDUC RES J, V31, P627, DOI 10.2307/1163230; Hastings R.P., 2003, EDUC PSYCHOL-UK, V23, P87, DOI [10.1080/01443410303223, DOI 10.1080/01443410303223]; Hemmings B, 2011, AUSTRALAS J SPEC EDU, V35, P103, DOI 10.1375/ajse.35.2.103; Hollins ER, 2011, J TEACH EDUC, V62, P395, DOI 10.1177/0022487111409415; Jordan A, 1997, REM SPEC EDUC, V18, P82, DOI 10.1177/074193259701800202; Lazarus R. S., 1987, STRESS APPRAISAL COP; Leyser Y., 2004, INT J DISABIL DEV ED, V51, P271, DOI DOI 10.1080/1034912042000259233; McKnight P. E., 2007, MISSING DATA GENTLE; MEIJER CJW, 1988, J SPEC EDUC, V22, P378, DOI 10.1177/002246698802200309; Meyers L. S., 2006, APPL MULTIVARIATE RE; OECD, 2005, STUD DIS LEARN DIFF; Ross-Hill R, 2009, J RES SPEC EDUC NEED, V9, P188, DOI 10.1111/j.1471-3802.2009.01135.x; Savolainen H, 2012, EUR J SPEC NEEDS EDU, V27, P51, DOI 10.1080/08856257.2011.613603; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Scruggs TE, 1996, EXCEPT CHILDREN, V63, P59, DOI 10.1177/001440299606300106; Sharma U, 2006, INT J INCLUSIVE ED, V21; Sharma U, 2012, J RES SPEC EDUC NEED, V12, P12, DOI 10.1111/j.1471-3802.2011.01200.x; Shulman LS., 1986, EDUC RESEARCHER, V15, P4, DOI [10.3102/0013189X015002004, 10.3102%2F0013189X015002004, DOI 10.3102/0013189X015002004]; Soodak LC, 1998, J SPEC EDUC, V31, P480, DOI 10.1177/002246699803100405; Subban P., 2006, INT J SPEC EDUC, V21, P42; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tait K., 2000, INT J DISABIL DEV ED, V47, P25, DOI [10.1080/103491200116110, DOI 10.1080/103491200116110]; Tschannen-Moran M, 1998, REV EDUC RES, V68, P202, DOI 10.2307/1170754; UNESCO, 1994, SALAMANCA STATEMENT; UNESCO, 1994, THE SALAMANCA STATEM; Van Reusen A. K., 2000, HIGH SCH J, V84, P7; Vaz S, 2010, FACTORS AFFECTING ST; Vaz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099576; Weisel A, 2006, EDUC CITIZSH SOC JUS, V1, P157, DOI 10.1177/1746197906064677; Wilson NJ, 2009, J INTELL DISABIL RES, V53, P106, DOI 10.1111/j.1365-2788.2008.01133.x; Wilson NJ, 2011, INTELLECT DEV DISAB, V49, P341, DOI 10.1352/1934-9556-49.5.341; Woodcock S, 2013, AUST J TEACH EDUC, V38, P16, DOI 10.14221/ajte.2013v38n8.6	65	67	70	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137002	10.1371/journal.pone.0137002	http://dx.doi.org/10.1371/journal.pone.0137002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317862	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100192
J	Grenier, C; Cao, TV; Ospina, Y; Quintero, C; Chatel, MH; Tohme, J; Courtois, B; Ahmadi, N				Grenier, Cecile; Cao, Tuong-Vi; Ospina, Yolima; Quintero, Constanza; Chatel, Marc Henri; Tohme, Joe; Courtois, Brigitte; Ahmadi, Nourollah			Accuracy of Genomic Selection in a Rice Synthetic Population Developed for Recurrent Selection Breeding	PLOS ONE			English	Article							QUANTITATIVE TRAITS; RIDGE-REGRESSION; GENOMEWIDE SELECTION; MOLECULAR MARKERS; ENABLED PREDICTION; UNIFIED APPROACH; ORYZA-SATIVA; PEDIGREE; PACKAGE; PLANT	Genomic selection (GS) is a promising strategy for enhancing genetic gain. We investigated the accuracy of genomic estimated breeding values (GEBV) in four inter-related synthetic populations that underwent several cycles of recurrent selection in an upland rice-breeding program. A total of 343 S-2:4 lines extracted from those populations were phenotyped for flowering time, plant height, grain yield and panicle weight, and genotyped with an average density of one marker per 44.8 kb. The relative effect of the linkage disequilibrium (LD) and minor allele frequency (MAF) thresholds for selecting markers, the relative size of the training population (TP) and of the validation population (VP), the selected trait and the genomic prediction models (frequentist and Bayesian) on the accuracy of GEBVs was investigated in 540 cross validation experiments with 100 replicates. The effect of kinship between the training and validation populations was tested in an additional set of 840 cross validation experiments with a single genomic prediction model. LD was high (average r(2) = 0.59 at 25 kb) and decreased slowly, distribution of allele frequencies at individual loci was markedly skewed toward unbalanced frequencies (MAF average value 15.2% and median 9.6%), and differentiation between the four synthetic populations was low (F-ST <= 0.06). The accuracy of GEBV across all cross validation experiments ranged from 0.12 to 0.54 with an average of 0.30. Significant differences in accuracy were observed among the different levels of each factor investigated. Phenotypic traits had the biggest effect, and the size of the incidence matrix had the smallest. Significant first degree interaction was observed for GEBV accuracy between traits and all the other factors studied, and between prediction models and LD, MAF and composition of the TP. The potential of GS to accelerate genetic gain and breeding options to increase the accuracy of predictions are discussed.	[Grenier, Cecile; Ospina, Yolima; Quintero, Constanza; Chatel, Marc Henri; Tohme, Joe] CIAT, Cali 6713, Colombia; [Grenier, Cecile; Cao, Tuong-Vi; Courtois, Brigitte; Ahmadi, Nourollah] CIRAD, AGAP, UMR, F-34398 Montpellier, France	Alliance; International Center for Tropical Agriculture - CIAT; CIRAD; Universite de Montpellier	Grenier, C (corresponding author), CIAT, Cali 6713, Colombia.	c.grenier@cgiar.org	COURTOIS, Brigitte/A-4004-2009	COURTOIS, Brigitte/0000-0003-2118-7102; AHMADI, Nourollah/0000-0003-0072-6285	Cirad; CIAT (Centro International de Agricultura Tropical); Agropolis Foundation	Cirad; CIAT (Centro International de Agricultura Tropical); Agropolis Foundation	The research activity was funded as part of the core budget of Cirad, and CIAT (Centro International de Agricultura Tropical) and specific funds from the Agropolis Foundation.	Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de Los Campos Gustavo, 2013, Methods Mol Biol, V1019, P299, DOI 10.1007/978-1-62703-447-0_12; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frouin J, 2014, MOL BREEDING, V33, P555, DOI 10.1007/s11032-013-9972-3; Gilmour A, 2009, ASREML USER GUIDE; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Guimar~aes EP, 2005, POPULATION IMPROVEME; Guo ZG, 2014, THEOR APPL GENET, V127, P749, DOI 10.1007/s00122-013-2255-x; Guo ZG, 2012, THEOR APPL GENET, V124, P261, DOI 10.1007/s00122-011-1702-9; Hallauer AR, 2010, HANDB PLANT BREED, V6, P577, DOI 10.1007/978-1-4419-0766-0_12; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Lorieux M, 2000, THEOR APPL GENET, V100, P593, DOI 10.1007/s001229900061; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Mayor PJ, 2009, CROP SCI, V49, P1719, DOI 10.2135/cropsci2008.10.0587; Meuwissen THE, 2011, J ANIM BREED GENET, V128, P429, DOI 10.1111/j.1439-0388.2011.00966.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Nomura T, 2008, EVOL APPL, V1, P462, DOI 10.1111/j.1752-4571.2008.00015.x; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Perez-Rodriguez P, 2012, G3-GENES GENOM GENET, V2, P1595, DOI 10.1534/g3.112.003665; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Scutari M, 2013, BAYESIAN ANAL, V8, P505, DOI 10.1214/13-BA819; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Wright S, 1931, GENETICS, V16, P0097; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Zhang LY, 2008, GENETICS, V180, P1177, DOI 10.1534/genetics.108.092122; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	55	54	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136594	10.1371/journal.pone.0136594	http://dx.doi.org/10.1371/journal.pone.0136594			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313446	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000072
J	Lang, C; Costa, FRC; Camargo, JLC; Durgante, FM; Vicentini, A				Lang, Carla; Capellotto Costa, Flavia Regina; Campana Camargo, Jose Luis; Durgante, Flavia Machado; Vicentini, Alberto			Near Infrared Spectroscopy Facilitates Rapid Identification of Both Young and Mature Amazonian Tree Species	PLOS ONE			English	Article							ECOLOGICAL APPLICATIONS; ONTOGENIC TRANSITION; PLANT; FOREST; DNA; SPECTRA; WALL; DISCRIMINATION; BIODIVERSITY; PREDICTION	Precise identification of plant species requires a high level of knowledge by taxonomists and presence of reproductive material. This represents a major limitation for those working with seedlings and juveniles, which differ morphologically from adults and do not bear reproductive structures. Near-infrared spectroscopy (FT-NIR) has previously been shown to be effective in species discrimination of adult plants, so if young and adults have a similar spectral signature, discriminant functions based on FT-NIR spectra of adults can be used to identify leaves from young plants. We tested this with a sample of 419 plants in 13 Amazonian species from the genera Protium and Crepidospermum (Burseraceae). We obtained 12 spectral readings per plant, from adaxial and abaxial surfaces of dried leaves, and compared the rate of correct predictions of species with discriminant functions for different combinations of readings. We showed that the best models for predicting species in early developmental stages are those containing spectral data from both young and adult plants (98% correct predictions of external samples), but even using only adult spectra it is still possible to attain good levels of identification of young. We obtained an average of 75% correct identifications of young plants by discriminant equations based only on adults, when the most informative wavelengths were selected. Most species were accurately predicted (75-100% correct identifications), and only three had poor predictions (27-60%). These results were obtained despite the fact that spectra of young individuals were distinct from those of adults when species were analyzed individually. We concluded that FT-NIR has a high potential in the identification of species even at different ontogenetic stages, and that young plants can be identified based on spectra of adults with reasonable confidence.	[Lang, Carla] Inst Nacl de Pesquisas da Amazonia, Grad Program Bot, Manaus, Amazonas, Brazil; [Capellotto Costa, Flavia Regina] Inst Nacl de Pesquisas da Amazonia, Dept Biodivers, Manaus, Amazonas, Brazil; [Campana Camargo, Jose Luis] Biol Dynam Forest Fragments Project INPA STRI, Manaus, Amazonas, Brazil; [Durgante, Flavia Machado; Vicentini, Alberto] Inst Nacl de Pesquisas da Amazonia, Dept Environm Dynam, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Lang, C (corresponding author), Inst Nacl de Pesquisas da Amazonia, Grad Program Bot, Manaus, Amazonas, Brazil.	carlangbio@gmail.com	Vicentini, Alberto/F-7479-2012; Camargo, José Luís C/C-3137-2015; Costa, Flavia/K-4386-2014	Vicentini, Alberto/0000-0002-5906-9358; Costa, Flavia/0000-0002-9600-4625; Campana Camargo, Jose Luis/0000-0003-0370-9878; Durgante, Flavia/0000-0002-5517-8821	Brazilian National Research Council (CNPq); CNPq-PELD project; CNPq Universal [481297/2011-1]; Conselho Nacional de Pesquisa (CNPq) [481297/2011-1, 403764/2012-2]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq-PELD project; CNPq Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This contribution is part of a Master's thesis at the Instituto Nacional de Pesquisas da Amazonia (INPA), which was supported by a fellowship from the Brazilian National Research Council (CNPq), the CNPq-PELD project and CNPq Universal 481297/2011-1. Flavia R C Costa is the recipient of Conselho Nacional de Pesquisa (CNPq) (http://www.cnpq.br/) Grant # 403764/2012-2 and Grant # 481297/2011-1.	Abasolo M, 2013, FOREST ECOL MANAG, V304, P121, DOI 10.1016/j.foreco.2013.04.040; Acuna MA, 2006, FOREST PROD J, V56, P67; Andreata R. H. P., 1990, PESQ BOT, V41, p,; Dang-Le AT, 2013, TREES-STRUCT FUNCT, V27, P773, DOI 10.1007/s00468-012-0832-2; Asner GP, 2014, NEW PHYTOL, V204, P127, DOI 10.1111/nph.12895; CABRAL D, 1993, MYCOL RES, V97, P367, DOI 10.1016/S0953-7562(09)81140-4; Camargo J.L.C., 2008, GUIA PROPAGULOS PLAN; Carlson KM, 2007, ECOSYSTEMS, V10, P536, DOI 10.1007/s10021-007-9041-z; Castillo R, 2008, J CHIL CHEM SOC, V53, P1709, DOI 10.4067/S0717-97072008000400016; Castro-Esau KL, 2004, REMOTE SENS ENVIRON, V90, P353, DOI 10.1016/j.rse.2004.01.013; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Curty C, 2013, THESIS INPA AMAZONAS; da Luz BR, 2006, NEW PHYTOL, V172, P305, DOI 10.1111/j.1469-8137.2006.01823.x; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Dhugga KS, 2001, CURR OPIN PLANT BIOL, V4, P488, DOI 10.1016/S1369-5266(00)00205-3; Durgante FM, 2013, FOREST ECOL MANAG, V291, P240, DOI 10.1016/j.foreco.2012.10.045; Eastrada C, 2014, FUNGAL ECOL, V8, P37, DOI 10.1016/j.funeco.2013.12.009; Fan Q, 2010, TALANTA, V80, P1245, DOI 10.1016/j.talanta.2009.09.018; Fernandez JIR, 2011, ZOOTAXA, V2933, P46; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Frago E, 2012, TRENDS ECOL EVOL, V27, P705, DOI 10.1016/j.tree.2012.08.013; Gomes ACS, 2013, J VEG SCI, V24, P70, DOI 10.1111/j.1654-1103.2012.01441.x; Gonzalez MA, 2009, PLOS ONE, V4, P1; Gorshkova TA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P159, DOI 10.1134/S0006297910020069; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hauksson JB, 2001, WOOD SCI TECHNOL, V35, P475, DOI 10.1007/s00226-001-0123-3; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; HIGGINS HG, 1961, J POLYM SCI, V51, P59, DOI 10.1002/pol.1961.1205115505; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hopkins Michael J.G., 2005, Rodriguésia, V56, P9, DOI 10.1590/2175-78602005568602; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Ishida A, 2005, TREE PHYSIOL, V25, P513, DOI 10.1093/treephys/25.5.513; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kursar TA, 1999, PHARM BIOL, V37, P114, DOI 10.1076/1388-0209(200010)37:SUP;1-W;FT114; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Li BX, 2012, VIB SPECTROSC, V62, P17, DOI 10.1016/j.vibspec.2012.05.001; Luz BR, 2007, REMOTE SENS ENVIRON, V109, P393; Maree JE, 2011, VIB SPECTROSC, V55, P146, DOI 10.1016/j.vibspec.2010.10.005; Mediavilla S, 2014, J PLANT ECOL, V7, P567, DOI 10.1093/jpe/rtt059; Mediavilla S, 2009, ECOL RES, V24, P1083, DOI 10.1007/s11284-009-0587-4; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Pasquini C, 2003, J BRAZIL CHEM SOC, V14, P198, DOI 10.1590/S0103-50532003000200006; R Core Team, 2020, R LANG ENV STAT COMP; Raven PH, 2014, PLANT BIOLOGY; Roberts DA, 1998, TREES-STRUCT FUNCT, V12, P315, DOI 10.1007/s004680050157; Russell MF, 2003, PHYTOCHEMISTRY, V62, P683, DOI 10.1016/S0031-9422(02)00607-6; Schwanninger M, 2004, HOLZ ROH WERKST, V62, P483, DOI 10.1007/s00107-004-0520-z; SP, 2002, SENSORIAMENTO REMOTO; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Strgulc Krajsek S, 2008, CHEM BIODIVERS, V5, P310, DOI 10.1002/cbdv.200890028; Terdwongworakul A, 2005, J WOOD SCI, V51, P167, DOI 10.1007/s10086-004-0633-3; Uchitel A, 2011, OECOLOGIA, V165, P465, DOI 10.1007/s00442-010-1740-z; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; vanSoest JJG, 1995, CARBOHYD RES, V279, P201, DOI 10.1016/0008-6215(95)00270-7; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Weihs C, 2005, ST CLASS DAT ANAL, P335; WILLIAMS BK, 1988, ECOLOGY, V69, P1275, DOI 10.2307/1941283; Wilson RH, 2000, PLANT PHYSIOL, V124, P397, DOI 10.1104/pp.124.1.397; WONG CL, 1967, AUST J BIOL SCI, V20, P501, DOI 10.1071/BI9670501; Workman Jr J, 2007, PRACTICAL GUIDE INTE	63	30	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0134521	10.1371/journal.pone.0134521	http://dx.doi.org/10.1371/journal.pone.0134521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312996	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000008
J	Papler, TB; Bokal, EV; Maver, A; Kopitar, AN; Lovrecic, L				Papler, Tanja Burnik; Bokal, Eda Vrtacnik; Maver, Ales; Kopitar, Andreja Natasa; Lovrecic, Luca			Transcriptomic Analysis and Meta-Analysis of Human Granulosa and Cumulus Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LONG NONCODING RNAS; CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; OOCYTE DEVELOPMENTAL COMPETENCE; DIFFERENTIALLY EXPRESSED GENES; FALSE DISCOVERY RATE; EXTRACELLULAR-MATRIX; MICROARRAY ANALYSIS; INTERLEUKIN-1 FAMILY; FOLLICLE DEVELOPMENT	Specific gene expression in oocytes and its surrounding cumulus (CC) and granulosa (GC) cells is needed for successful folliculogenesis and oocyte maturation. The aim of the present study was to compare genome-wide gene expression and biological functions of human GC and CC. Individual GC and CC were derived from 37 women undergoing IVF procedures. Gene expression analysis was performed using microarrays, followed by a meta-analysis. Results were validated using quantitative real-time PCR. There were 6029 differentially expressed genes (q < 10(-4)); of which 650 genes had a log2 FC >= 2. After the meta-analysis there were 3156 genes differentially expressed. Among these there were genes that have previously not been reported in human somatic follicular cells, like prokineticin 2 (PROK2), higher expressed in GC, and pregnancy up-regulated nonubiquitous CaM kinase (PNCK), higher expressed in CC. Pathways like inflammatory response and angiogenesis were enriched in GC, whereas in CC, cell differentiation and multicellular organismal development were among enriched pathways. In conclusion, transcriptomes of GC and CC as well as biological functions, are distinctive for each cell subpopulation. By describing novel genes like PROK2 and PNCK, expressed in GC and CC, we upgraded the existing data on human follicular biology.	[Papler, Tanja Burnik; Bokal, Eda Vrtacnik] Univ Med Ctr Ljubljana, Div Obstet & Gynaecol, Dept Human Reprod, Ljubljana 2, Slovenia; [Maver, Ales; Lovrecic, Luca] Univ Med Ctr, Div Obstet & Gynaecol, Dept Med Genet, Ljubljana, Slovenia; [Kopitar, Andreja Natasa] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana	Lovrecic, L (corresponding author), Univ Med Ctr, Div Obstet & Gynaecol, Dept Med Genet, Slajmerjeva 4, Ljubljana, Slovenia.	lucalovrecic@gmail.com	Lovrecic, Luca/S-8196-2018	Lovrecic, Luca/0000-0003-4119-9530	Slovenian Research Agency [P3-0326]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was funded by the Slovenian Research Agency (https://www.arrs.gov.si/en/novo.asp), grant number P3-0326. Tanja Burnik Papler is funded as a young researcher by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; AREND WP, 1991, J CLIN INVEST, V88, P1445, DOI 10.1172/JCI115453; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Balasubramanian R, 2011, MOL CELL ENDOCRINOL, V346, P44, DOI 10.1016/j.mce.2011.05.040; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Bonnet A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-904; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Deb TB, 2008, AM J PHYSIOL-CELL PH, V295, pC365, DOI 10.1152/ajpcell.00449.2007; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Dragovic RA, 2005, ENDOCRINOLOGY, V146, P2798, DOI 10.1210/en.2005-0098; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; Familiari G, 1996, MOL REPROD DEV, V43, P392, DOI 10.1002/(SICI)1098-2795(199603)43:3<392::AID-MRD14>3.0.CO;2-3; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fleming JS, 2006, MOL CELL ENDOCRINOL, V247, P4, DOI 10.1016/j.mce.2005.09.014; Gardner HP, 2000, GENOMICS, V63, P279, DOI 10.1006/geno.1999.6091; Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203; Ghosh Debashis, 2003, Functional & Integrative Genomics, V3, P180; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; GIUDICE LC, 1992, ENDOCR REV, V13, P641, DOI 10.1210/er.13.4.641; Greenwald G.S., 1988, P387; Grondahl ML, 2012, MOL HUM REPROD, V18, P572, DOI 10.1093/molehr/gas035; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ingman WV, 2000, MOL CELL ENDOCRINOL, V164, P53, DOI 10.1016/S0303-7207(00)00240-9; Jusuf AA, 2002, NEUROSCIENCE, V109, P407, DOI 10.1016/S0306-4522(01)00514-0; Kawasaki F, 2003, CLIN EXP MED, V3, P27, DOI 10.1007/s102380300012; Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/Y10-009, 10.1139/y10-009]; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Koks S, 2010, MOL HUM REPROD, V16, P229, DOI 10.1093/molehr/gap103; Lam PM, 2005, FERTIL STERIL, V84, P1775, DOI 10.1016/j.fertnstert.2005.05.059; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Li QL, 2008, MOL HUM REPROD, V14, P673, DOI 10.1093/molehr/gan064; Lin R, 2002, J BIOL CHEM, V277, P8724, DOI 10.1074/jbc.M110594200; Liu Z, 2008, J ASSIST REPROD GEN, V25, P223, DOI 10.1007/s10815-008-9219-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martoriati Alain, 2003, Reprod Biol Endocrinol, V1, P42; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; MOLEY KH, 1995, ADV EXP MED BIOL, V377, P103; Monget P, 2000, MOL CELL ENDOCRINOL, V163, P89, DOI 10.1016/S0303-7207(99)00244-0; Murdoch WJ, 1999, BIOL REPROD, V61, P1655, DOI 10.1095/biolreprod61.6.1655; Naito Y, 1997, J BIOL CHEM, V272, P32704, DOI 10.1074/jbc.272.51.32704; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; PARROTT JA, 1993, ENDOCRINOLOGY, V133, P1645, DOI 10.1210/en.133.4.1645; PIQUETTE GN, 1994, FERTIL STERIL, V62, P760; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pricci F, 1996, ENDOCRINOLOGY, V137, P879, DOI 10.1210/en.137.3.879; Rae MT, 2004, J ENDOCRINOL, V183, P19, DOI 10.1677/joe.1.05754; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Shimada M, 2006, MOL ENDOCRINOL, V20, P3228, DOI 10.1210/me.2006-0194; SIMS JE, 1994, EUR CYTOKINE NETW, V5, P539; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suzuki T, 1998, HUM REPROD, V13, P953, DOI 10.1093/humrep/13.4.953; Szaniszlo P, 2004, CYTOM PART A, V59A, P191, DOI 10.1002/cyto.a.20055; Thomas FH, 2005, ENDOCRINOLOGY, V146, P941, DOI 10.1210/en.2004-0826; Vanderhyden BC, 2003, REPRODUCTION, P55; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wilson KE, 1999, BRIT J CANCER, V80, P685, DOI 10.1038/sj.bjc.6690410; Wilson KE, 1996, BRIT J CANCER, V74, P999, DOI 10.1038/bjc.1996.480; Woods DC, 2009, REPRODUCTION, V137, P987, DOI 10.1530/REP-08-0320; Xu XF, 2015, REPROD SCI, V22, P672, DOI 10.1177/1933719114561562; Yerushalmi GM, 2014, MOL HUM REPROD, V20, P719, DOI 10.1093/molehr/gau031; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x	75	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136473	10.1371/journal.pone.0136473	http://dx.doi.org/10.1371/journal.pone.0136473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313571	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000061
J	Yu, XF; Yang, HJ; Yu, Y; Zou, DH; Miao, LL				Yu, Xing-Fei; Yang, Hong-Jian; Yu, Yang; Zou, De-Hong; Miao, Lu-Lu			A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC)	PLOS ONE			English	Article							POPULATION; EXPRESSION; CARCINOMA	Background Male breast cancer (MBC) is known to be rare compared with female breast cancer (FBC) and to account for only 1% of all breast cancers. To date, male patients diagnosed with breast cancer are normally treated based on the guidelines for FBC. Specifically, studies have found that diagnosing and treating MBC patients under the guidelines for the treatment of post-menopausal FBC are more favorable than are those of pre/peri-menopausal FBC from a physiological perspective because MBC and post-menopausal FBC patients show high estrogen receptor (ER) expression in the tumor and low estrogen expression in the body. In this medical study, we aimed to examine whether MBC actually has the same prognosis as post-menopausal FBC. Method We identified MBC patients who were diagnosed as operable and who completed clinical treatment and we used follow-up data that were collected from January 2001 to January 2011. Each MBC patient was paired with four FBC patients who were diagnosed within the same period (two were pre/peri-menopausal, and two were post-menopausal). We compared disease-free survival (DFS) and overall survival (OS) among three groups, i.e., pre/peri-menopausal FBC (group A), post-menopausal FBC (group B) and MBC (group M), using the Kaplan-Meier method and a Cox proportional hazards regression model. We also evaluated the clinical characteristics of breast cancer patients using t-tests and chi-square tests. We used ten consecutive years of data that were collected at Zhejiang Provincial Cancer Hospital. Results We identified 91 MBC cases for group M, 182 FBC cases for group A and 182 FBC cases for group B. The median follow-up period was 112 months. MBC cases were much more frequently ER positive than those of group A and group B (p< 0.01); a similar trend was also found for progesterone (PR)-positive cases (p< 0.01). The MBC group showed much lower human epidermal growth factor receptor-2 (HER2) expression than did the other groups (p< 0.01). The 10-year OS rates were 79.1% for group M (72/91), 79.1%(144/182) for group A, and 87.9% (160/182) for group B, log-rank test indicated that group M had similar mean OS time as group A and group B (GourpM vs group A: p = 0.709; group M vs group B: p = 0.042). The Cox proportional hazards regression model indicated that pre/peri-menopausal FBC had similar DFS (hazard ratio (HR) = 0.706, p = 0.262) and OS (HR = 1.029, p = 0.941) values compared with MBC, whereas post-menopausal FBC had higher DFS (HR = 0.454, p = 0.004) and OS (HR = 0.353, p = 0.003) values than did MBC. Conclusion Based on this study, we can conclude that MBC displayed higher ER-and PR-positive expression and lower HER2-positive expression than both post-menopausal and pre/perimenopausal FBC. However, the DFS and OS values of MBC were similar to those of pre/peri-menopausal FBC and were worse than were those of post-menopausal FBC.	[Yu, Xing-Fei; Yang, Hong-Jian; Yu, Yang; Zou, De-Hong] Zhejiang Prov Canc Hosp, Dept Breast Tumor Surg, Hangzhou, Zhejiang, Peoples R China; [Miao, Lu-Lu] Zhejiang Prov Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Miao, LL (corresponding author), Zhejiang Prov Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.	miaolulu1983@hotmail.com			Zhejiang Medical Technology and Education Funding [2011RCA015]	Zhejiang Medical Technology and Education Funding	Funding provided by Zhejiang Medical Technology and Education Funding, 2011RCA015. Data collection was sponsored by the funders.	Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Arslan UY, 2012, MED ONCOL, V29, P554, DOI 10.1007/s12032-011-9978-9; Bloom KJ, 2001, AM J SURG, V182, P382; Cardoso F, 2014, SAN ANT BREAST CANC; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; Field KM, 2008, ASIA-PAC J CLIN ONCO, V4, P6, DOI 10.1111/j.1743-7563.2008.00141.x; Foerster R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-335; Ge YM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2258; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312; Giordano SH, 2002, ANN INTERN MED, V137, P678, DOI 10.7326/0003-4819-137-8-200210150-00013; Gnerlich JL, 2011, ANN SURG ONCOL, V18, P1837, DOI 10.1245/s10434-010-1468-3; Hinrichs CS, 2004, ANN SURG ONCOL, V11, P573, DOI 10.1245/ASO.2004.04.017; Ly D, 2013, INT J CANCER, V132, P1918, DOI 10.1002/ijc.27841; Meguerditchian AN, 2002, CAN J SURG, V45, P296; Muir D, 2003, ARCH PATHOL LAB MED, V127, P36; Murphy CE, 2006, EJSO-EUR J SURG ONC, V32, P44, DOI 10.1016/j.ejso.2005.09.013; Nahleh ZA, 2007, CANCER-AM CANCER SOC, V109, P1471, DOI 10.1002/cncr.22589; Rudlowski C, 2004, BREAST CANCER RES TR, V84, P215, DOI 10.1023/B:BREA.0000019953.92921.7e; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Speirs V, 2010, BREAST CANC RES S, V12, P1; Tajima N, 2001, J Epidemiol, V11, P1; Wang-Rodriguez J, 2002, MODERN PATHOL, V15, P853, DOI 10.1097/01.MP.0000022251.61944.1D; Yu XF, 2013, BREAST, V2, P5	23	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136670	10.1371/journal.pone.0136670	http://dx.doi.org/10.1371/journal.pone.0136670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313461	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000084
J	Starha, P; Dvorak, Z; Travnicek, Z				Starha, Pavel; Dvorak, Zdenek; Travnicek, Zdenek			Highly and Broad-Spectrum In Vitro Antitumor Active cis-Dichloridoplatinum(II) Complexes with 7-Azaindoles	PLOS ONE			English	Article							ANTI-TUMOR ACTIVITY; CISPLATIN RESISTANCE; PLATINUM COMPOUNDS; OVARIAN-CANCER; DERIVATIVES; CELLS; PHENANTHRIPLATIN; OXALIPLATIN; INHIBITION; MODULATION	The cis-[PtCl2(naza)(2)] complexes (1-3) containing monosubstituted 7-azaindole halogeno-derivatives (naza), showed significantly higher activity than cisplatin towards ovarian carcinoma A2780, its cisplatin-resistant variant A2780R, osteosarcoma HOS, breast carcinoma MCF7 and cervix carcinoma HeLa cell lines, with the IC50 values of 3.8, 3.5, 4.5, 2.7, and 9.2 mu M, respectively, obtained for the most active complex 3. As for 4 and 5 having disubstituted 7-azaindoles in their molecule, the significant cytotoxicity was detected only for 4 against A2780 (IC50 = 4.8 mu M), A2780R (IC50 = 3.8 mu M) and HOS (IC50 = 4.3 mu M), while 5 was evaluated as having only moderate antiproliferative effect against the mentioned cancer cell lines with IC50 = 33.4, 24.7 and 46.7 mu M, respectively. All the studied complexes 15 effectively avoided the acquired resistance of ovarian carcinoma cell line. On the other hand, the complexes did not reveal any inhibition activity on the purified 20S proteasome from the A2780 cells. The representative complexes 3 and 5 showed low ability to be hydrolysed, but their stability was markedly lowered in the presence of physiological sulphur-containing biomolecule glutathione (GSH), as proved by the H-1 NMR spectroscopy and mass spectrometry studies. A rate of interaction of the studied complexes with GSH was affected by an addition of another mechanistically relevant biomolecule guanosine monophosphate. The differences in interactions of 3 and 5 with GSH correlate well with their different cytotoxicity profiles.	[Starha, Pavel; Dvorak, Zdenek; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol, Div Biol Act Complexes & Mol Magnets, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol, Div Biol Act Complexes & Mol Magnets, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Starha, Pavel/H-3902-2016	Dvorak, Zdenek/0000-0002-3938-3585; Travnicek, Zdenek/0000-0002-5890-7874	Ministry of Education, Youth and Sports of the Czech Republic [LO1305]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The authors gratefully thank the National Program of Sustainability I (LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic for financial support (www.msmt.cz).	AKAMATSU K, 1992, BRIT J CANCER, V66, P827, DOI 10.1038/bjc.1992.368; Chen Y, 1998, CHEM-EUR J, V4, P672, DOI 10.1002/(SICI)1521-3765(19980416)4:4<672::AID-CHEM672>3.0.CO;2-8; Cvek B, 2008, DRUG DISCOV TODAY, V13, P716, DOI 10.1016/j.drudis.2008.05.003; DEJONG WH, 1983, CANCER RES, V43, P4927; HARRAP KR, 1985, CANCER TREAT REV, V12, P21, DOI 10.1016/0305-7372(85)90015-5; Hirano Y, 2005, METHOD ENZYMOL, V399, P227, DOI 10.1016/S0076-6879(05)99015-0; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Holford J, 1998, ANTI-CANCER DRUG DES, V13, P1; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Johnstone TC, 2014, ANTICANCER RES, V34, P471; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 1999, J INORG BIOCHEM, V77, P111, DOI 10.1016/S0162-0134(99)00141-5; KIDANI Y, 1978, J MED CHEM, V21, P1315, DOI 10.1021/jm00210a029; KOBAYASHI H, 1991, INVEST NEW DRUG, V9, P313; Laurent A, 2005, CANCER RES, V65, P948; Lewandowicz GM, 2002, GYNECOL ONCOL, V85, P298, DOI 10.1006/gyno.2002.6617; Marverti G, 2008, J INORG BIOCHEM, V102, P699, DOI 10.1016/j.jinorgbio.2007.10.015; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; Ohmichi M, 2005, TRENDS PHARMACOL SCI, V26, P113, DOI 10.1016/j.tips.2005.01.002; Park GY, 2012, P NATL ACAD SCI USA, V109, P11987, DOI 10.1073/pnas.1207670109; PEREZSOLER R, 1988, CANCER RES, V48, P4509; Pichler V, 2012, J MED CHEM, V55, P11052, DOI 10.1021/jm301645g; Rice JR, 2006, CLIN CANCER RES, V12, P2248, DOI 10.1158/1078-0432.CCR-05-2169; Romero-Canelon I, 2013, INORG CHEM, V52, P12276, DOI 10.1021/ic400835n; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; Sharp SY, 2002, EUR J CANCER, V38, P2309, DOI 10.1016/S0959-8049(02)00244-7; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; Travnicek Z, 2010, EUR J MED CHEM, V45, P4609, DOI 10.1016/j.ejmech.2010.07.025; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e	33	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136338	10.1371/journal.pone.0136338	http://dx.doi.org/10.1371/journal.pone.0136338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309251	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400110
J	Augustinos, AA; Kyritsis, GA; Papadopoulos, NT; Abd-Alla, AMM; Caceres, C; Bourtzis, K				Augustinos, Antonios A.; Kyritsis, Georgios A.; Papadopoulos, Nikos T.; Abd-Alla, Adly M. M.; Caceres, Carlos; Bourtzis, Kostas			Exploitation of the Medfly Gut Microbiota for the Enhancement of Sterile Insect Technique: Use of Enterobacter sp in Larval Diet-Based Probiotic Applications	PLOS ONE			English	Article							CANDIDATUS ERWINIA DACICOLA; FRUIT-FLY; BACTROCERA-DORSALIS; DIPTERA TEPHRITIDAE; CERATITIS-CAPITATA; BACTERIAL COMMUNITIES; CULTIVABLE BACTERIA; INTESTINAL-TRACT; DIVERSITY; POPULATIONS	The Mediterranean fruit fly (medfly), Ceratitis capitata, is a pest of worldwide substantial economic importance, as well as a Tephritidae model for sterile insect technique (SIT) applications. The latter is partially due to the development and utilization of genetic sexing strains (GSS) for this species, such as the Vienna 8 strain, which is currently used in mass rearing facilities worldwide. Improving the performance of such a strain both in mass rearing facilities and in the field could significantly enhance the efficacy of SIT and reduce operational costs. Recent studies have suggested that the manipulation of gut symbionts can have a significant positive effect on the overall fitness of insect strains. We used culture-based approaches to isolate and characterize gut-associated bacterial species of the Vienna 8 strain under mass rearing conditions. We also exploited one of the isolated bacterial species, Enterobacter sp., as dietary supplement (probiotic) to the larval diet, and we assessed its effects on fitness parameters under the standard operating procedures used in SIT operational programs. Probiotic application of Enterobacter sp. resulted in improvement of both pupal and adult productivity, as well as reduced rearing duration, particularly for males, without affecting pupal weight, sex ratio, male mating competitiveness, flight ability and longevity under starvation.	[Augustinos, Antonios A.; Kyritsis, Georgios A.; Abd-Alla, Adly M. M.; Caceres, Carlos; Bourtzis, Kostas] Seibersdorf, Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Augustinos, Antonios A.] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Kyritsis, Georgios A.; Papadopoulos, Nikos T.] Univ Thessaly, Lab Entomol & Agr Zool, Dept Agr Crop Prod & Rural Environm, N Ionia Magnisia, Greece	International Atomic Energy Agency; University of Patras; University of Thessaly	Bourtzis, K (corresponding author), Seibersdorf, Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	K.Bourtzis@iaea.org	Augustinos, Antonios/C-1318-2019; Papadopoulos, Nikos T./B-9156-2011; Papadopoulos, Nikos/AAJ-1721-2020	Augustinos, Antonios/0000-0003-3682-6077; Papadopoulos, Nikos T./0000-0003-2480-8189; Papadopoulos, Nikos/0000-0003-2480-8189; ABD-ALLA, Adly/0000-0001-7540-4462	Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture	Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture	This study was supported by the Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture.	Aharon Y, 2013, APPL ENVIRON MICROB, V79, P303, DOI 10.1128/AEM.02761-12; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Ben-Yosef M, 2014, J EVOLUTION BIOL, V27, P2695, DOI 10.1111/jeb.12527; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Ben-Yosef M, 2010, P ROY SOC B-BIOL SCI, V277, P1545, DOI 10.1098/rspb.2009.2102; Bourtzis K, 2003, CONT T ENT, P217; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caceres C, 2002, GENETICA, V116, P107, DOI 10.1023/A:1020967810703; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Capuzzo C, 2005, INT J SYST EVOL MICR, V55, P1641, DOI 10.1099/ijs.0.63653-0; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Estes AM, 2012, ENVIRON ENTOMOL, V41, P265, DOI 10.1603/EN11245; Estes AM, 2009, APPL ENVIRON MICROB, V75, P7097, DOI 10.1128/AEM.00778-09; FAO/IAEA/USDA, 2014, PRODUCT QUALITY CONT; Florez LV, 2015, NAT PROD REP, V32, P904, DOI 10.1039/c5np00010f; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gavriel S, 2011, J APPL ENTOMOL, V135, P564, DOI 10.1111/j.1439-0418.2010.01605.x; Hamden H, 2013, J ECON ENTOMOL, V106, P641, DOI 10.1603/EC12362; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Kikuchi Y, 2011, APPL ENVIRON MICROB, V77, P4075, DOI 10.1128/AEM.00358-11; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; Morrow JL, 2015, MICROB ECOL, V70, P498, DOI 10.1007/s00248-015-0571-1; Nash WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086029; Prabhakar CS, 2013, PHYTOPARASITICA, V41, P193, DOI 10.1007/s12600-012-0278-5; Prabhakar CS, 2009, J GEN APPL MICROBIOL, V55, P479; Pramanik M. K., 2014, Research Journal of Microbiology, V9, P278; Reed DW, 2002, APPL ENVIRON MICROB, V68, P3759, DOI 10.1128/AEM.68.8.3759-3770.2002; Sacchetti P, 2014, ANN APPL BIOL, V164, P138, DOI 10.1111/aab.12088; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Savio C, 2012, INT J SYST EVOL MICR, V62, P179, DOI 10.1099/ijs.0.030668-0; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANAKA N, 1969, J ECON ENTOMOL, V62, P967, DOI 10.1093/jee/62.4.967; Thaochan N, 2013, PHILIPP AGRIC SCI, V96, P384; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wang HX, 2014, PEST MANAG SCI, V70, P80, DOI 10.1002/ps.3528; Watanabe K, 2014, P NATL ACAD SCI USA, V111, P7433, DOI 10.1073/pnas.1402476111; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zchori-Fein E, 2012, FRONT MICROBIOL SER, pIX	49	101	104	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136459	10.1371/journal.pone.0136459	http://dx.doi.org/10.1371/journal.pone.0136459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325068	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700044
J	Chen, XM; Wang, CY; Yin, J; Xu, JH; Wei, J; Zhang, YC				Chen, Xiaomei; Wang, Chunyan; Yin, Jin; Xu, Jinhuan; Wei, Jia; Zhang, Yicheng			Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PLATELET LYSATE; STROMAL CELLS; EXTRACORPOREAL PHOTOCHEMOTHERAPY; IMMUNOSUPPRESSIVE PROPERTIES; MYCOPHENOLATE-MOFETIL; CHRONIC GVHD; IN-VITRO; RESISTANT; PHASE; SAFETY	Background Mesenchymal stem cells (MSCs) have been broadly used experimentally in various clinical contexts. The addition of MSCs to initial steroid therapy for acute graft-versus-host disease (aGVHD) may improve patient outcomes. However, investigations regarding prognostic factors affecting the efficacy of MSC therapy for steroid-refractory aGVHD remain controversial. We thus conducted a systematic review and meta-analysis of published clinical trials to determine possible prognostic factors affecting the efficacy of MSCs in treating steroid-refractory aGVHD. Methods and Findings Clinical trials using MSC therapy for steroid-refractory aGVHD were identified by searching PubMed and EMBASE databases. A total of 6,963 citations were reviewed, and 13 studies met the inclusion criteria. A total of 301 patients from thirteen studies were included. Of these, 136 patients showed a complete response (CR), and 69 patients displayed a partial (PR) or mixed response (MR). In total, 205 patients exhibited overall response (ORR). Patients with skin steroid-refractory aGVHD showed a better clinical response than gastrointestinal (CR: odds ratio [OR] = 1.93, 95% confidence interval [95% CI]: 1.05-3.57, p < 0.05) and liver (CR: OR = 2.30, 95% CI: 1.12-4.69, p < 0.05, and ORR: OR = 2.93, 95% CI: 1.06-8.08, p < 0.05) steroid-refractory aGVHD. Those with grade II steroid-refractory aGVHD exhibited a better clinical response following MSC therapy than recipients with grade III-IV (CR: OR = 3.22, 95% CI: 1.24-8.34, p < 0.05). Completion therapy may improve the CR but reduce ORR compared with induction therapy (CR: OR = 0.20, 95% CI: 0.09-0.44, p < 0.05; ORR: OR = 2.18, 95% CI: 1.17-4.05, p = 0.01). There was also a trend towards a better clinical response in children compared with adults (CR: OR = 2.41, 95% CI: 1.01-5.73, p = 0.05). Conclusions Age, skin involvement, lower aGVHD grade, and the number of infusions are the main prognostic factors affecting the efficacy of MSC therapy for steroid-refractory aGVHD.	[Chen, Xiaomei; Wang, Chunyan; Yin, Jin; Xu, Jinhuan; Wei, Jia; Zhang, Yicheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wei, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan 430074, Peoples R China.	jiawei@tjh.tjmu.edu.cn; yczhang@tjh.tjmu.edu.cn	Wei, Jia/M-5397-2013		National Science Foundation of China [30971293]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Science Foundation of China (grant no. 30971293).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ball LM, 2013, BRIT J HAEMATOL, V163, P501, DOI 10.1111/bjh.12545; Basara N, 1998, TRANSPLANT P, V30, P4087, DOI 10.1016/S0041-1345(98)01351-7; Basara N, 2001, TRANSPLANT P, V33, P2121, DOI 10.1016/S0041-1345(01)01968-6; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Benito AI, 2001, TRANSPLANTATION, V72, P1924, DOI 10.1097/00007890-200112270-00010; Bolanos-Meade J, 2005, J CLIN ONCOL, V23, P2661, DOI 10.1200/JCO.2005.06.130; Bolno PB, 2004, J AM COLL SURGEONS, V199, pS33; Busca A, 2007, AM J HEMATOL, V82, P45, DOI 10.1002/ajh.20752; Calore E, 2008, BONE MARROW TRANSPL, V42, P421, DOI 10.1038/bmt.2008.174; Carpenter PA, 2005, BIOL BLOOD MARROW TR, V11, P465, DOI 10.1016/j.bbmt.2005.03.002; Dazzi F, 2008, EUR J IMMUNOL, V38, P1479, DOI 10.1002/eji.200838433; De Miguel MP, 2012, CURR MOL MED, V12, P574; Deeg HJ, 2007, BLOOD, V109, P4119, DOI 10.1182/blood-2006-12-041889; Fang B, 2007, TRANSPL P, V39, P3358, DOI 10.1016/j.transproceed.2007.08.103; GOLDMAN JM, 1982, LANCET, V2, P623; Greinix HT, 2000, BLOOD, V96, P2426; Herrmann R, 2012, INT J HEMATOL, V95, P182, DOI 10.1007/s12185-011-0989-2; Ho VT, 2004, BLOOD, V104, P1224, DOI 10.1182/blood-2004-01-0028; Introna M, 2014, BIOL BLOOD MARROW TR, V20, P375, DOI 10.1016/j.bbmt.2013.11.033; Khoury H, 2001, BONE MARROW TRANSPL, V27, P1059, DOI 10.1038/sj.bmt.1703032; Kurtzberg J, 2014, BIOL BLOOD MARROW TR, V20, P229, DOI 10.1016/j.bbmt.2013.11.001; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lucchini G, 2010, BIOL BLOOD MARROW TR, V16, P1293, DOI 10.1016/j.bbmt.2010.03.017; MacMillan ML, 2007, BLOOD, V109, P2657, DOI 10.1182/blood-2006-08-013995; MacMillan ML, 2010, BLOOD, V115, P5412, DOI 10.1182/blood-2009-12-258442; McCaul KG, 2000, J HEMATOTH STEM CELL, V9, P367, DOI 10.1089/15258160050079470; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Miano M, 2009, BONE MARROW TRANSPL, V43, P423, DOI 10.1038/bmt.2008.331; Muroi K, 2013, INT J HEMATOL, V98, P206, DOI 10.1007/s12185-013-1399-4; Patriarca F, 2004, HAEMATOLOGICA, V89, P1352; Perales MA, 2007, BONE MARROW TRANSPL, V40, P481, DOI 10.1038/sj.bmt.1705762; Perez L, 2011, CURR OPIN HEMATOL, V18, P408, DOI 10.1097/MOH.0b013e32834b6196; Perez-Simon JA, 2011, HAEMATOL-HEMATOL J, V96, P1072, DOI 10.3324/haematol.2010.038356; Perfetti P, 2008, BONE MARROW TRANSPL, V42, P609, DOI 10.1038/bmt.2008.221; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Przepiorka D, 2000, BLOOD, V95, P83, DOI 10.1182/blood.V95.1.83.001k18_83_89; RINGDEN O, 1985, TRANSPLANTATION, V40, P39; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Sanchez-Guijo F, 2014, BIOL BLOOD MARROW TR, V20, P1580, DOI 10.1016/j.bbmt.2014.06.015; Seo J, 2013, RES VET SCI, V95, P693, DOI 10.1016/j.rvsc.2013.04.024; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; Sleight BS, 2007, BONE MARROW TRANSPL, V40, P473, DOI 10.1038/sj.bmt.1705761; Stolzing A, 2008, MECH AGEING DEV; STORB R, 1985, IMMUNOL REV, V88, P215, DOI 10.1111/j.1600-065X.1985.tb01160.x; von Bonin M, 2009, BONE MARROW TRANSPL, V43, P245, DOI 10.1038/bmt.2008.316; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	51	50	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136991	10.1371/journal.pone.0136991	http://dx.doi.org/10.1371/journal.pone.0136991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323092	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500058
J	Fagoonee, S; Famulari, ES; Silengo, L; Tolosano, E; Altruda, F				Fagoonee, Sharmila; Famulari, Elvira Smeralda; Silengo, Lorenzo; Tolosano, Emanuela; Altruda, Fiorella			Long Term Liver Engraftment of Functional Hepatocytes Obtained from Germline Cell-Derived Pluripotent Stem Cells	PLOS ONE			English	Article							NEONATAL MOUSE TESTIS; DIRECTED DIFFERENTIATION; GENERATION; REGENERATION; HEMOCHROMATOSIS; TRANSPLANTATION; MONOCROTALINE; REPOPULATION; MICE	One of the major hurdles in liver gene and cell therapy is availability of ex vivo-expanded hepatocytes. Pluripotent stem cells are an attractive alternative. Here, we show that hepatocyte precursors can be isolated from male germline cell-derived pluripotent stem cells (GPSCs) using the hepatoblast marker, Liv2, and induced to differentiate into hepatocytes in vitro. These cells expressed hepatic-specific genes and were functional as demonstrated by their ability to secrete albumin and produce urea. When transplanted in the liver parenchyma of partially hepatectomised mice, Liv2-sorted cells showed regional and heterogeneous engraftment in the injected lobe. Moreover, approximately 50% of Y chromosomepositive, GPSC-derived cells were found in the female livers, in the region of engraftment, even one month after cell injection. This is the first study showing that Liv2-sorted GPSCs-derived hepatocytes can undergo long lasting engraftment in the mouse liver. Thus, GPSCs might offer promise for regenerative medicine.	[Fagoonee, Sharmila] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Inst Biostruct & Bioimages CNR, Turin, Italy; [Famulari, Elvira Smeralda; Silengo, Lorenzo; Tolosano, Emanuela; Altruda, Fiorella] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Turin; University of Turin	Fagoonee, S (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Inst Biostruct & Bioimages CNR, Turin, Italy.	sharmila.fagoonee@unito.it; fiorella.altruda@unito.it	Fagoonee, Sharmila/L-1940-2019; Tolosano, Emanuela/L-8080-2019	Fagoonee, Sharmila/0000-0001-6070-6716; Tolosano, Emanuela/0000-0002-1622-2340	PRIN (Progetti di Rilevante Interesse Nazionale) [2010B5B2NL 003]	PRIN (Progetti di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by PRIN (Progetti di Rilevante Interesse Nazionale) to FA (Grant number: 2010B5B2NL 003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Baba S, 2007, STEM CELLS, V25, P1375, DOI 10.1634/stemcells.2006-0574; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Carvalho KAT, 2008, TRANSPL P, V40, P839, DOI 10.1016/j.transproceed.2008.03.004; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; Cho CH, 2008, FASEB J, V22, P898, DOI 10.1096/fj.06-7764com; De Chiara L, 2014, J AM SOC NEPHROL, V25, P316, DOI 10.1681/ASN.2013040367; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fagoonee S, 2011, ORGANOGENESIS, V7, P116, DOI 10.4161/org.7.2.16284; Fagoonee S, 2010, STEM CELLS DEV, V19, P1183, DOI 10.1089/scd.2009.0496; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Fuller R, 2008, INT J HEAT MASS TRAN, V51, P5650, DOI 10.1016/j.ijheatmasstransfer.2008.04.021; Gabriel E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044912; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guan K, 2007, CIRC RES, V100, P1615, DOI 10.1161/01.RES.0000269182.22798.d9; Ikeda O, 2009, J SURG RES, V152, P218, DOI 10.1016/j.jss.2008.02.059; Joseph B, 2006, HEPATOLOGY, V44, P1411, DOI 10.1002/hep.21416; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Ning LA, 2010, HUM REPROD, V25, P3101, DOI 10.1093/humrep/deq269; Pettinato G, 2014, SCI REP-UK, V4, DOI 10.1038/srep07402; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Streckfuss-Bomeke K, 2009, STEM CELL RES, V2, P139, DOI 10.1016/j.scr.2008.09.001; Takashimizu I, 2009, THESCIENTIFICWORLDJO, V9, P190, DOI 10.1100/tsw.2009.18; Tolosano E, 2005, BLOOD, V105, P3353, DOI 10.1182/blood-2004-07-2814; Watanabe T, 2002, DEV BIOL, V250, P332, DOI 10.1006/dbio.2002.0781; Witek RP, 2005, CELL TRANSPLANT, V14, P41, DOI 10.3727/000000005783983278; YOKOYAMA HO, 1953, CANCER RES, V13, P80; Yoshimoto M, 2009, EXP HEMATOL, V37, P1400, DOI 10.1016/j.exphem.2009.09.006; Yu Y, 2012, LIVER TRANSPLANT, V18, P9, DOI 10.1002/lt.22467; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	35	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136762	10.1371/journal.pone.0136762	http://dx.doi.org/10.1371/journal.pone.0136762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323094	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500034
J	Butler, TM; Johnson-Camacho, K; Peto, M; Wang, NJ; Macey, TA; Korkola, JE; Koppie, TM; Corless, CL; Gray, JW; Spellman, PT				Butler, Timothy M.; Johnson-Camacho, Katherine; Peto, Myron; Wang, Nicholas J.; Macey, Tara A.; Korkola, James E.; Koppie, Theresa M.; Corless, Christopher L.; Gray, Joe W.; Spellman, Paul T.			Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; BREAST-CANCER; PLASMA DNA; ACQUIRED-RESISTANCE; SENSITIVE DETECTION; COLORECTAL-CANCER; POINT MUTATIONS; NUCLEIC-ACIDS; BLOOD; EVOLUTION	The identification of the molecular drivers of cancer by sequencing is the backbone of precision medicine and the basis of personalized therapy; however, biopsies of primary tumors provide only a snapshot of the evolution of the disease and may miss potential therapeutic targets, especially in the metastatic setting. A liquid biopsy, in the form of cell-free DNA (cfDNA) sequencing, has the potential to capture the inter-and intra-tumoral heterogeneity present in metastatic disease, and, through serial blood draws, track the evolution of the tumor genome. In order to determine the clinical utility of cfDNA sequencing we performed whole-exome sequencing on cfDNA and tumor DNA from two patients with metastatic disease; only minor modifications to our sequencing and analysis pipelines were required for sequencing and mutation calling of cfDNA. The first patient had metastatic sarcoma and 47 of 48 mutations present in the primary tumor were also found in the cell-free DNA. The second patient had metastatic breast cancer and sequencing identified an ESR1 mutation in the cfDNA and metastatic site, but not in the primary tumor. This likely explains tumor progression on Anastrozole. Significant heterogeneity between the primary and metastatic tumors, with cfDNA reflecting the metastases, suggested separation from the primary lesion early in tumor evolution. This is best illustrated by an activating PIK3CA mutation (H1047R) which was clonal in the primary tumor, but completely absent from either the metastasis or cfDNA. Here we show that cfDNA sequencing supplies clinically actionable information with minimal risks compared to metastatic biopsies. This study demonstrates the utility of whole-exome sequencing of cell-free DNA from patients with metastatic disease. cfDNA sequencing identified an ESR1 mutation, potentially explaining a patient's resistance to aromatase inhibition, and gave insight into how metastatic lesions differ from the primary tumor.	[Butler, Timothy M.; Johnson-Camacho, Katherine; Peto, Myron; Wang, Nicholas J.; Macey, Tara A.; Korkola, James E.; Koppie, Theresa M.; Corless, Christopher L.; Gray, Joe W.; Spellman, Paul T.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University	Spellman, PT (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.	spellmap@ohsu.edu	Gray, Joe/AAX-9549-2020	, James/0000-0002-0030-6216; Butler, Timothy/0000-0001-5803-1035	Ion Torrent/ThermoFisher	Ion Torrent/ThermoFisher	Chritopher Corless received honoraria and research support from Ion Torrent/ThermoFisher. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Beadling C, 2011, J MOL DIAGN, V13, P504, DOI 10.1016/j.jmoldx.2011.04.003; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Board RE, 2010, BREAST CANCER RES TR, V120, P461, DOI 10.1007/s10549-010-0747-9; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frattini M, 2008, CANCER LETT, V263, P170, DOI 10.1016/j.canlet.2008.03.021; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakamura T, 2012, J THORAC ONCOL, V7, P1369, DOI 10.1097/JTO.0b013e31825f2821; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shinozaki M, 2007, CLIN CANCER RES, V13, P2068, DOI 10.1158/1078-0432.CCR-06-2120; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Swisher EM, 2005, AM J OBSTET GYNECOL, V193, P662, DOI 10.1016/j.ajog.2005.01.054; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; VASIOUKHIN V, 1994, BRIT J HAEMATOL, V86, P774, DOI 10.1111/j.1365-2141.1994.tb04828.x	34	79	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136407	10.1371/journal.pone.0136407	http://dx.doi.org/10.1371/journal.pone.0136407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317216	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100082
J	Ji, YC; Gray, RA; Fenton, FH				Ji, Yanyan Claire; Gray, Richard A.; Fenton, Flavio H.			Implementation of Contraction to Electrophysiological Ventricular Myocyte Models, and Their Quantitative Characterization via Post-Extrasystolic Potentiation	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; HEART; MODULATION; MUSCLE; DYNAMICS; DEPENDENCE; EFFICACY; CAMKII; CA2+; CRT	Heart failure (HF) affects over 5 million Americans and is characterized by impairment of cellular cardiac contractile function resulting in reduced ejection fraction in patients. Electrical stimulation such as cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM) have shown some success in treating patients with HF. Computer simulations have the potential to help improve such therapy (e.g. suggest optimal lead placement) as well as provide insight into the underlying mechanisms which could be beneficial. However, these myocyte models require a quantitatively accurate excitation-contraction coupling such that the electrical and contraction predictions are correct. While currently there are close to a hundred models describing the detailed electrophysiology of cardiac cells, the majority of cell models do not include the equations to reproduce contractile force or they have been added ad hoc. Here we present a systematic methodology to couple first generation contraction models into electrophysiological models via intracellular calcium and then compare the resulting model predictions to experimental data. This is done by using a post-extrasystolic pacing protocol, which captures essential dynamics of contractile forces. We found that modeling the dynamic intracellular calcium buffers is necessary in order to reproduce the experimental data. Furthermore, we demonstrate that in models the mechanism of the post-extrasystolic potentiation is highly dependent on the calcium released from the Sarcoplasmic Reticulum. Overall this study provides new insights into both specific and general determinants of cellular contractile force and provides a framework for incorporating contraction into electrophysiological models, both of which will be necessary to develop reliable simulations to optimize electrical therapies for HF.	[Ji, Yanyan Claire; Fenton, Flavio H.] Georgia Inst Technol, Dept Phys, Atlanta, GA 30332 USA; [Gray, Richard A.] US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University System of Georgia; Georgia Institute of Technology; US Food & Drug Administration (FDA)	Ji, YC (corresponding author), Georgia Inst Technol, Dept Phys, Atlanta, GA 30332 USA.	yji47@gatech.edu			National Science Foundation [1347015]	National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the National Science Foundation grant number: 1347015, http://www.nsf.gov/.FHF received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blinova K, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12106; Borggrefe MM, 2008, EUR HEART J, V29, P1019, DOI 10.1093/eurheartj/ehn020; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V288, pH2550, DOI 10.1152/ajpheart.01311.2004; Burkhoff D, 2001, Heart Fail Rev, V6, P27, DOI 10.1023/A:1009851107189; Butter C, 2007, EUR J HEART FAIL, V9, P955, DOI 10.1016/j.ejheart.2007.05.012; Cooper J, 2009, AUTOMATIC VALIDATION; Cooper J, 2011, PROG BIOPHYS MOL BIO, V107, P74, DOI 10.1016/j.pbiomolbio.2011.06.002; COOPER MW, 1993, CIRCULATION, V88, P2962, DOI 10.1161/01.CIR.88.6.2962; De Lazzari C, 2010, EUR REV MED PHARMACO, V14, P969; DOBRUNZ LE, 1995, BIOPHYS J, V69, P189, DOI 10.1016/S0006-3495(95)79889-7; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fenton F.H., 2008, SCHOLARPEDIA, V3, P1868, DOI [10.4249/scholarpedia.1868, DOI 10.4249/SCHOLARPEDIA.1868]; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Flore V, 2015, J ELECTROCARDIOL, V48, P578, DOI 10.1016/j.jelectrocard.2015.02.004; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Iribe G, 2006, PHILOS T R SOC A, V364, P1107, DOI 10.1098/rsta.2006.1758; Ismail H, 2010, INT J CARDIOVAS IMAG, V26, P197, DOI 10.1007/s10554-009-9556-9; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Kuschyk J, 2015, INT J CARDIOL, V183, P76, DOI 10.1016/j.ijcard.2014.12.178; LANDESBERG A, 1994, AM J PHYSIOL, V267, pH779, DOI 10.1152/ajpheart.1994.267.2.H779; Livshitz LM, 2007, AM J PHYSIOL-HEART C, V292, pH2854, DOI 10.1152/ajpheart.01347.2006; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Matsuoka S, 2003, JPN J PHYSIOL, V53, P105, DOI 10.2170/jjphysiol.53.105; Mentz RJ, 2015, J CARD FAIL, V21, P24, DOI 10.1016/j.cardfail.2014.11.003; Miri R, 2009, IEEE T BIO-MED ENG, V56, P2573, DOI 10.1109/TBME.2009.2027692; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Niederer SA, 2009, EXP PHYSIOL, V94, P529, DOI 10.1113/expphysiol.2008.045880; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Potse M, 2012, J CARDIOVASC TRANSL, V5, P146, DOI 10.1007/s12265-011-9343-6; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Rice JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1734, DOI 10.1152/ajpheart.1999.276.5.H1734; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shea JB, 2003, CIRCULATION, V108, pE64, DOI 10.1161/01.CIR.0000085657.09097.38; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; van't Sant J, 2015, J ELECTROCARDIOL, V48, P601, DOI 10.1016/j.jelectrocard.2015.01.015; WIER WG, 1986, J PHYSIOL-LONDON, V376, P507, DOI 10.1113/jphysiol.1986.sp016167; YUE DT, 1985, CIRC RES, V56, P340, DOI 10.1161/01.RES.56.3.340	44	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135699	10.1371/journal.pone.0135699	http://dx.doi.org/10.1371/journal.pone.0135699			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317204	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100042
J	Olson, JC; Takahashi, A; Glotzbecker, MP; Snyder, BD				Olson, J. Casey; Takahashi, Ayuko; Glotzbecker, Michael P.; Snyder, Brian D.			Extent of Spine Deformity Predicts Lung Growth and Function in Rabbit Model of Early Onset Scoliosis	PLOS ONE			English	Article							THORACIC INSUFFICIENCY SYNDROME; PROSTHETIC TITANIUM RIB; RADIAL ALVEOLAR COUNT; PULMONARY-FUNCTION; EXPANSION THORACOPLASTY; FUSED RIBS; CHILDREN; REGISTRATION; HYPOPLASIA; PARAMETERS	Early onset deformity of the spine and chest wall (initiated < 8 years of age) is associated with increased morbidity at adulthood relative to adolescent onset deformity of comparable severity. Presumably, inhibition of thoracic growth during late stage alveolarization leads to an irreversible loss of pulmonary growth and thoracic function; however the natural history of this disease from onset to adulthood has not been well characterized. In this study we establish a rabbit model of early onset scoliosis to establish the extent that thoracic deformity affects structural and functional respiratory development. Using a surgical right unilateral rib-tethering procedure, rib fusion with early onset scoliosis was induced in 10 young New Zealand white rabbits (3 weeks old). Progression of spine deformity, functional residual capacity, total lung capacity, and lung mass was tracked through longitudinal breath-hold computed tomography imaging up to skeletal maturity (28 weeks old). Additionally at maturity forced vital capacity and regional specific volume were calculated as functional measurements and histo-morphometry performed with the radial alveolar count as a measure of acinar complexity. Data from tethered rib rabbits were compared to age matched healthy control rabbits (N = 8). Results show unilateral rib-tethering created a progressive spinal deformity ranging from 30 degrees to 120 degrees curvature, the severity of which was strongly associated with pulmonary growth and functional outcomes. At maturity rabbits with deformity greater than the median (55 degrees) had decreased body weight (89%), right (59%) and left (86%) lung mass, right (74%) and left (69%) radial alveolar count, right lung volume at total lung capacity (60%), and forced vital capacity (75%). Early treatment of spinal deformity in children may prevent pulmonary complications in adulthood and these results provide a basis for the prediction of pulmonary development from thoracic structure. This model may also have future use as a platform to evaluate treatment effectiveness.	[Olson, J. Casey; Snyder, Brian D.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Olson, J. Casey; Takahashi, Ayuko] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Glotzbecker, Michael P.; Snyder, Brian D.] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Boston University; Harvard University; Boston Children's Hospital	Olson, JC (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA.	olsonjc@bu.edu		Subbian, Selvakumar/0000-0003-2021-8632	National Institutes of Health [1R21AR057880-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health #1R21AR057880-01 received by BDS. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; ASKENAZI SS, 1979, ARCH DIS CHILD, V54, P614, DOI 10.1136/adc.54.8.614; BATES JHT, 1992, IEEE T BIO-MED ENG, V39, P94, DOI 10.1109/10.108133; BOFFA P, 1984, THORAX, V39, P681, DOI 10.1136/thx.39.9.681; BRANTHWAITE MA, 1986, BRIT J DIS CHEST, V80, P360, DOI 10.1016/0007-0971(86)90089-6; Campbell RM, 2003, J BONE JOINT SURG AM, V85A, P399, DOI 10.2106/00004623-200303000-00001; Campbell RM, 2007, J BONE JOINT SURG AM, V89A, P108, DOI 10.2106/JBJS.F.00270; Campbell Robert M Jr, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P51; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; DAVIES G, 1971, ARCH DIS CHILD, V46, P623, DOI 10.1136/adc.46.249.623; Dimeglio A., 1990, RACHIS CROISSANCE; DUNNILL M. S., 1962, THORAX, V17, P329, DOI 10.1136/thx.17.4.329; Emans JB, 2005, SPINE, V30, pS58, DOI 10.1097/01.brs.0000175194.31986.2f; Fuld MK, 2008, J APPL PHYSIOL, V104, P1177, DOI 10.1152/japplphysiol.00212.2007; Guerrero T, 2007, INT J RADIAT ONCOL, V67, P879, DOI 10.1016/j.ijrobp.2006.10.037; Herring MJ, 2014, AM J PHYSIOL-LUNG C, V307, pL338, DOI 10.1152/ajplung.00094.2014; HSIA CCW, 1994, J CLIN INVEST, V94, P405, DOI 10.1172/JCI117337; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; Hsia CCW, 2012, J APPL PHYSIOL, V113, P937, DOI 10.1152/japplphysiol.00289.2012; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Kaczka DW, 2011, ANN BIOMED ENG, V39, P1112, DOI 10.1007/s10439-010-0214-0; Karol LA, 2008, J BONE JOINT SURG AM, V90A, P1272, DOI 10.2106/JBJS.G.00184; Karol LA, 2011, CLIN ORTHOP RELAT R, V469, P1323, DOI 10.1007/s11999-010-1622-z; Kovar J, 2002, J APPL PHYSIOL, V93, P629, DOI 10.1152/japplphysiol.01044.2001; LAUZON AM, 1991, J APPL PHYSIOL, V71, P1159, DOI 10.1152/jappl.1991.71.3.1159; Mayer OH, 2009, J PEDIATR ORTHOPED, V29, P35, DOI 10.1097/BPO.0b013e3181929c8b; Mehta HP, 2006, SPINE, V31, P2654, DOI 10.1097/01.brs.0000244613.66055.b6; Mehta HP, 2010, SPINE, V35, P153, DOI 10.1097/BRS.0b013e3181c4b8c7; Motoyama EK, 2006, SPINE, V31, P284, DOI 10.1097/01.brs.0000197203.76653.d0; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; OWANGEIRAKA JW, 1984, EUR J PEDIATR, V142, P198, DOI 10.1007/BF00442448; PEHRSSON K, 1992, SPINE, V17, P1091, DOI 10.1097/00007632-199209000-00014; PEHRSSON K, 1992, SPINE, V17, P714, DOI 10.1097/00007632-199206000-00012; Ravikumar P, 2004, J APPL PHYSIOL, V97, P1567, DOI 10.1152/japplphysiol.00396.2004; Redding GJ, 2011, CLIN ORTHOP RELAT R, V469, P1330, DOI 10.1007/s11999-010-1621-0; SCOTT JC, 1955, J BONE JOINT SURG BR, V37, P400, DOI 10.1302/0301-620X.37B3.400; Skaggs DL, 2009, SPINE, V34, P2530, DOI 10.1097/BRS.0b013e3181bd09f5; Vitale MG, 2008, J PEDIATR ORTHOPED, V28, P239, DOI 10.1097/BPO.0b013e31816521bb; Yilmaz C, 2009, J APPL PHYSIOL, V107, P1569, DOI 10.1152/japplphysiol.00503.2009; Yin YB, 2011, PHYS MED BIOL, V56, P203, DOI 10.1088/0031-9155/56/1/013; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136941	10.1371/journal.pone.0136941	http://dx.doi.org/10.1371/journal.pone.0136941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317230	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100178
J	Tanaka, H; Sirich, TL; Plummer, NS; Weaver, DS; Meyer, TW				Tanaka, Hisae; Sirich, Tammy L.; Plummer, Natalie S.; Weaver, Daniel S.; Meyer, Timothy W.			An Enlarged Profile of Uremic Solutes	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CHRONIC KIDNEY-DISEASE; PROTEIN-BOUND SOLUTES; HEMODIALYSIS-PATIENTS; METABOLOMIC ANALYSIS; TOXINS; SERUM; ACID; POLYPHENOLS; EXCRETION	Better knowledge of the uremic solutes that accumulate when the kidneys fail could lead to improved renal replacement therapy. This study employed the largest widely available metabolomic platform to identify such solutes. Plasma and plasma ultrafiltrate from 6 maintenance hemodialysis (HD) patients and 6 normal controls were first compared using a platform combining gas and liquid chromatography with mass spectrometry. Further studies compared plasma from 6 HD patients who had undergone total colectomy and 9 with intact colons. We identified 120 solutes as uremic including 48 that had not been previously reported to accumulate in renal failure. Combination of the 48 newly identified solutes with those identified in previous reports yielded an extended list of more than 270 uremic solutes. Among the solutes identified as uremic in the current study, 9 were shown to be colon-derived, including 6 not previously identified as such. Literature search revealed that many uremic phenyl and indole solutes, including most of those shown to be colon-derived, come from plant foods. Some of these compounds can be absorbed directly from plant foods and others are produced by colon microbial metabolism of plant polyphenols that escape digestion in the small intestine. A limitation of the metabolomic method was that it underestimated the elevation in concentration of uremic solutes which were measured using more quantitative assays.	[Tanaka, Hisae; Sirich, Tammy L.; Plummer, Natalie S.; Meyer, Timothy W.] VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA; [Tanaka, Hisae; Sirich, Tammy L.; Plummer, Natalie S.; Meyer, Timothy W.] Stanford Univ, Palo Alto, CA 94304 USA; [Weaver, Daniel S.] SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; SRI International	Meyer, TW (corresponding author), VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA.	twmeyer@stanford.edu			National Institutes of Health (US) [R21 DK84439, R01 DK8012]; SRI International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084439] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001036] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SRI International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Funded by R21 DK84439 and R01 DK8012 from the National Institutes of Health (US) at www.nih.gov. SRI International provided support in the form of salary for author DSW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Biesaga M, 2007, J SEP SCI, V30, P2929, DOI 10.1002/jssc.200700247; Boelaert J, 2014, METABOLOMICS, V10, P425, DOI 10.1007/s11306-013-0592-z; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; CATHCARTRAKE W, 1975, AM J CLIN NUTR, V28, P1110, DOI 10.1093/ajcn/28.10.1110; Clase CM, 2013, SEMIN DIALYSIS, V26, P546, DOI 10.1111/sdi.12099; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kikuchi K, 2010, J CHROMATOGR B, V878, P1662, DOI 10.1016/j.jchromb.2009.11.040; Lindner A, 2002, AM J KIDNEY DIS, V39, P134, DOI 10.1053/ajkd.2002.29904; Lindner HA, 2008, BIOCHIMIE, V90, P773, DOI 10.1016/j.biochi.2007.12.006; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504; Meyer TW, 2004, J AM SOC NEPHROL, V15, P1927, DOI 10.1097/01.asn.0000131521.62256.f0; Mogk A, 2010, SCIENCE, V327, P966, DOI 10.1126/science.1187274; NIWA T, 1983, J CHROMATOGR, V277, P25, DOI 10.1016/S0378-4347(00)84820-3; Niwa T, 2011, MASS SPECTROM REV, V30, P510, DOI 10.1002/mas.20323; Poesen R, 2013, SEMIN DIALYSIS, V26, P323, DOI 10.1111/sdi.12082; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Raj DSC, 2000, BLOOD PURIFICAT, V18, P97, DOI 10.1159/000014431; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; ROBOZ J, 1990, CLIN CHEM, V36, P2082; Sass JO, 2006, AM J HUM GENET, V78, P401, DOI 10.1086/500563; Sato E, 2011, EUR J CLIN INVEST, V41, P241, DOI 10.1111/j.1365-2362.2010.02398.x; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; Sirich TL, 2014, J AM SOC NEPHROL, V25, P615, DOI 10.1681/ASN.2013060597; Sirich TL, 2013, KIDNEY INT, V84, P585, DOI 10.1038/ki.2013.154; SJOLIN J, 1987, METABOLISM, V36, P1175, DOI 10.1016/0026-0495(87)90245-9; Toyohara T, 2010, HYPERTENS RES, V33, P944, DOI 10.1038/hr.2010.113; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Tucker BM, 2015, J RENAL NUTR, V25, P257, DOI 10.1053/j.jrn.2014.09.003; Uribarri J, 2000, NEPHRON, V86, P105, DOI 10.1159/000045726; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; VINE JH, 1987, PLANT PHYSIOL, V85, P419, DOI 10.1104/pp.85.2.419; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wood A, 2011, MOL NUTR FOOD RES, V55, pS7, DOI 10.1002/mnfr.201000408; Yeung CK, 2014, KIDNEY INT, V85, P522, DOI 10.1038/ki.2013.399; YOUNG VR, 1972, J BIOL CHEM, V247, P3592; Yu B, 2014, CLIN J AM SOC NEPHRO, V9, P1410, DOI 10.2215/CJN.11971113	50	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135657	10.1371/journal.pone.0135657	http://dx.doi.org/10.1371/journal.pone.0135657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317986	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100041
J	Miotke, L; Maity, A; Ji, H; Brewer, J; Astakhova, K				Miotke, Laura; Maity, Arindam; Ji, Hanlee; Brewer, Jonathan; Astakhova, Kira			Enzyme-Free Detection of Mutations in Cancer DNA Using Synthetic Oligonucleotide Probes and Fluorescence Microscopy	PLOS ONE			English	Article							MOLECULAR BEACONS; SINGLE	Background Rapid reliable diagnostics of DNA mutations are highly desirable in research and clinical assays. Current development in this field goes simultaneously in two directions: 1) high-throughput methods, and 2) portable assays. Non-enzymatic approaches are attractive for both types of methods since they would allow rapid and relatively inexpensive detection of nucleic acids. Modern fluorescence microscopy is having a huge impact on detection of bio-molecules at previously unachievable resolution. However, no straightforward methods to detect DNA in a non-enzymatic way using fluorescence microscopy and nucleic acid analogues have been proposed so far. Methods and Results Here we report a novel enzyme-free approach to efficiently detect cancer mutations. This assay includes gene-specific target enrichment followed by annealing to oligonucleotides containing locked nucleic acids (LNAs) and finally, detection by fluorescence microscopy. The LNA containing probes display high binding affinity and specificity to DNA containing mutations, which allows for the detection of mutation abundance with an intercalating EvaGreen dye. We used a second probe, which increases the overall number of base pairs in order to produce a higher fluorescence signal by incorporating more dye molecules. Indeed we show here that using EvaGreen dye and LNA probes, genomic DNA containing BRAF V600E mutation could be detected by fluorescence microscopy at low femtomolar concentrations. Notably, this was at least 1000-fold above the potential detection limit. Conclusion Overall, the novel assay we describe could become a new approach to rapid, reliable and enzyme-free diagnostics of cancer or other associated DNA targets. Importantly, stoichiometry of wild type and mutant targets is conserved in our assay, which allows for an accurate estimation of mutant abundance when the detection limit requirement is met. Using fluorescence microscopy, this approach presents the opportunity to detect DNA at single-molecule resolution and directly in the biological sample of choice.	[Miotke, Laura; Ji, Hanlee] Stanford Univ, Stanford Sch Med, Div Oncol, Stanford, CA 94305 USA; [Maity, Arindam; Astakhova, Kira] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense, Denmark; [Brewer, Jonathan] Univ Southern Denmark, Memphys Ctr Biomembrane Phys, Dept Biochem & Mol Biol, Odense, Denmark; [Maity, Arindam] Dr BC Roy Coll Pharm & AHS, Durgapur, W Bengal, India	Stanford University; University of Southern Denmark; University of Southern Denmark	Astakhova, K (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense, Denmark.	ias@sdu.dk	Maity, Arindam/AAQ-4943-2020; Brewer, Jonathan/C-7079-2012; Astakhova, Kira/D-1432-2014	Maity, Arindam/0000-0002-9418-6963; Brewer, Jonathan/0000-0002-3444-1715; Astakhova, Kira/0000-0003-4878-0301	Augustinus Foundation [95 305 73949]; American Cancer Society [RSG-13-297-01-TBG]; Doris Duke Clinical Foundation; Howard Hughes Medical Institute; National Institutes of Health [P01 HG000205]; American Cancer Society; National Institutes of Health; Villum Fonden [00007268] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	Augustinus Foundation; American Cancer Society(American Cancer Society); Doris Duke Clinical Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Villum Fonden(Villum Fonden); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Augustinus Foundation (Grant. No. 95 305 73949; http://www.augustinusfonden.dk/) is acknowledged for funding AM and KA (reagents for the LNA probe synthesis and fluorescence microscopy, assay development and data analysis). The authors also acknowledge that HJ and LM were supported by a Research Scholar Grant, RSG-13-297-01-TBG from the American Cancer Society (http://www.cancer.org/). HJ received additional support from the Doris Duke Clinical Foundation Clinical Scientist Development Award (http://www.ddcf.org/programs/medical-research/goals-and-strategies/build-the-clinical-research-career-ladder/clinical-scientist-development-award/) and a Howard Hughes Medical Institute Early Career Grant (https://www.hhmi.org/). The authors also acknowledge support from National Institutes of Health P01 HG000205 (HJ; http://www.nih.gov/). The grants from American Cancer Society and National Institutes of Health supported design of the probes, genomic pre-enrichment, cancer cell line work and data analysis.	Arnspang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048521; Astakhova IK, 2014, ACCOUNTS CHEM RES, V47, P1768, DOI 10.1021/ar500014g; Astakhova IK, 2012, CHEMBIOCHEM, V13, P1509, DOI 10.1002/cbic.201200079; Astakhova K, 2014, CHEMOSENSORS, V2, P193, DOI 10.3390/chemosensors2030193; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Brewer J, 2013, J INVEST DERMATOL, V133, P1260, DOI 10.1038/jid.2012.461; Brown LJ, 2000, CHEM COMMUN, P621, DOI 10.1039/b000389l; Chen SX, 2013, NAT CHEM, V5, P782, DOI [10.1038/NCHEM.1713, 10.1038/nchem.1713]; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Hagglund H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0123-4; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; Hopmans ES, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku282; Janku F, 2014, ONCOTARGET, V5, P3607, DOI 10.18632/oncotarget.1964; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Li JWJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn033; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Marchant J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-519; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Ranasinghe RT, 2011, CHEM COMMUN, V47, P3717, DOI 10.1039/c0cc04215c; Rutkowski P, 2014, EXPERT OPIN DRUG SAF, V11, P1; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHIFFMAN MH, 1995, J CLIN MICROBIOL, V33, P545, DOI 10.1128/JCM.33.3.545-550.1995; Sclafani F, 2014, EUR J CANCER, V50, P1430, DOI 10.1016/j.ejca.2014.02.002; Sengstake S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-572; Song LA, 2013, ANAL CHEM, V85, P1932, DOI 10.1021/ac303426b; Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d; Wang ZJ, 2014, NANOSCALE, V6, P3110, DOI 10.1039/c3nr05625b; Xu MD, 2013, CHEM COMMUN, V49, P7304, DOI 10.1039/c3cc43205j	29	16	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136720	10.1371/journal.pone.0136720	http://dx.doi.org/10.1371/journal.pone.0136720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312489	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000090
J	Nobach, D; Bourg, M; Herzog, S; Lange-Herbst, H; Encarnacao, JA; Eickmann, M; Herden, C				Nobach, Daniel; Bourg, Manon; Herzog, Sibylle; Lange-Herbst, Hildburg; Encarnacao, Jorge A.; Eickmann, Markus; Herden, Christiane			Shedding of Infectious Borna Disease Virus-1 in Living Bicolored White-Toothed Shrews	PLOS ONE			English	Article							EMERGING VIRAL-INFECTIONS; RESERVOIR HOSTS; RATS; BATS; ENCEPHALITIS; REPLICATION; GERMANY; RISK	Background Many RNA viruses arise from animal reservoirs, namely bats, rodents and insectivores but mechanisms of virus maintenance and transmission still need to be addressed. The bicolored white-toothed shrew (Crocidura leucodon) has recently been identified as reservoir of the neurotropic Borna disease virus 1 (BoDV-1). Principal Findings Six out of eleven wild living bicoloured white-toothed shrews were trapped and revealed to be naturally infected with BoDV-1. All shrews were monitored in captivity in a long-term study over a time period up to 600 days that differed between the individual shrews. Interestingly, all six animals showed an asymptomatic course of infection despite virus shedding via various routes indicating a highly adapted host-pathogen interaction. Infectious virus and viral RNA were demonstrated in saliva, urine, skin swabs, lacrimal fluid and faeces, both during the first 8 weeks of the investigation period and for long time shedding after more than 250 days in captivity. Conclusions The various ways of shedding ensure successful virus maintenance in the reservoir population but also transmission to accidental hosts such as horses and sheep. Naturally BoDV-1infected living shrews serve as excellent tool to unravel host and pathogen factors responsible for persistent viral co-existence in reservoir species while maintaining their physiological integrity despite high viral load in many organ systems.	[Nobach, Daniel; Bourg, Manon; Herden, Christiane] Univ Giessen, Inst Vet Pathol, D-35390 Giessen, Germany; [Herzog, Sibylle; Lange-Herbst, Hildburg] Univ Giessen, Inst Virol, Giessen, Germany; [Encarnacao, Jorge A.] Univ Giessen, Dept Anim Ecol & Systemat, Mammalian Ecol Grp, Giessen, Germany; [Eickmann, Markus] Univ Marburg, Inst Virol, D-35032 Marburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Philipps University Marburg	Herden, C (corresponding author), Univ Giessen, Inst Vet Pathol, D-35390 Giessen, Germany.	Christiane.Herden@vetmed.uni-giessen.de	Encarnação, Jorge A./I-8644-2018	Encarnação, Jorge A./0000-0001-8766-0607; Herden, Christiane/0000-0003-1858-2267	Margarete Ammon Stiftung	Margarete Ammon Stiftung	HLH was funded by the Margarete Ammon Stiftung (http://www.ammon-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUTISTA JR, 1994, BRAIN RES BULL, V34, P31, DOI 10.1016/0361-9230(94)90183-X; Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; Brandes G, 2011, HISTOCHEM CELL BIOL, V135, P397, DOI 10.1007/s00418-011-0796-0; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Choate JR, 1998, J MAMMAL, V79, P1416; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; de la Torre JC, 2006, NAT REV MICROBIOL, V4, P777, DOI 10.1038/nrmicro1489; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Duarte LC, 2003, EVOLUTION, V57, P638; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093659; Eickmann M, 2003, SCIENCE, V302, P1504; Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Hallensleben W, 1998, J VIROL, V72, P4379, DOI 10.1128/JVI.72.5.4379-4386.1998; Herden C, 2000, BRAIN PATHOL, V10, P39; Herden C., 2013, FIELDS VIROLOGY, P1124; HERZOG S, 1984, MED MICROBIOL IMMUN, V173, P171, DOI 10.1007/BF02122108; HERZOG S, 1980, MED MICROBIOL IMMUN, V168, P153, DOI 10.1007/BF02122849; Herzog S, 2010, J CLIN MICROBIOL, V48, P2282, DOI 10.1128/JCM.00145-10; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Kramer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041476; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Rubin SA, 1999, BRAIN RES BULL, V48, P23, DOI 10.1016/S0361-9230(98)00133-6; Schindler AR, 2007, MOL CELL PROBE, V21, P47, DOI 10.1016/j.mcp.2006.08.001; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwarz AC, 2009, EMERG INFECT DIS, V15, P1032, DOI 10.3201/eid1507.081413; Sejvar JJ, 2006, CURR OPIN NEUROL, V19, P350, DOI 10.1097/01.wco.0000236613.74462.4c; SPRANKEL H, 1978, MED MICROBIOL IMMUN, V165, P1, DOI 10.1007/BF02121228; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P1065, DOI 10.1001/archneurol.2009.189; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; Vahlenkamp TW, 2002, J VIROL, V76, P9735, DOI 10.1128/JVI.76.19.9735-9743.2002; Werner-Keiss N, 2008, NEUROPATH APPL NEURO, V34, P590, DOI 10.1111/j.1365-2990.2008.00940.x; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520	39	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0137018	10.1371/journal.pone.0137018	http://dx.doi.org/10.1371/journal.pone.0137018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313904	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000112
J	Sonnaert, M; Luyten, FP; Schrooten, J; Papantoniou, I				Sonnaert, Maarten; Luyten, Frank P.; Schrooten, Jan; Papantoniou, Ioannis			Bioreactor-Based Online Recovery of Human Progenitor Cells with Uncompromised Regenerative Potential: A Bone Tissue Engineering Perspective	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CLINICAL-GRADE EXPANSION; EX-VIVO EXPANSION; OSTEOGENIC DIFFERENTIATION; CHONDROCYTE ISOLATION; EXTRACELLULAR-MATRIX; COMPUTED-TOMOGRAPHY; CULTURE; SYSTEM; MICROENVIRONMENT	The use of a 3D perfusion culture environment for stem cell expansion has been shown to be beneficial for maintenance of the original cell functionality but due to several system inherent characteristics such as the presence of extracellular matrix, the continued development and implementation of 3D perfusion bioreactor technologies is hampered. Therefore, this study developed a methodology for harvesting a progenitor cell population from a 3D open porous culture surface after expansion in a perfusion bioreactor and performed a functional characterization of the expanded cells. An initial screening showed collagenase to be the most interesting reagent to release the cells from the 3D culture surface as it resulted in high yields without compromising cell viability. Subsequently a Design of Experiment approach was used to obtain optimized 3D harvest conditions by assessing the interplay of flow rate, collagenase concentration and incubation time on the harvest efficiency, viability and single cell fraction. Cells that were recovered with the optimized harvest protocol, by perfusing a 880 U/ml collagenase solution for 7 hours at a flow rate of 4 ml/min, were thereafter functionally analyzed for their characteristics as expanded progenitor cell population. As both the in vitro tri-lineage differentiation capacity and the in vivo bone forming potential were maintained after 3D perfusion bioreactor expansion we concluded that the developed seeding, culture and harvest processes did not significantly compromise the viability and potency of the cells and can contribute to the future development of integrated bioprocesses for stem cell expansion.	[Sonnaert, Maarten; Luyten, Frank P.; Schrooten, Jan; Papantoniou, Ioannis] Katholieke Univ Leuven, Prometheus, Div Skeletal Tissue Engn, Leuven, Belgium; [Sonnaert, Maarten; Schrooten, Jan] Katholieke Univ Leuven, Dept Mat Engn, Heverlee, Belgium; [Luyten, Frank P.; Papantoniou, Ioannis] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Papantoniou, I (corresponding author), Katholieke Univ Leuven, Prometheus, Div Skeletal Tissue Engn, Leuven, Belgium.	Ioannis.papantoniou@med.kuleuven.be	Luyten, Frank/GPS-7793-2022; Papantoniou, Ioannis/ABF-1528-2021	Papantoniou, Ioannis/0000-0002-4754-5492	Agency for Innovation by Science and Technology [IWT/111457]; European Research Council under the European Union [294191]	Agency for Innovation by Science and Technology; European Research Council under the European Union(European Research Council (ERC))	MS is supported by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT/111457). IP was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement REJOIND no294191.	Abbasalizadeh S, 2013, BIOTECHNOL ADV, V31, P1600, DOI 10.1016/j.biotechadv.2013.08.009; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009; Centola M, 2014, J TISSUE ENG REGEN M, V8, P148; Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Chen YT, 2012, TISSUE ENG PART C-ME, V18, P444, DOI [10.1089/ten.tec.2011.0304, 10.1089/ten.TEC.2011.0304]; De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6; dos Santos F, 2014, BIOTECHNOL BIOENG, V111, P1116, DOI 10.1002/bit.25187; dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; dos Santos FF, 2013, BIOTECHNOL J, V8, P644, DOI 10.1002/biot.201200373; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203; Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; He F, 2009, TISSUE ENG PT A, V15, P3809, DOI [10.1089/ten.tea.2009.0188, 10.1089/ten.TEA.2009.0188]; Hewitt CJ, 2011, BIOTECHNOL LETT, V33, P2325, DOI 10.1007/s10529-011-0695-4; Jakob M, 2003, CONNECT TISSUE RES, V44, P173, DOI 10.1080/03008200390215836; Kerckhofs G, 2013, ADV ENG MATER, V15, P153, DOI 10.1002/adem.201200156; Kerckhofs G, 2013, EUR CELLS MATER, V25, P179, DOI 10.22203/eCM.v025a13; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lau TT, 2014, TISSUE ENG TISSUE C; Li JT, 2011, TISSUE ENG PT A, V17, P703, DOI [10.1089/ten.tea.2010.0339, 10.1089/ten.TEA.2010.0339]; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mulhall H, 2011, J TISSUE ENG REGEN M, V5, P629, DOI 10.1002/term.355; Nienow AW, 2014, BIOCHEM ENG J, V85, P79, DOI 10.1016/j.bej.2014.02.005; Oseni AO, 2013, J SURG RES, V181, P41, DOI 10.1016/j.jss.2012.05.087; Papadimitropoulos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102359; Papantoniou I, 2014, BIOTECHNOL BIOENG; Papantoniou I, 2014, TISSUE ENG PART C-ME, V20, P177, DOI [10.1089/ten.tec.2013.0041, 10.1089/ten.TEC.2013.0041]; Pei M, 2011, TISSUE ENG PT A, V17, P3067, DOI [10.1089/ten.TEA.2011.0158, 10.1089/ten.tea.2011.0158]; Pyka G, 2012, ADV ENG MATER, V14, P363, DOI 10.1002/adem.201100344; Rafiq QA, 2013, BIOTECHNOL LETT, V35, P1233, DOI 10.1007/s10529-013-1211-9; Roberts SJ, 2014, STEM CELL TRANSL MED, V3, P218, DOI 10.5966/sctm.2012-0137; Roberts SJ, 2011, BIOMATERIALS; Salter E, 2012, TISSUE ENG PART B-RE, V18, P62, DOI [10.1089/ten.TEB.2011.0209, 10.1089/ten.teb.2011.0209]; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schneider CK, 2010, NAT REV DRUG DISCOV, V9, P195, DOI 10.1038/nrd3052; Sonnaert M., 2014, TISSUE ENG C; Sonnaert M., 2014, J TISSUE ENG REGEN M; Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045; van Gastel N, 2012, STEM CELLS, V30, P2460, DOI 10.1002/stem.1210; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wersinger C, 2004, BIOCHEMISTRY-US, V43, P1242, DOI 10.1021/bi035308s; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yonenaga K, 2010, TISSUE ENG PART C-ME, V16, P1461, DOI [10.1089/ten.tec.2009.0597, 10.1089/ten.TEC.2009.0597]; Zhou L, 2013, BIOTECHNOL BIOPROC E, V18, P173, DOI 10.1007/s12257-012-0512-5; Zoro BJH, 2009, BIOTECHNOL BIOENG, V103, P1236, DOI 10.1002/bit.22356	50	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136875	10.1371/journal.pone.0136875	http://dx.doi.org/10.1371/journal.pone.0136875			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313143	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000105
J	Khunti, K; Mani, H; Achana, F; Cooper, N; Gray, LJ; Davies, MJ				Khunti, Kamlesh; Mani, Hamidreza; Achana, Felix; Cooper, Nicola; Gray, Laura J.; Davies, Melanie J.			Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; URBAN-RURAL EPIDEMIOLOGY; LIFE-STYLE-INTERVENTION; CARDIOVASCULAR RISK; METABOLIC SYNDROME; PLASMA-GLUCOSE; FOLLOW-UP; GLYCATED HEMOGLOBIN; ADULT-POPULATION; GENERAL-PRACTICE	Background Screening for type 2 diabetes (T2DM) and individuals at risk of diabetes has been advocated, yet information on the response rate and diagnostic yield of different screening strategies are lacking. Methods Studies (from 1998 to March/2015) were identified through Medline, Embase and the Cochrane library and included if they used oral glucose tolerance test (OGTT) and WHO-1998 diagnostic criteria for screening in a community setting. Studies were one-step strategy if participants were invited directly for OGTT and two, three/four step if participants were screened at one or more levels prior to invitation to OGTT. The response rate and diagnostic yield were pooled using Bayesian random-effect meta-analyses. Findings 47 studies (422754 participants); 29 one-step, 11 two-step and seven three/four-step were identified. Pooled response rate (95% Credible Interval) for invitation to OGTT was 65.5% (53.7, 75.6), 63.1% (44.0, 76.8), and 85.4%(76.4, 93.3) in one, two and three/four-step studies respectively. T2DM yield was 6.6% (5.3, 7.8), 13.1%(4.3, 30.9) and 27.9% (8.6, 66.3) for one, two and three/four-step strategies respectively. The number needed to invite to the OGTT to detect one case of T2DM was 15, 7.6 and 3.6 in one, two, and three/four-step strategies. In two step strategies, there was no difference between the response or yield rates whether the first step was blood test or risk-score. There was evidence of substantial heterogeneity in rates across study populations but this was not explained by the method of invitation, study location (rural versus urban) and developmental index of the country in which the study was performed. Conclusions Irrespective of the invitation method, developmental status of the countries and or rural/urban location, using a multi-step strategy increases the initial response rate to the invitation to screening for diabetes and reduces the number needed to have the final diagnostic test (OGTT in this study) for a definite diagnosis.	[Khunti, Kamlesh; Mani, Hamidreza; Davies, Melanie J.] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England; [Achana, Felix; Cooper, Nicola; Gray, Laura J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Achana, Felix] Univ Warwick, Clin Trials Unit, Sch Med, Coventry CV4 7AL, W Midlands, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester; University of Warwick	Khunti, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Schooling, Mary/0000-0001-9933-5887; Mani, Hamidreza/0000-0001-9021-8764; Gray, Laura/0000-0002-9284-9321; Davies, Melanie/0000-0002-9987-9371	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East-Midlands Scheme; National Institute for Health Research (NIHR) "Leicester and Loughborough Diet, Lifestyle and Physical activity Biomedical Research Unit" based at University Hospitals of Leicester NHS Trust / University of Leicester; National Institute for Health Research (NIHR) "Leicester and Loughborough Diet, Lifestyle and Physical activity Biomedical Research Unit" based at University Hospitals of Leicester NHS Trust / University of Loughborough; National Institute for Health Research [CL-2013-11-001] Funding Source: researchfish	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East-Midlands Scheme; National Institute for Health Research (NIHR) "Leicester and Loughborough Diet, Lifestyle and Physical activity Biomedical Research Unit" based at University Hospitals of Leicester NHS Trust / University of Leicester; National Institute for Health Research (NIHR) "Leicester and Loughborough Diet, Lifestyle and Physical activity Biomedical Research Unit" based at University Hospitals of Leicester NHS Trust / University of Loughborough; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East-Midlands Scheme and National Institute for Health Research (NIHR) "Leicester and Loughborough Diet, Lifestyle and Physical activity Biomedical Research Unit" based at University Hospitals of Leicester NHS Trust / Universities of Leicester and Loughborough. Funders had no role in study design, decision for publication.	Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; [Anonymous], 1994, BMJ, V308, P313; Azizi F, 2003, East Mediterr Health J, V9, P1122; Barakat MN, 2008, SAUDI MED J, V29, P1824; Bener A, 2009, DIABETES RES CLIN PR, V84, P99, DOI 10.1016/j.diabres.2009.02.003; Bhansali A, 2012, DIABETIC MED, V29, P1385, DOI 10.1111/j.1464-5491.2012.03634.x; Botas P, 2003, DIABETIC MED, V20, P904, DOI 10.1046/j.1464-5491.2003.01006.x; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Cho NH, 2007, DIABETES CARE, V30, P2566, DOI 10.2337/dc07-0106; Choi SJ, 2010, CIRC J, V74, P1357, DOI 10.1253/circj.CJ-09-0739; Choi SH, 2011, DIABETES CARE, V34, P944, DOI 10.2337/dc10-0644; Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2; Colagiuri S, 2004, DIABETES CARE, V27, P367, DOI 10.2337/diacare.27.2.367; Dalsgaard EM, 2010, PRIM CARE DIABETES, V4, P223, DOI 10.1016/j.pcd.2010.06.003; DAS M, 2011, J BIO-SCI, V19, P1; Deepa M, 2007, DIABETES-METAB RES, V23, P127, DOI 10.1002/dmrr.658; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; DUK, 2012, DIABETES IN THE UK20; Dunkley AJ, 2009, PRIM CARE DIABETES, V3, P49, DOI 10.1016/j.pcd.2009.02.002; Eborall H, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630106; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2012, DIABETES RES CLIN PR, V98, P199, DOI 10.1016/j.diabres.2012.08.003; Egeland GM, 2011, CAN MED ASSOC J, V183, P1022, DOI 10.1503/cmaj.101801; El Bassuoni Eman A, 2008, Prim Care Diabetes, V2, P147, DOI 10.1016/j.pcd.2008.04.005; Eriksson AK, 2012, EUR J EPIDEMIOL, V27, P153, DOI 10.1007/s10654-011-9630-1; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gardete-Correia L, 2010, DIABETIC MED, V27, P879, DOI 10.1111/j.1464-5491.2010.03017.x; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Glumer C, 2004, DIABETIC MED, V21, P874, DOI 10.1111/j.1464-5491.2004.01260.x; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Gomez-Perez FJ, 2010, ARCH MED RES, V41, P302, DOI 10.1016/j.arcmed.2010.05.007; Goyder E, 2008, FAM PRACT, V25, P370, DOI 10.1093/fampra/cmn054; Gray LJ, 2012, DIABETOLOGIA, V55, P3238, DOI 10.1007/s00125-012-2725-8; Habibi Moeine S, 2004, IJMS, V29, P21; Harris R, 2003, ANN INTERN MED, V138, P215, DOI 10.7326/0003-4819-138-3-200302040-00015; Hayes L, 2012, DIABETIC MED, V29, P115, DOI 10.1111/j.1464-5491.2011.03389.x; Heldgaard PE, 2006, DIABETIC MED, V23, P996, DOI 10.1111/j.1464-5491.2006.01929.x; Heldgaard PE, 2011, SCAND J PRIM HEALTH, V29, P85, DOI 10.3109/02813432.2011.565164; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052; Janssen Paul G H, 2007, Prim Care Diabetes, V1, P69, DOI 10.1016/j.pcd.2007.02.001; Janssen PGH, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-67; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; John WG, 2012, DIABETIC MED, V29, P1350, DOI 10.1111/j.1464-5491.2012.03762.x; John W Garry, 2007, Clin Biochem Rev, V28, P163; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; Karjalainen J, 2008, DIABETES RES CLIN PR, V81, P110, DOI 10.1016/j.diabres.2008.03.006; Khunti K, 2012, DIABET MED; Khunti K, 2012, DIABETES RES CLIN PR, V97, P505, DOI 10.1016/j.diabres.2012.03.009; Khunti K, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4514; Knowler WC., 2009, LANCET, V374, P1677, DOI [10.1016/S0140-6736(09)61457-4, DOI 10.1016/S0140-6736(09)61457-4, 10.1016/B978-0-323-29738-7]; Korhonen PE, 2009, EUR J PUBLIC HEALTH, V19, P95, DOI 10.1093/eurpub/ckn090; Lim S, 2006, J ENDOCRINOL INVEST, V29, P313, DOI 10.1007/BF03344102; Lin S, 2013, CLIN ENDOCRINOL OXF; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Mannucci E, 2003, ACTA DIABETOL, V40, P181, DOI 10.1007/s00592-003-0109-8; Marteau TM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2138; McAullay D, 2004, AUST NZ J PUBL HEAL, V28, P43, DOI 10.1111/j.1467-842X.2004.tb00631.x; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Mensink M, 2003, DIABETES RES CLIN PR, V61, P49, DOI 10.1016/S0168-8227(03)00067-6; Mohan V, 2007, DIABETES OBES METAB, V9, P337, DOI 10.1111/j.1463-1326.2006.00612.x; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; Nice P, 2012, PREVENTING TYPE 2 DI; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Oberlinner C, 2008, OCCUP MED-OXFORD, V58, P41, DOI 10.1093/occmed/kqm129; Ohkura T, 2009, YONAGO ACTA MED, V52, P105; Park P, 2010, J HEALTH PSYCHOL, V15, P196, DOI 10.1177/1359105309344896; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Phillips LS, 2009, DIABETOLOGIA, V52, P1798, DOI 10.1007/s00125-009-1407-7; Rahim M A, 2004, Bangladesh Med Res Counc Bull, V30, P60; Rahim MA, 2007, DIABETES RES CLIN PR, V77, P300, DOI 10.1016/j.diabres.2006.11.010; Rahim M A, 2010, Bangladesh Med Res Counc Bull, V36, P47; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Riste L, 2001, DIABETES CARE, V24, P1377, DOI 10.2337/diacare.24.8.1377; Rush E, 2008, DIABETIC MED, V25, P1070, DOI 10.1111/j.1464-5491.2008.02526.x; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Sadeghi M, 2007, ANN ACAD MED SINGAP, V36, P175; Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0; Sandbaek A, 2005, DIABETIC MED, V22, P1173, DOI 10.1111/j.1464-5491.2005.01491.x; Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x; Simmons D, 2005, DIABETES RES CLIN PR, V70, P287, DOI 10.1016/j.diabres.2005.04.004; Simmons RK, 2012, LANCET; Skinner TC, 2005, DIABETIC MED, V22, P1497, DOI 10.1111/j.1464-5491.2005.01680.x; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Spijkerman AMW, 2002, DIABETES CARE, V25, P1784, DOI 10.2337/diacare.25.10.1784; Sundborn Gerhard, 2007, N Z Med J, V120, pU2607; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 1999, DIAGNOSIS AND CLASSI; WHO, 2011, THE DIAGNOSIS OF DIA; WHO I, 2003, SCREENING FOR TYPE 2; WHO/IDF, 2006, REPORT OF A WHO IDF; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Ye Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087690; Zhou XH, 2009, DIABETIC MED, V26, P1262, DOI 10.1111/j.1464-5491.2009.02831.x; Zhou XH, 2009, DIABETES RES CLIN PR, V86, P233, DOI 10.1016/j.diabres.2009.09.014; Ziemer DC, 2008, J GEN INTERN MED, V23, P528, DOI 10.1007/s11606-008-0524-1; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	112	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135702	10.1371/journal.pone.0135702	http://dx.doi.org/10.1371/journal.pone.0135702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325182	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700023
J	Schmittmann, VD; Jahfari, S; Borsboom, D; Savi, AO; Waldorp, LJ				Schmittmann, Verena D.; Jahfari, Sara; Borsboom, Denny; Savi, Alexander O.; Waldorp, Lourens J.			Making Large-Scale Networks from fMRI Data	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; BRAIN NETWORKS; SMALL-WORLD; ARCHITECTURE; REGRESSION; EFFICIENCY; ALGORITHM; SYSTEM; GRAPHS	Pairwise correlations are currently a popular way to estimate a large-scale network (> 1000 nodes) from functional magnetic resonance imaging data. However, this approach generally results in a poor representation of the true underlying network. The reason is that pairwise correlations cannot distinguish between direct and indirect connectivity. As a result, pairwise correlation networks can lead to fallacious conclusions; for example, one may conclude that a network is a small-world when it is not. In a simulation study and an application to resting-state fMRI data, we compare the performance of pairwise correlations in large-scale networks (2000 nodes) against three other methods that are designed to filter out indirect connections. Recovery methods are evaluated in four simulated network topologies (small world or not, scale-free or not) in scenarios where the number of observations is very small compared to the number of nodes. Simulations clearly show that pairwise correlation networks are fragmented into separate unconnected components with excessive connectedness within components. This often leads to erroneous estimates of network metrics, like small-world structures or low betweenness centrality, and produces too many low-degree nodes. We conclude that using partial correlations, informed by a sparseness penalty, results in more accurate networks and corresponding metrics than pairwise correlation networks. However, even with these methods, the presence of hubs in the generating network can be problematic if the number of observations is too small. Additionally, we show for resting-state fMRI that partial correlations are more robust than correlations to different parcellation sets and to different lengths of time-series.	[Schmittmann, Verena D.] Tilburg Univ, Dept Methodol & Stat Social & Behav Sci, NL-5000 LE Tilburg, Netherlands; [Jahfari, Sara] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Borsboom, Denny; Savi, Alexander O.; Waldorp, Lourens J.] Univ Amsterdam, Psychol Methods Social & Behav Sci, Amsterdam, Netherlands	Tilburg University; Vrije Universiteit Amsterdam; University of Amsterdam	Schmittmann, VD (corresponding author), Tilburg Univ, Dept Methodol & Stat Social & Behav Sci, NL-5000 LE Tilburg, Netherlands.	v.d.schmittmann@uvt.nl	Savi, Alexander O./AAD-2195-2020	Savi, Alexander O./0000-0002-9271-7476; Borsboom, Denny/0000-0001-9720-4162	Netherlands Organization for Scientific Research (NWO) [451-03-068]; Mosaic grant from the Netherlands Organization for Scientific Research (NWO) [017.005.107]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Mosaic grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by innovational research grant no. 451-03-068 (VDS and DB) from the Netherlands Organization for Scientific Research (NWO), and by Mosaic grant no 017.005.107 (SJ) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Bollobas B., 1998, MODERN GRAPH THEORY; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cribben I, 2012, NEUROIMAGE, V61, P907, DOI 10.1016/j.neuroimage.2012.03.070; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; de Jong RM, 2000, ECONOMETRICA, V68, P407; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drton M, 2008, J STAT PLAN INFER, V138, P1179, DOI 10.1016/j.jspi.2007.05.035; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Friedman J., 2011, GLASSO GRAPHICAL LAS; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Itahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094115; Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones B, 2005, BIOMETRIKA, V92, P779, DOI 10.1093/biomet/92.4.779; Langford E, 2001, AM STAT, V55, P322, DOI 10.1198/000313001753272286; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Lemoine C, 2008, IEEE T ELECTROMAGN C, V50, P227, DOI 10.1109/TEMC.2008.919037; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Pircalabelu E, ANN APPL STAT UNDER; R Core Team, 2012, R LANG ENV STAT COMP; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2012, CORPCOR EFFICIENT ES; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Varoquaux G., 2010, ADV NEURAL INFORM PR, P2334; Varoquaux G, 2013, NEUROIMAGE, V80, P405, DOI 10.1016/j.neuroimage.2013.04.007; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001	59	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0129074	10.1371/journal.pone.0129074	http://dx.doi.org/10.1371/journal.pone.0129074			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325185	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700001
J	Liang, ZX; Liang, Y				Liang, Zhu-Xing; Liang, Yi			Significance of Polarization Charges and Isomagnetic Surface in Magnetohydrodynamics	PLOS ONE			English	Article							MAGNETIC-FIELD LINES; MOTION	From the frozen-in field lines concept, a highly conducting fluid can move freely along, but not traverse to, magnetic field lines. We discuss this topic and find that in the study of the frozen-in field lines concept, the effects of inductive and capacitive reactance have been omitted. When admitted, the relationships among the motional electromotive field, the induced electric field, the eddy electric current, and the magnetic field becomes clearer. We emphasize the importance of isomagnetic surfaces and polarization charges, and show analytically that whether a conducting fluid can freely traverse magnetic field lines or not depends solely on the magnetic gradient along the path of the fluid. If a fluid does not change its density distribution and shape (can be regarded as a quasi-rigid body) and moves along isomagnetic surface, it can freely traverse magnetic field lines without any magnetic drag, no matter how strong the magnetic field is. Besides theoretical analysis, we also present experimental results to support our analysis. The main purpose of this work is to correct a fallacy among some astrophysicists.			Liang, ZX (corresponding author), 18-4-102 Shuixiehuadu, Shijiazhuang 050035, Hebei, Peoples R China.	zx.liang55@hotmail.com		Liang, Zhu-Xing/0000-0002-2645-7856				AKASOFU SI, 1978, SPACE SCI REV, V21, P489, DOI 10.1007/BF00240906; ALFVEN H, 1958, TELLUS, V10, P104, DOI 10.1111/j.2153-3490.1958.tb01991.x; ALFVEN H, 1976, J GEOPHYS RES-SPACE, V81, P4019, DOI 10.1029/JA081i022p04019; Alfven H, 1942, NATURE, V150, P405, DOI 10.1038/150405d0; Alfven H, 1963, COSMICAL ELECTRODYNA, Vsecond edition, P110; Alfven H, 1963, COSMICAL ELECTRODYNA, Vsecond edition, P190; BACKUS G, 1956, ASTROPHYS J, V123, P508, DOI 10.1086/146187; Bateman G, 1978, MHD INSTABILITIES, P30; Bellan PM, 2006, FUNDAMENTALS PLASMA, P100; Bittencourt JA, 2004, FUNDAMENTALS PLASMA, Vthird edition, P315; Bittencourt JA, 2004, FUNDAMENTALS PLASMA, Vthird edition, P312; Bittencourt JA, 2004, FUNDAMENTALS PLASMA, Vthird edition, P51; Boyd TJM, 2003, PHYS PLASMAS, P79; Falthammar CG, 2006, AM J PHYS, V74, P454, DOI 10.1119/1.2180285; Falthammar CG, 2007, EOSTR, V88, P169; Feynman RP, 1964, THE FEYNMAN LECTURES, V2, P13; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; Goldston RJ, 1995, INTRO PLASMA PHYS, P124; Goldston RJ, 1995, INTRO PLASMA PHYS, P118; Ivonin IA, 1998, PHYS PLASMAS, V5, P2893, DOI 10.1063/1.873011; Li D, 2006, PLASMA PHYS, P69; Liang ZX, 2009, YOTUDOU; Liang ZX, 2009, YOUTUBE; Lundin R, 2005, ANN GEOPHYS-GERMANY, V23, P2565, DOI 10.5194/angeo-23-2565-2005; Lyne AG, 2005, PULSAR ASTRONOMY, Vthird, P23; Ma JC, 2012, FUNDAMENTALS PLASMA, Vsecond, P188; NEWCOMB WA, 1958, ANN PHYS-NEW YORK, V3, P347, DOI 10.1016/0003-4916(58)90024-1; NORTHROP TG, 1963, REV GEOPHYS, V1, P283, DOI 10.1029/RG001i003p00283; STERN DP, 1966, SPACE SCI REV, V6, P147; VASYLIUNAS VM, 1972, J GEOPHYS RES, V77, P6271, DOI 10.1029/JA077i031p06271; Zheng CK, 2009, PLASMA PHYS, P79	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136936	10.1371/journal.pone.0136936	http://dx.doi.org/10.1371/journal.pone.0136936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322894	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500050
J	Rouver, WN; Delgado, NTB; Menezes, JB; Santos, RL; Moyses, MR				Rouver, Wender Nascimento; Banhos Delgado, Nathalie Tristao; Menezes, Jussara Bezerra; Santos, Roger Lyrio; Moyses, Margareth Ribeiro			Testosterone Replacement Therapy Prevents Alterations of Coronary Vascular Reactivity Caused by Hormone Deficiency Induced by Castration	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; LIPOPROTEIN-LIPASE; GENDER-DIFFERENCES; VASODILATION; ANDROGENS; ARTERY; INHIBITION; RELAXATION; BRADYKININ; CHANNELS	The present study aimed to determine the effects of chronic treatment with different doses of testosterone on endothelium-dependent coronary vascular reactivity in male rats. Adult male rats were divided into four experimental groups: control (SHAM), castrated (CAST), castrated and immediately treated subcutaneously with a physiological dose (0.5 mg/kg/ day, PHYSIO group) or supraphysiological dose (2.5 mg/kg/day, SUPRA group) of testosterone for 15 days. Systolic blood pressure (SBP) was assessed at the end of treatment through tail plethysmography. After euthanasia, the heart was removed and coronary vascular reactivity was assessed using the Langendorff retrograde perfusion technique. A dose-response curve for bradykinin (BK) was constructed, followed by inhibition with 100 mu M L-NAME, 2.8 mu M indomethacin (INDO), L-NAME + INDO, or L-NAME + INDO + 0.75 mu M clotrimazole (CLOT). We observed significant endothelium-dependent, BK-induced coronary vasodilation, which was abolished in the castrated group and restored in the PHYSIO and SUPRA groups. Furthermore, castration modulated the lipid and hormonal profiles and decreased body weight, and testosterone therapy restored all of these parameters. Our results revealed an increase in SBP in the SUPRA group. In addition, our data led us to conclude that physiological concentrations of testosterone may play a beneficial role in the cardiovascular system by maintaining an environment that is favourable for the activity of an endothelium-dependent vasodilator without increasing SBP.	[Rouver, Wender Nascimento; Banhos Delgado, Nathalie Tristao; Menezes, Jussara Bezerra; Santos, Roger Lyrio; Moyses, Margareth Ribeiro] Univ Fed Espirito Santo, Fed Univ Espirito Santo, Dept Physiol Sci, Vitoria, Brazil	Universidade Federal do Espirito Santo	Santos, RL (corresponding author), Univ Fed Espirito Santo, Fed Univ Espirito Santo, Dept Physiol Sci, Vitoria, Brazil.	rogerlyrio@hotmail.com; mmoyses51@gmail.com	Rouver, Wender do Nascimento/AAH-7048-2020; dos Santos, Roger Lyrio/AAH-7100-2020	Rouver, Wender do Nascimento/0000-0002-4336-7422; dos Santos, Roger Lyrio/0000-0003-4316-7196; Tristao Banhos Delgado, Nathalie/0000-0001-7501-8940				ADAMS MR, 1995, ARTERIOSCL THROM VAS, V15, P562, DOI 10.1161/01.ATV.15.5.562; Baldo MP, 2011, PHARMACOL REP, V63, P975, DOI 10.1016/S1734-1140(11)70613-2; BARROW SE, 1986, BRIT J PHARMACOL, V87, P243, DOI 10.1111/j.1476-5381.1986.tb10177.x; Bissoli NS, 2009, PHARMACOL RES, V59, P379, DOI 10.1016/j.phrs.2009.03.001; Bourghardt J, 2010, ENDOCRINOLOGY, V151, P5428, DOI 10.1210/en.2010-0663; Bucci M, 2009, EUR UROL, V56, P378, DOI 10.1016/j.eururo.2008.05.014; Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806; Deenadayalu V, 2012, AM J PHYSIOL-HEART C, V302, pH115, DOI 10.1152/ajpheart.00046.2011; dos Santos RL, 2014, HORM MOL BIOL CLIN I, V18, P89, DOI 10.1515/hmbci-2013-0048; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; FORSTERMANN U, 1993, EUR HEART J, V14, P10; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Gomes HL, 2012, CAN J PHYSIOL PHARM, V90, P75, DOI [10.1139/Y11-102, 10.1139/y11-102]; Lee HK, 2013, WORLD J MENS HEALTH, V31, P136, DOI 10.5534/wjmh.2013.31.2.136; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; MELCHERT RB, 1995, MED SCI SPORT EXER, V27, P1252; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; MOMBOULI JV, 1992, CIRC RES, V71, P137, DOI 10.1161/01.RES.71.1.137; Mosca Lori, 2007, Circulation, V115, P1481, DOI 10.1161/CIRCULATIONAHA.107.181546; Moyses MR, 2001, BRAZ J MED BIOL RES, V34, P949, DOI 10.1590/S0100-879X2001000700014; OKANE KPJ, 1994, BRIT J CLIN PHARMACO, V38, P311, DOI 10.1111/j.1365-2125.1994.tb04359.x; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Perusquia M, 2012, AM J PHYSIOL-HEART C, V298, pH1301; Puttabyatappa Y, 2013, J PHARMACOL EXP THER, V345, P7, DOI 10.1124/jpet.112.201947; Ramirez ME, 1997, METABOLISM, V46, P179, DOI 10.1016/S0026-0495(97)90299-7; Ramirez-Rosas MB, 2011, STEROIDS, V76, P409, DOI 10.1016/j.steroids.2010.12.012; Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; SALT PJ, 1972, EUR J PHARMACOL, V20, P329, DOI 10.1016/0014-2999(72)90194-X; Santos RL, 2010, ACTA PHYSIOL, V200, P203, DOI 10.1111/j.1748-1716.2010.02140.x; Santos RL, 2004, BRAZ J MED BIOL RES, V37, P569, DOI 10.1590/S0100-879X2004000400014; Skogastierna C, 2014, EUR J PREV CARDIOL, V21, P1049, DOI 10.1177/2047487313481755; Tep-areenan P, 2002, BRIT J PHARMACOL, V135, P735, DOI 10.1038/sj.bjp.0704522; Toot JD, 2011, GENDER MED, V8, P40, DOI 10.1016/j.genm.2011.01.002; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Zhou P, 2008, EUR J PHARMACOL, V593, P87, DOI 10.1016/j.ejphar.2008.07.014	43	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137111	10.1371/journal.pone.0137111	http://dx.doi.org/10.1371/journal.pone.0137111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322637	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500066
J	Tarnawski, L; Xian, XJ; Monnerat, G; Macaulay, IC; Malan, D; Borgman, A; Wu, SM; Fleischmann, BK; Jovinge, S				Tarnawski, Laura; Xian, Xiaojie; Monnerat, Gustavo; Macaulay, Iain C.; Malan, Daniela; Borgman, Andrew; Wu, Sean M.; Fleischmann, Bernd K.; Jovinge, Stefan			Integrin Based Isolation Enables Purification of Murine Lineage Committed Cardiomyocytes	PLOS ONE			English	Article							EXPRESSION; DIFFERENTIATION; ALPHA; HEART	In contrast to mature cardiomyocytes which have limited regenerative capacity, pluripotent stem cells represent a promising source for the generation of new cardiomyocytes. The tendency of pluripotent stem cells to form teratomas and the heterogeneity fromvarious differentiation stages and cardiomyocyte cell sub-types, however, are major obstacles to overcome before this type of therapy could be applied in a clinical setting. Thus, the identification of extracellularmarkers for specific cardiomyocyte progenitors and mature subpopulations is of particular importance. The delineation of cardiomyocyte surfacemarker patterns not only serves as a means to derive homogeneous cell populations by FACS, but is also an essential tool to understand cardiac development. By using single-cell expression profiling in early mouse embryonic hearts, we found that a combination of integrin alpha-1, alpha-5, alpha-6 and N-cadherin enables isolation of lineage committed murine cardiomyocytes. Additionally, we were able to separate trabecular cardiomyocytes from solid ventricular myocardium and atrial murine cells. These cells exhibit expected subtype specific phenotype confirmed by electrophysiological analysis. We show that integrin expression can be used for the isolation of living, functional and lineage-specific murine cardiomyocytes.	[Tarnawski, Laura; Xian, Xiaojie; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Jovinge, Stefan] Van Andel Res Inst, Grand Rapids, MI USA; [Monnerat, Gustavo; Malan, Daniela; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, Dept Cardiac Surg, D-53115 Bonn, Germany; [Monnerat, Gustavo] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Macaulay, Iain C.] Univ Oxford, Haematopoiet Stem Cell Lab, Weatherall Inst Mol Med, Oxford, England; [Wu, Sean M.] Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Wu, Sean M.] Stanford Cardiovasc Inst, Stanford, CA USA; [Wu, Sean M.] Stanford Univ, Dept Med, Sch Med, Div Cardiol, Stanford, CA 94305 USA; [Fleischmann, Bernd K.] Univ Bonn, Pharma Ctr Bonn, Bonn, Germany; [Borgman, Andrew; Jovinge, Stefan] Spectrum Hlth Fredrik Meijer Heart & Vasc Inst, Grand Rapids, MI USA	Lund University; Van Andel Institute; University of Bonn; Universidade Federal do Rio de Janeiro; University of Oxford; Stanford University; University of Bonn	Tarnawski, L (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden.	laura.tarnawski@vai.org	monnerat, gustavo/E-3398-2015; Monnerat, Gustavo/J-6907-2019; Tarnawski, Laura/AAA-2254-2022; Tarnawski, Laura/ABB-1979-2020	monnerat, gustavo/0000-0002-1010-6314; Tarnawski, Laura/0000-0001-7993-0232; Wu, Sean/0000-0002-0000-3821; Macaulay, Iain/0000-0002-6761-757X	National Institutes of Health, National Heart, Lung, and Blood Institute [K08 HL081086, U01 HL009976-05]; National Institutes of Health Director's New Innovator's Award [DP2 OD004411]; Swedish Heart- and Lung Foundation; Swedish Research Council; European FP7 grant under CardioCell consortium; Richard and Hellen DeVos Foundation; German Research Foundation [FL 276/7-1/7-2]; Science without Borders program of The Brazilian National Council for Scientific and Technological Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081086, F32HL009976] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM012179] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004411] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Director's New Innovator's Award; Swedish Heart- and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European FP7 grant under CardioCell consortium; Richard and Hellen DeVos Foundation; German Research Foundation(German Research Foundation (DFG)); Science without Borders program of The Brazilian National Council for Scientific and Technological Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute [grant number K08 HL081086, U01 HL009976-05], http://www.nih.gov/about/almanac/archive/2003/organization/NHLBI.htm, the National Institutes of Health Director's New Innovator's Award [DP2 OD004411], https://commonfund.nih.gov/newinnovator/index [to SMW], the Swedish Heart- and Lung Foundation, http://www.hjart-lungfonden.se/Om-Hjart-lungfonden/About-HLF/, the Swedish Research Council, http://www.vr.se/, the European FP7 grant under CardioCell consortium, http://ec.europa.eu/research/fp7/index_en.cfm, the Richard and Hellen DeVos Foundation, http://www.centerfornonprofitexcellence.org/grantmakers-directory/richard-and-helen-devos-foundation [to SJ], the German Research Foundation [grant number FL 276/7-1/7-2], http://www.dfg.de/en/ [toBKF], and the Science without Borders program of The Brazilian National Council for Scientific and Technological Development, http://www.cienciasemfronteiras.gov.br/web/csf-eng/ [to GM]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, R LANG ENV STAT COMP; COLLO G, 1995, CELL ADHES COMMUN, V3, P101, DOI 10.3109/15419069509081280; Feiner L, 2001, DEVELOPMENT, V128, P3061; Henningsen A., 2013, CENSREG CENSORED REG; Hierck BP, 1996, DEV DYNAM, V206, P100, DOI 10.1002/(SICI)1097-0177(199605)206:1<100::AID-AJA9>3.0.CO;2-M; Jensen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044231; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; King T, 2002, DEV DYNAM, V225, P212, DOI 10.1002/dvdy.10142; Lal Hind, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P109, DOI 10.2174/187152507780363223; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Maitra N, 2000, CARDIOVASC RES, V47, P715, DOI 10.1016/S0008-6363(00)00140-1; Malan D, 2009, STEM CELLS, V27, P88, DOI 10.1634/stemcells.2008-0335; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Morales MO, 2005, MICROSC MICROANAL, V11, P260, DOI 10.1017/S1431927605050518; Ponten A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082403; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Samsa LA, 2013, AM J MED GENET C, V163, P157, DOI 10.1002/ajmg.c.31366; Small EM, 2004, TRENDS CARDIOVAS MED, V14, P13, DOI 10.1016/j.tcm.2003.09.005; VanDusen NJ, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.03.002; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zammit PS, 2000, DEV DYNAM, V217, P75, DOI 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135880	10.1371/journal.pone.0135880	http://dx.doi.org/10.1371/journal.pone.0135880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323090	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500010
J	Zhang, YQ; Xu, Q; Alos, J; Liu, H; Xu, QZ; Yang, HS				Zhang, Yingqiu; Xu, Qiang; Alos, Josep; Liu, Hui; Xu, Qinzeng; Yang, Hongsheng			Short-Term Fidelity, Habitat Use and Vertical Movement Behavior of the Black Rockfish Sebastes schlegelii as Determined by Acoustic Telemetry	PLOS ONE			English	Article							HOME-RANGE SIZE; ARTIFICIAL REEFS; SITE FIDELITY; ACTIVITY PATTERNS; STOCK ENHANCEMENT; FISH ASSEMBLAGE; MARINE RESERVE; DIEL BEHAVIOR; ROCKY REEF; DESIGN	The recent miniaturization of acoustic tracking devices has allowed fishery managers and scientists to collect spatial and temporal data for sustainable fishery management. The spatial and temporal dimensions of fish behavior (movement and/or vertical migrations) are particularly relevant for rockfishes (Sebastes spp.) because most rockfish species are long-lived and have high site fidelity, increasing their vulnerability to overexploitation. In this study, we describe the short-term (with a tracking period of up to 46 d) spatial behavior, as determined by acoustic tracking, of the black rockfish Sebastes schlegelii, a species subject to overexploitation in the Yellow Sea of China. The average residence index (the ratio of detected days to the total period from release to the last detection) in the study area was 0.92 +/- 0.13, and most of the tagged fish were detected by only one region of the acoustic receiver array, suggesting relatively high site fidelity to the study area. Acoustic tracking also suggested that this species is more frequently detected during the day than at night in our study area. However, the diel detection periodicity (24 h) was only evident for certain periods of the tracking time, as revealed by a continuous wavelet transform. The habitat selection index of tagged S. schlegelii suggested that S. schlegelii preferred natural reefs, mixed sand/artificial reef bottoms and mixed bottoms of boulder, cobble, gravel and artificial reefs. The preference of this species for the artificial reefs that were recently deployed in the study area suggests that artificial seascapes may be effective management tools to attract individuals. The vertical movement of tagged S. schlegelii was mostly characterized by bottom dwelling behavior, and there was high individual variability in the vertical migration pattern. Our results have important implications for S. schlegelii catchability, the implementation of marine protected areas, and the identification of key species habitats, and our study provides novel information for future studies on the sustainability of this important marine resource in eastern China.	[Zhang, Yingqiu; Xu, Qiang; Liu, Hui; Xu, Qinzeng; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Zhang, Yingqiu; Liu, Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Alos, Josep] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Xu, Q (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	xuqiangcas@126.com; hshyang@qdio.ac.cn		Alos, Josep/0000-0003-4385-9539	Ministry of Sciences and Technology of the People's Republic of China [2011BAD13B02]; State Oceanic Administration People's Republic of China [201205023, 201305043]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11020404]; Marie Curie Post-Doc grant (FP7-PEOPLE-IEF) [327160]	Ministry of Sciences and Technology of the People's Republic of China(Ministry of Science and Technology, China); State Oceanic Administration People's Republic of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Marie Curie Post-Doc grant (FP7-PEOPLE-IEF)	HY was supported through the National Key Technology Research and Development Program (grant no. 2011BAD13B02) provided by Ministry of Sciences and Technology of the People's Republic of China (URL: http://www.most.gov.cn/eng/), the Non-Profit Marine Sector (grant no. 201205023, 201305043) provided by State Oceanic Administration People's Republic of China (URL: http://www.soa.gov.cn/english/) and the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDA11020404) provided by Chinese Academy of Sciences (URL: http://english.cas.cn/). JA was supported through a Marie Curie Post-Doc grant (FP7-PEOPLE-2012-IEF, grant no. 327160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2008, ESTUAR COAST SHELF S, V79, P758, DOI 10.1016/j.ecss.2008.06.019; Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Addis DT, 2013, FISH RES, V147, P349, DOI 10.1016/j.fishres.2013.07.011; Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Alos J, 2012, J APPL ICHTHYOL, V28, P606, DOI 10.1111/j.1439-0426.2012.01955.x; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Baskett ML, 2006, CAN J FISH AQUAT SCI, V63, P1214, DOI 10.1139/F06-013; Bertrand S, 2004, ICES J MAR SCI, V61, P1127, DOI 10.1016/j.icesjms.2004.07.016; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2003, ECOL APPL, V13, pS25; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Cabanellas-Reboredo M, 2014, ICES J MAR SCI, V71, P1760, DOI 10.1093/icesjms/fst206; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Chin BS, 2013, REV FISH SCI, V21, P286, DOI 10.1080/10641262.2013.837364; Chin BS, 2010, ICHTHYOL RES, V57, P278, DOI 10.1007/s10228-010-0165-3; Claisse JT, 2014, P NATL ACAD SCI USA, V111, P15462, DOI 10.1073/pnas.1411477111; Clements S, 2005, N AM J FISH MANAGE, V25, P429, DOI 10.1577/M03-224.1; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Crook DA, 2004, J FISH BIOL, V64, P258, DOI 10.1111/j.1095-8649.2004.00282.x; Deegan LA, 2005, DECLINE FISHERIES RE, P67; Ding Z, 2007, RIZHAO QIANSAN ISLET; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Farmer NA, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-7; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Gaucherel C., 2011, Computational Ecology and Software, V1, P69; Gauthier S, 2002, J FISH BIOL, V61, P1135, DOI 10.1006/jfbi.2002.2128; [龚政 Gong Zheng], 2002, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V30, P5; Green KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098976; Green KM, 2011, MAR ECOL PROG SER, V436, P219, DOI 10.3354/meps09263; Greene HG, 2011, CONT SHELF RES, V31, pS39, DOI 10.1016/j.csr.2010.11.004; Hannah RW, 2011, N AM J FISH MANAGE, V31, P483, DOI 10.1080/02755947.2011.591239; Hart TD, 2010, FISH B-NOAA, V108, P466; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787521749; HILBORN R, 1992; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Jenkins JA, 2014, FISHERIES, V39, P415, DOI 10.1080/03632415.2014.924408; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; Kang K.M., 2006, FISH AQUAT SCI, V9, P91, DOI DOI 10.5657/FAS.2006.9.2.091; Koeck B, 2014, MAR ENVIRON RES, V94, P38, DOI 10.1016/j.marenvres.2013.12.002; Koeck B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069303; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; KRIEGER KJ, 1993, FISH B-NOAA, V91, P87; Leitao F, 2009, FISHERIES MANAG ECOL, V16, P88, DOI 10.1111/j.1365-2400.2008.00646.x; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Li L, 2012, RIZHAO QIANSAN ISLAN; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Liu H, 2015, CHIN J OCEANOL LIMN, V33, P107, DOI 10.1007/s00343-015-4049-2; Liu Lan, 2012, Marine Environmental Science, V31, P918; Lorenzen K, 2010, B MAR SCI, V86, P169; Lu HJ, 2014, CHIN J OCEANOL LIMN, V32, P810, DOI 10.1007/s00343-014-3252-x; Magnuson-Ford K, 2009, BIOL CONSERV, V142, P1787, DOI 10.1016/j.biocon.2009.03.020; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; MELLAS EJ, 1985, CAN J FISH AQUAT SCI, V42, P488, DOI 10.1139/f85-066; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Mitamura H, 2009, FISHERIES SCI, V75, P1133, DOI 10.1007/s12562-009-0142-9; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Mullon C, 2005, FISH FISH, V6, P111, DOI 10.1111/j.1467-2979.2005.00181.x; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Nakagawa M, 2007, AQUACULTURE, V263, P295, DOI 10.1016/j.aquaculture.2006.10.023; Nakagawa Masahiro, 2008, Bulletin of Fisheries Research Agency, P223; NMFS, 2008, PREL SCI CONCL REV S; Olsen EM, 2012, ECOL EVOL, V2, P1549, DOI 10.1002/ece3.244; Padman L, 2005, TIDE MODEL DRIVER TM; Parker SJ, 2008, AQUAT BIOL, V2, P57, DOI 10.3354/ab00036; Parker SJ, 2000, FISHERIES, V25, P22, DOI 10.1577/1548-8446(2000)025<0022:MOPR>2.0.CO;2; Parkinson EA, 2004, CAN J FISH AQUAT SCI, V61, P1658, DOI 10.1139/F04-101; Parsons D, 2005, MAR TECHNOL SOC J, V39, P56, DOI 10.4031/002533205787521703; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Pedersen MW, 2013, METHODS ECOL EVOL, V4, P920, DOI 10.1111/2041-210X.12086; Percival D. B., 2000, COMMUNICATIONS STAT, V10, P594; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Reynolds BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012130; Rilov G, 1998, MAR ENVIRON RES, V45, P431, DOI 10.1016/S0141-1136(98)00106-8; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Stanley RD, 1999, FISH B-NOAA, V97, P320; Starr RM, 2002, FISH B-NOAA, V100, P324; Sun L, 2010, EVALUATION ARTIFICIA; Syc TS, 2012, FISH B-NOAA, V110, P458; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Williams GD, 2010, MAR POLICY, V34, P1010, DOI 10.1016/j.marpol.2010.02.008; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; [谢飞 XIE Fei], 2007, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V35, P718; Xu BD, 2005, FISH RES, V71, P79, DOI 10.1016/j.fishres.2004.07.011; Zuur Alain F., 2009, P1	100	118	120	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134381	10.1371/journal.pone.0134381	http://dx.doi.org/10.1371/journal.pone.0134381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322604	Green Published, gold			2022-12-27	WOS:000360435500001
J	Aylward, FO; Khadempour, L; Tremmel, DM; McDonald, BR; Nicora, CD; Wu, S; Moore, RJ; Orton, DJ; Monroe, ME; Piehowski, PD; Purvine, SO; Smith, RD; Lipton, MS; Burnum-Johnson, KE; Currie, CR				Aylward, Frank O.; Khadempour, Lily; Tremmel, Daniel M.; McDonald, Bradon R.; Nicora, Carrie D.; Wu, Si; Moore, Ronald J.; Orton, Daniel J.; Monroe, Matthew E.; Piehowski, Paul D.; Purvine, Samuel O.; Smith, Richard D.; Lipton, Mary S.; Burnum-Johnson, Kristin E.; Currie, Cameron R.			Enrichment and Broad Representation of Plant Biomass-Degrading Enzymes in the Specialized Hyphal Swellings of Leucoagaricus gongylophorus, the Fungal Symbiont of Leaf-Cutter Ants	PLOS ONE			English	Article							ARYL-ALCOHOL OXIDASE; CUTTING ANTS; FECAL PROTEINASES; GROWING ANT; ATTA-TEXANA; DEGRADATION; CELLULOSE; DATABASE; GARDENS	Leaf-cutter ants are prolific and conspicuous constituents of Neotropical ecosystems that derive energy from specialized fungus gardens they cultivate using prodigious amounts of foliar biomass. The basidiomycetous cultivar of the ants, Leucoagaricus gongylophorus, produces specialized hyphal swellings called gongylidia that serve as the primary food source of ant colonies. Gongylidia also contain plant biomass-degrading enzymes that become concentrated in ant digestive tracts and are deposited within fecal droplets onto fresh foliar material as ants incorporate it into the fungus garden. Although the enzymes concentrated by L. gongylophorus within gongylidia are thought to be critical to the initial degradation of plant biomass, only a few enzymes present in these hyphal swellings have been identified. Here we use proteomic methods to identify proteins present in the gongylidia of three Atta cephalotes colonies. Our results demonstrate that a diverse but consistent set of enzymes is present in gongylidia, including numerous plant biomass-degrading enzymes likely involved in the degradation of polysaccharides, plant toxins, and proteins. Overall, gongylidia contained over three quarters of all biomass-degrading enzymes identified in the L. gongylophorus genome, demonstrating that the majority of the enzymes produced by this fungus for biomass breakdown are ingested by the ants. We also identify a set of 40 of these enzymes enriched in gongylidia compared to whole fungus garden samples, suggesting that certain enzymes may be particularly important in the initial degradation of foliar material. Our work sheds light on the complex interplay between leaf-cutter ants and their fungal symbiont that allows for the host insects to occupy an herbivorous niche by indirectly deriving energy from plant biomass.	[Aylward, Frank O.; Khadempour, Lily; Tremmel, Daniel M.; McDonald, Bradon R.; Currie, Cameron R.] Univ Wisconson Madison, Dept Bacteriol, Madison, WI USA; [Aylward, Frank O.; Khadempour, Lily; Tremmel, Daniel M.; McDonald, Bradon R.; Currie, Cameron R.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Nicora, Carrie D.; Wu, Si; Moore, Ronald J.; Orton, Daniel J.; Monroe, Matthew E.; Piehowski, Paul D.; Purvine, Samuel O.; Smith, Richard D.; Lipton, Mary S.; Burnum-Johnson, Kristin E.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Aylward, FO (corresponding author), Univ Hawaii Manoa, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA.	faylward@hawaii.edu; currie@bact.wisc.edu	Lipton, Mary S/H-3913-2012; Piehowski, Paul D/AAH-5497-2019; Monroe, Matthew/L-1157-2019; Smith, Richard D/J-3664-2012; Burnum, Kristin E/B-1308-2011; Purvine, Samuel O/O-3358-2017	Piehowski, Paul D/0000-0001-5108-2227; Smith, Richard D/0000-0002-2381-2349; Burnum, Kristin E/0000-0002-2722-4149; Purvine, Samuel O/0000-0002-2257-2400; Orton, Daniel/0000-0002-0253-6859; Aylward, Frank/0000-0002-1279-4050; Tremmel, Daniel/0000-0002-1725-5582; McDonald, Bradon/0000-0002-6150-8735	U.S. Department of Energy (DOE), Office of Biological and Environmental Research, Genomic Science Program under the Pacific Northwest National Laboratory (PNNL) Pan-omics Program; DOE [DE-AC05-76RLO01830]; National Science Foundation [DEB-0747002, MCB-0702025, MCB-0731822]; DOE Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; Division Of Environmental Biology [0747002] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	U.S. Department of Energy (DOE), Office of Biological and Environmental Research, Genomic Science Program under the Pacific Northwest National Laboratory (PNNL) Pan-omics Program(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); DOE Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Proteomics measurements were supported by the U.S. Department of Energy (DOE), Office of Biological and Environmental Research, Genomic Science Program under the Pacific Northwest National Laboratory (PNNL) Pan-omics Program, and were performed in the Environmental Molecular Science Laboratory, a U.S. DOE national scientific user facility at PNNL in Richland, WA. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830. This work was also supported by National Science Foundation grants DEB-0747002, MCB-0702025, and MCB-0731822 to CRC and the DOE Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494).	Abril AB, 2002, ECOL LETT, V5, P325, DOI 10.1046/j.1461-0248.2002.00327.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aylward FO, 2014, MBIO, V5, DOI 10.1128/mBio.02077-14; Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3770, DOI 10.1128/AEM.03833-12; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Aylward Frank O., 2012, Insects, V3, P41, DOI 10.3390/insects3010041; BACCI M, 1995, ANTON LEEUW INT J G, V67, P385, DOI 10.1007/BF00872939; Barrasa JM, 1998, APPL ENVIRON MICROB, V64, P325; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; Belt Thomas, 1911, NATURALIST NICARAGUA; Borodovsky M, 2002, CURRENT PROTOCOLS BI; BOYD ND, 1975, INSECT BIOCHEM, V5, P619, DOI 10.1016/0020-1790(75)90043-8; BOYD ND, 1975, J INSECT PHYSIOL, V21, P1815, DOI 10.1016/0022-1910(75)90247-4; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Cherrett J.M., 1989, P93; Costa AN, 2008, J VEG SCI, V19, P849, DOI 10.3170/2008-8-18461; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; De Siqueira CG, 1998, APPL ENVIRON MICROB, V64, P4820; Fernandez-Marin H, 2007, INSECT SOC, V54, P64, DOI 10.1007/s00040-007-0907-z; Fernandez-Marin H, 2009, P ROY SOC B-BIOL SCI, V276, P2263, DOI 10.1098/rspb.2009.0184; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Grell MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-928; Holldobler B., 2009, SUPERORGANISM; Huang EL, 2014, ENV MICROBIOL REP, V6, P389, DOI 10.1111/1758-2229.12163; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kooij PW, 2011, INSECT SOC, V58, P145, DOI 10.1007/s00040-010-0127-9; Lange L, 2014, APPL MICROBIOL BIOT, V98, P4839, DOI 10.1007/s00253-014-5708-5; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Licht HHD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6675; Licht HHDF, 2013, P NATL ACAD SCI USA, V110, P583, DOI 10.1073/pnas.1212709110; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; MARTIN MM, 1969, ANN ENTOMOL SOC AM, V62, P1386, DOI 10.1093/aesa/62.6.1386; MARTIN MM, 1975, J INSECT PHYSIOL, V21, P1887, DOI 10.1016/0022-1910(75)90219-X; MARTIN MM, 1976, COMP BIOCHEM PHYS A, V53, P331, DOI 10.1016/S0300-9629(76)80150-8; Moller IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017506; MUHEIM A, 1990, ENZYME MICROB TECH, V12, P204, DOI 10.1016/0141-0229(90)90039-S; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Piehowski PD, 2013, PROTEOMICS, V13, P766, DOI 10.1002/pmic.201200096; R Core Team, 2021, R LANGUAGE ENV STAT; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2005, FOLIA MICROBIOL, V50, P421, DOI 10.1007/BF02931424; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schiott M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-156; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Semenova TA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-15; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587	52	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134752	10.1371/journal.pone.0134752	http://dx.doi.org/10.1371/journal.pone.0134752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317212	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100018
J	Bonney, A; Mayne, DJ; Jones, BD; Bott, L; Andersen, SEJ; Caputi, P; Weston, KM; Iverson, DC				Bonney, Andrew; Mayne, Darren J.; Jones, Bryan D.; Bott, Lawrence; Andersen, Stephen E. J.; Caputi, Peter; Weston, Kathryn M.; Iverson, Don C.			Area-Level Socioeconomic Gradients in Overweight and Obesity in a Community-Derived Cohort of Health Service Users - A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; EDUCATION; WEIGHT; WOMEN	Background Overweight and obesity lead to higher probability of individuals accessing primary care but adiposity estimates are rarely available at regional levels to inform health service planning. This paper analyses a large, community-derived clinical database of objectively measured body mass index (BMI) to explore relationships with area-level socioeconomic disadvantage for informing regional level planning activities. Materials and Methods The study included 91776 adults who had BMI objectively measured between 1 July 2009 and 30 June 2011 by a single pathology provider. Demographic data and BMI were extracted and matched to 2006 national census socioeconomic data using geocoding. Adjusted odds-ratios for overweight and obesity were calculated using sex-stratified logistic regression models with socioeconomic disadvantage of census collection district of residence as the independent variable. Results The prevalence of overweight or obesity was 79.2%(males) and 65.8%(females); increased with age to 74 years; and was higher in rural (74%) versus urban areas (71.4%) (p<0.001). Increasing socioeconomic disadvantage was associated with increasing prevalence of overweight (p<0.0001), obesity (p<0.0001) and overweight or obesity (p<0.0001) in women and obesity (p<0.0001) in men. Socioeconomic disadvantage was unrelated to overweight (p = 0.2024) and overweight or obesity (p = 0.4896) in males. Conclusion It is feasible to link routinely-collected clinical data, representative of a discrete population, with geographic distribution of disadvantage, and to obtain meaningful area-level information useful for targeting interventions to improve population health. Our results demonstrate novel area-level socioeconomic gradients in overweight and obesity relevant to regional health service planning.	[Bonney, Andrew; Andersen, Stephen E. J.; Weston, Kathryn M.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia; [Mayne, Darren J.] Illawarra Shoalhaven Local Hlth Dist, Publ Hlth, Wollongong, NSW 2500, Australia; [Mayne, Darren J.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Mayne, Darren J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Jones, Bryan D.] Sonic Healthcare Ltd, N Ryde, NSW 2113, Australia; [Bott, Lawrence; Andersen, Stephen E. J.] Southern IML Pathol, Wollongong, NSW 2500, Australia; [Caputi, Peter] Univ Wollongong, Ctr Hlth Initiat, Wollongong, NSW 2522, Australia; [Iverson, Don C.] Swinburne Univ Technol, Fac Hlth Arts & Design, Hawthorn, Vic 3122, Australia	University of Wollongong; University of Wollongong; University of Sydney; University of Wollongong; Swinburne University of Technology	Weston, KM (corresponding author), Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia.	kathw@uow.edu.au	Bonney, Andrew/Y-5212-2019	Bonney, Andrew/0000-0003-2477-1646; Mayne, Darren/0000-0002-9370-3463	Sonic Healthcare; Southern; IML Pathology	Sonic Healthcare; Southern; IML Pathology	Three authors (BDJ, LB, SEJA) are affiliated with Sonic Healthcare or its subsidiary, Southern. IML Pathology. BDJ is Manager in information technology at Sonic Healthcare; LB is Chief Executive Officer at Southern. IML Pathology Ltd; SEJA is Consultant Pathologist at Southern. IML Pathology Ltd. The funding organisations, Sonic Healthcare and Southern. IML Pathology, provided support in the form of salaries for authors BDJ, LB and SEJA and access to the data, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Australian Bureau of Statistics, 2013, MAPP SEIFA; Australian Bureau of Statistics, 2011, CENS DICT 2006 REISS; Australian Bureau of Statistics, 2013, IND REL SOC DIS; Australian Bureau of Statistics, 2011, POP AG SEX REG AUSTR; Australian Bureau of Statistics, 2014, REM STRUCT; Australian Bureau of Statistics, 2014, 2006 CENS DAT; Ball K, 2012, INT J OBESITY, V36, P855, DOI 10.1038/ijo.2011.183; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Barr M, 2008, NSW POPULATION HLTH, V2; Bazemore A, 2010, J AM BOARD FAM MED, V23, P22, DOI 10.3122/jabfm.2010.01.090097; Brennan SL, 2010, J MENS HEALTH, V7, P31, DOI 10.1016/j.jomh.2009.10.004; Brown A, 2007, PUBLIC HEALTH, V121, P603, DOI 10.1016/j.puhe.2007.01.008; Butler DC, 2010, AUST J RURAL HEALTH, V18, P199, DOI 10.1111/j.1440-1584.2010.01154.x; CRIQUI MH, 1979, AM J EPIDEMIOL, V109, P394, DOI 10.1093/oxfordjournals.aje.a112695; Doherty E, 2012, ECON SOC REV, V43, P227; Drewnowski A, 2007, SOC SCI MED, V65, P2458, DOI 10.1016/j.socscimed.2007.07.001; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Gill T, 2010, STATE KNOWLEDGE ASSE; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hoad V, 2010, AUST NZ J PUBL HEAL, V34, P214, DOI 10.1111/j.1753-6405.2010.00509.x; IOM (Institute of Medicine), 2012, PRIM CAR PUBL HLTH E; Keegan THM, 2012, AM J PUBLIC HEALTH, V102, P689, DOI 10.2105/AJPH.2011.300150; Kifle T, 2012, INT J PUBLIC HEALTH, V57, P135, DOI 10.1007/s00038-011-0288-y; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Littenberg Benjamin, 2006, BMC Med Res Methodol, V6, P20, DOI 10.1186/1471-2288-6-20; Markwick A, 2013, AUST NZ J PUBL HEAL, V37, P32, DOI 10.1111/1753-6405.12007; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Mobley LR, 2004, J WOMENS HEALTH, V13, P519, DOI 10.1089/1540999041281034; Peeters A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003667; Rajgopal R, 2002, J NUTR EDUC BEHAV, V34, P26, DOI 10.1016/S1499-4046(06)60225-X; Roth C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-36; Roth C, 2013, STUD HEALTH TECHNOL, V192, P1100, DOI 10.3233/978-1-61499-289-9-1100; Springer KW, 2011, J HEALTH SOC BEHAV, V52, P212, DOI 10.1177/0022146510393972; WHO, 2010, GLOB STAT REP NONC D; Williams LK, 2013, AM J HEALTH PROMOT, V28, P59, DOI 10.4278/ajhp.120316-QUAN-143; World Health Organization, 2014, BMI CLASS GLOB DAT B	39	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137261	10.1371/journal.pone.0137261	http://dx.doi.org/10.1371/journal.pone.0137261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317861	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100216
J	Boothalingam, S; Allan, C; Allen, P; Purcell, D				Boothalingam, Sriram; Allan, Chris; Allen, Prudence; Purcell, David			Cochlear Delay and Medial Olivocochlear Functioning in Children with Suspected Auditory Processing Disorder	PLOS ONE			English	Article							STIMULUS-FREQUENCY; OTOACOUSTIC EMISSIONS; EFFERENT REFLEX; FILTER SHAPES; TUNING CURVES; HUMAN ADULTS; HUMANS; HEARING; SUPPRESSION; SPEECH	Behavioral manifestations of processing deficits associated with auditory processing disorder (APD) have been well documented. However, little is known about their anatomical underpinnings, especially cochlear processing. Cochlear delays, a proxy for cochlear tuning, measured using stimulus frequency otoacoustic emission (SFOAE) group delay, and the influence of the medial olivocochlear (MOC) system activation at the auditory periphery was studied in 23 children suspected with APD (sAPD) and 22 typically developing (TD) children. Results suggest that children suspected with APD have longer SFOAE group delays (possibly due to sharper cochlear tuning) and reduced MOC function compared to TD children. Other differences between the groups include correlation between MOC function and SFOAE delay in quiet in the TD group, and lack thereof in the sAPD group. MOC-mediated changes in SFOAE delay were in opposite directions between groups: increase in delay in TD vs. reduction in delay in the sAPD group. Longer SFOAE group delays in the sAPD group may lead to longer cochlear filter ringing, and potential increase in forward masking. These results indicate differences in cochlear and MOC function between sAPD and TD groups. Further studies are warranted to explore the possibility of cochlea as a potential site for processing deficits in APD.	[Boothalingam, Sriram; Allan, Chris; Allen, Prudence; Purcell, David] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada; [Allen, Prudence; Purcell, David] Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Boothalingam, S (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	sriram@northwestern.edu		Boothalingam, Sriram/0000-0003-3901-3071	Western Graduate Research Scholarship; Natural Sciences and Engineering Research Council of Canada [RGPIN-05320-2007]; Ontario Research Fund (LEF) [RE-03009]; Canada Foundation for Innovation (CFI) [11419]	Western Graduate Research Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Research Fund (LEF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by Western Graduate Research Scholarship (S.B.); Natural Sciences and Engineering Research Council of Canada (RGPIN-05320-2007) (D.P.); Ontario Research Fund (LEF#RE-03009) (National Centre for Audiology); and Canada Foundation for Innovation (CFI#11419) (National Centre for Audiology).	AAA, 2010, AM AC AUD CLIN PRACT; Abdala C, 2003, J ACOUST SOC AM, V114, P932, DOI 10.1121/1.1590973; Abdala C, 1996, HEARING RES, V98, P38, DOI 10.1016/0378-5955(96)00046-9; Abdala C, 2000, J ACOUST SOC AM, V107, P446, DOI 10.1121/1.428315; Abdala C, 2013, J ACOUST SOC AM, V133, P938, DOI 10.1121/1.4773265; Abdala C, 2012, JARO-J ASSOC RES OTO, V13, P403, DOI 10.1007/s10162-012-0319-2; Abrams DA, 2009, J NEUROSCI, V29, P7686, DOI 10.1523/JNEUROSCI.5242-08.2009; Allen P, 2014, INT J PEDIATR OTORHI, V78, P198, DOI 10.1016/j.ijporl.2013.10.048; ASHA American Speech-Language-Hearing Association, 2005, CENTR AUD PROC DIS, DOI 10.1044/policy.TR2005-00043; Backus BC, 2006, J ACOUST SOC AM, V119, P2889, DOI 10.1121/1.2169918; Badri R, 2011, J ACOUST SOC AM, V129, P852, DOI 10.1121/1.3523476; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergevin C, 2008, J COMP PHYSIOL A, V194, P665, DOI 10.1007/s00359-008-0338-y; Bhagat SP, 2014, NEUROSCI LETT, V559, P132, DOI 10.1016/j.neulet.2013.11.059; Boothalingam S, 2015, J ACOUST SOC AM, V137, P724, DOI 10.1121/1.4906250; Boothalingam S, 2014, NEUROSCI LETT, V580, P56, DOI 10.1016/j.neulet.2014.07.048; Boothalingam S, 2012, INT J AUDIOL, V51, P892, DOI 10.3109/14992027.2012.709641; Butler BE, 2011, INT J AUDIOL, V50, P530, DOI 10.3109/14992027.2011.582167; Chermak G D, 1999, J Am Acad Audiol, V10, P289; Clarke EM, 2006, EAR HEARING, V27, P153, DOI 10.1097/01.aud.0000204311.73871.41; Dhar S, 2009, CLIN NEUROPHYSIOL, V120, P959, DOI 10.1016/j.clinph.2009.02.172; Don M, 1998, J ACOUST SOC AM, V104, P2280, DOI 10.1121/1.423741; Dragicevic CD, 2015, JARO-J ASSOC RES OTO, V16, P223, DOI 10.1007/s10162-015-0509-9; Dubno JR, 2003, J ACOUST SOC AM, V113, P2084, DOI 10.1121/1.1555611; Feeney MP, 1999, J SPEECH LANG HEAR R, V42, P1029, DOI 10.1044/jslhr.4205.1029; FESTEN JM, 1983, J ACOUST SOC AM, V73, P652, DOI 10.1121/1.388957; Francis NA, 2010, HEARING RES, V267, P36, DOI 10.1016/j.heares.2010.04.009; Garinis AC, 2008, INT J AUDIOL, V47, P607, DOI 10.1080/14992020802129402; GLASBERG BR, 1986, J ACOUST SOC AM, V79, P1020, DOI 10.1121/1.393374; GUINAN JJ, 1988, HEARING RES, V33, P97, DOI 10.1016/0378-5955(88)90023-8; Guinan JJ, 2003, JARO-J ASSOC RES OTO, V4, P521, DOI 10.1007/s10162-002-3037-3; Guinan JJ, 1990, MECH BIOPHYSICS HEAR, P170; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Hamilton S., 2007, ANALOG ELECT COMPANI; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Ivey R.G., 1969, TESTS CNS FUNCTION; Katz J., 1998, STAGGERED SPONDAIC W, Vfifth; Moore BCJ, 2003, OTOL NEUROTOL, V24, P243, DOI 10.1097/00129492-200303000-00019; Moore D.R., 2006, AUDIOLOGICAL MED, V4, P4, DOI [DOI 10.1080/16513860600568573, 10.1080/16513860600568573]; Moore DR, 2007, J COMMUN DISORD, V40, P295, DOI 10.1016/j.jcomdis.2007.03.005; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Muchnik C, 2004, AUDIOL NEURO-OTOL, V9, P107, DOI 10.1159/000076001; Oppenhiem AV, 1997, SIGNALS SYSTEMS; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; Pinheiro M. L., 1977, CENTRAL AUDITORY DYS, P43; Purdy Suzanne C, 2002, J Am Acad Audiol, V13, P367; Quaranta N, 2005, ACTA OTO-LARYNGOL, V125, P520, DOI 10.1080/00016480510026214; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Schairer KS, 2006, J ACOUST SOC AM, V120, P901, DOI 10.1121/1.2214147; SHAILER MJ, 1983, J ACOUST SOC AM, V74, P467, DOI 10.1121/1.389812; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; SHERA CA, 1993, J ACOUST SOC AM, V93, P3333, DOI 10.1121/1.405717; Shera CA, 2003, J ACOUST SOC AM, V113, P2762, DOI 10.1121/1.1557211; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; Shera CA, 2013, J ACOUST SOC AM, V133, P2224, DOI 10.1121/1.4792129; Sisto R, 2008, J ACOUST SOC AM, V124, P2995, DOI 10.1121/1.2990711; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Walsh KP, 2014, HEARING RES, V312, P143, DOI 10.1016/j.heares.2014.03.012; Zhao W, 2012, J NEUROPHYSIOL, V108, P25, DOI 10.1152/jn.00051.2012	59	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136906	10.1371/journal.pone.0136906	http://dx.doi.org/10.1371/journal.pone.0136906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317850	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100168
J	Hu, W; Wei, YX; Xia, ZQ; Yan, Y; Hou, XW; Zou, ML; Lu, C; Wang, WQ; Peng, M				Hu, Wei; Wei, Yunxie; Xia, Zhiqiang; Yan, Yan; Hou, Xiaowan; Zou, Meiling; Lu, Cheng; Wang, Wenquan; Peng, Ming			Genome-Wide Identification and Expression Analysis of the NAC Transcription Factor Family in Cassava	PLOS ONE			English	Article							FACTOR GENE FAMILY; STRESS-RESPONSIVE GENES; NO-APICAL-MERISTEM; COMPREHENSIVE ANALYSIS; DROUGHT TOLERANCE; LEAF SENESCENCE; FUNCTIONAL-ANALYSIS; REGULATES SALT; GRAIN-YIELD; ARABIDOPSIS	NAC [no apical meristem (NAM), Arabidopsis transcription activation factor [ATAF1/2] and cup-shaped cotyledon (CUC2)] proteins is one of the largest groups of plant specific transcription factors and plays a crucial role in plant growth, development, and adaption to the environment. Currently, no information is known about the NAC family in cassava. In this study, 96 NAC genes (MeNACs) were identified from the cassava genome. Phylogenetic analysis of the NACs from cassava and Arabidopsis showed that MeNAC proteins can be clustered into 16 subgroups. Gene structure analysis found that the number of introns of MeNAC genes varied from 0 to 5, with the majority of MeNAC genes containing two introns, indicating a small gene structure diversity of cassava NAC genes. Conserved motif analysis revealed that all of the identified MeNACs had the conserved NAC domain and/or NAM domain. Global expression analysis suggested that MeNAC genes exhibited different expression profiles in different tissues between wild subspecies and cultivated varieties, indicating their involvement in the functional diversity of different accessions. Transcriptome analysis demonstrated that MeNACs had a widely transcriptional response to drought stress and that they had differential expression profiles in different accessions, implying their contribution to drought stress resistance in cassava. Finally, the expression of twelve MeNAC genes was analyzed under osmotic, salt, cold, ABA, and H2O2 treatments, indicating that cassava NACs may represent convergence points of different signaling pathways. Taken together, this work found some excellent tissue-specific and abiotic stress-responsive candidate MeNAC genes, which would provide a solid foundation for functional investigation of the NAC family, crop improvement and improved understanding of signal transduction in plants. These data bring new insight on the complexity of the transcriptional control of MeNAC genes and support the hypothesis that NACs play an important role in plant growth, development, and adaption of environment.	[Hu, Wei; Wei, Yunxie; Xia, Zhiqiang; Yan, Yan; Hou, Xiaowan; Zou, Meiling; Lu, Cheng; Wang, Wenquan; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Hu, W (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Xueyuan Rd 4, Haikou 571101, Hainan, Peoples R China.	huwei2010916@126.com; wangwenquan@itbb.org.cn; mmpeng_2000@yahoo.com		Wang, Wenquan/0000-0002-7603-3437	'973' Program of the Ministry of Science and Technology of China [2010CB126600]; '863' Program of the Ministry of Science and Technology of China [2012AA101204-2]; Natural Science Foundation of Hainan Province [314122, 20153048]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB2015ZD04, ITBB2015ZY09]; Major Technology Project of Hainan [ZDZX2013023-1]; International Science & Technology Cooperation Program of China [2013DFA32020]; International Science and Technology Cooperation Plan [2011DFB31690]	'973' Program of the Ministry of Science and Technology of China(National Basic Research Program of China); '863' Program of the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Natural Science Foundation of Hainan Province; National Nonprofit Institute Research Grant of CATAS-ITBB; Major Technology Project of Hainan; International Science & Technology Cooperation Program of China; International Science and Technology Cooperation Plan	This work was supported by the '973' Program of the Ministry of Science and Technology of China (2010CB126600), the '863' Program of the Ministry of Science and Technology of China (2012AA101204-2), the Natural Science Foundation of Hainan Province (314122, 20153048), the National Nonprofit Institute Research Grant of CATAS-ITBB (ITBB2015ZD04, ITBB2015ZY09), the Major Technology Project of Hainan (ZDZX2013023-1), the International Science & Technology Cooperation Program of China (2013DFA32020), and the International Science and Technology Cooperation Plan (2011DFB31690).	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Alaba OA, 2015, G3-GENES GENOM GENET, V5, P133, DOI 10.1534/g3.114.015008; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Chung PJ, 2009, PLANT SIGNAL BEHAV, V4, P675, DOI 10.4161/psb.4.7.9075; Costa A, 2010, PLANT J, V62, P760, DOI 10.1111/j.1365-313X.2010.04190.x; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Garapati P, 2015, PLANT PHYSIOL, V168, P1122, DOI 10.1104/pp.15.00567; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jiang GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109415; Jiang HL, 2009, PLANT SIGNAL BEHAV, V4, P464, DOI [10.1104/pp.109.135269, 10.4161/psb.4.5.8543]; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim HJ, 2014, J EXP BOT, V65, P4023, DOI 10.1093/jxb/eru112; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Ko JH, 2007, PLANT J, V50, P1035, DOI 10.1111/j.1365-313X.2007.03109.x; Kou XH, 2012, J EXP BOT, V63, P6139, DOI 10.1093/jxb/ers266; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Li XL, 2014, PLANT CELL REP, V33, P767, DOI 10.1007/s00299-014-1602-y; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2012, MOL GENET GENOMICS, V287, P389, DOI 10.1007/s00438-012-0686-8; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Oliveira EJ, 2014, GENET MOL RES, V13, P6683, DOI 10.4238/2014.August.28.13; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pandurangaiah M, 2014, MOL BIOTECHNOL, V56, P758, DOI 10.1007/s12033-014-9754-0; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Perera PIP, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu022; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, PLANT SIGNAL BEHAV, V6, P1588, DOI 10.4161/psb.6.10.17130; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; Sakuraba Y, 2015, PLANT CELL; Salcedo A, 2014, TROP PLANT BIOL, V7, P53, DOI 10.1007/s12042-014-9137-5; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Seo PJ, 2010, PLANT SIGNAL BEHAV, V5, P481, DOI 10.4161/psb.11083; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao P, 2014, MOL GENET GENOMICS, V289, P1131, DOI 10.1007/s00438-014-0874-9; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Wang G, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0219-1, 10.1186/s12862-014-0186-z]; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang WQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6110; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yao DX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S10; You J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122027; Zeng CY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0207-5; Zhao PJ, 2015, J EXP BOT, V66, P1477, DOI 10.1093/jxb/eru507; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhu MK, 2014, PLANT CELL REP, V33, P1851, DOI 10.1007/s00299-014-1662-z; Zidenga T, 2012, PLANT PHYSIOL, V159, P1396, DOI 10.1104/pp.112.200345	98	54	57	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136993	10.1371/journal.pone.0136993	http://dx.doi.org/10.1371/journal.pone.0136993			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317631	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100190
J	Muller, C; Hochhaus, NM; Fontana, X; Luhmann, HJ; White, R				Mueller, Christina; Hochhaus, Nina M.; Fontana, Xavier; Luhmann, Heiko J.; White, Robin			SncRNA715 Inhibits Schwann Cell Myelin Basic Protein Synthesis	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; RNA TRANSPORT; INJURY; NEUREGULIN-1; MECHANISMS; DEFICIENT; GENES; DICER; MICE; SHOW	Myelin basic proteins (MBP) are major constituents of the myelin sheath in the central nervous system (CNS) and the peripheral nervous system (PNS). In the CNS Mbp translation occurs locally at the axon-glial contact site in a neuronal activity-dependent manner. Recently we identified the small non-coding RNA 715 (sncRNA715) as a key inhibitor of Mbp translation during transport in oligodendrocytes. Mbp mRNA localization in Schwann cells has been observed, but has not been investigated in much detail. Here we could confirm translational repression of Mbp mRNA in Schwann cells. We show that sncRNA715 is expressed and its levels correlate inversely with MBP in cultured Schwann cells and in the sciatic nerve in vivo. Furthermore we could reduce MBP protein levels in cultured Schwann cells by increasing the levels of the inhibitory sncRNA715. Our findings suggest similarities in sncRNA715-mediated translational repression of Mbp mRNA in oligodendrocytes and Schwann cells.	[Mueller, Christina; Hochhaus, Nina M.; Luhmann, Heiko J.; White, Robin] Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany; [Fontana, Xavier] UCL, MRC, Mol Cell Biol Lab, London, England; [Fontana, Xavier] UCL, UCL Canc Inst, London, England	Johannes Gutenberg University of Mainz; University of London; University College London; University of London; University College London	White, R (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany.	white@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	Deutsche Forschungsgemeinschaft (DFG) [WH168/3-1]; FTN (Focus Program Translational Neuroscience, Mainz) scholarship	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FTN (Focus Program Translational Neuroscience, Mainz) scholarship	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/) grant WH168/3-1 to RW. CM received an FTN (Focus Program Translational Neuroscience, Mainz) scholarship.	Arthur-Farraj P, 2011, GLIA, V59, P720, DOI 10.1002/glia.21144; Bala Usman, 2014, BMC Res Notes, V7, P714, DOI 10.1186/1756-0500-7-714; Bauer NM, 2012, EMBO REP, V13, P827, DOI 10.1038/embor.2012.97; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Gould M, 1995, NUMBER SCHMIDT LANTE, V98, P85; Griffiths IR, 1989, EXPRESSION MYELIN PR, V352, P345; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grigoryan T, 2015, BIOESSAYS, V37, P502, DOI 10.1002/bies.201400172; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Kirschner DA, 1980, NATURE; MARTINI R, 1995, J NEUROSCI, V15, P4488; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Muller C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00169; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pfaffl MW, 2002, RELATIVE EXPRESSION, V30; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; Schmid D, 2014, ASN NEURO, V6, DOI 10.1042/AN20130031; Smith-Slatas C, 2000, MOL CELL NEUROSCI, V15, P343, DOI 10.1006/mcne.1999.0829; STAUGAITIS SM, 1990, J CELL BIOL, V110, P1719, DOI 10.1083/jcb.110.5.1719; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Verrier JD, 2010, J NEUROSCI RES, V88, P2558, DOI 10.1002/jnr.22418; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; WATABE K, 1995, J NEUROSCI RES, V41, P279, DOI 10.1002/jnr.490410215; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; White R, 2012, J BIOL CHEM, V287, P1742, DOI 10.1074/jbc.M111.235010; YOSHINO J, 1985, BRAIN RES, V325, P199, DOI 10.1016/0006-8993(85)90316-6; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010	35	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136900	10.1371/journal.pone.0136900	http://dx.doi.org/10.1371/journal.pone.0136900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317513	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100165
J	Park, JA; Gardner, C; Chang, MI; Kim, DH; Jang, YS				Park, Jeong-A; Gardner, Caleb; Chang, Myo-In; Kim, Do-Hoon; Jang, Young-Soo			Fuel Use and Greenhouse Gas Emissions from Offshore Fisheries of the Republic of Korea	PLOS ONE			English	Article							CARBON FOOTPRINT	Greenhouse Gas (GHG) emissions from the offshore fisheries industry in the Republic of Korea (Korea) were examined in response to growing concerns about global warming and the contribution of emissions from different industrial sectors. Fuel usage and GHG emissions (CO2, CH4, N2O) were analysed using the 'Tier 1' method provided by the Intergovernmental Panel on Climate Change (IPCC) from the offshore fishery, which is the primary domestic seafood production sector in Korea. In 2013, fuel usage in the offshore fishery accounted for 59.7% (557,463 KL) of total fuel consumption of fishing vessels in Korea. Fuel consumption and thus GHG emissions were not stable through time in this industry, increasing by 2.4% p.a. for three consecutive years, from 2011 to 2013, despite a decrease in the number of vessels operating. GHG emissions generated in offshore fisheries also changed through time and increased from 1,442,975 tCO(2)e/year in 2011 to 1,477,279 tCO(2)e/year in 2013. Changes in both fuel use and GHG emissions per kg offshore fish production appeared to be associated with decreasing catch rates by the fleet, which in turn were a reflection of decrease in fish biomass. Another important feature of GHG emissions in this industry was the high variation in GHG emission per kg fish product among different fishing methods. The long line fishery had approximately three times the emissions of the average production while the jigging fishery was more than two times higher than the average. Lowest emissions were from the trawl sector, which is regarded as having greatest environmental impact using traditional biodiversity metrics although had lowest environmental impact in terms of fuel and GHG emission metrics used in this study. The observed deterioration in fuel efficiency of the offshore fishery each year is of concern but also demonstrates that fuel efficiency can change, which shows there is opportunity to improve efficiency with changes to fishery management and harvesting operations.	[Park, Jeong-A; Gardner, Caleb] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Park, Jeong-A; Kim, Do-Hoon; Jang, Young-Soo] Pukyong Natl Univ, Dept Marine & Fisheries Business & Econ, Busan, South Korea; [Chang, Myo-In] Minist Oceans & Fisheries Korea, Sejong, South Korea	University of Tasmania; Pukyong National University	Jang, YS (corresponding author), Pukyong Natl Univ, Dept Marine & Fisheries Business & Econ, Busan, South Korea.	ysjang@pknu.ac.kr	Gardner, Caleb/I-7086-2013	Gardner, Caleb/0000-0003-0324-4337				Brasil. Ministerio da Saude, 2014, GUID BAL NUTR IND, P1; Choi J., 2012, J APPL MATH, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0037059; Crilly R, 2013, MAR POLICY, V37, P20, DOI 10.1016/j.marpol.2012.04.018; Ellingsen H, 2009, MAR POLICY, V33, P479, DOI 10.1016/j.marpol.2008.11.003; FAO (Food and Agriculture Organization), 2011, CONS FISH FISH PROD; Farmery A, 2014, J CLEAN PROD, V64, P368, DOI 10.1016/j.jclepro.2013.10.016; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Gardner C, 2015, FISH RES, V161, P285, DOI 10.1016/j.fishres.2014.08.015; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Jo J. H., 2010, STUDY IMPLEMENTATION, P1; Kang YJ, 2004, J KOR FISH RES, V21, P27; Kang YS, 2000, J KOR FISH BUS ADM, V31, P115; KangYeonSil, 2012, [the Journal of Korean Island, 한국도서연구], V24, P115; Lee HD, 2009, J KOR FISHERIES TREN, V7, P7; 이지훈, 2011, [Korean Journal of Fisheries and Aquatic Sciences, 한국수산과학회지], V44, P383; Lee K, 2009, BIOTECHNOL LETT, V31, P31, DOI 10.1007/s10529-008-9837-8; Lee Kwang-Nam, 2014, [The Journal of Fisheries Business Administration, 수산경영론집], V45, P73, DOI 10.12939/FBA.2014.45.2.073; Lee Kwang-Nam, 2012, [The Journal of Fisheries Business Administration, 수산경영론집], V43, P49; 박성욱, 2013, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V49, P291, DOI 10.3796/KSFT.2012.49.3.291; 박성욱, 2012, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V48, P360, DOI 10.3796/KSFT.2012.48.4.360; Maunder MN, 2001, CAN J FISH AQUAT SCI, V58, P795, DOI 10.1139/cjfas-58-4-795; National Federation of Fisheries Cooperatives(SUHYUP) Korea, 2011, TAX FREE OIL SAL DAT; NFRID(National Fisheries Research and Development Institute Korea), 2010, KOR COAST OFFSH FISH, P1; Statistics Korea, 2013, FISH PROD STAT; Statistics Korea, 2011, FISH MAN RES STAT; The Bank of Korea, 2012, INFORM INT EC, V37, P1; Vazquez-Rowe I, 2013, J CLEAN PROD, V44, P200, DOI 10.1016/j.jclepro.2012.11.049; Young-Il AN, 2014, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V50, P326, DOI 10.3796/KSFT.2014.50.3.326; 권유정, 2008, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V44, P194; Ziegler F, 2013, J IND ECOL, V17, P103, DOI 10.1111/j.1530-9290.2012.00485.x; 이지훈, 2013, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V49, P282, DOI 10.3796/KSFT.2012.49.3.282	31	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133778	10.1371/journal.pone.0133778	http://dx.doi.org/10.1371/journal.pone.0133778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317341	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100011
J	Trela, Z; Burdach, Z; Siemieniuk, A; Przestalski, S; Karcz, W				Trela, Zenon; Burdach, Zbigniew; Siemieniuk, Agnieszka; Przestalski, Stanislaw; Karcz, Waldemar			Effect of Trimethyltin Chloride on Slow Vacuolar (SV) Channels in Vacuoles from Red Beet (Beta vulgaris L.) Taproots	PLOS ONE			English	Article							ORGANOTIN COMPOUNDS; ION CHANNELS; TRIBUTYLTIN CHLORIDE; ERYTHROCYTE-MEMBRANE; ORGANIC TIN; TRIPHENYLTIN; TOXICITY; INHIBITION; MECHANISMS; TRANSPORT	In the present study, patch-clamp techniques have been used to investigate the effect of trimethyltin chloride (Met(3)SnCl) on the slow vacuolar (SV) channels in vacuoles from red beet (Beta vulgaris L.) taproots. Activity of SV channels has been measured in whole-vacuole and cytosolic side-out patch configurations. It was found that addition of trimethyltin chloride to the bath solution suppressed, in a concentration-dependent manner, SV currents in red beet vacuoles. The time constant, tau, increased significantly in the presence of the organotin. When single channel activity was analyzed, only little channel activity could be recorded at 100 mu M Met(3)SnCl. Trimethyltin chloride added to the bath medium significantly decreased (by ca. threefold at 100 mu M Met3SnCl and at 100 mV voltage, as compared to the control medium) the open probability of single channels. Single channel recordings obtained in the presence and absence of trimethyltin chloride showed that the organotin only slightly (by < 10%) decreased the unitary conductance of single channels. It was also found that Met3SnCl significantly diminished the number of SV channel openings, whereas it did not change the opening times of the channels. Taking into account the above and the fact that under the here applied experimental conditions (pH = 7.5) Met(3)SnCl is a non-dissociated (more lipophilic) compound, we suggest that the suppression of SV currents observed in the presence of the organotin results probably from its hydrophobic properties allowing this compound to translocate near the selectivity filter of the channel.	[Trela, Zenon; Przestalski, Stanislaw] Wroclaw Univ Environm & Life Sci, Dept Phys & Biophys, PL-50375 Wroclaw, Poland; [Burdach, Zbigniew; Siemieniuk, Agnieszka; Karcz, Waldemar] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, PL-40032 Katowice, Poland	Wroclaw University of Environmental & Life Sciences; University of Silesia in Katowice	Karcz, W (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, Jagiellonska 28, PL-40032 Katowice, Poland.	waldemar.karcz@us.edu.pl	Trela, Zenon/B-5592-2017; Trela, Zenon/ABB-9717-2021	Trela, Zenon/0000-0002-8249-6825; Karcz, Waldemar/0000-0001-7630-1553; Siemieniuk, Agnieszka/0000-0003-4530-3956				Arnold CG, 1997, ENVIRON SCI TECHNOL, V31, P2596, DOI 10.1021/es970009+; Barkla BJ, 1996, ANNU REV PLANT PHYS, V47, P159, DOI 10.1146/annurev.arplant.47.1.159; Bernat P, 2014, WORLD J MICROB BIOT, V30, P2343, DOI 10.1007/s11274-014-1659-3; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; Bethke PC, 1997, PLANT J, V11, P1227, DOI 10.1046/j.1365-313X.1997.11061227.x; Bonarska-Kujawa D, 2012, ECOTOX ENVIRON SAFE, V78, P232, DOI 10.1016/j.ecoenv.2011.11.027; Burda K, 2002, APPL ORGANOMET CHEM, V16, P148, DOI 10.1002/aoc.272; Burdach Z, 2014, ACTA BIOCHIM POL, V61, P213; Caratozzolo R, 2007, APPL ORGANOMET CHEM, V21, P66, DOI 10.1002/aoc.1175; Carpaneto A, 2003, EUR BIOPHYS J BIOPHY, V32, P60, DOI 10.1007/s00249-002-0268-5; Carpaneto A, 1999, FEBS LETT, V442, P129, DOI 10.1016/S0014-5793(98)01642-1; Ceccariglia S, 2014, NEUROSCIENCE, V274, P273, DOI 10.1016/j.neuroscience.2014.05.047; Chen JF, 2011, NEUROTOXICOL TERATOL, V33, P721, DOI 10.1016/j.ntt.2011.09.003; Chicano JJ, 2002, BBA-BIOMEMBRANES, V1558, P70, DOI 10.1016/S0005-2736(01)00426-6; Corvino V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088294; COYAUD L, 1987, BIOCHIM BIOPHYS ACTA, V902, P263, DOI 10.1016/0005-2736(87)90304-X; Crowe A.J., 1987, APPL ORGANOMET CHEM, V1, P143, DOI [10.1002/aoc.590010206, DOI 10.1002/AOC.590010206]; DAVIES JM, 1995, J MEMBRANE BIOL, V145, P75; Dobrovinskaya OR, 1999, J MEMBRANE BIOL, V167, P127, DOI 10.1007/s002329900477; ERNST WHO, 1992, ACTA BOT NEERL, V41, P229, DOI 10.1111/j.1438-8677.1992.tb01332.x; Evans C. J., 1998, CHEM TIN, P442; FARGASOVA A, 1994, BIOLOGIA, V49, P307; Fent K, 1996, SCI TOTAL ENVIRON, V185, P151, DOI 10.1016/0048-9697(95)05048-5; FENT K, 1995, WATER RES, V29, P1631, DOI 10.1016/0043-1354(94)00349-C; Florea AM, 2005, TOXICOLOGY, V216, P1, DOI 10.1016/j.tox.2005.05.029; Florea AM, 2005, CELL CALCIUM, V37, P251, DOI 10.1016/j.ceca.2004.10.005; Gabrielska J, 1997, Z NATURFORSCH C, V52, P209; Gabrielska J, 2004, APPL ORGANOMET CHEM, V18, P9, DOI 10.1002/aoc.561; Gutla PVK, 2012, J EXP BOT, V63, P6187, DOI 10.1093/jxb/ers272; Gutla PVK, 2010, THESIS U PADUA; HAMASAKI T, 1995, APPL ORGANOMET CHEM, V9, P95, DOI 10.1002/aoc.590090202; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Hoch M, 2001, APPL GEOCHEM, V16, P719, DOI 10.1016/S0883-2927(00)00067-6; Isayenkov S, 2010, FEBS LETT, V584, P1982, DOI 10.1016/j.febslet.2010.02.050; Kannan K, 1996, ENVIRON TOXICOL CHEM, V15, P1492, DOI [10.1002/etc.5620150911, 10.1897/1551-5028(1996)015&lt;1492:TAIDPI&gt;2.3.CO;2]; Kleszczynska H, 1997, Z NATURFORSCH C, V52, P65; Kleszczynska H, 1998, BIOCHEM MOL BIOL INT, V44, P305; Kleszczynska H, 1999, FOLIA HISTOCHEM CYTO, V37, P1; Kotake Y, 2012, BIOL PHARM BULL, V35, P1876, DOI 10.1248/bpb.b212017; Lespes G, 2009, J ENVIRON MANAGE, V90, pS60, DOI 10.1016/j.jenvman.2008.07.019; Miskiewicz J, 2010, EUR BIOPHYS J BIOPHY, V39, P1397, DOI 10.1007/s00249-010-0594-y; MOONEY HM, 1995, J IND MICROBIOL, V14, P265, DOI 10.1007/BF01569938; Murkowski A., 2008, ACTA AGROPHYS, V11, P131; Paganetto A, 2001, PLANT CELL ENVIRON, V24, P1329, DOI 10.1046/j.1365-3040.2001.00777.x; Pagliarani A, 2013, TOXICOL IN VITRO, V27, P978, DOI 10.1016/j.tiv.2012.12.002; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Pottosin I, 2014, J PLANT PHYSIOL, V171, P732, DOI 10.1016/j.jplph.2013.11.013; Przestalski S, 2000, ACTA BIOCHIM POL, V47, P627, DOI 10.18388/abp.2000_3984; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Reid BJ, 2000, ENVIRON POLLUT, V108, P103, DOI 10.1016/S0269-7491(99)00206-7; Schoenknecht Gerald, 2013, Plants-Basel, V2, P589, DOI 10.3390/plants2040589; SCHULZLESSDORF B, 1995, PLANTA, V197, P655; Song ZH, 2001, B ENVIRON CONTAM TOX, V67, P368; TAIZ L, 1992, J EXP BIOL, V172, P113; Tang XJ, 2010, TOXICOLOGY, V271, P45, DOI 10.1016/j.tox.2010.02.013; Trela Z, 2012, CR BIOL, V335, P722, DOI 10.1016/j.crvi.2012.11.004; van den Wijngaard PWJ, 2001, FEBS LETT, V488, P100, DOI 10.1016/S0014-5793(00)02394-2; Veltman K, 2006, MAR ENVIRON RES, V61, P511, DOI 10.1016/j.marenvres.2006.02.005; von Ballmoos C, 2004, P NATL ACAD SCI USA, V101, P11239, DOI 10.1073/pnas.0402869101; Zhang LP, 2006, SCI CHINA SER B, V49, P560, DOI 10.1007/s11426-006-2021-x; Zylka R, 2009, CELL BIOL INT, V33, P801, DOI 10.1016/j.cellbi.2009.04.016	64	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136346	10.1371/journal.pone.0136346	http://dx.doi.org/10.1371/journal.pone.0136346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317868	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100072
J	Yang, LP; Jiang, FJ; Wu, GS; Deng, K; Wen, M; Zhou, XJ; Hong, XC; Zhu, MX; Luo, HR				Yang, Li-Ping; Jiang, Fang-Jie; Wu, Gui-Sheng; Deng, Ke; Wen, Meng; Zhou, Xiaoju; Hong, Xuechuan; Zhu, Michael X.; Luo, Huai-Rong			Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PREFRONTAL CORTEX; ANXIETY DISORDERS; ANIMAL-MODELS; C-FOS; TRPC5; BEHAVIOR; MECHANISMS; AMYGDALA; PATHOPHYSIOLOGY	Transient receptor potential canonical (TRPC) channels are widely expressed in brain and involved in various aspects of brain function. Both TRPC4 and TRPC5 have been implicated in innate fear function, which represents a key response to environmental stress. However, to what extent the TRPC4/C5 channels are involved in psychiatric disorders remains unexplored. Here, we tested the antidepressant and anxiolytic-like effects of a newly identified TRPC4/C5 inhibitor, M084. We show that a single intraperitoneal administration of M084 at 10 mg/kg body weight to C57BL/6 male mice significantly shortened the immobility time in forced swim test and tail suspension test within as short as 2 hours. The M084-treated mice spent more time exploring in illuminated and open areas in light/dark transition test and elevated plus maze test. In mice subjected to chronic unpredictable stress, M084 treatment reversed the enhanced immobility time in forced swim test and decreased the latency to feed in novelty suppressed feeding test. The treatment of M084 increased BDNF expression in both mRNA and protein levels, as well as phosphorylation levels of AKT and ERK, in prefrontal cortex. Our results indicate that M084 exerts rapid antidepressant and anxiolytic-like effects at least in part by acting on BDNF and its downstream signaling. We propose M084 as a lead compound for further druggability research.	[Yang, Li-Ping; Jiang, Fang-Jie; Wu, Gui-Sheng; Deng, Ke; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China; [Yang, Li-Ping; Jiang, Fang-Jie] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Yang, Li-Ping] Yunnan Inst Tradit Chinese Med & Mat Med, Kunming 650223, Yunnan, Peoples R China; [Wen, Meng; Zhou, Xiaoju; Hong, Xuechuan] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, State Key Lab Virol, Minist Educ,Sch Pharmaceut Sci, Wuhan 430071, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; University of Texas System; University of Texas Health Science Center Houston	Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China.	luohuairong@mail.kib.ac.cn	Luo, Huai-Rong/ABE-7525-2021	zhou, xiaoju/0000-0003-0797-1312; hong, xuechuan/0000-0001-6834-3278	Yunnan provincial government [20080A007, 2012FB181, 2014BC011]; 100 Talents Program of the Chinese Academy of Sciences; National Natural Science Foundation of China [81373254, 21390402, 81228021]; Natural Science Foundation of Hubei Province [2014CFB704]; Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology; US National Institutes of Health [R01 DK081654, R01 NS092377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092377] Funding Source: NIH RePORTER	Yunnan provincial government; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by the Yunnan provincial government (20080A007, 2012FB181 and 2014BC011), the 100 Talents Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (81373254, 21390402, and 81228021), the Natural Science Foundation of Hubei Province (2014CFB704), the Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology, and the grants from US National Institutes of Health (R01 DK081654 and R01 NS092377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Du J, 2014, FASEB J, V28, P4677, DOI 10.1096/fj.14-251652; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M, 2011, J MOL NEUROSCI, V45, P246, DOI 10.1007/s12031-011-9515-5; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Heldt SA, 2010, J NEUROSCI, V30, P7139, DOI 10.1523/JNEUROSCI.0693-10.2010; Idayu NF, 2011, PHYTOMEDICINE, V18, P402, DOI 10.1016/j.phymed.2010.08.011; Jiang LH, 2011, CURR DRUG TARGETS, V12, P724; Kaczmarek JS, 2012, P NATL ACAD SCI USA, V109, P7888, DOI 10.1073/pnas.1205869109; Karege F, 2007, BIOL PSYCHIAT, V61, P240, DOI 10.1016/j.biopsych.2006.04.036; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Muller MB, 2004, TRENDS MOL MED, V10, P409, DOI 10.1016/j.molmed.2004.06.007; Pedersen AG, 2005, INT CLIN PSYCHOPHARM, V20, P139, DOI 10.1097/00004850-200505000-00003; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Puram SV, 2011, GENE DEV, V25, P2659, DOI 10.1101/gad.174060.111; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Samuels B. A., 2011, NEUROMETHODS, V63, P107; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang SP, 2011, J NEUROPHYSIOL, V106, P1515, DOI 10.1152/jn.00025.2011; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wu D, 2008, J BIOL CHEM, V283, P416, DOI 10.1074/jbc.M703177200; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Zhu JM, 2013, BIOORGAN MED CHEM, V21, P4218, DOI 10.1016/j.bmc.2013.05.001; Zhu Y, 2015, BR J PHARM; Zunszain PA, 2013, MOL PSYCHIATR, V18, P1236, DOI 10.1038/mp.2013.87	51	36	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136255	10.1371/journal.pone.0136255	http://dx.doi.org/10.1371/journal.pone.0136255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317356	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100067
J	Balagopal, A; Barin, B; Quinn, J; Rogers, R; Sulkowski, MS; Stock, PG				Balagopal, Ashwin; Barin, Burc; Quinn, Jeffrey; Rogers, Rodney; Sulkowski, Mark S.; Stock, Peter G.			Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; MICROBIAL TRANSLOCATION; DISEASE; INTERLEUKIN-10; PROGRESSION; ACTIVATION; RECIPIENTS; CHALLENGE; STAGE	Liver disease is a leading cause of mortality among HIV-infected persons in the highly active anti-retroviral therapy (HAART) era. Hepatitis C Virus (HCV) co-infection is prevalent in, and worsened by HIV; consequently many co-infected persons require liver transplantation (LT). Despite the need, post-LT outcomes are poor in co-infection. We examined predictors of outcomes post-LT. Immunologic biomarkers of immune activation, microbial translocation, and Th1/Th2 skewing were measured pre-LT in participants enrolled in a cohort of HIV infected persons requiring solid organ transplant (HIVTR). Predictive biomarkers were analyzed in Cox-proportional hazards models; multivariate models included known predictors of outcome and biomarkers from univariate analyses. Sixty-nine HIV-HCV co-infected persons with available pre-LT samples were tested: median (IQR) CD4+ T-cell count was 286 (210-429) cells mm(-3); 6 (9%) had detectable HIV RNA. Median (IQR) follow-up was 2.1 (0.7-4.0) years, 29 (42%) people died, 35 (51%) had graft loss, 22 (32%) were treated for acute rejection, and 14 (20%) had severe recurrent HCV. In multivariate models, sCD14 levels were significantly lower in persons with graft loss post-LT (HR 0.10 [95% CI 0.02-0.68]). IL-10 levels were higher in persons with rejection (HR 2.10 [95% CI 1.01-4.34]). No markers predicted severe recurrent HCV. Monocyte activation pre-LT may be mechanistically linked to graft health in HIV-HCV co-infection.	[Balagopal, Ashwin; Quinn, Jeffrey; Sulkowski, Mark S.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Barin, Burc] EMMES Corp, Rockville, MD 20850 USA; [Rogers, Rodney; Stock, Peter G.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94122 USA	Johns Hopkins University; Emmes Corporation; University of California System; University of California San Francisco	Balagopal, A (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA.	abalago1@jhmi.edu		Quinn, Jeffrey/0000-0002-4734-5108	National Institute of Drug Abuse [DA 016078, DA 034621]; Johns Hopkins Center for AIDS Research [AI 094189]; National Institute of Allergy and Infectious Diseases [AI 052748]; EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052748, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078, K24DA034621] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute of Drug Abuse: DA 016078 (AB); DA 034621 (MSS) Johns Hopkins Center for AIDS Research: AI 094189 (AB and MSS) National Institute of Allergy and Infectious Diseases: AI 052748 (PGS). EMMES provided support in the form of salary for author BB and other EMMES employees involved in the study design, data collection and analysis, and preparation of the manuscript. The EMMES Corporation otherwise did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Balagopal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041258; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Chattergoon MA, 2011, J INFECT DIS, V204, P1730, DOI 10.1093/infdis/jir642; Chen Y, 2008, TRANSPL P, V40, P2691, DOI 10.1016/j.transproceed.2008.08.014; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Fox AN, 2012, SEMIN LIVER DIS, V32, P177, DOI 10.1055/s-0032-1316474; French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225; Goedert JJ, 2002, BLOOD, V100, P1584; Gras J, 2007, LIVER TRANSPLANT, V13, P426, DOI 10.1002/lt.21084; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Louis H, 2000, HEPATOLOGY, V31, P381, DOI 10.1002/hep.510310218; Marchetti G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-79; Meuleman P, 2006, CLIN CHIM ACTA, V366, P156, DOI 10.1016/j.cca.2005.09.022; Miro JM, 2012, AM J TRANSPLANT, V12, P1866, DOI 10.1111/j.1600-6143.2012.04028.x; Redd AD, 2013, AIDS RES HUM RETROV, V29, P1026, DOI [10.1089/aid.2013.0004, 10.1089/AID.2013.0004]; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Subramanian A, 2010, GASTROENTEROLOGY, V138, P159, DOI 10.1053/j.gastro.2009.09.053; Terrault NA, 2012, LIVER TRANSPLANT, V18, P716, DOI 10.1002/lt.23411; Thomas DL, 2008, ANNU REV MED, V59, P473, DOI 10.1146/annurev.med.59.081906.081110; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Wan Renhua, 2012, Front Biosci (Elite Ed), V4, P2121; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Zhang LJ, 2006, WORLD J GASTROENTERO, V12, P1681, DOI 10.3748/wjg.v12.i11.1681	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135882	10.1371/journal.pone.0135882	http://dx.doi.org/10.1371/journal.pone.0135882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313939	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000029
J	Boudard, M; Bernauer, J; Barth, D; Cohen, J; Denise, A				Boudard, Melanie; Bernauer, Julie; Barth, Dominique; Cohen, Johanne; Denise, Alain			GARN: Sampling RNA 3D Structure Space with Game Theory and Knowledge-Based Scoring Strategies	PLOS ONE			English	Article							STRUCTURE PREDICTION; SECONDARY STRUCTURES; MOTIFS; POTENTIALS; COMPLEXITY; MOLECULES; DATABASE; MFOLD	Cellular processes involve large numbers of RNA molecules. The functions of these RNA molecules and their binding to molecular machines are highly dependent on their 3D structures. One of the key challenges in RNA structure prediction and modeling is predicting the spatial arrangement of the various structural elements of RNA. As RNA folding is generally hierarchical, methods involving coarse-grained models hold great promise for this purpose. We present here a novel coarse-grained method for sampling, based on game theory and knowledge-based potentials. This strategy, GARN (Game Algorithm for RNa sampling), is often much faster than previously described techniques and generates large sets of solutions closely resembling the native structure. GARN is thus a suitable starting point for the molecular modeling of large RNAs, particularly those with experimental constraints. GARN is available from: http://garn.lri.fr/.	[Boudard, Melanie; Barth, Dominique] Univ Versailles St Quentin En Yvelines, PRiSM, CNRS, UMR 8144, F-78000 Versailles, France; [Boudard, Melanie; Cohen, Johanne; Denise, Alain] Univ Paris 11, LRI, CNRS, UMR 8623, F-91405 Orsay, France; [Bernauer, Julie; Denise, Alain] Inria Saclay Ile France, AMIB, F-91120 Palaiseau, France; [Bernauer, Julie] Ecole Polytech, LIX, CNRS, UMR 7161, F-91120 Palaiseau, France; [Denise, Alain] Univ Paris 11, CNRS, I2BC, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Boudard, M (corresponding author), Univ Versailles St Quentin En Yvelines, PRiSM, CNRS, UMR 8144, F-78000 Versailles, France.	melanie.boudard@lri.fr; johanne.cohen@lri.fr			Digiteo project JAPARIn-3D; Agence National de la Recherche [ANR-2011-BSV6-011/NGD-NSD]	Digiteo project JAPARIn-3D; Agence National de la Recherche(French National Research Agency (ANR))	M.B. received funding from the Digiteo project JAPARIn-3D. This work was partially supported by the Agence National de la Recherche (ANR-2011-BSV6-011/NGD-NSD).	Auer P, 2003, SIAM J COMPUT, V32, P48, DOI 10.1137/S0097539701398375; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Bernauer J, 2011, RNA, V17, P1066, DOI 10.1261/rna.2543711; Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Bohl K, 2014, MOL BIOSYST, V10, P3066, DOI 10.1039/c3mb70601j; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Cesa-Bianchi N., 1997, Proceedings of the Tenth Annual Conference on Computational Learning Theory, P163, DOI 10.1145/267460.267492; Cesa-Bianchi N., 2006, PREDICTION LEARNING, DOI DOI 10.1017/CBO9780511546921; Conlin PL, 2014, CURR OPIN MICROBIOL, V21, P35, DOI 10.1016/j.mib.2014.09.004; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cruz JA, 2012, RNA, V18, P610, DOI 10.1261/rna.031054.111; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Daskalakis C, 2009, COMMUN ACM, V52, P89, DOI 10.1145/1461928.1461951; Dast R, 2008, P NATL ACAD SCI USA, V105, P4144, DOI 10.1073/pnas.0709032105; Dima RI, 2005, J MOL BIOL, V347, P53, DOI 10.1016/j.jmb.2004.12.012; Flores SC, 2012, BRIEF BIOINFORM, V13, P395, DOI 10.1093/bib/bbr077; Flores SC, 2010, RNA, V16, P1769, DOI 10.1261/rna.2112110; Fonseca R, 2014, NUCLEIC ACIDS RES, V42, P9562, DOI 10.1093/nar/gku707; Frellsen J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000406; Gillespie J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-369; GRIGORIADIS MD, 1995, OPER RES LETT, V18, P53, DOI 10.1016/0167-6377(95)00032-0; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; HOFACKER IL, 2009, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1202S26; Jonikas MA, 2009, BIOINFORMATICS, V25, P3259, DOI 10.1093/bioinformatics/btp576; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kim N, 2014, P NATL ACAD SCI USA, V111, P4079, DOI 10.1073/pnas.1318893111; Laederach A, 2007, P NATL ACAD SCI USA, V104, P7045, DOI 10.1073/pnas.0608765104; Laing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071947; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Laing C, 2009, J MOL BIOL, V393, P67, DOI 10.1016/j.jmb.2009.07.089; Lamiable A, 2013, IEEE ACM T COMPUT BI, V10, P193, DOI 10.1109/TCBB.2012.148; Lamiable A, 2012, COMPUT BIOL CHEM, V37, P1, DOI 10.1016/j.compbiolchem.2011.11.001; LE SY, 1989, COMPUT BIOMED RES, V22, P461, DOI 10.1016/0010-4809(89)90039-6; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Murray LJW, 2003, P NATL ACAD SCI USA, V100, P13904, DOI 10.1073/pnas.1835769100; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nemirovski A, 2009, SIAM J OPTIMIZ, V19, P1574, DOI 10.1137/070704277; Papadimitriou C, 2014, P NATL ACAD SCI USA, V111, P15881, DOI 10.1073/pnas.1416954111; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Popenda M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-231; Reeder J, 2006, J BIOTECHNOL, V124, P41, DOI 10.1016/j.jbiotec.2006.01.034; Robbins H., 1985, H ROBBINS SELECTED P, P169; Rosenthal R. W., 1973, International Journal of Game Theory, V2, P65, DOI 10.1007/BF01737559; Rother M, 2011, BRIEF BIOINFORM, V12, P601, DOI 10.1093/bib/bbr050; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Sarver M, 2008, J MATH BIOL, V56, P215, DOI 10.1007/s00285-007-0110-x; SASTRY PS, 1994, IEEE T SYST MAN CYB, V24, P769, DOI 10.1109/21.293490; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Sharma S, 2008, BIOINFORMATICS, V24, P1951, DOI 10.1093/bioinformatics/btn328; Sim AYL, 2012, CURR OPIN STRUC BIOL, V22, P273, DOI 10.1016/j.sbi.2012.03.012; Sim AYL, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012410107; Sim AYL, 2012, P NATL ACAD SCI USA, V109, P2890, DOI 10.1073/pnas.1119918109; Summa CM, 2007, P NATL ACAD SCI USA, V104, P3177, DOI 10.1073/pnas.0611593104; Sykes MT, 2005, J MOL BIOL, V351, P26, DOI 10.1016/j.jmb.2005.06.024; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136444	10.1371/journal.pone.0136444	http://dx.doi.org/10.1371/journal.pone.0136444			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313379	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000059
J	Briere, DA; Ruan, XP; Cheng, CC; Siesky, AM; Fitch, TE; Dominguez, C; Sanfeliciano, SG; Montero, C; Suen, CS; Xu, YP; Coskun, T; Michael, MD				Briere, Daniel A.; Ruan, Xiaoping; Cheng, Christine C.; Siesky, Angela M.; Fitch, Thomas E.; Dominguez, Carmen; Sanfeliciano, Sonia Gutierrez; Montero, Carlos; Suen, Chen S.; Xu, Yanping; Coskun, Tamer; Michael, M. Dodson			Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BILE-ACID RECEPTOR; FOOD-INTAKE; POTENT; DERIVATIVES; MECHANISMS; SECRETION; OBESITY; WEIGHT; YY3-36	Activation of TGR5 via bile acids or bile acid analogs leads to the release of glucagon-like peptide-1 (GLP-1) from intestine, increases energy expenditure in brown adipose tissue, and increases gallbladder filling with bile. Here, we present compound 18, a non-bile acid agonist of TGR5 that demonstrates robust GLP-1 secretion in a mouse enteroendocrine cell line yet weak GLP-1 secretion in a human enteroendocrine cell line. Acute administration of compound 18 to mice increased GLP-1 and peptide YY (PYY) secretion, leading to a lowering of the glucose excursion in an oral glucose tolerance test (OGTT), while chronic administration led to weight loss. In addition, compound 18 showed a dose-dependent increase in gallbladder filling. Lastly, compound 18 failed to show similar pharmacological effects on GLP-1, PYY, and gallbladder filling in Tgr5 knockout mice. Together, these results demonstrate that compound 18 is a mouse-selective TGR5 agonist that induces GLP-1 and PYY secretion, and lowers the glucose excursion in an OGTT, but only at doses that simultaneously induce gallbladder filling. Overall, these data highlight the benefits and potential risks of using TGR5 agonists to treat diabetes and metabolic diseases.	[Briere, Daniel A.; Ruan, Xiaoping; Cheng, Christine C.; Siesky, Angela M.; Fitch, Thomas E.; Suen, Chen S.; Xu, Yanping; Coskun, Tamer; Michael, M. Dodson] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Dominguez, Carmen; Sanfeliciano, Sonia Gutierrez; Montero, Carlos] Eli Lilly & Co, Ctr Invest, Alcobendas, Spain	Eli Lilly; Eli Lilly	Michael, MD (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	dod.michael@lilly.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Eli Lilly and Company provided support in the form of salaries for authors DAB, XR, CCC, AMS, TEF, CD, SGS, CM, CSS, YX, TC, and MDM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Batterham RL, 2003, ANN NY ACAD SCI, V994, P162, DOI 10.1111/j.1749-6632.2003.tb03176.x; Bayliss WM, 1902, P R SOC LONDON, V69, P352; Diakogiannaki E, 2012, PHYSIOL BEHAV, V106, P387, DOI 10.1016/j.physbeh.2011.12.001; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duan HL, 2012, J MED CHEM, V55, P10475, DOI 10.1021/jm301071h; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Houten SM, 2004, ANN MED, V36, P482, DOI 10.1080/07853890410018790; Jansen PLM, 2010, J HEPATOL, V52, P937, DOI 10.1016/j.jhep.2010.02.003; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Pellicciari R, 2009, J MED CHEM, V52, P7958, DOI 10.1021/jm901390p; Phillips DP, 2014, J MED CHEM, V57, P3263, DOI 10.1021/jm401731q; Reimann F, 2006, DIABETES, V55, pS78, DOI 10.2337/db06-S010; RINDI G, 1990, AM J PATHOL, V136, P1349; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tiwari A, 2009, DRUG DISCOV TODAY, V14, P523, DOI 10.1016/j.drudis.2009.02.005; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Vrang N, 2006, AM J PHYSIOL-REG I, V291, pR367, DOI 10.1152/ajpregu.00726.2005; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zambad SP, 2014, DIABETES METAB SYNDR, V7, P1, DOI 10.2147/DMSO.S50209; Zou QA, 2014, EUR J MED CHEM, V82, P1, DOI 10.1016/j.ejmech.2014.05.031	31	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136873	10.1371/journal.pone.0136873	http://dx.doi.org/10.1371/journal.pone.0136873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312995	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000104
J	del Toro, FJ; Aguilar, E; Hernandez-Walias, FJ; Tenllado, F; Chung, BN; Canto, T				del Toro, Francisco J.; Aguilar, Emmanuel; Hernandez-Walias, Francisco J.; Tenllado, Francisco; Chung, Bong-Nam; Canto, Tomas			High Temperature, High Ambient CO2 Affect the Interactions between Three Positive-Sense RNA Viruses and a Compatible Host Differentially, but not Their Silencing Suppression Efficiencies	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; ELEVATED CO2; NICOTIANA-BENTHAMIANA; TRANSIENT EXPRESSION; 20S PROTEASOME; PROTEIN; PLANT; ARABIDOPSIS; DEFENSE; TOBACCO	We compared infection of Nicotiana benthamiana plants by the positive-sense RNA viruses Cucumber mosaic virus (CMV), Potato virus Y (PVY), and by a Potato virus X (PVX) vector, the latter either unaltered or expressing the CMV 2b protein or the PVY HCPro suppressors of silencing, at 25 degrees C vs. 30 degrees C, or at standard (similar to 401 parts per million, ppm) vs. elevated (970 ppm) CO2 levels. We also assessed the activities of their suppressors of silencing under those conditions. We found that at 30 degrees C, accumulation of the CMV isolate and infection symptoms remained comparable to those at 25 degrees C, whereas accumulation of the PVY isolate and those of the three PVX constructs decreased markedly, even when expressing the heterologous suppressors 2b or HCPro, and plants had either very attenuated or no symptoms. Under elevated CO2 plants grew larger, but contained less total protein/unit of leaf area. In contrast to temperature, infection symptoms remained unaltered for the five viruses at elevated CO2 levels, but viral titers in leaf disks as a proportion of the total protein content increased in all cases, markedly for CMV, and less so for PVY and the PVX constructs. Despite these differences, we found that neither high temperature nor elevated CO2 prevented efficient suppression of silencing by their viral suppressors in agropatch assays. Our results suggest that the strength of antiviral silencing at high temperature or CO2 levels, or those of the viral suppressors that counteract it, may not be the main determinants of the observed infection outcomes.	[del Toro, Francisco J.; Aguilar, Emmanuel; Hernandez-Walias, Francisco J.; Tenllado, Francisco; Canto, Tomas] CSIC, Ctr Invest Biol, Dept Biol Medioambiental, E-28040 Madrid, Spain; [Chung, Bong-Nam] Natl Inst Hort & Herbal Sci, Agr Res Ctr Climate Change, Jeju 690150, Jeju Island, South Korea	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea	Chung, BN (corresponding author), Natl Inst Hort & Herbal Sci, Agr Res Ctr Climate Change, 281 Ayeon Ro, Jeju 690150, Jeju Island, South Korea.	chbn7567@korea.kr; tomas.canto@cib.csic.es	peralo, francisco tenllado/E-5804-2016	peralo, francisco tenllado/0000-0002-5349-7642; AGUILAR PARRAS, EMMANUEL/0000-0002-4814-4623	Rural Development Administration (RDA) of the Republic of Korea [PJ009461]; Spanish Council for Scientific Research (CSIC); Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2013-47940-R]	Rural Development Administration (RDA) of the Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Spanish Council for Scientific Research (CSIC); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government)	This work was supported by grant PJ009461 from the Rural Development Administration (RDA) of the Republic of Korea (http://www.rda.go.kr/foreign/eng/), in cooperation with the Spanish Council for Scientific Research (CSIC; www.csic.es), and also by grant BIO2013-47940-R from the Spanish Ministry of Economy and Competitiveness (MINECO; http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballut L, 2005, J GEN VIROL, V86, P2595, DOI 10.1099/vir.0.81107-0; CANTO T, 1995, PLANT DIS, V79, P234, DOI 10.1094/PD-79-0234; Canto T, 2002, MOL PLANT MICROBE IN, V15, P1137, DOI 10.1094/MPMI.2002.15.11.1137; Canto T, 2009, GLOBAL CHANGE BIOL, V15, P1884, DOI 10.1111/j.1365-2486.2008.01820.x; Chellappan P, 2005, PLANT PHYSIOL, V138, P1828, DOI 10.1104/pp.105.066563; Cillo F, 2002, J VIROL, V76, P10654, DOI 10.1128/JVI.76.21.10654-10664.2002; del Toro F, 2014, MOL PLANT MICROBE IN, V27, P1331, DOI 10.1094/MPMI-05-14-0155-R; Del Toro F, 2014, MOL PLANT PATHOL, V15, P848, DOI 10.1111/mpp.12136; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Dielen AS, 2011, MOL PLANT PATHOL, V12, P137, DOI 10.1111/j.1364-3703.2010.00654.x; Dujovny G, 2009, PLANT BIOTECHNOL J, V7, P49, DOI 10.1111/j.1467-7652.2008.00373.x; Feng JL, 2006, ACTA BIOCH BIOPH SIN, V38, P669, DOI [10.1111/j.1745-7270.2006.00216.x, 10.1111/J.1745-7270.2006.00216.x]; Garcia D, 2014, CELL HOST MICROBE, V16, P391, DOI 10.1016/j.chom.2014.08.001; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Huang L, 2012, PLANT BIOLOGY, V14, P905, DOI 10.1111/j.1438-8677.2012.00582.x; Hull R., 2002, MATTHEWS PLANT VIROL; Jin YS, 2007, J VIROL, V81, P12881, DOI 10.1128/JVI.00913-07; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Moreno AA, 2011, BIOL RES, V44, P75, DOI 10.4067/S0716-97602011000100010; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Parmar VM, 2012, ADV EXP MED BIOL, V738, P153, DOI 10.1007/978-1-4614-1680-7_10; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; RIZZO TM, 1990, MOL GEN GENET, V222, P249, DOI 10.1007/BF00633825; Sahana N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052546; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Sun YC, 2013, PLANT SCI, V210, P128, DOI 10.1016/j.plantsci.2013.05.014; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Fernandez FT, 2013, MOL PLANT PATHOL, V14, P530, DOI 10.1111/mpp.12025; Velazquez K, 2010, PLANT PATHOL, V59, P982, DOI 10.1111/j.1365-3059.2010.02315.x; Verchot J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00066; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wei TY, 2010, J VIROL, V84, P799, DOI 10.1128/JVI.01824-09; Ye LF, 2010, PLANT SCI, V179, P219, DOI 10.1016/j.plantsci.2010.05.004; Zhang S, 2015, J EXP BOT, V66, P1951, DOI 10.1093/jxb/eru538; Zhang XC, 2012, J VIROL, V86, P6847, DOI 10.1128/JVI.00497-12; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110	44	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136062	10.1371/journal.pone.0136062	http://dx.doi.org/10.1371/journal.pone.0136062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313753	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000039
J	Nemeth, Z; Cziraki, A; Szabados, S; Biri, B; Keki, S; Koller, A				Nemeth, Zoltan; Cziraki, Attila; Szabados, Sandor; Biri, Bernadett; Keki, Sandor; Koller, Akos			Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CHRONIC KIDNEY-DISEASE; NITRIC-OXIDE; L-ARGININE; ANGIOTENSIN-II; HEART; INCREASE; RISK; ENDOTHELIN-1; ACCUMULATION	Background Pericardial fluid (PF) contains several biologically active substances, which may provide information regarding the cardiac conditions. Nitric oxide (NO) has been implicated in cardiac remodeling. We hypothesized that L-arginine (L-Arg) precursor of NO-synthase (NOS) and asymmetric dimethylarginine (ADMA), an inhibitor of NOS, are present in PF of cardiac patients and their altered levels may contribute to altered cardiac morphology. Methods L-Arg and ADMA concentrations in plasma and PF, and echocardiographic parameters of patients undergoing coronary artery bypass graft (CABG, n = 28) or valve replacement (VR, n = 25) were determined. Results We have found LV hypertrophy in 35.7% of CABG, and 80% of VR patients. In all groups, plasma and PF L-Arg levels were higher than that of ADMA. Plasma L-Arg level was higher in CABG than VR (75.7 +/- 4.6 mu mol/L vs. 58.1 +/- 4.9 mu mol/L, p = 0.011), whereas PF ADMA level was higher in VR than CABG (0.9 +/- 0.0 mu mol/L vs. 0.7 +/- 0.0 mu mol/L, p = 0.009). L-Arg/ADMA ratio was lower in the VR than CABG (VRplasma: 76.1 +/- 6.6 vs. CABGplasma: 125.4 +/- 10.7, p = 0.004; VRPF: 81.7 +/- 4.8 vs. CABGPF: 110.4 +/- 7.2, p = 0.009). There was a positive correlation between plasma L-Arg and ADMA in CABG (r = 0.539, p = 0.015); and plasma and PF L-Arg in CABG (r = 0.357, p = 0.031); and plasma and PF ADMA in VR (r = 0.529, p = 0.003); and PF L-Arg and ADMA in both CABG and VR (CABG: r = 0.468, p = 0.006; VR: r = 0.371, p = 0.034). The following echocardiographic parameters were higher in VR compared to CABG: interventricular septum (14.7 +/- 0.5mm vs. 11.9 +/- 0.4mm, p = 0.000); posterior wall thickness (12.6 +/- 0.3 mm vs. 11.5 +/- 0.2 mm, p = 0.000); left ventricular (LV) mass (318.6 +/- 23.5 g vs. 234.6 +/- 12.3 g, p = 0.007); right ventricular (RV) (33.9 +/- 0.9 cm(2) vs. 29.7 +/- 0.7 cm(2), p = 0.004); right atrial (18.6 +/- 1.0 cm(2) vs. 15.4 +/- 0.6 cm(2), p = 0.020); left atrial (19.8 +/- 1.0 cm(2) vs. 16.9 +/- 0.6 cm(2), p = 0.033) areas. There was a positive correlation between plasma ADMA and RV area (r = 0.453, p = 0.011); PF ADMA and end-diastolic (r = 0.434, p = 0.015) and systolic diameter of LV (r = 0.487, p = 0.007); and negative correlation between PF ADMA and LV ejection fraction (r = -0.445, p = 0.013) in VR. Conclusion We suggest that elevated levels of ADMA in the PF of patients indicate upregulated RAS and reduced bioavailability of NO, which can contribute to the development of cardiac hypertrophy and remodeling.	[Nemeth, Zoltan; Koller, Akos] Univ Pecs, Sch Med, Dept Pathophysiol & Gerontol, Pecs, Hungary; [Nemeth, Zoltan; Koller, Akos] Univ Pecs, Sch Med, Szentagothai Res Ctr, Pecs, Hungary; [Cziraki, Attila; Szabados, Sandor] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Biri, Bernadett; Keki, Sandor] Univ Debrecen, Fac Sci, Dept Appl Chem, Debrecen, Hungary; [Koller, Akos] Univ Phys Educ, Inst Nat Sci, Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of Pecs; University of Pecs; University of Pecs; University of Debrecen; University of Physical Education; New York Medical College	Koller, A (corresponding author), Univ Pecs, Sch Med, Dept Pathophysiol & Gerontol, Pecs, Hungary.	koller@nymc.edu	Ákos, Koller/Q-4672-2019	Cziraki MD.PhD. Professor., Attila/0000-0002-8231-3312	Hungarian Scientific Research Fund (OTKA) [K 108444, SROP-4.2.2.A-11/1/KONV-2012-0024, SPOR-4.2.2.A11/1/KONV-2012-0017]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study is sponsored by the Hungarian Scientific Research Fund (OTKA) K 108444, SROP-4.2.2.A-11/1/KONV-2012-0024, and SPOR-4.2.2.A11/1/KONV-2012-0017.	Ajtay Z, 2009, INT J MOL MED, V23, P651, DOI 10.3892/ijmm_00000176; AMANO J, 1993, CLIN SCI, V85, P165, DOI 10.1042/cs0850165; Baue A E, 1972, Ann Thorac Surg, V14, P81; Ben-Horin S, 2005, AM J MED, V118, P636, DOI 10.1016/j.amjmed.2005.01.066; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Celik M, 2012, CARDIOL J, V19, P29, DOI 10.5603/CJ.2012.0006; Chambers JB, 2009, EUR J ECHOCARDIOGR, V10, pI11, DOI 10.1093/ejechocard/jen240; Cziraki A, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-23; Gomes RAD, 2008, ARQ BRAS CARDIOL, V91, P172, DOI 10.1590/S0066-782X2008001500006; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fazekas L, 1999, LIFE SCI, V65, P1005, DOI 10.1016/S0024-3205(99)00331-8; Fernandez Angel L, 2008, Interact Cardiovasc Thorac Surg, V7, P373, DOI 10.1510/icvts.2007.168302; Gaasch WH, 2007, CIRCULATION, V116, P591, DOI 10.1161/CIRCULATIONAHA.107.716647; Gad MZ, 2010, BIOMARKERS, V15, P746, DOI 10.3109/1354750X.2010.519784; Garcia Jose Antonio Dias, 2008, Arq Bras Cardiol, V90, P409; Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399; GIBSON AT, 1978, J PHYSIOL-LONDON, V277, P367, DOI 10.1113/jphysiol.1978.sp012277; Hedner T, 2002, BLOOD PRESSURE, V11, P197, DOI 10.1080/08037050213763; HORKAY F, 1995, J CARDIOVASC PHARM, V26, pS502; Horkay F, 1997, LIFE SCI, V62, P267, DOI 10.1016/S0024-3205(97)01105-3; Horowitz JD, 2007, J CHROMATOGR B, V851, P42, DOI 10.1016/j.jchromb.2006.09.023; Hunter JC, 2009, J MOL CELL CARDIOL, V47, P810, DOI 10.1016/j.yjmcc.2009.09.012; HUTCHIN P, 1971, ARCH SURG-CHICAGO, V102, P28; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Lu TM, 2003, CLIN CARDIOL, V26, P458, DOI 10.1002/clc.4960261006; Luneburg N, 2011, J NUTR, V141, P2186, DOI 10.3945/jn.111.148197; Luo ZM, 2010, HYPERTENSION, V56, P498, DOI 10.1161/HYPERTENSIONAHA.110.152959; Mancia G, 2014, BLOOD PRESSURE, V23, P3, DOI 10.3109/08037051.2014.868629; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; Mittermayer F, 2006, ARTERIOSCL THROM VAS, V26, P2536, DOI 10.1161/01.ATV.0000242801.38419.48; MOLLER P, 1983, GERONTOLOGY, V29, P1; Namiki A, 2003, JPN HEART J, V44, P633, DOI 10.1536/jhj.44.633; Napora M, 2012, POL ARCH MED WEWN, V122, P226, DOI 10.20452/pamw.1222; Ngo DTM, 2007, NITRIC OXIDE-BIOL CH, V16, P197, DOI 10.1016/j.niox.2006.10.003; Nonaka S, 2005, J CHROMATOGR A, V1066, P41, DOI 10.1016/j.chroma.2005.01.052; Pecchini P, 2012, J NEPHROL, V25, P1016, DOI 10.5301/jn.5000085; Pope AJ, 2009, PHARMACOL RES, V60, P461, DOI 10.1016/j.phrs.2009.07.016; Ronden RA, 2012, AM J PHYSIOL-RENAL, V303, pF149, DOI 10.1152/ajprenal.00045.2012; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8; Sharma V, 2012, AM J PHYSIOL-GASTR L, V303, pG435, DOI 10.1152/ajpgi.00268.2011; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Simko F, 2000, PHYSIOL RES, V49, P37; Speeckaert MM, 2012, CLIN CHEM LAB MED, V50, P1597, DOI 10.1515/cclm-2012-0033; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Teerlink T, 2007, J CHROMATOGR B, V851, P21, DOI 10.1016/j.jchromb.2006.07.024; Tirziu D, 2007, J CLIN INVEST, V117, P3188, DOI 10.1172/JCI32024; Toth J, 2007, HYPERTENSION, V49, P563, DOI 10.1161/01.HYP.0000256764.86208.3d; Turbucz P, 1998, J CARDIOVASC PHARM, V31, pS287, DOI 10.1097/00005344-199800001-00080; Ueda Seiji, 2007, Clin Exp Nephrol, V11, P115, DOI 10.1007/s10157-007-0471-x; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; VATNER DE, 1984, J CLIN INVEST, V73, P1473, DOI 10.1172/JCI111351; Veresh Z, 2008, HYPERTENSION, V52, P960, DOI 10.1161/HYPERTENSIONAHA.108.116731; Veresh Z, 2012, J VASC RES, V49, P363, DOI 10.1159/000337485; Visser M, 2010, EUR J HEART FAIL, V12, P1274, DOI 10.1093/eurjhf/hfq158; Wandt B, 1999, HEART, V82, P192, DOI 10.1136/hrt.82.2.192; Wolf C, 2012, INT J CARDIOL, V156, P289, DOI 10.1016/j.ijcard.2010.11.003; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zoccali C, 2002, KIDNEY INT, V62, P339, DOI 10.1046/j.1523-1755.2002.00437.x; Zsuga J, 2007, CEREBROVASC DIS, V23, P388, DOI 10.1159/000101461	63	12	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135498	10.1371/journal.pone.0135498	http://dx.doi.org/10.1371/journal.pone.0135498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313940	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000017
J	Read, SA; Tay, ES; Shahidi, M; O'Connor, KS; Booth, DR; George, J; Douglas, MW				Read, Scott A.; Tay, Enoch S.; Shahidi, Mahsa; O'Connor, Kate S.; Booth, David R.; George, Jacob; Douglas, Mark W.			Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HEPATOCELLULAR-CARCINOMA; CORE PROTEIN; DIFFERENTIAL EXPRESSION; CYTOKINE SIGNALING-3; INSULIN-RESISTANCE; GENETIC-VARIATION; ALPHA; INFECTION; GENOTYPE	Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated genes (ISGs), termed interferon refractoriness, are less likely to mount a strong antiviral response and achieve viral clearance when placed on treatment. As a result, suppressor of cytokine signalling (SOCS) 3 and other regulators of the IFN response have been identified as key candidates for the IFN refractory phenotype due to their regulatory role on the IFN response. AXL is a receptor tyrosine kinase that has been identified as a key regulator of interferon (IFN) signalling in myeloid cells of the immune system, but has not been examined in the context of chronic HCV infection. Here, we show that AXL is up-regulated following HCV infection, both in vitro and in vivo and is likely induced by type I/III IFNs and inflammatory signalling pathways. AXL inhibited type IFN alpha mediated ISG expression resulting in a decrease in its antiviral efficacy against HCV in vitro. Furthermore, patients possessing the favourable IFNL3 rs12979860 genotype associated with treatment response, showed lower AXL expression in the liver and a stronger induction of AXL in the blood, following their first dose of IFN. Together, these data suggest that elevated AXL expression in the liver may mediate an IFN-refractory phenotype characteristic of patients possessing the unfavourable rs12979860 genotype, which is associated with lower rates of viral clearance.	[Read, Scott A.; Tay, Enoch S.; Shahidi, Mahsa; George, Jacob; Douglas, Mark W.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Ctr, Westmead, NSW 2145, Australia; [O'Connor, Kate S.; Booth, David R.] Univ Sydney, Westmead Hosp, Ctr Immunol & Allergy Res, Westmead, NSW 2145, Australia; [Douglas, Mark W.] Univ Sydney, Westmead Hosp, Marie Bashir Inst Infect Dis & Biosecur, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Douglas, MW (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Ctr, Westmead, NSW 2145, Australia.	Mark.douglas@sydney.edu.au	Read, Scott/K-6462-2019; George, jacob/P-1496-2014; Douglas, Mark/D-5513-2011	Read, Scott/0000-0001-6775-2061; Douglas, Mark/0000-0003-4621-3485	National Health and Medical Research Council of Australia [358772, 1003767, 1047417, 1053206]; Natural Sciences and Engineering Research Council of Canada [PGSD3-346640-2008]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Work on this manuscript was in part supported by program and project grants from the National Health and Medical Research Council of Australia (358772, 1003767, 1047417 and 1053206), the Natural Sciences and Engineering Research Council of Canada PhD scholarship PGSD3-346640-2008 and by the Robert W. Storr bequest to the Sydney Medical Foundation, University of Sydney.	Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; He L, 2010, MOL CARCINOGEN, V49, P882, DOI 10.1002/mc.20664; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lanford RE, 2007, HEPATOLOGY, V46, P999, DOI 10.1002/hep.21776; Lee HJ, 2014, CARCINOGENESIS, V35, P769, DOI 10.1093/carcin/bgt372; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; O'Connor KS, 2014, GENES IMMUN, V15, P88, DOI 10.1038/gene.2013.66; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Persico M, 2007, HEPATOLOGY, V46, P1009, DOI 10.1002/hep.21782; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Read SA, 2015, J INTERFERON CYTOKIN; Read SA, 2014, J GEN VIROL, V95, P1900, DOI 10.1099/vir.0.065300-0; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Soo HM, 2002, VIROLOGY, V303, P253, DOI 10.1006/viro.2002.1617; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Tsou AP, 1998, GENOMICS, V50, P331, DOI 10.1006/geno.1998.5338; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; You LR, 1999, J VIROL, V73, P1672, DOI 10.1128/JVI.73.2.1672-1681.1999; Zheng SS, 2015, J IMMUNOL, V194, P1928, DOI 10.4049/jimmunol.1401933	42	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136227	10.1371/journal.pone.0136227	http://dx.doi.org/10.1371/journal.pone.0136227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313459	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000048
J	Sensinger, J; Aleman-Zapata, A; Englehart, K				Sensinger, Jonathon; Aleman-Zapata, Adrian; Englehart, Kevin			Do Cost Functions for Tracking Error Generalize across Tasks with Different Noise Levels?	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; SYSTEM; EMG	Control of human-machine interfaces are well modeled by computational control models, which take into account the behavioral decisions people make in estimating task dynamics and state for a given control law. This control law is optimized according to a cost function, which for the sake of mathematical tractability is typically represented as a series of quadratic terms. Recent studies have found that people actually use cost functions for reaching tasks that are slightly different than a quadratic function, but it is unclear which of several cost functions best explain human behavior and if these cost functions generalize across tasks of similar nature but different scale. In this study, we used an inverse-decision-theory technique to reconstruct the cost function from empirical data collected on 24 able-bodied subjects controlling a myoelectric interface. Compared with previous studies, this experimental paradigm involved a different control source (myoelectric control, which has inherently large multiplicative noise), a different control interface (control signal was mapped to cursor velocity), and a different task (the tracking position dynamically moved on the screen throughout each trial). Several cost functions, including a linear-quadratic; an inverted Gaussian, and a power function, accurately described the behavior of subjects throughout this experiment better than a quadratic cost function or other explored candidate cost functions (p<0.05). Importantly, despite the differences in the experimental paradigm and a substantially larger scale of error, we found only one candidate cost function whose parameter was consistent with the previous studies: a power function (cost proportional to error(alpha)) with a parameter value of alpha = 1.69 (1.53-1.78 inter-quartile range). This result suggests that a power-function is a representative function of user's error cost over a range of noise amplitudes for pointing and tracking tasks.	[Sensinger, Jonathon; Englehart, Kevin] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada; [Sensinger, Jonathon; Englehart, Kevin] Univ New Brunswick, Dept Elect & Comp Engn, Fredericton, NB, Canada; [Aleman-Zapata, Adrian] Univ Guadalajara, Dept Elect & Comp Engn, Guadalajara 44430, Jalisco, Mexico	University of New Brunswick; University of New Brunswick; Universidad de Guadalajara	Sensinger, J (corresponding author), Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada.	j.sensinger@unb.ca		Englehart, Kevin/0000-0003-4525-1121	MITACS Globalink summer internship; Canadian Natural Sciences and Engineering Research Council Discovery award; New Brunswick Innovation Foundation award; New Brunswick Health Research Foundation award	MITACS Globalink summer internship; Canadian Natural Sciences and Engineering Research Council Discovery award; New Brunswick Innovation Foundation award; New Brunswick Health Research Foundation award	AA was supported by a MITACS Globalink summer internship: https://www.mitacs.ca/en/programs/globalink. Equipment for the project was purchased using funds from: A Canadian Natural Sciences and Engineering Research Council Discovery award (JS): http://www.nserc-crsng.gc.ca/, A New Brunswick Innovation Foundation award (JS): http://nbif.ca. Fees to pay for the repository of data were paid for using funds from a New Brunswick Health Research Foundation award (JS): http://www.nbhrf.com/. The authors received no other specific funding for this work.	Acerbi L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003661; Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; Chhabra M, 2006, J NEUROSCI, V26, P10883, DOI 10.1523/JNEUROSCI.2238-06.2006; Clancy EA, 2001, IEEE ENG MED BIOL, V20, P47, DOI 10.1109/51.982275; ENGLEHART KB, 1994, IEEE T BIO-MED ENG, V41, P168, DOI 10.1109/10.284928; Johnson RE, 2015, IEEE EMBS C NEUR ENG; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kording KP, 2004, PLOS BIOL, V2, P1652, DOI 10.1371/journal.pbio.0020330; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Lobo-Prat J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-68; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; Niu X, 2012, MOTOR CONTROL, V16, P195, DOI 10.1123/mcj.16.2.195; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Scheme E, 2008, MYOEL CONTR SYMPOSIU; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Zecca M, 2002, Crit Rev Biomed Eng, V30, P459, DOI 10.1615/CritRevBiomedEng.v30.i456.80	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136251	10.1371/journal.pone.0136251	http://dx.doi.org/10.1371/journal.pone.0136251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313560	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000049
J	Sirbu, A; Becker, M; Caminiti, S; De Baets, B; Elen, B; Francis, L; Gravino, P; Hotho, A; Ingarra, S; Loreto, V; Molino, A; Mueller, J; Peters, J; Ricchiuti, F; Saracino, F; Servedio, VDP; Stumme, G; Theunis, J; Tria, F; Van den Bossche, J				Sirbu, Alina; Becker, Martin; Caminiti, Saverio; De Baets, Bernard; Elen, Bart; Francis, Louise; Gravino, Pietro; Hotho, Andreas; Ingarra, Stefano; Loreto, Vittorio; Molino, Andrea; Mueller, Juergen; Peters, Jan; Ricchiuti, Ferdinando; Saracino, Fabio; Servedio, Vito D. P.; Stumme, Gerd; Theunis, Jan; Tria, Francesca; Van den Bossche, Joris			Participatory Patterns in an International Air Quality Monitoring Initiative	PLOS ONE			English	Article							EXPOSURE; POLLUTION; CARBON	The issue of sustainability is at the top of the political and societal agenda, being considered of extreme importance and urgency. Human individual action impacts the environment both locally (e.g., local air/water quality, noise disturbance) and globally (e.g., climate change, resource use). Urban environments represent a crucial example, with an increasing realization that the most effective way of producing a change is involving the citizens themselves in monitoring campaigns (a citizen science bottom-up approach). This is possible by developing novel technologies and IT infrastructures enabling large citizen participation. Here, in the wider framework of one of the first such projects, we show results from an international competition where citizens were involved in mobile air pollution monitoring using low cost sensing devices, combined with a web-based game to monitor perceived levels of pollution. Measures of shift in perceptions over the course of the campaign are provided, together with insights into participatory patterns emerging from this study. Interesting effects related to inertia and to direct involvement in measurement activities rather than indirect information exposure are also highlighted, indicating that direct involvement can enhance learning and environmental awareness. In the future, this could result in better adoption of policies towards decreasing pollution.	[Sirbu, Alina; Ingarra, Stefano; Loreto, Vittorio; Saracino, Fabio; Tria, Francesca] Inst Sci Interchange Fdn, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Sirbu, Alina] Univ Bologna, Dept Comp Sci & Engn, Bologna, Italy; [Becker, Martin; Hotho, Andreas] Univ Wurzburg, Dept Artificial Intelligence & Appl Comp Sci, D-97070 Wurzburg, Germany; [Becker, Martin; Hotho, Andreas; Mueller, Juergen; Stumme, Gerd] Leibniz Univ Hannover, Res Ctr L3S, D-30167 Hannover, Germany; [Caminiti, Saverio; Servedio, Vito D. P.] CNR, ISC, Rome, Italy; [Elen, Bart; Peters, Jan; Theunis, Jan; Van den Bossche, Joris] VITO Flemish Inst Technol Res, Mol, Belgium; [Francis, Louise] UCL, Dept Civil Environm & Geomat Engn, Extreme Citizen Sci Res Grp, London, England; [Gravino, Pietro] Univ Bologna, Dept Phys, I-40126 Bologna, Italy; [Loreto, Vittorio; Servedio, Vito D. P.] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Loreto, Vittorio] SONY CSL Comp Sci Lab, Paris, France; [Molino, Andrea; Ricchiuti, Ferdinando] CSP Innovat ICT, Turin, Italy; [Mueller, Juergen; Stumme, Gerd] Univ Kassel, Dept Elect Engn & Comp Sci, D-34125 Kassel, Germany; [Van den Bossche, Joris] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, KERMIT, B-9000 Ghent, Belgium	University of Bologna; University of Wurzburg; Leibniz University Hannover; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); VITO; University of London; University College London; University of Bologna; Sapienza University Rome; Universitat Kassel; Ghent University	Sirbu, A (corresponding author), Inst Sci Interchange Fdn, Complex Networks & Syst Lagrange Lab, Turin, Italy.	alina.sirbu@unibo.it	Servedio, Vito D. P./P-4965-2015; Sirbu, Alina/I-3288-2014; Stumme, Gerd/AAR-1955-2020; De Baets, Bernard/E-8877-2010	Servedio, Vito D. P./0000-0003-3221-5973; Sirbu, Alina/0000-0002-3947-7143; Stumme, Gerd/0000-0002-0570-7908; De Baets, Bernard/0000-0002-3876-620X; Theunis, Jan/0000-0002-4191-5667; Van den Bossche, Joris/0000-0003-3284-2977	EveryAware project - Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD [IST-265432]; SONY-CSL Computer Science Lab	EveryAware project - Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD; SONY-CSL Computer Science Lab	This research has been supported by the EveryAware project funded by the Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD contract IST-265432. SONY-CSL Computer Science Lab provided support in the form of salaries for author VL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assembly UG, 1992, AGENDA, P21; Becker M., 2013, P 2013 ACM C PERV UB, P1175, DOI DOI 10.1145/2494091.2499776; Becker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081638; Caminiti S, 2013, 2013 IEEE THIRD INTERNATIONAL CONFERENCE ON CLOUD AND GREEN COMPUTING (CGC 2013), P397, DOI 10.1109/CGC.2013.69; Castell N, 2014, URBAN CLIMATE; Dons E, 2012, ATMOS ENVIRON, V55, P392, DOI 10.1016/j.atmosenv.2012.03.020; Dutta Prabal, 2009, 7th ACM Conference on Embedded Networked Sensor Systems 2009 (SenSys 09), P349; European Environment Agency, 2013, AIR QUAL EUR 2013 RE; Everyaware Consortium, 2013, AIRPROBE INT CHALL; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; Hasenfratz D, 2012, MOB SENS; Kaur S, 2007, ATMOS ENVIRON, V41, P4781, DOI 10.1016/j.atmosenv.2007.02.002; Lave L., 2013, AIR POLLUTION HUMAN, V6; Mead MI, 2013, ATMOS ENVIRON, V70, P186, DOI 10.1016/j.atmosenv.2012.11.060; Peters J, 2014, ATMOS ENVIRON, V92, P31, DOI 10.1016/j.atmosenv.2014.03.039; Peters J, 2013, AEROSOL AIR QUAL RES, V13, P509, DOI 10.4209/aaqr.2012.06.0152; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Science Communication Unit University of the West of England Bristol, 2013, SCI ENV POL IN DEPTH; Setton E, 2011, J EXPO SCI ENV EPID, V21, P42, DOI 10.1038/jes.2010.14; Tangient LLC, 2013, AIR QUAL EGG PROJ; Tria F, 2014, NAT SCI REP, V4; Van den Bossche J, 2015, ATMOS ENV; Zuffc A, 2008, COMMUN ACM, V51, P24, DOI 10.1145/1325555.1325562	23	16	16	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136763	10.1371/journal.pone.0136763	http://dx.doi.org/10.1371/journal.pone.0136763			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313263	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000094
J	Eriksson, J; Helmfors, H; Langel, U				Eriksson, Jonas; Helmfors, Henrik; Langel, Ulo			A High-Throughput Kinetic Assay for RNA-Cleaving Deoxyribozymes	PLOS ONE			English	Article							DNA ENZYME; CATALYTIC DNA; SELECTION; DNAZYME	Determining kinetic constants is important in the field of RNA-cleaving deoxyribozymes (DNAzymes). Using todays conventional gel assays for DNAzyme assays is time-consuming and laborious. There have been previous attempts at producing new and improved assays; however these have drawbacks such as incompatibility with structured DNAzymes, enzyme or substrate modifications and increased cost. Here we present a new method for determining single-turnover kinetics of RNA-cleaving DNAzymes in real-time and in a high-throughput fashion. The assay is based on an intercalating fluorescent dye, PicoGreen, with high specificity for double-stranded DNA and heteroduplex DNA-RNA in this case formed between the DNAzyme and the target RNA. The fluorescence decreases as substrate is converted to product and is released from the enzyme. Using a Flexstation II multi-mode plate reader with built in liquid handling we could automate parts of the assay. This assay gives the possibility to determine single-turnover kinetics for up to 48 DNAzymes simultaneously. As the fluorescent probe is extrinsic there is no need for enzyme or substrate modifications, making this method less costly compared to other methods. The main novelty of this assay is the possibility of using full-length mRNA as the DNAzyme target.	[Eriksson, Jonas; Helmfors, Henrik; Langel, Ulo] Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden	Stockholm University	Eriksson, J (corresponding author), Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden.	jonas.eriksson@neurochem.su.se		Langel, Ulo/0000-0001-6107-0844; Eriksson, Jonas/0000-0001-8813-1096	Swedish Research Council for Natural Sciences [621-20115902]; Swedish Research Council for Medical Research [K2012-66X-21148-04-5]; Swedish Cancer Society [CAN 2012/251]	Swedish Research Council for Natural Sciences; Swedish Research Council for Medical Research; Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Swedish Research Council for Natural Sciences [621-20115902]; Swedish Research Council for Medical Research [K2012-66X-21148-04-5]; and the Swedish Cancer Society [CAN 2012/251]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgany A, 2007, J GENE MED, V9, P727, DOI 10.1002/jgm.1061; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Dragan AI, 2010, BIOPHYS J, V99, P3010, DOI 10.1016/j.bpj.2010.09.012; Ferrari D, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf111; Kankia BI, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl594; Leontis N., 2012, RNA 3D STRUCTURE ANA; Li J, 2000, J AM CHEM SOC, V122, P10466, DOI 10.1021/ja0021316; Liu JW, 2003, ANAL CHEM, V75, P6666, DOI 10.1021/AC034924r; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; Oketani M, 1999, J HEPATOL, V31, P628, DOI 10.1016/S0168-8278(99)80341-9; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schubert S, 2003, NUCLEIC ACIDS RES, V31, P5982, DOI 10.1093/nar/gkg791; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Torabi SF, 2015, P NATL ACAD SCI USA, V112, P5903, DOI 10.1073/pnas.1420361112; Zaborowska Z, 2002, J BIOL CHEM, V277, P40617, DOI 10.1074/jbc.M207094200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	18	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135984	10.1371/journal.pone.0135984	http://dx.doi.org/10.1371/journal.pone.0135984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309222	Green Submitted, Green Published, gold			2022-12-27	WOS:000360069400083
J	Kitatani, R; Yamada, M; Kamio, M; Nagai, H				Kitatani, Ryuju; Yamada, Mayu; Kamio, Michiya; Nagai, Hiroshi			Length Is Associated with Pain: Jellyfish with Painful Sting Have Longer Nematocyst Tubules than Harmless Jellyfish	PLOS ONE			English	Article							CHIRONEX-FLECKERI VENOM; CNIDARIA CUBOZOA; HABU-KURAGE; SEA WASP; SCYPHOZOA; DISCHARGE; TOXIN; RATS; QUADRIGATUS; ANTIVENOM	A large number of humans are stung by jellyfish all over the world. The stings cause acute pain followed by persistent pain and local inflammation. Harmful jellyfish species typically cause strong pain, whereas harmless jellyfish cause subtle or no pain. Jellyfish sting humans by injecting a tubule, contained in the nematocyst, the stinging organ of jellyfish. The tubule penetrates into the skin leading to venom injection. The detailed morphology of the nematocyst tubule and molecular structure of the venom in the nematocyst has been reported; however, the mechanism responsible for the difference in pain that is caused by harmful and harmless jellyfish sting has not yet been explored or explained. Therefore, we hypothesized that differences in the length of the nematocyst tubule leads to different degrees of epithelial damage. The initial acute pain might be generated by penetration of the tubule, which stimulates pain receptor neurons, whilst persistent pain might be caused by injection of venom into the epithelium. To test this hypothesis we compared the lengths of discharged nematocyst tubules from harmful and harmless jellyfish species and evaluated their ability to penetrate human skin. The results showed that the harmful jellyfish species, Chrysaora pacifica, Carybdea brevipedalia, and Chironex yamaguchii, causing moderate to severe pain, have nematocyst tubules longer than 200 mu m, compared with a jellyfish species that cause little or no pain, Aurelia aurita. The majority of the tubules of harmful jellyfishes, C. yamaguchii and C. brevipedalia, were sufficiently long to penetrate the human epidermis and physically stimulate the free nerve endings of A delta pain receptor fibers around plexuses to cause acute pain and inject the venom into the human skin epithelium to cause persistent pain and inflammation.	[Kitatani, Ryuju; Yamada, Mayu; Kamio, Michiya; Nagai, Hiroshi] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo, Japan	Tokyo University of Marine Science & Technology	Nagai, H (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo, Japan.	nagai@kaiyodai.ac.jp	Kamio, Michiya/O-1923-2014; NAGAI, Hiroshi/O-1894-2014	Kamio, Michiya/0000-0003-3505-1978; 	Japan Society for the Promotion of Science [24510294]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-aid for scientific research (no. 24510294 to H.N.) from Japan Society for the Promotion of Science.	Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Bruschetta G, 2014, MAR DRUGS, V12, P2182, DOI 10.3390/md12042182; CALDER DR, 1971, T AM MICROSC SOC, V90, P269, DOI 10.2307/3225186; Cunningham P, 1996, VENOMOUS TOXIC MARIN, P30; Fenner PJ, 1998, J TRAVEL MED, V5, P135, DOI 10.1111/j.1708-8305.1998.tb00487.x; Gershwin LA, 2006, ZOOTAXA, P1; Halstead B. W., 1988, POISONOUS VENOMOUS M, P99; HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kass-Simon G, 2002, CAN J ZOOL, V80, P1772, DOI 10.1139/Z02-135; KENNEDY WR, 1993, J NEUROL SCI, V115, P184, DOI 10.1016/0022-510X(93)90223-L; Klug M., 1988, P543; Lewis C, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2030.1.5; Little Mark, 2002, Emerg Med (Fremantle), V14, P171, DOI 10.1046/j.1442-2026.2002.00291.x; Lotan A, 1996, J EXP ZOOL, V275, P444, DOI 10.1002/(SICI)1097-010X(19960815)275:6<444::AID-JEZ6>3.0.CO;2-O; Mariscal R.N., 1974, pUnpaginated; Morabito R, 2014, TOXICON, V83, P52, DOI 10.1016/j.toxicon.2014.03.002; Nagai H, 2003, J HEALTH SCI, V49, P337, DOI 10.1248/jhs.49.337; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; Namikawa H, 2000, JELLYFISH JAPANESE W; Oba A, 2004, HYDROBIOLOGIA, V530, P173, DOI 10.1007/s10750-004-2692-2; OHTAKI N, 1990, Journal of Dermatology (Tokyo), V17, P108; Okinawa Prefectural Institute for Health and Environment, 1999, KAIYO KIK SEIB TAIS, P1; Ostman C, 2000, SCI MAR, V64, P31; Purcell J.E., 1988, P463; R Core Team, 2012, R LANG ENV STAT COMP; Ramasamy S, 2005, TOXICOL LETT, V155, P219, DOI 10.1016/j.toxlet.2004.09.018; Ramasamy S, 2004, TOXICON, V43, P685, DOI 10.1016/j.toxicon.2004.02.024; Rasband W., 2006, IMAGEJ; RIFKIN J, 1983, CELL TISSUE RES, V233, P563; Simone DA, 1998, J NEUROSCI, V18, P8947; THORINGTON GU, 1988, BIOL BULL, V174, P163, DOI 10.2307/1541783; Toyokawa Masaya, 2011, Plankton & Benthos Research, V6, P175; Williamson John, 1995, P89; Winter KL, 2007, TOXICON, V49, P804, DOI 10.1016/j.toxicon.2006.11.031; Winter KL, 2007, TOXICOL LETT, V168, P13, DOI 10.1016/j.toxlet.2006.10.011; Winter KL, 2009, TOXICOL LETT, V187, P94, DOI 10.1016/j.toxlet.2009.02.008; Yanagihara AA, 2002, CELL TISSUE RES, V308, P307, DOI 10.1007/s00441-002-0545-8; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	40	23	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135015	10.1371/journal.pone.0135015	http://dx.doi.org/10.1371/journal.pone.0135015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309256	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400045
J	Demment, MM; Peters, K; Dykens, JA; Dozier, A; Nawaz, H; McIntosh, S; Smith, JS; Sy, A; Irwin, T; Fogg, TT; Khaliq, M; Blumenfeld, R; Massoudi, M; Dye, TD				Demment, Margaret M.; Peters, Karen; Dykens, J. Andrew; Dozier, Ann; Nawaz, Haq; McIntosh, Scott; Smith, Jennifer S.; Sy, Angela; Irwin, Tracy; Fogg, Thomas T.; Khaliq, Mahmooda; Blumenfeld, Rachel; Massoudi, Mehran; Dye, Timothy De Ver			Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries	PLOS ONE			English	Review							LIMITED-RESOURCE COUNTRIES; HUMAN-PAPILLOMAVIRUS VACCINATION; ASIA CONSENSUS STATEMENT; GUIDELINE IMPLEMENTATION; HEALTH-CARE; HPV VACCINATION; PRECANCEROUS LESIONS; VISUAL INSPECTION; SUPPORTIVE CARE; GLOBAL HEALTH	Background Breast and cervical cancers have emerged as major global health challenges and disproportionately lead to excess morbidity and mortality in low- and middle-income countries (LMICs) when compared to high-income countries. The objective of this paper was to highlight key findings, recommendations, and gaps in research and practice identified through a scoping study of recent reviews in breast and cervical cancer in LMICs. Methods We conducted a scoping study based on the six-stage framework of Arskey and O'Malley. We searched PubMed, Cochrane Reviews, and CINAHL with the following inclusion criteria: 1) published between 2005-February 2015, 2) focused on breast or cervical cancer 3) focused on LMIC, 4) review article, and 5) published in English. Results Through our systematic search, 63 out of the 94 identified cervical cancer reviews met our selection criteria and 36 of the 54 in breast cancer. Cervical cancer reviews were more likely to focus upon prevention and screening, while breast cancer reviews were more likely to focus upon treatment and survivorship. Few of the breast cancer reviews referenced research and data from LMICs themselves; cervical cancer reviews were more likely to do so. Most reviews did not include elements of the PRISMA checklist. Conclusion Overall, a limited evidence base supports breast and cervical cancer control in LMICs. Further breast and cervical cancer prevention and control studies are necessary in LMICs.	[Demment, Margaret M.; Fogg, Thomas T.; Dye, Timothy De Ver] Univ Rochester, Clin & Translat Res Inst, Rochester, NY 14627 USA; [Peters, Karen] Univ Illinois, Div Community Hlth Sci, Chicago, IL USA; [Dykens, J. Andrew] Univ Illinois, Dept Family Med, Chicago, IL USA; [Dozier, Ann; McIntosh, Scott] Univ Rochester, Dept Publ Hlth Sci, Rochester, NY USA; [Smith, Jennifer S.] Griffin Hosp, Dept Med, New Haven, CT USA; [Nawaz, Haq] Yale Univ, Griffin Prevent Res Ctr, New Haven, CT USA; [Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Sy, Angela] Univ Hawaii Manoa, Sch Nursing & Dent Hyg, Honolulu, HI 96822 USA; [Irwin, Tracy] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Khaliq, Mahmooda] Univ S Florida, Dept Community & Family Hlth, Tampa, FL USA; [Blumenfeld, Rachel; Massoudi, Mehran] Ctr Dis Control & Prevent, Div Populat Hlth, Atlanta, GA USA; [Dye, Timothy De Ver] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA	University of Rochester; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Rochester; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of Hawaii System; University of Hawaii Manoa; University of Washington; University of Washington Seattle; State University System of Florida; University of South Florida; Centers for Disease Control & Prevention - USA; University of Rochester	Dye, TD (corresponding author), Univ Rochester, Clin & Translat Res Inst, Rochester, NY 14627 USA.	tim_dye@urmc.rochester.edu	Dye, Timothy/HHY-9965-2022; Dykens, Andrew/N-6983-2018	Dykens, Andrew/0000-0002-4194-8725; McIntosh, Scott/0000-0002-5776-9617; Sy, Angela/0000-0002-8071-899X	Centers for Disease Control and Prevention, Prevention Research Centers Program [1U48DP005026-01S1, 1U48DP005010-01S1, 1U48DP005023-01S1]; U.S. Centers for Disease Control and Prevention (CDC); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP005026, U48DP005010, U48DP005023] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, Prevention Research Centers Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported and funded by the Centers for Disease Control and Prevention, Prevention Research Centers Program (Cooperative agreements: 1U48DP005026-01S1, 1U48DP005010-01S1, and 1U48DP005023-01S1). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This review falls under the scope of work for the U.S. Centers for Disease Control and Prevention (CDC) funded Global and Territorial Health Research Network through the Prevention Research Centers Program, with the goal to translate chronic disease prevention research into practice. In addition to several partnering institutions, the Global Network Steering Committee consists of two CDC representatives who participated in the study design and review of the manuscript. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The corresponding author had final responsibility to submit the report for publication.	Adefuye PO, 2013, VACCINE, V31, pF53, DOI 10.1016/j.vaccine.2012.06.070; Al-Foheidi M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0471-5; Almonte M, 2011, BEST PRACT RES CL OB, V25, P617, DOI 10.1016/j.bpobgyn.2011.05.003; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; Anderson BO, 2015, BREAST J, V21, P111, DOI 10.1111/tbj.12357; Anderson BO, 2006, BREAST J, V12, pS54, DOI 10.1111/j.1075-122X.2006.00203.x; Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; Anorlu R I, 2007, Niger Postgrad Med J, V14, P242; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Asadzadeh VF, 2011, ASIAN PAC J CANCER P, V12, P2467; Batson A, 2006, VACCINE, V24, P219, DOI 10.1016/j.vaccine.2006.05.042; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Belinson SE, 2010, MOL DIAGN THER, V14, P215, DOI 10.2165/11534780-000000000-00000; Bello F A, 2011, Afr J Reprod Health, V15, P25; Bese NS, 2008, CANCER-AM CANCER SOC, V113, P2305, DOI 10.1002/cncr.23838; Bharadwaj M, 2009, INDIAN J MED RES, V130, P327; Bradford L, 2013, CLIN OBSTET GYNECOL, V56, P76, DOI 10.1097/GRF.0b013e31828237ac; Bradley J, 2005, INT J GYNECOL OBSTET, V89, pS21, DOI 10.1016/j.ijgo.2005.01.013; Bradley J, 2006, WOMEN HEALTH, V43, P103, DOI 10.1300/J013v43n03_06; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cardoso F, 2013, BREAST, V22, P593, DOI 10.1016/j.breast.2013.07.050; Chamot E, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-11; Chavarri-Guerra Y, 2012, LANCET ONCOL, V13, pE335, DOI 10.1016/S1470-2045(12)70246-2; Chirenje ZM, 2005, BEST PRACT RES CL OB, V19, P269, DOI 10.1016/j.bpobgyn.2004.10.002; Cleary J, 2013, BREAST, V22, P616, DOI 10.1016/j.breast.2013.07.052; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; Corbex M, 2012, BREAST, V21, P428, DOI 10.1016/j.breast.2012.01.002; Cronje HS, 2011, BEST PRACT RES CL OB, V25, P575, DOI 10.1016/j.bpobgyn.2011.05.002; Cronje HS, 2005, BEST PRACT RES CL OB, V19, P517, DOI 10.1016/j.bpobgyn.2005.02.005; Cunningham MS, 2014, PREV MED, V69, P274, DOI 10.1016/j.ypmed.2014.08.035; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Datta NR, 2006, CLIN ONCOL-UK, V18, P306, DOI 10.1016/j.clon.2005.12.005; Denny L, 2005, BJOG-INT J OBSTET GY, V112, P1204, DOI 10.1111/j.1471-0528.2005.00713.x; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Denny L, 2012, DISCOV MED, V14, P125; Denny L, 2012, BEST PRACT RES CL OB, V26, P189, DOI 10.1016/j.bpobgyn.2011.08.001; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; El Saghir NS, 2008, CANCER-AM CANCER SOC, V113, P2315, DOI 10.1002/cncr.23836; El Saghir Nagi S, 2007, Int J Surg, V5, P225; El Saghir NS, 2011, BREAST, V20, pS3, DOI 10.1016/j.breast.2011.02.006; Elit Laurie, 2011, J Obstet Gynaecol Can, V33, P272; Eniu A, 2008, CANCER-AM CANCER SOC, V113, P2269, DOI 10.1002/cncr.23843; Farmer P.E, 2001, INFECT INEQUALITIES; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Ganz PA, 2013, BREAST, V22, P606, DOI 10.1016/j.breast.2013.07.049; Carranca AG, 2007, EXPERT REV VACCINES, V6, P497, DOI 10.1586/14760584.6.4.497; Gravitt PE, 2011, INT J CANCER, V129, P517, DOI 10.1002/ijc.25974; Harford J, 2008, CANCER-AM CANCER SOC, V113, P2282, DOI 10.1002/cncr.23841; Hoppenot C, 2012, OBSTET GYNECOL SURV, V67, P658, DOI 10.1097/OGX.0b013e3182732375; Jacob M, 2005, INT J GYNECOL OBSTET, V89, pS13, DOI 10.1016/j.ijgo.2005.01.026; Miranda JJ, 2010, REV SAUDE PUBL, V44, P185, DOI 10.1590/S0034-89102010000100020; Juneja A, 2007, Indian J Med Sci, V61, P34; Kanavos P, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-19; Kane MA, 2012, VACCINE, V30, pF192, DOI 10.1016/j.vaccine.2012.06.075; Kantelhardt EJ, 2008, BREAST CARE, V3, P10, DOI 10.1159/000114409; Karimi ZM, 2009, ASIAN PAC J CANCER P, V10, P969; Katz IT, 2010, SEX HEALTH, V7, P279, DOI 10.1071/SH09130; Keshtgar M, 2011, WORLD J SURG, V35, P1159, DOI 10.1007/s00268-011-0956-3; Kibriya MG, 1999, DIABETES RES CLIN PR, V46, P253, DOI 10.1016/S0168-8227(99)00093-5; Kushner AL, 2010, J SURG EDUC, V67, P270, DOI 10.1016/j.jsurg.2010.05.004; Lee BL, 2012, LANCET ONCOL, V13, pE95, DOI 10.1016/S1470-2045(11)70323-0; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lodge M, 2013, CANC CONTROL, P153; Lodge M, 2011, BREAST, V20, pS65, DOI 10.1016/j.breast.2011.01.012; Lowy DR, 2012, CANCER PREV RES, V5, P18, DOI 10.1158/1940-6207.CAPR-11-0542; Luciani S, 2009, IMMUNOTHERAPY-UK, V1, P795, DOI 10.2217/IMT.09.48; Masood S, 2008, CANCER-AM CANCER SOC, V113, P2297, DOI 10.1002/cncr.23833; Maule M, 2012, LANCET ONCOL, V13, P745, DOI 10.1016/S1470-2045(12)70268-1; McClung E C, 2012, Minerva Ginecol, V64, P149; McMichael C, 2005, J PUBLIC HEALTH-UK, V27, P215, DOI 10.1093/pubmed/fdi024; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; National Cancer Institute, 2015, CANC CONTR CONT; Natunen Kari, 2011, Infect Dis Obstet Gynecol, V2011, P675858, DOI 10.1155/2011/675858; Organization WH, WORLD CANC REP 2014; Panieri E, 2012, BEST PRACT RES CL OB, V26, P283, DOI 10.1016/j.bpobgyn.2011.11.007; Parkhurst JO, 2013, GLOB PUBLIC HEALTH, V8, P1093, DOI 10.1080/17441692.2013.850524; Patani N, 2013, INT J CANCER, V133, P1, DOI 10.1002/ijc.27997; Patro B K, 2007, Indian J Public Health, V51, P216; Peters DH, 2013, INPLEMENTATION RESEARCH IN HEALTH: A PRACTICAL GUIDE, pCOVER1; Peters DH, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7888-5; Pinsky RW, 2015, ROLE SCREENING MAMMO, P13; Reeler A, 2009, ASIAN PAC J CANCER P, V10, P519; Rizvi JH, 2006, BEST PRACT RES CL OB, V20, P907, DOI 10.1016/j.bpobgyn.2006.06.005; Romieu I, 2011, SALUD PUBLICA MEXICO, V53, P430; Safaeian M, 2007, OBSTET GYN CLIN N AM, V34, P739, DOI 10.1016/j.ogc.2007.09.004; Sahasrabuddhe VV, 2012, CANCER PREV RES, V5, P11, DOI 10.1158/1940-6207.CAPR-11-0540; Saleem A, 2009, MINERVA MED, V100, P503; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Sankaranarayanan R, 2006, INT J GYNECOL OBSTET, V95, pS205, DOI 10.1016/S0020-7292(06)60035-0; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Sankaranarayanan R, 2009, INDIAN J MED RES, V130, P322; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Saxena U, 2012, ASIAN PAC J CANCER P, V13, P1699, DOI 10.7314/APJCP.2012.13.4.1699; Sherris J, 2005, INT J GYNECOL OBSTET, V89, pS46, DOI 10.1016/j.ijgo.2005.01.010; Shetty MK, 2011, SEMIN ULTRASOUND CT, V32, P300, DOI 10.1053/j.sult.2011.04.002; Shyyan R, 2006, BREAST J, V12, pS27, DOI 10.1111/j.1075-122X.2006.00201.x; Shyyan R, 2008, CANCER-AM CANCER SOC, V113, P2257, DOI 10.1002/cncr.23840; Smith RA, 2006, BREAST J, V12, pS16, DOI 10.1111/j.1075-122X.2006.00200.x; Stanley M, 2007, BRIT J CANCER, V96, P1320, DOI 10.1038/sj.bjc.6603695; Stanley M, 2006, BEST PRACT RES CL OB, V20, P279, DOI 10.1016/j.bpobgyn.2005.10.011; Steben M, 2012, VACCINE, V30, pF183, DOI 10.1016/j.vaccine.2012.06.031; Sylla BS, 2012, INT J CANCER, V130, P245, DOI 10.1002/ijc.26333; Tangjitgamol S, 2009, LANCET ONCOL, V10, P1119, DOI 10.1016/S1470-2045(09)70290-6; Tomljenovic L, 2013, ANN MED, V45, P182, DOI 10.3109/07853890.2011.645353; Tsu V, 2012, BRIT J CANCER, V107, P1445, DOI 10.1038/bjc.2012.404; Tsu VD, 2005, INT J GYNECOL OBSTET, V89, pS55, DOI 10.1016/j.ijgo.2005.01.011; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; Wild CP, 2012, J NATL CANCER I, V104, P1051, DOI 10.1093/jnci/djs262; Williams-Brennan L, 2012, ARCH GYNECOL OBSTET, V286, P1487, DOI 10.1007/s00404-012-2575-0; Wong NS, 2009, LANCET ONCOL, V10, P1077, DOI 10.1016/S1470-2045(09)70230-X; Woo YL, 2011, BEST PRACT RES CL OB, V25, P597, DOI 10.1016/j.bpobgyn.2011.05.004; Wright TC, 2012, BEST PRACT RES CL OB, V26, P197, DOI 10.1016/j.bpobgyn.2011.11.004; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yip CH, 2008, CANCER-AM CANCER SOC, V113, P2244, DOI 10.1002/cncr.23842; Yip CH, 2012, FUTURE ONCOL, V8, P1575, DOI [10.2217/FON.12.141, 10.2217/fon.12.141]; Yip CH, 2011, BREAST, V20, pS12, DOI 10.1016/j.breast.2011.02.015; Zelle SG, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-20	123	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134618	10.1371/journal.pone.0134618	http://dx.doi.org/10.1371/journal.pone.0134618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325181	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700012
J	Alexander, JS; Gopalaswamy, AM; Shi, K; Riordan, P				Alexander, Justine S.; Gopalaswamy, Arjun M.; Shi, Kun; Riordan, Philip			Face Value: Towards Robust Estimates of Snow Leopard Densities	PLOS ONE			English	Article							ELUSIVE CARNIVORES; POPULATION-SIZE; CAPTURE; MODELS; ABUNDANCE; INFERENCE; CONSERVATION; INFORMATION; QILIANSHAN; MOVEMENTS	When densities of large carnivores fall below certain thresholds, dramatic ecological effects can follow, leading to oversimplified ecosystems. Understanding the population status of such species remains a major challenge as they occur in low densities and their ranges are wide. This paper describes the use of non-invasive data collection techniques combined with recent spatial capture-recapture methods to estimate the density of snow leopards Panthera uncia. It also investigates the influence of environmental and human activity indicators on their spatial distribution. A total of 60 camera traps were systematically set up during a three-month period over a 480 km(2) study area in Qilianshan National Nature Reserve, Gansu Province, China. We recorded 76 separate snow leopard captures over 2,906 trap-days, representing an average capture success of 2.62 captures/100 trap-days. We identified a total number of 20 unique individuals from photographs and estimated snow leopard density at 3.31 (SE = 1.01) individuals per 100 km(2). Results of our simulation exercise indicate that our estimates from the Spatial Capture Recapture models were not optimal to respect to bias and precision (RMSEs for density parameters less or equal to 0.87). Our results underline the critical challenge in achieving sufficient sample sizes of snow leopard captures and recaptures. Possible performance improvements are discussed, principally by optimising effective camera capture and photographic data quality.	[Alexander, Justine S.; Shi, Kun; Riordan, Philip] Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing, Peoples R China; [Gopalaswamy, Arjun M.] Univ Oxford, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Dept Zool, Abingdon, Oxon, England; [Riordan, Philip] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Riordan, Philip] Wildlife Borders UK, Bampton OX13 5QL, Oxon, England	Beijing Forestry University; University of Oxford; University of Oxford	Shi, K (corresponding author), Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing, Peoples R China.	kunshi@bjfu.edu.cn	Riordan, Philip/AAY-6420-2020; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Riordan, Philip/0000-0001-6285-8596; Alexander, Justine Shanti/0000-0002-7474-9247	National Geographic Society Young Explorer Grant. NGS YEgrant [9236-12]; Star Foundation; China's State Forestry Department; National Natural Science Foundation of China [31470567]	National Geographic Society Young Explorer Grant. NGS YEgrant(National Geographic Society); Star Foundation; China's State Forestry Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was suppoted by 1. National Geographic Society Young Explorer Grant. NGS YEgrant #9236-12. (http://www.nationalgeographic.com/explorers/grants-programs/young-explorers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. The Star Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. China's State Forestry Department. 4. National Natural Science Foundation of China (Grant No. 31470567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2015, BIOL CONSERV, V187, P1, DOI 10.1016/j.biocon.2015.04.002; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; [Anonymous], 2014, R LANG ENV STAT COMP; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Blomqvist L., 1980, INT PEDIGREE BOOK SN, V2, P159; Bolker B, 2008, ECOLOGICAL MODELS DA; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Dias BNO, 2010, ENRIQUECIMENTO AMBIE; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; ESRI, 2014, ARCGIS GEOST AN METH; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fox J.L, 1989, REV STATUS ECOLOGY S; FOX JL, 1991, BIOL CONSERV, V55, P283, DOI 10.1016/0006-3207(91)90033-6; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; Gerber BD, 2014, POPUL ECOL, V56, P463, DOI 10.1007/s10144-014-0431-8; Gopalaswamy A., 2014, SPACECAP R PACKAGE E; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gopalaswamy AM, 2013, CAPTURE RECAPTURE MO; Gopalaswamy AM, 2015, METHODS ECOL EVOL, pn/a; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Jackson, 1996, HOME RANGE MOVEMENTS; Jackson R., 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Lovari S, 2013, J ZOOL, V291, P127, DOI 10.1111/jzo.12053; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; McCarthy KP, 2008, J WILDLIFE MANAGE, V72, P1826, DOI 10.2193/2008-040; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; Mccarthy TM., 2014, SNOW LEOPARD SURVIVA, P1; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; Miller Brian, 2001, Endangered Species Update, V18, P202; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Ngoprasert D., 2012, BIOTROPICA, V1, P1; OTIS DL, 1978, WILDLIFE MONOGR, P1; Quantum GIS Development Team, 2014, QUANT GIS GOEGR INF; Reich BJ, 2014, ENVIRONMETRICS, pn/a; Riordan P, 2010, SNOW LEOPARD CHINA P; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sharma K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101319; Shehzad W, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UMAL.P0NE.0032104; Shrestha B., 2008, PREY ABUNDANCE PREY; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; WILSON KR, 1985, J MAMMAL, V66, P13, DOI 10.2307/1380951; Wilton CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111257; Yang Q, 2009, QILIAN MOUNTAIN NATL, V2012, P75	70	47	56	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134815	10.1371/journal.pone.0134815	http://dx.doi.org/10.1371/journal.pone.0134815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322682	Green Published, gold			2022-12-27	WOS:000360435500002
J	White, MJ; Kodaman, NM; Harder, RH; Asselbergs, FW; Vaughan, DE; Brown, NJ; Moore, JH; Williams, SM				White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Asselbergs, Folkert W.; Vaughan, Douglas E.; Brown, Nancy J.; Moore, Jason H.; Williams, Scott M.			Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population	PLOS ONE			English	Article							CIRCADIAN CLOCK GENES; PLASMA T-PA; MYOCARDIAL-INFARCTION; ANGIOTENSIN PEPTIDES; 4G/5G POLYMORPHISM; INSULIN-RESISTANCE; HUMAN TREHALASE; CANDIDATE GENE; SNP SELECTION; ASSOCIATION	Plasminogen activator inhibitor 1 (PAI-1), a major modulator of the fibrinolytic system, is an important factor in cardiovascular disease (CVD) susceptibility and severity. PAI-1 is highly heritable, but the few genes associated with it explain only a small portion of its variation. Studies of PAI-1 typically employ linear regression to estimate the effects of genetic variants on PAI-1 levels, but PAI-1 is not normally distributed, even after transformation. Therefore, alternative statistical methods may provide greater power to identify important genetic variants. Additionally, most genetic studies of PAI-1 have been performed on populations of European descent, limiting the generalizability of their results. We analyzed >30,000 variants for association with PAI-1 in a Ghanaian population, using median regression, a non-parametric alternative to linear regression. Three variants associated with median PAI-1, the most significant of which was in the gene arylsulfatase B (ARSB) (p = 1.09 x 10(-7)). We also analyzed the upper quartile of PAI-1, the most clinically relevant part of the distribution, and found 19 SNPs significantly associated in this quartile. Of note an association was found in period circadian clock 3 (PER3). Our results reveal novel associations with median and elevated PAI-1 in an understudied population. The lack of overlap between the two analyses indicates that the genetic effects on PAI-1 are not uniform across its distribution. They also provide evidence of the generalizability of the circadian pathway's effect on PAI-1, as a recent meta-analysis performed in Caucasian populations identified another circadian clock gene (ARNTL).	[White, Marquitta J.; Kodaman, Nuri M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Moore, Jason H.; Williams, Scott M.] Dartmouth Coll, Dept Genet, Hanover, NH 03755 USA; [White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Moore, Jason H.; Williams, Scott M.] Dartmouth Coll, Inst Quantitat Biomed Sci, Hanover, NH 03755 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Heart & Lungs, NL-3584 CX Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Inst Cardiovasc Sci, London, England; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Vaughan, Douglas E.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Brown, Nancy J.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA	Vanderbilt University; Dartmouth College; Dartmouth College; Utrecht University; Utrecht University Medical Center; University of London; University College London; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Williams, SM (corresponding author), Dartmouth Coll, Dept Genet, Hanover, NH 03755 USA.	scott.williams@dartmouth.edu	Moore, Jason H./AAV-9645-2021; Williams, Scott/Q-4812-2019; Asselbergs, Folkert W./ABD-6752-2021	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544; Asselbergs, Folkert W./0000-0002-1692-8669	National Institutes of Health [5P20GM103534-04, 5R01LM010098-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, T32GM080178] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding provided by National Institutes of Health, http://www.nih.gov/, 5P20GM103534-04, JHM and National Institutes of Health, http://www.nih.gov/, 5R01LM010098-06, JHM, FWA, SMW.	Abboud N, 2010, GENET TEST MOL BIOMA, V14, P23, DOI 10.1089/gtmb.2009.0039; Alessi MC, 2004, ARCH MAL COEUR VAISS, V97, P673; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2008, SEMIN THROMB HEMOST, V34, P562, DOI 10.1055/s-0028-1103367; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bentley L, 2003, J MED GENET, V40, P249, DOI 10.1136/jmg.40.4.249; Bhattacharyya S, 2012, J NUTR BIOCHEM, V23, P1058, DOI 10.1016/j.jnutbio.2011.05.012; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; BOOTH NA, 1994, BAILLIERE CLIN HAEM, V7, P559, DOI 10.1016/S0950-3536(05)80099-X; BraunFahrlander C, 1997, PEDIATR ALLERGY IMMU, V8, P75, DOI 10.1111/j.1399-3038.1997.tb00147.x; Briollais L, 2014, HUM GENET; Brown NJ, 1999, HYPERTENSION, V34, P285, DOI 10.1161/01.HYP.34.2.285; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cesari M, 1999, ARTERIOSCL THROM VAS, V19, P316, DOI 10.1161/01.ATV.19.2.316; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Chong NW, 2006, FEBS LETT, V580, P4469, DOI 10.1016/j.febslet.2006.07.014; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; Guess J, 2009, INTEGR CANCER THER, V8, P329, DOI 10.1177/1534735409352029; Hossain GS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000134; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; ISO H, 1993, THROMB HAEMOSTASIS, V70, P475; Iwai N, 1998, ATHEROSCLEROSIS, V136, P109, DOI 10.1016/S0021-9150(97)00191-3; John O.O., 2009, SCI AFRICANA, V8, P61, DOI [10.14419/ijasp.v3i2.4686, DOI 10.14419/IJASP.V3I2.4686]; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P2322, DOI 10.1046/j.1538-7836.2003.00458.x; Juhan-Vague I, 2000, ANN MED, V32, P78; Kawasaki T, 2000, BLOOD, V96, P153, DOI 10.1182/blood.V96.1.153.013k11_153_160; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; KONKLE BA, 1990, J BIOL CHEM, V265, P21867; Liu L, 2013, HUM GENET, V132, P139, DOI 10.1007/s00439-012-1231-x; Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x; Matthews KA, 2005, AM HEART J, V149, P1066, DOI 10.1016/j.ahj.2004.08.027; Muller YL, 2013, HUM GENET, V132, P697, DOI 10.1007/s00439-013-1278-3; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; NORMANT E, 1995, J BIOL CHEM, V270, P20543, DOI 10.1074/jbc.270.35.20543; Ocaranza MP, 2012, INT J HYPERTENS, V2012, DOI [10.1155/2012/594361, DOI 10.1155/2012/594361]; Organization WH, 2016, GLOBAL STATUS REPORT; Ouyang YH, 2009, BIOCHEM BIOPH RES CO, V379, P621, DOI 10.1016/j.bbrc.2008.12.134; Peetz D, 2004, THROMB HAEMOSTASIS, V92, P344, DOI 10.1160/TH04-01-0001; Penrod NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016639; Pereira HJV, 2012, PEPTIDES, V33, P67, DOI 10.1016/j.peptides.2011.12.001; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RCore Team, 2020, R LANG ENV STAT COMP; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; RONA G, 1966, CAN MED ASSOC J, V95, P1012; Schoenhard JA, 2008, HUM GENET, V124, P479, DOI 10.1007/s00439-008-0573-x; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Skurk T, 2001, HORM METAB RES, V33, P196, DOI 10.1055/s-2001-14948; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; StataCorp, 2021, STATA STAT SOFTWARE; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wende H, 2000, IMMUNOGENETICS, V51, P703, DOI 10.1007/s002510000187; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028764; Williams SM, 2007, ETHNIC DIS, V17, P492; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	65	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136379	10.1371/journal.pone.0136379	http://dx.doi.org/10.1371/journal.pone.0136379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322636	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500018
J	Becker, EF; Christ, AM				Becker, Earl F.; Christ, Aaron M.			A Unimodal Model for Double Observer Distance Sampling Surveys	PLOS ONE			English	Article							MARK-RECAPTURE; LINE; BIAS	Distance sampling is a widely used method to estimate animal population size. Most distance sampling models utilize a monotonically decreasing detection function such as a half-normal. Recent advances in distance sampling modeling allow for the incorporation of covariates into the distance model, and the elimination of the assumption of perfect detection at some fixed distance (usually the transect line) with the use of double-observer models. The assumption of full observer independence in the double-observer model is problematic, but can be addressed by using the point independence assumption which assumes there is one distance, the apex of the detection function, where the 2 observers are assumed independent. Aerially collected distance sampling data can have a unimodal shape and have been successfully modeled with a gamma detection function. Covariates in gamma detection models cause the apex of detection to shift depending upon covariate levels, making this model incompatible with the point independence assumption when using double-observer data. This paper reports a unimodal detection model based on a two-piece normal distribution that allows covariates, has only one apex, and is consistent with the point independence assumption when double-observer data are utilized. An aerial line-transect survey of black bears in Alaska illustrate how this method can be applied.	[Becker, Earl F.; Christ, Aaron M.] Alaska Dept Fish & Game, Anchorage, AK 99518 USA	Alaska Department of Fish & Game	Becker, EF (corresponding author), Alaska Dept Fish & Game, 333 Raspberry Rd, Anchorage, AK 99518 USA.	earl.becker@alaska.gov			Alaska Department of Fish and Game, Federal Aid in Wildlife Restoration Funds	Alaska Department of Fish and Game, Federal Aid in Wildlife Restoration Funds	Funding was provided by the Alaska Department of Fish and Game, Federal Aid in Wildlife Restoration Funds.	Akaike H., 1985, CELEBRATION STAT, P1; Alpizar-Jara R, 1998, ENVIRON ECOL STAT, V3, P311; [Anonymous], 1994, CONTINUOUS UNIVARIAT; [Anonymous], 2014, R LANG ENV STAT COMP; Becker EF, 2009, J AGR BIOL ENVIR ST, V14, P207, DOI 10.1198/jabes.2009.0013; Borchers DL, 1998, BIOMETRICS, V54, P1207, DOI 10.2307/2533651; Borchers DL, 2006, BIOMETRICS, V62, P372, DOI 10.1111/j.1541-0420.2005.00493.x; Buckland S.T., 2001, pi; Buckland ST, 2010, BIOMETRICS, V66, P169, DOI 10.1111/j.1541-0420.2009.01239.x; Burnham KP, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P307; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Conn PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042294; DRUMMER TD, 1987, BIOMETRICS, V43, P13, DOI 10.2307/2531944; Hastie J. M, 1997, STAT MODELS, P249; Hiby L, 2001, BIOMETRICS, V57, P727, DOI 10.1111/j.0006-341X.2001.00727.x; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Laake J, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P137; Laake J, 2008, WILDLIFE RES, V35, P299, DOI 10.1071/WR07034; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; Laake JL, 2015, MARK RECAPTURE DISTA; Manly Bryan F.J., 1996, Journal of Agricultural Biological and Environmental Statistics, V1, P170, DOI 10.2307/1400364; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Nielson RM, 2014, J WILDLIFE MANAGE, V78, P721, DOI 10.1002/jwmg.704; Quang Pham X., 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P230, DOI 10.2307/1400405; Quang PX, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P87; Quang PX, 1996, ECOLOGY, V77, P1297, DOI 10.2307/2265601; RAMSEY FL, 1987, BIOMETRICS, V43, P1, DOI 10.2307/2531943; THOMPSON SK, 2002, SAMPLING; VENABLES WN, 1997, MODERN APPL STAT S P	30	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136403	10.1371/journal.pone.0136403	http://dx.doi.org/10.1371/journal.pone.0136403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317984	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100081
J	Chen, HH; Horng, MH; Yeh, SY; Lin, IC; Yeh, CJ; Muo, CH; Sung, FC; Kao, CH				Chen, Hsin-Hung; Horng, Ming-Hwarng; Yeh, Su-Yin; Lin, I-Ching; Yeh, Chih-Jung; Muo, Chih-Hsin; Sung, Fung-Chang; Kao, Chia-Hung			Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; COMBINATION THERAPY; CONTROLLED-TRIAL; BONE-FORMATION; ROSIGLITAZONE; RISK; METAANALYSIS; REPAGLINIDE; METFORMIN; WOMEN	Objective Diabetes is a common diseases and a major problem worldwide. Diabetic osteopathy might be elevated in diabetic patients and is usually caused by bone fracture. Several diabetes medications, such as thiazolidinediones (TZDs), could lead to increased risks of fracture. Methods We used the nationwide database to identified 32466 patients who had developed type 2 diabetes from 2000 to 2010 as the diabetic cohort and, from that group, we selected 3427 diabetic patients who had developed bone fracture to survey the possible risk factors, includng commonly used diabetes medication. Results We found that TZDs might present increased risks for fracture in patients who used it for an extended period (7 to 730 days before the index date), especially in female patients younger than 64 years old, for whom the risk was elevated from a 1.74- to a 2.58-fold odds ratio. Conclusions We recommend that clinics follow up with non-osteoporotic female patients younger than 64 years old who are using TZDs, to avoid the associated risks of fracture.	[Chen, Hsin-Hung; Yeh, Chih-Jung] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Chen, Hsin-Hung; Lin, I-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hung] Changhua Christian Hosp, Div Endocrinol & Metab, Changhua, Taiwan; [Chen, Hsin-Hung] Nantou Christian Hosp, Div Endocrinol & Metab, Nantou, Taiwan; [Horng, Ming-Hwarng] Changhua Christian Hosp, Div Crit Care Med, Dept Internal Med, Changhua, Taiwan; [Horng, Ming-Hwarng] Yuanlin Christian Hosp, Changhua Christian Med Fdn, Changhua, Taiwan; [Yeh, Su-Yin] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Lin, I-Ching] Changhua Christian Hosp, Dept Family Med, Changhua, Taiwan; [Yeh, Chih-Jung] Chung Shan Med Univ, Educ & Res Geriatr & Gerontol, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung, Taiwan; [Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; Asia University Taiwan; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yeh, CJ (corresponding author), Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan.	chh2019@gmail.com; d10040@mail.cmuh.org.tw	Yeh, Cj/AFC-0951-2022		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare surcharge of tobacco products; China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW104-TDU-B-212-124-002]; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare surcharge of tobacco products; China Medical University Hospital Cancer Research Center of Excellence (Taiwan); CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); the China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); the NRPB Stroke Clinical Trial Consortium(MOST 103-2325-B-039 -006); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; the Katsuzo and Kiyo Aoshima Memorial Funds, Japan; the Taiwan Ministry of Health and Welfare surcharge of tobacco products; the China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B-212-124-002, Taiwan); and the CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Bazelier Marloes T, 2013, Front Endocrinol (Lausanne), V4, P11, DOI 10.3389/fendo.2013.00011; Berberoglu Z, 2007, J CLIN ENDOCR METAB, V92, P3523, DOI 10.1210/jc.2007-0431; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; COZEN L, 1972, CLIN ORTHOP RELAT R, P134; Damsbo P, 1999, DIABETES RES CLIN PR, V45, P31, DOI 10.1016/S0168-8227(99)00057-1; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kahn SE, N ENGL J MED, V355, P2427; Khazai NB, 2009, CURR OPIN ENDOCRINOL, V16, P435, DOI 10.1097/MED.0b013e328331c7eb; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P178, DOI 10.1007/s11914-010-0027-y; Lin MC, 2013, ANN ONCOL, V24, P1675, DOI 10.1093/annonc/mdt016; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Madsbad S, 2001, DIABETIC MED, V18, P395, DOI 10.1046/j.1464-5491.2001.00490.x; Mayne D, 2010, AGE AGEING, V39, P522, DOI 10.1093/ageing/afq081; Raskin P, 2000, DIABETES CARE, V23, P979, DOI 10.2337/diacare.23.7.979; Rosenstock J, 2002, DIABETES CARE, V25, P1529, DOI 10.2337/diacare.25.9.1529; Schwartz AV, 2012, DIABETES CARE, V35, P1525, DOI 10.2337/dc11-2184; Simpson CM, 2012, EXPERT OPIN DRUG SAF, V11, P215, DOI 10.1517/14740338.2012.639359; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhu ZN, 2014, BONE, V68, P115, DOI 10.1016/j.bone.2014.08.010	25	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135530	10.1371/journal.pone.0135530	http://dx.doi.org/10.1371/journal.pone.0135530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317995	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100033
J	de Guzman, RC; Tsuda, SM; Ton, MTN; Zhang, X; Esker, AR; Van Dyke, ME				de Guzman, Roche C.; Tsuda, Shanel M.; Ton, Minh-Thi N.; Zhang, Xiao; Esker, Alan R.; Van Dyke, Mark E.			Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; BOVINE SERUM-ALBUMIN; DISULFIDE BONDS; LIGAND-BINDING; ELECTROSTATIC INTERACTIONS; INTERMEDIATE-FILAMENTS; SURFACE; ADSORPTION; SULFUR; INTEGRIN	Hair-derived keratin biomaterials composed mostly of reduced keratin proteins (kerateines) have demonstrated their utility as carriers of biologics and drugs for tissue engineering. Electrostatic forces between negatively-charged keratins and biologic macromolecules allow for effective drug retention; attraction to positively-charged growth factors like bone morphogenetic protein 2 (BMP-2) has been used as a strategy for osteoinduction. In this study, the intermolecular surface and bulk interaction properties of kerateines were investigated. Thiol-rich kerateines were chemisorbed onto gold substrates to form an irreversible 2-nm rigid layer for surface plasmon resonance analysis. Kerateine-to-kerateine cohesion was observed in pH-neutral water with an equilibrium dissociation constant (K-D) of 1.8 x 10(-4) M, indicating that non-coulombic attractive forces (i.e. hydrophobic and van der Waals) were at work. The association of BMP-2 to kerateine was found to be greater (K-D = 1.1 x 10(-7) M), within the range of specific binding. Addition of salts (phosphate-buffered saline; PBS) shortened the Debye length or the electrostatic field influence which weakened the kerateine-BMP-2 binding (K-D = 3.2 x 10(-5) M). BMP-2 in bulk kerateine gels provided a limited release in PBS (similar to 10% dissociation in 4 weeks), suggesting that electrostatic intermolecular attraction was significant to retain BMP-2 within the keratin matrix. Complete dissociation between kerateine and BMP-2 occurred when the PBS pH was lowered (to 4.5), below the keratin isoelectric point of 5.3. This phenomenon can be attributed to the protonation of keratin at a lower pH, leading to positive-positive repulsion. Therefore, the dynamics of kerateine-BMP-2 binding is highly dependent on pH and salt concentration, as well as on BMP-2 solubility at different pH and molarity. The study findings may contribute to our understanding of the release kinetics of drugs from keratin biomaterials and allow for the development of better, more clinically relevant BMP-2-conjugated systems for bone repair and regeneration.	[de Guzman, Roche C.; Tsuda, Shanel M.; Ton, Minh-Thi N.; Van Dyke, Mark E.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Zhang, Xiao; Esker, Alan R.] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	de Guzman, RC (corresponding author), Hofstra Univ, Dept Engn, Hempstead, NY 11550 USA.	roche.c.deguzman@hofstra.edu	de Guzman, Roche C./K-8832-2015	de Guzman, Roche C./0000-0001-6051-4765; Esker, Alan/0000-0003-1440-5933				Adamson AW, 1997, PHYS CHEM SURFACES, Vxxi; Alting AC, 2000, J AGR FOOD CHEM, V48, P5001, DOI 10.1021/jf000474h; [Anonymous], 2008, HDB SURFACE PLASMON, P1; [Anonymous], INFUSE BONE GRAFT PR; Arkhangelsky E, 2007, J MEMBRANE SCI, V305, P176, DOI 10.1016/j.memsci.2007.08.007; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aubin-Tam ME, 2013, METHODS MOL BIOL, V1025, P19, DOI 10.1007/978-1-62703-462-3_3; Baier SK, 2005, COMPR REV FOOD SCI F, V4, P43, DOI 10.1111/j.1541-4337.2005.tb00072.x; Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192; Berezhkovskiy LM, 2001, BIOPHYS CHEM, V91, P319, DOI 10.1016/S0301-4622(01)00147-8; Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Bigott-Hennkens HM, 2008, Q J NUCL MED MOL IM, V52, P245; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Bukar N, 2014, CHEM COMMUN, V50, P4947, DOI 10.1039/c4cc01423e; Bulaj G, 2005, BIOTECHNOL ADV, V23, P87, DOI 10.1016/j.biotechadv.2004.09.002; Carreno-Fuentes L, 2014, LANGMUIR, V30, P14991, DOI 10.1021/la503704a; Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w; Chen Lin, 2001, Curr Protoc Protein Sci, VChapter 18, DOI 10.1002/0471140864.ps1806s23; CHIARI M, 1991, ELECTROPHORESIS, V12, P376, DOI 10.1002/elps.1150120510; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; de Guzman RC, 2013, BIOMATERIALS, V34, P1644, DOI 10.1016/j.biomaterials.2012.11.002; de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054; DeChancie J, 2007, J AM CHEM SOC, V129, P5419, DOI 10.1021/ja066950n; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908; Digilio G, 2014, EUR J MED CHEM, V79, P13, DOI 10.1016/j.ejmech.2014.03.064; Doliska A, 2013, CARBOHYD POLYM, V93, P246, DOI 10.1016/j.carbpol.2012.02.075; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; FLORENCE TM, 1980, BIOCHEM J, V189, P507, DOI 10.1042/bj1890507; Foegeding A, 2005, ROY SOC CH, P3; Freundlich H, 1906, ADSORPTION LOSUNGEN; FUGGLE JC, 1980, J ELECTRON SPECTROSC, V21, P275, DOI 10.1016/0368-2048(80)85056-0; GARYBOBO CM, 1968, J GEN PHYSIOL, V52, P825, DOI 10.1085/jgp.52.5.825; Ge SR, 1998, J BIOMAT SCI-POLYM E, V9, P131; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gilbert JB, 2013, P NATL ACAD SCI USA, V110, P6651, DOI 10.1073/pnas.1222325110; Glatz C E, 1990, Bioprocess Technol, V9, P329; Goddard DR, 1935, J BIOL CHEM, V112, P361; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/NCHEM.1352, 10.1038/nchem.1352]; Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Honda Y, 2014, CELL STRUCT FUNCT, V39, P31, DOI 10.1247/csf.13021; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Ke S, 2007, BIOCONJUGATE CHEM, V18, P2109, DOI 10.1021/bc700204k; Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q; Kou J, 2010, COLLOID SURFACE A, V368, P75, DOI 10.1016/j.colsurfa.2010.07.017; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Kukic P, 2010, FUTURE MED CHEM, V2, P647, DOI 10.4155/FMC.10.6; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Li FY, 2011, J CONTROL RELEASE, V152, pE92, DOI 10.1016/j.jconrel.2011.08.144; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lusiana, 2011, EUR J PHARM BIOPHARM, V78, P432, DOI 10.1016/j.ejpb.2011.01.022; Lv ZJ, 2009, NANOSCALE RES LETT, V4, P1403, DOI 10.1007/s11671-009-9412-9; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McArthur S. L., 2014, SURFACE ANAL TECHNIQ, P9, DOI DOI 10.1007/978-3-319-01360-2_2; McArthur SL, 2001, BIOMATERIALS, V22, P3295, DOI 10.1016/S0142-9612(01)00166-1; McArthur SL, 2000, COLLOID SURFACE B, V17, P37, DOI 10.1016/S0927-7765(99)00086-7; Mogosanu GD, 2014, CURR DRUG TARGETS, V15, P518, DOI 10.2174/1389450115666140307154143; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nghiem LD, 2006, J MEMBRANE SCI, V286, P52, DOI 10.1016/j.memsci.2006.09.011; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PETHIG R, 1984, IEEE T ELECTR INSUL, V19, P453, DOI 10.1109/TEI.1984.298769; Peyton CC, 2012, J SURG RES, V178, P545, DOI 10.1016/j.jss.2012.07.053; Plowman JE, 2003, PROTEOMICS, V3, P942, DOI 10.1002/pmic.200300419; Popescu C, 2009, INT REV CEL MOL BIO, V277, P137, DOI 10.1016/S1937-6448(09)77004-2; Pritchett TJ, 1996, ELECTROPHORESIS, V17, P1195, DOI 10.1002/elps.1150170705; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; Richter JR, 2012, ACTA BIOMATER, V8, P274, DOI 10.1016/j.actbio.2011.08.020; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rodriguez JA, 2003, J AM CHEM SOC, V125, P276, DOI 10.1021/ja021007e; Samba R., 2013, OPEN SURF SCI J, V5, P17, DOI DOI 10.2174/1876531901305010017; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; Siriwardana K, 2015, J PHYS CHEM C, V119, P2910, DOI 10.1021/jp512440z; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483; Stillman Martin J., 1999, Metal-Based Drugs, V6, P277, DOI 10.1155/MBD.1999.277; Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425; Technologies SC, 2007, PROD INF SHEET REC H; Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024; Tulpar A, 2004, J PHYS CHEM B, V108, P1667, DOI 10.1021/jp0347668; Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x; VANTRIEST A, 1990, J PHYS-CONDENS MAT, V2, P8733, DOI 10.1088/0953-8984/2/44/001; Vasconcelos A, 2013, CURR DRUG TARGETS, V14, P612, DOI 10.2174/1389450111314050010; Walczak M, 2013, PHARMACOL REP, V65, P1294, DOI 10.1016/S1734-1140(13)71487-7; WALL JS, 1971, J AGR FOOD CHEM, V19, P619, DOI 10.1021/jf60176a003; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; WORLEY CG, 1995, J VAC SCI TECHNOL A, V13, P2281, DOI 10.1116/1.579510; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001	101	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137233	10.1371/journal.pone.0137233	http://dx.doi.org/10.1371/journal.pone.0137233			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317522	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100213
J	Liu, YY; Rzeszutek, E; van der Voort, M; Wu, CH; Thoen, E; Skaar, I; Bulone, V; Dorrestein, PC; Raaijmakers, JM; de Bruijn, I				Liu, Yiying; Rzeszutek, Elzbieta; van der Voort, Menno; Wu, Cheng-Hsuan; Thoen, Even; Skaar, Ida; Bulone, Vincent; Dorrestein, Pieter C.; Raaijmakers, Jos M.; de Bruijn, Irene			Diversity of Aquatic Pseudomonas Species and Their Activity against the Fish Pathogenic Oomycete Saprolegnia	PLOS ONE			English	Article							CYCLIC LIPOPEPTIDE SURFACTANTS; BIOSYNTHESIS; PARASITICA; AUSTRALIS; BACTERIA; INFECTIONS; INHIBITION; NETWORKING; DISCOVERY; DICLINA	Emerging fungal and oomycete pathogens are increasingly threatening animals and plants globally. Amongst oomycetes, Saprolegnia species adversely affect wild and cultivated populations of amphibians and fish, leading to substantial reductions in biodiversity and food productivity. With the ban of several chemical control measures, new sustainable methods are needed to mitigate Saprolegnia infections in aquaculture. Here, PhyloChip-based community analyses showed that the Pseudomonadales, particularly Pseudomonas species, represent one of the largest bacterial orders associated with salmon eggs from a commercial hatchery. Among the Pseudomonas species isolated from salmon eggs, significantly more biosurfactant producers were retrieved from healthy salmon eggs than from Saprolegnia-infected eggs. Subsequent in vivo activity bioassays showed that Pseudomonas isolate H6 significantly reduced salmon egg mortality caused by Saprolegnia diclina. Live colony mass spectrometry showed that strain H6 produces a viscosin-like lipopeptide surfactant. This biosurfactant inhibited growth of Saprolegnia in vitro, but no significant protection of salmon eggs against Saprolegniosis was observed. These results indicate that live inocula of aquatic Pseudomonas strains, instead of their bioactive compound, can provide new (micro) biological and sustainable means to mitigate oomycete diseases in aquaculture.	[Liu, Yiying; Raaijmakers, Jos M.; de Bruijn, Irene] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Liu, Yiying; van der Voort, Menno] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Rzeszutek, Elzbieta; Bulone, Vincent] Royal Inst Technol, Sch Biotechnol, Div Glycosci, Stockholm, Sweden; [Wu, Cheng-Hsuan; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wu, Cheng-Hsuan] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Thoen, Even; Skaar, Ida] Norwegian Vet Inst, Oslo, Norway; [Thoen, Even] Norwegian Univ Life Sci, Oslo, Norway; [Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Royal Institute of Technology; University of California System; University of California San Diego; Boston University; Norwegian Veterinary Institute; Norwegian University of Life Sciences; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	de Bruijn, I (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	i.debruijn@nioo.knaw.nl	de Bruijn, Irene/A-7437-2014; Dorrestein, Pieter/ABF-2930-2020; Bulone, Vincent/C-8492-2019; Bulone, Vincent/D-7469-2013; Raaijmakers, Jos M/D-1574-2014; KNAW, NIOO-KNAW/A-4320-2012	de Bruijn, Irene/0000-0002-4889-3253; Bulone, Vincent/0000-0003-2809-4160; Raaijmakers, Jos M/0000-0003-1608-6614; KNAW, NIOO-KNAW/0000-0002-3835-159X	SAPRO (Sustainable Approaches to Reduce Oomycete (Saprolegnia) Infections in Aquaculture) [238550]; Marie Curie Initial Training Network - European Commission; ParaFishControl (Advanced Tools and Research Strategies for Parasite Control in European farmed fish) [634429]; Research and Innovation action - European Commission under HORIZON; BE-Basic Foundation [F07.003.01]	SAPRO (Sustainable Approaches to Reduce Oomycete (Saprolegnia) Infections in Aquaculture); Marie Curie Initial Training Network - European Commission; ParaFishControl (Advanced Tools and Research Strategies for Parasite Control in European farmed fish); Research and Innovation action - European Commission under HORIZON; BE-Basic Foundation	This work was financially supported by SAPRO (Sustainable Approaches to Reduce Oomycete (Saprolegnia) Infections in Aquaculture, 238550), a Marie Curie Initial Training Network funded by the European Commission under Framework Program 7; ParaFishControl (Advanced Tools and Research Strategies for Parasite Control in European farmed fish, 634429), a Research and Innovation action funded by the European Commission under HORIZON 2020; and BE-Basic Foundation (project number F07.003.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Allah AMA, 1998, WATER RES, V32, P944, DOI 10.1016/S0043-1354(97)00223-6; Abu-Ghunmi L, 2014, J SURFACTANTS DETERG, V17, P833, DOI 10.1007/s11743-014-1584-3; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Bly JE, 1997, J FISH DIS, V20, P35, DOI 10.1046/j.1365-2761.1997.d01-104.x; Bruno DW, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P669, DOI 10.1079/9781845935542.0669; Carbajal-Gonzalez MT, 2011, DIS AQUAT ORGAN, V96, P125, DOI 10.3354/dao02391; Cheng X, 2015, ENV MICROBIOL REP, V7, P139, DOI 10.1111/1758-2229.12231; Das SK, 2012, J ENVIRON BIOL, V33, P545; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; de Bruijn I, 2007, MOL MICROBIOL, V63, P417, DOI 10.1111/j.1365-2958.2006.05525.x; de Souza JT, 2003, APPL ENVIRON MICROB, V69, P7161, DOI 10.1128/AEM.69.12.7161-7172.2003; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Garces ME, 2015, DIS AQUAT ORGAN, V113, P41, DOI 10.3354/dao02815; Gozlan RE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00062; HATAI K, 1992, J WILDLIFE DIS, V28, P532, DOI 10.7589/0090-3558-28.4.532; Hatai K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P27; Hatai K, 1994, SALMON SAPROLEGNIASI; Hussein MMA, 2001, FISH PATHOL, V36, P73, DOI 10.3147/jsfp.36.73; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krugner-Higby L, 2010, DIS AQUAT ORGAN, V91, P57, DOI 10.3354/dao02237; Lategan MJ, 2004, AQUACULTURE, V240, P19, DOI 10.1016/j.aquaculture.2004.04.009; Lategan MJ, 2004, AQUACULTURE, V235, P77, DOI 10.1016/j.aquaculture.2003.09.014; Lategan MJ, 2003, J FISH DIS, V26, P147, DOI 10.1046/j.1365-2761.2003.00443.x; Liu Y, 2014, ISME J, V8, P2002, DOI 10.1038/ismej.2014.44; Loch TP, 2012, J FISH DIS, V35, P39, DOI 10.1111/j.1365-2761.2011.01322.x; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Nielsen TH, 2003, APPL ENVIRON MICROB, V69, P861, DOI 10.1128/AEM.69.2.861-868.2003; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; Pierce CY, 2007, CHEM COMMUN, P807, DOI 10.1039/b613200f; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Rademaker J. L. W., 1998, MOL MICROBIAL ECOLOG, P1; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song CX, 2014, FEMS MICROBIOL LETT, V356, P166, DOI 10.1111/1574-6968.12404; van de Mortel JE, 2009, APPL ENVIRON MICROB, V75, P4950, DOI 10.1128/AEM.00241-09; van den Berg AH, 2013, FUNGAL BIOL REV, V27, P33, DOI 10.1016/j.fbr.2013.05.001; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	45	28	30	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136241	10.1371/journal.pone.0136241	http://dx.doi.org/10.1371/journal.pone.0136241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317985	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100065
J	Martinez-Gonzalez, AE; Rodriguez-Jimenez, T; Piqueras, JA; Vera-Villarroel, P; Godoy, A				Martinez-Gonzalez, Agustin E.; Rodriguez-Jimenez, Tiscar; Piqueras, Jose A.; Vera-Villarroel, Pablo; Godoy, Antonio			Psychometric Properties of the Obsessive-Compulsive Inventory-Child Version (OCI-CV) in Chilean Children and Adolescents	PLOS ONE			English	Article							FIT INDEXES; DISORDER; VALIDATION; SYMPTOMS; ANXIETY; RELIABILITY; DIMENSIONS; SAMPLE	In recent years, there has been a considerable increase in the development of assessment tools for obsessive-compulsive symptomatology in children and adolescents. The Obsessive Compulsive Inventory-Child Version (OCI-CV) is a well-established assessment self-report, with special interest for the assessment of dimensions of Obsessive Compulsive Disorder (OCD). This instrument has shown to be useful for clinical and non-clinical populations in two languages (English and European Spanish). Thus, the aim of this study was to analyze the psychometric properties of the OCI-CV in a Chilean community sample. The sample consisted of 816 children and adolescents with a mean age of 14.54 years (SD = 2.21; range = 10-18 years). Factor structure, internal consistency, test-retest reliability, convergent/ divergent validity, and gender/age differences were examined. Confirmatory factor analysis showed a 6-factor structure (Doubting/Checking, Obsessing, Hoarding, Washing, Ordering, and Neutralizing) with one second-order factor. Good estimates of reliability (including internal consistency and test-retest), evidence supporting the validity, and small age and gender differences (higher levels of OCD symptomatology among older participants and women, respectively) are found. The OCI-CV is also an adequate scale for the assessment of obsessions and compulsions in a general population of Chilean children and adolescents.	[Martinez-Gonzalez, Agustin E.] Univ Alicante, Dept Dev Psychol & Didact, E-03080 Alicante, Spain; [Rodriguez-Jimenez, Tiscar; Piqueras, Jose A.] Miguel Hernandez Univ, Dept Hlth Psychol, Elche, Spain; [Vera-Villarroel, Pablo] Univ Santiago Chile, Sch Psychol, Santiago, Chile; [Godoy, Antonio] Univ Malaga, Dept Personal Assessment & Psychol Treatment, E-29071 Malaga, Spain	Universitat d'Alacant; Universidad Miguel Hernandez de Elche; Universidad de Santiago de Chile; Universidad de Malaga	Martinez-Gonzalez, AE (corresponding author), Univ Alicante, Dept Dev Psychol & Didact, E-03080 Alicante, Spain.	agustin.emartinez@ua.es	Godoy, Antonio/AAC-7087-2020; MARTINEZ-GONZALEZ, AGUSTIN ERNESTO/Z-1311-2019; Vera-Villarroel, Pablo/A-1134-2011; Rodriguez-Jimenez, Tiscar/K-5785-2017; MARTINEZ-GONZALEZ, AGUSTIN ERNESTO/L-8523-2014; Piqueras, Jose A/C-6011-2011; Godoy, Antonio/ABF-9863-2020; Vera-Villarroel, Pablo/AAQ-8476-2020	Godoy, Antonio/0000-0003-2736-9871; MARTINEZ-GONZALEZ, AGUSTIN ERNESTO/0000-0002-9576-7348; Vera-Villarroel, Pablo/0000-0001-9187-8414; MARTINEZ-GONZALEZ, AGUSTIN ERNESTO/0000-0002-9576-7348; Piqueras, Jose A/0000-0002-3604-5441; 	SCHOLARSHIPS IBEROAMERICA	SCHOLARSHIPS IBEROAMERICA	SCHOLARSHIPS IBEROAMERICA for Young Teachers and Researchers (Santander Universities. 2013).	Abramowitz JS, 2010, PSYCHOL ASSESSMENT, V22, P180, DOI 10.1037/a0018260; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Araya R, 2013, JAMA PEDIATR, V167, P1004, DOI 10.1001/jamapediatrics.2013.2361; Canals J, 2012, J ANXIETY DISORD, V26, P746, DOI 10.1016/j.janxdis.2012.06.003; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen LL, 2008, J PEDIATR PSYCHOL, V33, P911, DOI 10.1093/jpepsy/jsj115; Dimitrov Dimiter M, 2006, Work, V26, P429; Martinez-Gonzalez AE, 2011, AN PSICOL-SPAIN, V27, P763; Esbjorn BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037339; Farrell L, 2006, BRIT J PSYCHOL, V97, P95, DOI 10.1348/000712605X58592; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Foa EB, 2010, BEHAV THER, V41, P121, DOI 10.1016/j.beth.2009.02.001; Godoy A, 2011, PSICOTHEMA, V23, P289; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huey SJ, 2008, J CLIN CHILD ADOLESC, V37, P262, DOI 10.1080/15374410701820174; Iniesta-Sepulveda M, 2014, J CHILD FAM STUD, V23, P1455, DOI 10.1007/s10826-013-9801-7; Jones AM, 2013, CHILD PSYCHIAT HUM D, V44, P137, DOI 10.1007/s10578-012-0315-0; Lewin AB, 2010, CHILD PSYCHIAT HUM D, V41, P675, DOI 10.1007/s10578-010-0196-z; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Mataix-Cols D, 2010, DEPRESS ANXIETY, V27, P556, DOI 10.1002/da.20693; McDonald, 1999, TEST THEORY UNIFIED, DOI DOI 10.4324/9781410601087; McGuire JF, 2012, CHILD PSYCHIAT HUM D, V43, P855, DOI 10.1007/s10578-012-0300-7; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Arjona RN, 2012, PSICOTHEMA, V24, P674; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Olatunji BO, 2008, DEPRESS ANXIETY, V25, P956, DOI 10.1002/da.20387; Orgiles M, 2012, REV PSIQUIATR SALUD, V5, P115, DOI 10.1016/j.rpsm.2012.01.005; Overduin MK, 2012, J OBSESS-COMPULS REL, V1, P312, DOI 10.1016/j.jocrd.2012.08.001; Piqueras JA, 2015, FACTOR STRUCTU UNPUB; Piqueras JA, 2015, BJPSYCH OPEN, V1, P21, DOI 10.1192/bjpo.bp.115.000695; Piqueras JA, 2009, BEHAV PSYCHOL, V17, P561; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Jimenez T, EUR J PSYCH IN PRESS; Rodriguez-Jimenez T, 2014, BEHAV PSYCHOL, V22, P203; Rosa-Alcazar AI, 2014, PSICOTHEMA, V26, P174, DOI 10.7334/psicothema2013.210; Sandin B, 2009, REV PSICOP PSIC CL, V14, P193, DOI DOI 10.5944/RPPC.VOL.14.NUM.3.2009.4078; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schweizer K, 2011, EUR J PSYCHOL ASSESS, V27, P143, DOI 10.1027/1015-5759/a000069; Storch EA, 2011, CHILD PSYCHIAT HUM D, V42, P166, DOI 10.1007/s10578-010-0207-0; Storch EA, 2010, J ANXIETY DISORD, V24, P275, DOI 10.1016/j.janxdis.2009.12.004; Storch EA, 2009, CHILD PSYCHIAT HUM D, V40, P467, DOI 10.1007/s10578-009-0138-9; Uher R, 2007, BRIT J PSYCHIAT, V191, P353, DOI 10.1192/bjp.bp.106.034967; WOODHOUSE B, 1977, PSYCHOMETRIKA, V42, P579, DOI 10.1007/BF02295980	46	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136842	10.1371/journal.pone.0136842	http://dx.doi.org/10.1371/journal.pone.0136842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317404	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100148
J	Okoro, EU; Zhang, HF; Guo, ZM; Yang, F; Smith, C; Yang, H				Okoro, Emmanuel U.; Zhang, Hongfeng; Guo, Zhongmao; Yang, Fang; Smith, Carlie, Jr.; Yang, Hong			A Subregion of Reelin Suppresses Lipoprotein-Induced Cholesterol Accumulation in Macrophages	PLOS ONE			English	Article							TRANSPORTER A1 EXPRESSION; FOAM CELL-FORMATION; APOLIPOPROTEIN-E; TANGIER-DISEASE; DOWN-REGULATION; VLDL RECEPTOR; BINDING; PROTEIN; INDUCTION; FRAGMENT	Activation of apolipoprotein E receptor-2 (apoER2) and very low density lipoprotein receptor (VLDLR) inhibits foam cell formation. Reelin is a ligand of these receptors. Here we generated two reelin subregions containing the receptor binding domain with or without its C-terminal region (R5-6C and R5-6, respectively) and studied the impact of these peptides on macrophage cholesterol metabolism. We found that both R5-6C and R5-6 can be secreted by cells. Purified R5-6 protein can bind apoER2 and VLDLR. Overexpression of apoER2 in macrophages increased the amount of R5-6 bound to the cell surface. Treatment of macrophages with 0.2 mu g/ml R5-6 elevated ATP binding cassette A1 (ABCA1) protein level by similar to 72% and apoAI-mediated cholesterol efflux by similar to 39%. In addition, the medium harvested from cells overexpressing R5-6 or R5-6C (R5-6- and R5-6C-conditioned media, respectively) also up-regulated ABCA1 protein expression, which was associated with accelerated cholesterol efflux and enhanced phosphorylation of phosphatidylinositol 3 kinase (PI3K) and specificity protein-1 (Sp1) in macrophages. The increased ABCA1 expression and cholesterol efflux by R5-6- and R5-6C-conditioned media were diminished by Sp1 or PI3K inhibitors mithramycin A and LY294002. Further, the cholesterol accumulation induced by apoB-containing, apoE-free lipoproteins was significantly less in macrophages incubated with R5-6- or R5-6C-conditioned medium than in those incubated with control conditioned medium. Knockdown of apoER2 or VLDLR attenuated the inhibitory role of R5-6-conditioned medium against lipoprotein-induced cholesterol accumulation. These results suggest that the reelin subregion R5-6 can serve as a tool for studying the role of apoER2 and VLDLR in atherogenesis.	[Okoro, Emmanuel U.; Zhang, Hongfeng; Guo, Zhongmao; Yang, Fang; Smith, Carlie, Jr.; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Zhang, Hongfeng] Cent Hosp Wuhan, Dept Pathol, Wuhan, Peoples R China; [Yang, Fang] Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Peoples R China	Meharry Medical College; Wuhan University	Yang, H (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			US National Institutes of Health [SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the US National Institutes of Health SC1HL101431 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HUAZHONG U SCI TEC; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen XP, 2011, J BIOL CHEM, V286, P8917, DOI 10.1074/jbc.M110.214429; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P561, DOI 10.1021/bi010719z; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kabanova S, 2009, INT J MED SCI, V6, P156; Korporaal SJA, 2009, ARTERIOSCL THROM VAS, V29, P372, DOI 10.1161/ATVBAHA.108.173278; Lambert de RC, 1998, ADV ANAT EMBRYOL CEL, V150, P1; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Okoro EU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044430; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Quinn KL, 2011, ARTERIOSCL THROM VAS, V31, P2070, DOI 10.1161/ATVBAHA.111.227116; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Tacken PJ, 2000, BIOCHEM J, V347, P357, DOI 10.1042/0264-6021:3470357; Tacken PJ, 2002, ATHEROSCLEROSIS, V162, P103, DOI 10.1016/S0021-9150(01)00697-9; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; Van Eck M, 2005, ATHEROSCLEROSIS, V183, P230, DOI 10.1016/j.atherosclerosis.2005.03.045; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vashist SK, 2015, BIOSENS BIOELECTRON, V67, P73, DOI 10.1016/j.bios.2014.06.058; WALKER KW, 1992, J IMMUNOL METHODS, V154, P121, DOI 10.1016/0022-1759(92)90219-J; Waltmann MD, 2014, BBA-MOL BASIS DIS, V1842, P1395, DOI 10.1016/j.bbadis.2014.05.009; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; White-Adams TC, 2009, ARTERIOSCL THROM VAS, V29, P1602, DOI 10.1161/ATVBAHA.109.187393; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yang H, 2003, FREE RADICAL BIO MED, V35, P266, DOI 10.1016/S0891-5849(03)00277-6; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104; Zhao YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021453	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136895	10.1371/journal.pone.0136895	http://dx.doi.org/10.1371/journal.pone.0136895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317415	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100164
J	Zhao, Y; Zhang, MJ; Shi, CX; Zhang, Y; Cai, WP; Zhao, QX; Li, Y; Li, HQ; Liu, X; Chen, LM; Ma, Y; Zhang, FJ; Liu, ZF; Wu, ZY				Zhao, Yan; Zhang, Mingjie; Shi, Cynthia X.; Zhang, Yao; Cai, Weiping; Zhao, Qingxia; Li, Yong; Li, Huiqin; Liu, Xia; Chen, Limeng; Ma, Ye; Zhang, Fujie; Liu, Zhongfu; Wu, Zunyou			Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; INFECTED PATIENTS; RISK-FACTORS; PREVALENCE; COHORT; ASSOCIATION; TENOFOVIR; METAANALYSIS; NEPHROPATHY	Aim To identify the prevalence and predictors of abnormal renal function among HIV-positive Chinese patients prior to antiretroviral therapy (ART) initiation and to evaluate subsequent changes in renal function after ART exposure. Methods We conducted a nationwide cohort study of subjects who enrolled in the national Chinese ART program from January 1, 2012 to December 31, 2012. We estimated the glomerular filtration rate (eGFR) of subjects prior to and after initiating ART. Risk factors for abnormal renal function, as defined by eGFR < 60 ml/min/1.73m(2), at baseline and follow-up were assessed by logistic regression and Cox proportional hazards regression models, respectively. Results Among 41,862 subjects, at ART baseline, 3.3% had a baseline eGFR < 60 ml/min/1.73m(2) and 24.2% had eGFR = 60-90 ml/min/1.73m(2). Adjusted baseline risk factors for baseline eGFR < 60 ml/min/1.73m(2) were older age (Adjusted odds ratio [AOR] = 5.19, 95% confidence interval [CI]: 4.52-5.67), female (AOR = 1.68, 95% CI: 1.47-1.93), hemoglobin < 120g/L (AOR = 1.68, 95% CI: 1.47-1.93), blood glucose > 6.1 mmol/L (AOR = 1.46, 95% CI: 1.25-1.72), and hepatitis C co-infection (AOR = 1.36, 95% CI: 1.06-1.73). Among subjects with baseline eGFR > 90 ml/min/1.73m(2), the incidence of the eGFR falling to < 60 ml/min/1.73m(2) was 0.92/100 person-years after a median of 15.0 months of ART. Being on a tenofovir with lopinavir/ritonavir regimen (Adjusted hazard ratio [AHR] = 3.02, 95% CI: 1.96-4.66) and having an unsuppressed viral load (AHR = 2.70, 95% CI: 1.80-4.03) were independent predictors for eGFR < 60 ml/min/1.73m(2) after ART initiation as well as older age, female, and hemoglobin < 120 g/L. Conclusion A high proportion of HIV-positive subjects in China presented with abnormal renal function prior to ART initiation. But the incidence of the eGFR decrease after ART was low. Patient renal function should be regularly monitored by eGFR before initiating and during ART.	[Zhao, Yan; Zhang, Mingjie; Shi, Cynthia X.; Zhang, Yao; Liu, Xia; Ma, Ye; Zhang, Fujie; Liu, Zhongfu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Cai, Weiping] Guangzhou 8th Hosp, Guangzhou, Guangdong, Peoples R China; [Zhao, Qingxia] Zhengzhou 6th Hosp, Zhengzhou, Henan, Peoples R China; [Li, Yong] Longtan Hosp, Guangxi, Peoples R China; [Li, Huiqin] Ctr AIDS Care, Kunming, Yunnan, Peoples R China; [Chen, Limeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, FJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	zhang.fujie.t@gmail.com; zhongfuliu@163.com	Burdmann, Emmanuel/B-7023-2009; Burdmann, Emmanuel/AAY-1966-2020	Burdmann, Emmanuel/0000-0002-7644-8579; 	Chinese Government AIDS Program	Chinese Government AIDS Program	This study was supported by Chinese Government AIDS Program. The funding organizations had no role in the design of this study, in the analysis, or interpretation of data, or in the final decision to submit the manuscript for publication. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the affiliated institutions.	Ando M, 2012, CLIN EXP NEPHROL, V16, P363, DOI 10.1007/s10157-012-0585-7; Bruggeman Leslie A, 2009, Curr Infect Dis Rep, V11, P479, DOI 10.1007/s11908-009-0069-4; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; Cao Y, 2013, NEPHROLOGY, V18, P307, DOI 10.1111/nep.12031; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Dabrowska MM, 2012, CURR HIV RES, V10, P247, DOI 10.2174/157016212800618147; del Palacio M, 2012, CURR HIV RES, V10, P521, DOI 10.2174/157016212802429802; Fafin C, 2012, NEPHRON CLIN PRACT, V120, pC205, DOI 10.1159/000342377; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Ibrahim F, 2012, AM J KIDNEY DIS, V60, P539, DOI 10.1053/j.ajkd.2012.03.006; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Izzedine H, 2007, NEPHROL DIAL TRANSPL, V22, P2757, DOI 10.1093/ndt/gfm404; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kalayjian RC, 2010, ADV CHRONIC KIDNEY D, V17, P59, DOI 10.1053/j.ackd.2009.08.013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Longenecker CT, 2009, AIDS, V23, P1089, DOI 10.1097/QAD.0b013e32832a3f24; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Ministry of Health Working Group on Clinical AIDS Treatment, 2012, CHIN FREE ANT THER M; Monteagudo-Chu Maricelle O, 2012, J Pharm Pract, V25, P552; Naicker S, 2010, CLIN NEPHROL, V74, pS51; Orlando G, 2006, HIV MED, V7, P549, DOI 10.1111/j.1468-1293.2006.00420.x; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Rasch MG, 2012, SCAND J INFECT DIS, V44, P689, DOI 10.3109/00365548.2012.673730; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Winston JA, 2010, ADV CHRONIC KIDNEY D, V17, P19, DOI 10.1053/j.ackd.2009.08.006; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	30	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135462	10.1371/journal.pone.0135462	http://dx.doi.org/10.1371/journal.pone.0135462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317657	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100030
J	Zheng, SS; Lu, Q; Xu, YH; Wang, XN; Shen, JL; Wang, W				Zheng, Shengsheng; Lu, Qiang; Xu, Yuanhong; Wang, Xiaonan; Shen, Jilong; Wang, Wei			GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver	PLOS ONE			English	Article							KUPFFER CELLS; OPPOSING ROLES; IL-13 RECEPTOR; DECOY RECEPTOR; GROWTH-FACTOR; UP-REGULATION; ACTIVATION; INFLAMMATION; EXPRESSION; DEPLETION	Early-stage hepatic granuloma and advanced-stage fibrosis are important characteristics of schistosomiasis. The direct consequences of gadolinium chloride (GdCl3) in egg-induced granuloma formation have not been reported, although GdCl3 is known to block the macrophages. In present study, mice were infected with 15 Schistosoma japonicum (S. japonicum) cercariae and treated with GdCl3 (10 mg/kg body weight) twice weekly from day 21 to day 42 post-infection during the onset of egg-laying towards early granuloma formation. Histochemical staining showed that repeated injection of GdCl3 decreased macrophages infiltration in liver of mice infected with S. japonicum. Macrophage depletion by GdCl3 during the initial phase attenuated liver pathological injury characterized by smaller granuloma size and decreased immune inflammation as well as less fibrogenesis. In addition, IL-13R alpha 2 expression was reduced by GdCl3 in liver of mice infected with S. japonicum. The results suggest that GdCl3 depleted macrophages, which attenuated helminth infected immune responses involving with IL-13R alpha 2 signal. These findings would highlight a therapeutic potential via manipulating IL-13R alpha 2+ macrophage in schistosomiasis.	[Zheng, Shengsheng; Wang, Xiaonan; Shen, Jilong; Wang, Wei] Anhui Med Univ, Dept Pathobiol, Key Labs Zoonoses Anhui Prov, Hefei 230032, Peoples R China; [Lu, Qiang] Anhui Med Univ, Dept Clin Med, Hefei 230032, Peoples R China; [Xu, Yuanhong] Anhui Med Univ, Dept Lab Diagnost, Affiliated Hosp 1, Hefei 230032, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wang, W (corresponding author), Anhui Med Univ, Dept Pathobiol, Key Labs Zoonoses Anhui Prov, Hefei 230032, Peoples R China.	aydwwei@163.com			Natural Science Foundation of China [30940061, 81171606]; Foundation of Anhui Medical University [XJ201012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Anhui Medical University	This work was supported by the Natural Science Foundation of China (No. 30940061 and No. 81171606) and the Foundation of Anhui Medical University (No. XJ201012).	Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Bernard J, 2001, LAB INVEST, V81, P1223, DOI 10.1038/labinvest.3780336; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Brunner SM, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-16; Chen MG, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-6; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Dang H, 2014, INT J ENV RES PUB HE, V11, P2278, DOI 10.3390/ijerph110202278; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Friedman SL, 2005, J CLIN INVEST, V115, P29, DOI 10.1172/JCI200523928; Greenwald B, 2005, GASTROENTEROL NURS, V28, P206; Greenwald Beverly, 2005, Gastroenterol Nurs, V28, P203, DOI 10.1097/00001610-200505000-00002; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hu Y, 2014, INT J ENV RES PUB HE, V11, P701, DOI 10.3390/ijerph110100701; HUSZTIK E, 1980, BRIT J EXP PATHOL, V61, P624; Kaplan MH, 1998, J IMMUNOL, V160, P1850; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Liu Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00116; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Magalhaes A, 2004, MEM I OSWALDO CRUZ, V99, P21, DOI 10.1590/S0074-02762004000900004; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mentink-Kane MM, 2004, P NATL ACAD SCI USA, V101, P586, DOI 10.1073/pnas.0305064101; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Mizgerd JP, 1996, J LEUKOCYTE BIOL, V59, P189, DOI 10.1002/jlb.59.2.189; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muriel P, 2003, J APPL TOXICOL, V23, P103, DOI 10.1002/jat.892; Qi Y, 2012, IMMUNOL LETT, V144, P60, DOI 10.1016/j.imlet.2012.03.007; RAGHEB S, 1989, J IMMUNOL, V142, P3239; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Smith P, 2004, J IMMUNOL, V173, P1240, DOI 10.4049/jimmunol.173.2.1240; Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tucker Matthew S, 2013, Curr Protoc Immunol, V103, DOI 10.1002/0471142735.im1901s103; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang W, 2009, CHINESE MED J-PEKING, V122, P1650, DOI 10.3760/cma.j.issn.0366-6999.2009.14.009; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	52	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0132222	10.1371/journal.pone.0132222	http://dx.doi.org/10.1371/journal.pone.0132222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317423	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100004
J	Guevara, RE; Motala, T; Terashita, D				Guevara, Ramon E.; Motala, Tasneem; Terashita, Dawn			The Changing Epidemiology of Coccidioidomycosis in Los Angeles (LA) County, California, 1973-2011	PLOS ONE			English	Article							OUTBREAK; ARIZONA; WORKERS; USA	Coccidioidomycosis, also known as Valley Fever, is often thought of as an endemic disease of central California exclusive of Los Angeles County. The fungus that causes Valley Fever, Coccidioides spp., grows in previously undisturbed soil of semi-arid and arid environments of certain areas of the Americas. LA County has a few large areas with such environments, particularly the Antelope Valley which has been having substantial land development. Coccidioidomycosis that is both clinically-and laboratory-confirmed is a mandated reportable disease in LA County. Population surveillance data for 1973-2011 reveals an annual rate increase from 0.87 to 3.2 cases per 100,000 population (n = 61 to 306 annual cases). In 2004, case frequency started substantially increasing with notable epidemiologic changes such as a rising 2.1 to 5.7 male-to-female case ratio stabilizing to 1.4-2.2. Additionally, new building construction in Antelope Valley greatly rose in 2003 and displayed a strong correlation (R = 0.92, Pearson p< 0.0001) with overall LA County incidence rates for 1996-2007. Of the 24 LA County health districts, 19 had a 100%-1500% increase in cases when comparing 2000-2003 to 2008-2011. Case residents of endemic areas had stronger odds of local exposures, but cases from areas not known to be endemic had greater mortality (14% versus 9%) with notably more deaths during 2008-2011. Compared to the 57 other California counties during 2001-2011, LA County had the third highest average annual number of cases and Antelope Valley had a higher incidence rate than all but six counties. With the large number of reported coccidioidomycosis cases, multi-agency and community partnering is recommended to develop effective education and prevention strategies to protect residents and travelers.	[Guevara, Ramon E.] Cty Los Angeles, Dept Publ Hlth, Emergency Preparedness & Response Program, Los Angeles, CA 90059 USA; [Motala, Tasneem; Terashita, Dawn] Cty Los Angeles, Acute Communicable Dis Control Program, Dept Publ Hlth, Los Angeles, CA USA	Los Angeles County Department of Public Health; Los Angeles County Department of Public Health	Guevara, RE (corresponding author), Cty Los Angeles, Dept Publ Hlth, Emergency Preparedness & Response Program, Los Angeles, CA 90059 USA.	rguevara@ph.lacounty.gov						Ampel Neil M, 2010, Curr Infect Dis Rep, V12, P211, DOI 10.1007/s11908-010-0094-3; California Department of Public Health, 2010, YEARLY SUMMARIES OF; Centers for Disease Control and Prevention, 2011, NNDSS CONDITION CASE; Centers for Disease Control and Prevention, 2014, VALLEY FEVER COCCIDI; Chapman R, 2010, CALIFORNIA DEPARTMEN; Chen S, 2011, MED MYCOL, V49, P649, DOI 10.3109/13693786.2010.547995; Comrie AC, 2005, ENVIRON HEALTH PERSP, V113, P688, DOI 10.1289/ehp.7786; Comrie AC, 2007, ANN NY ACAD SCI, V1111, P83, DOI 10.1196/annals.1406.024; COWPER H. H., 1953, CALIFORNIA MED, V79, P97; Cummings KC, 2010, EPIDEMIOL INFECT, V138, P507, DOI 10.1017/S0950268809990999; Faber HK, 1939, J PEDIATR-US, V15, P163, DOI 10.1016/S0022-3476(39)80026-9; Flaherman VJ, 2007, EMERG INFECT DIS, V13, P1087, DOI 10.3201/eid1307.061480; Galgiani JN, 2005, CLIN INFECT DIS, V41, P1217, DOI 10.1086/496991; Johnson RH, 1996, COCCIDIOIDOMYCOSIS, P77; KRITZER MD, 1950, ANN INTERN MED, V33, P960, DOI 10.7326/0003-4819-33-4-960; Laniado-Laborin R, 2007, ANN NY ACAD SCI, V1111, P19, DOI 10.1196/annals.1406.004; Lauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111921; LEVAN NE, 1965, ARCH DERMATOL, V92, P215, DOI 10.1001/archderm.92.3.215; LEVAN NORMAN E., 1954, CALIFORNIA MED, V80, P294; Maclean ML, 2014, THE EPIDEMIOLOGY OF; Marsden-Haug N, 2014, MMWR-MORBID MORTAL W, V63, P450; MATLOF H, 1970, PUBLIC HEALTH REP, V85, P393, DOI 10.2307/4593861; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; Perera P, 2002, ANN EMERG MED, V39, P566, DOI 10.1067/mem.2002.123550; Saubolle MA, 2007, J CLIN MICROBIOL, V45, P26, DOI 10.1128/JCM.02230-06; SCHMELZER LL, 1968, AM J PUBLIC HEALTH N, V58, P107, DOI 10.2105/AJPH.58.1.107; Schmitt SJ, 2009, U S GEOLOGICAL SURVE, V479, P79; Schneider E, 1997, JAMA-J AM MED ASSOC, V277, P904, DOI 10.1001/jama.277.11.904; Silvaggio J, 2013, ACUTE COMMUN DIS CON, P27; Sondermeyer G, 2013, EMERG INFECT DIS, V19, P1590, DOI 10.3201/eid1910.130427; Tsang CA, 2013, MMWR-MORBID MORTAL W, V62, P217; Tsang CA, 2010, EMERG INFECT DIS, V16, P1738, DOI 10.3201/eid1611.100475; United States Bureau of Labor Statistics, 2013, HOUSEHOLD DATA ANNUA; US Census Bureau Data Integration Division, 2012, POPULATION ESTIMATES; Werner SB, 1996, COCCIDIOIDOMYCOSIS, P363; Wilken J., 2013, 2013 CSTE ANNUAL CON; Wilken JA, 2014, MMWR-MORBID MORTAL W, V63, P321; WILLIAMS PL, 1979, CHEST, V76, P566, DOI 10.1378/chest.76.5.566	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136753	10.1371/journal.pone.0136753	http://dx.doi.org/10.1371/journal.pone.0136753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313151	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000093
J	Martinez-Garcia, PM; Rodriguez-Palenzuela, P; Arrebola, E; Carrion, VJ; Gutierrez-Barranquero, JA; Perez-Garcia, A; Ramos, C; Cazorla, FM; de Vicente, A				Manuel Martinez-Garcia, Pedro; Rodriguez-Palenzuela, Pablo; Arrebola, Eva; Carrion, Victor J.; Antonio Gutierrez-Barranquero, Jose; Perez-Garcia, Alejandro; Ramos, Cayo; Cazorla, Francisco M.; de Vicente, Antonio			Bioinformatics Analysis of the Complete Genome Sequence of the Mango Tree Pathogen Pseudomonas syringae pv. syringae UMAF0158 Reveals Traits Relevant to Virulence and Epiphytic Lifestyle	PLOS ONE			English	Article							III SECRETION SYSTEMS; GENE-CLUSTER; VI SECRETION; HYPERSENSITIVE RESPONSE; PHASEOLICOLA 1448A; COPPER RESISTANCE; EFFECTOR PROTEINS; PLANT-PATHOGENS; TOMATO; HOST	The genome sequence of more than 100 Pseudomonas syringae strains has been sequenced to date; however only few of them have been fully assembled, including P. syringae pv. syringae B728a. Different strains of pv. syringae cause different diseases and have different host specificities; so, UMAF0158 is a P. syringae pv. syringae strain related to B728a but instead of being a bean pathogen it causes apical necrosis of mango trees, and the two strains belong to different phylotypes of pv. syringae and clades of P. syringae. In this study we report the complete sequence and annotation of P. syringae pv. syringae UMAF0158 chromosome and plasmid pPSS158. A comparative analysis with the available sequenced genomes of other 25 P. syringae strains, both closed (the reference genomes DC3000, 1448A and B728a) and draft genomes was performed. The 5.8 Mb UMAF0158 chromosome has 59.3% GC content and comprises 5017 predicted protein-coding genes. Bioinformatics analysis revealed the presence of genes potentially implicated in the virulence and epiphytic fitness of this strain. We identified several genetic features, which are absent in B728a, that may explain the ability of UMAF0158 to colonize and infect mango trees: the mangotoxin biosynthetic operon mbo, a gene cluster for cellulose production, two different type III and two type VI secretion systems, and a particular T3SS effector repertoire. A mutant strain defective in the rhizobial-like T3SS Rhc showed no differences compared to wild-type during its interaction with host and non-host plants and worms. Here we report the first complete sequence of the chromosome of a pv. syringae strain pathogenic to a woody plant host. Our data also shed light on the genetic factors that possibly determine the pathogenic and epiphytic lifestyle of UMAF0158. This work provides the basis for further analysis on specific mechanisms that enable this strain to infect woody plants and for the functional analysis of host specificity in the P. syringae complex.	[Manuel Martinez-Garcia, Pedro; Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Ctr Biotecnol Genom Plantas UPM INIA, Madrid, Spain; [Arrebola, Eva] Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Estn Expt La Mayora, E-29071 Malaga, Spain; [Carrion, Victor J.; Antonio Gutierrez-Barranquero, Jose; Perez-Garcia, Alejandro; Cazorla, Francisco M.; de Vicente, Antonio] Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Dept Microbiol,Fac Ciencias, E-29071 Malaga, Spain; [Manuel Martinez-Garcia, Pedro; Ramos, Cayo] Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Area Genet,Fac Ciencias, E-29071 Malaga, Spain	Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	de Vicente, A (corresponding author), Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Dept Microbiol,Fac Ciencias, E-29071 Malaga, Spain.	adevicente@uma.es	Perez-Garcia, Alejandro/D-9373-2013; Arrebola, Eva/AGY-5955-2022; Carrion, Victor/GPG-1248-2022; RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; RAMOS, CAYO/G-3818-2011; de Vicente, Antonio/G-4405-2011; Bravo, Victor Carrion/A-9387-2014; Arrebola-Diez, Eva/H-1628-2011; Barranquero, Jose Antonio Gutiérrez/AAS-5444-2021; Gutierrez Barranquero, Jose Antonio/K-7745-2014; Cazorla, Francisco M./G-3907-2011	Perez-Garcia, Alejandro/0000-0002-1065-0360; Arrebola, Eva/0000-0002-2308-7829; RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; RAMOS, CAYO/0000-0002-2362-5041; de Vicente, Antonio/0000-0003-2716-9861; Bravo, Victor Carrion/0000-0002-4093-0355; Arrebola-Diez, Eva/0000-0002-2308-7829; Barranquero, Jose Antonio Gutiérrez/0000-0003-1810-699X; Gutierrez Barranquero, Jose Antonio/0000-0003-1810-699X; Martinez Garcia, Pedro Manuel/0000-0002-2119-2465; Cazorla, Francisco M./0000-0003-0798-0964	Consejeria de Innovacion, Ciencia y Empresa, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spain [P07-AGR-2471, P12-AGR-1473]; FEDER; ESF; Campus de Excelencia Internacional Andalucia Tech	Consejeria de Innovacion, Ciencia y Empresa, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spain; FEDER(European Commission); ESF(European Commission); Campus de Excelencia Internacional Andalucia Tech	This study was supported by funding from Consejeria de Innovacion, Ciencia y Empresa, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spain (Incentivos a Proyectos de Excelencia P07-AGR-2471 and P12-AGR- 1473), cofinanced by FEDER funds (EU). This work was developed during EA hired in the CSIC by the program mode JAEDoc "Junta para la Ampliacion de Estudios" cofinanced by ESF. PMMG was supported by the Campus de Excelencia Internacional Andalucia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Adaikkalam V, 2002, MICROBIOL-SGM, V148, P2857, DOI 10.1099/00221287-148-9-2857; Agrios GN, 2005, PLANT PATHOLOGY; Aguilera S, 2007, J BACTERIOL, V189, P2834, DOI 10.1128/JB.01845-06; Arrebola E, 2003, PHYSIOL MOL PLANT P, V63, P117, DOI 10.1016/j.pmpp.2003.11.003; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Arrebola E, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-10; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bartoli C, 2015, MOL PLANT PATHOL, V16, P137, DOI 10.1111/mpp.12167; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Bose M., 2006, In Silico Biology, V6, P223; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Bull CT, 2010, J PLANT PATHOL, V92, P551; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cai RM, 2011, INFECT GENET EVOL, V11, P1738, DOI 10.1016/j.meegid.2011.07.012; Carrion VJ, 2013, APPL ENVIRON MICROB, V79, P756, DOI 10.1128/AEM.03007-12; Carrion VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036709; Cazorla FM, 2008, MICROB ECOL, V56, P283, DOI 10.1007/s00248-007-9346-7; Cazorla FM, 2002, PHYTOPATHOLOGY, V92, P909, DOI 10.1094/PHYTO.2002.92.8.909; Cazorla FM, 1998, PHYTOPATHOLOGY, V88, P614, DOI 10.1094/PHYTO.1998.88.7.614; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Clarke CR, 2010, MOL PLANT MICROBE IN, V23, P198, DOI 10.1094/MPMI-23-2-0198; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Egan F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00034; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gazi AD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-188; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Gutierrez-Barranquero JA, 2013, PHYTOPATHOLOGY, V103, P1115, DOI 10.1094/PHYTO-04-13-0093-R; Gutierrez-Barranquero JA, 2013, APPL ENVIRON MICROB, V79, P1028, DOI 10.1128/AEM.02644-12; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Hoss S, 2012, ENVIRON TOXICOL CHEM, V31, P1525, DOI 10.1002/etc.1843; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; Krahn D, 2011, NAT PROD REP, V28, P1854, DOI [10.1039/c1np00048a, 10.1039/C1NP00048A]; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamichhane JR, 2014, ADV AGRON, V126, P235, DOI 10.1016/B978-0-12-800132-5.00004-3; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Li JY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-31; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Lindow SE, 1985, ENG ORGANISMS ENV SC, P23; Martinez-Garcia PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119317; Marcelletti S, 2014, PHYTOPATHOLOGY, V104, P1274, DOI 10.1094/PHYTO-12-13-0344-R; Matas IM, 2014, MOL PLANT MICROBE IN, V27, P424, DOI 10.1094/MPMI-07-13-0206-R; Matthysse AG, 2008, CAN J MICROBIOL, V54, P241, DOI [10.1139/W08-005, 10.1139/w08-005]; Mhedbi-Hajri N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-67; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Mutka AM, 2013, PLANT J, V74, P746, DOI 10.1111/tpj.12157; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PenalozaVazquez A, 1997, J BACTERIOL, V179, P4464, DOI 10.1128/jb.179.14.4464-4472.1997; Perez-Martinez I, 2010, APPL ENVIRON MICROB, V76, P3611, DOI 10.1128/AEM.00133-10; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pradhan BB, 2012, MOL PLANT MICROBE IN, V25, P1157, DOI 10.1094/MPMI-02-12-0049-R; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schellenberg B, 2010, MOL PLANT MICROBE IN, V23, P1287, DOI 10.1094/MPMI-04-10-0094; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sudo T, 1996, BIOCHEM J, V319, P99, DOI 10.1042/bj3190099; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Volksch B, 1998, J BASIC MICROB, V38, P135; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Wensing A, 2010, APPL ENVIRON MICROB, V76, P2704, DOI 10.1128/AEM.02979-09; Zhang LL, 2007, MOL MICROBIOL, V65, P121, DOI 10.1111/j.1365-2958.2007.05775.x; Zhang XX, 2013, EVOLUTION, V67, P3161, DOI 10.1111/evo.12183; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zumaquero A, 2010, J BACTERIOL, V192, P4474, DOI 10.1128/JB.00260-10	99	25	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136101	10.1371/journal.pone.0136101	http://dx.doi.org/10.1371/journal.pone.0136101			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313942	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000041
J	Ullman, C; Mathonet, P; Oleksy, A; Diamandakis, A; Tomei, L; Demartis, A; Nardi, C; Sambucini, S; Missineo, A; Alt, K; Hagemeyer, CE; Harris, M; Hedt, A; Weis, R; Gehlsen, KR				Ullman, Christopher; Mathonet, Pascale; Oleksy, Arkadiusz; Diamandakis, Agata; Tomei, Licia; Demartis, Anna; Nardi, Chiara; Sambucini, Sonia; Missineo, Antonino; Alt, Karen; Hagemeyer, Christoph E.; Harris, Matt; Hedt, Amos; Weis, Roland; Gehlsen, Kurt R.			High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting	PLOS ONE			English	Article							IN-VITRO SELECTION; ANTIBODY FRAGMENTS; PROTEINS; LIGAND; PEPTIDES; EFFICACY; DOMAINS; PK	Abdurins are a novel antibody-like scaffold derived from the engineering of a single isolated CH2 domain of human IgG. Previous studies established the prolonged serum half-life of Abdurins, the result of a retained FcRn binding motif. Here we present data on the construction of large, diverse, phage-display and cell-free DNA display libraries and the isolation of high affinity binders to the cancer target, membrane-bound ephrin receptor tyrosine kinase class A2 (EphA2). Antigen binding regions were created by designing combinatorial libraries into the structural loops and Abdurins were selected using phage display methods. Initial binders were reformatted into new maturation libraries and low nanomolar binders were isolated using cell-free DNA display, CIS display. Further characterization confirmed binding of the Abdurins to both human and murine EphA2 proteins and exclusively to cell lines that expressed EphA2, followed by rapid internalization. Two different EphA2 binders were labeled with Cu-64, using a bifunctional MeCOSar chelator, and administered to mice bearing tumors from transplanted human prostate cancer cells, followed by PET/CT imaging. The anti-EphA2 Abdurins localized in the tumors as early as 4 hours after injection and continued to accumulate up to 48 hours when the imaging was completed. These data demonstrate the ability to isolate high affinity binders from the engineered Abdurin scaffold, which retain a long serum half-life, and specifically target tumors in a xenograft model.	[Ullman, Christopher; Mathonet, Pascale; Oleksy, Arkadiusz; Diamandakis, Agata] Isogenica Ltd, Cambridge, England; [Tomei, Licia; Demartis, Anna; Nardi, Chiara; Sambucini, Sonia; Missineo, Antonino] IRBM Sci Pk, Rome, Italy; [Alt, Karen; Hagemeyer, Christoph E.] Baker IDI, Vasc Biotechnol, Melbourne, Vic, Australia; [Harris, Matt; Hedt, Amos] Clar Pharmaceut Ltd, Sydney, NSW, Australia; [Weis, Roland] VTU Technol, Grambach, Austria; [Gehlsen, Kurt R.] Res Corp Technol Inc, Tucson, AZ 85711 USA	Isogenica Limited	Gehlsen, KR (corresponding author), Res Corp Technol Inc, Tucson, AZ 85711 USA.	kgehlsen@rctech.com	Hagemeyer, Christoph/E-8958-2011; Alt, Karen/E-8364-2019	Hagemeyer, Christoph/0000-0002-7114-4023; Alt, Karen/0000-0002-6252-1931	Research Corporation Technologies, Inc.; Isogenica, Ltd.; IRBM Science Park; Baker IDI; Clarity Pharmaceuticals; VTU Technology Ltd.	Research Corporation Technologies, Inc.; Isogenica, Ltd.; IRBM Science Park; Baker IDI; Clarity Pharmaceuticals; VTU Technology Ltd.	This study was funded and sponsored by Research Corporation Technologies, Inc. and the research activities directed by KRG. KRG and the authors made the decision to publish this work. Research Corporation Technologies, Inc., Isogenica, Ltd., IRBM Science Park, Baker IDI, Clarity Pharmaceuticals and VTU Technology Ltd. provided support in the form of salaries for the authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Annunziata CM, 2013, INVEST NEW DRUG, V31, P77, DOI 10.1007/s10637-012-9801-2; Ansuini H, 2009, J ONCOL, V2009, DOI 10.1155/2009/951917; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Di Bartolo NM, 2001, J CHEM SOC DALTON, P2303, DOI 10.1039/b103242a; Diem MD, 2014, PROTEIN ENG DES SEL, V27, P419, DOI 10.1093/protein/gzu016; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Eldridge B, 2009, PROTEIN ENG DES SEL, V22, P691, DOI 10.1093/protein/gzp052; Erickson HK, 2012, AAPS J, V14, P799, DOI 10.1208/s12248-012-9386-x; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Gehlsen KR, 2012, MABS, V4, P1; Gong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042288; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Graff CP, 2003, CANCER RES, V63, P1288; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Muchekehu R, 2013, TRANSL ONCOL, V6, P562, DOI 10.1593/tlo.13409; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Paterson BM, 2014, DALTON T, V43, P1386, DOI 10.1039/c3dt52647j; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Wang S, 2012, J MED CHEM, V55, P2427, DOI 10.1021/jm201743s; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V387, P387, DOI 10.1016/j.bbrc.2009.07.044; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	36	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135278	10.1371/journal.pone.0135278	http://dx.doi.org/10.1371/journal.pone.0135278			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313909	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000016
J	Becnel, LB; Darlington, YF; Ochsner, SA; Easton-Marks, JR; Watkins, CM; McOwiti, A; Kankanamge, WH; Wise, MW; DeHart, M; Margolis, RN; McKenna, NJ				Becnel, Lauren B.; Darlington, Yolanda F.; Ochsner, Scott A.; Easton-Marks, Jeremy R.; Watkins, Christopher M.; McOwiti, Apollo; Kankanamge, Wasula H.; Wise, Michael W.; DeHart, Michael; Margolis, Ronald N.; McKenna, Neil J.			Nuclear Receptor Signaling Atlas: Opening Access to the Biology of Nuclear Receptor Signaling Pathways	PLOS ONE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; ER-ALPHA; ESTROGEN; COREGULATORS; NETWORKS; RESOURCE	Signaling pathways involving nuclear receptors (NRs), their ligands and coregulators, regulate tissue-specific transcriptomes in diverse processes, including development, metabolism, reproduction, the immune response and neuronal function, as well as in their associated pathologies. The Nuclear Receptor Signaling Atlas (NURSA) is a Consortium focused around a Hub website (www.nursa.org) that annotates and integrates diverse 'omics datasets originating from the published literature and NURSA-funded Data Source Projects (NDSPs). These datasets are then exposed to the scientific community on an Open Access basis through user-friendly data browsing and search interfaces. Here, we describe the redesign of the Hub, version 3.0, to deploy "Web 2.0" technologies and add richer, more diverse content. The Molecule Pages, which aggregate information relevant to NR signaling pathways from myriad external databases, have been enhanced to include resources for basic scientists, such as post-translational modification sites and targeting miRNAs, and for clinicians, such as clinical trials. A portal to NURSA's Open Access, PubMed-indexed journal Nuclear Receptor Signaling has been added to facilitate manuscript submissions. Datasets and information on reagents generated by NDSPs are available, as is information concerning periodic new NDSP funding solicitations. Finally, the new website integrates the Transcriptomine analysis tool, which allows for mining of millions of richly annotated public transcriptomic data points in the field, providing an environment for dataset re-use and citation, bench data validation and hypothesis generation. We anticipate that this new release of the NURSA database will have tangible, long term benefits for both basic and clinical research in this field.	[Becnel, Lauren B.; Darlington, Yolanda F.; Easton-Marks, Jeremy R.; Watkins, Christopher M.; McOwiti, Apollo; Kankanamge, Wasula H.; DeHart, Michael] Dan L Duncan Comprehens Canc Ctr, Biomed Informat Grp, Houston, TX USA; [Ochsner, Scott A.; McKenna, Neil J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wise, Michael W.; Margolis, Ronald N.] NIDDK, Div Diabet & Metab Dis, Bethesda, MD USA; [Becnel, Lauren B.; Darlington, Yolanda F.; Ochsner, Scott A.; Easton-Marks, Jeremy R.; Watkins, Christopher M.; McOwiti, Apollo; Kankanamge, Wasula H.; Wise, Michael W.; DeHart, Michael; McKenna, Neil J.] Nucl Receptor Signaling Atlas NURSA Informat Hub, Bethesda, MD USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	McKenna, NJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	nmckenna@bcm.edu	Margolis, Ronald N/O-7773-2015	Margolis, Ronald N/0000-0002-8956-0455; Easton-Marks, Jeremy/0000-0002-2263-7454; Ochsner, Scott/0000-0003-1099-7863	National Institute of Diabetes Digestive and Kidney Diseases; Eunice Kennedy Shriver National Institute of Child Health and Development [DK097748]; National Institutes of Health Big Data To Knowledge (BD2K) program [DK097748-S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097748] Funding Source: NIH RePORTER	National Institute of Diabetes Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Big Data To Knowledge (BD2K) program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NURSA is supported by grants from the National Institute of Diabetes Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Development (DK097748) and by the National Institutes of Health Big Data To Knowledge (BD2K) program (DK097748-S1).	Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; De Mattia E, 2013, PHARMACOGENOMICS, V14, P2035, DOI [10.2217/pgs.13.214, 10.2217/PGS.13.214]; Delfosse V, 2015, ACTA PHARMACOL SIN, V36, P88, DOI 10.1038/aps.2014.133; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Jelinsky SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-27; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; Martinez E, 1997, NUCLEIC ACIDS RES, V25, P163, DOI 10.1093/nar/25.1.163; Maslov S, 2008, J NEUROSCI, V28, P11103, DOI 10.1523/JNEUROSCI.0002-08.2008; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; McKenna Neil J, 2014, Nucl Recept Signal, V12, pe006, DOI 10.1621/nrs.12006; McKenna Neil J, 2005, Sci STKE, V2005, ptr22, DOI 10.1126/stke.2992005tr22; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1589, DOI 10.1289/ehp.7345; Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027; Naciff JM, 2010, TOXICOLOGY, V270, P137, DOI 10.1016/j.tox.2010.02.008; Nott SL, 2009, J BIOL CHEM, V284, P15277, DOI 10.1074/jbc.M900365200; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Schulman IG, 2010, ADV DRUG DELIVER REV, V62, P1307, DOI 10.1016/j.addr.2010.07.002; Snyder EM, 2009, BIOL REPROD, V81, P707, DOI 10.1095/biolreprod.109.079053; Tolhurst RS, 2011, BREAST CANCER RES TR, V128, P357, DOI 10.1007/s10549-010-1122-6; Vroling B, 2012, NUCLEIC ACIDS RES, V40, pD377, DOI 10.1093/nar/gkr960	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135615	10.1371/journal.pone.0135615	http://dx.doi.org/10.1371/journal.pone.0135615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325041	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700022
J	Gao, CL; Cai, Y; Zhang, XB; Huang, HL; Wang, J; Wang, YJ; Tong, XG; Wang, JH; Wu, JL				Gao, Chunlin; Cai, Ying; Zhang, Xuebin; Huang, Huiling; Wang, Jin; Wang, Yajing; Tong, Xiaoguang; Wang, Jinhuan; Wu, Jialing			Ischemic Preconditioning Mediates Neuroprotection against Ischemia in Mouse Hippocampal CA1 Neurons by Inducing Autophagy	PLOS ONE			English	Article							NEONATAL HYPOXIA-ISCHEMIA; CEREBRAL-ISCHEMIA; PLASMINOGEN-ACTIVATOR; SIGNALING PATHWAY; CELL-DEATH; PROTECTS; INJURY; DAMAGE; BRAIN; INHIBITION	The hippocampal CA1 region is sensitive to hypoxic and ischemic injury but can be protected by ischemic preconditioning (IPC). However, the mechanism through which IPC protects hippocampal CA1 neurons is still under investigation. Additionally, the role of autophagy in determining the fate of hippocampal neurons is unclear. Here, we examined whether IPC induced autophagy to alleviate hippocampal CA1 neuronal death in vitro and in vivo with oxygen glucose deprivation (OGD) and bilateral carotid artery occlusion (BCCAO) models. Survival of hippocampal neurons increased from 51.5% +/- 6.3% in the non-IPC group (55 min of OGD) to 77.3% +/- 7.9% in the IPC group (15 min of OGD, followed by 55 min of OGD 24 h later). The number of hippocampal CA1 layer neurons increased from 182 +/- 26 cells/mm(2) in the non-IPC group (20 min of BCCAO) to 278 +/- 55 cells/mm(2) in the IPC group (1 min x 3 BCCAO, followed by 20 min of BCCAO 24 h later). Akt phosphorylation and microtubule-associated protein light chain 3 (LC3)-II/LC3-I expression were increased in the preconditioning group. Moreover, the protective effects of IPC were abolished only by inhibiting the activity of autophagy, but not by blocking the activation of Akt in vitro. Using in vivo experiments, we found that LC3 expression was upregulated, accompanied by an increase in neuronal survival in hippocampal CA1 neurons in the preconditioning group. The neuroprotective effects of IPC on hippocampal CA1 neurons were completely inhibited by treatment with 3-MA. In contrast, hippocampal CA3 neurons did not show changes in autophagic activity or beneficial effects of IPC. These data suggested that IPC may attenuate ischemic injury in hippocampal CA1 neurons through induction of Akt-independent autophagy.	[Gao, Chunlin; Wang, Jin; Wang, Yajing; Wu, Jialing] Tianjin Huanhu Hosp, Dept Neurol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Cai, Ying; Huang, Huiling] Tianjin Huanhu Hosp, Dept Neurosci, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin Neurosurg Inst, Tianjin, Peoples R China; [Zhang, Xuebin] Tianjin Huanhu Hosp, Dept Pathol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Tong, Xiaoguang; Wang, Jinhuan] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin Neurosurg Inst, Tianjin, Peoples R China		Wu, JL (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China.	wywjl2009@hotmail.com			Tianjin Public Health Bureau [2013KG122]; Tianjin Municipal Science and Technology Commission [13JCYBJC23200, 13ZCZDSY01600]	Tianjin Public Health Bureau; Tianjin Municipal Science and Technology Commission	The work reported in this article was generously supported by grants from Tianjin Public Health Bureau (2013KG122) to J.W. (http://www.tjwsj.gov.cn), Tianjin Municipal Science and Technology Commission (13JCYBJC23200) to J.W. (http://www.tstc.gov.cn), and (13ZCZDSY01600) to X.T. (http://www.tstc.gov.cn).	An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Cohen MV, 2006, CARDIOVASC RES, V70, P231, DOI 10.1016/j.cardiores.2005.10.021; Cui DR, 2013, NEUROSCIENCE, V246, P117, DOI 10.1016/j.neuroscience.2013.04.054; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Feng YZ, 2010, BRAIN RES, V1325, P1, DOI 10.1016/j.brainres.2010.02.029; Galle AA, 2013, BRAIN RES, V1498, P1, DOI 10.1016/j.brainres.2012.12.026; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Giricz Z, 2012, J CARDIOVASC PHARM, V60, P125, DOI 10.1097/FJC.0b013e318256ce10; Gu WW, 2013, ACTA PHARMACOL SIN, V34, P1007, DOI 10.1038/aps.2013.30; Jeffs GJ, 2008, EXP NEUROL, V210, P268, DOI 10.1016/j.expneurol.2007.10.013; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069910; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lehotsky J, 2009, ANAT REC, V292, P2002, DOI 10.1002/ar.20970; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Papadakis M, 2013, NAT MED, V19, P351, DOI 10.1038/nm.3097; PEDIGO NW, 1975, J PHARMACOL EXP THER, V193, P845; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Qi ZF, 2012, CNS NEUROSCI THER, V18, P965, DOI 10.1111/cns.12016; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Surendra H, 2013, J MOL CELL CARDIOL, V60, P142, DOI 10.1016/j.yjmcc.2013.04.010; Tu XK, 2015, J MOL NEUROSCI, V55, P912, DOI 10.1007/s12031-014-0446-9; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang RM, 2009, BRAIN RES, V1255, P32, DOI 10.1016/j.brainres.2008.12.011; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Xiang J, 2010, CAN J PHYSIOL PHARM, V88, P907, DOI [10.1139/Y10-069, 10.1139/y10-069]; Yan WJ, 2013, ACTA PHARMACOL SIN, V34, P636, DOI 10.1038/aps.2013.18; Yang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096509; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhou CF, 2011, NEUROCHEM INT, V59, P749, DOI 10.1016/j.neuint.2011.08.008	35	18	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137146	10.1371/journal.pone.0137146	http://dx.doi.org/10.1371/journal.pone.0137146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325184	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700100
J	Aguera, ML; Martin-Malo, A; Alvarez-Lara, MA; Garcia-Montemayor, VE; Canton, P; Soriano, S; Aljama, P				Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Eugenia Garcia-Montemayor, Victoria; Canton, Petra; Soriano, Sagrario; Aljama, Pedro			Efficiency of Original versus Generic Intravenous Iron Formulations in Patients on Haemodialysis	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; ANEMIA MANAGEMENT; MORTALITY; DISEASE; DRUGS; OUTCOMES	Aims The appropriate use of intravenous (IV) iron is essential to minimise the requirements for erythropoiesis-stimulating agents (ESAs). The clinical efficacy of generic IV iron compared to the original formulation is controversial. We evaluated the changes that were induced after switching from a generic IV iron to an original formulation in a stable, prevalent haemodialysis (HD) population. Methods A total of 342 patients were included, and the follow-up period was 56 weeks for each formulation. Anaemia parameters and doses of ESA and IV iron were prospectively recorded before and after the switch from generic to original IV iron. Results To maintain the same haemoglobin (Hb) levels after switching from the generic to the original formulation, the requirements for IV iron doses were reduced by 34.3% (from 52.8 +/- 33.9 to 34.7 +/- 31.8mg/week, p<0.001), and the ESA doses were also decreased by 12.5% (from 30.6 +/- 23.6 to 27 +/- 21 mu g/week, p<0.001). The erythropoietin resistance index declined from 8.4 +/- 7.7 to 7.4 +/- 6.7 IU/kg/week/g/dl after the switch from the generic to the original drug (p = 0.001). After the switch, the transferrin saturation ratio (TSAT) and serum ferritin levels rose by 6.8%(p<0.001) and 12.4%(p = 0.001), respectively. The mortality rate was similar for both periods. Conclusions The iron and ESA requirements are lower with the original IV iron compared to the generic drug. In addition, the uses of the original formulation results in higher ferritin and TSAT levels despite the lower dose of IV iron. Further studies are necessary to analyse the adverse effects of higher IV iron dosages.	[Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Soriano, Sagrario; Aljama, Pedro] Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain; [Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Soriano, Sagrario; Aljama, Pedro] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Soriano, Sagrario; Aljama, Pedro] Inst Salud Carlos III, RedInRen, Madrid, Spain; [Eugenia Garcia-Montemayor, Victoria; Canton, Petra] SOCODI SL, Dialysis Unit, Cordoba, Spain	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Instituto de Salud Carlos III	Aguera, ML (corresponding author), Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain.	marisa.aguera@gmail.com		Aguera Morales, Maria Luisa/0000-0002-7736-908X	Fundacion Nefrologica, Hospital Universitario Reina Sofia, Cordoba, Spain	Fundacion Nefrologica, Hospital Universitario Reina Sofia, Cordoba, Spain	This study was supported by the Fundacion Nefrologica, Hospital Universitario Reina Sofia, Cordoba, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2015, KIDNEY INT, V88, P905, DOI 10.1038/ki.2015.163; [Anonymous], 2013, EU CLIN TRIALS REGIS; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Brookhart MA, 2010, JAMA-J AM MED ASSOC, V303, P857, DOI 10.1001/jama.2010.206; Charytan DM, 2015, J AM SOC NEPHROL, V26, P1238, DOI 10.1681/ASN.2014090922; Connor JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125272; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; Dunne S, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-1; Eduardo Toblli Jorge, 2012, Inflammation & Allergy Drug Targets, V11, P66; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Fishbane S, 2014, NEPHROL DIAL TRANSPL, V29, P255, DOI 10.1093/ndt/gft269; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; Fuller DS, 2013, AM J KIDNEY DIS, V62, P1213, DOI 10.1053/j.ajkd.2013.09.006; Gaweda AE, 2015, NEPHROL DIAL TRANSPL, V30, P187, DOI 10.1093/ndt/gfu104; Gaweda AE, 2014, J AM SOC NEPHROL, V25, P159, DOI 10.1681/ASN.2013010089; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Harrison JJ, 2012, TRANSPLANTATION, V93, P657, DOI 10.1097/TP.0b013e3182445e9d; Ichii H, 2012, AM J NEPHROL, V36, P50, DOI 10.1159/000339285; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kshirsagar AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078930; Locatelli F, 2014, NEPHRON CLIN PRACT, V128, P323, DOI 10.1159/000366478; Locatelli F, 2013, NEPHROL DIAL TRANSPL, V28, P1346, DOI 10.1093/ndt/gft033; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; Martin-Malo A, 2012, NEPHROL DIAL TRANSPL, V27, P2465, DOI 10.1093/ndt/gfr711; Miskulin DC, 2014, CLIN J AM SOC NEPHRO, V9, P1930, DOI 10.2215/CJN.03370414; Nishio A, 2013, BLOOD PURIFICAT, V36, P29, DOI 10.1159/000350583; Pai AB, 2011, BIOMETALS, V24, P603, DOI 10.1007/s10534-011-9409-6; Panichi V, 2011, NEPHROL DIAL TRANSPL, V26, P2641, DOI 10.1093/ndt/gfq802; Ramsey S., 2013, WHO GUIDELINE COUNTR; Rosati A, 2015, J NEPHROL, V28, P603, DOI 10.1007/s40620-014-0127-3; Rostoker G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115096; Rottembourg J, 2011, NEPHROL DIAL TRANSPL, V26, P3262, DOI 10.1093/ndt/gfr024; Schellekens H, 2011, REGUL TOXICOL PHARM, V59, P176, DOI 10.1016/j.yrtph.2010.09.021; Slotki I, 2015, J AM SOC NEPHROL, V26, P2612, DOI 10.1681/ASN.2015010052; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; van der Meersch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023611; Vaziri ND, 2013, AM J KIDNEY DIS, V61, P992, DOI 10.1053/j.ajkd.2012.10.027; Zhou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043655; Zitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114144	44	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135967	10.1371/journal.pone.0135967	http://dx.doi.org/10.1371/journal.pone.0135967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322790	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500013
J	Chen, GJ; Yuan, A; Shriner, D; Tekola-Ayele, F; Zhou, J; Bentley, AR; Zhou, YX; Wang, CT; Newport, MJ; Adeyemo, A; Rotimi, CN				Chen, Guanjie; Yuan, Ao; Shriner, Daniel; Tekola-Ayele, Fasil; Zhou, Jie; Bentley, Amy R.; Zhou, Yanxun; Wang, Chuntao; Newport, Melanie J.; Adeyemo, Adebowale; Rotimi, Charles N.			An Improved F-st Estimator	PLOS ONE			English	Article							GENE FLOW; DIFFERENTIATION	The fixation index F-st plays a central role in ecological and evolutionary genetic studies. The estimators of Wright ((F) over cap (st1)), Weir and Cockerham ((F) over cap (st2)), and Hudson et al. ((F) over cap st3) are widely used to measure genetic differences among different populations, but all have limitations. We propose a minimum variance estimator (F) over cap (stm) using (F) over cap (st1) and (F) over cap (st2). We tested (F) over cap (stm) in simulations and applied it to 120 unrelated East African individuals from Ethiopia and 11 subpopulations in HapMap 3 with 464,642 SNPs. Our simulation study showed that (F) over cap (stm) has smaller bias than (F) over cap (st2) for small sample sizes and smaller bias than (F) over cap (st1) for large sample sizes. Also, (F) over cap (stm) has smaller variance than (F) over cap (st2) for small F-st values and smaller variance than (F) over cap (st1) for large F-st values. We demonstrated that approximately 30 subpopulations and 30 individuals per subpopulation are required in order to accurately estimate F-st.	[Chen, Guanjie; Shriner, Daniel; Tekola-Ayele, Fasil; Zhou, Jie; Bentley, Amy R.; Adeyemo, Adebowale; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Yuan, Ao] Georgetown Univ, Dept Biostat Bioinformat & Biomath, Washington, DC USA; [Zhou, Yanxun; Wang, Chuntao] Suizhou Cent Hosp, Suizhou, Hubei, Peoples R China; [Newport, Melanie J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; University of Brighton; University of Sussex	Chen, GJ (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.	chengu@mail.nih.gov		Tekola-Ayele, Fasil/0000-0003-4194-9370; Shriner, Daniel/0000-0003-1928-5520; Newport, Melanie/0000-0002-8946-7525; Adeyemo, Adebowale/0000-0002-3105-3231	Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology; National Institutes of Health [Z01HG200362]; Wellcome Trust [079791]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by the Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is supported by the National Human Genome Research Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Center for Information Technology, and the Office of the Director at the National Institutes of Health (Z01HG200362). The data from the Wolaita came from a study supported by the Wellcome Trust (Grant #079791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; HUDSON RR, 1992, GENETICS, V132, P583; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Shriner D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06055; Tekola-Ayele F, 2015, PHARMACOGENOMICS J, V15, P101, DOI 10.1038/tpj.2014.39; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0	14	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135368	10.1371/journal.pone.0135368	http://dx.doi.org/10.1371/journal.pone.0135368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317214	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100026
J	Fertner, M; Sanchez, J; Boklund, A; Stryhn, H; Dupont, N; Toft, N				Fertner, Mette; Sanchez, Javier; Boklund, Anette; Stryhn, Henrik; Dupont, Nana; Toft, Nils			Persistent Spatial Clusters of Prescribed Antimicrobials among Danish Pig Farms - A Register-Based Study	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PRRS VIRUS; HERDS; EPIDEMIOLOGY; SURVEILLANCE; CONSUMPTION; STATISTICS; INFECTION; BACTERIA; ANIMALS	The emergence of pathogens resistant to antimicrobials has prompted political initiatives targeting a reduction in the use of veterinary antimicrobials in Denmark, especially for pigs. This study elucidates the tendency of pig farms with a significantly higher antimicrobial use to remain in clusters in certain geographical regions of Denmark. Animal Daily Doses/100 pigs/day were calculated for all three age groups of pigs (weaners, finishers and sows) for each quarter during 2012-13 in 6,143 commercial indoor pig producing farms. The data were split into four time periods of six months. Repeated spatial cluster analyses were performed to identify persistent clusters, i.e. areas included in a significant cluster throughout all four time periods. Antimicrobials prescribed for weaners did not result in any persistent clusters. In contrast, antimicrobial use in finishers clustered persistently in two areas (157 farms), while those issued for sows clustered in one area (51 farms). A multivariate analysis including data on antimicrobial use for weaners, finishers and sows as three separate outcomes resulted in three persistent clusters (551 farms). Compared to farms outside the clusters during this period, weaners, finishers and sows on farms within these clusters had 19%, 104% and 4% higher use of antimicrobials, respectively. Production type, farm type and farm size seemed to have some bearing on the clustering effect. Adding these factors as categorical covariates one at a time in the multivariate analysis reduced the persistent clusters by 24.3%, 30.5% and 34.1%, respectively.	[Fertner, Mette; Boklund, Anette; Toft, Nils] Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg, Denmark; [Sanchez, Javier; Stryhn, Henrik] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada; [Dupont, Nana] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark	Technical University of Denmark; University of Prince Edward Island; University of Copenhagen	Fertner, M (corresponding author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg, Denmark.	memun@vet.dtu.dk	Boklund, Anette/HGE-8502-2022; sanchez, javier/AAA-4179-2022	Toft, Nils/0000-0002-0265-3764; Stryhn, Henrik/0000-0002-4284-9999; Boklund, Anette/0000-0001-6359-3403; Fertner, Mette Ely/0000-0001-6697-5327				Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; [Anonymous], 2014, DK5332014; [Anonymous], 2014, DK5342014; [Anonymous], 2015, SPF HLTH REGULATIONS; [Anonymous], 2010, DK13192010; [Anonymous], 2014, STAT ANAL SYSTEM SOF; [Anonymous], 2011, DK10852011; [Anonymous], 2014, DK1782014; Baekbo P, 2012, TRANSBOUND EMERG DIS, V59, P60, DOI 10.1111/j.1865-1682.2011.01288.x; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Christiansen JP, 2011, HLTH PIGS BIOSECURIT, V5, P25; Danmap 2012, 2013, US ANT AG OCC ANT; Dunlop RH, 1998, PREV VET MED, V34, P247, DOI 10.1016/S0167-5877(97)00093-7; Dupont N, 2014, DANSK VETTIDSSKRI, V97, P33; Elvstrom Anders, 2015, COMMUNICATION; Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013; Hybschmann GK, 2011, PREV VET MED, V98, P190, DOI 10.1016/j.prevetmed.2010.10.005; Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Kristensen CS, 2004, VET MICROBIOL, V98, P243, DOI 10.1016/j.vetmic.2003.10.026; Kristensen CS, 2004, VET MICROBIOL, V99, P197, DOI 10.1016/j.vetmic.2004.01.005; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2014, INFORM MANAGEMENT SE; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; Moore JE, 2012, PREV VET MED, V107, P286, DOI 10.1016/j.prevetmed.2012.09.006; Mortensen S, 2002, PREV VET MED, V53, P83, DOI 10.1016/S0167-5877(01)00260-4; Nielsen E. O., 2002, Dansk Veterinartidsskrift, V85, P6; Patanasatienkul T, 2015, PREV VET MED, V120, P219, DOI 10.1016/j.prevetmed.2015.03.006; R Core Team, 2014, LANG ENV STAT COMP; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Stege H, 2003, PREV VET MED, V57, P105, DOI 10.1016/S0167-5877(02)00233-7; Taylor DJ, 2006, PIG DIS; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; Vigre H, 2010, PREV VET MED, V93, P98, DOI 10.1016/j.prevetmed.2009.10.010	37	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136834	10.1371/journal.pone.0136834	http://dx.doi.org/10.1371/journal.pone.0136834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317206	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100146
J	Thompson, JW; Wei, JQ; Appau, K; Wang, HL; Yu, H; Spiga, MG; Graham, RM; Webster, KA				Thompson, John W.; Wei, Jianqin; Appau, Kweku; Wang, Huilan; Yu, Hong; Spiga, Maria G.; Graham, Regina M.; Webster, Keith A.			Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; PERMEABILITY TRANSITION PORE; CELL-DEATH; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; DILATED CARDIOMYOPATHY; MAMMALIAN TARGET; IN-VIVO; MITOCHONDRIAL; HYPOXIA	Bnip3 is a hypoxia-regulated member of the Bcl-2 family of proteins that is implicated in apoptosis, programmed necrosis, autophagy and mitophagy. Mitochondria are thought to be the primary targets of Bnip3 although its activities may extend to the ER, cytoplasm, and nucleus. Bnip3 is induced in the heart by ischemia and pressure-overload, and may contribute to cardiomyopathy and heart failure. Only mitochondrial-dependent programmed death actions have been described for Bnip3 in the heart. Here we describe a novel activity of Bnip3 in cultured cardiac myocytes and transgenic mice overexpressing Bnip3 in the heart (Bnip3-TG). In cultured myocytes Bnip3 bound and activated the acetyltransferase p300, increased acetylation of histones and the transcription factor GATA4, and conferred p300 and GATA4-sensitive cellular morphological changes. In intact Bnip3-TG hearts Bnip3 also bound p300 and GATA4 and conferred enhanced GATA4 acetylation. Bnip3-TG mice underwent age-dependent ventricular dilation and heart failure that was partially prevented by p300 inhibition with curcumin. The results suggest that Bnip3 regulates cardiac gene expression and perhaps myocyte morphology by activating nuclear p300 acetyltransferase activity and hyperacetylating histones and p300-selective transcription factors.	[Thompson, John W.; Wei, Jianqin; Appau, Kweku; Wang, Huilan; Spiga, Maria G.; Graham, Regina M.; Webster, Keith A.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Thompson, John W.; Wei, Jianqin; Appau, Kweku; Wang, Huilan; Spiga, Maria G.; Graham, Regina M.; Webster, Keith A.] Univ Miami, Miller Sch Med, Vasc Biol Inst, Miami, FL 33136 USA; [Yu, Hong] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	University of Miami; University of Miami; Zhejiang University	Webster, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kwebster@med.miami.edu		graham, regina/0000-0003-0103-2971; Webster, Keith A/0000-0002-6431-3642	NHLBI [HL072924, HL44578]; American Heart Association, Greater Southeast Affiliate Postdoctoral grant [12090006]; Walter G. Ross Distinguished Chair in vascular biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072924, R29HL044578, R01HL044578] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association, Greater Southeast Affiliate Postdoctoral grant; Walter G. Ross Distinguished Chair in vascular biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NHLBI grants # HL072924 and HL44578 (KAW) and by a Walter G. Ross Distinguished Chair in vascular biology (KAW). JWT was supported by American Heart Association, Greater Southeast Affiliate Postdoctoral grant #12090006.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Burton TR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.100; Burton TR, 2009, J NEUROSCI, V29, P4189, DOI 10.1523/JNEUROSCI.5747-08.2009; Burton TR, 2006, INT J CANCER, V118, P1660, DOI 10.1002/ijc.21547; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chaanine AH, 2013, CIRC-HEART FAIL, V6, P572, DOI 10.1161/CIRCHEARTFAILURE.112.000200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P5566, DOI 10.1158/1078-0432.CCR-04-0076; Graham RM, 2007, ANTIOXID REDOX SIGN, V9, P1309, DOI 10.1089/ars.2007.1726; Graham RM, 2014, ONCOTARGET, V5, P1162, DOI 10.18632/oncotarget.1699; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Sciarretta S, 2011, PEDIATR CARDIOL, V32, P275, DOI 10.1007/s00246-010-9855-x; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tamai T, 2013, J BIOL CHEM, V288, P10176, DOI 10.1074/jbc.M112.423640; Thompson JW, 2012, LIFE SCI, V91, P223, DOI 10.1016/j.lfs.2012.03.034; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Wang YN, 2008, J MOL CELL CARDIOL, V45, P812, DOI 10.1016/j.yjmcc.2008.07.016; Webster KA, 1999, J CLIN INVEST, V104, P239; Webster KA, 2006, ANTIOXID REDOX SIGN, V8, P1667, DOI 10.1089/ars.2006.8.1667; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yoshida Y, 2010, CIRC J, V74, P156, DOI 10.1253/circj.CJ-09-0050; Zhang J, 2011, ANTIOXID REDOX SIGN, V14, P1959, DOI 10.1089/ars.2010.3772	45	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136847	10.1371/journal.pone.0136847	http://dx.doi.org/10.1371/journal.pone.0136847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317696	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100151
J	Pang, T; Guo, LL; Shim, D; Cannon, N; Tang, S; Chen, JH; Xia, XL; Yin, WL; Carlson, JE				Pang, Tao; Guo, Lili; Shim, Donghwan; Cannon, Nathaniel; Tang, Sha; Chen, Jinhuan; Xia, Xinli; Yin, Weilun; Carlson, John E.			Characterization of the Transcriptome of the Xerophyte Ammopiptanthus mongolicus Leaves under Drought Stress by 454 Pyrosequencing	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; ARABIDOPSIS-THALIANA; REGULATORY NETWORKS; CELLULAR-RESPONSES; ROOT TRANSCRIPTOME; ABIOTIC STRESSES; PLANT-RESPONSES	Background Ammopiptanthus mongolicus (Maxim. Ex Kom.) Cheng f., an endangered ancient legume species, endemic to the Gobi desert in north-western China. As the only evergreen broadleaf shrub in this area, A. mongolicus plays an important role in the region's ecological-environmental stability. Despite the strong potential of A. mongolicus in providing new insights on drought tolerance, sequence information on the species in public databases remains scarce. To both learn about the role of gene expression in drought stress tolerance in A. mongolicus and to expand genomic resources for the species, transcriptome sequencing of stress-treated A. mongolicus plants was performed. Results Using 454 pyrosequencing technology, 8,480 and 7,474 contigs were generated after de novo assembly of RNA sequences from leaves of untreated and drought-treated plants, respectively. After clustering using TGICL and CAP3 programs, a combined assembly of all reads produced a total of 11,357 putative unique transcripts (PUTs). Functional annotation and classification of the transcripts were conducted by aligning the 11,357 PUTs against the public protein databases and nucleotide database (Nt). Between control and drought-treated plants, 1,620 differentially expressed genes (DEGs) were identified, of which 1,106 were up-regulated and 514 were down-regulated. The differential expression of twenty candidate genes in metabolic pathways and transcription factors families related to stress-response were confirmed by quantitative real-time PCR. Representatives of several large gene families, such as WRKY and P5CS, were identified and verified in A. mongolicus for the first time. Conclusions The additional transcriptome resources, gene expression profiles, functional annotations, and candidate genes provide a more comprehensive understanding of the stress response pathways in xeric-adapted plant species such as A. mongolicus.	[Pang, Tao; Guo, Lili; Tang, Sha; Chen, Jinhuan; Xia, Xinli; Yin, Weilun] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Guo, Lili] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Shim, Donghwan; Cannon, Nathaniel; Carlson, John E.] Penn State Univ, Dept Ecosyst Sci & Management, Schatz Ctr Tree Mol Genet, University Pk, PA 16802 USA; [Shim, Donghwan] Korea Forest Res Inst, Dept Forest Genet Resources, Suwon 441350, South Korea	Beijing Forestry University; Henan University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea Forest Research Institute (KFRI)	Xia, XL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	xiaxl@bjfu.edu.cn; yinwl@bjfu.edu.cn; jec16@psu.edu	Shim, Donghwan/AAN-3014-2020	, Sha/0000-0002-5825-9598; Yin, Weilun/0000-0002-6754-5772	National Natural Science Foundation of China [31070597, 31270656]; Scientific Research and Graduate Training Joint Programs from BMEC (Stress Resistance Mechanism of Poplar)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research and Graduate Training Joint Programs from BMEC (Stress Resistance Mechanism of Poplar)	work was supported by the following: The National Natural Science Foundation of China (31070597, 31270656), http://www.nsfc.gov.cn/; and Scientific Research and Graduate Training Joint Programs from BMEC (Stress Resistance Mechanism of Poplar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bhushan D, 2007, MOL CELL PROTEOMICS, V6, P1868, DOI 10.1074/mcp.M700015-MCP200; Bota J, 2004, NEW PHYTOL, V162, P671, DOI 10.1111/j.1469-8137.2004.01056.x; Cao PX, 2009, PLANT MOL BIOL, V69, P529, DOI 10.1007/s11103-008-9434-1; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen JH, 2011, PLANT GROWTH REGUL, V63, P259, DOI 10.1007/s10725-010-9523-4; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; Dinakar C, 2012, PLANT SCI, V182, P29, DOI 10.1016/j.plantsci.2011.01.018; Eulgem T, 2006, PLOS PATHOG, V2, P1028, DOI 10.1371/journal.ppat.0020126; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Ge XJ, 2005, ANN BOT-LONDON, V95, P843, DOI 10.1093/aob/mci089; Gechev TS, 2012, CELL MOL LIFE SCI, V69, P3175, DOI 10.1007/s00018-012-1088-0; Guo LL, 2011, AFR J BIOTECHNOL, V10, P3715; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; Levee V, 2009, NEW PHYTOL, V184, P48, DOI 10.1111/j.1469-8137.2009.02955.x; Li B, 2013, PLANT PHYSIOL BIOCH, V67, P7, DOI 10.1016/j.plaphy.2013.02.016; Liang HY, 2011, TREE GENET GENOMES, V7, P941, DOI 10.1007/s11295-011-0386-2; Liu G.-H., 1998, B BOT RES, V18, P341; Liu MQ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-88; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu RL, 2010, PLANT GROWTH REGUL, V60, P163, DOI 10.1007/s10725-009-9432-6; Liu YH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Mohammadi M, 2007, PLANT CELL ENVIRON, V30, P630, DOI 10.1111/j.1365-3040.2007.01645.x; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Prentis PJ, 2010, ANN BOT-LONDON, V106, P1009, DOI 10.1093/aob/mcq201; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Ruiz-Lozano J. M., 2008, MYCORRHIZA STATE ART, P185, DOI [10.1007/978-3-540- 78826-3_10, DOI 10.1007/978-3-540-78826-3_10]; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Todd J, 2008, PLANT SCI, V175, P799, DOI 10.1016/j.plantsci.2008.08.004; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang HB, 2005, J PLANT PHYSIOL, V162, P81, DOI 10.1016/j.jplph.2004.07.006; Wang JM, 2014, MOL BIOL REP, V41, P8231, DOI 10.1007/s11033-014-3725-1; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei Q, 2012, PLANT CELL TISS ORG, V110, P359, DOI 10.1007/s11240-012-0157-2; Wei Q, 2011, PLANT CELL TISS ORG, V105, P309, DOI 10.1007/s11240-010-9869-3; Wu YQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-671; Xie L, 2012, INT J PLANT SCI, V173, P944, DOI 10.1086/667232; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang HY, 2011, PLANT SIGNAL BEHAV, V6, P652, DOI 10.4161/psb.6.5.14945; Zhang JT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030355, 10.1371/journal.pone.0041657]; Zhang XF, 2013, PLANT MOL BIOL, V83, P205, DOI 10.1007/s11103-013-0082-8; Zhang XT, 2013, MOL BIOL REP, V40, P1407, DOI 10.1007/s11033-012-2184-9; Zhao Y, 2013, PLANTA, V237, P755, DOI 10.1007/s00425-012-1783-y; Zhou G, 2012, PLANT MOL BIOL REP, V30, P349, DOI 10.1007/s11105-011-0343-0; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	83	6	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136495	10.1371/journal.pone.0136495	http://dx.doi.org/10.1371/journal.pone.0136495			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313687	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000062
J	Simmons, R; Malyuta, R; Chentsova, N; Medoeva, A; Kruglov, Y; Yurchenko, A; Copas, A; Porter, K				Simmons, Ruth; Malyuta, Ruslan; Chentsova, Nelli; Medoeva, Antonia; Kruglov, Yuri; Yurchenko, Alexander; Copas, Andrew; Porter, Kholoud		CASCADE Collaboration EuroCoord	HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014	PLOS ONE			English	Article							EASTERN-EUROPE; EPIDEMIC; SEROCONVERSION; PREDICTORS; HIV/AIDS	Objective Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates. Methods As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (>= 16yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev. Results During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners. Conclusion Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures.	[Simmons, Ruth; Copas, Andrew; Porter, Kholoud] UCL, Clin Trials Unit, MRC, London, England; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Chentsova, Nelli; Medoeva, Antonia; Yurchenko, Alexander] Kyiv City AIDS Ctr, Kiev, Ukraine; [Kruglov, Yuri] Inst Epidemiol, Kiev, Ukraine	Medical Research Council Clinical Trials Unit; University of London; University College London; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine	Porter, K (corresponding author), UCL, Clin Trials Unit, MRC, London, England.	kholoud.porter@ucl.ac.uk	Muga, Roberto/AAY-8655-2021; Guiguet, Marguerite/L-8480-2018; DEL AMO VALERO, JULIA/M-7020-2015; DORRUCCI, MARIA/C-6485-2016; rezza, giovanni/D-4393-2016	Muga, Roberto/0000-0001-6301-431X; DEL AMO VALERO, JULIA/0000-0002-3104-540X; DORRUCCI, MARIA/0000-0002-8543-6430; rezza, giovanni/0000-0003-0268-6790; Porter, Kholoud/0000-0002-9226-6206; Copas, Andrew/0000-0001-8968-5963	European Union Seventh Framework Programme (FP7) under EuroCoord grant [260694]; Medical Research Council [MC_UU_12023/23, MC_UU_12023/15] Funding Source: researchfish; MRC [MC_UU_12023/15] Funding Source: UKRI	European Union Seventh Framework Programme (FP7) under EuroCoord grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was conducted on behalf of a CASCADE Collaboration in EuroCoord, funded from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694.	AIDS Alliance, 2010, ANAL REPORT BAS SOC; AIDS Alliance, 2014, MARP COV 2012; [Anonymous], 2010, HIV AIDS SURV EUR 20; [Anonymous], HIV AIDS SURV EUR 20; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; Bolshov Y., 2012, ANAL REPORT BEHAV MO; Burchell AN, 2003, INT J STD AIDS, V14, P601, DOI 10.1258/095646203322301059; Clark F, 2014, LANCET, V383, P500, DOI 10.1016/S0140-6736(14)60169-0; Dehne KL, 1999, AIDS, V13, P741, DOI 10.1097/00002030-199905070-00002; Fernyak SE, 2002, JAIDS-J ACQ IMM DEF, V31, P63, DOI 10.1097/00126334-200209010-00009; Gaventa M., 2013, KEEPING WOMEN WHO US; Giaquinto C, 2006, AIDS, V20, P1419, DOI 10.1097/01.aids.0000233576.33973.b3; Hightow LB, 2004, SEX TRANSM DIS, V31, P455, DOI 10.1097/01.olq.0000135984.27593.5f; Kelly JA, 2003, INT J STD AIDS, V14, P361, DOI 10.1258/095646203765371231; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-919; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; Nieburg P, 2012, INJECTION DRUG USE U; Organisation World Health, 2010, SCAL HIV TEST COUNS; Pinkman S, 2010, MAKING HARM REDUCTIO; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Schwarcz SK, 1997, SEX TRANSM DIS, V24, P347, DOI 10.1097/00007435-199707000-00007; State Statistics Service of Ukraine, 2013, UKR CENS; Stern D, 2012, URKAINE TAKES AIM GA; UNAIDS, 2009, HIDD HIV EP MSM E EU; UNAIDS, 2010, GLOB REP UNAIDS REP; United Nations, 2004, AIDS E EUR COMM IND	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137062	10.1371/journal.pone.0137062	http://dx.doi.org/10.1371/journal.pone.0137062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322977	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500063
J	Willner, M; Fior, G; Marschner, M; Birnbacher, L; Schock, J; Braun, C; Fingerle, AA; Noel, PB; Rummeny, EJ; Pfeiffer, F; Herzen, J				Willner, Marian; Fior, Gabriel; Marschner, Mathias; Birnbacher, Lorenz; Schock, Jonathan; Braun, Christian; Fingerle, Alexander A.; Noel, Peter B.; Rummeny, Ernst J.; Pfeiffer, Franz; Herzen, Julia			Phase-Contrast Hounsfield Units of Fixated and Non-Fixated Soft-Tissue Samples	PLOS ONE			English	Article							SKIN EXCISION SPECIMENS; QUANTITATIVE PHASE; RAY; TOMOGRAPHY; ABSORPTION; SHRINKAGE	X-ray phase-contrast imaging is a novel technology that achieves high soft-tissue contrast. Although its clinical impact is still under investigation, the technique may potentially improve clinical diagnostics. In conventional attenuation-based X-ray computed tomography, radiological diagnostics are quantified by Hounsfield units. Corresponding Hounsfield units for phase-contrast imaging have been recently introduced, enabling a setup-independent comparison and standardized interpretation of imaging results. Thus far, the experimental values of few tissue types have been reported; these values have been determined from fixated tissue samples. This study presents phase-contrast Hounsfield units for various types of non-fixated human soft tissues. A large variety of tissue specimens ranging from adipose, muscle and connective tissues to liver, kidney and pancreas tissues were imaged by a grating interferometer with a rotating-anode X-ray tube and a photon-counting detector. Furthermore, we investigated the effects of formalin fixation on the quantitative phase-contrast imaging results.	[Willner, Marian; Fior, Gabriel; Marschner, Mathias; Birnbacher, Lorenz; Schock, Jonathan; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Dept Phys, Garching, Germany; [Willner, Marian; Fior, Gabriel; Marschner, Mathias; Birnbacher, Lorenz; Schock, Jonathan; Noel, Peter B.; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Braun, Christian] Univ Munich, Inst Forens Med, Munich, Germany; [Fingerle, Alexander A.; Rummeny, Ernst J.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Willner, M (corresponding author), Tech Univ Munich, Dept Phys, Garching, Germany.	marian.willner@ph.tum.de		Noel, Peter/0000-0002-9671-6171	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC, FP7) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC, FP7)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). M.W. further acknowledges the Graduate School of Information Science in Health (GSISH). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT).	Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Buesa RJ, 2008, ANN DIAGN PATHOL, V12, P387, DOI 10.1016/j.anndiagpath.2008.07.004; Chabior M, 2011, MED PHYS, V38, P1189, DOI 10.1118/1.3553408; Dauendorffer JN, 2009, BRIT J DERMATOL, V160, P810, DOI 10.1111/j.1365-2133.2008.08994.x; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; GOLOMB FM, 1991, PLAST RECONSTR SURG, V88, P804, DOI 10.1097/00006534-199111000-00010; Grandl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097101; Gregory N, 2003, ARCH DERMATOL, V139, P542, DOI 10.1001/archderm.139.4.542; Herzen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083369; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; HESLINGA FJ, 1962, J HISTOCHEM CYTOCHEM, V10, P704, DOI 10.1177/10.6.704; Hetterich H, 2014, RADIOLOGY, V271, P870, DOI 10.1148/radiol.14131554; HUDSONPEACOCK MJ, 1995, J AM ACAD DERMATOL, V32, P1010, DOI 10.1016/0190-9622(95)91341-6; ICRU, 1989, 44 ICRU; Kiernan J.A., 2000, MICROSC TODAY, V1, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Thuring T, 2013, SKELETAL RADIOL, V42, P827, DOI 10.1007/s00256-013-1606-7; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; Zanette I, 2011, PHYS STATUS SOLIDI A, V208, P2526, DOI 10.1002/pssa.201184276; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	28	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137016	10.1371/journal.pone.0137016	http://dx.doi.org/10.1371/journal.pone.0137016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322638	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500060
J	Brugnara, L; Mallol, R; Ribalta, J; Vinaixa, M; Murillo, S; Casserras, T; Guardiola, M; Vallve, JC; Kalko, SG; Correig, X; Novials, A				Brugnara, Laura; Mallol, Roger; Ribalta, Josep; Vinaixa, Maria; Murillo, Serafin; Casserras, Teresa; Guardiola, Montse; Vallve, Joan Carles; Kalko, Susana G.; Correig, Xavier; Novials, Anna			Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; WEIGHT-GAIN; HDL; CHOLESTEROL; POPULATION; MORTALITY	Patients with type 1 diabetes (T1D) present increased risk of cardiovascular disease (CVD). The aim of this study is to improve the assessment of lipoprotein profile in patients with T1D by using a robust developed method 1H nuclear magnetic resonance spectroscopy (1H NMR), for further correlation with clinical factors associated to CVD. Thirty patients with T1D and 30 non-diabetes control (CT) subjects, matched for gender, age, body composition (DXA, BMI, waist/hip ratio), regular physical activity levels and cardiorespiratory capacity (VO2peak), were analyzed. Dietary records and routine lipids were assessed. Serum lipoprotein particle subfractions, particle sizes, and cholesterol and triglycerides subfractions were analyzed by 1H NMR. It was evidenced that subjects with T1D presented lower concentrations of small LDL cholesterol, medium VLDL particles, large VLDL triglycerides, and total triglycerides as compared to CT subjects. Women with T1D presented a positive association with HDL size (p<0.005; R = 0.601) and large HDL triglycerides (p<0.005; R = 0.534) and negative (p<0.005; R = -0.586) to small HDL triglycerides. Body fat composition represented an important factor independently of normal BMI, with large LDL particles presenting a positive correlation to total body fat (p<0.005; R = 0.505), and total LDL cholesterol and small LDL cholesterol a positive correlation (p<0.005; R = 0.502 and R = 0.552, respectively) to abdominal fat in T1D subjects; meanwhile, in CT subjects, body fat composition was mainly associated to HDL subclasses. VO2peak was negatively associated (p<0.005; R = -0.520) to large LDL-particles only in the group of patients with T1D. In conclusion, patients with T1D with adequate glycemic control and BMI and without chronic complications presented a more favourable lipoprotein profile as compared to control counterparts. In addition, slight alterations in BMI and/or body fat composition showed to be relevant to provoking alterations in lipoproteins profiles. Finally, body fat composition appears to be a determinant for cardioprotector lipoprotein profile.	[Brugnara, Laura; Murillo, Serafin; Novials, Anna] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Mallol, Roger; Vinaixa, Maria; Correig, Xavier] Univ Rovira & Virgili, Metabol Platform, E-43201 Reus, Spain; [Ribalta, Josep; Guardiola, Montse; Vallve, Joan Carles] Univ Rovira & Virgili, Hosp Univ St Joan Reus, Unitat Recerca Lipids Arteriosclerosi URLA, E-43201 Reus, Spain; [Mallol, Roger; Ribalta, Josep; Vinaixa, Maria; Guardiola, Montse; Vallve, Joan Carles; Correig, Xavier] Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain; [Casserras, Teresa; Kalko, Susana G.] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Bioinformat Core Facil, Barcelona, Spain; [Brugnara, Laura; Ribalta, Josep; Vinaixa, Maria; Murillo, Serafin; Guardiola, Montse; Vallve, Joan Carles; Correig, Xavier; Novials, Anna] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Novials, A (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	anovials@clinic.ub.es	Correig, Xavier/K-9836-2014; Vinaixa, Maria/L-7236-2014; Vinaixa, Maria/AAB-1176-2020; Vallvé, Joan-Carles/T-6742-2019; Ribalta, Josep/AAD-4859-2020	Correig, Xavier/0000-0002-6902-3054; Vinaixa, Maria/0000-0001-9804-0171; Vinaixa, Maria/0000-0001-9804-0171; Vallvé, Joan-Carles/0000-0001-8711-9618; Ribalta, Josep/0000-0002-8879-4719; Guardiola, Montse/0000-0002-9696-7384; Kalko, Susana/0000-0002-6701-0233; Novials, Anna/0000-0003-0465-2949; Mallol, Roger/0000-0001-5374-1580	Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM-METADIAB); Instituto de Salud Carlos III; Ministerio de Economia y Competitividad [PI081579]; Sarda Farriol Research Programme; Department of Universities, Research and Information Society of the Government of Catalonia [2014_SGR_520]	Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM-METADIAB); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); Sarda Farriol Research Programme; Department of Universities, Research and Information Society of the Government of Catalonia	This work was founded by grants from the Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM-METADIAB 12/12/2009 to A.N. and X.C.) and from the Instituto de Salud Carlos III and Ministerio de Economia y Competitividad (PI081579 to J.R.); and also was supported by Sarda Farriol Research Programme and by the project number 2014_SGR_520 of the Department of Universities, Research and Information Society of the Government of Catalonia.	Albers JJ, 2008, J CLIN ENDOCR METAB, V93, P735, DOI 10.1210/jc.2007-2176; [Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berrougui H, 2007, J LIPID RES, V48, P328, DOI 10.1194/jlr.M600167-JLR200; Caixas A, 1997, DIABETES, V46, P1207, DOI 10.2337/diabetes.46.7.1207; Centre D'Ensenyament Superior de Nutricio I Dietetica (CESNID), 2014, CESNID PCN 1 0; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; Diffenderfer MR, 2014, CURR OPIN LIPIDOL, V25, P221, DOI 10.1097/MOL.0000000000000067; Ferriss JB, 2006, DIABETIC MED, V23, P557, DOI 10.1111/j.1464-5491.2006.01847.x; Gonzalez M, 2010, J RHEUMATOL, V37, P2259, DOI 10.3899/jrheum.091175; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guardiola M, 2015, CLIN SCI, V128, P877, DOI 10.1042/CS20140832; GUPTA AK, 1993, METABOLISM, V42, P684, DOI 10.1016/0026-0495(93)90233-E; Guy J, 2009, DIABETES CARE, V32, P416, DOI 10.2337/dc08-1775; Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Hovingh GK, 2015, CURR OPIN LIPIDOL, V26, P127, DOI 10.1097/MOL.0000000000000161; Jenkins AJ, 2003, KIDNEY INT, V64, P817, DOI 10.1046/j.1523-1755.2003.00164.x; Laaksonen DE, 2000, MED SCI SPORT EXER, V32, P1541, DOI 10.1097/00005768-200009000-00003; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Lehmann R, 1997, DIABETES CARE, V20, P1603, DOI 10.2337/diacare.20.10.1603; Lind M, 2013, DIABETOLOGIA, V56, P2601, DOI 10.1007/s00125-013-3063-1; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Maahs DM, 2011, DIABETIC MED, V28, P148, DOI 10.1111/j.1464-5491.2010.03143.x; Makinen VP, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-54; Mallol R, 2015, J LIPID RES, V56, P737, DOI 10.1194/jlr.D050120; Mallol R, 2011, METABOLOMICS, V7, P572, DOI 10.1007/s11306-011-0273-8; Malpique R, 2014, DIABETOLOGIA, V57, P1219, DOI 10.1007/s00125-014-3205-0; NAKAJIMA K, 1993, CLIN CHIM ACTA, V223, P53, DOI 10.1016/0009-8981(93)90062-9; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Olchawa B, 2004, ARTERIOSCL THROM VAS, V24, P1087, DOI 10.1161/01.ATV.0000128124.72935.0f; Orchard TJ, 1998, INT J EPIDEMIOL, V27, P976, DOI 10.1093/ije/27.6.976; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; PATTI L, 1995, DIABETOLOGIA, V38, P1419, DOI 10.1007/BF00400602; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Purnell JQ, 1998, JAMA-J AM MED ASSOC, V280, P140, DOI 10.1001/jama.280.2.140; Rached FH, 2015, BIOFACTORS, V41, P67, DOI 10.1002/biof.1202; Rigla M, 2000, METABOLISM, V49, P640, DOI 10.1016/S0026-0495(00)80041-4; SALONEN JT, 1991, CIRCULATION, V84, P129, DOI 10.1161/01.CIR.84.1.129; SEIP RL, 1993, ARTERIOSCLER THROMB, V13, P1359, DOI 10.1161/01.ATV.13.9.1359; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soedamah-Muthu SS, 2003, DIABETOLOGIA, V46, P674, DOI 10.1007/s00125-003-1094-8; Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4; Soran H, 2012, CURR OPIN LIPIDOL, V23, P353, DOI 10.1097/MOL.0b013e328355ca25; Spate-Douglas T, 1999, ARCH PHYS MED REHAB, V80, P691, DOI 10.1016/S0003-9993(99)90174-0; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626; World Health Organization, 2004, GLOB STRAT DIET PHYS	51	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136348	10.1371/journal.pone.0136348	http://dx.doi.org/10.1371/journal.pone.0136348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317989	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100073
J	Ferguson, KK; McElrath, TF; Mukherjee, B; Loch-Caruso, R; Meeker, JD				Ferguson, Kelly K.; McElrath, Thomas F.; Mukherjee, Bhramar; Loch-Caruso, Rita; Meeker, John D.			Associations between Maternal Biomarkers of Phthalate Exposure and Inflammation Using Repeated Measurements across Pregnancy	PLOS ONE			English	Article							DI-(2-ETHYLHEXYL) PHTHALATE; OXIDATIVE STRESS; PRETERM BIRTH; BISPHENOL-A; METABOLITES; CYTOKINES; WOMEN	Phthalate exposure is prevalent in populations worldwide, including pregnant women. Maternal urinary metabolite concentrations have been associated with adverse reproductive outcomes, but underlying mechanisms remain unclear. Here we investigate inflammation as a possible pathway by examining phthalates in association with inflammation biomarkers, including C-reactive protein (CRP) and a panel of cytokines (IL-1 beta, IL-6, IL-10, and TNF-alpha) in a repeated measures analysis of pregnant women (N = 480). Urinary phthalate metabolites and plasma inflammation biomarkers were measured from samples collected at up to four visits per subject during gestation (median 10, 18, 26, and 35 weeks). Associations were examined using mixed models to account for within-individual correlation of measures. Few statistically significant associations or clear trends were observed, although in full models mono-carboxypropyl phthalate (MCPP) was significantly (percent change with interquartile range increase in exposure [%Delta] = 8.89, 95% confidence interval [CI] = 3.28, 14.8), and mono-benzyl phthalate (MBzP) was suggestively (%Delta = 6.79, 95% CI = -1.21, 15.4) associated with IL-6. Overall these findings show little evidence of an association between phthalate exposure and peripheral inflammation in pregnant women. To investigate inflammation as a mechanism of phthalate effects in humans, biomarkers from target tissues or fluids, though difficult to measure in large-scale studies, may be necessary to detect effects.	[Ferguson, Kelly K.; Loch-Caruso, Rita; Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [McElrath, Thomas F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Maternal Fetal Med, Boston, MA 02115 USA; [Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan	Meeker, JD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	meekerj@umich.edu	Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250; Meeker, John/0000-0001-8357-5085	National Institute of Environmental Health Sciences, National Institutes of Health [R01ES018872, P42ES017198, P01ES022844, P30ES017885]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES017198, P01ES022844, T32ES007062, R01ES018872, P30ES017885] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this project was provided by the National Institute of Environmental Health Sciences, National Institutes of Health, grant numbers R01ES018872, P42ES017198, P01ES022844, and P30ES017885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; Arbuckle TE, 2014, ENVIRON INT, V68, P55, DOI 10.1016/j.envint.2014.02.010; de Renzy-Martin KT, 2014, REPRODUCTION, V147, P443, DOI 10.1530/REP-13-0461; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Ferguson KK, 2014, AM J REPROD IMMUNOL, V72, P326, DOI 10.1111/aji.12265; Ferguson KK, 2014, ENVIRON INT, V70, P118, DOI 10.1016/j.envint.2014.05.016; Ferguson KK, 2014, ENVIRON SCI TECHNOL, V48, P7018, DOI 10.1021/es502076j; Ferguson KK, 2014, JAMA PEDIATR, V168, P61, DOI 10.1001/jamapediatrics.2013.3699; Ferguson KK, 2012, ENVIRON SCI TECHNOL, V46, P477, DOI 10.1021/es202340b; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Ferguson KK, 2014, ENV HLTH PERSPECTIVE; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039008; Hansen JS, 2007, TOXICOLOGY, V232, P79, DOI 10.1016/j.tox.2006.12.011; He M, 2013, IMMUNOPHARM IMMUNOT, V35, P390, DOI 10.3109/08923973.2013.787432; Hodyl NA, 2011, PRENATAL PROGRAMMING; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008; Jiang YN, 2006, STAT MED, V25, P1323, DOI 10.1002/sim.2283; Just AC, 2012, AM J RESP CRIT CARE, V186, P830, DOI 10.1164/rccm.201203-0398OC; Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Kuo CH, 2013, ALLERGY, V68, P870, DOI 10.1111/all.12162; Larsen ST, 2007, TOXICOLOGY, V235, P119, DOI 10.1016/j.tox.2007.03.010; Latini G, 2005, TOXICOL SCI, V85, P743, DOI 10.1093/toxsci/kfi131; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Lewis RC, 2013, CHEMOSPHERE, V93, P2390, DOI 10.1016/j.chemosphere.2013.08.038; Luppi P, 2003, VACCINE, V21, P3352, DOI 10.1016/S0264-410X(03)00331-1; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522; Nishioka J, 2012, INFLAMM RES, V61, P69, DOI 10.1007/s00011-011-0390-x; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Shin IS, 2014, TOXICOL APPL PHARM, V274, P402, DOI 10.1016/j.taap.2013.12.009; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Team RC, 2014, R LANG ENV STAT COMP; Vadillo-Ortega F, 2014, MED HYPOTHESES, V82, P219, DOI 10.1016/j.mehy.2013.11.042; Vetrano AM, 2010, PEDIATR RES, V68, P134, DOI 10.1203/00006450-201011001-00260; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	43	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135601	10.1371/journal.pone.0135601	http://dx.doi.org/10.1371/journal.pone.0135601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317519	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100037
J	Graf, PM; Wilson, RP; Qasem, L; Hacklander, K; Rosell, F				Graf, Patricia M.; Wilson, Rory P.; Qasem, Lama; Hacklaender, Klaus; Rosell, Frank			The Use of Acceleration to Code for Animal Behaviours; A Case Study in Free-Ranging Eurasian Beavers Castor fiber	PLOS ONE			English	Article							DOUBLY LABELED WATER; REPRODUCTIVE SUCCESS; WEDDELL SEALS; TRIAXIAL ACCELEROMETER; FORAGING BEHAVIOR; PAW PREFERENCE; METABOLIC-RATE; CLASSIFICATION; MOVEMENT; PATTERNS	Recent technological innovations have led to the development of miniature, accelerometer-containing electronic loggers which can be attached to free-living animals. Accelerometers provide information on both body posture and dynamism which can be used as descriptors to define behaviour. We deployed tri-axial accelerometer loggers on 12 free-ranging Eurasian beavers Castor fiber in the county of Telemark, Norway, and on four captive beavers ( two Eurasian beavers and two North American beavers C. canadensis) to corroborate acceleration signals with observed behaviours. By using random forests for classifying behavioural patterns of beavers from accelerometry data, we were able to distinguish seven behaviours; standing, walking, swimming, feeding, grooming, diving and sleeping. We show how to apply the use of acceleration to determine behaviour, and emphasise the ease with which this non-invasive method can be implemented. Furthermore, we discuss the strengths and weaknesses of this, and the implementation of accelerometry on animals, illustrating limitations, suggestions and solutions. Ultimately, this approach may also serve as a template facilitating studies on other animals with similar locomotor modes and deliver new insights into hitherto unknown aspects of behavioural ecology.	[Graf, Patricia M.; Rosell, Frank] Telemark Univ Coll, Fac Arts & Sci, Dept Environm Sci, Bo I Telemark, Norway; [Graf, Patricia M.; Hacklaender, Klaus] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Wilson, Rory P.; Qasem, Lama] Swansea Univ, Coll Sci, Biosci, Swansea Moving Anim Res Team, Swansea, W Glam, Wales	University College of Southeast Norway; University of Natural Resources & Life Sciences, Vienna; Swansea University	Graf, PM (corresponding author), Telemark Univ Coll, Fac Arts & Sci, Dept Environm Sci, Bo I Telemark, Norway.	patricia.m.graf@hit.no	Hackländer, Klaus/ABC-4327-2020	Hacklander, Klaus/0000-0002-6774-435X				Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; Arai Nobuaki, 2000, Polar Bioscience, V13, P95; BEUTLER FJ, 1966, SIAM REV, V8, P328, DOI 10.1137/1008065; BEVAN RM, 1995, FUNCT ECOL, V9, P40, DOI 10.2307/2390088; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bidder OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050556; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Bishop C. M, 2006, PATTERN RECOGNITION; Bradshaw R. H., 1996, Animal Science (Pencaitland), V62, P547; Breiman L., 2001, MACH LEARN, V45, P5; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Byrnes G, 2011, J MAMMAL, V92, P444, DOI 10.1644/10-MAMM-A-048.1; Campbell HA, 2013, J EXP BIOL, V216, P4501, DOI 10.1242/jeb.089805; Campbell RD, 2005, BEHAV ECOL SOCIOBIOL, V58, P597, DOI 10.1007/s00265-005-0942-6; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; Curry A, 2014, NATURE, V513, P157, DOI 10.1038/513157a; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Elliott KH, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0017-2; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Fossette S, 2010, J EXP BIOL, V213, P4074, DOI 10.1242/jeb.048207; Gerencser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077814; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Grundy E, 2009, COMPUT GRAPH FORUM, V28, P815, DOI 10.1111/j.1467-8659.2009.01469.x; Guven M, 2003, INT J NEUROSCI, V113, P1675, DOI 10.1080/00207450390249258; Haarberg O, 2006, J ZOOL, V270, P201, DOI 10.1111/j.1469-7998.2006.00142.x; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Herr J, 2004, J ZOOL, V262, P257, DOI 10.1017/S0952836903004606; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; Lagarde F, 2008, ANIM BEHAV, V75, P319, DOI 10.1016/j.anbehav.2007.01.010; Manning A., 2012, INTRO ANIMAL BEHAV, V6th; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; McClune DW, 2014, ANIM BIOTELEM, V2, P5, DOI [DOI 10.1186/2050-3385-2-5, 10.1186/2050-3385-2-5]; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Mitani Y, 2004, MAR ECOL PROG SER, V281, P275, DOI 10.3354/meps281275; Moreau M, 2009, APPL ANIM BEHAV SCI, V119, P158, DOI 10.1016/j.applanim.2009.04.008; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nishizawa H, 2013, J ETHOL, V31, P315, DOI 10.1007/s10164-013-0381-1; Olstad O, 1937, NYTT MAGASIN NATURVI, V77, P217; PATENAUDE F, 1984, CAN J ZOOL, V62, P1872, DOI 10.1139/z84-273; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Ringgenberg N, 2010, APPL ANIM BEHAV SCI, V128, P37, DOI 10.1016/j.applanim.2010.09.018; Robert B, 2009, COMPUT ELECTRON AGR, V67, P80, DOI 10.1016/j.compag.2009.03.002; Roitberg Bernard D., 2007, Entomological Research, V37, P14, DOI 10.1111/j.1748-5967.2007.00045.x; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Rosell F, 1999, WILDLIFE BIOL, V5, P119, DOI 10.2981/wlb.1999.015; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2002, J EXP BIOL, V205, P1189; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Spiegel O, 2015, AM NAT, V185, pE44, DOI 10.1086/679314; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Tanida H, 2011, ANIM SCI J, V82, P792, DOI 10.1111/j.1740-0929.2011.00903.x; Tsai LS, 1930, SCIENCE, V72, P436, DOI 10.1126/science.72.1869.436; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Vos M, 2003, BEHAV ECOL, V14, P236, DOI 10.1093/beheco/14.2.236; Wang YW, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0030-0; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; WATERS NS, 1994, BEHAV BRAIN RES, V63, P195, DOI 10.1016/0166-4328(94)90091-4; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Wilsson L, 1971, VILTREVY, V8, P115; Yoda K, 2007, MAR BIOL, V151, P1951, DOI 10.1007/s00227-007-0631-2; Yoda K, 1999, J EXP BIOL, V202, P3121	84	45	45	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136751	10.1371/journal.pone.0136751	http://dx.doi.org/10.1371/journal.pone.0136751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317623	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100134
J	Liu, JX; Hou, JY; Jiang, C; Li, G; Lu, H; Meng, FY; Shi, LC				Liu, Jinxin; Hou, Jingyi; Jiang, Chao; Li, Geng; Lu, Heng; Meng, Fanyun; Shi, Linchun			Deep Sequencing of the Scutellaria baicalensis Georgi Transcriptome Reveals Flavonoid Biosynthetic Profiling and Organ-Specific Gene Expression	PLOS ONE			English	Article							HAIRY ROOT CULTURES; MOLECULAR-CLONING; RNA-SEQ; CINNAMATE 4-HYDROXYLASE; FUNCTIONAL EXPRESSION; ARABIDOPSIS-THALIANA; PURIFICATION; BAICALIN; SYNTHASE; WOGONIN	Scutellaria baicalensis Georgi has long been used in traditional medicine to treat various such widely varying diseases and has been listed in the Chinese Pharmacopeia, the Japanese Pharmacopeia, the Korean Pharmacopoeia and the European Pharmacopoeia. Flavonoids, especially wogonin, wogonoside, baicalin, and baicalein, are its main functional ingredients with various pharmacological activities. Although pharmaological studies for these flavonoid components have been well conducted, the molecular mechanism of their biosynthesis remains unclear in S. baicalensis. In this study, Illumina/Solexa deep sequencing generated more than 91 million paired-end reads and 49,507 unigenes from S. baicalensis roots, stems, leaves and flowers. More than 70% unigenes were annotated in at least one of the five public databases and 13,627 unigenes were assigned to 3,810 KEGG genes involved in 579 different pathways. 54 unigenes that encode 12 key enzymes involved in the pathway of flavonoid biosynthesis were discovered. One baicalinase and three baicalein 7-O-glucuronosyltransferases genes potentially involved in the transformation between baicalin/wogonoside and baicalein/wogonin were identified. Four candidate 6-hydroxylase genes for the formation of baicalin/baicalein and one candidate 8-O-methyltransferase gene for the biosynthesis of wogonoside/wogonin were also recognized. Our results further support the conclusion that, in S. baicalensis, 3,5,7-trihydroxyflavone was the precursor of the four above compounds. Then, the differential expression models and simple sequence repeats associated with these genes were carefully analyzed. All of these results not only enrich the gene resource but also benefit research into the molecular genetics and functional genomics in S. baicalensis.	[Liu, Jinxin; Hou, Jingyi] Chengde Med Univ, Inst Tradit Chinese Med, Key Lab Tradit Chinese Med Res & Dev Hebei Prov, Chengde 067000, Peoples R China; [Liu, Jinxin; Hou, Jingyi; Jiang, Chao; Li, Geng; Lu, Heng; Meng, Fanyun] Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China; [Liu, Jinxin; Hou, Jingyi; Jiang, Chao; Li, Geng; Lu, Heng; Meng, Fanyun] China Acad Chinese Med Sci, State Key Lab Breeding Base Dao Di Herbs, Beijing 100700, Peoples R China; [Shi, Linchun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100193, Peoples R China	Chengde Medical University; Beijing Normal University; China Academy of Chinese Medical Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Meng, FY (corresponding author), Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China.	mfy@bnu.edu.cn; lcshi@implad.ac.cn			Projects in the National Science & Technology Pillar Program - Ministry of Science and Technology of the People's Republic of China [2012BAI29B02]; Fundamental Research Funds for the Central Universities - Beijing Normal University [2012LZD06]; Research Fund for the Doctoral Program - Chengde Medical University [201502]; Natural Science Foundation - National Natural Science Foundation of China [81303158]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" - Ministry of Science and Technology of the People's Republic of China [2014ZX09304307001]	Projects in the National Science & Technology Pillar Program - Ministry of Science and Technology of the People's Republic of China; Fundamental Research Funds for the Central Universities - Beijing Normal University; Research Fund for the Doctoral Program - Chengde Medical University; Natural Science Foundation - National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Creation" - Ministry of Science and Technology of the People's Republic of China	This work was supported by the Projects in the National Science & Technology Pillar Program funded by the Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn) to FM [Grant number: 2012BAI29B02], the Fundamental Research Funds for the Central Universities funded by the Beijing Normal University (www.bnu.edu.cn) to FM [Grant number: 2012LZD06], the Research Fund for the Doctoral Program funded by the Chengde Medical University (www.cdmc.edu.cn) to JL [Grant number: 201502], the Natural Science Foundation for the Youth funded by the National Natural Science Foundation of China (www.nsfc.gov.cn) to LS [Grant number: 81303158] and the Major Scientific and Technological Special Project for "Significant New Drugs Creation" funded by the Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn) to LS [Grant number: 2014ZX09304307001]. All the funders are noncommercial funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYABE SI, 1988, ARCH BIOCHEM BIOPHYS, V261, P458, DOI 10.1016/0003-9861(88)90362-1; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen S, 2001, CELL PROLIFERAT, V34, P293, DOI 10.1046/j.0960-7722.2001.00213.x; Chen Y, 2009, TOXICOLOGY, V259, P10, DOI 10.1016/j.tox.2009.01.010; Chiou SJ, 2010, PLANTA, V232, P963, DOI 10.1007/s00425-010-1229-3; Committee JPE, 2006, JAP PHARM; Costa MA, 2003, PHYTOCHEMISTRY, V64, P1097, DOI 10.1016/S0031-9422(03)00517-X; Dong LL, 2012, FOOD CHEM, V131, P1422, DOI 10.1016/j.foodchem.2011.10.013; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Food K. Drug Administration, 2008, KOR PHARM 9; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064643; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamarsheh O, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-189; Harborne J.B., 1999, HDB NATURAL FLAVONOI, V1; Harborne J.B, 1999, HDB NATURAL FLAVONOI, V1; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/PL00008158; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; IKEGAMI F, 1995, BIOL PHARM BULL, V18, P1531, DOI 10.1248/bpb.18.1531; Ikemoto S, 2000, UROLOGY, V55, P951, DOI 10.1016/S0090-4295(00)00467-2; JAY M, 1985, EUR J BIOCHEM, V153, P321, DOI 10.1111/j.1432-1033.1985.tb09304.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KHOURI HE, 1987, J CHROMATOGR, V407, P291, DOI 10.1016/S0021-9673(01)92626-3; Kim JH, 2006, PLANT SCI, V170, P897, DOI 10.1016/j.plantsci.2005.12.013; Kim YO, 2001, J ETHNOPHARMACOL, V77, P183, DOI 10.1016/S0378-8741(01)00283-5; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lei W, 2011, GENET MOL RES, V10, P3385, DOI 10.4238/2011.November.22.7; Lei W, 2010, GENET MOL BIOL, V33, P285, DOI 10.1590/S1415-47572010005000031; LEVVY GA, 1954, BIOCHEM J, V58, P462, DOI 10.1042/bj0580462; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li X., 1994, FLORA CHINA, P50; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lim BO, 2003, J ETHNOPHARMACOL, V84, P23, DOI 10.1016/S0378-8741(02)00257-X; Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050; Liu JJ, 2003, INT J CANCER, V106, P559, DOI 10.1002/ijc.11267; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou Qian, 2014, J Exp Bot, V65, P3157, DOI 10.1093/jxb/eru168; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Medicines EDftQo Commission EP, 2009, EUROPEAN PHARMACOPOE; Mizutani M, 1997, PLANT PHYSIOL, V113, P755, DOI 10.1104/pp.113.3.755; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; MOUSTAFA E, 1967, PHYTOCHEMISTRY, V6, P625, DOI 10.1016/S0031-9422(00)86001-X; NAGAI T, 1995, ANTIVIR RES, V26, P11, DOI 10.1016/0166-3542(94)00062-D; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Park NI, 2011, FUNCT INTEGR GENOMIC, V11, P491, DOI 10.1007/s10142-011-0229-0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Taira Z, 2004, FOOD CHEM TOXICOL, V42, P803, DOI 10.1016/j.fct.2003.12.017; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; TOGURI T, 1993, PLANT MOL BIOL, V23, P933, DOI 10.1007/BF00021810; Verma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103583; Wang Hong-zhi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1637; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; WELLE R, 1991, EUR J BIOCHEM, V196, P423, DOI 10.1111/j.1432-1033.1991.tb15833.x; Wellmann F, 2002, EUR J BIOCHEM, V269, P4134, DOI 10.1046/j.1432-1033.2002.03108.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao JB, 2014, BIOTECHNOL ADV, V32, P1145, DOI 10.1016/j.biotechadv.2014.04.006; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063168	74	16	18	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136397	10.1371/journal.pone.0136397	http://dx.doi.org/10.1371/journal.pone.0136397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317778	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100079
J	Priya, PP; Grover, M; Tatu, US; Natarajan, V				Priya, P. Padma; Grover, Manish; Tatu, Utpal S.; Natarajan, Vasant			Characterization of Precursor PfHsp60 in Plasmodium falciparum Cytosol during Its Asexual Development in Human Erythrocytes	PLOS ONE			English	Article							MITOCHONDRIAL PROTEINS; MALARIA; IDENTIFICATION; EXPRESSION; HSP60; LOCALIZATION; APICOPLAST; EVOLUTION; PARASITES; ENZYMES	Mitochondrial heat shock protein 60 (Hsp60) is a nuclear encoded gene product that gets post-translationally translocated into the mitochondria. Using multiple approaches such as immunofluorescence experiments, isoelectric point analysis with two-dimensional gel electrophoresis, and mass spectrometric identification of the signal peptide, we show that Hsp60 from Plasmodium falciparum (PfHsp60) accumulates in the parasite cytoplasm during the ring, trophozoite, and schizont stages of parasite development before being imported into the parasite mitochondria. Using co-immunoprecipitation experiments with antibodies specific to cytoplasmic PfHsp90, PfHsp70-1, and PfHsp60, we show association of precursor PfHsp60 with cytoplasmic chaperone machinery. Metabolic labeling involving pulse and chase indicates translocation of the precursor pool into the parasite mitochondrion during chase. Analysis of results obtained with Geldanamycin treatment confirmed precursor PfHsp60 to be one of the clients for PfHsp90. Cytosolic chaperones bind precursor PfHsp60 prior to its import into the mitochondrion of the parasite. Our data suggests an inefficient co-ordination in the synthesis and translocation of mitochondrial PfHsp60 during asexual growth of malaria parasite in human erythrocytes.	[Priya, P. Padma; Natarajan, Vasant] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Priya, P. Padma; Grover, Manish; Tatu, Utpal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Natarajan, V (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.	vasant@physics.iisc.ernet.in	Priya, S/GQH-7176-2022; PRIYA, PADMA/ABC-3121-2021	Tatu, Utpal/0000-0003-0404-8872; GROVER, MANISH/0000-0002-1625-7930	DST [201]; UGC [F.4-2/2006(BSR)/13-610/2012(BSR)]	DST(Department of Science & Technology (India)); UGC(University Grants Commission, India)	This work was supported by DST 201 (http://dst.gov.in/) and UGC, Dr. D. S. KOTHARI POST DOCTORAL FELLOWSHIP Ref No: F.4-2/2006(BSR)/13-610/2012(BSR) (http://www.ugc.ac.in/).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Akide-Ndunge OB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-113; ANDERSON L, 1981, P NATL ACAD SCI-BIOL, V78, P2407, DOI 10.1073/pnas.78.4.2407; [Anonymous], GENOME BIOL; [Anonymous], NATURE; [Anonymous], 2000, METHODS MALARIA RES; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Belles C, 1999, INFECT IMMUN, V67, P4191, DOI 10.1128/IAI.67.8.4191-4200.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Das A, 1997, MOL BIOCHEM PARASIT, V88, P95, DOI 10.1016/S0166-6851(97)00081-9; Deponte M, 2012, MOL BIOCHEM PARASIT, V186, P95, DOI 10.1016/j.molbiopara.2012.09.007; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Grallert H, 2001, J STRUCT BIOL, V135, P95, DOI 10.1006/jsbi.2001.4387; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Grover M, 2013, PARASITE, V20, DOI 10.1051/parasite/2012002; Gupta Radhey S, 2008, Novartis Found Symp, V291, P59; Haider A, 2015, MOL MICROBIOL, V96, P796, DOI 10.1111/mmi.12972; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Hatherley R, 2015, BIOCHEM BIOPH RES CO, V456, P440, DOI 10.1016/j.bbrc.2014.11.103; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kobayashi T, 2007, MITOCHONDRION, V7, P125, DOI 10.1016/j.mito.2006.11.021; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; Motoyama S, 2004, SHOCK, V22, P234, DOI 10.1097/01.shk.0000132459.68561.f4; Nagaraj VA, 2009, MOL BIOCHEM PARASIT, V168, P109, DOI 10.1016/j.molbiopara.2009.05.008; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sanchez GI, 1999, EXP PARASITOL, V93, P181, DOI 10.1006/expr.1999.4455; Sato S, 2005, MOL BIOCHEM PARASIT, V141, P133, DOI 10.1016/j.molbiopara.2005.01.010; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Syin C, 1996, MOL BIOCHEM PARASIT, V79, P13, DOI 10.1016/0166-6851(96)02633-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vilasi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097657; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wilairat P., 1985, Annali dell'Istituto Superiore di Sanita, V21, P299; Wu Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-105	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136401	10.1371/journal.pone.0136401	http://dx.doi.org/10.1371/journal.pone.0136401			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317863	Green Published, gold, Green Accepted			2022-12-27	WOS:000360299100080
J	Salaets, T; Richter, J; Brady, P; Jimenez, J; Nagatomo, T; Deprest, J; Toelen, J				Salaets, Thomas; Richter, Jute; Brady, Paul; Jimenez, Julio; Nagatomo, Taro; Deprest, Jan; Toelen, Jaan			Transcriptome Analysis of the Preterm Rabbit Lung after Seven Days of Hyperoxic Exposure	PLOS ONE			English	Article							RECEPTOR-GAMMA AGONIST; BRONCHOPULMONARY DYSPLASIA; NEONATAL HYPEROXIA; PREMATURE-INFANTS; RAT MODEL; INJURY; EXPRESSION; ROSIGLITAZONE; INFLAMMATION; ACTIVATION	The neonatal management of preterm born infants often results in damage to the developing lung and subsequent morbidity, referred to as bronchopulmonary dysplasia (BPD). Animal models may help in understanding the molecular processes involved in this condition and define therapeutic targets. Our goal was to identify molecular pathways using the earlier described preterm rabbit model of hyperoxia induced lung-injury. Transcriptome analysis by mRNA-sequencing was performed on lungs from preterm rabbit pups born at day 28 of gestation (term: 31 days) and kept in hyperoxia (95% O-2) for 7 days. Controls were preterm pups kept in normoxia. Transcriptomic data were analyzed using Array Studio and Ingenuity Pathway Analysis (IPA), in order to identify the central molecules responsible for the observed transcriptional changes. We detected 2217 significantly dysregulated transcripts following hyperoxia, of which 90% could be identified. Major pathophysiological dysregulations were found in inflammation, lung development, vascular development and reactive oxygen species (ROS) metabolism. To conclude, amongst the many dysregulated transcripts, major changes were found in the inflammatory, oxidative stress and lung developmental pathways. This information may be used for the generation of new treatment hypotheses for hyperoxia-induced lung injury and BPD.	[Salaets, Thomas; Toelen, Jaan] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Richter, Jute; Jimenez, Julio; Nagatomo, Taro; Deprest, Jan; Toelen, Jaan] Katholieke Univ Leuven, Dept Dev & Regenerat, Res Unit Fetus Placenta Neonate, Grp Biomed Sci, Leuven, Belgium; [Richter, Jute; Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium; [Brady, Paul] Katholieke Univ Leuven, Grp Biomed Sci, Dept Genet, Leuven, Belgium; [Jimenez, Julio] Clin Alemana, Dept Ginecol & Obstet, Santiago, Chile; [Nagatomo, Taro] Ehime Prefectural Cent Hosp, Dept Neonatol, Matsuyama, Ehime, Japan	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Clinica Alemana	Deprest, J (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Res Unit Fetus Placenta Neonate, Grp Biomed Sci, Leuven, Belgium.	Jan.Deprest@uzleuven.be	Jimenez, Julio/AAN-9679-2020	Richter, Jute/0000-0001-8415-6747; Jimenez, Julio/0000-0001-6260-2814; Salaets, Thomas/0000-0002-0971-5147; Deprest, Jan/0000-0002-4920-945X	Fonds Wetenschappelijk Onderzoek Vlaanderen [1801207]; Flemish Hercules foundation [AKUL/09/033]; KU Leuven [OT/13/115]; European Commission via its Erasmus Joint Doctoral program [2013-0040]; University Hospitals Leuven	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Flemish Hercules foundation; KU Leuven(KU Leuven); European Commission via its Erasmus Joint Doctoral program; University Hospitals Leuven	JDP was a beneficiary of a fundamental clinical research grant of the Fonds Wetenschappelijk Onderzoek Vlaanderen (1801207), and JT from the "Klinische Opleidings- en Onderzoeks-Raad" of the University Hospitals Leuven. Our experimental program is supported by the Flemish Hercules foundation (large infrastructure investments AKUL/09/033), by the KU Leuven (OT/13/115) and by the European Commission via its Erasmus Joint Doctoral program (2013-0040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Auten RL, 2001, AM J PHYSIOL-LUNG C, V281, pL336, DOI 10.1152/ajplung.2001.281.2.L336; Bhandari V, 2014, BIRTH DEFECTS RES A, V100, P189, DOI 10.1002/bdra.23220; Bhattacharya S, 2014, AM J PHYSIOL-LUNG C, V307, pL516, DOI 10.1152/ajplung.00200.2014; Bhattacharya S, 2013, PEDIATR RES, V73, P514, DOI 10.1038/pr.2013.7; Boucherat O, 2007, PHYSIOL GENOMICS, V32, P128, DOI 10.1152/physiolgenomics.00108.2007; Capelari DN, 2012, REGUL PEPTIDES, V177, P97, DOI 10.1016/j.regpep.2012.05.092; Chang YS, 2014, AM J RESP CELL MOL, V51, P391, DOI 10.1165/rcmb.2013-0385OC; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Couroucli XI, 2011, TOXICOL APPL PHARM, V256, P83, DOI 10.1016/j.taap.2011.06.018; D'Angio CT, 1999, EXP LUNG RES, V25, P443; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Debeer A, 2010, EARLY HUM DEV, V86, P99, DOI 10.1016/j.earlhumdev.2010.01.025; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Jensen EA, 2014, BIRTH DEFECTS RES A, V100, P145, DOI 10.1002/bdra.23235; Jiang JS, 2012, NEONATOLOGY, V101, P47, DOI 10.1159/000329451; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kapadia VS, 2013, PEDIATRICS, V132, pE1488, DOI 10.1542/peds.2013-0978; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Lee HJ, 2014, YONSEI MED J, V55, P99, DOI 10.3349/ymj.2014.55.1.99; Mascaretti RS, 2009, CLINICS, V64, P1099, DOI 10.1590/S1807-59322009001100010; Mataloun Marta M. G. B., 2006, J. Pediatr. (Rio J.), V82, P179, DOI [10.2223/JPED.1471, 10.1590/S0021-75572006000300005]; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PRINGLE KC, 1986, CLIN OBSTET GYNECOL, V29, P502, DOI 10.1097/00003081-198609000-00006; Rehan VK, 2006, PEDIATR PULM, V41, P558, DOI 10.1002/ppul.20407; Rehan VK, 2010, AM J PHYSIOL-LUNG C, V299, pL672, DOI 10.1152/ajplung.00240.2010; Richter J, 2014, AM J PHYSIOL-LUNG C, V306, pL277, DOI 10.1152/ajplung.00315.2013; Rutter M, 2008, THE NEWBORN LUNG, V1st, P3; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Shivanna B, 2011, J PHARMACOL EXP THER, V339, P106, DOI 10.1124/jpet.111.182980; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Su BH, 2005, J FORMOS MED ASSOC, V104, P244; TSAN MF, 1995, EXP LUNG RES, V21, P589, DOI 10.3109/01902149509031761; Vento G, 2009, INTENS CARE MED, V35, P2115, DOI 10.1007/s00134-009-1646-6; Viscardi RM, 2012, SEMIN FETAL NEONAT M, V17, P30, DOI 10.1016/j.siny.2011.08.002; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; Wang Y, 2009, PEDIATR RES, V65, P150, DOI 10.1203/PDR.0b013e3181938c40; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Weichelt U, 2013, EUR RESPIR J, V41, P966, DOI 10.1183/09031936.00012412; Weng TT, 2006, AM J PHYSIOL-LUNG C, V291, pL1027, DOI 10.1152/ajplung.00435.2005; WHITE C W, 1989, Biotherapy (Dordrecht), V1, P361, DOI 10.1007/BF02171012	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136569	10.1371/journal.pone.0136569	http://dx.doi.org/10.1371/journal.pone.0136569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317699	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100103
J	Shi, FF; Len, YM; Gong, YP; Shi, R; Yang, X; Naren, D; Yan, TY				Shi, Fangfang; Len, Yamei; Gong, Yuping; Shi, Rui; Yang, Xi; Naren, Duolan; Yan, Tianyou			Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph plus Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PHILADELPHIA-CHROMOSOME; TRANSLATION INITIATION; EIF4E; COMBINATION; MNK; ACTIVATION; PROMOTES; SURVIVAL; CANCERS	The eukaryotic translation initiation factor 4E (eIF4E), which is the main composition factor of eIF4F translation initiation complex, influences the growth of tumor through modulating cap-dependent protein translation. Previous studies reported that ribavirin could suppress eIF4E-controlled translation and reduce the synthesis of onco-proteins. Here, we investigated the anti-leukemic effects of ribavirin alone or in combination with tyrosine kinase inhibitor imatinib in Philadelphia chromosome positive (Ph+) leukemia cell lines SUP-B15 (Ph+ acute lymphoblastic leukemia cell line, Ph+ ALL) and K562 (chronic myelogenous leukemia cell line, CML). Our results showed that ribavirin had anti-proliferation effect; it down-regulated the phosphorylation levels of Akt, mTOR, 4EBP1, and eIF4E proteins in the mTOR/eIF4E signaling pathway, and MEK, ERK, Mnk1 and eIF4E proteins in ERK/Mnk1/eIF4E signaling pathway; reduced the expression of Mcl-1 (a translation substrates of eIF4F translation initiation complex) at protein synthesis level not mRNA transcriptional level; and induced cell apoptosis in both SUP-B15 and K562. 7-Methyl-guanosine cap affinity assay further demonstrated that ribavirin remarkably increased the eIF4E binding to 4EBP1 and decreased the combination of eIF4E with eIF4G, consequently resulting in a major inhibition of eIF4F complex assembly. The combination of ribavirin with imatinib enhanced antileukemic effects mentioned above, indicating that two drugs have synergistic anti-leukemic effect. Consistent with the cell lines, similar results were observed in Ph+ acute lymphoblastic primary leukemic blasts; however, the anti-proliferative role of ribavirin in other types of acute primary leukemic blasts was not obvious, which indicated that the anti-leukemic effect of ribavirin was different in cell lineages.	[Shi, Fangfang; Len, Yamei; Gong, Yuping; Shi, Rui; Yang, Xi; Naren, Duolan; Yan, Tianyou] Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Gong, YP (corresponding author), Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	gongyuping2010@aliyun.com		Shi, Rui/0000-0003-1664-468X	Doctoral Fund of the Ministry of Education [20120181110008]; Foundation of the Science & Technology Department of Sichuan Province [2013SZ0025]; Foundation of the Administration of traditional Chinese medicine of Sichuan Province [2014A038]	Doctoral Fund of the Ministry of Education(Ministry of Education, China); Foundation of the Science & Technology Department of Sichuan Province; Foundation of the Administration of traditional Chinese medicine of Sichuan Province	This work was supported by the Doctoral Fund of the Ministry of Education (No. 20120181110008), Foundation of the Science & Technology Department of Sichuan Province (No. 2013SZ0025), Foundation of the Administration of traditional Chinese medicine of Sichuan Province (No. 2014A038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; de Labarthe A, 2007, BLOOD, V109, P1408, DOI 10.1182/blood-2006-03-011908; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fielding AK, 2011, HEMATOL-AM SOC HEMAT, P231, DOI 10.1182/asheducation-2011.1.231; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Guo Y, 2012, CANCER BIOL THER, V13, P1244, DOI 10.4161/cbt.21460; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Kentsis A, 2005, RNA, V11, P1762, DOI 10.1261/rna.2238705; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kokeny S, 2009, ANTICANCER RES, V29, P1971; Kraljacic BC, 2011, LEUKEMIA, V25, P1197, DOI 10.1038/leu.2011.57; Lee HJ, 2011, CANCER-AM CANCER SOC, V117, P1583, DOI 10.1002/cncr.25690; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Meng HT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-18; Messina V, 2010, BIOL REPROD, V83, P607, DOI 10.1095/biolreprod.110.085050; Muta D, 2011, J NEURO-ONCOL, V101, P33, DOI 10.1007/s11060-010-0233-6; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Prabhu S, 2007, ONCOGENE, V26, P1188, DOI 10.1038/sj.onc.1209901; Shi FF, 2015, ANTI-CANCER DRUG, V26, P410, DOI 10.1097/CAD.0000000000000200; Silva RLA, 2008, CELL CYCLE, V7, P553, DOI 10.4161/cc.7.5.5486; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Tan K, 2008, BIOCHEM BIOPH RES CO, V375, P341, DOI 10.1016/j.bbrc.2008.07.163; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zhou Y, 2003, PROG PHARM SCI, V27, P314	32	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136746	10.1371/journal.pone.0136746	http://dx.doi.org/10.1371/journal.pone.0136746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317515	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100133
J	Xiong, W; Li, ZG; Liu, HJ; Xue, C; Zhang, RF; Wu, HS; Li, R; Shen, QR				Xiong, Wu; Li, Zhigang; Liu, Hongjun; Xue, Chao; Zhang, Ruifu; Wu, Huasong; Li, Rong; Shen, Qirong			The Effect of Long-Term Continuous Cropping of Black Pepper on Soil Bacterial Communities as Determined by 454 Pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BIOORGANIC FERTILIZER; FUSARIUM-WILT; DIVERSITY; RHIZOSPHERE; FUNGAL; REPLANT; CUCUMBER; GROWTH; ROOT	In the present study, 3 replanted black pepper orchards with continuously cropping histories for 10, 21, and 55 years in tropical China, were selected for investigating the effect of monoculture on soil physiochemical properties, enzyme activities, bacterial abundance, and bacterial community structures. Results showed long-term continuous cropping led to a significant decline in soil pH, organic matter contents, enzymatic activities, and resulted in a decrease in soil bacterial abundance. 454 pyrosequencing analysis of 16S rRNA genes revealed that the Acidobacteria and Proteobacteria were the main phyla in the replanted black pepper orchard soils, comprising up to 73.82% of the total sequences; the relative abundances of Bacteroidetes and Firmicutes phyla decreased with long-term continuous cropping; and at genus level, the Pseudomonas abundance significantly depleted after 21 years continuous cropping. In addition, bacterial diversity significantly decreased after 55 years black pepper continuous cropping; obvious variations for community structures across the 3 time-scale replanted black pepper orchards were observed, suggesting monoculture duration was the major determinant for bacterial community structure. Overall, continuous cropping during black pepper cultivation led to a significant decline in soil pH, organic matter contents, enzymatic activities, resulted a decrease in soil bacterial abundance, and altered soil microbial community membership and structure, which in turn resulted in black pepper poor growth in the continuous cropping system.	[Xiong, Wu; Li, Zhigang; Wu, Huasong] Chinese Acad Trop Agr Sci, Spice & Beverage Res Inst, Wanning 571533, Hainan, Peoples R China; [Xiong, Wu; Liu, Hongjun; Xue, Chao; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Key Lab Solid Organ Waste Utilizat, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Ruifu] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Microbial Resources Collect & Preservat, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Wu, HS (corresponding author), Chinese Acad Trop Agr Sci, Spice & Beverage Res Inst, Wanning 571533, Hainan, Peoples R China.	wuhuasong2000@163.com; lirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Zhang, Ruifu/HDN-0417-2022; Zhang, Ruifu/HDN-0340-2022		National Key Basic Research Program of China [2015CB150500]; Natural Science Foundation of China [31301857]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 project [B12009]	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 project(Ministry of Education, China - 111 Project)	This study was financially supported by the National Key Basic Research Program of China (2015CB150500), Natural Science Foundation of China (31301857), the Innovative Research Team Development Plan of the Ministry of Education of China under Grant IRT1256, the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and the 111 project (B12009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef K., 1995, METHODS APPL SOIL MI, P350; Aravind R, 2009, LETT APPL MICROBIOL, V48, P58, DOI 10.1111/j.1472-765X.2008.02486.x; Barak P, 1997, PLANT SOIL, V197, P61, DOI 10.1023/A:1004297607070; CATSKA V, 1982, PLANT SOIL, V69, P187, DOI 10.1007/BF02374514; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; Chen LH, 2012, J SCI FOOD AGR, V92, P2465, DOI 10.1002/jsfa.5653; Chen L, 2014, EUR J SOIL BIOL, V62, P121, DOI 10.1016/j.ejsobi.2014.03.006; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fuentes M, 2009, EUR J AGRON, V30, P228, DOI 10.1016/j.eja.2008.10.005; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gianfreda L, 2005, SCI TOTAL ENVIRON, V341, P265, DOI 10.1016/j.scitotenv.2004.10.005; Guo H, 2014, CROP PROT, V62, P1, DOI 10.1016/j.cropro.2014.03.020; Guo XW, 2011, BIOTECHNOL BIOTEC EQ, V25, P2334, DOI 10.5504/BBEQ.2011.0045; Huang LF, 2013, J CHEM ECOL, V39, P232, DOI 10.1007/s10886-013-0244-9; Johnsen K, 2001, BIOL FERT SOILS, V33, P443, DOI 10.1007/s003740100351; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kuramae EE, 2012, FEMS MICROBIOL ECOL, V79, P12, DOI 10.1111/j.1574-6941.2011.01192.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Li PeiDong, 2012, African Journal of Agricultural Research, V7, P1870; Li XG, 2014, SOIL BIOL BIOCHEM, V72, P11, DOI 10.1016/j.soilbio.2014.01.019; Li Z, CHINESE J TROPICAL C, V33, P1245; Liu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086610, 10.1371/journal.pone.0087996]; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Quadros P. D. de, 2012, Diversity, V4, P375, DOI 10.3390/d4040375; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rumberger A, 2007, SOIL BIOL BIOCHEM, V39, P1645, DOI 10.1016/j.soilbio.2007.01.023; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098420; SHIPTON PJ, 1977, ANNU REV PHYTOPATHOL, V15, P387, DOI 10.1146/annurev.py.15.090177.002131; Sindhu SS, 1999, BIOL FERT SOILS, V29, P62, DOI 10.1007/s003740050525; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Sun YB, 2012, J ENVIRON SCI, V24, P1799, DOI 10.1016/S1001-0742(11)61010-3; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Xiong Weili, 2014, ABSTR APPL ANAL, V2014, P1; Yadvinder-Singh, 2004, SOIL SCI SOC AM J, V68, P854; Yang JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046420; Zhang MK, 2004, GEODERMA, V118, P167, DOI 10.1016/S0016-7061(03)00191-5; Zhang W, 2013, MICROB ECOL, V66, P385, DOI 10.1007/s00248-012-0160-5; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11; Zhou XG, 2012, FEMS MICROBIOL ECOL, V80, P469, DOI 10.1111/j.1574-6941.2012.01312.x; Zu Chao, 2014, Agricultural Sciences, V5, P466	52	91	100	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136946	10.1371/journal.pone.0136946	http://dx.doi.org/10.1371/journal.pone.0136946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317364	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100179
J	Hsieh, CF; Huang, WF; Chiang, YT; Chen, CY				Hsieh, Chi-Feng; Huang, Weng-Foung; Chiang, Yi-Ting; Chen, Chun-Yen			Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; EXPERT CONSENSUS DOCUMENT; CONCOMITANT USE; ANTIPLATELET THERAPY; GASTROINTESTINAL RISKS; NONDIABETIC PATIENTS; PLATELET REACTIVITY; ADVERSE OUTCOMES; PACLITAXEL; EVEROLIMUS	Objective To investigate whether there is an increased risk of cardiac events in diabetic patients with a combined therapy of clopidogrel (CLO) and proton pump inhibitors (PPIs) after drug-eluting stent (DES) deployment. Methods By using National Health Insurance Research Database, all patients who received CLO with or without PPI therapy within 90 days after undergoing DES (limus-eluting or paclitax-eleluting stents) deployment were enrolled. Endpoints were acute coronary syndrome (ACS) and readmission for revascularization (percutaneous coronary intervention or coronary artery bypass graft surgery) after 3, 6, and 12 months. Results A total of 6,603 diabetic patients received LESs (5,933 in the CLO subgroup and 670 in the CLO plus PPIs subgroup), and 3,202 patients received PESs (2,923 in the CLO subgroup and 279 in the CLO plus PPIs subgroup). The patients who received CLO plus PPIs were at higher risk of ACS than those receiving CLO within 1 year after DES deployment (LESs: 6-month hazard ratio [HR] = 1.63, and 1-year HR = 1.37; PESs: 3-month HR = 1.72). Patients with a history of ACS who received CLO plus PPIs were at higher risk of ACS after LES implantation (HR = 1.55) than those in the CLO group. Conclusion In "real-world" diabetic patients with LES deployment, the combination of PPIs and CLO is associated with higher rates of ACS after 6 months and 1 year. Even after correction for confounding factors, concomitant PPI use remained an independent predictor of cardiac events, emphasizing the clinical importance of this drug-drug interaction.	[Hsieh, Chi-Feng; Huang, Weng-Foung; Chiang, Yi-Ting] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei 112, Taiwan; [Chen, Chun-Yen] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Chen, Chun-Yen] Mackay Med Coll, Dept Med, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College	Chen, CY (corresponding author), Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	mwplasma@ms9.hinet.net			National Science Council [NSC99- 2320-B-010-018-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the National Science Council (NSC99- 2320-B-010-018-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Huang CC, 2010, AM J CARDIOL, V105, P1705, DOI 10.1016/j.amjcard.2010.01.348; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Jiang P, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-7; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Kereiakes DJ, 2010, J AM COLL CARDIOL, V56, P2084, DOI 10.1016/j.jacc.2010.10.006; Kirchheiner J, 2005, CLIN PHARMACOKINET, V44, P1209, DOI 10.2165/00003088-200544120-00002; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Kufner S, 2014, CARDIOVASC REVASCULA, V15, P69, DOI 10.1016/j.carrev.2014.02.001; Kuo CH, 2009, J ANTIMICROB CHEMOTH, V63, P1017, DOI 10.1093/jac/dkp034; Lee JJ, 2010, ARCH PHARM RES, V33, P387, DOI 10.1007/s12272-010-0307-1; Lin CF, 2012, BRIT J CLIN PHARMACO, V74, P824, DOI 10.1111/j.1365-2125.2012.04250.x; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Ojeifo O, 2013, JACC-CARDIOVASC INTE, V6, P1275, DOI 10.1016/j.jcin.2013.06.014; Pezalla E, 2008, J AM COLL CARDIOL, V52, P1038, DOI 10.1016/j.jacc.2008.05.053; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2009, AM J CARDIOL, V103, P1339, DOI 10.1016/j.amjcard.2009.01.341; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stockl KM, 2010, ARCH INTERN MED, V170, P704, DOI 10.1001/archinternmed.2010.34; Stone GW, 2011, CIRCULATION, V124, P893, DOI 10.1161/CIRCULATIONAHA.111.031070; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Yusuf S, 2001, NEW ENGL J MED, V345, P494	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135915	10.1371/journal.pone.0135915	http://dx.doi.org/10.1371/journal.pone.0135915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313000	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000032
J	Nocturne, G; Pavy, S; Boudaoud, S; Seror, R; Goupille, P; Chanson, P; van der Heijde, D; van Gaalen, F; Berenbaum, F; Mariette, X; Briot, K; Feydy, A; Claudepierre, P; Dieude, P; Nithitham, J; Taylor, KE; Criswell, LA; Dougados, M; Roux, C; Miceli-Richard, C				Nocturne, Gaetane; Pavy, Stephan; Boudaoud, Saida; Seror, Raphaele; Goupille, Philippe; Chanson, Philippe; van der Heijde, Desiree; van Gaalen, Floris; Berenbaum, Francis; Mariette, Xavier; Briot, Karine; Feydy, Antoine; Claudepierre, Pascal; Dieude, Philippe; Nithitham, Joanne; Taylor, Kimberly E.; Criswell, Lindsey A.; Dougados, Maxime; Roux, Christian; Miceli-Richard, Corinne			Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort	PLOS ONE			English	Article							INFLAMMATORY BACK-PAIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANKYLOSING-SPONDYLITIS; RADIOGRAPHIC PROGRESSION; BONE-FORMATION; CLINICAL HISTORY; SCLEROSTIN; CLASSIFICATION; POPULATION; INHIBITION	Objectives To investigate DKK-1 and SOST serum levels among patients with recent inflammatory back pain (IBP) fulfilling ASAS criteria for SpA and associated factors. Methods The DESIR cohort is a prospective, multicenter French cohort of 708 patients with early IBP (duration >3 months and <3 years) suggestive of AxSpA. DKK-1 and SOST serum levels were assessed at baseline and were compared between the subgroup of patients fulfilling ASAS criteria for SpA (n = 486; 68.6%) and 80 healthy controls. Results Mean SOST serum levels were lower in ASAS+ patients than healthy controls (49.21 +/- 25.9 vs. 87.8 +/- 26 pmol/L; p<0.0001). In multivariate analysis, age (p = 5.4 10(-9)), CRP level (p<0.0001) and serum DKK-1 level (p = 0.001) were associated with SOST level. Mean DKK-1 serum levels were higher in axial SpA patients than controls (30.03 +/- 15.5 vs. 11.6 +/- 4.2 pmol/L; p<0.0001). In multivariate analysis, DKK-1 serum levels were associated male gender (p = 0.03), CRP level (p = 0.006), SOST serum level (p = 0.002) and presence of sacroiliitis on radiography (p = 0.05). Genetic association testing of 10 SNPs encompassing the DKK-1 locus failed to demonstrate a significant contribution of genetics to control of DKK-1 serum levels. Conclusions DKK-1 serum levels were increased and SOST levels were decreased among a large cohort of patients with early axial SpA compared to healthy controls. DKK-1 serum levels were mostly associated with biological inflammation and SOST serum levels.	[Nocturne, Gaetane; Boudaoud, Saida; Mariette, Xavier; Miceli-Richard, Corinne] Univ Paris 11, INSERM, U1184, Le Kremlin Bicetre, France; [Pavy, Stephan; Seror, Raphaele; Mariette, Xavier; Miceli-Richard, Corinne] Hop Bicetre, AP HP, Serv Rhumatol, Le Kremlin Bicetre, France; [Goupille, Philippe] CHU Tours, Serv Rhumatol, Tours, France; [Goupille, Philippe] Univ Tours, CNRS, UMR 7292, Tours, France; [Goupille, Philippe] CIC INSERM 1415, Tours, France; [Chanson, Philippe] Hop Bicetre, AP HP, Serv Endocrinol, Le Kremlin Bicetre, France; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Leiden, Netherlands; [van Gaalen, Floris] LUMC, Dept Rheumatol & Internal Med, Leiden, Netherlands; [Berenbaum, Francis] Univ Paris 06, Hop St Antoine, AP HP, Sorbonne Univ,Rheumatol Dept, Paris, France; [Briot, Karine; Dougados, Maxime; Roux, Christian] Univ Paris 05, AP HP, Serv Rhumatol B, Paris, France; [Feydy, Antoine] Hop Cochin, AP HP, Serv Radiol, F-75674 Paris, France; [Claudepierre, Pascal] Hop Henri Mondor, AP HP, Serv Rhumatol, F-94010 Creteil, France; [Dieude, Philippe] Hop Bichat Claude Bernard, AP HP, Serv Rhumatol, F-75877 Paris, France; [Nithitham, Joanne; Taylor, Kimberly E.; Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Ephraim P Engleman Rheumatol Res, San Francisco, CA 94143 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco	Miceli-Richard, C (corresponding author), Univ Paris 11, INSERM, U1184, Le Kremlin Bicetre, France.	corinne.miceli@bct.aphp.fr	Briot, Karine/P-2116-2016; Dougados, Maxime/P-5287-2016; FEYDY, ANTOINE/P-5289-2016; Berenbaum, Francis/AAO-5690-2020; van der Heijde, Désirée/I-6774-2019; SEROR, Raphaele/E-2283-2017; Chanson, Philippe/F-8511-2013	Briot, Karine/0000-0002-6238-2601; Berenbaum, Francis/0000-0001-8252-7815; van der Heijde, Désirée/0000-0002-5781-158X; SEROR, Raphaele/0000-0002-5523-1856; Chanson, Philippe/0000-0001-5096-5722; Dieude, Philippe/0000-0002-4814-0307; Nocturne, Gaetane/0000-0001-6809-0733	French Society of Rheumatology; Pfizer Ltd, France; Pfizer "Passerelle"; Programme Hospitalier de Recherche Clinique, French Ministry of Health [P081216 / IDRCB 2009-A00892-55]	French Society of Rheumatology; Pfizer Ltd, France; Pfizer "Passerelle"; Programme Hospitalier de Recherche Clinique, French Ministry of Health	An unrestricted grant from Wyeth Pharmaceuticals was allocated for the first 5 years of the follow-up of the recruited patients. The DESIR-cohort is financially supported by unrestricted grants from both the French Society of Rheumatology, and Pfizer Ltd, France. A research grant from Pfizer "Passerelle" was obtained for DKK-1 and SOST quantification for the entire cohort and for genetic analysis of the DKK-1 locus. The Variete cohort was supported by a grant from the Programme Hospitalier de Recherche Clinique, French Ministry of Health (no. P081216 / IDRCB 2009-A00892-55). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel H, 2010, J RHEUMATOL, V37, P823, DOI 10.3899/jrheum.090986; Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Ardawi MSM, 2011, J BONE MINER RES, V26, P2812, DOI 10.1002/jbmr.479; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613, DOI 10.1001/jama.237.24.2613; Chen XX, 2013, ANN RHEUM DIS, V72, P1732, DOI 10.1136/annrheumdis-2013-203345; Cortes A, 2015, ANN RHEUM DIS, V74, P1387, DOI 10.1136/annrheumdis-2013-204835; Costantino F, 2015, ANN RHEUM DIS, V74, P689, DOI 10.1136/annrheumdis-2013-204436; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Daoussis D, 2010, ARTHRITIS RHEUM-US, V62, P150, DOI 10.1002/art.27231; de Rooy DPC, 2013, ANN RHEUM DIS, V72, P769, DOI 10.1136/annrheumdis-2012-202184; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dougados M, 2011, JOINT BONE SPINE, V78, P598, DOI 10.1016/j.jbspin.2011.01.013; Hamilton L, 2014, RHEUMATOLOGY, V53, P161, DOI 10.1093/rheumatology/ket344; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Heiland GR, 2012, ANN RHEUM DIS, V71, P572, DOI 10.1136/annrheumdis-2011-200216; Heiland GR, 2010, ANN RHEUM DIS, pannrheumdis132852; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Navarro-Compan V, 2013, ANN RHEUM DIS, V72, P785, DOI 10.1136/annrheumdis-2012-202504; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Poddubnyy D, 2012, ANN RHEUM DIS, V71, P1616, DOI 10.1136/annrheumdis-2011-201252; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Seror R, 2014, DATA FROM THE ESPOIR; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Uderhardt S, 2010, ANN RHEUM DIS, V69, P592, DOI 10.1136/ard.2008.102046; van den Berg R, 2014, ARTHRITIS RHEUMATOL; van den Berg R, 2013, ANN RHEUM DIS, V72, P1646, DOI 10.1136/annrheumdis-2012-201884; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P3063, DOI 10.1002/art.23901; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599	36	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0134974	10.1371/journal.pone.0134974	http://dx.doi.org/10.1371/journal.pone.0134974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313358	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000011
J	Meyer, T; Chavanon, ML; Herrrmann-Lingen, C; Roggenthien, M; Nolte, K; Pieske, B; Wachter, R; Edelmann, F				Meyer, Thomas; Chavanon, Mira-Lynn; Herrrmann-Lingen, Christoph; Roggenthien, Maren; Nolte, Kathleen; Pieske, Burkert; Wachter, Rolf; Edelmann, Frank			Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DEPRESSION SCALE; HOSPITAL ANXIETY; HEART-FAILURE; EJECTION FRACTION; DYSFUNCTION; ACTIVATION; EXPRESSION; ISCHEMIA; DISEASE	Background The role of endothelin-1 (ET-1) in the neurobiology of anxiety is unknown, therefore, we assessed in the observational multicenter DIAST-CHF study whether the C-terminal ET-1 precursor fragment (CT-proET-1) is linked to anxiety. Methods Plasma concentrations of CT-proET-1 were measured in a total of 1,410 patients presenting with cardiovascular risk factors (mean age 66.91 +/- 8.2 years, 49.3% males, mean left ventricular ejection fraction 60.0 +/- 8.2%) who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. Results Among the total study cohort (n = 1,410), there were 118 subjects (8.4%) with an HADS anxiety score above the cut-off level of 11 suggestive of clinically relevant anxiety. Plasma CT-proET-1 levels were significantly lower in the group of anxious patients as compared to non-anxious patients (p = 0.013). In regression models adjusted for sex, age, systolic blood pressure, and diameters of left atrium and ventricle, plasma CT-proET-1 was again linked to anxiety (Exp(beta) = 0.247, 95%-confidence interval [95%-CI] = 0.067-0.914, p = 0.036). Given the high prevalence of depressive disorders in anxious patients, we additionally included the HADS depression score as an independent variable in the models and found that CT-proET-1 remained a significant predictor of anxiety, independent of comorbid depression (Exp(beta) = 0.114, 95%-CI = 0.023-0.566, p = 0.008). Conclusions Our data from a population-based study in outpatients with cardiovascular risk factors revealed that circulating CT-proET-1 levels are negatively associated with anxiety. Further investigations are required to clarify the putative anxiolytic effect of ET-1 or its precursor molecules in humans and to decipher its mechanistic pathways.	[Meyer, Thomas; Chavanon, Mira-Lynn; Herrrmann-Lingen, Christoph; Roggenthien, Maren] Univ Gottingen, Dept Psychosomat Med & Psychotherapy, D-37073 Gottingen, Germany; [Nolte, Kathleen; Wachter, Rolf; Edelmann, Frank] Univ Gottingen, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany; [Pieske, Burkert; Edelmann, Frank] Charite, Dept Internal Med & Cardiol, D-13353 Berlin, Germany; [Meyer, Thomas; Chavanon, Mira-Lynn; Herrrmann-Lingen, Christoph; Pieske, Burkert; Wachter, Rolf; Edelmann, Frank] German Ctr Cardiovasc Res, Gottingen, Germany	University of Gottingen; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Edelmann, F (corresponding author), Univ Gottingen, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany.	fedelmann@med.uni-goettingen.de	Chavanon, Mira-Lynn/L-6676-2017; Wachter, Rolf/AAA-4037-2020; Pieske, Burkert/M-8089-2016	Chavanon, Mira-Lynn/0000-0003-1575-2486; Pieske, Burkert/0000-0002-6466-5306; Edelmann, Frank/0000-0003-4401-5936				Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Browatzki M, 2005, EUR J MED RES, V10, P197; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Burg MM, 2011, PSYCHOSOM MED, V73, P2, DOI 10.1097/PSY.0b013e3181fdfb25; DENAULT JB, 1995, FEBS LETT, V362, P276, DOI 10.1016/0014-5793(95)00249-9; Edelmann F, 2012, EUR HEART J, V33, P203, DOI 10.1093/eurheartj/ehr292; Edelmann F, 2011, AM HEART J, V161, P797, DOI 10.1016/j.ahj.2011.01.003; Endepols H., 2014, J NEUROSCI METHODS; FIRTH JD, 1992, J CLIN INVEST, V90, P1023, DOI 10.1172/JCI115915; Gombos T, 2009, INFLAMM RES, V58, P298, DOI 10.1007/s00011-008-8184-5; Harvey BH, 2012, PHARMACOL BIOCHEM BE, V100, P775, DOI 10.1016/j.pbb.2011.06.014; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Herrmann-Lingen C, 2003, PSYCHOSOM MED, V65, P517, DOI 10.1097/01.PSY.0000073870.93003.C4; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Leonova J, 2001, AM J PHYSIOL-CELL PH, V281, pC1495, DOI 10.1152/ajpcell.2001.281.5.C1495; Loria AS, 2010, AM J PHYSIOL-REG I, V299, pR185, DOI 10.1152/ajpregu.00333.2009; Modi S, 2014, PSYCHIAT RES-NEUROIM, V224, P34, DOI 10.1016/j.pscychresns.2014.03.001; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Pinho-Ribeiro FA, 2014, NEUROSCI LETT, V560, P57, DOI 10.1016/j.neulet.2013.12.018; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Stahrenberg R, 2010, DIABETOLOGIA, V53, P1331, DOI 10.1007/s00125-010-1718-8; Stahrenberg R, 2010, EUR J HEART FAIL, V12, P1309, DOI 10.1093/eurjhf/hfq151; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Woods M, 1999, MOL PHARMACOL, V55, P902; Yammine L, 2014, J PSYCHOSOM RES, V77, P430, DOI 10.1016/j.jpsychores.2014.07.019; Zhang X, 2013, NEUROBIOL LEARN MEM, V101, P46, DOI 10.1016/j.nlm.2013.01.002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zwanzger P, 2013, NEUROPSYCHOPHARMACOL, V38, P1648, DOI 10.1038/npp.2013.61	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136739	10.1371/journal.pone.0136739	http://dx.doi.org/10.1371/journal.pone.0136739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322793	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500031
J	Pacana, T; Cazanave, S; Verdianelli, A; Patel, V; Min, HK; Mirshahi, F; Quinlivan, E; Sanyal, AJ				Pacana, Tommy; Cazanave, Sophie; Verdianelli, Aurora; Patel, Vaishali; Min, Hae-Ki; Mirshahi, Faridoddin; Quinlivan, Eoin; Sanyal, Arun J.			Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; NITRIC-OXIDE SYNTHASE; ONE-CARBON METABOLISM; OXIDATIVE STRESS; DNA METHYLATION; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; MASS-SPECTROMETRY; FOLLOW-UP; STEATOHEPATITIS	Methionine metabolism plays a central role in methylation reactions, production of glutathione and methylarginines, and modulating homocysteine levels. The mechanisms by which these are affected in NAFLD are not fully understood. The aim is to perform a metabolomic, molecular and epigenetic analyses of hepatic methionine metabolism in diet-induced NAFLD. Female 129S1/SvlmJ; C57Bl/6J mice were fed a chow (n = 6) or high-fat high-cholesterol (HFHC) diet (n = 8) for 52 weeks. Metabolomic study, enzymatic expression and DNA methylation analyses were performed. HFHC diet led to weight gain, marked steatosis and extensive fibrosis. In the methionine cycle, hepatic methionine was depleted (30%, p<0.01) while s-adenosylmethionine (SAM)/methionine ratio (p<0.05), s-adenosylhomocysteine (SAH) (35%, p<0.01) and homocysteine (25%, p<0.01) were increased significantly. SAH hydrolase protein levels decreased significantly (p<0.01). Serine, a substrate for both homocysteine remethylation and transsulfuration, was depleted (45%, p<0.01). In the transsulfuration pathway, cystathionine and cysteine trended upward while glutathione decreased significantly (p<0.05). In the transmethylation pathway, levels of glycine N-methyltransferase (GNMT), the most abundant methyltransferase in the liver, decreased. The phosphatidylcholine (PC)/phosphatidylethanolamine (PE) ratio increased significantly (p<0.01), indicative of increased phosphatidylethanolamine methyltransferase (PEMT) activity. The protein levels of protein arginine methytransferase 1 (PRMT1) increased significantly, but its products, monomethylarginine (MMA) and asymmetric dimethylarginine (ADMA), decreased significantly. Circulating ADMA increased and approached significance (p<0.06). Protein expression of methionine adenosyltransferase 1A, cystathionine beta-synthase, gamma-glutamylcysteine synthetase, betaine-homocysteine methyltransferase, and methionine synthase remained unchanged. Although gene expression of the DNA methyltransferase Dnmt3a decreased, the global DNA methylation was unaltered. Among individual genes, only HMG-CoA reductase (Hmgcr) was hypermethylated, and no methylation changes were observed in fatty acid synthase (Fasn), nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (Nf kappa b1), c-Jun, B-cell lymphoma 2 (Bcl-2) and Caspase 3. NAFLD was associated with hepatic methionine deficiency and homocysteine elevation, resulting mainly from impaired homocysteine remethylation, and aberrancy in methyltransferase reactions. Despite increased PRMT1 expression, hepatic ADMA was depleted while circulating ADMA was increased, suggesting increased export to circulation.	[Pacana, Tommy; Cazanave, Sophie; Verdianelli, Aurora; Patel, Vaishali; Min, Hae-Ki; Mirshahi, Faridoddin; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23298 USA; [Quinlivan, Eoin] Univ Florida, Gen Clin Res Ctr, Biomed Mass Spectrometry Lab, Gainesville, FL USA	Virginia Commonwealth University; State University System of Florida; University of Florida	Pacana, T (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tpacana@mcvh-vcu.edu; asanyal@mcvh-vcu.edu	Quinlivan, Eoin/AAJ-1979-2021; Quinlivan, Eoin P/B-8454-2008	Quinlivan, Eoin/0000-0002-0908-1762; Quinlivan, Eoin P/0000-0002-0908-1762	National Institutes of Health [RO1 DK 081450-03, T32 DK 007150-37]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK081450, T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by two grants from the National Institutes of Health to Dr. Sanyal: RO1 DK 081450-03 and T32 DK 007150-37.	[Anonymous], 2008, BIOMARKER METHODS IN; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Cheng JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044106; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Cook RJ, 2000, AM J CLIN NUTR, V72, P1419; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; Dasarathy S, 2009, AM J PHYSIOL-GASTR L, V297, pG567, DOI 10.1152/ajpgi.00042.2009; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Finkelstein JD, 2003, AM J CLIN NUTR, V77, P1094, DOI 10.1093/ajcn/77.5.1094; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fujita K, 2010, ALCOHOL CLIN EXP RES, V34, pS18, DOI 10.1111/j.1530-0277.2008.00756.x; Garcia-Tevijano ER, 2001, HYPERTENSION, V38, P1217, DOI 10.1161/hy1101.099499; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Gulsen M, 2005, J GASTROEN HEPATOL, V20, P1448, DOI 10.1111/j.1440-1746.2005.03891.x; Ha SK, 2010, EXP ANIM TOKYO, V59, P595, DOI 10.1538/expanim.59.595; Hajer GR, 2007, HEART, V93, P216, DOI 10.1136/hrt.2006.093971; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060; Kasumov T, 2011, METABOLISM, V60, P776, DOI 10.1016/j.metabol.2010.07.027; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Kwon DY, 2009, J NUTR, V139, P63, DOI 10.3945/jn.108.094771; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; Matte C, 2009, INT J DEV NEUROSCI, V27, P337, DOI 10.1016/j.ijdevneu.2009.03.005; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Quinlivan EP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn534; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; de Carvalho SCR, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-37; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Spruss A, 2011, ANTIOXID REDOX SIGN, V14, P2121, DOI 10.1089/ars.2010.3263; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Wan GH, 2000, BIOSCI BIOTECH BIOCH, V64, P555, DOI 10.1271/bbb.64.555; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; Williams KT, 2010, BIOFACTORS, V36, P19, DOI 10.1002/biof.71; Yun KU, 2013, EUR J NUTR, V52, P127, DOI 10.1007/s00394-011-0294-0	59	65	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136822	10.1371/journal.pone.0136822	http://dx.doi.org/10.1371/journal.pone.0136822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322888	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500038
J	Almela, MJ; Lozano, S; Lelievre, J; Colmenarejo, G; Coteron, JM; Rodrigues, J; Gonzalez, C; Herreros, E				Jesus Almela, Maria; Lozano, Sonia; Lelievre, Joel; Colmenarejo, Gonzalo; Miguel Coteron, Jose; Rodrigues, Janneth; Gonzalez, Carolina; Herreros, Esperanza			A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery	PLOS ONE			English	Article							MALARIA; IDENTIFICATION; INHIBITORS; ASSAY; IDENTIFY; PARASITE; ATP	The discovery of new antimalarials with transmission blocking activity remains a key issue in efforts to control malaria and eventually eradicate the disease. Recently, high-throughput screening (HTS) assays have been successfully applied to Plasmodium falciparum asexual stages to screen millions of compounds, with the identification of thousands of new active molecules, some of which are already in clinical phases. The same approach has now been applied to identify compounds that are active against P. falciparum gametocytes, the parasite stage responsible for transmission. This study reports screening results for the Tres Cantos Antimalarial Set (TCAMS), of approximately 13,533 molecules, against P. falciparum stage V gametocytes. Secondary confirmation and cytotoxicity assays led to the identification of 98 selective molecules with dual activity against gametocytes and asexual stages. Hit compounds were chemically clustered and analyzed for appropriate physicochemical properties. The TCAMS chemical space around the prioritized hits was also studied. A selection of hit compounds was assessed ex vivo in the standard membrane feeding assay and demonstrated complete block in transmission. As a result of this effort, new chemical structures not connected to previously described antimalarials have been identified. This new set of compounds may serve as starting points for future drug discovery programs as well as tool compounds for identifying new modes of action involved in malaria transmission.	[Jesus Almela, Maria; Lozano, Sonia; Lelievre, Joel; Miguel Coteron, Jose; Rodrigues, Janneth; Gonzalez, Carolina; Herreros, Esperanza] GlaxoSmithKline, Madrid 28760, Spain; [Jesus Almela, Maria] Univ Nacl Educ Distancia, E-28040 Madrid, Spain; [Colmenarejo, Gonzalo] GlaxoSmithKline, Basic Res Ctr, Computat Chem Dept, Madrid 28760, Spain	GlaxoSmithKline; Universidad Nacional de Educacion a Distancia (UNED); GlaxoSmithKline	Herreros, E (corresponding author), GlaxoSmithKline, Tres Cantos Medicines Dev Campus Dis Dev World, Madrid 28760, Spain.	esperanza.a.herreros@gsk.com	Colmenarejo, Gonzalo/Q-6535-2018; Herreros, Esperanza/GQH-7182-2022	Colmenarejo, Gonzalo/0000-0002-8249-4547; Gonzalez Cortes, Carolina/0000-0002-8103-8996; Rodrigues, Janneth/0000-0001-9693-1958	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The funder, GlaxoSmithKline, provided support in the form of salaries for authors [MJA, SL, JL, GC, JMC, JR, CG and EH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Avery VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-190; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Calderon F, 2011, ACS MED CHEM LETT, V2, P741, DOI 10.1021/ml200135p; Cree IA, 1997, TOXICOL IN VITRO, V11, P553, DOI 10.1016/S0887-2333(97)00060-X; Crowther GJ, 2011, MOL BIOCHEM PARASIT, V175, P21, DOI 10.1016/j.molbiopara.2010.08.005; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; Delves MJ, 2013, ANTIMICROB AGENTS CH, V57, P3268, DOI 10.1128/AAC.00325-13; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; KANGAS L, 1984, MED BIOL, V62, P338; Lelievre J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035019; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Miret S, 2006, J BIOMOL SCREEN, V11, P184, DOI 10.1177/1087057105283787; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Open access Malaria Box, 2015, OP ACC MAL BOX; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032264; RDKit, 2014, CHEM MACH LEARN SOFT; Ruecker A, 2014, ANTIMICROB AGENTS CH, V58, P7292, DOI 10.1128/AAC.03666-14; Sanders NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105817; Smith TG, 2000, PARASITOLOGY, V121, P127, DOI 10.1017/S0031182099006265; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; VANHUYSSEN W, 1993, TROP MED PARASITOL, V44, P329; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187; WHO, 2013, WORLD MALARIA REPORT 2013, P1	32	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135139	10.1371/journal.pone.0135139	http://dx.doi.org/10.1371/journal.pone.0135139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317851	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100024
J	Kaur, G; Singh, S; Singh, H; Dutta, MCT; Kaur, H; Kaur, H; Bender, K; Snedden, WA; Kapoor, S; Pareek, A; Singh, P				Kaur, Gundeep; Singh, Supreet; Singh, Harpreet; Chawla, Mrinalini; Dutta, Tanima; Kaur, Harsimran; Bender, Kyle; Snedden, W. A.; Kapoor, Sanjay; Pareek, Ashwani; Singh, Prabhjeet			Characterization of Peptidyl-Prolyl Cis-Trans Isomerase- and Calmodulin-Binding Activity of a Cytosolic Arabidopsis thaliana Cyclophilin AtCyp19-3	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HEAT-SHOCK; FUNCTIONAL-CHARACTERIZATION; CHLOROPLAST CYCLOPHILIN; RESPONSIVE CYCLOPHILIN; EXPRESSION; REDOX; GENE; STRESS; FAMILY	Cyclophilins, which bind to immunosuppressant cyclosporin A (CsA), are ubiquitous proteins and constitute a multigene family in higher organisms. Several members of this family are reported to catalyze cis-trans isomerisation of the peptidyl-prolyl bond, which is a rate limiting step in protein folding. The physiological role of these proteins in plants, with few exceptions, is still a matter of speculation. Although Arabidopsis genome is predicted to contain 35 cyclophilin genes, biochemical characterization, imperative for understanding their cellular function(s), has been carried only for few of the members. The present study reports the biochemical characterization of an Arabidopsis cyclophilin, AtCyp19-3, which demonstrated that this protein is enzymatically active and possesses peptidyl-prolyl cis-trans isomerase (PPIase) activity that is specifically inhibited by CsA with an inhibition constant (Ki) of 18.75 nM. The PPIase activity of AtCyp19-3 was also sensitive to Cu2+, which covalently reacts with the sulfhydryl groups, implying redox regulation. Further, using calmodulin (CaM) gel overlay assays it was demonstrated that in vitro interaction of AtCyp19-3 with CaM is Ca2+-dependent, and CaM-binding domain is localized to 35-70 amino acid residues in the N-terminus. Bimolecular fluorescence complementation assays showed that AtCyp19-3 interacts with CaM in vivo also, thus, validating the in vitro observations. However, the PPIase activity of the Arabidopsis cyclophilin was not affected by CaM. The implications of these findings are discussed in the context of Ca2+ signaling and cyclophilin activity in Arabidopsis.	[Kaur, Gundeep; Singh, Supreet; Singh, Harpreet; Dutta, Tanima; Kaur, Harsimran; Singh, Prabhjeet] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India; [Singh, Harpreet] Hans Raj Mahila Maha Vidayalaya, Dept Bioinformat, Jalandhar, Punjab, India; [Chawla, Mrinalini; Kapoor, Sanjay] Univ Delhi, Interdiscipinary Ctr Plant Genom, New Delhi, India; [Chawla, Mrinalini; Kapoor, Sanjay] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Bender, Kyle; Snedden, W. A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Pareek, Ashwani] Nehru Univ, Sch Life Sci, Stress Physiol & Mol Biol Lab, New Delhi, India	Guru Nanak Dev University; University of Delhi; University of Delhi; Queens University - Canada; Jawaharlal Nehru University, New Delhi	Singh, P (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India.	singhprabhjeet62@gmail.com	Bender, Kyle/AAJ-5993-2020; Bender, Kyle W/V-4678-2017; Dutta, Tanima/N-7222-2015	Bender, Kyle/0000-0002-1805-8097; Bender, Kyle W/0000-0002-1805-8097; Dutta, Tanima/0000-0002-2801-0687; SINGH, HARPREET/0000-0001-7202-3912; Kapoor, Sanjay/0000-0002-0283-1137	University Grants Commission, Govt. of India; Department of Biotechnology, Govt. of India; Council of Industrial and Scientific Research, Govt. of India	University Grants Commission, Govt. of India(University Grants Commission, India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Industrial and Scientific Research, Govt. of India	GK, TD and HK are thankful to University Grants Commission, Govt. of India, Department of Biotechnology, Govt. of India and Council of Industrial and Scientific Research, Govt. of India for the award of fellowships. Financial assistance for this work from the Department of Biotechnology, Govt. of India is gratefully acknowledged.	Ahn JC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-253; Alberto AI, 1984, PHOTOSYNTH RES, V5, P215, DOI [10.1007/BF00030021, DOI 10.1007/BF00030021]; Bender KW, 2013, PLANT PHYSIOL, V163, P486, DOI 10.1104/pp.113.221069; Berardini TZ, 2001, SCIENCE, V291, P2405, DOI 10.1126/science.1057144; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIMAN A, 1992, J BIOL CHEM, V267, P21293; Campos BM, 2013, PLANT PHYSIOL, V162, P1311, DOI 10.1104/pp.113.218339; Chen AP, 2007, PLANT CELL REP, V26, P237, DOI 10.1007/s00299-006-0238-y; Cho H, 1997, BIOCHEMISTRY-US, V36, P382, DOI 10.1021/bi9624604; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x; Daum S, 2009, BIOCHEMISTRY-US, V48, P6268, DOI 10.1021/bi9007287; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dominguez-Solis JR, 2008, P NATL ACAD SCI USA, V105, P16386, DOI 10.1073/pnas.0808204105; Dornan J, 1999, J BIOL CHEM, V274, P34877, DOI 10.1074/jbc.274.49.34877; E.coli Genomic DNA Extraction, 2011, BIOPROTOCOL BIO, V101, pe97; Eidne KA, 2002, TRENDS ENDOCRIN MET, V13, P415, DOI 10.1016/S1043-2760(02)00669-0; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104; Fulgosi H, 1998, EMBO J, V17, P1577, DOI 10.1093/emboj/17.6.1577; Galat S, 1998, RIVIERE PEPTIDYL PRO; GASSER CS, 1990, P NATL ACAD SCI USA, V87, P9519, DOI 10.1073/pnas.87.24.9519; Gottschalk M, 2008, PLANTA, V228, P687, DOI 10.1007/s00425-008-0771-8; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; Grebe M, 2000, PLANT CELL, V12, P343, DOI 10.1105/tpc.12.3.343; Hanahisa Y, 1998, BIOL PHARM BULL, V21, P1222; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HAYANO T, 1991, BIOCHEMISTRY-US, V30, P3041, DOI 10.1021/bi00226a009; He Z, 2004, PLANT PHYSIOL, V134, P1; Kang B, 2013, PLANT J, V74, P86, DOI 10.1111/tpj.12106; KIEFFER LJ, 1992, J BIOL CHEM, V267, P5503; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Krajewska B, 2008, J ENZYM INHIB MED CH, V23, P535, DOI [10.1080/14756360701743051, 10.1080/14756360701743051 ]; Kumari S, 2012, PLANT SIGNAL BEHAV, V8, P25; Kumari S, 2009, MOL BIOTECHNOL, V42, P195, DOI 10.1007/s12033-009-9153-0; Kurek I, 2002, PLANT MOL BIOL, V48, P369, DOI 10.1023/A:1014023329807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laxa M, 2007, BIOCHEM J, V401, P287, DOI 10.1042/BJ20061092; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li BB, 2010, J PROTEOME RES, V9, P4242, DOI 10.1021/pr100560v; LIPPUNER V, 1994, J BIOL CHEM, V269, P7863; LUAN S, 1994, PLANT CELL, V6, P885, DOI 10.1105/tpc.6.6.885; MARIVET J, 1992, PLANT SCI, V84, P171, DOI 10.1016/0168-9452(92)90131-5; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; O'Neil T, 1990, TRENDS BIOCHEM SCI, P54; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pogorelko GV, 2014, GENE, V538, P12, DOI 10.1016/j.gene.2014.01.029; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Quig D, 1998, Altern Med Rev, V3, P262; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Sekhar K, 2010, PLANT CELL ENVIRON, V33, P1324, DOI 10.1111/j.1365-3040.2010.02151.x; Sekhon SS, 2013, ACTA CRYSTALLOGR D, V69, P555, DOI 10.1107/S0907444912051529; Shapiguzov A, 2006, FEBS LETT, V580, P3671, DOI 10.1016/j.febslet.2006.05.054; Sharma AD, 2003, J PLANT BIOCHEM BIOT, V12, P77, DOI 10.1007/BF03263165; Sharma AD, 2003, CURRENT SCI, V84, P912; Sheldon PS, 1996, BIOCHEM J, V315, P965, DOI 10.1042/bj3150965; Singh P., 2013, STRESS SIGNALING PLA, P1, DOI DOI 10.1007/978-1-4614-6372-6_1; Snedden WA, 2001, NEW PHYTOL, V51, P35; Trivedi DK, 2012, PLANT SIGNAL BEHAV, V7, P1653, DOI 10.4161/psb.22306; Trupkin SA, 2012, PLANT J, V71, P712, DOI 10.1111/j.1365-313X.2012.05013.x; Vasudevan D, 2012, PLANT CELL, V24, P2666, DOI 10.1105/tpc.111.093781; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; Virdi AS, 2011, PLANT SIGNAL BEHAV, V6, P393, DOI 10.4161/psb.6.3.13867; Virdi AS, 2009, FEBS LETT, V583, P767, DOI 10.1016/j.febslet.2009.01.025; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Wu HC, 2012, PLANT CELL ENVIRON, V35, P1543, DOI 10.1111/j.1365-3040.2012.02508.x; Yang TB, 2010, J BIOL CHEM, V285, P7119, DOI 10.1074/jbc.M109.035659; Zhong SL, 2008, TRANSGENIC RES, V17, P985, DOI 10.1007/s11248-008-9199-y	76	19	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136692	10.1371/journal.pone.0136692	http://dx.doi.org/10.1371/journal.pone.0136692			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317213	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100122
J	Schalinski, I; Elbert, T; Steudte-Schmiedgen, S; Kirschbaum, C				Schalinski, Inga; Elbert, Thomas; Steudte-Schmiedgen, Susann; Kirschbaum, Clemens			The Cortisol Paradox of Trauma-Related Disorders: Lower Phasic Responses but Higher Tonic Levels of Cortisol Are Associated with Sexual Abuse in Childhood	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HPA-AXIS FUNCTION; HAIR CORTISOL; PHYSICAL ABUSE; PTSD; DYSREGULATION; INDIVIDUALS; REACTIVITY; ADVERSITY; CHALLENGE	Objectives Inconsistent findings exist for the activity of the hypothalamic-pituitary-adrenal (HPA) axis in patients with stress related disorders. Recent studies point towards early life stress as a potential modulator. Methods We investigated the impact of childhood sexual abuse on phasic (saliva cortisol reactivity) and tonic (hair cortisol) regulation. Furthermore, we assessed predictors on cortisol accumulation in hair. Women (N = 43) with stress-related disorders underwent a standardized assessment of idiographic adverse and traumatic experiences and psychopathology, while measuring salivary cortisol and, heart rate and blood pressure. Results Comparing women with and without childhood sexual abuse revealed lower rates of responders and distinct levels of salivary cortisol to the interview in conjunction with a lower heart rate for the abused group. Childhood adversities, traumatic experiences, and depression contributed to higher hair cortisol levels. Conclusions Our finding of lower response rate and distinct salivary cortisol pattern in individuals with childhood sexual abuse compared to individuals without early sexual abuse supports the role of environmental programming for the HPA axis. Both, childhood adversities and traumatic stress emerge as crucial factors for long-term cortisol secretion. Lower or suppressed phasic cortisol responses to trauma-related stimuli may therefore be associated with higher tonic values. Thus, early exposure to adversities may result in a biological distinct phenotype in adult patients with stress-related disorders.	[Schalinski, Inga; Elbert, Thomas] Univ Konstanz, Dept Psychol, Clin Psychol, Constance, Germany; [Steudte-Schmiedgen, Susann; Kirschbaum, Clemens] Tech Univ Dresden, Inst Biol Psychol, D-01062 Dresden, Germany	University of Konstanz; Technische Universitat Dresden	Schalinski, I (corresponding author), Univ Konstanz, Dept Psychol, Clin Psychol, Constance, Germany.	inga.schalinski@uni-konstanz.de	Elbert, Thomas/C-8556-2009; Kirschbaum, Clemens/AAB-1752-2020; Steudte-Schmiedgen, Susann/HHZ-4248-2022	Elbert, Thomas/0000-0003-1332-4939; Steudte-Schmiedgen, Susann/0000-0002-1171-7133; Schalinski, Inga/0000-0003-1665-7640	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was supported by the Deutsche Forschungsgemeinschaft (DFG).	Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bosch NM, 2012, PSYCHONEUROENDOCRINO, V37, P1439, DOI 10.1016/j.psyneuen.2012.01.013; Bremner JD, 2003, PSYCHONEUROENDOCRINO, V28, P733, DOI 10.1016/S0306-4530(02)00067-7; Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4; Coid J, 2001, LANCET, V358, P450, DOI 10.1016/S0140-6736(01)05622-7; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Eckart C, 2009, PSYCHONEUROENDOCRINO, V34, P523, DOI 10.1016/j.psyneuen.2008.10.012; Elzinga BM, 2003, NEUROPSYCHOPHARMACOL, V28, P1656, DOI 10.1038/sj.npp.1300226; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Gola H, 2012, PSYCHONEUROENDOCRINO, V37, P213, DOI 10.1016/j.psyneuen.2011.06.005; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Griffin MG, 1997, AM J PSYCHIAT, V154, P1081; Hamel AF, 2011, CLIN CHIM ACTA, V412, P382, DOI 10.1016/j.cca.2010.10.019; Heidt JM, 2005, BEHAV RES THER, V43, P1157, DOI 10.1016/j.brat.2004.08.005; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C., 2000, DTSCH VERSION UNPUB; Hinkelmann K, 2013, BIOL PSYCHIAT, V74, pE15, DOI 10.1016/j.biopsych.2013.04.021; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kolassa IT, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-54; KOOPMAN C, 2003, J TRAUMA DISSOCIATIO, V4, P29, DOI DOI 10.1300/J229V04N04_03; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lang P. J., 1985, ANXIETY ANXIETY DISO, P131; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Loussouarn G, 2001, BRIT J DERMATOL, V145, P294, DOI 10.1046/j.1365-2133.2001.04350.x; Lovallo WR, 2012, BIOL PSYCHIAT, V71, P344, DOI 10.1016/j.biopsych.2011.10.018; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miller R, 2013, PSYCHOSOM MED, V75, P832, DOI 10.1097/PSY.0000000000000002; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Schalinski I, 2015, EUR J PSYCHOTRAUMATO, V6; Schauer M, 2010, Z PSYCHOL, V218, P109, DOI 10.1027/0044-3409/a000018; Shea A, 2005, PSYCHONEUROENDOCRINO, V30, P162, DOI 10.1016/j.psyneuen.2004.07.001; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slopen N, 2013, BRAIN BEHAV IMMUN, V28, P63, DOI 10.1016/j.bbi.2012.10.018; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Steudte S, 2011, PSYCHONEUROENDOCRINO, V36, P1193, DOI 10.1016/j.psyneuen.2011.02.012; Steudte-Schmiedgen S, 2015, PSYCHONEUROENDOCRINO, V59, P123, DOI 10.1016/j.psyneuen.2015.05.007; Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Wingenfeld K, 2011, DIAGNOSTICA, V57, P27, DOI 10.1026/0012-1924/a000036; Wosu AC, 2015, ANN EPIDEMIOL, V25, P90, DOI 10.1016/j.annepidem.2014.11.022; Zaba M, 2015, PSYCHONEUROENDOCRINO, V55, P102, DOI 10.1016/j.psyneuen.2015.02.005	55	58	58	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136921	10.1371/journal.pone.0136921	http://dx.doi.org/10.1371/journal.pone.0136921			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317554	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100173
J	Su, XM; Chu, YP; Kordower, JH; Li, B; Cao, H; Huang, L; Nishida, M; Song, L; Wang, DF; Federoff, HJ				Su, Xiaomin; Chu, Yaping; Kordower, Jeffrey H.; Li, Bin; Cao, Hong; Huang, Liang; Nishida, Maki; Song, Lei; Wang, Difei; Federoff, Howard J.			PGC-1 alpha Promoter Methylation in Parkinson's Disease	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; INDUCED ER STRESS; NF-KAPPA-B; DNA METHYLATION; ALPHA-SYNUCLEIN; TRANSCRIPTIONAL REPRESSION; MITOCHONDRIAL BIOGENESIS; PROTEIN PALMITOYLATION; TRANSGENIC MICE; NEURODEGENERATION	The etiopathogenesis of sporadic Parkinson's disease (PD) remains elusive although mitochondrial dysfunction has long been implicated. Recent evidence revealed reduced expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) and downstream regulated nuclear encoded respiratory complex genes in affected brain tissue from PD patients. We sought to determine whether epigenetic modification of the PGC-1 alpha gene could account for diminished expression. In substantia nigra from PD patients but not control subjects, we show significant promoter-proximal non-canonical cytosine methylation of the PGC-1 alpha gene but not an adjacent gene. As neuroinflammation is a prominent feature of PD and a mediator of epigenetic change, we evaluated whether the pro-inflammatory fatty acid, palmitate, would stimulate PGC-1 alpha promoter methylation in different cell types from the CNS. Indeed, in mouse primary cortical neurons, microglia and astrocytes, palmitate causes PGC-1 alpha gene promoter non-canonical cytosine methylation, reduced expression of the gene and reduced mitochondrial content. Moreover, intracerebroventricular (ICV) injection of palmitate to transgenic human alpha-synuclein mutant mice resulted in increased PGC-1 alpha promoter methylation, decreased PGC-1 alpha expression and reduced mitochondrial content in substantia nigra. Finally we provide evidence that dysregulation of ER stress and inflammatory signaling is associated with PGC-1 alpha promoter methylation. Together, these data strengthen the connection between saturated fatty acids, neuroflammation, ER stress, epigenetic alteration and bioenergetic compromise in PD.	[Su, Xiaomin; Li, Bin; Cao, Hong; Huang, Liang; Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Chu, Yaping; Kordower, Jeffrey H.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Nishida, Maki; Song, Lei; Wang, Difei] Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	Georgetown University; Rush University; Georgetown University; Georgetown University	Federoff, HJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	federoff@uci.edu	Song, Lei/F-6946-2018; Wang, Difei/E-7066-2010		Department of Defense [WX81XWH-11-49-0126]	Department of Defense(United States Department of Defense)	WX81XWH-11-49-0126 (Federoff, Howard J), Department of Defense, 'PGC-1 alpha Therapy for Parkinsonian Neurodegeneration'.	Baldwin AC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1390, DOI 10.1152/ajpendo.00519.2011; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bjorkqvist M, 2009, NEURON, V64, P21, DOI 10.1016/j.neuron.2009.09.034; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Burdge GC, 2014, CURR OPIN CLIN NUTR, V17, P156, DOI 10.1097/MCO.0000000000000023; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen H, 2003, AM J EPIDEMIOL, V157, P1007, DOI 10.1093/aje/kwg073; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Eschbach J, 2015, ANN NEUROL, V77, P15, DOI 10.1002/ana.24294; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hsiao YH, 2014, INT J MOL SCI, V15, P20876, DOI 10.3390/ijms151120876; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Logroscino G, 1996, ANN NEUROL, V39, P89, DOI 10.1002/ana.410390113; Lu M, 2012, CLIN EXP PHARMACOL P, V39, P577, DOI 10.1111/j.1440-1681.2011.05650.x; Morris JK, 2010, AM J PHYSIOL-REG I, V299, pR1082, DOI 10.1152/ajpregu.00449.2010; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nicolai E, 1999, J NUCL CARDIOL, V6, P270, DOI 10.1016/S1071-3581(99)90038-7; Nijland PG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0170-2; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Sczelecki S, 2014, AM J PHYSIOL-ENDOC M, V306, pE157, DOI 10.1152/ajpendo.00578.2013; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	61	63	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134087	10.1371/journal.pone.0134087	http://dx.doi.org/10.1371/journal.pone.0134087			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317511	Green Published, gold			2022-12-27	WOS:000360299100013
J	Teixeira, LGD; Malavolta, L; Bersanetti, PA; Schreier, S; Carmona, AK; Nakaie, CR				Teixeira, Luis Gustavo D.; Malavolta, Luciana; Bersanetti, Patrcia A.; Schreier, Shirley; Carmona, Adriana K.; Nakaie, Clovis R.			Conformational Properties of Seven Toac-Labeled Angiotensin I Analogues Correlate with Their Muscle Contraction Activity and Their Ability to Act as ACE Substrates	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; AMINO-ACID TOAC; CONVERTING-ENZYME; AQUEOUS-SOLUTION; CIRCULAR-DICHROISM; MAGNETIC-RESONANCE; BRADYKININ ANALOGS; PEPTIDE-SYNTHESIS; PH-DEPENDENCE; FLUORESCENCE	Conformational properties of the angiotensin II precursor, angiotensin I (AngI) and analogues containing the paramagnetic amino acid TOAC (2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid) at positions 0, 1, 3, 5, 8, 9, and 10, were examined by EPR, CD, and fluorescence. The conformational data were correlated to their activity in muscle contraction experiments and to their properties as substrates of the angiotensin I-converting enzyme (ACE). Biological activity studies indicated that TOAC(0)-AngI and TOAC(1)-AngI maintained partial potency in guinea pig ileum and rat uterus. Kinetic parameters revealed that only derivatives labeled closer to the N-terminus (positions 0, 1, 3, and 5) were hydrolyzed by ACE, indicating that peptides bearing the TOAC moiety far from the ACE cleavage site (Phe(8)-His(9) peptide bond) were susceptible to hydrolysis, albeit less effectively than the parent compound. CD spectra indicated that AngI exhibited a flexible structure resulting from equilibrium between different conformers. While the conformation of N-terminally-labeled derivatives was similar to that of the native peptide, a greater propensity to acquire folded structures was observed for internally-labeled, as well as C-terminally labeled, analogues. These structures were stabilized in secondary structure-inducing agent, TFE. Different analogues gave rise to different beta-turns. EPR spectra in aqueous solution also distinguished between N-terminally, internally-, and C-terminally labeled peptides, yielding narrower lines, indicative of greater mobility for the former. Interestingly, the spectra of peptides labeled at, or close, to the C-terminus, showed that the motion in this part of the peptides was intermediate between that of N-terminally and internally-labeled peptides, in agreement with the suggestion of turn formation provided by the CD spectra. Quenching of the Tyr(4) fluorescence by the differently positioned TOAC residues corroborated the data obtained by the other spectroscopic techniques. Lastly, we demonstrated the feasibility of monitoring the progress of ACE-catalyzed hydrolysis of TOAC-labeled peptides by following time-dependent changes in their EPR spectra.	[Teixeira, Luis Gustavo D.; Carmona, Adriana K.; Nakaie, Clovis R.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, SP, Brazil; [Malavolta, Luciana] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, Sao Paulo, SP, Brazil; [Bersanetti, Patrcia A.] Univ Fed Sao Paulo, Dept Hlth & Informat, Sao Paulo, SP, Brazil; [Schreier, Shirley] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Nakaie, CR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, SP, Brazil.	cnakaie@unifesp.br	Carmona, Adriana K/D-2240-2012; Schreier, Shirley/F-7001-2014; Bersanetti, Patrícia A/B-9703-2012	Carmona, Adriana K/0000-0003-3311-5456; Bersanetti, Patrícia A/0000-0002-9262-2151	Sao Paulo State Research Foundation (FAPESP); Brazilian National Council for Scientific and Technological Research (CNPq)	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors' research is supported by the Sao Paulo State Research Foundation (FAPESP) and by the Brazilian National Council for Scientific and Technological Research (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGUS CW, 1973, BIOCHIM BIOPHYS ACTA, V309, P169, DOI 10.1016/0005-2744(73)90328-8; Barany G, 1980, THE PEPTIDES ANALYSI; Barbosa SR, 1999, FEBS LETT, V446, P45, DOI 10.1016/S0014-5793(99)00172-6; Bersanetti PA, 2004, BIOCHEMISTRY-US, V43, P15729, DOI 10.1021/bi048423r; Bettio A, 2002, J PEPT SCI, V8, P671, DOI 10.1002/psc.428; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; CATT KJK, 1993, CELLULAR MOL BIOL RE; Chatterjee A, 2010, INT J INTEGR BIOL, V9, P21; CORDOPATIS P, 1983, EXPERIENTIA, V39, P106, DOI 10.1007/BF01960656; Teixeira LGDD, 2007, FEBS LETT, V581, P2411, DOI 10.1016/j.febslet.2007.04.058; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FOX JW, 1980, ARCH BIOCHEM BIOPHYS, V201, P375, DOI 10.1016/0003-9861(80)90525-1; Galanis AS, 2004, BIOPOLYMERS, V76, P512, DOI 10.1002/bip.20163; GALARDY RE, 1976, BIOCHEMISTRY-US, V15, P2303, DOI 10.1021/bi00656a009; GLICKSON JD, 1973, BIOCHEMISTRY-US, V12, P3684, DOI 10.1021/bi00743a018; Jahli PR, 2008, ANAL BIOCHEM, V374, P346, DOI 10.1016/j.ab.2007.11.038; JULIANO L, 1974, BIOCHEMISTRY-US, V13, P2445, DOI 10.1021/bi00708a032; LINTNER K, 1977, BIOCHEMISTRY-US, V16, P806, DOI 10.1021/bi00623a037; Lopes DD, 2008, INT J PEPT RES THER, V14, P121, DOI 10.1007/s10989-007-9120-1; Lopes DD, 2013, AMINO ACIDS, V44, P835, DOI 10.1007/s00726-012-1405-9; MARCHETTO R, 1993, J AM CHEM SOC, V115, P11042, DOI 10.1021/ja00076a093; Marshall GR, 1972, PROGR PEPTIDE RES, P15; McNulty JC, 2000, BIO MAGN RE, V19, P277; NAKAIE CR, 1983, BIOCHIM BIOPHYS ACTA, V742, P63, DOI 10.1016/0167-4838(83)90359-X; Nakaie CR, 2001, FEBS LETT, V497, P103, DOI 10.1016/S0014-5793(01)02449-8; NAKAIE CR, 1981, BRAZ J MED BIOL RES, V14, P173; Nakaie CR, 2002, PEPTIDES, V23, P65, DOI 10.1016/S0196-9781(01)00580-0; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; OLIVEIRA MCF, 1977, BIOCHEMISTRY-US, V16, P2606, DOI 10.1021/bi00631a005; OPARIL S, 1974, CIRC RES, V34, P19, DOI 10.1161/01.RES.34.1.19; PAIVA ACM, 1960, BIOCHEM PHARMACOL, V5, P187, DOI 10.1016/0006-2952(60)90062-9; PAIVA TB, 1963, BIOCHEMISTRY-US, V2, P1327, DOI 10.1021/bi00906a026; Passos-Silva DG, 2015, TRENDS PHARMACOL SCI, V36, P310, DOI 10.1016/j.tips.2015.03.001; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Santos EL, 2008, INT IMMUNOPHARMACOL, V8, P293, DOI 10.1016/j.intimp.2007.07.029; Schreier S, 2004, BIOPOLYMERS, V74, P389, DOI 10.1002/bip.20092; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P375; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Shafer AM, 2008, PEPTIDES, V29, P1919, DOI 10.1016/j.peptides.2008.08.002; Spyroulias GA, 2003, EUR J BIOCHEM, V270, P2163, DOI 10.1046/j.1432-1033.2003.03573.x; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Toniolo C, 1998, BIOPOLYMERS, V47, P153, DOI 10.1002/(SICI)1097-0282(1998)47:2<153::AID-BIP4>3.0.CO;2-T; Venkateshwaran TG, 1998, J PHARMACEUT BIOMED, V17, P57, DOI 10.1016/S0731-7085(97)00160-X; Vieira RFF, 2009, BIOPOLYMERS, V92, P525, DOI 10.1002/bip.21295; WU CSC, 1982, BIOCHEMISTRY-US, V21, P4556, DOI 10.1021/bi00262a007; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; ZHOU N, 1991, J PROTEIN CHEM, V10, P333, DOI 10.1007/BF01025632	48	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136608	10.1371/journal.pone.0136608	http://dx.doi.org/10.1371/journal.pone.0136608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317625	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100110
J	Al-Saari, N; Gao, F; Rohul, AAKM; Sato, K; Sato, K; Mino, S; Suda, W; Oshima, K; Hattori, M; Ohkuma, M; Meirelles, PM; Thompson, FL; Thompson, C; Filho, GMA; Gomez-Gil, B; Sawabe, T; Sawabe, T				Al-Saari, Nurhidayu; Gao, Feng; Rohul, Amin A. K. M.; Sato, Kazumichi; Sato, Keisuke; Mino, Sayaka; Suda, Wataru; Oshima, Kenshiro; Hattori, Masahira; Ohkuma, Moriya; Meirelles, Pedro M.; Thompson, Fabiano L.; Thompson, Cristiane; Filho, Gilberto M. A.; Gomez-Gil, Bruno; Sawabe, Toko; Sawabe, Tomoo			Advanced Microbial Taxonomy Combined with Genome-Based-Approaches Reveals that Vibrio astriarenae sp nov., an Agarolytic Marine Bacterium, Forms a New Clade in Vibrionaceae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DEOXYRIBONUCLEIC-ACID; HYBRIDIZATION; AGARASE; IDENTIFICATION; PURIFICATION; NEIGHBOR; STAIN	Advances in genomic microbial taxonomy have opened the way to create a more universal and transparent concept of species but is still in a transitional stage towards becoming a defining robust criteria for describing new microbial species with minimum features obtained using both genome and classical polyphasic taxonomies. Here we performed advanced microbial taxonomies combined with both genome-based and classical approaches for new agarolytic vibrio isolates to describe not only a novel Vibrio species but also a member of a new Vibrio clade. Two novel vibrio strains (Vibrio astriarenae sp. nov. C7(T) and C20) showing agarolytic, halophilic and fermentative metabolic activity were isolated from a seawater sample collected in a coral reef in Okinawa. Intraspecific similarities of the isolates were identical in both sequences on the 16S rRNA and pyrH genes, but the closest relatives on the molecular phylogenetic trees on the basis of 16S rRNA and pyrH gene sequences were V. hangzhouensis JCM 15146(T) (97.8% similarity) and V. agarivorans CECT 5085(T) (97.3% similarity), respectively. Further multilocus sequence analysis (MLSA) on the basis of 8 protein coding genes (ftsZ, gapA, gyrB, mreB, pyrH, recA, rpoA, and topA) obtained by the genome sequences clearly showed the V. astriarenae strain C7(T) and C20 formed a distinct new clade protruded next to V. agarivorans CECT 5085(T). The singleton V. agarivorans has never been included in previous MLSA of Vibrionaceae due to the lack of some gene sequences. Now the gene sequences are completed and analysis of 100 taxa in total provided a clear picture describing the association of V. agarivorans into pre-existing concatenated network tree and concluded its relationship to our vibrio strains. Experimental DNA-DNA hybridization (DDH) data showed that the strains C7(T) and C20 were conspecific but were separated from all of the other Vibrio species related on the basis of both 16S rRNA and pyrH gene phylogenies (e.g., V. agarivorans CECT 5085(T), V. hangzhouensis JCM 15146(T) V. maritimus LMG 25439(T), and V. variabilis LMG 25438(T)). In silico DDH data also supported the genomic relationship. The strains C7(T) also had less than 95% average amino acid identity (AAI) and average nucleotide identity (ANI) towards V. maritimus C210, V. variabilis C206, and V. mediterranei AK1(T), V. brasiliensis LMG 20546(T), V. orientalis ATCC 33934(T), and V. sinaloensis DSM 21326. The name Vibrio astriarenae sp. nov. is proposed with C7 as the type strains. Both V. agarivorans CECT 5058(T) and V. astriarenae C7(T) are members of the newest clade of Vibrionaceae named Agarivorans.	[Al-Saari, Nurhidayu; Gao, Feng; Rohul, Amin A. K. M.; Sato, Kazumichi; Sato, Keisuke; Mino, Sayaka; Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido 041, Japan; [Suda, Wataru; Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Lab Metagen, Kashiwa, Chiba, Japan; [Suda, Wataru] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Div Microbe, Ibaraki, Japan; [Meirelles, Pedro M.; Thompson, Fabiano L.; Thompson, Cristiane] Univ Fed Rio de Janeiro, COPPE, SAGE, Inst Biol, BR-21945 Rio De Janeiro, Brazil; [Filho, Gilberto M. A.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Gomez-Gil, Bruno] CIAD, AC Mazatlan Unit Aquaculture & Environm Managemen, Mazatlan, Mexico; [Sawabe, Toko] Hakodate Jr Coll, Dept Food & Nutr, Hakodate, Hokkaido, Japan	Hokkaido University; University of Tokyo; Keio University; Waseda University; RIKEN; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Al-Saari, N (corresponding author), Hokkaido Univ, Fac Fisheries, Microbiol Lab, Minato Cho, Hakodate, Hokkaido 041, Japan.	hidayu@fish.hokudai.ac.jp	Meirelles, Pedro/GRY-0806-2022; Al-saari, Nurhidayu/V-3466-2019; Suda, Wataru/AAF-4469-2019; Ohkuma, Moriya/A-8100-2011; Meirelles, Pedro/AAK-5942-2021; Thompson, Cristiane C/I-5783-2016; Meirelles, Pedro/AAL-4542-2020; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Gomez-Gil, Bruno/AAD-8658-2020	Meirelles, Pedro/0000-0002-1306-0331; Hattori, Masahira/0000-0001-9467-0344; Gomez-Gil, Bruno/0000-0002-3695-3597; Thompson, Fabiano/0000-0002-7562-1683; Al-saari, Nurhidayu/0000-0002-2952-7039	Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Strategic Japanese-Brazilian Cooperative Program, Biomass and Bioenergy; JSPS-CAPES bilateral cooperative program; Kaken [26660168]; CAPES; CNPq; FAPERJ; CAPES [4848-14-9CAPES/JSPS]	Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Strategic Japanese-Brazilian Cooperative Program, Biomass and Bioenergy; JSPS-CAPES bilateral cooperative program; Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (MH and MO), Strategic Japanese-Brazilian Cooperative Program, Biomass and Bioenergy (TS and FLT), JSPS-CAPES bilateral cooperative program (TS and FLT), and Kaken (26660168) (TS). FLT and CCT thank CAPES, CNPq, and FAPERJ for funding. PMM thanks CAPES for the PhD scholarship (4848-14-9CAPES/JSPS), and MARA for the PhD education loan to NA.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Amaral GRS, 2015, ANTON LEEUW INT J G, V107, P1351, DOI 10.1007/s10482-015-0414-6; Amaral GRS, 2014, INT J SYST EVOL MICR, V64, P357, DOI 10.1099/ijs.0.057927-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Barton L. L., 2005, STRUCTURAL FUNCTIONA, P3; Baumann P, 1984, BERGEYS MANUAL SYSTE, V1, P516; Boucher Y, 2006, BIOLOGY OF VIBRIOS, P84; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHEN LCM, 1994, J APPL PHYCOL, V6, P35, DOI 10.1007/BF02185902; Chimetto LA, 2011, INT J SYST EVOL MICR, V61, P3009, DOI 10.1099/ijs.0.026997-0; Dipakkore S, 2005, J APPL PHYCOL, V17, P331, DOI 10.1007/s10811-005-7291-8; EZAKI T, 1988, J CLIN MICROBIOL, V26, P1708, DOI 10.1128/JCM.26.9.1708-1713.1988; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Gomez-Gil B, 2003, INT J SYST EVOL MICR, V53, P1569, DOI 10.1099/ijs.0.02670-0; Gupta V, 2013, BIOMASS BIOENERG, V49, P290, DOI 10.1016/j.biombioe.2012.12.027; HIDAKA T, 1968, Bulletin of the Misaki Marine Biological Institute Kyoto University, V12, P125; HOLT JG, 1994, BERGEYS MANUAL DETER, P190; Hu Z, 2009, J APPL MICROBIOL, V106, P181, DOI 10.1111/j.1365-2672.2008.03990.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KITATSUKAMOTO K, 1993, INT J SYST BACTERIOL, V43, P8, DOI 10.1099/00207713-43-1-8; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kornberg HL, 2001, J MOL MICROB BIOTECH, V3, P355; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leifson E., 1963, J BACTERIOL, V82, P33; Macian MC, 2004, SYST APPL MICROBIOL, V27, P535, DOI 10.1078/0723202041748127; Macian MC, 2001, INT J SYST EVOL MICR, V51, P2031, DOI 10.1099/00207713-51-6-2031; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Matsumura Y, 2014, INT J HYDROGEN ENERG, V39, P7270, DOI 10.1016/j.ijhydene.2014.02.164; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OPPENHEIMER CH, 1952, J MAR RES, V11, P10; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Rossello-Mora R, 2015, SYST APPL MICROBIOL, V38, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawabe T, 1998, INT J SYST BACTERIOL, V48, P573, DOI 10.1099/00207713-48-2-573; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1016/0378-1097(84)90059-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CC, 2015, ARCH MICROBIOL, V197, P359, DOI 10.1007/s00203-014-1071-2; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P245, DOI 10.1099/ijs.0.02447-0; Thompson JR, 2006, BIOLOGY OF VIBRIOS, P190; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Vandamme P, 2014, ANTON LEEUW INT J G, V106, P57, DOI 10.1007/s10482-014-0148-x; WEST M, 1977, J CLIN MICROBIOL, V6, P414; Xu XW, 2009, INT J SYST EVOL MICR, V59, P2099, DOI 10.1099/ijs.0.008698-0	52	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136279	10.1371/journal.pone.0136279	http://dx.doi.org/10.1371/journal.pone.0136279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313925	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000052
J	Garcia-Carmona, JA; Camejo, DM; Almela, P; Jimenez, A; Milanes, MV; Sevilla, F; Laorden, ML				Garcia-Carmona, Juan-Antonio; Camejo, Daymi M.; Almela, Pilar; Jimenez, Ana; Milanes, Mara-Victoria; Sevilla, Francisca; Laorden, Maria-Luisa			CP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place Preference	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ELEMENT-BINDING PROTEIN; PITUITARY-ADRENAL AXIS; NF-KAPPA-B; CRF1 RECEPTOR; NUCLEUS-ACCUMBENS; STRESS; DOPAMINE; HORMONE; RAT	Corticotropin-releasing factor (CRF) acts as neuro-regulator of the behavioral and emotional integration of environmental and endogenous stimuli associated with drug dependence. Thioredoxin-1 (Trx-1) is a functional protein controlling the redox status of several proteins, which is involved in addictive processes. In the present study, we have evaluated the role of CRF1 receptor (CRF1R) in the rewarding properties of morphine by using the conditioned place preference (CPP) paradigm. We also investigate the effects of the CRF1R antagonist, CP-154,526, on the morphine CPP-induced activation of CRF neurons, CREB phosphorylation and Trx expression in paraventricular nucleus (PVN) and dentate gyrus (DG) of the mice brain. CP-154,526 abolished the acquisition of morphine CPP and the increase of CRF/pCREB positive neurons in PVN. Moreover, this CRF1R antagonist prevented morphine-induced CRF-immunoreactive fibers in DG, as well as the increase in pCREB expression in both the PVN and DG. In addition, morphine exposure induced an increase in Trx-1 expression in DG without any alterations in PVN. We also observed that the majority of pCREB positive neurons in DG co-expressed Trx-1, suggesting that Trx-1 could activate CREB in the DG, a brain region involved in memory consolidation. Altogether, these results support the idea that CRF1R antagonist blocked Trx-1 expression and pCREB/Trx-1 co-localization, indicating a critical role of CRF, through CRF1R, in molecular changes involved in morphine associated behaviors.	[Garcia-Carmona, Juan-Antonio; Almela, Pilar; Milanes, Mara-Victoria; Laorden, Maria-Luisa] Univ Murcia, Fac Med, Dept Pharmacol, Murcia, Spain; [Camejo, Daymi M.; Jimenez, Ana; Sevilla, Francisca] CSIC, CEBAS, Dept Stress Biol & Plant Pathol, Murcia, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Almela, P (corresponding author), Univ Murcia, Fac Med, Dept Pharmacol, Murcia, Spain.	palmela@um.es	López, Daymi Mercedes Camejo/AAB-7466-2019; Milanés, M. Victoria/AGB-4075-2022; Sevilla, Francisca/X-8632-2019; García-Carmona, Juan-Antonio/AAA-8173-2021; Milanés, M Victoria/K-6591-2017	Milanés, M. Victoria/0000-0002-0984-2218; Sevilla, Francisca/0000-0002-2986-1889; Milanés, M Victoria/0000-0002-0984-2218; Garcia-Carmona, Juan Antonio/0000-0003-3938-7698	Ministerio de Ciencia e Innovacion [SAF/FEDER 2010-17907, BFU2011-28716]; Red de Trastornos Adicitivos [RETICS RD/12/0028/0003]; Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia [15519/FPI/10]; CSIC-Spain (JAE-doc)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adicitivos; Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca); CSIC-Spain (JAE-doc)	This research was supported by grants from the Ministerio de Ciencia e Innovacion (Grants SAF/FEDER 2010-17907 and BFU2011-28716) and Red de Trastornos Adicitivos (RETICS RD/12/0028/0003). JAGC was supported by a predoctoral fellowship from Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia (15519/FPI/10) and DMC by CSIC-Spain (JAE-doc).	Almela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047089; Barcia C, 2004, GLIA, V46, P402, DOI 10.1002/glia.20015; Lasheras MC, 2015, NEUROPHARMACOLOGY, V95, P168, DOI 10.1016/j.neuropharm.2014.12.021; Chauveau F, 2009, NEUROBIOL LEARN MEM, V91, P447, DOI 10.1016/j.nlm.2008.12.003; Chen YC, 2004, P NATL ACAD SCI USA, V101, P15782, DOI 10.1073/pnas.0403975101; Chen YC, 2001, J NEUROSCI, V21, P7171, DOI 10.1523/JNEUROSCI.21-18-07171.2001; Choi WK, 2012, KOREAN J PHYSIOL PHA, V16, P17, DOI 10.4196/kjpp.2012.16.1.17; Dallman MF, 1995, ANN NY ACAD SCI, V771, P730, DOI 10.1111/j.1749-6632.1995.tb44724.x; DEFONSECA FR, 1995, EUR J PHARMACOL, V274, P47, DOI 10.1016/0014-2999(94)00708-F; Douma TN, 2014, PSYCHOPHARMACOLOGY, V231, P1289, DOI 10.1007/s00213-013-3315-2; Ewan EE, 2011, ANESTHESIOLOGY, V115, P1271, DOI 10.1097/ALN.0b013e3182330448; Fazal N, 1998, FEBS LETT, V435, P187, DOI 10.1016/S0014-5793(98)01067-9; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Garcia-Carmona JA, 2013, INT J NEUROPSYCHOPH, V10, P1; Garcia-Carmona JA, 2012, PSYCHOPHARMACOLOGY, V220, P379, DOI 10.1007/s00213-011-2478-y; Goeders NE, 2000, NEUROPSYCHOPHARMACOL, V23, P577, DOI 10.1016/S0893-133X(00)00148-2; Gonzalez-Cuello A, 2010, N-S ARCH PHARMACOL, V382, P525, DOI 10.1007/s00210-010-0567-9; Gonzalo-Ruiz A, 1999, ANAT EMBRYOL, V200, P377, DOI 10.1007/s004290050287; Gozzi A, 2013, NEUROPSYCHOPHARMACOL, V38, P2120, DOI 10.1038/npp.2013.109; Haass-Koffler CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00091; Haghparast A, 2013, NEUROSCI LETT, V541, P138, DOI 10.1016/j.neulet.2013.03.001; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Jia JJ, 2013, CELL SIGNAL, V25, P1194, DOI 10.1016/j.cellsig.2013.02.007; Karami M, 2002, EUR J PHARMACOL, V449, P113, DOI 10.1016/S0014-2999(02)01991-X; Kasagi Y, 2002, J NEUROENDOCRINOL, V14, P587, DOI 10.1046/j.1365-2826.2002.00816.x; Keller C, 2002, DRUG METAB DISPOS, V30, P173, DOI 10.1124/dmd.30.2.173; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kreibich AS, 2009, NEUROPSYCHOPHARMACOL, V34, P2609, DOI 10.1038/npp.2009.91; Li CT, 2015, BEHAV BRAIN RES, V288, P39, DOI 10.1016/j.bbr.2015.04.007; Lim MM, 2006, BRAIN BEHAV EVOLUT, V68, P229, DOI 10.1159/000094360; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lu L, 2003, J NEUROCHEM, V84, P1378, DOI 10.1046/j.1471-4159.2003.01635.x; Luo FC, 2012, NEUROSCI LETT, V523, P50, DOI 10.1016/j.neulet.2012.06.039; Luo FC, 2012, FREE RADICAL BIO MED, V52, P1218, DOI 10.1016/j.freeradbiomed.2012.01.004; Lv T, 2013, CELL MOL NEUROBIOL, V33, P319, DOI 10.1007/s10571-012-9897-0; Ma YY, 2009, BEHAV BRAIN RES, V204, P192, DOI 10.1016/j.bbr.2009.06.017; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Martin F, 2011, BRIT J PHARMACOL, V163, P857, DOI 10.1111/j.1476-5381.2011.01287.x; Martin F, 2009, J NEUROCHEM, V110, P1422, DOI 10.1111/j.1471-4159.2009.06234.x; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Moron JA, 2010, NEUROPSYCHOPHARMACOL, V35, P955, DOI 10.1038/npp.2009.199; Navarro-Zaragoza J, 2010, MOL PHARM, V77; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Pisarchik A, 2004, EUR J BIOCHEM, V271, P2821, DOI 10.1111/j.1432-1033.2004.04216.x; Portugal GS, 2014, J NEUROSCI, V34, P527, DOI 10.1523/JNEUROSCI.2838-13.2014; Ramos AD, 2014, BEHAV BRAIN RES, V265, P69, DOI 10.1016/j.bbr.2014.02.024; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Rezayof A, 2003, J PSYCHOPHARMACOL, V17, P415, DOI 10.1177/0269881103174005; SEGUELA P, 1988, BRAIN RES, V442, P11, DOI 10.1016/0006-8993(88)91427-8; Sinha R, 2003, PSYCHOPHARMACOLOGY, V170, P62, DOI 10.1007/s00213-003-1525-8; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; VOORN P, 1986, J COMP NEUROL, V251, P84, DOI 10.1002/cne.902510106; Waldrop AE, 2010, PSYCHONEUROENDOCRINO, V35, P798, DOI 10.1016/j.psyneuen.2009.11.005; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; Wiesner B, 2003, J CELL SCI, V116, P1261, DOI 10.1242/jcs.00301; Zarrindast MR, 2007, BEHAV BRAIN RES, V181, P35, DOI 10.1016/j.bbr.2007.03.019; Zbytek B, 2004, J ENDOCRINOL, V181, pR1, DOI 10.1677/joe.0.181R001; Zbytek B, 2005, BRIT J DERMATOL, V152, P474, DOI 10.1111/J.1365-2133.2005.06217.X; Zbytek B, 2005, J CELL PHYSIOL, V203, P118, DOI 10.1002/jcp.20209; Zhou Lian-fang, 2006, J Zhejiang Univ Sci B, V7, P107, DOI 10.1631/jzus.2006.B0107; Zmijewski MA, 2009, J CELL PHYSIOL, V218, P593, DOI 10.1002/jcp.21632	67	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136164	10.1371/journal.pone.0136164	http://dx.doi.org/10.1371/journal.pone.0136164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313266	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000046
J	Larmann, J; Jurk, K; Janssen, H; Muller, M; Herzog, C; Lorenz, A; Schmitz, M; Nofer, JR; Theilmeier, G				Larmann, Jan; Jurk, Kerstin; Janssen, Henrike; Mueller, Martin; Herzog, Christine; Lorenz, Anika; Schmitz, Martina; Nofer, Jerzy-Roch; Theilmeier, Gregor			Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; NEOINTIMA FORMATION; GENE-TRANSFER; IN-VIVO; PLAQUE RUPTURE; MACROPHAGES; EXPRESSION; INJURY; METALLOPROTEINASES; MECHANISMS	Objective Atherosclerosis, a chronic inflammatory disease, arises from metabolic disorders and is driven by inappropriate recruitment and proliferation of monocytes macrophages and vascular smooth-muscle-cells. The receptor for the urokinase-type plasminogen activator (uPAR, Plaur) regulates the proteolytic activation of plasminogen. It is also a coactivator of integrins and facilitates leukocyte-endothelial interactions and vascular smooth-muscle-cell migration. The role of uPAR in atherogenesis remains elusive. Methods and Results We generated C57Bl6J low-density lipoprotein receptor (LDL) and uPAR double knockout (uPAR(-/-) LDLR-/-) mice to test the role of uPAR in two distinct atherosclerosis models. In LDLR-/- mice, hepatic overexpression following hydrodynamic transfection of soluble uPAR that competes with endogenous membrane-bound uPAR was performed as an interventional strategy. Aortic root atherosclerotic lesions induced by feeding a high-fat diet were smaller and comprised less macrophages and vascular smooth-muscle-cells in double knockout mice and animals overexpressing soluble uPAR when compared to controls. In contrast, lesion size, lipid-, macrophage-, and vascular smooth muscle cell content of guide-wire-induced intima lesions in the carotid artery were not affected by uPAR deficiency. Adhesion of uPAR(-/-)-macrophages to TNFa-stimulated endothelial cells was decreased in vitro accompanied by reduced VCAM-1 expression on primary endothelial cells. Hepatic overexpression of soluble full-length murine uPAR in LDLR-/- mice led to a reduction of diet-induced atherosclerotic lesion formation and monocyte recruitment into plaques. Ex vivo incubation with soluble uPAR protein also inhibited adhesion of macrophages to TNF alpha-stimulat endothelial cells in vitro. Conclusion uPAR-deficiency as well as competitive soluble uPAR reduced diet-promoted but not guide-wire induced atherosclerotic lesions in mice by preventing monocyte recruitment and vascular smooth-muscle-cell infiltration. Soluble uPAR may represent a therapeutic tool for the modulation of hyperlipidemia-associated atherosclerotic lesion formation.	[Larmann, Jan; Janssen, Henrike; Mueller, Martin; Herzog, Christine; Lorenz, Anika; Theilmeier, Gregor] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Larmann, Jan] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany; [Jurk, Kerstin] Univ Med Ctr, Ctr Thrombosis & Hemostasis CTH, Mainz, Germany; [Schmitz, Martina] Univ Munster, Inst Anat, D-48149 Munster, Germany; [Nofer, Jerzy-Roch] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Theilmeier, Gregor] Carl von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci, Dept Hlth Serv Sci, D-26111 Oldenburg, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Munster; University of Munster; Carl von Ossietzky Universitat Oldenburg	Theilmeier, G (corresponding author), Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany.	gregor.theilmeier@uni-oldenburg.de	Larmann, Jan/ABI-3699-2020; Jurk, Kerstin/AAT-7768-2020; Larmann, Jan/B-4034-2011	Larmann, Jan/0000-0003-3365-4572; Larmann, Jan/0000-0003-3365-4572	Interdisziplinares Zentrum Klinische Forschung (IZKF), Munster [The1/68/04(C12)]; Deutsche Forschungsgemeinschaft (DFG) [TH667/3-1]	Interdisziplinares Zentrum Klinische Forschung (IZKF), Munster; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Interdisziplinares Zentrum Klinische Forschung (IZKF), Munster (http://campus.uni-muenster.de/izkf.html), grant: The1/68/04(C12) to GT, and Deutsche Forschungsgemeinschaft, (DFG) (www.dfg.de), grant (TH667/3-1) to GT.	Anaraki PK, 2014, STEM CELLS DEV, V23, P352, DOI 10.1089/scd.2013.0318; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chen W, 2012, INT J CARDIOL, V161, P103, DOI 10.1016/j.ijcard.2011.12.094; DeGeest B, 1997, CIRCULATION, V96, P4349; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Farris SD, 2011, J BIOL CHEM, V286, P22665, DOI 10.1074/jbc.M110.202135; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Hui, 2008, CURR DRUG TARGETS, V9, P251; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Kiyan J, 2007, ATHEROSCLEROSIS, V195, P254, DOI 10.1016/j.atherosclerosis.2006.12.030; Kiyan Y, 2014, J MOL CELL CARDIOL, V66, P72, DOI 10.1016/j.yjmcc.2013.11.005; Larmann J, 2005, ANESTHESIOLOGY, V103, P1149; Larmann J, 2010, ANESTHESIOLOGY, V113, P610, DOI 10.1097/ALN.0b013e3181e99bfc; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; May AE, 1998, J EXP MED, V188, P1029, DOI 10.1084/jem.188.6.1029; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Plekhanova O, 2001, ATHEROSCLEROSIS, V159, P297, DOI 10.1016/S0021-9150(01)00511-1; Quarck R, 2001, CIRCULATION, V103, P2495; SHAH PK, 1995, CIRCULATION, V92, P1565; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Svensson PA, 2008, INT J MOL MED, V22, P459, DOI 10.3892/ijmm_00000043; Theilmeier G, 2002, CARDIOVASC RES, V55, P385, DOI 10.1016/S0008-6363(02)00409-1; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Vorup-Jensen T, 2001, MOL THER, V3, P867, DOI 10.1006/mthe.2001.0335; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Ye X, 2003, J THROMB HAEMOST, V1, P103, DOI 10.1046/j.1538-7836.2003.00024.x	28	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0131854	10.1371/journal.pone.0131854	http://dx.doi.org/10.1371/journal.pone.0131854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313756	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000003
J	Nyholm, O; Halkilahti, J; Wiklund, G; Okeke, U; Paulin, L; Auvinen, P; Haukka, K; Siitonen, A				Nyholm, Outi; Halkilahti, Jani; Wiklund, Gudrun; Okeke, Uche; Paulin, Lars; Auvinen, Petri; Haukka, Kaisa; Siitonen, Anja			Comparative Genomics and Characterization of Hybrid Shigatoxigenic and Enterotoxigenic Escherichia coli (STEC/ETEC) Strains	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; COLONIZATION FACTORS; VIRULENCE GENES; TOXIN; PREVALENCE; SEQUENCES; IDENTIFICATION; MICROARRAY; CHROMOSOME; LINEAGES	Background Shigatoxigenic Escherichia coli (STEC) and enterotoxigenic E. coli (ETEC) cause serious foodborne infections in humans. These two pathogroups are defined based on the pathogroup-associated virulence genes: stx encoding Shiga toxin (Stx) for STEC and elt encoding heat-labile and/or est encoding heat-stable enterotoxin (ST) for ETEC. The study investigated the genomics of STEC/ETEC hybrid strains to determine their phylogenetic position among E. coli and to define the virulence genes they harbor. Methods The whole genomes of three STEC/ETEC strains possessing both stx and est genes were sequenced using PacBio RS sequencer. Two of the strains were isolated from the patients, one with hemolytic uremic syndrome, and one with diarrhea. The third strain was of bovine origin. Core genome analysis of the shared chromosomal genes and comparison with E. coli and Shigella spp. reference genomes was performed to determine the phylogenetic position of the STEC/ETEC strains. In addition, a set of virulence genes and ETEC colonization factors were extracted from the genomes. The production of Stx and ST were studied. Results The human STEC/ETEC strains clustered with strains representing ETEC, STEC, entero-aggregative E. coli, and commensal and laboratory-adapted E. coli. However, the bovine STEC/ETEC strain formed a remote cluster with two STECs of bovine origin. All three STEC/ETEC strains harbored several other virulence genes, apart from stx and est, and lacked ETEC colonization factors. Two STEC/ETEC strains produced both toxins and one strain Stx only. Conclusions This study shows that pathogroup-associated virulence genes of different E. coli can coexist in strains originating from different phylogenetic lineages. The possibility of virulence genes to be associated with several E. coli pathogroups should be taken into account in strain typing and in epidemiological surveillance. Development of novel hybrid E. coli strains may cause a new public health risk, which challenges the traditional diagnostics of E. coli infections.	[Nyholm, Outi; Halkilahti, Jani; Haukka, Kaisa; Siitonen, Anja] Natl Inst Hlth & Welf THL, Dept Infect Dis, Bacterial Infect Unit, Helsinki, Finland; [Wiklund, Gudrun] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden; [Okeke, Uche; Paulin, Lars; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Haukka, Kaisa] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Gothenburg; University of Helsinki; University of Helsinki	Nyholm, O (corresponding author), Natl Inst Hlth & Welf THL, Dept Infect Dis, Bacterial Infect Unit, Helsinki, Finland.	outi.nyholm@thl.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021	Auvinen, Petri/0000-0002-3947-4778; 	Finnish Graduate School on Applied Biosciences: Bioengineering, Food & Nutrition, and Environment	Finnish Graduate School on Applied Biosciences: Bioengineering, Food & Nutrition, and Environment	ON received support from The Finnish Graduate School on Applied Biosciences: Bioengineering, Food & Nutrition, and Environment. No grant number is available. http://www.vetmed.helsinki.fi/abs/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmer K, 2007, J CLIN MICROBIOL, V45, P370, DOI 10.1128/JCM.01361-06; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, ENVIRON MICROBIOL, V13, P2468, DOI 10.1111/j.1462-2920.2011.02519.x; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Cuccuru G, 2014, BIOINFORMATICS, V30, P1928, DOI 10.1093/bioinformatics/btu135; de Sousa CP, 2001, INT J MED MICROBIOL, V291, P15, DOI 10.1078/1438-4221-00097; Del Canto F, 2011, J CLIN MICROBIOL, V49, P3198, DOI 10.1128/JCM.02473-10; Fratamico PM, 2008, FOODBORNE PATHOG DIS, V5, P827, DOI 10.1089/fpd.2008.0147; Geue L, 2014, MICROBIOL IMMUNOL, V58, P77, DOI 10.1111/1348-0421.12120; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lloyd AL, 2009, INFECT IMMUN, V77, P5322, DOI 10.1128/IAI.00779-09; Martikainen O, 2012, FOODBORNE PATHOG DIS, V9, P1015, DOI 10.1089/fpd.2012.1228; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nyholm O, 2015, ZOONOSES PUBLIC HLTH, V62, P518, DOI 10.1111/zph.12177; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Olesen B, 2013, J CLIN MICROBIOL, V51, P1779, DOI 10.1128/JCM.00346-13; Prager R, 2011, INT J MED MICROBIOL, V301, P181, DOI 10.1016/j.ijmm.2010.06.003; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; RATINER Y, 1991, HARNWEGSINFEKTION AK, P47; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Schmidt H, 2001, RES MICROBIOL, V152, P687, DOI 10.1016/S0923-2508(01)01249-9; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Serra-Moreno R, 2007, J BACTERIOL, V189, P6645, DOI 10.1128/JB.00466-07; Shen JL, 2015, FOOD MICROBIOL, V50, P20, DOI 10.1016/j.fm.2015.02.007; Shepard SM, 2012, J BACTERIOL, V194, P395, DOI 10.1128/JB.06225-11; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Statens Serum Institute, IDENTIFICATION OF TH; Steyert SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00133; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; Telli M, 2010, FEMS MICROBIOL LETT, V306, P117, DOI 10.1111/j.1574-6968.2010.01945.x; Toval F, 2014, INFECT IMMUN, V82, P4631, DOI 10.1128/IAI.01701-14; Toval F, 2014, J CLIN MICROBIOL, V52, P407, DOI 10.1128/JCM.02069-13; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Vidal RM, 2009, DIAGN MICR INFEC DIS, V65, P217, DOI 10.1016/j.diagmicrobio.2009.07.005; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Vu-Khac H, 2007, VET J, V174, P176, DOI 10.1016/j.tvjl.2006.05.019; Wells TJ, 2010, MICROBIOL-SGM, V156, P2459, DOI 10.1099/mic.0.039024-0; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	50	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135936	10.1371/journal.pone.0135936	http://dx.doi.org/10.1371/journal.pone.0135936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313149	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000033
J	Wang, XL; Zhang, T; Wang, J; Zhang, DB; Zhao, F; Lin, XW; Wang, Z; Shi, P; Pang, XN				Wang, Xi-liang; Zhang, Tao; Wang, Jing; Zhang, Dian-bao; Zhao, Feng; Lin, Xue-wen; Wang, Zhe; Shi, Ping; Pang, Xi-ning			miR-378b Promotes Differentiation of Keratinocytes through NKX3.1	PLOS ONE			English	Article							EXPRESSION; MICRORNAS; BIOGENESIS; MECHANISM; STEMNESS; CANCER; CELLS; SKIN	MicroRNA (miRNA) is a kind of short non-coding RNA, involved in various cellular processes. During keratinocyte differentiation, miRNAs act as important regulators. In this study, we demonstrated by microarray assay that the expression of miR-378b significantly increased during keratinocytes differentiation. Our findings showed that miR-378b could inhibit proliferation, migration and differentiation in keratinocytes. Luciferase reporter assays showed that miR-378b directly target NKX3.1. Silencing of NKX3.1 could coincide with the effects of miR-24 overexpression. In conclusion, our results demonstrate miR-378b promote keratinocytes differentiation by targeting NKX3.1. Manipulation of miR-378b may afford a new strategy to clinic treatment of skin injury and repair.	[Wang, Xi-liang; Zhang, Tao; Zhang, Dian-bao; Zhao, Feng; Lin, Xue-wen; Pang, Xi-ning] China Med Univ, Dept Stem Cells & Regenerat Med, Key Lab Cell Biol, Minist Publ Hlth China, Shenyang 110122, Peoples R China; [Wang, Jing] China Med Univ, Affiliated Hosp 1, Dept Anus & Intestine Surg, Shenyang 110001, Peoples R China; [Wang, Zhe] China Med Univ, Shengjing Hosp, Dept Blood Transfus, Shenyang 110004, Peoples R China; [Shi, Ping] China Med Univ, Affiliated Hosp 1, Dept Gen Practice, Shenyang 110001, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Pang, XN (corresponding author), China Med Univ, Dept Stem Cells & Regenerat Med, Key Lab Cell Biol, Minist Publ Hlth China, Shenyang 110122, Peoples R China.	pangxining@126.com	Dianbao, Zhang/F-3608-2011	Dianbao, Zhang/0000-0001-7063-7742	National Basic Research Program of China [2012CB518103]; National Natural Science Foundation of China [81450017]; Science and Technology Department of Liaoning Province [2012225080, 2014305012]; Science and Technology Bureau of Shenyang City [F11-262-9-01, F15-157-1-00]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province; Science and Technology Bureau of Shenyang City	This study was supported by the grants from the National Basic Research Program of China (http://www.most.gov.cn) Grants 2012CB518103 (to XP), the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) Grants 81450017 (to XP), the Science and Technology Department of Liaoning Province (http://www.lninfo.gov.cn/) Grants 2012225080 (to XP) and Grants 2014305012 (to JW), the Science and Technology Bureau of Shenyang City (http://www.syskjj.gov.cn/websiteManageMain_init.do) Grants F11-262-9-01 (to PS) and Grants F15-157-1-00 (to XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelio I, 2012, J CELL BIOL, V199, P347, DOI 10.1083/jcb.201203134; Bartel B, 2005, NAT STRUCT MOL BIOL, V12, P569, DOI 10.1038/nsmb0705-569; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Holmes KA, 2008, CANCER RES, V68, P7380, DOI 10.1158/0008-5472.CAN-08-0133; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hupkes M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-1; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kruithof-de Julio M, 2013, DEV DYNAM, V242, P1160, DOI 10.1002/dvdy.24008; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Martinez EE, 2014, CANCER PREV RES, V7, P950, DOI 10.1158/1940-6207.CAPR-14-0075; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Omori A, 2014, ENDOCRINOLOGY, V155, P2534, DOI 10.1210/en.2013-2054; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Pfeffer S, 2006, ONCOGENE, V25, P6211, DOI 10.1038/sj.onc.1209915; Ren SC, 2013, PROSTATE, V73, P1591, DOI 10.1002/pros.22709; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045761; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; You L, 2014, INT J CLIN EXP PATHO, V7, P7249; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	30	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136049	10.1371/journal.pone.0136049	http://dx.doi.org/10.1371/journal.pone.0136049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313654	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000038
J	Wu, Y; Zhong, A; Zheng, HY; Jiang, M; Xia, ZR; Yu, JJ; Chen, L; Huang, XY				Wu, Yibo; Zhong, Ahong; Zheng, Haoyu; Jiang, Min; Xia, Zhengrong; Yu, Jinjin; Chen, Ling; Huang, Xiaoyan			Expression of Flotilin-2 and Acrosome Biogenesis Are Regulated by MiR-124 during Spermatogenesis	PLOS ONE			English	Article							STEM-CELL NICHE; MICRORNA TARGETS; SPERM ACROSOME; LIFE-HISTORY; SMALL RNAS; DIFFERENTIATION; FLOTILLIN-1; MOUSE; PROLIFERATION; SPERMATOCYTES	MicroRNAs (miRNAs) are a class of short non-coding RNA molecules, which diversely regulate gene expression in organisms. Although the regulatory role of these small RNA molecules has been recently explored in animal spermatogenesis, the role of miR-124 in male germ cells is poorly defined. In our previous study, flotillin-2 was investigated as a novel Golgi-related protein involved in sperm acrosome biogenesis. The current study was designed to analyze the contribution of miR-124 in the regulation of flotillin-2 expression during mouse acrosome biogenesis. Luciferase assays revealed the target effects of miR-124 on flotillin-2 expression. Following intratesticular injection of miR-124 in 3-week-old male mice, quantitative real-time RT-PCR and western blot analysis were employed to confirm the function of miR-124 in regulating flotillin-2 after 48 hours. Sperm abnormalities were assessed 3 weeks later by ordinary optical microscopy, the acrosome abnormalities were also assessed by PNA staining and transmission electron microscopy. The results showed the proportion of sperm acrosome abnormalities was significantly higher than that of the control group. The expression of flotillin-2 and caveolin-1 was significantly downregulated during acrosome biogenesis. These results indicated that miR-124 could potentially play a role in caveolin-independent vesicle trafficking and modulation of flotillin-2 expression in mouse acrosome biogenesis.	[Wu, Yibo; Chen, Ling] Jiangnan Univ, Affiliated Hosp, Dept Reprod Med, Wuxi, Jiangsu, Peoples R China; [Zhong, Ahong; Yu, Jinjin] Soochow Univ, Affiliated Hosp 4, Dept Obstet & Gynecol, Wuxi, Jiangsu, Peoples R China; [Zheng, Haoyu; Jiang, Min; Xia, Zhengrong; Huang, Xiaoyan] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Soochow University - China; Nanjing Medical University	Huang, XY (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	rainbow_lyn@163.com; bbhxy@njmu.edu.cn			Natural Science Foundation of Jiangsu Province [BK20140170]; Wuxi Science and Technology Bureau [CSE31N1316]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Wuxi Science and Technology Bureau	This work was supported by grants from the Natural Science Foundation of Jiangsu Province (No. BK20140170) (http://www.jstd.gov.cn/) and the Wuxi Science and Technology Bureau (CSE31N1316) (http://www.wxstc.js.cn/).	Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Arkhipova KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-100; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bitel CL, 2012, CURR EYE RES, V37, P388, DOI 10.3109/02713683.2011.635833; Bjork JK, 2010, DEVELOPMENT, V137, P3177, DOI 10.1242/dev.050955; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Damestoy A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-22; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guo XJ, 2010, J PROTEOME RES, V9, P1246, DOI 10.1021/pr900735k; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Huang XY, 2011, ASIAN J ANDROL, V13, P18, DOI 10.1038/aja.2010.71; Huszar JM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103747; Ikawa M, 2002, P NATL ACAD SCI USA, V99, P7524, DOI 10.1073/pnas.072207299; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kiss AL, 2012, ADV EXP MED BIOL, V729, P14, DOI 10.1007/978-1-4614-1222-9_2; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kostereva N, 2008, REPROD DOMEST ANIM, V43, P386, DOI 10.1111/j.1439-0531.2008.01189.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-163; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Moreno RD, 2000, BIOL REPROD, V63, P89, DOI 10.1095/biolreprod63.1.89; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Real FM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110957; Sharpe RM, 2012, EMBO REP, V13, P398, DOI 10.1038/embor.2012.50; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tian H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.138; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Tulsiani DRP, 1998, EXP CELL RES, V240, P151, DOI 10.1006/excr.1998.3943; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Wu YB, 2012, J BIOMED RES, V26, P278, DOI 10.7555/JBR.26.20120030; Yang QE, 2013, DEVELOPMENT, V140, P280, DOI 10.1242/dev.087403; Yassine S, 2015, MOL HUM REPROD, V21, P169, DOI 10.1093/molehr/gau099; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zimmermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107023	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136671	10.1371/journal.pone.0136671	http://dx.doi.org/10.1371/journal.pone.0136671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313572	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000085
J	Xu, BJ; Wozniak, DJ				Xu, Binjie; Wozniak, Daniel J.			Development of a Novel Method for Analyzing Pseudomonas aeruginosa Twitching Motility and Its Application to Define the AmrZ Regulon	PLOS ONE			English	Article							CHP CHEMOSENSORY SYSTEM; CYCLIC-DI-GMP; IV PILI; BIOFILM FORMATION; BINDING PROTEIN; DNA-BINDING; SWARMING MOTILITY; LECTIN LECB; BACTERIA; RHAMNOLIPIDS	Twitching motility is an important migration mechanism for the Gram-negative bacterium Pseudomonas aeruginosa. In the commonly used subsurface twitching assay, the sub-population of P. aeruginosa with active twitching motility is difficult to harvest for high-throughput studies. Here we describe the development of a novel method that allows efficient isolation of bacterial sub-populations conducting highly active twitching motility. The transcription factor AmrZ regulates multiple P. aeruginosa virulence factors including twitching motility, yet the mechanism of this activation remains unclear. We therefore set out to understand this mechanism by defining the AmrZ regulon using DNA microarrays in combination with the newly developed twitching motility method. We discovered 112 genes in the AmrZ regulon and many encode virulence factors. One gene of interest and the subsequent focus was lecB, which encodes a fucose-binding lectin. DNA binding assays revealed that AmrZ activates lecB transcription by directly binding to its promoter. The lecB gene was previously shown to be required for twitching motility in P. aeruginosa strain PAK; however, our lecB deletion had no effect on twitching motility in strain PAO1. Collectively, in this study a novel condition was developed for quantitative studies of twitching motility, under which the AmrZ regulon was defined.	[Xu, Binjie; Wozniak, Daniel J.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Xu, Binjie; Wozniak, Daniel J.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Wozniak, Daniel J.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wozniak, DJ (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	Daniel.Wozniak@osumc.edu			National Institutes of Health [HL058334, AI097511, NR013898]; Cystic Fibrosis Foundation [XU13H0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funded by National Institutes of Health (nih.gov) grants HL058334, AI097511, and NR013898 to DJW and Cystic Fibrosis Foundation (cff.org) grant (XU13H0) to BX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baynham PJ, 2006, J BACTERIOL, V188, P132, DOI 10.1128/JB.188.1.132-140.2006; Baynham PJ, 1996, MOL MICROBIOL, V22, P97, DOI 10.1111/j.1365-2958.1996.tb02659.x; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chemani C, 2009, INFECT IMMUN, V77, P2065, DOI 10.1128/IAI.01204-08; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; DOIG P, 1988, INFECT IMMUN, V56, P1641, DOI 10.1128/IAI.56.6.1641-1646.1988; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOBBS M, 1993, MOL MICROBIOL, V7, P669, DOI 10.1111/j.1365-2958.1993.tb01158.x; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jain R, 2012, J BACTERIOL, V194, P4285, DOI 10.1128/JB.00803-12; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Jones CJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003984; Jones CJ, 2013, J BACTERIOL, V195, P1637, DOI 10.1128/JB.02190-12; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loris R, 2003, J MOL BIOL, V331, P861, DOI 10.1016/S0022-2836(03)00754-X; Luo Y, 2015, MBIO, V6, DOI 10.1128/mBio.02456-14; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Martinez-Granero F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-237; MATSUI H, 1993, J BACTERIOL, V175, P1257, DOI 10.1128/JB.175.5.1257-1263.1993; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Murray TS, 2008, J BACTERIOL, V190, P2700, DOI 10.1128/JB.01620-07; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; O'Connor JR, 2012, MOL MICROBIOL, V86, P720, DOI 10.1111/mmi.12013; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petrova OE, 2014, J BACTERIOL, V196, P2827, DOI 10.1128/JB.01628-14; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; SANO Y, 1993, J BACTERIOL, V175, P2907, DOI 10.1128/JB.175.10.2907-2916.1993; Schobert M, 2002, J MOL MICROB BIOTECH, V4, P287; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; Sonawane A, 2006, INFECT IMMUN, V74, P7035, DOI 10.1128/IAI.00551-06; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Turnbull L, 2014, METHODS MOL BIOL, V1149, P73, DOI 10.1007/978-1-4939-0473-0_9; Waligora EA, 2010, J BACTERIOL, V192, P5390, DOI 10.1128/JB.00711-10; Wang SW, 2013, ENVIRON MICROBIOL, V15, P2238, DOI 10.1111/1462-2920.12095; Zolfaghar I, 2003, INFECT IMMUN, V71, P5389, DOI 10.1128/IAI.71.9.5389-5393.2003	61	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136426	10.1371/journal.pone.0136426	http://dx.doi.org/10.1371/journal.pone.0136426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309248	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400123
J	Bertalan, Z; Budrikis, Z; La Porta, CAM; Zapperi, S				Bertalan, Zsolt; Budrikis, Zoe; La Porta, Caterina A. M.; Zapperi, Stefano			Navigation Strategies of Motor Proteins on Decorated Tracks	PLOS ONE			English	Article							HAND-OVER-HAND; CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; KINETOCHORE DYNEIN; STEPPING BEHAVIOR; MICROTUBULE; CELLS; PROTOFILAMENTS; SPINDLE; FORCE	Motor proteins display widely different stepping patterns as they move on microtubule tracks, from the deterministic linear or helical motion performed by the protein kinesin to the uncoordinated random steps made by dynein. How these different strategies produce an efficient navigation system needed to ensure correct cellular functioning is still unclear. Here, we show by numerical simulations that deterministic and random motor steps yield different outcomes when random obstacles decorate the microtubule tracks: kinesin moves faster on clean tracks but its motion is strongly hindered on decorated tracks, while dynein is slower on clean tracks but more efficient in avoiding obstacles. Further simulations indicate that dynein's advantage on decorated tracks is due to its ability to step backwards. Our results explain how different navigation strategies are employed by the cell to optimize motor driven cargo transport.	[Bertalan, Zsolt; Budrikis, Zoe; Zapperi, Stefano] Inst Sci Interchange Fdn, Turin, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biosci, Ctr Complex & Biosyst, Milan, Italy; [Zapperi, Stefano] Univ Milan, Dept Phys, Ctr Complex & Biosyst, Milan, Italy; [Zapperi, Stefano] CNR, Ist Energet & Interfasi, I-20133 Milan, Italy; [Zapperi, Stefano] Aalto Univ, Dept Appl Phys, Espoo, Finland	University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Aalto University	La Porta, CAM (corresponding author), Univ Milan, Dept Biosci, Ctr Complex & Biosyst, Milan, Italy.	caterina.laporta@unimi.it; stefano.zapperi@unimi.it	Zapperi, Stefano/C-9473-2009; la porta, caterina/K-7345-2013	Zapperi, Stefano/0000-0001-5692-5465; la porta, caterina/0000-0002-3010-8966	ERC advanced grant SIZEFFECTS; Academy of Finland FiDiPro progam [13282993]	ERC advanced grant SIZEFFECTS; Academy of Finland FiDiPro progam	Zsolt B., Zoe B., and SZ are supported by the ERC advanced grant SIZEFFECTS. SZ acknowledges partial support from the Academy of Finland FiDiPro progam, project 13282993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormuth V, 2012, BIOPHYS J, V103, pL04, DOI 10.1016/j.bpj.2012.05.024; Bressloff PC, 2013, REV MOD PHYS, V85, P135, DOI 10.1103/RevModPhys.85.135; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Bugiel M, 2015, BIOPHYS J, V108, P2019, DOI 10.1016/j.bpj.2015.03.022; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Can S, 2014, ELIFE, V3, DOI 10.7554/eLife.03205; Chen KJ, 2015, NAT MATER, V14, P589, DOI [10.1038/NMAT4239, 10.1038/nmat4239]; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; von Massowan, 1989, CELL MOT CYT, V14, P562, DOI [10.1002/cm.970140413, DOI 10.1002/CM.970140413]; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Wang B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.208102; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	35	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136945	10.1371/journal.pone.0136945	http://dx.doi.org/10.1371/journal.pone.0136945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323095	Green Published, gold			2022-12-27	WOS:000360435500052
J	Michel, A; Downey, P; Van Damme, X; De Wolf, C; Schwarting, R; Scheller, D				Michel, Anne; Downey, Patrick; Van Damme, Xavier; De Wolf, Catherine; Schwarting, Rainer; Scheller, Dieter			Behavioural Assessment of the A(2 alpha)/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; NMDA RECEPTOR ANTAGONIST; ANIMAL-MODELS; PARKINSONS-DISEASE; ROTATIONAL BEHAVIOR; MOTOR COMPLICATIONS; ISTRADEFYLLINE	In Parkinson's disease (PD), dopaminergic therapies are often associated with the development of motor complications. Attention has therefore been focused on the use of non-dopaminergic drugs. This study developed a new behavioural method capable of demonstrating the added value of combining adenosinergic and glutamatergic receptor antagonists in unilateral 6-OHDA lesioned rats. Rats were dosed orally with Tozadenant, a selective A(2A) receptor antagonist, and three different doses of Radiprodil, an NR2B-selective NMDA receptor antagonist. The drugs were given alone or in combination and rats were placed in an open-field for behavioural monitoring. Video recordings were automatically analysed. Five different behaviours were scored: distance traveled, ipsi- and contraversive turns, body position, and space occupancy. The results show that A(2A) or NR2B receptor antagonists given alone or in combination did not produce enhanced turning as observed with an active dose of L-Dopa/benserazide. Instead the treated rats maintained a straight body position, were able to shift from one direction to the other and occupied a significantly larger space in the arena. The highest "Tozadenant/Radiprodil" dose combination significantly increased all five behavioural parameters recorded compared to rats treated with vehicle or the same doses of the drugs alone. Our data suggest that the A(2A)/NR2B antagonist combination may be able to stimulate motor activity to a similar level as that achieved by L-Dopa but in the absence of the side-effects that are associated with dopaminergic hyperstimulation. If these results translate into the clinic, this combination could represent an alternative symptomatic treatment option for PD.	[Michel, Anne; Downey, Patrick; De Wolf, Catherine; Scheller, Dieter] UCB Biopharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium; [Van Damme, Xavier] UCB Biopharma SPRL, Strategy & Alliance Management, Braine Lalleud, Belgium; [Schwarting, Rainer] Univ Marburg, Behav Neurosci, Marburg, Germany	Philipps University Marburg	Michel, A (corresponding author), UCB Biopharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium.	anne.michel@ucb.com	Schwarting, RAINER/AAJ-1516-2021	Schwarting, Rainer/0000-0002-4686-3974	UCB Biopharma SPRL	UCB Biopharma SPRL	UCB Biopharma SPRL provided support in the form of salaries for authors (AM, PD, DS, XVD, and CDW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addy C, 2009, J CLIN PHARMACOL, V49, P856, DOI 10.1177/0091270009336735; Bibbiani F, 2003, EXP NEUROL, V184, P285, DOI 10.1016/S0014-4886(03)00250-4; Blanchet PJ, 1999, J PHARMACOL EXP THER, V290, P1034; Carta AR, 2006, BEHAV PHARMACOL, V17, P393, DOI 10.1097/00008877-200609000-00005; Cerasa A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00049; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Fernandez HH, 2010, PARKINSONISM RELAT D, V16, P16, DOI 10.1016/j.parkreldis.2009.06.008; Ferreira Joaquim J., 2000, Current Opinion in Neurology, V13, P431, DOI 10.1097/00019052-200008000-00011; Hauser RA, 2014, LANCET NEUROL, V13, P767, DOI 10.1016/S1474-4422(14)70148-6; Heeringa MJ, 1997, J NEURAL TRANSM, V104, P593, DOI 10.1007/BF01291878; Iravani M M, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS123, DOI 10.1016/S1353-8020(11)70038-4; Jenner P, 2011, J NEURAL TRANSM, V118, P1691, DOI 10.1007/s00702-011-0703-9; Jones N, 2013, BRAIN RES BULL, V98, P163, DOI 10.1016/j.brainresbull.2013.07.001; Konitsiotis S, 2006, BEHAV BRAIN RES, V170, P337, DOI 10.1016/j.bbr.2006.02.030; Lane EL, 2006, EXP NEUROL, V197, P284, DOI 10.1016/j.expneurol.2005.06.006; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Michel A, 2008, SOC NEUROSCIENCE, pS742; Michel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114086; Morissette M, 2006, SYNAPSE, V60, P239, DOI 10.1002/syn.20295; Nadjar A, 2009, PROG NEUROBIOL, V87, P1, DOI 10.1016/j.pneurobio.2008.09.013; News CT, RADIPRODIL TRIAL FAI; NUTT JG, 1990, NEUROLOGY, V40, P340; Park A, 2012, EXPERT OPIN PHARMACO, V13, P111, DOI 10.1517/14656566.2012.643869; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; Prat G, 2000, J NEURAL TRANSM, V107, P409, DOI 10.1007/s007020070083; Rodnitzky RL, 2014, NEUROLOGY, V82, P288, DOI 10.1212/WNL.0000000000000068; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Taylor JL, 2006, NEUROPHARMACOLOGY, V50, P761, DOI 10.1016/j.neuropharm.2005.12.004; Toulouse A, 2008, PROG NEUROBIOL, V85, P376, DOI 10.1016/j.pneurobio.2008.05.003; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135949	10.1371/journal.pone.0135949	http://dx.doi.org/10.1371/journal.pone.0135949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322641	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500012
J	Romero-Saavedra, F; Laverde, D; Budin-Verneuil, A; Muller, C; Bernay, B; Benachour, A; Hartke, A; Huebner, J				Romero-Saavedra, Felipe; Laverde, Diana; Budin-Verneuil, Aurelie; Muller, Cecile; Bernay, Benoit; Benachour, Abdellah; Hartke, Axel; Huebner, Johannes			Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections	PLOS ONE			English	Article							PNEUMOCOCCAL SURFACE ADHESIN; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; ABC TRANSPORTERS; FAECALIS; IDENTIFICATION; PSAA; IMMUNIZATION; DIVERSITY; IMMUNITY	Background Enterococcus faecium and faecalis are Gram-positive opportunistic pathogens that have become leading causes of nosocomial infections over the last decades. Especially multidrug resistant enterococci have become a challenging clinical problem worldwide. Therefore, new treatment options are needed and the identification of alternative targets for vaccine development has emerged as a feasible alternative to fight the infections caused by these pathogens. Results We extrapolate the transcriptomic data from a mice peritonitis infection model in E. faecalis to identify putative up-regulated surface proteins under infection conditions in E. faecium. After the bionformatic analyses two metal binding lipoproteins were identified to have a high homology (>72%) between the two species, the manganese ABC transporter substrate-binding lipoprotein (PsaA(fm),) and the zinc ABC transporter substrate-binding lipoprotein (AdcA(fm)). These candidate lipoproteins were overexpressed in Escherichia coli and purified. The recombinant proteins were used to produce rabbit polyclonal antibodies that were able to induce specific opsonic antibodies that mediated killing of the homologous strain E. faecium E155 as well as clinical strains E. faecium E1162, Enterococcus faecalis 12030, type 2 and type 5. Mice were passively immunized with the antibodies raised against recombinant lipoproteins, showing significant reduction of colony counts in mice livers after the bacterial challenge and demonstrating the efficacy of these metal binding lipoproteins as promising vaccine candidates to treat infections caused by these enterococcal pathogens. Conclusion Overall, our results demonstrate that these two metal binding lipoproteins elicited specific, opsonic and protective antibodies, with an extensive cross-reactivity and serotype-independent coverage among these two important nocosomial pathogens. Pointing these two protein antigens as promising immunogens, that can be used as single components or as carrier proteins together with polysaccharide antigens in vaccine development against enterococcal infections.	[Romero-Saavedra, Felipe; Laverde, Diana; Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Romero-Saavedra, Felipe; Laverde, Diana; Budin-Verneuil, Aurelie; Muller, Cecile; Benachour, Abdellah; Hartke, Axel] Univ Caen Lower Normandy, Stress Virulence EA4655 U2RM, Caen, France; [Huebner, Johannes] Univ Munich, Div Pediat Infect Dis, Dr von Hauner Childrens Hosp, Munich, Germany; [Bernay, Benoit] Univ Caen Lower Normandy, Proteogen Platform SFR ICORE 4206, Caen, France	University of Freiburg; Universite de Caen Normandie; University of Munich; Universite de Caen Normandie	Huebner, J (corresponding author), Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany.	johannes.huebner@med.uni-muenchen.de		Muller, Cecile/0000-0003-3078-1920; Huebner, Johannes/0000-0003-1232-4646; BUDIN-VERNEUIL, Aurelie/0000-0002-1173-251X				Aarestrup FM, 2002, APPL ENVIRON MICROB, V68, P4127, DOI 10.1128/AEM.68.8.4127-4129.2002; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Betts JC, 2002, IUBMB LIFE, V53, P239, DOI 10.1080/15216540212651; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Burnie J, 2002, FEMS IMMUNOL MED MIC, V33, P179, DOI 10.1111/j.1574-695X.2002.tb00589.x; Chen QY, 2008, J IMMUNOL, V181, P8258, DOI 10.4049/jimmunol.181.12.8258; Fernebro J, 2011, DRUG RESIST UPDATE, V14, P125, DOI 10.1016/j.drup.2011.02.001; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2003, INT J FOOD MICROBIOL, V88, P263, DOI 10.1016/S0168-1605(03)00189-2; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kropec A, 2011, MICROBIOL-SGM, V157, P3429, DOI 10.1099/mic.0.053207-0; Laverde D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110953; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Muller C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126143; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Reffuveille F, 2012, MICROBIOL-SGM, V158, P816, DOI 10.1099/mic.0.055319-0; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Romero-Saavedra F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111880; Sambrook J., 2001, COLD SPRING HARBOR L, V3, P2344, DOI DOI 10.1016/0307-4412(83)90068-7; Sampson JS, 1997, INFECT IMMUN, V65, P1967, DOI 10.1128/IAI.65.5.1967-1971.1997; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Talkington DF, 1996, MICROB PATHOGENESIS, V21, P17, DOI 10.1006/mpat.1996.0038; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P453, DOI 10.1093/jac/40.3.453; Werner G., 2008, EURO SURVEILL, V13, P19046; Whaley MJ, 2010, VACCINE, V28, P3071, DOI 10.1016/j.vaccine.2010.02.086; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Zarb P, 2012, EUROSURVEILLANCE, V17, P4	46	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136625	10.1371/journal.pone.0136625	http://dx.doi.org/10.1371/journal.pone.0136625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322633	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500024
J	Soyka, F; Bulthoff, HH; Barnett-Cowan, M				Soyka, Florian; Buelthoff, Heinrich H.; Barnett-Cowan, Michael			Integration of Semi-Circular Canal and Otolith Cues for Direction Discrimination during Eccentric Rotations	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; QUALITATIVELY DIFFERENT MECHANISMS; GRAVITO-INERTIAL CUES; VERTICAL AXIS; WHOLE-BODY; VESTIBULAR PERCEPTION; BAYESIAN INTEGRATION; SPATIAL ORIENTATION; HUMANS; MODEL	Humans are capable of moving about the world in complex ways. Every time we move, our self-motion must be detected and interpreted by the central nervous system in order to make appropriate sequential movements and informed decisions. The vestibular labyrinth consists of two unique sensory organs the semi-circular canals and the otoliths that are specialized to detect rotation and translation of the head, respectively. While thresholds for pure rotational and translational self-motion are well understood surprisingly little research has investigated the relative role of each organ on thresholds for more complex motion. Eccentric (off-center) rotations during which the participant faces away from the center of rotation stimulate both organs and are thus well suited for investigating integration of rotational and translational sensory information. Ten participants completed a psychophysical direction discrimination task for pure head-centered rotations, translations and eccentric rotations with 5 different radii. Discrimination thresholds for eccentric rotations reduced with increasing radii, indicating that additional tangential accelerations (which increase with radius length) increased sensitivity. Two competing models were used to predict the eccentric thresholds based on the pure rotation and translation thresholds: one assuming that information from the two organs is integrated in an optimal fashion and another assuming that motion discrimination is solved solely by relying on the sensor which is most strongly stimulated. Our findings clearly show that information from the two organs is integrated. However the measured thresholds for 3 of the 5 eccentric rotations are even more sensitive than predictions from the optimal integration model suggesting additional non-vestibular sources of information may be involved.	[Soyka, Florian; Buelthoff, Heinrich H.; Barnett-Cowan, Michael] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Barnett-Cowan, Michael] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	Max Planck Society; Korea University; University of Waterloo	Soyka, F (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	florian.soyka@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Soyka, Florian/M-4404-2019; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Soyka, Florian/0000-0003-1546-0491	Max Planck Society stipends; WCU (World Class University) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [R31-10008]	Max Planck Society stipends; WCU (World Class University) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by Max Planck Society stipends and by the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008).	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Barnett-Cowan M, 2005, ANN NY ACAD SCI, V1039, P314, DOI 10.1196/annals.1325.030; Barnett-Cowan M, 2012, JOVE-J VIS EXP, DOI 10.3791/3436; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Crane BT, 1999, BIOL CYBERN, V81, P109, DOI 10.1007/s004220050548; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Giordano P. Robuffo, 2010, 2010 IEEE International Conference on Robotics and Automation (ICRA 2010), P3896, DOI 10.1109/ROBOT.2010.5509945; Giordano PR, 2010, IEEE INT CONF ROBOT, P3876, DOI 10.1109/ROBOT.2010.5509647; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Heerspink MH, 2005, AIAA MOD SIM TECHN C, P1; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Israel I, 2005, EXP BRAIN RES, V163, P540, DOI 10.1007/s00221-005-2323-9; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; MacNeilage PR, 2010, J NEUROPHYSIOL, V104, P765, DOI 10.1152/jn.01067.2009; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P199, DOI 10.1152/jn.00905.2004; MERFELD DM, 1995, ACTA OTO-LARYNGOL, P354; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Merfeld DM, 2001, J NEUROPHYSIOL, V85, P1648, DOI 10.1152/jn.2001.85.4.1648; Mittelstaedt ML, 1996, J VESTIBUL RES-EQUIL, V6, P355, DOI 10.1016/0957-4271(96)00067-5; Nesti A, 2012, DRIV SIM C; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Seidman SH, 2002, EXP BRAIN RES, V147, P29, DOI 10.1007/s00221-002-1214-6; Soyka F, 2015, SUPPLEMENTARY MAT; Soyka F, 2013, EXP BRAIN RES, V228, P51, DOI 10.1007/s00221-013-3536-y; Soyka F, 2012, EXP BRAIN RES, V220, P89, DOI 10.1007/s00221-012-3120-x; Soyka F, 2011, EXP BRAIN RES, V209, P95, DOI 10.1007/s00221-010-2523-9; Tanner T, 2008, PERCEPTION, V37, P93; Teufel H.J., 2007, AIAA MOD SIM TECHN C, V1, P1; Valko Y, 2012, J NEUROSCI, V32, P13537, DOI 10.1523/JNEUROSCI.2157-12.2012; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; WALSH EG, 1961, J PHYSIOL-LONDON, V155, P506, DOI 10.1113/jphysiol.1961.sp006643; Wood S, 2004, J VESTIBUL RES-EQUIL, V14, P109; Zupan LH, 2000, J NEUROPHYSIOL, V84, P2001, DOI 10.1152/jn.2000.84.4.2001; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136925	10.1371/journal.pone.0136925	http://dx.doi.org/10.1371/journal.pone.0136925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322782	Green Published, Green Submitted, gold			2022-12-27	WOS:000360435500049
J	Aerenhouts, D; Clarys, P; Taeymans, J; Van Cauwenberg, J				Aerenhouts, Dirk; Clarys, Peter; Taeymans, Jan; Van Cauwenberg, Jelle			Estimating Body Composition in Adolescent Sprint Athletes: Comparison of Different Methods in a 3 Years Longitudinal Design	PLOS ONE			English	Article							SKINFOLD-THICKNESS EQUATIONS; NUTRITION; EXERCISE; FAT	A recommended field method to assess body composition in adolescent sprint athletes is currently lacking. Existing methods developed for non-athletic adolescents were not longitudinally validated and do not take maturation status into account. This longitudinal study compared two field methods, i.e., a Bio Impedance Analysis (BIA) and a skinfold based equation, with underwater densitometry to track body fat percentage relative to years from age at peak height velocity in adolescent sprint athletes. In this study, adolescent sprint athletes (34 girls, 35 boys) were measured every 6 months during 3 years (age at start = 14.8 +/- 1.5yrs in girls and 14.7 +/- 1.9yrs in boys). Body fat percentage was estimated in 3 different ways: 1) using BIA with the TANITA TBF 410; 2) using a skinfold based equation; 3) using underwater densitometry which was considered as the reference method. Height for age since birth was used to estimate age at peak height velocity. Cross-sectional analyses were performed using repeated measures ANOVA and Pearson correlations between measurement methods at each occasion. Data were analyzed longitudinally using a multilevel cross-classified model with the PROC Mixed procedure. In boys, compared to underwater densitometry, the skinfold based formula revealed comparable values for body fatness during the study period whereas BIA showed a different pattern leading to an overestimation of body fatness starting from 4 years after age at peak height velocity. In girls, both the skinfold based formula and BIA overestimated body fatness across the whole range of years from peak height velocity. The skinfold based method appears to give an acceptable estimation of body composition during growth as compared to underwater densitometry in male adolescent sprinters. In girls, caution is warranted when interpreting estimations of body fatness by both BIA and a skinfold based formula since both methods tend to give an overestimation.	[Aerenhouts, Dirk; Clarys, Peter; Taeymans, Jan; Van Cauwenberg, Jelle] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, Brussels, Belgium; [Aerenhouts, Dirk] Univ Antwerp, Dept Physiotherapy, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Taeymans, Jan] Bern Univ Appl Sci, Dept Hlth, Bern, Switzerland; [Van Cauwenberg, Jelle] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle] Fund Sci Res Flanders, Brussels, Belgium	Vrije Universiteit Brussel; University of Antwerp; Ghent University	Aerenhouts, D (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, Brussels, Belgium.	dirk.aerenhouts@vub.ac.be	Aerenhouts, Dirk/ADX-0930-2022; Dirk, Aerenhouts/AAI-5769-2021	Dirk, Aerenhouts/0000-0001-6154-5264; Taeymans, Jan/0000-0003-1583-4043; Van Cauwenberg, Jelle/0000-0003-1292-6241	Vrije Universiteit Brussel Research Council under the project 'OZR1401	Vrije Universiteit Brussel Research Council under the project 'OZR1401	This study was funded by the Vrije Universiteit Brussel Research Council under the project 'OZR1401. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi H, 1996, GROWTH DEVELOP AGING, V60, P126; Barker AR, 2011, MED SPORT SCI, V56, P106, DOI 10.1159/000320642; Fogelholm M, 1997, EUR J CLIN NUTR, V51, P495, DOI 10.1038/sj.ejcn.1600448; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kushner RF, 1996, AM J CLIN NUTR, V64, P423, DOI 10.1093/ajcn/64.3.423S; Loucks AB, 2004, J SPORT SCI, V22, P1, DOI 10.1080/0264041031000140518; Loucks AB, 2011, J SPORT SCI, V29, pS7, DOI 10.1080/02640414.2011.588958; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Norgan NG, 2005, PUBLIC HEALTH NUTR, V8, P1108, DOI 10.1079/PHN2005799; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Rodriguez G, 2005, EUR J CLIN NUTR, V59, P1158, DOI 10.1038/sj.ejcn.1602226; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Siri W. E., 1961, NUTRITION; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Tanner J.M., 1989, FETUS MAN PHYS GROWT, DOI 10.1002/ajhb.1310030224; Tipton KD, 2007, J SPORT SCI, V25, pS5, DOI 10.1080/02640410701607205; Verbeke G., 2000, SPRINGER SERIES STAT; Wong WW, 2000, AM J CLIN NUTR, V72, P348	18	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136788	10.1371/journal.pone.0136788	http://dx.doi.org/10.1371/journal.pone.0136788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317426	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100140
J	Batchelder, CA; Martinez, ML; Duru, N; Meyers, FJ; Tarantal, AF				Batchelder, Cynthia A.; Martinez, Michele L.; Duru, Nadire; Meyers, Frederick J.; Tarantal, Alice F.			Three Dimensional Culture of Human Renal Cell Carcinoma Organoids	PLOS ONE			English	Article							IN-VITRO; STEM-CELLS; KIDNEY; CANCER; MODEL	Renal cell carcinomas arise from the nephron but are heterogeneous in disease biology, clinical behavior, prognosis, and response to systemic therapy. Development of patient-specific in vitro models that efficiently and faithfully reproduce the in vivo phenotype may provide a means to develop personalized therapies for this diverse carcinoma. Studies to maintain and model tumor phenotypes in vitro were conducted with emerging three-dimensional culture techniques and natural scaffolding materials. Human renal cell carcinomas were individually characterized by histology, immunohistochemistry, and quantitative PCR to establish the characteristics of each tumor. Isolated cells were cultured on renal extracellular matrix and compared to a novel polysaccharide scaffold to assess cell-scaffold interactions, development of organoids, and maintenance of gene expression signatures over time in culture. Renal cell carcinomas cultured on renal extracellular matrix repopulated tubules or vessel lumens in renal pyramids and medullary rays, but cells were not observed in glomeruli or outer cortical regions of the scaffold. In the polysaccharide scaffold, renal cell carcinomas formed aggregates that were loosely attached to the scaffold or free-floating within the matrix. Molecular analysis of cell-scaffold constructs including immunohistochemistry and quantitative PCR demonstrated that individual tumor phenotypes could be sustained for up to 21 days in culture on both scaffolds, and in comparison to outcomes in two-dimensional monolayer cultures. The use of three-dimensional scaffolds to engineer a personalized in vitro renal cell carcinoma model provides opportunities to advance understanding of this disease.	[Batchelder, Cynthia A.; Martinez, Michele L.; Duru, Nadire; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Meyers, Frederick J.] Univ Calif Davis, Sch Med, Dept Internal Med, Davis, CA 95616 USA; [Meyers, Frederick J.; Tarantal, Alice F.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tarantal, AF (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	aftarantal@ucdavis.edu			UC Davis Comprehensive Cancer Center Biorepository [P30 CA093373]; California Institute for Regenerative Medicine UC Davis Stem Cell Training Program [TG2-01163]; California National Primate Research Center [P51 OD011107]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	UC Davis Comprehensive Cancer Center Biorepository; California Institute for Regenerative Medicine UC Davis Stem Cell Training Program; California National Primate Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the UC Davis Comprehensive Cancer Center Biorepository (P30 CA093373), California Institute for Regenerative Medicine UC Davis Stem Cell Training Program (TG2-01163), and the California National Primate Research Center base operating grant (P51 OD011107). These entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; ANGLARD P, 1992, CANCER RES, V52, P348; Astashkina A, 2014, ADV DRUG DELIVER REV, V69, P1, DOI 10.1016/j.addr.2014.02.008; Astashkina AI, 2012, BIOMATERIALS, V33, P4712, DOI 10.1016/j.biomaterials.2012.03.001; Astashkina AI, 2012, BIOMATERIALS, V33, P4700, DOI 10.1016/j.biomaterials.2012.02.063; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bianchi C, 2010, AM J PATHOL, V176, P1660, DOI 10.2353/ajpath.2010.090402; Bielecka ZF, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00194; Brannon AR, 2010, GENES CANC, V1, P154; Cifola I, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-244; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002; DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219; EBERT T, 1990, CANCER RES, V50, P5531; Fisher R, 2012, EPMA J, V3, DOI 10.1007/s13167-011-0137-3; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grainger DW, 2014, ADV DRUG DELIVER REV, V69, pVII, DOI 10.1016/j.addr.2014.04.001; Hoppensack A, 2014, TISSUE ENG PART C-ME, V20, P599, DOI [10.1089/ten.tec.2013.0446, 10.1089/ten.TEC.2013.0446]; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nakayama KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064134; Nakayama KH, 2011, TISSUE ENG PT A, V17, P2891, DOI [10.1089/ten.TEA.2010.0714, 10.1089/ten.tea.2010.0714]; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Pavia-Jimenez A, 2014, NAT PROTOC, V9, P1848, DOI 10.1038/nprot.2014.108; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimazui T, 2004, ONCOL REP, V11, P357; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013	36	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136758	10.1371/journal.pone.0136758	http://dx.doi.org/10.1371/journal.pone.0136758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317980	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100137
J	Deng, LB; Liang, QZ; He, XH; Luo, C; Chen, H; Qin, ZS				Deng, Libao; Liang, Qingzhi; He, Xinhua; Luo, Cong; Chen, Hu; Qin, Zhenshi			Investigation and Analysis of Genetic Diversity of Diospyros Germplasms Using SCoT Molecular Markers in Guangxi	PLOS ONE			English	Article							KAKI THUNB.; MICROSATELLITE MARKERS; ISSR MARKERS; POLYMORPHISM; CULTIVARS; DISTANCE; PCR; DIFFERENTIATION; GENTIANACEAE; MULTIVARIATE	Background Knowledge about genetic diversity and relationships among germplasms could be an invaluable aid in diospyros improvement strategies. Methods This study was designed to analyze the genetic diversity and relationship of local and natural varieties in Guangxi Zhuang Autonomous Region of China using start codon targeted polymorphism (SCoT) markers. The accessions of 95 diospyros germplasms belonging to four species Diospyros kaki Thunb, D. oleifera Cheng, D. kaki var. silverstris Mak, and D. lotus Linn were collected from different eco-climatic zones in Guangxi and were analyzed using SCoT markers. Results Results indicated that the accessions of 95 diospyros germplasms could be distinguished using SCoT markers, and were divided into three groups at similarity coefficient of 0.608; these germplasms that belong to the same species were clustered together; of these, the degree of genetic diversity of the natural D. kaki var. silverstris Mak population was richest among the four species; the geographical distance showed that the 12 natural populations of D. kaki var. silverstris Mak were divided into two groups at similarity coefficient of 0.19. Meanwhile, in order to further verify the stable and useful of SCoT markers in diospyros germplasms, SSR markers were also used in current research to analyze the genetic diversity and relationship in the same diospyros germplasms. Once again, majority of germplasms that belong to the same species were clustered together. Thus SCoT markers were stable and especially useful for analysis of the genetic diversity and relationship in diospyros germplasms. Discussion The molecular characterization and diversity assessment of diospyros were very important for conservation of diospyros germplasm resources, meanwhile for diospyros improvement.	[Deng, Libao; He, Xinhua; Luo, Cong; Chen, Hu] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Liang, Qingzhi] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Natl Field Genebank Trop Fruit, Zhanjiang 524091, Peoples R China; [Deng, Libao] Adm Comm Guangxi Baise Natl Agr Sci & Technol Zon, Baise 533612, Peoples R China; [He, Xinhua] Guangxi Crop Genet Improvement & Biotechnol Lab, Nanning 530007, Peoples R China; [Qin, Zhenshi] Guangxi Subtrop Crop Res Inst, Expt Stn, Chongzuo 532415, Peoples R China	Guangxi University; Chinese Academy of Tropical Agricultural Sciences	He, XH (corresponding author), Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China.	honest66222@163.com	He, Xinhua/AAE-6796-2020		public basic scientific research project foundation of Guangxi Zhuang Autonomous Region [Rzz200901]; National Natural Science Foundation of China [31471849]; Fund on Basic Scientific Research Project of Nonprofit Central Research Institutions [SSCRI 1630062014002]	public basic scientific research project foundation of Guangxi Zhuang Autonomous Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund on Basic Scientific Research Project of Nonprofit Central Research Institutions	The research was supported by the public basic scientific research project foundation of Guangxi Zhuang Autonomous Region (Rzz200901), National Natural Science Foundation of China (No. 31471849) and Fund on Basic Scientific Research Project of Nonprofit Central Research Institutions. No. SSCRI 1630062014002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Cheng-xiang, 2011, Xibei Zhiwu Xuebao, V31, P2185; Amirmoradi B, 2012, PLANT SYST EVOL, V298, P1679, DOI 10.1007/s00606-012-0669-6; [Anonymous], 2017, RES AN IS MARS MER K; CAI L H, 1996, HUAZHONG AGR U J, V15, P381; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Naval MD, 2010, TREE GENET GENOMES, V6, P677, DOI 10.1007/s11295-010-0283-0; Deng LB, 2013, THESIS GUANGXI U NAN, P15; Deng LiBao, 2012, Acta Horticulturae Sinica, V39, P215; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du XiaoYun, 2009, Acta Horticulturae Sinica, V36, P481; Fischer M, 1998, AM J BOT, V85, P811, DOI 10.2307/2446416; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Gong BC, 2011, HIGH QUALITY PRACTIC, P67; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Guo DL, 2006, GENET RESOUR CROP EV, V53, P1597, DOI 10.1007/s10722-005-8717-5; Guo DaLong, 2004, Journal of Agricultural Biotechnology, V12, P386; He XH, 2010, AGR SCI CHINA, V9, P626, DOI 10.1016/S1671-2927(09)60137-1; [何新华 He Xinhua], 2005, [分子植物育种, Molecular Plant Breeding], V3, P829; Hu DC, 2008, SCI HORTIC-AMSTERDAM, V117, P32, DOI 10.1016/j.scienta.2008.02.001; Kim TC, 1997, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.1997.436.8; Liang QZ, 2014, ELECTROPHORESIS, V35, P2520, DOI 10.1002/elps.201400182; Luo ZR, 1995, J JPN SOC HORTIC SCI, V64, P535, DOI 10.2503/jjshs.64.535; Mulpuri S, 2013, PLANT SCI, V207, P117, DOI 10.1016/j.plantsci.2013.02.013; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Soriano JM, 2006, MOL ECOL NOTES, V6, P368, DOI 10.1111/j.1471-8286.2006.01236.x; Wang R, 1997, ACTA HORTIC, V436, P43; Wang RZ, 1987, PERSIMMMON, P619; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu S, 2012, J CENTRAL S U FOR TE, V32, P153; Xiong FQ, 2011, MOL BIOL REP, V38, P3487, DOI 10.1007/s11033-010-0459-6; Yang Y., 1999, ACTA AGR BOREALI OCC, V8, P64; [杨勇 Yang Yong], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P133; Yonemori K, 1997, ACTA HORTIC, V436, P21; Yonemori K, 2008, GENET RESOUR CROP EV, V55, P81, DOI 10.1007/s10722-007-9216-7; Zhang YF, 2009, BIOTECHNOL BIOTEC EQ, V23, P1474, DOI 10.2478/V10133-009-0014-6	38	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136510	10.1371/journal.pone.0136510	http://dx.doi.org/10.1371/journal.pone.0136510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317414	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100092
J	Luddecke, J; Forchhammer, K				Lueddecke, Jan; Forchhammer, Karl			Energy Sensing versus 2-Oxoglutarate Dependent ATPase Switch in the Control of Synechococcus P-II Interaction with Its Targets NAGK and PipX	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PROTEINS; L-GLUTAMATE KINASE; NITROGEN REGULATION; COMPLEX-FORMATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; PII; MECHANISM; INSIGHTS; BINDING	P-II proteins constitute a superfamily of highly conserved signaling devices, common in all domains of life. Through binding of the metabolites ATP, ADP and 2-oxoglutarate (2-OG), they undergo conformational changes which allow them to regulate a variety of target proteins including enzymes, transport proteins and transcription factors. But, in reverse, these target proteins also modulate the metabolite sensing properties of P-II, as has been recently shown. We used this effect to refine our P-II based Forster resonance energy transfer (FRET) sensor and amplify its sensitivity towards ADP. With this enhanced sensor setup we addressed the question whether the P-II protein from the model organism Synechococcus elongatus autonomously switches into the ADP conformation through ATPase activity as proposed in a recently published model. The present study disproves ATPase activity as a relevant mechanism for the transition of P-II into the ADP state. In the absence of 2-OG, only the ATP/ADP ratio and concentration of ADP directs the competitive interaction of P-II with two targets, one of which preferentially binds P-II in the ATP-state, the other in the ADP-state.	[Lueddecke, Jan; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Div Organism Interact, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Div Organism Interact, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [DFG Fo195/9]; Open Access Publishing Fund of Tubingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University	This work was supported by Deutsche Forschungsgemeinschaft (DFG Fo195/9) (http://www.dfg.de/en/) to KF, and the Open Access Publishing Fund of Tubingen University (http://www.unituebingen.de/einrichtungen/universitaetsbibliothek/publizieren/open-access-publikationsfonds.html) to KF.	BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Chellamuthu VR, 2013, PLANTA, V237, P451, DOI 10.1007/s00425-012-1801-0; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Fokina O, 2011, BIOCHEM J, V440, P147, DOI 10.1042/BJ20110536; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Jiang P, 2007, BIOCHEMISTRY-US, V46, P4117, DOI 10.1021/bi0620508; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2010, P NATL ACAD SCI USA, V107, P15397, DOI 10.1073/pnas.1007015107; Luddecke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083181; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Radchenko MV, 2013, P NATL ACAD SCI USA, V110, P12948, DOI 10.1073/pnas.1304386110; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Truan D, 2014, J MOL BIOL, V426, P2783, DOI 10.1016/j.jmb.2014.05.008; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zeth K, 2014, J BIOL CHEM, V289, P8960, DOI 10.1074/jbc.M113.536557; Zeth K, 2012, ACTA CRYSTALLOGR D, V68, P901, DOI 10.1107/S0907444912016447	27	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137114	10.1371/journal.pone.0137114	http://dx.doi.org/10.1371/journal.pone.0137114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317540	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100205
J	Moser, O; Tschakert, G; Mueller, A; Groeschl, W; Pieber, TR; Obermayer-Pietsch, B; Koehler, G; Hofmann, P				Moser, Othmar; Tschakert, Gerhard; Mueller, Alexander; Groeschl, Werner; Pieber, Thomas R.; Obermayer-Pietsch, Barbara; Koehler, Gerd; Hofmann, Peter			Effects of High-Intensity Interval Exercise versus Moderate Continuous Exercise on Glucose Homeostasis and Hormone Response in Patients with Type 1 Diabetes Mellitus Using Novel Ultra-Long-Acting Insulin	PLOS ONE			English	Article							TARGET HEART-RATE; RECOMMENDATIONS; HYPOGLYCEMIA; INDIVIDUALS; PERFORMANCE; RISK	Introduction We investigated blood glucose (BG) and hormone response to aerobic high-intensity interval exercise (HIIE) and moderate continuous exercise (CON) matched for mean load and duration in type 1 diabetes mellitus (T1DM). Material and Methods Seven trained male subjects with T1DM performed a maximal incremental exercise test and HIIE and CON at 3 different mean intensities below (A) and above (B) the first lactate turn point and below the second lactate turn point (C) on a cycle ergometer. Subjects were adjusted to ultra-long-acting insulin Degludec (Tresiba/Novo Nordisk, Denmark). Before exercise, standardized meals were administered, and short-acting insulin dose was reduced by 25% (A), 50% (B), and 75% (C) dependent on mean exercise intensity. During exercise, BG, adrenaline, noradrenaline, dopamine, cortisol, glucagon, and insulin-like growth factor-1, blood lactate, heart rate, and gas exchange variables were measured. For 24 h after exercise, interstitial glucose was measured by continuous glucose monitoring system. Results BG decrease during HIIE was significantly smaller for B (p = 0.024) and tended to be smaller for A and C compared to CON. No differences were found for post-exercise interstitial glucose, acute hormone response, and carbohydrate utilization between HIIE and CON for A, B, and C. In HIIE, blood lactate for A (p = 0.006) and B (p = 0.004) and respiratory exchange ratio for A (p = 0.003) and B (p = 0.003) were significantly higher compared to CON but not for C. Conclusion Hypoglycemia did not occur during or after HIIE and CON when using ultra-long-acting insulin and applying our methodological approach for exercise prescription. HIIE led to a smaller BG decrease compared to CON, although both exercises modes were matched for mean load and duration, even despite markedly higher peak workloads applied in HIIE. Therefore, HIIE and CON could be safely performed in T1DM.	[Moser, Othmar; Pieber, Thomas R.; Obermayer-Pietsch, Barbara; Koehler, Gerd] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria; [Moser, Othmar; Tschakert, Gerhard; Mueller, Alexander; Groeschl, Werner; Hofmann, Peter] Graz Univ, Exercise Physiol & Training Res Grp, Inst Sports Sci, Graz, Austria; [Moser, Othmar] Univ Potsdam, Univ Outpatient Clin, Ctr Sports Med & Sports Orthoped, Potsdam, Germany	Medical University of Graz; University of Graz; University of Potsdam	Moser, O (corresponding author), Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria.	othmar.moser@uni-potsdam.de	Hofmann, Peter/ABG-8872-2020	Hofmann, Peter/0000-0003-4836-1238; Pieber, Thomas/0000-0003-3554-0405	Novo Nordisk; AstraZeneca; Bristol-Myers Squibb; Roche Diagnostics; Novartis; MSD; Eli Lilly	Novo Nordisk(Novo Nordisk); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Roche Diagnostics; Novartis(Novartis); MSD; Eli Lilly(Eli Lilly)	No conflict of interest: Othmar Moser, Gerhard Tschakert, Alexander Mueller, Werner Groeschl, Barbara Obermayer-Pietsch and Peter Hofmann. Duality of interests: Gerd Koehler has received lecture fees from Novo Nordisk, AstraZeneca, Bristol-Myers Squibb, Roche Diagnostics, Novartis, MSD and Eli Lilly. Thomas R. Pieber has participated in advisory panels and acted as a consultant for Novo Nordisk. This does not alter the authors' adherence to PLOS ONE policies on sharing data and material.	ASTRAND I, 1960, ACTA PHYSIOL SCAND, V48, P448, DOI 10.1111/j.1748-1716.1960.tb01879.x; Billat LV, 2001, SPORTS MED, V31, P13, DOI 10.2165/00007256-200131010-00002; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Bussau VA, 2006, DIABETES CARE, V29, P601, DOI 10.2337/diacare.29.03.06.dc05-1764; Campbell MD, 2015, SCAND J MED SCI SPOR, V25, P216, DOI 10.1111/sms.12192; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; DAVIS HA, 1983, EUR J APPL PHYSIOL, V50, P383, DOI 10.1007/BF00423244; Emhoff CAW, 2013, J APPL PHYSIOL, V115, P829, DOI 10.1152/japplphysiol.00538.2013; Guelfi KJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE865, DOI 10.1152/ajpendo.00533.2006; Guelfi KJ, 2005, DIABETES CARE, V28, P416, DOI 10.2337/diacare.28.2.416; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Heise T, 2013, WORLD DIAB C 2 6 DEC; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hofmann P, 2001, MED SCI SPORT EXER, V33, P1726, DOI 10.1097/00005768-200110000-00017; Hofmann P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/209302; Iellamo F, 2013, INT J CARDIOL, V167, P2561, DOI 10.1016/j.ijcard.2012.06.057; Iscoe KE, 2011, DIABETIC MED, V28, P824, DOI 10.1111/j.1464-5491.2011.03274.x; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; Keteyian SJ, 2012, CIRCULATION, V126, P1431, DOI 10.1161/CIRCULATIONAHA.112.129171; Kodama S, 2013, DIABETES CARE, V36, P471, DOI 10.2337/dc12-0783; Maran A, 2010, DIABETES TECHNOL THE, V12, P763, DOI 10.1089/dia.2010.0038; Meyer K, 1997, MED SCI SPORT EXER, V29, P306, DOI 10.1097/00005768-199703000-00004; PURDON C, 1993, J CLIN ENDOCR METAB, V76, P566, DOI 10.1210/jc.76.3.566; Rabasa-Lhoret R, 2001, DIABETES CARE, V24, P625, DOI 10.2337/diacare.24.4.625; Scharhag-Rosenberger F, 2010, J SCI MED SPORT, V13, P74, DOI 10.1016/j.jsams.2008.12.626; SIGAL RJ, 1994, J CLIN ENDOCR METAB, V79, P1049, DOI 10.1210/jc.79.4.1049; SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234, DOI 10.1080/02701367.1980.10609285; Smart NA, 2013, INT J CARDIOL, V166, P352, DOI 10.1016/j.ijcard.2011.10.075; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tschakert G, 2015, J SPORT SCI MED, V14, P29; Tschakert G, 2013, INT J SPORT PHYSIOL, V8, P600, DOI 10.1123/ijspp.8.6.600; Walsh John, 2011, J Diabetes Sci Technol, V5, P129; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Wonisch M, 2003, EUR J CARDIOV PREV R, V10, P296, DOI 10.1097/00149831-200308000-00013	36	63	64	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136489	10.1371/journal.pone.0136489	http://dx.doi.org/10.1371/journal.pone.0136489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317981	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100089
J	Roura, M; Bisoffi, F; Navaza, B; Pool, R				Roura, Maria; Bisoffi, Federico; Navaza, Barbara; Pool, Robert			"Carrying Ibuprofen in the Bag": Priority Health Concerns of Latin American Migrants in Spain- A Participatory Qualitative Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PROSPECTIVE COHORT; SWEDISH MEN; IMMIGRANTS; STRESS; EUROPE; RISK; DETERMINANTS; SERVICE; MORTALITY	Background An estimated 2.7 million Latin Americans reside in Europe, mostly in Spain. Part of a broader project aimed at developing a research agenda on the health status and determinants of this population, this qualitative study engaged Latin American migrants in the identification of research priorities. Methods We conducted 30 group discussions between November 2012-March 2013 with 84 participants purposively selected for maximum diversity in Madrid and Barcelona (Spain). We facilitated sequences of task-oriented visual activities to explore their views on priority health concerns. We tape-recorded and transcribed discussions and developed a coding frame based on socio-ecological frameworks, which we applied to all the data using NVIVO-10. A final round of eight group discussions allowed us to triangulate and enrich interpretations by including participants' insights. Findings The cumulative toll of daily stresses was the major health concern perceived by a population that conceptualised ill-health as a constellation of symptoms rather than as specific diseases. Work-related factors, legislative frameworks regulating citizenship entitlements and feeling ethnically discriminated were major sources of psycho-social strain. Except for sexually transmitted infections, participants rarely referred to communicable diseases as a concern. The perception that clinicians systematically prescribed painkillers discouraged health seeking and fostered self-medication. Participants felt that the medicalised, chemicalised, sexually liberal and accelerated culture of the host society damaged their own, and the local populations' health. Conclusion Health systems bear a disproportionate responsibility in addressing health problems rooted in other sectors. Occupational and migration policies should be recognised explicitly as health policies. The mismatch between researchers' emphasis on communicable infections and the health concerns of Latin American migrants highlights the need for greater interaction between different forms of knowledge. In this process, the biomedical culture of reliance on pharmacological solutions should not remain unquestioned.	[Roura, Maria; Bisoffi, Federico; Navaza, Barbara] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam	Roura, M (corresponding author), Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain.	maria.roura@isglobal.org	Roura, Maria/K-6668-2014	Roura, Maria/0000-0001-9556-1940	European Commission [FP7-GA-261495]; Spanish Ministry of Economy and Competitiveness (MINECO) under the Ramon y Cajal Fellowship program [RYC-2011-08428]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness (MINECO) under the Ramon y Cajal Fellowship program	This research was undertaken as part of the COHEMI project supported by the European Commission 7th Framework Program, Grant Agreement no FP7-GA-261495, (http://ec.europa.eu/research/health/public-health/public-health-and-health-systems/projects/cohemi_en.html). MR is financed by the Spanish Ministry of Economy and Competitiveness (MINECO) under the Ramon y Cajal Fellowship program (RYC-2011-08428),(http://www.idi.mineco.gob.es/portal/site/MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen EQ, 2010, AM J IND MED, V53, P405, DOI 10.1002/ajim.20710; Aragona M, 2012, ETHNIC HEALTH, V17, P477, DOI 10.1080/13557858.2012.661406; Arango Joaquin., 2013, PROMOTING INTEGRATIO; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; Brigidi S., 2009, MIGRACIONES Y SALUD, P300; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Brunner E, 2011, SOCIAL DETERMINANTS; Campanya Tanquem els CIE, 2015, CAMP PEL TANC DELS C; Casino G, 2012, LANCET, V379, P1777, DOI 10.1016/S0140-6736(12)60745-4; Castaneda H., 2010, NAPA B, V34, P6, DOI DOI 10.1111/J.1556-4797.2010.01049.X; Ceberio M., 2012, INTERIOR PROHIBE RED; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Coyne JC, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2009.03.004; Cruz Ines, 2010, BMC Public Health, V10, P255, DOI 10.1186/1471-2458-10-255; Davies A.A., 2006, MIGRATION SOCIAL DET; EFE, 2015, PAIS; Espinosa P., 2013, ULISES VIVEN ANDALUC; Factor R, 2011, SOC SCI MED, V73, P1292, DOI 10.1016/j.socscimed.2011.07.027; Ferrie JE, 2001, BMJ-BRIT MED J, V322, P647, DOI 10.1136/bmj.322.7287.647; Frank J., 2013, J EPIDEMIOL COMMUNIT, V67, P469; Ganann R, 2013, J IMMIGR MINOR HEALT, V15, P341, DOI 10.1007/s10903-012-9622-6; Garcia-Ramirez M, 2009, INT J MIGR HEALTH SO, V5, P2, DOI 10.1108/17479894200900001; GILL PS, 2007, HLTH CARE NEEDS ASSE, P227; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Good B., 1985, CULTURE DEPRESSION; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Guta A, 2014, SOC SCI MED, V123, P250, DOI 10.1016/j.socscimed.2014.07.028; Guta A, 2013, CRIT PUBLIC HEALTH, V23, P432, DOI 10.1080/09581596.2012.761675; Gutthann SP, 1997, EPIDEMIOLOGY, V8, P18, DOI 10.1097/00001648-199701000-00003; Horowitz CR, 2009, CIRCULATION, V119, P2633, DOI 10.1161/CIRCULATIONAHA.107.729863; Ingleby D, 2010, HLTH SYSTEMS CAN ADD; International Centre for Migration Policy Development, 2012, CLAND DAT IRR MIGR S; Johannes Siegrist, 2002, RES OCCUPATIONAL STR, V2, P261; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Kristenson M, 2004, SOC SCI MED, V58, P1511, DOI 10.1016/S0277-9536(03)00353-8; Kristenson M, 1997, BRIT MED J, V314, P629, DOI 10.1136/bmj.314.7081.629; Kunst A. E., 2011, Migration and health in the European Union, P101; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Lo MCM, 2008, SOCIOL HEALTH ILL, V30, P741, DOI 10.1111/j.1467-9566.2008.01091.x; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Ministerio de Interior, 2013, LUCH INM IRR BAL 201; Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007; MOYNIHAN R, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F7141; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Patino C, 2010, PSYCHOPATHOLOGY, V43, P17, DOI 10.1159/000255959; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; QSR International, NVIVO 10 WIND; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Roberts E, 2015, ANN RHEUMATIC DIS; Ronda E, 2013, J IMMIGR MINOR HEALT, V15, P164, DOI 10.1007/s10903-012-9664-9; Perez ER, 2012, ETHNIC HEALTH, V17, P563, DOI 10.1080/13557858.2012.730606; Roura M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1799-x; Villarroel N, 2012, HEALTH PLACE, V18, P1282, DOI 10.1016/j.healthplace.2012.09.009; Viruell-Fuentes EA, 2007, SOC SCI MED, V65, P1524, DOI 10.1016/j.socscimed.2007.05.010; Whitehead M, 1991, GEOL FORENINGAN STOC; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; World Health Organization, 2005, HLTH ALL POL FRAM WH	70	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136315	10.1371/journal.pone.0136315	http://dx.doi.org/10.1371/journal.pone.0136315			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317781	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100071
J	Wang, H; Qu, H; Deng, HC				Wang, Hang; Qu, Hua; Deng, Huacong			Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; GENE-EXPRESSION; HUMAN ADIPOCYTES; RECEPTOR TLR; BINDING; INSULIN; SECRETION; RAGE; B1; INTERLEUKIN-6	Object To detect the levels of plasma High-Mobility Group Box-1(HMGB1) in Chinese subject with obesity and type 2 diabetes mellitus (T2DM), and to investigate the correlations between plasma HMGB1 concentration and parameters of body fat, insulin resistance (IR) metabolism and inflammation. Methods This study recruited 79 normal glucose tolerance (NGT) subjects and 76 newly diagnosed T2DM patients. NGT and T2DM groups were divided into normal weight (NW) and obese (OB) subgroups respectively. Anthropometric parameters such as height, weight, waist circumference, hip circumference and blood pressure were measured. Plasma concentrations of HMGB1, IL-6, fasting plasma glucose (FPG), 2 hours post challenge plasma glucose (2hPG), serum lipid, glycated hemoglobin (HbA(1C)) and fasting insulin (FINS) were examined. The homeostasis model assessment (HOMA) was performed to assess IR status. Results Plasma HMGB1 levels were higher in T2DM group than that in NGT group. The concentrations of serum HMGB1 were also higher in subjects with OB than those in subjects with NW both in NGT and T2DM groups. Plasma levels of HMGB1 were positively correlated with waist hip ratio (WHR), blood pressure, FPG, FINS, HOMA-IR, TG, IL-6 and negatively correlated with HOMA-beta and high-density lipoprotein-cholesterol (HDL-c) independent of age, gender and BMI. Plasma levels of HMGB1 were significantly correlated with diabetes in fully adjusted models. Conclusion Plasma HMGB1 levels were increased in Chinese subjects with pure T2DM, which might be caused by IR. Serum HMGB1 participated in the pathological process of obesity and T2DM via its proinflammatory effect.	[Wang, Hang; Qu, Hua; Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China	Chongqing Medical University	Deng, HC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China.	deng_huacong@126.com		Qu, Hua/0000-0002-4895-5979	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China [81070639, 81270911, 30771038]	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Clinical Specialties Construction Program of China and the National Natural Science Foundation of China (No. 81070639, No. 81270911, No. 30771038).	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Arrigo T, 2013, EUR J ENDOCRINOL, V168, P631, DOI 10.1530/EJE-13-0037; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Ciubotaru M, 2004, MOL CELL BIOL, V24, P8727, DOI 10.1128/MCB.24.19.8727-8744.2004; Czura CJ, 2003, CRIT CARE MED, V31, pS46, DOI 10.1097/00003246-200301001-00007; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Gunasekaran MK, 2013, CYTOKINE, V64, P103, DOI 10.1016/j.cyto.2013.07.017; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Harwood HJ, 2012, NEUROPHARMACOLOGY, V63, P57, DOI 10.1016/j.neuropharm.2011.12.010; *HLTH COMM AUSTR P, 2000, AS PAC PERSP RED OB; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 2002, CANCER RES, V62, P4805; JAVAHERIAN K, 1978, SCIENCE, V199, P1345, DOI 10.1126/science.628842; Jin DQ, 2012, EXP THER MED, V4, P1124, DOI 10.3892/etm.2012.732; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Lee BW, 2010, INT J MOL MED, V26, P813, DOI 10.3892/ijmm_00000529; Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039; Ni XR, 2015, REPROD SCI, V22, P271, DOI 10.1177/1933719114549852; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; PASQUALINI JR, 1989, BIOCHEM BIOPH RES CO, V161, P1260, DOI 10.1016/0006-291X(89)91378-8; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Tan BK, 2008, DIABETES, V57, P801, DOI 10.2337/db07-0990; Unger RH, 2005, BIOCHIMIE, V87, P57, DOI 10.1016/j.biochi.2004.11.014; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; *WHO, 1999, WHONCDNCS992 DEP NON; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632	36	49	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136564	10.1371/journal.pone.0136564	http://dx.doi.org/10.1371/journal.pone.0136564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317615	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100102
J	Wong, JK; Chen, L; Huang, Y; Sehba, FA; Friedel, RH; Zou, HY				Wong, Jamie K.; Chen, Lei; Huang, Yong; Sehba, Fatima A.; Friedel, Roland H.; Zou, Hongyan			Attenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; OXIDATIVE STRESS; PROTECTS NEURONS; ARTERY OCCLUSION; STROKE; CELLS; MECHANISMS; EXPRESSION; GENE; NEUROPROTECTION	Stroke results in brain tissue damage from ischemia and oxidative stress. Molecular regulators of the protective versus deleterious cellular responses after cerebral ischemia remain to be identified. Here, we show that deletion of Smad1, a conserved transcription factor that mediates canonical bone morphogenetic protein (BMP) signaling, results in neuroprotection in an ischemia-reperfusion (I/R) stroke model. Uninjured mice with conditional deletion of Smad1 in the CNS (Smad1 cKO) displayed upregulation of the reactive astrocyte marker GFAP and hypertrophic morphological changes in astrocytes compared to littermate controls. Additionally, cultured Smad1(-/-) astrocytes exhibited an enhanced antioxidant capacity. When subjected to I/R injury by transient middle cerebral artery occlusion (tMCAO), Smad1 cKO mice showed enhanced neuronal survival and improved neurological recovery at 7 days post-stroke. This neuroprotective phenotype is associated with attenuated reactive astrocytosis and neuroinflammation, along with reductions in oxidative stress, p53 induction, and apoptosis. Our data suggest that Smad1-mediated signaling pathway is involved in stroke pathophysiology and may present a new potential target for stroke therapy.	[Wong, Jamie K.; Chen, Lei; Huang, Yong; Friedel, Roland H.; Zou, Hongyan] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Sehba, Fatima A.; Friedel, Roland H.; Zou, Hongyan] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zou, HY (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA.	hongyan.zou@mssm.edu	Huang, Yong/C-8558-2011	Huang, Yong/0000-0001-8095-4215; Wong, Jamie/0000-0002-9059-0053; Friedel, Roland/0000-0002-7513-3604; Zou, Hongyan/0000-0003-4216-5607	American Heart Association [13IRG14560007]; Irma T. Hirschl/Monique Weill-Caulier Foundations; National Institute of Neurological Disorders and Stroke [NS073596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073596] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Irma T. Hirschl/Monique Weill-Caulier Foundations; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association 13IRG14560007, Irma T. Hirschl/Monique Weill-Caulier Foundations, and National Institute of Neurological Disorders and Stroke NS073596 to HZ.	BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bell KFS, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/689524; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Chen C, 2011, J NEUROSCI RES, V89, P1194, DOI 10.1002/jnr.22662; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Finelli MJ, 2013, CELL REP, V3, P1592, DOI 10.1016/j.celrep.2013.04.011; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Gupta K, 2012, CELL DEATH DIFFER, V19, P779, DOI 10.1038/cdd.2011.154; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Huang SX, 2002, GENESIS, V32, P76, DOI 10.1002/gene.10059; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI 10.1016/j.bbrc.2011.08.114; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Pachori AS, 2010, J MOL CELL CARDIOL, V48, P1255, DOI 10.1016/j.yjmcc.2010.01.010; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Radermacher Kim A, 2012, Exp Transl Stroke Med, V4, P11, DOI 10.1186/2040-7378-4-11; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Rigelsky CM, 2008, AM J MED GENET A, V146A, P2551, DOI 10.1002/ajmg.a.32468; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Samanta J, 2010, STROKE, V41, P357, DOI 10.1161/STROKEAHA.109.565523; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shin JA, 2012, CELL MOL NEUROBIOL, V32, P587, DOI 10.1007/s10571-012-9806-6; Sloan SA, 2014, NEURON, V81, P221, DOI 10.1016/j.neuron.2013.12.032; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wong WT, 2010, CIRC RES, V107, P984, DOI 10.1161/CIRCRESAHA.110.222794; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang F., 2012, ANIMAL MODELS ACUTE, V9, P93, DOI [10.1007/978-1-61779-782-8_9, DOI 10.1007/978-1-61779-782-8_9]; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136967	10.1371/journal.pone.0136967	http://dx.doi.org/10.1371/journal.pone.0136967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317208	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100186
J	Yamada, H; Takahashi, K; Lim, O; Svay, S; Chuon, C; Hok, S; Do, SH; Fujimoto, M; Akita, T; Goto, N; Katayama, K; Arai, M; Tanaka, J				Yamada, Hiroko; Takahashi, Kazuaki; Lim, Olline; Svay, Somana; Chuon, Channarena; Hok, Sirany; Do, Son Huy; Fujimoto, Mayumi; Akita, Tomoyuki; Goto, Noboru; Katayama, Keiko; Arai, Masahiro; Tanaka, Junko			Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4	PLOS ONE			English	Article							RISK-FACTORS; E EPIDEMIC; TRANSPLANT RECIPIENTS; SPORADIC HEPATITIS; JAPAN; INFECTION; TRANSMISSION; OUTBREAK; HOKKAIDO; FEATURES	Hepatitis E virus (HEV) is a growing public health problem in many countries. In this study, we investigated HEV seroprevalence among the general population in the Siem Reap province, Cambodia, and performed HEV genetic analysis with the aim to develop an HEV prevention strategy. This seroepidemiological cross-sectional study conducted from 2010 to 2014 included 868 participants from four different locations in Siem Reap province, Cambodia. They answered questionnaires and provided blood samples for the analysis of hepatitis virus infections. Among the participants (360 men and 508 women; age range, 7-90 years), the prevalence of anti-HEV IgG was 18.4%(95% confidence interval: 15.9-21.0); HEV RNA was detected in two participants (0.23%) and was classified as genotype 3 and 4. Full-length genome of the genotype 4 isolate, CVS-Sie10, was sequenced; it contained 7,222 nucleotides and three ORFs and demonstrated high sequence identity with the swine China isolates swGX40 (95.57%), SS19 (94.37%), and swDQ (91.94%). Multivariate logistic regression analysis revealed that men, elderly people, and house workers were risk groups significantly associated with the positivity for anti-HEV IgG. This is the first report on the detection of HEV genotype 4 in humans in Cambodia and on the complete genome sequence of HEV genotype 4 from this country. Our study demonstrates that new HEV infection cases occur frequently among the general population in Cambodia, and effective preventive measures are required.	[Yamada, Hiroko; Chuon, Channarena; Do, Son Huy; Fujimoto, Mayumi; Akita, Tomoyuki; Katayama, Keiko; Tanaka, Junko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan; [Takahashi, Kazuaki; Arai, Masahiro] Toshiba Gen Hosp, Dept Med Sci, Tokyo, Japan; [Lim, Olline; Svay, Somana; Hok, Sirany] Minist Hlth, Phnom Penh, Cambodia; [Do, Son Huy] Binh Thuan Med Coll, Phan Thiet City, Binh Thuan Prov, Vietnam; [Goto, Noboru] Hiroshima Univ, Grad Sch Social Sci, Dept Management Studies, Hiroshima, Japan	Hiroshima University; Toshiba Corporation; Hiroshima University	Tanaka, J (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan.	jun-tanaka@hiroshima-u.ac.jp	Tanaka, Junko/G-6166-2019	Tanaka, Junko/0000-0002-5669-4051	JSPS KAKENHI [24590793]; Japanese Ministry of Health, Labour and Welfare	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by JSPS KAKENHI Grant Number 24590793 and a Health Sciences Research Grant for Policy Research for Hepatitis Measures from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, KANZO, V47, P384; BILE K, 1994, AM J TROP MED HYG, V51, P466, DOI 10.4269/ajtmh.1994.51.466; Buchy P, 2004, Bull Soc Pathol Exot, V97, P165; Caron M, 2006, J CLIN MICROBIOL, V44, P3440, DOI 10.1128/JCM.00939-06; Corwin A, 1997, AM J TROP MED HYG, V57, P62, DOI 10.4269/ajtmh.1997.57.62; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Hau CH, 1999, AM J TROP MED HYG, V60, P277, DOI 10.4269/ajtmh.1999.60.277; Imai M, 1997, Kansenshogaku Zasshi, V71, P918; Inoue G, 2006, KANZO, V47, P459; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Kitajima M, 2009, T ROY SOC TROP MED H, V103, P955, DOI 10.1016/j.trstmh.2009.04.004; Kokuryu H, 2010, ACTA HEPATOL JPN, V51, P536, DOI DOI 10.2957/KANZO.51.536; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Labrique AB, 2010, AM J EPIDEMIOL, V172, P952, DOI 10.1093/aje/kwq225; Lewis HC, 2008, EMERG INFECT DIS, V14, P165, DOI 10.3201/eid1401.070307; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x; Mizuo H, 2005, J MED VIROL, V76, P341, DOI 10.1002/jmv.20364; Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002; NAIK SR, 1992, B WORLD HEALTH ORGAN, V70, P597; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division MoH, 2014, INFECT AGENTS SURVEI, V35, P1; National Institute of Statistics, GEN POP CENS CAMB 20; Okamoto H, 2003, INTERNAL MED, V42, P1065, DOI 10.2169/internalmedicine.42.1065; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Rab MA, 1997, AM J TROP MED HYG, V57, P151, DOI 10.4269/ajtmh.1997.57.151; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shrestha A, 2015, EMERG INFECT DIS, V21, P711, DOI 10.3201/eid2104.141512; Takahashi K, 2002, J INFECT DIS, V185, P1342, DOI 10.1086/340023; Takahashi M, 2003, J GEN VIROL, V84, P851, DOI 10.1099/vir.0.18918-0; Takahashi M, 2007, J CLIN MICROBIOL, V45, P3671, DOI 10.1128/JCM.01086-07; Takahashi M, 2014, HEPATOL RES, V44, P43, DOI 10.1111/hepr.12175; Takeda H, 2010, VOX SANG, V99, P307, DOI 10.1111/j.1423-0410.2010.01362.x; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; World Health Organization, 2014, HEP E; World Health Organization, 2012, PREV CONTR VIR HEP I; Worm HC, 2002, MICROBES INFECT, V4, P657, DOI 10.1016/S1286-4579(02)01584-8; Yamada H, 2015, HEPATOL RES, V45, P480, DOI 10.1111/hepr.12367; Zhu FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087154	46	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136903	10.1371/journal.pone.0136903	http://dx.doi.org/10.1371/journal.pone.0136903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317620	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100166
J	Bruckert, H; Marchetti, G; Ramialison, M; Besse, F				Bruckert, Helene; Marchetti, Giovanni; Ramialison, Mirana; Besse, Florence			Drosophila Hrp48 Is Required for Mushroom Body Axon Growth, Branching and Guidance	PLOS ONE			English	Article							RNA-BINDING PROTEINS; A2 RESPONSE ELEMENT; MESSENGER-RNA; HNRNPA/B HOMOLOG; LOCALIZATION; TRANSLATION; NEURODEGENERATION; TRAFFICKING; EXPRESSION; MUTATIONS	RNA binding proteins assemble on mRNAs to control every single step of their life cycle, from nuclear splicing to cytoplasmic localization, stabilization or translation. Consistent with an essential role of RNA binding proteins in neuronal maturation and function, mutations in this class of proteins, in particular in members of the hnRNP family, have been associated with neurological diseases. To date, however, the physiological function of hnRNPs during in vivo neuronal development has remained poorly explored. Here, we have investigated the role of Drosophila Hrp48, a fly homologue of mammalian hnRNP A2/B1, during central nervous system development. Using a combination of mutant conditions, we showed that hrp48 is required for the formation, growth and guidance of axonal branches in Mushroom Body neurons. Furthermore, our results revealed that hrp48 inactivation induces an overextension of Mushroom Body dorsal axonal branches, with a significantly higher penetrance in females than in males. Finally, as demonstrated by immunolocalization studies, Hrp48 is confined to Mushroom Body neuron cell bodies, where it accumulates in the cytoplasm from larval stages to adulthood. Altogether, our data provide evidence for a crucial in vivo role of the hnRNP Hrp48 in multiple aspects of axon guidance and branching during nervous system development. They also indicate cryptic sex differences in the development of sexually non-dimorphic neuronal structures.	[Bruckert, Helene; Marchetti, Giovanni; Besse, Florence] Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06189 Nice, France; [Bruckert, Helene; Marchetti, Giovanni; Besse, Florence] Inst Biol Valrose, CNRS, UMR7277, Nice, France; [Bruckert, Helene; Marchetti, Giovanni; Besse, Florence] Inst Biol Valrose, INSERM, UMR1091, Nice, France; [Ramialison, Mirana] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Australian Regenerative Medicine Institute; Monash University	Besse, F (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06189 Nice, France.	besse@unice.fr	Ramialison, Mirana/AEG-6305-2022	Ramialison, Mirana/0000-0001-6315-4777; Besse, Florence/0000-0003-4672-1068	Centre National de la Recherche Scientifique (ATIP); Human Frontier Science Program [CDA-00015/2009]; Association pour la Recherche sur le Cancer [ARC-Fixe 4988]; Agence Nationale de la Recherche [ANR-11-JSV2-001-01]	Centre National de la Recherche Scientifique (ATIP)(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (ATIP), the Human Frontier Science Program (CDA-00015/2009), the Association pour la Recherche sur le Cancer (ARC-Fixe 4988), and the Agence Nationale de la Recherche (ANR-11-JSV2-001-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Lee T, 1999, DEVELOPMENT, V126, P4065; Lenzken SC, 2014, WIRES RNA, V5, P565, DOI 10.1002/wrna.1231; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Marchetti G, 2014, J NEUROSCI, V34, P13855, DOI 10.1523/JNEUROSCI.3285-13.2014; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Muslimov IA, 2011, J CELL BIOL, V194, P441, DOI 10.1083/jcb.201010027; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Shan JG, 2003, J NEUROSCI, V23, P8859; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Suissa Y, 2010, P NATL ACAD SCI USA, V107, P6930, DOI 10.1073/pnas.0910570107; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136610	10.1371/journal.pone.0136610	http://dx.doi.org/10.1371/journal.pone.0136610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313745	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000075
J	Gallos, LK; Fefferman, NH				Gallos, Lazaros K.; Fefferman, Nina H.			The Effect of Disease-Induced Mortality on Structural Network Properties	PLOS ONE			English	Article							MODELS; EPIDEMICS; OUTBREAKS; GEOMETRY; COMPLEX; TIME	As the understanding of the importance of social contact networks in the spread of infectious diseases has increased, so has the interest in understanding the feedback process of the disease altering the social network. While many studies have explored the influence of individual epidemiological parameters and/or underlying network topologies on the resulting disease dynamics, we here provide a systematic overview of the interactions between these two influences on population-level disease outcomes. We show that the sensitivity of the population-level disease outcomes to the combination of epidemiological parameters that describe the disease are critically dependent on the topological structure of the population's contact network. We introduce a new metric for assessing disease-driven structural damage to a network as a population-level outcome. Lastly, we discuss how the expected individual-level disease burden is influenced by the complete suite of epidemiological characteristics for the circulating disease and the ongoing process of network compromise. Our results have broad implications for prediction and mitigation of outbreaks in both natural and human populations.	[Gallos, Lazaros K.; Fefferman, Nina H.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Gallos, Lazaros K.; Fefferman, Nina H.] Rutgers State Univ, DIMACS, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Gallos, LK (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	lgallos@gmail.com	Fefferman, Nina/AAQ-7378-2021	Fefferman, Nina/0000-0003-0233-1404; Gallos, Lazaros/0000-0002-2713-7934	Dept. of Homeland Security through the CCICADA Center at Rutgers; NSF EaSM [1049088]	Dept. of Homeland Security through the CCICADA Center at Rutgers; NSF EaSM	The authors thank the Dept. of Homeland Security for funds in support of this research through the CCICADA Center at Rutgers, and NSF EaSM grant No. 1049088.	ANDERSON R M, 1991; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Black AJ, 2014, J THEOR BIOL, V359, P45, DOI 10.1016/j.jtbi.2014.05.042; Bolton KJ, 2011, INFLUENZA OTHER RESP, V5, P208; Brauer F, 2008, LECT NOTES MATH, V1945, P19; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Chakrabarti D, 2008, ACM T INFORM SYST SE, V10, DOI 10.1145/1284680.1284681; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R., 2010, COMPLEX NETWORKS STR; Eubank S., 2010, Journal of Biological Dynamics, V4, P446, DOI 10.1080/17513751003778687; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fefferman NH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031919; Ferrari MJ, 2006, P ROY SOC B-BIOL SCI, V273, P2743, DOI 10.1098/rspb.2006.3636; Franke JE, 2008, J MATH BIOL, V57, P755, DOI 10.1007/s00285-008-0188-9; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Goltsev AV, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128702; Handcock MS, 2006, THEOR POPUL BIOL, V70, P125, DOI 10.1016/j.tpb.2006.02.004; Jones JH, 2003, P ROY SOC B-BIOL SCI, V270, P1123, DOI 10.1098/rspb.2003.2369; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lopez E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188701; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R, ARXIV14082701; Sah P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-220; Saramaki J, 2005, J THEOR BIOL, V234, P413, DOI 10.1016/j.jtbi.2004.12.003; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Suzan G, 2015, ECOL EVOL, V5, P865, DOI 10.1002/ece3.1404; Verdasca J, 2005, J THEOR BIOL, V233, P553, DOI 10.1016/j.jtbi.2004.10.031	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136704	10.1371/journal.pone.0136704	http://dx.doi.org/10.1371/journal.pone.0136704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313926	Green Submitted, gold, Green Published			2022-12-27	WOS:000360144000088
J	Muller, OA; Grau, J; Thieme, S; Prochaska, H; Adlung, N; Sorgatz, A; Bonas, U				Mueller, Oliver A.; Grau, Jan; Thieme, Sabine; Prochaska, Heike; Adlung, Norman; Sorgatz, Anika; Bonas, Ulla			Genome-Wide Identification and Validation of Reference Genes in Infected Tomato Leaves for Quantitative RT-PCR Analyses	PLOS ONE			English	Article							DEFINING REFERENCE GENES; SYRINGAE PV. TOMATO; REAL-TIME PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; TRIGGERED IMMUNITY; INTERNAL CONTROL; QPCR DATA; NORMALIZATION; PEPPER	The Gram-negative bacterium Xanthomonas campestris pv. vesicatoria (Xcv) causes bacterial spot disease of pepper and tomato by direct translocation of type III effector proteins into the plant cell cytosol. Once in the plant cell the effectors interfere with host cell processes and manipulate the plant transcriptome. Quantitative RT-PCR (qRT-PCR) is usually the method of choice to analyze transcriptional changes of selected plant genes. Reliable results depend, however, on measuring stably expressed reference genes that serve as internal normalization controls. We identified the most stably expressed tomato genes based on microarray analyses of Xcv-infected tomato leaves and evaluated the reliability of 11 genes for qRT-PCR studies in comparison to four traditionally employed reference genes. Three different statistical algorithms, geNorm, NormFinder and BestKeeper, concordantly determined the superiority of the newly identified reference genes. The most suitable reference genes encode proteins with homology to PHD finger family proteins and the U6 snRNA-associated protein LSm7. In addition, we identified pepper orthologs and validated several genes as reliable normalization controls for qRT-PCR analysis of Xcv-infected pepper plants. The newly identified reference genes will be beneficial for future qRT-PCR studies of the Xcv-tomato and Xcv-pepper pathosystems, as well as for the identification of suitable normalization controls for qRT-PCR studies of other plant-pathogen interactions, especially, if related plant species are used in combination with bacterial pathogens.	[Mueller, Oliver A.; Thieme, Sabine; Prochaska, Heike; Adlung, Norman; Sorgatz, Anika; Bonas, Ulla] Univ Halle Wittenberg, Inst Biol, Dept Genet, D-06108 Halle, Saale, Germany; [Grau, Jan] Univ Halle Wittenberg, Inst Informat, Dept Bioinformat, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Bonas, U (corresponding author), Univ Halle Wittenberg, Inst Biol, Dept Genet, D-06108 Halle, Saale, Germany.	ulla.bonas@genetik.uni-halle.de	Adlung, Norman/P-8812-2018; Grau, Jan/H-5465-2019	Adlung, Norman/0000-0002-4871-7970; Grau, Jan/0000-0003-2081-6405	Deutsche Forschungsgemeinschaft [SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 648) to UB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandra L, 2010, J PLANT PHYSIOL, V167, P1398, DOI 10.1016/j.jplph.2010.05.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ballvora A, 2001, MOL PLANT MICROBE IN, V14, P629, DOI 10.1094/MPMI.2001.14.5.629; Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; BONAS U, 1993, MOL GEN GENET, V238, P261, DOI 10.1007/BF00279555; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; de Oliveira LA, 2012, PLANT CELL PHYSIOL, V53, P405, DOI 10.1093/pcp/pcr187; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041790; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Gao Song, 2012, African Journal of Biotechnology, V11, P12983, DOI 10.5897/AJB12.931; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Grewal RK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-49; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Lin F, 2014, PLANT MOL BIOL, V86, P543, DOI 10.1007/s11103-014-0246-1; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro TT, 2011, GENET MOL RES, V10, P3291, DOI 10.4238/2011.November.17.4; Pombo MA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0492-1; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; R Core Team, 2021, R LANGUAGE ENV STAT; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Saha G. C., 2012, American Journal of Plant Sciences, V3, P235, DOI 10.4236/ajps.2012.32028; Saha GC, 2013, PLANT MOL BIOL REP, V31, P1109, DOI 10.1007/s11105-013-0579-y; Schreiber T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120214; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Soria-Guerra RE, 2010, THEOR APPL GENET, V120, P1315, DOI 10.1007/s00122-009-1258-0; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Stall R. E., 1995, PATHOGENESIS HOST SP, P167; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Taylor KW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002768; Teper D, 2014, PLANT J, V77, P297, DOI 10.1111/tpj.12391; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Wieczorek P, 2013, J VIROL METHODS, V194, P161, DOI 10.1016/j.jviromet.2013.08.010; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	76	34	34	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136499	10.1371/journal.pone.0136499	http://dx.doi.org/10.1371/journal.pone.0136499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313760	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000063
J	Dai, LS; Qian, C; Zhang, CF; Wang, L; Wei, GQ; Li, J; Zhu, BJ; Liu, CL				Dai, Lishang; Qian, Cen; Zhang, Congfen; Wang, Lei; Wei, Guoqing; Li, Jun; Zhu, Baojian; Liu, Chaoliang			Characterization of the Complete Mitochondrial Genome of Cerura menciana and Comparison with Other Lepidopteran Insects	PLOS ONE			English	Article							COMPLETE MITOGENOME; SILKWORM MOTH; EVOLUTION; SEQUENCE; MANDARINA; PROGRAM	The complete mitochondrial genome (mitogenome) of Cerura menciana (Lepidoptera: Notodontidae) was sequenced and analyzed in this study. The mitogenome is a circular molecule of 15,369 bp, containing 13 protein-coding genes (PCGs), two ribosomal RNA (rRNA) genes, 22 transfer RNA (tRNA) genes and a A+T-rich region. The positive AT skew (0.031) indicated that more As than Ts were present. All PCGs were initiated by ATN codons, except for the cytochrome c oxidase subunit 1 (cox1) gene, which was initiated by CAG. Two of the 13 PCGs contained the incomplete termination codon T or TA, while the others were terminated with the stop codon TAA. The A+T-rich region was 372 bp in length and consisted of an 'ATAGA' motif followed by an 18 bp poly-T stretch, a microsatellite-like (AT) 8 and a poly-A element upstream of the trnM gene. Results examining codon usage indicated that Asn, Ile, Leu2, Lys, Tyr and Phe were the six most frequently occurring amino acids, while Cys was the rarest. Phylogenetic relationships, analyzed based on the nucleotide sequences of the 13 PCGs from other insect mitogenomes, confirmed that C. menciana belongs to the Notodontidae family.	[Dai, Lishang; Qian, Cen; Zhang, Congfen; Wang, Lei; Wei, Guoqing; Li, Jun; Zhu, Baojian; Liu, Chaoliang] Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Zhu, BJ (corresponding author), Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China.	zhubaojian@ahau.edu.cn; clliu@ahau.edu.cn	Zhu, Baojian/ABG-4522-2021		Modern Argo-industry Technology Research System [CARS-22 SYZ10]; Anhui High Schools Natural Science Foundation [KJ2013B320]; National 863 Plans Projects of China [2011AA100306]; Sericulture Biotechnology Innovation Team [2013xkdt-05]; Ph.D. Programs in Biochemistry and Molecular Biology [xk2013042]; Natural Science Foundation of the Anhui Higher Education Institutions of China [KJ2014A071]	Modern Argo-industry Technology Research System; Anhui High Schools Natural Science Foundation; National 863 Plans Projects of China(National High Technology Research and Development Program of China); Sericulture Biotechnology Innovation Team; Ph.D. Programs in Biochemistry and Molecular Biology; Natural Science Foundation of the Anhui Higher Education Institutions of China	Modern Argo-industry Technology Research System (CARS-22 SYZ10), Anhui High Schools Natural Science Foundation (KJ2013B320), National 863 Plans Projects of China (2011AA100306), Sericulture Biotechnology Innovation Team (2013xkdt-05), Ph.D. Programs in Biochemistry and Molecular Biology (xk2013042) and Natural Science Foundation of the Anhui Higher Education Institutions of China (KJ2014A071).	Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Chai HN, 2012, INT J MOL SCI, V13, P10236, DOI 10.3390/ijms130810236; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; Chen Mei, 2012, Zoological Research, V33, P191, DOI 10.3724/SP.J.1141.2012.02191; Dai LS, 2016, MITOCHONDRIAL DNA A, V27, P1512, DOI 10.3109/19401736.2014.953116; Dai LS, 2013, GENE, V519, P326, DOI 10.1016/j.gene.2013.02.002; De Re FC, 2014, GENETICA, V142, P525, DOI 10.1007/s10709-014-9799-9; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; He JiangCheng, 2006, Xinjiang Agricultural Sciences, V43, P224; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Kim MJ, 2010, AFR J BIOTECHNOL, V9, P735; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu QN, 2016, MITOCHONDRIAL DNA A, V27, P122, DOI 10.3109/19401736.2013.873934; Liu QN, 2013, GENOMICS, V101, P64, DOI 10.1016/j.ygeno.2012.10.002; Liu QN, 2012, GENE, V505, P291, DOI 10.1016/j.gene.2012.06.003; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072410; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Park JS, 2012, J ASIA-PAC ENTOMOL, V15, P331, DOI 10.1016/j.aspen.2012.01.002; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; Shi BC, 2013, MITOCHONDR DNA, V24, P37, DOI 10.3109/19401736.2012.716054; Speidel W., 2004, Systematics and Biodiversity, V2, P191, DOI 10.1017/S1477200004001409; Sun QQ, 2012, GENET MOL RES, V11, P4213, DOI 10.4238/2012.September.10.2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timmermans MJTN, 2014, MOL PHYLOGENET EVOL, V79, P169, DOI 10.1016/j.ympev.2014.05.031; Wang J, 2014, MITOCHONDR DNA, V15, P1, DOI DOI 10.1111/1755-0998.12278; Wu QL, 2015, MITOCHONDR DNA, V26, P139, DOI 10.3109/19401736.2013.815175; Xing LX, 2014, MITOCHONDR DNA, V25, P122, DOI 10.3109/19401736.2013.800506; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Ye F, 2015, MITOCHONDR DNA, V26, P853, DOI 10.3109/19401736.2013.861427; Yin J, 2011, MITOCHONDR DNA, V22, P41, DOI 10.3109/19401736.2011.605126; Yin JA, 2010, MITOCHONDR DNA, V21, P160, DOI 10.3109/19401736.2010.503242; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zheng P, 2009, JOURNAL OF INNER MON, V35, P45; Zhu BJ, 2013, GENE, V527, P283, DOI 10.1016/j.gene.2013.06.035	44	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0132951	10.1371/journal.pone.0132951	http://dx.doi.org/10.1371/journal.pone.0132951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309239	gold, Green Submitted, Green Published			2022-12-27	WOS:000360069400006
J	Ahn, SH; Kim, DH; Lee, AR; Kim, BK; Park, YK; Park, ES; Ahn, SH; Shin, GC; Park, S; Kang, HS; Rhee, JK; Yang, SI; Chong, Y; Kim, KH				Ahn, Sung Hyun; Kim, Doo Hyun; Lee, Ah Ram; Kim, Beom Kyung; Park, Yong Kwang; Park, Eun-Sook; Ahn, Sang Hoon; Shin, Gu-Choul; Park, Soree; Kang, Hong Seok; Rhee, Jin-Kyu; Yang, Sung-Il; Chong, Youhoon; Kim, Kyun-Hwan			Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance	PLOS ONE			English	Article							DRUG-RESISTANCE; REVERSE-TRANSCRIPTASE; LAMIVUDINE THERAPY; REPLICATION; ENTECAVIR; INHIBITION; MECHANISMS; ADEFOVIR; PROTEIN; 3TC	The emergence of compensatory mutations in the polymerase gene of drug resistant hepatitis B virus (HBV) is associated with treatment failure. We previously identified a multi-drug resistant HBV mutant, which displayed resistance towards lamivudine (LMV), clevudine (CLV), and entecavir (ETV), along with a strong replication capacity. The aim of this study was to identify the previously unknown compensatory mutations, and to determine the clinical relevance of this mutation during antiviral therapy. In vitro mutagenesis, drug susceptibility assay, and molecular modeling studies were performed. The rtL269I substitution conferred 2-to 7-fold higher replication capacity in the wild-type (WT) or YMDD mutation backbone, regardless of drug treatment. The rtL269I substitution alone did not confer resistance to LMV, ETV, adefovir (ADV), or tenofovir (TDF). However, upon combination with YMDD mutation, the replication capacity under LMV or ETV treatment was enhanced by several folds. Molecular modeling studies suggested that the rtL269I substitution affects template binding, which may eventually lead to the enhanced activity of rtI269-HBV polymerase in both WT virus and YMDD mutant. The clinical relevance of the rtL269I substitution was validated by its emergence in association with YMDD mutation in chronic hepatitis B (CHB) patients with sub-optimal response or treatment failure to LMV or CLV. Our study suggests that substitution at rt269 in HBV polymerase is associated with multi-drug resistance, which may serve as a novel compensatory mutation for replication-defective multidrug resistant HBV.	[Ahn, Sung Hyun; Kim, Doo Hyun; Lee, Ah Ram; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu-Choul; Park, Soree; Kang, Hong Seok; Yang, Sung-Il; Kim, Kyun-Hwan] Konkuk Univ, Dept Pharmacol, Ctr Canc Res & Diagnost Med, IBST,Sch Med, Seoul, South Korea; [Kim, Beom Kyung; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Eun-Sook; Shin, Gu-Choul; Kim, Kyun-Hwan] Konkuk Univ, KU Open Innovat Ctr, Seoul, South Korea; [Chong, Youhoon] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul, South Korea; [Rhee, Jin-Kyu] Ewha Womans Univ, Dept Food Sci, Seoul, South Korea; [Rhee, Jin-Kyu] Ewha Womans Univ, Dept Engn, Seoul, South Korea; [Kim, Kyun-Hwan] Konkuk Univ, Res Inst Med Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Konkuk University; Konkuk University; Ewha Womans University; Ewha Womans University; Konkuk University	Kim, KH (corresponding author), Konkuk Univ, Dept Pharmacol, Ctr Canc Res & Diagnost Med, IBST,Sch Med, Seoul, South Korea.	khkim10@kku.ac.kr		Lee, Ah Ram/0000-0001-6075-3352; Rhee, Jin-Kyu/0000-0002-2507-6664; Kim, Beom Kyung/0000-0002-5363-2496; Park, Eun-Sook/0000-0002-6652-9404; Park, Soree/0000-0003-0500-2227; Kim, Kyun-Hwan/0000-0001-5266-072X; Shin, Gu-Choul/0000-0001-8200-9700; Ahn, Sang Hoon/0000-0002-3629-4624	Konkuk University	Konkuk University	This study was supported by Konkuk University.	Ahn SH, 2014, J VIROL, V88, P6805, DOI 10.1128/JVI.00635-14; Block TM, 1998, NAT MED, V4, P610, DOI 10.1038/nm0598-610; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ji D, 2012, J CLIN VIROL, V54, P66, DOI 10.1016/j.jcv.2012.02.003; KASL Clinical Practice Guidelines, 2012, CLIN MOL HEPATOL, V18, P109, DOI DOI 10.3350/CMH.2012.18.2.109; Kim JH, 2014, WORLD J GASTROENTERO, V20, P5708, DOI 10.3748/wjg.v20.i19.5708; Kim KH, 2010, MOLECULES, V15, P5878, DOI 10.3390/molecules15095878; Kim KH, 2010, EXPERT OPIN DRUG DIS, V5, P205, DOI 10.1517/17460441003592072; Kwon SY, 2010, J VIROL, V84, P4494, DOI 10.1128/JVI.02066-09; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Li J, 2013, ACTA PHARMACOL SIN, V34, P319, DOI 10.1038/aps.2012.146; Lin CL, 2012, J ANTIMICROB CHEMOTH, V67, P39, DOI 10.1093/jac/dkr416; Locarnini S, 2006, J HEPATOL, V44, P422, DOI 10.1016/j.jhep.2005.11.036; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Melegari M, 1998, HEPATOLOGY, V27, P628, DOI 10.1002/hep.510270243; Shin GC, 2013, BBA-MOL BASIS DIS, V1832, P1569, DOI 10.1016/j.bbadis.2013.04.026; Walsh AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009195; Wu HL, 2005, GASTROENTEROLOGY, V128, P708, DOI 10.1053/j.gastro.2004.12.007; Yano Y, 2015, WORLD J HEPATOL, V7, P583, DOI 10.4254/wjh.v7.i3.583; Yim HJ, 2013, CLIN MOL HEPATOL, V19, P195, DOI 10.3350/cmh.2013.19.3.195; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	27	13	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136728	10.1371/journal.pone.0136728	http://dx.doi.org/10.1371/journal.pone.0136728			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322642	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500030
J	de Chaisemartin, L; Meatchi, T; Malamut, G; Fernani-Oukil, F; Hosking, F; Rault, D; Bellery, F; Cellier, C; Dragon-Durey, MA				de Chaisemartin, Luc; Meatchi, Tchao; Malamut, Georgia; Fernani-Oukil, Fahima; Hosking, Frederique; Rault, Dorothee; Bellery, Fabienne; Cellier, Christophe; Dragon-Durey, Marie-Agnes			Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease	PLOS ONE			English	Article							GLUTEN-FREE DIET; TRANSGLUTAMINASE ANTIBODIES; TISSUE TRANSGLUTAMINASE; PEPTIDES; CHILDHOOD; DIAGNOSIS; RECOVERY; MULTICENTER; PREDICTORS; ADULTS	Introduction The role of serological tests such as IgA anti-transglutaminase autoantibodies has become increasingly important in celiac disease (CD) diagnosis. However, the efficiency of these tests for patient follow-up is controversial. We investigated the correlation of 12 different serological tests, including recent deamidated gliadin and actin IgA tests, with villous atrophy (VA) in a retrospective cohort of treated celiac patients. Materials and Methods Serum samples were collected from 100 treated CD patients who had intestinal biopsy in the course of their follow-up. Antibodies against transglutaminase, deamidated gliadin peptides, and native gliadin were measured, along with IgA anti-actin. The biopsy slides were all blind-reviewed and scored according to Marsh classification. Results For all deamidated gliadin and transglutaminase tests, we found that a positive result was significantly associated with persistence of intestinal VA, with a diagnostic efficacy up to 80%. Furthermore, antibodies titers directly correlated with the degree of VA, indicating a strong link between disease activity and presence of antibodies in the serum. Interestingly, the tests with the highest association with persistent VA were those for deamidated gliadin IgG. Using a test positivity pattern analysis, we were also able to identify several groups of patients with distinct antibody profiles that showed significant differences in intestinal damage and diet compliance. Conclusions Altogether, these results show that deamidated gliadin antibodies are strongly correlated with VA and should be considered valuable tools in CD follow-up and that multiplex serologic analysis for treated CD represents a promising tool for personalized patient management.	[de Chaisemartin, Luc; Fernani-Oukil, Fahima; Hosking, Frederique; Bellery, Fabienne; Dragon-Durey, Marie-Agnes] Georges Pompidou European Hosp, Dept Immunol, Assistance Publ Hop Paris, Paris, France; [de Chaisemartin, Luc] Univ Paris Sud, INSERM, UMR 996, Chatenay Malabry, France; [Meatchi, Tchao] Georges Pompidou European Hosp, Dept Pathol, Assistance Publ Hop Paris, Paris, France; [Malamut, Georgia; Rault, Dorothee; Cellier, Christophe] Georges Pompidou European Hosp, Dept Gastroenterol, Assistance Publ Hop Paris, Paris, France; [Malamut, Georgia; Cellier, Christophe; Dragon-Durey, Marie-Agnes] Paris Descartes Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Dragon-Durey, MA (corresponding author), Georges Pompidou European Hosp, Dept Immunol, Assistance Publ Hop Paris, Paris, France.	marie-agnes.durey@egp.aphp.fr	, Dragon-Durey/AGM-3653-2022	Malamut, Georgia/0000-0003-4030-3025; christophe, Cellier/0000-0003-0784-2318; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122				Agardh D, 2007, CLIN GASTROENTEROL H, V5, P1276, DOI 10.1016/j.cgh.2007.05.024; Ankelo M, 2007, CLIN EXP IMMUNOL, V150, P285, DOI 10.1111/j.1365-2249.2007.03487.x; Bazzigaluppi E, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-25; Carroccio A, 2007, DIGEST LIVER DIS, V39, P818, DOI 10.1016/j.dld.2007.06.004; Clemente MG, 2000, GUT, V47, P520, DOI 10.1136/gut.47.4.520; Clemente MG, 2004, AM J GASTROENTEROL, V99, P1551, DOI 10.1111/j.1572-0241.2004.30296.x; Dickey W, 2000, AM J GASTROENTEROL, V95, P712, DOI 10.1111/j.1572-0241.2000.01838.x; Dickson BC, 2006, J CLIN PATHOL, V59, P1008, DOI 10.1136/jcp.2005.035345; Falini ML, 2008, DIGEST DIS SCI, V53, P2697, DOI 10.1007/s10620-007-0191-9; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Gatselis NK, 2012, CLIN CHIM ACTA, V413, P1683, DOI 10.1016/j.cca.2012.05.015; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2005, BEST PRACT RES CL GA, V19, P389, DOI 10.1016/j.bpg.2005.02.006; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Korponay-Szabo IR, 2008, J PEDIATR GASTR NUTR, V46, P253, DOI 10.1097/MPG.0b013e31815ee555; Leffler DA, 2007, ALIMENT PHARM THER, V26, P1227, DOI 10.1111/j.1365-2036.2007.03501.x; Liu E, 2007, J PEDIATR GASTR NUTR, V45, P293, DOI 10.1097/MPG.0b013e31806c7b34; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Monzani A, 2011, J PEDIATR GASTR NUTR, V53, P55, DOI 10.1097/MPG.0b013e3182145511; Niveloni S, 2007, CLIN CHEM, V53, P2186, DOI 10.1373/clinchem.2006.081364; Prause C, 2009, J PEDIATR GASTR NUTR, V49, P52, DOI 10.1097/MPG.0b013e318195dae3; Rashtak S, 2008, CLIN GASTROENTEROL H, V6, P426, DOI 10.1016/j.cgh.2007.12.030; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Sugai E, 2006, CLIN GASTROENTEROL H, V4, P1112, DOI 10.1016/j.cgh.2006.05.004; Tursi A, 2003, J CLIN GASTROENTEROL, V37, P387, DOI 10.1097/00004836-200311000-00007; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; Vermeersch P, 2012, CLIN CHIM ACTA, V413, P1761, DOI 10.1016/j.cca.2012.06.024; Vermeersch P, 2010, CLIN CHIM ACTA, V411, P931, DOI 10.1016/j.cca.2010.02.060; Volta U, 2008, DIGEST DIS SCI, V53, P1582, DOI 10.1007/s10620-007-0058-0; Zanini B, 2013, CLIN GASTROENTEROL H, V11, P253, DOI 10.1016/j.cgh.2012.09.027; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136745	10.1371/journal.pone.0136745	http://dx.doi.org/10.1371/journal.pone.0136745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322980	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500033
J	Lensen, JFM; van der Vlag, J; Versteeg, EMM; Wetzels, JFM; van den Heuvel, LPWJ; Berden, JHM; van Kuppevelt, TH; Rops, ALWMM				Lensen, Joost F. M.; van der Vlag, Johan; Versteeg, Elly M. M.; Wetzels, Jack F. M.; van den Heuvel, Lambert P. W. J.; Berden, Jo H. M.; van Kuppevelt, Toin H.; Rops, Angelique L. W. M. M.			Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLLAGEN TYPE-I; CHONDROITIN SULFATE; HEPARAN-SULFATE; SMALL PROTEOGLYCANS; TGF-BETA; DECORIN; BIGLYCAN; KIDNEY; GLYCOSAMINOGLYCANS	Dermatan sulfate (DS), also known as chondroitin sulfate (CS)-B, is a member of the linear polysaccharides called glycosaminoglycans (GAGs). The expression of CS/DS and DS proteoglycans is increased in several fibrotic renal diseases, including interstitial fibrosis, diabetic nephropathy, mesangial sclerosis and nephrosclerosis. Little, however, is known about structural alterations in DS in renal diseases. The aim of this study was to evaluate the renal expression of two different DS domains in renal transplant rejection and glomerular pathologies. DS expression was evaluated in normal renal tissue and in kidney biopsies obtained from patients with acute interstitial or vascular renal allograft rejection, patients with interstitial fibrosis and tubular atrophy (IF/TA), and from patients with focal segmental glomerulosclerosis (FSGS), membranous glomerulopathy (MGP) or systemic lupus erythematosus (SLE), using our unique specific anti-DS antibodies LKN1 and GD3A12. Expression of the 4/2,4-di-O-sulfated DS domain recognized by antibody LKN1 was decreased in the interstitium of transplant kidneys with IF/TA, which was accompanied by an increased expression of type I collagen, decorin and transforming growth factor beta (TGF-beta), while its expression was increased in the interstitium in FSGS, MGP and SLE. Importantly, all patients showed glomerular LKN1 staining in contrast to the controls. Expression of the IdoA-Gal-NAc4SDS domain recognized by GD3A12 was similar in controls and patients. Our data suggest a role for the DS domain recognized by antibody LKN1 in renal diseases with early fibrosis. Further research is required to delineate the exact role of different DS domains in renal fibrosis.	[Lensen, Joost F. M.; Versteeg, Elly M. M.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van der Vlag, Johan; Wetzels, Jack F. M.; Berden, Jo H. M.; Rops, Angelique L. W. M. M.] Radboud Univ Nijmegen, Med Ctr, Nephrol Res Lab, Radboud Inst Mol Life Sci,Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [van den Heuvel, Lambert P. W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Rops, ALWMM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nephrol Res Lab, Radboud Inst Mol Life Sci,Dept Nephrol, NL-6525 ED Nijmegen, Netherlands.	Angelique.Meulemans-Rops@radboudumc.nl	Berden, J.H.M./H-8009-2014; van Kuppevelt, A.H.M.S.M./L-4463-2015; Van der Vlag, Johan/E-4636-2010; van den Heuvel, L.P.W.J./H-8044-2014; Wetzels, Jack F.M./A-1720-2014; van den Heuvel, Lambertus/AAM-1772-2021	Van der Vlag, Johan/0000-0001-7843-5918; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Wetzels, Jack F.M./0000-0002-0650-6921; van den Heuvel, Lambertus/0000-0003-3917-6727; Versteeg, Elly/0000-0001-7047-5173; Lensen, Joost/0000-0003-2854-3149	Dutch Organization for Scientific Research [902-27-292]; Dutch Kidney Foundation [KJPB 09.010]	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation	This study was supported by the Dutch Organization for Scientific Research (grant 902-27-292) (JFML, ALWMMR) and the Dutch Kidney Foundation (grant KJPB 09.010) (ALWMMR).	Alhasan AA, 2014, J BIOL CHEM, V289, P20295, DOI 10.1074/jbc.M114.554691; Ali S, 2005, TRANSPLANTATION, V79, P672, DOI 10.1097/01.TP.0000155961.57664.DB; Baboolal K, 2002, KIDNEY INT, V61, P686, DOI 10.1046/j.1523-1755.2002.00149.x; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; DANIELSEN CC, 1982, CONNECT TISSUE RES, V9, P219, DOI 10.3109/03008208209160265; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Deng SP, 1996, TRANSPLANTATION, V61, P1300, DOI 10.1097/00007890-199605150-00003; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Hadad SJ, 1996, BBA-GEN SUBJECTS, V1290, P18, DOI 10.1016/0304-4165(95)00183-2; Jain S, 2000, TRANSPLANTATION, V69, P1759, DOI 10.1097/00007890-200005150-00001; KLEIN DJ, 1986, J BIOL CHEM, V261, P6636; Koshiishi I, 2002, ARCH BIOCHEM BIOPHYS, V401, P38, DOI 10.1016/S0003-9861(02)00032-2; Kuwaba K, 2002, J DERMATOL SCI, V29, P185, DOI 10.1016/S0923-1811(02)00023-3; Lensen JFM, 2006, MATRIX BIOL, V25, P457, DOI 10.1016/j.matbio.2006.06.003; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; Muda AO, 1998, NEPHROL DIAL TRANSPL, V13, P279, DOI 10.1093/oxfordjournals.ndt.a027819; Papaioannou EG, 2004, SURG TODAY, V34, P668, DOI 10.1007/s00595-004-2795-4; Pecly IMD, 2006, NEPHROL DIAL TRANSPL, V21, P1212, DOI 10.1093/ndt/gfk076; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reine TM, 2013, J HISTOCHEM CYTOCHEM, V61, P606, DOI 10.1369/0022155413494392; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L, 2011, J AM SOC NEPHROL, V22, P1200, DOI 10.1681/ASN.2010050570; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Sorrell JM, 1999, HISTOCHEM J, V31, P549; STEVENS RR, 1993, TRANSPLANT P, V25, P382; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; Stokes MB, 2001, KIDNEY INT, V59, P532, DOI 10.1046/j.1523-1755.2001.059002532.x; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; VANDELEST CHA, 1994, ANAL BIOCHEM, V221, P356, DOI 10.1006/abio.1994.1425; Yang CW, 1997, NEPHRON, V77, P290, DOI 10.1159/000190290	36	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134946	10.1371/journal.pone.0134946	http://dx.doi.org/10.1371/journal.pone.0134946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322947	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500004
J	Steiber, N				Steiber, Nadia			Population Aging at Cross-Roads: Diverging Secular Trends in Average Cognitive Functioning and Physical Health in the Older Population of Germany	PLOS ONE			English	Article							COHORT DIFFERENCES; MENTAL-HEALTH; GENERAL-POPULATION; LIFE-COURSE; YOUNG-OLD; DISABILITY; MORTALITY; AGE; SF-12; COMPRESSION	This paper uses individual-level data from the German Socio-Economic Panel to model trends in population health in terms of cognition, physical fitness, and mental health between 2006 and 2012. The focus is on the population aged 50-90. We use a repeated population-based cross-sectional design. As outcome measures, we use SF-12 measures of physical and mental health and the Symbol-Digit Test (SDT) that captures cognitive processing speed. In line with previous research we find a highly significant Flynn effect on cognition; i.e., SDT scores are higher among those who were tested more recently (at the same age). This result holds for men and women, all age groups, and across all levels of education. While we observe a secular improvement in terms of cognitive functioning, at the same time, average physical and mental health has declined. The decline in average physical health is shown to be stronger for men than for women and found to be strongest for low-educated, young-old men aged 50-64: the decline over the 6-year interval in average physical health is estimated to amount to about 0.37 SD, whereas average fluid cognition improved by about 0.29 SD. This pattern of results at the population-level (trends in average population health) stands in interesting contrast to the positive association of physical health and cognitive functioning at the individual-level. The findings underscore the multi-dimensionality of health and the aging process.	[Steiber, Nadia] Int Inst Appl Syst Anal IIASA, Wittgenstein Ctr IIASA, VID OAW, WU, Laxenburg, Austria; [Steiber, Nadia] Univ Vienna, Dept Econ Sociol, Vienna, Austria	International Institute for Applied Systems Analysis (IIASA); University of Vienna	Steiber, N (corresponding author), Int Inst Appl Syst Anal IIASA, Wittgenstein Ctr IIASA, VID OAW, WU, Laxenburg, Austria.	steiber@iiasa.ac.at		Steiber, Nadia/0000-0002-9425-8840	European Research Council [ERC2013-AdG 323947-Re-Ageing]	European Research Council(European Research Council (ERC)European Commission)	The work was supported by funding from the European Research Council, Grant No. ERC2013-AdG 323947-Re-Ageing.	Ambrasat J, 2011, SOEP PAPERS; Andel R, 2015, J GERONTOL B-PSYCHOL, V70, P314, DOI 10.1093/geronb/gbu110; Andersen HH., 2007, SCHMOLLERS JB, V127, P171; Baxendale S, 2010, J CLIN EXP NEUROPSYC, V32, P699, DOI 10.1080/13803390903493515; Bilotta C, 2012, AGING MENT HEALTH, V16, P273, DOI 10.1080/13607863.2011.609534; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bordone V, 2015, INTELLIGENCE, V52, P90, DOI 10.1016/j.intell.2015.07.005; Bosma H, 2003, EXP AGING RES, V29, P33, DOI 10.1080/03610730303710; Burdine JN, 2000, HEALTH SERV RES, V35, P885; Cambois E, 2013, EUR J PUBLIC HEALTH, V23, P575, DOI 10.1093/eurpub/cks136; Cambois E, 2008, EUR J AGEING, V5, P287, DOI 10.1007/s10433-008-0097-1; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; Cooper R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2219; Ribeiro PCC, 2013, OCCUP MED-OXFORD, V63, P556, DOI 10.1093/occmed/kqt115; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; de Rotrou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078646; Doblhammer G, 2014, ALZHEIMERS DEMENT J, V10, pP279, DOI [10.1016/j.jalz.2014.04.527, DOI 10.1016/J.JALZ.2014.04.527]; Eibich P, 2014, REG SCI URBAN ECON, V49, P305, DOI 10.1016/j.regsciurbeco.2014.06.005; Falk H, 2014, AGE AGEING, V43, P636, DOI 10.1093/ageing/afu018; Ferrer E, 2004, PSYCHOL AGING, V19, P243, DOI 10.1037/0882-7974.19.2.243; Finkel D, 2007, J GERONTOL B-PSYCHOL, V62, pP286, DOI 10.1093/geronb/62.5.P286; Fleishman JA, 2003, MED CARE, V41, P75, DOI 10.1097/01.MLR.0000076052.42628.CF; Fleishman JA, 2010, QUAL LIFE RES, V19, P231, DOI 10.1007/s11136-009-9582-z; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gerstorf D, 2011, DEV PSYCHOL, V47, P1026, DOI 10.1037/a0023426; Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005; Hays RD, 1995, RAND MONOGR REP; Heikkinen E, 2011, AGING CLIN EXP RES, V23, P126, DOI 10.3275/6932; Heineck G, 2010, LABOUR ECON, V17, P535, DOI 10.1016/j.labeco.2009.06.001; Hiscock M, 2007, J CLIN EXP NEUROPSYC, V29, P514, DOI 10.1080/13803390600813841; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; Jagger C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-156; Kluge F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108501; Kuh D, 2014, P NUTR SOC, V73, P237, DOI 10.1017/S0029665113003923; Lacson E, 2010, CLIN J AM SOC NEPHRO, V5, P252, DOI 10.2215/CJN.07231009; Lafortune G., 2007, TRENDS SEVERE DISABI, VVol. 26, DOI [10.1787/217072070078, DOI 10.1787/217072070078]; Lang F.R., 2007, SCHMOLLERS JB J APPL, V127, P183; Llewellyn DJ, 2009, AGING NEUROPSYCHOL C, V16, P433, DOI 10.1080/13825580902773867; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; Marioni RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050940; Marshall S, 2010, AM J PREV MED, V39, P389, DOI 10.1016/j.amepre.2010.07.001; Martin LG, 2014, DISABIL HEALTH J, V7, pS4, DOI 10.1016/j.dhjo.2013.06.007; Martin LG, 2012, J EPIDEMIOL COMMUN H, V66, P874, DOI 10.1136/jech-2011-200251; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mishra GD, 2014, QUAL LIFE RES, V23, P1515, DOI 10.1007/s11136-013-0586-3; Oesch D., 2013, OCCUPATIONAL CHANGE; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Peres K, 2013, ANNU REV GERONTOL GE, V33, P293, DOI 10.1891/0198-8794.33.293; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Robertson DA, 2013, AGEING RES REV, V12, P840, DOI 10.1016/j.arr.2013.06.004; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Ronnlund M, 2008, INTELLIGENCE, V36, P192, DOI 10.1016/j.intell.2007.05.002; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Ruesten A, 2011, PLOS ONE, V6, P27455, DOI DOI 10.1371/J0URNAL.P0NE.0027455; Sacuiu S, 2010, NEUROLOGY, V75, P779, DOI 10.1212/WNL.0b013e3181f0737c; Salthouse TA, 2015, INTELLIGENCE, V48, P51, DOI 10.1016/j.intell.2014.10.007; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Schupp J., 2008, ERFASSUNG KOGNITIVER; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Skirbekk V, 2013, INTELLIGENCE, V41, P169, DOI 10.1016/j.intell.2013.02.001; Smith A, 1982, SYMBOL DIGITS MODALI; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vilagut G, 2013, VALUE HEALTH, V16, P564, DOI 10.1016/j.jval.2013.01.006; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weber D, 2014, P NATL ACAD SCI USA, V111, P11673, DOI 10.1073/pnas.1319538111	72	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136583	10.1371/journal.pone.0136583	http://dx.doi.org/10.1371/journal.pone.0136583			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26323093	gold, Green Accepted, Green Published			2022-12-27	WOS:000360435500022
J	Alaerts, K; Geerlings, F; Herremans, L; Swinnen, SP; Verhoeven, J; Sunaert, S; Wenderoth, N				Alaerts, Kaat; Geerlings, Franca; Herremans, Lynn; Swinnen, Stephan P.; Verhoeven, Judith; Sunaert, Stefan; Wenderoth, Nicole			Functional Organization of the Action Observation Network in Autism: A Graph Theory Approach	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; BIOLOGICAL MOTION PERCEPTION; HUMAN BRAIN; CORTICAL ACTIVATION; SPECTRUM DISORDERS; CONNECTIVITY MRI; SHORT FORMS; IMITATION; DYSFUNCTION; CHILDREN	Background The ability to recognize, understand and interpret other's actions and emotions has been linked to the mirror system or action-observation-network (AON). Although variations in these abilities are prevalent in the neuro-typical population, persons diagnosed with autism spectrum disorders (ASD) have deficits in the social domain and exhibit alterations in this neural network. Method Here, we examined functional network properties of the AON using graph theory measures and region-to-region functional connectivity analyses of resting-state fMRI-data from adolescents and young adults with ASD and typical controls (TC). Results Overall, our graph theory analyses provided convergent evidence that the network integrity of the AON is altered in ASD, and that reductions in network efficiency relate to reductions in overall network density (i.e., decreased overall connection strength). Compared to TC, individuals with ASD showed significant reductions in network efficiency and increased shortest path lengths and centrality. Importantly, when adjusting for overall differences in network density between ASD and TC groups, participants with ASD continued to display reductions in network integrity, suggesting that also network-level organizational properties of the AON are altered in ASD. Conclusion While differences in empirical connectivity contributed to reductions in network integrity, graph theoretical analyses provided indications that also changes in the high-level network organization reduced integrity of the AON.	[Alaerts, Kaat; Geerlings, Franca; Herremans, Lynn; Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Dept Kinesiol, Leuven, Belgium; [Alaerts, Kaat] Katholieke Univ Leuven, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium; [Verhoeven, Judith; Sunaert, Stefan] Katholieke Univ Leuven, Translat MRI, Dept Imaging & Pathol, Leuven, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wenderoth, N (corresponding author), ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland.	nicole.wenderoth@hest.ethz.ch	Wenderoth, Nicole/D-7262-2015; Alaerts, Kaat/HGV-0661-2022; Sunaert, Stefan/E-8031-2011	Wenderoth, Nicole/0000-0002-3246-9386; Sunaert, Stefan/0000-0002-1177-4680; Alaerts, Kaat/0000-0001-8665-6374	Flanders Fund for Scientific Research (FWO) [1521313N, G.0401.12]; FWO [1206013N]; Branco Weiss fellowship of the Society in Science - ETH Zurich	Flanders Fund for Scientific Research (FWO)(FWO); FWO(FWO); Branco Weiss fellowship of the Society in Science - ETH Zurich(ETH Zurich)	This work was supported by grants from the Flanders Fund for Scientific Research (FWO projects 1521313N & G.0401.12) (http://www.fwo.be/). KA was supported by an FWO postdoctoral research fellowship (1206013N) and by a Branco Weiss fellowship of the Society in Science - ETH Zurich (http://www.society-in-science.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2014, SOC COGN AFFECT NEUR, V9, P1589, DOI 10.1093/scan/nst156; Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Enticott PG, 2012, BIOL PSYCHIAT, V71, P427, DOI 10.1016/j.biopsych.2011.09.001; Fan YT, 2010, J CHILD PSYCHOL PSYC, V51, P981, DOI 10.1111/j.1469-7610.2010.02269.x; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fishman I, 2014, JAMA PSYCHIAT, V71, P751, DOI 10.1001/jamapsychiatry.2014.83; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Girard TA, 2010, ASSESSMENT, V17, P400, DOI 10.1177/1073191110369763; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Hamilton AFD, 2013, DEV COGN NEUROS-NETH, V3, P91, DOI 10.1016/j.dcn.2012.09.008; Heitger MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062133; Herrington JD, 2011, BRAIN COGNITION, V77, P372, DOI 10.1016/j.bandc.2011.09.001; Herrington JD, 2007, RES AUTISM SPECT DIS, V1, P14, DOI 10.1016/j.rasd.2006.07.002; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kaiser MD, 2012, DEV COGN NEUROS-NETH, V2, P25, DOI 10.1016/j.dcn.2011.05.005; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kana RK, 2014, SOC COGN AFFECT NEUR, V9, P98, DOI 10.1093/scan/nss106; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Martineau J, 2008, INT J PSYCHOPHYSIOL, V68, P35, DOI 10.1016/j.ijpsycho.2008.01.002; McKay LS, 2012, NEUROIMAGE, V59, P1524, DOI 10.1016/j.neuroimage.2011.08.033; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Nackaerts E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044473; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pelphrey KA, 2006, CURR DIR PSYCHOL SCI, V15, P136, DOI 10.1111/j.0963-7214.2006.00423.x; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raymaekers R, 2009, BRAIN RES, V1304, P113, DOI 10.1016/j.brainres.2009.09.068; Redcay E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00573; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Rudie JD, 2012, CEREB CORTEX, V22, P1025, DOI 10.1093/cercor/bhr171; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schipul SE, 2012, CEREB CORTEX, V22, P937, DOI 10.1093/cercor/bhr162; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Skuse D, 2004, J AM ACAD CHILD PSY, V43, P548, DOI 10.1097/00004583-200405000-00008; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004	72	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137020	10.1371/journal.pone.0137020	http://dx.doi.org/10.1371/journal.pone.0137020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317222	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100194
J	Hamour, S; Gan, PY; Pepper, R; Barros, FF; Wang, HH; O'Sullivan, K; Iwakura, Y; Cook, T; Pusey, C; Holdsworth, S; Salama, A				Hamour, Sally; Gan, Poh-Yi; Pepper, Ruth; Barros, Fernanda Florez; Wang, Hsu-Han; O'Sullivan, Kim; Iwakura, Yoichiro; Cook, Terence; Pusey, Charles; Holdsworth, Stephen; Salama, Alan			Local IL-17 Production Exerts a Protective Role in Murine Experimental Glomerulonephritis	PLOS ONE			English	Article							MAST-CELLS; CRESCENTIC GLOMERULONEPHRITIS; T-CELLS; RENAL INJURY; INTERLEUKIN-17; DISTINCT; INFLAMMATION; ACTIVATION; EXPRESSION; CONTRIBUTE	IL-17 is a pro-inflammatory cytokine implicated in the pathogenesis of glomerulonephritis and IL-17 deficient mice are protected from nephrotoxic nephritis. However, a regulatory role for IL-17 has recently emerged. We describe a novel protective function for IL-17 in the kidney. Bone marrow chimeras were created using wild-type and IL-17 deficient mice and nephrotoxic nephritis was induced. IL-17 deficient hosts transplanted with wild-type bone marrow had worse disease by all indices compared to wild-type to wild-type bone marrow transplants (serum urea p<0.05; glomerular thrombosis p<0.05; tubular damage p<0.01), suggesting that in wild-type mice, IL-17 production by renal cells resistant to radiation is protective. IL-17 deficient mice transplanted with wild-type bone marrow also had a comparatively altered renal phenotype, with significant differences in renal cytokines (IL-10 p<0.01; IL-1 beta p<0.001; IL-23 p<0.01), and macrophage phenotype (expression of mannose receptor p<0.05; inducible nitric oxide synthase p<0.001). Finally we show that renal mast cells are resistant to radiation and produce IL-17, suggesting they are potential local mediators of disease protection. This is a novel role for intrinsic cells in the kidney that are radio-resistant and produce IL-17 to mediate protection in nephrotoxic nephritis. This has clinical significance as IL-17 blockade is being trialled as a therapeutic strategy in some autoimmune diseases.	[Hamour, Sally; Pepper, Ruth; Barros, Fernanda Florez; Wang, Hsu-Han; Salama, Alan] Royal Free Hosp, UCL Ctr Nephrol, London NW3 2QG, England; [Gan, Poh-Yi; O'Sullivan, Kim; Holdsworth, Stephen] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan; [Cook, Terence] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Inflammat & Complement Res, London, England; [Pusey, Charles] Univ London Imperial Coll Sci Technol & Med, Dept Med, Renal Sect, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Monash University; Tokyo University of Science; Imperial College London; Imperial College London	Salama, A (corresponding author), Royal Free Hosp, UCL Ctr Nephrol, Pond St, London NW3 2QG, England.	a.salama@ucl.ac.uk	Wang, Hsu-Han/Q-7331-2019; Iwakura, Yoichiro/E-5457-2011	Wang, Hsu-Han/0000-0001-6590-7736; Iwakura, Yoichiro/0000-0002-9934-5775; Gan, Poh Yi/0000-0001-8373-7144; O'Sullivan, Kim Maree/0000-0002-3098-7948	Wellcome Trust [083688/z/07/z]; National Health and Medical Research Council of Australia [1011724]; MRC clinical training fellowship [G0802260]; MRC [G0802260] Funding Source: UKRI; Medical Research Council [G0802260] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC clinical training fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SH was supported by a clinical research training fellowship (grant number 083688/z/07/z) from the Wellcome Trust www.wellcome.ac.uk. PG and KS were supported by a grant (1011724) from the National Health and Medical Research Council of Australia www.nhmrc.gov.au. RP was supported by a MRC clinical training fellowship G0802260 www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; FARNSWORTH A, 1988, TRANSPLANTATION, V46, P418, DOI 10.1097/00007890-198809000-00017; Gan PY, 2012, J AM SOC NEPHROL, V23, P1955, DOI 10.1681/ASN.2012060572; Gan PY, 2010, J AM SOC NEPHROL, V21, P925, DOI 10.1681/ASN.2009070763; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hamour S, 2009, CRITICAL ROLE IL 17; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochegger K, 2005, EUR J IMMUNOL, V35, P3074, DOI 10.1002/eji.200526250; HOLDSWORTH SR, 1981, J CLIN INVEST, V68, P686, DOI 10.1172/JCI110304; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ishizuka T, 1999, CLIN EXP ALLERGY, V29, P1424; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kitching AR, 2000, KIDNEY INT, V57, P518, DOI 10.1046/j.1523-1755.2000.t01-1-00872.x; KOJIMA S, 1974, J IMMUNOL, V113, P673; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Odobasic D, 2011, AM J PATHOL, V179, P1188, DOI 10.1016/j.ajpath.2011.05.039; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ooi JD, 2009, J AM SOC NEPHROL, V20, P980, DOI 10.1681/ASN.2008080891; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Phoon RKS, 2008, J AM SOC NEPHROL, V19, P477, DOI 10.1681/ASN.2007030392; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Tam FWK, 1997, KIDNEY INT, V52, P1224, DOI 10.1038/ki.1997.447; Tao J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3545; Timoshanko JR, 2006, J AM SOC NEPHROL, V17, P150, DOI 10.1681/ASN.2005080799; Tipping PG, 1998, AM J PATHOL, V152, P1541; Tulone C, 2011, AM J PATHOL, V179, P2683, DOI 10.1016/j.ajpath.2011.08.017; Velden J, 2012, AM J PHYSIOL-RENAL, V302, pF1663, DOI 10.1152/ajprenal.00683.2011; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yang M, 2012, AM J PATHOL, V180, P2375, DOI 10.1016/j.ajpath.2012.03.010; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136238	10.1371/journal.pone.0136238	http://dx.doi.org/10.1371/journal.pone.0136238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317864	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100064
J	Kotta, J; Oganjan, K; Lauringson, V; Parnoja, M; Kaasik, A; Rohtla, L; Kotta, I; Orav-Kotta, H				Kotta, Jonne; Oganjan, Katarina; Lauringson, Velda; Paernoja, Merli; Kaasik, Ants; Rohtla, Liisa; Kotta, Ilmar; Orav-Kotta, Helen			Establishing Functional Relationships between Abiotic Environment, Macrophyte Coverage, Resource Gradients and the Distribution of Mytilus trossulus in a Brackish Non-Tidal Environment	PLOS ONE			English	Article							BENTHIC SUSPENSION FEEDER; WAVE EXPOSURE; BLUE MUSSELS; SPECIES DISTRIBUTION; SPATIAL-PATTERNS; NORTH-SEA; EDULIS-L; COMMUNITY REGULATION; CLIMATE-CHANGE; HYBRID ZONE	Benthic suspension feeding mussels are an important functional guild in coastal and estuarine ecosystems. To date we lack information on how various environmental gradients and biotic interactions separately and interactively shape the distribution patterns of mussels in non-tidal environments. Opposing to tidal environments, mussels inhabit solely subtidal zone in non-tidal waterbodies and, thereby, driving factors for mussel populations are expected to differ from the tidal areas. In the present study, we used the boosted regression tree modelling (BRT), an ensemble method for statistical techniques and machine learning, in order to explain the distribution and biomass of the suspension feeding mussel Mytilus trossulus in the non-tidal Baltic Sea. BRT models suggested that (1) distribution patterns of M. trossulus are largely driven by separate effects of direct environmental gradients and partly by interactive effects of resource gradients with direct environmental gradients. (2) Within its suitable habitat range, however, resource gradients had an important role in shaping the biomass distribution of M. trossulus. (3) Contrary to tidal areas, mussels were not competitively superior over macrophytes with patterns indicating either facilitative interactions between mussels and macrophytes or co-variance due to common stressor. To conclude, direct environmental gradients seem to define the distribution pattern of M. trossulus, and within the favourable distribution range, resource gradients in interaction with direct environmental gradients are expected to set the biomass level of mussels.	[Kotta, Jonne; Oganjan, Katarina; Lauringson, Velda; Paernoja, Merli; Rohtla, Liisa; Kotta, Ilmar; Orav-Kotta, Helen] Univ Tartu, Estonian Marine Inst, Dept Marine Biol, EE-12618 Tallinn, Estonia; [Kaasik, Ants] Univ Tartu, Inst Ecol & Earth Sci, Chair Zool, EE-51014 Tartu, Estonia; [Rohtla, Liisa] Nova SE Univ, Halmos Coll Nat Sci & Oceanog, Dania, FL USA	University of Tartu; Estonian Marine Institute; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Nova Southeastern University	Kotta, J (corresponding author), Univ Tartu, Estonian Marine Inst, Dept Marine Biol, Maealuse 14, EE-12618 Tallinn, Estonia.	jonne.kotta@sea.ee	Rohtla, Liisa/G-6403-2017; Melzner, Frank/X-4339-2018; Kotta, Jonne/B-5542-2009; Orav-Kotta, Helen/E-2810-2013; Kaasik, Ants/H-2462-2012	Rohtla, Liisa/0000-0001-7301-0232; Melzner, Frank/0000-0002-5884-1318; Kotta, Jonne/0000-0002-4970-6755; Orav-Kotta, Helen/0000-0002-3029-5642; Kaasik, Ants/0000-0002-4904-0877; Ratsep, Merli/0000-0002-2841-7452	Estonian Research Council [IUT02-20]; Estonian Science Foundation [8807]; project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" of Environmental protection and technology program of the European Regional Fund [3.2.0801.11-0029]; BONUS project BIO-C3 from the European Union	Estonian Research Council(Estonian Research Council); Estonian Science Foundation; project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" of Environmental protection and technology program of the European Regional Fund; BONUS project BIO-C3 from the European Union	Funding for this research was provided by Institutional research funding IUT02-20 of the Estonian Research Council. The study has been also supported by the Estonian Science Foundation grant 8807, the project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" No 3.2.0801.11-0029 of Environmental protection and technology program of the European Regional Fund. The project has received funding from the BONUS project BIO-C3, funded jointly from the European Union's Seventh Programme for research, technological development and demonstration and from the Estonian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, AM NAT, V127, P819, DOI 10.1086/284527; Alenius P., 1998, BOREAL ENVIRON RES, V3, P97; Alimov AF, 1981, LENINGR SCI; Altieri AH, 2006, MAR ECOL PROG SER, V325, P295, DOI 10.3354/meps325295; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; AUSTIN MP, 1980, VEGETATIO, V43, P87, DOI 10.1007/BF00121021; AUSTIN MP, 1980, VEGETATIO, V42, P11, DOI 10.1007/BF00048865; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Back S, 1996, MAPPING MONITORING P; BAYNE BL, 1977, PHYSL RESPONSES MARI, P379; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; Bekkby T, 2008, MAR GEOD, V31, P117, DOI 10.1080/01490410802053674; Bendtsen J, 2009, J MARINE SYST, V75, P138, DOI 10.1016/j.jmarsys.2008.08.006; BERGLUND A, 1982, OECOLOGIA, V54, P1, DOI 10.1007/BF00541099; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Blok J.W. De, 1958, ARCH NEERL ZOOL JUBI, V13, P446; Buttger H, 2008, HELGOLAND MAR RES, V62, P23, DOI 10.1007/s10152-007-0099-y; Chapman MG, 1998, J EXP MAR BIOL ECOL, V224, P265, DOI 10.1016/S0022-0981(97)00202-5; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Christensen TK, 2008, THESIS U AARHUS DENM; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; CLOERN JE, 1982, MAR ECOL PROG SER, V9, P191, DOI 10.3354/meps009191; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Commito JA, 2001, ECOL STU AN, V151, P39; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; Conley DJ, 2011, ENVIRON SCI TECHNOL, V45, P6777, DOI 10.1021/es201212r; Dahlhoff EP, 1996, MAR ECOL PROG SER, V144, P97, DOI 10.3354/meps144097; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; Frandsen RP, 2002, MAR BIOL, V141, P253, DOI 10.1007/s00227-002-0831-8; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; FRECHETTE M, 1992, MAR ECOL PROG SER, V83, P55, DOI 10.3354/meps083055; Frechette Marcel, 1993, NATO ASI Series Series G Ecological Sciences, V33, P325; Gilek M, 2001, HYDROBIOLOGIA, V452, P59, DOI 10.1023/A:1011919826002; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Hastie T., 2009, UNSUPERVISED LEARNIN; Helsinki Commission (HELCOM), 2008, MAN MAR MON COMBINE; Herkul K, 2006, OCEANOLOGIA, V48, P267; Hoffman JR, 2003, J PHYCOL, V39, P268, DOI 10.1046/j.1529-8817.2003.01111.x; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Holmes KW, 2007, AQUAT CONSERV, V17, P385, DOI 10.1002/aqc.772; Howard JK, 2003, J N AM BENTHOL SOC, V22, P63, DOI 10.2307/1467978; Huston M. A., 1994, BIOL DIVERSITY; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; INCZE LS, 1980, MAR BIOL, V57, P147, DOI 10.1007/BF00390733; Isaeus M., 2004, THESIS STOCKHOLM U S; Jarv L, 2011, ANN ZOOL FENN, V48, P129; JORGENSEN CB, 1990, MAR ECOL PROG SER, V64, P89, DOI 10.3354/meps064089; KAUTSKY H, 1990, MAR ECOL PROG SER, V60, P169, DOI 10.3354/meps060169; KAUTSKY L, 1989, VEGETATIO, V83, P259, DOI 10.1007/BF00031698; KAUTSKY N, 1987, MAR ECOL PROG SER, V38, P201, DOI 10.3354/meps038201; KAUTSKY N, 1982, MAR BIOL, V68, P117, DOI 10.1007/BF00397599; Kendrick GA, 2008, ECOGRAPHY, V31, P191, DOI 10.1111/j.0906-7590.2008.5252.x; Kiirikki M, 1996, EUR J PHYCOL, V31, P225, DOI 10.1080/09670269600651421; Kont A, 2007, BOREAL ENVIRON RES, V12, P653; Kotta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063946; Kotta J, 2009, MAR ECOL-EVOL PERSP, V30, P56, DOI 10.1111/j.1439-0485.2009.00303.x; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Leichter JJ, 1997, J EXP MAR BIOL ECOL, V209, P293, DOI 10.1016/S0022-0981(96)02702-5; Littorin B, 1999, HYDROBIOLOGIA, V393, P211, DOI 10.1023/A:1003565602858; MacArthur R.H., 1969, POPULATION BIOL EVOL, P159; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Norkko A, 2001, LIMNOL OCEANOGR, V46, P2067, DOI 10.4319/lo.2001.46.8.2067; Orviku K, 2003, J COASTAL RES, V19, P364; Pata MP, 2010, SORT-STAT OPER RES T, V34, P67; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Remane A, 1971, BIOL BRACKISH WATER; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; RIISGARD H U, 1991, Journal of Shellfish Research, V10, P29; Riisgard HU, 2013, HELGOLAND MAR RES, V67, P591, DOI 10.1007/s10152-013-0347-2; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Saier B, 2002, HELGOLAND MAR RES, V56, P44, DOI 10.1007/s10152-001-0097-4; Sandman AN, 2013, ECOGRAPHY, V36, P354, DOI 10.1111/j.1600-0587.2012.07053.x; Saurel C, 2007, LIMNOL OCEANOGR, V52, P1919, DOI 10.4319/lo.2007.52.5.1919; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Steffani CN, 2003, MAR ECOL PROG SER, V246, P197, DOI 10.3354/meps246197; Stuckas H, 2009, HEREDITY, V103, P146, DOI 10.1038/hdy.2009.37; SUCHANEK TH, 1978, J EXP MAR BIOL ECOL, V31, P105, DOI 10.1016/0022-0981(78)90139-9; Suchanek TH, 1997, BIOL BULL, V193, P187, DOI 10.2307/1542764; Team RC, 2013, R LANGUAGE ENV STAT; TEDENGREN M, 1986, OPHELIA, V25, P147, DOI 10.1080/00785326.1986.10429746; Underwood A.J., 1985, ECOLOGY ROCKY COASTS, P372; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; VAINOLA R, 1991, BIOL J LINN SOC, V43, P127, DOI 10.1111/j.1095-8312.1991.tb00589.x; Wallin A, 2011, AQUAT BIOL, V12, P119, DOI 10.3354/ab00329; Westerbom M, 2006, MAR ECOL PROG SER, V306, P191, DOI 10.3354/meps306191; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6; Westerbom M, 2008, MAR BIOL, V153, P1153, DOI 10.1007/s00227-007-0886-7; Wilson KA, 2006, J GREAT LAKES RES, V32, P11, DOI 10.3394/0380-1330(2006)32[11:ROZMBQ]2.0.CO;2; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Witman JD, 1998, ECOLOGY, V79, P2429, DOI 10.1890/0012-9658(1998)079[2429:LBRSAP]2.0.CO;2; WORCESTER SE, 1995, MAR ECOL PROG SER, V126, P223, DOI 10.3354/meps126223	107	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136949	10.1371/journal.pone.0136949	http://dx.doi.org/10.1371/journal.pone.0136949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317668	Green Accepted, gold, Green Published			2022-12-27	WOS:000360299100182
J	Martinez-Ortiz, J; Aires-Da-Silva, AM; Lennert-Cody, CE; Maunder, MN				Martinez-Ortiz, Jimmy; Aires-da-Silva, Alexandre M.; Lennert-Cody, Cleridy E.; Maunder, Mark N.			The Ecuadorian Artisanal Fishery for Large Pelagics: Species Composition and Spatio-Temporal Dynamics	PLOS ONE			English	Article							DOLPHINFISH CORYPHAENA-HIPPURUS; ALOPIAS-PELAGICUS; THRESHER SHARK; STOCK STATUS; PACIFIC; REPRODUCTION; POPULATIONS; INDICATORS; BIOLOGY; CATCH	The artisanal fisheries of Ecuador operate within one of the most dynamic and productive marine ecosystems of the world. This study investigates the catch composition of the Ecuadorian artisanal fishery for large pelagic fishes, including aspects of its spatio-temporal dynamics. The analyses of this study are based on the most extensive dataset available to date for this fishery: a total of 106,963 trip-landing inspection records collected at its five principal ports during 2008. 2012. Ecuadorian artisanal fisheries remove a substantial amount of biomass from the upper trophic-level predatory fish community of the eastern tropical Pacific Ocean. It is estimated that at least 135 thousand metric tons (mt) (about 15.5 million fish) were landed in the five principal ports during the study period. The great novelty of Ecuadorian artisanal fisheries is the "oceanic-artisanal" fleet component, which consists of mother-ship (nodriza) boats with their towed fiber-glass skiffs (fibras) operating with pelagic longlines. This fleet has fully expanded into oceanic waters as far offshore as 100 degrees W, west of the Galapagos Archipelago. It is estimated that nodriza operations produce as much as 80% of the total catches of the artisanal fishery. The remainder is produced by independent fibras operating in inshore waters with pelagic longlines and/or surface gillnets. A multivariate regression tree analysis was used to investigate spatio-environmental effects on the nodriza fleet (n = 6,821 trips). The catch species composition of the nodriza fleet is strongly influenced by the northwesterly circulation of the Humboldt Current along the coast of Peru and its associated cold waters masses. The target species and longline gear-type used by nodrizas change seasonally with the incursion of cool waters (< 25 degrees C) from the south and offshore. During this season, dolphinfish (Coryphaena hippurus) dominates the catches. However, in warmer waters, the fishery changes to tuna-billfish-shark longline gear and the catch composition becomes much more diverse.	[Martinez-Ortiz, Jimmy] Subsecretaria Recursos Pesqueros Viceministerio A, Manta, Manabi, Ecuador; [Aires-da-Silva, Alexandre M.; Lennert-Cody, Cleridy E.; Maunder, Mark N.] Inter Amer Trop Tuna Commiss, La Jolla, CA 92037 USA		Aires-Da-Silva, AM (corresponding author), Inter Amer Trop Tuna Commiss, La Jolla, CA 92037 USA.	alexdasilva@iattc.org						Aires-da-Silva A, 2014, STOCK ASSESSMENT REP, V15, P118; Arrizabalaga H, 2011, AQUAT LIVING RESOUR, V24, P1, DOI 10.1051/alr/2011007; Bentley N, 2015, ICES J MAR SCI, V72, P186, DOI 10.1093/icesjms/fsu023; Bobadilla-Jimenez M, 2007, THESIS CTR INVESTIGA, P83; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Bustamante C, 2013, FISH RES, V143, P174, DOI 10.1016/j.fishres.2013.02.007; Caetano N. BR, 2012, ACTA AGRON, P30; Cardenosa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110193; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Castro R, 1997, 9243 UEVECEP ALA TRA, P132; Castro R, 1993, B CIENT TEC I NAC PE, V12, P67; Cortes Enric, 2008, Fish and Aquatic Resources Series, V13, P309; Dapp D, 2013, J EXP MAR BIOL ECOL, V448, P228, DOI 10.1016/j.jembe.2013.07.014; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Diaz-Jaimes P, 2010, MOL PHYLOGENET EVOL, V57, P1209, DOI 10.1016/j.ympev.2010.10.005; Diaz-Jaimes P, 2006, FISH RES, V80, P333, DOI 10.1016/j.fishres.2006.04.015; Doherty PD, 2014, ECOL EVOL, V4, P2375, DOI 10.1002/ece3.1104; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fallows JA, 1990, INTERNAL REPORT, P15; FAO, 2012, AN EST PESC CUADR RE; Gallagher AJ, 2012, J FISH BIOL, V80, P1727, DOI 10.1111/j.1095-8649.2012.03235.x; Geromont HF, 2015, ICES J MAR SCI, V72, P251, DOI 10.1093/icesjms/fst232; Goicochea C, 2012, EDAD CRECIMIENTO COR, V39, P34; Herdson DW, 1985, B CIENT TECN I NAC P, V8, P1; Herrera M, 2013, B ESPEC I NAC PESCA, V1, P328; Hinton Michael G., 2014, Inter-American Tropical Tuna Commission Stock Assessment Report, V15, P142; Hutchings JA, 2012, ECOL APPL, V22, P1061, DOI 10.1890/11-1313.1; IATTC, 2015, 1 INT TROP TUN COMM; Jimenez R, 1987, REV COM PERM PACIFIC, V16, P167; Jimenez R, 1984, REV COM PERM PACIFIC, V15, P269; Jimenez R, 2008, ASPECTOS BIOL NINO O, P330; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Lasso J, 1999, SCI MAR, V63, P387, DOI 10.3989/scimar.1999.63n3-4387; Legendre L., 1998, NUMERICAL ECOLOGY, P852; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Li B., 1984, BIOMETRICS, V40, P358, DOI [10.2307/2530946, DOI 10.1002/WIDM.8]; Liu KM, 1999, COPEIA, P68; Martinez-Ortiz J, 2012, TIBURONES OCEANO PAC, P49; Martinez-Ortiz J, 1991, PROYECTO EVALUACION, V11, P1; Martinez-Ortiz J, 2012, ESTADO ACTUAL CONOCI, P122; Martinez-Ortiz J, 2010, B TEC SRP MAGAP, P35; Maunder Mark N., 2014, Inter-American Tropical Tuna Commission Stock Assessment Report, V15, P40; Maunder MN, 2015, ICES J MAR SCI, V72, P7, DOI 10.1093/icesjms/fsu015; Ministerio de Comercio Exterior Industrializacion Pesca y Competitividad (MICIP), 2006, PLAN ACC NAC CONS MA, P44; Palko BJ, 1982, FAO FISHERIES SYNOPS, P32; Peralta M, 2003, I NAC PESCA ECUADOR, V3, P51; Peralta M, 2003, I NAC PESCA ECUADOR, V3, P21; Philander S.G, 1989, NINO NINA SO OSCILLA, V46; R Core Team, 2018, R LANG ENV STAT COMP; Rocha-Olivares A, 2006, CIENC MAR, V32, P569, DOI 10.7773/cm.v32i3.1122; Romero-Caicedo AF, 2014, J MAR BIOL ASSOC UK, V94, P1501, DOI 10.1017/S0025315414000927; Rosales- Morales A, 2007, THESIS U MAR PUERTO, P69; SOLANO-SARE A., 2008, BIOL PESQUERIA PERIC; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tsai WP, 2010, MAR FRESHWATER RES, V61, P1056, DOI 10.1071/MF09303; Wessells C. R., 2001, FAO Fisheries Technical Paper; WOOSTER WS, 1969, DEEP-SEA RES, VS, P407; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Zuniga-Flores MS, 2012, DETERMINACION INTERP, P73	60	60	61	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135136	10.1371/journal.pone.0135136	http://dx.doi.org/10.1371/journal.pone.0135136			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317751	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100023
J	Panagioti, M; Stokes, J; Esmail, A; Coventry, P; Cheraghi-Sohi, S; Alam, R; Bower, P				Panagioti, Maria; Stokes, Jonathan; Esmail, Aneez; Coventry, Peter; Cheraghi-Sohi, Sudeh; Alam, Rahul; Bower, Peter			Multimorbidity and Patient Safety Incidents in Primary Care: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MULTIPLE CHRONIC CONDITIONS; QUALITY-OF-CARE; ADVERSE DRUG-REACTIONS; DIABETES CARE; ELDERLY-PATIENTS; HEART-FAILURE; CO-MORBIDITY; OLDER-ADULTS; RISK-FACTORS; RHEUMATOID-ARTHRITIS	Background Multimorbidity is increasingly prevalent and represents a major challenge in primary care. Patients with multimorbidity are potentially more likely to experience safety incidents due to the complexity of their needs and frequency of their interactions with health services. However, rigorous syntheses of the link between patient safety incidents and multimorbidity are not available. This review examined the relationship between multimorbidity and patient safety incidents in primary care. Methods We followed our published protocol (PROSPERO registration number: CRD42014007434). Medline, Embase and CINAHL were searched up to May 2015. Study design and quality were assessed. Odds ratios (OR) and 95% confidence intervals (95% CIs) were calculated for the associations between multimorbidity and two categories of patient safety outcomes: 'active patient safety incidents' (such as adverse drug events and medical complications) and 'precursors of safety incidents' (such as prescription errors, medication non-adherence, poor quality of care and diagnostic errors). Meta-analyses using random effects models were undertaken. Results Eighty six relevant comparisons from 75 studies were included in the analysis. Meta-analysis demonstrated that physical-mental multimorbidity was associated with an increased risk for 'active patient safety incidents' (OR = 2.39, 95% CI = 1.40 to 3.38) and 'precursors of safety incidents' (OR = 1.69, 95% CI = 1.36 to 2.03). Physical multimorbidity was associated with an increased risk for active safety incidents (OR = 1.63, 95% CI = 1.45 to 1.80) but was not associated with precursors of safety incidents (OR = 1.02, 95% CI = 0.90 to 1.13). Statistical heterogeneity was high and the methodological quality of the studies was generally low. Conclusions The association between multimorbidity and patient safety is complex, and varies by type of multimorbidity and type of safety incident. Our analyses suggest that multimorbidity involving mental health may be a key driver of safety incidents, which has important implication for the design and targeting of interventions to improve safety. High quality studies examining the mechanisms of patient safety incidents in patients with multimorbidity are needed, with the goal of promoting effective service delivery and ameliorating threats to safety in this group of patients.	[Panagioti, Maria] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester, Lancs, England; [Stokes, Jonathan; Esmail, Aneez; Cheraghi-Sohi, Sudeh; Alam, Rahul; Bower, Peter] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Greater Manchester Primary Care Patient Safe, Manchester, Lancs, England; [Coventry, Peter] Univ Manchester, NIHR Collaborat Leadership Appl Hlth Res & Care G, Manchester, Lancs, England; [Coventry, Peter] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Panagioti, M (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester, Lancs, England.	maria.panagioti@manchester.ac.uk	Coventry, Peter/AAA-9344-2019; Esmail, Aneez/I-6903-2013; Bower, Peter/A-1508-2011; Coventry, Peter/H-6714-2014; Stokes, Jonathan/GYR-0813-2022	Coventry, Peter/0000-0003-0625-3829; Bower, Peter/0000-0001-9558-3349; Coventry, Peter/0000-0003-0625-3829; Esmail, Aneez/0000-0001-7061-7434; Panagioti, Maria/0000-0002-7153-5745; Stokes, Jonathan/0000-0002-3266-1474	National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC); National Institute for Health Research School for Primary Care Research (NIHR SPCR); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester	National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC); National Institute for Health Research School for Primary Care Research (NIHR SPCR); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester	This study is funded by the National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC) http://www.population-health.manchester.ac.uk/primary-care-patient-safety/ and the National Institute for Health Research School for Primary Care Research (NIHR SPCR) http://www.spcr.nihr.ac.uk/. Peter Coventry was partly funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester. The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Bae S, 2008, J GEN INTERN MED, V23, P1933, DOI 10.1007/s11606-008-0784-9; Barham Ann Hiott, 2009, Prev Cardiol, V12, P95, DOI 10.1111/j.1751-7141.2008.00019.x; Beer C, 2011, BRIT J CLIN PHARMACO, V71, P592, DOI 10.1111/j.1365-2125.2010.03875.x; Berger Ariel, 2009, BMC Geriatr, V9, P31, DOI 10.1186/1471-2318-9-31; Bertomeu V, 2009, REV ESP CARDIOL, V62, P807, DOI 10.1016/S0300-8932(09)71694-X; Blais R, 2013, BMJ QUAL SAF, V22, P989, DOI 10.1136/bmjqs-2013-002039; Blakemore A, 2014, INT J CHRONIC OBSTR, V9, P501, DOI 10.2147/COPD.S58136; Blecker S, 2010, GEN HOSP PSYCHIAT, V32, P255, DOI 10.1016/j.genhosppsych.2010.02.002; Bont J, 2007, FAM PRACT, V24, P317, DOI 10.1093/fampra/cmm023; Borenstein M., 2009, INTRO METAANALYSIS; Bower P, 2013, J HEALTH SERV RES PO, V18, P29, DOI 10.1177/1355819613492148; Bower P, 2011, FAM PRACT, V28, P579, DOI 10.1093/fampra/cmr018; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, FUTURE MULTIMORBIDIT; Buja A, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-56; Cahir C, 2014, BRIT J CLIN PHARMACO, V77, P201, DOI 10.1111/bcp.12161; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Calvert MJ, 2009, FAM PRACT, V26, P145, DOI 10.1093/fampra/cmn105; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Classen Sherrilene, 2007, Res Social Adm Pharm, V3, P104, DOI 10.1016/j.sapharm.2006.06.002; Coventry P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h638; Coventry PA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0536-y; Coventry PA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-10; Daker-White G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005493; Dalton ARH, 2011, DIABETIC MED, V28, P525, DOI 10.1111/j.1464-5491.2011.03251.x; Davis JM, 2008, ARTHRITIS RHEUM, V58, P2603, DOI 10.1002/art.23798; Dawes M, 2010, FAM PRACT, V27, P1, DOI 10.1093/fampra/cmp106; Desai MM, 2006, MED CARE, V44, P175, DOI 10.1097/01.mlr.0000196962.97345.21; Desai MM, 2005, AM J PSYCHIAT, V162, P1521, DOI 10.1176/appi.ajp.162.8.1521; Drivenes E, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-42; Druss BG, 2012, MED CARE, V50, P428, DOI 10.1097/MLR.0b013e318245a528; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eguale T, 2012, ARCH INTERN MED, V172, P781, DOI 10.1001/archinternmed.2012.340; Fernandez-Villar A, 2015, INT J CHRONIC OBSTR, V10, P961, DOI 10.2147/COPD.S79547; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Frigola-Capell Eva, 2013, Qual Prim Care, V21, P211; Fung CH, 2008, J GEN INTERN MED, V23, P788, DOI 10.1007/s11606-008-0602-4; Ghembaza MA, 2014, CURR HYPERTENS REV, V10, P41, DOI 10.2174/157340211001141111160653; Goldberg RW, 2007, PSYCHIAT SERV, V58, P536, DOI 10.1176/appi.ps.58.4.536; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Harman JS, 2005, J AM GERIATR SOC, V53, P2178, DOI 10.1111/j.1532-5415.2005.00511.x; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Harrison M, 2012, PATIENT EDUC COUNS, V87, P67, DOI 10.1016/j.pec.2011.06.007; Hayes WN, 2014, HEMODIAL INT, V18, P481, DOI 10.1111/hdi.12140; Hesse K, 2014, STROKE, V45, P2677, DOI 10.1161/STROKEAHA.114.005845; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Mira JJ, 2014, EXPERT OPIN DRUG SAF, V13, P713, DOI 10.1517/14740338.2014.916272; Kanner AM, 2012, EPILEPSIA, V53, P1104, DOI 10.1111/j.1528-1167.2012.03488.x; Katerndahl D, 2012, PRIMARY CARE COMPANI, V14; Kenning C, 2014, SELF MANAGEMENT INTE, V4, P9, DOI 10.15256/joc.2014.4.33; Kenning Cassandra, 2014, J Comorb, V4, P37, DOI 10.15256/joc.2014.4.33; Klemp K, 2009, REPORT TAXONOMY ERRO; Knowles SE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0246-5; Ko Jocelyn, 2013, Hawaii J Med Public Health, V72, P191; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Krein SL, 2006, PSYCHIAT SERV, V57, P1016, DOI 10.1176/appi.ps.57.7.1016; Lagomasino IT, 2005, PSYCHIAT SERV, V56, P1517, DOI 10.1176/appi.ps.56.12.1517; Leendertse AJ, 2013, J CLIN PHARM THER, V38, P379, DOI 10.1111/jcpt.12069; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Lu CY, 2011, INT J CLIN PRACT, V65, P733, DOI 10.1111/j.1742-1241.2011.02671.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mand P, 2014, INT J CLIN PHARM TH, V52, P337, DOI 10.5414/CP202003; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; May C, 2009, BMJ-BRIT MED J, V23, P19; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McGovern AP, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-198; McGuiness C, 2003, INT J QUAL HEALTH C, V15, P309, DOI 10.1093/intqhc/mzg043; Mensah SA, 2007, EPILEPSY BEHAV, V11, P118, DOI 10.1016/j.yebeh.2007.04.012; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Min LL, 2014, J AM GERIATR SOC, V62, P1714, DOI 10.1111/jgs.12989; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; Nasser J, 2009, BAHRAIN MED B, V31; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Nuyen J, 2005, PSYCHOL MED, V35, P1185, DOI 10.1017/S0033291705004812; Obreli-Neto PR, 2012, EUR J CLIN PHARMACOL, V68, P1667, DOI 10.1007/s00228-012-1309-3; Parchman ML, 2005, MED CARE, V43, P1123, DOI 10.1097/01.mlr.0000182530.52979.29; Pawaskar Manjiri D, 2008, J Med Econ, V11, P41, DOI 10.3111/13696990701817491; Petersen LA, 2009, CIRCULATION, V119, P2978, DOI 10.1161/CIRCULATIONAHA.108.836544; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Pugh MJV, 2010, J AM GERIATR SOC, V58, P465, DOI 10.1111/j.1532-5415.2010.02732.x; Pugh MJV, 2005, J AM GERIATR SOC, V53, P1282, DOI 10.1111/j.1532-5415.2005.53402.x; Reeves D, 2008, BRIT J GEN PRACT, V58, P198, DOI 10.3399/bjgp08X277320; Reichard A, 2012, DISABIL HEALTH J, V5, P34, DOI 10.1016/j.dhjo.2011.09.003; Rigler Sally K, 2004, Am J Geriatr Pharmacother, V2, P239, DOI 10.1016/j.amjopharm.2004.12.003; Rubin G, 2003, QUAL SAF HEALTH CARE, V12, P443, DOI 10.1136/qhc.12.6.443; Ruigomez A, 2007, CLIN CARDIOL, V30, P624, DOI 10.1002/clc.20178; Ruppert K, 2010, DIABETES EDUCATOR, V36, P603, DOI 10.1177/0145721710369705; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schnitzer S, 2012, INT J QUAL HEALTH C, V24, P476, DOI 10.1093/intqhc/mzs036; Shinichi A., 2014, ONLINE KENSAKU, V35, P154; Shireman TI, 2010, DISABIL HEALTH J, V3, P179, DOI 10.1016/j.dhjo.2009.10.004; Simeone JC, 2012, ANN PHARMACOTHER, V46, P157, DOI 10.1345/aph.1Q352; Simpson CR, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-56; Sloane PD, 2004, ARCH INTERN MED, V164, P2031, DOI 10.1001/archinte.164.18.2031; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; St John of God Health Care, 2019, OUR VIS; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Streit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096142; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Thorpe CT, 2012, J AM GERIATR SOC, V60, P644, DOI 10.1111/j.1532-5415.2012.03907.x; Tomio J, 2010, J EVAL CLIN PRACT, V16, P1164, DOI 10.1111/j.1365-2753.2009.01287.x; Tsang C, 2013, BRIT J GEN PRACT, V63, pE534, DOI 10.3399/bjgp13X670660; van Dijk L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-51; van Dijk PTM, 2005, J AM GERIATR SOC, V53, P660, DOI 10.1111/j.1532-5415.2005.53216.x; Vincent C, 2005, PATIENT SAFETY; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Weisman MH, 2007, RHEUMATOLOGY, V46, P1122, DOI 10.1093/rheumatology/kem033; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wong MCS, 2011, CLIN THER, V33, P617, DOI 10.1016/j.clinthera.2011.04.019; Wong MKY, 2015, CAN MED ASSOC J, V187, pE160, DOI 10.1503/cmaj.141294; Woodard LD, 2012, AM J MANAG CARE, V18, P508; Zwar NA, 2011, MED J AUSTRALIA, V195, P168, DOI 10.5694/j.1326-5377.2011.tb03271.x	130	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135947	10.1371/journal.pone.0135947	http://dx.doi.org/10.1371/journal.pone.0135947			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317435	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100052
J	Schmidt, RL; Walker, BS; Cohen, MB				Schmidt, Robert L.; Walker, Brandon S.; Cohen, Michael B.			When Is Rapid On-Site Evaluation Cost-Effective for Fine-Needle Aspiration Biopsy?	PLOS ONE			English	Article							SOLID PANCREATIC LESIONS; RISK-BENEFIT ANALYSIS; SPECIMEN ADEQUACY; THYROID-NODULES; ONSITE EVALUATION; METAANALYSIS; PASSES; CYTOLOGY; CYTOTECHNOLOGISTS; STRATEGIES	Background Rapid on-site evaluation (ROSE) can improve adequacy rates of fine-needle aspiration biopsy (FNAB) but increases operational costs. The performance of ROSE relative to fixed sampling depends on many factors. It is not clear when ROSE is less costly than sampling with a fixed number of needle passes. The objective of this study was to determine the conditions under which ROSE is less costly than fixed sampling. Methods Cost comparison of sampling with and without ROSE using mathematical modeling. Models were based on a societal perspective and used a mechanistic, micro-costing approach. Sampling policies (ROSE, fixed) were compared using the difference in total expected costs per case. Scenarios were based on procedure complexity (palpation-guided or image-guided), adequacy rates (low, high) and sampling protocols (stopping criteria for ROSE and fixed sampling). One-way, probabilistic, and scenario-based sensitivity analysis was performed to determine which variables had the greatest influence on the cost difference. Results ROSE is favored relative to fixed sampling under the following conditions: (1) the cytologist is accurate, (2) the total variable cost ($/hr) is low, (3) fixed costs ($/procedure) are high, (4) the setup time is long, (5) the time between needle passes for ROSE is low, (6) when the per-pass adequacy rate is low, and (7) ROSE stops after observing one adequate sample. The model is most sensitive to variation in the fixed cost, the per-pass adequacy rate, and the time per needle pass with ROSE. Conclusions Mathematical modeling can be used to predict the difference in cost between sampling with and without ROSE.	[Schmidt, Robert L.; Cohen, Michael B.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Schmidt, Robert L.; Walker, Brandon S.; Cohen, Michael B.] ARUP Labs, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Schmidt, RL (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.	robert.schmidt@hsc.utah.edu						Bruno P, 2013, EUR REV MED PHARMACO, V17, P1517; Burgess C, 2013, J LARYNGOL OTOL, V127, P1122, DOI 10.1017/S0022215113002272; Cardozo EF, 2012, IEEE T BIO-MED ENG, V59, P2227, DOI 10.1109/TBME.2012.2201479; Collins JA, 2013, KOREAN J PATHOL, V47, P405, DOI 10.4132/KoreanJPathol.2013.47.5.405; Diacon AH, 2007, EUR RESPIR J, V29, P112, DOI 10.1183/09031936.00055506; Drobniewski F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19340; Drummond FM, 1997, METHODS EC EVALUATIO; Eedes CR, 2004, AM J CLIN PATHOL, V121, P64, DOI 10.1309/XLNDTE289WAQYK0Y; Gillett M, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19330; Gold MR, 1996, COST EFFECTIVENESS H; Goto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088113; Layfield LJ, 2001, CANCER CYTOPATHOL, V93, P319, DOI 10.1002/cncr.9046; Matynia AP, 2014, J GASTROEN HEPATOL, V29, P697, DOI 10.1111/jgh.12431; Mendes D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1332-8; Nasuti JF, 2002, DIAGN CYTOPATHOL, V27, P1, DOI 10.1002/dc.10065; O'Malley ME, 2002, RADIOLOGY, V222, P383, DOI 10.1148/radiol.2222010201; Olson MT, 2012, ACTA CYTOL, V56, P340, DOI 10.1159/000338646; Pellise Urquiza Maria, 2007, Gastroenterol Hepatol, V30, P319; Petrone MC, 2012, DIGEST LIVER DIS, V44, P311, DOI 10.1016/j.dld.2011.12.001; Redman R, 2006, THYROID, V16, P55, DOI 10.1089/thy.2006.16.55; Savoy AD, 2007, GASTROINTEST ENDOSC, V65, P953, DOI 10.1016/j.gie.2006.11.014; Schmidt RL, 2015, CYTOPATHOLOGY, V26, P217, DOI 10.1111/cyt.12163; Schmidt RL, CYTOPATHOLG IN PRESS; Schmidt RL, 2013, DIGEST DIS SCI, V58, P3280, DOI 10.1007/s10620-013-2750-6; Schmidt RL, 2013, DIGEST DIS SCI, V58, P872, DOI 10.1007/s10620-012-2411-1; Schmidt RL, 2013, AM J CLIN PATHOL, V139, P336, DOI 10.1309/AJCPEAKR4MO2GQBO; Schmidt RL, 2013, AM J CLIN PATHOL, V139, P300, DOI 10.1309/AJCPEGZMJKC42VUP; Schmidt RL, 2012, AM J CLIN PATHOL, V138, P823, DOI 10.1309/AJCP8BYTCFI0XJZU; Suzuki R, 2012, DIGEST ENDOSC, V24, P452, DOI 10.1111/j.1443-1661.2012.01311.x; Witt BL, 2013, THYROID, V23, P428, DOI 10.1089/thy.2012.0211; Wotruba AL, 2011, DIAGN CYTOPATHOL, V39, P896, DOI 10.1002/dc.21487; Zanocco K, 2013, ANN SURG ONCOL, V20, P2462, DOI 10.1245/s10434-013-2954-1	32	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135466	10.1371/journal.pone.0135466	http://dx.doi.org/10.1371/journal.pone.0135466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317785	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100031
J	van der Maaten, E; van der Maaten-Theunissen, M; Buras, A; Scharnweber, T; Simard, S; Kaiser, K; Lorenz, S; Wilmking, M				van der Maaten, Ernst; van der Maaten-Theunissen, Marieke; Buras, Allan; Scharnweber, Tobias; Simard, Sonia; Kaiser, Knut; Lorenz, Sebastian; Wilmking, Martin			Can We Use Tree Rings of Black Alder to Reconstruct Lake Levels? A Case Study for the Mecklenburg Lake District, Northeastern Germany	PLOS ONE			English	Article							CENTRAL-EUROPE; ALNUS-GLUTINOSA; DROUGHT; VARIABILITY; ANATOMY; SALT; FLOW	In this study, we explore the potential to reconstruct lake-level (and groundwater) fluctuations from tree-ring chronologies of black alder (Alnus glutinosa L.) for three study lakes in the Mecklenburg Lake District, northeastern Germany. As gauging records for lakes in this region are generally short, long-term reconstructions of lake-level fluctuations could provide valuable information on past hydrological conditions, which, in turn, are useful to assess dynamics of climate and landscape evolution. We selected black alder as our study species as alder typically thrives as riparian vegetation along lakeshores. For the study lakes, we tested whether a regional signal in lake-level fluctuations and in the growth of alder exists that could be used for long-term regional hydrological reconstructions, but found that local (i.e. site-specific) signals in lake level and tree-ring chronologies prevailed. Hence, we built lake/ground-water-level reconstruction models for the three study lakes individually. Two sets of models were considered based on (1) local tree-ring series of black alder, and (2) site-specific Standardized Precipitation Evapotranspiration Indices (SPEI). Although the SPEI-based models performed statistically well, we critically reflect on the reliability of these reconstructions, as SPEI cannot account for human influence. Tree-ring based reconstruction models, on the other hand, performed poor. Combined, our results suggest that, for our study area, long-term regional reconstructions of lake-level fluctuations that consider both recent and ancient (e.g., archaeological) wood of black alder seem extremely challenging, if not impossible.	[van der Maaten, Ernst; van der Maaten-Theunissen, Marieke; Buras, Allan; Scharnweber, Tobias; Wilmking, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Simard, Sonia] GFZ German Res Ctr Geosci, Climate Dynam & Landscape Evolut, Potsdam, Germany; [Kaiser, Knut] GFZ German Res Ctr Geosci, Staff Sci Execut Board, Potsdam, Germany; [Lorenz, Sebastian] Ernst Moritz Arndt Univ Greifswald, Inst Geog & Geol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Ernst Moritz Arndt Universitat Greifswald	van der Maaten, E (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany.	ernst.vandermaaten@uni-greifswald.de	Wilmking, Martin/AAV-9310-2020; Buras, Allan/B-1412-2012	Wilmking, Martin/0000-0003-4964-2402; van der Maaten, Ernst/0000-0002-5218-6682; Kaiser, Knut/0000-0002-5080-6075; Buras, Allan/0000-0003-2179-0681; Scharnweber, Tobias/0000-0002-4933-5296; Lorenz, Sebastian/0000-0001-9679-5984; van der Maaten-Theunissen, Marieke/0000-0002-2942-9180	Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA [VH-VI-415]	Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA	This study is a contribution to the Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA - (grant no. VH-VI-415) and to the Terrestrial Environmental Observatories project - TERENO - of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Argyilan EP, 2003, J GREAT LAKES RES, V29, P488, DOI 10.1016/S0380-1330(03)70453-5; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ballesteros JA, 2010, TREE PHYSIOL, V30, P773, DOI 10.1093/treephys/tpq031; Begin Y, 2001, QUATERNARY RES, V55, P133, DOI 10.1006/qres.2000.2203; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Crone A., 2014, J WETLAND ARCHAEOLOG, V14, P22, DOI 10.1179/1473297114Z.0000000007; Danis PA, 2006, EARTH PLANET SC LETT, V243, P439, DOI 10.1016/j.epsl.2006.01.023; Dearing J. A., 1986, HDB HOLOCENE PALAEOE, P67; DeRose RJ, 2014, HOLOCENE, V24, P805, DOI 10.1177/0959683614530441; Digerfeldt G., 1988, ROREAS, V17, P165, DOI DOI 10.1111/J.1502-3885.1988.TB00544.X; Elferts Didzis, 2011, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V65, P164, DOI 10.2478/v10046-011-0032-2; Fritts H. C., 1976, TREE RINGS CLIMATE; Grunewald U., 2012, WASSERBEZOGENE ANPAS, P148; Hacke U, 1996, PLANT PHYSIOL, V111, P413, DOI 10.1104/pp.111.2.413; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Kaiser K, 2012, SYSTEM ERDE, V2, P62; Kaiser K, 2015, J HYDROL, V529, P584, DOI 10.1016/j.jhydrol.2014.12.057; Kaiser K, 2014, REG ENVIRON CHANGE, V14, P1587, DOI 10.1007/s10113-014-0600-5; Kaiser K, 2014, GEOMORPHOLOGY, V216, P58, DOI 10.1016/j.geomorph.2014.03.025; Kleppe JA, 2011, QUATERNARY SCI REV, V30, P3269, DOI 10.1016/j.quascirev.2011.08.015; Kozlowski T.T., 1997, GROWTH CONTROL WOODY, P352; Laanis J, 2008, ECOL MODEL, V215, P180, DOI 10.1016/j.ecolmodel.2008.02.018; Liang W, 2013, TREE PHYSIOL, V33, P833, DOI 10.1093/treephys/tpt059; Lorenz S, 2010, AKTUELLE PROBLEME, P133; Lorenz S., 2007, THESIS U GREIFSWALD; MCVEAN DN, 1953, J ECOL, V41, P447, DOI 10.2307/2257070; Meko D. M., 2006, Canadian Water Resources Journal, V31, P229; Meko DM, 2001, J AM WATER RESOUR AS, V37, P1029, DOI 10.1111/j.1752-1688.2001.tb05530.x; Nicault A, 2014, J HYDROL, V513, P435, DOI 10.1016/j.jhydrol.2014.03.054; Owen LA, 2006, QUATERN INT, V154, P73, DOI 10.1016/j.quaint.2006.02.008; Perez-Valdivia C, 2011, DENDROCHRONOLOGIA, V29, P41, DOI 10.1016/j.dendro.2010.09.001; Quinn FH, 2006, J GREAT LAKES RES, V32, P29, DOI 10.3394/0380-1330(2006)32[29:AROLMW]2.0.CO;2; Rodriguez-Gonzalez PM, 2014, PLANT ECOL, V215, P233, DOI 10.1007/s11258-013-0292-9; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; SMITH LP, 1981, WATER RESOUR BULL, V17, P939; Vicente-Serrano, 2013, SPEI CALCULATION STA; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Webster KE, 2000, FRESHWATER BIOL, V43, P499, DOI 10.1046/j.1365-2427.2000.00571.x; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wiles GC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037164	43	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137054	10.1371/journal.pone.0137054	http://dx.doi.org/10.1371/journal.pone.0137054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317768	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100199
J	Yoo, YC; Kim, NY; Shin, S; Choi, YD; Hong, JH; Kim, CY; Park, H; Bai, SJ				Yoo, Young-Chul; Kim, Na Young; Shin, Seokyung; Choi, Young Deuk; Hong, Jung Hwa; Kim, Chan Yun; Park, HeeJoon; Bai, Sun-Joon			The Intraocular Pressure under Deep versus Moderate Neuromuscular Blockade during Low-Pressure Robot Assisted Laparoscopic Radical Prostatectomy in a Randomized Trial	PLOS ONE			English	Article							IMPROVES SURGICAL CONDITIONS; SHOULDER-TIP PAIN; STEEP TRENDELENBURG; STANDARD-PRESSURE; ABDOMINAL-WALL; BLOOD-PRESSURE; SURGERY; PNEUMOPERITONEUM; CHOLECYSTECTOMY; MUSCLE	Background This study aimed to determine whether continuous deep neuromuscular blockade (NMB) improves the surgical conditions and facilitates robotic-assisted laparoscopic radical prostatectomy (RALRP) under low intra-abdominal pressure (IAP) to attenuate the increase in intraocular pressure (IOP) during CO2 pneumoperitoneum in the steep Trendelenburg (ST) position. Methods Sixty-seven patients undergoing RALRP were randomly assigned to a moderate NMB group (Group M), including patients who received atracurium infusion until the end of the ST position, maintaining a train of four count of 1-2; and the deep NMB group (Group D), including patients who received rocuronium infusion, maintaining a post-tetanic count of 1-2. IOP was measured in all patients at nine separate time points. All RALRPs were performed by one surgeon, who rated the overall and worst surgical conditions at the end of the ST position. Results The highest IOP value was observed at T4 (60 min after the ST position) in both Group M (23.3 +/- 2.7 mmHg) and Group D (19.8 +/- 2.1 mmHg). RALRP was accomplished at an IAP of 8 mmHg in 88% Group D patients and 25% Group M patients. The overall surgical condition grade was 4.0 (3.0-5.0) in Group D and 3.0 (2.0-5.0) in Group M (P < 0.001). Conclusion The current study demonstrated that continuous deep NMB may improve surgical conditions and facilitate RALRP at a low IAP, resulting in significant attenuation of the increase on IOP. Moreover, low-pressure pneumoperitoneum, facilitated by deep NMB still provided acceptable surgical conditions.	[Yoo, Young-Chul; Kim, Na Young; Shin, Seokyung; Park, HeeJoon; Bai, Sun-Joon] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Anesthesia & Pain Res Inst, Seoul, South Korea; [Choi, Young Deuk] Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea; [Hong, Jung Hwa] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Units, Seoul, South Korea; [Kim, Chan Yun] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Bai, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Anesthesia & Pain Res Inst, Seoul, South Korea.	sjbai1@yuhs.ac		Bai, Sun Joon/0000-0001-5027-3232; Shin, Seokyung/0000-0002-2641-0070; Yoo, Young Chul/0000-0002-6334-7541; Choi, Young Deuk/0000-0002-8545-5797; Kim, Chan Yun/0000-0002-8373-9999; Kim, Na Young/0000-0003-3685-2005	Investigator-Initiated Studies Program of Merck Sharp Dohme Corp.	Investigator-Initiated Studies Program of Merck Sharp Dohme Corp.	This study was supported by the grants of the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp. (http://engagezone.merck.com/misp.html). No additional funding sources were received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2015, J ENDOUROL, V29, P304, DOI 10.1089/end.2014.0381; Awad H, 2009, ANESTH ANALG, V109, P473, DOI 10.1213/ane.0b013e3181a9098f; Barczynski M, 2003, SURG ENDOSC, V17, P533, DOI 10.1007/s00464-002-9121-2; Blobner M, 2015, SURG ENDOSC, V29, P627, DOI 10.1007/s00464-014-3711-7; Borahay MA, 2013, J MINIM INVAS GYN, V20, P819, DOI 10.1016/j.jmig.2013.05.005; Dubois PE, 2014, EUR J ANAESTH, V31, P430, DOI 10.1097/EJA.0000000000000094; Emam TA, 2000, ARCH SURG-CHICAGO, V135, P62, DOI 10.1001/archsurg.135.1.62; Frede T, 1999, J ENDOUROL, V13, P191, DOI 10.1089/end.1999.13.191; Fuchs-Buder T, 2007, ACTA ANAESTH SCAND, V51, P789, DOI 10.1111/j.1399-6576.2007.01352.x; Gainsburg DM, 2012, MINERVA ANESTESIOL, V78, P596; Hanna GB, 1997, BRIT J SURG, V84, P1460; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Hemmerling TM, 2003, CAN J ANAESTH, V50, P779, DOI 10.1007/BF03019373; Hong JY, 2010, J CLIN ANESTH, V22, P370, DOI 10.1016/j.jclinane.2009.05.010; Joshipura VP, 2009, SURG LAPARO ENDO PER, V19, P234, DOI 10.1097/SLE.0b013e3181a97012; Kawachi Mark H, 2007, J Natl Compr Canc Netw, V5, P689; Lindekaer AL, 2013, JOVE-J VIS EXP, DOI 10.3791/50045; Madsen MV, 2015, ACTA ANAESTH SCAND, V59, P1, DOI 10.1111/aas.12419; Martini CH, 2014, BRIT J ANAESTH, V112, P498, DOI 10.1093/bja/aet377; Neudecker J, 2002, SURG ENDOSC, V16, P1121, DOI 10.1007/s00464-001-9166-7; Saitoh Y, 2012, J ANESTH, V26, P28, DOI 10.1007/s00540-011-1262-9; Sarli L, 2000, BRIT J SURG, V87, P1161, DOI 10.1046/j.1365-2168.2000.01507.x; Song C, 2006, SURG ENDOSC, V20, P987, DOI 10.1007/s00464-005-0676-6; Song CL, 2006, J BIOMECH, V39, P587, DOI 10.1016/j.jbiomech.2004.12.019; Staehr-Rye AK, 2014, ANESTH ANALG, V119, P1084, DOI 10.1213/ANE.0000000000000316; TAMMISTO T, 1995, ANESTH ANALG, V80, P543, DOI 10.1097/00000539-199503000-00019; Vijayaraghavan N, 2014, SURG LAPARO ENDO PER, V24, P127, DOI 10.1097/SLE.0b013e3182937980; Vlot J, 2013, SURG ENDOSC, V27, P1668, DOI 10.1007/s00464-012-2654-0; Weber ED, 2007, J NEURO-OPHTHALMOL, V27, P285, DOI 10.1097/WNO.0b013e31815b9f67; Wong TT, 2009, INVEST OPHTH VIS SCI, V50, P4097, DOI 10.1167/iovs.08-2822; Yasir M, 2012, SURG-J R COLL SURG E, V10, P71, DOI 10.1016/j.surge.2011.02.003; Yoo YC, 2014, CAN J ANESTH, V61, P322, DOI 10.1007/s12630-014-0112-2	32	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135412	10.1371/journal.pone.0135412	http://dx.doi.org/10.1371/journal.pone.0135412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317357	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100027
J	Bhattacharjee, P; McClarty, LM; Musyoki, H; Anthony, J; Kioko, J; Kaosa, S; Ogwang, BE; Githuka, G; Sirengo, M; Birir, S; Blanchard, JF; Muraguri, N; Isac, S; Moses, S				Bhattacharjee, Parinita; McClarty, Leigh M.; Musyoki, Helgar; Anthony, John; Kioko, Japheth; Kaosa, Shem; Ogwang, Bernard E.; Githuka, George; Sirengo, Martin; Birir, Sarah; Blanchard, James F.; Muraguri, Nicholas; Isac, Shajy; Moses, Stephen			Monitoring HIV Prevention Programme Outcomes among Key Populations in Kenya: Findings from a National Survey	PLOS ONE			English	Article							FEMALE SEX WORKERS; SOCIAL DESIRABILITY BIAS; POLLING BOOTH SURVEYS; STRUCTURAL INTERVENTIONS; CONDOM USE; BEHAVIOR; VIOLENCE; HEALTH; RISK	In preparation for the implementation of the Kenya AIDS Strategic Framework 2014/15-2018/ 19, the Kenya National AIDS and STI Control Programme facilitated a national polling booth survey as part of a baseline assessment of HIV-related risk behaviours among FSWs, MSM, and PWID, and their utilization of existing preventive interventions, as well as structural factors that may influence KPs' vulnerability to HIV. The survey was conducted among " key populations" (female sex workers, men who have sex with men, and people who inject drugs) to understand current HIV risk and prevention behaviours, utilization of existing programmes and services, and experiences of violence. In total, 3,448 female sex workers, 1,308 men who have sex with men, and 690 people who inject drugs were randomly selected to participate in polling booth survey sessions from seven priority sites. Survey responses were aggregated and descriptive statistics derived. In general, reported condom use among all key populations was quite high with paying clients, and lower with regular, non-paying partners. Many participants reported unavailability of condoms or clean injecting equipment within the past month. Exposure to, and utilization of, existing HIV prevention services varied significantly among the groups, and was reported least commonly by female sex workers. Encouragingly, approximately three-quarters of all key population members reported receiving an HIV test in the past three months. All key population groups reported experiencing high levels of physical and sexual violence from partners/clients, and/or arrest and violence by law enforcement officials. Although some of the findings are encouraging, there is room for improvement in HIV prevention programmes and services for key populations across Kenya.	[Bhattacharjee, Parinita; McClarty, Leigh M.; Anthony, John; Blanchard, James F.; Isac, Shajy; Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Musyoki, Helgar; Kioko, Japheth; Kaosa, Shem; Ogwang, Bernard E.; Githuka, George; Sirengo, Martin; Birir, Sarah] Govt Kenya, Minist Hlth, Natl AIDS & STI Control Programme, Nairobi, Kenya; [Kioko, Japheth; Kaosa, Shem; Ogwang, Bernard E.] Partners Hlth & Dev Africa, Nairobi, Kenya; [Muraguri, Nicholas] Govt Kenya, Minist Hlth, Nairobi, Kenya	University of Manitoba	McClarty, LM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada.	ummcclar@myumanitoba.ca		Blanchard, James/0000-0002-4701-590X; McClarty, Leigh/0000-0003-0183-2768	Bill & Melinda Gates Foundation [OPP1032367]; Global Fund to Fight AIDS, Tuberculosis and Malaria [KEN-H-MOF]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Global Fund to Fight AIDS, Tuberculosis and Malaria	This University of Manitoba (principal investigator: JFB) received funding from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org; grant no. OPP1032367) and the Government of Kenya's Ministry of Health received funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria (http://www.theglobalfund.org/en/; grant no. KEN-H-MOF). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Behanzin L, 2013, SEX TRANSM INFECT, V89, P595, DOI 10.1136/sextrans-2012-050884; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Gregson S, 2004, SEX TRANSM INFECT, V80, P36, DOI 10.1136/sti.2004.012088; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hanck SE, 2008, SEX TRANSM DIS, V35, P489, DOI 10.1097/OLQ.0b013e3181653433; Kenya S, 2013, AIDS BEHAV, V17, P2927, DOI 10.1007/s10461-013-0440-1; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; KHPT, 2011, MEAS SEN BEH IND MET; Lowndes CM, 2012, AIDS BEHAV, V16, P1054, DOI 10.1007/s10461-011-0004-1; NACC, 2014, KEN AIDS RESP PROGR; NACC NASCOP, 2014, KEN HIV EST 2014; NASCOP, 2014, 2010 2011 INTE; NASCOP, 2013, KEN MOST RISK POPO S; NASCOP NACC, 2014, KEN HIV PREV REV ROA; National AIDS Control Council (NACC), 2014, KEN AIDS STRAT FRAM; National AIDS Control Council (NACC) and National AIDS and STI Control Programme (NASCOP), 2012, GEOGR MAPP MOST RISK; UNAIDS, 2008, FRAM MON EV HIV PREV; UNAIDS, 2010, COMB HIV PREV TAIL; UNODC, 2012, RAP SIT ASS HIV PREV; Vanwesenbeeck I, 2002, ANN REV SEX RES, V12, P242; Wangalwa G, 2012, PAN AFR MED J S1, V13, P1; Wirtz AL, 2015, JAIDS-J ACQ IMM DEF, V68, pS171, DOI 10.1097/QAI.0000000000000451; World Health Organization, 2014, POL BRIEF CONS GUID	25	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0137007	10.1371/journal.pone.0137007	http://dx.doi.org/10.1371/journal.pone.0137007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313642	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000110
J	Cappel, DA; Lantier, L; Palmisano, BT; Wasserman, DH; Stafford, JM				Cappel, David A.; Lantier, Louise; Palmisano, Brian T.; Wasserman, David H.; Stafford, John M.			CETP Expression Protects Female Mice from Obesity-Induced Decline in Exercise Capacity	PLOS ONE			English	Article							CHOLESTERYL ESTER TRANSFER; OXIDATIVE ENZYME CAPACITIES; HIGH-DENSITY-LIPOPROTEIN; DIABETIC FATTY RATS; SKELETAL-MUSCLE; TRANSGENIC MICE; CARBOHYDRATE FEEDINGS; GLUCOSE-TOLERANCE; GENE-EXPRESSION; WEIGHT-LOSS	Pharmacological approaches to reduce obesity have not resulted in dramatic reductions in the risk of coronary heart disease (CHD). Exercise, in contrast, reduces CHD risk even in the setting of obesity. Cholesteryl Ester Transfer Protein (CETP) is a lipid transfer protein that shuttles lipids between serum lipoproteins and tissues. There are sexual-dimorphisms in the effects of CETP in humans. Mice naturally lack CETP, but we previously reported that transgenic expression of CETP increases muscle glycolysis in fasting and protects against insulin resistance with high-fat diet (HFD) feeding in female but not male mice. Since glycolysis provides an important energy source for working muscle, we aimed to define if CETP expression protects against the decline in exercise capacity associated with obesity. We measured exercise capacity in female mice that were fed a chow diet and then switched to a HFD. There was no difference in exercise capacity between lean, chow-fed CETP female mice and their non-transgenic littermates. Female CETP transgenic mice were relatively protected against the decline in exercise capacity caused by obesity compared to WT. Despite gaining similar fat mass after 6 weeks of HFD-feeding, female CETP mice showed a nearly two-fold increase in run distance compared to WT. After an additional 6 weeks of HFD-feeding, mice were subjected to a final exercise bout and muscle mitochondria were isolated. We found that improved exercise capacity in CETP mice corresponded with increased muscle mitochondrial oxidative capacity, and increased expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha). These results suggest that CETP can protect against the obesity-induced impairment in exercise capacity and may be a target to improve exercise capacity in the context of obesity.	[Stafford, John M.] VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Stafford, John M.] Vanderbilt Univ, Sch Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Cappel, David A.; Lantier, Louise; Palmisano, Brian T.; Wasserman, David H.; Stafford, John M.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Stafford, JM (corresponding author), VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	john.stafford@vanderbilt.edu	Stafford, John/K-7763-2017	Stafford, John/0000-0001-6527-959X; Palmisano, Brian T./0000-0002-2140-1060; Cappel, David/0000-0003-4837-9139	Department of Veterans Affairs [BX002223]; American Heart Association [10GRNT3650024]; Vanderbilt Molecular Endocrinology Training Grant [T32DK007563]; National Institute of General Medical Studies [1F30DK104514, T32 GM07347]; National Institutes of Health Research [R01 DK054902]; National Institute of Diabetes and Digestive and Kidney Diseases national Mouse Metabolic Pheotyping Center program [DK059637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK054902, U2CDK059637, T32DK007563, U24DK059637, F30DK104514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002223] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); Vanderbilt Molecular Endocrinology Training Grant; National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases national Mouse Metabolic Pheotyping Center program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs Career Development Award and Merit Award (BX002223) and the American Heart Association (10GRNT3650024) funding to J.M.S. D.C. was supported by the Vanderbilt Molecular Endocrinology Training Grant (T32DK007563), B.P by Individual Predoctoral National Research Service Award for MD/PhD Fellowships (1F30DK104514) and Public Health Service award (T32 GM07347) from the National Institute of General Medical Studies for the Vanderbilt Medical-Scientist Training Program. D.W. and L.L. were supported by National Institutes of Health Research Project Grant (R01 DK054902). Studies were performed in collaboration with the Vanderbilt Mouse Metabolic Phenotyping Center, which is supported by the National Institute of Diabetes and Digestive and Kidney Diseases national Mouse Metabolic Pheotyping Center program (DK059637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 1994, ARTERIOSCLER THROMB, V14, P1129, DOI 10.1161/01.ATV.14.7.1129; Arii K, 1997, METABOLISM, V46, P1166, DOI 10.1016/S0026-0495(97)90211-0; Asztalos BF, 2010, J LIPID RES, V51, P2405, DOI 10.1194/jlr.P900015; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BARTER PJ, 1982, BIOCHEM J, V208, P1; Berti JA, 2003, J LIPID RES, V44, P1870, DOI 10.1194/jlr.M300036-JLR200; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Cappel DA, 2013, MOL METAB, V2, P457, DOI 10.1016/j.molmet.2013.08.007; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; COYLE EF, 1986, J APPL PHYSIOL, V61, P165, DOI 10.1152/jappl.1986.61.1.165; de Vries R, 2005, DIABETES, V54, P3554, DOI 10.2337/diabetes.54.12.3554; El Bouhassani M, 2011, J BIOL CHEM, V286, P17227, DOI 10.1074/jbc.M111.220483; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Fueger PT, 2004, DIABETES, V53, P306, DOI 10.2337/diabetes.53.2.306; Fujimoto Y, 2004, AM J PHYSIOL-ENDOC M, V287, pE414, DOI 10.1152/ajpendo.00575.2003; Fujimoto Y, 2006, DIABETES, V55, P2479, DOI 10.2337/db05-1511; Haseler LJ, 2004, J APPL PHYSIOL, V97, P1077, DOI 10.1152/japplphysiol.01321.2003; HUGHES VA, 1993, AM J PHYSIOL, V264, pE855, DOI 10.1152/ajpendo.1993.264.6.E855; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; KAHRI J, 1994, METABOLISM, V43, P1498, DOI 10.1016/0026-0495(94)90007-8; Kelley DE, 1996, DIABETES, V45, P371; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lehti M, 2013, CIRCULATION, V128, P2364, DOI 10.1161/CIRCULATIONAHA.113.001551; MacLean PS, 2005, J CLIN ENDOCR METAB, V90, P2250, DOI 10.1210/jc.2004-1325; MacLean PS, 2000, OBES RES, V8, P62, DOI 10.1038/oby.2000.9; Magkos F, 2009, LIPIDS, V44, P459, DOI 10.1007/s11745-009-3285-7; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MAROTTI KR, 1992, ARTERIOSCLER THROMB, V12, P736, DOI 10.1161/01.ATV.12.6.736; Mettaure B, 2001, J AM COLL CARDIOL, V38, P947, DOI 10.1016/S0735-1097(01)01460-7; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; NEUFER PD, 1987, J APPL PHYSIOL, V62, P983, DOI 10.1152/jappl.1987.62.3.983; Ribisl PM, 2007, DIABETES CARE, V30, P2679, DOI 10.2337/dc06-2487; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Sang H, 2015, J CLIN ENDOCR METAB, V100, P870, DOI 10.1210/jc.2014-2979; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; TATO F, 1995, ARTERIOSCL THROM VAS, V15, P446, DOI 10.1161/01.ATV.15.4.446; Villard EF, 2012, ARTERIOSCL THROM VAS, V32, P2341, DOI 10.1161/ATVBAHA.112.252841; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; WRIGHT DA, 1991, J APPL PHYSIOL, V71, P1082, DOI 10.1152/jappl.1991.71.3.1082; Wu K, 2010, ENDOCRINOLOGY, V151, P3566, DOI 10.1210/en.2010-0204; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136915	10.1371/journal.pone.0136915	http://dx.doi.org/10.1371/journal.pone.0136915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313355	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000107
J	Chan, T; de Lusignan, S; Cooper, A; Elliott, M				Chan, Tom; de Lusignan, Simon; Cooper, Alun; Elliott, Mary			Improving Osteoporosis Management in Primary Care: An Audit of the Impact of a Community Based Fracture Liaison Nurse	PLOS ONE			English	Article							PRACTICE COMPUTER RECORDS; SECONDARY PREVENTION; POSTMENOPAUSAL WOMEN; FRAGILITY FRACTURES; SOCIAL DEPRIVATION; OLDER-PEOPLE; UK; FALLS; LESSONS; QUALITY	Background Osteoporosis and associated fragility fractures are a major health problem; they are more common in women over 50 years old. Fracture liaison nurses have been widely used in secondary care to promote the recognition of fragility fractures and to promote the use of bone-sparing medication to reduce the risk of recurrent facture. Objective Audit the impact of a primary care based fracture liaison nurse on the detection of fragility fractures in people with osteoporosis and their treatment with a bone-sparing medication. Method This audit took place in 12 GP practices using 'before and after' cross-sectional extractions of anonymised routine data. We report, for females 50-74 years and >= 75 years old, socioeconomic deprivation index, the prevalence of osteoporosis, recording of fragility fractures, dual-energy X-ray absorptiometry (DXA), smoking, and body-mass index (BMI) and use of appropriate bone-sparing medication. We used Altman's test of independent proportions to compare before and after data. Results Recording of the diagnosis of osteoporosis increased from 1.5% to 1.7% (p = 0.059); the rate of DXA scans fell (1.8% to 1.4%; p = 0.002); recording of fractures and fragility fractures more than doubled (0.8% to 2.0%; p<0.001 and 0.5% to 1.5%; p<0.001, respectively) with approximate doubling of the recording of smoking, and BMI (p<0.001 level). Fragility fracture recording rose from 8.8% to 15% in females aged 50 to 74, and from 0.8% to 2.3% in people aged >= 75years old (p<0.001). There appeared to be inequity in the service, people who were least deprived were more likely to receive DXA scans and the more deprived to be prescribed bone sparing agents. Conclusion A fracture liaison nurse in primary care has been associated with a period of improved management. Liaison nurses based in different parts of the health system should be tested in a prospective trial.	[Chan, Tom; de Lusignan, Simon] Univ Surrey, Dept Hlth Care Policy & Management, Clin Informat, Guildford GU2 5XH, Surrey, England; [Cooper, Alun; Elliott, Mary] Bridge Med Ctr, Crawley, W Sussex, England	University of Surrey	Chan, T (corresponding author), Univ Surrey, Dept Hlth Care Policy & Management, Clin Informat, Guildford GU2 5XH, Surrey, England.	t.chan@surrey.ac.uk	de Lusignan, Smion/S-7838-2019	de Lusignan, Smion/0000-0002-8553-2641	Crawley Practice Based Commissioning (PBC) group	Crawley Practice Based Commissioning (PBC) group	Crawley Practice Based Commissioning (PBC) group funded the audit.	Altman DG, 1990, PRACTICAL STAT MED R, P234; [Anonymous], 2007, SUMM M REP WHO SCI G; [Anonymous], IR MED J; Chakravarthy J, 2008, INT J CLIN PRACT, V62, P382, DOI 10.1111/j.1742-1241.2007.01662.x; Charalambous CP, 2009, ANN ROY COLL SURG, V91, P596, DOI 10.1308/003588409X432400; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; Cooper A, 2002, BRIT J GEN PRACT, V52, P311; Court-Brown CM, 2011, OSTEOPOROSIS INT, V22, P1211, DOI 10.1007/s00198-010-1315-1; Crandall CJ, 2012, OSTEOPOROSIS INT, V23, P1503, DOI 10.1007/s00198-011-1736-5; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; de Lusignan S, 2006, FAM PRACT, V23, P253, DOI 10.1093/fampra/cmi106; de Lusignan S, 2005, PUBLIC HEALTH, V119, P771, DOI 10.1016/j.puhe.2004.10.018; de Lusignan S, 2011, Yearb Med Inform, V6, P112; de Lusignan S, 2003, PUBLIC HEALTH, V117, P438, DOI 10.1016/S0033-3506(03)00129-X; de Lusignan Simon, 2006, Inform Prim Care, V14, P59; de Lusignan S, 2007, INT J MED INFORM, V76, P261, DOI 10.1016/j.ijmedinf.2005.11.003; de Lusignan Simon, 2004, Inform Prim Care, V12, P147; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; de Lusignan Simon, 2011, Inform Prim Care, V19, P127; de Lusignan S, 2011, FAM PRACT, V28, P638, DOI 10.1093/fampra/cmr036; de Lusignan S, 2008, J AMBUL CARE MANAG, V31, P201, DOI 10.1097/01.JAC.0000324664.88131.d2; de Lusignan Simon, 2006, Inform Prim Care, V14, P153; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010; Department of Health, 2004, QUAL OUTC FRAM GUID; Department of Health, 2003, INV GEN PRACT NEW GE; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Goldhahn J, 2010, BONE, V46, P267, DOI 10.1016/j.bone.2009.10.004; Gormley KJ, 2011, INT J OLDER PEOPLE N, V6, P307, DOI 10.1111/j.1748-3743.2011.00303.x; Gray Sarah, 2012, Menopause Int, V18, P30, DOI 10.1258/mi.2012.012002; Harvey M, 2002, BRIT J GEN PRACT, V52, P496; Iki Masayuki, 2005, Clin Calcium, V15, P156; Ip TP, 2010, OSTEOPOROSIS INT, V21, pS605, DOI 10.1007/s00198-010-1398-8; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P1395, DOI 10.1007/s00198-008-0712-1; Larsson S, 2007, INJURY, V38, P1225, DOI 10.1016/j.injury.2007.09.004; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Michalakidis G, 2010, STUD HEALTH TECHNOL, V160, P724, DOI 10.3233/978-1-60750-588-4-724; Murray J, 2010, FAM PRACT, V27, P430, DOI 10.1093/fampra/cmq030; National Institute for Health and Care Excellence (NICE) Centre for Clinical Practice, 2013, NICE CLIN GUID; National Institute for Health and Clinical Excellence (NICE), 2008, COST REP TECHN APPR; National Osteoporosis Society (NOS), OST DIR ENH SERV DES; National Research Authority, NAT RES ETH SERV NRE; Neyens JC, 2011, J AM MED DIR ASSOC, V12, P410, DOI 10.1016/j.jamda.2010.07.018; NICE, 2008, AL ET RIS RAL STRONT; NOS (National Osteoporosis Society), 2013, VIT D BON HLTH PRACT; Office for National Statistics, 2003, CENS 2001 S; Oliver D, 2009, ARCH GERONTOL GERIAT, V49, pS7, DOI 10.1016/S0167-4943(09)70005-6; Pearson D, 2004, OSTEOPOROSIS INT, V15, P132, DOI 10.1007/s00198-003-1499-8; Prasad N, 2006, ANN ROY COLL SURG, V88, P470, DOI 10.1308/003588406X116891; Schade CP, 2006, J AM MED INFORM ASSN, V13, P470, DOI 10.1197/jamia.M2041; van Vlymen J, 2005, STUD HEALTH TECHNOL, V116, P1010	51	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0132146	10.1371/journal.pone.0132146	http://dx.doi.org/10.1371/journal.pone.0132146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313924	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000004
J	Del Pino, F; Jara, C; Pino, L; Medina-Munoz, MC; Alvarez, E; Godoy-Herrera, R				Del Pino, Francisco; Jara, Claudia; Pino, Luis; Cristina Medina-Munoz, Maria; Alvarez, Eduardo; Godoy-Herrera, Raul			The Identification of Congeners and Aliens by Drosophila Larvae	PLOS ONE			English	Article							BEHAVIOR; COMMUNITIES	We investigated the role of Drosophila larva olfactory system in identification of congeners and aliens. We discuss the importance of these activities in larva navigation across substrates, and the implications for allocation of space and food among species of similar ecologies. Wild type larvae of cosmopolitan D. melanogaster and endemic D. pavani, which cohabit the same breeding sites, used species-specific volatiles to identify conspecifics and aliens moving toward larvae of their species. D. gaucha larvae, a sibling species of D. pavani that is ecologically isolated from D. melanogaster, did not respond to melanogaster odor cues. Similar to D. pavani larvae, the navigation of pavani female x gaucha male hybrids was influenced by conspecific and alien odors, whereas gaucha female x pavani male hybrid larvae exhibited behavior similar to the D. gaucha parent. The two sibling species exhibited substantial evolutionary divergence in processing the odor inputs necessary to identify conspecifics. Orco (Or83b) mutant larvae of D. melanogaster, which exhibit a loss of sense of smell, did not distinguish conspecific from alien larvae, instead moving across the substrate. Syn(97CS) and rut larvae of D. melanogaster, which are unable to learn but can smell, moved across the substrate as well. The Orco (Or83b), Syn(97CS) and rut loci are necessary to orient navigation by D. melanogaster larvae. Individuals of the Trana strain of D. melanogaster did not respond to conspecific and alien larval volatiles and therefore navigated randomly across the substrate. By contrast, larvae of the Til-Til strain used larval volatiles to orient their movement. Natural populations of D. melanogaster may exhibit differences in identification of conspecific and alien larvae. Larval locomotion was not affected by the volatiles.	[Del Pino, Francisco; Jara, Claudia; Pino, Luis; Alvarez, Eduardo; Godoy-Herrera, Raul] Univ Chile, Inst Ciencias Biomed, Lab Etol Genet & Evoluc Conducta, Programa Genet Humana,Fac Med, Independencia 1027, Santiago, Chile; [Cristina Medina-Munoz, Maria] Univ Playa Ancha Ciencias Educ, Fac Ciencias, Dept Biol, Valparaiso, Chile	Universidad de Chile	Godoy-Herrera, R (corresponding author), Univ Chile, Inst Ciencias Biomed, Lab Etol Genet & Evoluc Conducta, Programa Genet Humana,Fac Med, Independencia 1027, Santiago, Chile.	raulgodoy.herrera@gmail.com	Corrêa, Marcio N Nunes/D-1034-2019	Corrêa, Marcio N Nunes/0000-0003-0855-2750; GODOY-HERRERA, RAUL/0000-0003-3272-839X				ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Ashburner M., 2004, DROSOPHILA LAB HDB; ATKINSON WD, 1981, J ANIM ECOL, V50, P461, DOI 10.2307/4067; Barker JSF, 1990, ECOLOGICAL EVOLUTION; BEAVER RA, 1977, J ANIM ECOL, V46, P783, DOI 10.2307/3640; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; BRNCIC D, 1957, EVOLUTION, V11, P300, DOI 10.2307/2405794; Brncic D, 1987, MEDIO AMBIENTE, V8, P3; BRNCIC D, 1970, ESSAYS EVOLUTION GEN, P401; Burdick A. B., 1954, DROSOPH INF SERV, V28, P170; Del Pino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102159; Del Pino F, 2012, BEHAV GENET, V42, P162, DOI 10.1007/s10519-011-9490-1; DESOUZA HML, 1970, AM NAT, V104, P175, DOI 10.1086/282648; Diegelmann S, 2013, J EXP BIOL, V216, P939, DOI 10.1242/jeb.076208; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Fogleman J.C., 1990, P121; FOSTER JLM, 1993, APPL ENVIRON MICROB, V59, P1; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Godoy-Herrera R, 2005, GENETICA, V124, P33, DOI 10.1007/s10709-004-5913-8; GODOYHERRERA R, 1986, HEREDITY, V56, P33, DOI 10.1038/hdy.1986.6; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Iyengar A, 2010, P NATL ACAD SCI USA, V107, P9855, DOI 10.1073/pnas.1003856107; KOREFSA.S, 1961, EVOLUTION, V15, P401, DOI 10.2307/2406308; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lavagnino NJ, 2013, BEHAV GENET, V43, P348, DOI 10.1007/s10519-013-9592-z; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; McCullagh G, 1989, GEN LINEAR METHODS; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Michels B, 2011, LEARN MEMORY, V18, P332, DOI 10.1101/lm.2101411; Parsons P, 1983, EVOLUTIONARY BIOL CO; Powell JR, 1997, PROGR PROSPECTS EVOL; Saumweber T, 2011, CHEM SENSES, V36, P223, DOI 10.1093/chemse/bjq128; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Swarup S, 2013, P NATL ACAD SCI USA, V110, P1017, DOI 10.1073/pnas.1220168110; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Wilson E.O., 1975, P1; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Zuleta V, 2008, BEHAV GENET, V38, P525, DOI [10.1007/s10519-008-9217-0, DOI 10.1007/S10519-008-9217-0]	44	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136363	10.1371/journal.pone.0136363	http://dx.doi.org/10.1371/journal.pone.0136363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313007	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000056
J	Mather, KJ; Pan, Q; Knowler, WC; Funahashi, T; Bray, GA; Arakaki, R; Falkner, B; Sharma, K; Goldstein, BJ				Mather, Kieren J.; Pan, Qing; Knowler, William C.; Funahashi, Tohru; Bray, George A.; Arakaki, Richard; Falkner, Bonita; Sharma, Kumar; Goldstein, Barry J.		DPP Res Grp	Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; TYPE-2; LEVEL; MICROALBUMINURIA; PROGRESSION; OBESITY; RATIO	Background and Objectives Molecular data suggests that adiponectin may directly regulate urinary albumin excretion. In the Diabetes Prevention Program (DPP) we measured adiponectin and albuminuria before and after intervention, and we previously reported increases in adiponectin with interventions. Here we have used the DPP dataset to test the hypothesis that treatment-related increases in adiponectin may reduce albuminuria in obesity. Design, Setting, Participants and Methods We evaluated cross-sectional correlations between plasma adiponectin and urinary albumin excretion at baseline, and the relationship of treatment-related changes in adiponectin and albuminuria. Baseline and follow-up urine albumin to creatinine ratios (ACR (albumin to creatinine ratio)) and plasma adiponectin concentration were available in 2553 subjects. Results Adjusting for age, sex and race/ethnicity, we observed a statistically significant but weak inverse relationship between adiponectin and ACR at baseline (conditional Spearman's rho = (-) 0.04, p = 0.04). Although DPP treatments significantly increased plasma adiponectin, there were no treatment effects on ACR and no differences in ACR across treatment groups. There was a weak direct (not inverse) association between change in adiponectin and change in albuminuria (adjusted Spearman's rho = (+) 0.04, p = 0.03). Conclusions In a large, well-characterized cohort of obese dysglycemic subjects we observed a weak inverse association between circulating adiponectin concentrations and urinary albumin excretion at baseline. Contrary to the hypothesized effect, treatment-related increases in plasma adiponectin were not associated with a reduction in ACR. The association of change in adiponectin with change in ACR should be assessed in populations with overt albuminuria before excluding a beneficial effect of increasing adiponectin to reduce ACR in obesity.	[Mather, Kieren J.] Indiana Univ, Div Endocrinol & Metab, Indianapolis, IN 46204 USA; [Pan, Qing] George Washington Univ, Biostat Ctr, Rockville, MD USA; [Knowler, William C.] NIDDK, Diabet Epidemiol & Clin Res Sect, Phoenix, AZ USA; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka, Japan; [Bray, George A.] Pennington Biomed Ctr, Baton Rouge, LA USA; [Arakaki, Richard] Univ Hawaii, Dept Med Diabet & Endocrinol, Honolulu, HI 96822 USA; [Falkner, Bonita] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Sharma, Kumar] Univ Calif San Diego, Div Nephrol & Hypertens, Vet Affairs San Diego Healthcare Syst, San Diego, CA 92103 USA; [Sharma, Kumar] Univ Calif San Diego, Ctr Renal Translat Med, Vet Affairs San Diego Healthcare Syst, Dept Med, San Diego, CA 92103 USA; [Goldstein, Barry J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Endocrinol Diabet & Metab Dis, Philadelphia, PA 19107 USA	Indiana University System; Indiana University-Purdue University Indianapolis; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Osaka University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Hawaii System; Jefferson University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Jefferson University	Mather, KJ (corresponding author), Indiana Univ, Div Endocrinol & Metab, Indianapolis, IN 46204 USA.	dppmail@bsc.gwu.edu	Falkner, Bonita/Y-8451-2019; Mather, Kieren/ABE-4117-2020		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [U01 DK048489]; NIDDK; Indian Health Service; Office of Research on Minority Health; National Institute of Child Health and Human Development; National Institute on Aging; Centers for Disease Control and Prevention; Office of Research on Women's Health; American Diabetes Association; Sandra A. Daugherty foundation; McKesson BioServices Corp.; Matthews Media Group, Inc.; Henry M. Jackson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048413, U01DK048407, ZIADK075078, U01DK048349, U01DK048489, U01DK048397, U01DK048411, U01DK048406, P30DK017047, U01DK048485, U01DK048380, U01DK048377, U01DK048404, U01DK048381, U01DK048375, U01DK048387, U01DK048443, U01DK048434, U01DK048514, U01DK048468, U01DK048412, U01DK048437, U01DK048400] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indian Health Service(United States Department of Health & Human Services); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); American Diabetes Association(American Diabetes Association); Sandra A. Daugherty foundation; McKesson BioServices Corp.; Matthews Media Group, Inc.; Henry M. Jackson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study; and collection, management, analysis, and interpretation of the data (U01 DK048489). The Southwestern American Indian Centers were supported directly by the NIDDK and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centers. Funding for data collection and participant support was also provided by the Office of Research on Minority Health, the National Institute of Child Health and Human Development, the National Institute on Aging, the Centers for Disease Control and Prevention, the Office of Research on Women's Health, and the American Diabetes Association. Bristol-Myers Squibb and Parke-Davis provided medication. This research was also supported, in part, by the intramural research program of the NIDDK. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center. Adiponectin analyses were supported by a grant from the Sandra A. Daugherty foundation (to KM). The sponsor of this study was represented on the Steering Committee and played a part in study design, how the study was done, and publication. The funding agency was not represented on the writing group, although all members of the Steering Committee had input into the report's contents. All authors in the writing group had access to all data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2008, DIABETOLOGIA, V51, P1707, DOI 10.1007/s00125-008-1081-1; Bray GA, 1999, DIABETES CARE, V22, P623; Costacou T, 2005, DIABETOLOGIA, V48, P41, DOI 10.1007/s00125-004-1597-y; Friedman A, 2008, DIABETES CARE, V31, P2344, DOI 10.2337/dc08-0148; Fujita H, 2006, ENDOCR J, V53, P745, DOI 10.1507/endocrj.K06-016; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Gui MH, 2008, CHINESE MED J-PEKING, V121, P2509, DOI 10.1097/00029330-200812020-00008; Kacso I, 2012, INT UROL NEPHROL, V44, P1151, DOI 10.1007/s11255-011-0064-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Looker HC, 2004, J CLIN ENDOCR METAB, V89, P4010, DOI 10.1210/jc.2003-031916; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Menzaghi C, 2011, DIABETOLOGIA, V54, P812, DOI 10.1007/s00125-010-2037-9; Meyvis K, 2013, METABOLISM, V62, P1570, DOI 10.1016/j.metabol.2013.05.023; Mills KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076902; Miyazaki Y, 2007, KIDNEY INT, V72, P1367, DOI 10.1038/sj.ki.5002516; Molitch ME, 2009, DIABETES CARE, V32, P720, DOI 10.2337/dc08-1400; Navaneethan SD, 2010, OBES SURG, V20, P308, DOI 10.1007/s11695-009-0026-1; Nishimura A, 2006, CLIN CHIM ACTA, V371, P163, DOI 10.1016/j.cca.2006.03.008; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; Saraheimo M, 2008, DIABETES CARE, V31, P1165, DOI 10.2337/dc07-2306; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Stepien M, 2013, MED SCI MONITOR, V19, P1063, DOI 10.12659/MSM.889390; Stevens LA, 2010, NEPHROL DIAL TRANSPL, V25, P449, DOI 10.1093/ndt/gfp510; Tsioufis C, 2005, AM J CARDIOL, V96, P946, DOI 10.1016/j.amjcard.2005.05.052; Yan M, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/868732; Yano Yuichiro, 2007, J Clin Hypertens (Greenwich), V9, P775, DOI 10.1111/j.1524-6175.2007.07321.x; Yenicesu M, 2005, CLIN NEPHROL, V64, P12; Yokoyama H, 2007, METABOLISM, V56, P1458, DOI 10.1016/j.metabol.2007.06.010	33	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136853	10.1371/journal.pone.0136853	http://dx.doi.org/10.1371/journal.pone.0136853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312480	Green Published, gold			2022-12-27	WOS:000360144000102
J	Plessow, R; Arora, NK; Brunner, B; Tzogiou, C; Eichler, K; Brugger, U; Wieser, S				Plessow, Rafael; Arora, Narendra Kumar; Brunner, Beatrice; Tzogiou, Christina; Eichler, Klaus; Bruegger, Urs; Wieser, Simon			Social Costs of Iron Deficiency Anemia in 6-59-Month-Old Children in India	PLOS ONE			English	Article							GLOBAL BURDEN; INFANCY; DISEASE	Introduction Inadequate nutrition has a severe impact on health in India. According to the WHO, iron deficiency is the single most important nutritional risk factor in India, accounting for more than 3% of all disability-adjusted life years (DALYs) lost. We estimate the social costs of iron deficiency anemia (IDA) in 6-59-month-old children in India in terms of intangible costs and production losses. Materials and Methods We build a health economic model estimating the life-time costs of a birth cohort suffering from IDA between the ages of 6 and 59 months. The model is stratified by 2 age groups (623 and 24-59-months), 2 geographical areas (urban and rural), 10 socio-economic strata and 3 degrees of severity of IDA (mild, moderate and severe). Prevalence of anemia is calculated with the last available National Family Health Survey. Information on the health consequences of IDA is extracted from the literature. Results IDA prevalence is 49.5% in 6-23-month-old and 39.9% in 24-58-month-old children. Children living in poor households in rural areas are particularly affected but prevalence is high even in wealthy urban households. The estimated yearly costs of IDA in 6-59-month-old children amount to intangible costs of 8.3 m DALYs and production losses of 24,001 m USD, equal to 1.3% of gross domestic product. Previous calculations have considerably underestimated the intangible costs of IDA as the improved WHO methodology leads to a threefold increase of DALYs due to IDA. Conclusion Despite years of iron supplementation programs and substantial economic growth, IDA remains a crucial public health issue in India and an obstacle to the economic advancement of the poor. Young children are especially vulnerable due to the irreversible effects of IDA on cognitive development. Our research may contribute to the design of new effective interventions aiming to reduce IDA in early childhood.	[Plessow, Rafael; Brunner, Beatrice; Tzogiou, Christina; Eichler, Klaus; Bruegger, Urs; Wieser, Simon] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland; [Arora, Narendra Kumar] INCLEN, Int Clin Epidemiol Network, New Delhi, India	Zurich University of Applied Sciences	Wieser, S (corresponding author), Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland.	simon.wieser@zhaw.ch	Wieser, Simon/AAC-1589-2022; Wieser, Simon/AAH-6581-2020	Wieser, Simon/0000-0003-1821-2944; Tzogiou, Christina/0000-0001-8100-0034	Nestle Research Center; Nestle Nutrition Institute; Winterthur Institute of Health Economics	Nestle Research Center(Nestle SA); Nestle Nutrition Institute(Nestle SA); Winterthur Institute of Health Economics	The study was supported by the Nestle Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KE and SW have received speaker honorarium and conference travel grants from Nestle Nutrition Institute. Winterthur Institute of Health Economics provided support in the form of salaries for authors RP, BB, CT, KE, UB and SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Winterthur Institute of Health Economics is an institute at the Zurich University of Applied Sciences, a publicly funded Swiss University. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwal R, 2013, NEONATOLOGY, V103, P54, DOI 10.1159/000342227; Almond DE, 2007, NBER WORKING PAPERS; Alvarez-Uria G, 2014, ANEMIA, V2014, DOI 10.1155/2014/176182; Anand T, 2014, NUTRITION, V30, P764, DOI 10.1016/j.nut.2013.11.022; Badham J, 2007, EC ADDRESSING NUTR A; Banerjee Abhijit, 2011, POOR ECONOMICS A RAD; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Deaton A., 2009, Economic and Political Weekly, V44, P42; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; Evaluation IfHMa, 2013, GLOB HLTH DAT EXCH I; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058573; Government of India, CENS IND 2011; Institue for Health Metrics and Evaluation, 2015, GBD PROF IND 2013; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International Labour Organization, 2015, ILOSTAT DAT 2015; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Lawlor DA, 2008, EPIDEMIOLOGY, V19, P206, DOI 10.1097/EDE.0b013e3181635ddc; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Misra S, CLIN EPIDEMIOL GLOB; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, 1996, GLOBAL BURDEN DIS; Nair KM, 2009, INDIAN J MED RES, V130, P634; OECD, OECD EC OUTLOOK; Pasricha SR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-617; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; R Core Team, 2021, R LANGUAGE ENV STAT; Rama M., 2015, ADDRESSING INEQUALIT; Rastogi T, 2002, GLOBAL BURDEN IRON D; Rutstein S. O., 2004, DHS WEALTH INDEX; Sachdev HPS, 2013, EUR J CLIN NUTR, V67, P475, DOI 10.1038/ejcn.2012.212; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Smith D, 2000, CHE TECHNICAL PAPER, V19; Song SG, 2013, ECON HUM BIOL, V11, P474, DOI 10.1016/j.ehb.2013.08.001; Srivastava A, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-8; Stein A. J., 2005, ANAL HLTH BENEFITS B; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO DoHSaIS, 2013, WHO METH DAT SOURC G; Wieser S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1167; World Bank, WORLD DEV IND WORLD; World Health Organization, 2011, SER FERR CONC ASS IR	44	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136581	10.1371/journal.pone.0136581	http://dx.doi.org/10.1371/journal.pone.0136581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313356	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000071
J	Ridderberg, W; Nielsen, SM; Norskov-Lauritsen, N				Ridderberg, Winnie; Nielsen, Signe Maria; Norskov-Lauritsen, Niels			Genetic Adaptation of Achromobacter sp during Persistence in the Lungs of Cystic Fibrosis Patients	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; ESCHERICHIA-COLI; ALCALIGENES XYLOSOXIDANS; BETA-LACTAMASE; KDP-ATPASE; RESISTANCE; EXPRESSION; REVEALS	Achromobacter species are increasingly isolated from the respiratory tract of cystic fibrosis patients and often a chronic infection is established. How Achromobacter sp. adapts to the human host remains uncharacterised. By comparing longitudinally collected isolates of Achromobacter sp. isolated from five CF patients, we have investigated the within-host evolution of clonal lineages. The majority of identified mutations were isolate-specific suggesting co-evolution of several subpopulations from the original infecting isolate. The largest proportion of mutated genes were involved in the general metabolism of the bacterium, but genes involved in virulence and antimicrobial resistance were also affected. A number of virulence genes required for initiation of acute infection were selected against, e.g. genes of the type I and type III secretion systems and genes related to pilus and flagellum formation or function. Six antimicrobial resistance genes or their regulatory genes were mutated, including large deletions affecting the repressor genes of an RND-family efflux pump and a beta-lactamase. Convergent evolution was observed for five genes that were all implicated in bacterial virulence. Characterisation of genes involved in adaptation of Achromobacter to the human host is required for understanding the pathogen-host interaction and facilitate design of future therapeutic interventions.	[Ridderberg, Winnie; Nielsen, Signe Maria; Norskov-Lauritsen, Niels] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Nielsen, Signe Maria] Aarhus Univ, Inst Clin Med, Hlth, Aarhus, Denmark	Aarhus University; Aarhus University	Ridderberg, W (corresponding author), Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark.	winnijen@rm.dk		Nielsen, Signe Maria/0000-0002-6846-0236	Augustinus Fonden	Augustinus Fonden	WR received funding from Augustinus Fonden (http://www.augustinusfonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoureux L, 2013, J CYST FIBROS, V12, P170, DOI 10.1016/j.jcf.2012.08.005; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bador J, 2013, ANTIMICROB AGENTS CH, V57, P603, DOI 10.1128/AAC.01243-12; Bador J, 2011, ANTIMICROB AGENTS CH, V55, P4912, DOI 10.1128/AAC.00341-11; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; BARTH AL, 1995, J CLIN MICROBIOL, V33, P2192, DOI 10.1128/JCM.33.8.2192-2194.1995; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brandon L, 2000, MOL MICROBIOL, V38, P1086, DOI 10.1046/j.1365-2958.2000.02219.x; Carpenter EP, 1998, NATURE, V394, P299, DOI 10.1038/28431; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Chrysostomou C, 2015, ACS CHEM BIOL, V10, P875, DOI 10.1021/cb500755j; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; Darch SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07649; Doi Y, 2008, ANTIMICROB AGENTS CH, V52, P1952, DOI 10.1128/AAC.01463-07; Dunn MF, 2008, TRENDS BIOCHEM SCI, V33, P254, DOI 10.1016/j.tibs.2008.04.008; Emerson J, 2010, PEDIATR PULM, V45, P363, DOI 10.1002/ppul.21198; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Escamilla-Hernandez R, 2012, J BACTERIOL, V194, P3137, DOI 10.1128/JB.00071-12; Gao QQ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-143; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; Grant GA, 1996, PROTEIN SCI, V5, P34; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Hirschhausen N, 2013, INT J MED MICROBIOL, V303, P685, DOI 10.1016/j.ijmm.2013.09.012; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Hu YF, 2015, ANTIMICROB AGENTS CH, V59, P1152, DOI 10.1128/AAC.04260-14; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; Jakobsen TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068484; Jin W, 2004, MICROBIOL-SGM, V150, P1485, DOI 10.1099/mic.0.26811-0; Kanellopoulou M, 2004, EUR J CLIN MICROBIOL, V23, P336, DOI 10.1007/s10096-004-1105-9; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Krzewinski JW, 2001, J CLIN MICROBIOL, V39, P3597, DOI 10.1128/JCM.39.10.3597-3602.2001; Lambiase A, 2011, EUR J CLIN MICROBIOL, V30, P973, DOI 10.1007/s10096-011-1182-5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; McAdam PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024301; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; Miyazaki E, 1999, J BACTERIOL, V181, P2846, DOI 10.1128/JB.181.9.2846-2851.1999; Negoro S, 2000, APPL MICROBIOL BIOT, V54, P461, DOI 10.1007/s002530000434; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; RAMAKRISHNAN T, 1964, J BACTERIOL, V87, P566, DOI 10.1128/JB.87.3.566-573.1964; Ricci V, 2014, WORLD J GASTROENTERO, V20, P630, DOI 10.3748/wjg.v20.i3.630; Ridderberg W, 2012, J CLIN MICROBIOL, V50, P2688, DOI 10.1128/JCM.00728-12; Ridderberg W, 2011, J CYST FIBROS, V10, P466, DOI 10.1016/j.jcf.2011.07.004; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thomas SR, 2000, THORAX, V55, P795, DOI 10.1136/thorax.55.9.795; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; Turabelidze D, 2000, J CLIN MICROBIOL, V38, P4242, DOI 10.1128/JCM.38.11.4242-4245.2000; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; Wang M, 2013, J CYST FIBROS, V12, P638, DOI 10.1016/j.jcf.2013.04.013; Watson ME, 2004, MICROBIOL-SGM, V150, P2947, DOI 10.1099/mic.0.27230-0; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zeng XM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00128; Zhuo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108409	77	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136790	10.1371/journal.pone.0136790	http://dx.doi.org/10.1371/journal.pone.0136790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313451	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000096
J	Wabnig, S; Liewald, JF; Yu, SC; Gottschalk, A				Wabnig, Sebastian; Liewald, Jana Fiona; Yu, Szi-chieh; Gottschalk, Alexander			High-Throughput All-Optical Analysis of Synaptic Transmission and Synaptic Vesicle Recycling in Caenorhabditis elegans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEINS; NEUROMUSCULAR-JUNCTION; OPTOGENETIC ANALYSIS; RNA INTERFERENCE; GENES; RECEPTOR; SYNAPTOTAGMIN; MUTANTS; CHANNELRHODOPSIN-2; INTERROGATION	Synaptic vesicles (SVs) undergo a cycle of biogenesis and membrane fusion to release transmitter, followed by recycling. How exocytosis and endocytosis are coupled is intensively investigated. We describe an all-optical method for identification of neurotransmission genes that can directly distinguish SV recycling factors in C. elegans, by motoneuron photostimulation and muscular RCaMP Ca2+ imaging. We verified our approach on mutants affecting synaptic transmission. Mutation of genes affecting SV recycling (unc-26 synaptojanin, unc-41 stonin, unc-57 endophilin, itsn-1 intersectin, snt-1 synaptotagmin) showed a distinct 'signature' of muscle Ca2+ dynamics, induced by cholinergic motoneuron photostimulation, i.e. faster rise, and earlier decrease of the signal, reflecting increased synaptic fatigue during ongoing photostimulation. To facilitate high throughput, we measured (3-5 times) similar to 1000 nematodes for each gene. We explored if this method enables RNAi screening for SV recycling genes. Previous screens for synaptic function genes, based on behavioral or pharmacological assays, allowed no distinction of the stage of the SV cycle in which a protein might act. We generated a strain enabling RNAi specifically only in cholinergic neurons, thus resulting in healthier animals and avoiding lethal phenotypes resulting from knockdown elsewhere. RNAi of control genes resulted in Ca2+ measurements that were consistent with results obtained in the respective genomic mutants, albeit to a weaker extent in most cases, and could further be confirmed by opto-electrophysiological measurements for mutants of some of the genes, including synaptojanin. We screened 95 genes that were previously implicated in cholinergic transmission, and several controls. We identified genes that clustered together with known SV recycling genes, exhibiting a similar signature of their Ca2+ dynamics. Five of these genes (C27B7.7, erp-1, inx-8, inx-10, spp-10) were further assessed in respective genomic mutants; however, while all showed electrophysiological phenotypes indicative of reduced cholinergic transmission, no obvious SV recycling phenotypes could be uncovered for these genes.	[Gottschalk, Alexander] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Gottschalk, A (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Max von Laue Str 9 & 15, D-60438 Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119	Deutsche Forschungsgemeinschaft [GO1011/3-2, SFB1080-B2, EXC115]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft grant GO1011/3-2, Deutsche Forschungsgemeinschaft grant SFB1080-B2 and Deutsche Forschungsgemeinschaft grant EXC115. URL: http://www.dfg.de/ (all grants to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; BRENNER S, 1974, GENETICS, V77, P71; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chen DD, 2010, SCIENCE, V327, P1261, DOI 10.1126/science.1184840; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Demarco RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001215; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Firnhaber C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003921; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Fleming JT, 1997, J NEUROSCI, V17, P5843; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Gu MY, 2013, ELIFE, V2, DOI 10.7554/eLife.00190; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Hu ZT, 2013, ELIFE, V2, DOI 10.7554/eLife.00967; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Imig C, 2014, NEURON, V84, P416, DOI 10.1016/j.neuron.2014.10.009; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kittelmann M, 2013, P NATL ACAD SCI USA, V110, pE3007, DOI 10.1073/pnas.1305679110; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076877; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Mullen GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040095; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Richter F, 2015, PHOTOCH PHOTOBIO SCI, V14, P270, DOI 10.1039/c4pp00361f; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shim J, 2000, MOL CELLS, V10, P309; Shipley FB, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00028; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Stirman JN, 2010, J NEUROSCI METH, V191, P90, DOI 10.1016/j.jneumeth.2010.05.019; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Yamashita T, 2012, NEUROSCI RES, V73, P1, DOI 10.1016/j.neures.2012.02.012; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; Yu SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057842; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhou KM, 2013, ELIFE, V2, DOI 10.7554/eLife.01180; Zhu HM, 2001, J BIOL CHEM, V276, P41580, DOI 10.1074/jbc.M103550200	77	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135584	10.1371/journal.pone.0135584	http://dx.doi.org/10.1371/journal.pone.0135584			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312752	Green Published, gold			2022-12-27	WOS:000360144000019
J	Leland, JC; Bucher, DJ; Coughran, J				Leland, Jesse C.; Bucher, Daniel J.; Coughran, Jason			Direct Age Determination of a Subtropical Freshwater Crayfish (Redclaw, Cherax quadricarinatus) Using Ossicular Growth Marks	PLOS ONE			English	Article							AUSTRALIA; PARASTACIDAE; VALIDATION; DECAPODA; LIPOFUSCIN; CRUSTACEA	Recent studies have reported that crustacean age determination is possible. We applied a direct ageing method (i.e. transverse cross sectioning of gastric ossicles) to a subtropical freshwater crayfish (Cherax quadricarinatus) sourced from an aquaculture population. Growth mark periodicity and the potential for chronological depositions were investigated by staining C. quadricarinatus with calcein and examining their ossicles a year later. Pterocardiac ossicles were superior to other ageing structures (i.e. other ossicles and eyestalks) and produced repeatable between-reader counts (87% were corroborated and 13% varied by +/- 1). C. quadricarinatus size-at-age data (for an aquaculture population) was described by a von Bertalanffy growth equation (L-infinity = 32 mm occipital carapace length; K = 0.64; t(0) = -0.18; R-2 = 0.81). Ossicular growth marks did not correspond to moult history. The calcein stain was retained over an annual cycle comprising multiple moults, demonstrating that pterocardiac ossicles retain chronological information. The maximum age (3+) corroborated other indirectly-obtained longevity estimates for C. quadricarinatus. Multiple lines of evidence indicate that the growth marks in C. quadricarinatus ossicles are probably deposited annually during winter. The ability to extract age information from subtropical decapods provides substantial opportunities for advancing fisheries and conservation research globally, but further research is needed to provide a definitive validation and elucidate the mechanism governing the accrual of ossicular growth marks.	[Leland, Jesse C.; Bucher, Daniel J.] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Coughran, Jason] Sheridan Coll, Fac Math Phys Sci & Life Sci, Perth, WA 6000, Australia	Southern Cross University	Leland, JC (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia.	jesse.leland@scu.edu.au		Bucher, Daniel/0000-0002-7640-4496	Australian Government [GMS-2010]	Australian Government(Australian GovernmentCGIAR)	This project was supported by funding from the Australian Government through the 2013 Science and Innovation Awards for Young People in Agriculture, Fisheries and Forestry program (http://www.daff.gov.au/Style%20Library/Images/DAFF//__data/assets/pdf/0010/2264509/2013-award-recipients.pdf) awarded to JCL (#GMS-2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu D, 2000, HYDROBIOLOGIA, V418, P15, DOI 10.1023/A:1003883419105; Barki A, 2004, AQUAC RES, V35, P559, DOI 10.1111/j.1365-2109.2004.01051.x; Belchier M, 1998, FRESHWATER BIOL, V39, P439, DOI 10.1046/j.1365-2427.1998.00292.x; Butler GL, 2008, MAR FRESHWATER RES, V59, P684, DOI 10.1071/MF07188; Cameron LM, 2011, AUST J ZOOL, V59, P242, DOI 10.1071/ZO11043; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Chatzinikolaou E, 2007, MAR ECOL PROG SER, V342, P163, DOI 10.3354/meps342163; Coughran Jason, 2013, Journal of Threatened Taxa, V5, P4840; Edsman L., 2010, IUCN 2010 IUCN RED L; Factor J. R., 1995, BIOL LOBSTER HOMARUS; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P25, DOI 10.3354/meps064025; Furse JM, 2012, J CRUSTACEAN BIOL, V32, P677, DOI 10.1163/193724012X633405; Gilligan D, NEW S WALES DEP PRIM, V89; Hartnoll RG, 2001, HYDROBIOLOGIA, V449, P111, DOI 10.1023/A:1017597104367; KAILOLA PJ, 1993, AUSTR FISHERIES RESO; Kilada R, 2015, J CRUSTACEAN BIOL, P1; Kilada R, 2015, FISH RES, V170, P134, DOI 10.1016/j.fishres.2015.05.026; Kilada R, 2012, CAN J FISH AQUAT SCI, V69, P1728, DOI 10.1139/cjfas-2012-0254; King M, 2007, FISHERIES BIOL ASSES, P189; Lawrence C, 2002, BIOL FRESHWATER CRAY; Leland J. C., 2011, V15, P57; Leland Jesse C., 2012, Crustacean Research, P85; Meyer KM, 2007, J ZOOL, V273, P364, DOI 10.1111/j.1469-7998.2007.00336.x; Montgomery SS, 2009, NEW ZEAL J MAR FRESH, V43, P113, DOI 10.1080/00288330909509986; Morgan Gary J., 1997, Records of the Australian Museum Supplement, V23, P1; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Richman NI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0060; SHEEHY MRJ, 1992, J EXP MAR BIOL ECOL, V161, P79, DOI 10.1016/0022-0981(92)90191-C; Stewart J, 2007, J FISH BIOL, V70, P65, DOI 10.1111/j.1095-8649.2006.01256.x; TRAVIS DF, 1963, J ULTRA MOL STRUCT R, V9, P285, DOI 10.1016/S0022-5320(63)80008-8; van der Geest M, 2011, J EXP MAR BIOL ECOL, V399, P1, DOI 10.1016/j.jembe.2011.01.003; Vogt G, 2012, ZOOL ANZ, V251, P1, DOI 10.1016/j.jcz.2011.05.003; Welden NA, 2015, J CRUSTACEAN BIOL, V35, P20, DOI 10.1163/1937240X-00002298	33	29	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134966	10.1371/journal.pone.0134966	http://dx.doi.org/10.1371/journal.pone.0134966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309228	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400044
J	Lai, YJ; Chen, HC; Chou, P				Lai, Yun-Ju; Chen, Hsi-Chung; Chou, Pesus			Gender Difference in the Interaction Effects of Diabetes and Hypertension on Stroke among the Elderly in the Shih-Pai Study, Taiwan	PLOS ONE			English	Article							SEX-DIFFERENCES; FAMILY-HISTORY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; TYPE-2; ATHEROSCLEROSIS; PREVALENCE; MELLITUS; SMOKING; OBESITY	Aims To investigate the interaction effects of diabetes and hypertension on stroke, and also investigate the independent and interaction effects of parental history and environmental factors on diabetes and hypertension in a cross-sectional elderly population. Methods The Shih-Pai Community Medical Service Program was a community-based, fixed cohort study conducted between June 1999 and November 2002. Socio-demographic and clinical data of subjects aged 65 years and older were collected by well-trained interviewers during home visits. Interaction effects were analyzed using Rothman's synergy index (SI). Results In total, 4,124 subjects were included in the study, with 2,284 males and 1,840 females. The synergistic interaction of diabetes and hypertension on stroke was statistically significant in women (SI = 3.16, 95% CI: 1.35-7.39). The synergistic interaction of parental diabetes and being overweight on diabetes was only statistically significant in men, and not in women (SI = 3.30, 95% CI: 1.00-10.83 in men, and SI = 1.15, 95% CI: 0.30-4.39 in women). Conclusions A synergistic interaction was found for diabetes and hypertension in both sexes when parental history and being overweight were combined. Furthermore, combining diabetes and hypertension in elderly women was significant in terms of the risk of stroke. Strategies to control risk factors in individuals at additional high risk are urgently needed.	[Lai, Yun-Ju] Taichung Vet Gen Hosp, Puli Branch, Dept Internal Med, Div Endocrinol & Metab, Nantou, Taiwan; [Lai, Yun-Ju; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lai, Yun-Ju; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lai, Yun-Ju] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Ctr Sleep Disorders, Taipei, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw	Lai, Yun-Ju/AAX-4990-2020; Chen, Hsi-Chung/E-9949-2017	Chen, Hsi-Chung/0000-0003-3191-0093	Shih-Pai Community Medical Service Program at Taipei Veterans General Hospital [VGH 89-404-1, VGH 90-445-1, VGH 91-382-1]	Shih-Pai Community Medical Service Program at Taipei Veterans General Hospital	This study was supported by a grant from the Shih-Pai Community Medical Service Program (VGH 89-404-1, VGH 90-445-1 and VGH 91-382-1) at Taipei Veterans General Hospital.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Cheng S, 2014, CIRCULATION, V130, P820, DOI 10.1161/CIRCULATIONAHA.113.008506; Fagard RH, 2009, DIABETES CARE, V32, pS429, DOI 10.2337/dc09-S354; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Haast RAM, 2012, J CEREBR BLOOD F MET, V32, P2100, DOI 10.1038/jcbfm.2012.141; Hu G, 2005, STROKE, V36, P2538, DOI 10.1161/01.STR.0000190894.30964.75; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Kelly LA, 2007, DIABETES CARE, V30, P2700, DOI 10.2337/dc07-0050; KHOURY MJ, 1995, EPIDEMIOLOGY, V6, P511, DOI 10.1097/00001648-199509000-00009; Lim SJ, 2012, MATURITAS, V73, P331, DOI 10.1016/j.maturitas.2012.09.002; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Machann J, 2005, MAGN RESON MATER PHY, V18, P128, DOI 10.1007/s10334-005-0104-x; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Natali A, 2010, J CLIN ENDOCR METAB, V95, P4703, DOI 10.1210/jc.2009-2721; Nguyen NT, 2011, OBES SURG, V21, P351, DOI 10.1007/s11695-010-0335-4; Ning F, 2013, CAN J DIABETES, V37, P65, DOI 10.1016/j.jcjd.2012.12.001; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Shahid A, 2008, HORM-INT J ENDOCRINO, V7, P313, DOI 10.14310/horm.2002.1212; Simsolo RB, 1999, AM J HYPERTENS, V12, P260, DOI 10.1016/S0895-7061(98)00253-2; Tsao PS, 1998, ARTERIOSCL THROM VAS, V18, P947, DOI 10.1161/01.ATV.18.6.947; Vitale C, 2007, CLIMACTERIC, V10, P16, DOI 10.1080/13697130701602712; Wada J, 1990, JAPANESE J PUBLIC HL, V37, P775; Wikner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061763	30	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136634	10.1371/journal.pone.0136634	http://dx.doi.org/10.1371/journal.pone.0136634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322779	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500025
J	Hess, G; Peterson, MN				Hess, George; Peterson, M. Nils			"Bicycles May Use Full Lane" Signage Communicates US Roadway Rules and Increases Perception of Safety	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRAFFIC SIGNS; COMPREHENSION; INJURIES; GERMANY; WALKING	Many global challenges, including obesity, health care costs, and climate change, could be addressed in part by increasing the use of bicycles for transportation. Concern about the safety of bicycling on roadways is frequently cited as a deterrent to increasing bicycle use in the USA. The use of effective signage along roadways might help alleviate these concerns by increasing knowledge about the rights and duties of bicyclists and motorists, ideally reducing crashes. We administered a web-based survey, using Twitter for recruitment, to examine how well three US traffic control devices communicated the message that bicyclists are permitted in the center of the travel lane and do not have to "get out of the way" to allow motorists to pass without changing lanes: "Bicycles May Use Full Lane" and "Share the Road" signage, and Shared Lane Markings on the pavement. Each was compared to an unsigned roadway. We also asked respondents whether it was safe for a bicyclist to occupy the center of the travel lane. "Bicycles May Use Full Lane" signage was the most consistently comprehended device for communicating the message that bicyclists may occupy the travel lane and also increased perceptions of safety. "Share the Road" signage did not increase comprehension or perceptions of safety. Shared Lane Markings fell somewhere between. "Bicycles May Use Full Lane" signage showed notable increases in comprehension among novice bicyclists and private motor vehicle commuters, critical target audiences for efforts to promote bicycling in the USA. Although limited in scope, our survey results are indicative and suggest that Departments of Transportation consider replacing "Share the Road" with "Bicycles May Use Full Lane" signage, possibly combined with Shared Lane Markings, if the intent is to increase awareness of roadway rights and responsibilities. Further evaluation through virtual reality simulations and on-road experiments is merited.	[Hess, George; Peterson, M. Nils] NC State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Hess, G (corresponding author), NC State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	george_hess@ncsu.edu		Peterson, Nils/0000-0002-4246-1206				AASHTO, 2013, COMM AM 2013 NAT REP; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Bike Delaware, 2014, WHY SHAR ROAD IS GON; Caffrey K, 2015, LANE WIDTH SPACE INT; Cycling Savvy, 10 TIPS SUCC CYCL; Davis S.C., 2011, TRANSPORTATION ENERG; DelawareDOT, 2013, MEM BIC WARN SIGN SH; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; ELLS JG, 1979, HUM FACTORS, V21, P161, DOI 10.1177/001872087902100203; Fishman E, 2012, J AUSTRALAS COLL ROA, V23, P19; Florida Dept. of Highway Safety & Motor Vehicles, 2014, FLOR DRIV HDB; Harris MA, 2011, INJURY PREV, V17, P1, DOI 10.1136/injuryprev-2011-040071; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Jordan PW, 1991, PEOPLE COMPUTERS, VVI, P237; Lay MG, 2004, HUMAN FACTORS OF TRANSPORT SIGNS, P25, DOI 10.1201/9780203457412.ch3; League of American Bicyclists, 2014, BETT BIC TRAFF LAWS; Macmillan A, 2015, ENVIRON HEALTH PERSP, V122, P335; McDougall SJP, 1999, BEHAV RES METH INS C, V31, P487, DOI 10.3758/BF03200730; National Highway Traffic Safety Administration (NHTSA), BIC; Ng AWY, 2007, ACCIDENT ANAL PREV, V39, P1245, DOI 10.1016/j.aap.2007.03.018; North Carolina Department of Transportation (undated), SHAR ROAD SIGN PROGR; North Carolina Division of Motor Vehicles, 2014, N CAR DRIV HDB; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Oswald F, 2011, BICYCLE RIGHT ROAD C; Pein W, 2012, SHARE ROAD SIGN; Peterson M.N.T.R., 2013, HOUSING BOMB WHY OUR; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Royal Muller-Steiger, 2008, NAT SURV BIC PED ATT; Sener IN, 2009, TRANSPORT RES REC, P63, DOI 10.3141/2134-08; Seyfried R., 2013, TRAFFIC CONTROL DEVI; Shanteau R, 2013, MARGINALIZATION BICY; Shinar D, 2013, TRANSPORT RES F-TRAF, V18, P72, DOI 10.1016/j.trf.2012.12.012; Siceloff B, 2015, RALEIGH NEWS OB 0127; Smith JW, 2015, LANDSCAPE U IN PRESS; Teschke K, 2012, AM J PUBLIC HEALTH, V102, P2336, DOI 10.2105/AJPH.2012.300762; US Departmant of Transportation-Federal Highway Administration, 2012, MAN UN TRAFF CONTR D; Wilkinson III WC, 1994, US FEDERAL HIGHWAY A, VFHWA-RD-92-073; Willis G.B, 2004, COGNITIVE INTERVIEWI; Winters M, 2011, TRANSPORTATION, V38, P153, DOI 10.1007/s11116-010-9284-y	41	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136973	10.1371/journal.pone.0136973	http://dx.doi.org/10.1371/journal.pone.0136973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317355	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100187
J	Jang, S; Choi, SC; Li, HY; An, G; Schmelzer, E				Jang, Seonghoe; Choi, Sang-Chul; Li, Hsing-Yi; An, Gynheung; Schmelzer, Elmon			Functional Characterization of Phalaenopsis aphrodite Flowering Genes PaFT1 and PaFD	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; LOCUS-T PROTEIN; LONG-DISTANCE; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; FLORAL TRANSITION; HEADING-DATE; RICE PLANTS; ARABIDOPSIS; TEMPERATURE	We show that the key flowering regulators encoded by Phalaenopsis aphrodite FLOWERING LOCUS T1 (PaFT1) and PaFD share high sequence homologies to these from long-day flowering Arabidopsis and short-day flowering rice. Interestingly, PaFT1 is specifically upregulated during flowering inductive cooling treatment but is not subjected to control by photoperiod in P. aphrodite. Phloem or shoot apex-specific expression of PaFT1 restores the late flowering of Arabidopsis ft mutants. Moreover, PaFT1 can suppress the delayed flowering caused by SHORT VEGATATIVE PHASE (SVP) overexpression as well as an active FRIGIDA (FRI) allele, indicating the functional conservation of flowering regulatory circuit in different plant species. PaFT1 promoter: GUS in Arabidopsis showed similar staining pattern to that of Arabidopsis FT in the leaves and guard cells but different in the shoot apex. A genomic clone or heat shock-inducible expression of PaFT1 is sufficient to the partial complementation of the ft mutants. Remarkably, ectopic PaFT1 expression also triggers precocious heading in rice. To further demonstrate the functional conservation of the flowering regulators, we show that PaFD, a bZIP transcription factor involved in flowering promotion, interacts with PaFT1, and PaFD partially complemented Arabidopsis fd mutants. Transgenic rice expressing PaFD also flowered early with increased expression of rice homologues of APETALA1 (AP1). Consistently, PaFT1 knock-down Phalaenopsis plants generated by virus-induced gene silencing exhibit delayed spiking. These studies suggest functional conservation of FT and FD genes, which may have evolved and integrated into distinct regulatory circuits in monopodial orchids, Arabidopsis and rice that promote flowering under their own inductive conditions.	[Jang, Seonghoe; Li, Hsing-Yi] Acad Sinica, Biotechnol Ctr Southern Taiwan, Tainan 741, Tainan County, Taiwan; [Jang, Seonghoe; Li, Hsing-Yi] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Choi, Sang-Chul; An, Gynheung] Kyung Hee Univ, Crop Biotechnol Ctr, Yongin 446701, South Korea; [Schmelzer, Elmon] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Kyung Hee University; Max Planck Society	Jang, S (corresponding author), Acad Sinica, Biotechnol Ctr Southern Taiwan, Tainan 741, Tainan County, Taiwan.	florigen@gate.sinica.edu.tw			Development Program of Industrialization for Agricultural Biotechnology (DPIAB, Taiwan ) [099S0030086-AA]	Development Program of Industrialization for Agricultural Biotechnology (DPIAB, Taiwan )	Funded by Development Program of Industrialization for Agricultural Biotechnology (DPIAB, Taiwan 099S0030086-AA to SJ), http://dpiab.sinica.edu.tw/index_en.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Bilgin DD, 2009, NAT PROTOC, V4, P333, DOI 10.1038/nprot.2008.249; Blanchard MG, 2006, J EXP BOT, V57, P4043, DOI 10.1093/jxb/erl176; Chen WH, 2008, PLANT CELL REP, V27, P1667, DOI 10.1007/s00299-008-0591-0; CHEN WS, 1994, PHYSIOL PLANTARUM, V90, P391, DOI 10.1111/j.1399-3054.1994.tb00404.x; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; ENDO M, 1989, PLANT CELL PHYSIOL, V30, P43, DOI 10.1093/oxfordjournals.pcp.a077715; Farrona S, 2011, PLANT CELL, V23, P3204, DOI 10.1105/tpc.111.087809; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Hou CJ, 2009, PLANT CELL PHYSIOL, V50, P1544, DOI 10.1093/pcp/pcp099; Hsieh MH, 2013, J EXP BOT, V64, P3869, DOI 10.1093/jxb/ert218; Hsieh MH, 2013, PLANT SCI, V201, P25, DOI 10.1016/j.plantsci.2012.11.003; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jang SH, 2002, PLANT CELL PHYSIOL, V43, P230, DOI 10.1093/pcp/pcf015; Jeon JS, 2000, MOL BREEDING, V6, P581, DOI 10.1023/A:1011388620872; Kawamoto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08341; Kim SR, 2009, J PLANT BIOL, V52, P73, DOI 10.1007/s12374-008-9008-4; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; Lee N, 1984, J CHINESE SOC HORT S, V30, P223; Lee N, 1987, P S FORC CULT HORT C, P27; Lee N., 1990, J CHINESE SOC HORT S, V36, P223; Li DM, 2014, GENET MOL RES, V13, P5982, DOI 10.4238/2014.August.7.14; Li Yan-Xiao, 2014, Plant Omics, V7, P328; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lin HY, 2014, PLANT MOL BIOL, V84, P203, DOI 10.1007/s11103-013-0128-y; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu LX, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-9; Lopez RG, 2005, HORTSCIENCE, V40, P1969, DOI 10.21273/HORTSCI.40.7.1969; Lu HC, 2007, PLANT PHYSIOL, V143, P558, DOI 10.1104/pp.106.092742; Lu SJ, 2012, PLANT MOL BIOL REP, V30, P1461, DOI 10.1007/s11105-012-0468-9; Luan WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005891; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Nishikawa F, 2007, J EXP BOT, V58, P3915, DOI 10.1093/jxb/erm246; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Noy-Porat T, 2013, J EXP BOT, V64, P3273, DOI 10.1093/jxb/ert165; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; SAKANISHI Y, 1980, Bulletin of the University of Osaka Prefecture Series B Agriculture and Life Sciences, V32, P1; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sinha Pinaki, 2010, Plant Tissue Culture & Biotechnology, V20, P185; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; TAKAHASHI T, 1989, MOL GEN GENET, V219, P365, DOI 10.1007/BF00259608; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; Tsuji H, 2013, PLANT CELL PHYSIOL, V54, P385, DOI 10.1093/pcp/pct005; Turck F, 2008, ANNU REV PLANT BIOL, V59; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang Y. T., 1995, American Orchid Society Bulletin, V64, P744; Xiang L, 2012, PLANT PHYSIOL BIOCH, V58, P98, DOI 10.1016/j.plaphy.2012.06.011; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; YONEDA K, 1991, J JPN SOC HORTIC SCI, V60, P651, DOI 10.2503/jjshs.60.651; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	85	32	35	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134987	10.1371/journal.pone.0134987	http://dx.doi.org/10.1371/journal.pone.0134987			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317412	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100020
J	Rossouw, D; Bagheri, B; Setati, ME; Bauer, FF				Rossouw, Debra; Bagheri, Bahareh; Setati, Mathabatha Evodia; Bauer, Florian Franz			Co-Flocculation of Yeast Species, a New Mechanism to Govern Population Dynamics in Microbial Ecosystems	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-MARXIANUS; GENE-EXPRESSION; ADHESION; FLO1; IDENTIFICATION; PROTEIN; CONSTRUCTION; FERMENTATION; GROWTH	Flocculation has primarily been studied as an important technological property of Saccharomyces cerevisiae yeast strains in fermentation processes such as brewing and winemaking. These studies have led to the identification of a group of closely related genes, referred to as the FLO gene family, which controls the flocculation phenotype. All naturally occurring S. cerevisiae strains assessed thus far possess at least four independent copies of structurally similar FLO genes, namely FLO1, FLO5, FLO9 and FLO10. The genes appear to differ primarily by the degree of flocculation induced by their expression. However, the reason for the existence of a large family of very similar genes, all involved in the same phenotype, has remained unclear. In natural ecosystems, and in wine production, S. cerevisiae growth together and competes with a large number of other Saccharomyces and many more non-Saccharomyces yeast species. Our data show that many strains of such wine-related non-Saccharomyces species, some of which have recently attracted significant biotechnological interest as they contribute positively to fermentation and wine character, were able to flocculate efficiently. The data also show that both flocculent and non-flocculent S. cerevisiae strains formed mixed species flocs (a process hereafter referred to as co-flocculation) with some of these non-Saccharomyces yeasts. This ability of yeast strains to impact flocculation behaviour of other species in mixed inocula has not been described previously. Further investigation into the genetic regulation of co-flocculation revealed that different FLO genes impact differently on such adhesion phenotypes, favouring adhesion with some species while excluding other species from such mixed flocs. The data therefore strongly suggest that FLO genes govern the selective association of S. cerevisiae with specific species of non-Saccharomyces yeasts, and may therefore be drivers of ecosystem organisational patterns. Our data provide, for the first time, insights into the role of the FLO gene family beyond intraspecies cellular association, and suggest a wider evolutionary role for the FLO genes. Such a role would explain the evolutionary persistence of a large multigene family of genes with apparently similar function.	[Rossouw, Debra; Bagheri, Bahareh; Setati, Mathabatha Evodia; Bauer, Florian Franz] Univ Stellenbosch, Dept Oenol & Viticulture, Inst Wine Biotechnol, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Bauer, FF (corresponding author), Univ Stellenbosch, Dept Oenol & Viticulture, Inst Wine Biotechnol, Private Bag X1, ZA-7600 Stellenbosch, South Africa.	fb2@sun.ac.za	Bauer, Florian/A-1078-2013	Bauer, Florian/0000-0001-5764-4542; Rossouw, Debra/0000-0002-6266-0210; Bagheri, Bahareh/0000-0002-3838-5669; Setati, Mathabatha/0000-0002-5450-009X	National Research Foundation of South Africa [SARChI UID 83471]; RCA grant [91448]	National Research Foundation of South Africa(National Research Foundation - South Africa); RCA grant	This work was funded by National Research Foundation of South Africa (http://www.nrf.ac.za/): SARChI UID 83471 to FFB, and RCA grant number 91448 to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri B, 2015, S AFR J ENOL VITIC, V36, P243; Barney MC, 1990, J AM SOC BREW CHEM, V38, P71; Bauer FF, 2010, APPL MICROBIOL BIOT, V88, P31, DOI 10.1007/s00253-010-2783-0; Bester MC, 2006, CURR GENET, V49, P375, DOI 10.1007/s00294-006-0068-z; Bester MC, 2012, G3-GENES GENOM GENET, V2, P131, DOI 10.1534/g3.111.001644; Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Carstens Elsa, 1998, South African Journal for Enology and Viticulture, V19, P52; Chovanova K, 2011, LETT APPL MICROBIOL, V53, P231, DOI 10.1111/j.1472-765X.2011.03097.x; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Domingues L., 2000, BIOTECHNOL BIOPROC E, V5, P288, DOI [DOI 10.1007/BF02942185, 10.1007/BF02942185]; Esteve-Zarzoso B, 1999, INT J SYST BACTERIOL, V49, P329, DOI 10.1099/00207713-49-1-329; Ghosh S, 2015, ANN MICROBIOL, V65, P1833, DOI 10.1007/s13213-014-1021-x; Goossens KVY, 2015, MBIO, V6, DOI 10.1128/mBio.00427-15; Govender P, 2008, APPL ENVIRON MICROB, V74, P6041, DOI 10.1128/AEM.00394-08; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hoffman S, 2003, CURRENT PROTOCOLS MO; Jolly NP, 2014, FEMS YEAST RES, V14, P215, DOI 10.1111/1567-1364.12111; Kobayashi O, 1999, CURR GENET, V36, P256, DOI 10.1007/s002940050498; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; Liu HP, 1996, GENETICS, V144, P967; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lopez CLF, 2014, WORLD J MICROB BIOT, V30, P2223, DOI 10.1007/s11274-014-1643-y; MIKI BLA, 1982, J BACTERIOL, V150, P878, DOI 10.1128/JB.150.2.878-889.1982; Noronha SB, 1998, J IND MICROBIOL BIOT, V20, P192, DOI 10.1038/sj.jim.2900507; Peng X, 2001, APPL MICROBIOL BIOT, V55, P777, DOI 10.1007/s002530000564; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; REGNACQ M, 1993, CURR GENET, V23, P435, DOI 10.1007/BF00312631; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; ROSE A H, 1984, P323; Sampermans S, 2005, J APPL MICROBIOL, V98, P525, DOI 10.1111/j.1365-2672.2004.02486.x; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; SOUSA MJ, 1992, BIOTECHNOL LETT, V14, P213, DOI 10.1007/BF01023361; TEUNISSEN AWRH, 1995, YEAST, V11, P1001, DOI 10.1002/yea.320111102; Van Mulders SE, 2009, FEMS YEAST RES, V9, P178, DOI 10.1111/j.1567-1364.2008.00462.x; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Verstrepen KJ, 2001, J AM SOC BREW CHEM, V59, P69; WATARI J, 1994, J I BREWING, V100, P73, DOI 10.1002/j.2050-0416.1994.tb00809.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	45	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136249	10.1371/journal.pone.0136249	http://dx.doi.org/10.1371/journal.pone.0136249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317200	gold, Green Published			2022-12-27	WOS:000360299100066
J	Zou, JX; Zhou, ZG; Wan, LP; Tong, Y; Qin, YW; Wang, C; Zhou, K				Zou, Jixue; Zhou, Zhigang; Wan, Liping; Tong, Yin; Qin, Youwen; Wang, Chun; Zhou, Kun			Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; P15(INK4B) GENE; PROMOTER HYPERMETHYLATION; DNA METHYLTRANSFERASES; DISEASE PROGRESSION; HEMATOPOIETIC-CELLS; PHASE-III; METHYLATION; CANCER; DECITABINE	The complex mechanistic array underlying the pathogenesis of myelodysplastic syndrome (MDS) is still unclear. Although dysregulations of different signaling pathways involved in MDS have been described, the identification of specific biomarkers and therapy targets remains an important task in order to establish novel therapeutic approaches. Here, we demonstrated that the Shh signaling pathway is active in MDS and correlated it with disease progression. Additionally, the knockdown of Gli1 significantly inhibited cell proliferation in vitro and in vivo. Gli1 silencing also induced apoptosis and G0/G1 phase arrest. Furthermore, Gli1 silencing enhanced the demethylating effect of 5-aza-2'-deoxycytidine on the p15 gene promoter and subsequently promoted its expression by inhibiting DNA methyltransferase 1(DNMT1). Our findings show that the Shh signaling pathway plays a role in the pathogenesis and disease progression of MDS, and proceeds by modulating DNA methylation. This pathway may prove to be a potential therapeutic target for enhancing the therapeutic effects of 5-azacytidine on malignant transformation of MDS.	[Zou, Jixue; Wan, Liping; Tong, Yin; Qin, Youwen; Wang, Chun; Zhou, Kun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China; [Zhou, Zhigang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Intens Care Unit, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China.	chunwang_sjtu@163.com; zhkzhw@163.com			National Natural Science Foundation of China [81200347]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (grant no. 81200347).	ABE S, 1982, GANN, V73, P961; Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Aoki E, 2000, LEUKEMIA, V14, P586, DOI 10.1038/sj.leu.2401719; Bai LY, 2008, LEUKEMIA, V22, P226, DOI 10.1038/sj.leu.2404978; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hopfer O, 2009, LEUKEMIA RES, V33, P434, DOI 10.1016/j.leukres.2008.08.014; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kobune M, 2009, CANCER SCI, V100, P948, DOI 10.1111/j.1349-7006.2009.01111.x; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ma D, 2015, GENE THER, V22, P287, DOI 10.1038/gt.2015.1; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Plass C, 1999, ONCOGENE, V18, P3159, DOI 10.1038/sj.onc.1202651; Quesnel B, 1998, BLOOD, V91, P2985, DOI 10.1182/blood.V91.8.2985.2985_2985_2990; Quesnel B, 1999, LEUKEMIA LYMPHOMA, V35, P437, DOI 10.1080/10428199909169608; Steube KG, 1997, LEUKEMIA LYMPHOMA, V25, P345, DOI 10.3109/10428199709114174; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tien HF, 2001, BRIT J HAEMATOL, V112, P148, DOI 10.1046/j.1365-2141.2001.02496.x; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Uchida T, 1998, LEUKEMIA LYMPHOMA, V32, P9, DOI 10.3109/10428199809059242; Uchida T, 1997, BLOOD, V90, P1403, DOI 10.1182/blood.V90.4.1403.1403_1403_1409; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Wong IHN, 2000, BLOOD, V95, P1942, DOI 10.1182/blood.V95.6.1942; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zou JX, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/957502	32	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136843	10.1371/journal.pone.0136843	http://dx.doi.org/10.1371/journal.pone.0136843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317501	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100149
J	Do, A; Mittal, Y; Liapakis, A; Cohen, E; Chau, H; Bertuccio, C; Sapir, D; Wright, J; Eggers, C; Drozd, K; Ciarleglio, M; Deng, YH; Lim, JK				Do, Albert; Mittal, Yash; Liapakis, AnnMarie; Cohen, Elizabeth; Chau, Hong; Bertuccio, Claudia; Sapir, Dana; Wright, Jessica; Eggers, Carol; Drozd, Kristine; Ciarleglio, Maria; Deng, Yanhong; Lim, Joseph K.			Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade	PLOS ONE			English	Article							HEPATITIS-C; ANTIVIRAL THERAPY; UNITED-STATES; HIV CARE; SOFOSBUVIR; LEDIPASVIR; STRATEGIES; ENGAGEMENT	Background New treatments for hepatitis C (HCV) infection hold great promise for cure, but numerous challenges to diagnosing, establishing care, and receiving therapy exist. There are limited data on insurance authorization for these medications. Materials and Methods We performed a retrospective chart review of patients receiving sofosbuvir/ledipasvir (SOF/LED) from October 11-December 31, 2014 to determine rates and timing of drug authorization. We also determined predictors of approval, and those factors associated with faster decision and approval times. Results Of 174 patients prescribed HCV therapy during this period, 129 requests were made for SOF/LED, of whom 100 (77.5%) received initial approval, and an additional 17 patients (13.9%) ultimately received approval through the appeals process. Faster approval times were seen in patients with Child-Pugh Class B disease (14.4 vs. 24.7 days, p = 0.048). A higher proportion of patients were initially approved in those with Medicare/Medicaid coverage (92.2% vs. 71.4%, p = 0.002) and those with baseline viral load >= 6 million IU/mL (84.1% vs. 62.5%, p = 0.040). Linear regression modeling identified advanced fibrosis, high Model of End Stage Liver Disease (MELD) score, and female gender as significant predictors of shorter decision and approval times. On logistic regression, Medicare/Medicaid coverage (OR 5.96, 95% CI 1.66-21.48) and high viral load (OR 4.52, 95% CI 1.08-19.08) were significant predictors for initial approval. Conclusions Early analysis of real-world drug authorization outcomes between October-December 2014 reveals that nearly one in four patients are initially denied access to SOF/LED upon initial prescription, although most patients are eventually approved through appeal, which delays treatment initiation. Having Medicare/Medicaid and advanced liver disease resulted in a higher likelihood of approval as well as earlier decision and approval times. More studies are needed to determine factors resulting in higher likelihood of denial and to evaluate approval rates and times after implementation of restrictive prior authorization guidelines.	[Do, Albert; Mittal, Yash; Liapakis, AnnMarie; Lim, Joseph K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Liapakis, AnnMarie; Chau, Hong; Bertuccio, Claudia; Sapir, Dana; Eggers, Carol; Drozd, Kristine; Ciarleglio, Maria; Deng, Yanhong; Lim, Joseph K.] Yale Liver Ctr, Sect Digest Dis, New Haven, CT USA; [Liapakis, AnnMarie; Cohen, Elizabeth; Lim, Joseph K.] Yale New Haven Med Ctr, Liver Transplantat Program, New Haven, CT 06504 USA; [Wright, Jessica] Yale New Haven Med Ctr, Apothecary & Wellness Ctr, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Lim, JK (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	joseph.lim@yale.edu	Cohen, Elizabeth/AAU-2982-2020	Cohen, Elizabeth/0000-0001-7853-4107; Wright, Jessica/0000-0001-9659-4875; Ciarleglio, Maria/0000-0002-6591-3674	Abbott; Achillion; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead; Globeimmune; Hologic; Janssen; Vertex; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	Abbott(Abbott Laboratories); Achillion; Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Globeimmune; Hologic; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Vertex(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors have read the journal's policy and have the following interests: Joseph K. Lim (consulting: Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Glaxo-Smith Kline, Janssen, Merck; research contracts: Abbott, Achillion, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Globeimmune, Hologic, Janssen, Vertex). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], REC TEST MAN TREAT H; Borgia SM, 2015, CAN J GASTROENTEROL, V29, P125, DOI 10.1155/2015/591260; Connecticut department of social services: Medical Assistance Program, NEW HEPATITIS C PRIO; Ditah I, 2015, AM J GASTROENTEROL; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; *I MED, 2010, HEPATITIS LIVER CANC; Klein SJ, 2007, PUBLIC HEALTH REP, V122, P83, DOI 10.1177/00333549071220S216; Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz EJ, 2014, J GASTROEN HEPATOL, V29, P1574, DOI 10.1111/jgh.12632; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Mehta SH, 2006, AIDS, V20, P2361, DOI 10.1097/QAD.0b013e32801086da; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Oramasionwu CU, 2014, AIDS PATIENT CARE ST, V28, P228, DOI 10.1089/apc.2014.0033; Pockros PJ, 2014, FRONT MED-PRC, V8, P166, DOI 10.1007/s11684-014-0334-2; Rose L, 2014, ANN PHARMACOTHER, V48, P1019, DOI 10.1177/1060028014534194; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554	24	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135645	10.1371/journal.pone.0135645	http://dx.doi.org/10.1371/journal.pone.0135645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312999	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000020
J	Gao, M; Ning, JC; Wu, XQ				Gao, Meng; Ning, Jicai; Wu, Xiaoqing			Normal and Extreme Wind Conditions for Power at Coastal Locations in China	PLOS ONE			English	Article							TROPICAL CYCLONES; RENEWABLE ENERGY; SPEED; DISTRIBUTIONS; FREQUENCY; IMPACTS; CHOICE; MODEL; FARM	In this paper, the normal and extreme wind conditions for power at 12 coastal locations along China's coastline were investigated. For this purpose, the daily meteorological data measured at the standard 10-m height above ground for periods of 40-62 years are statistically analyzed. The East Asian Monsoon that affects almost China's entire coastal region is considered as the leading factor determining wind energy resources. For most stations, the mean wind speed is higher in winter and lower in summer. Meanwhile, the wind direction analysis indicates that the prevalent winds in summer are southerly, while those in winter are northerly. The air densities at different coastal locations differ significantly, resulting in the difference in wind power density. The Weibull and lognormal distributions are applied to fit the yearly wind speeds. The lognormal distribution performs better than the Weibull distribution at 8 coastal stations according to two judgement criteria, the Kolmogorov-Smirnov test and absolute error (AE). Regarding the annual maximum extreme wind speed, the generalized extreme value (GEV) distribution performs better than the commonly-used Gumbel distribution. At these southeastern coastal locations, strong winds usually occur in typhoon season. These 4 coastal provinces, that is, Guangdong, Fujian, Hainan, and Zhejiang, which have abundant wind resources, are also prone to typhoon disasters.	[Gao, Meng; Ning, Jicai; Wu, Xiaoqing] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Gao, M (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.	gaomeng03@hotmail.com	Ning, Jicai/HHZ-2813-2022	Ning, Jicai/0000-0003-1715-8990; gao, meng/0000-0003-2422-8328	Chinese Academy of Sciences [KZCX2-EW-QN209]; Ministry of Science and Technology of China [2013AA06A211-4]; State Ocean Adminstration of China [20100509]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Ocean Adminstration of China	This work was supported by the Knowledge Innovation Project of Chinese Academy of Sciences (KZCX2-EW-QN209), Chinese Academy of Sciences (http://www.cas.cn/) to MG, Project and grant number: National High Technology Research and Development Program of China(2013AA06A211-4), Ministry of Science and Technology of China (http://www.most.gov.cn/) to MG, Project and grant number: Public S&T Research Funds Projects of Ocean(20100509), State Ocean Adminstration of China (http://www.soa.gov.cn/) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann T, 2002, RENEW SUST ENERG REV, V6, P67, DOI 10.1016/S1364-0321(02)00008-4; Akpinar A, 2013, ENERGY, V50, P395, DOI 10.1016/j.energy.2012.11.019; An Y, 2005, J WIND ENG IND AEROD, V93, P535, DOI 10.1016/j.jwei.2005.05.003; [Anonymous], 2008, RENEW ENERGY RES; Chan JCL, 2012, INT J CLIMATOL, V32, P1946, DOI 10.1002/joc.2410; Chang TP, 2011, APPL ENERG, V88, P1848, DOI 10.1016/j.apenergy.2010.11.010; Changliang X, 2009, RENEW SUST ENERG REV, V13, P1966, DOI 10.1016/j.rser.2009.01.004; China Meteorological Administration, 2010, ASS CHIN WIND EN RES; China Meteorological Administration, 2014, CHIN MET DAT SHAR SE; Chou JS, 2013, ENG FAIL ANAL, V27, P99, DOI 10.1016/j.engfailanal.2012.08.002; Coles S., 2001, INTRO STAT MODELING; Cook NJ, 2004, J WIND ENG IND AEROD, V92, P41, DOI 10.1016/j.jweia.2003.09.037; Cooley D, 2009, CLIMATIC CHANGE, V97, P77, DOI 10.1007/s10584-009-9627-x; Davenport AG, 1961, P I CIVIL ENG, V19, P449, DOI [10.1680/iicep.1961.11304, DOI 10.1680/IICEP.1961.11304]; Environmental Modeling Center, 2010, NCEP CLIM FOR SYST R; Garcia A, 1998, SOL ENERGY, V62, P139, DOI 10.1016/S0038-092X(97)00116-3; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Herzog AV, 2001, ENVIRONMENT, V43, P8, DOI 10.1080/00139150109605150; Holmes J.D, 2001, WIND LOADING STRUCTU, Vthird; Hong Kong Observatory, 2009, CLASS TROP CYCL; Hong LX, 2011, ENERGY, V36, P4482, DOI 10.1016/j.energy.2011.03.071; Huang RH, 2007, ADV ATMOS SCI, V24, P993, DOI 10.1007/s00376-007-0993-x; IEC, 2005, 61400 IEC 1; Ishihara T, 2005, P 6 AS PAC C WIND EN, P1413; Islam MR, 2011, ENERGY, V36, P985, DOI 10.1016/j.energy.2010.12.011; JENKINSON AF, 1955, Q J ROY METEOR SOC, V81, P158, DOI 10.1002/qj.49708134804; Kempton W, 2005, COAST MANAGE, V33, P119, DOI 10.1080/08920750590917530; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Ling Y, 2012, RENEW SUST ENERG REV, V16, P2111, DOI 10.1016/j.rser.2012.01.039; Liu FJ, 2011, ENERGY, V36, P2611, DOI 10.1016/j.energy.2011.02.001; Lun IYF, 2000, RENEW ENERG, V20, P145, DOI 10.1016/S0960-1481(99)00103-2; LUNA RE, 1974, J APPL METEOROL, V13, P910, DOI 10.1175/1520-0450(1974)013<0910:EOLTCU>2.0.CO;2; Lund H, 2007, ENERGY, V32, P912, DOI 10.1016/j.energy.2006.10.017; Mirhosseini M, 2011, RENEW SUST ENERG REV, V15, P449, DOI 10.1016/j.rser.2010.09.029; Oh KY, 2012, ENERGY, V46, P555, DOI 10.1016/j.energy.2012.07.056; PICKANDS J, 1975, ANN STAT, V3, P119; R Development Core Team, 2014, R LANG ENV STAT COMP; Rehman S, 2004, ENERGY, V29, P1105, DOI 10.1016/j.energy.2004.02.026; Sun LH, 2011, J TROP METEOROL, V17, P181, DOI 10.3969/j.issn.1006-8775.2011.02.011; Sun Y, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001287; Ucar A, 2009, APPL ENERG, V86, P1864, DOI 10.1016/j.apenergy.2008.12.016; Wang ZX, 2009, RENEW SUST ENERG REV, V13, P216, DOI 10.1016/j.rser.2007.07.004; World Meteorological Organization, 2008, TYPH COMM OP MAN; Wu J, 2013, RENEW SUST ENERG REV, V21, P215, DOI 10.1016/j.rser.2012.12.060; Wu LG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022937; Wu LG, 2004, J CLIMATE, V17, P1686, DOI 10.1175/1520-0442(2004)017<1686:AIOGWO>2.0.CO;2; Xiao YQ, 2006, ENG STRUCT, V28, P1173, DOI 10.1016/j.engstruct.2006.01.001; Zhang YX, 2012, ACTA METEOROL SIN, V26, P261, DOI 10.1007/s13351-012-0301-2; Zhao ZY, 2009, RENEW ENERG, V34, P2883, DOI 10.1016/j.renene.2009.06.008; Zhou W, 2006, RENEW ENERG, V31, P739, DOI 10.1016/j.renene.2005.05.006	50	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136876	10.1371/journal.pone.0136876	http://dx.doi.org/10.1371/journal.pone.0136876			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313256	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000106
J	Janse, M; van Faassen, M; Kema, I; Smink, A; Ranchor, AV; Fleer, J; Sprangers, MAG				Janse, Moniek; van Faassen, Martijn; Kema, Ido; Smink, Ans; Ranchor, Adelita V.; Fleer, Joke; Sprangers, Mirjam A. G.			The Impact of Goal Disturbance after Cancer on Cortisol Levels over Time and the Moderating Role of COMT	PLOS ONE			English	Article							QUALITY-OF-LIFE; AWAKENING RESPONSE; BREAST-CANCER; PSYCHOLOGICAL STRESS; METHYLTRANSFERASE COMT; SALIVARY CORTISOL; DAILY EXPERIENCES; HEALTH; AXIS; MEN	Due to physical hindrance and time spent in hospital, a cancer diagnosis can lead to disturbance of personally important goals. Goal disturbance in cancer patients has been related to poorer psychological well-being. However, the relation with physiological measures is yet unknown. The purpose of the current study is to examine the impact of goal disturbance on cortisol as a measure of response to stress over time, and a possibly moderating role of a DNA genotype associated with HPA-axis functioning, Catechol-O-Methyl transferase (COMT). We examined the predictive value of goal disturbance on Cortisol Awakening Response (CAR) and Diurnal Cortisol Slope (DCS) over two periods: 1-7 and 7-18 months post-diagnosis, and the moderating role of COMT during these periods. Hierarchical regression analyses showed that goal disturbance 7 months post-diagnosis significantly predicted a steeper CAR a year later. During that period, the slow COMT variant moderated the relation, in that patients reporting high goal disturbance and had the Met/Met variant, had a more flattened CAR. No other significant effects were found. As steeper CARs have been related to adverse health outcomes, and COMT genotype may modify this risk, these results indicate that goal disturbance and genotype may be important factors to consider in maintaining better psychological and physical health in the already vulnerable population of cancer patients.	[Janse, Moniek; Smink, Ans; Ranchor, Adelita V.; Fleer, Joke] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands; [van Faassen, Martijn; Kema, Ido] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Sprangers, Mirjam A. G.] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Med Psychol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Janse, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands.	m.janse01@umcg.nl	Ranchor, Adelita/X-5725-2019	Ranchor, Adelita/0000-0001-7048-3771; Fleer, Joke/0000-0002-9116-9404; Van Faassen, Martijn/0000-0002-9142-6263	Dutch Cancer Society [RUG 2009-4461]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was funded by the Dutch Cancer Society (RUG 2009-4461).	Abercrombie HC, 2004, PSYCHONEUROENDOCRINO, V29, P1082, DOI 10.1016/j.psyneuen.2003.11.003; Aberg E, 2011, J AFFECT DISORDERS, V129, P158, DOI 10.1016/j.jad.2010.08.009; Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; Aguinis H., 2004, REGRESSION ANAL CATE; Alexander N, 2011, BEHAV BRAIN RES, V216, P53, DOI 10.1016/j.bbr.2010.07.003; Almela M, 2012, PSYCHONEUROENDOCRINO, V37, P1929, DOI 10.1016/j.psyneuen.2012.04.009; Ambrogio AG, 2008, PITUITARY, V11, P219, DOI 10.1007/s11102-008-0114-6; ANDERSEN BL, 1994, AM PSYCHOL, V49, P389, DOI 10.1037/0003-066X.49.5.389; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Boersma S, 2005, QUAL LIFE RES, V14, P2265, DOI 10.1007/s11136-005-7406-3; Bradley AJ, 2010, J PSYCHOPHARMACOL, V24, P91, DOI 10.1177/1359786810385491; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Clow A, 2004, STRESS, V7, P29, DOI 10.1080/10253890410001667205; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Echteld MA, 2003, ANN BEHAV MED, V26, P49, DOI 10.1207/S15324796ABM2601_07; Echteld MA, 2001, QUAL LIFE RES, V10, P487, DOI 10.1023/A:1013083620565; Emmons RobertA., 1999, PSYCHOL ULTIMATE CON; Federenko I, 2004, PSYCHONEUROENDOCRINO, V29, P174, DOI 10.1016/S0306-4530(03)00021-0; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hellhammer J, 2007, PSYCHONEUROENDOCRINO, V32, P80, DOI 10.1016/j.psyneuen.2006.10.005; Hoppmann CA, 2012, J VOCAT BEHAV, V81, P191, DOI 10.1016/j.jvb.2012.07.001; Hullmann SE, 2016, PSYCHO-ONCOLOGY, V25, P387, DOI 10.1002/pon.3852; Iwasiow RM, DNA GENOTEK; Jabbi M, 2007, MOL PSYCHIATR, V12, P483, DOI 10.1038/sj.mp.4001975; Jabbi M, 2007, PSYCHIAT GENET, V17, P183, DOI 10.1097/YPG.0b013e32808374df; Jones R, 2012, J CHROMATOGR B, V15, P881; Karlamangla AS, 2013, PSYCHONEUROENDOCRINO, V38, P2585, DOI 10.1016/j.psyneuen.2013.06.010; Kern S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060647; Kirschbaum C., 2000, ENCY STRESS, V3, P379, DOI DOI 10.1159/000118611; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Laceulle OM, 2015, J PERS, V83, P262, DOI 10.1111/jopy.12101; Liu SW, 2013, J FAM PSYCHOL, V27, P579, DOI 10.1037/a0033735; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Muller L, 2010, EUR REV APPL PSYCHOL, V60, P105, DOI 10.1016/j.erap.2009.12.001; Offerman MPJ, 2010, EUR J ONCOL NURS, V14, P231, DOI 10.1016/j.ejon.2010.01.022; Piazza JR, 2010, J GERONTOL B-PSYCHOL, V65, P513, DOI 10.1093/geronb/gbq049; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner M, 2003, PSYCHOSOM MED, V65, P92, DOI 10.1097/01.PSY.0000040950.22044.10; Ruiz-Robledillo N, 2013, PSYCHOL HEALTH, V28, P1246, DOI 10.1080/08870446.2013.800517; Schlotz W, 2004, PSYCHOSOM MED, V66, P207, DOI 10.1097/01.psy.0000116715.78238.56; Schwartz LA, 2009, J PEDIATR PSYCHOL, V34, P954, DOI 10.1093/jpepsy/jsn144; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sephton SE, 2013, BRAIN BEHAV IMMUN, V30, pS163, DOI 10.1016/j.bbi.2012.07.019; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Stawski RS, 2013, PSYCHONEUROENDOCRINO, V38, P2654, DOI 10.1016/j.psyneuen.2013.06.023; Stefanic N, 2014, SUPPORT CARE CANCER, V22, P713, DOI 10.1007/s00520-013-2026-x; Steptoe A, 2000, PSYCHOSOM MED, V62, P286, DOI 10.1097/00006842-200003000-00022; Thorn L, 2006, PSYCHONEUROENDOCRINO, V31, P1009, DOI 10.1016/j.psyneuen.2006.05.012; Van der Veek SMC, 2007, J HEALTH PSYCHOL, V12, P225, DOI 10.1177/1359105307074249; Vedhara K, 2006, PSYCHONEUROENDOCRINO, V31, P299, DOI 10.1016/j.psyneuen.2005.08.006; Walder DJ, 2010, PSYCHIAT GENET, V20, P166, DOI 10.1097/YPG.0b013e32833a1ff3; Wolff K, 2012, J PSYCHOPHARMACOL, V26, P419, DOI 10.1177/0269881111415737; Wust S, 2000, PSYCHONEUROENDOCRINO, V25, P707, DOI 10.1016/s0306-4530(00)00021-4	63	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135708	10.1371/journal.pone.0135708	http://dx.doi.org/10.1371/journal.pone.0135708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313260	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000022
J	Cuevas, FJ; Pradas, I; Ruiz-Moreno, MJ; Arroyo, FT; Perez-Romero, LF; Montenegro, JC; Moreno-Rojas, JM				Julian Cuevas, Francisco; Pradas, Inmaculada; Jose Ruiz-Moreno, Maria; Teodoro Arroyo, Francisco; Felipe Perez-Romero, Luis; Carlos Montenegro, Jose; Manuel Moreno-Rojas, Jose			Effect of Organic and Conventional Management on Bio-Functional Quality of Thirteen Plum Cultivars (Prunus salicina Lindl.)	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; ASCORBIC-ACID CONTENT; PHENOLIC-COMPOUNDS; FRUIT-QUALITY; VITAMIN-C; DOMESTICA L.; PEACH; PARAMETERS; VEGETABLES; STRAWBERRY	In this study, thirteen Japanese plum cultivars (Prunus salicina Lindl.) grown under conventional and organic conditions were compared to evaluate the influence of the culture system on bioactive compounds. Their organic acids content (malic, citric, tartaric, succinic, shikimic, ascorbic and fumaric acid), total polyphenols, total anthocyanins, total carotenoids and antioxidant capacity (FRAP, ABTS) were evaluated. The study was performed during two consecutive seasons (2012 and 2013) in two experimental orchards located at the IFAPA centre Las Torres-Tomejil (Seville, SW Spain). The culture system affected all the studied parameters except for total carotenoid content. The organic plums had significantly higher polyphenol and anthocyanin concentrations and a greater antioxidant capacity. Additionally, significant differences between cultivars were also found. 'Showtime' and 'Friar' were the cultivars with the highest polyphenol concentration and antioxidant capacity. 'Black Amber' had the highest anthocyanin content and 'Larry Ann' and 'Songold' the highest carotenoid content. 'Sapphire' and 'Black amber' were the cultivars with the highest concentration of ascorbic acid. Our results showed a strong year effect. In conclusion, organic management had an impact on the production of phytochemical compounds in plums.	[Julian Cuevas, Francisco; Pradas, Inmaculada; Jose Ruiz-Moreno, Maria; Carlos Montenegro, Jose; Manuel Moreno-Rojas, Jose] Andalusian Inst Agr & Fishering Res & Training IF, Postharvest Technol & Agrifood Ind Area, Cordoba, Spain; [Teodoro Arroyo, Francisco; Felipe Perez-Romero, Luis] Andalusian Inst Agr & Fishering Res & Training IF, Organ Prod & Nat Resources, Seville, Spain		Moreno-Rojas, JM (corresponding author), Andalusian Inst Agr & Fishering Res & Training IF, Postharvest Technol & Agrifood Ind Area, Alameda Obispo, Cordoba, Spain.	josem.moreno.rojas@juntadeandalucia.es	Pérez-Romero, Luis Felipe/R-8912-2018; Arroyo, Francisco T/F-3617-2010; ROJAS, JOSE MANUEL MORENO/C-8399-2015; Ruiz Moreno, Maria Jose/C-7476-2016	Arroyo, Francisco T/0000-0003-4443-3476; ROJAS, JOSE MANUEL MORENO/0000-0002-9372-1346; Ruiz Moreno, Maria Jose/0000-0002-0688-3014; Cuevas, Francisco Julian/0000-0003-0304-6568	Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA) [PP.AVA.AVA201301.7]; European Commission with European Social Fund (ESF); European Rural Development Fund (ERDF); Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA); European Social Fund (ESF)	Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA); European Commission with European Social Fund (ESF); European Rural Development Fund (ERDF); Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA); European Social Fund (ESF)(European Social Fund (ESF))	This work has been funded by internal funds from Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA) through Project 'Caracterizacion organoleptica y funcional de productos ecologicos. Utilizacion de tecnicas isotopicas para la diferenciacion entre producto ecologico y convencional' (PP.AVA.AVA201301.7), European Commission with European Social Fund (ESF) and European Rural Development Fund (ERDF). Francisco Julian Cuevas is granted by the research contract funding by Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA) and European Social Fund (ESF). Maria Jose Ruiz Moreno is granted by a postdoctoral research contract funding by Andalusian Institute of Agricultural and Fishering Research and Training (IFAPA) and European Social Fund (ESF).	Amarjit Sahota, 2009, Sustainability in the food industry, P159; Amodio ML, 2007, J SCI FOOD AGR, V87, P1228, DOI 10.1002/jsfa.2820; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Barrett DM, 2007, J FOOD SCI, V72, pC441, DOI 10.1111/j.1750-3841.2007.00500.x; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Buendia B, 2008, J AGR FOOD CHEM, V56, P3601, DOI 10.1021/jf800190f; Carbonaro M, 2002, J AGR FOOD CHEM, V50, P5458, DOI 10.1021/jf0202584; Cayuela JA, 1997, J AGR FOOD CHEM, V45, P1736, DOI 10.1021/jf960745h; Cevallos-Casals BA, 2006, FOOD CHEM, V96, P273, DOI 10.1016/j.foodchem.2005.02.032; Chassy AW, 2006, J AGR FOOD CHEM, V54, P8244, DOI 10.1021/jf060950p; Chen FX, 2009, FOOD CHEM, V114, P657, DOI 10.1016/j.foodchem.2008.10.003; Chun OK, 2003, J AGR FOOD CHEM, V51, P7240, DOI 10.1021/jf0343579; Cordova F.M., 2010, BIOACTIVE FOODS EXTR, P205; Crisosto CH, 2007, POSTHARVEST BIOL TEC, V44, P271, DOI 10.1016/j.postharvbio.2006.12.005; Daza A, 2012, INT J FOOD SCI TECH, V47, P341, DOI 10.1111/j.1365-2621.2011.02844.x; del Amor FM, 2008, J SCI FOOD AGR, V88, P770, DOI 10.1002/jsfa.3140; Del Caro A, 2004, J AGR FOOD CHEM, V52, P4780, DOI 10.1021/jf049889j; Diaz-Mula HM, 2009, POSTHARVEST BIOL TEC, V51, P354, DOI 10.1016/j.postharvbio.2008.09.007; Du GR, 2009, FOOD CHEM, V113, P557, DOI 10.1016/j.foodchem.2008.08.025; FAOSTAT, 2011, FAO STAT DAT; Garcia-Marino N, 2008, FOOD SCI TECHNOL INT, V14, P187, DOI 10.1177/1082013208092150; Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b; Giorgi M, 2005, SCI HORTIC-AMSTERDAM, V107, P36, DOI 10.1016/j.scienta.2005.06.003; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Gross J., 1991, PIGMENT VEGETABLES C; Gunduz K, 2014, FOOD CHEM, V155, P298, DOI 10.1016/j.foodchem.2014.01.064; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Kader AA, 2008, J SCI FOOD AGR, V88, P1863, DOI 10.1002/jsfa.3293; Keutgen AJ, 2007, J AGR FOOD CHEM, V55, P4066, DOI 10.1021/jf070010k; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Kim DO, 2003, J AGR FOOD CHEM, V51, P6509, DOI 10.1021/jf0343074; Krinsky NI, 2003, BIOCHEM BIOPH RES CO, V305, P754, DOI 10.1016/S0006-291X(03)00816-7; Kristl J, 2011, FOOD CHEM, V125, P29, DOI 10.1016/j.foodchem.2010.08.027; Kumar S, 2010, EUPHYTICA, V173, P207, DOI 10.1007/s10681-009-0090-6; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Lombardi-Boccia G, 2004, J AGR FOOD CHEM, V52, P90, DOI 10.1021/jf0344690; Lopez-Bucio J, 2000, PLANT SCI, V160, P1, DOI 10.1016/S0168-9452(00)00347-2; Luthria D, 2010, FOOD CHEM, V121, P406, DOI 10.1016/j.foodchem.2009.12.055; Diaz-Mula HM, 2008, J SCI FOOD AGR, V88, P2499, DOI 10.1002/jsfa.3370; Melgarejo P, 2012, SCI HORTIC-AMSTERDAM, V134, P114, DOI 10.1016/j.scienta.2011.11.014; Murray XJ, 2005, POSTHARVEST BIOL TEC, V37, P81, DOI 10.1016/j.postharvbio.2005.02.014; NAGATA M, 1992, J JPN SOC FOOD SCI, V39, P925; Netzel M, 2012, ACS SYM SER, V1093, P375; Ogah O, 2014, J AGR FOOD CHEM, V62, P9369, DOI 10.1021/jf501574q; Oliveira AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056354; Peck GM, 2006, HORTSCIENCE, V41, P99, DOI 10.21273/HORTSCI.41.1.99; Lima GPP, 2008, INT J FOOD SCI TECH, V43, P1838, DOI 10.1111/j.1365-2621.2008.01725.x; Piga A, 2003, J AGR FOOD CHEM, V51, P3675, DOI 10.1021/jf021207+; Pizarro L, 2009, CIENC INVESTIG AGRAR, V36, P143; Raigon MD, 2010, J AGR FOOD CHEM, V58, P6833, DOI 10.1021/jf904438n; Ren HF, 2001, J SCI FOOD AGR, V81, P1426, DOI 10.1002/jsfa.955; Robbins RJ, 2003, J AGR FOOD CHEM, V51, P2866, DOI 10.1021/jf026182t; Roussos PA, 2001, SCI HORTICULTURAE, V129, P253; Sayyari M, 2011, FOOD CHEM, V124, P964, DOI 10.1016/j.foodchem.2010.07.036; Scalzo J, 2005, NUTRITION, V21, P207, DOI 10.1016/j.nut.2004.03.025; Schreiner M, 2005, EUR J NUTR, V44, P85, DOI 10.1007/s00394-004-0498-7; Singh SP, 2009, INT J FOOD SCI TECH, V44, P1973, DOI 10.1111/j.1365-2621.2009.02015.x; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Sousa C, 2005, J AGR FOOD CHEM, V53, P9128, DOI 10.1021/jf051445f; Stacewicz-Sapuntzakis M, 2001, CRIT REV FOOD SCI, V41, P251, DOI 10.1080/20014091091814; Szeto YT, 2002, BRIT J NUTR, V87, P55, DOI 10.1079/BJN2001483; Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959; Valavanidis A, 2009, INT J FOOD SCI TECH, V44, P1167, DOI 10.1111/j.1365-2621.2009.01937.x; Veberic R, 2005, J SCI FOOD AGR, V85, P1687, DOI 10.1002/jsfa.2113; Vicente AR, 2011, HEALTH-PROMOTING PROPERTIES OF FRUIT AND VEGETABLES, P238, DOI 10.1079/9781845935283.0238; Vizzotto M, 2007, J AM SOC HORTIC SCI, V132, P334, DOI 10.21273/JASHS.132.3.334; Walkowiak-Tomczak D, 2008, POLISH J FOOD NUTR S, V58; Wu XL, 2006, J AGR FOOD CHEM, V54, P4069, DOI 10.1021/jf060300l; Young JE, 2005, MOL NUTR FOOD RES, V49, P1136, DOI 10.1002/mnfr.200500080; Zhao X, 2006, HORTTECHNOLOGY, V16, P449, DOI 10.21273/HORTTECH.16.3.0449	70	19	19	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136596	10.1371/journal.pone.0136596	http://dx.doi.org/10.1371/journal.pone.0136596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313546	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000073
J	Yang, XW; Yang, S; Chai, HY; Yang, ZG; Lee, RJ; Liao, WW; Teng, LS				Yang, Xuewei; Yang, Shuang; Chai, Hongyu; Yang, Zhaogang; Lee, Robert J.; Liao, Weiwei; Teng, Lesheng			A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes	PLOS ONE			English	Article							METHYLENE-GAMMA-BUTYROLACTONES; ALLYLIC-ALKYLATION; LIGAND	We have screened 11 isoquinoline derivatives and alpha-methylene-gamma-butyrolactones using the 3-(4,5-dimethylthi-azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay in HeLa and HEK-293T cells. Compound 2 was identified as potential anticancer agent. To further improve its therapeutic potential, this agent was incorporated into transferrin (Tf)-conjugated liposomes (LPs) for targeted delivery to tumor cells. We have demonstrated Tf-LP-Compound 2 have superior antitumor activity compared to non-targeted controls and the free drug. These data show Tf-LP-Compound 2 to be a promising agent that warrants further evaluation.	[Yang, Xuewei; Yang, Shuang; Chai, Hongyu; Lee, Robert J.; Teng, Lesheng] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Yang, Zhaogang; Lee, Robert J.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Liao, Weiwei] Jilin Univ, Dept Organ Chem, Coll Chem, Changchun 130023, Peoples R China	Jilin University; University System of Ohio; Ohio State University; Jilin University	Liao, WW (corresponding author), Jilin Univ, Dept Organ Chem, Coll Chem, Changchun 130023, Peoples R China.	wliao@jlu.edu.cn; tenglesheng@jlu.edu.cn		Teng, Lesheng/0000-0003-1623-5384				Ahamad MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110003; Allen TM, 1998, DRUGS, V56, P747, DOI 10.2165/00003495-199856050-00001; Anabousi S, 2006, EUR J PHARM SCI, V29, P367, DOI 10.1016/j.ejps.2006.07.004; Bentley KW, 2006, NAT PROD REP, V23, P444, DOI 10.1039/b509523a; Chiu SJ, 2006, J CONTROL RELEASE, V112, P199, DOI 10.1016/j.jconrel.2006.02.011; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Farooq S, 2014, EUR J MED CHEM, V84, P545, DOI 10.1016/j.ejmech.2014.07.069; Fonseca C, 2005, EUR J PHARM BIOPHARM, V59, P359, DOI 10.1016/j.ejpb.2004.08.012; Hatakeyama H, 2004, INT J PHARMACEUT, V281, P25, DOI 10.1016/j.ijpharm.2004.05.025; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Ishida O, 2001, PHARMACEUT RES, V18, P1042, DOI 10.1023/A:1010960900254; Janecka A, 2012, DRUG DISCOV TODAY, V17, P561, DOI 10.1016/j.drudis.2012.01.013; Kitson RRA, 2009, ANGEW CHEM INT EDIT, V48, P9426, DOI 10.1002/anie.200903108; Kobayashi T, 2007, INT J PHARMACEUT, V329, P94, DOI 10.1016/j.ijpharm.2006.08.039; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023; Martin A, 2005, INT J TUBERC LUNG D, V9, P901; Moodley S, 2014, J MICROBIOL METH, V104, P72, DOI 10.1016/j.mimet.2014.06.014; Noble GT, 2014, TRENDS BIOTECHNOL, V32, P32, DOI 10.1016/j.tibtech.2013.09.007; Panwar P, 2010, INT J NANOMED, V5, P101; Prathapan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096220; Qin TY, 2013, ORG BIOMOL CHEM, V11, P984, DOI 10.1039/c2ob27269e; Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1588, DOI 10.1021/bc800126s; Wang XM, 2014, CURR PHARM BIOTECHNO, V15, P839, DOI 10.2174/1389201015666141031105234; Xie J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/710502; Xu SL, 2011, INT J PHARMACEUT, V404, P205, DOI 10.1016/j.ijpharm.2010.10.053; Yan Y, 2014, TETRAHEDRON LETT, V55, P479, DOI 10.1016/j.tetlet.2013.11.067; Yang ZG, 2014, NANOSCALE, V6, P9742, DOI 10.1039/c4nr01510j; Yang ZG, 2009, BBA-MOL CELL RES, V1793, P1868, DOI 10.1016/j.bbamcr.2009.10.007; Zhou CG, 2014, CURR PHARM BIOTECHNO, V15, P829, DOI 10.2174/1389201015666141020155620	30	48	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136649	10.1371/journal.pone.0136649	http://dx.doi.org/10.1371/journal.pone.0136649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309138	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400147
J	Ye, HD; Zhou, AN; Hong, QX; Tang, LL; Xu, XT; Xin, YF; Jiang, DJ; Dai, DJ; Li, YR; Wang, DW; Duan, SW				Ye, Huadan; Zhou, Annan; Hong, Qiangxiao; Tang, Linlin; Xu, Xuting; Xin, Yanfei; Jiang, Danjie; Dai, Dongjun; Li, Yirun; Wang, Dao Wen; Duan, Shiwei			Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							APOLIPOPROTEIN A5 GENE; PLASMA TRIGLYCERIDE LEVELS; ARTERY-DISEASE; LIPID-LEVELS; CONFERS SUSCEPTIBILITY; CHINESE POPULATION; PROMOTER REGION; RISK; VARIANTS; S19W	Objective Apolipoprotein A5 (APOA5) is associated with plasma triglyceride (TG) levels, a risk factor for coronary heart disease (CHD). This study explored the association between CHD and the APOA5 rs662799 polymorphism. Methods We collected 1,521 samples (783 CHD patients and 738 controls) for this case-control study. Meta-analysis was performed using Review Manager Software and Stata Software. Results Significant differences were observed between CHD cases and controls at the level of both genotype (chi(2) = 8.964, df = 2, P = 0.011) and allele (chi(2) = 9.180, df = 1, P = 0.002, OR = 1.275, 95% CI = 1.089-1.492). A breakdown analysis by gender showed a significant association of APOA5 rs662799 with CHD in males (chi(2) = 7.770, df = 1, P = 0.005; OR = 1.331, 95% CI = 1.088-1.628). An additional meta-analysis using 21378 cases and 28428 controls established that rs662799 is significantly associated with CHD (P < 0.00001). Conclusion Both our case-control study and meta-analysis confirm a significant association between APOA5 rs662799 and CHD. In addition, our results suggest a male-specific association between the APOA5 rs662799 polymorphism and CHD.	[Ye, Huadan; Zhou, Annan; Hong, Qiangxiao; Tang, Linlin; Xu, Xuting; Jiang, Danjie; Dai, Dongjun; Li, Yirun; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Xin, Yanfei] Zhejiang Acad Med Sci, Ctr Safety Evaluat, Hangzhou, Zhejiang, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China	Ningbo University; Zhejiang Academy of Medical Sciences; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, DW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China.	dwwang@tjh.tjmu.edu.cn; duanshiwei@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022	Wang, Dao Wen/0000-0002-9774-3980; Xin, Yanfei/0000-0001-6624-9333; Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919, 81371469]; Natural Science Foundation of Zhejiang Province [LR13H020003]; K. C. Wong Magna Fund in Ningbo University, Zhejiang Provincial Bureau of Traditional Chinese Medicine [2013ZZ003]; Sciences Technology Department of Zhejiang Province [2013F20005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); K. C. Wong Magna Fund in Ningbo University, Zhejiang Provincial Bureau of Traditional Chinese Medicine; Sciences Technology Department of Zhejiang Province	This work was supported by grants from National Natural Science Foundation of China (31100919 and 81371469), Natural Science Foundation of Zhejiang Province (LR13H020003), and K. C. Wong Magna Fund in Ningbo University, Zhejiang Provincial Bureau of Traditional Chinese Medicine (2013ZZ003) and the Sciences Technology Department of Zhejiang Province (2013F20005).	Angelakopoulou A, 2012, EUR HEART J, V33, P393, DOI 10.1093/eurheartj/ehr225; AshokKumar M, 2010, MOL BIOL REP, V37, P521, DOI 10.1007/s11033-009-9728-7; Bhanushali AA, 2010, J COMMUN GENET, V1, P139, DOI 10.1007/s12687-010-0025-x; Bhaskar S, 2011, GENET TEST MOL BIOMA, V15, P507, DOI 10.1089/gtmb.2010.0207; Bi N, 2004, MOL GENET METAB, V83, P280, DOI 10.1016/j.ymgme.2004.06.017; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen Q, 2011, J LIPID RES, V52, P801, DOI 10.1194/jlr.M012963; Chen Y, 2011, CHIN J CONVAL MED, V20, P487; Cheng XQ, 2007, MOL CARDIOLOGY CHINA, V7, P189; [戴海鹰 Dai Haiying], 2013, [中国全科医学, Chinese General Practice], V16, P3821; Dallongeville J, 2006, INT J CARDIOL, V106, P152, DOI 10.1016/j.ijcard.2004.10.065; De Andrade FM, 2011, NUTR METAB CARDIOVAS, V21, P584, DOI 10.1016/j.numecd.2009.12.013; De Caterina R, 2011, ATHEROSCLEROSIS, V214, P397, DOI 10.1016/j.atherosclerosis.2010.11.011; Ding Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/509420; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez R, 2015, J TRANSCULT NURS, V26, P57, DOI 10.1177/1043659614523996; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Ginter E, 2013, BRATISL MED J, V114, P45, DOI 10.4149/BLL_2013_011; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Hadarits F, 2012, MOL BIOL REP, V39, P1949, DOI 10.1007/s11033-011-0942-8; Han T, 2011, STUDY HAPLOTYPE APOL; Havasi V, 2006, J MOL NEUROSCI, V29, P177, DOI 10.1385/JMN:29:2:177; He Jun, 2012, Journal of Modern Laboratory Medicine, V27, P15; He YJ, 2013, MOL MED REP, V8, P662, DOI [10.3892/mmr.2013.1514, 10.3892/mmr.2013.1642]; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Huang Y, 2013, GENE, V521, P38, DOI 10.1016/j.gene.2013.02.047; Huang Y, 2013, GENET TEST MOL BIOMA, V17, P25, DOI 10.1089/gtmb.2012.0254; Hubacek JA, 2009, PHYSIOL RES, V58, pS101, DOI 10.33549/physiolres.931911; Hubacek JA, 2004, CLIN GENET, V65, P126, DOI 10.1111/j.0009-9163.2004.00199.x; Jang Y, 2009, CLIN CHIM ACTA, V402, P83, DOI 10.1016/j.cca.2008.12.024; Kisfali P, 2010, NUTR METAB CARDIOVAS, V20, P505, DOI 10.1016/j.numecd.2009.05.001; Laurila PP, 2010, ARTERIOSCL THROM VAS, V30, P346, DOI 10.1161/ATVBAHA.109.188912; Li XP, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-133; [李向平 LI Xiangping], 2007, [中国循环杂志, Chinese Circulation Journal], V22, P4; Li YY, 2013, MOL BIOL REP, V40, P1997, DOI 10.1007/s11033-012-2257-9; Lian JF, 2013, J THROMB THROMBOLYS, V36, P394, DOI 10.1007/s11239-012-0862-z; Liu HK, 2005, METABOLISM, V54, P568, DOI 10.1016/j.metabol.2004.11.009; Maasz A, 2008, CIRC J, V72, P1065, DOI 10.1253/circj.72.1065; Maasz A, 2008, J NEUROL, V255, P649, DOI 10.1007/s00415-008-0768-z; Martinelli N, 2007, ATHEROSCLEROSIS, V191, P409, DOI 10.1016/j.atherosclerosis.2006.04.009; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; PARK JH, 2010, J LIPID RES, P1, DOI DOI 10.1194/JLR.M010330; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Prochaska CL, 2010, CLIN CHEM LAB MED, V48, P419, DOI 10.1515/CCLM.2010.070; Qiu F, 2007, THE ASSOCIATION OF P; Rafiq S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-155; Rai M, 2012, AM J CARDIOL, V110, P1092, DOI 10.1016/j.amjcard.2012.05.048; Ramakrishnan L, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-68; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ruiz-Narvaez EA, 2005, J LIPID RES, V46, P2605, DOI 10.1194/jlr.M500040-JLR200; Saleheen D, 2010, CIRC-CARDIOVASC GENE, V3, P348, DOI 10.1161/CIRCGENETICS.109.906180; Seda O, 2003, PHYSIOL RES, V52, P141; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shi KQ, 2014, MOL BIOL REP, V41, P4713, DOI 10.1007/s11033-014-3342-z; Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003; Takeuchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046385; Tang Yi-bo, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P281; Vaessen SFC, 2006, J LIPID RES, V47, P2064, DOI 10.1194/jlr.M600233-JLR200; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; Wang C., 2002, POLYMORPHISM IN THE; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Xu LM, 2013, EXP THER MED, V5, P742, DOI 10.3892/etm.2013.911; Xu L, 2008, 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES: ITESS 2008, VOL 2, P48; Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105; Yang F, 2007, SHANDONG MED J, V47, P1; Yang Y, 2012, J CLIN LIPIDOL, V6, P462, DOI 10.1016/j.jacl.2012.02.004; Ye HD, 2013, GENE, V531, P71, DOI 10.1016/j.gene.2013.07.029; Yu Yang, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P576; Yuan Shan, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P73, DOI 10.3760/cma.j.issn.1003-9406.2011.01.017; Zhai GH, 2011, CLIN CHEM LAB MED, V49, P535, DOI 10.1515/CCLM.2011.070; Zhang C., 2009, THE ASSOCIATIONS BET; Zhang LN, 2013, MOL MED REP, V8, P260, DOI 10.3892/mmr.2013.1454; Zhang X, 2012, PROGR MODERN BIOMEDI, V12, P1401; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang Y., 2007, ASSOCIATIONS OF APOA; Zhang Z, 2011, BIOSCI TRENDS, V5, P165, DOI 10.5582/bst.2011.v5.4.165; Zhao L, 2008, ASSOCIATION BETWEEN; Zhao Y., 2012, TO EVALUATE THE EFFE; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023; 于慧会, 2011, [中国公共卫生, China Public Health], V27, P1195; 宋达琳, 2007, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V30, P65; 朱名安, 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P73	84	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135683	10.1371/journal.pone.0135683	http://dx.doi.org/10.1371/journal.pone.0135683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309253	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400071
J	van Mol, MMC; Kompanje, EJO; Benoit, DD; Bakker, J; Nijkamp, MD				van Mol, Margo M. C.; Kompanje, Erwin J. O.; Benoit, Dominique D.; Bakker, Jan; Nijkamp, Marjan D.			The Prevalence of Compassion Fatigue and Burnout among Healthcare Professionals in Intensive Care Units: A Systematic Review	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SECONDARY TRAUMATIC STRESS; JOB-SATISFACTION; NURSES WORKING; EMOTIONAL INTELLIGENCE; MORAL DISTRESS; SELF-CARE; PHYSICIANS; INTERVENTION; OUTCOMES	Background Working in the stressful environment of the Intensive Care Unit (ICU) is an emotionally charged challenge that might affect the emotional stability of medical staff. The quality of care for ICU patients and their relatives might be threatened through long-term absenteeism or a brain and skill drain if the healthcare professionals leave their jobs prematurely in order to preserve their own health. Purpose The purpose of this review is to evaluate the literature related to emotional distress among healthcare professionals in the ICU, with an emphasis on the prevalence of burnout and compassion fatigue and the available preventive strategies. Methods A systematic literature review was conducted, using Embase, Medline OvidSP, Cinahl, Web-of-science, PsychINFO, PubMed publisher, Cochrane and Google Scholar for articles published between 1992 and June, 2014. Studies reporting the prevalence of burnout, compassion fatigue, secondary traumatic stress and vicarious trauma in ICU healthcare professionals were included, as well as related intervention studies. Results Forty of the 1623 identified publications, which included 14,770 respondents, met the selection criteria. Two studies reported the prevalence of compassion fatigue as 7.3% and 40%; five studies described the prevalence of secondary traumatic stress ranging from 0% to 38.5%. The reported prevalence of burnout in the ICU varied from 0% to 70.1%. A wide range of intervention strategies emerged from the recent literature search, such as different intensivist work schedules, educational programs on coping with emotional distress, improving communication skills, and relaxation methods. Conclusions The true prevalence of burnout, compassion fatigue, secondary traumatic stress and vicarious trauma in ICU healthcare professionals remains open for discussion. A thorough exploration of emotional distress in relation to communication skills, ethical rounds, and mindfulness might provide an appropriate starting point for the development of further preventive strategies.	[van Mol, Margo M. C.; Kompanje, Erwin J. O.; Bakker, Jan] Erasmus MC Univ Med Ctr, Dept Intens Care Adults, Rotterdam, Netherlands; [Benoit, Dominique D.] Ghent Univ Hosp, Med Unit, Dept Intens Care, Ghent, Belgium; [Nijkamp, Marjan D.] Open Univ Netherlands, Fac Psychol & Educ Sci, Heerlen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; Open University Netherlands	van Mol, MMC (corresponding author), Erasmus MC Univ Med Ctr, Dept Intens Care Adults, Rotterdam, Netherlands.	m.vanmol@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391; van Mol, M/0000-0002-0213-6054; Seedat, Soraya/0000-0002-5118-786X; Nijkamp, Marjan/0000-0001-7335-9653				Ali NA, 2011, AM J RESP CRIT CARE, V184, P803, DOI 10.1164/rccm.201103-0555OC; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Aycock N, 2009, CLIN J ONCOL NURS, V13, P183, DOI 10.1188/09.CJON.183-191; Bakker AB, 2005, J ADV NURS, V51, P276, DOI 10.1111/j.1365-2648.2005.03494.x; Barbosa FT, 2012, SAO PAULO MED J, V130, P282, DOI 10.1590/S1516-31802012000500003; Beck CT, 2011, ARCH PSYCHIAT NURS, V25, P1, DOI 10.1016/j.apnu.2010.05.005; Bellieni CV, 2012, J MATERN-FETAL NEO M, V25, P2130, DOI 10.3109/14767058.2012.666590; Bockerman P, 2008, SOC SCI MED, V67, P520, DOI 10.1016/j.socscimed.2008.04.008; Caine Randy M, 2003, Crit Care Nurse, V23, P59; Cho SH, 2009, J CLIN NURS, V18, P1729, DOI 10.1111/j.1365-2702.2008.02721.x; Coetzee SK, 2010, NURS HEALTH SCI, V12, P235, DOI 10.1111/j.1442-2018.2010.00526.x; Crickmore R, 1987, Intensive Care Nurs, V3, P19, DOI 10.1016/0266-612X(87)90006-X; Curtis JR, 2014, INTENS CARE MED, V40, P606, DOI 10.1007/s00134-013-3201-8; Curtis JR, 2012, CONTEMP CLIN TRIALS, V33, P1245, DOI 10.1016/j.cct.2012.06.010; Czaja AS, 2012, J PEDIATR NURS, V27, P357, DOI 10.1016/j.pedn.2011.04.024; Davies William Richard, 2008, Holist Nurs Pract, V22, P32, DOI 10.1097/01.HNP.0000306326.56955.14; De Villers MJ, 2013, NURS ETHICS, V20, P589, DOI 10.1177/0969733012452882; Donchin Yoel, 2002, Curr Opin Crit Care, V8, P316, DOI 10.1097/00075198-200208000-00008; Eagle S, 2012, J PALLIAT MED, V15, P1178, DOI 10.1089/jpm.2012.0231; Elkonin D, 2011, HEALTH SA GESONDHEID, V16, DOI 10.4102/hsag.v16i1.436; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Epp Kirstin, 2012, Dynamics, V23, P25; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Figley C. R., 1995, COPING SECONDARY TRA, DOI [10.4324/9780203777381, DOI 10.4324/9780203777381]; Figley C. R., 2013, TRAUMA AND ITS WAKE; Fink A., 2010, CONDUCTING RES LIT R; Freudenberger H, 1980, BURNOUT COST HIGH AC; Garland A, 2012, AM J RESP CRIT CARE, V185, P738, DOI 10.1164/rccm.201109-1734OC; Goetz K, 2012, INT NURS REV, V59, P88, DOI 10.1111/j.1466-7657.2011.00921.x; Grzeskowiak M, 2011, E J MED, V17, P59; Guntupalli KK, 2014, INDIAN J CRIT CARE M, V18, P139, DOI 10.4103/0972-5229.128703; Guntupalli KK, 1996, INTENS CARE MED, V22, P625, DOI 10.1007/BF01709737; Hays MA, 2006, DIMENS CRIT CARE NUR, V25, P185, DOI 10.1097/00003465-200607000-00016; Jenkins B, 2012, CRIT CARE NURS Q, V35, P388, DOI 10.1097/CNQ.0b013e318268fe09; Jenkins SR, 2002, J TRAUMA STRESS, V15, P423, DOI 10.1023/A:1020193526843; Joinson C, 1992, Nursing, V22, P118; Karanikola MNK, 2012, DIMENS CRIT CARE NUR, V31, P94, DOI 10.1097/DCC.0b013e3182445fd2; Kaschka WP, 2011, DTSCH ARZTEBL INT, V108, P781, DOI 10.3238/arztebl.2011.0781; Kearney MK, 2009, JAMA-J AM MED ASSOC, V301, P1155, DOI 10.1001/jama.2009.352; Kerasiotis Bernadina, 2004, Int J Emerg Ment Health, V6, P121; Klopper HC, 2012, J NURS MANAGE, V20, P685, DOI 10.1111/j.1365-2834.2011.01350.x; Kompanje EJO, 2013, CURR OPIN CRIT CARE, V19, P630, DOI 10.1097/MCC.0000000000000026; Lan HK, 2014, AUST J ADV NURS, V31, P22; Lederer W, 2008, ANAESTH INTENS CARE, V36, P208, DOI 10.1177/0310057X0803600211; Leiter M.P., 2014, BURNOUT WORK PSYCHOL; Liberati, 2009, PLOS MED, V6; Liu K, 2012, J CLIN NURS, V21, P1476, DOI 10.1111/j.1365-2702.2011.03991.x; Liu YE, 2015, J NURS MANAGE, V23, P487, DOI 10.1111/jonm.12161; Loiselle Carmen G, 2012, Intensive Crit Care Nurs, V28, P32, DOI 10.1016/j.iccn.2011.11.006; Iglesias MEL, 2013, DIMENS CRIT CARE NUR, V32, P130, DOI 10.1097/DCC.0b013e31828647fc; Marcial L, 2013, DIMENS CRIT CARE NUR, V32, P18, DOI 10.1097/DCC.0b013e31826bc687; Mason VM, 2014, DIMENS CRIT CARE NUR, V33, P215, DOI 10.1097/DCC.0000000000000056; Meadors P, 2008, J PEDIATR HEALTH CAR, V22, P24, DOI 10.1016/j.pedhc.2007.01.006; Meadors P, 2009, OMEGA-J DEATH DYING, V60, P103, DOI 10.2190/OM.60.2.a; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Mehrabi Tayebe, 2012, Iran J Nurs Midwifery Res, V17, P421; Merlani P, 2011, AM J RESP CRIT CARE, V184, P1140, DOI 10.1164/rccm.201101-0068OC; Murphy, 1995, ORG RISK FACTORS JOB, P259, DOI [10.1037/10173-016, DOI 10.1037/10173-016]; Myhren H, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/786176; National Center for Post Traumatic Stress Disorder, 2014, HLTH SA GESONDHEID; Nimmo A., 2013, AUSTRALASIAN J DISAS, V1, P37; Nooryan K, 2011, INT J COLLAB RES INT, V3, P704; Nooryan K, 2012, INT J GEN MED, V5, P5, DOI 10.2147/IJGM.S25850; OALVAN ME, 2012, ARCH ARGENT PEDIATR, V110, P466, DOI DOI 10.1590/S0325-00752012000600003; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Quenot JP, 2012, INTENS CARE MED, V38, P55, DOI 10.1007/s00134-011-2413-z; Raftopoulos V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-457; Raggio B, 2007, MINERVA ANESTESIOL, V73, P195; Rochefort CM, 2010, J ADV NURS, V66, P2213, DOI 10.1111/j.1365-2648.2010.05376.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sabo Brenda, 2011, Online J Issues Nurs, V16, P1, DOI 10.3912/OJIN.Vol16No01Man01; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Saini R., 2011, J MENTAL HLTH HUM BE, V16, P43; Schaufeli W, 2013, PSYCHOL LABOR HLTH; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Shehabi Yahya, 2008, Crit Care Resusc, V10, P312; Sluiter JK, 2005, INTENS CARE MED, V31, P1409, DOI 10.1007/s00134-005-2769-z; Smart D, 2014, NURS HEALTH SCI, V16, P3, DOI 10.1111/nhs.12068; Stamm B.H., 2002, TREATING COMPASSION, P107, DOI DOI 10.4324/9780203890318; Stamm BH, 2010, CONCISE PROQOL MANUA; Su TP, 2007, J PSYCHIATR RES, V41, P119, DOI 10.1016/j.jpsychires.2005.12.006; Teixeira C, 2014, J MED ETHICS, V40, P97, DOI 10.1136/medethics-2012-100619; Teixeira C, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-38; Todaro-Franceschi V., 2019, COMPASSION FATIGUE B, V2nd; Todaro-Franceschi V, 2013, DIMENS CRIT CARE NUR, V32, P184, DOI 10.1097/DCC.0b013e31829980af; Verdon M, 2008, INTENS CARE MED, V34, P152, DOI 10.1007/s00134-007-0907-5; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387; West CP, 2014, JAMA INT MED; Whitebird RR, 2013, J PALLIAT MED, V16, P1534, DOI 10.1089/jpm.2013.0202; Yoder EA, 2010, APPL NURS RES, V23, P191, DOI 10.1016/j.apnr.2008.09.003; Young JL, 2011, CRIT CARE NURS Q, V34, P227, DOI 10.1097/CNQ.0b013e31821c67d5; Zhang XC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004813	93	288	291	10	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136955	10.1371/journal.pone.0136955	http://dx.doi.org/10.1371/journal.pone.0136955			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26322644	Green Published, gold			2022-12-27	WOS:000360435500054
J	Chaychi, S; Polosa, A; Lachapelle, P				Chaychi, Samaneh; Polosa, Anna; Lachapelle, Pierre			Differences in Retinal Structure and Function between Aging Male and Female Sprague-Dawley Rats are Strongly Influenced by the Estrus Cycle	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BEAVER DAM EYE; ESTROGEN-RECEPTOR; MACULAR DEGENERATION; POSTNATAL HYPEROXIA; INDUCED RETINOPATHY; ESTRADIOL PROTECTS; PIGMENT EPITHELIUM; MENSTRUAL-CYCLE; FISCHER-344 RAT	Purpose Biological sex and age are considered as two important factors that may influence the function and structure of the retina, an effect that might be governed by sexual hormones such as estrogen. The purpose of this study was to delineate the influence that biological sex and age exert on the retinal function and structure of rodents and also clarify the effect that the estrus cycle might exert on the retinal function of female rats. Method The retinal function of 50 normal male and female albino Sprague-Dawley (SD) rats was investigated with the electroretinogram (ERG) at postnatal day (P) 30, 60, 100, 200, and 300 (n = 5-6 male and female rats/age). Following the ERG recording sessions, retinal histology was performed in both sexes. In parallel, the retinal function of premenopausal and menopausal female rats aged P540 were also compared. Results Sex and age-related changes in retinal structure and function were observed in our animal model. However, irrespective of age, no significant difference was observed in ERG and retinal histology obtained from male and female rats. Notwithstanding the above we did however notice that between P60 and P200 there was a gradual increase in ERG amplitudes of female rats compared to males. Furthermore, the ERG of premenopausal female rats aged 18 months old (P540) was larger compared to age-matched menopausal female rats as well as that of male rats. Conclusion Our results showed that biological sex and age can influence the retinal function and structure of albino SD rats. Furthermore, we showed that cycled female rats have better retinal function compared to the menopausal female rats suggesting a beneficial effect of the estrus cycle on the retinal function.	[Chaychi, Samaneh; Polosa, Anna; Lachapelle, Pierre] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Chaychi, Samaneh; Polosa, Anna; Lachapelle, Pierre] McGill Univ, Dept Ophthalmol, Res Inst, Ctr Hlth, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Lachapelle, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	pierre.lachapelle@mcgill.ca		Lachapelle, Pierre/0000-0002-7792-1102	research grant from the Canadian Institutes of Health Research (CIHR) [MOP 11755]	research grant from the Canadian Institutes of Health Research (CIHR)	This study was supported by a research grant from the Canadian Institutes of Health Research (CIHR) (Grant #: MOP 11755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRIS MC, 1980, DOC OPHTHALMOL, V49, P293, DOI 10.1007/BF01886622; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Brule J, 2007, DOC OPHTHALMOL, V114, P125, DOI 10.1007/s10633-007-9045-1; Chen H, 2010, EYE SCI, V25, P103; Cumming RG, 1997, AM J EPIDEMIOL, V145, P242; CURCIO C A, 1990, Investigative Ophthalmology and Visual Science, V31, P38; DAWSON WW, 1979, INVEST OPHTH VIS SCI, V18, P988; Dembinska O, 2002, INVEST OPHTH VIS SCI, V43, P2481; DILORETO D, 1994, BRAIN RES, V647, P181, DOI 10.1016/0006-8993(94)91316-1; DILORETO D, 1995, CURR EYE RES, V14, P303, DOI 10.3109/02713689509033530; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; Dorfman AL, 2006, INVEST OPHTH VIS SCI, V47, P1101, DOI 10.1167/iovs.05-0727; Dorfman A, 2008, INVEST OPHTH VIS SCI, V49, P458, DOI 10.1167/iovs.07-0916; El-Sayyad HIH, 2014, CLIN EXP OPHTHALMOL, V42, P169, DOI 10.1111/ceo.12123; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; Giddabasappa A, 2010, INVEST OPHTH VIS SCI, V51, P5278, DOI 10.1167/iovs.10-5316; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Joly S, 2006, INVEST OPHTH VIS SCI, V47, P3202, DOI 10.1167/iovs.05-1515; KARPE G., 1950, ACTA OPHTHALMOL, V28, P301; KARPE G, 1948, J PHYSIOL-LONDON, V107, P272, DOI 10.1113/jphysiol.1948.sp004271; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; KATZ ML, 1986, EXP EYE RES, V42, P293, DOI 10.1016/0014-4835(86)90022-9; KATZ ML, 1985, MECH AGEING DEV, V30, P99, DOI 10.1016/0047-6374(85)90062-4; KATZ ML, 1984, EXP EYE RES, V38, P137, DOI 10.1016/0014-4835(84)90098-8; KLEIN BEK, 1994, ARCH OPHTHALMOL-CHIC, V112, P85, DOI 10.1001/archopht.1994.01090130095025; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Kobayashi K, 1998, INVEST OPHTH VIS SCI, V39, P2105; Kolb H, 2009, ORG RETINA VISUAL SY; Kumar DM, 2008, MOL VIS, V14, P1480; LACHAPELLE P, 1990, J NEUROSCI METH, V32, P245, DOI 10.1016/0165-0270(90)90147-8; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Nelson JF, 1980, AGING ITS CHEM, P64; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Prokai L, 2003, P NATL ACAD SCI USA, V100, P11741, DOI 10.1073/pnas.2032621100; Rahman T., 2012, ADV BIOSCIENCE BIOTE, V03, P997, DOI [10.4236/abb.2012.327123, DOI 10.4236/ABB.2012.327123]; Sandalon S, 2012, INVEST OPHTH VIS SCI, V53, P6532, DOI 10.1167/iovs.12-10103; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Snow KK, 2002, AM J OPHTHALMOL, V134, P842, DOI 10.1016/S0002-9394(02)01755-5; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; Xia S, 2002, NEUROBIOL DIS, V9, P282, DOI 10.1006/nbdi.2002.0478; Yamashita H, 2011, EXP EYE RES, V93, P75, DOI 10.1016/j.exer.2011.04.006; Yamashita H, 2010, EXP EYE RES, V90, P591, DOI 10.1016/j.exer.2010.02.003; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zinn KM, 1979, RETINAL PIGMENT EPIT	54	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136056	10.1371/journal.pone.0136056	http://dx.doi.org/10.1371/journal.pone.0136056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317201	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100058
J	Cardoso, LCD; Rodriguez-Laguna, L; Crespo, MD; Vallespin, E; Palomares-Bralo, M; Martin-Arenas, R; Rueda-Arenas, I; de Faria, PAS; Garcia-Miguel, P; Lapunzina, P; Vargas, FR; Seuanez, HN; Martinez-Glez, V				de Almeida Cardoso, Leila Cabral; Rodriguez-Laguna, Lara; Crespo, Maria del Carmen; Vallespin, Elena; Palomares-Bralo, Maria; Martin-Arenas, Ruben; Rueda-Arenas, Inmaculada; Silvestre de Faria, Paulo Antonio; Garcia-Miguel, Purificacion; Lapunzina, Pablo; Vargas, Fernando Regla; Seuanez, Hector N.; Martinez-Glez, Victor		GT CSGP Working Grp	Array CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms Tumor	PLOS ONE			English	Article							FRASIER-SYNDROME; SHORT ARM; WT1 GENE; MUTATIONS; HISTOLOGY; CANCER; REVEALS; PATHWAY; CELLS; GAIN	Wilms tumor (WT), the most common cancer of the kidney in infants and children, has a complex etiology that is still poorly understood. Identification of genomic copy number variants (CNV) in tumor genomes provides a better understanding of cancer development which may be useful for diagnosis and therapeutic targets. In paired blood and tumor DNA samples from 14 patients with sporadic WT, analyzed by aCGH, 22% of chromosome abnormalities were novel. All constitutional alterations identified in blood were segmental (in 28.6% of patients) and were also present in the paired tumor samples. Two segmental gains (2p21 and 20q13.3) and one loss (19q13.31) present in blood had not been previously described in WT. We also describe, for the first time, a small, constitutive partial gain of 3p22.1 comprising 2 exons of CTNNB1, a gene associated to WT. Among somatic alterations, novel structural chromosomal abnormalities were found, like gain of 19p13.3 and 20p12.3, and losses of 2p16.1-p15, 4q32.5-q35.1, 4q35.2-q28.1 and 19p13.3. Candidate genes included in these regions might be constitutively (SIX3, SALL4) or somatically (NEK1, PIAS4, BMP2) operational in the development and progression of WT. To our knowledge this is the first report of CNV in paired blood and tumor samples in sporadic WT.	[de Almeida Cardoso, Leila Cabral; Seuanez, Hector N.] Inst Nacl Canc, Div Genet, Rio De Janeiro, Brazil; [Rodriguez-Laguna, Lara; Crespo, Maria del Carmen; Vallespin, Elena; Palomares-Bralo, Maria; Martin-Arenas, Ruben; Rueda-Arenas, Inmaculada; Martinez-Glez, Victor] Hosp Univ La Paz, Inst Med & Mol Genet INGEMM IdiPAZ, Sect Funct & Struct Genom, Madrid, Spain; [Vallespin, Elena; Palomares-Bralo, Maria; Lapunzina, Pablo; Martinez-Glez, Victor] Ctr Invest Biomed Red Enfermedades Raras, CIBERER, Madrid, Spain; [Silvestre de Faria, Paulo Antonio] Inst Nacl Canc, Div Pathol, Rio De Janeiro, Brazil; [Garcia-Miguel, Purificacion] Hosp Univ La Paz, Serv Pediat Oncohematol IdiPAZ, Madrid, Spain; [Lapunzina, Pablo] Hosp Univ La Paz, Inst Med & Mol Genet INGEMM IdiPAZ, Clin Genet Sect, Madrid, Spain; [Vargas, Fernando Regla; Seuanez, Hector N.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Vargas, Fernando Regla] Fundacao Oswaldo Cruz, Birth Defects Epidemiol Lab, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; National Cancer Institute (Inca); Hospital Universitario La Paz; Hospital Universitario La Paz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Martinez-Glez, V (corresponding author), Hosp Univ La Paz, Inst Med & Mol Genet INGEMM IdiPAZ, Sect Funct & Struct Genom, Madrid, Spain.	vmartinezglez@salud.madrid.org	del Carmen Crespo, María/P-3925-2015; Vallespin, Elena/E-5277-2018; Martinez-Glez, Victor/E-2344-2011; Vargas, Fernando/V-1934-2019; Lapunzina, Pablo/L-7075-2014; Sabado, Constantino/E-6172-2016	del Carmen Crespo, María/0000-0003-0546-2143; Vallespin, Elena/0000-0002-8080-8629; Martinez-Glez, Victor/0000-0002-4680-881X; Rodriguez-Laguna, Lara/0000-0003-2863-3400; Martin Arenas, Ruben/0000-0003-4022-1783; Lapunzina, Pablo/0000-0002-6324-4825; Palomares-Bralo, Maria/0000-0002-2727-7654; Sabado, Constantino/0000-0003-3956-5466	Ministerio de Economia y Competitividad [SAF2010-18032]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad project SAF2010-18032.	Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Bhatnagar Sushmita, 2009, J Indian Assoc Pediatr Surg, V14, P6, DOI 10.4103/0971-9261.54811; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019901; BRESLOW N, 1993, MED PEDIATR ONCOL, V21, P172, DOI 10.1002/mpo.2950210305; Breslow NE, 2006, PEDIATR BLOOD CANCER, V47, P260, DOI 10.1002/pbc.20891; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cardoso LCA, 2013, ONCOL REP, V29, P315, DOI 10.3892/or.2012.2096; Chen Y, 2014, ONCOTARGET, V5, P4283, DOI 10.18632/oncotarget.2005; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Deisch J, 2011, PATHOL ONCOL RES, V17, P639, DOI 10.1007/s12253-011-9364-0; Dome JS, 1993, GENEREVIEWS; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fukuzawa R, 2008, J PATHOL, V215, P377, DOI 10.1002/path.2366; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Getman ME, 1998, CYTOGENET CELL GENET, V82, P284, DOI 10.1159/000015120; Grundy RG, 1998, BRIT J CANCER, V78, P1181, DOI 10.1038/bjc.1998.651; Hawthorn L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018941; Hiepen C, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-43; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; Huff V, 1998, AM J MED GENET, V79, P260, DOI 10.1002/(SICI)1096-8628(19981002)79:4<260::AID-AJMG6>3.0.CO;2-Q; Imoto S, 2004, BIOCHEM BIOPH RES CO, V319, P275, DOI 10.1016/j.bbrc.2004.04.161; Kahlert C, 2015, INT J CANCER, V137, P2104, DOI 10.1002/ijc.29596; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Koesters R, 1999, CANCER RES, V59, P3880; Koziell A, 2000, CLIN ENDOCRINOL, V52, P519; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Kumar R, 2010, CANCER RES, V70, P6649, DOI 10.1158/0008-5472.CAN-10-0909; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Majid S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-7; MAW MA, 1992, CANCER RES, V52, P3094; Md Zin R, 2011, PATHOLOGY, V43, P302, DOI 10.1097/PAT.0b013e3283463575; Megarbane A, 1997, J MED GENET, V34, P783, DOI 10.1136/jmg.34.9.783; MILLER RW, 1995, CANCER, V75, P395, DOI 10.1002/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakadate H, 2001, INT J CANCER, V94, P396, DOI 10.1002/ijc.1475; Natrajan R, 2006, J PATHOL, V210, P49, DOI 10.1002/path.2021; Natrajan R, 2007, J PATHOL, V211, P52, DOI 10.1002/path.2087; Peres EM, 2004, CANCER GENET CYTOGEN, V148, P66, DOI 10.1016/S0165-4608(03)00221-8; Rassekh SR, 2008, CANCER GENET CYTOGEN, V182, P84, DOI 10.1016/j.cancergencyto.2007.12.015; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Royer-Pokora B, 2004, AM J MED GENET A, V127A, P249, DOI 10.1002/ajmg.a.30015; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Satoh Y, 2006, BRIT J CANCER, V95, P541, DOI 10.1038/sj.bjc.6603302; Schell U, 1996, HUM MOL GENET, V5, P223, DOI 10.1093/hmg/5.2.223; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Segers H, 2013, GENE CHROMOSOME CANC, V52, P1065, DOI 10.1002/gcc.22101; Senanayake U, 2013, HUM PATHOL, V44, P336, DOI 10.1016/j.humpath.2012.05.021; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Singh N, 2015, GENE, V565, P295, DOI 10.1016/j.gene.2015.04.051; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Vallespin E, 2013, AM J MED GENET A, V161, P1950, DOI 10.1002/ajmg.a.35960; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Walz AL, 2015, CANCER CELL, V27, P286, DOI 10.1016/j.ccell.2015.01.003; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Williams RD, 2011, GENE CHROMOSOME CANC, V50, P982, DOI 10.1002/gcc.20907; Wolf S, 2014, INT J ONCOL, V44, P1727, DOI 10.3892/ijo.2014.2312; Zheng Y, 2014, TUMOR BIOL, V35, P5189, DOI 10.1007/s13277-014-1673-y; Zin R, 2012, CANCER GENET-NY, V205, P80, DOI 10.1016/j.cancergen.2011.12.003	62	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136812	10.1371/journal.pone.0136812	http://dx.doi.org/10.1371/journal.pone.0136812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317783	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100143
J	Estruch, G; Collado, MC; Penaranda, DS; Vidal, AT; Cerda, MJ; Martinez, GP; Martinez-Llorens, S				Estruch, G.; Collado, M. C.; Penaranda, D. S.; Tomas Vidal, A.; Jover Cerda, M.; Perez Martinez, G.; Martinez-Llorens, S.			Impact of Fishmeal Replacement in Diets for Gilthead Sea Bream (Sparus aurata) on the Gastrointestinal Microbiota Determined by Pyrosequencing the 16S rRNA Gene	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FARMED ATLANTIC SALMON; STANDARD SOYBEAN-MEAL; PLANT PROTEIN-SOURCES; INTESTINAL MICROBIOTA; NUTRIENT UTILIZATION; AQUACULTURE SYSTEMS; COMMUNITY STRUCTURE; GUT MICROBIOTA; FRESH-WATER	Recent studies have demonstrated the impact of diet on microbiota composition, but the essential need for the optimization of production rates and costs forces farms and aquaculture production to carry out continuous dietary tests. In order to understand the effect of total fishmeal replacement by vegetable-based feed in the sea bream (Sparus aurata), the microbial composition of the stomach, foregut, midgut and hindgut was analysed using high-throughput 16S rDNA sequencing, also considering parameters of growth, survival and nutrient utilisation indices. A total of 91,539 16S rRNA filtered-sequences were analysed, with an average number of 3661.56 taxonomically assigned, high-quality sequences per sample. The dominant phyla throughout the whole gastrointestinal tract were Actinobacteria, Protebacteria and Firmicutes. A lower diversity in the stomach in comparison to the other intestinal sections was observed. The microbial composition of the Recirculating Aquaculture System was totally different to that of the sea bream gastrointestinal tract. Total fishmeal replacement had an important impact on microbial profiles but not on diversity. Streptococcus (p-value: 0.043) and Photobacterium (p-value: 0.025) were highly represented in fish fed with fishmeal and vegetable-meal diets, respectively. In the stomach samples with the vegetable diet, reads of chloroplasts and mitochondria from vegetable dietary ingredients were rather abundant. Principal Coordinate Analysis showed a clear differentiation between diets in the microbiota present in the gut, supporting the presence of specific bacterial consortia associated with the diet. Although differences in growth and nutritive parameters were not observed, a negative effect of the vegetable diet on the survival rate was determined. Further studies are required to shed more light on the relationship between the immune system and sea bream gastrointestinal tract microbiota and should consider the modulation of the microbiota to improve the survival rate and nutritive efficacy when using plant-based diets.	[Estruch, G.; Penaranda, D. S.; Tomas Vidal, A.; Jover Cerda, M.; Martinez-Llorens, S.] Univ Politecn Valencia, Inst Sci & Anim Technol, Aquaculture & Biodivers Res Group, ICTA, E-46071 Valencia, Valencia, Spain; [Collado, M. C.; Perez Martinez, G.] Spanish Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Paterna, Valencia, Spain	Autonomous University of Barcelona; Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Martinez-Llorens, S (corresponding author), Univ Politecn Valencia, Inst Sci & Anim Technol, Aquaculture & Biodivers Res Group, ICTA, E-46071 Valencia, Valencia, Spain.	silmarll@dca.upv.es	Martinez, Gaspar Perez/H-4167-2012; COLLADO, MARIA CARMEN/H-4924-2012; Peñaranda, David Sanchez/L-3003-2014; TOMAS VIDAL, ANA/L-8254-2014	Martinez, Gaspar Perez/0000-0003-3501-1626; COLLADO, MARIA CARMEN/0000-0002-6204-4864; Peñaranda, David Sanchez/0000-0002-0861-976X; MARTINEZ LLORENS, SILVIA/0000-0002-9824-3267; TOMAS VIDAL, ANA/0000-0002-2985-9324	Vicerrectorat d'Investigacio, Innovacio i Transferencia - Universitat Politecnica de Valencia [SP20120603, 6.000,00]; Contrato Pre-doctoral del Programa para la Formacion de Personal Investigador - FPI from Programa de Ayudas de Investigacion y Desarrollo (PAID) of Universitat Politecnica de Valencia	Vicerrectorat d'Investigacio, Innovacio i Transferencia - Universitat Politecnica de Valencia; Contrato Pre-doctoral del Programa para la Formacion de Personal Investigador - FPI from Programa de Ayudas de Investigacion y Desarrollo (PAID) of Universitat Politecnica de Valencia	Project Name: Aquaculture feed without fishmeal(SP20120603). Grant Numbers: 6.000,00. Funding Institution: Vicerrectorat d'Investigacio, Innovacio i Transferencia - Universitat Politecnica de Valencia. Author who received the funding: ATV. URL of funder: http://www.upv.es/entidades/VIIT/info/indexnormalc.html. The first author was supported by a contract-grant (Contrato Pre-doctoral del Programa para la Formacion de Personal Investigador - FPI) from Programa de Ayudas de Investigacion y Desarrollo (PAID) of Universitat Politecnica de Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STATGR CENT 16; [Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], 2013, BOE; AOAC, 1997, AOAC OFF METH AN; Attramadal KJK, 2012, AQUACULT ENG, V46, P27, DOI 10.1016/j.aquaeng.2011.10.003; Baeza R, 2015, AQUACULT RE IN PRESS; Balcazar JL, 2008, AQUACULTURE, V278, P188, DOI 10.1016/j.aquaculture.2008.03.014; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Blancheton JP, 2013, AQUACULT ENG, V53, P30, DOI 10.1016/j.aquaeng.2012.11.009; Cai CF, 2013, AQUACULTURE, V410, P203, DOI 10.1016/j.aquaculture.2013.07.006; Carda-Dieguez M, 2014, FEMS MICROBIOL ECOL, V87, P451, DOI 10.1111/1574-6941.12236; Cerezuela R, 2013, FISH SHELLFISH IMMUN, V34, P1063, DOI 10.1016/j.fsi.2013.01.015; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Silva FCD, 2011, FEMS MICROBIOL ECOL, V78, P285, DOI 10.1111/j.1574-6941.2011.01155.x; Denev S., 2009, International Aquatic Research, V1, P1; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dimitroglou A, 2009, J ANIM SCI, V87, P3226, DOI 10.2527/jas.2008-1428; Dimitroglou A, 2010, AQUACULTURE, V300, P182, DOI 10.1016/j.aquaculture.2010.01.015; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Estensoro I, 2012, FISH SHELLFISH IMMUN, V33, P401, DOI 10.1016/j.fsi.2012.05.029; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Green TJ, 2013, VET MICROBIOL, V166, P286, DOI 10.1016/j.vetmic.2013.05.009; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Hedrera MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069983; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Hovda MB, 2007, AQUACULTURE, V272, P581, DOI 10.1016/j.aquaculture.2007.08.045; Kim DH, 2013, AQUACULTURE, V414, P103, DOI 10.1016/j.aquaculture.2013.06.008; Kissil GW, 2004, ISR J AQUACULT-BAMID, V56, P188; Kormas KA, 2014, MICROBIOLOGYOPEN, V3, P718, DOI 10.1002/mbo3.202; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Martinez-Llorens S, 2009, AQUACULT NUTR, V15, P320, DOI 10.1111/j.1365-2095.2008.00597.x; Michaud L, 2009, J APPL MICROBIOL, V107, P1935, DOI 10.1111/j.1365-2672.2009.04378.x; Morris PC, 2005, AQUACULTURE, V248, P147, DOI 10.1016/j.aquaculture.2005.04.021; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Navarrete P, 2010, FEMS MICROBIOL ECOL, V71, P148, DOI 10.1111/j.1574-6941.2009.00769.x; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Perez-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065457; Reveco FE, 2014, AQUACULTURE, V420, P262, DOI 10.1016/j.aquaculture.2013.11.007; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Ringo E, 2010, AQUAC RES, V41, P451, DOI 10.1111/j.1365-2109.2009.02339.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Sanchez-Lozano NB, 2011, AQUACULT NUTR, V17, pE604, DOI 10.1111/j.1365-2095.2010.00803.x; Santigosa E, 2011, AQUACULTURE, V317, P146, DOI 10.1016/j.aquaculture.2011.04.026; Savas S, 2005, ISR J AQUACULT-BAMID, V57, P3; Schreier HJ, 2010, CURR OPIN BIOTECH, V21, P318, DOI 10.1016/j.copbio.2010.03.011; Sharrer MJ, 2005, AQUACULT ENG, V33, P135, DOI 10.1016/j.aquaeng.2004.12.001; Sitja-Bobadilla A, 2005, AQUACULTURE, V249, P387, DOI 10.1016/j.aquaculture.2005.03.031; Spanggaard B, 2000, AQUACULTURE, V182, P1, DOI 10.1016/S0044-8486(99)00250-1; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Terova G, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-17; Uran PA, 2009, J FISH DIS, V32, P733, DOI 10.1111/j.1365-2761.2009.01049.x; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Venou B, 2006, AQUACULTURE, V261, P343, DOI 10.1016/j.aquaculture.2006.07.030; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xia Y, 2008, APPL ENVIRON MICROB, V74, P2229, DOI 10.1128/AEM.02502-07	66	111	114	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136389	10.1371/journal.pone.0136389	http://dx.doi.org/10.1371/journal.pone.0136389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317431	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100076
J	Lacerda, ALM; Fonseca, LN; Blawid, R; Boiteux, LS; Ribeiro, SG; Brasileiro, ACM				Lacerda, Ana L. M.; Fonseca, Leonardo N.; Blawid, Rosana; Boiteux, Leonardo S.; Ribeiro, Simone G.; Brasileiro, Ana C. M.			Reference Gene Selection for qPCR Analysis in Tomato-Bipartite Begomovirus Interaction and Validation in Additional Tomato-Virus Pathosystems	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CELL-DEATH; RT-PCR; NORMALIZATION; RESISTANCE; IDENTIFICATION; INFECTION; ARABIDOPSIS; INHERITANCE; DIVERSITY	Quantitative Polymerase Chain Reaction (qPCR) is currently the most sensitive technique used for absolute and relative quantification of a target gene transcript, requiring the use of appropriated reference genes for data normalization. To accurately estimate the relative expression of target tomato (Solanum lycopersicum L.) genes responsive to several virus species in reverse transcription qPCR analysis, the identification of reliable reference genes is mandatory. In the present study, ten reference genes were analyzed across a set of eight samples: two tomato contrasting genotypes ('Santa Clara', susceptible, and its near-isogenic line 'LAM 157', resistant); subjected to two treatments (inoculation with Tomato chlorotic mottle virus (ToCMoV) and its mock-inoculated control) and in two distinct times after inoculation (early and late). Reference genes stability was estimated by three statistical programs (geNorm, NormFinder and BestKeeper). To validate the results over broader experimental conditions, a set of ten samples, corresponding to additional three tomato-virus pathosystems that included tospovirus, crinivirus and tymovirus + tobamovirus, was analyzed together with the tomato-ToCMoV pathosystem dataset, using the same algorithms. Taking into account the combined analyses of the ranking order outputs from the three algorithms, TIP41 and EF1 were identified as the most stable genes for tomato-ToCMoV pathosystem, and TIP41 and EXP for the four pathosystems together, and selected to be used as reference in the forthcoming expression qPCR analysis of target genes in experimental conditions involving the aforementioned tomato-virus pathosystems.	[Lacerda, Ana L. M.; Fonseca, Leonardo N.; Blawid, Rosana; Ribeiro, Simone G.; Brasileiro, Ana C. M.] EMBRAPA, Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Boiteux, Leonardo S.] EMBRAPA, Embrapa Hortalicas, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Brasileiro, ACM (corresponding author), EMBRAPA, Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	ana.brasileiro@embrapa.br	Blawid, Rosana/F-6289-2014; Blawid, Rosana/AAH-5483-2019; Brasileiro, Ana Cristina Miranda/AAN-2187-2021	Blawid, Rosana/0000-0003-1001-7191; Brasileiro, Ana Cristina Miranda/0000-0003-0530-062X	Brazilian Agricultural Corporation (Embrapa); National Council for Scientific and Technological Development (CNPq); Fundacao de Apoio a Pesquisa do DF (FAPDF); National Research Institute for Plant-Pest Interactions (INCTIPP)	Brazilian Agricultural Corporation (Embrapa); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do DF (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Research Institute for Plant-Pest Interactions (INCTIPP)	The authors gratefully acknowledge Brazilian Agricultural Corporation (Embrapa); the National Council for Scientific and Technological Development (CNPq); Fundacao de Apoio a Pesquisa do DF (FAPDF) and the National Research Institute for Plant-Pest Interactions (INCTIPP) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [LNF; LSB; SGR and ACMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfenas-Zerbini P, 2009, MOL PLANT MICROBE IN, V22, P352, DOI 10.1094/MPMI-22-3-0352; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bergougnoux V, 2014, BIOTECHNOL ADV, V32, P170, DOI 10.1016/j.biotechadv.2013.11.003; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czosnek H, 2013, VIRUSES-BASEL, V5, P998, DOI 10.3390/v5030998; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Eybishtz A, 2009, PLANT MOL BIOL, V71, P157, DOI 10.1007/s11103-009-9515-9; Garcia-Cano E, 2008, PHYTOPATHOLOGY, V98, P618, DOI 10.1094/PHYTO-98-5-0618; Giordano LB, 2005, EUPHYTICA, V143, P27, DOI 10.1007/s10681-005-1685-1; Giordano Leonardo de B., 2005, Hortic. Bras., V23, P815, DOI 10.1590/S0102-05362005000300025; Gongora-Castillo E, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-295; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Morgante CV, 2013, FUNCT PLANT BIOL, V40, P1298, DOI 10.1071/FP13096; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Noutoshi Y, 2006, PLANT MOL BIOL, V62, P29, DOI 10.1007/s11103-006-9001-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ribeiro SG, 2003, ARCH VIROL, V148, P281, DOI 10.1007/s00705-002-0917-0; Ribeiro SG, 2007, PHYTOPATHOLOGY, V97, P702, DOI 10.1094/PHYTO-97-6-0702; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	40	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136820	10.1371/journal.pone.0136820	http://dx.doi.org/10.1371/journal.pone.0136820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317870	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100144
J	Nobre, L; Wise, D; Ron, D; Volmer, R				Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain			Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; HEPATITIS-C VIRUS; SELF-ASSOCIATION; MITOFUSIN 2; RIG-I; ACTIVATION; MITOCHONDRIA; INFECTION; PATHWAY; PHOSPHOLIPIDS	RIG-I-like receptors detect viral RNA in infected cells and promote oligomerization of the outer mitochondrial membrane protein MAVS to induce innate immunity to viral infection through type I interferon production. Mitochondrial reactive oxygen species (mROS) have been shown to enhance anti-viral MAVS signalling, but the mechanisms have remained obscure. Using a biochemical oligomerization-reporter fused to the transmembrane domain of MAVS, we found that mROS inducers promoted lipid-dependent MAVS transmembrane domain oligomerization in the plane of the outer mitochondrial membrane. These events were mirrored by Sendai virus infection, which similarly induced lipid peroxidation and promoted lipid-dependent MAVS transmembrane domain oligomerization. Our observations point to a role for mROS-induced changes in lipid bilayer properties in modulating antiviral innate signalling by favouring the oligomerization of MAVS transmembrane domain in the outer-mitochondrial membrane.	[Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain] Wellcome Trust MRC Inst Metab Sci, Cambridge, England; [Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Volmer, Romain] Univ Toulouse, UMR1225, INP, ENVT,IHAP, F-31076 Toulouse, France; [Volmer, Romain] INRA, UMR1225, IHAP, F-31076 Toulouse, France	University of Cambridge; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE	Volmer, R (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	r.volmer@envt.fr		Volmer, Romain/0000-0003-1591-3251; Ron, David/0000-0002-3014-5636; Nobre, Luis/0000-0003-0467-8989	Wellcome Trust Intermediate Clinical Fellowship [093764]; Wellcome Trust Principal Research Fellowship [084812]; European Union Seventh Framework Programme Grant (Beta Bat) [277713]; Wellcome Trust [100140]	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome Trust Principal Research Fellowship(Wellcome Trust); European Union Seventh Framework Programme Grant (Beta Bat); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Intermediate Clinical Fellowship (093764 o RV), a Wellcome Trust Principal Research Fellowship (084812 to DR), a Wellcome Trust Strategic Award for core facilities to the Cambridge Institute for Medical Research (100140) and European Union Seventh Framework Programme Grant (Beta Bat, 277713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Buege J A, 1978, Methods Enzymol, V52, P302; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Dey M, 2007, J BIOL CHEM, V282, P6653, DOI 10.1074/jbc.M607897200; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Mall S, 2001, BIOCHEMISTRY-US, V40, P12379, DOI 10.1021/bi011075y; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Reis A, 2012, BBA-BIOMEMBRANES, V1818, P2374, DOI 10.1016/j.bbamem.2012.02.002; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Tyurina YY, 2015, FREE RADICAL RES, V49, P681, DOI 10.3109/10715762.2015.1005085; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63; Wallgren M, 2013, FARADAY DISCUSS, V161, P499, DOI 10.1039/c2fd20089a; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086	49	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136883	10.1371/journal.pone.0136883	http://dx.doi.org/10.1371/journal.pone.0136883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317833	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100160
J	Peralta, L; Mourier, E; Richard, C; Charpigny, G; Larcher, T; Ait-Belkacem, D; Balla, NK; Brasselet, S; Tanter, M; Muller, M; Chavatte-Palmer, P				Peralta, Laura; Mourier, Eve; Richard, Christophe; Charpigny, Gilles; Larcher, Thibaut; Ait-Belkacem, Dora; Balla, Naveen K.; Brasselet, Sophie; Tanter, Mickael; Muller, Marie; Chavatte-Palmer, Pascale			In Vivo Evaluation of Cervical Stiffness Evolution during Induced Ripening Using Shear Wave Elastography, Histology and 2 Photon Excitation Microscopy: Insight from an Animal Model	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; UTERINE CERVIX; LABOR INDUCTION; OVARIAN-CANCER; PRETERM BIRTH; COLLAGEN; PREGNANCY; TERM; LENGTH; PARTURITION	Prematurity affects 11% of the births and is the main cause of infant mortality. On the opposite case, the failure of induction of parturition in the case of delayed spontaneous birth is associated with fetal suffering. Both conditions are associated with precocious and/or delayed cervical ripening. Quantitative and objective information about the temporal evolution of the cervical ripening may provide a complementary method to identify cases at risk of preterm delivery and to assess the likelihood of successful induction of labour. In this study, the cervical stiffness was measured in vivo in pregnant sheep by using Shear Wave Elastography (SWE). This technique assesses the stiffness of tissue through the measurement of shear waves speed (SWS). In the present study, 9 pregnant ewes were used. Cervical ripening was induced at 127 days of pregnancy (term: 145 days) by dexamethasone injection in 5 animals, while 4 animals were used as control. Elastographic images of the cervix were obtained by two independent operators every 4 hours during 24 hours after injection to monitor the cervical maturation induced by the dexamethasone. Based on the measurements of SWS during vaginal ultrasound examination, the stiffness in the second ring of the cervix was quantified over a circular region of interest of 5 mm diameter. SWS was found to decrease significantly in the first 4-8 hours after dexamethasone compared to controls, which was associated with cervical ripening induced by dexamethasone (from 1.779 m/s +/- 0.548 m/s, p < 0.0005, to 1.291 m/s +/- 0.516 m/s, p < 0.000). Consequently a drop in the cervical elasticity was quantified too (from 9.5 kPa +/- 0.9 kPa, p < 0.0005, to 5.0 kPa +/- 0.8 kPa, p < 0.000). Moreover, SWE measurements were highly reproducible between both operators at all times. Cervical ripening induced by dexamethasone was confirmed by the significant increase in maternal plasma Prostaglandin E2 (PGE2), as evidenced by the assay of its metabolite PGEM. Histological analyses and two-photon excitation microscopy, combining both Second Harmonic Generation (SHG) and Two-photon Fluorescence microscopy (2PF) contrasts, were used to investigate, at the microscopic scale, the structure of cervical tissue. Results show that both collagen and 2PF-active fibrillar structures could be closely related to the mechanical properties of cervical tissue that are perceptible in elastography. In conclusion, SWE may be a valuable method to objectively quantify the cervical stiffness and as a complementary diagnostic tool for preterm birth and for labour induction success.	[Peralta, Laura] Univ Granada, Dept Struct Mech, Granada, Spain; [Mourier, Eve; Richard, Christophe; Charpigny, Gilles; Chavatte-Palmer, Pascale] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Mourier, Eve; Richard, Christophe; Chavatte-Palmer, Pascale] PremUp Fdn, F-75006 Paris, France; [Larcher, Thibaut] INRA, UMR APEX 703, F-44307 Nantes, France; [Ait-Belkacem, Dora; Balla, Naveen K.; Brasselet, Sophie] Aix Marseille Univ, CNRS, Cent Marseille, Inst Fresnel,UMR 7249, F-13013 Marseille, France; [Tanter, Mickael; Muller, Marie] Univ Paris 07, CNRS, Inst Langevin, ESPCI ParisTech, Paris, France; [Muller, Marie] N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA	University of Granada; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; University of North Carolina; North Carolina State University	Peralta, L (corresponding author), Univ Granada, Dept Struct Mech, Granada, Spain.	lperalta@ugr.es	Mickael, Tanter/H-4657-2012; Larcher, Thibaut/X-8500-2019; Chavatte-Palmer, Pascale/K-7349-2012; Brasselet, Sophie/N-1089-2017; Peralta, Laura/I-4732-2019; Larcher, Thibaut/M-9160-2013	Mickael, Tanter/0000-0001-7739-8051; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Brasselet, Sophie/0000-0002-6766-9273; Peralta, Laura/0000-0002-3753-5370; Larcher, Thibaut/0000-0002-0396-3190				Ait-Belkacem D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.080506; Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; Badir S, 2013, PRENATAL DIAG, V33, P737, DOI 10.1002/pd.4116; BAKKE T, 1974, ACTA OBSTET GYN SCAN, V53, P293, DOI 10.3109/00016347409157742; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2004, APPL PHYS LETT, V84, P2202, DOI 10.1063/1.1667613; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Bernal M, 2013, ULTRASOUND MED BIOL, V39, P2123, DOI 10.1016/j.ultrasmedbio.2013.05.014; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CABROL D, 1991, SEMIN PERINATOL, V15, P133; CALDER AA, 1994, AUST NZ J OBSTET GYN, V34, P347, DOI 10.1111/j.1479-828X.1994.tb01087.x; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Carlson LC, 2014, ULTRASOUND OBST GYN, V43, P452, DOI 10.1002/uog.12555; Carlson L. C, 2014, ULTRASOUND OBSTET GY; Celik E, 2008, ULTRASOUND OBST GYN, V31, P549, DOI 10.1002/uog.5333; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chang SK, 2002, J BIOMED OPT, V7, P595, DOI 10.1117/1.1509753; Feltovich H, 2013, ULTRASOUND OBST GYN, V41, P121, DOI 10.1002/uog.12383; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Friedl Peter, 2007, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0415s34; GOMEZ R, 1994, AM J OBSTET GYNECOL, V171, P956, DOI 10.1016/0002-9378(94)90014-0; Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068; HALBERT GW, 1990, THERIOGENOLOGY, V33, P977, DOI 10.1016/0093-691X(90)90060-7; Hernandez-Andrade E, 2013, ULTRASOUND OBST GYN, V41, P152, DOI 10.1002/uog.12344; Hochhaus G, 2001, J CLIN PHARMACOL, V41, P425, DOI 10.1177/00912700122010285; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Ingoldby L, 2001, PRACTICE, P23; Isgro G, 2013, J GASTROENTEROL, V48, P921, DOI 10.1007/s00535-012-0694-9; Johnson MD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-373; Khalil MR, 2013, DAN MED J, V60; Kolkman DGE, 2013, AM J PERINAT, V30, P625, DOI 10.1055/s-0032-1331024; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; LIGGINS GC, 1968, J ENDOCRINOL, V42, P323, DOI 10.1677/joe.0.0420323; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Martin JA, 2013, NATL VITAL STAT REPO; Maul H, 2005, ACTA OBSTET GYN SCAN, V84, P534, DOI 10.1111/j.0001-6349.2005.00806.x; Mazza E, 2006, MED IMAGE ANAL, V10, P125, DOI 10.1016/j.media.2005.06.001; Mazza E, 2014, PRENATAL DIAG, V34, P33, DOI 10.1002/pd.4260; Molina FS, 2012, ULTRASOUND OBST GYN, V39, P685, DOI 10.1002/uog.11067; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; Nadiarnykh O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-94; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Pandis GK, 2001, ULTRASOUND OBST GYN, V18, P623, DOI 10.1046/j.0960-7692.2001.00580.x; Peralta L, 2015, J BIOMECH, V48, P1557, DOI 10.1016/j.jbiomech.2015.02.037; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Purohit GN, 2012, IRAN J APPL ANIM SCI, V2, P1; Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006; Reusch LM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031110; Sanchez-Ramos L, 2003, OBSTET GYNECOL, V101, P1312, DOI 10.1016/S0029-7844(03)00342-9; Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS70, DOI 10.1016/j.ejogrb.2009.02.036; SILVER M, 1990, EXP PHYSIOL, V75, P285, DOI 10.1113/expphysiol.1990.sp003405; Strupler M, 2007, OPT EXPRESS, V15, P4054, DOI 10.1364/OE.15.004054; Strupler M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981830; Swiatkowska-Freund M, 2011, ULTRASOUND OBST GYN, V38, P52, DOI 10.1002/uog.9021; Tang J, 2014, ASIAN J ANDROL, V16, P305, DOI 10.4103/1008-682X.122582; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Tanter M, 2014, IEEE T ULTRASON FERR, V61, P102, DOI [10.1109/TUFFC.2014.2882, 10.1109/TUFFC.2014.6689779]; Tiaho F, 2007, OPT EXPRESS, V15, P12286, DOI 10.1364/OE.15.012286; Tilbury K, 2014, BIOPHYS J, V106, P354, DOI 10.1016/j.bpj.2013.10.044; ULDBJERG N, 1981, LANCET, V1, P267; Verhoeven CJM, 2013, ULTRASOUND OBST GYN, V42, P500, DOI 10.1002/uog.12467; WHO, 2011, WHO REC IND LAB; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109	72	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133377	10.1371/journal.pone.0133377	http://dx.doi.org/10.1371/journal.pone.0133377			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317774	Green Published, gold			2022-12-27	WOS:000360299100007
J	Sanford, T; Porten, S; Meng, MV				Sanford, Thomas; Porten, Sima; Meng, Maxwell V.			Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison	PLOS ONE			English	Article							UPPER URINARY-TRACT; COMPARATIVE GENOMIC HYBRIDIZATION; TRANSITIONAL-CELL CARCINOMA; RENAL PELVIS; TUMOR SPECTRUM; PROBE LEVEL; EXPRESSION; CANCER; NEPHROURETERECTOMY; ABNORMALITIES	Introduction Prior studies have shown genetic similarities between upper tract and bladder urothelial carcinoma. However, upper tract urothelial carcinoma tends to be higher grade than bladder urothelial carcinoma and tends to form in patients with certain familial conditions (e.g. Lynch Syndrome), indicating there may be unique biologic processes in these tumors. The purpose of this study was to evaluate the differences in gene expression between upper tract and bladder urothelial carcinoma using microarray data. Design, Setting, Participants A search of publicly available microarray datasets identified a clinically annotated dataset of 12 upper tract and 20 bladder urothelial carcinoma specimens. Gene expression analysis of data derived from the Affymetrix HGU133Plus2 chip was performed. Bioconductor packages were used to evaluate clustering, differential gene expression, pathways relevant to oncology, and a basal/luminal signature in upper tract versus bladder urothelial carcinoma. Results When separated by pathologic T stage, there was evidence of differential clustering among pT3 tumors and significant gene expression differences in 81 genes. Pathway analysis revealed differences in HGF and TNF signaling pathways. Upper tract tumors tended to have high expression of genes associated with a luminal subtype. One of the genes most highly expressed in upper tract tumors, SLITRK6, is the target of an antibody drug conjugate (AGS15E) currently in phase I clinical trials. Conclusions This study provides evidence for molecular differences between upper tract and bladder urothelial carcinoma, some of which contribute to oncologic-relevant pathways. Upper tract tumors tended to express genes consistent with a luminal subtype. We also identify a marker, SLITRK6, as a potential target for patients with advanced upper tract urothelial carcinoma.	[Sanford, Thomas; Porten, Sima; Meng, Maxwell V.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Meng, MV (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	Max.Meng@ucsf.edu		Sanford, Thomas/0000-0002-7123-9807				Abouassaly R, 2010, UROLOGY, V76, P895, DOI 10.1016/j.urology.2010.04.020; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Audenet F, 2013, UROL ONCOL-SEMIN ORI, V31, P407, DOI 10.1016/j.urolonc.2010.07.016; Bing ZY, 2012, AM J CLIN PATHOL, V138, P382, DOI 10.1309/AJCPUXAP6P2GVBTI; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Carneiro BA, 2015, CANCER TREAT REV, V41, P170, DOI 10.1016/j.ctrv.2014.11.003; Chan Pei-Hui, 2005, J Chin Med Assoc, V68, P29, DOI 10.1016/S1726-4901(09)70128-5; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Do JH, 2008, MOL CELLS, V25, P279; Erickson DR, 2008, J UROLOGY, V180, P2681, DOI 10.1016/j.juro.2008.08.007; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Morrison K., 2012, DEV AGS15E NOVEL ANT; Munoz JJ, 2000, J UROLOGY, V164, P1523, DOI 10.1016/S0022-5347(05)67019-X; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Olgac S, 2004, AM J SURG PATHOL, V28, P1545, DOI 10.1097/00000478-200412000-00001; Ouzzane A, 2011, EUR UROL, V60, P1258, DOI 10.1016/j.eururo.2011.05.049; Patel N, 2014, UROL ONCOL; Qian CN, 2009, CANCER RES, V69, P8256, DOI 10.1158/0008-5472.CAN-09-1689; Rigola MA, 2001, CANCER GENET CYTOGEN, V127, P59, DOI 10.1016/S0165-4608(00)00426-X; Roupret M, 2008, EUR UROL, V54, P1226, DOI 10.1016/j.eururo.2008.08.008; Simon R, 2007, CANCER INFORM, V3, P11; Stefanovic V, 2006, AM J NEPHROL, V26, P1, DOI 10.1159/000090705; Stewart GD, 2005, BJU INT, V95, P791, DOI 10.1111/j.1464-410X.2005.05402.x; Uematsu K, 2010, BJU INT, V106, P873, DOI 10.1111/j.1464-410X.2009.09144.x; WATSON P, 1994, ANTICANCER RES, V14, P1635; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Zhang ZF, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-58	31	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137141	10.1371/journal.pone.0137141	http://dx.doi.org/10.1371/journal.pone.0137141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317352	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100211
J	Wu, HY; Chiang, SW; Yang, C; Lin, ZY; Liu, JP; Moon, KS; Kang, FY; Li, B; Wong, CP				Wu, Haoyi; Chiang, Sum Wai; Yang, Cheng; Lin, Ziyin; Liu, Jingping; Moon, Kyoung-Sik; Kang, Feiyu; Li, Bo; Wong, Ching Ping			Conformal Pad-Printing Electrically Conductive Composites onto Thermoplastic Hemispheres: Toward Sustainable Fabrication of 3-Cents Volumetric Electrically Small Antennas	PLOS ONE			English	Article							SILVER NANOWIRES; ELECTRONICS; ADHESIVES	Electrically small antennas (ESAs) are becoming one of the key components in the compact wireless devices for telecommunications, defence, and aerospace systems, especially for the spherical one whose geometric layout is more closely approaching Chu's limit, thus yielding significant bandwidth improvements relative to the linear and planar counterparts. Yet broad applications of the volumetric ESAs are still hindered since the low cost fabrication has remained a tremendous challenge. Here we report a state-of-the-art technology to transfer electrically conductive composites (ECCs) from a planar mould to a volumetric thermoplastic substrate by using pad-printing technology without pattern distortion, benefit from the excellent properties of the ECCs as well as the printing-calibration method that we developed. The antenna samples prepared in this way meet the stringent requirement of an ESA (ka is as low as 0.32 and the antenna efficiency is as high as 57%), suggesting that volumetric electronic components i.e. the antennas can be produced in such a simple, green, and cost-effective way. This work can be of interest for the development of studies on green and high performance wireless communication devices.	[Wu, Haoyi; Chiang, Sum Wai; Yang, Cheng; Liu, Jingping; Kang, Feiyu; Li, Bo] Tsinghua Univ, Grad Sch Shenzhen, Div Energy & Environm, Shenzhen 518057, Peoples R China; [Lin, Ziyin; Moon, Kyoung-Sik; Wong, Ching Ping] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Kang, Feiyu] Tsinghua Univ, Dept Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Wong, Ching Ping] Chinese Univ Hong Kong, Dept Elect Engn, Shatin, Hong Kong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University System of Georgia; Georgia Institute of Technology; Tsinghua University; Chinese University of Hong Kong	Yang, C (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Div Energy & Environm, Shenzhen 518057, Peoples R China.	yang.cheng@sz.tsinghua.edu.cn	Wong, CP/M-6587-2017; Moon, Kyoung-Sik/AAP-5877-2020	Wong, CP/0000-0003-3556-8053; Kang, Feiyu/0000-0002-3704-4379				Adams JJ, 2011, ADV MATER, V23, P1335, DOI 10.1002/adma.201003734; Best SR, 2004, IEEE T ANTENN PROPAG, V52, P953, DOI 10.1109/TAP.2004.825799; Best SR, 2010, IEEE ANTENN PROPAG M, V52, P47, DOI 10.1109/MAP.2010.5466398; CHU LJ, 1948, J APPL PHYS, V19, P1163, DOI 10.1063/1.1715038; Erentok A, 2008, IEEE T ANTENN PROPAG, V56, P691, DOI 10.1109/TAP.2008.916949; Farahani RD, 2014, NANOSCALE, V6, P10470, DOI 10.1039/c4nr02041c; Glenn S S., 1972, IEEE T ANTENN PROPAG, V20, P656, DOI [10.1109/TAP.1972.1140293, DOI 10.1109/TAP.1972.1140293]; Inui T, 2015, ADV MATER, V27, P1112, DOI 10.1002/adma.201404555; Jobs M, 2013, SMALL, V9, P3230, DOI 10.1002/smll.201300070; Kim OS, 2014, IEEE T ANTENN PROPAG, V62, P3839, DOI 10.1109/TAP.2014.2317489; Kim OS, 2010, IEEE T ANTENN PROPAG, V58, P2210, DOI 10.1109/TAP.2010.2048863; Komoda N, 2012, ACS APPL MATER INTER, V4, P5732, DOI 10.1021/am301747p; Kubo M, 2010, ADV MATER, V22, P2749, DOI 10.1002/adma.200904201; Lu DQ, 2000, INT J ADHES ADHES, V20, P189, DOI 10.1016/S0143-7496(99)00039-1; McLean JS, 1996, IEEE T ANTENN PROPAG, V44, P672, DOI 10.1109/8.496253; Meador MAB, 2012, ACS APPL MATER INTER, V4, P6346, DOI 10.1021/am301985s; NEWMAN EH, 1975, IEEE T ANTENN PROPAG, VAP23, P457, DOI 10.1109/TAP.1975.1141114; Nocera DG, 2012, DAEDALUS-US, V141, P45, DOI 10.1162/DAED_a_00160; Pfeiffer C, 2012, ADV MATER, V24, P1166, DOI 10.1002/adma.201104290; Sarma S., 2001, WHITE PAPER 5C TAG M; Shin DY, 2009, THIN SOLID FILMS, V517, P6112, DOI 10.1016/j.tsf.2009.05.019; So JH, 2009, ADV FUNCT MATER, V19, P3632, DOI 10.1002/adfm.200900604; Song LN, 2014, ACS APPL MATER INTER, V6, P4248, DOI 10.1021/am405972e; Tamboli MS, 2014, DALTON T, V43, P13232, DOI 10.1039/c4dt00947a; Toriz-Garcia JJ, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/5/055010; van Osch THJ, 2008, ADV MATER, V20, P343, DOI 10.1002/adma.200701876; Whitesides G., 2011, ECONOMIST, V17; Yaghjian AD, 2005, IEEE T ANTENN PROPAG, V53, P1298, DOI 10.1109/TAP.2005.844443; Yang C, 2011, ADV FUNCT MATER, V21, P4582, DOI 10.1002/adfm.201101433; Yang C, 2011, ADV MATER, V23, P3052, DOI 10.1002/adma.201100530; Yang C, 2010, ADV FUNCT MATER, V20, P2580, DOI 10.1002/adfm.201000673; Yang L, 2009, IEEE ANTENN WIREL PR, V8, P653, DOI 10.1109/LAWP.2009.2024104	32	11	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136939	10.1371/journal.pone.0136939	http://dx.doi.org/10.1371/journal.pone.0136939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317999	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100177
J	Maluccio, JA; Palermo, T; Kadiyala, S; Rawat, R				Maluccio, John A.; Palermo, Tia; Kadiyala, Suneetha; Rawat, Rahul			Improving Health-Related Quality of Life among People Living with HIV: Results from an Impact Evaluation of a Food Assistance Program in Uganda	PLOS ONE			English	Article							INSECURITY ACCESS SCALE; ANTIRETROVIRAL THERAPY; MEDICAL OUTCOMES; MATCHING ESTIMATORS; NUTRITIONAL-STATUS; SOCIAL-SERVICES; PUBLIC-HEALTH; INFECTION; ADHERENCE; HIV/AIDS	Introduction Widespread food insecurity in Africa continues to compromise an effective response to the AIDS epidemic. Health-related quality of life (HRQoL) is a comprehensive indicator of physical, mental, and social well-being that is associated with food insecurity and increasingly used to assess the well-being of people living with HIV/AIDS (PLHIV). We examined the impact of a food assistance intervention, previously shown to have reduced household food insecurity and improved nutritional status, on HRQoL of PLHIV. Methods We capitalized on an existing intervention targeting antiretroviral therapy (ART)-naive PLHIV in Uganda, and conducted a prospective impact evaluation including a treatment and a comparison group. Data analyzed included 640 participants from two districts (318 in the intervention district) interviewed in both clinic and household settings at baseline and again approximately one year later. The main outcomes considered were physical and mental health dimensions of HRQoL, and other outcomes included self-and healthcare provider-reported symptoms. We utilized difference-in-difference propensity score matching methodologies to infer causality and examine program impacts. Results Over 12 months, food assistance significantly increased physical health scores (PHS) by 2.85 (P < .01) or approximately 0.35 SD, and reduced substantially the number of self-and healthcare provider-reported HIV-related symptoms by 3.83 and 2.68, respectively (P < .01). There was no significant impact, however, on mental health scores (MHS). Conclusions This study demonstrates the potential importance for HRQoL of including food assistance programming as part of the standard of care for PLHIV in areas of widespread food insecurity.	[Maluccio, John A.] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Palermo, Tia] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA; [Kadiyala, Suneetha] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Rawat, Rahul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; London School of Hygiene & Tropical Medicine; CGIAR; International Food Policy Research Institute (IFPRI)	Maluccio, JA (corresponding author), Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA.	maluccio@middlebury.edu	Palermo, Tia/ABI-8328-2020	Kadiyala, Suneetha/0000-0002-9101-1471	International Initiative for Impact Evaluation (3ie), Concern Worldwide; Regional Network on AIDS, Livelihoods, and Food Security (RENEWAL); Irish Aid; Swedish International Development Cooperation Agency (SIDA)	International Initiative for Impact Evaluation (3ie), Concern Worldwide; Regional Network on AIDS, Livelihoods, and Food Security (RENEWAL); Irish Aid(CGIAR); Swedish International Development Cooperation Agency (SIDA)	This study was funded by the International Initiative for Impact Evaluation (3ie), Concern Worldwide, and the Regional Network on AIDS, Livelihoods, and Food Security (RENEWAL), facilitated by IFPRI. RENEWAL is grateful for support from Irish Aid and the Swedish International Development Cooperation Agency (SIDA). The funders had no role in the study design, data collection, analysis, interpretation, or manuscript preparation.	Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Adewuya AO, 2008, INT J PSYCHIAT MED, V38, P43, DOI 10.2190/PM.38.1.d; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Anema A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061277; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], 2014, GLOB UPD HLTH SECT R; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Armon C, 2011, QUAL LIFE RES; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS357, DOI 10.1097/QAI.0000000000000498; Becquey E, 2010, J NUTR, V140, P2233, DOI 10.3945/jn.110.125716; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; de Pee S, 2010, FOOD NUTR BULL, V31, pS313, DOI 10.1177/15648265100314S403; Deaton A, 2002, GUIDLINES CONSTRUCTI; Gibson K, 2011, AIDS PATIENT CARE ST, V25, P371, DOI 10.1089/apc.2010.0165; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hadley C, 2008, AM J PHYS ANTHROPOL, V135, P225, DOI 10.1002/ajpa.20724; Hughes J, 2004, DISABIL REHABIL, V26, P371, DOI 10.1080/09638280410001662932; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Kadiyala S, 2010, SOCIOECONOMIC DIMENS, P74; Kaleeba N, 1997, AIDS CARE, V9, P13, DOI 10.1080/09540129750125307; Kirkpatrick SI, 2008, J NUTR, V138, P604, DOI 10.1093/jn/138.3.604; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Laraia BA, 2006, J NUTR, V136, P177, DOI 10.1093/jn/136.1.177; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Leuven E., 2012, STAT SOFTW COMPONENT; Louwagie GM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-244; Mahlungulu S, 2007, COCHRANE DATABASE SY, V3; Marcellin F, 2010, AIDS, V24, pS17, DOI 10.1097/01.aids.0000366079.83568.a2; Mast TC, 2004, AIDS CARE, V16, P81, DOI 10.1080/09540120310001633994; Miners A, 2014, LANCET HIV, V1, pE32, DOI 10.1016/S2352-3018(14)70018-9; Musumari PM, 2013, AIDS CARE, P1; O'Leary JF, 1998, J ACQ IMMUN DEF SYND, V17, P433, DOI 10.1097/00042560-199804150-00008; OKeefe EA, 1996, QUAL LIFE RES, V5, P275, DOI 10.1007/BF00434749; Oketch JA, 2011, HEALTH POLICY, V99, P267, DOI 10.1016/j.healthpol.2010.08.018; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Pozniak A, 2014, LANCET HIV, V1, pE6, DOI 10.1016/S2352-3018(14)70003-7; Preau M, 2005, J PSYCHOSOM RES, V59, P407, DOI 10.1016/j.jpsychores.2005.06.005; Preau M, 2004, AIDS CARE, V16, P649, DOI 10.1080/09540120410001716441; Rawat R, 2014, JAIDS-J ACQ IMM DEF, V66, pE15, DOI 10.1097/QAI.0000000000000079; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; Romero R., 2015, P INT C INT SYST APP, P1; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Senkomago V, 2011, AIDS CARE, V23, P1246, DOI 10.1080/09540121.2011.564112; Stangl AL, 2007, AIDS CARE, V19, P626, DOI 10.1080/09540120701203915; Stangl AL, 2011, QUAL LIFE RES; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Tirivayi N, 2011, SOC SCI MED, V73, P685, DOI 10.1016/j.socscimed.2011.06.056; Todd PE, 2007, HDB DEV EC, P3847; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2012, JAIDS-J ACQ IMM DEF, V61, P179, DOI 10.1097/QAI.0b013e318261f064; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; WHO, 2010, 2010 GUID ANT TREATM; Wu AW, 1997, QUAL LIFE RES, V6, P531, DOI 10.1023/A:1018460132567; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Wu AW., 1999, MOS HIV HLTH SURVEY	70	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135879	10.1371/journal.pone.0135879	http://dx.doi.org/10.1371/journal.pone.0135879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313908	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000360144000028
J	Misialek, JR; Bekwelem, W; Chen, LY; Loehr, LR; Agarwal, SK; Soliman, EZ; Norby, FL; Alonso, A				Misialek, Jeffrey R.; Bekwelem, Wobo; Chen, Lin Y.; Loehr, Laura R.; Agarwal, Sunil K.; Soliman, Elsayed Z.; Norby, Faye L.; Alonso, Alvaro			Association of White Blood Cell Count and Differential with the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LEUKOCYTE COUNT; MATRIX; MYELOPEROXIDASE; INFLAMMATION; FIBROSIS; SURGERY; STROKE; COHORT; PREDICTORS	Background Although inflammation is involved in the development of atrial fibrillation (AF), the association of white blood cell (WBC) count and differential with AF has not been thoroughly examined in large cohorts with extended follow-up. Methods We studied 14,500 men and women (25% blacks, 55% women, mean age 54) free of AF at baseline (1987-89) from the Atherosclerosis Risk in Communities (ARIC) study, a community-based cohort in the United States. Incident AF cases through 2010 were identified from study electrocardiograms, hospital discharge records and death certificates. Multivariable Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for AF associated with WBC count and differential. Results Over a median follow-up time of 21.5 years for the entire cohort, 1928 participants had incident AF. Higher total WBC count was associated with higher AF risk independent of AF risk factors and potential confounders (HR 1.09, 95% CI 1.04-1.15 per 1-standard deviation [SD] increase). Higher neutrophil and monocyte counts were positively associated with AF risk, while an inverse association was identified between lymphocyte count and AF (multivariable adjusted HRs 1.16, 95% CI 1.09-1.23; 1.05, 95% CI 1.00-1.11; 0.91, 95% CI 0.86-0.97 per 1-SD, respectively). No significant association was identified between eosinophils or basophils and AF. Conclusions High total WBC, neutrophil, and monocyte counts were each associated with higher AF risk while lymphocyte count was inversely associated with AF risk. Systemic inflammation may underlie this association and requires further investigation for strategies to prevent AF.	[Misialek, Jeffrey R.; Norby, Faye L.; Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Bekwelem, Wobo; Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA; [Loehr, Laura R.] Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Agarwal, Sunil K.] Johns Hopkins Univ, Sch Med, Div Med, Baltimore, MD USA; [Agarwal, Sunil K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wake Forest University; Wake Forest University; Wake Forest University	Misialek, JR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	misi0020@umn.edu	Soliman, Elsayed Z/AAD-7135-2020; Alonso, Alvaro/A-4917-2010; Norby, Faye/FNA-7255-2022	Soliman, Elsayed Z/0000-0001-5632-8150; Alonso, Alvaro/0000-0002-2225-8323; Norby, Faye/0000-0002-1975-0405; Chen, Lin/0000-0002-0700-814X; Misialek, Jeffrey/0000-0003-4583-786X; Loehr, Laura/0000-0002-9054-1825	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; American Heart Association (AHA) in Dallas, Texas [09SDG2280087]; National Institutes of Health (NIH) [RC1-HL099452]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA) in Dallas, Texas; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C. This study was additionally funded by grants 09SDG2280087 from the American Heart Association (AHA) in Dallas, Texas, and RC1-HL099452 from the National Institutes of Health (NIH). Contents of this paper are solely the responsibility of the authors and do not necessarily represent the views of the NIH, NHLBI, or NIMHD.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Amar D, 2006, ANN THORAC SURG, V82, P1057, DOI 10.1016/j.athoracsur.2006.03.103; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bekwelem W, 2011, ANN EPIDEMIOL, V21, P739, DOI 10.1016/j.annepidem.2011.06.005; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Burstein B, 2007, CARDIOVASC RES, V76, P442, DOI 10.1016/j.cardiores.2007.07.013; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Chambless L E, 1992, Ann Epidemiol, V2, P723; Chen CL, 2008, J MOL CELL CARDIOL, V45, P742, DOI 10.1016/j.yjmcc.2008.07.007; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496; ERIKSSON H, 1987, EUR HEART J, V8, P1007, DOI 10.1093/oxfordjournals.eurheartj.a062365; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fontes ML, 2009, J CARDIOTHOR VASC AN, V23, P484, DOI 10.1053/j.jvca.2009.01.030; Friedrichs K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00214; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Huxley RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059052; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Lamm G, 2006, J CARDIOTHOR VASC AN, V20, P51, DOI 10.1053/j.jvca.2005.03.026; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P525, DOI 10.1093/oxfordjournals.aje.a116530; Nyrnes A, 2012, GENDER MED, V9, P536, DOI 10.1016/j.genm.2012.09.001; PAPP AC, 1989, THROMB HAEMOSTASIS, V61, P15; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Rienstra M, 2012, AM J CARDIOL, V109, P533, DOI 10.1016/j.amjcard.2011.09.049; Rossi MA, 1998, J HYPERTENS, V16, P1031, DOI 10.1097/00004872-199816070-00018; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Sinner MF, 2014, EUROPACE, V16, P1426, DOI 10.1093/europace/euu175; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Sood N, 2009, J CARDIOTHOR VASC AN, V23, P22, DOI 10.1053/j.jvca.2008.06.009; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136219	10.1371/journal.pone.0136219	http://dx.doi.org/10.1371/journal.pone.0136219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313365	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000047
J	Norberg, A; Rooyackers, O; Segersvard, R; Wernerman, J				Norberg, Ake; Rooyackers, Olav; Segersvard, Ralf; Wernerman, Jan			Albumin Kinetics in Patients Undergoing Major Abdominal Surgery	PLOS ONE			English	Article							TOTAL LIVER PROTEIN; HYDROXYETHYL STARCH; SYNTHESIS RATES; HUMANS; VOLUME; FLUID; HYPOALBUMINEMIA; RESUSCITATION; PERMEABILITY; INJURY	Background The drop in plasma albumin concentration following surgical trauma is well known, but the temporal pattern of the detailed mechanisms behind are less well described. The aim of this explorative study was to assess changes in albumin synthesis and transcapillary escape rate (TER) following major surgical trauma, at the time of peak elevations in two well-recognized markers of inflammation. Methods This was a clinical trial of radiolabeled human serum albumin for the study of TER and plasma volume. Ten patients were studied immediately preoperatively and on the 2nd postoperative day after major pancreatic surgery. Albumin synthesis rate was measured by the flooding dose technique employing incorporation of isotopically labelled phenylalanine. Results Fractional synthesis rate of albumin increased from 11.7 (95% CI: 8.9, 14.5) to 15.0 (11.7, 18.4)%/day (p = 0.027), whereas the corresponding absolute synthesis rate was unchanged, 175 (138, 212) versus 150 (107, 192) mg/kg/day (p = 0.21). TER was unchanged, 4.9 (3.1, 6.8) %/hour versus 5.5 (3.9, 7.2) (p = 0.63). Plasma volume was unchanged but plasma albumin decreased from 33.5 (30.9, 36.2) to 22.1 (19.8, 24.3) g/L. (p<0.001). Conclusion Two days after major abdominal surgery, at the time-point when two biomarkers of generalised inflammation were at their peak and the plasma albumin concentration had decreased by 33%, we were unable to show any difference in the absolute synthesis rate of albumin, TER and plasma volume as compared with values obtained immediately pre-operatively. This suggests that capillary leakage, if elevated postoperatively, had ceased at that time-point. The temporal relations between albumin kinetics, capillary leakage and generalised inflammation need to be further explored.	[Norberg, Ake; Rooyackers, Olav; Wernerman, Jan] Karolinska Univ Hosp Huddinge, Dept Anaesthesia & Intens Care, Stockholm, Sweden; [Norberg, Ake; Rooyackers, Olav; Wernerman, Jan] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Segersvard, Ralf] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Norberg, A (corresponding author), Karolinska Univ Hosp Huddinge, Dept Anaesthesia & Intens Care, Stockholm, Sweden.	ake.norberg@karolinska.se		Segersvard, Ralf/0000-0002-5702-7971	Stockholm County Council; Karolinska Institutet [20080109]	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support was provided through the regional agreement on clinical research (ALF) between Stockholm County Council and Karolinska Institutet, grant #20080109, to AN.	BALLMER PE, 1990, AM J PHYSIOL, V259, pE797, DOI 10.1152/ajpendo.1990.259.6.E797; Barle H, 2006, CLIN SCI, V110, P93, DOI 10.1042/CS20050222; Barle H, 1997, HEPATOLOGY, V25, P154, DOI 10.1053/jhep.1997.v25.pm0008985282; Barle H, 2004, CLIN PHYSIOL FUNCT I, V24, P91, DOI 10.1111/j.1475-097X.2004.00535.x; Baverstock K, GUIDELINES IODINE PR; BEEKEN WL, 1962, J CLIN INVEST, V41, P1312, DOI 10.1172/JCI104594; Brandstrup B, 2012, BRIT J ANAESTH, V109, P191, DOI 10.1093/bja/aes163; Bunn F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001319.pub5; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; FLECK A, 1985, LANCET, V1, P781; Gillies MA, 2014, BRIT J ANAESTH, V112, P25, DOI 10.1093/bja/aet303; Hartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607; Hovorka R, 2006, J LIPID RES, V47, P975, DOI 10.1194/jlr.M500358-JLR200; Hulshoff A, 2013, NUTRITION, V29, P703, DOI 10.1016/j.nut.2012.10.014; Margarson MP, 2002, J APPL PHYSIOL, V92, P2139, DOI 10.1152/japplphysiol.00201.2001; Miller TE, 2014, BEST PRACT RES-CLIN, V28, P261, DOI 10.1016/j.bpa.2014.07.003; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; NADLER SB, 1962, SURGERY, V51, P224; Niemi G, 1998, ACTA ANAESTH SCAND, V42, P897, DOI 10.1111/j.1399-6576.1998.tb05348.x; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Peters T., 1996, ALL ALBUMIN BIOCH GE; PETTIT JE, 1980, J NUCL MED, V21, P793; Prien T, 1990, J Clin Anesth, V2, P317; Rehm M, 1998, ACTA ANAESTH SCAND, V42, P39, DOI 10.1111/j.1399-6576.1998.tb05078.x; Relles DM, 2013, J GASTROINTEST SURG, V17, P326, DOI 10.1007/s11605-012-2093-1; Rittler P, 2007, SURGERY, V141, P660, DOI 10.1016/j.surg.2006.09.018; Rittler P, 2011, JPEN-PARENTER ENTER, V35, P405, DOI 10.1177/0148607110382782; Schricker T, 2008, ANN SURG, V248, P1051, DOI 10.1097/SLA.0b013e31818842d8; Verbruggen SC, 2011, CLIN NUTR, V30, P469, DOI 10.1016/j.clnu.2011.02.001; Yates DR, 2013, BR J ANAESTH; Yuan XY, 2008, AM J SURG, V196, P751, DOI 10.1016/j.amjsurg.2007.10.030; ZETTERSTROM H, 1981, ACTA ANAESTH SCAND, V25, P125, DOI 10.1111/j.1399-6576.1981.tb01622.x	32	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136371	10.1371/journal.pone.0136371	http://dx.doi.org/10.1371/journal.pone.0136371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313170	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000057
J	Tabo, DA; Granier, SA; Diguimbaye, CD; Marault, M; Brisabois, A; Mama, B; Millemann, Y				Tabo, Djim-Adjim; Granier, Sophie A.; Diguimbaye, Colette D.; Marault, Muriel; Brisabois, Anne; Mama, Baizina; Millemann, Yves			Are Salmonella-Induced Gastroenteritis Neglected in Developing Countries? Feedback from Microbiological Investigations in N'Djamena Hospitals, Chad	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; QUINOLONE RESISTANCE; BACTEREMIA; CHILDREN; TYPHIMURIUM; ENTERITIDIS; PREVALENCE; DISEASE	Salmonella is considered to be one of the main pathogens causing human gastroenteritis worldwide. Looking for Salmonella in Africa in patients suffering from gastroenteritis is rather unusual, and the use of antibiotics is not subject to any regulation. This study intends for stressing the possible prominent importance of Salmonella in digestive diseases in Africa as well as identifying antimicrobial resistance of Salmonella isolates from faeces samples of human origin. All samples were collected from five N'Djamena hospitals, from patients suffering from diarrhoea. The collecting was undertaken over two periods of six months each: from August 2010 to January 2011 and from September 2011 to February 2012. Salmonella isolates were obtained by standard cultivation and serotyping methods. A total of 43 Salmonella isolates were identified, belonging to 21 different serovars. The most prevalent serovar was Salmonella Stanleyville (n = 7), followed by S. Anatum (n = 4) and S. Kottbus (n = 3). The other serovars were under-represented. The majority of these isolates were susceptible to all antibiotics tested (CLSI Standards), except two S. Enteritidis isolates that exhibited resistance to fluoroquinolones. The different serovars and antibiotic resistance profiles that were observed highlight the substantial diversity of Salmonella in N'Djamena, Chad. Roughly, one out of ten patients who consulted for gastroenteritis was shedding Salmonella spp. and none of them would have been diagnosed outside the context of this research program. This study may encourage local clinicians to explore more often salmonellosis suspicion in their daily practice.	[Tabo, Djim-Adjim] Univ NDjamena, FSEA, Ndjamena, Chad; [Tabo, Djim-Adjim; Millemann, Yves] Univ Paris Est, Unite MASQ, ENVA, Maisons Alfort, France; [Granier, Sophie A.; Marault, Muriel; Brisabois, Anne; Millemann, Yves] Univ Paris Est, Lab Secur Aliments, Mission Antibioresistance, ANSES, Maisons Alfort, France; [Tabo, Djim-Adjim; Diguimbaye, Colette D.; Mama, Baizina] LRVZ F, Ndjamena, Chad	Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Securite Aliments; Ecole Nationale Veterinaire d'Alfort (ENVA)	Granier, SA (corresponding author), Univ Paris Est, Lab Secur Aliments, Mission Antibioresistance, ANSES, Maisons Alfort, France.	Sophie.GRANIER@anses.fr	Millemann, Yves/H-6999-2013; Granier, Sophie A./H-6796-2019	Millemann, Yves/0000-0001-5442-7016; Granier, Sophie A./0000-0001-9676-2402	French government through a program of Franco-Chadian cooperation	French government through a program of Franco-Chadian cooperation	This study was carried out with a grant from the French government through a program of Franco-Chadian cooperation.	Aarestrup FM, 2003, ANTIMICROB AGENTS CH, V47, P827, DOI 10.1128/AAC.47.2.827-829.2003; Baumler A. J., 2000, Salmonella in domestic animals., P57, DOI 10.1079/9780851992617.0057; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Clinical and Laboratory Standards Institute (CLSI), 2009, M2A10 CLSI; CLSI, 2011, M100S20 CLSI, P172; Delmas G, 2010, B EPIDEMIOL HEBD, V31-32, P44; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Frenzen P. D., 1999, FoodReview, V22, P10; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Guard O, 1973, REV ELEV MED VET PAY, P33; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Kariuki S, 2006, INT J ANTIMICROB AG, V28, P166, DOI 10.1016/j.ijantimicag.2006.05.026; Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585, DOI 10.3855/jidc.549; LEMINOR L, 1969, ANN I PASTEUR PARIS, V116, P775; Molbak K, 2002, EMERG INFECT DIS, V8, P514, DOI 10.3201/eid0805.010288; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Sarwari AR, 2001, J INFECT DIS, V183, P1295, DOI 10.1086/319671; Seydi M, 2008, MED MALADIES INFECT, V38, P25, DOI 10.1016/j.medmal.2007.10.007; Suresh T, 2006, FOOD MICROBIOL, V23, P294, DOI 10.1016/j.fm.2005.04.001; Tabo JA, 2013, VET MICROBIOL, V166, P293, DOI 10.1016/j.vetmic.2013.05.010; Vandenberg O, 2010, PEDIATR INFECT DIS J, V29, P504, DOI 10.1097/INF.0b013e3181cd615a; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Wattiau P, 2008, J CLIN MICROBIOL, V46, P4037, DOI 10.1128/JCM.01405-08	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136153	10.1371/journal.pone.0136153	http://dx.doi.org/10.1371/journal.pone.0136153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313150	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000045
J	Watanabe, E; Kiyono, K; Hayano, J; Yamamoto, Y; Inamasu, J; Yamamoto, M; Ichikawa, T; Sobue, Y; Harada, M; Ozaki, Y				Watanabe, Eiichi; Kiyono, Ken; Hayano, Junichiro; Yamamoto, Yoshiharu; Inamasu, Joji; Yamamoto, Mayumi; Ichikawa, Tomohide; Sobue, Yoshihiro; Harada, Masehide; Ozaki, Yukio			Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; PHYSIOLOGICAL TIME-SERIES; VENTRICULAR RESPONSE; APPROXIMATE ENTROPY; CIRCADIAN VARIATION; MORNING INCREASE; THROMBOEMBOLISM; ANTICOAGULATION; MORTALITY	Background Atrial fibrillation (AF) is a significant risk factor for ischemic strokes, and making a robust risk stratification scheme would be important. Few studies have examined whether nonlinear dynamics of the heart rate could predict ischemic strokes in AF. We examined whether a novel complexity measurement of the heart rate variability called multiscale entropy (MSE) was a useful risk stratification measure of ischemic strokes in patients with permanent AF. Methods and Results We examined 173 consecutive patients (age 69 +/- 11 years) with permanent AF who underwent 24-hour Holter electrocardiography from April 2005 to December 2006. We assessed several frequency ranges of the MSE and CHA(2)DS(2)-VASc score (1 point for congestive heart failure, hypertension, diabetes, vascular disease, an age 65 to 74 years, and a female sex and 2 points for an age >= 75 years and a stroke or transient ischemic attack). We found 22 (13%) incident ischemic strokes during a mean follow up of 3.8-years. The average value of the MSE in the very-low frequency subrange (90-300 s, MeanEn(VLF2)) was significantly higher in patients who developed ischemic strokes than in those who did not (0.68 +/- 0.15 vs. 0.60 +/- 0.14, P<0.01). There was no significant difference in the C-statistic between the CHA(2)DS(2)-VASc score and MeanEn(VLF2) (0.56; 95% confidence interval, 0.43-0.69 vs. 0.66; 95% confidence interval, 0.53-0.79). After an adjustment for the age, CHA(2)DS(2)-VASc score, and antithrombotic agent, a Cox hazard regression model revealed that the MeanEn(VLF2) was an independent predictor of an ischemic stroke (hazard ratio per 1-SD increment, 1.80; 95% confidence interval, 1.17-2.07, P<0.01). Conclusion The MeanEn(VLF2) in 24-hour Holter electrocardiography is a useful risk stratification measure of ischemic strokes during the long-term follow-up in patients with permanent AF.	[Watanabe, Eiichi; Yamamoto, Mayumi; Ichikawa, Tomohide; Sobue, Yoshihiro; Harada, Masehide; Ozaki, Yukio] Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan; [Kiyono, Ken] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka 560, Japan; [Hayano, Junichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Med Educ, Nagoya, Aichi, Japan; [Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Inamasu, Joji] Fujita Hlth Univ, Sch Med, Dept Neurosurg, Toyoake, Aichi 47011, Japan	Fujita Health University; Osaka University; Nagoya City University; University of Tokyo; Fujita Health University	Watanabe, E (corresponding author), Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan.	enwatan@fujita-hu.ac.jp	Kiyono, Ken/E-6325-2017; Inamasu, Joji/R-7314-2019	Kiyono, Ken/0000-0001-5433-7002; Watanabe, Eiichi/0000-0002-2375-2323; Harada, Masahide/0000-0002-2345-9557; Hayano, Junichiro/0000-0002-5340-6325; Yamamoto, Yoshiharu/0000-0002-1132-0355	Japan Society for the Promotion of Science KAKENHI; Suzuken Memorial Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI (to EW, KK) (http://www.e-rad.go.jp/kenkyu/index.html) and the Suzuken Memorial Foundation (to EW) (http://www.suzukenzaidan.or.jp/).	Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; ANAN T, 1990, J ELECTROCARDIOL, V23, P243, DOI 10.1016/0022-0736(90)90163-V; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 1996, CIRCULATION, V93, P1043; CHISHAKI AS, 1991, AM HEART J, V121, P820, DOI 10.1016/0002-8703(91)90194-M; CHORRO FJ, 1990, AM J PHYSIOL, V259, pH1015, DOI 10.1152/ajpheart.1990.259.4.H1015; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; EHRLY A M, 1973, Biorheology, V10, P577; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Hayano J, 1997, AM J PHYSIOL-HEART C, V273, pH2811, DOI 10.1152/ajpheart.1997.273.6.H2811; Hayano J, 1998, J AM COLL CARDIOL, V31, P158, DOI 10.1016/S0735-1097(97)00429-4; Ho YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018699; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Khaykin Y, 2011, EUROPACE, V13, P1797, DOI 10.1093/europace/eur203; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; MARLER JR, 1989, STROKE, V20, P473, DOI 10.1161/01.STR.20.4.473; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; MILLARCRAIG MW, 1978, LANCET, V1, P795; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Schurmann J, 1996, PATTERN CLASSIFICATI; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; VANDENBERG MP, 1994, CLIN SCI, V86, P531, DOI 10.1042/cs0860531; Yamada A, 2000, CIRCULATION, V102, P300	30	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137144	10.1371/journal.pone.0137144	http://dx.doi.org/10.1371/journal.pone.0137144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325058	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700099
J	Verma, M; Kumar, V; Patel, RK; Garg, R; Jain, M				Verma, Mohit; Kumar, Vinay; Patel, Ravi K.; Garg, Rohini; Jain, Mukesh			CTDB: An Integrated Chickpea Transcriptome Database for Functional and Applied Genomics	PLOS ONE			English	Article							GENE DISCOVERY; GLYCINE-MAX; ATLAS; EXPRESSION; RESOURCE; CROP; SEQUENCE; MARKERS	Chickpea is an important grain legume used as a rich source of protein in human diet. The narrow genetic diversity and limited availability of genomic resources are the major constraints in implementing breeding strategies and biotechnological interventions for genetic enhancement of chickpea. We developed an integrated Chickpea Transcriptome Database (CTDB), which provides the comprehensive web interface for visualization and easy retrieval of transcriptome data in chickpea. The database features many tools for similarity search, functional annotation (putative function, PFAM domain and gene ontology) search and comparative gene expression analysis. The current release of CTDB (v2.0) hosts transcriptome datasets with high quality functional annotation from cultivated (desi and kabuli types) and wild chickpea. A catalog of transcription factor families and their expression profiles in chickpea are available in the database. The gene expression data have been integrated to study the expression profiles of chickpea transcripts in major tissues/organs and various stages of flower development. The utilities, such as similarity search, ortholog identification and comparative gene expression have also been implemented in the database to facilitate comparative genomic studies among different legumes and Arabidopsis. Furthermore, the CTDB represents a resource for the discovery of functional molecular markers (microsatellites and single nucleotide polymorphisms) between different chickpea types. We anticipate that integrated information content of this database will accelerate the functional and applied genomic research for improvement of chickpea. The CTDB web service is freely available at http://nipgr.res.in/ctdb.html.	[Verma, Mohit; Kumar, Vinay; Patel, Ravi K.; Garg, Rohini; Jain, Mukesh] Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021; Verma, Mohit/ABB-7093-2020; Patel, Ravi K/W-4441-2019	Jain, Mukesh/0000-0002-7622-1083; Verma, Mohit/0000-0002-0438-5396; Patel, Ravi K/0000-0001-5203-899X	Department of Biotechnology, Government of India, New Delhi, under the Next Generation Challenge Program on Chickpea Genomics [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Government of India, New Delhi, under the Next Generation Challenge Program on Chickpea Genomics	The financial support was received from the Department of Biotechnology, Government of India, New Delhi, under the Next Generation Challenge Program on Chickpea Genomics (grant number BT/PR12919/AGR/02/676/2009 from 2009-2014).	Agarwal G, 2015, EUPHYTICA, V205, P381, DOI 10.1007/s10681-015-1394-3; Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Choudhary P, 2012, GENET MOL RES, V11, P891, DOI 10.4238/2012.April.10.5; Doddamani D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-212; Garg R, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.04.0011; Garg R, 2011, PLANT SIGNAL BEHAV, V6, P1868, DOI 10.4161/psb.6.11.17879; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gaur PM, 2012, AGRONOMY-BASEL, V2, P199, DOI 10.3390/agronomy2030199; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jaiswal DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04177; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kudapa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086039; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Li J, 2012, NUCLEIC ACIDS RES, V40, pD1221, DOI 10.1093/nar/gkr939; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lin YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102825; Millan T, 2006, EUPHYTICA, V147, P81, DOI 10.1007/s10681-006-4261-4; Roque E, 2013, PLANT J, V73, P663, DOI 10.1111/tpj.12068; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Singh KB, 1997, THEOR APPL GENET, V95, P418, DOI 10.1007/s001220050578; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119	27	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136880	10.1371/journal.pone.0136880	http://dx.doi.org/10.1371/journal.pone.0136880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322998	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500046
J	Wang, F; Zhou, JG; Zhang, Y; Wang, Y; Cheng, L; Bai, YJ; Ma, H				Wang, Fei; Zhou, Jianguo; Zhang, Yu; Wang, Yi; Cheng, Long; Bai, Yuju; Ma, Hu			The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							EXPRESSION; ERLOTINIB; MIR-155; CHEMOTHERAPY; RESISTANCE; INVASION; QUALITY; MIR-21; GROWTH; TIME	Background Recent studies have shown that miR-155 play a positive role in the development of carcinoma. This meta-analysis aimed to identify the role of miR-155 in the survival of non-small cell lung cancer patients. Methodology Eligible studies were identified through database searches. Relevant data were extracted from each eligible study to assess the correlation between miR-155 expression and survival in lung carcinoma patients. The hazard ratios (HRs) and 95% confidence intervals (CIs) of the patients' outcomes in relation to miR-155 were calculated. A total of 6 studies were included for this meta-analysis. For overall survival (OS), recurrence-free survival (RFS), disease-free survival (DFS), and cancer-specific survival (CSS), the combined HRs and 95% CIs were not statistically significant. Additionally, in Asian and America subgroups, greater expression levels of miR-155 were related to poor prognoses for lung cancer (HR 1.71 95% CI: 1.22-2.40, P = 0.002, HR 2.35 95% CI: 1.42-3.89 P = 0.001), while no significant relationship was present in a Europe subgroup (HR 0.75 95% CI: 0.27-2.10, P = 0.587). Conclusions These results suggest that miR-155 expression is not significantly related to non-small cell lung cancer patients except in patients from Asian and America.	[Wang, Fei; Zhou, Jianguo; Zhang, Yu; Wang, Yi; Cheng, Long; Bai, Yuju; Ma, Hu] Zunyi Med Univ, Affiliated Hosp, Dept Oncol, Zunyi, Guizhou Provinc, Peoples R China	Zunyi Medical University	Ma, H (corresponding author), Zunyi Med Univ, Affiliated Hosp, Dept Oncol, Zunyi, Guizhou Provinc, Peoples R China.	mahuab@163.com	Zhou, Jianguo/GRX-6659-2022; Zhou, Jian-Guo/AFK-7643-2022	Zhou, Jianguo/0000-0002-5021-3739; Zhou, Jian-Guo/0000-0002-5021-3739	NSFC (Natural Science Foundation of China) [81360351]; Start-Up Fund for Doctor of Zunyi Medical University; Department of Science and Technology of Guizhou Province [Qian Ke He SY[2013]3003]	NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Start-Up Fund for Doctor of Zunyi Medical University; Department of Science and Technology of Guizhou Province(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India))	This work was supported by NSFC (Natural Science Foundation of China) (81360351), Start-Up Fund for Doctor of Zunyi Medical University and the Department of Science and Technology of Guizhou Province (Grant No. Qian Ke He SY[2013]3003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Enfield KSS, 2012, GENET RES INT, V2012, DOI 10.1155/2012/737416; Gao Yi, 2014, Zhongguo Fei Ai Za Zhi, V17, P417, DOI 10.3779/j.issn.1009-3419.2014.05.10; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; He Fei, 2014, Wei Sheng Yan Jiu, V43, P1004; He J, 2013, DIS MARKERS, V34, P379, DOI [10.1155/2013/856750, 10.3233/DMA-130984]; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Ricciuti Biagio, 2014, Oncoscience, V1, P674; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/000323283; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soon YY, 2009, J CLIN ONCOL, V27, P3277, DOI 10.1200/JCO.2008.19.4522; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sun SB, 2014, ONCOL REP, V32, P951, DOI 10.3892/or.2014.3288; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Voortman J, 2010, CANC RES, V70; Wang Y, 2013, JPN J CLIN ONCOL, V43, P813, DOI 10.1093/jjco/hyt084; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Xu TP, 2013, ASIAN PAC J CANCER P, V14, P7085, DOI 10.7314/APJCP.2013.14.12.7085; Yang MM, 2013, EUR J CANCER, V49, P604, DOI 10.1016/j.ejca.2012.09.031; Yu F, 2013, MOL CANCER RES, V11, P923, DOI 10.1158/1541-7786.MCR-12-0686; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089105	33	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136889	10.1371/journal.pone.0136889	http://dx.doi.org/10.1371/journal.pone.0136889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322518	gold, Green Submitted, Green Published			2022-12-27	WOS:000360435500047
J	Younes, M; Robert, C; Cottin, F; Barrey, E				Younes, Mohamed; Robert, Celine; Cottin, Francois; Barrey, Eric			Speed and Cardiac Recovery Variables Predict the Probability of Elimination in Equine Endurance Events	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; EXERCISE; HORSES; PERFORMANCE; PARAMETERS	Nearly 50% of the horses participating in endurance events are eliminated at a veterinary examination (a vet gate). Detecting unfit horses before a health problem occurs and treatment is required is a challenge for veterinarians but is essential for improving equine welfare. We hypothesized that it would be possible to detect unfit horses earlier in the event by measuring heart rate recovery variables. Hence, the objective of the present study was to compute logistic regressions of heart rate, cardiac recovery time and average speed data recorded at the previous vet gate (n-1) and thus predict the probability of elimination during successive phases (n and following) in endurance events. Speed and heart rate data were extracted from an electronic database of endurance events (80-160 km in length) organized in four countries. Overall, 39% of the horses that started an event were eliminated-mostly due to lameness (64%) or metabolic disorders (15%). For each vet gate, logistic regressions of explanatory variables (average speed, cardiac recovery time and heart rate measured at the previous vet gate) and categorical variables (age and/or event distance) were computed to estimate the probability of elimination. The predictive logistic regressions for vet gates 2 to 5 correctly classified between 62% and 86% of the eliminated horses. The robustness of these results was confirmed by high areas under the receiving operating characteristic curves (0.68-0.84). Overall, a horse has a 70% chance of being eliminated at the next gate if its cardiac recovery time is longer than 11 min at vet gate 1 or 2, or longer than 13 min at vet gates 3 or 4. Heart rate recovery and average speed variables measured at the previous vet gate(s) enabled us to predict elimination at the following vet gate. These variables should be checked at each veterinary examination, in order to detect unfit horses as early as possible. Our predictive method may help to improve equine welfare and ethical considerations in endurance events.	[Younes, Mohamed; Barrey, Eric] Univ Evry Val dEssonne, UBIAE, Evry, France; [Robert, Celine; Barrey, Eric] INRA, GABI, UMR1313, Jouy En Josas, France; [Robert, Celine] Univ Paris Est, Ecole Natl Vet Alfort, Creteil, France; [Cottin, Francois] Univ Paris 11, CIAMS, EA4532, Orsay, France; [Cottin, Francois] Univ Evry Val dEssonne, Dept STAPS, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Barrey, E (corresponding author), Univ Evry Val dEssonne, UBIAE, Evry, France.	eric.barrey@inserm.fr	Robert, Céline/AAD-6158-2020	ROBERT, Celine/0000-0002-3899-1060; Cottin, Francois/0000-0002-7950-2163	Association du Cheval Arabe; Fond Eperon	Association du Cheval Arabe; Fond Eperon	This work was supported by the Association du Cheval Arabe 2011-2014 and Fond Eperon 2011-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory H, 2010, EQUINE VET J, V42, P216, DOI 10.1111/j.2042-3306.2010.00253.x; Barnes A, 2010, EQUINE VET J, V42, P6, DOI 10.1111/j.2042-3306.2010.00225.x; Barrey E, 2006, Equine Vet J Suppl, P43; Bitschnau C, 2010, EQUINE VET J, V42, P17, DOI 10.1111/j.2042-3306.2010.00260.x; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Cottin F, 2006, Equine Vet J Suppl, P204; EVANS DL, 1993, EQUINE VET J, V25, P441, DOI 10.1111/j.2042-3306.1993.tb02987.x; Federation Equestre Internationale, 2014, END RUL; Fielding CL, 2011, JAVMA-J AM VET MED A, V239, P493, DOI 10.2460/javma.239.4.493; Flaminio F, 1998, VET CLIN N AM-EQUINE, V14, P147, DOI 10.1016/S0749-0739(17)30217-1; Foreman JH, 1998, VET CLIN N AM-EQUINE, V14, P205, DOI 10.1016/S0749-0739(17)30220-1; Geor, 2013, EQUINE SPORTS MED SU, P1083; Hada T, 2006, Equine Vet J Suppl, P141; HAGBERG JM, 1980, J APPL PHYSIOL, V48, P218, DOI 10.1152/jappl.1980.48.2.218; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; LEE E T, 1974, Computer Programs in Biomedicine, V4, P80, DOI 10.1016/0010-468X(74)90011-7; Marlin DJ, 2008, P 4 INT C INT SOC EQ; Munsters CCBM, 2013, VET REC, V172, P15, DOI 10.1136/vr.100952; Nagy A, 2014, EQUINE VET J, V46, P38, DOI 10.1111/evj.12069; Nagy A, 2010, EQUINE VET J, V42, P637, DOI 10.1111/j.2042-3306.2010.00220.x; NCSS User's Guide-III, 2007, NCCS USERS GUIDE 3 R; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; Robert C, 2002, EQUINE VET J, V34, P106; Robert C, 2010, EQUINE VET J, V42, P98, DOI 10.1111/j.2042-3306.2010.00198.x; ROSE RJ, 1990, AUST VET J, V67, P345, DOI 10.1111/j.1751-0813.1990.tb07394.x; Schott H C 2nd, 2006, Equine Vet J Suppl, P37; Seshan VE, 2013, STAT MED, V32, P1483, DOI 10.1002/sim.5648; Valette JP, 1996, PFERDEHEILKUNDE, V12, P470; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007	29	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137013	10.1371/journal.pone.0137013	http://dx.doi.org/10.1371/journal.pone.0137013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322506	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500059
J	Enderle, D; Spiel, A; Coticchia, CM; Berghoff, E; Mueller, R; Schlumpberger, M; Sprenger-Haussels, M; Shaffer, JM; Lader, E; Skog, J; Noerholm, M				Enderle, Daniel; Spiel, Alexandra; Coticchia, Christine M.; Berghoff, Emily; Mueller, Romy; Schlumpberger, Martin; Sprenger-Haussels, Markus; Shaffer, Jonathan M.; Lader, Eric; Skog, Johan; Noerholm, Mikkel			Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; MICROVESICLES; PLASMA; CELLS; MICRORNAS; RECEPTOR; SERUM; RESISTANCE; STABILITY; GROWTH	Exosomes and other extracellular vesicles (commonly referred to as EVs) have generated a lot of attention for their potential applications in both diagnostics and therapeutics. The contents of these vesicles are the subject of intense research, and the relatively recent discovery of RNA inside EVs has raised interest in the biological function of these RNAs as well as their potential as biomarkers for cancer and other diseases. Traditional ultracentrifugation-based protocols to isolate EVs are labor-intensive and subject to significant variability. Various attempts to develop methods with robust, reproducible performance have not yet been completely successful. Here, we report the development and characterization of a spin column-based method for the isolation of total RNA from EVs in serum and plasma. This method isolates highly pure RNA of equal or higher quantity compared to ultracentrifugation, with high specificity for vesicular over non-vesicular RNA. The spin columns have a capacity to handle up to 4 mL sample volume, enabling detection of low-abundance transcripts in serum and plasma. We conclude that the method is an improvement over traditional methods in providing a faster, more standardized way to achieve reliable high quality RNA preparations from EVs in biofluids such as serum and plasma. The first kit utilizing this new method has recently been made available by Qiagen as "exoRNeasy Serum/Plasma Maxi Kit".	[Enderle, Daniel; Spiel, Alexandra; Mueller, Romy; Noerholm, Mikkel] Exosome Diagnost GmbH, D-82152 Martinsried, Germany; [Coticchia, Christine M.; Berghoff, Emily; Skog, Johan] Exosome Diagnost Inc, Cambridge, MA 02139 USA; [Schlumpberger, Martin; Sprenger-Haussels, Markus] QIAGEN GmbH, D-40274 Hilden, Germany; [Shaffer, Jonathan M.; Lader, Eric] QIAGEN, Frederick, MD 21703 USA	QIAGEN GmbH	Enderle, D (corresponding author), Exosome Diagnost GmbH, Klopferspitz 19a, D-82152 Martinsried, Germany.	daniel@exosomedx.com		Skog, Johan/0000-0002-0926-1691	M4 Spitzencluster Initiative of the German Bundesministerium fur Bildung und Forschung (BMBF) [FKD: 16EX1121D]; Exosome Diagnostics; QIAGEN	M4 Spitzencluster Initiative of the German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Exosome Diagnostics; QIAGEN	This work was partly supported by a grant from the M4 Spitzencluster Initiative of the German Bundesministerium fur Bildung und Forschung (BMBF) with the Forderkennzeichen FKD: 16EX1121D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no additional funding sources for this study. Exosome Diagnostics and QIAGEN provided support in the form of salaries for authors DE, AS, CC, EB, RM, MS, MSH, JMS, EL, JS, MN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Chevillet JR, 2014, P NATL ACAD SCI US; Crowley E, 2013, NAT REV CLIN ONCOL; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gould SJ, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20389; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jia SD, 2014, EXPERT REV MOL DIAGN, V14, P307, DOI 10.1586/14737159.2014.893828; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00162; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; Nolte-'t Hoen ENM, 2012, NUCL ACIDS RES; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pelloski CE, 2007, J CLIN ONCOL, V25, P2288, DOI 10.1200/JCO.2006.08.0705; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Ramachandran S, 2012, WIRES RNA, V3, P286, DOI 10.1002/wrna.115; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Schageman J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/253957; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vlassov Zeringer, 2013, WORLD J METHODOLOGY, P1; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489	48	210	225	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136133	10.1371/journal.pone.0136133	http://dx.doi.org/10.1371/journal.pone.0136133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317354	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100059
J	Giannantonio, S; Polonenko, MJ; Papsin, BC; Paludetti, G; Gordon, KA				Giannantonio, Sara; Polonenko, Melissa J.; Papsin, Blake C.; Paludetti, Gaetano; Gordon, Karen A.			Experience Changes How Emotion in Music Is Judged: Evidence from Children Listening with Bilateral Cochlear Implants, Bimodal Devices, and Normal Hearing	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; SHORT-TERM PLASTICITY; AGE-OF-ONSET; SENSITIVE PERIOD; TIME-COURSE; COGNITIVE-DEVELOPMENT; PITCH DISCRIMINATION; SONG RECOGNITION; MELODIC CONTOUR; YOUNG-CHILDREN	Children using unilateral cochlear implants abnormally rely on tempo rather than mode cues to distinguish whether a musical piece is happy or sad. This led us to question how this judgment is affected by the type of experience in early auditory development. We hypothesized that judgments of the emotional content of music would vary by the type and duration of access to sound in early life due to deafness, altered perception of musical cues through new ways of using auditory prostheses bilaterally, and formal music training during childhood. Seventy-five participants completed the Montreal Emotion Identification Test. Thirty-three had normal hearing (aged 6.6 to 40.0 years) and 42 children had hearing loss and used bilateral auditory prostheses (31 bilaterally implanted and 11 unilaterally implanted with contralateral hearing aid use). Reaction time and accuracy were measured. Accurate judgment of emotion in music was achieved across ages and musical experience. Musical training accentuated the reliance on mode cues which developed with age in the normal hearing group. Degrading pitch cues through cochlear implant-mediated hearing induced greater reliance on tempo cues, but mode cues grew in salience when at least partial acoustic information was available through some residual hearing in the contralateral ear. Finally, when pitch cues were experimentally distorted to represent cochlear implant hearing, individuals with normal hearing (including those with musical training) switched to an abnormal dependence on tempo cues. The data indicate that, in a western culture, access to acoustic hearing in early life promotes a preference for mode rather than tempo cues which is enhanced by musical training. The challenge to these preferred strategies during cochlear implant hearing (simulated and real), regardless of musical training, suggests that access to pitch cues for children with hearing loss must be improved by preservation of residual hearing and improvements in cochlear implant technology.	[Giannantonio, Sara; Paludetti, Gaetano] Univ Cattolica Sacro Cuore, Inst Otorhinolaryngol, Dept Head & Neck Surg, I-00168 Rome, Italy; [Polonenko, Melissa J.; Papsin, Blake C.; Gordon, Karen A.] Hosp Sick Children, Dept Otolaryngol, Cochlear Implant Lab, Archies, Toronto, ON M5G 1X8, Canada; [Polonenko, Melissa J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Papsin, Blake C.; Gordon, Karen A.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Gordon, KA (corresponding author), Hosp Sick Children, Dept Otolaryngol, Cochlear Implant Lab, Archies, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	karen.gordon@utoronto.ca	Giannantonio, Sara/AAA-7081-2020	Polonenko, Melissa/0000-0003-1914-6117; Giannantonio, Sara/0000-0002-5982-2581				[Anonymous], ANGELSIM; [Anonymous], 1990, COGNITIVE FDN MUSICA; Bailey J, 2012, ANN NY ACAD SCI, V1252, P163, DOI 10.1111/j.1749-6632.2011.06434.x; Bailey JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00227; Baker CA, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00019; Barrett KC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00713; BEISER M, 1985, INT J PEDIATR OTORHI, V9, P69, DOI 10.1016/S0165-5876(85)80005-7; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; COHEN AJ, 1987, CAN J PSYCHOL, V41, P33, DOI 10.1037/h0084148; Cooper WB, 2008, EAR HEARING, V29, P618, DOI 10.1097/AUD.0b013e318174e787; Dalla Bella S, 2001, ANN NY ACAD SCI, V930, P436, DOI 10.1111/j.1749-6632.2001.tb05763.x; David-Pur M, 2014, BIOMED MICRODEVICES, V16, P43, DOI 10.1007/s10544-013-9804-6; der Nederlanden CMV, 2015, COGNITION, V143, P135, DOI 10.1016/j.cognition.2015.06.015; Di Pietro M, 2004, NEUROPSYCHOLOGIA, V42, P868, DOI 10.1016/j.neuropsychologia.2003.12.004; EGGERMONT JJ, 1988, HEARING RES, V33, P35, DOI 10.1016/0378-5955(88)90019-6; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Francois C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00475; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Fujita S, 1999, ANN OTO RHINOL LARYN, V108, P634, DOI 10.1177/000348949910800702; Gabrielsson A, 2003, SER AFFECTIVE SCI, P503; Gagnon L, 2003, COGNITION EMOTION, V17, P25, DOI 10.1080/02699930302279; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Ganek H, 2012, OTOLARYNG CLIN N AM, V45, P173, DOI 10.1016/j.otc.2011.08.024; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; GERARDI GM, 1995, MUSIC PERCEPT, V12, P279; GFELLER K, 1991, J SPEECH HEAR RES, V34, P916, DOI 10.1044/jshr.3404.916; Gfeller K, 2005, EAR HEARING, V26, P237, DOI 10.1097/00003446-200506000-00001; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; Gfeller K, 2012, J MUSIC THER, V49, P68, DOI 10.1093/jmt/49.1.68; Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114841; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Gregory AH, 1996, MOTIV EMOTION, V20, P341, DOI 10.1007/BF02856522; Hargreaves D.J., 1986, PSYCHOL MUSIC, V14, P83, DOI [10.1177/0305735686142001, DOI 10.1177/0305735686142001]; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Hevner K, 1935, AM J PSYCHOL, V47, P103, DOI 10.2307/1416710; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; Hopyan T, 2011, Cochlear Implants Int, V12, P21, DOI 10.1179/146701010X12677899497399; Hopyan T, 2015, CHILD NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/09297049.2014.99; Hopyan T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00425; Hsiao Feilin, 2012, Update Univ S C Dep Music, V30, P5; Hughes Kathryn C, 2013, Cochlear Implants Int, V14, P121, DOI 10.1179/1754762812Y.0000000009; Hunter PG, 2010, SPRINGER HANDB AUDIT, V36, P129, DOI 10.1007/978-1-4419-6114-3_5; Huron D, 2001, ANN NY ACAD SCI, V930, P43, DOI 10.1111/j.1749-6632.2001.tb05724.x; Hyde KL, 2009, ANN NY ACAD SCI, V1169, P182, DOI 10.1111/j.1749-6632.2009.04852.x; IBBOTSON NR, 1981, COGNITION, V9, P125, DOI 10.1016/0010-0277(81)90008-1; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; JIANG ZD, 1991, HEARING RES, V54, P67, DOI 10.1016/0378-5955(91)90137-X; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Koelsch S, 2003, J COGNITIVE NEUROSCI, V15, P1149, DOI 10.1162/089892903322598111; Kraus N, 2012, ANN NY ACAD SCI, V1252, P100, DOI 10.1111/j.1749-6632.2012.06463.x; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kraus N, 2009, ANN NY ACAD SCI, V1169, P543, DOI 10.1111/j.1749-6632.2009.04549.x; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Limb CJ, 2014, HEARING RES, V308, P13, DOI 10.1016/j.heares.2013.04.009; Looi V, 2008, EAR HEARING, V29, P421, DOI 10.1097/AUD.0b013e31816a0d0b; Looi V, 2011, INT J PEDIATR OTORHI, V75, P472, DOI 10.1016/j.ijporl.2010.12.023; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Makris I, 2003, AM J PSYCHOL, V116, P581, DOI 10.2307/1423661; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Meyer M, 2011, EUR J NEUROSCI, V34, P755, DOI 10.1111/j.1460-9568.2011.07795.x; Mick P, 2014, OTOL NEUROTOL, V35, pE40, DOI 10.1097/MAO.0b013e318291c66d; Mikolajczak S, 2013, HNO, V61, P1032, DOI 10.1007/s00106-013-2770-8; Miranda P.C., 2014, INT J OTOLARYNGOL, V2014, DOI DOI 10.1155/2014/468515; Mitani C, 2007, EAR HEARING, V28, p29S, DOI 10.1097/AUD.0b013e318031547a; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Pals C, 2013, J SPEECH LANG HEAR R, V56, P1075, DOI 10.1044/1092-4388(2012/12-0074); Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Parbery-Clark A, 2013, J NEUROSCI, V33, P16741, DOI 10.1523/JNEUROSCI.5700-12.2013; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Pinchot Castner M., 1990, MUSIC PERCEPT, V8, P189; Reyes AD, 2011, HEARING RES, V279, P60, DOI 10.1016/j.heares.2011.04.017; Riss D, 2008, OTOL NEUROTOL, V29, P784, DOI 10.1097/MAO.0b013e31817fe00f; Riss D, 2014, EAR HEARING, V35, pE272, DOI 10.1097/AUD.0000000000000063; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Scorpecci A, 2012, INT J PEDIATR OTORHI, V76, P1507, DOI 10.1016/j.ijporl.2012.07.005; Shahin A, 2003, J NEUROSCI, V23, P5545; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Skoe E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00622; SPSS, 2013, SPSS SOFTW PACK; Steel MM, 2014, EAR HEARING, V35, pE291, DOI 10.1097/AUD.0000000000000069; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Stordahl J, 2002, J MUSIC THER, V39, P2, DOI 10.1093/jmt/39.1.2; Strait DL, 2014, HEARING RES, V308, P109, DOI 10.1016/j.heares.2013.08.004; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Tomblin JB, 2007, INT J AUDIOL, V46, P512, DOI 10.1080/14992020701383043; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; Virtala P, 2012, PSYCHOPHYSIOLOGY, V49, P1125, DOI 10.1111/j.1469-8986.2012.01386.x; Virtala P, 2011, NEUROSCI LETT, V487, P406, DOI 10.1016/j.neulet.2010.10.066; Vongpaisal T, 2006, J SPEECH LANG HEAR R, V49, P1091, DOI 10.1044/1092-4388(2006/078); Winn MB, 2015, EAR HEARING, P1; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2013, SCIENCE, V342, P585, DOI 10.1126/science.1238414; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeng FG, 2015, HEARING RES, V322, P188, DOI 10.1016/j.heares.2014.09.013	113	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136685	10.1371/journal.pone.0136685	http://dx.doi.org/10.1371/journal.pone.0136685			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317976	Green Submitted, gold, Green Published			2022-12-27	WOS:000360299100121
J	Ilievski, V; Cho, Y; Katwala, P; Rodriguez, H; Tulowiecka, M; Kurian, D; Leoni, L; Christman, JW; Unterman, TG; Watanabe, K				Ilievski, Vladimir; Cho, Yale; Katwala, Priya; Rodriguez, Heriberto; Tulowiecka, Margaret; Kurian, David; Leoni, Lara; Christman, John W.; Unterman, Terry G.; Watanabe, Keiko			TLR4 Expression by Liver Resident Cells Mediates the Development of Glucose Intolerance and Insulin Resistance in Experimental Periodontitis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KUPFFER CELLS; DIABETES-MELLITUS; RECEPTOR 4; BONE LOSS; LIPOPOLYSACCHARIDE; INFLAMMATION; PREVALENCE; DISEASE; INJURY	Background Results from epidemiological studies indicate a close association between periodontitis and type 2 diabetes mellitus. However, the mechanism linking periodontitis to glucose intolerance (GI) and insulin resistance (IR) is unknown. We therefore tested the hypothesis that periodontitis induces the development of GI/IR through a liver Toll-like receptor 4 (TLR4) dependent mechanism. Methods TLR4 chimeric mice were developed by bone marrow transplantation using green fluorescent protein expressing TLR4WT mouse (GFPWT) as donor and TLR4 WT or TLR4-/- as recipient mice (GFPWT:WT and GFPWT:KO chimeras respectively). These chimeras were subjected to experimental chronic periodontitis induced by repeated applications of LPS to the gingival sulci for 18 weeks. The levels of GI/IR were monitored and plasma cytokines and LPS were determined at 18 weeks when differences in glucose tolerance were most apparent. Cytokine gene expression was measured in liver tissue by qPCR. Results Alveolar bone loss was significantly greater in GFPWT:WT chimeras treated with LPS compared with chimeras treated with PBS or GFPWT:KO chimeras. However, the degree of gingival inflammation was similar between GFPWT:WT and GFPWT:KO mice with LPS application. Severe GI/IR occurred in GFPWT:WT chimeras but not in the GFPWT:KO chimeras that were subjected to 18 weeks of LPS. Serum LPS was detected only in animals to which LPS was applied and the level was similar in GFPWT:WT and GFPWT:KO mice at the 18 week time point. Surprisingly, there was no significant difference in the plasma levels of IL1 beta, IL6 and TNF alpha at 18 weeks in spite of the severe GI/IR in the GFPWT:WT chimeras with LPS application. Also, no difference in the expression of TNF alpha or IL6 mRNA was detected in the liver of GFPWT:WT vs GFPWT:KO mice. In contrast, liver IL1 beta expression was significantly greater in GFPWT:WT chimeras compared to GFPWT:KO chimeras treated with LPS. Conclusion We observed that GFPWT:WT, but not GFPWT:KO chimeras, treated with LPS developed GI/IR despite similar degrees of gingival inflammation, circulating cytokine levels, and LPS concentrations. We conclude that LPS from periodontitis sites has a pivotal role in triggering the development of GI/IR through a mechanism that involves TLR4 expression by resident macrophages/Kupffer cells in the liver.	[Ilievski, Vladimir; Watanabe, Keiko] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA; [Cho, Yale] Univ Illinois, Coll Dent, Undergrad Program, Chicago, IL USA; [Katwala, Priya; Rodriguez, Heriberto; Tulowiecka, Margaret; Kurian, David] Univ Illinois, Undergrad Program, Chicago, IL USA; [Leoni, Lara] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Christman, John W.] Ohio State Univ, Dept Internal Med, Sect Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Unterman, Terry G.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Watanabe, K (corresponding author), Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA.	keiko@uic.edu			National Institute of Health [R01DE021405, R01 HL075557, R01HL103643]; Department of Veterans Affairs Merit Review Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075557, R01HL103643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021405] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Health, R01DE021405 (KW), the National Institute of Health, R01 HL075557 and R01HL103643 (JWC), and the Department of Veterans Affairs Merit Review Program (TGU).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Arora N, 2014, J CLIN PERIODONTOL, V41, P643, DOI 10.1111/jcpe.12258; Benguigui C, 2010, J CLIN PERIODONTOL, V37, P601, DOI 10.1111/j.1600-051X.2010.01571.x; Bhat UG, 2014, J PERIODONTOL, V85, P1629, DOI 10.1902/jop.2014.140070; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Colombo NH, 2012, J PERIODONTOL, V83, P864, DOI 10.1902/jop.2011.110349; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Ekuni D, 2003, J PERIODONTAL RES, V38, P591, DOI 10.1034/j.1600-0765.2003.00694.x; Enomoto N, 2000, J GASTROEN HEPATOL, V15, pD20; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kennedy David W., 1997, Blood, V90, P986; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Li Y, 2014, J PAIN, V15, P712, DOI 10.1016/j.jpain.2014.04.001; Li ZH, 2006, AM J PHYSIOL-REG I, V290, pR1262, DOI 10.1152/ajpregu.00724.2005; LIU YC, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/407562; Lott MEJ, 2013, ACTA OPHTHALMOL, V91, pe462, DOI 10.1111/aos.12129; Nishimura F, 2001, J DENT RES, V80, P1690, DOI 10.1177/00220345010800080201; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Nwose EU, 2014, N AM J MED SCI, V6, P328, DOI 10.4103/1947-2714.136913; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rogers JE, 2007, J PERIODONTOL, V78, P550, DOI 10.1902/jop.2007.060321; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Su Y, 2013, J PERIODONTOL, V84, P1617, DOI 10.1902/jop.2013.120442; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Thakur V, 2007, J GASTROEN HEPATOL, V22, pS53, DOI 10.1111/j.1440-1746.2006.04650.x; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Timonen P, 2011, J CLIN PERIODONTOL, V38, P17, DOI 10.1111/j.1600-051X.2010.01642.x; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Watanabe K, 2011, J PERIODONTAL RES, V46, P21, DOI 10.1111/j.1600-0765.2010.01304.x; Watanabe K, 2008, J PERIODONTOL, V79, P1208, DOI [10.1902/jop.2008.070605, 10.1902/jop.2008.070605 ]; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796	44	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136502	10.1371/journal.pone.0136502	http://dx.doi.org/10.1371/journal.pone.0136502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317345	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100091
J	Joo, HM; Kang, SJ; Nam, SY; Yang, KH; Kim, CS; Lee, IK; Kim, JY				Joo, Hae Mi; Kang, Su Jin; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Lee, In Kyung; Kim, Ji Young			The Inhibitory Effects of Low-Dose Ionizing Radiation in IgE-Mediated Allergic Responses	PLOS ONE			English	Article							MAST-CELL; LATE-PHASE; SKIN REACTION; MICE	Ionizing radiation has different biological effects according to dose and dose rate. In particular, the biological effect of low-dose radiation is unclear. Low-dose whole-body gamma irradiation activates immune responses in several ways. However, the effects and mechanism of low-dose radiation on allergic responses remain poorly understood. Previously, we reported that low-dose ionizing radiation inhibits mediator release in IgE-mediated RBL-2H3 mast cell activation. In this study, to have any physiological relevance, we investigated whether low-dose radiation inhibits allergic responses in activated human mast cells (HMC-1(5C6) and LAD2 cells), mouse models of passive cutaneous anaphylaxis and the late-phase cutaneous response. High-dose radiation induced cell death, but low-dose ionizing radiation of <0.5 Gy did not induce mast cell death. Low-dose ionizing radiation that did not induce cell death significantly suppressed mediator release from human mast cells (HMC-1 (5C6) and LAD2 cells) that were activated by antigen-antibody reaction. To determine the inhibitory mechanism of mediator released by low-dose ionizing radiation, we examined the phosphorylation of intracellular signaling molecules such as Lyn, Syk, phospholipase C gamma, and protein kinase C, as well as the intracellular free Ca2+ concentration ([Ca2+](i)). The phosphorylation of signaling molecules and [Ca2+] i following stimulation of Fc epsilon RI receptors was inhibited by low dose ionizing radiation. In agreement with its in vitro effect, ionizing radiation also significantly inhibited inflammatory cells infiltration, cytokine mRNA expression (TNF-alpha, IL-4, IL-13), and symptoms of passive cutaneous anaphylaxis reaction and the late-phase cutaneous response in anti-dinitrophenyl IgE-sensitized mice. These results indicate that ionizing radiation inhibits both mast cell-mediated immediate- and delayed-type allergic reactions in vivo and in vitro.	[Joo, Hae Mi; Kang, Su Jin; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Lee, In Kyung; Kim, Ji Young] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Inst, Low Dose Radiat Res Team, Seoul, South Korea	Korea Hydro & Nuclear Power	Kim, JY (corresponding author), Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Inst, Low Dose Radiat Res Team, Seoul, South Korea.	elizabeth@khnp.co.kr			Korea Hydro & Nuclear Power Co., Ltd.	Korea Hydro & Nuclear Power Co., Ltd.	Korea Hydro & Nuclear Power Co., Ltd. provided support in the form of salaries for authors HMJ, SJK, SYN, KHY, CSK, IKL, and JYK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrevaya XC, 2007, GENET MOL BIOL, V30, P1139, DOI 10.1590/S1415-47572007000600018; Akiyama M., 1995, INT J RADIAT BIOL, V107, P417; BERK LB, 1991, YALE J BIOL MED, V64, P155; Bogoljubov WM, 1988, J PHYS MED BALNEOL M, V17, P59; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; Doss M, 2013, DOSE-RESPONSE, V11, P480, DOI 10.2203/dose-response.13-005.Doss; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P160, DOI 10.1016/0091-6749(82)90037-9; Guhl S, 2010, EXP DERMATOL, P1; Harrington NP, 1997, CLIN EXP IMMUNOL, V107, P417, DOI 10.1111/j.1365-2249.1997.272-ce1158.x; Joo HM, 2012, J BIOL CHEM, V287, P27789, DOI 10.1074/jbc.M112.378497; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KALINER MM, 1984, J ALLERGY CLIN IMMUN, V73, P311, DOI 10.1016/0091-6749(84)90401-9; KATAYAMA I, 1990, INT ARCH ALLER A IMM, V93, P148, DOI 10.1159/000235294; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Luckey T. D., 2006, Dose-Response, V4, P169, DOI 10.2203/dose-response.06-102.Luckey; Nagai H, 2000, J ALLERGY CLIN IMMUN, V106, pS91, DOI 10.1067/mai.2000.106778; Nagai H, 1995, J ALLERGY CLIN IMMUN, V52, P38; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; RAY MC, 1983, J IMMUNOL, V131, P1096; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; SCHLEIMER RP, 1985, J ALLERGY CLIN IMMUN, V76, P369, DOI 10.1016/0091-6749(85)90656-6; Scott S G, 1926, Br Med J, V1, P939; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Weber S, 1996, ARCH DERMATOL RES, V288, P778, DOI 10.1007/BF02505297; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136394	10.1371/journal.pone.0136394	http://dx.doi.org/10.1371/journal.pone.0136394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317642	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100078
J	Lehtomaki, J; Tuominen, S; Toivonen, T; Leinonen, A				Lehtomaki, Joona; Tuominen, Sakari; Toivonen, Tuuli; Leinonen, Antti			What Data to Use for Forest Conservation Planning? A Comparison of Coarse Open and Detailed Proprietary Forest Inventory Data in Finland	PLOS ONE			English	Article							WOODLAND KEY HABITATS; PROTECTED AREA; BOREAL FORESTS; CLIMATE-CHANGE; BIODIVERSITY; SELECTION; CONNECTIVITY; LANDSCAPES; CHALLENGES; MANAGEMENT	The boreal region is facing intensifying resource extraction pressure, but the lack of comprehensive biodiversity data makes operative forest conservation planning difficult. Many countries have implemented forest inventory schemes and are making extensive and up-to-date forest databases increasingly available. Some of the more detailed inventory databases, however, remain proprietary and unavailable for conservation planning. Here, we investigate how well different open and proprietary forest inventory data sets suit the purpose of conservation prioritization in Finland. We also explore how much priorities are affected by using the less accurate but open data. First, we construct a set of indices for forest conservation value based on quantitative information commonly found in forest inventories. These include the maturity of the trees, tree species composition, and site fertility. Secondly, using these data and accounting for connectivity between forest types, we investigate the patterns in conservation priority. For prioritization, we use Zonation, a method and software for spatial conservation prioritization. We then validate the prioritizations by comparing them to known areas of high conservation value. We show that the overall priority patterns are relatively consistent across different data sources and analysis options. However, the coarse data cannot be used to accurately identify the high-priority areas as it misses much of the fine-scale variation in forest structures. We conclude that, while inventory data collected for forestry purposes may be useful for forest conservation purposes, it needs to be detailed enough to be able to account for more fine-scaled features of high conservation value. These results underline the importance of making detailed inventory data publicly available. Finally, we discuss how the prioritization methodology we used could be integrated into operative forest management, especially in countries in the boreal zone.	[Lehtomaki, Joona; Toivonen, Tuuli] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Lehtomaki, Joona] Nat Environm Ctr, Finnish Environm Inst, Helsinki, Finland; [Tuominen, Sakari] Nat Resources Inst Finland, Vantaa, Finland; [Leinonen, Antti] Finnish Forest Ctr, Kajaani, Finland	University of Helsinki; Finnish Environment Institute; Natural Resources Institute Finland (Luke)	Lehtomaki, J (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	joona.lehtomaki@helsinki.fi		Toivonen, Tuuli/0000-0002-6625-4922; Leinonen, Antti/0000-0002-7074-9020				Andrew ME, 2012, BIOL CONSERV, V146, P97, DOI 10.1016/j.biocon.2011.11.029; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2013, FINN STAT YB FOR; Arponen A, 2007, CONSERV BIOL, V21, P527, DOI 10.1111/j.1523-1739.2006.00607.x; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Arzberger P, 2004, SCIENCE, V303, P1777, DOI 10.1126/science.1095958; Aune K, 2005, BIOL CONSERV, V124, P89, DOI 10.1016/j.biocon.2005.01.015; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Boitani L, 2011, PHILOS T R SOC B, V366, P2623, DOI 10.1098/rstb.2011.0117; Bradshaw CJA, 2009, TRENDS ECOL EVOL, V24, P541, DOI 10.1016/j.tree.2009.03.019; Branquart E, 2008, BIOL CONSERV, V141, P2795, DOI 10.1016/j.biocon.2008.08.015; Carpenter SR, 2009, BIOSCIENCE, V59, P699, DOI 10.1525/bio.2009.59.8.11; Chirici G, 2012, FOREST SCI, V58, P257, DOI 10.5849/forsci.12-003; Chirici G, 2011, MANAG FOR ECOSYST, V20, P191, DOI 10.1007/978-94-007-0482-4_6; Ciarleglio M, 2009, ECOGRAPHY, V32, P205, DOI 10.1111/j.1600-0587.2008.05721.x; Corona P, 2011, FOREST ECOL MANAG, V262, P2061, DOI 10.1016/j.foreco.2011.08.044; Egloff W, 2014, ZOOKEYS, P109, DOI 10.3897/zookeys.414.7717; Elbakidze M, 2013, AMBIO, V42, P201, DOI 10.1007/s13280-012-0375-1; ESRI, 2014, ARCGIS DESKT VERS 10; Esseen P-A, 1992, ECOLOGICAL PRINCIPLE, P252; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Ferrier S, 2009, SPATIAL CONSERVATION, P304; Ferrier S, 2010, DIVERS DISTRIB, V16, P386, DOI 10.1111/j.1472-4642.2010.00657.x; Finnish Forest Research Institute, 2014, MULT NAT FOR INV MS; Finnish Government, 2008, GOV RES FOR BIOD PRO; Game ET, 2014, CONSERV LETT, V7, P271, DOI 10.1111/conl.12050; GDAL Development Team, 2014, GDAL GEOSP DAT ABSTR; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Halme P, 2013, BIOL CONSERV, V167, P248, DOI 10.1016/j.biocon.2013.08.029; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I, 2000, ANN ZOOL FENN, V37, P271; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Kallio AMI, 2008, ECOL ECON, V67, P232, DOI 10.1016/j.ecolecon.2008.05.005; Keane A, 2013, ANIM CONSERV, V16, P604, DOI 10.1111/acv.12091; Knight A. T., 2013, KEY TOPICS CONSERVAT, V1st, P362, DOI 10.1002/9781118520178; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Korhonen K, 2013, FOREST POLICY ECON, V26, P82, DOI 10.1016/j.forpol.2012.08.010; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Kuuluvainen T, 2012, AMBIO, V41, P720, DOI 10.1007/s13280-012-0289-y; Kuuluvainen T, 2012, CAN J FOREST RES, V42, P1185, DOI [10.1139/X2012-064, 10.1139/x2012-064]; Langford WT, 2011, TRENDS ECOL EVOL, V26, P634, DOI 10.1016/j.tree.2011.08.001; Lehtomaki J, 2014, ZONATOR UTILITIES ZO; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Lehtomaki J, 2009, FOREST ECOL MANAG, V258, P2439, DOI 10.1016/j.foreco.2009.08.026; Mace G. M., 2005, ECOSYSTEMS HUMAN WEL, P79; Maeda EE, 2012, AMBIO, V41, P410, DOI 10.1007/s13280-012-0283-4; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; Moen J, 2014, CONSERV LETT, V7, P408, DOI 10.1111/conl.12098; Moilanen A, 2005, AM NAT, V165, P695, DOI 10.1086/430011; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Monkkonen M, 1999, BIODIVERS CONSERV, V8, P85, DOI 10.1023/A:1008813225086; Monkkonen M, 2014, J ENVIRON MANAGE, V134, P80, DOI 10.1016/j.jenvman.2013.12.021; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; NARENDRA PM, 1980, IEEE T PATTERN ANAL, V2, P185, DOI 10.1109/TPAMI.1980.4766999; Norden J, 2013, J ECOL, V101, P701, DOI 10.1111/1365-2745.12085; Pekkarinen A, 2002, REMOTE SENS ENVIRON, V82, P349, DOI 10.1016/S0034-4257(02)00052-4; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Pooley SP, 2014, CONSERV BIOL, V28, P22, DOI 10.1111/cobi.12183; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; Pressey RL, 2009, SPATIAL CONSERVATION, P211; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Pullin AS, 2010, CONSERV BIOL, V24, P915, DOI 10.1111/j.1523-1739.2010.01537.x; Puumalainen J, 2003, J ENVIRON MANAGE, V67, P5, DOI 10.1016/S0301-4797(02)00183-4; Pykala J, 2006, FOREST ECOL MANAG, V223, P84, DOI 10.1016/j.foreco.2005.10.059; Python Development Team, 2014, PYTH LANG REF VERS 2; Ranius T, 2006, LANDSCAPE ECOL, V21, P687, DOI 10.1007/s10980-005-5222-3; Rayfield B, 2009, ECOL MODEL, V220, P725, DOI 10.1016/j.ecolmodel.2008.11.016; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Reyers B, 2010, CONSERV BIOL, V24, P957, DOI 10.1111/j.1523-1739.2010.01497.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Scheller RM, 2007, LANDSCAPE ECOL, V22, P491, DOI 10.1007/s10980-006-9048-4; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Siitonen J, 2012, METSATIETEEN AIKAKAU, V4, P259; Sirkia S, 2012, WILDLIFE BIOL, V18, P337, DOI 10.2981/11-073; Soranno PA, 2015, BIOSCIENCE, V65, P69, DOI 10.1093/biosci/biu169; Stephens SL, 2014, FRONT ECOL ENVIRON, V12, P115, DOI 10.1890/120332; Timonen J, 2011, BIOL CONSERV, V144, P2061, DOI 10.1016/j.biocon.2011.02.016; Timonen J, 2010, SCAND J FOREST RES, V25, P309, DOI 10.1080/02827581.2010.497160; Tomppo E, 2006, MANAG FOR ECOSYST, V10, P179; Tomppo E, 2006, MANAG FOR ECOSYST, V10, P195; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P1, DOI 10.1007/978-90-481-3233-1; Tomppo E., 2008, MULTISOURCE NATL FOR; Tuominen S, 2014, SILVA FENN, V48, DOI 10.14214/sf.983; Uhlir P., 2007, DATA SCI J, V6, P36, DOI DOI 10.2481/DSJ.6.0D36; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Wilson K.A., 2009, SPATIAL CONSERVATION, P16; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Winter S, 2008, FORESTRY, V81, P33, DOI 10.1093/forestry/cpm042; Wolkovich EM, 2012, GLOBAL CHANGE BIOL, V18, P2102, DOI 10.1111/j.1365-2486.2012.02693.x	107	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135926	10.1371/journal.pone.0135926	http://dx.doi.org/10.1371/journal.pone.0135926			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317227	gold, Green Published			2022-12-27	WOS:000360299100050
J	Wang, TJC; Wu, CC; Chai, YF; Lam, RKK; Hamada, N; Kakinuma, S; Uchihori, Y; Yu, PKN; Hei, TK				Wang, Tony J. C.; Wu, Cheng-Chia; Chai, Yunfei; Lam, Roy K. K.; Hamada, Nobuyuki; Kakinuma, Shizuko; Uchihori, Yukio; Yu, Peter K. N.; Hei, Tom K.			Induction of Non-Targeted Stress Responses in Mammary Tissues by Heavy Ions	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; RAT LUNG IRRADIATION; DOUBLE-STRAND BREAKS; BYSTANDER CELLS; INTERCELLULAR COMMUNICATION; SIGNALING PATHWAY; DNA-DAMAGE; RADIATION; RADIOTHERAPY; CANCER	Purpose Side effects related to radiation exposures are based primarily on the assumption that the detrimental effects of radiation occur in directly irradiated cells. However, several studies have reported over the years of radiation-induced non-targeted/abscopal effects in vivo that challenge this paradigm. There is evidence that Cyclooxygenase-2 (COX2) plays an important role in modulating non-targeted effects, including DNA damages in vitro and mutagenesis in vivo. While most reports on radiation-induced non-targeted response utilize x-rays, there is little information available for heavy ions. Methods and Materials Adult female transgenic gpt delta mice were exposed to an equitoxic dose of either carbon or argon particles using the Heavy Ion Medical Accelerator in Chiba (HIMAC) at the National Institute of Radiological Sciences (NIRS) in Japan. The mice were stratified into 4 groups of 5 animals each: Control; animals irradiated under full shielding (Sham-irradiated); animals receiving whole body irradiation (WBIR); and animals receiving partial body irradiation (PBIR) to the lower abdomen with a 1 x 1 cm(2) field. The doses used in the carbon ion group (4.5 Gy) and in argon particle group (1.5 Gy) have a relative biological effectiveness equivalent to a 5 Gy dose of x-rays. 24 hours after irradiation, breast tissues in and out of the irradiated field were harvested for analysis. Induction of COX2, 8-hydroxydeoxyguanosine (8-OHdG), phosphorylated histone H2AX (gamma-H2AX), and apoptosis-related cysteine protease-3 (Caspase-3) antibodies were examined in the four categories of breast tissues using immunohistochemical techniques. Analysis was performed by measuring the intensity of more than 20 individual microscopic fields and comparing the relative fold difference. Results In the carbon ion group, the relative fold increase in COX2 expression was 1.01 in sham-irradiated group (p > 0.05), 3.07 in PBIR (p < 0.05) and 2.50 in WBIR (p < 0.05), respectively, when compared with controls. The relative fold increase in 8-OHdG expression was 1.29 in sham-irradiated (p > 0.05), 11.31 in PBIR (p < 0.05) and 11.79 in WBIR (p < 0.05), respectively, when compared with controls. A similar increase in gamma-H2AX expression was found in that, compared to controls, the increase was 1.41 fold in sham-irradiated (p > 0.05), 8.41 in PBIR (p < 0.05) and 10.59 in WBIR (p < 0.05). Results for the argon particle therapy group showed a similar magnitude of changes in the various biological end-points examined. There was no statistical significance observed in Caspase-3 expression among the 4 groups. Conclusions Our data show that both carbon and argon ions induced non-targeted, out of field induction of COX2 and DNA damages in breast tissues. These effects may pose new challenges to evaluate the risks associated with radiation exposure and understanding radiation-induced side effects.	[Wang, Tony J. C.; Wu, Cheng-Chia; Chai, Yunfei; Lam, Roy K. K.; Hei, Tom K.] Columbia Univ, Ctr Radiol Res, Dept Radiat Oncol, New York, NY 10032 USA; [Hamada, Nobuyuki; Kakinuma, Shizuko; Uchihori, Yukio] Natl Inst Radiol Sci, Chiba 260, Japan; [Lam, Roy K. K.; Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, Radiat Safety Res Ctr, Tokyo 201, Japan	Columbia University; National Institutes for Quantum Science & Technology; City University of Hong Kong; Central Research Institute of Electric Power Industry - Japan	Wang, TJC (corresponding author), Columbia Univ, Ctr Radiol Res, Dept Radiat Oncol, New York, NY 10032 USA.	tjw2117@cumc.columbia.edu		Wu, Cheng-Chia/0000-0002-5908-0143; YU, Kwan Ngok Peter/0000-0003-1669-5348; Wang, Tony/0000-0001-5809-3025; Hamada, Nobuyuki/0000-0003-2518-6131	National Institutes of Health [CA 49062, ES 12888]; NATIONAL CANCER INSTITUTE [P01CA049062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by funding from the National Institutes of Health grants CA 49062 and ES 12888.	Ando K, 2009, INT J RADIAT BIOL, V85, P715, DOI 10.1080/09553000903072470; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Calveley VL, 2005, INT J RADIAT BIOL, V81, P887, DOI 10.1080/09553000600568002; Chai Y, 2013, BRIT J CANCER, V108, P1106, DOI 10.1038/bjc.2013.53; Chai Y, 2013, BRIT J CANCER, V108, P91, DOI 10.1038/bjc.2012.498; Ermakov AV, 2009, MUTAT RES-FUND MOL M, V669, P155, DOI 10.1016/j.mrfmmm.2009.06.005; Fournier C, 2007, RADIAT RES, V167, P194, DOI 10.1667/RR0760.1; Hamada N, J RAD RES TOKYO, V51, P365; Hamada N, 2008, MUTAT RES-FUND MOL M, V639, P35, DOI 10.1016/j.mrfmmm.2007.11.001; Harada K, 2009, CANCER SCI, V100, P684, DOI 10.1111/j.1349-7006.2009.01093.x; Hasegawa A, 2006, INT J RADIAT ONCOL, V64, P396, DOI 10.1016/j.ijrobp.2005.07.298; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Imai R, 2004, CLIN CANCER RES, V10, P5741, DOI 10.1158/1078-0432.CCR-04-0301; Imai R, 2006, LANCET ONCOL, V7, P1034, DOI 10.1016/S1470-2045(06)70978-0; Ivanov VN, 2014, APOPTOSIS, V19, P399, DOI 10.1007/s10495-013-0925-4; Kamada T, 2002, J CLIN ONCOL, V20, P4466, DOI 10.1200/JCO.2002.10.050; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kashino G, 2009, INT J RADIAT ONCOL, V74, P229, DOI 10.1016/j.ijrobp.2008.09.060; Khan MA, 2003, RADIOTHER ONCOL, V66, P95, DOI 10.1016/S0167-8140(02)00325-0; Mancuso M, 2008, P NATL ACAD SCI USA, V105, P12445, DOI 10.1073/pnas.0804186105; Matsumoto Hideki, 2011, Curr Mol Pharmacol, V4, P126; Minohara S, J RAD RES TOKYO, V51, P385; Mizoe J, 2004, INT J RADIAT ONCOL, V60, P358, DOI 10.1016/j.ijrobp.2004.02.067; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; NAGASAWA H, 1992, CANCER RES, V52, P6394; Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; Ponnaiya B, RAD RES, V176, P280; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Sokolov MV, 2007, CELL CYCLE, V6, P2210, DOI 10.4161/cc.6.18.4682; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Tamminga J, CURR MOL PHARM, V4, P115; Tsuruoka C, 2005, RADIAT RES, V163, P494, DOI 10.1667/RR3360; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	39	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136307	10.1371/journal.pone.0136307	http://dx.doi.org/10.1371/journal.pone.0136307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317641	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100070
J	Zhang, Y; Nowicka, A; Solley, TN; Wei, CM; Parikh, A; Court, L; Burks, JK; Andreeff, M; Woodward, WA; Dadbin, A; Kolonin, MG; Lu, KH; Klopp, AH				Zhang, Yan; Nowicka, Aleksandra; Solley, Travis N.; Wei, Caimiao; Parikh, Aaroh; Court, Laurence; Burks, Jared K.; Andreeff, Michael; Woodward, Wendy A.; Dadbin, Ali; Kolonin, Mikhail G.; Lu, Karen H.; Klopp, Ann H.			Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers	PLOS ONE			English	Article							BREAST-CANCER; M2-POLARIZED MACROPHAGES; TUMOR MICROENVIRONMENT; INSULIN-RESISTANCE; COLORECTAL-CANCER; PROGENITOR CELLS; MOUSE MODELS; STEM-CELLS; ACTIVATION; EXPRESSION	Obesity, and in particular visceral obesity, has been associated with an increased risk of developing cancers as well as higher rates of mortality following diagnosis. The impact of obesity on adipose-derived stromal cells (ASC), which contribute to the formation of tumor stroma, is unknown. Here we hypothesized that visceral source and diet-induced obesity (DIO) changes the ASC phenotype, contributing to the tumor promoting effects of obesity. We found that ASC isolated from subcutaneous (SC-ASC) and visceral (V-ASC) white adipose tissue(WAT) of lean(Le) and obese(Ob) mice exhibited similar mesenchymal cell surface markers expression, and had comparable effects on ovarian cancer cell proliferation and migration. Obese and visceral derived ASC proliferated slower and exhibited impaired differentiation into adipocytes and osteocytes in vitro as compared to ASC derived from subcutaneous WAT of lean mice. Intraperitoneal co-injection of ovarian cancer cells with obese or visceral derived ASC, but not lean SC-ASC, increased growth of intraperitoneal ID8 tumors as compared to controls. Obese and V-ASC increased stromal infiltration of inflammatory cells, including CD3+ T cells and F4/80+ macrophages. Obese and visceral derived ASC, but not lean SC-ASC, increased expression of chemotactic factors IL-6, MIP2, and MCP-1 when cultured with tumor cells. Overall, these results demonstrate that obese and V-ASC have a unique phenotype, with more limited proliferation and differentiation capacity but enhanced expression of chemotactic factors in response to malignant cells which support infiltration of inflammatory cells and support tumor growth and dissemination.	[Zhang, Yan; Nowicka, Aleksandra; Solley, Travis N.; Court, Laurence; Woodward, Wendy A.; Klopp, Ann H.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lu, Karen H.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Wei, Caimiao] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Parikh, Aaroh] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Burks, Jared K.; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Dadbin, Ali; Kolonin, Mikhail G.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Klopp, AH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	Aklopp@mdanderson.org	Woodward, Wendy/AAX-6593-2020	Woodward, Wendy/0000-0002-7935-739X; Court, Laurence/0000-0002-3241-6145	Ovarian Cancer Research fund [LT/MDACC/01.2011]; American Cancer Society [RSG-14-159-01]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA083639] Funding Source: NIH RePORTER; Direct For Biological Sciences [1337525] Funding Source: National Science Foundation; Directorate For Engineering [1343533] Funding Source: National Science Foundation; Division Of Undergraduate Education [0941984] Funding Source: National Science Foundation	Ovarian Cancer Research fund; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This work was supported by grants from the Ovarian Cancer Research fund (LT/MDACC/01.2011) and the American Cancer Society (RSG-14-159-01) to AHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Daquinag AC, 2015, CELL DEATH DIFFER, V22, P351, DOI 10.1038/cdd.2014.148; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Delort L, 2009, ANTICANCER RES, V29, P5229; Doyle SL, 2012, P NUTR SOC, V71, P181, DOI 10.1017/S002966511100320X; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Jafri SH, 2013, FUTURE ONCOL, V9, P207, DOI [10.2217/fon.12.184, 10.2217/FON.12.184]; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klopp AH, 2012, CLIN CANCER RES, V18, P771, DOI 10.1158/1078-0432.CCR-11-1916; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nowicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081859; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Ray A, 2012, J BIOSCIENCES, V37, P289, DOI 10.1007/s12038-012-9191-9; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rowan BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089595; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Spaeth EL, 2013, CANCER RES, V73, P5347, DOI 10.1158/0008-5472.CAN-13-0087; Surmacz E, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1638; Takaishi K, 2010, CANCER SCI, V101, P2128, DOI 10.1111/j.1349-7006.2010.01652.x; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wang E, 2005, CLIN CANCER RES, V11, P113; WILK MB, 1968, BIOMETRIKA, V55, P1; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zhu GQ, 2014, NEOPLASIA, V16, P168, DOI 10.1593/neo.132034	38	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136361	10.1371/journal.pone.0136361	http://dx.doi.org/10.1371/journal.pone.0136361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317219	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100074
J	Awad, FG; Ahamed, SMS; Sibanda, P; Khumalo, M				Awad, Faiz G.; Ahamed, Sami M. S.; Sibanda, Precious; Khumalo, Melusi			The Effect of Thermophoresis on Unsteady Oldroyd-B Nanofluid Flow over Stretching Surface	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; POWER-LAW FLUID; HEAT-TRANSFER; THERMAL-CONDUCTIVITY; HELICAL FLOWS; CONVECTION; SHEET; RADIATION; PLATE	There are currently only a few theoretical studies on convective heat transfer in polymer nanocomposites. In this paper, the unsteady incompressible flow of a polymer nanocomposite represented by an Oldroyd-B nanofluid along a stretching sheet is investigated. Recent studies have assumed that the nanoparticle fraction can be actively controlled on the boundary, similar to the temperature. However, in practice, such control presents significant challenges and in this study the nanoparticle flux at the boundary surface is assumed to be zero. We have used a relatively novel numerical scheme; the spectral relaxation method to solve the momentum, heat and mass transport equations. The accuracy of the solutions has been determined by benchmarking the results against the quasilinearisation method. We have conducted a parametric study to determine the influence of the fluid parameters on the heat and mass transfer coefficients.	[Awad, Faiz G.; Khumalo, Melusi] Univ Johannesburg, Dept Math, ZA-2028 Doornfontein, South Africa; [Ahamed, Sami M. S.; Sibanda, Precious] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, ZA-3209 Pietermaritzburg, South Africa	University of Johannesburg; University of Kwazulu Natal	Sibanda, P (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	sibandap@ukzn.ac.za	Khumalo, Melusi/E-9615-2013; Sibanda, Precious/F-9616-2010	Khumalo, Melusi/0000-0001-5411-5389; Sibanda, Precious/0000-0003-2115-4642	university of KwaZulu-Natal; university of Johannesburg	university of KwaZulu-Natal; university of Johannesburg	The authors are grateful for funding from the universities of KwaZulu-Natal and Johannesburg.	Abel MS, 2009, INT J HEAT MASS TRAN, V52, P2902, DOI 10.1016/j.ijheatmasstransfer.2008.08.042; Bachok N, 2012, INT J HEAT MASS TRAN, V55, P2102, DOI 10.1016/j.ijheatmasstransfer.2011.12.013; Bellman R.E., 1965, QUASILINEARIZATION N; Chao H, 2014, ROYAL SOC CHEM, DOI [10.1039/c4sm01188k, DOI 10.1039/C4SM01188K]; Cheng CY, 2012, INT COMMUN HEAT MASS, V39, P231, DOI 10.1016/j.icheatmasstransfer.2011.11.002; Choi SUS., 1995, DEV APPL NONNEWTONIA, V6, P99; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Elbashbeshy EMA, 2010, COMPUT MATH APPL, V60, P2806, DOI 10.1016/j.camwa.2010.09.035; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P489, DOI 10.1007/s10483-013-1685-9; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2012, INT J CHEM REACT ENG, V10, DOI 10.1515/1542-6580.2655; Ibrahim W, 2012, INT J APPL MATH MECH, V8, P18; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Jamil M, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201201; Jamil M, 2012, J THEOR APP MECH-POL, V50, P549; Jang SP, 2004, APPL PHYS LETT, V84, P4316, DOI 10.1063/1.1756684; Kechil SA, 2008, PHYS LETT A, V372, P2258, DOI 10.1016/j.physleta.2007.11.027; Khan WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105107; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Motsa SS, 2014, CHEM ENG COMMUN, V201, P241, DOI 10.1080/00986445.2013.766882; Motsa SS, 2013, NONLINEAR DYNAM, V72, P265, DOI 10.1007/s11071-012-0712-8; Motsa SS, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/203461; Motsa SS, 2011, MATH METHOD APPL SCI, V34, P1406, DOI 10.1002/mma.1449; Motsa SS, 2013, CENT EUR J PHYS, V11, P363, DOI 10.2478/s11534-013-0182-8; Mukhopadhyay S, 2013, AIN SHAMS ENG J, V4, P933, DOI 10.1016/j.asej.2013.04.004; Mustafa M, 2013, J MECH, V29, P423, DOI 10.1017/jmech.2013.9; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Nield DA, 2014, INT J HEAT MASS TRAN, V77, P915, DOI 10.1016/j.ijheatmasstransfer.2014.06.020; Nield DA, 2014, INT J HEAT MASS TRAN, V70, P430, DOI 10.1016/j.ijheatmasstransfer.2013.11.016; Nield DA, 2014, INT J HEAT MASS TRAN, V68, P211, DOI 10.1016/j.ijheatmasstransfer.2013.09.026; Pal D, 2013, NUCL ENG DES, V256, P350, DOI 10.1016/j.nucengdes.2012.08.015; Pal D, 2011, COMMUN NONLINEAR SCI, V16, P1890, DOI 10.1016/j.cnsns.2010.08.023; Prasad KV, 2009, COMMUN NONLINEAR SCI, V14, P2178, DOI 10.1016/j.cnsns.2008.06.021; Qi HT, 2009, NONLINEAR ANAL-REAL, V10, P2700, DOI 10.1016/j.nonrwa.2008.07.008; Rajagopal K.R., 1982, ACTA SIN INDIA, V18, P1; RAJAGOPAL KR, 1995, NAVIER-STOKES EQUATIONS AND RELATED NONLINEAR PROBLEMS, P273; RAJAGOPAL KR, 1986, INT J NONLINEAR MECH, V21, P279, DOI 10.1016/0020-7462(86)90035-1; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Salleh MZ, 2010, J TAIWAN INST CHEM E, V41, P651, DOI 10.1016/j.jtice.2010.01.013; Sharidan S., 2006, International Journal of Applied Mechanics and Engineering, V11, P647; Shehzad SA, 2014, J TAIWAN INST CHEM E, V45, P787, DOI 10.1016/j.jtice.2013.08.022; Siddiqui AM, 2011, WORLD APP SCI J, V13, P2282; Tong DK, 2009, J NON-NEWTON FLUID, V156, P75, DOI 10.1016/j.jnnfm.2008.07.004; TSOU FK, 1967, INT J HEAT MASS TRAN, V10, P219, DOI 10.1016/0017-9310(67)90100-7; Zaimi K, 2014, INT J HEAT MASS TRAN, V68, P509, DOI 10.1016/j.ijheatmasstransfer.2013.09.047	47	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135914	10.1371/journal.pone.0135914	http://dx.doi.org/10.1371/journal.pone.0135914			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312754	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000031
J	Bacelo, AC; Ramalho, A; Brasil, PE; Cople-Rodrigues, CD; Georg, I; Paiva, E; Argolo, SVL; Rolla, VC				Bacelo, Adriana Costa; Ramalho, Andrea; Brasil, Pedro Emmanuel; Cople-Rodrigues, Claudia dos Santos; Georg, Ingebourg; Paiva, Eliane; Leandro Argolo, Sheila Vasques; Rolla, Valeria Cavalcante			Nutritional Supplementation Is a Necessary Complement to Dietary Counseling among Tuberculosis and Tuberculosis-HIV Patients	PLOS ONE			English	Article							RISK-FACTOR LEVELS; PULMONARY; DEFICIENCY; INFECTION; EFFICACY; SELENIUM; SUPPORT; HEALTH; ALPHA; INDEX	The Brazilian Ministry of Health and the World Health Organization recommend dietary counseling for patients with malnutrition during tuberculosis treatment. Patients under tuberculosis therapy (infected and not infected with HIV) were followed-up to evaluate the effectiveness of dietary counseling. Objective: describe the nutritional status of patients with tuberculosis. Methods: an observational follow-up study over a 180-day period of tuberculosis therapy in adults was conducted. Subjects were assessed for body composition (using BMI, TSF and MUAC parameters), serum biomarkers and offered dietary counseling. The data obtained at each visit (D15, D30, D60, D90, D120, D150, and D180) were analyzed, showing trajectories over time and central tendencies each time. Results: at baseline, the mean age was 41.1 (+/- 13.4) years; they were predominantly male, with income lower than a local minimum wage and at least six years of schooling. Patients showed predominantly pulmonary tuberculosis. At baseline, all patients suffered from malnutrition. The overall energy malnutrition prevalence was of 70.6%. Anemia at baseline was observed in both groups (63.2%), however, it was significantly more pronounced in the HIV+. At the end, energy malnutrition was reduced to 57.1% (42.9% of HIV- and 71.4% of the HIV+). Micronutrients malnutrition was evident in 71.4% of the HIV-patients and 85.7% of HIV+ patients at the end of tuberculosis therapy. Using BMI (<= 18.5 kg/m(2)cutoff) as an index of malnutrition, it was detected in 23.9% of the HIV- and 27.3% of the HIV+ patients at baseline, with no evident improvement over time; using TSF (<= 11.4mm as cutoff) or MUAC (<= 28.5cm as cutoff), malnutrition was detected in 70.1% and 85.3% of all patients, respectively. Nevertheless, combining all biomarkers, at the end of follow-up, all patients suffered from malnutrition. Conclusion: Although with a limited number of patients, the evidence does not support that dietary counseling is effective to recover from malnutrition in our population.	[Rolla, Valeria Cavalcante] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Clin Res Lab Mycobacteria, BR-21045900 Rio De Janeiro, RJ, Brazil; [Bacelo, Adriana Costa] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Nutr Serv, BR-21045900 Rio De Janeiro, RJ, Brazil; [Ramalho, Andrea] Univ Fed Rio de Janeiro, Josue de Castro Inst, Rio de Janeiro, RJ, Brazil; [Brasil, Pedro Emmanuel] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Clin Reasearch Lab Chagas Dis, BR-21045900 Rio De Janeiro, RJ, Brazil; [Cople-Rodrigues, Claudia dos Santos] Univ Estado Rio De Janeiro, Inst Nutr, Rio De Janeiro, RJ, Brazil; [Georg, Ingebourg] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Immunodiagnost Sect, Diagnost Activ Coordinating, BR-21045900 Rio De Janeiro, RJ, Brazil; [Paiva, Eliane] UNISUAM, Dept Nutr, Rio De Janeiro, RJ, Brazil; [Leandro Argolo, Sheila Vasques] Sergio Franco Lab, Caxias, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Centro Universitario Augusto Motta (UNISUAM)	Bacelo, AC (corresponding author), Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Nutr Serv, BR-21045900 Rio De Janeiro, RJ, Brazil.	adriana.bacelo@ini.fiocruz.br	Brasil, Pedro E A A/B-4357-2008; Bacelo, Adriana/G-4336-2015; Rolla, Valeria Cavalcanti/AAI-6078-2021	Brasil, Pedro E A A/0000-0002-6700-2268; Rolla, Valeria Cavalcanti/0000-0002-0841-1408				Al Moamary MS, 2014, ANN THORAC MED, V9, P3, DOI 10.4103/1817-1737.124408; Amin T, 2012, INDIAN HORTIC J, V2, P94; [Anonymous], 2013, STATE OF FOOD AND AG; Armijos RX, 2010, SALUD PUBLICA MEXICO, V52, P185, DOI 10.1590/s0036-36342010000300001; Baeten JM, 2006, J NUTR, V136, P1624, DOI 10.1093/jn/136.6.1624; Baruzzi R G, 2001, Cad Saude Publica, V17, P407, DOI 10.1590/S0102-311X2001000200015; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Cantalice JP, 2009, J BRAS PNEUMOL, V35, P992, DOI 10.1590/S1806-37132009001000008; Cardoso MC de AF, 2010, SISTEMA ESTOMATOGNAT; Chakraborty R, 2011, RURAL REMOTE HEALTH, V11; Freedman DS, 2013, AM J CLIN NUTR, V98, P1417, DOI 10.3945/ajcn.113.065961; Freedman DS, 2013, BRIT J NUTR, V109, P338, DOI 10.1017/S0007114512000979; Gaikwad SS., 2013, J MED NUTR NUTRACEUT, V2, P99, DOI [10.4103/2278-019X.114721, DOI 10.4103/2278-019X.114721]; Ghone RA, 2013, J CLIN DIAGN RES, V7, P2146, DOI 10.7860/JCDR/2013/6019.3454; Govender A, 2009, INT J ENVIRON AN CH, V89, P367, DOI 10.1080/03067310802627221; Guo CH, 2013, NUTRIENTS, V5, P594, DOI 10.3390/nu5020594; Gupta S, 2011, TROP MED INT HEALTH, V16, P74, DOI 10.1111/j.1365-3156.2010.02676.x; Hsu JW, 2005, MACRONUTRIENTS AND H, P10; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20, P130; Instituto Brasileiro de Geografia e Estatistica, 2010, COORDENACAO DE TRABA; Islam QS, 2013, PUBLIC HEALTH ACTION, V3, P136, DOI 10.5588/pha.13.0005; Kawai K, 2014, EPIDEMIOL INFECT, V142, P1505, DOI 10.1017/S0950268813002495; King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746; Klautau Giselle Burlamaqui, 2005, Braz J Infect Dis, V9, P464, DOI 10.1590/S1413-86702005000600004; Lohmann TG, 1988, ANTHROPOMETRIC STAND; Makanjuola T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087166; Maras JE, 2004, J AM DIET ASSOC, V104, P567, DOI 10.1016/j.jada.2004.01.004; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Martins N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4248; Mehdi Y, 2013, MOLECULES, V18, P3292, DOI 10.3390/molecules18033292; Ministerio da Saude do Brasil, 2014, GUIA ALIMENTAR PARA; Ministerio da Saude do Brasil, 2004, VIGILANCIA ALIMENTAR; Ministerio da Saude do Brasil, 2011, MANUAL DE RECOMENDAC; Ministerio da Saude do Brasil, 2008, RECOMENDACOES PARA T; Ministerio da Saude do Brasil Programa Nacional de Doencas Sexualmente Transmissiveis/AIDS (Brazil), 2006, PROGRAMA NACIONAL DE; Motswagole BS, 2013, ANN NUTR METAB, V62, P323, DOI 10.1159/000346966; NICUS NIC, 2007, TUB TB NUTR TUB TB N, P8; Piva SGN, 2013, J BRAS PNEUMOL, V39, P476, DOI 10.1590/S1806-37132013000400012; Oliveira Claudia Maria Costa de, 2010, Braz. J. Nephrol., V32, P57; Orellana Jesem D. Y., 2006, J. Pediatr. (Rio J.), V82, P383, DOI [10.1590/S0021-75572006000600013, 10.2223/JPED.1528]; Ramalho Rejane Andréa, 2002, Rev Panam Salud Publica, V12, P117, DOI 10.1590/S1020-49892002000800007; Saleem Khan, 2012, Sarhad Journal of Agriculture, V28, P303; Schwenk A, 2004, AM J CLIN NUTR, V79, P1006; Sinclair D, 2011, COCHRANE LIB    1109, P11; Swaminathan S, 2008, CLIN INFECT DIS, V46, P946, DOI 10.1086/528860; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Thomas C, 2011, INT J LAB HEMATOL, V33, P187, DOI 10.1111/j.1751-553X.2010.01265.x; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; Visser ME, 2011, AM J CLIN NUTR, V93, P93, DOI 10.3945/ajcn.110.001784; Wessels I, 2013, J NUTR BIOCHEM, V24, P289, DOI 10.1016/j.jnutbio.2012.06.007; World Health Organization, 2013, GUIDELINE NUTRITIONA	51	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0134785	10.1371/journal.pone.0134785	http://dx.doi.org/10.1371/journal.pone.0134785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313258	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000010
J	Ben Guerrero, E; Arneodo, J; Campanha, RB; de Oliveira, PA; Labate, MTV; Cataldi, TR; Campos, E; Cataldi, A; Labate, CA; Rodrigues, CM; Talia, P				Ben Guerrero, Emiliano; Arneodo, Joel; Campanha, Raquel Bombarda; de Oliveira, Patricia Abrao; Veneziano Labate, Monica T.; Cataldi, Thais Regiani; Campos, Eleonora; Cataldi, Angel; Labate, Carlos A.; Rodrigues, Clenilson Martins; Talia, Paola			Prospection and Evaluation of (Hemi) Cellulolytic Enzymes Using Untreated and Pretreated Biomasses in Two Argentinean Native Termites	PLOS ONE			English	Article							ETHANOL-PRODUCTION; GUT; PROTEINS; LIGNOCELLULOSE; IDENTIFICATION; CELLULASE; BACTERIA; WALL; ORTHOPTERA; DIVERSITY	Saccharum officinarum bagasse (common name: sugarcane bagasse) and Pennisetum purpureum (also known as Napier grass) are among the most promising feedstocks for bioethanol production in Argentina and Brazil. In this study, both biomasses were assessed before and after acid pretreatment and following hydrolysis with Nasutitermes aquilinus and Cortaritermes fulviceps termite gut digestome. The chemical composition analysis of the biomasses after diluted acid pretreatment showed that the hemicellulose fraction was partially removed. The (hemi) cellulolytic activities were evaluated in bacterial culture supernatants of termite gut homogenates grown in treated and untreated biomasses. In all cases, we detected significantly higher endoglucanase and xylanase activities using pretreated biomasses compared to untreated biomasses, carboxymethylcellulose and xylan. Several protein bands with (hemi) cellulolytic activity were detected in zymograms and two-dimensional gel electrophoresis. Some proteins of these bands or spots were identified as xylanolytic peptides by mass spectrometry. Finally, the diversity of cultured cellulolytic bacterial endosymbionts associated to both Argentinean native termite species was analyzed. This study describes, for the first time, bacterial endosymbionts and endogenous (hemi) cellulases of two Argentinean native termites as well as their potential application in degradation of lignocellulosic biomass for bioethanol production.	[Ben Guerrero, Emiliano; Campos, Eleonora; Cataldi, Angel; Talia, Paola] INTA Castelar, CNIA, CICVyA, Inst Biotecnol, RA-1686 Hurlingham, Buenos Aires, Argentina; [Arneodo, Joel; Campos, Eleonora; Cataldi, Angel; Talia, Paola] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Arneodo, Joel] INTA Castelar, CNIA, CICVyA, Inst Microbiol & Zool Agr, RA-1686 Hurlingham, Buenos Aires, Argentina; [Campanha, Raquel Bombarda; de Oliveira, Patricia Abrao; Rodrigues, Clenilson Martins] Embrapa Agroenergia, BR-70770901 Brasilia, DF, Brazil; [Veneziano Labate, Monica T.; Cataldi, Thais Regiani; Labate, Carlos A.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Lab Multiusuarios Centralizado Genom Func Aplicad, BR-13400970 Piracicaba, SP, Brazil	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Talia, P (corresponding author), INTA Castelar, CNIA, CICVyA, Inst Biotecnol, Dr N Repetto & Los Reseros S-N, RA-1686 Hurlingham, Buenos Aires, Argentina.	talia.paola@inta.gob.ar	Talia, Paola/AAV-2252-2020; Labate, Carlos Alberto/L-2183-2015; Campos, Eleonora/AAI-4883-2020; Talia, Paola/GZG-4723-2022; Cataldi, Thais Regiani/H-5430-2018	Talia, Paola/0000-0003-2877-8271; Labate, Carlos Alberto/0000-0001-7309-1300; Cataldi, Thais Regiani/0000-0002-9827-2017; Labate, Monica Teresa Veneziano/0000-0002-6447-3718	Instituto Nacional de Tecnologia Agropecuaria (INTA) [141130, PNAIyAV-1130034]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Proyecto de Investigacion Cientifica y Tecnologica (PICT) (Argentina) [1454]; international collaborative consortium by INTA-EMBRAPA (Empresa Brasileira de Pesquisa Agropecuaria)	Instituto Nacional de Tecnologia Agropecuaria (INTA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Proyecto de Investigacion Cientifica y Tecnologica (PICT) (Argentina); international collaborative consortium by INTA-EMBRAPA (Empresa Brasileira de Pesquisa Agropecuaria)	This work was supported by grants from the Instituto Nacional de Tecnologia Agropecuaria (INTA) (PN No. 141130 specific project and PNAIyAV-1130034), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Proyecto de Investigacion Cientifica y Tecnologica (PICT) 2013 No. 1454 (Argentina) and by an international collaborative consortium by INTA-EMBRAPA (Empresa Brasileira de Pesquisa Agropecuaria).	Adlakha N, 2011, APPL ENVIRON MICROB, V77, P4859, DOI 10.1128/AEM.02808-10; Agbor VB, 2011, BIOTECHNOL ADV, V29, P675, DOI 10.1016/j.biotechadv.2011.05.005; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-78; Bhatia L, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-65; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Burnum KE, 2011, ISME J, V5, P161, DOI 10.1038/ismej.2010.97; Celedon PAF, 2007, PROTEOMICS, V7, P2258, DOI 10.1002/pmic.200600989; Doyle J.J., 1987, FOCUS, V12, P13, DOI [10.4236/ajps.2017.86079, DOI 10.4236/AJPS.2017.86079]; Eida MF, 2012, MICROBES ENVIRON, V27, P226, DOI 10.1264/jsme2.ME11299; Ekperigin MM, 2007, AFR J BIOTECHNOL, V6, P28; FONTES L R, 1981, Revista Brasileira de Entomologia, V25, P171; Fujii K, 2012, INT MICROBIOL, V15, P121, DOI 10.2436/20.1501.01.165; Fujii K, 2012, BIOSCI BIOTECH BIOCH, V76, P906, DOI 10.1271/bbb.110881; Geib SM, 2010, INSECT SCI, V17, P253, DOI 10.1111/j.1744-7917.2010.01323.x; Ghio Silvina, 2012, Int J Biochem Mol Biol, V3, P352; HANKIN L, 1977, J GEN MICROBIOL, V98, P109, DOI 10.1099/00221287-98-1-109; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; KAUFMAN MG, 1991, COMP BIOCHEM PHYS A, V98, P117, DOI 10.1016/0300-9629(91)90588-4; Khianngam S, 2010, INT J SYST EVOL MICR, V60, P2284, DOI 10.1099/ijs.0.015859-0; King BC, 2009, BIOTECHNOL BIOENG, V102, P1033, DOI 10.1002/bit.22151; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Konig H, 2013, APPL MICROBIOL BIOTE; Laffont ER, 2004, SCI AGR, V61, P665, DOI 10.1590/S0103-90162004000600016; Lima MA, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-10; Lin CW, 2010, BIOMASS BIOENERG, V34, P1922, DOI 10.1016/j.biombioe.2010.07.032; Lin L, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue3-fulltext-1; Lucena SA, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-51; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maki Miranda L, 2011, Int J Biochem Mol Biol, V2, P146; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Nakajima H, 2006, BIOSCI BIOTECH BIOCH, V70, P211, DOI 10.1271/bbb.70.211; Nakashima K, 2002, INSECT BIOCHEM MOLEC, V32, P777, DOI 10.1016/S0965-1748(01)00160-6; Ni JF, 2013, BIOTECHNOL ADV, V31, P838, DOI 10.1016/j.biotechadv.2013.04.005; NREL, 2011, STAND BIOM AN PROC; Ohkuma M., 2001, RIKEN REV, V41, P73; Pandey A, 2011, BIOMASS BIOF BIOCHEM, pVII; Quiroz-Castaneda RE, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue4-fulltext-3; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Rehman FU, 2009, AFR J BIOTECHNOL, V8, P6710; Romano N, 2013, CURR MICROBIOL, V67, P138, DOI 10.1007/s00284-013-0345-2; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709; Scharf ME, 2010, INSECT SCI, V17, P166, DOI 10.1111/j.1744-7917.2009.01309.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi PJ, 2010, APPL ENVIRON MICROB, V76, P3620, DOI 10.1128/AEM.00345-10; Slaytor M., 2000, ENERGY METABOLISM TE, P307; Sun J., 2011, RECENT ADV ENTOMOLOG; Sun J., 2013, BIOLOGICAL CONVERSIO, P195, DOI [10.1039/9781849734738-00195, DOI 10.1039/9781849734738-00195]; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Talia P, 2012, RES MICROBIOL, V163, P221, DOI 10.1016/j.resmic.2011.12.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tokuda G, 2007, BIOL LETTERS, V3, P336, DOI 10.1098/rsbl.2007.0073; TOMASPEJO E, 2011, PRETREATMENT TECHNOL, P149; Uddin Mohammad Mosleh, 2012, Pak J Biol Sci, V15, P333, DOI 10.3923/pjbs.2012.333.340; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Willis JD, 2010, COMP BIOCHEM PHYS B, V157, P267, DOI 10.1016/j.cbpb.2010.06.012; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wyman CE, 1999, ANNU REV ENERG ENV, V24, P189, DOI 10.1146/annurev.energy.24.1.189; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Zhu JY, 2010, BIORESOURCE TECHNOL, V101, P4992, DOI 10.1016/j.biortech.2009.11.007	68	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136573	10.1371/journal.pone.0136573	http://dx.doi.org/10.1371/journal.pone.0136573			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313257	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000070
J	Chen, YM; Lai, CH; Chang, HC; Chao, TY; Tseng, CC; Fang, WF; Wang, CC; Chung, YH; Wang, YH; Su, MC; Huang, KT; Chen, HC; Chang, YC; Lin, MC				Chen, Yu-Mu; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Lin, Meng-Chih			Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							CLINICALLY SELECTED PATIENTS; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; MUTATIONS; GEFITINIB; SURVIVAL; CARBOPLATIN/PACLITAXEL; CTONG-0802; ERLOTINIB	Background Patients with early-stage lung cancer who have a high baseline lymphocyte-to-monocyte ratio (LMR) have a favorable prognosis. However, the prognostic significance of LMR in patients with advanced-stage EGFR-mutant non-small cell lung cancer (NSCLC) receiving first-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) has not been established. We conducted a retrospective analysis to investigate the influence of LMR on clinical outcomes including progression-free survival (PFS) and overall survival (OS) in EGFR-mutant patients with NSCLC. Materials and Methods Of 1310 lung cancer patients diagnosed between January 2011 and October 2013, 253 patients receiving first-line EGFR-TKIs for EGFR-mutant NSCLC were included. The cut-off values for baseline and the 1-month-to-baseline ratio of LMR (MBR), determined by using receiver operating characteristic curves, were 3.29 and 0.63, respectively. Patients were divided into 3 prognostic groups: high LMR and MBR, high LMR or MBR, and low LMR and MBR. Results The mean patient age was 65.2 years, and 41% were men. The median PFS and OS were 10.3 and 22.0 months, respectively. The PFS in patients with high LMR and MBR, high LMR or MBR, and low LMR and MBR were 15.4, 7.1, and 2.0 months, respectively (p < 0.001), whereas the OS were 32.6, 13.7, and 5.1 months, respectively (p < 0.001). Conclusion A combination of baseline and trend of LMR can be used to identify patients with a high mortality risk in EGFR-mutant NSCLC patients receiving first-line EGFR-TKIs.	[Chen, Yu-Mu; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Lin, Meng-Chih] Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Pulm & Crit Care Med,Dept Internal Med,Coll M, Kaohsiung, Taiwan; [Fang, Wen-Feng] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Lin, MC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Pulm & Crit Care Med,Dept Internal Med,Coll M, Kaohsiung, Taiwan.	mengchih@adm.cgmh.org.tw	Fang, Wen-Feng/AAT-6296-2021	Fang, Wen-Feng/0000-0003-0350-9059; chen, hong cheng/0000-0001-9713-3835				Aerts JG, 2013, CANCER RES, V73, P2381, DOI 10.1158/0008-5472.CAN-12-3932; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Facchinetti F, 2015, TUMOR BIOL, V36, P5943, DOI 10.1007/s13277-015-3269-6; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; LIN B, 2015, LEUKEMIA LYMPHOMA, V3, P1, DOI DOI 10.3389/FBI0E.2015.00039; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0070-0; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Porrata LF, 2012, LEUKEMIA LYMPHOMA, V53, P2159, DOI 10.3109/10428194.2012.690605; Remark R, 2015, AM J RESP CRIT CARE, V191, P377, DOI 10.1164/rccm.201409-1671PP; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang J, 2013, STEM CELLS, V31, P248, DOI 10.1002/stem.1281; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	23	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136252	10.1371/journal.pone.0136252	http://dx.doi.org/10.1371/journal.pone.0136252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313661	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000050
J	Geng, RZ; Wang, XY; Sharpley, AN; Meng, FD				Geng, Runzhe; Wang, Xiaoyan; Sharpley, Andrew N.; Meng, Fande			Spatially-Distributed Cost-Effectiveness Analysis Framework to Control Phosphorus from Agricultural Diffuse Pollution	PLOS ONE			English	Article							NONPOINT-SOURCE POLLUTION; CRITICAL SOURCE AREAS; LAND-USE; WATERSHED MANAGEMENT; DECISION-SUPPORT; BMP PLACEMENT; STRATEGIES; OPTIMIZATION; REDUCTION; RIVER	Best management practices (BMPs) for agricultural diffuse pollution control are implemented at the field or small-watershed scale. However, the benefits of BMP implementation on receiving water quality at multiple spatial is an ongoing challenge. In this paper, we introduce an integrated approach that combines risk assessment (i.e., Phosphorus (P) index), model simulation techniques (Hydrological Simulation Program-FORTRAN), and a BMP placement tool at various scales to identify the optimal location for implementing multiple BMPs and estimate BMP effectiveness after implementation. A statistically significant decrease in nutrient discharge from watersheds is proposed to evaluate the effectiveness of BMPs, strategically targeted within watersheds. Specifically, we estimate two types of cost-effectiveness curves (total pollution reduction and proportion of watersheds improved) for four allocation approaches. Selection of a "best approac" depends on the relative importance of the two types of effectiveness, which involves a value judgment based on the random/aggregated degree of BMP distribution among and within sub-watersheds. A statistical optimization framework is developed and evaluated in Chaohe River Watershed located in the northern mountain area of Beijing. Results show that BMP implementation significantly (p > 0.001) decrease P loss from the watershed. Remedial strategies where BMPs were targeted to areas of high risk of P loss, deceased P loads compared with strategies where BMPs were randomly located across watersheds. Sensitivity analysis indicated that aggregated BMP placement in particular watershed is the most cost-effective scenario to decrease P loss. The optimization approach outlined in this paper is a spatially hierarchical method for targeting nonpoint source controls across a range of scales from field to farm, to watersheds, to regions. Further, model estimates showed targeting at multiple scales is necessary to optimize program efficiency. The integrated model approach described that selects and places BMPs at varying levels of implementation, provides a new theoretical basis and technical guidance for diffuse pollution management in agricultural watersheds.	[Geng, Runzhe; Wang, Xiaoyan; Meng, Fande] Capital Normal Univ, Coll Resources Environm & Tourism, Beijing 100048, Peoples R China; [Geng, Runzhe] Minist Environm Protect, Policy Res Ctr Environm & Econ, Beijing 100029, Peoples R China; [Sharpley, Andrew N.] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Capital Normal University; University of Arkansas System; University of Arkansas Fayetteville	Wang, XY (corresponding author), Capital Normal Univ, Coll Resources Environm & Tourism, Beijing 100048, Peoples R China.	cnuwxy@gmail.com			National Natural Science Foundation of China [41271495]; Sino-German Intergovernmental S & T Cooperation Projects [2009DFA92440]; Specialized Research Fund for the Doctoral Program of Higher Education [20121108110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-German Intergovernmental S & T Cooperation Projects; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 41271495) and the Sino-German Intergovernmental S & T Cooperation Projects (No. 2009DFA92440), Specialized Research Fund for the Doctoral Program of Higher Education (20121108110006).	Akter A, 2012, J HYDROL, V452, P232, DOI 10.1016/j.jhydrol.2012.05.059; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Ancev T, 2008, 13 WORLD WAT C; Arabi M, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR004931; Babcock BA, 1997, LAND ECON, V73, P325, DOI 10.2307/3147171; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bicknell B.R., 1997, HYDROLOGICAL SIMULAT; Brazner JC, 2004, ENVIRON MANAGE, V33, P855, DOI 10.1007/s00267-004-3031-0; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Chang CL, 2009, ENVIRON MONIT ASSESS, V153, P359, DOI 10.1007/s10661-008-0362-y; Cherry KA, 2008, SCI TOTAL ENVIRON, V406, P1, DOI 10.1016/j.scitotenv.2008.07.015; Diebel MW, 2008, ENVIRON MANAGE, V42, P789, DOI 10.1007/s00267-008-9186-3; Diebel M, 2009, ENVIRON MANAGE, V43, P69, DOI 10.1007/s00267-008-9139-x; Gburek WJ, 2002, J SOIL WATER CONSERV, V57, P534; [耿润哲 Geng Runzhe], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P3292; Ghebremichael LT, 2009, J DAIRY SCI, V92, P4086, DOI 10.3168/jds.2009-2024; Ghebremichael LT, 2013, J ENVIRON MANAGE, V114, P381, DOI 10.1016/j.jenvman.2012.10.034; Gitau MW, 2004, T ASAE, V47, P1923, DOI 10.13031/2013.17805; Hsieh CD, 2007, J ENVIRON MANAGE, V85, P908, DOI 10.1016/j.jenvman.2006.10.022; Hyman JB, 2000, ENVIRON MANAGE, V25, P23, DOI 10.1007/s002679910003; Jokela W.E., 2004, EFFECTIVENESS AGR BE, P39; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Mostaghimi S, 1997, WATER RES, V31, P1867, DOI 10.1016/S0043-1354(97)00018-3; Muleta MK, 2005, J WATER RES PLAN MAN, V131, P35, DOI 10.1061/(ASCE)0733-9496(2005)131:1(35); Osei E, 2000, J SOIL WATER CONSERV, V55, P466; Ou Y, 2008, WATER SCI TECHNOL, V58, P2235, DOI 10.2166/wst.2008.831; Ouyang Y, 2012, J SOIL SEDIMENT, V12, P207, DOI 10.1007/s11368-011-0426-4; Panagopoulos Y, 2012, ENVIRON MODELL SOFTW, V30, P57, DOI 10.1016/j.envsoft.2011.11.006; Pionke HB, 2000, ECOL ENG, V14, P325, DOI 10.1016/S0925-8574(99)00059-2; Qi HH, 2011, J ENVIRON MANAGE, V92, P149, DOI 10.1016/j.jenvman.2010.08.023; Robertson DM, 2006, US GEOLOGICAL SURVEY, P1; Rodriguez HG, 2011, WATER RESOUR RES, V47, DOI 10.1029/2009WR008549; Rolle K, 2012, WATER SCI TECHNOL, V66, P1096, DOI 10.2166/wst.2012.282; Sharpley AN, 2003, J SOIL WATER CONSERV, V58, P137; Sharpley AN, 1999, AGR WATER MANAGE, V41, P77, DOI 10.1016/S0378-3774(99)00018-9; Sharpley AN, 2011, WATER SCI TECHNOL, V64, P945, DOI 10.2166/wst.2011.712; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Srivastava P, 2003, J AM WATER RESOUR AS, V39, P1043, DOI 10.1111/j.1752-1688.2003.tb03691.x; Veith TL, 2003, J AM WATER RESOUR AS, V39, P1331, DOI 10.1111/j.1752-1688.2003.tb04421.x; Wang LZ, 1997, FISHERIES, V22, P6, DOI 10.1577/1548-8446(1997)022&lt;0006:IOWLUO&gt;2.0.CO;2; Yin J., 2009, SOIL PHOSPHORUS MOBI; Zhang PF, 2013, NONPOINT SOURCE POLL	43	13	13	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0130607	10.1371/journal.pone.0130607	http://dx.doi.org/10.1371/journal.pone.0130607			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313561	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000001
J	Nasir, I; Fatih, W; Svensson, A; Radu, D; Linse, S; Lago, CC; Lundqvist, M				Nasir, Irem; Fatih, Warda; Svensson, Anja; Radu, Dennis; Linse, Sara; Lago, Celia Cabaleiro; Lundqvist, Martin			High Throughput Screening Method to Explore Protein Interactions with Nanoparticles	PLOS ONE			English	Article							HUMAN CARBONIC-ANHYDRASE; SILICA NANOPARTICLES; ENZYME-ACTIVITY; ADSORPTION; STABILITY; ORIENTATION; PARTICLES; LYSOZYME; SURFACES; MUTANT	The interactions of biological macromolecules with nanoparticles underlie a wide variety of current and future applications in the fields of biotechnology, medicine and bioremediation. The same interactions are also responsible for mediating potential biohazards of nanomaterials. Some applications require that proteins adsorb to the nanomaterial and that the protein resists or undergoes structural rearrangements. This article presents a screening method for detecting nanoparticle-protein partners and conformational changes on time scales ranging from milliseconds to days. Mobile fluorophores are used as reporters to study the interaction between proteins and nanoparticles in a high-throughput manner in multi-well format. Furthermore, the screening method may reveal changes in colloidal stability of nanomaterials depending on the physicochemical conditions.	[Nasir, Irem; Linse, Sara; Lago, Celia Cabaleiro; Lundqvist, Martin] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Fatih, Warda; Svensson, Anja; Radu, Dennis; Lundqvist, Martin] Upper 2nd Sch, Klippan, Sweden	Lund University	Lundqvist, M (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	Martin.Lundqvist@biochemistry.lu.se	Lundqvist, Martin/K-3908-2012	Lundqvist, Martin/0000-0003-1175-9103; NASIR, Irem/0000-0002-3128-2464	Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation; Swedish Research Council; Crafoord Foundation; Swedish Research Council (VR) via OMM	Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Swedish Research Council (VR) via OMM(Swedish Research Council)	This work was supported by the Marianne and Marcus Wallenberg Foundation, https://www.wallenberg.com/mmw/, M.L.; Magnus Bergvall Foundation, www.magnbergvallsstiftelse.nu/, M.L.; the Swedish Research Council, www.vr.se, C.C.L.; the Crafoord Foundation, www.crafoord.se/, C.C.L.; and the Swedish Research Council (VR) via OMM, www.omm.lu.se/, S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSSON G, 1995, BIOCHEMISTRY-US, V34, P2153, DOI 10.1021/bi00007a008; Assarsson A, 2014, ADDING CHARGE EFFECT; Assarsson A, 2014, LANGMUIR, V30, P9448, DOI 10.1021/la501413r; Billsten P, 1997, FEBS LETT, V402, P67, DOI 10.1016/S0014-5793(96)01431-7; BRODIN P, 1989, PROTEIN ENG, V2, P353, DOI 10.1093/protein/2.5.353; Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101; Ferreira SA, 2012, BBA-GEN SUBJECTS, V1820, P1043, DOI 10.1016/j.bbagen.2012.04.015; Fornaguera C, 2015, NANOSCALE, V7, P6045, DOI 10.1039/c5nr00733j; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; He XC, 2015, NANOMEDICINE-UK, V10, P121, DOI 10.2217/nnm.14.167; Huang RX, 2013, NANOSCALE, V5, P6928, DOI 10.1039/c3nr02117c; JOHANSSON C, 1990, EUR J BIOCHEM, V187, P455, DOI 10.1111/j.1432-1033.1990.tb15325.x; Karlsson M, 2005, BIOPHYS J, V88, P3536, DOI 10.1529/biophysj.104.054809; Kasche V, 2001, J BIOCHEM BIOPH METH, V49, P49, DOI 10.1016/S0165-022X(01)00188-9; Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331; Klymchenko AS, PROGR MOL BIOL TRANS, V1132013, P35; Li N, 2010, ANAL CHEM, V82, P7460, DOI 10.1021/ac101627p; Lundqvist M, 2005, LANGMUIR, V21, P11903, DOI 10.1021/la050477u; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2005, BIOCHEMISTRY-US, V44, P10093, DOI 10.1021/bi0500067; Lundqvist M, 2005, LANGMUIR, V21, P5974, DOI 10.1021/la050569j; Lundqvist M, 2006, ANGEW CHEM INT EDIT, V45, P8169, DOI 10.1002/anie.200600965; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Norde W, 2012, ADV COLLOID INTERFAC, V179, P5, DOI 10.1016/j.cis.2012.06.011; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sailor MJ, 2012, ADV MATER, V24, P3779, DOI 10.1002/adma.201200653; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Talbert JN, 2013, FOOD BIOPROD PROCESS, V91, P693, DOI 10.1016/j.fbp.2013.08.006; Tarasevich YI, 2002, COLLOID J+, V64, P482, DOI 10.1023/A:1016828322434; Vinoba M, 2012, CHEM-EUR J, V18, P12028, DOI 10.1002/chem.201201112; Wahlgren M, 1997, LANGMUIR, V13, P8, DOI 10.1021/la960171a; Xia XR, 2010, NAT NANOTECHNOL, V5, P671, DOI [10.1038/nnano.2010.164, 10.1038/NNANO.2010.164]; Yohan D, 2014, J BIOMED NANOTECHNOL, V10, P2371, DOI 10.1166/jbn.2014.2015; Yonzon CR, 2005, TALANTA, V67, P438, DOI 10.1016/j.talanta.2005.06.039; Zheng X, 2014, ENVIRON SCI TECHNOL, V48, P13800, DOI 10.1021/es504251v	39	9	9	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136687	10.1371/journal.pone.0136687	http://dx.doi.org/10.1371/journal.pone.0136687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313757	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000087
J	Xu, SN; Li, X; Zhang, JM; Chen, JP				Xu, Shuangnian; Li, Xi; Zhang, Jianmin; Chen, Jieping			Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis	PLOS ONE			English	Article							MAC-1 CD11B/CD18; POOR-PROGNOSIS; CELLS; ADHESION; RECEPTOR; SUBUNIT; TARGETS; RISK; MO1	Background Study results on the prognostic value of CD11b for acute myeloid leukemia (AML) patients are inconsistent. An up-to-date meta-analysis was conducted to assess the prognostic value of CD11b expression level for AML patients. Methods Electronic databases including PubMed, Embase, Cochrane Library, Web of Science and Chinese BioMedical Literature Database (CBM) were searched to identify studies that investigated the association between CD11b expression level and prognosis of AML patients. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS) and disease-free survival (DFS) and pooled odds ratio (OR) with 95% CI for complete remission rate (CRR) were calculated using Revman 5.3 and Stata 11.0. Results 13 total studies with 2619 patients were included in this meta-analysis. Results of the meta-analysis showed that CD11b positivity was associated with lower CRR (OR = 0.44; 95% CI, 0.25-0.79; p = 0.006) and shorter OS (HR = 0.66; 95% CI, 0.55-0.80; p < 0.0001), but did not affect DFS (HR = 0.67; 95% CI, 0.31-1.48; p = 0.32). Subgroup analysis by ethnicity, cut-off value for CD11b positivity, treatment, subtype and sample preparation method showed no significant interaction between these factors with the prognostic value of CD11b expression level for AML patients. Sensitivity analysis yielded consistent results with the main meta-analysis. Conclusion CD11b positivity could predict a poor prognosis for AML patients. Thus, CD11b expression level might be considered a prognostic biomarker for AML patients.	[Xu, Shuangnian; Li, Xi; Zhang, Jianmin; Chen, Jieping] Third Mil Med Univ, Southwest Hosp, Dept Hematol, Chongqing, Peoples R China	Army Medical University	Chen, JP (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Hematol, 30 Gaotanyan St, Chongqing, Peoples R China.	chenjpxn@163.com		Li, Xi/0000-0001-7106-1677; Stover, Cordula/0000-0002-0125-4868	National Science Foundation of China [81270605, 81470324]; Youth Cultivation Project of Medical Science and Technology of Chinese PLA [14QNP089]; Postgraduate Education Reform Project of Chongqing [yjg123114]; Third Military Medical University Clinic and Science Great Fund Project [2012XLC03]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Cultivation Project of Medical Science and Technology of Chinese PLA; Postgraduate Education Reform Project of Chongqing; Third Military Medical University Clinic and Science Great Fund Project	This work was funded by National Science Foundation of China (81270605, 81470324), Youth Cultivation Project of Medical Science and Technology of Chinese PLA (14QNP089), Postgraduate Education Reform Project of Chongqing (yjg123114), and Third Military Medical University Clinic and Science Great Fund Project (2012XLC03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Albitar M, 2011, BLOOD, V118, P1747; Amirghofran Z, 2001, INT J HEMATOL, V73, P502, DOI 10.1007/BF02994014; ARNAOUT MA, 1988, J CELL PHYSIOL, V137, P305, DOI 10.1002/jcp.1041370214; ARNAOUT MA, 1988, J CELL BIOL, V106, P2153, DOI 10.1083/jcb.106.6.2153; BRADSTOCK K, 1994, BLOOD, V84, P1220; Buzzai M, 2008, CURR OPIN HEMATOL, V15, P82, DOI 10.1097/MOH.0b013e3282f3ded0; Chen F, 2013, J CLIN HEMATOL CHINA, V26, P375; Chen MH, 2013, LEUKEMIA RES, V37, P122, DOI 10.1016/j.leukres.2012.09.019; COOMBE DR, 1994, BLOOD, V84, P739; De Veirman K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00349; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Foss B, 2010, BBA-BIOMEMBRANES, V1798, P1, DOI 10.1016/j.bbamem.2009.10.014; HICKSTEIN DD, 1987, J BIOL CHEM, V262, P5576; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildreth Carolyn J, 2010, JAMA, V304, P2759, DOI 10.1001/jama.302.22.2759; Johrer K, 2012, EXPERT OPIN BIOL TH, V12, P425, DOI 10.1517/14712598.2012.664128; Junca J, 2014, ANN HEMATOL, V93, P1483, DOI 10.1007/s00277-014-2082-4; Kawamoto A, 2004, INT J BIOCHEM CELL B, V36, P1374, DOI 10.1016/j.biocel.2004.01.020; Kohnke T, 2015, LEUKEMIA, V29, P377, DOI 10.1038/leu.2014.186; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Liang J, 2001, JIANGSU MED J, V27, P259; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Paietta E, 1998, BRIT J HAEMATOL, V100, P265, DOI 10.1046/j.1365-2141.1998.00561.x; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; SIMON DI, 1993, BLOOD, V82, P2414; Sison EAR, 2011, EXPERT REV HEMATOL, V4, P271, DOI [10.1586/ehm.11.30, 10.1586/EHM.11.30]; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tohda S, 2014, ANTICANCER RES, V34, P6259; TUCKER J, 1990, HEMATOL ONCOL, V8, P47, DOI 10.1002/hon.2900080107; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; Xu J, 2006, CYTOM PART B-CLIN CY, V70B, P377; Xu Na, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1605; Yang Lu-Lu, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P1, DOI 10.7534/j.issn.1009-2137.2014.01.001; Younos IH, 2015, LEUKEMIA LYMPHOMA, P1; Zhuang G, 2011, BEIJING MED J, V33, P929	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135981	10.1371/journal.pone.0135981	http://dx.doi.org/10.1371/journal.pone.0135981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309131	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400082
J	Iliadis, SI; Comasco, E; Sylven, S; Hellgren, C; Poromaa, IS; Skalkidou, A				Iliadis, Stavros I.; Comasco, Erika; Sylven, Sara; Hellgren, Charlotte; Poromaa, Inger Sundstrom; Skalkidou, Alkistis			Prenatal and Postpartum Evening Salivary Cortisol Levels in Association with Peripartum Depressive Symptoms	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; CARDIFF PUERPERAL MOOD; POSTNATAL-DEPRESSION; AWAKENING RESPONSE; PLASMA-CORTISOL; PSYCHOLOGICAL DISTRESS; PERINATAL DEPRESSION; PSYCHOSOCIAL STRESS; MORNING CORTISOL	Background The biology of peripartum depression remains unclear, with altered stress and the Hypothalamus- Pituitary-Adrenal axis response having been implicated in its pathophysiology. Methods The current study was undertaken as a part of the BASIC project (Biology, Affect, Stress, Imaging, Cognition), a population-based longitudinal study of psychological wellbeing during pregnancy and the postpartum period in Uppsala County, Sweden, in order to assess the association between evening salivary cortisol levels and depressive symptoms in the peripartum period. Three hundred and sixty-five pregnant women from the BASIC cohort were recruited at pregnancy week 18 and instructed to complete a Swedish validated version of the Edinburgh Postnatal Depression Scale at the 36th week of pregnancy as well as the sixth week after delivery. At both times, they were also asked to provide evening salivary samples for cortisol analysis. A comprehensive review of the relevant literature is also provided. Results Women with postpartum EPDS score >= 10 had higher salivary evening cortisol at six weeks postpartum compared to healthy controls (median cortisol 1.19 vs 0.89 nmol/L). A logistic regression model showed a positive association between cortisol levels and depressive symptoms postpartum (OR = 4.1; 95% CI 1.7-9.7). This association remained significant even after controlling for history of depression, use of tobacco, partner support, breastfeeding, stressful life events, and sleep problems, as possible confounders (aOR = 4.5; 95% CI 1.5-14.1). Additionally, women with postpartum depressive symptoms had higher postpartum cortisol levels compared to both women with depressive symptoms antenatally and controls (p = 0.019 and p = 0.004, respectively). Conclusions Women with depressive symptoms postpartum had higher postpartum cortisol levels, indicating an altered response of the HPA-axis in postpartum depression.	[Iliadis, Stavros I.; Comasco, Erika; Sylven, Sara; Hellgren, Charlotte; Poromaa, Inger Sundstrom; Skalkidou, Alkistis] Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden; [Comasco, Erika] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden	Uppsala University; Uppsala University	Iliadis, SI (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden.	stavros.iliadis@kbh.uu.se	Comasco, Erika/H-9337-2019; Skalkidou, Alkistis/C-1521-2015	Comasco, Erika/0000-0002-2174-2068; Skalkidou, Alkistis/0000-0002-4935-7532; Sundstrom Poromaa, Inger/0000-0002-2491-2042; Sylven, Sara M/0000-0002-3142-5111	Swedish Research Council [521-2013-2339]; Marianne and Marcus Wallenberg Foundation [MMW2011.0115]; Swedish Medical Association [SLS-250581]; Uppsala University Hospital [2012-Skalkidou]; Swedish Council for Working Life and Social Research [FAS: 2011-0627]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; Swedish Medical Association; Uppsala University Hospital; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was supported by the Swedish Research Council (grant number: 521-2013-2339), the Marianne and Marcus Wallenberg Foundation (grant number: MMW2011.0115), the Swedish Medical Association (grant number: SLS-250581), the Uppsala University Hospital (grant number: 2012-Skalkidou), and the Swedish Council for Working Life and Social Research to E.C. (FAS: 2011-0627). The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; inthe writing of the report; and in the decision to submit the article for publication.	Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Ahmed N, 2004, CEREBROVASC DIS, V18, P206, DOI 10.1159/000079943; ALLOLIO B, 1990, CLIN ENDOCRINOL, V33, P279, DOI 10.1111/j.1365-2265.1990.tb00492.x; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; AMICO JA, 1994, ENDOCR RES, V20, P79, DOI 10.3109/07435809409035858; Bissette G, 2003, NEUROPSYCHOPHARMACOL, V28, P1328, DOI 10.1038/sj.npp.1300191; Bloch M, 2005, J CLIN ENDOCR METAB, V90, P695, DOI 10.1210/jc.2004-1388; BONNIN F, 1992, J AFFECT DISORDERS, V26, P231, DOI 10.1016/0165-0327(92)90100-K; Brugha TS, 1998, PSYCHOL MED, V28, P63, DOI 10.1017/S0033291797005655; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Clements AD, 1998, PSYCHONEUROENDOCRINO, V23, P613; Cox EQ, 2015, PSYCHONEUROENDOCRINO, V55, P164, DOI 10.1016/j.psyneuen.2015.02.009; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dedovic K, 2015, NEUROPSYCH DIS TREAT, V11, P1181, DOI 10.2147/NDT.S62289; Dennis CL, 2004, J AFFECT DISORDERS, V78, P163, DOI 10.1016/S0165-0327(02)00299-9; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; EHLERT U, 1990, J PSYCHOSOM RES, V34, P319, DOI 10.1016/0022-3999(90)90088-L; Evans LM, 2008, ARCH WOMEN MENT HLTH, V11, P239, DOI 10.1007/s00737-008-0019-4; FEKSI A, 1984, J AFFECT DISORDERS, V6, P351, DOI 10.1016/S0165-0327(84)80013-0; Field T, 2006, INFANT BEHAV DEV, V29, P262, DOI 10.1016/j.infbeh.2005.12.009; Field Tiffany, 2008, Depress Anxiety, V25, pE11, DOI 10.1002/da.20307; Friedman B, 2013, MILBANK Q, V91, P491, DOI 10.1111/1468-0009.12024; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Giesbrecht GF, 2012, PSYCHONEUROENDOCRINO, V37, P270, DOI 10.1016/j.psyneuen.2011.06.011; Glynn LM, 2014, PSYCHOSOM MED, V76, P355, DOI 10.1097/PSY.0000000000000066; Glynn LM, 2013, NEUROPEPTIDES, V47, P363, DOI 10.1016/j.npep.2013.10.007; Gold PW, 1999, P ASSOC AM PHYSICIAN, V111, P22, DOI 10.1046/j.1525-1381.1999.09423.x; Goodyer IM, 2010, BRIT J PSYCHIAT, V197, P365, DOI 10.1192/bjp.bp.110.077750; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; Groschl M, 2003, CLIN CHEM, V49, P1688, DOI 10.1373/49.10.1688; HANDLEY SL, 1980, BRIT J PSYCHIAT, V136, P498, DOI 10.1192/bjp.136.5.498; HANDLEY SL, 1977, BRIT MED J, V2, P18, DOI 10.1136/bmj.2.6078.18; Handlin L, 2009, BREASTFEED MED, V4, P207, DOI 10.1089/bfm.2009.0001; Hanrahan K, 2006, APPL NURS RES, V19, P95, DOI 10.1016/j.apnr.2006.02.001; HARRIS B, 1994, BRIT MED J, V308, P949, DOI 10.1136/bmj.308.6934.949; Harris B, 1996, BRIT J PSYCHIAT, V168, P739, DOI 10.1192/bjp.168.6.739; HARRIS B, 1989, BRIT J PSYCHIAT, V154, P660, DOI 10.1192/bjp.154.5.660; Harris TO, 2000, BRIT J PSYCHIAT, V177, P505, DOI 10.1192/bjp.177.6.505; Heinrichs M, 2001, J CLIN ENDOCR METAB, V86, P4798, DOI 10.1210/jc.86.10.4798; Hellgren C, 2013, PSYCHONEUROENDOCRINO; Inder WJ, 2012, CLIN ENDOCRINOL, V77, P645, DOI 10.1111/j.1365-2265.2012.04508.x; Johnson DM, 2008, J ANXIETY DISORD, V22, P793, DOI 10.1016/j.janxdis.2007.08.006; Jolley SN, 2007, BIOL RES NURS, V8, P210, DOI 10.1177/1099800406294598; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Kammerer M, 2006, ARCH WOMEN MENT HLTH, V9, P187, DOI 10.1007/s00737-006-0131-2; KUEVI V, 1983, CLIN ENDOCRINOL, V19, P39, DOI 10.1111/j.1365-2265.1983.tb00740.x; KUMAR R, 1984, BRIT J PSYCHIAT, V144, P35, DOI 10.1192/bjp.144.1.35; Leproult R, 1997, SLEEP, V20, P865; Llewellyn AM, 1997, J CLIN PSYCHIAT, V58, P26; Lommatzsch M, 2006, PSYCHONEUROENDOCRINO, V31, P388, DOI 10.1016/j.psyneuen.2005.09.003; Magiakou MA, 1996, J CLIN ENDOCR METAB, V81, P1912, DOI 10.1210/jc.81.5.1912; Martin-Santos R, 2012, PSYCHOL MED, V42, P1559, DOI 10.1017/S0033291712000712; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; Meinlschmidt G, 2010, STRESS, V13, P163, DOI 10.3109/10253890903128632; Meliska CJ, 2013, CHRONOBIOL INT, V30, P1160, DOI 10.3109/07420528.2013.808652; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Nierop A, 2006, PSYCHOSOM MED, V68, P931, DOI 10.1097/01.psy.0000244385.93141.3b; O'Keane V, 2011, J NEUROENDOCRINOL, V23, P1149, DOI 10.1111/j.1365-2826.2011.02139.x; O'Keane V, 2011, J AFFECT DISORDERS, V130, P300, DOI 10.1016/j.jad.2010.10.004; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Oglodek E, 2014, PHARMACOL REP, V66, P776, DOI 10.1016/j.pharep.2014.04.009; OHARA MW, 1991, J ABNORM PSYCHOL, V100, P63, DOI 10.1037/0021-843X.100.1.63; OKANO T, 1992, PROG NEURO-PSYCHOPH, V16, P921, DOI 10.1016/0278-5846(92)90110-Z; Parry Barbara L, 2003, Curr Womens Health Rep, V3, P230; PEDERSEN CA, 1993, J AFFECT DISORDERS, V29, P201, DOI 10.1016/0165-0327(93)90034-H; Peer M, 2013, CAN J PSYCHIAT, V58, P579, DOI 10.1177/070674371305801007; Petrozzi A, 2013, J PERINAT MED, V41, P343, DOI 10.1515/jpm-2012-0258; Pluess M, 2010, BIOL PSYCHOL, V83, P169, DOI 10.1016/j.biopsycho.2009.12.005; ROSENGREN A, 1993, BRIT MED J, V307, P1102, DOI 10.1136/bmj.307.6912.1102; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Salacz P, 2012, EUR J OBSTET GYN R B, V165, P225, DOI 10.1016/j.ejogrb.2012.08.017; Saleh ES, 2013, NEUROPSYCH DIS TREAT, V9, P15, DOI 10.2147/NDT.S37156; SBU, 2012, DIAGN TREATM MOOD DI; Shea AK, 2007, PSYCHONEUROENDOCRINO, V32, P1013, DOI 10.1016/j.psyneuen.2007.07.006; Skalkidou A, 2012, WOMENS HEALTH, V8, P659, DOI [10.2217/WHE.12.55, 10.2217/whe.12.55]; SMITH R, 1990, J PSYCHOSOM RES, V34, P53, DOI 10.1016/0022-3999(90)90008-R; Suglia SF, 2010, PSYCHOL TRAUMA-US, V2, P326, DOI 10.1037/a0018953; Susman EJ, 1999, J AM ACAD CHILD PSY, V38, P460, DOI 10.1097/00004583-199904000-00020; TAYLOR A, 1994, PSYCHIAT RES, V54, P241, DOI 10.1016/0165-1781(94)90018-3; Taylor A, 2009, PSYCHONEUROENDOCRINO, V34, P1184, DOI 10.1016/j.psyneuen.2009.03.004; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Voegtline KM, 2013, ARCH WOMEN MENT HLTH, V16, P101, DOI 10.1007/s00737-012-0321-z; Vrshek-Schallhorn S, 2013, PSYCHOL MED, V43, P483, DOI 10.1017/S0033291712001213; Wesstrom J, 2014, J CLIN SLEEP MED, V10, P527, DOI 10.5664/jcsm.3704; Wickberg B, 1996, ACTA PSYCHIAT SCAND, V94, P181, DOI 10.1111/j.1600-0447.1996.tb09845.x; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Yim IS, 2009, ARCH GEN PSYCHIAT, V66, P162, DOI 10.1001/archgenpsychiatry.2008.533	89	46	47	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135471	10.1371/journal.pone.0135471	http://dx.doi.org/10.1371/journal.pone.0135471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322643	gold, Green Published, Green Submitted			2022-12-27	WOS:000360435500006
J	Schroder, J; Girirajan, S; Papenfuss, AT; Medvedev, P				Schroeder, Jan; Girirajan, Santhosh; Papenfuss, Anthony T.; Medvedev, Paul			Improving the Power of Structural Variation Detection by Augmenting the Reference	PLOS ONE			English	Article							READ ALIGNMENT	The uses of the Genome Reference Consortium's human reference sequence can be roughly categorized into three related but distinct categories: as a representative species genome, as a coordinate system for identifying variants, and as an alignment reference for variation detection algorithms. However, the use of this reference sequence as simultaneously a representative species genome and as an alignment reference leads to unnecessary artifacts for structural variation detection algorithms and limits their accuracy. We show how decoupling these two references and developing a separate alignment reference can significantly improve the accuracy of structural variation detection, lead to improved genotyping of disease related genes, and decrease the cost of studying polymorphismin a population.	[Schroeder, Jan; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Schroeder, Jan] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Schroeder, Jan; Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Medvedev, Paul] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16801 USA; [Girirajan, Santhosh; Medvedev, Paul] Penn State Univ, Genom Sci Inst Huck, State Coll, PA USA; [Girirajan, Santhosh; Medvedev, Paul] Penn State Univ, Dept Comp Sci & Engn, State Coll, PA USA	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Medvedev, P (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16801 USA.	paul.medvedev@psu.edu	Girirajan, Santhosh/AAR-3659-2020; Papenfuss, Anthony T/C-6297-2008	Papenfuss, Anthony T/0000-0002-1102-8506; SCHROEDER, JAN/0000-0001-5270-0605	National Science Foundation [DBI-1356529, IIS-1453527]; NHMRC Program Grant [1054618]; Direct For Computer & Info Scie & Enginr [1453527] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1356529] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	PM was funded in part by National Science Foundation (nsf.gov), grants DBI-1356529 and IIS-1453527. J.S. and A.T.P. were supported by an NHMRC Program Grant (1054618) (www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Kim S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt339; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rizk G, 2014, BIOINFORMATICS; Siren J, 2014, IEEE ACM T COMPUT BI, V11, P375, DOI 10.1109/TCBB.2013.2297101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolfe D, 2013, VISUALIZING GENOMIC; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	16	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136771	10.1371/journal.pone.0136771	http://dx.doi.org/10.1371/journal.pone.0136771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322511	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500035
J	Endo-Munoz, L; Cai, N; Cumming, A; Macklin, R; de Long, LM; Topkas, E; Mukhopadhyay, P; Hill, M; Saunders, NA				Endo-Munoz, Liliana; Cai, Na; Cumming, Andrew; Macklin, Rebecca; de Long, Lilia Merida; Topkas, Eleni; Mukhopadhyay, Pamela; Hill, Michelle; Saunders, Nicholas A.			Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis	PLOS ONE			English	Article							UROKINASE-PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; CARCINOMA-CELLS; CANCER INVASION; TUMOR-GROWTH; RECEPTOR; SYSTEM; INHIBITOR; THERAPY; TARGET	Pulmonary metastasis is the major untreatable complication of osteosarcoma (OS) resulting in 10-20% long-term survival. The factors and pathways regulating these processes remain unclear, yet their identification is crucial in order to find new therapeutic targets. In this study we used a multi-omics approach to identify molecules in metastatic and non-metastatic OS cells that may contribute to OS metastasis, followed by validation in vitro and in vivo. We found elevated levels of the urokinase plasminogen activator (uPA) and of the uPA receptor (uPAR) exclusively in metastatic OS cells. uPA was secreted in soluble form and as part of the protein cargo of OS-secreted extracellular vesicles, including exosomes. In addition, in the tumour microenvironment, uPA was expressed and secreted by bone marrow cells (BMC), and OS-and BMC-derived uPA significantly and specifically stimulated migration of metastatic OS cells via uPA-dependent signaling pathways. Silencing of uPAR in metastatic OS cells abrogated the migratory response to uPA in vitro and decreased metastasis in vivo. Finally, a novel small-molecule inhibitor of uPA significantly (P = 0.0004) inhibited metastasis in an orthotopic mouse model of OS. Thus, we show for the first time that malignant conversion of OS cells to a metastatic phenotype is defined by activation of the uPA/uPAR axis in both an autocrine and paracrine fashion. Furthermore, metastasis is driven by changes in OS cells as well as in the microenvironment. Finally, our data show that pharmacological inhibition of the uPA/uPAR axis with a novel small-molecule inhibitor can prevent the emergence of metastatic foci.	[Endo-Munoz, Liliana; Cai, Na; Cumming, Andrew; Macklin, Rebecca; de Long, Lilia Merida; Topkas, Eleni; Mukhopadhyay, Pamela; Hill, Michelle; Saunders, Nicholas A.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia	University of Queensland	Endo-Munoz, L (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia.	l.munoz@uq.edu.au	McTaggart, Jill/G-4696-2010; Cai, Na/L-4951-2019; Hill, Michelle Mei Chih/G-4417-2010; saunders, nicholas/AAJ-6101-2020; Endo-Munoz, Liliana/G-3309-2010	McTaggart, Jill/0000-0002-9000-8529; Cai, Na/0000-0002-7548-4359; Hill, Michelle Mei Chih/0000-0003-1134-0951; saunders, nicholas/0000-0002-2478-3420; Endo-Munoz, Liliana/0000-0001-5706-920X	National Health and Medical Research Council [1049182, 569689]; Wesley Research Institute [2006/10]; Cancer Council Queensland [401542]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wesley Research Institute; Cancer Council Queensland(Cancer Council Queensland)	LEM was funded by The National Health and Medical Research Council (Grant ID 1049182, https://www.nhmrc.gov.au). LEM and NAS were funded by The Wesley Research Institute (Grant ID 2006/10, http://www.wesleyresearch.org.au). NAS was funded by The National Health and Medical Research Council (Grant ID 569689, https://www.nhmrc.gov.au), and by the Cancer Council Queensland (Grant ID 401542, http://www.cancerqld.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bacci G, 1997, CANCER-AM CANCER SOC, V79, P245; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; BERLIN O, 1993, CANCER RES, V53, P4890; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carriero MV, 2011, CURR DRUG TARGETS, V12, P1761; Choong PFM, 1996, INT J CANCER, V69, P268, DOI 10.1002/(SICI)1097-0215(19960822)69:4<268::AID-IJC5>3.0.CO;2-V; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dass CR, 2005, CLIN EXP METASTAS, V22, P643, DOI 10.1007/s10585-006-9004-3; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Endo-Munoz L, 2010, CANCER RES, V70, P7063, DOI 10.1158/0008-5472.CAN-09-4291; Ertongur S, 2004, INT J CANCER, V110, P815, DOI 10.1002/ijc.20192; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fisher JL, 2001, CLIN CANCER RES, V7, P1654; Hackel CG, 2000, CANCER-AM CANCER SOC, V89, P995; Haeckel C, 1999, ARCH PATHOL LAB MED, V123, P213; Hakel C, 1994, Zentralbl Pathol, V140, P363; Hayden JB, 2006, ORTHOP CLIN N AM, V37, P1, DOI 10.1016/j.ocl.2005.06.004; Heinemann V, 2013, BRIT J CANCER, V108, P766, DOI 10.1038/bjc.2013.62; Hildenbrand R, 2010, EXPERT OPIN INV DRUG, V19, P641, DOI 10.1517/13543781003767400; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Killeen S, 2008, DRUG NEWS PERSPECT, V21, P107, DOI 10.1358/dnp.2008.21.2.1188197; Lund IK, 2011, CURR DRUG TARGETS, V12, P1744; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mekkawy AH, 2009, FUTURE ONCOL, V5, P1487, DOI 10.2217/FON.09.108; Meyers P A, 1987, Hematol Oncol Clin North Am, V1, P655; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; Rabbani S A, 2001, Surg Oncol Clin N Am, V10, P393; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schmitt M, 2011, EXPERT REV MOL DIAGN, V11, P617, DOI [10.1586/ERM.11.47, 10.1586/erm.11.47]; Setyono-Han B, 2005, THROMB HAEMOSTASIS, V93, P779, DOI 10.1160/TH04-11-0712; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; WANG Y, 1995, CLIN EXP METASTAS, V13, P196, DOI 10.1007/BF00132208; Wang Y, 2001, MED RES REV, V21, P146, DOI 10.1002/1098-1128(200103)21:2<146::AID-MED1004>3.0.CO;2-B; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027	50	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133592	10.1371/journal.pone.0133592	http://dx.doi.org/10.1371/journal.pone.0133592			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317203	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100010
J	in't Holt, AFV; Severin, JA; Goessens, WHF; Witt, RT; Vos, MC				in't Holt, Anne F. Voor; Severin, Juliette A.; Goessens, Wil H. F.; Witt, Rene te; Vos, Margreet C.			Instant Typing Is Essential to Detect Transmission of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEUS-MIRABILIS; EPIDEMIOLOGY; PNEUMONIAE; SURVEILLANCE; STRAINS; INFECTIONS; RESISTANCE; PATIENT; LONG	Background Infections with multidrug-resistant (MDR) microorganisms are an increasing threat to hospitalized patients. Although rapid typing of MDR microorganisms is required to apply targeted prevention measures, technical barriers often prevent this. We aimed to assess whether extended-spectrum beta-lactamase (ESBL)-producing Klebsiella species are transmitted between patients and whether routine, rapid typing is needed. Methods For 43 months, the clonality of all ESBL-producing Klebsiella isolates from patients admitted to Erasmus MC University Medical Center in Rotterdam, the Netherlands was assessed with Raman spectroscopy. A cluster was defined as n >= 2 patients who had identical isolates. Primary patients were the first patients in each cluster. Secondary patients were those identified with an isolate clonally related to the isolate of the primary patient. Results Isolates from 132 patients were analyzed. We identified 17 clusters, with 17 primary and 56 secondary patients. Fifty-nine patients had a unique isolate. Patients (n = 15) in four out of the 17 clusters were epidemiologically related. Ten of these 15 patients developed an infection. Conclusions Clonal outbreaks of ESBL-producing Klebsiella species were detected in our hospital. Theoretically, after Raman spectroscopy had detected a cluster of n >= 2, six infections in secondary patients could have been prevented. These findings demonstrate that spread of ESBL-producing Klebsiella species occurs, even in a non-outbreak setting, and underscore the need for routine rapid typing of these MDR bacteria.	[in't Holt, Anne F. Voor; Severin, Juliette A.; Goessens, Wil H. F.; Witt, Rene te; Vos, Margreet C.] Erasmus MC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vos, MC (corresponding author), Erasmus MC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	m.vos@erasmusmc.nl		Voor in 't holt, Anne/0000-0002-3560-1725	Erasmus MC University Medical Center	Erasmus MC University Medical Center	This work was supported by Erasmus MC University Medical Center funding, 2013, no grant number available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benenson S, 2013, NEONATOLOGY, V103, P155, DOI 10.1159/000343150; Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Chong Y, 2011, EUR J CLIN MICROBIOL, V30, P83, DOI 10.1007/s10096-010-1057-1; Chong Y, 2013, J MED MICROBIOL, V62, P1038, DOI 10.1099/jmm.0.059279-0; Dautzenberg MJ, 2014, EUROSURVEILLANCE, V19; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; DiPersio JR, 2005, DIAGN MICR INFEC DIS, V51, P1, DOI 10.1016/j.diagmicrobio.2004.08.001; Dutch Working Group on Preventing Infections (WIP), 2012, BIJZ RES MICR BRMO; Freeman JT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-5; Harris AD, 2007, CLIN INFECT DIS, V45, P1347, DOI 10.1086/522657; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; JARVIS WR, 1985, INFECT CONT HOSP EP, V6, P68, DOI 10.1017/S0195941700062639; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Maquelin K, 2006, J MICROBIOL METH, V64, P126, DOI 10.1016/j.mimet.2005.04.028; Nakamura T, 2012, AM J CLIN PATHOL, V137, P620, DOI 10.1309/AJCP48PDVKWQOXEZ; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Potz NAC, 2004, J ANTIMICROB CHEMOTH, V53, P545, DOI 10.1093/jac/dkh112; Severin JA, 2012, TROP MED INT HEALTH, V17, P455, DOI 10.1111/j.1365-3156.2011.02949.x; Shorr AF, 2009, CRIT CARE MED, V37, P1463, DOI 10.1097/CCM.0b013e31819ced02; Souverein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101212; te Witt R, 2013, J CLIN MICROBIOL, V51, P1434, DOI 10.1128/JCM.02101-12; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Willemse-Erix D, 2012, J CLIN MICROBIOL, V50, P1370, DOI 10.1128/JCM.05423-11; Willemse-Erix DFM, 2009, J CLIN MICROBIOL, V47, P652, DOI 10.1128/JCM.01900-08	26	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136135	10.1371/journal.pone.0136135	http://dx.doi.org/10.1371/journal.pone.0136135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317428	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100060
J	O'Flaherty, BM; Matar, CG; Wakeman, BS; Garcia, A; Wilke, CA; Courtney, CL; Moore, BB; Speck, SH				O'Flaherty, Brigid M.; Matar, Caline G.; Wakeman, Brian S.; Garcia, AnaPatricia; Wilke, Carol A.; Courtney, Cynthia L.; Moore, Bethany B.; Speck, Samuel H.			CD8(+) T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice	PLOS ONE			English	Article							IDIOPATHIC-PULMONARY-FIBROSIS; BARR-VIRUS DNA; EPITHELIAL-MESENCHYMAL TRANSITION; BRONCHOALVEOLAR LAVAGE FLUID; INDUCED LUNG FIBROSIS; MURINE GAMMAHERPESVIRUS; HERPESVIRUS-INFECTION; NEUTROPHIL ELASTASE; INTERSTITIAL PNEUMONIA; COLLAGEN DEPOSITION	Idiopathic pulmonary fibrosis (IPF), one of the most severe interstitial lung diseases, is a progressive fibrotic disorder of unknown etiology. However, there is growing appreciation for the role of viral infection in disease induction and/or progression. A small animal model of multi-organ fibrosis, which involves murine gammaherpesvirus (MHV68) infection of interferon gamma receptor deficient (IFN gamma R-/-) mice, has been utilized to model the association of gammaherpesvirus infections and lung fibrosis. Notably, several MHV68 mutants which fail to induce fibrosis have been identified. Our current study aimed to better define the role of the unique MHV68 gene, M1, in development of pulmonary fibrosis. We have previously shown that the M1 gene encodes a secreted protein which possesses superantigen-like function to drive the expansion and activation of V beta 4(+) CD8(+) T cells. Here we show that M1-dependent fibrosis is correlated with heightened levels of inflammation in the lung. We observe an M1-dependent cellular infiltrate of innate immune cells with most striking differences at 28 days-post infection. Furthermore, in the absence of M1 protein expression we observed reduced CD8(+) T cells and MHV68 epitope specific CD8(+) T cells to the lungs-despite equivalent levels of viral replication between M1 null and wild type MHV68. Notably, backcrossing the IFN gamma R-/- onto the Balb/c background, which has previously been shown to exhibit weak MHV68-driven V beta 4(+) CD8(+) T cell expansion, eliminated MHV68-induced fibrosis-further implicating the activated V beta 4(+) CD8(+) T cell population in the induction of fibrosis. We further addressed the role that CD8(+) T cells play in the induction of fibrosis by depleting CD8(+) T cells, which protected the mice from fibrotic disease. Taken together these findings are consistent with the hypothesized role of V beta 4(+) CD8(+) T cells as mediators of fibrotic disease in IFN gamma R-/- mice.	[O'Flaherty, Brigid M.; Matar, Caline G.; Wakeman, Brian S.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [O'Flaherty, Brigid M.; Matar, Caline G.; Wakeman, Brian S.; Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Garcia, AnaPatricia; Courtney, Cynthia L.] Emory Univ, Div Pathol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Wilke, Carol A.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Emory University; Emory University; Emory University; University of Michigan System; University of Michigan	Speck, SH (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019	Moore, Bethany/0000-0003-3051-745X	NIH grant [R01 AI073830]; author discretionary funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073830, R01AI117229] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); author discretionary funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NIH grant (R01 AI073830) and author discretionary funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Christensen PJ, 1999, AM J PATHOL, V155, P1773, DOI 10.1016/S0002-9440(10)65493-4; Clambey ET, 2000, J VIROL, V74, P1973, DOI 10.1128/JVI.74.4.1973-1984.2000; Coppola MA, 1999, J IMMUNOL, V163, P1481; CORSINI E, 1994, AM J RESP CELL MOL, V11, P531, DOI 10.1165/ajrcmb.11.5.7946383; Daniil Z, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-81; Dutia BM, 1997, J VIROL, V71, P4278, DOI 10.1128/JVI.71.6.4278-4283.1997; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; Egan JJ, 2011, PULM MED, V2011, DOI 10.1155/2011/240805; Evans AG, 2008, J EXP MED, V205, P669, DOI 10.1084/jem.20071135; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fireman E, 1998, EUR RESPIR J, V11, P706; Flaherty KR, 2001, AM J MED, V110, P278, DOI 10.1016/S0002-9343(00)00711-7; Flano E, 2004, J IMMUNOL, V172, P3078, DOI 10.4049/jimmunol.172.5.3078; Freeman ML, 2012, J IMMUNOL, V188, P3812, DOI 10.4049/jimmunol.1102787; Freeman ML, 2010, J VIROL, V84, P2881, DOI 10.1128/JVI.02229-09; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; HUNNINGHAKE GW, 1981, J CLIN INVEST, V68, P259, DOI 10.1172/JCI110242; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; KRADIN RL, 1986, CLIN IMMUNOL IMMUNOP, V40, P224, DOI 10.1016/0090-1229(86)90025-5; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Kropski JA, 2013, DIS MODEL MECH, V6, P9, DOI 10.1242/dmm.010736; Kropski JA, 2012, AM J PHYSIOL-LUNG C, V302, pL441, DOI 10.1152/ajplung.00335.2011; Krug LT, 2013, J VIROL, V87, P3597, DOI 10.1128/JVI.01953-12; Krug LT, 2010, AM J PATHOL, V177, P608, DOI 10.2353/ajpath.2010.091122; Lake-Bullock MHV, 1999, J LEUKOCYTE BIOL, V65, P187, DOI 10.1002/jlb.65.2.187; Lee KS, 2009, CANCER RES, V69, P5481, DOI 10.1158/0008-5472.CAN-09-0291; Liu LZ, 1999, J VIROL, V73, P9849, DOI 10.1128/JVI.73.12.9849-9857.1999; Luzina IG, 2008, J LEUKOCYTE BIOL, V83, P237, DOI 10.1189/jlb.0707504; Luzina IG, 2006, ARTHRITIS RHEUM-US, V54, P2643, DOI 10.1002/art.21950; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Manika K, 2007, SARCOIDOSIS VASC DIF, V24, P134; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Molyneaux PL, 2013, EUR RESPIR REV, V22, P376, DOI 10.1183/09059180.00000713; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Nagai S, 1999, SARCOIDOSIS VASC DIF, V16, P209; Naik Payal K, 2010, Expert Rev Respir Med, V4, P759, DOI 10.1586/ers.10.73; Nuovo GJ, 2012, MODERN PATHOL, V25, P416, DOI 10.1038/modpathol.2011.166; Obayashi Y, 1997, CHEST, V112, P1338, DOI 10.1378/chest.112.5.1338; Okazaki T, 2001, J IMMUNOL, V167, P1977, DOI 10.4049/jimmunol.167.4.1977; Paden CR, 2010, J VIROL, V84, P7214, DOI 10.1128/JVI.00133-10; Papiris SA, 2005, CHEST, V128, P2971, DOI 10.1378/chest.128.4.2971; Papiris Spyros A, 2007, J Inflamm (Lond), V4, P14, DOI 10.1186/1476-9255-4-14; Parra ER, 2007, RESPIRATION, V74, P159, DOI 10.1159/000097133; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pozharskaya VP, 2011, PROSPECTIVE LONGITUD; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sides MD, 2011, AM J RESP CELL MOL, V44, P852, DOI 10.1165/rcmb.2009-0232OC; Simas JP, 1998, J GEN VIROL, V79, P149, DOI 10.1099/0022-1317-79-1-149; Song JS, 2009, EXP LUNG RES, V35, P817, DOI 10.3109/01902140902912527; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stevenson PG, 1998, P NATL ACAD SCI USA, V95, P15565, DOI 10.1073/pnas.95.26.15565; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stoolman JS, 2011, AM J PHYSIOL-LUNG C, V300, pL274, DOI 10.1152/ajplung.00028.2010; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Tripp RA, 1997, J EXP MED, V185, P1641, DOI 10.1084/jem.185.9.1641; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Wangoo A, 1997, THORAX, V52, P888, DOI 10.1136/thx.52.10.888; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yamanouchi H, 1998, EUR RESPIR J, V11, P120, DOI 10.1183/09031936.98.11010120; Zamo A, 2005, SARCOIDOSIS VASC DIF, V22, P123	78	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135719	10.1371/journal.pone.0135719	http://dx.doi.org/10.1371/journal.pone.0135719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317335	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100043
J	Reckien, D; Flacke, J; Olazabal, M; Heidrich, O				Reckien, Diana; Flacke, Johannes; Olazabal, Marta; Heidrich, Oliver			The Influence of Drivers and Barriers on Urban Adaptation and Mitigation Plans-An Empirical Analysis of European Cities	PLOS ONE			English	Article							CLIMATE-CHANGE ADAPTATION; ADAPTIVE CAPACITY; GLOBAL CLIMATE; CHANGE POLICY; VULNERABILITY; AREAS; INFORMATION; GOVERNANCE; FRAMEWORK; KNOWLEDGE	Cities are recognised as key players in global adaptation and mitigation efforts because the majority of people live in cities. However, in Europe, which is highly urbanized and one of the most advanced regions in terms of environmental policies, there is considerable diversity in the regional distribution, ambition and scope of climate change responses. This paper explores potential factors contributing to such diversity in 200 large and medium-sized cities across 11 European countries. We statistically investigate institutional, socioeconomic, environmental and vulnerability characteristics of cities as potential drivers of or barriers to the development of urban climate change plans. Our results show that factors such as membership of climate networks, population size, GDP per capita and adaptive capacity act as drivers of mitigation and adaptation plans. By contrast, factors such as the unemployment rate, warmer summers, proximity to the coast and projected exposure to future climate impacts act as barriers. We see that, overall, it is predominantly large and prosperous cities that engage in climate planning, while vulnerable cities and those at risk of severe climate impacts in the future are less active. Our analysis suggests that climate change planning in European cities is not proactive, i.e. not significantly influenced by anticipated future impacts. Instead, we found that the current adaptive capacity of a city significantly relates to climate planning. Along with the need to further explore these relations, we see a need for more economic and institutional support for smaller and less resourceful cities and those at high risk from climate change impacts in the future.	[Reckien, Diana] Columbia Univ, Ctr Res Environm Decis, New York, NY 10027 USA; [Flacke, Johannes] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Olazabal, Marta] Basque Ctr Climate Change BC3, Bilbao, Spain; [Olazabal, Marta] Univ Cambridge, Dept Land Econ, Cambridge, England; [Heidrich, Oliver] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Columbia University; University of Twente; Basque Centre for Climate Change (BC3); University of Cambridge; Newcastle University - UK	Reckien, D (corresponding author), Columbia Univ, Ctr Res Environm Decis, New York, NY 10027 USA.	d.reckien@utwente.nl	Reckien, Diana/P-7348-2015; Olazabal, Marta/AFT-6957-2022; Flacke, Johannes/C-9941-2013; Olazabal, Marta/C-3027-2008	Reckien, Diana/0000-0002-1145-9509; Olazabal, Marta/0000-0002-3381-0654; Flacke, Johannes/0000-0001-8906-7719; Olazabal, Marta/0000-0002-3381-0654; Heidrich, Oliver/0000-0002-6581-5572	European Science Foundation [TU0902]; German Research Foundation [RE 2927/2-1]; Engineering & Physical Sciences Research Council Fellowship [EP/H003630/1]; Engineering and Physical Sciences Research Council [EP/K012398/1, EP/H003630/1] Funding Source: researchfish; EPSRC [EP/K012398/1, EP/H003630/1] Funding Source: UKRI	European Science Foundation(European Science Foundation (ESF)European Commission); German Research Foundation(German Research Foundation (DFG)); Engineering & Physical Sciences Research Council Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Research undertaken for this paper was conducted as part of the European Science Foundation funded COST Action network Integrated assessment technologies to support the sustainable development of urban areas (TU0902). D.R. was funded by the German Research Foundation (RE 2927/2-1). O.H. was funded through an Engineering & Physical Sciences Research Council Fellowship (EP/H003630/1). The authors thank the city representatives and specifically S. Scharf, J.J.-P. Hamann, H. Orru, M. Salvia, K. Oinonen, S. De Gregorio, F. Pietrapertosa, D. Geneletti, A. M. Foley, V. D'Alonzo, E. Feliu, and S. Reiter for their contributions to data gathering. The authors also thank IRPUD, TU Dortmund, and ESPON Climate-Climate Change and Territorial Effects on Regions and Local Economies in Europe for providing data from the (C) ESPON Database (2011).	Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Adu-Boateng A, 2015, CURR OPIN ENV SUST, V13, P49, DOI 10.1016/j.cosust.2015.02.001; Amundsen H, 2010, ENVIRON PLANN C, V28, P276, DOI 10.1068/c0941; [Anonymous], 2004, LOCAL ENVIRON, DOI [DOI 10.1080/1354983042000246252, 10.1080/1354983042000246252]; Archie KM, 2014, J ENVIRON MANAGE, V133, P397, DOI 10.1016/j.jenvman.2013.12.015; Baker I, 2012, LANDSCAPE URBAN PLAN, V107, P127, DOI 10.1016/j.landurbplan.2012.05.009; Betsill MM, 2004, INT STUD QUART, V48, P471, DOI 10.1111/j.0020-8833.2004.00310.x; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Biesbroek GR, 2013, REG ENVIRON CHANGE, V13, P1119, DOI 10.1007/s10113-013-0421-y; Brody SD, 2008, LANDSCAPE URBAN PLAN, V87, P33, DOI 10.1016/j.landurbplan.2008.04.003; Broto VC, 2013, GLOBAL ENVIRON CHANG, V23, P92, DOI 10.1016/j.gloenvcha.2012.07.005; Bulkeley H, 2009, URB RES S CIT CLIM C, P1; Caragliu A, 2011, J URBAN TECHNOL, V18, P65, DOI 10.1080/10630732.2011.601117; Corfee-Morlot J, 2011, CLIMATIC CHANGE, V104, P169, DOI 10.1007/s10584-010-9980-9; De Gregorio Hurtado S, 2014, IMPLICATIONS GOVERNA; Decker EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000934; Dodman D, 2011, CURR OPIN ENV SUST, V3, P121, DOI 10.1016/j.cosust.2010.12.013; EEA, 1998, EUR ENV 2 ASS COP; Engle NL, 2011, GLOBAL ENVIRON CHANG, V21, P647, DOI 10.1016/j.gloenvcha.2011.01.019; Eriksen S, 2008, CLIMATE CHANGE E SO; ESPON & IRPUD TU Dortmund University, 2011, ESPON CLIM CLIM CHAN; Eurostat, 2014, URB AUD STAT DAT 201; Eurostat, 2012, URB AUD DAT COLL 201; Eurostat, 2007, URB AUD REF GUID DAT; Ford JD, 2015, MITIG ADAPT STRAT GL, V20, P505, DOI 10.1007/s11027-013-9505-8; Fussel HM, 2007, GLOBAL ENVIRON CHANG, V17, P155, DOI 10.1016/j.gloenvcha.2006.05.002; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Garb Y, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045015; Garschagen M, 2015, CLIMATIC CHANGE, V133, P37, DOI 10.1007/s10584-013-0812-6; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Gonzalez-Eguino M, 2011, ECOL ECON, V70, P2292, DOI 10.1016/j.ecolecon.2011.05.023; Granberg M, 2007, LOCAL ENVIRON, V12, P537, DOI 10.1080/13549830701656911; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Hardoy J, 2011, CURR OPIN ENV SUST, V3, P158, DOI 10.1016/j.cosust.2011.01.004; Harvey J, 2014, PROC INST CIV ENG-U, V167, P165, DOI 10.1680/udap.14.00001; Heidrich O, 2013, CLIMATIC CHANGE, V120, P771, DOI 10.1007/s10584-013-0846-9; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hulme M, 2007, LIMITS BARRIERS ADAP; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; IPCC, 2014, CLIMATE CHANGE MITIG; Johnson CA, 2013, NAT CLIM CHANGE, V3, P537, DOI 10.1038/nclimate1912; Juhola S, 2015, MITIG ADAPT STRAT GL, V20, P99, DOI 10.1007/s11027-013-9481-z; Klein RJT, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P899; Klinenberg E., 2002, HEAT WAVE SOCIAL AUT; Kousky C, 2003, CLIM POLICY, V3, P359, DOI 10.1016/j.clipol.2003.08.002; Kriegler E, 2012, GLOBAL ENVIRON CHANG, V22, P807, DOI 10.1016/j.gloenvcha.2012.05.005; Lamb WF, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014011; Lankao PR, 2011, CURR OPIN ENV SUST, V3, P142, DOI 10.1016/j.cosust.2010.12.016; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; McEvoy D, 2006, P I CIVIL ENG-MUNIC, V159, P185, DOI 10.1680/muen.2006.159.4.185; Milfont TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103180; Millard-Ball A, 2012, J URBAN ECON, V71, P289, DOI 10.1016/j.jue.2011.12.004; Minx J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035039; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; O'Brien K, 2006, AMBIO, V35, P50, DOI 10.1579/0044-7447(2006)35[50:QCCCIV]2.0.CO;2; OECD, 2004, OECD JRC HDB PRACT D; OECD, 1994, ENV IND OECD COR SET; Olazabal M, 2014, ARE ITALIAN SPANISH; Parson EA, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045016; Patt A, 2010, MAKING CLIMATE CHANG, P369; Posey J, 2009, GLOBAL ENVIRON CHANG, V19, P482, DOI 10.1016/j.gloenvcha.2009.06.003; Pradhan NS, 2012, ROLE POLICY I LOCAL; Preston B, 2007, FRAMING VULNERABILIT; Reckien D, 2014, CLIMATIC CHANGE, V122, P331, DOI 10.1007/s10584-013-0989-8; Reckien D., 2014, UNDERSTANDING CITIES, P45; Reckien D, 2007, URBAN STUD, V44, P339, DOI 10.1080/00420980601136588; Reckien D, 2014, GLOBAL ENVIRON CHANG, V26, P1, DOI 10.1016/j.gloenvcha.2014.03.005; Reckien D, 2013, SUSTAIN SCI, V8, P159, DOI 10.1007/s11625-012-0179-z; Reckien D, 2011, ENVIRON MODEL ASSESS, V16, P465, DOI 10.1007/s10666-011-9254-6; Revi A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P535; Romero-Lankao P, 2012, GLOBAL ENVIRON CHANG, V22, P670, DOI 10.1016/j.gloenvcha.2012.04.002; Rosenzweig C, 2010, NATURE, V467, P909, DOI 10.1038/467909a; Rutland T, 2008, ENVIRON PLANN D, V26, P627, DOI 10.1068/d6907; Schreurs MA, 2007, GLOBAL ENVIRON POLIT, V7, P19, DOI 10.1162/glep.2007.7.4.19; Seto KC, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P923; Slocum R, 2004, ENVIRON PLANN A, V36, P763, DOI 10.1068/a36139; Slovic P, 2000, PERCEPTION RISK; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Stecker R., 2012, Z UMWELTPOLITIK UMWE, V2, P179; Stone B, 2012, LANDSCAPE URBAN PLAN, V107, P263, DOI 10.1016/j.landurbplan.2012.05.014; Tribbia J, 2008, ENVIRON SCI POLICY, V11, P315, DOI 10.1016/j.envsci.2008.01.003; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Wheeler S, 2008, J AM PLANN ASSOC, V74, P481, DOI 10.1080/01944360802377973	86	80	80	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135597	10.1371/journal.pone.0135597	http://dx.doi.org/10.1371/journal.pone.0135597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317420	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100036
J	Wear, MP; Kryndushkin, D; O'Meally, R; Sonnenberg, JL; Cole, RN; Shewmaker, FP				Wear, Maggie P.; Kryndushkin, Dmitry; O'Meally, Robert; Sonnenberg, Jason L.; Cole, Robert N.; Shewmaker, Frank P.			Proteins with Intrinsically Disordered Domains Are Preferentially Recruited to Polyglutamine Aggregates	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT HUNTINGTIN PROTEIN; RNA-BINDING PROTEINS; NEURODEGENERATIVE DISEASE; SACCHAROMYCES-CEREVISIAE; EXPRESSION CHANGES; UNSTRUCTURED PROTEINS; STRESS GRANULES; GENOME DATABASE; ENERGY CONTENT	Intracellular protein aggregation is the hallmark of several neurodegenerative diseases. Aggregates formed by polyglutamine (polyQ)-expanded proteins, such as Huntingtin, adopt amyloid-like structures that are resistant to denaturation. We used a novel purification strategy to isolate aggregates formed by human Huntingtin N-terminal fragments with expanded polyQ tracts from both yeast and mammalian (PC-12) cells. Using mass spectrometry we identified the protein species that are trapped within these polyQ aggregates. We found that proteins with very long intrinsically-disordered (ID) domains (>= 100 amino acids) and RNA-binding proteins were disproportionately recruited into aggregates. The removal of the ID domains from selected proteins was sufficient to eliminate their recruitment into polyQ aggregates. We also observed that several neurodegenerative disease-linked proteins were reproducibly trapped within the polyQ aggregates purified from mammalian cells. Many of these proteins have large ID domains and are found in neuronal inclusions in their respective diseases. Our study indicates that neurodegenerative disease-associated proteins are particularly vulnerable to recruitment into polyQ aggregates via their ID domains. Also, the high frequency of ID domains in RNA- binding proteins may explain why RNA-binding proteins are frequently found in pathological inclusions in various neurodegenerative diseases.	[Wear, Maggie P.; Kryndushkin, Dmitry; Shewmaker, Frank P.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [O'Meally, Robert; Cole, Robert N.] Johns Hopkins Univ, Johns Hopkins Mass Spectrometry & Prote Facil, Baltimore, MD 21218 USA; [Sonnenberg, Jason L.] Stevenson Univ, Dept Chem, Sch Sci, Stevenson, MD 21153 USA	Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Shewmaker, FP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	fshewmaker@usuhs.edu	Sonnenberg, Jason L./B-3485-2008	Sonnenberg, Jason L./0000-0003-0122-5108; Wear, Maggie/0000-0002-8581-7831	Uniformed Services University New Investigator Award [RO75QF]	Uniformed Services University New Investigator Award	This work was supported by the Uniformed Services University New Investigator Award, Grant # RO75QF.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Baxa U, 2008, CURR ALZHEIMER RES, V5, P308, DOI 10.2174/156720508784533367; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Dong JJ, 2010, NAT STRUCT MOL BIOL, V17, P1422, DOI 10.1038/nsmb.1954; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Edskes HK, 2000, P NATL ACAD SCI USA, V97, P6625, DOI 10.1073/pnas.120168697; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Fushimi K, 2011, PROTEIN CELL, V2, P141, DOI 10.1007/s13238-011-1014-5; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gourfinkel-An I, 1998, NEUROREPORT, V9, P1823, DOI 10.1097/00001756-199806010-00028; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Henshall TL, 2009, HUM MOL GENET, V18, P4830, DOI 10.1093/hmg/ddp455; Hoffner G, 2014, BRAIN SCI, V4, P91, DOI 10.3390/brainsci4010091; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Ishiura H, 2012, AM J HUM GENET, V91, P320, DOI 10.1016/j.ajhg.2012.07.014; Ivanyi-Nagy R, 2005, CELL MOL LIFE SCI, V62, P1409, DOI 10.1007/s00018-005-5100-9; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kawamoto Y, 2005, ACTA NEUROPATHOL, V110, P203, DOI 10.1007/s00401-005-1039-z; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kim WY, 2005, MOL CELL NEUROSCI, V29, P536, DOI 10.1016/j.mcn.2005.04.005; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kryndushkin D, 2011, PROTEIN CELL; Kryndushkin D, 2013, PRION, V7, P464, DOI 10.4161/pri.27503; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Mizuno Y, 2006, J NEUROL SCI, V249, P13, DOI 10.1016/j.jns.2006.05.060; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Newman JR, 2006, NATURE, V441; Niikura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101080; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; O'Rourke JG, 2013, CELL REP, V4, P362, DOI 10.1016/j.celrep.2013.06.034; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ramirez A, 2014, HUM MOL GENET, V23, P6644, DOI 10.1093/hmg/ddu372; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Shi BX, 2014, INT J MOL SCI, V15, P22918, DOI 10.3390/ijms151222918; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vendruscolo M, 2014, COLD SPRING HARBOR P, V3; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wiederhold E, 2010, MOL CELL PROTEOMICS, V9, P431, DOI 10.1074/mcp.R900002-MCP200; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093891; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Yao J, 2014, MOL CELL NEUROSCI, V63, P96, DOI 10.1016/j.mcn.2014.10.003; Zainelli GM, 2005, J NEUROPATH EXP NEUR, V64, P58, DOI 10.1093/jnen/64.1.58; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhou L., 2014, J BUS RES, V1, P1, DOI DOI 10.1007/S12035-014-8908-1; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	125	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136362	10.1371/journal.pone.0136362	http://dx.doi.org/10.1371/journal.pone.0136362			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317359	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100075
J	Western, D; Mose, VN; Worden, J; Maitumo, D				Western, David; Mose, Victor N.; Worden, Jeffrey; Maitumo, David			Predicting Extreme Droughts in Savannah Africa: A Comparison of Proxy and Direct Measures in Detecting Biomass Fluctuations, Trends and Their Causes	PLOS ONE			English	Article							AMBOSELI NATIONAL-PARK; NOAA-AVHRR; HERBACEOUS BIOMASS; VEGETATION COVER; FORAGE QUALITY; FOOD SECURITY; NDVI; RAINFALL; INFORMATION; PERCEPTIONS	We monitored pasture biomass on 20 permanent plots over 35 years to gauge the reliability of rainfall and NDVI as proxy measures of forage shortfalls in a savannah ecosystem. Both proxies are reliable indicators of pasture biomass at the onset of dry periods but fail to predict shortfalls in prolonged dry spells. In contrast, grazing pressure predicts pasture deficits with a high degree of accuracy. Large herbivores play a primary role in determining the severity of pasture deficits and variation across habitats. Grazing pressure also explains oscillations in plant biomass unrelated to rainfall. Plant biomass has declined steadily and biomass per unit of rainfall has fallen by a third, corresponding to a doubling in grazing intensity over the study period. The rising probability of forage deficits fits local pastoral perceptions of an increasing frequency of extreme shortfalls. The decline in forage is linked to sedentarization, range loss and herbivore compression into drought refuges, rather than climate change. The results show that the decline in rangeland productivity and increasing frequency of pasture shortfalls can be ameliorated by better husbandry practices and reinforces the need for ground monitoring to complement remote sensing in forecasting pasture shortfalls.	[Western, David; Mose, Victor N.; Worden, Jeffrey; Maitumo, David] African Conservat Ctr, Nairobi 1528900509, Kenya		Mose, VN (corresponding author), African Conservat Ctr, Nairobi 1528900509, Kenya.	vnmose@gmail.com	Mose, Victor N./AAT-3677-2021	Mose, Victor N./0000-0001-6859-4667	Ford Foundation; Wildlife Conservation International; Liz Claiborne Ortenberg Foundation; Amboseli Conservation Program (ACP) long term monitoring; long-term Amboseli Conservation Program	Ford Foundation; Wildlife Conservation International; Liz Claiborne Ortenberg Foundation; Amboseli Conservation Program (ACP) long term monitoring; long-term Amboseli Conservation Program	This work was supported by Ford Foundation (www.fordfoundation.org/), funding Amboseli Conservation Program (ACP) long term monitoring; Wildlife Conservation International (www. wcs.org/), funding long-term Amboseli Conservation Program; and Liz Claiborne Ortenberg Foundation (www.lcaof.org), funding field work by the Amboseli Conservation Program-African Conservation Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2002, AFR J ECOL, V40, P248, DOI 10.1046/j.1365-2028.2002.00366.x; [Anonymous], 2014, R LANG ENV STAT COMP; Arzani H, 2004, J RANGE MANAGE, V57, P624, DOI 10.2307/4004019; Baro M, 2006, ANNU REV ANTHROPOL, V35, P521, DOI 10.1146/annurev.anthro.35.081705.123224; Bollig M, 1999, HUM ECOL, V27, P493, DOI 10.1023/A:1018783725398; Box G.E., 2011, TIME SERIES ANAL FOR; Campbell BM, 2006, ECOL ECON, V60, P75, DOI 10.1016/j.ecolecon.2006.05.010; Campbell D.J., 2003, 19 LUCID ILRI; Carabine E., 2014, RESILIENCE RANGELAND; De Leeuw P.N., 1990, CONCEPT RANGELAND CA; Devereux S, 2009, FOOD SECUR, V1, P25, DOI 10.1007/s12571-008-0005-8; Dobson A. J, 2002, INTRO GEN LINEAR MOD; DRACUP JA, 1980, WATER RESOUR RES, V16, P297, DOI 10.1029/WR016i002p00297; Dunne T, 2011, J ARID ENVIRON, V75, P58, DOI 10.1016/j.jaridenv.2010.09.001; Eisfelder C, 2012, INT J REMOTE SENS, V33, P2937, DOI 10.1080/01431161.2011.620034; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Fox J, 2002, APPEND R S PLUS COMP; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Funk C, 2010, SATELLITE RAINFALL APPLICATIONS FOR SURFACE HYDROLOGY, P295, DOI 10.1007/978-90-481-2915-7_17; Glantz M. H., 1988, DROUGHT HUNGER AFRIC; Groom RJ, 2013, RANGELAND ECOL MANAG, V66, P1, DOI 10.2111/REM-D-11-00021.1; Heim RR, 2002, B AM METEOROL SOC, V83, P1149, DOI 10.1175/1520-0477-83.8.1149; Hellden U, 2008, GLOBAL PLANET CHANGE, V64, P169, DOI 10.1016/j.gloplacha.2008.10.006; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Hunt ER, 2006, RANGELAND ECOL MANAG, V59, P11, DOI 10.2111/04-177R.1; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; Ji L, 2003, REMOTE SENS ENVIRON, V87, P85, DOI 10.1016/S0034-4257(03)00174-3; Keyantash J, 2002, B AM METEOROL SOC, V83, P1167, DOI 10.1175/1520-0477(2002)083&lt;1191:TQODAE&gt;2.3.CO;2; Khalil HK, 2002, NONLINEAR SYSTEMS, V3; Le Houerou HN, 1989, ECOL STUD, P75; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lin D., 2012, VIF VIF REGRESSION F; Liu WT, 2001, INT J REMOTE SENS, V22, P3483, DOI 10.1080/01431160010006430; Lu H, 2003, REMOTE SENS ENVIRON, V86, P1, DOI 10.1016/S0034-4257(03)00054-3; Madden EA, 1933, NZ J AGR, V46, P179; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; Meroni M, 2014, REMOTE SENS ENVIRON, V142, P57, DOI 10.1016/j.rse.2013.11.012; Milich L, 2000, INT J REMOTE SENS, V21, P235, DOI 10.1080/014311600210812; Mose VN, 2013, ECOL MODEL, V254, P43, DOI 10.1016/j.ecolmodel.2013.01.016; Mutanga O, 2004, REMOTE SENS ENVIRON, V90, P104, DOI 10.1016/j.rse.2003.12.004; Niemeyer S., 2008, OPTIONS MEDITERRAN A, V80, P267, DOI DOI 10.1017/CBO9781107415324.004; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; OCONNOR TG, 1994, J APPL ECOL, V31, P155, DOI 10.2307/2404608; Oesterheld M, 1998, ECOL APPL, V8, P207, DOI 10.1890/1051-0761(1998)008[0207:RBNASD]2.0.CO;2; Okello MM, 2008, J ARID ENVIRON, V72, P2179, DOI 10.1016/j.jaridenv.2008.07.008; Palmer WC, 1965, 45 WEATH BUR DEP COM; Peters AJ, 2002, PHOTOGRAMM ENG REM S, V68, P71; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pinheiro J., 2014, NLME LINEAR NONLINEA, V3, P1; Pinstrup-Andersen P, 1994, INT FOOD POLICY RES; PITT MD, 1986, J RANGE MANAGE, V39, P175, DOI 10.2307/3899293; PRINCE SD, 1986, INT J REMOTE SENS, V7, P1555, DOI 10.1080/01431168608948953; Purevdorj T, 1998, INT J REMOTE SENS, V19, P3519, DOI 10.1080/014311698213795; Qi JG, 2002, INT GEOSCI REMOTE SE, P2000, DOI 10.1109/IGARSS.2002.1026426; Samimi C., 2004, GeoJournal, V59, P177, DOI 10.1023/B:GEJO.0000026688.74589.58; Sandford S., 1978, P S DROUGHT BOTSW JU, P33; Sannier CAD, 2002, INT J REMOTE SENS, V23, P71, DOI 10.1080/01431160010006863; Slegers MFW, 2008, J ARID ENVIRON, V72, P2106, DOI 10.1016/j.jaridenv.2008.06.011; Smith RJ, 2009, NATURE, V462, P280, DOI 10.1038/462280a; van de Koppel J, 2000, OIKOS, V90, P253, DOI 10.1034/j.1600-0706.2000.900205.x; Verdin J, 2005, PHILOS T R SOC B, V360, P2155, DOI 10.1098/rstb.2005.1754; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Vogel C, 2006, CLIM RES, V33, P111, DOI 10.3354/cr033111; Wessels KJ, 2006, INT J REMOTE SENS, V27, P951, DOI 10.1080/01431160500169098; Western D, 2004, AFR J ECOL, V42, P111, DOI 10.1111/j.1365-2028.2004.00506.x; WESTERN D, 1984, AFR J ECOL, V22, P229, DOI 10.1111/j.1365-2028.1984.tb00699.x; Western D., 2009, BETTER GRAZING PRACT; Western D., 2003, ENV CHANGE VULNERABI; Western D., 1973, STRUCTURE DYNAMICS C; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; Western D, 2007, AFR J ECOL, V45, P302, DOI 10.1111/j.1365-2028.2006.00710.x; Western D, 2009, BIOL CONSERV, V142, P2538, DOI 10.1016/j.biocon.2009.05.025; Whitman WC, 1954, ECOLOGY JSTOR, P431; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Worden JS, 2007, FRAGMENTATION SETTLE; Wylie B. K., 1992, Geocarto International, V7, P79, DOI 10.1080/10106049209354355; WYLIE BK, 1995, J RANGE MANAGE, V48, P159, DOI 10.2307/4002804; Xu DD, 2014, REMOTE SENS ENVIRON, V142, P33, DOI 10.1016/j.rse.2013.11.017	79	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136516	10.1371/journal.pone.0136516	http://dx.doi.org/10.1371/journal.pone.0136516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317512	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100093
J	Xu, YD; Deng, XL; Han, Y; Zhou, LX; He, WQ; Chen, SB; Nong, LB; Huang, H; Zhang, Y; Yu, TO; Li, YM; Liu, XQ				Xu, Yuanda; Deng, Xilong; Han, Yun; Zhou, Lixin; He, Weiqun; Chen, Sibei; Nong, Lingbo; Huang, Huang; Zhang, Yan; Yu, Tieou; Li, Yimin; Liu, Xiaoqing			A Multicenter Retrospective Review of Prone Position Ventilation (PPV) in Treatment of Severe Human H7N9 Avian Flu	PLOS ONE			English	Article								Background Patients with H7N9 avian flu concurrent with severe acute respiratory distress syndrome (ARDS) usually have a poor clinical outcome. Prone position ventilation (PPV) has been shown to improve the prognosis of patients with severe ARDS. This study explored the effects of PPV on the respiratory and circulatory mechanics of H7N9-infected patients with severe ARDS. Methods Individuals admitted to four hospitals designated for H7N9 patients in Guangdong province were treated with PPV, and their clinical data were recorded before and after receiving PPV. Results Six of 20 critically ill patients in the ICU received PPV. After treatment with 35 PPV sessions, the oxygenation index (OI) values of the six patients when measured post-PPV and post-supine position ventilation (SPV) were significantly higher than those measured pre-PPV (P < 0.05). The six patients showed no significant differences in their values for respiratory rate (RR), peak inspiratory pressure (PIP), tidal volume (TV) or arterial partial pressure of carbon dioxide (PaCO2) when compared pre-PPV, post-PPV, and post-SPV. Additionally, there were no significant differences in the mean values for arterial pressure (MAP), cardiac index (CI), central venous pressure (CVP), heart rate (HR), lactic acid (LAC) levels or the doses of norepinephrine (NE) administered when compared pre-PPV, post-PPV, and post-SPV. Conclusion PPV provided improved oxygenation that was sustained after returning to a supine position, and resulted in decreased carbon dioxide retention. PPV can thus serve as an alternative lung protective ventilation strategy for use in patients with H7N9 avian flu concurrent with severe ARDS.	[Xu, Yuanda; He, Weiqun; Chen, Sibei; Nong, Lingbo; Li, Yimin; Liu, Xiaoqing] Guangzhou Med Univ, Dept Crit Care Med, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China; [Deng, Xilong; Huang, Huang] Guangzhou Eighth Peoples Hosp, Dept Crit Care Med, Guangzhou 510060, Guangdong, Peoples R China; [Han, Yun; Zhang, Yan] Guangdong Hosp Tradit Chinese Med, Dept Crit Care Med, Fangcun Branch, Guangzhou 510360, Guangdong, Peoples R China; [Zhou, Lixin; Yu, Tieou] Foshan First Peoples Hosp, Dept Crit Care Med, Foshan 528000, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou University of Chinese Medicine	Li, YM (corresponding author), Guangzhou Med Univ, Dept Crit Care Med, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.	dryiminli@vip.163.com; lxq1118@126.com	Zhou, Li/GSE-4531-2022					[Anonymous], CHINESE J CLIN RATIO; Charron C, 2011, CRIT CARE, V15, DOI 10.1186/cc10324; Chiumello D, 2006, CRIT CARE, V10, DOI 10.1186/cc4933; Diaz JV, 2010, CRIT CARE MED, V38, P1644, DOI 10.1097/CCM.0b013e3181e795ee; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hay AJ, 2013, LANCET, V381, P2230, DOI 10.1016/S0140-6736(13)61209-X; Hering R, 2001, ANESTH ANALG, V92, P1226, DOI 10.1097/00000539-200105000-00027; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; Liu L, 2005, CHINESE J ANESTHESIO, V9, P20; Mure M, 2000, J APPL PHYSIOL, V88, P1076, DOI 10.1152/jappl.2000.88.3.1076; National Health and Family Planning Commission of the People's Republic of China, 2014, INFECT DIS INFORM, V01, P1; Pelosi P, 1998, AM J RESP CRIT CARE, V157, P387, DOI 10.1164/ajrccm.157.2.97-04023; PIEHL MA, 1976, CRIT CARE MED, V4, P13, DOI 10.1097/00003246-197601000-00003; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; The Chinese Medical Association Society of critical care medicine, 2007, CHINESE J INTERNAL M, V5, P430; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Zhan HQ, 2014, CAPITAL MED, V12, P52	18	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136520	10.1371/journal.pone.0136520	http://dx.doi.org/10.1371/journal.pone.0136520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317621	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100094
J	Ye, J; Lou, LX; Jin, K; Xu, YF; Ye, X; Moss, T; McBain, H				Ye, Juan; Lou, Lixia; Jin, Kai; Xu, Yufeng; Ye, Xin; Moss, Timothy; McBain, Hayley			Vision-Related Quality of Life and Appearance Concerns Are Associated with Anxiety and Depression after Eye Enucleation: A Cross-Sectional Study	PLOS ONE			English	Article							PROSTHESIS; PREVALENCE; DISORDERS; HEALTH; IMPACT	Aims To investigate the association of demographic, clinical and psychosocial variables with levels of anxiety and depression in participants wearing an ocular prosthesis after eye enucleation. Methods This cross-sectional study included 195 participants with an enucleated eye who were attending an ophthalmic clinic for prosthetic rehabilitation between July and November 2014. Demographic and clinical data, and self-reported feelings of shame, sadness and anger were collected. Participants also completed the National Eye Institute Visual Function Questionnaire, the Facial Appearance subscale of the Negative Physical Self Scale, and the Hospital Anxiety and Depression Scale. Regression models were used to identify the factors associated with anxiety and depression. Results The proportion of participants with clinical anxiety was 11.8% and clinical depression 13.8%. More anxiety and depression were associated with poorer vision-related quality of life and greater levels of appearance concerns. Younger age was related to greater levels of anxiety. Less educated participants and those feeling more angry about losing an eye are more prone to experience depression. Clinical variables were unrelated to anxiety or depression. Conclusions Anxiety and depression are more prevalent in eye-enucleated patients than the general population, which brings up the issues of psychiatric support in these patients. Psychosocial rather than clinical characteristics were associated with anxiety and depression. Longitudinal studies need to be conducted to further elucidate the direction of causality before interventions to improve mood states are developed.	[Ye, Juan; Lou, Lixia; Jin, Kai; Xu, Yufeng; Ye, Xin] Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Moss, Timothy] Univ W England, Fac Hlth & Life Sci, Ctr Appearance Res, Bristol BS16 1QY, Avon, England; [McBain, Hayley] City Univ London, Sch Hlth Sci, London EC1V 0HB, England	Zhejiang University; University of West England; City University London	Ye, J (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	yejuan@zju.edu.cn	Jin, Kai/S-9997-2019; Moss, Timothy/A-3501-2014	Moss, Timothy/0000-0003-0543-6228	Natural Science Foundation of China [81070756]; National "Twelfth Five-Year" Plan for Science & Technology Support of China [2012BAI08B01]; Program for New Century Excellent Talents in University, China [NCET-11-0161]; Zhejiang Provincial Program for Cultivation of High-Level Innovative Health Talents; Specialized Key Science & Technology Foundation of Zhejiang Provincial S T Department [2012C13023-2]; Zhejiang Provincial Key Project of Medical and Health [2011ZDA014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support of China; Program for New Century Excellent Talents in University, China(Program for New Century Excellent Talents in University (NCET)); Zhejiang Provincial Program for Cultivation of High-Level Innovative Health Talents; Specialized Key Science & Technology Foundation of Zhejiang Provincial S T Department; Zhejiang Provincial Key Project of Medical and Health	This work was funded by the following: 1. Natural Science Foundation of China (No.81070756); 2. National "Twelfth Five-Year" Plan for Science & Technology Support of China (No. 2012BAI08B01); 3. Program for New Century Excellent Talents in University, China (No. NCET-11-0161); 4. Zhejiang Provincial Program for Cultivation of High-Level Innovative Health Talents; 5. The Specialized Key Science & Technology Foundation of Zhejiang Provincial S & T Department (No. 2012C13023-2); and 6. Zhejiang Provincial Key Project of Medical and Health (No. 2011ZDA014). The author who received the funding is JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2010, AM J OPHTHALMOL, V149, P1005, DOI 10.1016/j.ajo.2009.12.036; [Anonymous], SPSS BAS 10 0 APPL G; Bashour M, 2007, OPHTHAL PLAST RECONS, V23, P52, DOI 10.1097/IOP.0b013e31802dd7dc; Chan CWS, 2009, BRIT J OPHTHALMOL, V93, P1431, DOI 10.1136/bjo.2009.158428; Chen FS, 2013, PSYCHOL SCI, V24, P2254, DOI 10.1177/0956797613491968; Chen Hong, 2006, Body Image, V3, P401, DOI 10.1016/j.bodyim.2006.07.005; Cheng GY, 2008, EYE, V22, P1404, DOI 10.1038/sj.eye.6702919; Chin Kimberly, 2006, Optometry, V77, P71, DOI 10.1016/j.optm.2005.12.012; Clarke A, 2003, EYE, V17, P35, DOI 10.1038/sj.eye.6700234; Coday MP, 2002, OPHTHALMIC PLAST REC, V18, P56, DOI 10.1097/00002341-200201000-00009; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; GAMBA A, 1992, HEAD NECK-J SCI SPEC, V14, P218, DOI 10.1002/hed.2880140309; Gerrits MMJG, 2012, PAIN, V153, P429, DOI 10.1016/j.pain.2011.11.001; Goiato MC, 2013, INT J ORAL MAX SURG, V42, P113, DOI 10.1016/j.ijom.2012.05.028; Hirneiss C, 2009, ORBIT, V28, P332, DOI 10.3109/01676830903104702; Hua W., 2013, BUYING BEAUTY COSMET; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Kondo T, 2013, OPHTHAL PLAST RECONS, V29, P51, DOI 10.1097/IOP.0b013e318275b754; Leung C, 1993, INT J PSYCHOSOMATICS; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; McBain HB, 2014, BRIT J OPHTHALMOL, V98, P550, DOI 10.1136/bjophthalmol-2013-304220; McBain HB, 2014, ORBIT-ABINGDON, V33, P39, DOI 10.3109/01676830.2013.851251; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Parslow RA, 2000, AUST NZ J PSYCHIAT, V34, P997, DOI 10.1080/000486700276; Rasmussen MLR, 2012, ACTA OPHTHALMOL, V90, P435, DOI 10.1111/j.1755-3768.2010.02092.x; Shen Y, 2009, PSYCHOSIS; Soros P, 2003, NEUROLOGY, V60, P1542, DOI 10.1212/01.WNL.0000059547.68899.F5; Wang JM, 2012, OPHTHAL PLAST RECONS, V28, P324, DOI 10.1097/IOP.0b013e31825238c9; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; Watts J, 2004, LANCET, V363, P958, DOI 10.1016/S0140-6736(04)15832-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136460	10.1371/journal.pone.0136460	http://dx.doi.org/10.1371/journal.pone.0136460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317860	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100088
J	Zhang, L; Li, M; Wu, N; Chen, YH				Zhang, Li; Li, Meng; Wu, Ning; Chen, Yuheng			Time Trends in Epidemiologic Characteristics and Imaging Features of Lung Adenocarcinoma: A Population Study of 21,113 Cases in China	PLOS ONE			English	Article							SUBSOLID PULMONARY NODULES; IASLC/ATS/ERS CLASSIFICATION; AIR-POLLUTION; CANCER; TOBACCO; WOMEN; NITROSAMINES; ASSOCIATION; CARCINOGENS; MORTALITY	Objectives This study aims to describe time trends of epidemiologic characteristics and imaging features over 14 years among histologically confirmed lung adenocarcinoma (ADC) in China and to discuss the possible reasons for these changes. Materials and Methods Data of 21,113 pathologically confirmed lung cancer patients from January 1999 to December 2012 were analyzed retrospectively. Preoperative high-resolution computer tomography (HRCT) images were available and reviewed in 5,439 lung ADC patients since 2005. Time trends of the ADC proportion of lung cancer cases, gender distribution, age at diagnosis, the proportion of early-stage ADC and imaging features were investigated. Results The proportion of ADC increased during the 14 years (P = 0.000). The ratio of female to male ADC cases was higher than both squamous cell carcinoma (SQCC) and total lung cancer cases (P = 0.000). The median age at diagnosis of ADC patients was younger than that of both SQCC and total lung cancer during the 14 years (P = 0.000). The proportion of age group 45-59 years increased in total lung cancer cases (P = 0.000). When stratified by lung cancer histopathologic subtypes, this trend was also observed in ADC (P = 0.001) and SQCC (P = 0.007). The proportion of early-stage cases of ADC increased from 2008 to 2012 (P < 0.001). The proportion of subsolid nodules (SSN) in ADC increased (P = 0.001) from 2005 to 2012. Conclusion The data suggests that the proportion of ADC increased from 1999 to 2012 especially in middle-aged, female patients; early-stage ADC and SSN on HRCT images gradually increased, which may have been caused by a change in smoking habits and increased application of HRCT.	[Zhang, Li; Li, Meng; Wu, Ning] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China; [Wu, Ning] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, PET CT Ctr, Beijing 100730, Peoples R China; [Chen, Yuheng] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Canc Fdn China, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Wu, N (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China.	cjr.wuning@vip.163.com	meng, li/GVT-2063-2022					Agudo A, 2000, INT J CANCER, V88, P820, DOI 10.1002/1097-0215(20001201)88:5&lt;820::AID-IJC21&gt;3.0.CO;2-J; ALAVANJA MCR, 1992, AM J EPIDEMIOL, V136, P623, DOI 10.1093/oxfordjournals.aje.a116542; Burns DM, 2011, CANCER CAUSE CONTROL, V22, P13, DOI 10.1007/s10552-010-9660-0; Carter D, 2007, LUNG CANCER, V56, P193, DOI 10.1016/j.lungcan.2006.12.001; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Chen YC, 2004, CANCER-AM CANCER SOC, V101, P1428, DOI 10.1002/cncr.20538; Chiou HL, 2003, CANCER, V97, P1558, DOI 10.1002/cncr.11191; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Clement-Duchene C, 2010, LUNG CANCER, V67, P144, DOI 10.1016/j.lungcan.2009.04.005; DAVIS BR, 1975, BRIT J CANCER, V31, P469, DOI 10.1038/bjc.1975.87; De Stefani E, 2002, LUNG CANCER-J IASLC, V35, P43, DOI 10.1016/S0169-5002(01)00281-1; Felix L, 2011, EUR J RADIOL, V77, P410, DOI 10.1016/j.ejrad.2009.09.008; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Gu J, 2013, J SURG ONCOL, V107, P474, DOI 10.1002/jso.23259; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; He J., 2012, CHINESE CANCER REGIS; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; HOFFMANN D, 1994, J TOXICOL ENV HEALTH, V41, P1, DOI 10.1080/15287399409531825; IARC, 2008, CANC INCIDENCE 5 CON, VIX, P1; Jia X, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P332; Jiang XH, 2012, LUNG CANCER, V78, P16, DOI 10.1016/j.lungcan.2012.06.002; Keith C. H., 1960, J COLL SCI IMP U TOK, V15, P340; Matsuguma H, 2013, CHEST, V143, P436, DOI 10.1378/chest.11-3306; Metayer C, 2002, LUNG CANCER, V35, P111, DOI 10.1016/S0169-5002(01)00412-3; National Cancer Institute, THE SEER CANCER STAT, P28; Okazaki I, 2014, ANTICANCER RES, V34, P5229; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Rachtan J, 2002, LUNG CANCER-J IASLC, V35, P129, DOI 10.1016/S0169-5002(01)00330-0; Ringer G, 2005, CLIN LUNG CANCER, V7, P180, DOI 10.3816/CLC.2005.n.033; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Shen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096911; The New Age Group Classification of Human Being, 2005, MODERN HEALTH, V9, P16; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; Travis WD, 2004, CLASSIFICATION OF TU; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; [王冬梅 Wang Dongmei], 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P1446; Woo T, 2012, PATHOL INT, V62, P785, DOI 10.1111/pin.12016; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; ZHENG TZ, 1994, CANCER, V74, P1556, DOI 10.1002/1097-0142(19940901)74:5<1556::AID-CNCR2820740511>3.0.CO;2-0; Zhou BS, 2000, ONCOL REP, V7, P1253	45	17	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136727	10.1371/journal.pone.0136727	http://dx.doi.org/10.1371/journal.pone.0136727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317971	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100129
J	David, GK; Wilson, RS				David, Gwendolyn Kim; Wilson, Robbie Stuart			Cooperation Improves Success during Intergroup Competition: An Analysis Using Data from Professional Soccer Tournaments	PLOS ONE			English	Article							GROUP SELECTION; EVOLUTION; ALTRUISM; CULTURE	The benefit mutually gained by cooperators is considered the ultimate explanation for why cooperation evolved among non-relatives. During intergroup competition, cooperative behaviours within groups that provide a competitive edge over their opposition should be favoured by selection, particularly in lethal human warfare. Aside from forming larger groups, three other ways that individuals within a group can cooperate to improve their chances of gaining a mutual benefit are: (i) greater networking, (ii) contributing more effort, and (iii) dividing labour. Greater cooperation is expected to increase the chances of gaining a group benefit by improving proficiency in the tasks critical to success-yet empirical tests of this prediction using real-world cases are absent. In this study, we used data derived from 12 international and professional soccer competitions to test the predictions that: 1) greater levels of cooperative behaviour are associated with winning group contests, 2) the three forms of cooperation differ in relative importance for winning matches, 3) competition and tournament-type affect the levels of cooperation and shooting proficiency in matches, and 4) greater levels of networking behaviour are associated with increased proficiency in the most critical task linked with winning success in soccer-shooting at goal. Winners were best predicted by higher shooting proficiency, followed by greater frequencies of networking interactions within a team but unexpectedly, fewer networking partners and less division of labour. Although significant variation was detected across competitions and tournament-types, greater levels of networking behaviour were consistently associated with increased proficiency in shooting at goal, which in turn was linked with winning success. This study empirically supports the idea that intergroup competition can favour cooperation among non-relatives.	[David, Gwendolyn Kim; Wilson, Robbie Stuart] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia	University of Queensland	Wilson, RS (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia.	r.wilson@uq.edu.au	David, Gwendolyn/M-1703-2018	David, Gwendolyn/0000-0002-8422-9093; Wilson, Robbie/0000-0002-0116-5427	Australian Postgraduate Award; University of Queensland Graduate School International Travel Award	Australian Postgraduate Award(Australian Government); University of Queensland Graduate School International Travel Award	This work was supported by the Australian Postgraduate Award and the University of Queensland Graduate School International Travel Award.	Bowles S, 2012, SCIENCE, V336, P876, DOI 10.1126/science.1217336; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Boyd R, 2009, PHILOS T R SOC B, V364, P3281, DOI 10.1098/rstb.2009.0134; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; Calcott B, 2008, BIOL PHILOS, V23, P179, DOI 10.1007/s10539-007-9095-5; D'Orazio AE, 2008, J THEOR BIOL, V250, P449, DOI 10.1016/j.jtbi.2007.09.040; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2006, COGN SYST RES, V7, P220, DOI 10.1016/j.cogsys.2005.11.010; Kline R.B., 2011, PRINCIPLES PRACTICE; Leimar O, 2010, PHILOS T R SOC B, V365, P2619, DOI 10.1098/rstb.2010.0116; Muthen L.K., 2010, MPLUS USERS GUIDE; Roberts ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022377; Rotte R, 2003, DEFENCE PEACE ECON, V14, P175, DOI 10.1080/1024269022000000868; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Streiner DL, 2006, CAN J PSYCHIAT, V51, P317, DOI 10.1177/070674370605100507; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Whitehead H., 2008, ANAL ANIMAL SOC; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	23	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136503	10.1371/journal.pone.0136503	http://dx.doi.org/10.1371/journal.pone.0136503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313929	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000064
J	Hassegawa, M; Havreljuk, F; Ouimet, R; Auty, D; Pothier, D; Achim, A				Hassegawa, Mariana; Havreljuk, Filip; Ouimet, Rock; Auty, David; Pothier, David; Achim, Alexis			Large-Scale Variations in Lumber Value Recovery of Yellow Birch and Sugar Maple in Quebec, Canada	PLOS ONE			English	Article							HAUT-SAINT-LAURENT; DIAMETER-LIMIT; WOOD QUALITY; STRUCTURAL DIVERSITY; REGRESSION TREES; HARDWOOD FORESTS; NEW-BRUNSWICK; BASAL AREA; OLD-GROWTH; SOIL	Silvicultural restoration measures have been implemented in the northern hardwoods forests of southern Quebec, Canada, but their financial applicability is often hampered by the depleted state of the resource. To help identify sites most suited for the production of high quality timber, where the potential return on silvicultural investments should be the highest, this study assessed the impact of stand and site characteristics on timber quality in sugar maple (Acer saccharum Marsh.) and yellow birch (Betula alleghaniensis Britt.). For this purpose, lumber value recovery (LVR), an estimate of the summed value of boards contained in a unit volume of round wood, was used as an indicator of timber quality. Predictions of LVR were made for yellow birch and sugar maple trees contained in a network of more than 22000 temporary sample plots across the Province. Next, stand-level variables were selected and models to predict LVR were built using the boosted regression trees method. Finally, the occurrence of spatial clusters was verified by a hotspot analysis. Results showed that in both species LVR was positively correlated with the stand age and structural diversity index, and negatively correlated with the number of merchantable stems. Yellow birch had higher LVR in areas with shallower soils, whereas sugar maple had higher LVR in regions with deeper soils. The hotspot analysis indicated that clusters of high and low LVR exist across the province for both species. Although it remains uncertain to what extent the variability of LVR may result from variations in past management practices or in inherent site quality, we argue that efforts to produce high quality timber should be prioritized in sites where LVR is predicted to be the highest.	[Hassegawa, Mariana; Auty, David; Pothier, David; Achim, Alexis] Univ Laval, Dept Wood & Forest Sci, Quebec City, PQ, Canada; [Havreljuk, Filip; Ouimet, Rock] Minist Forests Wildlife & Pk, Forest Res Div, Quebec City, PQ, Canada	Laval University	Hassegawa, M (corresponding author), Univ Laval, Dept Wood & Forest Sci, Quebec City, PQ, Canada.	mariana.hassegawa.1@ulaval.ca	Ouimet/AAF-1773-2020	Ouimet, Rock/0000-0003-1282-2493; Hassegawa, Mariana/0000-0002-2215-9093; Achim, Alexis/0000-0003-0118-1651; Havreljuk, Filip/0000-0003-1436-8730; Pothier, David/0000-0001-6259-0470	Fonds de recherche du Quebec - Nature et Technologie [2010-FT-134070]	Fonds de recherche du Quebec - Nature et Technologie	Funding for this study was provided by the Fonds de recherche du Quebec - Nature et Technologie (http://www.frqnt.gouv.qc.ca/), grant number 2010-FT-134070. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeare S, 2009, COMP BOOSTED REGRESS; Alqadi KA, 2014, ENVIRON EARTH SCI, V71, P2309, DOI 10.1007/s12665-013-2632-4; Amoroso MM, 2006, CAN J FOREST RES, V36, P1484, DOI 10.1139/X06-042; [Anonymous], 2014, R LANG ENV STAT COMP; Auty D, 2014, CAN J FOREST RES, V44, P638, DOI 10.1139/cjfr-2013-0500; Barrette J, 2012, ANN FOREST SCI, V69, P603, DOI 10.1007/s13595-011-0178-8; Bedard S., 2002, EFFETS REELS COUPES; Berger J. P, 2008, NORME STRATIFICATION; Berger J-P, 2004, QUEBEC GUIDE RECONNA; Boulet B., 2007, DEFAUTS INDICES CARI; Briggs D.G., 1986, DOUGLAS FIR STAND MA, P108; Briggs D, 2010, J FOREST, V108, P174; BRISSON J, 1988, CAN J BOT, V66, P1192, DOI 10.1139/b88-170; Carslaw DC, 2009, ATMOS ENVIRON, V43, P3563, DOI 10.1016/j.atmosenv.2009.04.001; Carty DM, 2011, ANAL BOOSTED REGRESS; Clement C, 2005, FOREST PROD J, V55, P71; Cockwell M, 2014, FOREST PROD J, V64, P250, DOI 10.13073/FPJ-D-14-00026; Cogliastro A, 1997, FOREST ECOL MANAG, V96, P49, DOI 10.1016/S0378-1127(97)00042-X; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; Delisle-Boulianne S, 2014, FORESTRY, V87, P607, DOI 10.1093/forestry/cpu034; Deluca T, 2009, NORTH J APPL FOR, V26, P52, DOI 10.1093/njaf/26.2.52; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duarte N, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1355-6; Duchesne L, 2005, FOREST ECOL MANAG, V208, P223, DOI 10.1016/j.foreco.2004.12.003; Duchesne L, 2002, J ENVIRON QUAL, V31, P1676, DOI 10.2134/jeq2002.1676; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ESRI, 2012, ARCGIS REL 10 1; Fortin M, 2009, CAN J FOREST RES, V39, P1928, DOI 10.1139/X09-108; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gagne LV, 2013, FORESTS, V4, P766, DOI 10.3390/f4040766; GAUTHIER S, 1990, CAN J BOT, V68, P391, DOI 10.1139/b90-051; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Giguere M., 1998, GUIDE SCIAGE BILLONS; Goldblum D, 2005, CAN J FOREST RES, V35, P2709, DOI 10.1139/X05-185; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Goodburn JM, 1998, CAN J FOREST RES, V28, P427, DOI 10.1139/cjfr-28-3-427; GRACE J, 1988, AGR ECOSYST ENVIRON, V22-3, P71, DOI 10.1016/0167-8809(88)90008-4; Grondin P, 2007, ATLAS UNITES HOMOGEN, P138; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hanks L.F., 1976, NE333 USDA FOR SERV; Havreljuk F, 2014, CAN J FOREST RES, V44, P750, DOI 10.1139/cjfr-2013-0407; Havreljuk F, 2013, CAN J FOREST RES, V43, P278, DOI 10.1139/cjfr-2012-0479; Hijmans R.J., DISMO SPECIES DISTRI; HMR, 2012, HARDW MARK REP LUMB; Hoad SP, 1998, TREES-STRUCT FUNCT, V13, P1; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; Jiang ZH, 2007, ANN FOREST SCI, V64, P807, DOI 10.1051/forest:2007063; Kenefic LS, 2005, NORTH J APPL FOR, V22, P77, DOI 10.1093/njaf/22.2.77; Lei XD, 2009, CAN J FOREST RES, V39, P1835, DOI 10.1139/X09-089; Lenz P, 2014, CAN J FOREST RES, V44, P1383, DOI 10.1139/cjfr-2014-0206; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Macdonald E, 2002, FORESTRY, V75, P107, DOI 10.1093/forestry/75.2.107; Makinen H, 2007, FOREST ECOL MANAG, V241, P175, DOI 10.1016/j.foreco.2007.01.017; McCauley OD, 1969, NE149 USDA FOR SERV; MEILLEUR A, 1994, VEGETATIO, V111, P173, DOI 10.1007/BF00040336; Moisen GG, 2006, ECOL MODEL, V199, P176, DOI 10.1016/j.ecolmodel.2006.05.021; Monger R., 1989, CLASSIFICATION TIGES; Moore JD, 2008, FOREST ECOL MANAG, V255, P3460, DOI 10.1016/j.foreco.2008.02.026; Moore JR, 2009, SILVA FENN, V43, P383, DOI 10.14214/sf.195; NHLA, 2011, RUL MEAS INSP HARDW; Nicoll BC, 1996, TREE PHYSIOL, V16, P891; Nyland RD, 2005, NORTH J APPL FOR, V22, P111, DOI 10.1093/njaf/22.2.111; NYLAND RD, 1992, J FOREST, V90, P33; Ouimet R, 2009, 134 MIN RESS NAT FAU; Ouimet R., 2001, WATER AIR SOIL POLL, V1, P119, DOI DOI 10.1023/A:1011544325004; Ouimet R, 2008, J PLANT NUTR SOIL SC, V171, P858, DOI 10.1002/jpln.200700197; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Petro FJ, 1976, GRADE HARDWOOD LOGS; Pokharel B, 2014, CAN J FOREST RES, V44, P465, DOI 10.1139/cjfr-2013-0252; Pothier D, 2013, CAN J FOREST RES, V43, P288, DOI 10.1139/cjfr-2012-0402; Pretzsch H, 2005, ECOL STUD-ANAL SYNTH, V176, P41; Pretzsch H., 2005, FOREST DIVERSITY FUN; Regniere J., 2014, LAUX137E CAN FOR SER; Ridgeway G., 2015, GBM GEN BOOSTED REGR; Robitaille L., 1981, Revue Forestiere Francaise, V33, P105; Rogers R., 1990, SILVICS N AM, V2; Russell-Roy ET, 2014, CAN J FOREST RES, V44, P614, DOI 10.1139/cjfr-2013-0437; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; SAKAI A, 1970, ECOLOGY, V51, P657, DOI 10.2307/1934045; Saucier J-P, 2006, C E CANUSA E CANUSA; Schneider R., 2013, MEMOIRE RECHERCHE FO; Sendak PE, 1982, LUMBER VALUE LOSS AS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Steele P. H, 1984, FPL39 USDA FOR SERV; Sutton CD, 2005, HANDB STAT, V24, P303, DOI 10.1016/S0169-7161(04)24011-1; Tranquillini W., 1979, PHYSL ECOLOGY ALPINE, VVolume 31; Vaughan CL, 1966, HARDWOOD LOG GRADES; Wang WF, 2011, FOREST SCI, V57, P506	92	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136674	10.1371/journal.pone.0136674	http://dx.doi.org/10.1371/journal.pone.0136674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313689	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000086
J	Lundin, O; Rundlof, M; Smith, HG; Fries, I; Bommarco, R				Lundin, Ola; Rundlof, Maj; Smith, Henrik G.; Fries, Ingemar; Bommarco, Riccardo			Neonicotinoid Insecticides and Their Impacts on Bees: A Systematic Review of Research Approaches and Identification of Knowledge Gaps	PLOS ONE			English	Article							DECREASES FORAGING SUCCESS; HONEYBEES APIS-MELLIFERA; SEED-TREATED CANOLA; LIFE-HISTORY TRAITS; NATIVE BEES; PESTICIDE-RESIDUES; POTENTIAL EXPOSURE; RISK-ASSESSMENT; COLONY HEALTH; BUMBLE BEES	It has been suggested that the widespread use of neonicotinoid insecticides threatens bees, but research on this topic has been surrounded by controversy. In order to synthesize which research approaches have been used to examine the effect of neonicotinoids on bees and to identify knowledge gaps, we systematically reviewed research on this subject that was available on the Web of Science and PubMed in June 2015. Most of the 216 primary research studies were conducted in Europe or North America (82%), involved the neonicotinoid imidacloprid (78%), and concerned the western honey bee Apis mellifera (75%). Thus, little seems to be known about neonicotinoids and bees in areas outside Europe and North America. Furthermore, because there is considerable variation in ecological traits among bee taxa, studies on honey bees are not likely to fully predict impacts of neonicotinoids on other species. Studies on crops were dominated by seed-treated maize, oilseed rape (canola) and sunflower, whereas less is known about potential side effects on bees from the use of other application methods on insect pollinated fruit and vegetable crops, or on lawns and ornamental plants. Laboratory approaches were most common, and we suggest that their capability to infer real-world consequences are improved when combined with information from field studies about realistic exposures to neonicotinoids. Studies using field approaches often examined only bee exposure to neonicotinoids and more field studies are needed that measure impacts of exposure. Most studies measured effects on individual bees. We suggest that effects on the individual bee should be linked to both mechanisms at the sub-individual level and also to the consequences for the colony and wider bee populations. As bees are increasingly facing multiple interacting pressures future research needs to clarify the role of neonicotinoids in relative to other drivers of bee declines.	[Lundin, Ola; Fries, Ingemar; Bommarco, Riccardo] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Lundin, Ola] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Rundlof, Maj; Smith, Henrik G.] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Smith, Henrik G.] Lund Univ, Ctr Environm & Climate Res, SE-22362 Lund, Sweden	Swedish University of Agricultural Sciences; University of California System; University of California Davis; Lund University; Lund University	Lundin, O (corresponding author), Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden.	ola.lundin@slu.se	Rundlöf, Maj/AAB-7401-2022; Lundin, Ola/X-7392-2019; Bommarco, Riccardo/E-7109-2016	Rundlöf, Maj/0000-0003-3014-1544; Lundin, Ola/0000-0002-5948-0761; Bommarco, Riccardo/0000-0001-8888-0476	Swedish Civil Contingencies Agency	Swedish Civil Contingencies Agency	This research was financed by a grant from the Swedish Civil Contingencies Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaga NOZ, 2011, CHEMOSPHERE, V83, P585, DOI 10.1016/j.chemosphere.2010.12.021; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alburaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125790; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Banks JE, 2014, ECOL APPL, V24, P770, DOI 10.1890/13-0937.1; Barbosa WF, 2015, PEST MANAG SCI, V71, P1049, DOI 10.1002/ps.4025; Bayer CropScience, 2015, PROD INF BISC OD 240; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Brunet JL, 2005, PEST MANAG SCI, V61, P742, DOI 10.1002/ps.1046; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2010, J APICULT RES, V49, P113, DOI 10.3896/IBRA.1.49.1.22; Chen M, 2014, J AGR FOOD CHEM, V62, P6082, DOI 10.1021/jf501397m; Choudhary A, 2008, ENVIRON MONIT ASSESS, V144, P143, DOI 10.1007/s10661-007-9952-3; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Cresswell JE, 2012, SCIENCE, V337, DOI 10.1126/science.1224618; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, ECOTOXICOLOGY, V23, P1755, DOI 10.1007/s10646-014-1340-5; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devillers J, 2003, SAR QSAR ENVIRON RES, V14, P389, DOI 10.1080/10629360310001623980; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dicks L, 2013, NATURE, V494, P283, DOI 10.1038/494283a; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Elston C, 2013, APIDOLOGIE, V44, P563, DOI 10.1007/s13592-013-0206-9; EU, 2013, OFFICIAL J EUROPEAN, V139, P12; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; European Food Safety Authority, 2015, BEE HLTH; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Farooqui T, 2013, NEUROCHEM INT, V62, P122, DOI 10.1016/j.neuint.2012.09.020; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2013, J APPL ENTOMOL, V137, P35, DOI 10.1111/j.1439-0418.2012.01718.x; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Goulson D., 2013, SIGNIFICANCE, V10, P6; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gross M, 2013, CURR BIOL, V23, pR462, DOI 10.1016/j.cub.2013.05.030; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hoffmann EJ, 2012, J ECON ENTOMOL, V105, P67, DOI 10.1603/EC11251; Hopwood J., 2012, ARE NEONICOTINOIDS K; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Larson JL, 2015, ENVIRON TOXICOL CHEM, V34, P127, DOI 10.1002/etc.2768; Larson JL, 2014, ECOTOXICOLOGY, V23, P252, DOI 10.1007/s10646-013-1168-4; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laycock I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079872; Lu CS, 2014, B INSECTOL, V67, P125; Macfadyen S, 2014, ANNU REV ENTOMOL, V59, P383, DOI 10.1146/annurev-ento-011613-162109; Maini S, 2010, B INSECTOL, V63, P153; Moffat C, 2015, FASEB J, V29, P2112, DOI 10.1096/fj.14-267179; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pareja L, 2011, INT J ENV RES PUB HE, V8, P3844, DOI 10.3390/ijerph8103844; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pirk CWW, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.13; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1; Retschnig G, 2015, ENVIRON MICROBIOL, V17, P4322, DOI 10.1111/1462-2920.12825; Retschnig G, 2014, J INVERTEBR PATHOL, V118, P18, DOI 10.1016/j.jip.2014.02.008; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; SCHMID-HEMPEL P, 1991, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V64, P93; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Schreinemachers P, 2012, FOOD POLICY, V37, P616, DOI 10.1016/j.foodpol.2012.06.003; Sechser B, 2003, ANZ SCHADL-J PEST SC, V76, P74, DOI 10.1046/j.1439-0280.2003.03017.x; Skerl MIS, 2009, B ENVIRON CONTAM TOX, V83, P374, DOI 10.1007/s00128-009-9762-0; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; STARK JD, 1995, J ECON ENTOMOL, V88, P1081, DOI 10.1093/jee/88.5.1081; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Tan K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10989; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; The Food and Environment Research Agency, 2013, EFF NEON SEED TREATM; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Thompson HM, 1999, ECOTOXICOLOGY, V8, P147, DOI 10.1023/A:1026444029579; TOMIZAWA M, 1992, J PESTIC SCI, V17, P231; Vaikkinen A, 2015, RAPID COMMUN MASS SP, V29, P424, DOI 10.1002/rcm.7123; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472	135	167	172	18	557	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136928	10.1371/journal.pone.0136928	http://dx.doi.org/10.1371/journal.pone.0136928			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313444	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360144000108
J	Heavner, ME; Qiu, WG; Cheng, HP				Heavner, Mary Ellen; Qiu, Wei-Gang; Cheng, Hai-Ping			Phylogenetic Co-Occurrence of ExoR, ExoS, and ChvI, Components of the RSI Bacterial Invasion Switch, Suggests a Key Adaptive Mechanism Regulating the Transition between Free-Living and Host-Invading Phases in Rhizobiales	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI-EXOR; PROTEIN FOLD RECOGNITION; OUTER-MEMBRANE PROTEINS; BRUCELLA-ABORTUS; SUCCINOGLYCAN BIOSYNTHESIS; 2-COMPONENT SYSTEM; EXOPOLYSACCHARIDE SYNTHESIS; ALPHA-PROTEOBACTERIA; BAYESIAN-INFERENCE; GENOME SEQUENCE	Both bacterial symbionts and pathogens rely on their host-sensing mechanisms to activate the biosynthetic pathways necessary for their invasion into host cells. The Gram-negative bacterium Sinorhizobium meliloti relies on its RSI (ExoR-ExoS-ChvI) Invasion Switch to turn on the production of succinoglycan, an exopolysaccharide required for its host invasion. Recent whole-genome sequencing efforts have uncovered putative components of RSI-like invasion switches in many other symbiotic and pathogenic bacteria. To explore the possibility of the existence of a common invasion switch, we have conducted a phylogenomic survey of orthologous ExoR, ExoS, and ChvI tripartite sets in more than ninety proteobacterial genomes. Our analyses suggest that functional orthologs of the RSI invasion switch co-exist in Rhizobiales, an order characterized by numerous invasive species, but not in the order's close relatives. Phylogenomic analyses and reconstruction of orthologous sets of the three proteins in Alphaproteobacteria confirm Rhizobiales-specific gene synteny and congruent RSI evolutionary histories. Evolutionary analyses further revealed site-specific substitutions correlated specifically to either animal-bacteria or plant-bacteria associations. Lineage restricted conservation of any one specialized gene is in itself an indication of species adaptation. However, the orthologous phylogenetic co-occurrence of all interacting partners within this single signaling pathway strongly suggests that the development of the RSI switch was a key adaptive mechanism. The RSI invasion switch, originally found in S. meliloti, is a characteristic of the Rhizobiales, and potentially a conserved crucial activation step that may be targeted to control host invasion by pathogenic bacterial species.	[Heavner, Mary Ellen; Cheng, Hai-Ping] CUNY, Grad Ctr, Biochem Program, New York, NY 10021 USA; [Qiu, Wei-Gang] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Cheng, Hai-Ping] CUNY Herbert H Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Lehman College (CUNY)	Cheng, HP (corresponding author), CUNY, Grad Ctr, Biochem Program, New York, NY 10021 USA.	haiping.cheng@lehman.cuny.edu		Heavner, Mary/0000-0003-4625-4228	National Institute of Health [SGM081147]; National Science Foundation [CNS-0958379, CNS-0855217]; National Science Foundation (XSEDE CIPRES project); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI107955] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Foundation (XSEDE CIPRES project)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (SGM081147 to HPC) and the National Science Foundation (CNS-0958379 and CNS-0855217 to CUNY CSI HPCC and the XSEDE CIPRES project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angermuller C, 2012, BIOINFORMATICS, V28, P3240, DOI 10.1093/bioinformatics/bts622; Bahlawane C, 2008, MOL PLANT MICROBE IN, V21, P1498, DOI 10.1094/MPMI-21-11-1498; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belanger L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-132; Belanger L, 2009, MOL MICROBIOL, V74, P1223, DOI 10.1111/j.1365-2958.2009.06931.x; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Chen EJ, 2008, MOL MICROBIOL, V69, P1290, DOI 10.1111/j.1365-2958.2008.06362.x; Chen EJ, 2009, J BACTERIOL, V191, P6833, DOI 10.1128/JB.00734-09; Cheng HP, 2004, FEMS MICROBIOL LETT, V231, P131, DOI 10.1016/S0378-1097(03)00952-2; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; DOHERTY D, 1988, J BACTERIOL, V170, P4249, DOI 10.1128/jb.170.9.4249-4256.1988; Fiebig A, 2013, STAND GENOMIC SCI, V7, P440, DOI 10.4056/sigs.3486982; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Foreman DL, 2010, J BACTERIOL, V192, P975, DOI 10.1128/JB.01140-09; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gomi M, 2005, CHEM BIO INFORM J, V5, P56; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gross R, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, pXI; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Heckel BC, 2014, J BACTERIOL, V196, P3221, DOI 10.1128/JB.01751-14; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keating DH, 2007, FEMS MICROBIOL LETT, V267, P23, DOI 10.1111/j.1574-6968.2006.00498.x; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; LEIGH JA, 1994, TRENDS GENET, V10, P63, DOI 10.1016/0168-9525(94)90151-1; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; Lopez-Goni I, 2002, VET MICROBIOL, V90, P329, DOI 10.1016/S0378-1135(02)00218-3; Lu H-Y, 2012, J BACTERIOL IN PRESS; Lu HY, 2012, J BACTERIOL, V194, P4029, DOI 10.1128/JB.00313-12; Lu HY, 2010, MICROBIOL-SGM, V156, P2092, DOI 10.1099/mic.0.038547-0; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; Manterola L, 2007, INFECT IMMUN, V75, P4867, DOI 10.1128/IAI.00439-07; MANTIS NJ, 1993, J BACTERIOL, V175, P6626, DOI 10.1128/jb.175.20.6626-6636.1993; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Miller M.A., 2010, P GAT COMP ENV WORKS; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; OSTERAS M, 1995, J BACTERIOL, V177, P5485, DOI 10.1128/jb.177.19.5485-5494.1995; Palacios L, 2006, INT J SYST EVOL MICR, V56, P1991, DOI 10.1099/ijs.0.64238-0; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pellegrini M, 1999, PROTEINS, V35, P440, DOI 10.1002/(SICI)1097-0134(19990601)35:4<440::AID-PROT7>3.3.CO;2-P; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09; REED JW, 1991, J BACTERIOL, V173, P3789, DOI 10.1128/JB.173.12.3789-3794.1991; Reeve WG, 1997, MICROBIOL-UK, V143, P1951, DOI 10.1099/00221287-143-6-1951; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2005, LECTURE NOTES IN COM, V3606, P4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vallat BK, 2008, PROTEINS, V72, P910, DOI 10.1002/prot.21976; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; Vanderlinde EM, 2011, J BACTERIOL; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Vogt SL, 2010, MOL MICROBIOL, V76, P1095, DOI 10.1111/j.1365-2958.2010.07145.x; Wang CX, 2010, MOL PLANT MICROBE IN, V23, P153, DOI 10.1094/MPMI-23-2-0153; Wang LC, 2012, EMBO J, V31, P2648, DOI 10.1038/emboj.2012.99; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x; Wiech EM, 2015, PROTEIN SCI, V24, P319, DOI 10.1002/pro.2616; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Yao SY, 2004, J BACTERIOL, V186, P6042, DOI [10.1128/JB.186.18.6042-6049.2004, 10.1128/jb.186.18.6042-6049.2004]; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07	104	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0135655	10.1371/journal.pone.0135655	http://dx.doi.org/10.1371/journal.pone.0135655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309130	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400069
J	Orihuela, RLL; Peres, CA; Mendes, G; Jarenkow, JA; Tabarelli, M				Orihuela, Rodrigo L. L.; Peres, Carlos A.; Mendes, Gabriel; Jarenkow, Joao A.; Tabarelli, Marcelo			Markedly Divergent Tree Assemblage Responses to Tropical Forest Loss and Fragmentation across a Strong Seasonality Gradient	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; ARAUCARIA FOREST; SPECIES RICHNESS; SEED DISPERSAL; BIODIVERSITY; EDGE; CONSERVATION; GRASSLAND; EXPANSION; PROSPECTS	We examine the effects of forest fragmentation on the structure and composition of tree assemblages within three seasonal and aseasonal forest types of southern Brazil, including evergreen, Araucaria, and deciduous forests. We sampled three southernmost Atlantic Forest landscapes, including the largest continuous forest protected areas within each forest type. Tree assemblages in each forest type were sampled within 10 plots of 0.1 ha in both continuous forests and 10 adjacent forest fragments. All trees within each plot were assigned to trait categories describing their regeneration strategy, vertical stratification, seed-dispersal mode, seed size, and wood density. We detected differences among both forest types and landscape contexts in terms of overall tree species richness, and the density and species richness of different functional groups in terms of regeneration strategy, seed dispersal mode and woody density. Overall, evergreen forest fragments exhibited the largest deviations from continuous forest plots in assemblage structure. Evergreen, Araucaria and deciduous forests diverge in the functional composition of tree floras, particularly in relation to regeneration strategy and stress tolerance. By supporting a more diversified light-demanding and stress-tolerant flora with reduced richness and abundance of shade-tolerant, old-growth species, both deciduous and Araucaria forest tree assemblages are more intrinsically resilient to contemporary human-disturbances, including fragmentation-induced edge effects, in terms of species erosion and functional shifts. We suggest that these intrinsic differences in the direction and magnitude of responses to changes in landscape structure between forest types should guide a wide range of conservation strategies in restoring fragmented tropical forest landscapes worldwide.	[Orihuela, Rodrigo L. L.; Jarenkow, Joao A.] Univ Fed Rio Grande do Sul, Dept Bot, Porto Alegre, RS, Brazil; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Mendes, Gabriel; Tabarelli, Marcelo] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil	Universidade Federal do Rio Grande do Sul; University of East Anglia; Universidade Federal de Pernambuco	Orihuela, RLL (corresponding author), Univ Fed Rio Grande do Sul, Dept Bot, Porto Alegre, RS, Brazil.	rleonel7@gmail.com	Peres, Carlos A./B-1276-2013; Peres, Carlos A./ABE-8361-2020; Tabarelli, Marcelo/F-1088-2010; Jarenkow, João André/E-1574-2013; Gomory, Dusan/AAC-5840-2019; Jarenkow, João André/AAS-3713-2020; Peres, Carlos Augusto/N-8275-2019	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Tabarelli, Marcelo/0000-0001-7573-7216; Jarenkow, João André/0000-0003-2747-3468; Gomory, Dusan/0000-0002-9426-4247; 	Fundacao Boticario de Protecao a Natureza [0864_20101]; FAPERGS [1015179]; CNPq [141496/2010-0]; CAPES at the University of East Anglia, UK [8174-12-1]	Fundacao Boticario de Protecao a Natureza; FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES at the University of East Anglia, UK	This work was funded by Fundacao Boticario de Protecao a Natureza (project 0864_20101), FAPERGS (process 1015179) and CNPq (141496/2010-0). This manuscript was co-written by R.L.L.O during a CAPES-funded doctoral scholarship (process 8174-12-1) at the University of East Anglia, UK.	BAZZAZ FA, 1980, ANNU REV ECOL SYST, V11, P287, DOI 10.1146/annurev.es.11.110180.001443; Bazzaz FA, 2000, PLANTS CHANGING ENV; Behling H, 2005, REV PALAEOBOT PALYNO, V133, P235, DOI 10.1016/j.revpalbo.2004.10.004; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Benchimol M, 2015, J ECOL, V103, P408, DOI 10.1111/1365-2745.12371; Bierregaard ROJ, 2001, LESSONS FROM AMAZONI; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Carlucci MB, 2011, COMMUNITY ECOL, V12, P196, DOI 10.1556/ComEc.12.2011.2.7; Castillo-Campos G, 2008, BIODIVERS CONSERV, V17, P1701, DOI 10.1007/s10531-008-9375-7; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Duarte LDS, 2006, AUSTRAL ECOL, V31, P520, DOI 10.1111/j.1442-9993.2006.01602.x; Duarte LD, 2009, GLOBAL ECOL BIOGEOGR, V18, P314, DOI 10.1111/j.1466-8238.2009.00448.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Engelbrecht BMJ, 2012, NATURE, V491, P675, DOI 10.1038/nature11756; Faria D, 2007, BIODIVERS CONSERV, V16, P2335, DOI 10.1007/s10531-007-9189-z; FATMA-Fundacao de Amparo Tecnologia e ao Meio Ambiente, 2004, PARQ EST AR PLAN MAN, VI; Ferraz SFB, 2014, LANDSCAPE ECOL, V29, P187, DOI 10.1007/s10980-014-9988-z; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FONTANA S, 2003, LIVRO VERMELHO FAUNA; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Halffter Gonzalo, 2005, Acta Zool. Mex, V21, P133; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Giehl ELH, 2012, ECOGRAPHY, V35, P933, DOI 10.1111/j.1600-0587.2011.07430.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holbrook N. Michele, 1995, P243, DOI 10.1017/CBO9780511753398.010; IBGE (Brazilian Institute of Geography and Statistics), 2012, MAN TECN GEOC MAN TE; IBGE-Instituto Brasileiro de Geografia e Estatistica, 1990, GEOGRAFIA BRASIL; Inácio Camila Dellanhese, 2008, Braz. J. Bot., V31, P41, DOI 10.1590/S0100-84042008000100005; Janzen D.H., 1988, P130; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Laurance W. F., 2001, LESSONS AMAZONIA ECO, P158; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 1997, TROPICAL FOREST REMN, P275; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lima AR, 1997, DOCUMENTOS ISA; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Melo FPL, 2007, ECOSCIENCE, V14, P124, DOI 10.2980/1195-6860(2007)14[124:EOLSFT]2.0.CO;2; LORENZI H., 2002, ARVORES BRASILEIRAS, V1; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Michalski F, 2007, BIOTROPICA, V39, P691, DOI 10.1111/j.1744-7429.2007.00318.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nimer E., 1990, CLIMA GEOGRAFIA BRAS, V2, P151; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Oliveira AT, 2015, J PLANT ECOL, V8, P242, DOI 10.1093/jpe/rtt058; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Putz S, 2011, ECOL MODEL, V222, P1986, DOI 10.1016/j.ecolmodel.2011.03.038; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; Rambo B., 1956, FISIONOMIA RIO GRAND; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ruschel AR, 2007, BIODIVERS CONSERV, V16, P1699, DOI 10.1007/s10531-006-9044-7; Santo-Silva EE, 2013, BIOTROPICA, V45, P386, DOI 10.1111/btp.12013; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; SEMA-Secretaria Estadual do Meio Ambiente, 2005, PLAN MAN PARQ EST TU; Sobral M., 2006, FLORA ARBOREA ARBORE; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Tabarelli M, 2002, BIOL CONSERV, V106, P165, DOI 10.1016/S0006-3207(01)00243-9; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Team RDC, 2012, R LANG ENV STAT COMP; VANDERPIJL, 1982, PRINCIPLES DISPERSAL; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; WAECHTER JL, 2002, CIENCIA AMBIENTE SAN, V24, P93; Werneck FP, 2006, J BIOGEOGR, V33, P1983, DOI 10.1111/j.1365-2699.2006.01553.x; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; WHITMORE TC, 1991, INTRO TROPICAL RAIN; WILSON JB, 1989, OECOLOGIA, V80, P263, DOI 10.1007/BF00380161; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	77	17	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136018	10.1371/journal.pone.0136018	http://dx.doi.org/10.1371/journal.pone.0136018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309252	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400084
J	Winter, B; Brunecker, P; Fiebach, JB; Jungehulsing, GJ; Kronenberg, G; Endres, M				Winter, Benjamin; Brunecker, Peter; Fiebach, Jochen B.; Jungehulsing, Gerhard Jan; Kronenberg, Golo; Endres, Matthias			Striatal Infarction Elicits Secondary Extrafocal MRI Changes in Ipsilateral Substantia Nigra	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; APPARENT DIFFUSION-COEFFICIENT; TRANSIENT FOREBRAIN ISCHEMIA; POSTISCHEMIC NEURONAL DEATH; OCCLUSION; STROKE; RATS; DEGENERATION; DAMAGE; AGONIST	Focal ischemia may induce pathological alterations in brain areas distant from the primary lesion. In animal models, exofocal neuron death in the ipsilateral midbrain has been described after occlusion of the middle cerebral artery (MCA). Using sequential magnetic resonance imaging (T2- and diffusion-weighted) at 3 Tesla, we investigated acute ischemic stroke patients on days 1, 2, 6, 8, and 10 after stroke onset. Sixteen consecutive patients who had suffered a stroke involving the caudate nucleus and/or putamen of either hemisphere were recruited into the study. Four additional patients with strokes sparing the caudate nucleus and putamen but encompassing at least one-third of the MCA territory served as controls. Ischemic lesions involving striatal structures resulted in hyperintense lesions in ipsilateral midbrain that emerged between days 6 and 10 after stroke and were not present on the initial scans. In contrast, none of the control stroke patients developed secondary midbrain lesions. Hyperintense lesions in the pyramidal tract or the brain stem caused by degeneration of the corticospinal tract could be clearly distinguished from these secondary midbrain gray matter lesions and were detectable from day 2 after ischemia. Co-registration of high-resolution images with a digitized anatomic atlas revealed localization of secondary lesions primarily in the substantia nigra pars compacta. Apparent diffusion coefficient (ADC) values in the secondary lesions showed a delayed sharp decline through day 10. Normalization of ADC values was observed at late measurements. Taken together, our study demonstrates that striatal infarction elicits delayed degenerative changes in ipsilateral substantia nigra pars compacta.	[Winter, Benjamin; Brunecker, Peter; Fiebach, Jochen B.; Jungehulsing, Gerhard Jan; Kronenberg, Golo; Endres, Matthias] Charite, Ctr Stroke Res Berlin CSB, D-10117 Berlin, Germany; [Winter, Benjamin; Kronenberg, Golo; Endres, Matthias] Charite, Dept Neurol, D-10117 Berlin, Germany; [Jungehulsing, Gerhard Jan] Jud Krankenhaus Berlin, Dept Neurol, D-13347 Berlin, Germany; [Kronenberg, Golo] Charite, Dept Psychiat, D-10117 Berlin, Germany; [Kronenberg, Golo] Max Delbruck Ctr, D-13125 Berlin, Germany; [Kronenberg, Golo] Charite Med Fac, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Endres, Matthias] Charite, Excellence Cluster Neurocure, D-10117 Berlin, Germany; [Endres, Matthias] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Endres, Matthias] German Ctr Cardiovasc Res DZHK, D-13347 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); German Centre for Cardiovascular Research	Endres, M (corresponding author), Charite, Ctr Stroke Res Berlin CSB, Charitepl 1, D-10117 Berlin, Germany.	matthias.endres@charite.de		Endres, Matthias/0000-0001-6520-3720; Fiebach, Jochen B./0000-0002-7936-6958; Kronenberg, Golo/0000-0002-5310-9849	Deutsche Forschungsgesellschaft (Excellence cluster NeuroCure) [SFB TR 43, KFO 247, KFO 213]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin); European Union (European Stroke Network, WakeUp, Counterstroke); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	Deutsche Forschungsgesellschaft (Excellence cluster NeuroCure); Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)(Federal Ministry of Education & Research (BMBF)); European Union (European Stroke Network, WakeUp, Counterstroke); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	ME receives funding from the Deutsche Forschungsgesellschaft (Excellence cluster NeuroCure; SFB TR 43, KFO 247, KFO 213), Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin), European Union (European Stroke Network, WakeUp, Counterstroke), Volkswagen Foundation (Lichtenberg Program) and the Corona Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2003, NMR BIOMED, V16, P152, DOI 10.1002/nbm.823; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Boutin H, 2007, ACTA NEUROPATHOL, V114, P491, DOI 10.1007/s00401-007-0269-7; Ebinger M, 2012, STROKE, V43, P539, DOI 10.1161/STROKEAHA.111.632026; FORNO LS, 1983, ACTA NEUROPATHOL, V62, P96, DOI 10.1007/BF00684925; Hall ED, 1996, BRAIN RES, V742, P80, DOI 10.1016/S0006-8993(96)00968-7; Hirouchi Y, 2007, EXP TOXICOL PATHOL, V59, P9, DOI 10.1016/j.etp.2007.02.008; HOEHNBERLAGE M, 1995, MAGN RESON MED, V34, P824, DOI 10.1002/mrm.1910340607; Hotter B, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-60; Kinoshita Toshibumi, 2002, Magn Reson Med Sci, V1, P175, DOI 10.2463/mrms.1.175; Kronenberg G, 2014, BRIT J PHARMACOL, V171, P4673, DOI 10.1111/bph.12775; Kronenberg G, 2012, BIOL PSYCHIAT, V72, P273, DOI 10.1016/j.biopsych.2012.02.026; LAPCHAK PA, 1993, NEUROSCIENCE, V53, P639, DOI 10.1016/0306-4522(93)90612-J; MAI JK, 2003, ATLAS HUMAN BRAIN; Nakajima M, 2010, INTERNAL MED, V49, P65, DOI 10.2169/internalmedicine.49.2694; Nakane M, 2001, AM J NEURORADIOL, V22, P660; NAKANE M, 1992, STROKE, V23, P328, DOI 10.1161/01.STR.23.3.328; NAKAYAMA H, 1990, Neurological Research, V12, P231; Ogawa T, 1997, RADIOLOGY, V204, P847, DOI 10.1148/radiology.204.3.9280270; Ohara S, 1989, Rinsho Shinkeigaku, V29, P1352; SAJI M, 1987, SCIENCE, V235, P66, DOI 10.1126/science.3798095; SAJI M, 1993, NEUROSCI LETT, V155, P47, DOI 10.1016/0304-3940(93)90670-G; Soriano MA, 1997, NEUROBIOL DIS, V4, P376, DOI 10.1006/nbdi.1997.0166; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; TAMURA A, 1990, BRAIN RES, V510, P154, DOI 10.1016/0006-8993(90)90744-V; Taskin B, 2006, CEREB CORTEX, V16, P1431, DOI 10.1093/cercor/bhj080; TULLOCH IF, 1978, J ANAT, V127, P425; Venkatesan R, 2000, MAGNET RESON MED, V43, P146, DOI 10.1002/(SICI)1522-2594(200001)43:1<146::AID-MRM18>3.0.CO;2-L; VOLPE BT, 1995, NEUROBIOL DIS, V2, P119, DOI 10.1006/nbdi.1995.0012; Zhang J, 2012, STROKE, V43, P1700, DOI 10.1161/STROKEAHA.111.632448; Zhao FY, 2001, BRAIN RES, V895, P238, DOI 10.1016/S0006-8993(00)03281-9; Zuhayra M, 2011, NEUROPATH APPL NEURO, V37, P738, DOI 10.1111/j.1365-2990.2011.01169.x	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136483	10.1371/journal.pone.0136483	http://dx.doi.org/10.1371/journal.pone.0136483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325192	Green Published, gold, Green Accepted			2022-12-27	WOS:000360437700045
J	Seppala, J; Tossavainen, H; Rodic, N; Permi, P; Pentikainen, U; Ylanne, J				Seppala, Jonne; Tossavainen, Helena; Rodic, Nebojsa; Permi, Perttu; Pentikainen, Ulla; Ylanne, Jari			Flexible Structure of Peptide-Bound Filamin A Mechanosensor Domain Pair 20-21	PLOS ONE			English	Article							BIOLOGICAL MACROMOLECULES; AUTO-INHIBITION; BINDING; SCATTERING; FRAGMENT; MODEL; PHOSPHORYLATION; COMPETITION; RESOLUTION; MIGFILIN	Filamins (FLNs) are large, multidomain actin cross-linking proteins with diverse functions. Besides regulating the actin cytoskeleton, they serve as important links between the extracellular matrix and the cytoskeleton by binding cell surface receptors, functioning as scaffolds for signaling proteins, and binding several other cytoskeletal proteins that regulate cell adhesion dynamics. Structurally, FLNs are formed of an amino terminal actin-binding domain followed by 24 immunoglobulin-like domains (IgFLNs). Recent studies have demonstrated that myosin-mediated contractile forces can reveal hidden protein binding sites in the domain pairs IgFLNa18-19 and 20-21, enabling FLNs to transduce mechanical signals in cells. The atomic structures of these mechanosensor domain pairs in the resting state are known, as well as the structures of individual IgFLN21 with ligand peptides. However, little experimental data is available on how interacting protein binding deforms the domain pair structures. Here, using small-angle x-ray scattering-based modelling, x-ray crystallography, and NMR, we show that the adaptor protein migfilin-derived peptide-bound structure of IgFLNa20-21 is flexible and adopts distinctive conformations depending on the presence or absence of the interacting peptide. The conformational changes reported here may be common for all peptides and may play a role in the mechanosensor function of the site.	[Seppala, Jonne; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Seppala, Jonne; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Tossavainen, Helena; Rodic, Nebojsa; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Helsinki	Seppala, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	jonne.s.seppala@jyu.fi		Pentikainen, Ulla/0000-0001-6547-1282; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [138327, 259447, 121393, 283481]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (http://www.aka.fi/en-GB/A/), grants 138327 (JY), 259447 (PP), 121393 and 283481 (UP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; Chen H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01642; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kolahi KS, 2008, BIOPHYS J, V94, P1075, DOI 10.1529/biophysj.107.118802; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5656; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pentikainen U, 2011, J BIOL CHEM, V286, P26921, DOI 10.1074/jbc.M110.195958; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Rognoni L, 2012, P NATL ACAD SCI USA, V109, P19679, DOI 10.1073/pnas.1211274109; Ruskamo S, 2012, BIOCHEM J, V446, P261, DOI 10.1042/BJ20120361; Seo MD, 2009, PROTEINS, V75, P258, DOI 10.1002/prot.22336; Sethi R, 2014, J BIOL CHEM, V289, P8588, DOI 10.1074/jbc.M113.537456; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tossavainen H, 2012, J AM CHEM SOC, V134, P6660, DOI 10.1021/ja2114882; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001	55	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136969	10.1371/journal.pone.0136969	http://dx.doi.org/10.1371/journal.pone.0136969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322797	Green Submitted, Green Published, gold			2022-12-27	WOS:000360435500055
J	Bachmann, NL; Katouli, M; Polkinghorne, A				Bachmann, Nathan L.; Katouli, Mohammad; Polkinghorne, Adam			Genomic Comparison of Translocating and Non-Translocating Escherichia coli	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; STRAINS; VIRULENCE; PHYLOGENY; STRESS; ADHESION; SEQUENCE; ARTEMIS; DISEASE; FLORA	Translocation of E. coli across the gut epithelium can result in fatal sepsis in post-surgical patients. In vitro and in vivo experiments have identified the existence of a novel pathotype of translocating E. coli (TEC) that employs an unknown mechanism for translocating across epithelial cells to the mesenteric lymph nodes and the blood stream in both humans and animal models. In this study the genomes of four TEC strains isolated from the mesenteric lymph nodes of a fatal case of hospitalised patient (HMLN-1), blood of pigs after experimental shock (PC-1) and after non-lethal haemorrhage in rats (KIC-1 and KIC-2) were sequenced in order to identify the genes associated with their adhesion and/or translocation. To facilitate the comparison, the genomes of a non-adhering, non-translocating E. coli (46-4) and adhering but non-translocating E. coli (73-89) were also sequenced and compared. Whole genome comparison revealed that three (HMLN-1, PC-1 and KIC-2) of the four TEC strains carried a genomic island that encodes a Type 6 Secretion System that may contribute to adhesion of the bacteria to gut epithelial cells. The human TEC strain HMLN-1 also carried the invasion ibeA gene, which was absent in the animal TEC strains and is likely to be associated with host-specific translocation. Phylogenetic analysis revealed that the four TEC strains were distributed amongst three distinct E. coli phylogroups, which was supported by the presence of phylogroup specific fimbriae gene clusters. The genomic comparison has identified potential genes that can be targeted with knock-out experiments to further characterise the mechanisms of E. coli translocation.	[Bachmann, Nathan L.; Katouli, Mohammad; Polkinghorne, Adam] Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4558, Australia	University of the Sunshine Coast	Polkinghorne, A (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4558, Australia.	apolking@usc.edu.au		Polkinghorne, Adam/0000-0002-6803-9222; Polkinghorne, Adam/0000-0002-6567-2962				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARK T, 1993, CIRC SHOCK, V41, P60; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Bingen E, 1998, J INFECT DIS, V177, P642, DOI 10.1086/514217; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Cieza RJ, 2015, INFECT IMMUN; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Flechard M, 2012, J BACTERIOL, V194, P4550, DOI 10.1128/JB.00089-12; Girardeau JP, 2003, J CLIN MICROBIOL, V41, P218, DOI 10.1128/JCM.41.1.218-226.2003; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Katouli M, 1997, J MED MICROBIOL, V46, P571, DOI 10.1099/00222615-46-7-571; KATOULI M, 1994, INFECT IMMUN, V62, P4768, DOI 10.1128/IAI.62.11.4768-4774.1994; Katouli M, 2009, EUR J CLIN MICROBIOL, V28, P1095, DOI 10.1007/s10096-009-0754-0; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Liu L, 2015, INFECT IMMUN; Ljungdahl M, 2000, SCAND J GASTROENTERO, V35, P389, DOI 10.1080/003655200750023958; Martinez-Medina M, 2011, APPL ENVIRON MICROB, V77, P5813, DOI 10.1128/AEM.02614-10; Nettelbladt CG, 2000, J TRAUMA, V48, P314, DOI 10.1097/00005373-200002000-00021; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Pavelka Jr MS, 1991, J BACTERIOL, V173, P4603; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Pupo GM, 1997, INFECT IMMUN, V65, P2685, DOI 10.1128/IAI.65.7.2685-2692.1997; Ramos NL, 2011, MICROB PATHOGENESIS, V50, P81, DOI 10.1016/j.micpath.2010.11.003; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Yu Y, 2012, ARCH MICROBIOL, V194, P827, DOI 10.1007/s00203-012-0816-z; Zou YM, 2008, MED MICROBIOL IMMUN, V197, P337, DOI 10.1007/s00430-007-0065-y	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137131	10.1371/journal.pone.0137131	http://dx.doi.org/10.1371/journal.pone.0137131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317913	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100208
J	Chen, X; Xie, CS; Sun, LX; Ding, JH; Cai, HB				Chen, Xi; Xie, Chengsong; Sun, Lixin; Ding, Jinhui; Cai, Huaibin			Longitudinal Metabolomics Profiling of Parkinson's Disease-Related alpha-Synuclein A53T Transgenic Mice	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DOPAMINERGIC-NEURONS; ALANINE METABOLISM; REDOX PROTEOMICS; GLUTATHIONE; BRAIN; GUANOSINE; TRANSPORT; URATE; LOCALIZATION	Metabolic homeostasis is critical for all biological processes in the brain. The metabolites are considered the best indicators of cell states and their rapid fluxes are extremely sensitive to cellular changes. While there are a few studies on the metabolomics of Parkinson's disease, it lacks longitudinal studies of the brain metabolic pathways affected by aging and the disease. Using ultra-high performance liquid chromatography and tandem mass spectroscopy (UPLC/MS), we generated the metabolomics profiling data from the brains of young and aged male PD-related alpha-synuclein A53T transgenic mice as well as the age- and gender-matched non-transgenic (nTg) controls. Principal component and unsupervised hierarchical clustering analyses identified distinctive metabolites influenced by aging and the A53T mutation. The following metabolite set enrichment classification revealed the alanine metabolism, redox and acetyl-CoA biosynthesis pathways were substantially disturbed in the aged mouse brains regardless of the genotypes, suggesting that aging plays a more prominent role in the alterations of brain metabolism. Further examination showed that the interaction effect of aging and genotype only disturbed the guanosine levels. The young A53T mice exhibited lower levels of guanosine compared to the age- matched nTg controls. The guanosine levels remained constant between the young and aged nTg mice, whereas the aged A53T mice showed substantially increased guanosine levels compared to the young mutant ones. In light of the neuroprotective function of guanosine, our findings suggest that the increase of guanosine metabolism in aged A53T mice likely represents a protective mechanism against neurodegeneration, while monitoring guanosine levels could be applicable to the early diagnosis of the disease.	[Chen, Xi; Xie, Chengsong; Sun, Lixin; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Ding, Jinhui] NIA, Bioinformat Core, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cai, HB (corresponding author), NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	caih@mail.nih.gov	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Institutes of Health [AG000928, AG000929]; NATIONAL INSTITUTE ON AGING [ZIAAG000929, ZIAAG000945, ZIAAG000928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG000928 and AG000929, http://grants.nih.gov/grants/oer.htm.	Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; BIFFO S, 1990, NEUROSCIENCE, V35, P637, DOI 10.1016/0306-4522(90)90335-2; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; Breiman L., 2001, MACH LEARN, V45, P5; Broer S, 2007, J NEUROCHEM, V102, P1758, DOI 10.1111/j.1471-4159.2007.04654.x; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Cascante M, 1996, J THEOR BIOL, V182, P317, DOI 10.1006/jtbi.1996.0170; Chang R, 2008, NEUROSCI LETT, V431, P101, DOI 10.1016/j.neulet.2007.11.072; CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399; Di Iorio P, 2004, GLIA, V46, P356, DOI 10.1002/glia.20002; Giordano G, 2011, METHODS MOL BIOL, V758, P205, DOI 10.1007/978-1-61779-170-3_14; Kaiser LG, 2005, NEUROBIOL AGING, V26, P665, DOI 10.1016/j.neurobiolaging.2004.07.001; LeWitt Peter, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS49, DOI 10.1016/S1353-8020(11)70017-7; Li DW, 2013, INT J MOL MED, V32, P108, DOI 10.3892/ijmm.2013.1361; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lopez M, 2008, CURR OPIN CLIN NUTR, V11, P483, DOI 10.1097/MCO.0b013e328302f3d8; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Nie K, 2013, PARKINSONISM RELAT D, V19, P329, DOI 10.1016/j.parkreldis.2012.11.012; O'Reilly EJ, 2010, AM J EPIDEMIOL, V172, P666, DOI 10.1093/aje/kwq195; Pal NR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-5; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Perluigi M, 2014, AGEING RES REV, V13, P75, DOI 10.1016/j.arr.2013.12.005; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Pettifer KM, 2004, NEUROREPORT, V15, P833, DOI 10.1097/00001756-200404090-00019; Poliquin PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069146; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schlesinger I, 2008, MOVEMENT DISORD, V23, P1653, DOI 10.1002/mds.22139; Schuff N, 2001, MAGN RESON MED, V45, P899, DOI 10.1002/mrm.1119; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W; Zhang C, 2012, J ALZHEIMERS DIS, V28, P655, DOI 10.3233/JAD-2011-111244; Zhu YG, 2006, BRAIN RES, V1090, P35, DOI 10.1016/j.brainres.2006.03.063; Zwingmann C, 2001, GLIA, V34, P200, DOI 10.1002/glia.1054; Zwingmann C, 2000, GLIA, V32, P286, DOI 10.1002/1098-1136(200012)32:3<286::AID-GLIA80>3.0.CO;2-P	45	29	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136612	10.1371/journal.pone.0136612	http://dx.doi.org/10.1371/journal.pone.0136612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317866	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100112
J	Garcia-Lopez, L; Moore, HTA				Garcia-Lopez, LuisJoaquin; Moore, Harry T. A.			Validation and Diagnostic Efficiency of the Mini-SPIN in Spanish-Speaking Adolescents	PLOS ONE			English	Article							SOCIAL ANXIETY DISORDER; PSYCHOMETRIC PROPERTIES; BRIEF FORM; SPAI-B; PHOBIA; DSM-5	Objectives Social Anxiety Disorder (SAD) is one of the most common mental disorders in adolescence. Many validated psychometric tools are available to diagnose individuals with SAD efficaciously. However, there is a demand for shortened self-report instruments that identify adolescents at risk of developing SAD. We validate the Mini-SPIN and its diagnostic efficiency in overcoming this problem in Spanish-speaking adolescents in Spain. Methods The psychometric properties of the 3-item Mini-SPIN scale for adolescents were assessed in a community (study 1) and clinical sample (study 2). Results Study 1 consisted of 573 adolescents, and found the Mini-SPIN to have appropriate internal consistency and high construct validity. Study 2 consisted of 354 adolescents (147 participants diagnosed with SAD and 207 healthy controls). Data revealed that the Mini-SPIN has good internal consistency, high construct validity and adequate diagnostic efficiency. Conclusions Our findings suggest that the Mini-SPIN has good psychometric properties on clinical and healthy control adolescents and general population, which indicates that it can be used as a screening tool in Spanish-speaking adolescents. Cut-off scores are provided.	[Garcia-Lopez, LuisJoaquin; Moore, Harry T. A.] Univ Jaen, Jaen, Spain; [Moore, Harry T. A.] Univ Amsterdam, Amsterdam, Netherlands	Universidad de Jaen; University of Amsterdam	Garcia-Lopez, L (corresponding author), Univ Jaen, Jaen, Spain.	ljgarcia@ujaen.es	GARCIA-LOPEZ, LUISJOAQUIN/C-8215-2011; Moore, Harry/AAP-5319-2020	GARCIA-LOPEZ, LUISJOAQUIN/0000-0003-0446-6740; Moore, Harry/0000-0001-5426-3429				Aderka IM, 2012, J BEHAV THER EXP PSY, V43, P752, DOI 10.1016/j.jbtep.2011.10.012; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; Crome E, 2015, AUST NZ J PSYCHIAT, V49, P227, DOI 10.1177/0004867414546699; De Los Reyes A, 2013, J ABNORM PSYCHOL, V122, P376, DOI 10.1037/a0031150; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Eapen V, 2014, ASIAN J PSYCHIATR, V11, P114, DOI 10.1016/j.ajp.2014.04.008; Garcia-Lopez L. J., 2015, SOCIAL ANXIETY PHOBI, P121, DOI DOI 10.1007/978-3-319-16703; Garcia-Lopez LJ, 2013, TRATANDO TRASTORNO A; Garcia-Lopez LJ, EUR J PSYCHOL ASSESS; Garcia-Lopez LJ, J DEV BEHAV IN PRESS; Garcia-Lopez LJ, 2008, BEHAV PSYCHOL, V16, P361; Garcia-Lopez LJ, 2008, EUR J PSYCHOL ASSESS, V24, P150, DOI 10.1027/1015-5759.24.3.150; Heimberg RG, 2014, DEPRESS ANXIETY, V31, P472, DOI 10.1002/da.22231; Garcia-Lopez LJ, 2014, J ANXIETY DISORD, V28, P812, DOI 10.1016/j.janxdis.2014.09.001; Garcia-Lopez LJ, 2010, SPAN J PSYCHOL, V13, P970, DOI 10.1017/S1138741600002614; Kerns CE, 2013, DEPRESS ANXIETY, V30, P709, DOI 10.1002/da.22067; Knappe S., 2015, SOCIAL ANXIETY PHOBI, P39, DOI [DOI 10.1007/978-3-319-16703-9_3, 10.1007/978-3-319-16703-9_3]; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Osorio FD, 2007, EUR PSYCHIAT, V22, P239, DOI 10.1016/j.eurpsy.2007.01.003; Peters G.J.Y., 2014, EUROPEAN HLTH PSYCHO, V16, P56, DOI [DOI 10.31234/OSF.IO/H47FV, 10.31234/osf.io/h47fv]; Piqueras JA, 2012, BEHAV PSYCHOL, V20, P505; R Core Team, 2021, R LANGUAGE ENV STAT; Ranta K, 2012, COMPR PSYCHIAT, V53, P630, DOI 10.1016/j.comppsych.2011.07.007; Revelle W., 2020, PSYCH PROCEDURES PER; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Ruscio AM, 2010, J ABNORM PSYCHOL, V119, P662, DOI 10.1037/a0019341; Seeley-Wait Elizabeth, 2009, Prim Care Companion J Clin Psychiatry, V11, P231, DOI 10.4088/PCC.07m00576; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Silverman W, 1996, ANXIETY DISORDERS IN; Smits N, 2007, INT J METH PSYCH RES, V16, P219, DOI 10.1002/mpr.230; Turner S. M., 1989, PSYCHOL ASSESSMENT J, V1, P35, DOI [10.1037/1040-3590.1.1.35, DOI 10.1037/1040-3590.1.1.35]; Weeks JW, 2007, DEPRESS ANXIETY, V24, P382, DOI 10.1002/da.20250; Weeks JW, 2010, J ANXIETY DISORD, V24, P734, DOI 10.1016/j.janxdis.2010.05.006; Weiss BJ, 2013, BEHAV THER, V44, P1, DOI 10.1016/j.beth.2012.07.006; Wong Q.J.J., 2015, SOCIAL ANXIETY PHOBI, P11, DOI DOI 10.1007/978-3-319-16703-9_2; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135862	10.1371/journal.pone.0135862	http://dx.doi.org/10.1371/journal.pone.0135862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317695	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100047
J	Hajjej, A; Almawi, WY; Hattab, L; El-Gaaied, A; Hmida, S				Hajjej, Abdelhafidh; Almawi, Wassim Y.; Hattab, Lasmar; El-Gaaied, Amel; Hmida, Slama			HLA Class I and Class II Alleles and Haplotypes Confirm the Berber Origin of the Present Day Tunisian Population	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; MAXIMUM-LIKELIHOOD; PHYLOGENETIC TREES; DNA; FREQUENCIES; POLYMORPHISM; BASQUES; RELATEDNESS; MOROCCAN	In view of its distinct geographical location and relatively small area, Tunisia witnessed the presence of many civilizations and ethnic groups throughout history, thereby questioning the origin of present-day Tunisian population. We investigated HLA class I and class II gene profiles in Tunisians, and compared this profile with those of Mediterranean and Sub-Sahara African populations. A total of 376 unrelated Tunisian individuals of both genders were genotyped for HLA class I (A, B) and class II (DRB1, DQB1), using reverse dot-blot hybridization (PCR-SSO) method. Statistical analysis was performed using Arlequin software. Phylogenetic trees were constructed by DISPAN software, and correspondence analysis was carried out by VISTA software. One hundred fifty-three HLA alleles were identified in the studied sample, which comprised 41, 50, 40 and 22 alleles at HLA-A,-B,-DRB1 and -DQB1 loci, respectively. The most frequent alleles were HLA-A*02:01 (16.76%), HLAB*44:02/03 (17.82%), HLA-DRB1*07:01 (19.02%), and HLA-DQB1*03:01 (17.95%). Four-locus haplotype analysis identified HLA-A*02: 01-B*50:01-DRB1*07:01-DQB1*02:02 (2.2%) as the common haplotype in Tunisians. Compared to other nearby populations, Tunisians appear to be genetically related to Western Mediterranean population, in particular North Africans and Berbers. In conclusion, HLA genotype results indicate that Tunisians are related to present-day North Africans, Berbers and to Iberians, but not to Eastern Arabs (Palestinians, Jordanians and Lebanese). This suggests that the genetic contribution of Arab invasion of 7th-11th century A.D. had little impact of the North African gene pool.	[Hajjej, Abdelhafidh; Hmida, Slama] Natl Blood Transfus Ctr, Dept Immunogenet, Tunis, Tunisia; [Almawi, Wassim Y.] Arabian Gulf Univ, Coll Med & Med Sci, Dept Biochem, Manama, Bahrain; [Hattab, Lasmar] Reg Hosp Gabes, Dept Med Anal, Gabes, Tunisia; [El-Gaaied, Amel] Univ Tunis El Manar, Dept Biol, Immunogenet Lab, Tunis, Tunisia	Universite de Tunis-El-Manar; Centre National de Transfusion Sanguine; Arabian Gulf University; Universite de Tunis-El-Manar	Hajjej, A (corresponding author), Natl Blood Transfus Ctr, Dept Immunogenet, Tunis, Tunisia.	hajjejj@yahoo.fr	Almawi, Wassim/FGW-0821-2022; Elgaaied, Amel Ben Ammar/AAL-1183-2020					Abun-Nasr J. M, 1987, HIST MAGHRIB ISLAMIC, P455; Arnaiz-Villena A, 1999, TISSUE ANTIGENS, V53, P213, DOI 10.1034/j.1399-0039.1999.530301.x; Arnaiz-Villena A, 2002, TISSUE ANTIGENS, V60, P111, DOI 10.1034/j.1399-0039.2002.600201.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P308, DOI 10.1034/j.1399-0039.2001.057004308.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P118, DOI 10.1034/j.1399-0039.2001.057002118.x; Arnaiz-Villena A, 2001, HUM IMMUNOL, V62, P869, DOI 10.1016/S0198-8859(01)00285-3; ARNAIZVILLENA A, 1995, HUM IMMUNOL, V43, P259, DOI 10.1016/0198-8859(95)00024-X; Ayed K, 2004, TISSUE ANTIGENS, V64, P520, DOI 10.1111/j.1399-0039.2004.00313.x; Bosworth CE, HIST CITIES ISLAMIC, P264; Brett Michael, 1997, BERBERS; BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x; Camps G., 1984, ENCY BERBER; Clancy-Smith J.A., 1997, REBEL SAINT MUSLIM N, P157; Clayton J, 1997, GENETIC DIVERSITY HL, P665; Comas D, 1998, TISSUE ANTIGENS, V51, P30, DOI 10.1111/j.1399-0039.1998.tb02944.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Direskeneli GS, 1997, HLA ALLELE FREQUENCI; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fischer T., 1920, INT GEOGRAPHY, P368; Galgani A, 2013, HUM IMMUNOL, V74, P52, DOI 10.1016/j.humimm.2012.10.001; Gibbon E., 1776, DECLINE FALL ROMAN E; Gomez-Casado E, 2000, TISSUE ANTIGENS, V55, P239, DOI 10.1034/j.1399-0039.2000.550307.x; Gourraud PA, 2005, TRANSPL IMMUNOL, V14, P245, DOI 10.1016/j.trim.2005.03.016; Grimaldi MC, 2001, TISSUE ANTIGENS, V58, P281, DOI 10.1034/j.1399-0039.2001.580501.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hajjej A, 2006, TISSUE ANTIGENS, V68, P153, DOI 10.1111/j.1399-0039.2006.00622.x; Hajjej A, 2006, EUR J MED GENET, V49, P43, DOI 10.1016/j.ejmg.2005.01.001; Hajjej A, 2011, INT J IMMUNOGENET, V38, P191, DOI 10.1111/j.1744-313X.2011.01003.x; Hajjej A, 2011, ANN HUM BIOL, V38, P156, DOI 10.3109/03014460.2010.504195; HMIDA S, 1995, TISSUE ANTIGENS, V45, P63, DOI 10.1111/j.1399-0039.1995.tb02416.x; Imanish T, 1992, HLA 1991, V1, P1065; Izaabel H, 1998, TISSUE ANTIGENS, V51, P106, DOI 10.1111/j.1399-0039.1998.tb02954.x; Lapidus IM., 2002, HIST ISLAMIC SOC, P302; Le Bon G., 1884, ARAB CIVILISATION; Lewis Bernard, 1986, STUDIES ISLAMIC HIST, p[527, 233]; Mahfoudh N, 2013, ANN HUM BIOL, V40, P41, DOI 10.3109/03014460.2012.734334; MARTINEZLASO J, 1995, TISSUE ANTIGENS, V45, P237, DOI 10.1111/j.1399-0039.1995.tb02446.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; National Institute of Statistics-Tunisia, 2014, STAT TUNISIA; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Rodd F., 1925, B SCH ORIENTAL STUDI, V3, P731; ROITBERGTAMBUR A, 1995, TISSUE ANTIGENS, V46, P104, DOI 10.1111/j.1399-0039.1995.tb02485.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samso Julio, 1998, FORMATION AL ANDALUS, P41; Sanchez-Mazas A, 2000, PREHISTORIC IBERIA: GENETICS, ANTHROPOLOGY, AND LINGUISTICS, P65; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sanchez-Velasco P, 2001, HUM IMMUNOL, V62, P901, DOI 10.1016/S0198-8859(01)00289-0; Sanchez-Velasco P, 2003, TISSUE ANTIGENS, V61, P384, DOI 10.1034/j.1399-0039.2003.00041.x; Sasazuki T., 1992, HLA 1991, P76; Schneider S, 1996, ARLEQUIN SOFTWARE EN; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Stearns P. N., 2001, ENCY WORLD HIST ANCI, P129; Young FW, 1996, STAT COMPUTING ENV S, ps207	56	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136909	10.1371/journal.pone.0136909	http://dx.doi.org/10.1371/journal.pone.0136909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317228	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100170
J	Nouraie, M; Kansal, V; Belfonte, C; Ghazvini, M; Haidari, T; Shahnazi, A; Brim, H; Soliman, EZ; Ashktorab, H				Nouraie, Mehdi; Kansal, Vandana; Belfonte, Cassius; Ghazvini, Mohammad; Haidari, Tahmineh; Shahnazi, Anahita; Brim, Hassan; Soliman, Elsayed Z.; Ashktorab, Hassan			Atrial Fibrillation and Colonic Neoplasia in African Americans	PLOS ONE			English	Article							COLORECTAL-CANCER; RISK-FACTORS; RACIAL-DIFFERENCES; PREVALENCE; DISPARITIES; STROKE; EPIDEMIOLOGY; SURVIVAL; OUTCOMES; COHORT	Background Colorectal cancer (CRC) and atrial fibrillation/flutter (AF) share several risk factors including increasing age and obesity. However, the association between CRC and AF has not been thoroughly examined, especially in African Americans. In this study we aimed to assess the prevalence of AF and its risk factors in colorectal neoplasia in an African American. Methods We reviewed records of 527 African American patients diagnosed with CRC and 1008 patients diagnosed with benign colonic lesions at Howard University Hospital from January 2000 to December 2012. A control group of 731 hospitalized patients without any cancer or colonic lesion were randomly selected from the same time and age range, excluding patients who had diagnosis of both CRC and/or adenoma. The presence or absence of AF was based upon ICD-9 code documentation. The prevalence of AF in these three groups was compared by multivariate logistic regression. Results The prevalence of AF was highest among CRC patients (10%) followed by adenoma patients (7.2%) then the control group (5.4%, P for trend = 0.002). In the three groups of participants, older age (P<0.008) and heart failure (P<0.001) were significantly associated with higher risk of AF. After adjusting for these risk factors, CRC (OR: 1.4(95% CI): 0.9-2.2, P = 0.2) and adenoma (OR: 1.1(95% CI): 0.7-1.6, P = 0.7) were not significantly associated AF compared to control group. Conclusions AF is highly prevalent among CRC patients; 1 in 10 patients had AF in our study. The predictors of AF in CRC was similar to that in adenoma and other patients after adjustment for potential confounders suggesting that the increased AF risk in CRC is explained by higher prevalence of AF risk factors.	[Nouraie, Mehdi; Kansal, Vandana; Haidari, Tahmineh; Shahnazi, Anahita; Brim, Hassan; Ashktorab, Hassan] Howard Univ, Coll Med, Canc Res Ctr, Washington, DC 20059 USA; [Nouraie, Mehdi; Kansal, Vandana; Haidari, Tahmineh; Shahnazi, Anahita; Ashktorab, Hassan] Howard Univ, Coll Med, Dept Med, Washington, DC USA; [Belfonte, Cassius; Ghazvini, Mohammad] Howard Univ, Coll Med, Dept Med, Div Cardiol, Washington, DC USA; [Brim, Hassan] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Internal Med Cardiol, Winston Salem, NC USA	Howard University; Howard University; Howard University; Howard University; Wake Forest University; Wake Forest University	Nouraie, M (corresponding author), Howard Univ, Coll Med, Canc Res Ctr, Washington, DC 20059 USA.	snouraie@howard.edu; hashktorab@howard.edu	Ashktorab, hassan/AAJ-2908-2020; Nouraie, Seyed Mehdi/O-4071-2018; Soliman, Elsayed Z/AAD-7135-2020	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Soliman, Elsayed Z/0000-0001-5632-8150	National Institute on Minority Health and Health Disparities of the National Institutes of Health [G12MD007597]; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number G12MD007597. Sponsor had no role in study design and report.	Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Ashktorab H, 2014, DIGEST DIS SCI, V59, P446, DOI 10.1007/s10620-013-2898-0; Aziz S A, 1998, Clin Oncol (R Coll Radiol), V10, P377, DOI 10.1016/S0936-6555(98)80033-2; Batra GS, 2001, ANN ROY COLL SURG, V83, P174; Borzecki AM, 2008, J NATL MED ASSOC, V100, P237, DOI 10.1016/S0027-9684(15)31212-8; Brandstedt J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-293; Delaney JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032338; Dimou A, 2009, WORLD J GASTROENTERO, V15, P3734, DOI 10.3748/wjg.15.3734; Erichsen R, 2012, INTERN EMERG MED, V7, P431, DOI 10.1007/s11739-011-0701-9; Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Guzzetti S, 2002, CIRCULATION, V106, pE40, DOI 10.1161/01.CIR.0000028399.42411.13; Guzzetti S, 2002, AM J MED, V112, P587, DOI 10.1016/S0002-9343(02)01029-X; Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4; Guzzetti Stefano, 2003, Recenti Progressi in Medicina, V94, P260; Hernandez MB, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/275624; Imperatori Andrea, 2012, J Cardiothorac Surg, V7, P4, DOI 10.1186/1749-8090-7-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KANNEL WB, 1998, AM J CARDIOL, V0082; Knuiman M, 2014, EUR J EPIDEMIOL, V29, P181, DOI 10.1007/s10654-013-9875-y; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Laiyemo AO, 2010, JNCI-J NATL CANCER I, V102, P538, DOI 10.1093/jnci/djq068; MAY D, 1990, DEUT MED WOCHENSCHR, V115, P618, DOI 10.1055/s-2008-1065055; MULLER AD, 1994, DIGEST DIS SCI, V39, P2480, DOI 10.1007/BF02087670; Okin PM, 2014, AM J HYPERTENS, V27, P966, DOI 10.1093/ajh/hpu006; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Psaty BM, 1997, CIRCULATION, V96, P2455; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Soliman EZ, 2009, FUTUR CARDIOL, V5, P547, DOI 10.2217/FCA.09.49; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd; Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17430; Thomas KL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000200; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Upshaw CB, 2002, J NATL MED ASSOC, V94, P204; Vivas Yoel, 2005, Conn Med, V69, P405; Weng M C, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V55, P266; White A, 2008, CANCER, V113, P3400, DOI 10.1002/cncr.23924; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang TL, 2014, J CHIN MED ASSOC, V77, P117, DOI 10.1016/j.jcma.2013.11.004	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135609	10.1371/journal.pone.0135609	http://dx.doi.org/10.1371/journal.pone.0135609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317627	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100038
J	Ramirez, HA; Liang, L; Pastar, I; Rosa, AM; Stojadinovic, O; Zwick, TG; Kirsner, RS; Maione, AG; Garlick, JA; Tomic-Canic, M				Ramirez, Horacio A.; Liang, Liang; Pastar, Irena; Rosa, Ashley M.; Stojadinovic, Olivera; Zwick, Thomas G.; Kirsner, Robert S.; Maione, Anna G.; Garlick, Jonathan A.; Tomic-Canic, Marjana			Comparative Genomic, MicroRNA, and Tissue Analyses Reveal Subtle Differences between Non-Diabetic and Diabetic Foot Skin	PLOS ONE			English	Article							VENOUS ULCERS; KERATINOCYTE DIFFERENTIATION; ATOPIC-DERMATITIS; VESSEL DENSITY; CHRONIC WOUNDS; INFLAMMATION; FIBROBLASTS; PSORIASIS; TARGET; CELLS	Diabetes Mellitus (DM) is a chronic, severe disease rapidly increasing in incidence and prevalence and is associated with numerous complications. Patients with DM are at high risk of developing diabetic foot ulcers (DFU) that often lead to lower limb amputations, long term disability, and a shortened lifespan. Despite this, the effects of DM on human foot skin biology are largely unknown. Thus, the focus of this study was to determine whether DM changes foot skin biology predisposing it for healing impairment and development of DFU. Foot skin samples were collected from 20 patients receiving corrective foot surgery and, using a combination of multiple molecular and cellular approaches, we performed comparative analyses of non-ulcerated non-neuropathic diabetic foot skin (DFS) and healthy nondiabetic foot skin (NFS). MicroRNA (miR) profiling of laser captured epidermis and primary dermal fibroblasts from both DFS and NFS samples identified 5 miRs de-regulated in the epidermis of DFS though none reached statistical significance. MiR-31-5p and miR-31-3p were most profoundly induced. Although none were significantly regulated in diabetic fibroblasts, miR-29c-3p showed a trend of up-regulation, which was confirmed by qPCR in a prospective set of 20 skin samples. Gene expression profiling of full thickness biopsies identified 36 de-regulated genes in DFS (>2 fold-change, unadjusted p-value <= 0.05). Of this group, three out of seven tested genes were confirmed by qPCR: SERPINB3 was up-regulated whereas OR2A4 and LGR5 were down-regulated in DFS. However no morphological differences in histology, collagen deposition, and number of blood vessels or lymphocytes were found. No difference in proliferative capacity was observed by quantification of Ki67 positive cells in epidermis. These findings suggest DM causes only subtle changes to foot skin. Since morphology, mRNA and miR levels were not affected in a major way, additional factors, such as neuropathy, vascular complications, or duration of DM, may further compromise tissue's healing ability leading to development of DFUs.	[Ramirez, Horacio A.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Human Genet & Genom Grad Program Biomed Sci, Miami, FL 33136 USA; [Ramirez, Horacio A.; Liang, Liang; Pastar, Irena; Rosa, Ashley M.; Stojadinovic, Olivera; Kirsner, Robert S.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Zwick, Thomas G.; Kirsner, Robert S.] Univ Miami Hosp, UM Hlth Syst, Miami, FL USA; [Maione, Anna G.; Garlick, Jonathan A.] Tufts Univ, Sackler Sch Grad Biomed Sci, Cell, Mol,Dev Biol, Boston, MA 02111 USA; [Maione, Anna G.; Garlick, Jonathan A.] Tufts Univ, Oral Med & Craniofacial Pain Sch Dent Med, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA	University of Miami; University of Miami; University of Miami; Tufts University; Tufts University	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Human Genet & Genom Grad Program Biomed Sci, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	NIH [RC1DK086364, R01NR013881, R01DK098055]; University of Miami SAC Award SAC; UMSDRC of the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098055, RC1DK086364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR015649, R01NR013881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami SAC Award SAC; UMSDRC of the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was funded by NIH grants RC1DK086364 (MT-C), R01NR013881 (MT-C) and R01DK098055 (JG), University of Miami SAC Award SAC 2013-19 (MT-C), and the UMSDRC of the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin C, 2007, CLIN IMMUNOL, V123, P268, DOI 10.1016/j.clim.2007.02.007; [Anonymous], 2015, JID UNPUB; Arya AK, 2014, WORLD J DIABETES, V5, P756, DOI 10.4239/wjd.v5.i6.756; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benoit S, 2006, BRIT J DERMATOL, V155, P62, DOI 10.1111/j.1365-2133.2006.07198.x; Brem H, 2007, EXP GERONTOL, V42, P523, DOI 10.1016/j.exger.2006.11.018; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Charles CA, 2008, J AM ACAD DERMATOL, V59, P758, DOI 10.1016/j.jaad.2008.07.018; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Ge K, 2015, GENET MOL RES, V14, P4802, DOI 10.4238/2015.May.11.12; Gebhardt C, 2002, ONCOGENE, V21, P4266, DOI 10.1038/sj.onc.1205521; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Haemmerle M, 2013, DIABETES, V62, P2509, DOI 10.2337/db12-0844; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Jin S, 2014, EXP DERMATOL, V23, P938, DOI 10.1111/exd.12563; Lantis JC, 2013, J VASC SURG, V58, P433, DOI 10.1016/j.jvs.2012.12.055; Li T, 2015, BIOTECHNOL LETT, V37, P523, DOI 10.1007/s10529-014-1715-y; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Madhyastha R, 2012, INT WOUND J, V9, P355, DOI 10.1111/j.1742-481X.2011.00890.x; Otton R, 2004, J ENDOCRINOL, V182, P145, DOI 10.1677/joe.0.1820145; Park LK, 2014, EPIGENETICS-US, V9, P1339, DOI 10.4161/15592294.2014.967584; Pastar Irena, 2011, Surg Technol Int, V21, P51; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; PEREZ MI, 1994, J AM ACAD DERMATOL, V30, P519, DOI 10.1016/S0190-9622(94)70058-3; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Reiber G.E., 1995, DIABETES AM, P409; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Sivaprasad U, 2015, J INVEST DERMATOL, V135, P160, DOI 10.1038/jid.2014.353; Slusarz A, 2015, J CARDIOVASC MED, V16, P480, DOI 10.2459/JCM.0000000000000246; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; SPANHEIMER RG, 1988, DIABETES, V37, P371, DOI 10.2337/diabetes.37.4.371; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2013, EXP DERMATOL, V22, P216, DOI 10.1111/exd.12104; Stojadinovic O, 2008, J CELL MOL MED, V12, P2675, DOI 10.1111/j.1582-4934.2008.00321.x; Tellechea A, 2013, INT J LOW EXTR WOUND, V12, P4, DOI 10.1177/1534734612474303; Van Hattem S, 2008, CLEV CLIN J MED, V75, P772, DOI 10.3949/ccjm.75.11.772; Xu L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-13; Xu N, 2013, J IMMUNOL, V190, P678, DOI 10.4049/jimmunol.1202695; Ye X, 2013, CLIN EXP DERMATOL, V38, P530, DOI 10.1111/ced.12002; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhong Xiaomin, 2012, Methods Mol Biol, V822, P295, DOI 10.1007/978-1-61779-427-8_21	55	40	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137133	10.1371/journal.pone.0137133	http://dx.doi.org/10.1371/journal.pone.0137133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26318001	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100209
J	Terres, MA; Lawrence, E; Hosack, GR; Haywood, MDE; Babcock, RC				Terres, Maria A.; Lawrence, Emma; Hosack, Geoffrey R.; Haywood, Michael D. E.; Babcock, Russell C.			Assessing Habitat Use by Snapper (Chrysophrys auratus) from Baited Underwater Video Data in a Coastal Marine Park	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; LONG-TERM PROTECTION; PAGRUS-AURATUS; TEMPORAL VARIATION; RESERVES; AREAS; RECOVERY; PREDICTION; AUSTRALIA; SPARIDAE	Baited Underwater Video (BUV) systems have become increasingly popular for assessing marine biodiversity. These systems provide video footage from which biologists can identify the individual fish species present. Here we explore the relevance of spatial dependence and marine park boundaries while estimating the distribution and habitat associations of the commercially and recreationally important snapper species Chrysophrys auratus in Moreton Bay Marine Park during a period when new Marine National Parks zoned as no-take or "green" areas (i.e., areas with no legal fishing) were introduced. BUV studies typically enforce a minimum distance among BUV sites, and then assume that observations from different sites are independent conditional on the measured covariates. In this study, we additionally incorporated the spatial dependence among BUV sites into the modelling framework. This modelling approach allowed us to test whether or not the incorporation of highly correlated environmental covariates or the geographic placement of BUV sites produced spatial dependence, which if unaccounted for could lead to model bias. We fitted Bayesian logistic models with and without spatial random effects to determine if the Marine National Park boundaries and available environmental covariates had an effect on snapper presence and habitat preference. Adding the spatial dependence component had little effect on the resulting model parameter estimates that emphasized positive association for particular coastal habitat types by snapper. Strong positive relationships between the presence of snapper and rock habitat, particularly rocky substrate composed of indurated freshwater sediments known as coffee rock, and kelp habitat reinforce the consideration of habitat availability in marine reserve design and the design of any associated monitoring programs.	[Terres, Maria A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Lawrence, Emma] CSIRO, Digital Prod Flagship, Dutton Pk, Qld, Australia; [Hosack, Geoffrey R.] CSIRO, Digital Prod Flagship, Hobart, Tas, Australia; [Haywood, Michael D. E.; Babcock, Russell C.] CSIRO, Oceans & Atmosphere Flagship, Dutton Pk, Qld, Australia	University of North Carolina; North Carolina State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Terres, MA (corresponding author), N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	mterres.stat@gmail.com	Babcock, Russell C/A-3794-2012; Hosack, Geoffrey R/E-8566-2010; Lawrence, Emma/A-5584-2009	Babcock, Russell C/0000-0002-7756-1290; Hosack, Geoffrey R/0000-0002-6462-6817; 	Australian Government's National Environmental Research Program (NERP); CSIRO Marine and Atmospheric Research; DERM (Queensland Department of Environment and Resource Management)	Australian Government's National Environmental Research Program (NERP)(Australian Government); CSIRO Marine and Atmospheric Research(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); DERM (Queensland Department of Environment and Resource Management)	This work was undertaken for the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding for the fieldwork was jointly (50:50) provided by CSIRO Marine and Atmospheric Research and DERM (Queensland Department of Environment and Resource Management).	Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; [Anonymous], 2011, STOCK STATUS QUEENSL; Banerjee S., 2004, HIERARCHICAL MODELIN; Brooke B, 2008, AUSTR J EARTH SCI, V107, P18278; Campbell A.B., 2009, STOCK ASSESSMENT SUM; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Cappo M, 2003, AQUATIC PROTECTED AR; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Denny Christopher M., 2003, DOC Science Internal Series, V142, P1; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Dunlop KM, 2014, MARINE ECOLOGY, P1; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferrell D., 1997, ASSESSMENT FISHERY S; Fletcher WJ, ECOLOGICAL IN PRESS; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Lubchenco J, 2003, ECOL APPL, V13, pS1; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127616; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McCook LJ, 2010, P NATL ACAD SCI US; Mclean DL, 2011, J EXP MAR BIOL ECOL, V406, P71, DOI 10.1016/j.jembe.2011.06.009; McLean DL, 2010, MAR ECOL PROG SER, V418, P189, DOI 10.3354/meps08834; McPhee DP, 2007, 2007053 FRDC AUSTR G; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Parsons DM, 2011, CAN J FISH AQUAT SCI, V68, P632, DOI 10.1139/F11-005; Parsons DM, 2003, MAR ECOL PROG SER, V262, P253, DOI 10.3354/meps262253; Roberts CM, 2003, ECOL APPL, V13, pS199; Ross PM, 2007, MAR FRESHWATER RES, V58, P1144, DOI 10.1071/MF07017; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 2002, YET ANOTHER REV MARI, P421; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Sangil C, 2012, ESTUAR COAST SHELF S, V112, P207, DOI 10.1016/j.ecss.2012.07.025; Smith ANH, 2014, MAR ECOL PROG SER, V499, P203, DOI 10.3354/meps10653; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Sumpton W, 2005, FISH RES, V71, P335, DOI 10.1016/j.fishres.2004.07.003; Sumpton W, 2003, MAR FRESH RES, V54, P1, DOI [10.1071/MF02041, DOI 10.1071/MF02041]; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2006, USE OF UNDERWATER ST; Webley J, 2009, SURVEY MARINE BOAT B; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024	57	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136799	10.1371/journal.pone.0136799	http://dx.doi.org/10.1371/journal.pone.0136799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317655	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100142
J	Wu, S; Wu, QP; Zhang, JM; Chen, MT; Yan, ZA; Hu, HJ				Wu, Shi; Wu, Qingping; Zhang, Jumei; Chen, Moutong; Yan, Ze'an; Hu, Huijuan			Listeria monocytogenes Prevalence and Characteristics in Retail Raw Foods in China	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; EPIDEMIC CLONES; PROCESSING ENVIRONMENT; CONTAMINATION PATTERNS; GENETIC DIVERSITY; GENUS LISTERIA; MULTIPLEX PCR; VIRULENCE; STRAINS	The prevalence and levels of Listeria monocytogenes in retail raw foods covering most provincial capitals in China were studied with testing of 1036 samples of vegetables, edible mushrooms, raw meat, aquatic products and quick-frozen products from September 2012 to January 2014. The total prevalence of Listeria monocytogenes was 20.0% (207/1036), and the most probable number (MPN) values of 65.7% of the positive samples ranged from 0.3 to 110 MPN/g. Geographical differences were observed in this survey, and the results of both qualitative and quantitative methods indicated that the levels in the samples from North China were higher than those in the samples from South China. A total of 248 isolates were analyzed, of which approximately half belonged to molecular serogroup 1/2a-3a (45.2%), followed by 1/2b-3b-7 (30.6%), 1/2c-3c (16.1%), 4b-4d-4e (5.2%) and 4a-4c (2.8%). Most of the isolates carried hly (100%), inlB (98.8%), inlA (99.6%), inlC (98.0%) and inlJ (99.2%), and 44.8% of the isolates were llsX-positive. Seventeen epidemic clones (ECs) were detected, with 7 strains belonging to ECI (2.8%) and 10 belonging to ECIII (4.03%). Resistance to clindamycin (46.8%) was commonly observed, and 59 strains (23.8%) were susceptible to all 14 tested antibiotics, whereas 84 (33.9%) showed an intermediate level of resistance or were resistant to two or more antibiotics, including 7 multiresistant strains that exhibited resistance to more than 10 antibiotics. The data obtained in the present study provides useful information for assessment of the possible risk posed to Chinese consumers, and this information will have a significant public health impact in China. Furthermore, the presence of virulence markers, epidemic clones, as well as the antibiotic resistance amongst the isolates strongly implies that many of these strains might be capable of causing listeriosis, and more accurate treatment of human listeriosis with effective antibiotics should be considered. This research represents a more full-scale and systematical investigation of the prevalence of L. monocytogenes in retail raw foods in China, and it provides baseline information for Chinese regulatory authorities that will aid in the formulation of a regulatory framework for controlling L. monocytogenes with the aim of improving the microbiological safety of raw foods.	[Wu, Shi; Chen, Moutong; Hu, Huijuan] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Wu, Shi; Wu, Qingping; Zhang, Jumei; Chen, Moutong; Yan, Ze'an; Hu, Huijuan] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wu, QP (corresponding author), Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China.	wuqp203@163.com			National Natural Science Foundation of China [U1031003, 31471664]; Key Projects in the National Science & Technology Pillar Program [2013BAD16B05]; Science and Technology Projects of Guangdong [2013B050800026]; Science and Technology Projects of Guangzhou [201504010036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Science and Technology Projects of Guangdong; Science and Technology Projects of Guangzhou	Our study was supported by the financing support of National Natural Science Foundation of China (No. U1031003, QPW; No. 31471664, QPW), Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2013BAD16B05, QPW), the Science and Technology Projects of Guangdong (2013B050800026, JMZ) and the Science and Technology Projects of Guangzhou (201504010036, QPW).	Adzitey F, 2013, FOOD CONTROL, V32, P607, DOI 10.1016/j.foodcont.2012.12.016; [Anonymous], 2001, J FOOD SCI, DOI DOI 10.1111/J.1365-2621.2001.TB15526.X; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bayles DO, 1996, APPL ENVIRON MICROB, V62, P1116, DOI 10.1128/AEM.62.3.1116-1119.1996; Beauchamp CS, 2010, FOOD MICROBIOL, V27, P144, DOI 10.1016/j.fm.2009.09.007; Borucki MK, 2003, VET MICROBIOL, V92, P351, DOI 10.1016/S0378-1135(02)00423-6; BUCHRIESER C, 1993, CAN J MICROBIOL, V39, P395, DOI 10.1139/m93-058; BULA CJ, 1995, CLIN INFECT DIS, V20, P66, DOI 10.1093/clinids/20.1.66; Chao GX, 2007, FOODBORNE PATHOG DIS, V4, P277, DOI 10.1089/fpd.2007.0088; Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103, DOI 10.1128/AAC.43.9.2103; Chen BY, 2010, LETT APPL MICROBIOL, V50, P626, DOI 10.1111/j.1472-765X.2010.02843.x; Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P7, DOI 10.1089/fpd.2008.0139; Chen MT, 2014, FOODBORNE PATHOG DIS, V11, P620, DOI 10.1089/fpd.2013.1727; Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061; Chen Y, 2007, APPL ENVIRON MICROB, V73, P6299, DOI 10.1128/AEM.00961-07; Chen Y, 2007, J CLIN MICROBIOL, V45, P835, DOI 10.1128/JCM.01575-06; Clayton EM, 2011, APPL ENVIRON MICROB, V77, P163, DOI 10.1128/AEM.01673-10; Clinical and Laboratory Standards Institute, 2006, M2A9 CLSI; Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Dmowska K, 2013, B VET I PULAWY, V57, P179, DOI 10.2478/bvip-2013-0033; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Filiousis G, 2009, FOOD CONTROL, V20, P314, DOI 10.1016/j.foodcont.2008.05.018; Godreuil S, 2003, ANTIMICROB AGENTS CH, V47, P704, DOI 10.1128/AAC.47.2.704-708.2003; Gombas DE, 2003, J FOOD PROTECT, V66, P559, DOI 10.4315/0362-028X-66.4.559; Gudbjornsdottir B, 2004, FOOD MICROBIOL, V21, P217, DOI 10.1016/S0740-0020(03)00012-1; Hansen CH, 2006, J FOOD PROTECT, V69, P2113, DOI 10.4315/0362-028X-69.9.2113; Harakeh S, 2009, SCI TOTAL ENVIRON, V407, P4022, DOI 10.1016/j.scitotenv.2009.04.010; HEISICK JE, 1989, APPL ENVIRON MICROB, V55, P1925, DOI 10.1128/AEM.55.8.1925-1927.1989; Helwigh B, 2007, COMMUNITY SUMMARY RE; Hoffman AD, 2003, J FOOD PROTECT, V66, P52, DOI 10.4315/0362-028X-66.1.52; Inoue S, 2000, INT J FOOD MICROBIOL, V59, P73, DOI 10.1016/S0168-1605(00)00284-1; Jensen A, 2008, INT J FOOD MICROBIOL, V123, P254, DOI 10.1016/j.ijfoodmicro.2008.02.016; Jia YM, 2007, FOODBORNE PATHOG DIS, V4, P222, DOI 10.1089/fpd.2006.0081; Kathariou S., 2003, Microbial food safety in animal agriculture: current topics, P243, DOI 10.1002/9780470752616.ch25; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Korsak D, 2012, INT J FOOD MICROBIOL, V158, P203, DOI 10.1016/j.ijfoodmicro.2012.07.016; Liu D., 2008, HDB LISTERIA MONOCYT; Liu D, 2007, J MICROBIOL METH, V71, P133, DOI 10.1016/j.mimet.2007.08.007; Lomonaco S, 2009, INT J FOOD MICROBIOL, V128, P516, DOI 10.1016/j.ijfoodmicro.2008.10.009; Lomonaco S, 2013, EMERG INFECT DIS, V19, P147, DOI 10.3201/eid1901.121167; Mammina C, 2009, J CLIN MICROBIOL, V47, P2925, DOI 10.1128/JCM.00102-09; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; Nesbakken T, 1996, INT J FOOD MICROBIOL, V31, P161, DOI 10.1016/0168-1605(96)00978-6; Norhana MNW, 2010, FOOD CONTROL, V21, P343, DOI 10.1016/j.foodcont.2009.06.020; Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012; Rahimi E, 2012, ANN MICROBIOL, V62, P37, DOI 10.1007/s13213-011-0222-9; Razavilar V, 1998, INT J FOOD MICROBIOL, V40, P149, DOI 10.1016/S0168-1605(98)00014-2; Ryser ET., 2007, FOOD SCI TECH-BRAZIL; Sant'Ana AS, 2012, INT J FOOD MICROBIOL, V155, P1, DOI 10.1016/j.ijfoodmicro.2011.12.036; Sauders BD, 2006, J FOOD PROTECT, V69, P1680, DOI 10.4315/0362-028X-69.7.1680; Shen JL, 2013, FOOD MICROBIOL, V35, P58, DOI 10.1016/j.fm.2013.02.014; Shen Y, 2006, APPL ENVIRON MICROB, V72, P5073, DOI 10.1128/AEM.00435-06; Soni DK, 2013, INFECT GENET EVOL, V14, P83, DOI 10.1016/j.meegid.2012.09.019; Todd ECD, 2011, FOOD CONTROL, V22, P1484, DOI 10.1016/j.foodcont.2010.07.021; Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032; Wang YM, 2010, CHINESE J FOOD HYGIE, V5, P018; Wieczorek K, 2012, APPL ENVIRON MICROB, V78, P2043, DOI 10.1128/AEM.07156-11; Wong W. C., 2012, International Food Research Journal, V19, P1751; World Health Organization, 2007, P 2 WHO EXP M COP DE; Wu S, 2015, FOOD CONTROL, V47, P340, DOI 10.1016/j.foodcont.2014.07.028; Xu X. K., 2009, CHINESE J HLTH LAB T, V19, P1199; Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015; Yu T, 2014, FOOD CONTROL, V37, P228, DOI 10.1016/j.foodcont.2013.09.047; Zarei M, 2012, FOODBORNE PATHOG DIS, V9, P108, DOI 10.1089/fpd.2011.0989	68	69	78	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136682	10.1371/journal.pone.0136682	http://dx.doi.org/10.1371/journal.pone.0136682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317852	Green Submitted, Green Published, gold			2022-12-27	WOS:000360299100120
J	Li, CM; Liu, YJ; Zhang, WY				Li, Chunming; Liu, Yajun; Zhang, Weiyuan			Joint and Independent Associations of Gestational Weight Gain and Pre-Pregnancy Body Mass Index with Outcomes of Pregnancy in Chinese Women: A Retrospective Cohort Study	PLOS ONE			English	Article							ASIAN POPULATIONS; DIABETES-MELLITUS; CESAREAN DELIVERY; MATERNAL OBESITY; RISK-FACTORS; HYPERGLYCEMIA; OVERWEIGHT; RETENTION	Objective To explore the joint and independent effects of gestational weight gain (GWG) and pre-pregnancy body mass index (BMI) on pregnancy outcomes in a population of Chinese Han women and to evaluate pregnant women's adherence to the 2009 Institute of Medicine (IOM) gestational weight gain guidelines. Methods This was a multicenter, retrospective cohort study of 48,867 primiparous women from mainland China who had a full-term singleton birth between January 1, 2011 and December 30, 2011. The independent associations of pre-pregnancy BMI, GWG and categories of combined pre-pregnancy BMI and GWG with outcomes of interest were examined using an adjusted multivariate regression model. In addition, women with pre-pregnancy hypertension were excluded from the analysis of the relationship between GWG and delivery of small-for-gestational-age (SGA) infants, and women with gestational diabetes (GDM) were excluded from the analysis of the relationship between GWG and delivery of large-for-gestational-age (LGA) infants. Results Only 36.8% of the women had a weight gain that was within the recommended range; 25% and 38.2% had weight gains that were below and above the recommended range, respectively. The contribution of GWG to the risk of adverse maternal and fetal outcomes was modest. Women with excessive GWG had an increased likelihood of gestational hypertension (adjusted OR 2.55; 95% CI = 1.92-2.80), postpartum hemorrhage (adjusted OR 1.30; 95% CI = 1.17-1.45), cesarean section (adjusted OR 1.31; 95% CI = 1.18-1.36) and delivery of an LGA infant (adjusted OR 2.1; 95% CI = 1.76-2.26) compared with women with normal weight gain. Conversely, the incidence of GDM (adjusted OR 1.64; 95% CI = 1.20-1.85) and SGA infants (adjusted OR 1.51; 95% CI = 1.32-1.72) was increased in the group of women with inadequate GWG. Moreover, in the obese women, excessive GWG was associated with an apparent increased risk of delivering an LGA infant. In the women who were underweight, poor weight gain was associated with an increased likelihood of delivering an SGA infant. After excluding the mothers with GDM or gestational hypertension, the ORs for delivery of LGA and SGA infants decreased for women with high GWG and increased for women with low GWG. Conclusions GWG above the recommended range is common in this population and is associated with multiple unfavorable outcomes independent of pre-pregnancy BMI. Obese women may benefit from avoiding weight gain above the range recommended by the 2009 IOM. Underweight women should avoid low GWG to prevent delivering an SGA infant. Pregnant women should therefore be monitored to comply with the IOM recommendations and should have a balanced weight gain that is within a range based on their pre-pregnancy BMI.	[Li, Chunming] Zhejiang Univ, Sch Med, Womens Hosp, Dept Obstet, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Chunming; Liu, Yajun; Zhang, Weiyuan] Capital Med Univ, Dept Obstet, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China	Zhejiang University; Capital Medical University	Zhang, WY (corresponding author), Capital Med Univ, Dept Obstet, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China.	zhangwy9921@hotmail.com			"Health industry special funds for Public Benefit Research Foundation" from the Ministry of Health, People's Republic of China [201002013]; "the Health Excellent Talent Foundation of Beijing" from Beijing Health Bureau [2009-2-11]	"Health industry special funds for Public Benefit Research Foundation" from the Ministry of Health, People's Republic of China; "the Health Excellent Talent Foundation of Beijing" from Beijing Health Bureau	This project was supported by "Health industry special funds for Public Benefit Research Foundation" from the Ministry of Health, People's Republic of China (Grant number 201002013) and "the Health Excellent Talent Foundation of Beijing" from Beijing Health Bureau (Grant number 2009-2-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, OKLA NURSE, V42, P15; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; Chung JGY, 2013, EUR J OBSTET GYN R B, V167, P149, DOI 10.1016/j.ejogrb.2012.11.020; COGSWELL ME, 1995, AM J OBSTET GYNECOL, V172, P705, DOI 10.1016/0002-9378(95)90598-7; Durie DE, 2011, OBSTET GYNECOL, V118, P569, DOI 10.1097/AOG.0b013e3182289f42; Egan AM, 2014, J CLIN ENDOCR METAB, V99, P212, DOI 10.1210/jc.2013-2684; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Gore SA, 2003, ANN BEHAV MED, V26, P149, DOI 10.1207/S15324796ABM2602_07; Grisaru-Granovsky S, 2007, AM J OBSTET GYNECOL, V196, P331; Gunderson EP, 2000, EPIDEMIOL REV, V22, P261, DOI 10.1093/oxfordjournals.epirev.a018038; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, P201, DOI DOI 10.1186/1471-2393-14-201; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heude B, 2012, MATERN CHILD HLTH J, V16, P355, DOI 10.1007/s10995-011-0741-9; Jang DG, 2011, ARCH GYNECOL OBSTET, V284, P1389, DOI 10.1007/s00404-011-1868-z; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Li CM, 2013, CHINESE MED J-PEKING, V126, P4585, DOI 10.3760/cma.j.issn.0366-6999.20131126; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Misra VK, 2010, J MATERN-FETAL NEO M, V23, P842, DOI 10.3109/14767050903387037; Munim S, 2012, JCPSP-J COLL PHYSICI, V22, P694, DOI 11.2012/JCPSP.694698; Murakami Maki, 2005, Archives of Gynecology and Obstetrics, V271, P311, DOI 10.1007/s00404-004-0629-7; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101; Rasmussen KM, 2009, WEIGHT GAIN DURING P; Ricci E, 2010, J MATERN-FETAL NEO M, V23, P501, DOI 10.3109/14767050903216025; Riskin-Mashiah S, 2011, GYNECOL ENDOCRINOL, V27, P464, DOI 10.3109/09513590.2010.495436; Rosenberg TJ, 2005, AM J PUBLIC HEALTH, V95, P1545, DOI 10.2105/AJPH.2005.065680; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Seligman LC, 2006, REV SAUDE PUBL, V40, P457, DOI 10.1590/S0034-89102006000300014; Shiwaku K, 2004, LANCET, V363, P1077, DOI 10.1016/S0140-6736(04)15856-X; Tanaka T, 2014, J OBSTET GYNAECOL RE, V40, P1296, DOI 10.1111/jog.12353; Vesco KK, 2011, OBSTET GYNECOL, V117, P812, DOI 10.1097/AOG.0b013e3182113ae4; Young TK, 2002, AM J OBSTET GYNECOL, V187, P312, DOI 10.1067/mob.2002.126200; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	38	81	97	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136850	10.1371/journal.pone.0136850	http://dx.doi.org/10.1371/journal.pone.0136850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313941	Green Submitted, Green Published, gold			2022-12-27	WOS:000360144000101
J	Nagaya, T; Sato, K; Harada, T; Nakamura, Y; Choyke, PL; Kobayashi, H				Nagaya, Tadanobu; Sato, Kazuhide; Harada, Toshiko; Nakamura, Yuko; Choyke, Peter L.; Kobayashi, Hisataka			Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODIES; ENHANCED PERMEABILITY; PHOTODYNAMIC THERAPY; TUMOR-MODEL; EXPRESSION; EFFICACY; SUBTYPES; CETUXIMAB; COCKTAIL	Aim Triple-negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer. Near infrared photoimmunotherapy (NIR-PIT) is a cancer treatment that employs an antibody-photosensitizer conjugate (APC) followed by exposure of NIR light for activating selective cytotoxicity on targeted cancer cells and may have application to TNBC. In order to minimize the dose of APC while maximizing the therapeutic effects, dosing of the APC and NIR light need to be optimized. In this study, we investigate in vitro and in vivo efficacy of cetuximab (cet)-IR700 NIR-PIT on two breast cancer models MDAMB231 (TNBC, EGFR moderate) and MDAMB468 (TNBC, EGFR high) cell lines, and demonstrate a method to optimize the dosing APC and NIR light. Method After validating in vitro cell-specific cytotoxicity, NIR-PIT therapeutic effects were investigated in mouse models using cell lines derived from TNBC tumors. Tumor-bearing mice were separated into 4 groups for the following treatments: (1) no treatment (control); (2) 300 mu g of cet-IR700 i.v., (APC i.v. only); (3) NIR light exposure only, NIR light was administered at 50 J/cm(2) on day 1 and 100 J/cm(2) on day 2 (NIR light only); (4) 300 mu g of cet-IR700 i.v., NIR light was administered at 50 J/cm(2) on day 1 after injection and 100 J/cm(2) of light on day 2 after injection (one shot NIR-PIT). To compare different treatment regimens with a fixed dose of APC, we added the following treatments (5) 100 mu g of cet-IR700 i.v., NIR light administered at 50 J/cm(2) on day 1 and 50 mu g of cet-IR700 i.v. immediately after NIR-PIT, then NIR light was administered at 100 J/cm(2) on day 2, which were performed two times every week ("two split" NIR-PIT) and (6) 100 mu g of cet-IR700 i.v., NIR light was administered at 50 J/cm(2) on day 1 and 100 J/cm(2) on day 2, which were performed three times per week ("three split" NIR-PIT). Result Both specific binding and NIR-PIT effects were greater with MDAMB468 than MDAMB231 cells in vitro. Tumor accumulation of cet-IR700 in MDAMB468 tumors was significantly higher (p < 0.05) than in MDAMB231 tumors in vivo. Tumor growth and survival of MDAMB231 tumor bearing mice was significantly lower in the NIR-PIT treatment group (p < 0.05). In MDAMB468 bearing mice, tumor growth and survival was significantly improved in the NIR-PIT treatment groups in all treatment regimens (one shot NIR-PIT; p < 0.05, "two split" NIR-PIT; p < 0.01, "three split" NIR-PIT; p < 0.001) compared with control groups. Conclusion NIR-PIT for TNBC was effective regardless of expression of EGFR, however, greater cell killing was shown with higher EGFR expression tumor in vitro. In all treatment regimens, NIR-PIT suppressed tumor growth, resulting in significantly prolonged survival that further improved by splitting the APC dose and using repeated light exposures.	[Nagaya, Tadanobu; Sato, Kazuhide; Harada, Toshiko; Nakamura, Yuko; Choyke, Peter L.; Kobayashi, Hisataka] NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kobayashi, H (corresponding author), NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA.	kobayash@mail.nih.gov		Sato, Kazuhide/0000-0003-3025-088X	National Cancer Institute [ZIA BC 011513]; NATIONAL CANCER INSTITUTE [ZIABC011513] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	HK received funding from the National Cancer Institute, ZIA BC 011513, https://ccrod.cancer.gov/confluence/display/CCRARSINFO/Z+Numbers+-+2013+Completed+Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2007, CLIN CANCER RES, V13, P6639, DOI 10.1158/1078-0432.CCR-07-1119; Baselga J, 2013, J CLIN ONCOL, V31, P2586, DOI 10.1200/JCO.2012.46.2408; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Chen B, 2006, CLIN CANCER RES, V12, P917, DOI 10.1158/1078-0432.CCR-05-1673; Engebraaten O, 2013, AM J PATHOL, V183, P1064, DOI 10.1016/j.ajpath.2013.05.033; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gelmon K, 2012, ANN ONCOL, V23, P2223, DOI 10.1093/annonc/mds067; Gil M, 2011, BRIT J CANCER, V105, P1512, DOI 10.1038/bjc.2011.429; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kaufmann M, 2011, CANCER-AM CANCER SOC, V117, P1575, DOI 10.1002/cncr.25660; Kobayashi H, 2014, THERANOSTICS, V4, P81, DOI 10.7150/thno.7193; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; MEW D, 1983, J IMMUNOL, V130, P1473; Mitsunaga M, 2012, BIOCONJUGATE CHEM, V23, P604, DOI 10.1021/bc200648m; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Modi S, 2006, CLIN BREAST CANCER, V7, P270, DOI 10.3816/CBC.2006.n.040; Momiyama M, 2013, J CELL BIOCHEM, V114, P428, DOI 10.1002/jcb.24381; Momiyama M, 2012, ANTICANCER RES, V32, P4327; Nakajima T, 2013, THERANOSTICS, V3, P357, DOI 10.7150/thno.5908; Nechushtan H, 2014, BREAST, V23, P435, DOI 10.1016/j.breast.2014.03.003; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sano K, 2014, MOL CANCER THER, V13, P426, DOI 10.1158/1535-7163.MCT-13-0633; Sano K, 2013, ACS NANO, V7, P717, DOI 10.1021/nn305011p; Sato K, 2015, THERANOSTICS, V5, P698, DOI 10.7150/thno.11559; Sato K, 2015, MOL CANCER THER, V14, P141, DOI 10.1158/1535-7163.MCT-14-0658; Sato K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113276; Sato K, 2014, MOL ONCOL, V8, P620, DOI 10.1016/j.molonc.2014.01.006; Snyder JW, 2003, CANCER RES, V63, P8126; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	33	60	68	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136829	10.1371/journal.pone.0136829	http://dx.doi.org/10.1371/journal.pone.0136829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313651	Green Published, gold, Green Submitted			2022-12-27	WOS:000360144000098
J	Wang, Y; Wang, BH				Wang, Yang; Wang, Binghong			Evolution of Cooperation on Spatial Network with Limited Resource	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; RECIPROCITY; PUNISHMENT; EMERGENCE; DIVERSITY; PROMOTES	Considering the external resource offered by environment is limited, here, we will explore the cooperation on spatial networks with limited resource. The individual distributes the limited resource according to the payoffs acquired in games, and one with resource amounts is lower than critical survival resource level will be replaced by the offspring of its neighbors. We find that, for larger temptation to defect, the number of the dead decreases with the resource amount. However the cooperation behavior is interesting, the lower total resource and intermediate temptation to defect can greatly promote the cooperation on square lattice. Our result reveals that the limited resource contributes most to the cooperation.	[Wang, Yang; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Binghong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Binghong] Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; Southwest University of Science & Technology - China	Wang, BH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.	bhwang@ustc.edu.cn						Axelrod R., 2006, EVOLUTION COOPERATIO; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Challet D, 1998, PHYSICA A, V256, P514, DOI 10.1016/S0378-4371(98)00260-X; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Gintis H., 2000, GAME THEORY EVOLVING; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064677; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Jiang LL, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031144; Johnson NF, 1999, PHYS REV LETT, V82, P3360, DOI 10.1103/PhysRevLett.82.3360; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043013; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sekiguchi T, 2009, J THEOR BIOL, V256, P297, DOI 10.1016/j.jtbi.2008.09.025; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, EUR PHYS J B, V61, P505, DOI 10.1140/epjb/e2008-00099-7; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Taylor P, 2010, J EVOLUTION BIOL, V23, P2569, DOI 10.1111/j.1420-9101.2010.02122.x; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang WX, 2011, CHAOS, V21, DOI 10.1063/1.3621719; Wang XW, 2015, APPL MATH COMPUT, V250, P848, DOI 10.1016/j.amc.2014.11.023; Wang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121508; Wang XW, 2013, PHYSICA A, V392, P4668, DOI 10.1016/j.physa.2013.05.020; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu ZX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012109; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang HF, 2014, PHYSICA A, V414, P86, DOI 10.1016/j.physa.2014.07.013; Zukewich J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054639	40	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136295	10.1371/journal.pone.0136295	http://dx.doi.org/10.1371/journal.pone.0136295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313944	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000053
J	Landowski, CP; Huuskonen, A; Wahl, R; Westerholm-Parvinen, A; Kanerva, A; Hanninen, AL; Salovuori, N; Penttila, M; Natunen, J; Ostermeier, C; Helk, B; Saarinen, J; Saloheimo, M				Landowski, Christopher P.; Huuskonen, Anne; Wahl, Ramon; Westerholm-Parvinen, Ann; Kanerva, Anne; Hanninen, Anna-Liisa; Salovuori, Noora; Penttila, Merja; Natunen, Jari; Ostermeier, Christian; Helk, Bernhard; Saarinen, Juhani; Saloheimo, Markku			Enabling Low Cost Biopharmaceuticals: A Systematic Approach to Delete Proteases from a Well-Known Protein Production Host Trichoderma reesei	PLOS ONE			English	Article							FACTORS INFLUENCING GLYCOSYLATION; ASPERGILLUS-NIGER; TRANSFORMATION SYSTEM; EXTRACELLULAR PROTEASES; HETEROLOGOUS PROTEINS; N-GLYCOSYLATION; SERINE-PROTEASE; O-GLYCOSYLATION; HUMAN LYSOZYME; YEAST	The filamentous fungus Trichoderma reesei has tremendous capability to secrete proteins. Therefore, it would be an excellent host for producing high levels of therapeutic proteins at low cost. Developing a filamentous fungus to produce sensitive therapeutic proteins requires that protease secretion is drastically reduced. We have identified 13 major secreted proteases that are related to degradation of therapeutic antibodies, interferon alpha 2b, and insulin like growth factor. The major proteases observed were aspartic, glutamic, subtilisin-like, and trypsin-like proteases. The seven most problematic proteases were sequentially removed from a strain to develop it for producing therapeutic proteins. After this the protease activity in the supernatant was dramatically reduced down to 4% of the original level based upon a casein substrate. When antibody was incubated in the six protease deletion strain supernatant, the heavy chain remained fully intact and no degradation products were observed. Interferon alpha 2b and insulin like growth factor were less stable in the same supernatant, but full length proteins remained when incubated overnight, in contrast to the original strain. As additional benefits, the multiple protease deletions have led to faster strain growth and higher levels of total protein in the culture supernatant.	[Landowski, Christopher P.; Huuskonen, Anne; Westerholm-Parvinen, Ann; Penttila, Merja; Saloheimo, Markku] VTT Tech Res Ctr Finland, Espoo, Finland; [Wahl, Ramon; Ostermeier, Christian; Helk, Bernhard] Novartis Pharma AG, Basel, Switzerland; [Kanerva, Anne; Hanninen, Anna-Liisa; Salovuori, Noora; Natunen, Jari; Saarinen, Juhani] Glykos Finland Oy, Helsinki, Finland	VTT Technical Research Center Finland; Novartis	Landowski, CP (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	christopher.landowski@vtt.fi	Penttilä, Merja E/A-4710-2013	Penttila, Merja/0000-0002-6929-1032; Landowski, Christopher/0000-0003-1775-8646	Novartis Pharma AG; Glykos Finland Oy	Novartis Pharma AG; Glykos Finland Oy	This work was supported by Novartis Pharma AG and Glykos Finland Oy. The funders provided support in the form of salaries for authors RW, CO, BH, AK, ALH, NS, JN, and JS retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adav SS, 2011, J PROTEOME RES, V10, P4579, DOI 10.1021/pr200416t; ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Bailey MJ, 2003, APPL MICROBIOL BIOT, V62, P156, DOI 10.1007/s00253-003-1276-9; Braaksma M, 2009, MICROBIOL-SGM, V155, P3430, DOI 10.1099/mic.0.031062-0; Braaksma Machtelt, 2008, V26, P441; Budak SO, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-523; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Delgado-Jarana J, 2000, BBA-PROTEIN STRUCT M, V1481, P289, DOI 10.1016/S0167-4838(00)00172-2; Dienes D, 2007, ENZYME MICROB TECH, V40, P1087, DOI 10.1016/j.enzmictec.2006.08.013; Dube AK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0380-1; Eneyskaya EV, 1999, APPL MICROBIOL BIOT, V52, P226, DOI 10.1007/s002530051513; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; HAAB D, 1990, J BIOTECHNOL, V16, P187, DOI 10.1016/0168-1656(90)90035-A; Hagag S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033604; HAGSPIEL K, 1989, APPL MICROBIOL BIOT, V32, P61, DOI 10.1007/BF00164824; Hartl L, 2005, CURR GENET, V48, P204, DOI 10.1007/s00294-005-0011-8; Idiris A, 2006, APPL MICROBIOL BIOT, V73, P404, DOI 10.1007/s00253-006-0489-0; Jin FJ, 2007, APPL MICROBIOL BIOT, V76, P1059, DOI 10.1007/s00253-007-1088-4; Kataoka Y, 2005, FEBS LETT, V579, P2991, DOI 10.1016/j.febslet.2005.04.050; Katz ME, 2008, CURR GENET, V54, P47, DOI 10.1007/s00294-008-0198-6; Katz ME, 2006, FUNGAL GENET BIOL, V43, P190, DOI 10.1016/j.fgb.2005.12.001; Kiiskinen LL, 2004, MICROBIOL-SGM, V150, P3065, DOI 10.1099/mic.0.27147-0; Kimura S, 2008, BIOSCI BIOTECH BIOCH, V72, P499, DOI 10.1271/bbb.70582; Krysan DJ, 2005, EUKARYOT CELL, V4, P1364, DOI 10.1128/EC.4.8.1364-1374.2005; Kuroda K, 2007, FEMS YEAST RES, V7, P1307, DOI 10.1111/j.1567-1364.2007.00291.x; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Corchero JL, 2013, BIOTECHNOL ADV, V31, P140, DOI 10.1016/j.biotechadv.2012.09.001; Maiyuran S, 2011, Methods for producing polypeptides in protease-deficient mutants of Trichoderma, Patent No. [WO 2011/075677, 2011075677]; Mantyla A., 1998, TRICHODERMA GLIOCLAD, V2, P291; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MATTERN IE, 1992, MOL GEN GENET, V234, P332, DOI 10.1007/BF00283855; NYYSSONEN E, 1993, BIO-TECHNOL, V11, P591, DOI 10.1038/nbt0593-591; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Punt PJ, 2008, FUNGAL GENET BIOL, V45, P1591, DOI 10.1016/j.fgb.2008.09.007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Selinheimo E, 2006, FEBS J, V273, P4322, DOI 10.1111/j.1742-4658.2006.05429.x; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Simkovi M., 2008, ACTA CHIMICA SLOVACA, V1, P250; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; Steiger MG, 2011, APPL ENVIRON MICROB, V77, P114, DOI 10.1128/AEM.02100-10; UUSITALO JM, 1991, J BIOTECHNOL, V17, P35, DOI 10.1016/0168-1656(91)90025-Q; vandenHombergh JPTW, 1997, TRENDS BIOTECHNOL, V15, P256, DOI 10.1016/S0167-7799(97)01020-2; Verdoes J.C., 2007, IND BIOTECHNOL, V3, P48, DOI [10.1089/ind.2007.3.048, DOI 10.1089/IND.2007.3.048]; Wang YC, 2008, FUNGAL GENET BIOL, V45, P17, DOI 10.1016/j.fgb.2007.09.012; Yoon J, 2011, APPL MICROBIOL BIOT, V89, P747, DOI 10.1007/s00253-010-2937-0; Yoon J, 2009, APPL MICROBIOL BIOT, V82, P691, DOI 10.1007/s00253-008-1815-5; Zhang GX, 2014, PLASMID, V71, P16, DOI 10.1016/j.plasmid.2014.01.001	50	42	49	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0134723	10.1371/journal.pone.0134723	http://dx.doi.org/10.1371/journal.pone.0134723			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309247	gold, Green Published, Green Submitted			2022-12-27	WOS:000360069400032
J	Tang, CT; Liao, MY; Chiu, CY; Shen, WF; Chiu, CY; Cheng, PC; Chang, GJJ; Wu, HC				Tang, Chung-Tao; Liao, Mei-Ying; Chiu, Chien-Yu; Shen, Wen-Fan; Chiu, Chiung-Yi; Cheng, Ping-Chang; Chang, Gwong-Jen J.; Wu, Han-Chung			Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein	PLOS ONE			English	Article							DOMAIN-III; NEUTRALIZING ANTIBODIES; DEPENDENT ENHANCEMENT; IN-VIVO; INFECTION; GLYCOPROTEIN; CHALLENGES; PEPTIDE; FUSION; ORGANIZATION	The four serotypes of dengue virus (DENV1-4) pose a serious threat to global health. Cross-reactive and non-neutralizing antibodies enhance viral infection, thereby exacerbating the disease via antibody-dependent enhancement (ADE). Studying the epitopes targeted by these enhancing antibodies would improve the immune responses against DENV infection. In order to investigate the roles of antibodies in the pathogenesis of dengue, we generated a panel of 16 new monoclonal antibodies (mAbs) against DENV4. Using plaque reduction neutralization test (PRNT), we examined the neutralizing activity of these mAbs. Furthermore, we used the in vitro and in vivo ADE assay to evaluate the enhancement of DENV infection by mAbs. The results indicate that the cross-reactive and poorly neutralizing mAbs, DD11-4 and DD18-5, strongly enhance DENV1-4 infection of K562 cells and increase mortality in AG129 mice. The epitope residues of these enhancing mAbs were identified using virus-like particle (VLP) mutants. W212 and E26 are the epitope residues of DD11-4 and DD18-5, respectively. In conclusion, we generated and characterized 16 new mAbs against DENV4. DD11-4 and D18-5 possessed non-neutralizing activities and enhanced viral infection. Moreover, we identified the epitope residues of enhancing mAbs on envelope protein. These results may provide useful information for development of safe dengue vaccine.	[Tang, Chung-Tao; Liao, Mei-Ying; Chiu, Chien-Yu; Shen, Wen-Fan; Chiu, Chiung-Yi; Cheng, Ping-Chang; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chang, Gwong-Jen J.] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Publ Hlth Serv,US Dept HHS, Ft Collins, CO USA	Academia Sinica - Taiwan; Centers for Disease Control & Prevention - USA; United States Public Health Service	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Academia Sinica; Ministry of Science and Technology [104-0210-01-09-02]; National Science Council, Taiwan [NSC102-2325-B-001-010]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This funding was supported by grants from Academia Sinica, Ministry of Science and Technology (104-0210-01-09-02) and the National Science Council (NSC102-2325-B-001-010), Taiwan (to H-C Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chawla T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065231; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001636; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Tang CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003903; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	42	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136328	10.1371/journal.pone.0136328	http://dx.doi.org/10.1371/journal.pone.0136328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309127	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400108
J	Burton, A; Osborn, D; Atkins, L; Michie, S; Gray, B; Stevenson, F; Gilbert, H; Walters, K				Burton, Alexandra; Osborn, David; Atkins, Lou; Michie, Susan; Gray, Ben; Stevenson, Fiona; Gilbert, Hazel; Walters, Kate			Lowering Cardiovascular Disease Risk for People with Severe Mental Illnesses in Primary Care: A Focus Group Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INTERVENTION; BARRIERS; MOTIVATION; ADULTS	Background People with severe mental illnesses die early from cardiovascular disease. Evidence is lacking regarding effective primary care based interventions to tackle this problem. Aim To identify current procedures for, barriers to, and facilitators of the delivery of primary care based interventions for lowering cardiovascular risk for people with severe mental illnesses. Method 75 GPs, practice nurses, service users, community mental health staff and carers in UK GP practice or community mental health settings were interviewed in 14 focus groups which were audio-recorded, transcribed and analysed using Framework Analysis. Results Five barriers to delivering primary care based interventions for lowering cardiovascular risk in people with severe mental illnesses were identified by the groups: negative perceptions of people with severe mental illnesses amongst some health professionals, difficulties accessing GP and community-based services, difficulties in managing a healthy lifestyle, not attending appointments, and a lack of awareness of increased cardiovascular risk in people with severe mental illnesses by some health professionals. Identified facilitators included involving supportive others, improving patient engagement with services, continuity of care, providing positive feedback in consultations and goal setting. Conclusion We identified a range of factors which can be incorporated in to the design, delivery and evaluation of services to reduce cardiovascular risk for people with severe mental illnesses in primary care. The next step is determining the clinical and cost effectiveness of primary care based interventions for lowering cardiovascular risk in people with severe mental illnesses, and evaluating the most important components of such interventions.	[Burton, Alexandra; Osborn, David] UCL, Fac Brain Sci, Div Psychiat, Epidemiol & Appl Clin Res Dept, London, England; [Atkins, Lou; Michie, Susan] UCL, Ctr Behav Change, Dept Clin Educ & Hlth Psychol, Div Psychol & Language Sci,Fac Brain Sci, London, England; [Gray, Ben] McPin Fdn, London, England; [Stevenson, Fiona; Gilbert, Hazel; Walters, Kate] UCL, Inst Epidemiol & Hlth Care, Fac Populat Hlth Sci, Dept Primary Care & Populat Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Burton, A (corresponding author), UCL, Fac Brain Sci, Div Psychiat, Epidemiol & Appl Clin Res Dept, London, England.	a.burton@ucl.ac.uk; d.osborn@ucl.ac.uk	Gray, Ben/AAG-6312-2020; Atkins, Louise/C-7740-2011; Gray, Ben/R-6326-2017; Stevenson, Fiona/AAJ-2727-2021; Osborn PhD FRCPsych, David/B-8165-2009	Gray, Ben/0000-0001-7647-9474; Stevenson, Fiona/0000-0003-2139-2309; Gilbert, Hazel/0000-0002-1254-6874; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Walters, Kate/0000-0003-2173-2430	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) scheme [RP-PG-0609-10156]; National Institute for Health Research [RP-PG-0609-10156] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) scheme; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) scheme (Grant Reference Number RP-PG-0609-10156). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The findings from this work have been used to develop an intervention and training programme for lowering CVD risk in people with SMI in primary care. The clinical and cost effectiveness of the intervention is being tested in a clinical trial: ISRCTN13762819.	Bassilios B, 2014, AUSTRALAS PSYCHIATRY, V22, P71, DOI 10.1177/1039856213510575; Bonfioli E, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-78; Disability Rights Commission, 2006, EQ TREATM CLOS GAP F; Gierisch JM, 2014, J CLIN PSYCHIAT, V75, pE424, DOI 10.4088/JCP.13r08558; Gray B, 2013, J MENT HEALTH TRAIN, V8, P141, DOI 10.1108/JMHTEP-03-2013-0008; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Hardy S, 2012, MENT HLTH FAM MED, V9, P33; Hardy S, 2014, INT J SOC PSYCHIATR, V60, P236, DOI 10.1177/0020764013483721; Hardy S, 2013, J MENT HEALTH, V22, P42, DOI 10.3109/09638237.2012.759194; Heffner JL, 2011, BIPOLAR DISORD, V13, P439, DOI 10.1111/j.1399-5618.2011.00943.x; Klingaman EA, 2014, PSYCHIATR REHABIL J, V37, P270, DOI 10.1037/prj0000084; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; McCabe Marita P, 2008, Psychol Health Med, V13, P303, DOI 10.1080/13548500701473952; McDevitt J, 2006, J NURS SCHOLARSHIP, V38, P50, DOI 10.1111/j.1547-5069.2006.00077.x; National Institute of Health and Care Excellence, 2014, PSYCH SCHIZ AD TREAT; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Osborn DPJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-61; Pearson ES, 2012, PATIENT EDUC COUNS, V87, P32, DOI 10.1016/j.pec.2011.07.018; Pitman AL, 2011, PSYCHIAT SERV, V62, P1338, DOI 10.1176/ps.62.11.pss6211_1338; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; QSR International, 1999, NVIVO QUAL DAT AN SO; Rethink Mental Illness, 2013, STOP LETH DISCR; Ritchie J, 1993, ANAL QUALITATIVE DAT, P173, DOI DOI 10.1016/J.JPSYCHORES.2008.12.001; Roberts SH, 2011, J ADV NURS, V67, P690, DOI 10.1111/j.1365-2648.2010.05546.x; Royal College of Psychiatrists, 2018, WHOL PERS CAR RHET R; Schizophrenia Commission, 2012, AB ILLN REP SCHIZ CO; Tetlie T, 2009, J PSYCHOSOC NURS MEN, V47, P32, DOI 10.3928/02793695-20090201-14; Tsoi DT, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007253.pub2; Vancampfort D, 2013, PSYCHIAT RES, V210, P812, DOI 10.1016/j.psychres.2013.10.004; Wright CA, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-16	31	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136603	10.1371/journal.pone.0136603	http://dx.doi.org/10.1371/journal.pone.0136603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317516	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100109
J	Chuang, YF; Chen, MC; Huang, SW; Hsu, YF; Ou, G; Tsai, YJ; Hsu, MJ				Chuang, Yu-Fan; Chen, Mei-Chieh; Huang, Shiu-Wen; Hsu, Ya-Fen; Ou, George; Tsai, Yu-Jou; Hsu, Ming-Jen			Protein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-REGULATING KINASE-1; TRANSCRIPTIONAL REGULATION; NUCLEAR-FACTOR; PROMOTER ELEMENTS; IMMUNE-RESPONSE; GENE-EXPRESSION; SEPTIC SHOCK; 1 ASK1; APOPTOSIS	The lymphatic endothelium plays an important role in the maintenance of tissue fluid homeostasis. It also participates in the pathogenesis of several inflammatory diseases. However, little is known about the underlying mechanisms by which lymphatic endothelial cell responds to inflammatory stimuli. In this study, we explored the mechanisms by which lipopolysaccharide (LPS) induces cyclooxygenase (COX)-2 expression in murine lymphatic endothelial cells (SV-LECs). LPS caused increases in cox-2 mRNA and protein levels, as well as in COX-2 promoter luciferase activity in SV-LECs. These actions were associated with protein phosphatase 2A (PP2A), apoptosis signal-regulating kinase 1 (ASK1), JNK1/2 and p38MAPK activation, and NF-kappa B subunit p65 and C/EBP beta phosphorylation. PP2A-ASK1 signaling blockade reduced LPS-induced JNK1/2, p38MAPK, p65 and C/EBP beta phosphorylation. Transfection with PP2A siRNA reduced LPS's effects on p65 and C/EBP beta binding to the COX-2 promoter region. Transfected with the NF-kappa B or C/EBP beta site deletion of COX-2 reporter construct also abrogated LPS's enhancing effect on COX-2 promoter luciferase activity in SV-LECs. Taken together, the induction of COX-2 in SV-LECs exposed to LPS may involve PP2A-ASK1-JNK and/or p38MAPK-NF-kappa B and/or C/EBP beta cascade.	[Chuang, Yu-Fan; Hsu, Ming-Jen] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chen, Mei-Chieh] Taipei Med Univ, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Huang, Shiu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Pharmacol, Taipei 10764, Taiwan; [Hsu, Ya-Fen] Landseed Hosp, Div Gen Surg, Dept Surg, Taoyuan, Taiwan; [Ou, George] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Tsai, Yu-Jou] Yuans Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Ming-Jen] Taipei Med Univ, Sch Med, Dept Pharmacol, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University; University of British Columbia; Taipei Medical University	Tsai, YJ (corresponding author), Yuans Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan.	yjtsaihome@yahoo.com.tw; aspirin@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	Ministry of Science and Technology of Taiwan [MOST 103-2320-B-038-018]; Yuan's General Hospital, Kaohsiung, Taiwan [103YGH-TMU-01-4]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Yuan's General Hospital, Kaohsiung, Taiwan	This work was supported by grant (MOST 103-2320-B-038-018) from the Ministry of Science and Technology of Taiwan, M.J.H; grant (103YGH-TMU-01-4) from the Yuan's General Hospital, Kaohsiung, Taiwan, Y.J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Chang YF, 2015, ONCOTARGET, V6, P85, DOI 10.18632/oncotarget.2765; Chen JC, 2004, EXP CELL RES, V301, P305, DOI 10.1016/j.yexcr.2004.05.039; Chen MC, 2003, J BIOL CHEM, V278, P16073, DOI 10.1074/jbc.M208661200; Chen YY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05651; Chuang YF, 2014, BIOCHEM PHARMACOL, V88, P372, DOI 10.1016/j.bcp.2014.02.004; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Han EH, 2008, TOXICOL APPL PHARM, V233, P333, DOI 10.1016/j.taap.2008.09.003; Hsieh CY, 2011, J BIOL CHEM, V286, P5942, DOI 10.1074/jbc.M110.123968; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Hsu MJ, 2010, J LEUKOCYTE BIOL, V87, P1069, DOI 10.1189/jlb.1009668; Hsu YF, 2011, BBA-GEN SUBJECTS, V1810, P1160, DOI 10.1016/j.bbagen.2011.08.015; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jurisic G, 2010, GENES IMMUN, V11, P219, DOI 10.1038/gene.2010.4; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Manna PR, 2009, MOL CELL ENDOCRINOL, V302, P1, DOI 10.1016/j.mce.2008.12.009; Marshall JC, 2002, CRIT CARE, V6, P342, DOI 10.1186/cc1522; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nizamutdinova IT, 2007, INT IMMUNOPHARMACOL, V7, P343, DOI 10.1016/j.intimp.2006.11.004; Proulx ST, 2013, J CONTROL RELEASE, V172, P550, DOI 10.1016/j.jconrel.2013.04.027; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shi VY, 2012, MICROCIRCULATION, V19, P567, DOI 10.1111/j.1549-8719.2012.00189.x; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Straccia M, 2013, GLIA, V61, P1607, DOI 10.1002/glia.22542; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	64	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137177	10.1371/journal.pone.0137177	http://dx.doi.org/10.1371/journal.pone.0137177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317424	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100212
J	Gordoa, A; Sanz, N; Vinas, J				Gordoa, Ana; Sanz, Nuria; Vinas, Jordi			Individual Spawning Duration of Captive Atlantic Bluefin Tuna (Thunnus thynnus) Revealed by Mitochondrial DNA Analysis of Eggs	PLOS ONE			English	Article							POPULATION-STRUCTURE; SEXUAL-MATURITY; L. 1758; WESTERN; SIZE; PREFERENCES; SATELLITE; FECUNDITY; FISHERIES; SOFTWARE	This study presents the first results on Atlantic bluefin tuna (Thunnus thynnus) individual spawning duration and its short-term temporal behavior. The study was based on direct measurements resulting from mtDNA analysis of the offspring of spawners held in transport cages during the 2013 spawning monitoring survey in Balearic waters. The number of females consisted of approximately 259 individuals with an average weight of 186 kg. The survey began on May 22 and ended on July 3. Spawning started on May 30 and was observed every night afterwards. The sampling of eggs for genetic monitoring was conducted for 9 days interspersed from the beginning of spawning to the end of the survey. A total of 946 eggs were analyzed and revealed 129 different haplotypes; 77 of these were not previously detected in the Mediterranean. A total of 69 haplotypes were observed in more than one spawning event and those with higher frequency lasted their maximum possible duration. The haplotypes present at the beginning of spawning were also identified at the end of the sampling, indicating a minimum spawning duration of 34 days, and individual annual fecundity was estimated at around 1290 eggs gr(-1). These results differed from those generally presumed until now and are indicative of a much higher fecundity. Females exhibited a regular spawning schedule but with the capacity to shift the spawning hour during the spawning season. These results were observed for the eastern population of Atlantic bluefin tuna and before extrapolating to the western population, their validity should be proved.	[Gordoa, Ana] CSIC, Dept Marine Ecol, Ctr Estudios Avanzados Blanes, Blanes, Girona, Spain; [Sanz, Nuria; Vinas, Jordi] Univ Girona, Fac Ciencies, Dept Biol, Lab Ictiol Genet, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Universitat de Girona	Gordoa, A (corresponding author), CSIC, Dept Marine Ecol, Ctr Estudios Avanzados Blanes, Blanes, Girona, Spain.	gordoa@ceab.csic.es	Viñas, Jordi/A-5397-2010; Sanz, Nuria/L-3074-2014	Viñas, Jordi/0000-0003-0193-1141; Sanz, Nuria/0000-0001-5274-1917	Balfego Tuna SL Group under a programme of scientific cooperation with the Spanish National Research Council; Spanish Ministry of the Economy and Competitiveness [CTM2011-29525-C04-04]	Balfego Tuna SL Group under a programme of scientific cooperation with the Spanish National Research Council; Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This study was funded by the Balfego Tuna SL Group under a programme of scientific cooperation with the Spanish National Research Council and by the Spanish Ministry of the Economy and Competitiveness (CTM2011-29525-C04-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ICCAT MADRID; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Baglin Jr RE, 1982, FISHERY B US NATL MA; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Bremer JRA, 1997, J FISH BIOL, V50, P540, DOI 10.1006/jfbi.1996.0321; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Claramunt G, 2007, FISH RES, V85, P248, DOI 10.1016/j.fishres.2007.01.009; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Diaz Guillermo A., 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1216; Duclerc J., 1973, Revue Trav Inst Peches Marit, V37, P163; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frade F, 1933, ETAT MATURITE GONADE; Fromentin J-M, 2010, ICCAT COL VOL SCI PA, V65, P1052; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; GARCIA A, 2005, ICCAT COL VOL SCI PA, V58, P1261; Gordoa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090691; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Heinisch G, 2014, SCI REPORTS, P4; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; HUNTER JR, 1992, FISH B-NOAA, V90, P101; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kell L, 2009, ICCAT COL VOL SCI PA, V64, P633; Knapp JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098233; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Margulies D, 2007, FISH B-NOAA, V105, P249; Masuma S, 2003, B FISHERIES RES AGEN; Masuma S, 2008, REV FISH SCI, V16, P385, DOI 10.1080/10641260701484325; Masuma Shukei, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V63, P207; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Melich B., 2011, COLLECTIVE VOLUME SC, V66, P759; Nakadate M, 2011, AQUACULTURE, V310, P325, DOI 10.1016/j.aquaculture.2010.11.007; Niwa Y, 2003, AQUACULTURE, V218, P387, DOI 10.1016/S0044-8486(03)00015-2; Oray IK, 2005, J APPL ICHTHYOL, V21, P236, DOI 10.1111/j.1439-0426.2005.00658.x; PARRISH RH, 1985, FISH B-NOAA, V83, P483; Reglero P, 2014, AQUACULTURE, V433, P94, DOI 10.1016/j.aquaculture.2014.05.050; Richards WJ, 1976, COL VOL SCI PAP ICCA, V5, P267; Rickman SJ, 2000, CAN J FISH AQUAT SCI, V57, P116, DOI 10.1139/cjfas-57-1-116; Rodriguez-Roda J, 1967, INVESTIGACION PESQUE, V31, P35; RODRIGUEZ-RODA JULIO, 1964, INVEST PESQUERA, V25, P33; RODRIGUEZRODA J, 1967, INVEST PESQ, V31, P33; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; SARA R, 1973, Bollettino di Pesca Piscicoltura e Idrobiologia, V28, P217; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Secor DH, 2015, CONSERV BIOL, V29, P400, DOI 10.1111/cobi.12392; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Susca V, 2001, J FISH BIOL, V58, P815, DOI 10.1111/j.1095-8649.2001.tb00533.x; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; Trippel Edward A., 1997, Fish and Fisheries Series, V21, P31; Vinas J, 2011, REV FISH BIOL FISHER, V21, P527, DOI 10.1007/s11160-010-9174-6; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Vlaming V. de, 1983, Control processes in fish physiology., P176	61	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136733	10.1371/journal.pone.0136733	http://dx.doi.org/10.1371/journal.pone.0136733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317343	gold, Green Submitted, Green Published			2022-12-27	WOS:000360299100131
J	Iliyasu, G; Ogoina, D; Otu, AA; Dayyab, FM; Ebenso, B; Otokpa, D; Rotifa, S; Olomo, WT; Habib, AG				Iliyasu, Garba; Ogoina, Dimie; Otu, Akan A.; Dayyab, Farouq M.; Ebenso, Bassey; Otokpa, Daniel; Rotifa, Stella; Olomo, Wisdom T.; Habib, Abdulrazaq G.			A Multi-Site Knowledge Attitude and Practice Survey of Ebola Virus Disease in Nigeria	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; EPIDEMIC; CONGO	Background The 2014 Ebola Virus Disease (EVD) outbreak was characterised by fear, misconceptions and irrational behaviours. We conducted a knowledge attitude and practice survey of EVD in Nigeria to inform implementation of effective control measures. Methods Between July 30th and September 30th 2014, we undertook a cross sectional study on knowledge, attitude and practice (KAP) of Ebola Virus Disease (EVD) among adults of the general population and healthcare workers (HCW) in three states of Nigeria, namely Bayelsa, Cross River and Kano states. Demographic information and data on KAP were obtained using a self-administered standardized questionnaire. The percentage KAP scores were categorised as good and poor. Independent predictors of good knowledge of EVD were ascertained using a binary logistic regression model. Results Out of 1035 study participants with median age of 32 years, 648 (62.6%) were males, 846 (81.7%) had tertiary education and 441 (42.6%) were HCW. There were 218, 239 and 578 respondents from Bayelsa, Cross River and Kano states respectively. The overall median percentage KAP scores and interquartile ranges (IQR) were 79.46% (15.07%), 95.0% (33.33%) and 49.95% (37.50%) respectively. Out of the 1035 respondents, 470 (45.4%), 544(52.56%) and 252 (24.35%) had good KAP of EVD defined using 80%, 90% and 70% score cut-offs respectively. Independent predictors of good knowledge of EVD were being a HCW (Odds Ratio-OR-2.89, 95% Confidence interval-CI of 1.41-5.90), reporting 'moderate to high fear of EVD' (OR-2.15, 95% CI-(1.47-3.13) and 'willingness to modify habit' (OR-1.68, 95% CI-1.23-2.30). Conclusion Our results reveal suboptimal EVD-related knowledge, attitude and practice among adults in Nigeria. To effectively control future outbreaks of EVD in Nigeria, there is a need to implement public sensitization programmes that improve understanding of EVD and address EVD-related myths and misconceptions, especially among the general population.	[Iliyasu, Garba; Habib, Abdulrazaq G.] Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Kano State, Nigeria; [Ogoina, Dimie] Niger Delta Univ, Niger Delta Univ Teaching Hosp NDUTH, Dept Internal Med, Okolobiri, Bayelsa State, Nigeria; [Otu, Akan A.; Ebenso, Bassey; Otokpa, Daniel] Univ Calabar, Dept Internal Med, Calabar, Cross River Sta, Nigeria; [Dayyab, Farouq M.] Aminu Kano Teaching Hosp, Dept Med, Infect & Trop Dis Unit, Kano, Kano State, Nigeria; [Ebenso, Bassey] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Rotifa, Stella] Fed Med Ctr, Dept Publ Hlth, Yenagoa, Bayelsa State, Nigeria; [Olomo, Wisdom T.] Niger Delta Univ, Teaching Hosp, Infect Control Unit, Okolobiri, Bayelsa State, Nigeria	Bayero University; University of Calabar; University of Leeds	Habib, AG (corresponding author), Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Kano State, Nigeria.	abdulrazaq_habib@yahoo.co.uk	Dayyab, Farouq/R-5746-2019; Ogoina, Dimie/H-4091-2019; Ebenso, Dr. Bassey E./H-5536-2017	Ogoina, Dimie/0000-0002-2098-6300; Ebenso, Dr. Bassey E./0000-0003-4147-0968; Dayyab, Farouq/0000-0001-8920-6483				[Anonymous], 2014, FOCUS 1000 TECHNICAL; [Anonymous], 2014, ALL AFRUCA NIGERIA H; Ansumana R, 2014, LANCET, V384, P303, DOI 10.1016/S0140-6736(14)61119-3; Atinuke B., 2019, STAT ANAL EBOLA VIRU; Beeching NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7348; Birmingham K, 2002, NAT MED, V8, P313, DOI 10.1038/nm0402-313; CDC, EB VIR DIS; Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859; Colebunders R, 2000, J INFECTION, V40, P16, DOI 10.1053/jinf.1999.0603; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Iftikhar R, 2012, ISRA MED J, V4, P86; Kass N, 2014, ANN INTERN MED, V161, P744, DOI 10.7326/M14-1864; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Oyeyemi SO, 2014, BMJ, P349; Pan American Health Organization, 2014, ORGANIZATION; Rahnavardi M, 2008, J HOSP INFECT, V69, P77, DOI 10.1016/j.jhin.2008.02.007; Shuaib F, 2010, W INDIAN MED J, V59, P139; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; United Nations Children's Fund [UNICEF], 2014, SIT REP EB OUTBR NIG; Washington Post-ABC News Poll, 2014, THE WASHINGTON POST; World Health Organization, EB VIR DIS; World Health Organization, PUBL HLTH EM INT CON; World Health Organization, EB DAT STAT; World Health Organization, 2014, EB EXP THER RUM REM	27	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135955	10.1371/journal.pone.0135955	http://dx.doi.org/10.1371/journal.pone.0135955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317535	Green Published, gold, Green Submitted			2022-12-27	WOS:000360299100053
J	Murakami, T; Yoshikawa, T; Maekawa, Y; Ueda, T; Isogai, T; Sakata, K; Nagao, K; Yamamoto, T; Takayama, M				Murakami, Tsutomu; Yoshikawa, Tsutomu; Maekawa, Yuichiro; Ueda, Tetsuro; Isogai, Toshiaki; Sakata, Konomi; Nagao, Ken; Yamamoto, Takeshi; Takayama, Morimasa			Gender Differences in Patients with Takotsubo Cardiomyopathy: Multi-Center Registry from Tokyo CCU Network	PLOS ONE			English	Article							TAKO-TSUBO CARDIOMYOPATHY; ACUTE MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM; NATURAL-HISTORY; HEART-FAILURE; FOLLOW-UP; STRESS; ESTROGEN; SYSTEM; WOMEN	Background The clinical features of gender differences in takotsubo cardiomyopathy (TC) remain to be determined. The aim of this study was to evaluate the differences in clinical characteristics of male and female patients with TC. Methods We obtained the clinical information of 368 patients diagnosed with TC (84 male, 284 female) from the Tokyo CCU Network database collected from 1 January 2010 to 31 December 2012; the Network is comprised of 71 cardiovascular centers in the Tokyo (Japan) metropolitan area. We attempted to characterize clinical differences during hospitalization, comparing male and female patients with TC. Results There were no significant differences in apical ballooning type, median echocardiography ejection fraction, serious ventricular arrhythmias (such as ventricular tachycardia or fibrillation), or cardiovascular death between male and female patients. Male patients were younger than female patients (median age at hospitalization for male patients was 72 years vs. 76 years for female patients; p = 0.040). Prior physical stress was more common in male than female patients (50.0% vs. 31.3%; p = 0.002), while emotional stress was more common in female patients (19.0% vs. 31.0%; p = 0.039). Severe pump failure (defined as Killip Class >= III) (20.2% vs. 10.6%; p = 0.020) and cardiopulmonary supportive therapies (28.6% vs. 12.7%, p < 0.001) were more common in male than female patients. Multivariate analysis revealed that male gender (odds ratio = 4.32, 95% CI = 1.41-13.6, p = 0.011) was an independent predictor of adverse composite cardiac events, including cardiovascular death, severe pump failure, and serious ventricular arrhythmia. Conclusions Cardiac complications in our dataset appeared to be more common in male than female patients with TC during their hospitalization. Further investigation is required to clarify the underlying mechanisms responsible for the observed gender differences.	[Murakami, Tsutomu; Yoshikawa, Tsutomu; Maekawa, Yuichiro; Ueda, Tetsuro; Isogai, Toshiaki; Sakata, Konomi; Nagao, Ken; Yamamoto, Takeshi; Takayama, Morimasa] Tokyo CCU Network Sci Comm, Tokyo, Japan		Yoshikawa, T (corresponding author), Tokyo CCU Network Sci Comm, Tokyo, Japan.	tyoshi@shi.heart.or.jp						Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Bielecka-Dabrowa A, 2010, INT J CARDIOL, V142, P120, DOI 10.1016/j.ijcard.2009.11.040; Brenner R, 2012, CLIN CARDIOL, V35, P340, DOI 10.1002/clc.21986; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; DELRIO G, 1994, J CLIN ENDOCR METAB, V79, P836, DOI 10.1210/jc.79.3.836; Eitel I, 2010, EUR RADIOL, V20, P422, DOI 10.1007/s00330-009-1549-5; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Heer T, 2002, AM J CARDIOL, V89, P511, DOI 10.1016/S0002-9149(01)02289-5; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kuo BT, 2010, GENDER MED, V7, P71, DOI 10.1016/j.genm.2010.01.006; Kurisu S, 2012, J CARDIOL, V60, P429, DOI 10.1016/j.jjcc.2012.06.015; Kurisu S, 2010, CLIN CARDIOL, V33, P42, DOI [10.1002/clc.20700, 10.1002/clc.20726]; Maekawa Y, 2012, INTERNAL MED, V51, P257, DOI 10.2169/internalmedicine.51.6559; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morel O, 2009, J CARD FAIL, V15, P206, DOI 10.1016/j.cardfail.2008.10.031; Murakami T, 2014, J CARDIOL, V63, P269, DOI 10.1016/j.jjcc.2013.09.003; Obayashi T, 2010, CIRC J, V74, P289, DOI 10.1253/circj.CJ-09-0623; Parodi G, 2011, CHEST, V139, P887, DOI 10.1378/chest.10-1041; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Roberts BJ, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-25; Schneider B, 2013, HEART FAIL CLIN, V9, P137, DOI 10.1016/j.hfc.2012.12.005; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Takahashi M, 2011, J CARD FAIL, V17, P742, DOI 10.1016/j.cardfail.2011.05.005; Tanabe Y, 2014, J CARDIOL, V63, P385, DOI 10.1016/j.jjcc.2013.10.003; Thawornkaiwong A, 2003, LIFE SCI, V72, P1813, DOI 10.1016/S0024-3205(02)02473-6; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Ueyama T, 2007, CIRC J, V71, P565, DOI 10.1253/circj.71.565; Ueyama T, 2008, ANN NY ACAD SCI, V1148, P479, DOI 10.1196/annals.1410.079; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Wattanapermpool J, 2000, LIFE SCI, V66, P533, DOI 10.1016/S0024-3205(99)00623-2; Zimmermann S, 2009, CLIN RES CARDIOL, V98, P709, DOI 10.1007/s00392-009-0055-8	32	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136655	10.1371/journal.pone.0136655	http://dx.doi.org/10.1371/journal.pone.0136655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317750	gold, Green Published, Green Submitted			2022-12-27	WOS:000360299100119
J	Uchiyama, H; Zhao, QL; Hassan, MA; Andocs, G; Nojima, N; Takeda, K; Ishikawa, K; Hori, M; Kondo, T				Uchiyama, Hidefumi; Zhao, Qing-Li; Hassan, Mariame Ali; Andocs, Gabor; Nojima, Nobuyuki; Takeda, Keigo; Ishikawa, Kenji; Hori, Masaru; Kondo, Takashi			EPR-Spin Trapping and Flow Cytometric Studies of Free Radicals Generated Using Cold Atmospheric Argon Plasma and X-Ray Irradiation in Aqueous Solutions and Intracellular Milieu	PLOS ONE			English	Article							NONVOLATILE SOLUTES; NONTHERMAL PLASMA; NITRIC-OXIDE; ULTRASOUND; CELLS; RESONANCE; HYDROGEN; SONOCHEMISTRY; PYROLYSIS; APOPTOSIS	Electron paramagnetic resonance (EPR)-spin trapping and flow cytometry were used to identify free radicals generated using argon-cold atmospheric plasma (Ar-CAP) in aqueous solutions and intracellularly in comparison with those generated by X-irradiation. Ar-CAP was generated using a high-voltage power supply unit with low-frequency excitation. The characteristics of Ar-CAP were estimated by vacuum UV absorption and emission spectra measurements. Hydroxyl (center dot OH) radicals and hydrogen (H) atoms in aqueous solutions were identified with the spin traps 5,5-dimethyl-1-pyrroline N-oxide (DMPO), 3,3,5,5-tetramethyl-1-pyrroline-N-oxide (M4PO), and phenyl N-t-butylnitrone (PBN). The occurrence of Ar-CAP-induced pyrolysis was evaluated using the spin trap 3,5-dibromo-4-nitrosobenzene sulfonate (DBNBS) in aqueous solutions of DNA constituents, sodium acetate, and L-alanine. Human lymphoma U937 cells were used to study intracellular oxidative stress using five fluorescent probes with different affinities to a number of reactive species. The analysis and quantification of EPR spectra revealed the formation of enormous amounts of center dot OH radicals using ArCAP compared with that by X-irradiation. Very small amounts of H atoms were detected whereas nitric oxide was not found. The formation of center dot OH radicals depended on the type of rare gas used and the yield correlated inversely with ionization energy in the order of krypton > argon = neon > helium. No pyrolysis radicals were detected in aqueous solutions exposed to Ar-CAP. Intracellularly, center dot OH, H2O2, which is the recombination product of center dot OH, and OCl- were the most likely formed reactive oxygen species after exposure to Ar-CAP. Intracellularly, there was no practical evidence for the formation of NO whereas very small amounts of superoxides were formed. Despite the superiority of Ar-CAP in forming center dot OH radicals, the exposure to X-rays proved more lethal. The mechanism of free radical formation in aqueous solutions and an intracellular milieu is discussed.	[Uchiyama, Hidefumi; Andocs, Gabor; Nojima, Nobuyuki] Tateyama Machine Co Ltd, Toyama 9301305, Japan; [Zhao, Qing-Li; Hassan, Mariame Ali; Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Takeda, Keigo; Ishikawa, Kenji; Hori, Masaru] Nagoya Univ, Plasma Nanotechnol Res Ctr, Nagoya, Aichi 4648601, Japan	University of Toyama; Nagoya University	Kondo, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan.	kondot@med.u-toyama.ac.jp	Ishikawa, Kenji/I-6758-2014; Kamachi, Toshiaki/C-4230-2015	Ishikawa, Kenji/0000-0002-8288-6620; Kamachi, Toshiaki/0000-0002-9720-0265	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25108503]; Tateyama Machine Co., Ltd	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tateyama Machine Co., Ltd	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Grant No. 25108503 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a Grant-in-Aid for Practical and Commercial Application of Advanced Technology (TONIO), Toyama Prefecture. The funders had no role in study design, data collection, analysis, decision, and preparation of the manuscript or publishing. Tateyama Machine Co., Ltd provided support in the form of salaries for authors (HU, GA and NN), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Alkawareek MY, 2014, INT J ANTIMICROB AG, V43, P154, DOI 10.1016/j.ijantimicag.2013.08.022; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Bundscherer L, 2013, IMMUNOBIOLOGY, V218, P1248, DOI 10.1016/j.imbio.2013.04.015; CARMICHAEL AJ, 1984, RADIAT RES, V100, P222, DOI 10.2307/3576343; Chang JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092198; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x; Hoffmann C, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-21; Honda H, 2004, ULTRASOUND MED BIOL, V30, P683, DOI 10.1016/j.ultrasmedbio.2004.02.008; Idlibi AN, 2013, BIOFOULING, V29, P369, DOI 10.1080/08927014.2013.775255; Ikawa S, 2010, PLASMA PROCESS POLYM, V7, P33, DOI 10.1002/ppap.200900090; Ikuse K, 2014, P 8 INT C REACT PLAS; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; KONDO T, 1989, RADIAT RES, V118, P211, DOI 10.2307/3577438; KONDO T, 1988, INT J RADIAT BIOL, V53, P331, DOI 10.1080/09553008814550681; KONDO T, 1989, FREE RADICAL BIO MED, V7, P259, DOI 10.1016/0891-5849(89)90133-0; KONDO T, 1993, FREE RADICAL RES COM, V19, pS193, DOI 10.3109/10715769309056s193; Lackmann JW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0591; Li P, 2014, APOPTOSIS, V19, P1043, DOI 10.1007/s10495-014-0984-1; Lu H, 2014, J APPL MICROBIOL, V116, P784, DOI 10.1111/jam.12426; Mai-Prochnow A, 2014, INT J ANTIMICROB AG, V43, P508, DOI 10.1016/j.ijantimicag.2014.01.025; Maisch T, 2012, J IND MICROBIOL BIOT, V39, P1367, DOI 10.1007/s10295-012-1137-6; Mastanaiah N, 2013, PLASMA PROCESS POLYM, V10, P1120, DOI 10.1002/ppap.201300108; PUMMER H, 1983, PHYS REV A, V28, P795, DOI 10.1103/PhysRevA.28.795; Reszka KJ, 2006, NITRIC OXIDE-BIOL CH, V15, P133, DOI 10.1016/j.niox.2006.03.004; RIESZ P, 1990, ULTRASONICS, V28, P295, DOI 10.1016/0041-624X(90)90035-M; RIESZ P, 1992, FREE RADICAL BIO MED, V13, P247, DOI 10.1016/0891-5849(92)90021-8; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Steinbeck MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082143; Takeda K, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/46/464006; Utsumi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081576; Walk RM, 2013, J PEDIATR SURG, V48, P67, DOI 10.1016/j.jpedsurg.2012.10.020; Wang MA, 2014, TISSUE ENG PT A, V20, P1060, DOI [10.1089/ten.tea.2013.0235, 10.1089/ten.TEA.2013.0235]; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073741; Zhao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073665	42	54	54	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136956	10.1371/journal.pone.0136956	http://dx.doi.org/10.1371/journal.pone.0136956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26318000	Green Published, Green Submitted, gold			2022-12-27	WOS:000360299100185
J	Zhao, C; Sander, HA				Zhao, Chang; Sander, Heather A.			Quantifying and Mapping the Supply of and Demand for Carbon Storage and Sequestration Service from Urban Trees	PLOS ONE			English	Article							CULTURAL ECOSYSTEM SERVICES; CONCEPTUAL-FRAMEWORK; TROPICAL FORESTS; LIDAR DATA; DECOMPOSITION; BIOMASS; CONSERVATION; VALUATION; CAPACITY; DYNAMICS	Studies that assess the distribution of benefits provided by ecosystem services across urban areas are increasingly common. Nevertheless, current knowledge of both the supply and demand sides of ecosystem services remains limited, leaving a gap in our understanding of balance between ecosystem service supply and demand that restricts our ability to assess and manage these services. The present study seeks to fill this gap by developing and applying an integrated approach to quantifying the supply and demand of a key ecosystem service, carbon storage and sequestration, at the local level. This approach follows three basic steps: (1) quantifying and mapping service supply based upon Light Detection and Ranging (LiDAR) processing and allometric models, (2) quantifying and mapping demand for carbon sequestration using an indicator based on local anthropogenic CO2 emissions, and (3) mapping a supply-to-demand ratio. We illustrate this approach using a portion of the Twin Cities Metropolitan Area of Minnesota, USA. Our results indicate that 1735.69 million kg carbon are stored by urban trees in our study area. Annually, 33.43 million kg carbon are sequestered by trees, whereas 3087.60 million kg carbon are emitted by human sources. Thus, carbon sequestration service provided by urban trees in the study location play a minor role in combating climate change, offsetting approximately 1% of local anthropogenic carbon emissions per year, although avoided emissions via storage in trees are substantial. Our supply-to-demand ratio map provides insight into the balance between carbon sequestration supply in urban trees and demand for such sequestration at the local level, pinpointing critical locations where higher levels of supply and demand exist. Such a ratio map could help planners and policy makers to assess and manage the supply of and demand for carbon sequestration.	[Zhao, Chang; Sander, Heather A.] Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA	University of Iowa	Zhao, C (corresponding author), Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA.	chang-zhao@uiowa.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Bond-Lamberty, Benjamin/C-6058-2008	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Bond-Lamberty, Benjamin/0000-0001-9525-4633; Zhao, Chang/0000-0002-5389-0479				ALBAN DH, 1993, CAN J FOREST RES, V23, P1744, DOI 10.1139/x93-220; Alonzo M, 2014, REMOTE SENS ENVIRON, V148, P70, DOI 10.1016/j.rse.2014.03.018; [Anonymous], 2015, EC US; [Anonymous], 2007, TERR CARB CYCL MAN F; [Anonymous], 2015, MINN NAT BIG TREE RE; [Anonymous], 2012, ESRI ARCGIS V 10 1; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Baro F, 2014, AMBIO, V43, P466, DOI 10.1007/s13280-014-0507-x; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; BERENDSE F, 1987, CAN J BOT, V65, P1116, DOI 10.1139/b87-155; Berland A, 2012, TWIN CITIES URBANIZA; Boddy L, 1989, FEMS MICROBIOL LETT, P62; Boithias L, 2014, SCI TOTAL ENVIRON, V470, P567, DOI 10.1016/j.scitotenv.2013.10.003; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; Burkhard B., 2014, Landscape Online; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Casado-Arzuaga I, 2013, J ENVIRON MANAGE, V129, P33, DOI 10.1016/j.jenvman.2013.05.059; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Conte M, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P111; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Estornell J, 2011, FOREST ECOL MANAG, V262, P1697, DOI 10.1016/j.foreco.2011.07.026; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fraver S, 2013, ECOSYSTEMS, V16, P1262, DOI 10.1007/s10021-013-9682-z; Geijzendorffer IR, 2015, ECOL INDIC, V52, P320, DOI 10.1016/j.ecolind.2014.12.016; Gill SJ, 2000, FOREST ECOL MANAG, V126, P405, DOI 10.1016/S0378-1127(99)00113-9; Haase D, 2014, AMBIO, V43, P407, DOI 10.1007/s13280-014-0503-1; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Honey-Roses J, 2013, ECOSYST SERV, V5, pE160, DOI 10.1016/j.ecoser.2013.04.007; Iverson L.R., 1994, EFFECTS LAND USE CHA, P67, DOI DOI 10.1007/978-1-4613-8363-5_3; Jacobs S, 2015, ECOL MODEL, V295, P21, DOI 10.1016/j.ecolmodel.2014.08.024; Jenkins J, 2004, COMPREHENSIVE DATABA, P319; Jenkins JC, 2003, FOREST SCI, V49, P12; LAMBERT RL, 1980, ECOLOGY, V61, P1460, DOI 10.2307/1939054; Liquete C, 2013, ECOL INDIC, V30, P205, DOI 10.1016/j.ecolind.2013.02.013; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Locatelli B, 2014, ENVIRON CONSERV, V41, P27, DOI 10.1017/S0376892913000234; Locatelli B, 2011, REG ENVIRON CHANGE, V11, P393, DOI 10.1007/s10113-010-0149-x; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; McPherson E.G., 1994, CHICAGOS URBAN FORES; Mcpherson EG, 1999, URBAN FORESTRY GUIDE, P171; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Minnesota Geographic Metadata, 2011, MET GEN LAND US 2010; Myeong S, 2006, REMOTE SENS ENVIRON, V101, P277, DOI 10.1016/j.rse.2005.12.001; Nedkov S, 2012, ECOL INDIC, V21, P67, DOI 10.1016/j.ecolind.2011.06.022; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nowak DJ, 2013, ENVIRON POLLUT, V178, P229, DOI 10.1016/j.envpol.2013.03.019; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; NOWAK DJ, 1993, J ENVIRON MANAGE, V37, P207, DOI 10.1006/jema.1993.1017; Nowak DJ, 2002, BROOKLYNS URBAN FORE, P290; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Opitz D, 2008, ASPRS 2008 ANN C POR, P0; Overwatch, 2015, OVERWATCH; Paetzold A, 2010, ECOL COMPLEX, V7, P273, DOI 10.1016/j.ecocom.2009.11.003; Palomo I, 2013, ECOSYST SERV, V4, P104, DOI 10.1016/j.ecoser.2012.09.001; Paracchini ML, 2014, ECOL INDIC, V45, P371, DOI 10.1016/j.ecolind.2014.04.018; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Phillips DL, 2011, ASSESSMENT ECOSYSTEM, P1; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Popescu SC, 2007, BIOMASS BIOENERG, V31, P646, DOI 10.1016/j.biombioe.2007.06.022; Romaguera M, 2010, REMOTE SENS-BASEL, V2, P1177, DOI 10.3390/rs2041177; Russell MB, 2015, FOREST ECOL MANAG, V350, P107, DOI 10.1016/j.foreco.2015.04.033; SCHEU S, 1994, PLANT SOIL, V163, P13, DOI 10.1007/BF00033936; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Schulp CJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109643; Serna-Chavez HM, 2014, ECOL INDIC, V39, P24, DOI 10.1016/j.ecolind.2013.11.024; Simpson JR, 2002, ENERG BUILDINGS, V34, P1067, DOI 10.1016/S0378-7788(02)00028-2; Sturck J, 2014, ECOL INDIC, V38, P198, DOI 10.1016/j.ecolind.2013.11.010; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Teck R.M., 1991, INDIVIDUAL TREE DIAM; U.S. Census Bureau, 2010, 2010 CENS URB RUR CL; van Berkel DB, 2014, ECOL INDIC, V37, P163, DOI 10.1016/j.ecolind.2012.06.025; Villa F., 2009, 11 ANN BIOECON C EC; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Willemen L, 2008, LANDSCAPE URBAN PLAN, V88, P34, DOI 10.1016/j.landurbplan.2008.08.004; Wolff S, 2015, ECOL INDIC, V55, P159, DOI 10.1016/j.ecolind.2015.03.016; Xcel Energy Inc, 2013, POW GEN SUPPL	89	23	27	17	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136392	10.1371/journal.pone.0136392	http://dx.doi.org/10.1371/journal.pone.0136392			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317530	gold, Green Published			2022-12-27	WOS:000360299100077
J	Ferreira, JC; Marcondes, MF; Icimoto, MY; Cardoso, THS; Tofanello, A; Pessoto, FS; Miranda, EGA; Prieto, T; Nascimento, OR; Oliveira, V; Nantes, IL				Ferreira, Juliana C.; Marcondes, Marcelo F.; Icimoto, Marcelo Y.; Cardoso, Thyago H. S.; Tofanello, Aryane; Pessoto, Felipe S.; Miranda, Erica G. A.; Prieto, Tatiana; Nascimento, Otaciro R.; Oliveira, Vitor; Nantes, Iseli L.			Intermediate Tyrosyl Radical and Amyloid Structure in Peroxide-Activated Cytoglobin	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN SECONDARY STRUCTURE; VERTEBRATE GLOBIN FAMILY; CYTOCHROME-C-OXIDASE; LIGAND-BINDING; CIRCULAR-DICHROISM; NITRIC-OXIDE; HYDROGEN-PEROXIDE; THIOFLAVIN-T; INTERACTION NETWORKS	We characterized the peroxidase mechanism of recombinant rat brain cytoglobin (Cygb) challenged by hydrogen peroxide, tert-butylhydroperoxide and by cumene hydroperoxide. The peroxidase mechanism of Cygb is similar to that of myoglobin. Cygb challenged by hydrogen peroxide is converted to a Fe4+ oxoferryl p cation, which is converted to Fe4+ oxoferryl and tyrosyl radical detected by direct continuous wave-electron paramagnetic resonance and by 3,5-dibromo-4-nitrosobenzene sulfonate spin trapping. When organic peroxides are used as substrates at initial reaction times, and given an excess of peroxide present, the EPR signals of the corresponding peroxyl radicals precede those of the direct tyrosyl radical. This result is consistent with the use of peroxide as a reducing agent for the recycling of Cygb high-valence species. Furthermore, we found that the Cygb oxidation by peroxides leads to the formation of amyloid fibrils. This result suggests that Cygb possibly participates in the development of degenerative diseases; our findings also support the possible biological role of Cygb related to peroxidase activity.	[Ferreira, Juliana C.; Marcondes, Marcelo F.; Icimoto, Marcelo Y.; Cardoso, Thyago H. S.; Oliveira, Vitor; Nantes, Iseli L.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil; [Tofanello, Aryane; Pessoto, Felipe S.; Miranda, Erica G. A.; Prieto, Tatiana; Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Lab Nanoestruturas Biol & Mat Avancados, Santo Andre, SP, Brazil; [Prieto, Tatiana; Nascimento, Otaciro R.] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, Sao Carlos, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Nantes, IL (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil.	ilnantes@ufabc.edu.br	Tofanello, Aryane/AAV-1091-2020; Nantes, Iseli Lourenço/B-9517-2012; Icimoto, Marcelo Yudi/L-6275-2016; Oliveira, Vitor/AAT-5981-2020; Marcondes, Marcelo FM/I-2234-2013; Oliveira, Vitor/L-3709-2013	Nantes, Iseli Lourenço/0000-0003-1434-3154; Icimoto, Marcelo Yudi/0000-0002-0746-5279; Oliveira, Vitor/0000-0002-4662-1377; Tofanello, Aryane/0000-0001-5623-4832	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/07456-7]; Conselho Nacional de Desenvolvimento Cientifico (CNPq); Nucleo de Bioquimica e Biotecnologia (NBB)-Universidade Federal	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nucleo de Bioquimica e Biotecnologia (NBB)-Universidade Federal	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process number 2012/07456-7, Conselho Nacional de Desenvolvimento Cientifico (CNPq), and Nucleo de Bioquimica e Biotecnologia (NBB)-Universidade Federal do ABC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astudillo L, 2013, J INORG BIOCHEM, V129, P23, DOI 10.1016/j.jinorgbio.2013.08.006; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; Beckerson Penny, 2015, F1000Res, V4, P87, DOI 10.12688/f1000research.5971.1; Beckerson P, 2015, BIOCHEM J, V465, P127, DOI 10.1042/BJ20140827; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger N, 2001, INT J PHARM, V223, P55, DOI 10.1016/S0378-5173(01)00721-9; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; BRUNORI M, 1971, BIOCHEMISTRY-US, V10, P1604, DOI 10.1021/bi00785a016; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; CHAMULITRAT W, 1989, J BIOL CHEM, V264, P7889; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Deterding LJ, 1998, J BIOL CHEM, V273, P12863, DOI 10.1074/jbc.273.21.12863; Detweiler CD, 2005, FREE RADICAL BIO MED, V38, P969, DOI 10.1016/j.freeradbiomed.2004.12.031; dos Santos CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076857; Du WH, 2003, J AM CHEM SOC, V125, P8080, DOI 10.1021/ja034584r; Dzwolak W, 2005, FEBS LETT, V579, P6601, DOI 10.1016/j.febslet.2005.10.048; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079102; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; GEORGE P, 1952, BIOCHEM J, V52, P511, DOI 10.1042/bj0520511; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Gibney BR, 2000, BIOCHEMISTRY-US, V39, P11041, DOI 10.1021/bi000925r; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hardison R, 1998, J EXP BIOL, V201, P1099; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Isogai Y, 1999, BIOCHEMISTRY-US, V38, P7431, DOI 10.1021/bi983006y; KALYANARAMAN B, 1983, J BIOL CHEM, V258, P3855; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lardinois OM, 2001, J BIOL CHEM, V276, P23186, DOI 10.1074/jbc.M102084200; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Merx Marc W., 2001, FASEB Journal, V15, P1077; Mimura I, 2010, AM J PHYSIOL-RENAL, V299, pF1120, DOI 10.1152/ajprenal.00145.2010; Nienhuis AW, 1986, HEMOGLOBIN MOL GENET, V48, P731, DOI [10.1016/0092-8674(87)90069-9, DOI 10.1016/0092-8674(87)90069-9]; Oleksiewicz U, 2011, CELL MOL LIFE SCI, V68, P3869, DOI 10.1007/s00018-011-0764-9; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Singh S, 2014, P NATL ACAD SCI USA, V111, pE129, DOI 10.1073/pnas.1314962111; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Solomon EI, 2003, COMPREHENSIVE COORDI, V2, P339; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Tian SF, 2013, J BIOL CHEM, V288, P15988, DOI 10.1074/jbc.M112.428789; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Uno T, 2004, J BIOL CHEM, V279, P5886, DOI 10.1074/jbc.M311748200; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Wittenberg JB, 1992, BLOOD TISSUE OXYGEN, P59; Wu C, 2007, J AM CHEM SOC, V129, P1225, DOI 10.1021/ja0662772; Wu C, 2008, J MOL BIOL, V384, P718, DOI 10.1016/j.jmb.2008.09.062; Xinarianos G, 2006, HUM MOL GENET, V15, P2038, DOI 10.1093/hmg/ddl128; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Yu MA, 2011, BBA-BIOENERGETICS, V1807, P1295, DOI 10.1016/j.bbabio.2011.06.012; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zucchi MR, 2003, BIOCHEM J, V370, P671, DOI 10.1042/BJ20021521	79	8	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136554	10.1371/journal.pone.0136554	http://dx.doi.org/10.1371/journal.pone.0136554			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26312997	gold, Green Submitted, Green Published			2022-12-27	WOS:000360144000068
J	Muhammad, SA; Fatima, N; Syed, NIH; Wu, XG; Yang, XF; Chen, JY				Muhammad, Syed Aun; Fatima, Nighat; Syed, Nawazish-i-Husain; Wu, Xiaogang; Yang, X. Frank; Chen, Jake Y.			MicroRNA Expression Profiling of Human Respiratory Epithelium Affected by Invasive Candida Infection	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; LUNG; CELLS; PROLIFERATION; ASSOCIATION; MIR-15A	Invasive candidiasis is potentially life-threatening systemic fungal infection caused by Candida albicans (C. albicans). Candida enters the blood stream and disseminate throughout the body and it is often observed in hospitalized patients, immunocompromised individuals or those with chronic diseases. This infection is opportunistic and risk starts with the colonization of C. albicans on mucocutaneous surfaces and respiratory epithelium. MicroRNAs (miRNAs) are small non-coding RNAs which are involved in the regulation of virtually every cellular process. They regulate and control the levels of mRNA stability and post-transcriptional gene expression. Aberrant expression of miRNAs has been associated in many disease states, and miRNA-based therapies are in progress. In this study, we investigated possible variations of miRNA expression profiles of respiratory epithelial cells infected by invasive Candida species. For this purpose, respiratory epithelial tissues of infected individuals from hospital laboratory were accessed before their treatment. Invasive Candida infection was confirmed by isolation of Candia albicans from the blood cultures of the same infected individuals. The purity of epithelial tissues was assessed by flow cytometry (FACS-Calibur cytometer; BD Biosciences, Heidelberg, Germany) using statin antibody (S-44). TaqMan quantitative real-time PCR (in a TaqMan Low Density Array format) was used for miRNA expression profiling. MiRNAs investigated, the levels of expression of 55 miRNA were significantly altered in infected tissues. Some miRNAs showed dramatic increase (miR-16-1) or decrease of expression (miR-17-3p) as compared to control. Gene ontology enrichment analysis of these miRNA-targeted genes suggests that Candidal infection affect many important biological pathways. In summary, disturbance in miRNA expression levels indicated the change in cascade of pathological processes and the regulation of respiratory epithelial functions following invasive Candidal infection. These findings contribute to our understanding of host cell response to Candidal systemic infections.	[Muhammad, Syed Aun] Bahauddin Zakariya Univ BZU, Inst Mol Biol & Biotechnol, Multan, Pakistan; [Fatima, Nighat] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad 22060, Pakistan; [Syed, Nawazish-i-Husain] Univ Punjab, Univ Coll Pharm, Lahore, Pakistan; [Wu, Xiaogang] Inst Syst Biol, Seattle, WA USA; [Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Chen, Jake Y.] Indiana Univ Purdue Univ, Indiana Ctr Syst Biol & Personalized Med, Indianapolis, IN 46202 USA; [Chen, Jake Y.] Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46204 USA; [Chen, Jake Y.] Purdue Univ, Sch Sci, Dept Comp & Informat Sci, Indianapolis, IN USA; [Chen, Jake Y.] Wenzhou Med Univ, Inst Biopharmaceut Informat & Technol, Wenzhou, Zhejiang, Peoples R China	COMSATS University Islamabad (CUI); University of Punjab; Institute for Systems Biology (ISB); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Wenzhou Medical University	Muhammad, SA (corresponding author), Bahauddin Zakariya Univ BZU, Inst Mol Biol & Biotechnol, Multan, Pakistan.	aunmuhammad78@yahoo.com; jakechen@iupui.edu	Muhammad, Syed Aun/ABF-5369-2020	Chen, Jake/0000-0001-8829-7504	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001108] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barbato C., 2009, J BIOMED BIOTECHNOL, V2009, P1, DOI DOI 10.1155/2009/803069; Chen PJ, 2012, HEPATOLOGY, V56, P632, DOI 10.1002/hep.25695; Dolin Mandell GL, 2010, MANDELL DOUGLAS BENN, pChapter 250; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heguy A, 2007, PHYSIOL GENOMICS, V29, P139, DOI 10.1152/physiolgenomics.00167.2006; Horvath LL, 2003, J CLIN MICROBIOL, V41, P2629, DOI 10.1128/JCM.41.6.2629-2632.2003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Incoronato M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027722; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kilic A, 2011, J ALLERGY CLIN IMMUN, V128, P1058, DOI 10.1016/j.jaci.2011.06.017; Komabayashi Y, 2014, AM J HEMATOL, V89, P25, DOI 10.1002/ajh.23570; Kourkoumpetis T, 2010, VIRULENCE, V1, P359, DOI 10.4161/viru.1.5.12795; LASH LH, 1989, ANAL BIOCHEM, V182, P271, DOI 10.1016/0003-2697(89)90593-9; Lemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478; Lim CSY, 2011, INT J MED MICROBIOL, V301, P536, DOI 10.1016/j.ijmm.2010.12.002; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lu L, 2013, INT J BIOCHEM CELL B, V45, P2530, DOI 10.1016/j.biocel.2013.08.007; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Nana-Sinkam Serge Patrick, 2009, Expert Rev Respir Med, V3, P373, DOI 10.1586/ers.09.30; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SESTER U, 1989, EXP CELL RES, V182, P550, DOI 10.1016/0014-4827(89)90258-9; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Duan-bo, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P15, DOI 10.3760/cma.j.issn.0529-5807.2013.01.004; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Tafsiri E, 2015, TUMOR BIOL, V36, P1603, DOI 10.1007/s13277-014-2755-6; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh TJ, 1996, BARONS MED MICROBIOL; WILSON JS, 1986, CYTOMETRY, V7, P157, DOI 10.1002/cyto.990070206; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530	39	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136454	10.1371/journal.pone.0136454	http://dx.doi.org/10.1371/journal.pone.0136454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313489	Green Published, Green Submitted, gold			2022-12-27	WOS:000360144000060
J	van Dijk, CE; Hooiveld, M; Jentink, A; Isken, LD; Timen, A; Yzermans, CJ				van Dijk, Christel E.; Hooiveld, Mariette; Jentink, Anne; Isken, Leslie D.; Timen, Aura; Yzermans, C. Joris			Experiences of General Practitioners and Practice Assistants during the Influenza A (H1N1) Pandemic in the Netherlands: A Cross-Sectional Survey	PLOS ONE			English	Article							PRIMARY-CARE; MANAGEMENT	Objectives Since few pandemics have occurred since the Spanish influenza pandemic, we should learn from every (mild) pandemic that occurs. The objective of this study was to report on general practitioners' and practice assistants' acceptance of the chosen national policy, and experiences in the Netherlands during the influenza A(H1N1) pdm09 pandemic. Methods Data on experience and acceptance of the chosen national policy were obtained by structured questionnaires for general practitioners (n = 372) and practice assistants (n = 503) in April 2010. Results The primary policy chosen for general practice was not always accepted and complied with by general practitioners, although the communication (of changes) and collaboration with involved organisations were rated as positive. In particular, the advised personal protective measures were difficult to implement in daily work and thus not executed by 44% of general practitioners. Half of the general practitioners were not satisfied with the patient information provided by the government. The influenza A(H1N1) pandemic highly impacted on general practitioners' and practice assistants' workloads, which was not always deemed to be adequately compensated. Discussion Involvement of general practitioners in future infectious disease outbreaks is essential. This study addresses issues in the pandemic policy which might be critical in a more severe pandemic.	[van Dijk, Christel E.; Hooiveld, Mariette; Jentink, Anne; Yzermans, C. Joris] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Isken, Leslie D.; Timen, Aura] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Preparedness & Response Unit, Bilthoven, Netherlands	Netherlands Institute for Health Services Research; Netherlands National Institute for Public Health & the Environment	van Dijk, CE (corresponding author), Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands.	c.vandijk@nivel.nl	Timen, Aura/GLV-4130-2022		Dutch Research Foundation, ZonMw [125050003]	Dutch Research Foundation, ZonMw(Netherlands Organization for Health Research and Development)	This work was supported by a grant from the Dutch Research Foundation, ZonMw (nr. 125050003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan M., 2009, WORLD NOW START 2009; Corley A, 2010, INT J NURS STUD, V47, P577, DOI 10.1016/j.ijnurstu.2009.11.015; FitzGerald G, 2012, EMERG MED AUSTRALAS, V24, P159, DOI 10.1111/j.1742-6723.2011.01519.x; Gezondheidsraad, 2009, BRIEF VACC TEG PAND; Hingstman L, 2010, CIJF REG HUIS PEIL 2; Kunin M, 2013, AUST HEALTH REV, V37, P291, DOI 10.1071/AH12022; Landelijke Coordinatie Infectieziekte bestrijding RIVM, 2009, OP DEELDR INC INTR N; Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169; Nhan C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-115; Staes CJ, 2011, J PUBLIC HEALTH MAN, V17, P36, DOI 10.1097/PHH.0b013e3181ee9b29; Stein ML, 2010, CHRONOLOGISCH OVERZI; Van 't Klooster TM, 2010, EUROSURVEILLANCE, V15; Vinck L, 2011, EURO SURVEILL, V16; WHO, 2014, EBOL VIR DIS; Wong SYS, 2005, FAM PRACT, V22, P361, DOI 10.1093/fampra/cmi036; Zwar N, 2007, AUST NZ J PUBL HEAL, V31, P558, DOI 10.1111/j.1753-6405.2007.00143.x	16	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135666	10.1371/journal.pone.0135666	http://dx.doi.org/10.1371/journal.pone.0135666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313147	gold, Green Published, Green Submitted			2022-12-27	WOS:000360144000021
J	Lubega, M; Nakyaanjo, N; Nansubuga, S; Hiire, E; Kigozi, G; Nakigozi, G; Lutalo, T; Nalugoda, F; Serwadda, D; Gray, R; Wawer, M; Kennedy, C; Reynolds, SJ				Lubega, Muhamadi; Nakyaanjo, Neema; Nansubuga, Sumaya; Hiire, Edgar; Kigozi, Godfrey; Nakigozi, Gertrude; Lutalo, Tom; Nalugoda, Fred; Serwadda, David; Gray, Ronald; Wawer, Maria; Kennedy, Caitylin; Reynolds, Steven James			Risk Denial and Socio-Economic Factors Related to High HIV Transmission in a Fishing Community in Rakai, Uganda: A Qualitative Study	PLOS ONE			English	Article							LAKE VICTORIA; FOR-SEX; HIV/AIDS; PREVALENCE; PATTERNS; WOMEN	Background In Kasensero fishing community, home of the first recorded case of HIV in Uganda, HIV transmission is still very high with an incidence of 4.3 and 3.1 per 100 person-years in women and men, respectively, and an HIV prevalence of 44%, reaching up to 74% among female sex workers. We explored drivers for the high HIV transmission at Kasensero from the perspective of fishermen and other community members to inform future policy and preventive interventions. Methods 20 in-depth interviews including both HIV positive and HIV negative respondents, and 12 focus-group discussions involving a total of 92 respondents from the Kasensero fishing community were conducted during April-September 2014. Content analysis was performed to identify recurrent themes. Results The socio-economic risk factors for high HIV transmission in Kasensero fishing community cited were multiple and cross-cutting and categorized into the following themes: power of money, risk denial, environmental triggers and a predisposing lifestyle and alcoholism and drug abuse. Others were: peer pressure, poor housing and the search for financial support for both the men and women which made them vulnerable to HIV exposure and or risk behavior. Conclusions There is a need for context specific combination prevention interventions in Kasensero that includes the fisher folk and other influential community leaders. Such groups could be empowered with the knowledge and social mobilization skills to fight the negative and risky behaviors, perceptions, beliefs, misconceptions and submission attitudes to fate that exposes the community to high HIV transmission. There is also need for government/partners to ensure effective policy implementation, life jackets for all fishermen, improve the poor housing at the community so as to reduce overcrowding and other housing related predispositions to high HIV rates at the community. Work place AIDS-competence teams have been successfully used to address high HIV transmission in similar settings.	[Lubega, Muhamadi; Nakyaanjo, Neema; Hiire, Edgar; Kigozi, Godfrey; Nakigozi, Gertrude; Lutalo, Tom; Nalugoda, Fred; Serwadda, David; Gray, Ronald; Wawer, Maria; Reynolds, Steven James] Rakai Hlth Sci Program, Kalisizo, Uganda; [Lubega, Muhamadi] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, S-17177 Stockholm, Sweden; [Lubega, Muhamadi] Busoga Univ, Sch Grad Studies & Res, Iganga, Uganda; [Lubega, Muhamadi; Reynolds, Steven James] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Lubega, Muhamadi; Reynolds, Steven James] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Gray, Ronald; Wawer, Maria; Kennedy, Caitylin; Reynolds, Steven James] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Rakai Health Sciences Program; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lubega, M (corresponding author), Rakai Hlth Sci Program, Old Bukoba Rd,POB 279, Kalisizo, Uganda.	dlmuhamadi@yahoo.co.uk		Reynolds, Steven/0000-0002-5403-2759	National Institute of Allergy and Infectious Diseases [A1001040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institute of Allergy and Infectious Diseases, Grant number A1001040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2004, SCIENCE, V305, P1104; [Anonymous], 2011, WORLD AIDS DAY REP; Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Bene C, 2008, WORLD DEV, V36, P875, DOI 10.1016/j.worlddev.2007.05.010; Boyden E, 1997, MANUAL PARTICIPATORY; Choudhry V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-128; Dahlgren L., 2004, QUALITATIVE METHODOL, DOI 10.1016/j.socscimed.2003.10.033; Fleury J, 2006, AM J COMMUN PSYCHOL, V37, P129, DOI 10.1007/s10464-005-9002-7; Gordon, 2005, HIV AIDS FISHERIES S; Gordon CM, 2005, AIDS EDUC PREV, V17, P6, DOI 10.1521/aeap.17.2.6.58697; Holloway, 2008, A Z QUALITATIVE RES; ICAD, 2010, AIDS HOUS ISS; Isaacs M, 2008, MAINSTREAMING HIV AI, P1; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; KMCC, 2014, MOST RISK POP FISH C; Kwena Bukusi E, 2011, AFRICAN J AIDS RES, V11, P9; Lwenya Y, 2012, CASE LAKE VICTORIA K, V37, P566; Mazzeo, 2004, DYNAMICS HIV AIDS FI; Merten S, 2007, CULT HEALTH SEX, V9, P69, DOI 10.1080/13691050600965968; Ministry of Health Kampala Uganda, 2011, UG AIDS IND SURV AIS, P1; Mojola SA, 2011, SOC SCI MED, V72, P149, DOI 10.1016/j.socscimed.2010.11.006; Morse F., 1995, QUALITATIVE RES METH; Pickering H, 1997, INT J STD AIDS, V8, P495, DOI 10.1258/0956462971920640; Pickering H, 1997, Health Transit Rev, V7, P13; RHSP, 2013, ANN PREL REP; RHSP, 2013, RAK HLTH SCI PROGR W; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Seeley J, 2009, ANTHROPOL WORK REV, V30, P66, DOI 10.1111/j.1548-1417.2009.01022.x; Shubert G., 2013, EFFECTS INCARCERATIO; Stewart D., 2007, FOCUS GROUPS; Tanzarn N, 2013, DYNAMICS HIV AIDS SM; TRANG NQ, 2002, SEAFARERS HIV VULNER; UAC, 2012, GLOB AIDS RESP PROGR; UFFCA, 2013, UG FISH FISH CONS AS, P6; UFFCA, 2003, UFFCAS 5 YEAR STRAT; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, 2010, GLOB REP GLOB AIDS E; *UNAIDS, 2007, PRACT GUID INT HIV P; Wamsler DC, 2010, MAINSTREAMING HIV AI; WHO, 2012, TRENDS DET MAL CIRC; [No title captured]	44	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0132740	10.1371/journal.pone.0132740	http://dx.doi.org/10.1371/journal.pone.0132740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LO	26309179	Green Published, Green Submitted, gold			2022-12-27	WOS:000360069400005
J	Tu, YY; Zhang, ZQ; Li, DF; Li, H; Dong, JL; Wang, T				Tu, Yayi; Zhang, Zhenqian; Li, Daofeng; Li, Heng; Dong, Jiangli; Wang, Tao			Potato virus Y HC-Pro Reduces the ATPase Activity of NtMinD, Which Results in Enlarged Chloroplasts in HC-Pro Transgenic Tobacco	PLOS ONE			English	Article							HELPER COMPONENT-PROTEINASE; LONG-DISTANCE MOVEMENT; YELLOW-MOSAIC-VIRUS; PLASTID DIVISION; MULTIFUNCTIONAL PROTEIN; VIRAL PATHOGENICITY; HIGHER-PLANTS; FTSZ-RING; GENE; POTYVIRUS	Potato virus Y (PVY) is an important plant virus and causes great losses every year. Viral infection often leads to abnormal chloroplasts. The first step of chloroplast division is the formation of FtsZ ring (Z-ring), and the placement of Z-ring is coordinated by the Min system in both bacteria and plants. In our lab, the helper-component proteinase (HC-Pro) of PVY was previously found to interact with the chloroplast division protein NtMinD through a yeast two-hybrid screening assay and a bimolecular fluorescence complementation (BiFC) assay in vivo. Here, we further investigated the biological significance of the NtMinD/HC-Pro interaction. We purified the NtMinD and HC-Pro proteins using a prokaryotic protein purification system and tested the effect of HC-Pro on the ATPase activity of NtMinD in vitro. We found that the ATPase activity of NtMinD was reduced in the presence of HC-Pro. In addition, another important chloroplast division related protein, NtMinE, was cloned from the cDNA of Nicotiana tabacum. And the NtMinD/NtMinE interaction site was mapped to the C-terminus of NtMinD, which overlaps the NtMinD/HC-Pro interaction site. Yeast three-hybrid assay demonstrated that HC-Pro competes with NtMinE for binding to NtMinD. HC-Pro was previously reported to accumulate in the chloroplasts of PVY-infected tobacco and we confirmed this result in our present work. The NtMinD/NtMinE interaction is very important in the regulation of chloroplast division. To demonstrate the influence of HC-Pro on chloroplast division, we generated HC-Pro transgenic tobacco with a transit peptide to retarget HC-Pro to the chloroplasts. The HC-Pro transgenic plants showed enlarged chloroplasts. Our present study demonstrated that the interaction between HC-Pro and NtMinD interfered with the function of NtMinD in chloroplast division, which results in enlarged chloroplasts in HC-Pro transgenic tobacco. The HC-Pro/NtMinD interaction may cause the formation of abnormal chloroplasts in PVY-infected plants.	[Tu, Yayi; Zhang, Zhenqian; Li, Daofeng; Li, Heng; Dong, Jiangli; Wang, Tao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Wang, T (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	wangt@cau.edu.cn	Li, Daofeng/L-8143-2019; Li, Daofeng/E-5386-2011	Li, Daofeng/0000-0001-7492-3703; Li, Daofeng/0000-0001-7492-3703	National Natural Science Foundation of China [30830077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (30830077), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Aldridge C, 2005, J BIOL CHEM, V280, P31673, DOI 10.1074/jbc.M505126200; Aldridge C, 2005, J EXP BOT, V56, P1061, DOI 10.1093/jxb/eri118; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; ATREYA CD, 1993, P NATL ACAD SCI USA, V90, P11919, DOI 10.1073/pnas.90.24.11919; Balachandran S, 1997, PHYSIOL PLANTARUM, V100, P203, DOI 10.1034/j.1399-3054.1997.1000201.x; Boonrod K, 2011, BIOL CHEM, V392, P937, DOI 10.1515/BC.2011.097; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; CRONIN S, 1995, PLANT CELL, V7, P549, DOI 10.1105/tpc.7.5.549; Dinkins R, 2001, PLANTA, V214, P180, DOI 10.1007/s004250100605; Elena SF, 2012, CURR OPIN VIROL, V2, P719, DOI 10.1016/j.coviro.2012.09.004; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Fernandez-Calvino L, 2010, J GEN VIROL, V91, P2862, DOI 10.1099/vir.0.022335-0; Fujiwara MT, 2008, PLANT CELL PHYSIOL, V49, P345, DOI 10.1093/pcp/pcn012; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; GRAY MW, 1989, TRENDS GENET, V5, P294, DOI 10.1016/0168-9525(89)90111-X; GUNASINGHE UB, 1991, MOL PLANT MICROBE IN, V4, P452, DOI 10.1094/MPMI-4-452; Guo DY, 2003, MOL PLANT MICROBE IN, V16, P405, DOI 10.1094/MPMI.2003.16.5.405; Haikonen T, 2013, MOL PLANT MICROBE IN, V26, P721, DOI 10.1094/MPMI-01-13-0024-R; Haikonen T, 2013, MOL PLANT MICROBE IN, V26, P734, DOI 10.1094/MPMI-01-13-0023-R; Herbers K, 1997, PLANT J, V12, P1045, DOI 10.1046/j.1365-313X.1997.12051045.x; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Itoh Ryuuichi, 2001, Cytologia (Tokyo), V66, P427, DOI 10.1508/cytologia.66.427; Jin YS, 2007, J VIROL, V81, P12881, DOI 10.1128/JVI.00913-07; Jin YS, 2007, MOL PLANT MICROBE IN, V20, P1505, DOI 10.1094/MPMI-20-12-1505; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Maia IG, 1996, J GEN VIROL, V77, P1335, DOI 10.1099/0022-1317-77-7-1335; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; Maple J, 2007, ANN BOT-LONDON, V99, P565, DOI 10.1093/aob/mcl249; Miyagishima S, 2011, INT REV CEL MOL BIO, V291, P115, DOI 10.1016/B978-0-12-386035-4.00004-5; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; Peng YanHui, 2004, Acta Phytopathologica Sinica, V34, P32; Pompe-Novak M, 2001, PHYTON-ANN REI BOT A, V41, P215; Rahoutei J, 2000, PHYSIOL PLANTARUM, V110, P286, DOI 10.1034/j.1399-3054.2000.110220.x; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Ryslava H, 2003, PHOTOSYNTHETICA, V41, P357, DOI 10.1023/B:PHOT.0000015459.22769.bf; Saenz P, 2002, J VIROL, V76, P1922, DOI 10.1128/JVI.76.4.1922-1931.2002; Sahana N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052546; Sampol B, 2003, NEW PHYTOL, V160, P403, DOI 10.1046/j.1469-8137.2003.00882.x; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Shan CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6519; Shen WT, 2010, MOL PLANT PATHOL, V11, P335, DOI [10.1111/J.1364-3703.2009.0060.X, 10.1111/j.1364-3703.2009.00606.x]; TECSI LI, 1994, PLANT J, V5, P837, DOI 10.1046/j.1365-313X.1994.5060837.x; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Wu HW, 2010, MOL PLANT MICROBE IN, V23, P17, DOI 10.1094/MPMI-23-1-0017; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047	52	2	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2015	10	8							e0136210	10.1371/journal.pone.0136210	http://dx.doi.org/10.1371/journal.pone.0136210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LO	26309250	Green Published, gold, Green Submitted			2022-12-27	WOS:000360069400097
J	Yamamoto, M; Lopez, MT; Hart, LA				Yamamoto, Mariko; Lopez, Mayllynne T.; Hart, Lynette A.			Registrations of Assistance Dogs in California for Identification Tags: 1999-2012	PLOS ONE			English	Article							GUIDE DOGS; SERVICE; SUITABILITY; EVOLUTION; BEHAVIOR; FUTURE	Dogs are filling a growing number of roles supporting people with various disabilities, leading to a chaotic situation in the U.S. Although the federal laws allow public access with working dogs only for people with disabilities, no governmental enforcement or management system for such dogs exists. Furthermore, there is no substantive way to confirm whether the dog is an adequately trained assistance dog or not, as neither the handlers nor the dogs are required to carry any particular certification or identification. Therefore, unqualified assistance dogs and incidents such as dog bites by assistance dogs sometimes are problems in the U.S. A governmental oversight system could reduce problems, but no information is available about the current uses of assistance dogs in the U.S. We aimed to investigate the current demographics of registered assistance dogs and the evolving patterns in uses of dogs during 1999-2012 in California. We acquired data on assistance dogs registered by animal control facilities throughout California. We used descriptive statistics to describe the uses of these assistance dogs. The number of assistance dogs sharply increased, especially service dogs, in the past decade. Dogs with small body sizes, and new types of service dogs, such as service dogs for psychiatric and medical assistance, strongly contributed to the increase. The Assistance Dog Identification tags sometimes were mistakenly issued to dogs not fitting the definition of assistance dogs under the law, such as emotional support animals and some cats; this reveals errors in the California governmental registering system. Seemingly inappropriate dogs also were registered, such as those registered for the first time at older than 10 years of age. This study reveals a prevalence of misuse and misunderstanding of regulations and legislation on assistance dogs in California.	[Yamamoto, Mariko; Lopez, Mayllynne T.; Hart, Lynette A.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis	Yamamoto, M (corresponding author), Teikyo Univ Sci, Dept Anim Sci, Yamanashi, Japan.	yamamoto-mariko@ntu.ac.jp	Hart, Lynette/L-4833-2019; Ogura, Yasuhiro/A-2557-2016; Nagao, Miki/ABG-8561-2021	Hart, Lynette/0000-0002-7133-6535; Ogura, Yasuhiro/0000-0001-5768-6160; Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Yamamoto, Masaki/0000-0002-7822-3269				Adams B, 2000, BEHAV BRAIN RES, V108, P47, DOI 10.1016/S0166-4328(99)00132-1; American Kennel Club, 2014, DOG BREEDS; American Veterinary Medical Association, 2012, US PET OWN STAT; Assistance Dogs International, 2014, DOG BREEDS BEH; Assistance Dogs International, 2014, GUID DOGS; Assistance Dogs International, 2014, TYP ASS DOGS; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Bergeron R, 2002, CAN J VET RES, V66, P211; Burrows KE, 2008, J APPL ANIM WELF SCI, V11, P42, DOI 10.1080/10888700701555550; Canine Companions for Independence, 2009, WHAT HAPP RET LOSS A; Clutton-Brock Juliet, 1995, P7; Cobb M, 2015, BEHAV PROCESS, V110, P96, DOI 10.1016/j.beproc.2014.10.012; Coppinger R, 1998, J Appl Anim Welf Sci, V1, P133, DOI 10.1207/s15327604jaws0102_4; Davis BW, 2004, ANTHROZOOS, V17, P130, DOI 10.2752/089279304786991765; DogsBite.org, 2012, 2012 DOG BIT FAT STA; Ennik I, 2006, J VET BEHAV, V1, P67, DOI 10.1016/j.jveb.2006.06.004; Fairman S K, 2001, Occup Ther Health Care, V13, P41, DOI 10.1080/J003v13n02_03; Fishman GA, 2003, SURV OPHTHALMOL, V48, P452, DOI 10.1016/S0039-6257(03)00052-3; Guide Dogs for the Blind Association, 2014, REH GUID DOG; Hart BL, 1988, PERFECT PUPPY CHOOSE, P40; Hart LA, 1996, APPL ANIM BEHAV SCI, V47, P7, DOI 10.1016/0168-1591(95)01006-8; Hawks E, 1975, EVENING SUN      DEC; Hoffman CL, 2014, J APPL ANIM WELF SCI, V17, P322, DOI 10.1080/10888705.2014.895904; KNOL BW, 1988, VET QUART, V10, P198, DOI 10.1080/01652176.1988.9694171; Meyers DM, 2014, YAKIMAHERALD; Ministry of Health Labour and Welfare, 2002, ACT ASS DOGS PHYS DI; MOREY DF, 1994, AM SCI, V82, P336; Parenti L, 2013, J REHABIL RES DEV, V50, P745, DOI 10.1682/JRRD.2012.11.0216; Rintala DH, 2002, SCI PSYCHOSOC PROCES, V15, p[65, 70]; Tapp PD, 2003, LEARN MEMORY, V10, P64, DOI 10.1101/lm.54403; VALENTINE DP, 1993, SOC WORK HEALTH CARE, V19, P109, DOI 10.1300/J010v19n01_07; Weiss E, 1997, APPL ANIM BEHAV SCI, V53, P297, DOI 10.1016/S0168-1591(96)01176-8; Whitmarsh L., 2005, VISUAL IMPAIRMENT RE, V7, P27, DOI [DOI 10.1080/13882350590956439, 10.1080/13882350590956439]	33	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0132820	10.1371/journal.pone.0132820	http://dx.doi.org/10.1371/journal.pone.0132820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26322891	Green Published, gold			2022-12-27	WOS:000360018600004
J	Yamamoto, M; Takakura, S; Iinuma, Y; Hotta, G; Matsumura, Y; Matsushima, A; Nagao, M; Ogawa, K; Fujimoto, Y; Mori, A; Ogura, Y; Kaido, T; Uemoto, S; Ichiyama, S				Yamamoto, Masaki; Takakura, Shunji; Iinuma, Yoshitsugu; Hotta, Go; Matsumura, Yasufumi; Matsushima, Aki; Nagao, Miki; Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Ogura, Yasuhiro; Kaido, Toshimi; Uemoto, Shinji; Ichiyama, Satoshi			Changes in Surgical Site Infections after Living Donor Liver Transplantation	PLOS ONE			English	Article							RISK-FACTORS; COMPLICATIONS; PREVENTION; RECIPIENTS; ASSOCIATION; PROPHYLAXIS; SPECTRUM	Surgical site infections (SSIs) are a major threat for liver transplant recipients. We prospectively studied SSIs after living donor liver transplantation (LDLT) at Kyoto University Hospital from April 2001 to March 2002 (1st period) and from January 2011 to June 2012 (2nd period). We investigated the epidemiology of SSIs after LDLT and determined the differences between the two periods. A total of 129 adult recipients (66 during the 1st period and 63 during the 2nd period) and 72 pediatric recipients (39 and 33) were included in this study. The SSI rates for each period were 30.3% (1st period) and 41.3% (2nd period) among the adult recipients and 25.6% and 30.3% among the pediatric recipients. The overall rates of 30-day mortality among adult transplant recipients with SSIs were 10.0% (1st period) and 3.9% (2nd period). No pediatric recipient died from SSIs after LDLT in either period. The incidence of Enterococcus faecium increased from 5.0% to 26.9% in the adults and from 10.0% to 40.0% in the pediatric patients. Extended-spectrum beta-lactamase-producing Enterobacteriaceae were emerging important isolates during the 2nd period. For this period, a univariate analysis showed that ABO incompatibility (P=0.02), total operation duration (P=0.01), graft-to-recipient body weight ratio (GRWR [P=0.04]), and Roux-en-Y biliary reconstruction (P<0.01) in the adults and age (P=0.01) and NHSN risk index (P=0.02) in the children were associated with SSI development. In a multivariate analysis, lower GRWR (P=0.02) and Roux-en-Y biliary reconstruction (P<0.01) in the adults and older age (P=0.01) in the children were independent risk factors for SSIs during the 2nd period. In conclusion, SSIs caused by antibiotic resistant bacteria may become a major concern. Lower GRWR and Roux-en-Y biliary reconstruction among adult LDLT recipients and older age among pediatric LDLT recipients increased the risk of developing SSIs after LDLT.	[Yamamoto, Masaki; Takakura, Shunji; Hotta, Go; Matsumura, Yasufumi; Matsushima, Aki; Nagao, Miki; Ichiyama, Satoshi] Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Kyoto, Japan; [Iinuma, Yoshitsugu] Kanazawa Med Univ, Dept Infect Dis, Kanazawa, Ishikawa, Japan; [Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Ogura, Yasuhiro] Nagoya Univ Hosp, Dept Transplantat Surg, Nagoya, Aichi, Japan	Kyoto University; Kanazawa Medical University; Kyoto University; Nagoya University	Takakura, S (corresponding author), Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Kyoto, Japan.	stakakr@kuhp.kyoto-u.ac.jp	Hart, Lynette/L-4833-2019; Ogura, Yasuhiro/A-2557-2016; Nagao, Miki/ABG-8561-2021	Hart, Lynette/0000-0002-7133-6535; Ogura, Yasuhiro/0000-0001-5768-6160; Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Yamamoto, Masaki/0000-0002-7822-3269	Ministry of Health, Labor and Welfare of Japan [H21-Shinko-Ippan-009, H23-Shinko-Ippan-018]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (H21-Shinko-Ippan-009 and H23-Shinko-Ippan-018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio A, 2008, LIVER TRANSPLANT, V14, P799, DOI 10.1002/lt.21435; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; COLONNA JO, 1988, ARCH SURG-CHICAGO, V123, P360; de Villa VH, 2003, TRANSPLANTATION, V75, pS2, DOI 10.1097/01.TP.0000046532.44975.57; Prado MEG, 2008, TRANSPLANTATION, V85, P1849, DOI 10.1097/TP.0b013e3181735407; Hashimoto M, 2009, TRANSPL INFECT DIS, V11, P11, DOI 10.1111/j.1399-3062.2008.00341.x; Hellinger WC, 2011, AM J TRANSPLANT, V11, P1877, DOI 10.1111/j.1600-6143.2011.03644.x; Hellinger WC, 2009, TRANSPLANTATION, V87, P1387, DOI 10.1097/TP.0b013e3181a25133; Iinuma Y, 2004, TRANSPLANTATION, V78, P704, DOI 10.1097/01.TP.0000130178.17216.28; Kaido T, 2012, WORLD J SURG, V36, P1666, DOI 10.1007/s00268-012-1529-9; Lee SO, 2011, LIVER TRANSPLANT, V17, P733, DOI 10.1002/lt.22296; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Matsuo K, 2004, TRANSPLANT P, V36, P2299, DOI 10.1016/j.transproceed.2004.08.043; Mrzljak A, 2010, LIVER TRANSPLANT, V16, P1217, DOI 10.1002/lt.22137; Muiesan P, 2007, J HEPATOL, V46, P340, DOI 10.1016/j.jhep.2006.11.006; Nafady-Hego H, 2011, LIVER TRANSPLANT, V17, P976, DOI 10.1002/lt.22278; OZAKI CF, 1994, SURG CLIN N AM, V74, P1155, DOI 10.1016/S0039-6109(16)46438-8; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; PAYA CV, 1989, EUR J CLIN MICROBIOL, V8, P499, DOI 10.1007/BF01967467; Pungpapong S, 2006, LIVER TRANSPLANT, V12, P1244, DOI 10.1002/lt.20801; Reid GE, 2009, TRANSPLANTATION, V87, P1706, DOI 10.1097/TP.0b013e3181a60338; Shah H, 2014, LIVER TRANSPLANT, V20, P930, DOI 10.1002/lt.23890; SINGH N, 1994, TRANSPLANTATION, V58, P774, DOI 10.1097/00007890-199410150-00004; Vandecasteele E, 2010, TRANSPL INT, V23, P182, DOI 10.1111/j.1432-2277.2009.00974.x	26	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136559	10.1371/journal.pone.0136559	http://dx.doi.org/10.1371/journal.pone.0136559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322891	Green Published, gold, Green Submitted			2022-12-27	WOS:000360435500020
